data_1lm0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1lm0 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.456 -0.155 0 N-CA-C 109.515 -0.55 . . . . 3.13 109.515 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -99.03 126.06 44.65 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.108 1.363 . . . . 3.69 110.511 -172.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -133.27 153.98 51.09 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.148 1.379 . . . . 3.83 111.565 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.9 m -73.81 131.31 81.94 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.768 1.627 . . . . 3.17 111.307 -177.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -56.04 -52.04 8.21 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.358 2.705 . . . . 0.87 112.598 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.6 m -53.97 -35.89 62.29 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.831 0.852 . . . . 4.11 112.382 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -62.57 -58.32 7.96 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.434 -0.58 . . . . 2.09 109.434 173.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.4 pt -71.76 33.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 114.416 1.265 . . . . 2.4 114.416 -177.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.6 t -111.99 -76.41 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 105.579 -2.008 . . . . 3.64 105.579 161.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -64.38 101.3 0.42 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 126.633 1.973 . . . . 2.66 111.328 -162.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.74 40.1 53.81 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.086 -1.206 . . . . 2.43 110.086 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -139.79 -105.3 0.16 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.279 1.431 . . . . 3.99 107.815 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.8 t -72.28 -53.84 11.28 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 120.0 1.273 . . . . 4.66 109.49 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.27 -48.69 24.63 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 124.902 1.281 . . . . 3.08 109.507 -174.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.92 -5.09 42.24 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.137 -1.392 . . . . 2.47 111.069 -173.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 48.15 47.44 26.97 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 126.362 1.934 . . . . 1.32 114.371 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.7 m -98.64 -52.75 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 118.967 1.384 . . . . 2.12 113.696 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt -101.73 -68.72 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 124.0 0.92 . . . . 3.82 112.117 -173.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -71.75 177.08 7.35 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 121.876 1.718 . . . . 1.53 108.56 167.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -155.3 158.48 38.84 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.822 -1.547 . . . . 3.55 106.822 -175.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.32 125.02 24.79 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.696 -1.224 . . . . 1.88 107.696 174.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 138.67 -36.82 1.85 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 123.911 0.767 . . . . 1.9 111.343 -172.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.93 143.52 29.8 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.086 0.943 . . . . 2.86 110.617 -175.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -92.23 129.5 38.16 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.163 0.985 . . . . 6.67 108.632 172.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.7 pt -140.43 177.95 3.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 107.495 -1.298 . . . . 1.95 107.495 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -121.13 123.02 41.29 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.241 -0.652 . . . . 3.78 109.241 170.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.15 133.4 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 106.916 -1.513 . . . . 1.93 106.916 171.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -137.57 120.43 2.06 Favored Glycine 0 CA--C 1.519 0.335 0 N-CA-C 109.422 -1.471 . . . . 0.54 109.422 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -179.02 -169.36 39.49 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.243 -1.143 . . . . 0.67 110.243 -173.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.9 ptp -102.01 133.16 47.26 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.095 0.558 . . . . 3.32 111.076 -173.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.7 p -85.03 134.43 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.856 -0.794 . . . . 3.41 108.856 175.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.5 150.0 29.81 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 122.194 0.997 . . . . 2.63 108.775 176.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.0 p -48.68 -46.87 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.286 1.034 . . . . 2.6 112.003 -175.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.87 21.85 42.63 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 119.283 -0.731 . . . . 1.66 113.217 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.7 m -81.96 -36.05 28.38 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.92 1.36 . . . . 2.02 113.179 -175.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.1 tmm? -75.96 125.48 29.19 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.595 -0.52 . . . . 2.82 109.595 -169.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.0 m -134.34 123.91 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.912 -0.773 . . . . 1.95 108.912 170.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 36.0 ptt85 -100.7 152.79 20.04 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.382 1.073 . . . . 6.56 109.8 175.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -77.16 159.38 78.21 Favored Pre-proline 0 C--O 1.238 0.47 0 N-CA-C 109.439 -0.578 . . . . 2.19 109.439 167.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -63.89 -26.73 67.04 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.134 2.556 . . . . 1.39 111.009 165.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -40.91 -44.91 2.42 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 124.409 1.084 . . . . 1.16 109.47 165.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.8 m 73.86 12.17 4.41 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.324 1.45 . . . . 1.59 113.041 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.25 -30.83 6.18 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.5 1.52 . . . . 2.97 110.866 168.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -93.45 132.16 37.98 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.599 -1.259 . . . . 1.37 107.599 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.78 141.49 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 107.868 -1.16 . . . . 1.84 107.868 -174.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -144.34 154.03 42.6 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.654 -0.869 . . . . 1.03 108.654 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -146.81 142.96 28.25 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.806 -0.634 . . . . 3.52 109.723 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.05 144.86 27.34 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.657 -0.868 . . . . 1.7 108.657 168.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.88 145.02 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 108.973 -0.751 . . . . 2.93 108.973 177.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.5 p80 -142.71 -177.34 5.26 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.626 0.77 . . . . 1.76 111.012 -169.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.9 t70 . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 108.339 -0.986 . . . . 2.35 108.339 173.622 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 106.252 -2.739 . . . . 2.17 106.252 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -120.48 129.54 53.9 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.348 -1.353 . . . . 3.23 107.348 -177.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.18 137.98 42.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 106.664 -1.606 . . . . 2.35 106.664 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 mt -90.38 133.2 35.15 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.467 0.707 . . . . 1.81 109.451 176.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.6 t -119.28 135.51 59.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 125.168 1.387 . . . . 1.98 107.695 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.6 p -112.25 146.68 37.75 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.647 0.779 . . . . 1.46 109.414 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -146.02 136.39 23.93 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.891 1.276 . . . . 3.12 108.267 -171.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -125.18 37.17 4.44 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.821 1.248 . . . . 2.02 112.667 -164.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -158.9 179.44 9.08 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.402 1.881 . . . . 2.87 106.245 167.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.3 mp -67.91 128.96 38.45 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 120.708 -1.245 . . . . 2.23 110.75 177.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.9 mt -71.1 148.56 94.26 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 123.481 0.712 . . . . 2.1 110.836 176.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -62.44 139.16 75.09 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.003 2.469 . . . . 2.43 109.173 173.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 50.58 29.01 3.77 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.581 1.152 . . . . 3.28 112.119 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 36.8 tp 59.99 6.79 1.0 Allowed 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.043 -1.036 . . . . 4.06 112.359 -174.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.9 t80 59.24 88.67 0.07 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.714 1.606 . . . . 4.71 109.97 -170.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -73.86 136.97 43.47 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 106.776 -1.564 . . . . 5.94 106.776 -174.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.2 mp0 -84.33 168.62 15.46 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 123.165 0.586 . . . . 3.03 110.052 -171.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 62.06 47.04 92.63 Favored Glycine 0 CA--C 1.531 1.084 0 O-C-N 121.925 -0.484 . . . . 0.85 112.916 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -146.67 177.74 8.85 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.873 1.269 . . . . 3.06 108.644 171.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -117.92 116.63 3.51 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.268 -0.733 . . . . 1.05 111.268 177.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.2 pp -117.95 168.62 9.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 125.45 1.5 . . . . 2.16 108.557 -174.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 30.8 m -117.09 139.89 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 108.165 -1.05 . . . . 1.88 108.165 166.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -126.03 126.13 43.77 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.132 1.373 . . . . 1.79 108.569 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -98.91 133.97 42.44 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.872 -1.159 . . . . 3.36 107.872 175.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -162.34 170.81 38.06 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 110.812 -0.915 . . . . 2.17 110.812 -175.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.4 p -111.87 136.95 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 108.315 -0.994 . . . . 2.21 108.315 173.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.4 mp -72.1 125.09 26.4 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.073 -1.084 . . . . 3.51 108.073 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -140.77 -28.52 0.19 Allowed Glycine 0 CA--C 1.526 0.746 0 CA-C-O 119.501 -0.611 . . . . 2.22 113.336 -169.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -115.86 49.27 1.12 Allowed 'General case' 0 C--O 1.239 0.525 0 CA-C-N 118.446 1.123 . . . . 5.99 108.148 -164.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 40.9 t0 12.16 70.01 0.01 OUTLIER 'General case' 0 C--N 1.341 0.205 0 C-N-CA 130.144 3.378 . . . . 3.01 112.161 -177.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 134.52 -36.15 2.12 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 114.574 -1.194 . . . . 1.04 112.097 -172.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.41 155.32 22.35 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 118.178 0.989 . . . . 4.07 109.203 174.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.78 130.6 56.82 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 124.648 1.218 . . . . 3.07 108.074 -175.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -92.08 111.73 23.39 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.505 -1.294 . . . . 1.87 107.505 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -126.81 132.62 50.97 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 123.795 0.838 . . . . 1.7 109.525 -176.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.3 t -122.05 -20.52 6.26 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.35 0.66 . . . . 1.66 112.114 175.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -96.31 82.74 3.46 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 120.488 -1.383 . . . . 3.73 107.727 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 31.8 m -97.53 125.72 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.281 0.632 . . . . 1.86 110.324 173.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -114.78 102.36 9.93 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.742 -1.207 . . . . 1.71 107.742 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.05 56.37 3.46 Favored 'General case' 0 CA--C 1.53 0.212 0 O-C-N 121.76 -0.587 . . . . 1.89 110.908 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.87 55.39 0.69 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 122.98 0.512 . . . . 5.73 111.251 175.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 3.0 p80 . . . . . 0 C--O 1.228 -0.067 0 O-C-N 121.241 -0.912 . . . . 8.16 109.875 -178.711 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.199 0 CA-C-O 120.375 0.131 . . . . 4.27 110.717 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -88.37 115.53 25.94 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.147 0.979 . . . . 3.93 109.261 -177.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -120.82 155.61 33.7 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.608 1.163 . . . . 4.32 109.503 175.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.8 p -85.57 146.85 45.13 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 123.787 0.835 . . . . 2.67 110.25 174.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -59.96 -44.23 31.51 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.369 2.713 . . . . 0.82 111.85 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 p -39.29 -57.39 1.37 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.548 1.539 . . . . 3.03 111.369 174.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.423 ' OE2' ' NZ ' ' A' ' 47' ' ' LYS . 2.4 tt0 -58.09 -54.51 46.19 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.294 -0.866 . . . . 2.26 110.1 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.339 26.4 pt -65.28 -12.05 12.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 114.701 1.371 . . . . 1.94 114.701 -173.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 82.1 t -75.79 -38.28 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 123.596 0.758 . . . . 2.93 111.217 166.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -106.7 92.63 4.18 Favored 'General case' 0 C--N 1.335 -0.06 0 O-C-N 120.999 -1.063 . . . . 2.17 111.121 -160.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.81 47.02 58.03 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.907 -1.277 . . . . 1.93 109.907 174.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.423 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 12.1 mmtp -156.49 -155.39 0.53 Allowed 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 128.849 2.859 . . . . 2.85 105.822 -172.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.2 m -37.07 -55.57 0.94 Allowed 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 127.389 2.276 . . . . 2.58 114.319 -174.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -38.48 -46.86 1.21 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.214 0.916 . . . . 2.41 112.626 176.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.24 -4.29 25.96 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.495 1.118 . . . . 3.05 111.387 -173.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 54.64 30.23 50.73 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.644 1.592 . . . . 0.98 113.815 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.7 m -86.1 -29.52 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 118.585 1.193 . . . . 2.18 113.124 -172.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -121.41 -71.94 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 124.161 0.984 . . . . 6.84 112.084 -176.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -66.08 128.63 19.99 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 N-CA-C 107.472 -1.78 . . . . 1.15 107.472 167.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.09 168.8 17.37 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.761 -0.829 . . . . 3.56 108.761 169.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.48 175.94 6.55 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.691 -0.855 . . . . 2.16 108.691 163.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.99 -87.75 0.47 Allowed Glycine 0 C--O 1.22 -0.749 1 N-CA-C 100.346 -5.102 . . . . 3.29 100.346 -150.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -98.93 169.99 9.05 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 105.619 -1.993 . . . . 1.78 105.619 -81.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -84.72 122.13 28.66 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 118.025 -0.988 . . . . 4.02 108.69 176.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.6 pt -148.91 175.63 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 107.195 -1.409 . . . . 1.73 107.195 171.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -121.02 127.58 51.89 Favored 'General case' 0 CA--C 1.527 0.06 0 N-CA-C 108.824 -0.806 . . . . 2.38 108.824 168.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.2 p -93.46 123.92 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 107.523 -1.288 . . . . 1.85 107.523 170.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -124.16 123.57 5.2 Favored Glycine 0 C--N 1.332 0.354 0 N-CA-C 109.862 -1.295 . . . . 0.52 109.862 -177.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -174.75 -171.22 38.71 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 110.379 -1.088 . . . . 0.61 110.379 -176.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 6.3 ptp -94.35 135.0 36.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.125 -0.695 . . . . 3.38 109.125 177.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.9 t -59.76 133.86 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 123.229 0.612 . . . . 2.94 110.27 177.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.88 -9.49 55.05 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.16 1.17 . . . . 3.56 114.16 -172.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.28 9.1 p 50.43 47.62 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 123.917 1.818 . . . . 4.13 112.551 175.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 178.98 40.48 0.07 OUTLIER Glycine 0 CA--C 1.527 0.811 0 CA-C-N 112.429 -2.169 . . . . 2.97 111.919 169.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.4 m -150.41 1.92 0.47 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.89 1.441 . . . . 2.47 114.89 175.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.0 tpt -72.69 97.15 2.13 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.922 1.237 . . . . 2.66 108.347 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.9 m -116.69 140.45 39.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.533 -0.914 . . . . 1.69 108.533 174.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.22 149.86 50.84 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.268 1.027 . . . . 5.85 109.225 -176.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -75.86 153.92 85.01 Favored Pre-proline 0 N--CA 1.454 -0.23 0 N-CA-C 109.789 -0.449 . . . . 2.23 109.789 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -62.52 -25.56 75.78 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.303 2.002 . . . . 1.42 111.055 165.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -44.27 -37.03 3.01 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.824 0.85 . . . . 1.41 110.626 165.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.6 m 72.5 24.17 2.95 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.62 1.568 . . . . 1.62 112.489 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.47 -48.25 2.07 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 125.506 1.522 . . . . 3.22 110.366 169.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -75.41 130.21 38.6 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.774 -0.825 . . . . 1.64 108.774 -177.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.6 m -142.44 131.04 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 125.191 1.397 . . . . 1.83 107.308 -176.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -139.0 146.57 41.05 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 121.806 -0.559 . . . . 1.03 109.537 177.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -149.46 160.61 43.31 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.117 0.567 . . . . 3.15 109.782 -168.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -115.52 138.55 50.92 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.42 -0.585 . . . . 1.69 109.42 174.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.9 p -127.3 137.78 56.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.202 -1.036 . . . . 2.89 108.202 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -130.68 174.26 10.1 Favored 'General case' 0 CA--C 1.522 -0.122 0 C-N-CA 124.46 1.104 . . . . 2.0 110.309 -175.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.2 t0 . . . . . 0 CA--C 1.534 0.339 0 C-N-CA 123.321 0.649 . . . . 2.74 109.926 -179.164 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.544 0 N-CA-C 108.299 -1.92 . . . . 2.58 108.299 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -120.88 151.32 39.81 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.731 1.212 . . . . 3.11 109.219 174.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.22 160.01 12.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 107.702 -1.221 . . . . 1.89 107.702 173.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.2 mt -118.2 124.42 47.88 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.133 0.973 . . . . 1.96 108.729 -172.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.7 t -114.0 138.41 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 125.609 1.564 . . . . 1.91 108.16 -173.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.7 p -112.54 155.07 24.96 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.642 1.177 . . . . 1.87 108.603 173.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -151.84 132.5 13.98 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.447 -1.686 . . . . 4.32 106.447 175.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -104.15 1.04 30.28 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.175 1.39 . . . . 2.7 113.121 -173.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -120.38 166.85 12.98 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 124.931 1.293 . . . . 3.02 108.79 167.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.8 mp -63.06 144.37 56.96 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.765 0.793 . . . . 2.01 111.2 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.3 mt -72.25 162.28 74.56 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 124.562 1.145 . . . . 2.35 110.146 171.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.21 -95.34 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.853 3.036 . . . . 2.19 109.333 173.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -76.15 44.95 0.34 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.524 1.13 . . . . 3.0 111.061 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.4 tp 60.82 -11.12 0.05 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.856 1.663 . . . . 4.07 114.87 -177.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 44.7 t80 64.57 88.36 0.1 Allowed 'General case' 0 C--N 1.343 0.288 0 C-N-CA 125.157 1.383 . . . . 4.25 107.958 -161.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.62 134.34 38.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.782 -1.562 . . . . 4.75 106.782 175.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.5 mp0 -82.05 147.89 28.89 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 123.559 0.744 . . . . 2.78 109.729 -171.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.89 47.82 23.7 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 111.671 -0.571 . . . . 0.79 111.671 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -138.16 178.37 7.18 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 107.056 -1.461 . . . . 2.88 107.056 168.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -105.29 134.19 11.94 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.909 -0.876 . . . . 1.18 110.909 171.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.82 160.01 37.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 108.673 -0.862 . . . . 1.81 108.673 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.8 m -116.91 120.54 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 107.873 -1.158 . . . . 1.84 107.873 170.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -113.77 115.85 28.45 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.762 1.225 . . . . 1.5 109.385 -173.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -116.29 140.58 49.18 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.475 1.11 . . . . 3.61 109.809 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -170.35 -104.87 0.18 Allowed Glycine 0 C--N 1.335 0.504 0 N-CA-C 107.408 -2.277 . . . . 1.42 107.408 166.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.5 p -156.12 148.47 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 107.339 -1.356 . . . . 2.17 107.339 176.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.29 150.42 43.28 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 119.028 -1.069 . . . . 3.44 109.986 175.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -105.79 -92.03 2.25 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 110.514 -1.034 . . . . 2.25 110.514 -171.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -73.42 -68.81 0.47 Allowed 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.887 -1.523 . . . . 4.63 106.887 175.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -163.12 -71.18 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.211 -1.403 . . . . 4.72 107.211 164.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.47 -23.57 72.0 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.347 0.975 . . . . 1.5 113.184 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -95.58 119.89 34.87 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.221 1.011 . . . . 3.61 108.706 173.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.66 131.22 45.01 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 108.955 -0.757 . . . . 3.5 108.955 -176.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -89.98 93.74 9.52 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 107.784 -1.191 . . . . 1.88 107.784 177.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -99.97 151.76 20.97 Favored 'General case' 0 C--N 1.337 0.065 0 CA-C-N 117.856 0.298 . . . . 1.87 110.319 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.7 t -140.12 -44.42 0.42 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 122.933 0.493 . . . . 2.18 111.66 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -82.4 84.43 7.16 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.032 -1.47 . . . . 2.91 107.032 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.0 m -96.58 94.73 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.834 1.654 . . . . 1.9 110.274 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.57 121.64 35.19 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.81 -0.811 . . . . 1.74 108.81 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.16 62.54 1.81 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.189 0.996 . . . . 1.63 111.41 -174.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.42 -24.14 59.29 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.417 0.895 . . . . 4.97 113.417 -172.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 . . . . . 0 CA--C 1.539 0.539 0 CA-C-O 119.073 -0.489 . . . . 5.78 112.129 178.73 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 N--CA 1.466 0.341 0 N-CA-C 112.087 0.403 . . . . 3.34 112.087 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -84.25 120.54 26.35 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 124.467 1.107 . . . . 3.52 109.729 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.92 156.96 41.8 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.607 0.763 . . . . 3.56 112.378 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 m -86.6 124.46 69.46 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 126.074 1.75 . . . . 3.57 112.811 -167.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . 2.256 0.1 OUTLIER -6.37 -72.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.151 1 C-N-CA 128.016 5.811 . . . . 2.89 118.345 161.31 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.5 m -70.5 -29.4 65.91 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 113.996 -1.456 . . . . 3.48 113.186 -173.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -62.57 -56.44 17.86 Favored 'General case' 0 C--N 1.335 -0.041 0 N-CA-C 108.898 -0.779 . . . . 3.13 108.898 -177.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 33.1 pt -59.39 -16.15 9.43 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 114.265 1.209 . . . . 2.46 114.265 -174.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.6 t -73.19 -38.39 54.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 124.759 1.224 . . . . 2.99 111.071 172.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -104.7 85.89 2.39 Favored 'General case' 0 C--N 1.333 -0.118 0 O-C-N 121.127 -0.983 . . . . 2.03 110.783 -159.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.17 51.38 18.18 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.138 -1.185 . . . . 1.99 110.138 174.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.9 mmtt -150.18 -124.15 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.423 -1.325 . . . . 3.46 107.423 -171.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.1 m -59.19 -58.45 8.59 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.929 1.292 . . . . 2.62 110.414 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -36.81 -51.84 0.9 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 122.709 1.242 . . . . 3.23 111.12 178.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.83 -11.95 37.81 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 113.577 -1.647 . . . . 1.96 111.328 -169.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 54.26 35.37 55.15 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 126.197 1.856 . . . . 1.18 112.649 -177.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.8 m -92.92 -22.4 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 118.032 0.916 . . . . 2.03 112.715 -174.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.5 mmpp? -124.36 -78.93 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 125.343 1.457 . . . . 5.34 111.11 174.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.22 149.47 35.85 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 CA-C-N 120.95 1.375 . . . . 1.12 109.375 173.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -112.92 156.46 22.94 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.309 1.844 . . . . 2.68 108.675 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.35 160.98 2.77 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.595 0.712 . . . . 2.37 110.958 168.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.77 -12.7 62.83 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 121.705 -0.622 . . . . 1.41 112.385 -176.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -82.57 154.69 24.87 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 118.436 1.118 . . . . 2.7 109.325 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 74.2 mtt-85 -96.06 132.48 41.38 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.45 -0.944 . . . . 6.11 108.45 170.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.6 pt -145.97 177.47 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 105.839 -1.912 . . . . 1.8 105.839 165.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 -117.27 135.37 53.87 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 105.973 -1.862 . . . . 2.48 105.973 173.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.4 p -103.84 136.26 37.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 107.361 -1.348 . . . . 2.71 107.361 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.82 120.16 1.59 Allowed Glycine 0 C--N 1.334 0.422 0 N-CA-C 110.777 -0.929 . . . . 0.63 110.777 -176.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -172.15 -163.12 25.51 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 109.309 -1.516 . . . . 0.68 109.309 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.2 ptm -102.87 135.0 45.35 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.54 0.736 . . . . 5.27 109.511 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 p -98.54 135.32 33.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 109.863 -0.421 . . . . 3.46 109.863 175.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.1 m -68.63 151.72 46.33 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 122.243 1.02 . . . . 3.01 108.826 169.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.8 p -61.42 -66.24 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 114.718 -1.128 . . . . 3.19 111.218 -174.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -81.86 40.8 2.67 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 120.8 -1.187 . . . . 1.78 112.713 -172.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.6 m -108.87 -28.1 9.35 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 117.82 0.81 . . . . 1.55 112.705 -172.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.413 ' SD ' ' HB3' ' A' ' 104' ' ' PHE . 0.8 OUTLIER -79.22 103.11 8.93 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.74 0.7 . . . . 3.26 110.087 -175.063 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.6 m -100.27 147.52 7.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 107.811 -1.181 . . . . 1.77 107.811 175.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.85 137.51 29.65 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.427 0.691 . . . . 7.71 109.829 -165.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.19 153.88 94.95 Favored Pre-proline 0 N--CA 1.452 -0.327 0 N-CA-C 109.607 -0.516 . . . . 2.05 109.607 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -65.51 -25.63 55.25 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.218 1.946 . . . . 1.54 111.306 165.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -48.94 -29.98 5.4 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.934 0.494 . . . . 1.54 110.831 164.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.1 m 67.43 23.68 9.04 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 125.362 1.465 . . . . 1.62 112.114 173.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.38 -44.28 1.72 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 127.875 2.47 . . . . 2.83 110.757 177.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -84.39 129.08 34.9 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 107.692 -1.225 . . . . 1.55 107.692 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 20.1 m -147.43 145.72 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.174 -1.417 . . . . 2.04 107.174 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -150.65 154.92 38.35 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.599 -0.688 . . . . 1.36 111.48 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -155.14 138.0 15.36 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 123.404 0.682 . . . . 3.21 111.573 -173.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.04 124.33 30.97 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.296 -0.631 . . . . 1.7 109.296 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 t -108.4 147.62 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 124.267 1.027 . . . . 2.86 108.835 173.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -144.91 178.92 7.67 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.024 -1.102 . . . . 1.81 108.024 177.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.4 t0 . . . . . 0 CA--C 1.532 0.264 0 CA-C-O 122.1 0.952 . . . . 2.84 109.711 175.727 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.66 0 N-CA-C 108.582 -1.807 . . . . 2.19 108.582 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -136.41 145.11 44.92 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.625 -1.991 . . . . 3.28 105.625 174.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -126.67 158.28 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.013 -1.847 . . . . 2.51 106.013 175.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.442 2.9 mt -107.69 117.49 34.25 Favored 'General case' 0 CA--C 1.545 0.77 1 N-CA-C 123.136 4.495 . . . . 2.16 123.136 164.394 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.1 t -86.52 141.29 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 107.331 -1.359 . . . . 1.87 107.331 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.2 p -120.86 149.6 42.35 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.595 1.158 . . . . 1.66 107.959 -176.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -145.65 142.25 28.88 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.588 1.155 . . . . 4.68 108.031 -176.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -115.29 14.33 16.83 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.275 1.43 . . . . 2.54 111.649 171.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -117.69 163.38 16.56 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 124.449 1.1 . . . . 4.71 110.618 170.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.8 mp -67.84 113.14 5.33 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.342 -0.845 . . . . 2.17 109.202 163.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.8 mt -62.18 156.09 61.5 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.067 0.947 . . . . 2.42 110.246 171.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -68.07 147.69 74.0 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 123.651 2.901 . . . . 2.23 110.767 174.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 41.55 49.44 3.63 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.376 1.47 . . . . 2.98 111.629 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 44.89 22.01 0.06 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 127.089 2.156 . . . . 3.27 115.326 -174.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.413 ' HB3' ' SD ' ' A' ' 71' ' ' MET . 67.1 t80 51.0 110.94 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.125 2.17 . . . . 3.87 110.764 -159.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.5 mmt85 -77.75 112.7 14.87 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.251 -1.388 . . . . 5.84 107.251 -176.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -82.36 172.75 12.72 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.416 0.627 . . . . 3.4 111.005 -170.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 62.26 43.67 98.76 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 121.861 -0.525 . . . . 1.03 112.61 171.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -157.16 176.88 12.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.092 1.357 . . . . 3.15 108.101 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -93.31 140.37 15.03 Favored Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 109.893 -1.283 . . . . 0.9 109.893 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.5 pp -148.01 165.15 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.999 -1.482 . . . . 1.88 106.999 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.25 135.89 60.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 108.373 -0.973 . . . . 2.1 108.373 174.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -128.39 152.87 47.69 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 126.285 1.834 . . . . 1.53 110.071 -170.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -147.95 155.13 41.22 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 119.439 1.018 . . . . 2.92 113.13 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 175.62 -89.07 0.08 OUTLIER Glycine 0 C--N 1.345 1.054 0 CA-C-O 119.728 -0.485 . . . . 2.17 112.473 172.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.7 p -164.24 148.78 2.76 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 C-N-CA 124.351 1.061 . . . . 2.46 109.677 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.1 mt -90.91 141.74 28.51 Favored 'General case' 0 N--CA 1.453 -0.275 0 O-C-N 122.087 -0.383 . . . . 3.61 110.69 -177.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -131.67 158.28 22.74 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 109.132 -1.587 . . . . 3.63 109.132 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 55.52 33.76 21.72 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.934 1.294 . . . . 4.33 110.629 169.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 27.25 45.06 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 128.194 2.597 . . . . 4.07 112.173 -165.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -176.37 -48.2 0.06 OUTLIER Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.07 -1.062 . . . . 1.53 113.487 -164.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -91.66 114.25 26.73 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 118.502 1.151 . . . . 3.43 109.001 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.8 mt -87.62 114.47 24.27 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 106.742 -1.577 . . . . 2.99 106.742 -174.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -88.04 98.45 11.53 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.325 -1.361 . . . . 1.77 107.325 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -101.86 159.17 15.57 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.84 -0.43 . . . . 2.04 109.84 -178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.1 t -136.05 -41.76 0.66 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.233 0.613 . . . . 2.02 111.787 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -92.84 129.84 38.63 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 120.921 -1.112 . . . . 4.12 108.367 175.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.2 m -127.47 140.07 50.15 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 C-N-CA 124.23 1.012 . . . . 2.27 109.37 168.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -114.22 87.48 2.64 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.374 -1.343 . . . . 2.47 107.374 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.44 57.35 2.36 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.613 1.165 . . . . 1.97 110.952 -174.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -79.02 47.69 0.79 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.272 1.029 . . . . 4.22 112.95 -169.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 . . . . . 0 CA--C 1.533 0.312 0 C-N-CA 124.402 1.081 . . . . 6.1 110.071 -177.014 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 pt? . . . . . 0 N--CA 1.465 0.285 0 N-CA-C 111.873 0.323 . . . . 3.01 111.873 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -82.62 121.21 26.53 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.672 1.189 . . . . 3.62 110.219 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -128.27 145.36 51.07 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.422 1.089 . . . . 4.72 110.872 177.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 91.5 m -69.24 127.5 92.91 Favored Pre-proline 0 N--CA 1.45 -0.437 0 C-N-CA 126.44 1.896 . . . . 2.87 110.115 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -57.57 -41.68 68.76 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.036 1.824 . . . . 1.28 111.995 -175.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.4 m -47.17 -43.02 20.83 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.71 1.141 . . . . 2.55 113.39 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -60.74 -40.63 93.14 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.363 -0.606 . . . . 3.52 109.363 178.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 40.5 pt -102.69 35.22 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.867 1.667 . . . . 3.12 111.847 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -114.98 -31.25 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 119.322 0.965 . . . . 2.88 111.535 176.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -117.22 126.19 52.36 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.433 1.093 . . . . 3.23 108.112 -175.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.03 -69.9 0.79 Allowed Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.623 1.106 . . . . 4.8 111.66 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -30.93 -89.07 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.571 0 C-N-CA 129.639 3.175 . . . . 3.31 111.645 175.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.4 m -71.33 -51.0 26.68 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 119.48 1.036 . . . . 2.64 109.69 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -33.03 -50.23 0.27 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 128.307 2.643 . . . . 3.11 114.707 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.2 m -127.76 15.28 6.96 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.15 2.18 . . . . 4.22 109.171 -175.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 51.89 39.22 47.62 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-O 117.382 -1.788 . . . . 1.45 113.989 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.2 m -84.42 -45.13 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 121.843 2.822 . . . . 2.1 112.421 -169.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -92.76 -57.37 0.23 Allowed Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 125.128 1.371 . . . . 4.08 113.383 178.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -75.84 179.88 5.84 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.323 2.016 . . . . 1.58 108.418 172.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -135.43 128.14 30.96 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 106.716 -1.587 . . . . 5.66 106.716 -176.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.38 125.76 24.92 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.905 -0.776 . . . . 2.05 108.905 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.18 -11.46 19.88 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 119.179 -0.789 . . . . 1.12 113.021 -175.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -83.4 146.21 28.57 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 119.124 1.462 . . . . 2.51 109.332 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -86.91 139.33 30.73 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.79 -0.641 . . . . 5.1 109.998 167.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.4 pt -148.7 172.27 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 107.124 -1.436 . . . . 2.03 107.124 171.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.6 mtt180 -114.19 110.0 19.29 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 106.825 -1.546 . . . . 2.66 106.825 174.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.3 p -79.26 127.74 38.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.299 -1.371 . . . . 1.9 107.299 175.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.54 114.87 1.51 Allowed Glycine 0 C--N 1.335 0.487 0 N-CA-C 110.191 -1.164 . . . . 0.7 110.191 -177.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.05 -173.22 29.41 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.154 -1.178 . . . . 0.97 110.154 -175.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.1 ptp -101.08 126.64 47.79 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 124.027 0.931 . . . . 3.82 110.234 -176.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.0 m -89.58 157.51 3.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 109.843 -0.428 . . . . 3.52 109.843 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.8 -172.57 2.69 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.591 -0.277 . . . . 3.35 110.26 176.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.3 p -116.98 71.98 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 126.937 2.095 . . . . 3.78 106.958 174.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.65 63.82 0.09 OUTLIER Glycine 0 CA--C 1.53 0.975 0 C-N-CA 126.671 2.081 . . . . 2.55 111.311 -178.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.7 m -146.12 64.55 1.22 Allowed 'General case' 0 CA--C 1.519 -0.238 0 O-C-N 121.243 -1.151 . . . . 2.05 110.642 163.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.14 115.81 18.27 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.381 -1.34 . . . . 3.17 107.381 176.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.6 m -125.15 127.72 72.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 108.363 -0.977 . . . . 1.85 108.363 170.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.47 149.84 29.73 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.444 1.098 . . . . 6.3 110.421 175.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.405 ' C ' ' H ' ' A' ' 76' ' ' ASN . 45.6 m-20 -86.58 150.49 51.19 Favored Pre-proline 0 C--O 1.235 0.339 0 N-CA-C 109.002 -0.74 . . . . 1.94 109.002 177.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.45 28.9 0.37 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.89 2.393 . . . . 2.33 112.961 173.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.405 ' H ' ' C ' ' A' ' 74' ' ' ASP . 79.7 m-20 -89.44 -27.63 20.26 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.329 1.052 . . . . 1.38 108.847 166.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.5 m 69.95 12.29 7.83 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 125.594 1.558 . . . . 2.01 112.177 -172.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.45 32.04 3.39 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.918 1.287 . . . . 3.12 113.36 170.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -153.48 131.86 12.05 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 121.827 -0.545 . . . . 1.46 109.927 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.98 146.3 16.26 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 C-N-CA 123.666 0.786 . . . . 2.2 110.409 -172.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -152.74 156.91 40.04 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 120.659 -1.276 . . . . 1.0 110.989 175.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -155.44 160.21 40.44 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.257 0.623 . . . . 3.22 110.645 -173.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.94 139.34 39.79 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.5 -0.926 . . . . 1.76 108.5 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.6 p -125.34 143.76 37.78 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.063 0 N-CA-C 107.87 -1.159 . . . . 3.02 107.87 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -124.29 -171.04 2.25 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.63 1.172 . . . . 2.19 109.814 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.0 t70 . . . . . 0 C--O 1.233 0.192 0 N-CA-C 110.244 -0.28 . . . . 2.66 110.244 174.59 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.342 0 CA-C-O 119.04 -0.867 . . . . 2.91 113.41 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -66.79 96.15 0.39 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.042 0.921 . . . . 2.84 110.213 -173.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -121.84 140.49 45.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 107.828 -1.175 . . . . 2.79 107.828 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.2 mt -90.18 124.89 35.22 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.452 1.101 . . . . 1.71 110.048 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.1 t -106.0 119.89 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 125.082 1.353 . . . . 2.2 107.578 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 65.5 p -98.69 144.06 28.37 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.173 0.589 . . . . 1.73 109.668 175.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.411 ' CE2' HD23 ' A' ' 100' ' ' LEU . 1.9 t80 -137.89 143.13 40.71 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.721 1.608 . . . . 3.94 107.411 -173.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -85.94 -82.43 0.19 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.132 0.973 . . . . 3.12 109.764 175.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -62.29 166.83 4.6 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.455 0.645 . . . . 3.36 111.382 -168.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.4 mp -60.66 131.78 51.81 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 119.998 -1.689 . . . . 4.5 111.685 175.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.411 HD23 ' CE2' ' A' ' 96' ' ' TYR . 26.7 mt -60.61 158.02 33.72 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 114.559 -1.201 . . . . 2.33 109.757 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -67.9 -85.11 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.234 2.623 . . . . 2.29 111.145 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -122.83 52.09 1.37 Allowed 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 124.76 1.224 . . . . 3.0 108.749 -172.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 34.63 41.75 0.06 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.73 1.612 . . . . 4.55 113.096 -173.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 40.7 p90 31.48 74.56 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.34 1.856 . . . . 4.56 112.151 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.29 125.36 23.39 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 119.854 -1.779 . . . . 8.34 110.177 -124.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -72.19 143.74 48.77 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 119.826 -0.749 . . . . 4.81 109.882 -153.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.14 22.22 23.2 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.675 1.607 . . . . 1.46 113.591 -172.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -137.43 178.68 6.91 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 119.519 1.66 . . . . 3.98 110.604 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -92.71 128.1 9.27 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.997 -0.441 . . . . 1.35 111.997 170.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.3 pp -131.18 159.85 42.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 124.901 1.28 . . . . 1.8 107.915 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.1 m -113.82 140.25 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.67 -1.233 . . . . 2.06 107.67 175.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -129.68 123.5 31.31 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.063 0.945 . . . . 1.74 109.606 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -107.24 136.68 46.66 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 126.065 1.746 . . . . 4.09 109.855 -175.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 168.69 -142.4 7.38 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 108.745 -1.742 . . . . 0.91 108.745 172.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.4 p -123.97 153.0 29.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 C-N-CA 124.507 1.123 . . . . 2.48 109.949 -170.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -54.59 137.95 42.2 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.373 -0.531 . . . . 3.14 110.507 168.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -86.89 -146.45 10.23 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 109.716 -1.354 . . . . 2.84 109.716 175.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -72.34 109.08 5.81 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.408 -1.701 . . . . 5.41 106.408 172.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -6.17 72.56 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.347 1 C-N-CA 132.678 4.391 . . . . 3.65 112.835 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 154.41 -45.74 0.55 Allowed Glycine 0 CA--C 1.523 0.534 0 CA-C-N 113.679 -1.601 . . . . 1.18 111.381 -172.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.92 163.76 13.37 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.509 0.654 . . . . 3.6 111.576 177.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 11.8 mt -123.11 130.27 52.56 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.627 1.171 . . . . 2.83 108.387 176.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -103.75 106.24 16.69 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 108.38 -0.97 . . . . 2.06 108.38 176.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -131.86 126.14 33.51 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 123.075 0.55 . . . . 1.79 110.95 -176.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.9 t -113.67 -24.41 9.21 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.407 1.083 . . . . 2.04 111.367 178.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -86.62 78.79 9.09 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 119.662 -1.898 . . . . 3.43 108.141 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.0 m -91.9 130.88 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 119.333 0.97 . . . . 2.02 110.959 174.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.37 127.67 45.86 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.213 -1.032 . . . . 2.39 108.213 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.14 97.41 9.18 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.236 1.414 . . . . 1.88 108.972 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.1 pttt -93.5 23.9 4.31 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.456 0.702 . . . . 4.6 112.096 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 . . . . . 0 N--CA 1.452 -0.341 0 C-N-CA 125.262 1.425 . . . . 5.37 107.272 173.5 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.469 0.518 0 N-CA-C 112.438 0.532 . . . . 3.08 112.438 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -86.19 117.73 25.2 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 125.374 1.47 . . . . 3.53 111.436 -174.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -116.89 151.64 36.16 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 127.207 2.203 . . . . 4.29 109.519 -175.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 57.8 m -90.54 136.43 28.18 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.27 1.428 . . . . 3.09 109.611 -175.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -61.98 -48.32 8.74 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.025 2.483 . . . . 0.82 112.879 -174.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 p -53.75 -36.06 61.94 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.973 0.806 . . . . 2.48 111.948 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -54.74 -57.67 10.6 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.316 1.046 . . . . 2.42 109.098 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.306 8.3 pt -70.0 1.68 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 114.352 1.242 . . . . 2.08 114.352 -172.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.4 t -85.64 -28.73 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.8 1.24 . . . . 3.1 111.09 170.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -128.57 93.54 3.66 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.964 -1.085 . . . . 2.2 112.344 -160.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.45 37.75 53.15 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.516 -1.034 . . . . 2.09 110.516 176.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.4 -153.87 0.5 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.786 2.834 . . . . 3.49 103.371 178.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.2 m -28.97 -58.16 0.14 Allowed 'General case' 0 C--N 1.339 0.118 0 C-N-CA 126.905 2.082 . . . . 2.13 115.444 -172.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -44.48 -47.84 10.05 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.586 0.754 . . . . 2.58 112.272 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.6 m -93.51 -23.59 18.3 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.757 0.823 . . . . 2.34 111.409 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.95 35.6 84.7 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.984 1.278 . . . . 0.99 112.381 176.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.7 m -82.08 -39.45 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 117.525 0.662 . . . . 1.8 111.816 -175.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -105.81 -63.03 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 124.482 1.113 . . . . 5.1 111.116 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -80.93 142.16 13.71 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 CA-C-N 121.07 1.418 . . . . 1.2 109.369 171.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -90.53 154.35 19.69 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.279 1.031 . . . . 2.85 109.484 167.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.58 140.73 49.93 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.114 -1.069 . . . . 1.92 108.114 169.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 105.51 16.84 14.8 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.073 0.844 . . . . 1.23 113.36 -176.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -112.73 154.38 26.25 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.746 1.219 . . . . 1.85 109.785 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.41 ' NH1' ' OE2' ' A' ' 126' ' ' GLU . 0.3 OUTLIER -84.84 127.45 34.15 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.868 0.867 . . . . 5.21 109.085 173.11 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.9 pt -144.52 177.78 1.85 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 106.554 -1.647 . . . . 1.87 106.554 166.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.3 mtm180 -122.77 122.67 39.28 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.754 -1.202 . . . . 2.65 107.754 173.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.1 p -87.75 132.98 31.6 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 N-CA-C 107.282 -1.377 . . . . 1.87 107.282 173.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -135.75 120.63 2.31 Favored Glycine 0 C--N 1.334 0.421 0 N-CA-C 109.89 -1.284 . . . . 0.71 109.89 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.39 -166.32 31.55 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.314 -1.115 . . . . 0.82 110.314 -175.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.16 130.83 51.91 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.168 0.508 . . . . 3.79 111.462 -174.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.6 t -76.29 130.65 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 124.267 1.027 . . . . 3.01 108.527 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.6 m -49.27 -85.43 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.294 1.838 . . . . 3.25 114.581 -170.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.1 p 174.45 -40.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 126.093 1.757 . . . . 2.71 109.276 -171.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -151.8 38.2 0.81 Allowed Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.214 -1.155 . . . . 1.81 110.214 175.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 57.1 m -94.74 -8.61 37.16 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 117.923 0.861 . . . . 1.58 112.221 178.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 52.8 tpp -65.52 128.89 37.75 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.794 -0.817 . . . . 3.49 108.794 172.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.5 m -127.43 141.79 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 N-CA-C 107.425 -1.324 . . . . 1.86 107.425 164.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.76 135.13 48.77 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.43 -0.952 . . . . 5.4 108.43 -172.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -82.27 152.4 67.67 Favored Pre-proline 0 C--O 1.235 0.298 0 N-CA-C 109.851 -0.426 . . . . 2.11 109.851 -176.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -70.97 3.87 3.07 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.114 2.543 . . . . 1.49 112.346 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -70.81 -33.65 70.93 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.503 -0.554 . . . . 1.32 109.503 168.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.1 m 73.63 9.51 4.93 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.405 1.482 . . . . 1.52 113.452 -173.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.27 16.56 9.08 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.583 1.553 . . . . 2.65 111.323 172.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -143.79 125.96 15.54 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.178 -1.045 . . . . 1.53 108.178 -177.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.08 140.16 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.993 1.317 . . . . 2.45 107.712 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -140.32 153.82 46.57 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.879 -0.513 . . . . 1.22 109.813 172.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -153.27 146.19 24.47 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.43 -0.35 . . . . 3.32 110.808 -170.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.3 125.66 39.08 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.382 -0.599 . . . . 1.47 109.382 175.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.3 t -106.65 132.72 53.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 107.063 -1.458 . . . . 2.97 107.063 176.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -115.53 -178.28 3.35 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.236 0.614 . . . . 2.42 111.329 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.0 t0 . . . . . 0 N--CA 1.445 -0.719 0 C-N-CA 124.101 0.96 . . . . 3.58 110.98 177.227 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.622 0 N-CA-C 110.658 -0.977 . . . . 1.99 110.658 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -115.75 150.5 36.78 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.237 1.015 . . . . 2.9 110.413 -174.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.49 152.95 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 107.967 -1.123 . . . . 2.41 107.967 178.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.0 mt -100.58 121.77 42.15 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.312 -0.996 . . . . 1.77 108.312 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.7 t -107.09 133.34 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 107.437 -1.32 . . . . 1.79 107.437 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 82.2 p -107.46 149.49 27.88 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.531 -0.915 . . . . 1.51 108.531 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.443 ' CE2' ' HA ' ' A' ' 125' ' ' THR . 11.2 t80 -146.65 126.9 13.87 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.026 -1.101 . . . . 3.88 108.026 -173.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -113.85 46.62 1.29 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.003 1.321 . . . . 2.06 111.745 -165.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -166.75 -179.64 4.9 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.847 2.059 . . . . 3.36 106.286 169.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.4 mp -67.68 131.38 45.47 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.399 1.0 . . . . 2.44 111.145 172.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.2 mt -83.55 155.29 65.8 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.485 1.114 . . . . 2.32 110.579 174.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.62 112.44 2.4 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.954 2.436 . . . . 2.85 109.538 175.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 39.74 47.7 1.81 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.011 1.724 . . . . 5.83 111.504 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 48.76 13.52 0.06 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 127.782 2.433 . . . . 4.1 116.374 -178.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 51.49 114.29 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 122.226 1.012 . . . . 6.27 109.987 -148.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -74.16 100.63 3.71 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 104.837 -2.282 . . . . 6.33 104.837 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -71.94 157.55 37.63 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 119.776 -0.77 . . . . 5.08 110.965 -148.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.09 37.87 6.6 Favored Glycine 0 CA--C 1.531 1.09 0 N-CA-C 110.608 -0.997 . . . . 0.94 110.608 -167.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -138.2 162.21 34.85 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.773 1.229 . . . . 3.58 108.896 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -102.3 129.79 10.01 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 110.476 -1.05 . . . . 1.23 110.476 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.5 pp -140.56 161.22 24.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 108.208 -1.034 . . . . 1.96 108.208 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.3 m -114.45 141.66 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.091 -1.078 . . . . 2.07 108.091 174.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -127.34 116.9 21.21 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.602 1.161 . . . . 2.02 108.7 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -101.12 149.38 24.02 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.135 -0.691 . . . . 3.88 109.135 175.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 162.11 -140.84 6.83 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 107.451 -2.26 . . . . 0.94 107.451 173.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.5 p -136.04 142.94 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 118.084 0.942 . . . . 1.89 109.996 -164.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.86 162.32 29.64 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.456 -0.793 . . . . 3.08 109.99 173.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -169.73 -52.35 0.03 OUTLIER Glycine 0 C--N 1.332 0.351 0 C-N-CA 119.951 -1.119 . . . . 2.39 111.726 166.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -67.0 141.25 57.65 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.55 -0.908 . . . . 4.37 108.55 174.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.08 64.8 0.54 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 128.651 2.78 . . . . 4.46 110.299 -171.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 128.51 8.22 4.04 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.635 2.064 . . . . 1.17 113.368 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.16 153.9 51.82 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.539 1.67 . . . . 3.13 109.885 177.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.3 mp -121.69 134.7 54.96 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.348 1.059 . . . . 3.13 109.714 -166.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.68 101.3 12.15 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.388 -1.338 . . . . 1.72 107.388 177.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -127.52 83.27 2.15 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 112.211 0.449 . . . . 2.15 112.211 -166.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.443 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 14.6 t -83.01 -22.25 33.66 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.959 0.726 . . . . 2.06 112.959 -174.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.41 ' OE2' ' NH1' ' A' ' 59' ' ' ARG . 20.6 mt-10 -83.5 75.11 10.04 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 120.445 -1.409 . . . . 4.48 107.981 -176.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.0 m -92.33 131.16 40.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 O-C-N 121.527 -0.733 . . . . 2.18 111.534 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.28 124.33 44.35 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.031 -1.47 . . . . 2.08 107.031 176.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -94.31 124.8 38.56 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.258 -1.016 . . . . 2.39 108.258 175.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -153.56 58.14 0.75 Allowed 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.594 0.758 . . . . 5.33 109.92 -176.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 4.9 p80 . . . . . 0 N--CA 1.454 -0.231 0 C-N-CA 125.229 1.412 . . . . 8.03 107.932 179.81 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 pt? . . . . . 0 CA--C 1.531 0.222 0 N-CA-C 111.361 0.134 . . . . 3.09 111.361 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -83.83 123.15 29.61 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.106 1.362 . . . . 3.5 110.954 -175.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.03 156.03 43.39 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.393 1.477 . . . . 4.05 110.954 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.3 139.58 52.25 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 123.125 0.57 . . . . 3.34 111.311 -175.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.38 -35.0 99.18 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.63 2.22 . . . . 0.93 113.45 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -57.19 -29.31 63.58 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 119.988 1.267 . . . . 3.81 112.056 176.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -67.55 -56.98 7.33 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.244 -1.021 . . . . 2.32 108.244 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.0 pt -74.17 36.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.025 1.33 . . . . 1.84 113.175 -174.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 43.1 t -123.38 -68.68 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 105.757 -1.942 . . . . 3.05 105.757 168.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -79.0 102.5 8.37 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.266 1.826 . . . . 2.26 110.728 -164.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.9 32.89 74.01 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.408 -1.077 . . . . 2.1 110.408 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -140.32 -110.83 0.15 Allowed 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 126.44 1.896 . . . . 3.6 108.341 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 29.6 m -73.83 -56.68 4.67 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 119.147 0.885 . . . . 2.51 112.177 -172.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -58.55 -46.89 85.91 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 122.135 0.969 . . . . 2.85 109.068 -174.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -68.16 -35.9 78.79 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.8 -0.637 . . . . 2.45 112.345 173.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.29 47.68 42.63 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.977 1.275 . . . . 1.38 111.882 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.251 32.6 m -112.89 -70.39 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 113.984 1.105 . . . . 2.37 113.984 -174.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.7 mttt -73.14 -62.22 1.31 Allowed Pre-proline 0 CA--C 1.535 0.403 0 O-C-N 121.4 -0.813 . . . . 5.84 112.101 -172.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.36 111.65 2.64 Favored 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 121.867 1.711 . . . . 1.1 107.684 175.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -62.03 148.68 43.24 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.101 -0.703 . . . . 3.26 109.101 172.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.61 162.68 10.15 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.842 -0.617 . . . . 2.4 110.409 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.91 14.37 82.24 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 119.672 -0.516 . . . . 1.19 113.387 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -93.75 158.94 15.42 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-N 118.284 1.042 . . . . 1.66 109.433 172.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -98.38 135.37 40.07 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.448 0.699 . . . . 5.58 110.425 174.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.2 pt -150.53 178.47 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 125.821 1.649 . . . . 1.74 106.798 174.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.5 mtt180 -123.52 131.96 53.78 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.682 -1.229 . . . . 2.51 107.682 165.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.2 p -92.07 140.75 15.62 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.08 0 N-CA-C 107.359 -1.348 . . . . 1.97 107.359 171.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.19 124.37 2.41 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.002 -1.239 . . . . 0.62 110.002 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -169.3 -163.53 23.49 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 108.622 -1.791 . . . . 0.75 108.622 -175.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.71 139.43 38.97 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 117.358 0.579 . . . . 3.78 109.585 -178.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.5 m -94.24 148.98 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 110.229 -0.286 . . . . 3.45 110.229 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.9 m -84.61 146.34 27.55 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.255 1.022 . . . . 2.4 109.17 175.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.1 p -49.74 -57.43 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.489 1.516 . . . . 2.68 111.44 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.75 71.96 0.49 Allowed Glycine 0 CA--C 1.522 0.521 0 N-CA-C 109.386 -1.486 . . . . 1.62 109.386 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.6 m -153.01 48.38 0.71 Allowed 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 117.738 0.769 . . . . 2.4 111.936 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.1 ttp -141.08 132.7 27.13 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.589 -1.634 . . . . 3.51 106.589 168.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.7 m -135.51 144.28 34.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 107.334 -1.358 . . . . 1.98 107.334 173.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -127.46 149.92 49.89 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 123.974 0.91 . . . . 5.32 110.541 -174.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.59 154.25 83.61 Favored Pre-proline 0 N--CA 1.451 -0.403 0 N-CA-C 109.93 -0.396 . . . . 2.94 109.93 175.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -65.32 -24.03 58.27 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.445 2.097 . . . . 1.67 111.601 167.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -47.56 -28.81 2.45 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.509 0.724 . . . . 1.66 110.735 165.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.3 m 64.84 25.98 12.89 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 125.081 1.352 . . . . 1.44 111.472 175.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.24 -46.23 1.36 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.758 2.423 . . . . 2.74 111.127 176.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -83.29 136.35 34.41 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.628 -0.879 . . . . 1.69 108.628 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.7 m -147.25 143.54 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 107.068 -1.456 . . . . 2.08 107.068 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -144.05 154.62 43.43 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.22 -0.659 . . . . 1.01 109.22 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -148.35 151.62 35.65 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.761 -0.654 . . . . 3.15 109.887 -173.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.81 142.01 30.88 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.049 -1.093 . . . . 1.89 108.049 171.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.0 p -130.38 149.59 33.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 107.112 -1.44 . . . . 3.18 107.112 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -130.46 167.22 18.98 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.4 0.619 . . . . 2.0 109.546 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.1 t70 . . . . . 0 N--CA 1.444 -0.765 0 CA-C-N 114.779 -1.1 . . . . 3.68 109.028 -177.285 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.807 0 N-CA-C 111.14 -0.784 . . . . 3.13 111.14 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 35.64 58.05 0.89 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.298 1.839 . . . . 4.25 111.317 -176.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -112.24 157.06 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 124.464 1.106 . . . . 2.4 109.087 -169.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.3 mt -118.44 125.6 50.3 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.832 0.853 . . . . 1.76 109.49 -173.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 75.7 t -114.26 133.28 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.791 1.236 . . . . 2.06 107.954 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 61.3 p -108.79 155.47 20.74 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.497 1.119 . . . . 1.4 110.204 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -153.48 136.85 15.79 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.504 -1.295 . . . . 3.18 107.504 -174.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.8 p-10 -128.94 49.87 2.19 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.564 1.545 . . . . 2.22 112.57 -172.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -171.72 52.43 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.982 0.913 . . . . 2.99 111.533 178.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.9 mp 52.69 -147.41 0.47 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.877 1.271 . . . . 2.36 110.417 -172.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.7 mt -150.28 158.16 36.52 Favored Pre-proline 0 N--CA 1.454 -0.226 0 N-CA-C 105.811 -1.922 . . . . 2.59 105.811 -176.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -71.27 -94.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.433 2.755 . . . . 2.0 107.923 172.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -77.4 38.17 0.23 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.554 1.142 . . . . 3.78 110.306 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 19.8 tp 52.37 23.19 2.34 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.825 -1.172 . . . . 3.83 112.716 -177.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 76.9 t80 53.9 84.05 0.07 Allowed 'General case' 0 N--CA 1.465 0.283 0 O-C-N 120.618 -1.301 . . . . 4.11 109.076 -171.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -75.86 123.14 25.18 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.94 -1.133 . . . . 6.8 107.94 -171.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -84.17 156.26 22.16 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 126.046 1.739 . . . . 3.68 110.482 -169.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.49 33.3 43.85 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 123.757 0.694 . . . . 1.19 112.267 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -156.08 178.9 9.75 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.802 1.241 . . . . 4.09 108.138 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -85.43 147.64 22.41 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.685 -0.966 . . . . 1.0 110.685 166.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.9 pp -140.23 162.5 24.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 105.618 -1.993 . . . . 1.91 105.618 166.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.3 m -125.0 135.27 64.62 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.132 0 N-CA-C 109.055 -0.72 . . . . 2.04 109.055 173.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -122.84 125.73 45.98 Favored 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 124.842 1.257 . . . . 1.83 109.919 -170.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -115.83 143.58 45.21 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.958 1.303 . . . . 3.89 110.126 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 168.79 -131.4 2.29 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 107.576 -2.21 . . . . 0.92 107.576 173.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.8 p -128.17 150.03 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 124.701 1.2 . . . . 2.3 109.752 -171.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -55.89 143.44 31.65 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.161 -0.681 . . . . 2.94 109.161 170.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.69 -150.62 10.6 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.208 -1.157 . . . . 3.0 110.208 -178.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -63.14 -67.15 0.45 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.264 0.625 . . . . 5.3 110.021 -174.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -166.45 98.62 0.59 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.759 -1.571 . . . . 3.7 106.759 -178.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 109.59 -41.27 2.28 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.378 0.99 . . . . 1.5 111.199 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -82.79 161.73 21.91 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.252 1.021 . . . . 3.71 110.662 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 mp -128.56 140.05 51.99 Favored 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 124.25 1.02 . . . . 3.24 108.3 174.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -107.9 108.96 20.35 Favored 'General case' 0 CA--C 1.527 0.083 0 N-CA-C 107.924 -1.139 . . . . 1.89 107.924 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -134.82 109.33 8.46 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.274 0.488 . . . . 1.85 111.705 -171.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.7 t -96.66 -34.24 11.46 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.957 0.903 . . . . 1.89 111.656 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.3 mp0 -83.45 89.96 7.13 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 119.863 -1.773 . . . . 3.46 108.168 175.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.4 m -96.89 124.68 49.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 123.446 0.698 . . . . 1.83 109.743 171.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -115.68 110.71 19.53 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.02 1.328 . . . . 1.81 107.797 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.47 61.4 6.57 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.121 0.968 . . . . 1.8 110.62 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -22.72 67.05 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.712 1.004 . . . . 3.57 113.712 -173.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 . . . . . 0 CA--C 1.528 0.113 0 C-N-CA 123.846 0.858 . . . . 6.94 110.113 -177.926 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.4 pt? . . . . . 0 C--O 1.232 0.15 0 N-CA-C 108.924 -0.769 . . . . 3.48 108.924 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -88.7 131.79 34.87 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.696 0.798 . . . . 3.35 109.619 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -138.34 155.77 48.25 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.003 1.321 . . . . 3.55 110.833 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.2 m -80.57 131.16 62.04 Favored Pre-proline 0 N--CA 1.447 -0.621 0 C-N-CA 125.53 1.532 . . . . 2.96 111.048 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -57.02 -46.47 28.77 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 123.026 2.484 . . . . 0.8 112.328 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.7 t -54.41 -32.86 58.2 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 122.865 0.466 . . . . 3.04 111.419 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.27 -58.5 8.23 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.55 -0.908 . . . . 3.09 108.55 172.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.259 30.7 pt -73.19 28.8 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 114.017 1.118 . . . . 1.92 114.017 -172.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -118.62 -27.53 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.508 1.123 . . . . 3.03 111.986 160.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 -83.95 -68.62 0.7 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.599 1.09 . . . . 2.47 112.389 -163.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.02 54.25 0.59 Allowed Glycine 0 C--N 1.333 0.408 0 N-CA-C 108.668 -1.773 . . . . 2.78 108.668 -174.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -148.98 -109.64 0.07 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.641 1.976 . . . . 3.75 107.082 -167.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 41.0 m -67.59 -65.44 0.69 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.542 1.137 . . . . 2.14 111.587 -173.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -49.59 -51.07 39.81 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.816 0.817 . . . . 2.57 110.444 -172.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.79 -24.09 61.68 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.141 1.376 . . . . 2.83 112.661 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.1 39.81 97.64 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.463 1.506 . . . . 1.34 112.786 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.8 m -97.96 -35.32 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 117.986 0.893 . . . . 2.33 113.054 -172.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -107.41 -68.15 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 117.981 -1.009 . . . . 4.19 112.104 177.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -77.05 131.12 11.74 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 121.606 1.538 . . . . 1.2 108.77 175.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -76.4 157.35 32.38 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.766 -0.827 . . . . 3.02 108.766 169.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.02 170.22 4.6 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.93 0.492 . . . . 2.24 109.71 170.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.86 40.54 98.47 Favored Glycine 0 CA--C 1.531 1.081 0 O-C-N 121.63 -0.669 . . . . 1.63 112.046 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -127.2 156.7 41.42 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 107.916 -1.142 . . . . 1.58 107.916 169.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -96.71 128.47 43.69 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.002 0.921 . . . . 5.54 108.992 176.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.2 pt -137.17 168.23 21.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 108.32 -0.993 . . . . 1.77 108.32 173.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 31.2 mtm180 -117.59 111.07 18.7 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.13 -1.063 . . . . 3.4 108.13 173.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.7 p -78.87 130.14 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.812 -1.551 . . . . 1.86 106.812 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.55 125.33 2.98 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 109.629 -1.389 . . . . 0.53 109.629 -177.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.96 -155.4 17.09 Favored Glycine 0 C--N 1.334 0.423 0 N-CA-C 108.535 -1.826 . . . . 0.73 108.535 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -97.61 134.38 40.9 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.48 0.657 . . . . 3.48 109.705 177.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.4 m -68.95 159.79 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.964 -1.124 . . . . 3.44 107.964 172.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.2 m -74.03 -116.85 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 109.188 -0.671 . . . . 3.33 109.188 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.1 p -156.99 -59.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 O-C-N 120.49 -1.381 . . . . 3.2 109.418 -175.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.66 -11.05 56.06 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 121.943 -0.473 . . . . 2.26 112.591 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.1 m -67.37 -20.91 65.62 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 114.14 1.163 . . . . 1.89 114.14 -165.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 6.6 tpt -71.39 94.6 1.25 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.655 0.782 . . . . 2.91 109.814 -176.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.6 m -102.31 130.44 52.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 107.364 -1.347 . . . . 1.81 107.364 174.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -126.44 141.48 51.87 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.506 1.122 . . . . 6.93 108.323 -173.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.99 143.82 31.88 Favored Pre-proline 0 C--O 1.234 0.244 0 N-CA-C 110.34 -0.244 . . . . 2.67 110.34 -176.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -60.16 -27.16 84.32 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.125 2.55 . . . . 2.39 110.846 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -42.94 -40.63 3.05 Favored 'General case' 0 C--O 1.226 -0.151 0 C-N-CA 125.678 1.591 . . . . 2.62 110.013 172.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.4 m 78.31 12.04 1.71 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.963 1.705 . . . . 1.73 112.861 177.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.69 31.53 5.31 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.888 0.875 . . . . 4.04 112.382 165.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -150.24 131.82 14.85 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 122.05 -0.406 . . . . 1.45 110.545 175.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.59 131.26 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 125.14 1.376 . . . . 2.24 108.714 -177.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -137.9 144.08 41.16 Favored 'General case' 0 C--N 1.34 0.183 0 O-C-N 120.536 -1.352 . . . . 1.21 110.745 172.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -139.35 160.22 40.34 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.392 0.677 . . . . 3.29 109.854 -175.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.67 127.61 54.12 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.529 -1.285 . . . . 1.89 107.529 170.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.6 p -116.02 146.55 20.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.314 -0.995 . . . . 2.98 108.314 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -142.88 -178.5 5.84 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.217 1.007 . . . . 1.73 109.661 -173.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.6 t70 . . . . . 0 N--CA 1.465 0.311 0 CA-C-O 121.581 0.705 . . . . 2.69 111.734 177.967 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.91 0 N-CA-C 110.597 -1.001 . . . . 1.82 110.597 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -120.78 133.13 55.34 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.178 -1.786 . . . . 4.77 106.178 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -123.4 138.51 53.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 108.051 -1.092 . . . . 2.79 108.051 -176.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.8 mt -89.8 124.44 34.66 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.954 0.902 . . . . 1.65 110.294 -176.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.0 t -109.0 118.46 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 126.216 1.806 . . . . 1.78 107.045 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.4 p -99.54 140.06 34.27 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.723 -0.843 . . . . 1.78 108.723 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -141.71 139.61 32.96 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 107.849 -1.167 . . . . 3.72 107.849 -173.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -81.79 -91.01 0.07 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.98 0.912 . . . . 3.62 110.692 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -55.15 168.74 0.3 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.646 1.179 . . . . 3.92 113.237 -171.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 mt -57.7 116.34 3.36 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 120.197 -1.564 . . . . 3.05 110.95 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.0 mt -54.97 145.74 41.89 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 123.511 0.724 . . . . 2.34 109.839 170.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -62.32 143.3 93.65 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.598 2.199 . . . . 2.55 109.692 177.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 47.16 40.39 9.92 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.955 1.302 . . . . 2.8 111.285 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 56.05 4.75 0.14 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 128.277 2.631 . . . . 2.91 115.466 -175.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 57.0 t80 58.37 101.99 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.251 1.02 . . . . 4.35 109.089 -155.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -78.09 150.94 33.64 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.89 -1.152 . . . . 4.82 107.89 168.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -91.96 165.63 13.11 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 125.867 1.667 . . . . 3.33 109.595 -175.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 42.15 48.86 5.47 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.153 1.358 . . . . 1.07 114.408 -177.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -155.7 87.81 1.1 Allowed 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.83 1.252 . . . . 3.25 107.632 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -49.08 135.77 21.41 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 123.459 0.552 . . . . 1.3 113.857 -169.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.3 pp -139.23 168.04 19.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 124.731 1.212 . . . . 1.99 108.69 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 15.7 m -110.6 137.76 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.271 -1.011 . . . . 2.0 108.271 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -125.04 122.17 36.49 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.525 1.13 . . . . 1.73 109.333 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -99.35 127.4 45.36 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.018 -1.104 . . . . 3.3 108.018 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -159.79 169.19 35.73 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.197 -0.525 . . . . 2.05 112.36 -173.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.1 p -108.38 139.35 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 124.439 1.096 . . . . 1.88 108.184 177.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.9 mp -68.43 118.29 11.31 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.55 -0.907 . . . . 3.83 108.55 174.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.34 -91.65 0.33 Allowed Glycine 0 C--N 1.335 0.524 0 O-C-N 124.054 0.847 . . . . 2.54 111.107 -171.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -82.0 -77.86 0.21 Allowed 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.395 -1.335 . . . . 6.15 107.395 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -175.58 108.35 0.09 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.969 1.708 . . . . 3.6 107.099 173.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 118.8 -41.71 1.95 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.066 -1.214 . . . . 1.33 110.066 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.69 131.63 34.93 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.485 0.714 . . . . 3.61 110.628 -178.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -97.52 113.98 25.79 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.204 -1.036 . . . . 3.65 108.204 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -88.58 102.58 15.08 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 107.246 -1.39 . . . . 1.75 107.246 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -122.0 132.29 54.44 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 123.922 0.889 . . . . 1.91 109.306 -175.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.8 t -125.7 -8.61 6.75 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.918 0.487 . . . . 2.55 112.236 172.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -111.41 74.54 0.87 Allowed 'General case' 0 CA--C 1.532 0.254 0 O-C-N 120.473 -1.392 . . . . 3.75 108.548 -174.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 35.8 m -87.58 150.93 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 118.279 0.491 . . . . 1.9 111.08 176.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.23 135.68 51.89 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.348 -0.982 . . . . 2.05 108.348 171.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.3 122.95 34.36 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.765 -1.198 . . . . 2.75 107.765 169.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -143.9 46.34 1.46 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.352 0.661 . . . . 3.77 110.278 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 . . . . . 0 N--CA 1.455 -0.179 0 C-N-CA 124.443 1.097 . . . . 5.98 109.317 -179.079 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.5 pp . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 109.477 -0.564 . . . . 3.43 109.477 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -90.69 116.33 28.48 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 124.146 0.978 . . . . 3.46 110.409 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.95 152.82 28.92 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.99 1.316 . . . . 4.07 110.122 175.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.0 p -83.27 133.66 47.22 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 124.814 1.246 . . . . 2.54 109.871 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.41 -40.71 72.54 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.882 2.388 . . . . 0.83 112.236 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.7 t -54.8 -29.38 54.33 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.265 0.468 . . . . 2.91 112.265 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.11 -56.46 11.38 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.751 -1.203 . . . . 3.02 107.751 175.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.8 pt -73.23 28.99 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 114.217 1.191 . . . . 1.92 114.217 -174.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.9 t -109.56 -24.42 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 126.82 2.048 . . . . 2.74 111.007 163.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -120.65 75.02 1.1 Allowed 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 121.558 -0.714 . . . . 2.07 111.197 -157.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.72 49.76 8.65 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 109.067 -1.613 . . . . 1.83 109.067 174.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -146.55 -125.5 0.07 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.131 -1.804 . . . . 3.76 106.131 -173.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.2 m -62.65 -43.0 99.92 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 119.408 1.004 . . . . 2.52 111.448 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -31.89 -72.51 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 126.655 1.982 . . . . 5.35 112.809 172.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 45.7 m -89.23 -14.45 35.92 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.816 0.846 . . . . 2.83 110.2 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.76 32.86 60.88 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.048 -0.821 . . . . 1.45 111.048 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.6 m -75.99 -36.24 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 117.702 0.751 . . . . 2.1 111.418 -173.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt -113.88 -70.37 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 124.541 1.136 . . . . 4.18 110.156 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.27 108.32 2.16 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 121.257 1.305 . . . . 1.38 109.714 176.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.55 154.37 38.87 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.819 -0.808 . . . . 2.84 108.819 169.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.98 164.1 13.36 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.188 -0.671 . . . . 1.96 109.188 169.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.42 30.69 39.94 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.252 -0.739 . . . . 1.5 111.252 -175.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -125.56 152.5 44.99 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.968 1.307 . . . . 1.58 108.458 173.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -97.51 121.24 39.18 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 108.25 -1.019 . . . . 5.52 108.25 -176.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.5 pt -144.04 177.76 2.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 124.674 1.19 . . . . 1.88 108.287 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -125.98 131.37 52.25 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.602 -0.888 . . . . 3.06 108.602 175.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.5 p -94.73 124.5 47.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 107.014 -1.476 . . . . 2.12 107.014 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.62 124.82 4.16 Favored Glycine 0 C--O 1.225 -0.437 0 N-CA-C 108.982 -1.647 . . . . 0.47 108.982 178.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.39 -166.0 33.46 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 108.701 -1.76 . . . . 0.61 108.701 -175.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.28 138.37 36.46 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.509 -0.552 . . . . 3.7 109.509 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 32.6 t -98.77 108.22 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-O 121.239 0.542 . . . . 3.39 110.087 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.442 ' HG1' ' CE1' ' A' ' 85' ' ' HIS . 4.2 m -39.15 132.75 1.32 Allowed 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 127.541 2.337 . . . . 2.41 111.356 168.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.5 p -55.49 -62.8 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.656 0.782 . . . . 2.52 110.731 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -83.27 68.5 3.54 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 109.951 -1.26 . . . . 2.19 109.951 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.3 m -152.12 -33.64 0.14 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 114.858 1.429 . . . . 1.23 114.858 -176.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.3 tpp -62.06 120.06 10.11 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 108.353 -0.98 . . . . 3.3 108.353 170.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.2 m -122.35 133.94 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.341 -1.355 . . . . 1.96 107.341 167.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.38 137.77 54.43 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.557 1.143 . . . . 7.17 109.038 -173.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.62 143.33 50.76 Favored Pre-proline 0 N--CA 1.454 -0.244 0 N-CA-C 109.738 -0.468 . . . . 2.01 109.738 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -59.85 -25.83 80.5 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.48 2.12 . . . . 1.63 110.787 170.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -40.98 -42.94 2.0 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 124.653 1.181 . . . . 1.54 110.668 168.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.6 m 84.41 -0.34 0.94 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.143 1.777 . . . . 1.39 113.647 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.2 18.35 11.55 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.321 0.964 . . . . 3.84 112.641 172.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -138.35 125.9 22.03 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.491 -1.3 . . . . 1.35 107.491 174.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.6 m -145.19 144.48 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 106.62 -1.622 . . . . 2.0 106.62 175.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -148.02 155.88 42.01 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 121.361 -0.837 . . . . 1.26 109.777 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -151.35 137.97 18.75 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.49 -0.323 . . . . 3.26 111.106 -171.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.29 138.3 33.62 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.212 -1.032 . . . . 1.61 108.212 166.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.0 p -130.79 146.61 33.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 106.412 -1.699 . . . . 2.96 106.412 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.442 ' CE1' ' HG1' ' A' ' 67' ' ' THR . 0.7 OUTLIER -143.37 175.29 10.03 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.645 0.657 . . . . 2.5 110.88 -174.209 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.9 t70 . . . . . 0 CA--C 1.531 0.222 0 O-C-N 123.465 0.478 . . . . 2.51 111.537 -178.125 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.97 0 N-CA-C 109.903 -1.279 . . . . 1.88 109.903 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -112.37 150.64 30.79 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.37 1.468 . . . . 3.23 107.29 165.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -131.32 153.14 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 107.776 -1.194 . . . . 2.23 107.776 175.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.4 mt -110.18 115.14 29.19 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.794 0.838 . . . . 2.1 109.036 -172.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.8 t -96.5 138.58 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 124.734 1.214 . . . . 1.99 107.845 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 77.6 p -114.46 149.57 36.1 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.738 -0.838 . . . . 1.88 108.738 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.489 ' CE2' ' HA ' ' A' ' 125' ' ' THR . 6.7 t80 -149.79 116.99 6.02 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.519 -0.919 . . . . 3.25 108.519 -173.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -104.29 51.47 0.77 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.633 1.173 . . . . 2.11 111.86 -170.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -168.16 -179.37 4.03 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.527 1.931 . . . . 3.02 107.14 170.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.0 mp -67.51 148.57 51.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 118.703 0.683 . . . . 2.03 111.075 171.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.2 mt -101.81 152.24 38.09 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 125.093 1.357 . . . . 2.28 110.291 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -60.34 137.7 76.21 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 123.983 3.122 . . . . 2.05 109.756 174.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 49.27 30.3 3.09 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.944 1.698 . . . . 3.02 112.495 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.0 tp 58.15 13.29 2.22 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.211 1.004 . . . . 4.59 111.97 -175.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.3 t80 57.07 95.68 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.422 1.489 . . . . 4.24 109.049 -172.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -76.15 124.9 28.18 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 105.47 -2.048 . . . . 8.61 105.47 -176.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -80.47 168.14 19.31 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.902 -0.499 . . . . 2.97 110.187 -170.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.25 45.56 47.83 Favored Glycine 0 CA--C 1.528 0.906 0 O-C-N 121.505 -0.747 . . . . 0.99 112.336 174.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -155.8 170.39 22.19 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.492 1.117 . . . . 2.97 108.333 174.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.476 ' H ' ' CD2' ' A' ' 131' ' ' HIS . . . -90.9 130.33 10.22 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 111.188 -0.765 . . . . 0.9 111.188 174.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.9 pp -137.94 158.4 33.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 107.01 -1.478 . . . . 1.77 107.01 176.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.3 m -120.02 126.57 75.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 108.258 -1.016 . . . . 1.78 108.258 175.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -117.44 127.09 53.68 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 124.403 1.081 . . . . 1.94 109.929 -173.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -107.84 143.42 36.46 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.62 0.768 . . . . 4.46 110.333 -178.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 167.15 -142.46 7.58 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 110.057 -1.217 . . . . 0.99 110.057 171.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.9 p -132.31 144.91 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-O 121.517 0.675 . . . . 2.39 110.477 -164.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.402 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 3.4 mp -87.35 153.9 21.1 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.678 -1.23 . . . . 3.73 107.678 176.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -159.47 -59.79 0.01 OUTLIER Glycine 0 C--N 1.334 0.43 0 C-N-CA 119.686 -1.245 . . . . 2.67 111.646 177.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -60.41 142.74 54.61 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.809 -1.182 . . . . 4.44 107.809 167.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -78.99 57.62 2.22 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.819 1.648 . . . . 4.11 108.934 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 164.12 -32.38 0.26 Allowed Glycine 0 CA--C 1.53 0.979 0 CA-C-N 115.75 -0.659 . . . . 1.04 113.02 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -113.14 157.22 21.93 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 118.181 0.99 . . . . 3.41 109.642 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.2 mp -118.09 143.92 46.06 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.089 0.955 . . . . 3.04 108.517 -176.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -105.61 97.24 7.1 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.209 -1.404 . . . . 1.9 107.209 175.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -106.16 143.92 33.59 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.719 -0.845 . . . . 1.69 108.719 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.489 ' HA ' ' CE2' ' A' ' 96' ' ' TYR 0.254 12.1 t -129.36 -32.04 2.01 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.122 0.786 . . . . 2.08 113.122 174.622 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -84.96 84.8 7.59 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 120.713 -1.242 . . . . 3.13 108.406 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.7 m -88.76 105.77 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 119.294 0.952 . . . . 1.81 111.339 175.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -96.36 105.92 18.07 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.429 -0.952 . . . . 1.77 108.429 175.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.79 52.19 1.67 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.356 1.062 . . . . 1.81 111.574 -177.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -79.19 72.6 5.77 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.751 -0.593 . . . . 3.86 111.035 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.476 ' CD2' ' H ' ' A' ' 109' ' ' GLY . 11.0 t-80 . . . . . 0 CA--C 1.534 0.343 0 C-N-CA 123.817 0.847 . . . . 5.95 111.538 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.527 0.084 0 N-CA-C 110.396 -0.224 . . . . 2.85 110.396 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -84.76 119.49 25.35 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.071 -0.714 . . . . 3.61 109.071 173.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.53 155.92 49.71 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.347 1.059 . . . . 3.75 109.944 -178.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.2 p -88.07 146.9 39.38 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-O 119.242 -0.409 . . . . 2.53 110.728 -173.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -52.83 -50.82 12.73 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 123.399 2.733 . . . . 1.03 110.371 173.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.7 m -48.13 -47.66 34.54 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 125.531 1.532 . . . . 2.97 112.748 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -57.54 -59.58 4.95 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.478 -0.934 . . . . 2.3 108.478 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.267 32.4 pt -61.74 -16.5 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 114.504 1.298 . . . . 2.29 114.504 -170.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.47 -57.42 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 120.056 1.298 . . . . 3.05 111.226 167.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -84.71 80.37 9.28 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.149 -0.97 . . . . 2.22 112.098 -154.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.47 48.35 5.96 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 109.653 -1.379 . . . . 1.82 109.653 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.56 -100.84 0.08 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.136 -1.061 . . . . 3.02 108.136 -177.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 92.9 m -79.28 -60.8 2.23 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 126.187 1.795 . . . . 1.97 111.043 -176.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.43 -33.25 59.14 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.321 0.964 . . . . 4.15 111.205 -178.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.28 -17.72 31.87 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.35 1.06 . . . . 2.31 112.379 178.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 52.7 43.18 59.67 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 126.158 1.837 . . . . 1.09 112.936 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.4 m -95.88 -43.06 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 118.301 1.051 . . . . 2.18 112.817 -173.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -111.88 -71.09 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.25 0 C-N-CA 124.546 1.138 . . . . 4.43 111.021 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -70.69 96.32 0.67 Allowed 'Trans proline' 0 N--CA 1.444 -1.397 0 N-CA-C 108.356 -1.44 . . . . 1.69 108.356 172.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -49.51 162.65 0.14 Allowed 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.322 1.049 . . . . 4.12 111.441 170.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.35 144.27 51.08 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.35 -0.981 . . . . 2.12 108.35 169.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.85 21.91 67.45 Favored Glycine 0 CA--C 1.536 1.396 0 O-C-N 121.554 -0.716 . . . . 1.34 113.261 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -89.62 148.55 23.28 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 118.42 1.11 . . . . 3.95 108.117 170.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.97 113.84 26.06 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.474 1.11 . . . . 4.67 108.249 -171.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.27 175.96 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 123.131 0.572 . . . . 3.05 109.477 -177.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -111.27 112.15 23.72 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 108.84 -0.8 . . . . 4.11 108.84 175.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.9 p -77.01 122.24 31.1 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.038 0 N-CA-C 106.944 -1.502 . . . . 1.92 106.944 172.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.09 120.66 2.97 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 108.537 -1.825 . . . . 0.64 108.537 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.07 -160.02 22.78 Favored Glycine 0 CA--C 1.52 0.347 0 N-CA-C 108.92 -1.672 . . . . 0.68 108.92 -174.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.6 ptp -112.7 136.29 52.45 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.229 0.612 . . . . 3.31 110.272 -176.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.8 p -93.93 138.68 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 109.091 -0.707 . . . . 3.53 109.091 172.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.99 163.32 26.8 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.221 -1.029 . . . . 3.7 108.221 168.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.6 p -58.78 -65.31 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 124.368 1.067 . . . . 2.63 110.763 173.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.25 59.44 4.33 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 121.545 -0.722 . . . . 2.06 111.388 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.5 m -126.06 -41.95 1.9 Allowed 'General case' 0 C--N 1.334 -0.07 0 C-N-CA 124.744 1.218 . . . . 1.94 111.449 -177.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -71.78 121.37 18.82 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.11 -0.7 . . . . 2.86 109.11 -178.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.8 m -127.47 130.35 70.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 108.002 -1.111 . . . . 2.11 108.002 170.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -109.49 147.26 33.19 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 124.072 0.949 . . . . 5.41 110.73 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.46 151.89 95.53 Favored Pre-proline 0 N--CA 1.45 -0.44 0 N-CA-C 109.046 -0.724 . . . . 2.18 109.046 174.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -61.67 -28.37 82.38 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.012 1.808 . . . . 1.98 110.946 166.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -44.88 -34.71 2.47 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.141 0.976 . . . . 1.43 110.655 167.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.6 m 67.63 23.87 8.65 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.084 1.354 . . . . 2.44 112.241 176.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.47 -42.37 2.23 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.848 2.059 . . . . 3.08 111.788 172.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -90.8 138.94 31.2 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.624 -1.25 . . . . 1.73 107.624 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.2 m -152.29 130.11 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 107.125 -1.435 . . . . 1.92 107.125 -173.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -135.11 146.71 49.11 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 118.929 0.786 . . . . 1.81 110.394 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -140.0 144.5 36.99 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.221 0.608 . . . . 3.29 110.171 -172.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.07 139.14 31.96 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.89 -0.782 . . . . 1.68 108.89 170.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 t -125.76 143.66 38.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 105.855 -1.906 . . . . 3.0 105.855 172.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -144.15 177.99 8.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.191 -1.04 . . . . 3.57 108.191 176.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.1 t0 . . . . . 0 N--CA 1.451 -0.425 0 N-CA-C 108.811 -0.811 . . . . 2.64 108.811 169.887 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.626 0 N-CA-C 109.12 -1.592 . . . . 2.01 109.12 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -133.16 138.24 46.53 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.339 -1.356 . . . . 2.75 107.339 177.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.35 154.46 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 107.258 -1.386 . . . . 2.01 107.258 -176.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.2 mt -116.14 121.43 42.1 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.52 0.728 . . . . 1.99 109.334 -177.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.8 t -109.27 129.0 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.88 -1.155 . . . . 2.11 107.88 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 77.5 p -103.94 140.15 38.11 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.73 1.212 . . . . 1.48 109.233 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -134.41 160.23 38.63 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.112 1.765 . . . . 3.25 108.191 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -145.68 146.5 31.31 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 128.097 2.559 . . . . 3.13 105.449 -171.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 69.82 59.97 0.28 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 130.085 3.354 . . . . 3.19 111.083 -175.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 mt 55.93 -156.05 0.28 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.482 1.113 . . . . 2.57 109.27 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.5 mt -145.0 154.42 54.73 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 105.827 -1.916 . . . . 2.16 105.827 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -63.09 -82.86 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 124.276 3.317 . . . . 2.35 110.536 -176.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -76.5 35.49 0.15 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.073 0.949 . . . . 4.11 110.752 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 39.6 6.31 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 128.505 2.722 . . . . 4.12 117.538 -164.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 61.91 89.96 0.08 Allowed 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 124.846 1.258 . . . . 4.54 109.643 -166.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.272 15.0 mmm180 -91.85 30.39 1.39 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 117.859 -1.536 . . . . 6.31 111.559 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . 0.339 4.3 mt-10 79.38 172.38 0.16 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.986 1.266 . . . . 3.04 109.714 146.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 39.39 37.52 0.79 Allowed Glycine 0 CA--C 1.537 1.467 0 N-CA-C 116.143 1.217 . . . . 0.91 116.143 163.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -148.18 176.57 10.11 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.551 1.54 . . . . 3.08 107.847 -175.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -109.08 129.38 9.48 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.174 -1.17 . . . . 0.97 110.174 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.0 pp -133.99 165.39 31.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 125.475 1.51 . . . . 1.9 106.994 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.4 m -115.56 144.27 23.54 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 N-CA-C 108.087 -1.079 . . . . 2.03 108.087 170.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -134.05 129.68 36.41 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 124.073 0.949 . . . . 1.6 110.325 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.79 143.83 34.32 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.633 1.173 . . . . 4.45 111.425 177.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 166.02 -150.64 18.28 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 109.17 -1.572 . . . . 1.01 109.17 169.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.9 p -127.69 146.28 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 123.78 0.832 . . . . 1.97 109.38 -168.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.6 mp -61.71 142.65 57.09 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 122.119 -0.363 . . . . 3.34 110.483 174.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -98.38 -108.21 2.74 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 109.263 -1.535 . . . . 2.06 109.263 -169.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -60.29 -49.21 78.52 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.323 0.649 . . . . 5.18 109.259 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.2 t70 177.27 -87.86 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.364 2.266 . . . . 4.3 106.089 -177.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.23 -26.54 72.57 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.72 1.629 . . . . 2.04 113.433 -177.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -86.66 136.5 33.01 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.12 0.96 . . . . 3.82 109.935 174.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.4 mp -107.37 133.9 51.23 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 123.107 0.563 . . . . 3.31 109.495 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.09 106.5 18.81 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.58 -0.526 . . . . 1.58 109.58 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -121.27 136.99 54.89 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.719 0.808 . . . . 1.84 110.224 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.3 t -128.28 4.14 5.75 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.216 0.606 . . . . 2.03 111.885 173.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -118.6 82.03 1.78 Allowed 'General case' 0 CA--C 1.531 0.237 0 O-C-N 120.914 -1.116 . . . . 2.98 108.368 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.2 m -99.59 133.92 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 118.333 0.515 . . . . 1.72 110.701 175.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.87 118.81 27.94 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.215 -1.402 . . . . 1.86 107.215 177.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.22 84.2 7.7 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.631 0.772 . . . . 1.78 110.433 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.17 34.52 0.11 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.736 1.013 . . . . 5.14 113.736 -174.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.529 0.15 0 C-N-CA 126.765 2.026 . . . . 5.02 105.596 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 109.75 -0.463 . . . . 3.61 109.75 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -85.68 124.78 32.6 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.724 1.209 . . . . 3.41 109.465 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.16 149.39 51.88 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.003 1.321 . . . . 4.31 110.54 -177.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.5 m -77.09 132.33 70.88 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 125.713 1.605 . . . . 2.79 110.728 -177.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -59.3 -33.05 97.77 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.968 2.445 . . . . 0.99 113.616 -176.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.5 p -61.09 -21.04 63.3 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.171 -0.956 . . . . 2.64 112.713 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -96.8 14.2 26.0 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.774 0.715 . . . . 3.7 111.753 173.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.312 8.0 pt -124.26 35.02 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 O-C-N 120.607 -1.308 . . . . 2.04 111.613 163.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.0 p -122.61 -79.11 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 O-C-N 121.922 -0.486 . . . . 3.58 110.426 163.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -69.75 103.8 2.26 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 125.497 1.519 . . . . 2.3 110.896 -162.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.96 39.33 96.39 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 109.029 -1.628 . . . . 2.21 109.029 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -141.43 -110.42 0.14 Allowed 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.521 -1.659 . . . . 2.98 106.521 -176.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 56.3 m -80.45 -48.19 13.21 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 119.96 1.254 . . . . 1.97 112.475 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -55.0 -49.33 71.77 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.828 0.823 . . . . 2.66 109.694 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -72.32 -33.47 67.38 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.371 -0.831 . . . . 1.99 111.619 175.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.22 41.04 39.86 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.744 1.164 . . . . 1.2 112.198 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.6 m -99.97 -42.3 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 117.999 0.9 . . . . 2.05 113.228 -172.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -109.29 -67.51 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.519 1.128 . . . . 4.53 111.433 -176.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -76.37 78.81 3.15 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.062 1.842 . . . . 2.27 108.828 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -55.74 140.04 43.14 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.656 0.782 . . . . 3.2 109.031 175.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.83 147.18 47.34 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.951 -0.759 . . . . 1.99 108.951 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.17 -8.28 31.04 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.839 1.209 . . . . 1.13 112.069 -170.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -96.32 140.49 30.92 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.325 1.063 . . . . 1.63 109.548 -175.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -89.31 118.56 29.07 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.274 1.029 . . . . 5.59 108.569 176.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.7 pt -142.21 175.9 4.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 107.903 -1.147 . . . . 2.55 107.903 172.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.4 mtm180 -121.15 113.57 20.19 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.197 -1.038 . . . . 2.56 108.197 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.2 p -81.24 127.86 39.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 107.108 -1.441 . . . . 2.05 107.108 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.99 114.93 1.76 Allowed Glycine 0 C--N 1.332 0.332 0 N-CA-C 109.856 -1.297 . . . . 0.48 109.856 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.57 -173.37 39.76 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.876 -0.89 . . . . 0.81 110.876 -172.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.4 ptp -93.37 132.82 37.25 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.947 0.899 . . . . 3.75 111.343 -171.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.1 t -102.34 137.22 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 O-C-N 123.794 0.684 . . . . 3.27 109.936 174.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.2 m -40.75 -88.0 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 128.192 2.597 . . . . 2.83 114.329 -175.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.3 p 176.18 -36.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.309 1.443 . . . . 2.82 110.038 -174.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -155.82 42.35 0.56 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.788 -1.325 . . . . 2.82 109.788 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.9 m -84.65 -11.46 55.89 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.972 0.386 . . . . 1.39 111.321 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 16.8 ptm -68.8 132.48 46.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 118.292 0.496 . . . . 3.26 110.686 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.1 m -117.65 125.45 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 106.621 -1.622 . . . . 2.48 106.621 170.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -101.4 146.77 27.16 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.535 0.734 . . . . 6.1 110.136 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -84.42 151.36 59.05 Favored Pre-proline 0 C--O 1.232 0.147 0 N-CA-C 109.381 -0.6 . . . . 2.17 109.381 170.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -67.55 -21.15 46.57 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.933 2.422 . . . . 1.99 112.367 174.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -43.7 -37.98 2.91 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.565 -0.531 . . . . 1.74 109.565 163.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.0 m 72.79 9.75 5.52 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 126.125 1.77 . . . . 1.91 111.508 177.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 pp -123.63 17.78 9.57 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.16 1.784 . . . . 2.69 110.644 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -146.1 130.19 17.42 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.588 1.555 . . . . 2.42 108.271 173.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.29 109.77 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 125.105 1.362 . . . . 2.27 107.523 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -109.38 150.07 28.58 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 109.22 -0.659 . . . . 1.68 109.22 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -150.85 142.3 23.44 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.981 0.419 . . . . 3.25 110.727 -171.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.69 135.16 33.88 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.275 -0.639 . . . . 1.88 109.275 175.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 38.7 t -115.21 152.16 16.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 126.365 1.866 . . . . 3.37 106.512 175.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -134.18 -175.93 4.02 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.376 0.67 . . . . 1.89 109.744 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.7 t0 . . . . . 0 N--CA 1.452 -0.361 0 C-N-CA 123.716 0.806 . . . . 3.93 110.506 177.176 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 110.458 -1.057 . . . . 2.67 110.458 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -65.88 111.75 3.44 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.997 -1.112 . . . . 3.59 107.997 -175.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -144.51 153.85 14.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 N-CA-C 108.416 -0.957 . . . . 2.0 108.416 -176.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mt -108.42 124.57 50.6 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.911 0.884 . . . . 2.04 109.116 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.6 t -107.21 132.55 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 107.299 -1.371 . . . . 1.82 107.299 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 76.6 p -106.25 143.6 34.14 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.513 -0.921 . . . . 1.51 108.513 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -137.67 167.05 22.47 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.775 1.23 . . . . 3.69 108.655 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -144.49 147.84 33.78 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 127.801 2.44 . . . . 3.44 107.088 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 65.78 71.86 0.41 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 129.786 3.234 . . . . 3.08 112.66 -178.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.7 mp 46.07 -148.54 0.11 Allowed 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 125.377 1.471 . . . . 2.88 109.867 -175.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.8 mt -156.31 152.18 22.68 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 105.492 -2.04 . . . . 2.12 105.492 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -71.54 108.69 2.45 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.274 2.649 . . . . 2.66 109.929 176.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 45.04 45.11 8.78 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.205 1.402 . . . . 4.3 111.706 176.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . 0.296 2.3 pp 35.69 47.3 0.37 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.259 1.424 . . . . 4.55 112.793 -172.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 20.3 p90 38.85 56.59 1.95 Allowed 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 127.647 2.379 . . . . 4.74 114.115 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.253 0.1 OUTLIER -37.91 130.45 1.12 Allowed 'General case' 0 CA--C 1.543 0.711 0 O-C-N 116.971 -3.58 . . . . 7.27 113.189 -119.073 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -74.13 154.88 38.94 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.401 -0.812 . . . . 3.54 110.345 -164.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.61 33.21 11.67 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.181 0.896 . . . . 1.01 112.395 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -156.74 178.54 10.23 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.091 1.356 . . . . 3.1 108.183 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -88.82 139.53 15.4 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 112.122 -0.391 . . . . 1.18 112.122 175.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.69 162.76 28.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 124.152 0.981 . . . . 2.15 108.54 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 17.6 m -120.2 122.74 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.304 -0.628 . . . . 1.83 109.304 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -113.67 120.98 42.74 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 125.189 1.396 . . . . 1.66 109.047 -176.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -99.67 135.28 41.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.369 -1.345 . . . . 4.14 107.369 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -169.27 -169.72 32.95 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 110.065 -1.214 . . . . 1.43 110.065 -173.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.4 p -122.98 136.94 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 107.804 -1.184 . . . . 2.07 107.804 172.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 9.6 mp -73.78 155.24 39.06 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 107.882 -1.155 . . . . 3.58 107.882 174.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -172.02 -44.42 0.04 OUTLIER Glycine 0 C--N 1.332 0.313 0 C-N-CA 119.878 -1.154 . . . . 2.65 112.215 175.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -58.9 154.85 14.33 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 119.295 -0.962 . . . . 5.17 110.083 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -80.17 72.54 6.99 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 106.511 -1.663 . . . . 4.55 106.511 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 115.24 4.53 20.35 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.413 1.482 . . . . 1.39 114.265 170.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.13 170.17 9.55 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.785 1.293 . . . . 3.7 109.342 171.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.9 mp -123.74 145.25 49.15 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.044 0.937 . . . . 3.13 109.578 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -110.85 109.76 20.08 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.426 0.691 . . . . 1.63 109.197 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -132.63 136.63 46.63 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 123.41 0.684 . . . . 1.64 110.277 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.4 t -121.44 -2.37 9.49 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.975 0.51 . . . . 2.07 111.96 173.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -111.7 83.01 1.71 Allowed 'General case' 0 CA--C 1.532 0.27 0 O-C-N 120.434 -1.416 . . . . 3.79 108.403 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.3 m -96.65 126.89 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 118.383 0.538 . . . . 1.65 110.886 174.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -113.95 106.57 14.59 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.03 -1.47 . . . . 1.98 107.03 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.1 50.01 1.93 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.979 0.912 . . . . 1.98 110.622 -178.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -78.83 64.39 3.78 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.357 0.663 . . . . 4.0 111.096 -170.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 . . . . . 0 N--CA 1.449 -0.52 0 N-CA-C 106.592 -1.633 . . . . 5.08 106.592 -178.165 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 pt? . . . . . 0 N--CA 1.464 0.26 0 N-CA-C 111.921 0.341 . . . . 2.79 111.921 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -91.45 135.21 34.01 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.424 1.09 . . . . 3.22 109.906 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.41 161.44 34.54 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.002 1.321 . . . . 4.23 109.883 170.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 p -83.28 144.82 47.38 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.65 1.18 . . . . 2.97 110.522 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -62.0 -44.47 20.08 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.786 2.991 . . . . 1.02 112.407 -177.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.8 p -45.83 -56.18 5.7 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.258 1.423 . . . . 3.17 110.923 176.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -46.56 -56.11 6.54 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.446 -1.252 . . . . 3.01 109.174 178.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.25 24.2 pt -70.37 11.42 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 114.862 1.43 . . . . 2.05 114.862 -173.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 82.0 t -98.4 -57.59 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 119.455 1.025 . . . . 2.9 110.934 173.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -95.68 90.27 5.63 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 121.618 -0.676 . . . . 2.29 111.822 -162.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.72 41.75 12.36 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.442 -1.063 . . . . 1.98 110.442 176.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.91 -161.61 1.17 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 104.168 -2.53 . . . . 3.8 104.168 -178.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 m -27.6 -59.04 0.11 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.797 2.439 . . . . 2.77 116.356 -175.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -57.66 -43.62 85.12 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 120.625 1.557 . . . . 3.95 110.889 -177.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.04 -34.81 75.81 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.762 0.825 . . . . 2.89 110.586 174.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.09 46.86 14.7 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.118 1.342 . . . . 1.57 111.566 177.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 m -99.17 -89.61 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 117.252 0.526 . . . . 2.46 111.639 177.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -58.53 -60.8 9.13 Favored Pre-proline 0 CA--C 1.538 0.49 0 O-C-N 121.33 -0.856 . . . . 3.73 112.891 -176.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.62 147.18 27.82 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.564 1.509 . . . . 1.19 109.072 172.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -116.52 135.05 54.15 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.099 1.76 . . . . 3.04 107.302 -176.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.01 146.78 45.86 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.447 -0.575 . . . . 2.09 109.447 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.59 -26.24 9.14 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 123.927 0.775 . . . . 1.01 111.915 -169.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -84.71 151.63 24.29 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.195 0.998 . . . . 1.86 109.969 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -95.23 130.68 41.88 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.806 0.842 . . . . 6.14 108.851 175.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.6 pt -141.31 177.63 3.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 125.025 1.33 . . . . 1.73 108.243 177.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.8 mtm-85 -125.7 137.83 53.86 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 122.31 -0.244 . . . . 3.57 111.115 166.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.6 p -97.66 134.07 37.16 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.171 0 C-N-CA 124.686 1.194 . . . . 2.03 108.049 172.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.09 119.14 1.76 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.602 -0.999 . . . . 0.66 110.602 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.59 -163.34 29.27 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.295 -1.522 . . . . 0.71 109.295 -175.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.44 142.04 27.87 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.011 0.905 . . . . 3.51 111.733 -177.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 39.3 t -87.44 122.55 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-N 115.545 -0.752 . . . . 3.19 109.407 172.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.5 m -30.34 -91.62 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 128.843 2.857 . . . . 3.05 115.382 -175.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.5 p -172.42 -37.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 124.061 0.944 . . . . 3.24 111.027 -177.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -158.96 40.66 0.49 Allowed Glycine 0 CA--C 1.521 0.439 0 N-CA-C 109.617 -1.393 . . . . 1.87 109.617 174.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.3 m -82.25 -17.33 46.35 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.868 -0.195 . . . . 1.79 111.093 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.1 ttp -63.23 128.79 37.47 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 122.717 0.407 . . . . 3.4 110.487 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.5 m -135.22 143.99 35.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 108.132 -1.062 . . . . 1.62 108.132 172.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 47.8 ptt85 -132.39 147.52 52.39 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 124.422 1.089 . . . . 5.98 108.516 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -99.76 154.37 37.29 Favored Pre-proline 0 C--O 1.235 0.313 0 N-CA-C 107.944 -1.132 . . . . 2.09 107.944 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.41 44.71 1.56 Allowed 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.485 2.79 . . . . 1.86 111.526 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -105.75 -41.45 5.43 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.667 1.587 . . . . 1.71 109.088 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.2 m 107.55 -30.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 129.134 2.974 . . . . 3.18 110.214 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.34 32.87 4.83 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 124.321 1.048 . . . . 4.03 111.741 -177.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -140.04 110.08 6.49 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.41 -1.33 . . . . 4.45 107.41 175.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.75 134.17 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.226 -1.398 . . . . 2.11 107.226 177.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -144.46 157.17 44.37 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 120.884 -1.135 . . . . 1.0 109.199 175.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -155.09 161.02 41.4 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.691 -0.855 . . . . 3.25 108.691 -173.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -106.74 145.21 32.33 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.548 -0.908 . . . . 1.63 108.548 175.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.9 t -127.96 140.2 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 108.473 -0.936 . . . . 2.92 108.473 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -137.17 168.96 18.61 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.552 0.741 . . . . 1.77 110.195 -178.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.5 t0 . . . . . 0 CA--C 1.534 0.357 0 C-N-CA 123.733 0.813 . . . . 2.86 110.517 179.922 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.615 0 N-CA-C 106.98 -2.448 . . . . 1.68 106.98 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -126.87 128.75 46.99 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.084 -1.821 . . . . 3.74 106.084 174.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.2 tp -108.83 160.2 7.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 C-N-CA 125.36 1.464 . . . . 2.36 108.14 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 mt -114.65 133.38 55.9 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 108.231 -1.026 . . . . 1.99 108.231 -175.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 89.2 t -127.59 131.62 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 124.76 1.224 . . . . 2.22 107.798 -174.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.0 p -107.2 150.4 26.66 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.929 0.892 . . . . 1.75 109.762 178.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -147.39 140.62 25.25 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.49 1.516 . . . . 3.21 107.064 -173.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -132.95 41.45 3.15 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.366 1.066 . . . . 2.13 112.574 -168.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -168.25 53.24 0.05 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.557 0.743 . . . . 2.68 111.631 -176.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.2 mp 51.02 -155.03 0.14 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.827 1.251 . . . . 2.28 111.067 -171.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 81.8 mt -150.18 156.99 37.63 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 106.535 -1.654 . . . . 2.45 106.535 -178.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.22 -88.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.434 2.756 . . . . 1.95 110.556 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -77.1 36.36 0.18 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.814 1.246 . . . . 3.64 111.254 -175.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 39.89 11.67 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.824 2.849 . . . . 3.03 116.983 -163.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 56.08 96.83 0.02 OUTLIER 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.681 1.128 . . . . 4.67 109.911 -161.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 7.0 mtm180 -107.92 35.15 3.22 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 117.356 -1.306 . . . . 6.87 112.448 172.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . 0.378 4.3 mm-40 78.81 157.75 0.17 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 121.443 1.928 . . . . 4.51 112.99 140.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 52.1 26.59 20.44 Favored Glycine 0 CA--C 1.534 1.219 0 O-C-N 120.578 -1.326 . . . . 1.4 113.631 167.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -139.73 163.75 31.76 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.54 1.936 . . . . 2.83 105.813 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -89.28 145.77 18.66 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.74 -0.944 . . . . 0.96 110.74 174.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.7 pp -141.26 159.98 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 106.074 -1.824 . . . . 2.01 106.074 173.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.2 m -124.02 122.82 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 108.488 -0.93 . . . . 1.76 108.488 172.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -115.32 127.77 55.66 Favored 'General case' 0 C--O 1.228 -0.072 0 C-N-CA 125.747 1.619 . . . . 1.67 109.93 -172.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -106.74 134.99 49.04 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.863 1.265 . . . . 3.25 109.502 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -173.72 -175.93 41.79 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.398 -0.429 . . . . 1.49 112.97 -174.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.6 p -124.41 141.57 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 124.58 1.152 . . . . 2.2 109.394 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.2 mp -78.11 137.74 38.36 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.276 -0.875 . . . . 3.52 109.014 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -156.42 37.16 0.59 Allowed Glycine 0 CA--C 1.521 0.453 0 N-CA-C 111.3 -0.72 . . . . 2.58 111.3 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -157.45 27.86 0.29 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.882 0.873 . . . . 4.31 109.545 -175.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 43.91 41.72 4.09 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.045 0.938 . . . . 4.0 111.915 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 159.88 -60.33 0.31 Allowed Glycine 0 CA--C 1.529 0.947 0 N-CA-C 110.837 -0.905 . . . . 1.99 110.837 -171.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.44 160.69 20.53 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 122.307 -0.525 . . . . 3.74 111.096 -173.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 mp -125.26 126.26 44.86 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.072 0.949 . . . . 3.11 110.036 -170.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -92.8 108.97 20.4 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.096 -1.076 . . . . 1.81 108.096 172.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -134.04 102.05 5.27 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.425 0.69 . . . . 1.9 111.938 -173.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.8 t -86.43 -25.01 25.46 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.193 0.997 . . . . 2.07 111.843 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -88.43 79.43 7.69 Favored 'General case' 0 N--CA 1.455 -0.22 0 O-C-N 119.84 -1.788 . . . . 2.64 109.713 -174.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.9 m -96.42 122.37 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 118.306 0.503 . . . . 1.67 110.907 174.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -112.44 113.63 25.92 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.684 -1.599 . . . . 2.09 106.684 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -99.87 26.73 6.04 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.855 0.862 . . . . 2.36 112.606 -172.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.13 42.0 0.63 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.55 0.945 . . . . 6.3 113.55 -164.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 . . . . . 0 C--N 1.333 -0.111 0 O-C-N 121.585 -0.697 . . . . 6.23 109.216 173.49 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.465 0.317 0 N-CA-C 112.475 0.546 . . . . 3.04 112.475 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -84.13 126.49 33.15 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.424 1.49 . . . . 3.45 110.11 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.16 150.71 52.03 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.27 1.428 . . . . 4.15 110.518 -177.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 36.2 m -76.7 124.05 87.66 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 125.73 1.612 . . . . 3.28 111.48 -175.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -55.36 -43.4 58.81 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.987 2.458 . . . . 0.76 111.857 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.6 m -60.1 -25.17 65.22 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.131 0.789 . . . . 3.63 113.131 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -68.65 -56.88 6.73 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.139 -1.06 . . . . 3.25 108.139 171.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.6 pt -72.96 30.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 114.571 1.323 . . . . 2.09 114.571 -171.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.2 p -107.51 -29.73 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 125.214 1.406 . . . . 2.9 110.827 170.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -87.1 -118.7 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.969 0.89 . . . . 3.39 109.937 -170.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -84.88 66.61 3.84 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 108.554 -1.818 . . . . 2.39 108.554 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -142.38 -125.31 0.09 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.503 1.121 . . . . 3.72 108.074 -173.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -76.66 -38.4 54.6 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 119.183 0.901 . . . . 3.76 111.387 -172.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -58.31 -50.35 73.95 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.397 0.618 . . . . 2.74 109.537 -178.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.9 m -81.04 -24.95 37.5 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.211 -0.904 . . . . 2.37 111.269 177.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.21 43.34 47.61 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.663 1.125 . . . . 1.09 111.988 175.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.0 m -98.41 -42.18 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 117.657 0.728 . . . . 1.96 112.757 -172.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -109.71 -65.77 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.777 1.231 . . . . 4.42 111.975 -176.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -76.85 171.25 18.32 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 N-CA-C 108.224 -1.491 . . . . 1.18 108.224 169.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.5 158.56 43.82 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.351 0.66 . . . . 5.41 109.39 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.57 126.94 31.26 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.489 -1.3 . . . . 1.84 107.489 175.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 127.31 -17.68 6.19 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.275 1.417 . . . . 1.18 112.198 -176.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -93.31 148.7 21.82 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.192 0.997 . . . . 2.94 110.523 -172.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -85.49 134.58 34.04 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.051 -0.722 . . . . 3.98 109.051 172.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.1 pt -145.73 175.03 2.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 105.685 -1.969 . . . . 1.8 105.685 164.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -120.89 122.99 41.44 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.329 -1.36 . . . . 2.68 107.329 171.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.7 p -88.81 131.91 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 107.558 -1.275 . . . . 1.78 107.558 176.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -135.42 121.66 2.6 Favored Glycine 0 C--N 1.336 0.529 0 CA-C-N 119.052 0.842 . . . . 0.51 111.002 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -172.88 -172.47 38.56 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.907 -0.877 . . . . 0.59 110.907 -175.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -92.48 127.79 38.09 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.579 1.152 . . . . 5.68 109.649 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.7 t -77.65 146.97 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.583 -0.735 . . . . 3.23 109.721 176.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.1 m -55.66 -90.36 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.927 1.691 . . . . 3.04 114.155 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.4 p 176.16 -44.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.757 1.623 . . . . 2.43 109.956 -170.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -150.26 39.44 0.86 Allowed Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.382 -1.087 . . . . 2.16 110.382 176.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 61.6 m -87.22 -19.09 28.86 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 117.4 0.6 . . . . 1.61 112.153 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.3 ttp -71.76 123.82 23.44 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 118.803 0.729 . . . . 3.53 109.101 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.6 m -121.61 132.49 70.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 107.592 -1.262 . . . . 1.66 107.592 173.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.7 ptt85 -117.2 153.27 33.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.939 0.895 . . . . 6.21 109.904 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.28 170.19 17.39 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 109.9 -0.407 . . . . 2.5 109.9 170.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.35 -33.28 5.7 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.424 2.749 . . . . 1.61 110.604 163.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -46.13 -40.17 10.58 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 126.221 1.808 . . . . 1.65 110.232 -177.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.2 m 78.68 17.53 1.02 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.616 1.966 . . . . 1.71 112.666 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.76 23.96 7.21 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.445 0.698 . . . . 4.46 112.407 164.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -144.87 118.75 9.3 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.183 -1.043 . . . . 1.69 108.183 177.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.8 m -139.82 143.56 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 106.928 -1.508 . . . . 2.24 106.928 173.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -139.49 159.03 43.1 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.419 -0.586 . . . . 1.02 109.419 172.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -154.84 159.17 40.36 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 122.975 0.51 . . . . 3.2 109.73 -175.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.55 147.63 26.53 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.834 -0.802 . . . . 1.84 108.834 172.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.3 p -144.6 144.77 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 109.244 -0.65 . . . . 2.91 109.244 174.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -141.0 175.84 9.3 Favored 'General case' 0 C--O 1.228 -0.053 0 C-N-CA 125.359 1.464 . . . . 1.65 107.947 -175.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.3 t0 . . . . . 0 CA--C 1.534 0.348 0 CA-C-O 121.367 0.603 . . . . 2.67 110.97 175.632 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 108.345 -1.902 . . . . 1.81 108.345 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -135.67 145.78 47.12 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 105.745 -1.946 . . . . 3.32 105.745 178.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.36 139.32 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 107.351 -1.351 . . . . 2.16 107.351 176.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.0 mt -87.73 138.36 31.53 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.684 -0.858 . . . . 1.98 108.684 173.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.5 t -124.38 135.71 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 C-N-CA 126.002 1.721 . . . . 1.91 106.608 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.1 p -110.13 156.38 20.67 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.997 1.319 . . . . 1.43 108.236 178.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -151.7 108.07 3.45 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.597 -1.26 . . . . 4.19 107.597 177.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -84.17 51.36 2.05 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.733 1.213 . . . . 2.67 110.75 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -164.64 -178.17 5.19 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.867 1.267 . . . . 2.66 108.094 171.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.03 158.5 32.78 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.115 0.966 . . . . 2.19 111.563 169.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.1 mt -96.04 165.27 16.72 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 126.123 1.769 . . . . 2.67 109.923 174.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.96 -100.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.758 2.972 . . . . 2.2 109.4 172.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -78.32 54.55 1.42 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.281 1.033 . . . . 2.88 110.537 -175.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 42.1 18.58 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.822 2.449 . . . . 3.11 115.678 -171.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 6.2 t80 60.61 97.25 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.91 0.884 . . . . 3.48 110.688 -163.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 -77.91 111.45 13.77 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 105.736 -1.95 . . . . 9.27 105.736 175.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -81.99 173.78 11.88 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.778 0.323 . . . . 5.1 110.747 178.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.13 34.89 89.57 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.923 -0.471 . . . . 0.99 111.923 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -156.3 175.84 13.47 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.655 1.582 . . . . 3.22 107.136 175.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -92.87 134.89 12.39 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.565 -0.614 . . . . 1.07 111.565 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.2 pp -133.05 159.48 43.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.941 -0.763 . . . . 1.83 108.941 174.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 31.5 m -125.67 122.86 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 107.808 -1.182 . . . . 1.76 107.808 176.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -119.51 117.22 27.82 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.854 1.262 . . . . 1.42 109.901 -171.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -106.84 143.35 35.06 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.379 1.071 . . . . 3.74 110.711 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 179.66 -118.79 0.61 Allowed Glycine 0 C--N 1.335 0.501 0 N-CA-C 108.823 -1.711 . . . . 1.07 108.823 169.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.8 p -150.91 144.38 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 118.006 0.903 . . . . 2.06 109.217 -176.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.5 mt -81.98 139.36 34.61 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.306 -1.368 . . . . 3.47 107.306 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -177.43 26.4 0.06 OUTLIER Glycine 0 C--N 1.333 0.414 0 C-N-CA 119.045 -1.55 . . . . 2.64 113.053 -174.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -141.25 41.18 1.77 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.974 -0.75 . . . . 6.38 108.974 -172.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 22.28 57.84 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 129.541 3.136 . . . . 4.43 112.933 175.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 139.79 -33.84 2.08 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-N 115.377 -0.829 . . . . 1.26 112.492 -171.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.88 167.42 12.14 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.428 1.114 . . . . 3.4 110.334 -175.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.4 mt -118.15 128.94 55.21 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.659 1.183 . . . . 2.85 109.486 -174.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -89.15 94.66 10.01 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.096 -1.446 . . . . 1.68 107.096 175.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -115.5 111.29 20.52 Favored 'General case' 0 C--O 1.228 -0.069 0 C-N-CA 122.949 0.5 . . . . 1.77 110.163 -173.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.85 -43.66 8.1 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.12 0.968 . . . . 2.19 110.44 -174.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -84.51 79.06 9.7 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.95 -1.13 . . . . 3.91 107.95 -170.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.4 m -90.0 96.44 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 125.794 1.637 . . . . 1.91 111.262 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.81 149.97 20.93 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 108.81 -0.811 . . . . 2.0 108.81 175.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -126.56 70.72 1.26 Allowed 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 123.894 0.878 . . . . 2.47 109.915 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -65.27 -10.04 29.02 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.482 0.919 . . . . 4.49 113.482 -177.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 76.5 m80 . . . . . 0 CA--C 1.532 0.263 0 C-N-CA 123.468 0.707 . . . . 6.99 109.63 176.283 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.0 pp . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 112.693 0.627 . . . . 3.24 112.693 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -92.29 127.64 37.84 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.773 1.629 . . . . 3.46 111.366 -175.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.59 152.32 50.09 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.21 1.804 . . . . 3.93 110.405 -173.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.4 m -89.91 129.35 46.62 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.103 1.361 . . . . 2.86 111.525 -174.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -57.23 -53.24 5.06 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.543 2.828 . . . . 0.83 112.594 -176.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.0 m -57.38 -12.41 2.51 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 114.29 1.219 . . . . 3.98 114.29 176.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -82.67 -53.17 6.14 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 118.861 0.755 . . . . 3.09 108.985 170.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 26.8 pt -73.27 33.11 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 114.106 1.151 . . . . 1.98 114.106 -176.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.0 m -126.64 -54.61 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 126.323 1.849 . . . . 4.04 109.786 169.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -65.23 -34.49 78.49 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.701 0.8 . . . . 2.77 112.761 -163.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.62 68.71 0.1 OUTLIER Glycine 0 C--N 1.335 0.518 0 N-CA-C 110.27 -1.132 . . . . 2.5 110.27 -177.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -165.41 -99.24 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.992 1.717 . . . . 3.87 108.36 -171.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 55.8 m -62.99 -63.71 1.12 Allowed 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 119.094 0.861 . . . . 2.13 110.561 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.2 -44.8 64.93 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.777 0.799 . . . . 3.57 111.162 -172.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.79 -17.81 52.48 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.619 1.168 . . . . 2.49 112.516 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 53.36 52.05 43.4 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.76 1.648 . . . . 1.41 112.233 -175.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.1 m -105.99 -60.33 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 117.94 0.87 . . . . 2.3 113.088 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.1 mmtt -80.18 -61.49 0.44 Allowed Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 118.512 -0.756 . . . . 4.58 112.339 -178.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -79.82 148.68 20.09 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 121.891 1.727 . . . . 1.59 108.643 174.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -93.12 145.93 24.03 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.004 -1.11 . . . . 3.7 108.004 165.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.88 169.02 5.58 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.136 0.574 . . . . 2.39 110.33 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.04 33.82 86.92 Favored Glycine 0 CA--C 1.532 1.1 0 O-C-N 121.928 -0.482 . . . . 1.25 112.57 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -118.54 159.1 24.15 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.308 1.043 . . . . 1.98 108.764 170.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.5 128.02 45.59 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.122 1.369 . . . . 5.79 108.765 -177.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.2 pt -146.17 176.84 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 124.062 0.945 . . . . 1.96 108.56 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.3 mtt85 -119.14 130.66 55.66 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.679 -0.86 . . . . 3.64 108.679 167.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.9 p -95.43 130.37 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 107.041 -1.466 . . . . 1.95 107.041 171.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.58 120.06 1.88 Allowed Glycine 0 C--N 1.332 0.36 0 N-CA-C 110.131 -1.188 . . . . 0.47 110.131 -176.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.47 -159.67 21.87 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.45 -1.46 . . . . 0.63 109.45 -178.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.69 132.22 46.19 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.918 0.866 . . . . 3.75 111.922 -174.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.1 t -86.47 111.7 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.433 -0.951 . . . . 3.04 108.433 176.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 t -5.82 -102.31 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 128.624 2.769 . . . . 4.05 114.668 163.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.7 p -158.69 -41.59 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 N-CA-C 113.548 0.944 . . . . 2.74 113.548 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -161.26 33.33 0.38 Allowed Glycine 0 C--N 1.332 0.357 0 N-CA-C 110.995 -0.842 . . . . 3.0 110.995 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.2 m -80.25 12.73 2.72 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.739 0.644 . . . . 1.87 112.739 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -78.04 107.6 10.72 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.948 -1.13 . . . . 3.08 107.948 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -106.83 127.65 62.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 108.043 -1.095 . . . . 1.69 108.043 176.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.37 142.75 38.24 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.071 0.949 . . . . 6.0 110.273 178.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -71.79 158.02 88.56 Favored Pre-proline 0 C--O 1.232 0.146 0 C-N-CA 123.18 0.592 . . . . 2.13 109.521 170.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.4 -24.64 64.1 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.73 2.287 . . . . 1.38 112.346 170.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 76.1 m-80 -44.69 -34.4 2.21 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.11 0.564 . . . . 1.43 110.886 165.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.9 m 75.2 1.53 3.73 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.801 1.64 . . . . 1.59 112.73 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.77 -13.74 8.23 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.937 1.695 . . . . 3.09 112.689 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -106.48 121.41 44.21 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 105.897 -1.89 . . . . 1.6 105.897 176.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.0 m -145.88 137.87 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 107.314 -1.365 . . . . 1.96 107.314 -172.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -139.46 152.68 47.2 Favored 'General case' 0 C--O 1.233 0.223 0 O-C-N 121.604 -0.685 . . . . 1.1 110.452 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -150.88 158.19 43.84 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.981 -0.554 . . . . 3.21 110.411 -173.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -112.51 141.72 45.92 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.688 -1.227 . . . . 1.91 107.688 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.5 p -141.87 146.16 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.244 0.618 . . . . 3.15 109.95 -174.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -145.2 -177.94 5.81 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.99 1.316 . . . . 1.84 109.49 -170.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.2 t70 . . . . . 0 CA--C 1.534 0.359 0 C-N-CA 123.436 0.694 . . . . 2.29 109.858 175.622 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.852 0 CA-C-O 118.748 -1.029 . . . . 2.2 111.074 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -117.61 132.08 56.57 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 108.024 -1.102 . . . . 3.5 108.024 174.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.6 tp -114.71 160.06 14.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 124.292 1.037 . . . . 2.14 108.403 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.2 mt -112.28 128.81 56.38 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.6 0.76 . . . . 1.97 109.091 -173.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.0 t -114.77 125.8 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 125.52 1.528 . . . . 2.19 107.549 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.9 p -102.22 138.9 38.55 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.904 -0.776 . . . . 1.93 108.904 175.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -132.7 111.74 11.42 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.134 1.374 . . . . 3.33 107.415 -176.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -98.79 45.96 1.0 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.161 1.384 . . . . 1.94 110.998 -176.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -164.6 -178.49 5.38 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.325 1.85 . . . . 2.74 107.526 170.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.4 mp -80.77 148.66 29.96 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.738 0.78 . . . . 2.24 111.462 176.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -76.72 159.37 79.25 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 124.955 1.302 . . . . 3.71 110.295 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.29 -90.3 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.514 2.809 . . . . 2.12 109.274 168.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.88 50.05 0.56 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.765 1.626 . . . . 3.03 110.781 178.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . 0.254 0.3 OUTLIER 44.15 7.4 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 118.53 2.789 . . . . 4.23 118.53 -177.653 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 79.4 t80 72.26 99.56 0.07 Allowed 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 126.148 1.779 . . . . 4.35 109.192 -162.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -81.38 103.45 11.14 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.092 0.957 . . . . 5.58 109.75 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -80.95 163.86 23.0 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.099 0.863 . . . . 3.19 111.932 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.56 17.4 66.68 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 118.594 -1.114 . . . . 1.47 113.372 172.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -157.29 42.13 0.33 Allowed 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 119.308 1.554 . . . . 4.45 113.452 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 31.29 141.53 0.0 OUTLIER Glycine 0 CA--C 1.531 1.079 0 C-N-CA 128.689 3.043 . . . . 2.48 118.847 -172.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.3 pp -140.39 163.23 23.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 120.099 -1.824 . . . . 2.23 107.537 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.6 m -110.28 137.05 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 107.628 -1.249 . . . . 1.9 107.628 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -123.12 128.84 50.64 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 124.076 0.95 . . . . 1.71 109.185 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -111.06 140.02 45.95 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.687 -0.486 . . . . 3.66 109.687 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 168.81 -152.04 19.3 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 121.028 -0.606 . . . . 1.07 111.606 173.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.1 p -113.76 145.73 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.008 0.923 . . . . 1.82 108.917 -169.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -55.22 142.52 31.11 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.437 -0.579 . . . . 2.95 109.437 168.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.51 -131.71 1.6 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.312 -1.115 . . . . 2.32 110.312 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -63.31 -82.24 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.339 1.056 . . . . 5.61 109.886 -177.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -159.65 62.67 0.37 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 107.828 -1.175 . . . . 3.72 107.828 173.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 163.52 -61.04 0.26 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.102 -1.199 . . . . 1.21 110.102 -172.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.18 160.87 26.76 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.692 -0.887 . . . . 3.01 108.994 -175.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 mp -122.68 137.34 54.94 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 109.62 -0.511 . . . . 3.06 109.62 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -103.37 103.24 13.22 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.365 -0.976 . . . . 1.79 108.365 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -131.15 115.42 16.36 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 122.587 0.355 . . . . 1.67 111.017 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.2 t -109.42 -15.44 14.23 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.586 1.154 . . . . 1.92 111.749 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -104.21 80.2 1.69 Allowed 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.626 -1.296 . . . . 3.15 109.081 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.6 m -90.12 149.44 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 118.784 0.72 . . . . 1.7 111.496 174.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.17 142.81 51.37 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.283 -1.006 . . . . 1.96 108.283 169.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -122.9 65.46 0.97 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.426 1.09 . . . . 1.8 111.109 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.21 42.58 1.04 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.777 0.658 . . . . 3.8 112.777 -175.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 29.2 m170 . . . . . 0 CA--C 1.535 0.369 0 C-N-CA 123.666 0.786 . . . . 7.01 110.122 -175.487 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.6 pt? . . . . . 0 N--CA 1.464 0.248 0 N-CA-C 112.022 0.378 . . . . 2.57 112.022 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -83.72 122.36 28.53 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.433 1.093 . . . . 3.41 109.059 176.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.33 159.58 37.49 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.282 1.033 . . . . 4.57 108.853 171.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 53.3 p -79.73 148.4 68.99 Favored Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 109.147 -0.686 . . . . 2.44 109.147 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -60.87 -28.87 87.07 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 121.335 1.356 . . . . 0.99 110.697 176.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.5 p -52.67 -28.8 23.21 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.153 0.981 . . . . 2.91 112.775 171.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -81.78 -10.48 59.33 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.019 -0.425 . . . . 2.16 111.424 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.3 pt -127.68 34.19 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 O-C-N 120.788 -1.195 . . . . 1.99 113.832 -176.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.6 m -119.85 -23.66 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 119.129 0.877 . . . . 4.19 113.072 -176.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -139.21 132.28 29.59 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 107.123 -1.436 . . . . 4.04 107.123 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.59 -73.06 1.2 Allowed Glycine 0 CA--C 1.529 0.931 0 CA-C-O 122.465 1.036 . . . . 3.84 111.173 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.4 mttt -44.1 -83.77 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 129.891 3.276 . . . . 5.16 111.428 -174.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.2 m -75.63 -48.02 23.95 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 121.273 1.851 . . . . 2.48 109.803 171.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -49.74 -36.78 26.88 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.078 1.14 . . . . 3.4 114.078 -172.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.1 m -123.96 19.09 9.28 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.266 1.426 . . . . 3.34 109.602 176.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 48.13 37.01 16.36 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 117.245 -1.864 . . . . 2.25 114.7 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.257 21.9 m -82.85 -43.08 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 122.106 2.953 . . . . 2.34 113.18 -168.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -93.73 -64.01 0.14 Allowed Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.585 1.154 . . . . 5.79 112.718 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.38 166.14 30.68 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.484 2.122 . . . . 1.8 109.705 176.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -118.65 129.25 55.2 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.335 0.654 . . . . 4.67 109.907 170.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.12 111.74 1.29 Allowed 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.513 -0.551 . . . . 2.2 109.513 173.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 133.65 -20.81 4.08 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 124.363 0.982 . . . . 1.72 111.567 -176.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -83.18 155.85 23.53 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 117.758 0.779 . . . . 3.37 109.211 177.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.0 mtt-85 -87.2 144.95 26.6 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.669 -0.863 . . . . 5.61 108.669 170.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.4 pt -146.96 173.4 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 106.505 -1.665 . . . . 1.95 106.505 170.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -124.67 118.36 26.31 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.516 -1.29 . . . . 2.86 107.516 174.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.27 121.13 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.666 -1.235 . . . . 1.81 107.666 177.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -127.83 123.44 4.47 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 109.907 -1.277 . . . . 0.49 109.907 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.79 -162.66 23.52 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 108.068 -2.013 . . . . 0.64 108.068 -176.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.78 137.02 37.97 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.804 0.811 . . . . 3.46 110.565 177.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.5 t -79.23 137.86 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 108.5 -0.926 . . . . 3.17 108.5 171.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.451 ' HG1' ' CD2' ' A' ' 85' ' ' HIS . 1.1 m -89.92 148.65 23.0 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.317 -0.994 . . . . 2.79 108.317 169.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.4 p -57.67 -61.12 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.189 0.996 . . . . 2.65 110.796 178.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.55 73.46 2.05 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 109.161 -1.575 . . . . 2.15 109.161 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.5 m -148.51 -44.42 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.152 0.797 . . . . 1.65 113.152 -177.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.81 122.31 17.39 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.227 0.467 . . . . 2.69 110.162 -177.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.24 120.42 48.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 108.336 -0.987 . . . . 1.77 108.336 169.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.29 147.89 24.19 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.912 1.285 . . . . 5.42 109.407 177.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -76.34 154.92 84.15 Favored Pre-proline 0 N--CA 1.455 -0.211 0 N-CA-C 109.008 -0.738 . . . . 1.91 109.008 171.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -63.89 -22.8 68.68 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.608 2.205 . . . . 1.17 111.963 166.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -47.22 -29.12 2.19 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.401 0.68 . . . . 1.12 110.809 164.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.1 m 68.71 15.97 8.99 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 125.261 1.424 . . . . 1.57 112.081 176.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.2 pp -125.8 -41.57 1.97 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 126.712 2.005 . . . . 2.71 111.744 -178.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -85.43 132.31 34.24 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.538 -1.282 . . . . 1.42 107.538 175.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.18 127.91 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 107.058 -1.46 . . . . 1.98 107.058 176.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -130.48 149.9 51.94 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.018 -0.734 . . . . 1.0 109.018 176.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -145.3 143.35 30.15 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.33 -0.618 . . . . 3.26 109.33 -175.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.84 141.87 33.05 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.327 -0.99 . . . . 1.7 108.327 164.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.6 p -128.02 153.48 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 107.472 -1.307 . . . . 2.85 107.472 170.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.451 ' CD2' ' HG1' ' A' ' 67' ' ' THR . 5.3 p80 -140.18 179.96 6.33 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.235 0.471 . . . . 2.02 111.735 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.2 t70 . . . . . 0 N--CA 1.448 -0.544 0 C-N-CA 124.461 1.104 . . . . 2.34 108.278 -177.821 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.559 0 CA-C-O 118.721 -1.044 . . . . 2.57 113.296 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -63.43 108.57 1.37 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.295 1.547 . . . . 3.18 110.216 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -130.53 143.85 39.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 108.447 -0.945 . . . . 2.44 108.447 176.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 17.9 mt -92.02 126.01 36.94 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.273 1.029 . . . . 2.07 110.75 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.5 t -108.84 122.79 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 125.879 1.671 . . . . 1.95 107.504 175.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.6 p -102.4 136.15 42.75 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.321 1.048 . . . . 1.46 108.954 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -130.85 109.22 10.41 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.222 1.409 . . . . 3.1 107.933 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -91.93 47.91 1.39 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.885 1.274 . . . . 2.33 111.683 -176.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -167.68 173.37 8.53 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.22 1.808 . . . . 2.53 107.07 170.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.4 mp -70.37 127.02 31.32 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.981 -1.074 . . . . 2.27 111.261 -177.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.9 mt -73.44 149.67 88.91 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 123.94 0.896 . . . . 2.34 110.75 174.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -68.53 140.95 49.08 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.838 3.026 . . . . 2.22 109.696 175.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 45.85 43.92 10.48 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.307 1.443 . . . . 3.17 111.238 -175.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 47.68 16.39 0.07 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 127.229 2.212 . . . . 2.82 115.332 -171.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 69.0 t80 59.61 103.72 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.231 1.412 . . . . 4.03 110.204 -161.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -78.75 119.93 22.67 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.238 -0.892 . . . . 6.49 108.696 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -83.68 165.13 19.19 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 123.311 0.644 . . . . 3.0 111.044 -174.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.06 25.39 69.09 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 119.58 -0.567 . . . . 0.93 114.146 172.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -143.55 170.57 15.58 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.734 1.214 . . . . 3.45 108.075 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -84.92 129.28 9.14 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 109.775 -1.33 . . . . 1.0 109.775 175.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.5 pp -136.17 152.77 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 106.434 -1.691 . . . . 1.7 106.434 171.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 18.1 m -115.99 125.69 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 107.863 -1.162 . . . . 1.93 107.863 177.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -116.46 134.39 54.92 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 125.09 1.356 . . . . 1.49 109.839 -170.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -126.23 143.28 51.2 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.945 1.298 . . . . 3.14 110.628 -176.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 176.51 -123.43 0.9 Allowed Glycine 0 C--N 1.334 0.44 0 N-CA-C 108.55 -1.82 . . . . 0.83 108.55 169.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.4 p -139.46 150.98 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 118.381 1.09 . . . . 1.89 109.346 -175.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -55.61 133.81 50.69 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.871 -0.604 . . . . 2.89 109.789 171.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.74 -135.51 2.35 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 109.135 -1.586 . . . . 2.34 109.135 173.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -74.1 78.25 1.74 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 109.155 -0.683 . . . . 5.68 109.155 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.8 t0 19.34 61.37 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 129.414 3.086 . . . . 4.61 113.086 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 166.73 -54.4 0.24 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.825 -0.91 . . . . 1.42 110.825 -163.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.61 154.05 19.3 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 122.246 -0.561 . . . . 3.57 109.521 172.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -111.48 123.84 51.05 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.442 1.097 . . . . 3.1 108.646 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -97.25 93.62 6.63 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.054 -1.091 . . . . 1.69 108.054 175.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.55 136.8 47.56 Favored 'General case' 0 C--O 1.227 -0.117 0 N-CA-C 109.46 -0.57 . . . . 1.56 109.46 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.9 t -124.65 -26.68 3.79 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.236 1.014 . . . . 2.0 112.743 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -89.48 88.3 7.4 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 120.472 -1.393 . . . . 3.17 108.357 177.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.1 m -99.37 125.83 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 118.873 0.76 . . . . 1.69 110.798 174.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.03 113.12 20.46 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.171 -1.418 . . . . 1.67 107.171 178.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.41 101.85 10.12 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 108.291 -1.003 . . . . 1.98 108.291 172.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -143.21 65.84 1.32 Allowed 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.431 0.692 . . . . 3.75 109.461 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 106.077 -1.823 . . . . 6.61 106.077 175.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.367 0 N-CA-C 112.948 0.721 . . . . 4.59 112.948 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -85.61 122.59 29.94 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 123.812 0.845 . . . . 3.55 109.384 170.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -140.78 169.17 18.13 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.768 0.827 . . . . 4.81 109.84 171.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.2 p -91.6 148.06 36.53 Favored Pre-proline 0 N--CA 1.45 -0.471 0 C-N-CA 124.096 0.958 . . . . 3.02 110.737 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -60.98 -35.85 85.77 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.564 2.843 . . . . 1.16 111.354 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.1 p -50.57 -38.6 46.2 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.918 1.287 . . . . 3.11 112.031 174.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -60.27 -57.33 13.26 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.074 -1.084 . . . . 2.13 108.074 177.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.256 19.5 pt -74.87 21.36 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 115.128 1.529 . . . . 2.2 115.128 -166.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.7 p -107.13 -33.56 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 125.02 1.328 . . . . 3.0 112.127 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -116.57 94.14 4.5 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.29 -0.881 . . . . 2.21 110.141 -170.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.31 45.66 46.72 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.739 -0.945 . . . . 2.11 110.739 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.23 -159.33 0.88 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 103.902 -2.629 . . . . 3.17 103.902 178.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.0 m -41.32 -45.83 3.1 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.445 1.898 . . . . 2.69 115.078 -167.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -51.11 -47.72 61.9 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.833 0.742 . . . . 2.97 112.014 176.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.1 m -78.2 -32.95 50.25 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.148 0.579 . . . . 2.15 111.02 174.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.43 48.49 18.29 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.429 1.014 . . . . 1.31 111.145 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -89.37 -91.61 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 117.042 0.421 . . . . 2.26 110.677 177.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 19.0 mmmt -65.71 -56.67 17.01 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 118.452 -0.785 . . . . 4.12 111.945 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.86 120.95 5.25 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 121.426 1.417 . . . . 1.22 109.844 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.24 165.74 18.09 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.582 0.753 . . . . 4.61 109.053 170.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.41 173.63 7.63 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 109.07 -0.715 . . . . 2.29 109.07 171.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.16 -2.5 84.2 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 121.033 -1.042 . . . . 1.13 113.471 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -94.15 148.8 21.84 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.282 1.041 . . . . 1.84 109.198 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -92.78 130.04 38.52 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.105 -0.702 . . . . 5.08 109.105 172.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.5 pt -142.66 167.3 14.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 106.426 -1.694 . . . . 1.79 106.426 168.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.2 mtt180 -118.09 115.08 24.1 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.88 -1.526 . . . . 2.35 106.88 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.7 p -92.79 123.54 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.767 -1.197 . . . . 2.06 107.767 178.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.34 148.97 20.63 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 118.975 0.807 . . . . 1.24 111.682 -177.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 167.13 -100.45 0.17 Allowed Glycine 0 C--N 1.335 0.517 0 N-CA-C 109.077 -1.609 . . . . 1.79 109.077 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.7 ptp -145.46 131.23 19.02 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.738 0.769 . . . . 3.62 110.016 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.2 p -67.11 157.08 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 119.483 -0.887 . . . . 3.67 109.726 178.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.7 -9.88 31.66 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.908 1.077 . . . . 3.39 113.908 175.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.253 7.6 p 49.51 68.76 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 123.863 1.792 . . . . 4.67 111.564 177.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 142.57 47.75 0.05 OUTLIER Glycine 0 CA--C 1.526 0.731 0 CA-C-N 111.874 -2.421 . . . . 2.11 109.861 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.0 m -156.45 -7.52 0.1 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 114.824 1.416 . . . . 1.94 114.824 177.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.92 109.89 1.39 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 121.449 1.931 . . . . 2.96 108.278 171.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.2 m -124.66 134.92 65.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 108.459 -0.941 . . . . 2.01 108.459 174.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.3 ptt85 -113.67 151.05 32.35 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.424 1.089 . . . . 5.83 109.677 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.07 160.52 65.63 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 123.082 0.553 . . . . 1.81 110.268 175.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -74.54 -26.45 11.89 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.479 2.786 . . . . 1.22 110.584 171.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -43.4 -38.57 2.82 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 124.595 1.158 . . . . 1.71 109.023 169.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.2 m 79.38 2.7 2.28 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.687 1.995 . . . . 1.57 112.012 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.16 31.19 6.07 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.056 2.142 . . . . 3.15 109.27 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -156.56 132.49 9.69 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.789 -0.819 . . . . 2.13 108.789 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.89 134.47 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 125.75 1.62 . . . . 1.93 109.026 -177.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -138.03 158.64 43.91 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 120.826 -1.171 . . . . 1.02 110.783 172.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -155.36 153.4 30.4 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.363 0.665 . . . . 3.28 109.845 -174.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -112.2 134.8 53.54 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.685 0.794 . . . . 1.6 109.633 -179.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.8 t -126.04 142.78 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 108.189 -1.041 . . . . 2.9 108.189 -173.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -139.42 -175.39 4.17 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.859 -0.793 . . . . 1.97 108.859 177.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.1 t0 . . . . . 0 CA--C 1.534 0.353 0 C-N-CA 124.781 1.232 . . . . 2.58 109.327 177.052 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.902 0 N-CA-C 109.804 -1.318 . . . . 2.68 109.804 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -116.88 159.41 22.44 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.246 2.218 . . . . 2.93 107.557 178.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -137.77 163.91 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 108.236 -1.024 . . . . 1.87 108.236 166.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.7 mt -112.94 132.52 55.31 Favored 'General case' 0 C--N 1.338 0.087 0 C-N-CA 124.625 1.17 . . . . 1.68 108.685 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.3 t -118.25 129.94 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 125.193 1.397 . . . . 1.87 107.477 -177.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.8 p -107.74 149.75 27.79 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.298 1.039 . . . . 1.68 108.299 177.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -144.1 129.75 19.17 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.05 -1.463 . . . . 4.31 107.05 176.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -69.33 -84.31 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.359 -0.838 . . . . 2.9 110.379 166.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -56.97 163.28 2.06 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.983 0.897 . . . . 2.57 112.825 -172.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 mp -63.45 145.54 55.42 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 122.225 1.012 . . . . 2.35 111.986 -174.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 24.9 mt -67.85 156.4 89.4 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 115.023 -0.99 . . . . 2.42 109.997 169.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.77 -89.4 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.492 3.461 . . . . 2.35 109.619 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.2 17.82 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.94 1.296 . . . . 2.9 113.581 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 16.5 tp 53.24 20.6 1.92 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.485 1.114 . . . . 4.56 111.937 -167.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 49.55 81.75 0.05 Allowed 'General case' 0 C--N 1.344 0.368 0 C-N-CA 124.94 1.296 . . . . 3.86 110.828 173.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.294 7.8 mmm180 -87.72 29.75 0.88 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 117.872 -1.531 . . . . 6.76 112.452 -166.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . 0.604 25.9 mt-10 80.26 161.87 0.17 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.517 1.527 . . . . 4.51 111.807 157.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 29.9 52.95 0.19 Allowed Glycine 0 CA--C 1.533 1.198 0 C-N-CA 126.346 1.927 . . . . 1.33 115.785 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -152.54 51.34 0.77 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.853 1.326 . . . . 3.43 112.536 -174.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 4.67 98.34 0.0 OUTLIER Glycine 0 CA--C 1.535 1.332 0 C-N-CA 127.888 2.661 . . . . 1.58 116.354 -174.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.0 pp -108.4 165.13 5.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 106.977 -1.49 . . . . 1.85 106.977 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.6 m -123.62 133.97 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 107.583 -1.266 . . . . 1.86 107.583 173.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -126.54 138.1 53.44 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.15 1.78 . . . . 1.87 108.891 -170.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -143.02 155.88 44.73 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.972 0.805 . . . . 3.89 112.403 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -177.08 -100.26 0.13 Allowed Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 108.386 -1.886 . . . . 1.38 108.386 172.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.9 p -155.91 151.0 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 118.153 0.976 . . . . 1.83 110.153 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.1 mp -85.64 150.95 24.26 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.226 1.01 . . . . 3.43 108.809 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -166.99 -53.86 0.03 OUTLIER Glycine 0 C--O 1.227 -0.322 0 C-N-CA 120.577 -0.82 . . . . 2.38 111.223 177.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -64.18 144.19 57.31 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.36 -0.978 . . . . 5.8 108.36 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.31 58.99 2.21 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.188 1.795 . . . . 4.84 109.268 -172.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 127.4 18.53 2.02 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 127.123 2.297 . . . . 1.74 113.6 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.29 160.63 38.98 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.937 1.369 . . . . 3.64 109.63 166.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.16 129.39 54.98 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.437 1.095 . . . . 3.43 108.351 -172.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -90.44 95.25 10.08 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 107.767 -1.197 . . . . 1.63 107.767 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.84 140.86 41.71 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 123.346 0.658 . . . . 1.57 109.972 -176.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -125.24 -47.22 1.76 Allowed 'General case' 0 C--O 1.232 0.165 0 C-N-CA 123.864 0.866 . . . . 2.14 111.254 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -83.42 101.36 11.32 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 106.3 -1.741 . . . . 3.52 106.3 -173.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.4 m -108.51 116.31 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 125.932 1.693 . . . . 1.84 109.266 -178.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.13 113.25 25.8 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.89 -1.152 . . . . 1.8 107.89 -177.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -99.82 45.64 0.98 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.322 1.049 . . . . 1.62 111.581 -176.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.43 48.91 1.08 Allowed 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.136 -0.977 . . . . 3.69 111.628 -175.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.5 p80 . . . . . 0 CA--C 1.53 0.205 0 O-C-N 121.734 -0.604 . . . . 8.23 110.252 -175.633 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.6 pt? . . . . . 0 N--CA 1.463 0.209 0 N-CA-C 110.727 -0.101 . . . . 2.72 110.727 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -83.78 129.72 34.94 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.395 1.078 . . . . 3.29 110.138 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -132.75 144.32 50.19 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.127 1.371 . . . . 4.44 110.556 -178.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.0 m -76.39 133.67 71.01 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 125.707 1.603 . . . . 3.19 110.677 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.48 -41.35 58.24 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.527 2.151 . . . . 0.94 112.673 -178.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.7 t -47.96 -49.81 29.24 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 121.628 -0.67 . . . . 3.14 111.858 175.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -48.42 -56.3 8.58 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.901 0.88 . . . . 2.39 108.992 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 32.9 pt -70.09 -10.13 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 113.883 1.068 . . . . 2.28 113.883 -173.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.9 t -82.04 -28.68 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 118.74 0.7 . . . . 2.9 111.014 170.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -117.57 90.58 3.36 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 121.196 -0.94 . . . . 1.98 111.426 -161.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.72 41.22 89.49 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.228 -1.149 . . . . 2.09 110.228 177.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.68 -154.0 0.47 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 128.878 2.871 . . . . 3.26 103.406 174.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.2 m -26.84 -60.57 0.09 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 116.498 2.036 . . . . 2.0 116.498 -165.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -39.04 -51.46 1.84 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.265 0.939 . . . . 3.1 111.671 175.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.08 -21.81 18.89 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.171 2.188 . . . . 2.17 110.829 -175.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.12 31.34 80.52 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 126.3 1.905 . . . . 1.11 113.794 171.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.8 m -80.55 -37.3 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 118.283 1.042 . . . . 2.18 112.043 -174.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 33.0 mmtt -107.94 -75.41 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 124.665 1.186 . . . . 3.76 111.281 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -73.04 116.78 4.84 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 CA-C-N 120.782 1.315 . . . . 1.24 109.689 176.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -76.48 161.5 28.58 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.518 0.727 . . . . 3.22 109.77 170.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.9 169.64 6.41 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.079 0.951 . . . . 1.95 111.261 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.12 5.8 66.85 Favored Glycine 0 CA--C 1.532 1.137 0 O-C-N 121.803 -0.56 . . . . 1.12 113.584 176.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -91.3 155.39 18.57 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 118.319 1.06 . . . . 1.73 109.125 175.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -97.24 130.67 44.42 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.29 0.636 . . . . 3.69 109.515 177.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.1 pt -146.36 177.56 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 106.74 -1.578 . . . . 1.87 106.74 173.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 42.1 mtt85 -119.41 116.4 26.07 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.881 -1.155 . . . . 4.03 107.881 167.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.6 p -80.99 127.4 39.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 N-CA-C 107.18 -1.415 . . . . 1.97 107.18 174.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.4 122.57 3.31 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 109.678 -1.369 . . . . 0.75 109.678 -177.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -169.84 -170.09 33.85 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 109.383 -1.487 . . . . 0.83 109.383 -175.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.2 ptp -99.37 137.38 37.95 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.354 0.662 . . . . 3.71 109.508 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.4 m -100.76 135.81 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 122.606 0.362 . . . . 3.67 111.43 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.441 ' HG1' ' CD2' ' A' ' 85' ' ' HIS . 1.3 m -73.57 151.64 40.85 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.364 1.066 . . . . 2.68 109.292 176.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.5 p -55.57 -56.14 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 125.351 1.46 . . . . 2.83 111.173 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.07 71.63 1.22 Allowed Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.625 -1.39 . . . . 1.68 109.625 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.3 m -151.98 46.82 0.77 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 117.758 0.779 . . . . 2.51 112.28 -176.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.44 121.94 20.65 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 105.862 -1.903 . . . . 2.63 105.862 176.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.0 m -132.72 140.04 48.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 119.584 1.083 . . . . 1.81 108.705 170.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -122.22 150.9 41.63 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.37 1.068 . . . . 7.36 110.57 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.66 156.09 75.56 Favored Pre-proline 0 N--CA 1.453 -0.299 0 N-CA-C 109.809 -0.441 . . . . 2.0 109.809 170.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -68.3 -24.38 37.53 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.873 2.382 . . . . 1.67 111.466 166.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -45.45 -36.62 4.52 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.773 -0.454 . . . . 1.53 109.773 163.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.8 m 66.17 10.65 7.27 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 125.04 1.336 . . . . 1.74 112.999 176.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.2 pp -125.12 9.42 8.04 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 128.687 2.795 . . . . 2.6 110.2 175.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -137.79 130.34 29.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.09 -1.819 . . . . 1.58 106.09 176.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.5 146.0 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 107.036 -1.468 . . . . 2.32 107.036 -170.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -152.12 153.94 34.9 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 121.593 -0.692 . . . . 1.48 110.118 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -145.99 156.06 43.24 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.924 -0.58 . . . . 3.22 109.646 -171.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.91 140.5 37.6 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.451 -0.574 . . . . 1.93 109.451 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.0 t -120.9 151.5 23.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 106.899 -1.519 . . . . 2.97 106.899 176.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.441 ' CD2' ' HG1' ' A' ' 67' ' ' THR . 3.2 p80 -133.18 -177.25 4.43 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.685 0.794 . . . . 2.17 109.489 177.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 35.3 t70 . . . . . 0 N--CA 1.45 -0.431 0 C-N-CA 123.869 0.868 . . . . 3.28 109.197 177.963 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.447 0 N-CA-C 111.319 -0.712 . . . . 2.14 111.319 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -63.11 114.27 3.64 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.383 0.673 . . . . 3.24 109.238 -174.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.3 153.53 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 C-N-CA 124.391 1.076 . . . . 2.17 108.606 -178.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.8 mt -114.01 129.18 56.62 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.087 0.955 . . . . 1.87 108.582 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.3 t -116.03 130.1 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.229 1.412 . . . . 1.97 107.193 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 81.6 p -106.21 150.12 26.19 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.864 0.866 . . . . 1.45 110.235 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -144.13 120.59 11.01 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.305 1.442 . . . . 3.22 107.618 -174.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -109.58 46.49 1.0 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.34 1.456 . . . . 2.07 111.985 -169.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -170.32 -178.2 2.68 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 128.334 2.654 . . . . 2.68 105.614 169.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.6 mp -71.02 141.67 50.94 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.89 1.223 . . . . 2.11 111.363 175.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.51 161.36 35.39 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.342 1.057 . . . . 3.9 110.372 171.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -68.55 -97.32 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.781 2.987 . . . . 2.24 109.395 168.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -75.79 55.73 0.89 Allowed 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.925 -1.109 . . . . 3.14 109.965 177.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 47.7 0.89 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 129.145 2.978 . . . . 3.35 118.113 -177.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 72.7 t80 70.84 94.74 0.07 Allowed 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 125.693 1.597 . . . . 4.49 108.425 -156.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 54.4 mtt180 -79.54 121.15 24.87 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.689 -1.226 . . . . 7.8 107.689 175.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -83.97 173.34 11.26 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 123.07 0.548 . . . . 3.25 111.26 -175.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 61.37 41.2 99.46 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.464 0.555 . . . . 0.89 112.95 174.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -157.47 177.56 11.29 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.842 1.257 . . . . 3.16 108.897 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -96.63 132.59 11.08 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 109.997 -1.241 . . . . 1.02 109.997 171.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.7 pp -137.44 162.2 33.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 107.238 -1.393 . . . . 1.73 107.238 174.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.4 m -124.51 135.59 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 108.857 -0.794 . . . . 1.85 108.857 178.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -124.23 117.71 25.2 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 124.93 1.292 . . . . 1.47 109.902 -170.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -105.7 142.21 35.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.479 1.512 . . . . 3.85 110.779 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 168.89 -132.79 2.65 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 107.047 -2.421 . . . . 0.82 107.047 171.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.8 p -132.93 147.38 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 C-N-CA 123.84 0.856 . . . . 1.83 110.178 -169.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -58.91 129.57 42.81 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.662 -0.866 . . . . 2.79 108.662 169.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -90.9 -101.23 1.22 Allowed Glycine 0 C--N 1.337 0.629 0 N-CA-C 110.63 -0.988 . . . . 2.12 110.63 -166.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.404 ' OE1' ' NZ ' ' A' ' 121' ' ' LYS . 28.6 tt0 -58.56 -68.31 0.27 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.901 1.28 . . . . 4.8 108.248 174.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -165.48 -70.81 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.38 -1.711 . . . . 4.19 106.38 168.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.9 -44.92 96.67 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.536 1.065 . . . . 1.8 112.227 178.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.404 ' NZ ' ' OE1' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -83.86 145.61 28.54 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.286 0.634 . . . . 3.64 110.631 -176.394 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.4 mp -106.5 140.26 39.67 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 108.55 -0.908 . . . . 3.16 108.55 -176.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -105.99 103.4 12.88 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 107.528 -1.286 . . . . 1.48 107.528 172.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -131.39 89.67 2.75 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 122.711 0.404 . . . . 1.8 111.995 -168.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.0 t -83.45 -18.08 39.87 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.761 0.652 . . . . 1.72 112.761 -176.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -98.46 82.72 2.91 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 119.303 0.956 . . . . 2.79 109.035 -177.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 33.1 m -93.76 123.5 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 123.041 0.536 . . . . 1.82 110.285 177.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -112.8 122.66 48.3 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.155 -1.424 . . . . 1.88 107.155 173.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -93.3 126.47 38.44 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.915 -1.143 . . . . 1.92 107.915 171.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.73 91.48 2.54 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 108.678 -0.86 . . . . 4.3 108.678 174.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 12.9 p80 . . . . . 0 C--N 1.33 -0.244 0 C-N-CA 124.439 1.096 . . . . 8.65 109.579 -170.391 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 N--CA 1.464 0.23 0 CA-C-O 119.983 -0.056 . . . . 3.13 110.919 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -83.89 137.22 33.77 Favored 'General case' 0 C--N 1.338 0.072 0 C-N-CA 124.054 0.942 . . . . 3.27 110.555 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.93 148.95 34.42 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.852 1.261 . . . . 3.75 110.471 -171.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.1 m -79.74 132.59 60.74 Favored Pre-proline 0 N--CA 1.449 -0.495 0 C-N-CA 124.891 1.276 . . . . 2.57 110.667 -177.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.03 -41.05 78.59 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.554 2.17 . . . . 1.17 112.452 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 m -56.92 -23.56 45.97 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 114.392 1.256 . . . . 2.51 114.392 178.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.45 -57.91 4.65 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 106.771 -1.566 . . . . 2.46 106.771 173.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.2 pt -69.35 15.02 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 115.385 1.624 . . . . 1.86 115.385 -166.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.3 m -109.37 -21.03 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.557 1.943 . . . . 4.1 111.967 172.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -122.99 99.58 6.45 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.735 1.152 . . . . 2.23 110.892 -171.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.47 44.09 95.54 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.478 -1.049 . . . . 2.03 110.478 175.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.1 mmmt -150.83 -157.88 0.86 Allowed 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 104.455 -2.424 . . . . 4.26 104.455 -175.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.9 m -45.17 -46.82 12.28 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.301 1.84 . . . . 3.11 115.914 -170.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -40.0 -57.82 1.55 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.49 1.041 . . . . 2.57 111.037 171.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.39 -24.96 27.31 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.05 1.34 . . . . 2.12 110.382 -172.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.03 33.97 75.47 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.464 1.507 . . . . 1.16 112.438 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.7 m -81.48 -27.81 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 118.052 0.926 . . . . 2.02 112.091 -175.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -119.47 -71.67 0.02 OUTLIER Pre-proline 0 N--CA 1.451 -0.376 0 C-N-CA 124.736 1.214 . . . . 5.29 109.98 177.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -77.12 114.03 3.71 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 CA-C-N 120.456 1.199 . . . . 1.43 110.116 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -74.5 166.37 23.63 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.362 -0.607 . . . . 2.93 109.362 171.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.5 169.18 13.05 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.65 0.262 . . . . 2.53 110.461 175.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.59 5.12 87.08 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 121.748 -0.595 . . . . 1.29 112.411 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -103.1 150.97 23.1 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.455 1.102 . . . . 1.79 108.92 176.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -91.03 129.55 37.02 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.239 -0.652 . . . . 4.06 109.239 175.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.8 pt -143.2 166.54 14.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 106.11 -1.811 . . . . 1.69 106.11 167.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 47.6 mtt180 -119.61 116.01 25.14 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.337 -0.986 . . . . 3.7 108.337 175.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.3 p -84.99 122.46 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 107.518 -1.29 . . . . 2.08 107.518 176.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -124.98 119.69 3.7 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 109.622 -1.391 . . . . 0.59 109.622 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.38 -156.49 15.45 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.61 -1.396 . . . . 0.69 109.61 -175.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.4 ptp -106.64 131.15 54.12 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.805 0.812 . . . . 3.76 110.448 -172.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.7 m -84.1 152.82 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 115.491 -0.777 . . . . 3.71 109.59 -175.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.3 m -64.94 179.79 0.63 Allowed 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.478 1.111 . . . . 2.47 110.487 176.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.7 p -116.51 73.2 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 126.234 1.814 . . . . 2.89 108.25 -175.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.18 50.84 0.91 Allowed Glycine 0 CA--C 1.525 0.681 0 CA-C-N 113.154 -1.839 . . . . 2.25 111.404 171.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.7 m -110.99 8.8 22.1 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.407 0.683 . . . . 1.92 111.915 174.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.98 109.87 6.85 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 106.541 -1.651 . . . . 3.23 106.541 175.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.8 m -121.11 129.09 76.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 108.707 -0.849 . . . . 2.25 108.707 171.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -111.1 148.62 32.28 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.405 1.082 . . . . 6.35 110.793 177.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -82.37 153.21 68.46 Favored Pre-proline 0 C--O 1.234 0.26 0 N-CA-C 109.148 -0.686 . . . . 2.09 109.148 170.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -71.64 8.65 1.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.958 2.439 . . . . 1.71 113.789 176.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -69.32 -26.54 64.76 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.756 -0.59 . . . . 1.68 109.84 161.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.0 m 72.25 1.34 3.91 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.158 1.783 . . . . 1.68 113.51 -174.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.38 -3.71 8.9 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.694 1.198 . . . . 3.22 113.505 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -117.55 125.85 51.55 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.786 -1.561 . . . . 1.6 106.786 174.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.2 m -144.45 150.43 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 108.149 -1.056 . . . . 2.19 108.149 -175.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -151.58 154.82 37.21 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.875 -0.516 . . . . 1.18 110.439 -179.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.438 ' CE1' ' CE1' ' A' ' 104' ' ' PHE . 33.8 p90 -156.77 153.04 27.72 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.059 0.457 . . . . 3.34 111.69 -176.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.24 154.71 19.9 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 123.47 0.708 . . . . 1.83 109.978 170.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.3 m -132.54 163.24 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 108.191 -1.04 . . . . 3.54 108.191 163.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -137.8 -168.24 2.3 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.352 1.061 . . . . 2.33 109.885 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.7 t70 . . . . . 0 C--O 1.234 0.278 0 C-N-CA 123.594 0.758 . . . . 2.4 109.453 175.272 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.669 0 N-CA-C 111.129 -0.788 . . . . 2.67 111.129 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -58.25 112.07 1.42 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 117.898 0.849 . . . . 4.19 110.049 -178.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.0 tp -143.79 160.27 16.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 108.093 -1.077 . . . . 2.68 108.093 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.68 129.09 50.58 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.265 1.026 . . . . 1.94 108.533 -168.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.413 ' CG2' ' CE1' ' A' ' 82' ' ' PHE . 5.3 m -115.15 146.77 19.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 109.14 -0.689 . . . . 3.92 109.14 173.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.4 p -110.19 155.77 21.53 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.963 1.705 . . . . 1.46 107.863 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -150.08 113.41 4.92 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.973 -1.491 . . . . 3.22 106.973 -175.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -101.47 45.2 0.98 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.186 1.394 . . . . 2.09 110.906 -173.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -162.95 -176.77 5.08 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.65 1.98 . . . . 2.44 106.201 170.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.1 mp -79.67 146.25 32.56 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.868 0.867 . . . . 2.48 111.081 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 78.3 mt -82.06 155.38 69.99 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 123.962 0.905 . . . . 2.72 109.412 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.99 -89.95 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.554 2.836 . . . . 2.01 110.173 176.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.78 45.72 0.43 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.284 1.434 . . . . 3.48 110.613 -176.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 44.19 8.25 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.279 2.632 . . . . 2.98 115.854 -164.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.438 ' CE1' ' CE1' ' A' ' 82' ' ' PHE . 65.4 t80 50.74 91.91 0.02 OUTLIER 'General case' 0 C--N 1.34 0.171 0 CA-C-N 119.339 0.972 . . . . 4.2 109.873 -153.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -78.6 146.17 34.32 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.814 -1.18 . . . . 7.68 107.814 173.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -93.11 167.19 11.94 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 125.401 1.481 . . . . 3.28 109.567 -169.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 47.56 44.17 22.14 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 123.532 0.587 . . . . 1.03 113.739 -177.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -153.24 120.03 5.68 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.793 1.637 . . . . 2.9 107.387 176.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -63.61 135.24 41.58 Favored Glycine 0 CA--C 1.523 0.54 0 O-C-N 121.207 -0.933 . . . . 1.15 111.368 -175.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.2 pp -135.97 166.09 27.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.817 -1.179 . . . . 1.74 107.817 177.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 17.6 m -118.79 128.94 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 108.983 -0.747 . . . . 1.76 108.983 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -120.45 118.22 29.72 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 125.023 1.329 . . . . 1.7 109.727 -168.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -114.91 150.31 35.84 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.65 1.58 . . . . 3.81 109.915 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 173.33 -122.57 0.93 Allowed Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 106.61 -2.596 . . . . 0.98 106.61 165.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.0 p -143.44 148.24 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 118.204 1.002 . . . . 2.06 109.821 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -69.85 143.03 52.97 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.251 -0.648 . . . . 3.24 109.251 168.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -166.04 26.18 0.17 Allowed Glycine 0 CA--C 1.523 0.565 0 C-N-CA 119.602 -1.285 . . . . 2.82 113.146 171.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -151.91 45.01 0.75 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.926 0.891 . . . . 6.1 108.748 -174.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 24.86 59.95 0.05 Allowed 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 128.976 2.91 . . . . 4.03 112.481 172.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 139.27 -47.93 0.88 Allowed Glycine 0 CA--C 1.529 0.949 0 CA-C-N 114.77 -1.105 . . . . 1.22 110.948 -172.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.5 151.27 20.8 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 117.885 0.842 . . . . 3.04 110.184 -174.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 mp -112.68 121.89 46.08 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.721 1.208 . . . . 3.08 109.364 -169.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -82.89 88.23 6.81 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.403 -1.702 . . . . 1.78 106.403 175.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -106.62 72.41 0.9 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.168 0.987 . . . . 1.84 110.723 -165.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.9 t -80.79 -6.66 58.82 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.037 0.754 . . . . 1.9 113.037 -168.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -113.06 88.63 2.88 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 120.799 -1.188 . . . . 4.12 108.864 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 27.0 m -96.74 125.93 49.58 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 C-N-CA 123.312 0.645 . . . . 1.89 109.826 174.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -111.94 113.33 25.57 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.68 -1.6 . . . . 2.0 106.68 177.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.34 36.79 0.25 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.078 0.551 . . . . 1.66 112.069 -178.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.0 ptmt -85.09 60.68 6.4 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.233 -0.917 . . . . 4.09 110.307 -173.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 7.1 p80 . . . . . 0 CA--C 1.533 0.289 0 C-N-CA 123.942 0.897 . . . . 6.59 111.27 -178.843 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 pt? . . . . . 0 N--CA 1.456 -0.132 0 N-CA-C 109.926 -0.398 . . . . 3.01 109.926 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -92.04 111.07 22.48 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.751 1.22 . . . . 3.62 109.414 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -125.59 160.16 30.31 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.879 1.272 . . . . 4.79 110.104 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.4 p -72.09 135.58 82.46 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 109.599 -0.519 . . . . 2.43 109.599 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -55.89 -29.59 73.49 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.866 3.044 . . . . 1.04 112.337 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.0 p -66.96 -35.82 80.83 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.024 0.75 . . . . 2.86 113.024 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -45.0 -47.79 11.49 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 118.882 0.765 . . . . 3.03 110.036 177.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.34 0.2 OUTLIER -85.76 11.51 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 114.784 1.402 . . . . 3.23 114.784 -170.009 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -103.13 -8.95 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 123.445 0.698 . . . . 2.97 112.553 179.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -105.79 -58.15 1.95 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.527 0.603 . . . . 2.57 111.964 -171.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -160.71 64.56 0.28 Allowed Glycine 0 C--N 1.335 0.5 0 N-CA-C 109.266 -1.534 . . . . 2.5 109.266 -170.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt -153.96 -111.93 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 106.339 -1.726 . . . . 3.04 106.339 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.4 m -54.17 -63.03 1.28 Allowed 'General case' 0 C--N 1.343 0.323 0 C-N-CA 126.851 2.06 . . . . 2.08 113.298 177.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -49.46 -42.27 42.62 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.964 0.888 . . . . 2.42 110.993 -172.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.86 -9.54 45.97 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.338 1.855 . . . . 2.31 113.323 -178.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 48.62 48.93 28.35 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 126.26 1.886 . . . . 1.2 113.763 -174.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.5 m -95.18 -55.71 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 118.566 1.183 . . . . 2.29 112.275 -177.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.1 mmtt -87.34 -59.82 0.26 Allowed Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 123.762 0.825 . . . . 3.88 111.035 178.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -81.79 155.48 17.97 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 121.942 1.761 . . . . 1.49 109.89 174.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -124.02 60.21 1.13 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.676 1.19 . . . . 3.57 109.037 174.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 48.7 -144.46 0.42 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.318 1.047 . . . . 2.67 110.116 -174.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 40.23 30.83 0.3 Allowed Glycine 0 CA--C 1.533 1.165 0 C-N-CA 127.83 2.633 . . . . 1.37 117.527 165.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -134.62 167.41 20.87 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.857 1.663 . . . . 1.88 108.017 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -101.46 134.56 44.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.681 -0.859 . . . . 4.18 108.681 171.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.4 pt -139.22 167.68 19.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 105.055 -2.202 . . . . 2.16 105.055 168.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.8 mtm180 -126.74 122.89 36.13 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.86 -1.533 . . . . 2.63 106.86 174.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.7 m -88.56 138.12 19.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 107.691 -1.226 . . . . 3.84 107.691 177.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.0 110.4 0.58 Allowed Glycine 0 C--O 1.226 -0.393 0 N-CA-C 109.599 -1.401 . . . . 0.89 109.599 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -172.78 -161.37 23.08 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 108.862 -1.695 . . . . 0.84 108.862 -173.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.17 132.74 41.27 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 117.694 0.747 . . . . 3.65 110.843 -176.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.1 m -91.07 150.93 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-N 116.165 -0.47 . . . . 3.74 110.097 174.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.13 -179.31 0.42 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.704 0.764 . . . . 2.28 109.856 174.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.6 p -123.7 71.02 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 126.176 1.79 . . . . 2.64 107.893 175.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.33 -21.75 1.21 Allowed Glycine 0 CA--C 1.53 1.012 0 CA-C-N 114.167 -1.379 . . . . 2.46 113.93 174.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.8 m -62.12 -17.65 58.44 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.655 1.227 . . . . 1.55 113.713 -178.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.5 ttm -58.85 125.88 25.35 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 122.972 0.509 . . . . 3.09 109.87 171.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.28 130.67 67.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 107.615 -1.254 . . . . 1.87 107.615 166.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -114.46 143.59 44.69 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.599 1.159 . . . . 5.23 109.36 -177.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.49 147.05 51.76 Favored Pre-proline 0 N--CA 1.454 -0.246 0 N-CA-C 109.626 -0.509 . . . . 1.85 109.626 177.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -62.51 -25.93 76.01 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.664 2.242 . . . . 1.46 110.826 170.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -42.38 -41.64 2.93 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.572 1.549 . . . . 1.72 110.475 174.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.3 m 87.95 5.9 0.23 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 126.927 2.091 . . . . 1.51 113.064 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.84 3.79 9.45 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.011 0.924 . . . . 3.6 113.355 173.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -128.06 135.07 49.34 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 119.044 0.838 . . . . 1.45 109.633 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.2 m -149.88 138.76 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 106.928 -1.508 . . . . 1.74 106.928 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -142.11 157.93 44.33 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.46 -0.571 . . . . 1.67 109.46 174.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -156.14 152.32 27.78 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.946 -0.39 . . . . 3.25 109.946 -174.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.93 149.0 22.38 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.46 -0.57 . . . . 1.67 109.46 170.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.1 p -136.78 152.76 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.385 1.074 . . . . 3.15 108.919 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -143.01 179.5 7.0 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.43 0.692 . . . . 1.89 111.524 -174.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 C--N 1.341 0.223 0 N-CA-C 109.845 -0.428 . . . . 2.4 109.845 177.703 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.654 0 N-CA-C 107.802 -2.119 . . . . 1.69 107.802 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -120.55 130.52 54.26 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 106.943 -1.502 . . . . 4.36 106.943 177.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -132.04 146.27 33.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.297 -1.001 . . . . 1.84 108.297 174.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 mt -101.88 128.35 48.3 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.208 1.403 . . . . 1.93 109.913 -175.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.3 t -119.33 125.83 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 124.914 1.285 . . . . 2.18 108.14 -178.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 42.3 p -95.85 152.18 18.73 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.681 0.792 . . . . 1.87 108.926 174.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -145.84 166.96 24.4 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.411 1.085 . . . . 3.9 108.733 -177.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -155.61 150.7 26.67 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 105.373 -2.084 . . . . 3.26 105.373 -169.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 62.96 61.54 1.11 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 129.299 3.039 . . . . 3.01 111.587 -176.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.3 mt 51.68 -152.32 0.23 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.552 1.141 . . . . 2.58 109.158 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.6 mt -146.57 153.69 47.59 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 105.764 -1.939 . . . . 2.0 105.764 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.84 -83.44 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 125.118 3.879 . . . . 2.64 109.853 -174.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.418 ' C ' ' H ' ' A' ' 104' ' ' PHE . 40.7 m-20 -73.75 34.09 0.08 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.34 1.456 . . . . 5.69 110.701 177.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 61.19 -22.61 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.658 1.983 . . . . 4.74 114.155 -170.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.418 ' H ' ' C ' ' A' ' 102' ' ' ASP . 64.6 t80 59.69 86.91 0.09 Allowed 'General case' 0 C--N 1.342 0.275 0 CA-C-N 120.286 1.403 . . . . 3.97 107.7 -155.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 19.8 mtp85 -82.95 127.64 33.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 105.663 -1.977 . . . . 4.87 105.663 175.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -81.37 169.33 17.35 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.101 0.477 . . . . 2.86 110.284 -170.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.15 45.67 90.76 Favored Glycine 0 CA--C 1.533 1.188 0 O-C-N 121.765 -0.585 . . . . 0.96 113.399 177.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -155.78 179.57 9.07 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.487 1.515 . . . . 3.21 107.756 175.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -94.82 133.78 11.7 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 109.625 -1.39 . . . . 0.9 109.625 170.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.4 pp -138.73 161.92 29.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 107.477 -1.305 . . . . 2.06 107.477 175.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 18.6 m -118.7 123.66 71.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.321 -0.992 . . . . 1.85 108.321 177.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -110.37 136.81 48.97 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 125.902 1.681 . . . . 1.59 109.732 -175.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -128.81 141.53 51.27 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.036 1.734 . . . . 3.08 108.612 -175.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 173.29 -121.83 0.88 Allowed Glycine 0 C--N 1.336 0.547 0 N-CA-C 109.218 -1.553 . . . . 0.9 109.218 168.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.04 153.21 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.861 -0.792 . . . . 1.89 108.861 -173.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -57.71 142.38 45.41 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.186 -0.672 . . . . 2.75 109.186 171.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -87.13 -126.27 2.15 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 109.355 -1.498 . . . . 2.51 109.355 -174.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -60.66 -64.87 0.8 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.265 0.626 . . . . 5.13 109.512 178.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -149.87 -74.08 0.17 Allowed 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 107.043 -1.465 . . . . 3.68 107.043 173.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -72.54 -39.73 55.65 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.055 -0.975 . . . . 1.96 111.626 -174.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.57 153.47 26.73 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.615 0.766 . . . . 4.79 109.699 -175.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -110.06 136.4 49.36 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 125.12 1.368 . . . . 3.21 108.275 -176.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -105.78 90.22 3.32 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.712 -1.218 . . . . 1.79 107.712 174.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.17 145.22 26.02 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 108.388 -0.968 . . . . 2.27 108.388 176.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.4 t -134.73 0.06 2.92 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.977 0.732 . . . . 2.11 112.977 169.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -129.48 99.89 5.35 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 120.669 -1.269 . . . . 2.88 109.123 171.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 29.4 m -98.69 148.27 6.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-N 118.885 0.766 . . . . 2.29 111.546 166.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.35 112.5 16.41 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.033 -1.84 . . . . 1.91 106.033 176.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -100.23 41.52 1.16 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.088 0.955 . . . . 2.4 111.482 -175.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -73.63 71.91 1.42 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.844 1.258 . . . . 5.36 111.282 -176.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 . . . . . 0 CA--C 1.532 0.254 0 CA-C-N 118.749 0.704 . . . . 5.02 112.697 -170.965 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 pt? . . . . . 0 C--O 1.233 0.206 0 CA-C-O 121.018 0.437 . . . . 2.91 111.612 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -82.05 132.05 35.25 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.084 0.954 . . . . 3.62 109.238 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -131.59 152.92 50.42 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.126 1.77 . . . . 5.37 108.589 176.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.9 p -94.19 143.73 26.87 Favored Pre-proline 0 N--CA 1.442 -0.853 0 C-N-CA 125.203 1.401 . . . . 3.21 108.729 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -61.57 -18.09 57.84 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.598 2.199 . . . . 1.42 112.465 178.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.0 p -47.46 -40.48 18.31 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.32 1.048 . . . . 4.92 112.181 165.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -83.11 -52.48 6.59 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.966 -1.124 . . . . 2.48 107.966 -169.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 26.8 pt -81.11 30.83 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.046 0.938 . . . . 2.0 113.126 -170.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.0 p -122.88 -44.91 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.923 1.689 . . . . 3.72 110.59 173.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -77.21 -41.6 40.72 Favored 'General case' 0 C--N 1.34 0.157 0 O-C-N 121.718 -0.614 . . . . 2.52 112.37 -162.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.04 59.66 0.13 Allowed Glycine 0 C--N 1.332 0.346 0 N-CA-C 109.439 -1.464 . . . . 2.3 109.439 -170.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -155.19 -94.48 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.522 1.929 . . . . 3.06 108.364 -178.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 97.7 m -71.95 -58.39 3.49 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 119.271 0.941 . . . . 2.56 111.877 -172.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -46.83 -53.67 11.51 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.778 0.799 . . . . 2.51 110.243 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.43 -23.8 29.83 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.747 -1.115 . . . . 2.28 111.965 -171.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.7 53.41 41.43 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.203 1.383 . . . . 1.37 111.864 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.274 31.8 m -110.13 -73.58 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 113.73 1.011 . . . . 2.41 113.73 -178.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -64.44 -56.59 21.77 Favored Pre-proline 0 CA--C 1.538 0.507 0 O-C-N 120.953 -1.092 . . . . 3.85 113.017 -176.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -87.26 159.23 8.33 Favored 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 123.391 2.728 . . . . 1.32 108.371 175.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -100.19 150.76 22.19 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.738 -0.838 . . . . 3.62 108.738 171.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.46 157.97 10.4 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.275 -0.639 . . . . 1.66 109.275 169.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.57 -0.24 70.8 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 119.041 -0.866 . . . . 1.33 113.819 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -81.39 158.97 24.46 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 119.415 1.608 . . . . 1.59 108.456 169.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 45.4 mtt180 -92.82 137.23 32.55 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.71 -0.478 . . . . 3.98 109.71 170.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.6 pt -144.7 175.07 3.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 107.482 -1.303 . . . . 2.09 107.482 167.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -121.68 124.26 43.85 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-O 119.079 -0.486 . . . . 2.72 110.236 168.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.0 p -82.59 128.5 38.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 N-CA-C 107.537 -1.283 . . . . 2.2 107.537 170.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -128.21 129.27 6.23 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 109.16 -1.576 . . . . 0.56 109.16 172.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 176.89 -150.96 10.69 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 107.576 -2.209 . . . . 0.77 107.576 -175.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.8 ppp? -125.27 155.6 39.89 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 118.473 1.136 . . . . 5.57 111.843 177.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.8 p -100.97 131.73 48.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 114.471 -1.241 . . . . 3.4 109.799 -174.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.11 159.54 20.18 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 122.228 1.013 . . . . 2.26 109.509 174.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.9 p -67.56 -34.31 67.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.859 1.264 . . . . 2.49 112.89 -175.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -120.86 84.07 0.37 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 108.956 -1.658 . . . . 2.06 108.956 175.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.3 m -140.29 -43.96 0.41 Allowed 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.909 0.884 . . . . 1.71 112.322 -176.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.16 109.77 3.19 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.567 0.747 . . . . 2.98 110.184 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.8 m -111.33 117.24 54.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 107.417 -1.327 . . . . 1.79 107.417 169.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.95 140.06 42.96 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.86 1.264 . . . . 7.19 109.416 -176.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -82.13 149.31 62.22 Favored Pre-proline 0 N--CA 1.455 -0.221 0 N-CA-C 108.903 -0.777 . . . . 1.78 108.903 176.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -66.11 -20.89 56.47 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.497 2.131 . . . . 1.76 110.227 167.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -41.53 -43.36 2.65 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 123.75 0.82 . . . . 1.2 109.415 163.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.8 m 73.49 4.2 4.74 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.055 1.342 . . . . 1.54 112.905 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.2 18.44 10.72 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.882 1.673 . . . . 2.89 110.539 173.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 48.9 m-70 -150.79 119.21 6.42 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.478 -1.675 . . . . 1.35 106.478 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.7 m -148.54 135.95 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 105.974 -1.861 . . . . 1.97 105.974 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -138.78 152.34 47.83 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 119.853 1.206 . . . . 1.15 110.799 -177.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -149.33 153.11 36.97 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.28 0.632 . . . . 3.16 109.693 -172.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.59 147.41 23.94 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.637 0.775 . . . . 2.1 109.414 169.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.0 t -124.55 146.61 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 N-CA-C 107.429 -1.323 . . . . 2.91 107.429 169.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -150.9 -167.06 2.71 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 108.603 -0.888 . . . . 1.67 108.603 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.2 t0 . . . . . 0 CA--C 1.512 -0.495 0 N-CA-C 107.871 -1.159 . . . . 3.57 107.871 166.046 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.845 0 CA-C-O 119.034 -0.87 . . . . 2.22 113.002 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -171.01 156.72 4.96 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.689 1.996 . . . . 2.57 106.81 168.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.5 tp -151.18 162.17 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.834 1.254 . . . . 2.41 108.19 172.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mt -124.25 131.21 53.51 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 124.545 1.138 . . . . 2.15 109.928 -176.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.6 p -135.16 142.17 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.822 0.849 . . . . 4.25 110.166 -174.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.6 p -105.28 153.46 21.57 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.172 1.389 . . . . 1.85 108.973 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -141.43 138.93 33.27 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.268 -1.753 . . . . 3.56 106.268 178.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -128.45 39.43 3.82 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.249 1.02 . . . . 2.2 112.138 -165.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -166.22 56.93 0.1 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.945 0.898 . . . . 2.9 110.934 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.8 mp 51.95 -168.35 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.911 1.284 . . . . 2.12 111.366 -170.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.2 mt -148.34 150.69 35.11 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.286 1.434 . . . . 2.31 107.215 174.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -62.16 132.75 40.41 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 123.413 2.742 . . . . 2.69 109.746 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 37.3 49.25 0.9 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.391 1.877 . . . . 4.36 111.645 -173.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 56.72 10.69 0.76 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 128.73 2.812 . . . . 3.12 115.518 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.6 t80 64.73 99.79 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.788 1.235 . . . . 4.02 108.134 -162.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 46.0 mtt180 -77.44 131.44 37.99 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.441 -1.688 . . . . 5.97 106.441 172.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -83.58 170.72 14.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.102 0.561 . . . . 4.59 109.6 -176.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.42 46.9 91.57 Favored Glycine 0 CA--C 1.531 1.058 0 O-C-N 121.924 -0.485 . . . . 0.9 112.826 174.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -151.7 179.07 8.73 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.895 1.678 . . . . 2.69 108.555 178.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -111.24 142.97 17.11 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.2 -0.76 . . . . 1.03 111.2 171.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.4 pp -145.84 168.97 6.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 125.498 1.519 . . . . 2.09 106.917 -178.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.0 m -120.77 138.73 50.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 N-CA-C 108.011 -1.107 . . . . 1.71 108.011 167.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -127.28 118.17 23.7 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 124.627 1.171 . . . . 1.47 109.439 -176.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.67 132.86 52.88 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.197 1.399 . . . . 3.37 108.639 -175.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 178.47 -160.75 26.93 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 120.858 -0.687 . . . . 1.26 112.308 -177.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.6 p -123.52 138.39 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 125.114 1.365 . . . . 2.17 110.121 -169.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.8 mp -68.56 138.8 55.42 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.768 -0.583 . . . . 3.5 111.027 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -95.98 -114.9 2.98 Favored Glycine 0 C--N 1.341 0.809 0 N-CA-C 109.943 -1.263 . . . . 2.09 109.943 -166.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -46.82 -55.92 7.12 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 117.876 0.838 . . . . 4.36 112.318 175.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 176.25 -79.08 0.0 OUTLIER 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 128.004 2.522 . . . . 3.47 105.251 -174.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.5 -25.13 76.16 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.601 1.096 . . . . 2.16 112.679 -174.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.55 152.47 21.68 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.528 1.531 . . . . 3.37 109.572 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.0 mp -117.8 156.53 28.19 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.08 0.552 . . . . 3.29 109.911 -178.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -120.07 107.42 13.03 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.065 1.346 . . . . 1.87 107.979 173.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.24 132.9 41.99 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 118.951 -0.547 . . . . 1.91 110.743 -175.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.3 t -122.2 4.4 9.78 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.38 0.672 . . . . 2.23 112.473 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -113.1 79.55 1.25 Allowed 'General case' 0 CA--C 1.531 0.229 0 O-C-N 120.587 -1.321 . . . . 2.58 109.361 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.1 m -95.41 132.42 39.53 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 C-N-CA 122.918 0.487 . . . . 1.65 110.325 174.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.06 107.13 14.14 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.245 -1.761 . . . . 1.84 106.245 175.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.52 105.4 13.54 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.194 -1.039 . . . . 1.78 108.194 175.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -121.68 71.21 0.97 Allowed 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.84 0.856 . . . . 3.76 109.618 -176.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 107.082 -1.451 . . . . 4.97 107.082 178.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.376 0.131 . . . . 3.67 111.087 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -83.68 120.26 25.78 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.782 1.233 . . . . 3.83 109.695 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -116.17 163.33 16.12 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.615 1.566 . . . . 4.12 109.705 177.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.8 m -84.91 132.89 44.54 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 109.306 -0.628 . . . . 3.02 109.306 -174.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -56.45 -45.33 38.22 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 123.191 2.594 . . . . 0.95 111.741 -176.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.0 t -61.74 -23.35 66.1 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.351 -0.843 . . . . 3.1 112.341 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -66.74 -45.94 77.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.926 -1.138 . . . . 3.32 107.926 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.388 18.6 pt -65.56 -11.68 12.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 114.233 1.197 . . . . 2.23 114.233 -177.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -79.68 -30.83 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.409 0.683 . . . . 3.15 112.266 169.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -81.26 -76.4 0.25 Allowed 'General case' 0 N--CA 1.466 0.354 0 O-C-N 121.087 -1.008 . . . . 3.08 112.968 -162.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -133.34 51.26 0.85 Allowed Glycine 0 C--N 1.333 0.415 0 N-CA-C 108.055 -2.018 . . . . 3.47 108.055 -174.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -147.04 -114.03 0.08 Allowed 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 125.669 1.588 . . . . 5.04 108.483 -164.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.0 m -77.12 -55.83 5.1 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 119.401 1.0 . . . . 2.19 110.877 -169.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -44.3 -59.82 2.21 Favored 'General case' 0 C--N 1.341 0.204 0 O-C-N 123.87 0.732 . . . . 3.09 110.459 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.9 m -84.47 -16.11 43.65 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.216 -0.902 . . . . 2.63 110.907 -174.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 65.19 50.44 56.79 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 124.077 0.846 . . . . 1.33 112.36 170.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.9 m -106.3 -54.31 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 117.832 0.816 . . . . 2.37 112.982 -175.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -90.06 -62.02 0.21 Allowed Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 123.645 0.778 . . . . 6.41 112.242 -176.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -80.34 170.77 15.72 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.795 2.33 . . . . 1.53 108.096 170.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.412 ' H ' ' NE2' ' A' ' 58' ' ' GLN . 22.4 tt0 -128.53 160.24 32.98 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.593 -1.632 . . . . 3.5 106.593 168.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.38 156.78 37.11 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.135 -1.061 . . . . 2.4 108.135 171.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.49 10.85 60.12 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.093 0.854 . . . . 1.04 112.316 -173.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.412 ' NE2' ' H ' ' A' ' 55' ' ' GLU . 33.5 mt-30 -110.13 149.52 29.94 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 118.195 0.997 . . . . 1.74 109.598 177.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.12 119.11 35.0 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.688 1.195 . . . . 5.31 108.0 -177.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.5 pt -143.6 179.33 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 107.881 -1.155 . . . . 1.99 107.881 177.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.3 mtt-85 -126.81 141.26 51.87 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.683 -1.229 . . . . 3.65 107.683 172.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.4 p -108.6 132.46 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 106.827 -1.546 . . . . 1.92 106.827 176.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.2 124.27 2.75 Favored Glycine 0 C--N 1.334 0.44 0 N-CA-C 109.719 -1.352 . . . . 0.52 109.719 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 179.67 -156.95 19.47 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 107.906 -2.077 . . . . 0.64 107.906 -176.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -104.66 134.6 47.55 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 118.315 1.058 . . . . 5.74 110.646 -172.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.8 m -79.92 141.04 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.736 -0.665 . . . . 3.43 109.408 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.0 m -76.87 133.61 39.26 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.802 -0.814 . . . . 2.39 108.802 172.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.1 p -45.92 -51.24 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 125.651 1.58 . . . . 2.39 112.2 177.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.63 61.74 1.18 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.296 -1.122 . . . . 2.03 110.296 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.1 m -154.83 53.15 0.64 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.589 1.194 . . . . 2.26 112.718 -176.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.14 104.88 5.34 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 107.725 -1.213 . . . . 2.54 107.725 174.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.1 m -123.6 135.13 64.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 109.17 -0.678 . . . . 1.8 109.17 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.38 147.4 50.27 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.714 1.605 . . . . 6.74 110.496 -172.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -75.79 157.19 84.15 Favored Pre-proline 0 CA--C 1.529 0.172 0 C-N-CA 122.788 0.435 . . . . 2.56 110.525 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -66.5 -19.85 54.51 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 123.032 2.488 . . . . 1.47 111.762 166.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -50.16 -35.23 25.28 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.105 0.562 . . . . 1.82 110.573 163.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.6 m 71.07 18.46 5.86 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.728 1.611 . . . . 2.07 112.813 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.18 -45.45 2.11 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 125.352 1.461 . . . . 3.67 111.429 170.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -78.46 131.66 36.96 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 107.302 -1.37 . . . . 2.13 107.302 -177.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.6 m -147.02 147.52 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 107.784 -1.191 . . . . 1.95 107.784 -174.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -149.71 156.79 42.45 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.54 -0.725 . . . . 1.78 110.217 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -154.09 161.01 42.21 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.401 -0.818 . . . . 3.46 109.93 -173.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -105.98 138.66 41.78 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.879 -0.785 . . . . 1.65 108.879 174.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 t -121.19 142.0 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 107.678 -1.23 . . . . 3.13 107.678 176.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -144.09 -175.72 4.72 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.02 -0.733 . . . . 2.42 109.02 177.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.8 t70 . . . . . 0 N--CA 1.449 -0.512 0 N-CA-C 109.054 -0.721 . . . . 2.62 109.054 165.072 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.776 0 N-CA-C 110.912 -0.875 . . . . 1.86 110.912 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -123.36 150.78 43.25 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.435 1.894 . . . . 4.42 107.533 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 11.3 tp -146.34 146.39 19.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 122.986 0.514 . . . . 2.39 110.041 174.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.4 mt -91.05 137.26 32.5 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.452 1.101 . . . . 2.03 110.61 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.3 t -127.3 129.47 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 126.214 1.806 . . . . 2.28 107.636 -178.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 44.2 p -107.98 145.19 34.23 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.766 1.226 . . . . 1.59 109.463 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -138.7 126.89 22.74 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.685 1.594 . . . . 3.14 107.277 -175.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -108.36 44.62 1.1 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.817 1.247 . . . . 1.94 112.331 -170.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -170.7 171.98 5.98 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.593 1.957 . . . . 3.06 107.733 172.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.2 mp -66.46 137.63 56.97 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.579 -0.701 . . . . 2.29 110.661 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 19.2 mt -76.21 159.0 81.18 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.224 0.609 . . . . 2.82 109.465 176.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -64.83 -88.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.59 2.86 . . . . 2.01 109.843 170.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.6 29.4 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.171 1.388 . . . . 3.53 113.011 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 50.7 1.66 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 115.923 1.823 . . . . 3.06 115.923 -168.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 26.6 t80 58.58 93.98 0.03 OUTLIER 'General case' 0 C--N 1.342 0.281 0 C-N-CA 124.652 1.181 . . . . 4.34 109.135 -156.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 26.8 mtp85 -77.78 157.43 29.99 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 107.095 -1.446 . . . . 4.82 107.095 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -83.93 119.99 25.55 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.388 -0.968 . . . . 4.36 108.388 -169.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.3 68.02 1.73 Allowed Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.458 1.028 . . . . 1.14 113.09 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -156.64 62.61 0.53 Allowed 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 124.141 0.976 . . . . 3.34 110.519 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -27.66 119.56 0.05 OUTLIER Glycine 0 CA--C 1.529 0.93 0 C-N-CA 126.028 1.775 . . . . 1.76 114.997 -166.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.6 pp -121.68 167.88 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 108.602 -0.888 . . . . 1.78 108.602 -173.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.8 m -117.66 134.41 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.583 -0.895 . . . . 1.84 108.583 177.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -122.72 136.25 54.82 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.84 1.656 . . . . 1.41 108.623 -175.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -119.81 144.95 47.05 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.327 1.451 . . . . 4.35 108.942 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 162.82 -147.84 14.1 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 110.132 -1.187 . . . . 0.92 110.132 173.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.9 p -126.13 136.53 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 123.435 0.694 . . . . 1.77 109.801 -166.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.9 mp -80.92 153.43 27.56 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.901 -1.518 . . . . 3.61 106.901 175.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -172.21 -47.65 0.04 OUTLIER Glycine 0 C--N 1.333 0.394 0 C-N-CA 119.584 -1.293 . . . . 2.53 112.88 -178.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -62.33 158.66 16.88 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.832 -0.803 . . . . 4.77 108.832 172.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -81.5 64.0 6.04 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 122.218 1.009 . . . . 4.74 108.297 -175.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 116.07 17.93 6.11 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 126.04 1.781 . . . . 1.81 113.749 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.31 156.09 49.07 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.004 1.402 . . . . 3.55 109.591 169.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.1 mt -114.67 141.52 47.69 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.326 0.65 . . . . 3.16 110.432 -173.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -101.22 104.47 15.52 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.4 -0.963 . . . . 1.68 108.4 175.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -128.66 117.6 21.48 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 123.131 0.572 . . . . 1.5 109.78 -177.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.2 t -110.59 -6.61 14.83 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.338 1.055 . . . . 2.09 111.614 177.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -99.54 89.59 4.21 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.658 -1.277 . . . . 3.91 108.375 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.9 m -106.76 133.92 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 121.829 2.104 . . . . 1.77 111.848 175.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -123.36 104.25 8.99 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.771 1.228 . . . . 2.1 108.626 -175.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.34 59.89 3.58 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.493 -0.754 . . . . 1.85 110.832 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.34 -24.29 61.27 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.209 0.818 . . . . 4.18 113.209 -175.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 . . . . . 0 N--CA 1.466 0.362 0 C-N-CA 124.019 0.928 . . . . 6.17 110.546 -178.13 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.5 pt? . . . . . 0 N--CA 1.465 0.286 0 N-CA-C 112.365 0.506 . . . . 2.77 112.365 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -83.1 119.21 24.22 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 125.168 1.387 . . . . 4.06 109.267 176.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.59 159.19 19.89 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.195 0.998 . . . . 3.58 110.808 178.889 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.36 144.01 91.4 Favored Pre-proline 0 N--CA 1.451 -0.402 0 C-N-CA 123.783 0.833 . . . . 2.58 109.313 175.019 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.52 -45.58 4.84 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.636 2.224 . . . . 1.21 111.031 179.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.5 p -45.28 -46.39 12.64 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.412 1.485 . . . . 2.88 112.34 -179.588 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.84 -57.1 10.31 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.071 -1.085 . . . . 3.62 108.071 179.589 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 31.2 pt -73.18 30.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 113.712 1.004 . . . . 1.91 113.712 -171.56 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.6 t -120.13 -18.5 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.682 1.993 . . . . 3.22 111.837 173.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -139.57 91.63 2.5 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.945 1.248 . . . . 2.49 111.826 -170.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.4 46.66 68.48 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 109.99 -1.244 . . . . 2.09 109.99 176.168 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -146.42 -139.52 0.1 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 104.404 -2.443 . . . . 6.04 104.404 172.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 94.5 m -52.19 -54.13 34.65 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 117.197 -1.383 . . . . 2.76 114.599 -178.413 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -36.36 -56.63 0.77 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.856 1.207 . . . . 2.55 111.321 174.21 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.61 -7.71 59.45 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 113.895 -1.502 . . . . 2.59 111.268 -171.409 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 56.74 35.9 69.74 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.325 1.44 . . . . 1.15 112.373 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.8 m -89.44 -42.54 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 117.893 0.847 . . . . 2.19 110.979 -178.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.7 mmtt -81.39 -63.88 0.3 Allowed Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 118.325 -0.845 . . . . 4.11 112.55 176.324 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -81.79 152.47 17.07 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.533 1.489 . . . . 2.31 110.168 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -100.4 43.05 1.08 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.261 1.424 . . . . 3.82 109.493 175.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 33.14 59.88 0.45 Allowed 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 127.232 2.213 . . . . 2.29 115.459 177.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.42 30.86 0.2 Allowed Glycine 0 CA--C 1.524 0.639 0 CA-C-N 113.757 -1.565 . . . . 2.69 112.664 177.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -121.98 154.06 37.71 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.193 0.997 . . . . 2.89 109.522 -176.118 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 13.9 ttp85 -96.82 114.07 25.67 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.101 -1.074 . . . . 5.72 108.101 -178.344 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.7 pt -132.99 178.15 6.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 C-N-CA 124.271 1.028 . . . . 2.03 109.158 -176.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -136.12 150.68 49.2 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.087 -1.079 . . . . 2.38 108.087 174.095 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.33 143.63 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.821 1.248 . . . . 2.18 107.734 177.243 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.91 123.23 1.81 Allowed Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.363 -1.095 . . . . 0.55 110.363 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -178.63 -171.36 41.81 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 109.573 -1.411 . . . . 0.69 109.573 -177.237 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.41 135.36 33.36 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.936 0.874 . . . . 3.5 110.945 178.193 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.98 131.02 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 114.99 -1.004 . . . . 3.7 108.295 167.36 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.2 m -37.77 -82.75 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 126.531 1.932 . . . . 3.26 113.128 176.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.6 p 175.84 -40.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.511 1.124 . . . . 3.57 109.497 179.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -142.45 25.34 2.31 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.923 -0.376 . . . . 1.75 112.181 179.638 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.3 m -84.21 -8.86 58.93 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 117.756 0.778 . . . . 2.01 112.461 -178.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.1 tpt -68.29 115.06 7.31 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.803 0.841 . . . . 2.67 108.85 176.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.1 m -125.84 135.61 63.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 108.363 -0.977 . . . . 1.74 108.363 171.535 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 ptm85 -128.0 133.08 49.12 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.719 1.208 . . . . 7.53 108.515 -171.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -85.36 146.23 44.27 Favored Pre-proline 0 C--O 1.234 0.287 0 N-CA-C 108.767 -0.827 . . . . 2.19 108.767 -176.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -70.69 12.97 0.38 Allowed 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.893 2.395 . . . . 1.49 113.703 178.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -75.95 -29.91 58.47 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.246 0.618 . . . . 1.12 109.655 163.415 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 m 85.47 -18.91 0.34 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.821 2.048 . . . . 1.8 112.757 -174.049 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -104.91 8.78 34.74 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.487 1.115 . . . . 3.12 113.093 -172.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 -133.55 126.81 31.82 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.334 -1.358 . . . . 1.4 107.334 172.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.93 125.3 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.001 -1.851 . . . . 2.06 106.001 -175.769 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -137.85 146.44 43.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 119.683 1.128 . . . . 0.96 109.713 179.401 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -142.89 152.36 42.02 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.008 -0.738 . . . . 3.21 109.008 -174.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.86 150.77 24.55 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.452 -0.573 . . . . 1.67 109.452 171.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.9 p -143.43 147.27 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.246 1.018 . . . . 2.99 108.331 -171.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -153.93 -179.88 8.26 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 112.136 0.421 . . . . 2.38 112.136 -174.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.536 0.412 0 C-N-CA 123.912 0.885 . . . . 2.49 110.736 176.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.947 0 CA-C-O 119.044 -0.864 . . . . 2.72 111.065 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -116.27 145.77 42.89 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.995 2.118 . . . . 3.5 107.731 175.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.3 tp -128.46 159.04 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 123.845 0.858 . . . . 2.3 109.35 175.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.3 mt -109.42 138.16 46.2 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.552 1.141 . . . . 1.62 110.873 -176.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.34 124.79 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 125.987 1.715 . . . . 1.89 107.383 -178.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.9 p -101.72 135.68 42.84 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.71 -0.848 . . . . 1.46 108.71 176.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -128.76 163.39 25.27 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.283 2.233 . . . . 3.68 107.997 -176.083 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -159.92 156.45 27.27 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 105.299 -2.111 . . . . 3.44 105.299 -170.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 60.16 66.81 0.92 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 130.26 3.424 . . . . 2.97 111.854 -169.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 51.65 -160.52 0.09 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.176 0.99 . . . . 2.26 109.902 -178.296 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.9 mt -145.14 157.39 53.7 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 104.555 -2.387 . . . . 2.33 104.555 175.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.01 -88.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.923 2.415 . . . . 2.21 109.585 178.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -78.07 46.82 0.62 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.366 1.066 . . . . 3.25 109.957 179.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 45.55 -2.62 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 129.437 3.095 . . . . 2.99 117.787 -171.366 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 58.2 t80 56.58 88.51 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.619 1.167 . . . . 4.08 108.858 -153.195 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 22.3 mtp-105 -79.88 155.77 27.63 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.593 -1.262 . . . . 5.81 107.593 172.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -89.88 156.44 18.46 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.139 1.376 . . . . 3.35 111.183 -170.031 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 52.15 47.38 55.29 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.274 0.94 . . . . 0.92 112.935 175.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.06 101.18 2.07 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 105.518 -2.03 . . . . 2.99 105.518 -178.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -60.87 138.61 48.09 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.714 -0.554 . . . . 1.03 111.714 -169.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.2 pp -136.75 174.71 11.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 124.25 1.02 . . . . 2.13 108.778 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.4 m -122.6 145.83 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 108.83 -0.804 . . . . 1.81 108.83 175.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -135.05 127.65 30.8 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.9 1.28 . . . . 1.74 109.501 -174.257 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -113.38 141.52 46.96 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.072 1.349 . . . . 2.96 109.628 -178.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 175.05 -136.39 3.42 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 110.919 -0.872 . . . . 0.85 110.919 164.11 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.0 p -129.62 151.3 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 123.632 0.773 . . . . 1.65 109.466 -167.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -54.55 135.5 46.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.407 -0.815 . . . . 3.19 110.714 172.084 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -94.41 -115.55 2.7 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 109.448 -1.461 . . . . 2.13 109.448 179.049 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -56.63 -55.75 30.0 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.121 0.969 . . . . 4.54 111.135 179.042 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.8 p30 179.98 -65.82 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 127.755 2.422 . . . . 4.1 107.718 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.16 -38.2 35.35 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.353 -0.699 . . . . 1.72 111.353 178.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.54 138.55 34.25 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 117.554 0.677 . . . . 3.08 110.85 -175.323 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -103.28 123.58 47.05 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 124.29 1.036 . . . . 3.46 108.506 -175.331 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.6 97.29 10.95 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.384 -0.969 . . . . 1.58 108.384 176.463 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -118.77 119.11 33.43 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 108.804 -0.813 . . . . 1.51 108.804 -177.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.8 t -117.87 10.69 13.27 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.867 0.867 . . . . 2.35 111.168 176.55 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -119.03 90.02 3.25 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 120.78 -1.2 . . . . 2.99 109.148 170.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.7 m -91.68 137.1 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 118.949 0.795 . . . . 1.94 110.018 168.19 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -118.2 120.96 39.28 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.541 -1.652 . . . . 1.94 106.541 173.021 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.05 121.47 27.07 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.884 -1.154 . . . . 2.42 107.884 171.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -130.84 25.36 5.0 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.118 0.567 . . . . 4.64 111.564 -179.674 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.201 0 N-CA-C 108.672 -0.862 . . . . 5.68 108.672 -172.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 N--CA 1.464 0.237 0 N-CA-C 112.695 0.628 . . . . 2.76 112.695 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -81.59 127.66 33.11 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.245 1.018 . . . . 3.28 109.871 -178.123 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -129.67 157.46 42.06 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.571 1.949 . . . . 4.0 109.065 177.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.4 p -94.01 149.37 36.81 Favored Pre-proline 0 N--CA 1.446 -0.667 0 C-N-CA 124.455 1.102 . . . . 2.88 108.6 179.206 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.26 -31.85 58.06 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.638 2.225 . . . . 1.32 112.342 174.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -46.71 -43.63 18.06 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.509 0.724 . . . . 3.25 111.827 171.268 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -76.85 -7.31 55.25 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.796 -0.565 . . . . 2.33 111.857 -175.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.3 pt -124.92 40.56 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 125.696 1.599 . . . . 2.35 110.164 176.018 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.5 p -124.27 -60.7 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 CA-C-O 121.543 0.687 . . . . 3.61 112.022 160.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -83.51 73.37 10.21 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 120.324 -1.485 . . . . 2.16 112.137 -162.504 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.79 70.93 1.09 Allowed Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.832 -1.307 . . . . 2.35 109.832 176.73 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.78 -123.06 0.06 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.05 -1.833 . . . . 4.07 106.05 175.744 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 t -63.91 -37.16 86.39 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 118.396 0.543 . . . . 2.82 110.871 -172.578 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -43.27 -42.48 4.42 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 127.058 2.143 . . . . 4.43 112.079 177.278 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.2 m -116.28 9.52 14.56 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.852 1.261 . . . . 3.07 109.991 -175.256 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 45.73 33.66 4.93 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.597 1.57 . . . . 1.31 113.667 -173.58 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.1 m -81.56 -25.75 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 119.076 1.438 . . . . 2.45 111.872 -173.073 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -121.44 -75.46 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.226 0 C-N-CA 123.922 0.889 . . . . 4.51 111.137 177.274 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -75.57 121.47 6.38 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 CA-C-N 120.48 1.207 . . . . 1.19 109.192 177.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -69.04 158.36 34.95 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.483 -0.562 . . . . 3.3 109.483 169.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.36 167.66 5.15 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.719 0.808 . . . . 2.54 110.801 174.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.3 11.31 79.58 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 119.589 -0.562 . . . . 1.12 113.589 178.187 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -95.02 147.69 23.13 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.442 1.121 . . . . 1.92 109.646 175.076 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.19 125.1 31.87 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 107.261 -1.385 . . . . 4.8 107.261 177.265 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.2 pt -140.7 176.93 4.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 107.796 -1.187 . . . . 2.03 107.796 168.091 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.0 mtt180 -130.75 127.08 38.02 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.696 -0.853 . . . . 3.13 108.696 173.616 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.5 p -92.28 127.32 44.56 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.076 0 N-CA-C 108.239 -1.023 . . . . 1.98 108.239 177.537 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -122.24 127.86 6.96 Favored Glycine 0 C--N 1.333 0.397 0 N-CA-C 110.317 -1.113 . . . . 0.87 110.317 177.314 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.49 -164.03 32.91 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 117.751 0.776 . . . . 0.91 111.294 -177.037 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.56 127.6 52.33 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.108 0.963 . . . . 3.59 109.99 -175.183 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.5 t -59.49 139.49 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 106.971 -1.492 . . . . 3.11 106.971 169.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 57.2 m -50.9 -79.93 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.198 0.599 . . . . 3.34 112.059 -176.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.1 p 172.42 -39.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 126.175 1.79 . . . . 2.67 108.286 -176.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -149.39 28.55 1.21 Allowed Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.982 -0.343 . . . . 2.38 112.345 176.059 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.3 m -86.59 4.34 40.59 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 117.713 0.757 . . . . 1.51 111.983 176.096 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.79 110.35 2.79 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.878 -1.156 . . . . 2.57 107.878 172.927 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.9 m -118.14 111.83 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 107.396 -1.335 . . . . 2.13 107.396 170.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -98.73 148.96 23.34 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.347 1.059 . . . . 6.23 110.678 175.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -84.72 151.74 58.75 Favored Pre-proline 0 C--O 1.235 0.294 0 N-CA-C 109.088 -0.708 . . . . 2.32 109.088 173.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.02 25.86 0.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.663 2.242 . . . . 1.9 112.861 168.434 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -87.62 -24.61 23.9 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.822 0.849 . . . . 1.47 108.746 163.325 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 m 67.97 11.34 8.32 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.353 1.461 . . . . 1.87 112.486 -175.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.0 pp -127.37 3.1 6.3 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.655 1.582 . . . . 2.76 112.323 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -136.65 135.68 38.47 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.071 1.348 . . . . 1.74 109.301 -178.634 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.07 130.08 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 107.659 -1.237 . . . . 2.0 107.659 -170.358 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -135.81 156.2 49.16 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 119.49 1.041 . . . . 1.62 110.195 173.559 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -150.25 144.21 25.45 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.935 -0.575 . . . . 3.47 110.382 -173.351 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.49 130.16 35.87 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.857 -0.794 . . . . 1.7 108.857 173.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.6 t -110.24 130.8 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 106.399 -1.704 . . . . 2.89 106.399 174.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -157.7 157.28 33.2 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 118.618 -0.706 . . . . 4.1 109.277 -179.736 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.0 t0 . . . . . 0 N--CA 1.456 -0.16 0 C-N-CA 123.952 0.901 . . . . 5.87 109.556 171.911 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.857 0 N-CA-C 114.371 0.509 . . . . 2.27 114.371 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -165.88 139.31 4.31 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 104.956 -2.238 . . . . 4.2 104.956 167.231 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.6 tp -154.81 152.78 8.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 119.102 0.865 . . . . 2.11 110.461 172.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.5 mt -100.18 122.74 43.49 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.287 1.035 . . . . 1.62 110.594 -179.475 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.0 t -109.74 127.49 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 124.983 1.313 . . . . 2.07 107.8 -177.752 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.6 p -104.81 144.84 31.2 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.779 0.832 . . . . 1.81 109.585 179.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -142.78 163.27 33.25 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.981 1.712 . . . . 3.53 107.823 -174.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -148.79 146.22 27.92 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 127.742 2.417 . . . . 3.64 105.365 -174.535 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 67.87 60.84 0.43 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 129.661 3.185 . . . . 2.84 112.147 -171.403 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 mt 54.41 -169.6 0.06 Allowed 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 125.553 1.541 . . . . 3.51 111.375 176.506 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.0 mt -143.67 148.94 45.11 Favored Pre-proline 0 C--O 1.233 0.227 0 N-CA-C 106.657 -1.609 . . . . 2.36 106.657 179.374 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -64.33 111.29 1.58 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.898 2.399 . . . . 3.04 109.273 -176.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 42.09 46.69 3.75 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.252 1.421 . . . . 4.61 111.121 -174.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 48.79 11.41 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 116.246 1.943 . . . . 3.83 116.246 -176.127 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 53.38 115.92 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 123.52 0.728 . . . . 6.19 109.546 -148.059 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -74.41 113.81 12.07 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.638 -1.616 . . . . 6.42 106.638 -176.453 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -74.83 133.77 41.84 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 118.44 -1.304 . . . . 3.95 112.277 -126.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.54 53.52 3.38 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.638 1.114 . . . . 1.76 111.55 -176.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.0 54.97 1.9 Allowed 'General case' 0 C--N 1.341 0.224 0 CA-C-N 117.5 0.65 . . . . 3.8 112.021 -172.394 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -9.73 124.36 0.01 OUTLIER Glycine 0 CA--C 1.533 1.191 0 C-N-CA 128.723 3.058 . . . . 1.39 116.66 -163.735 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.7 pp -134.63 169.19 22.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 O-C-N 121.455 -1.027 . . . . 2.15 110.056 -172.761 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.6 m -121.37 139.38 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 108.718 -0.845 . . . . 1.98 108.718 175.029 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -128.34 121.0 28.14 Favored 'General case' 0 N--CA 1.458 -0.052 0 C-N-CA 125.013 1.325 . . . . 1.44 108.831 -176.568 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -103.81 142.45 34.35 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.541 0.736 . . . . 4.04 109.572 -179.341 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 171.59 -141.33 6.33 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.653 -0.979 . . . . 1.19 110.653 169.367 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.0 p -129.72 149.24 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 109.311 -0.625 . . . . 1.91 109.311 -168.42 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -56.05 132.35 49.89 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 119.666 -0.814 . . . . 3.57 109.523 170.716 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -80.29 -124.6 0.55 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 109.391 -1.484 . . . . 2.04 109.391 177.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -70.9 -67.67 0.49 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.945 -0.391 . . . . 5.2 109.945 -174.461 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -167.31 102.27 0.52 Allowed 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.177 -1.416 . . . . 3.18 107.177 174.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 104.34 -30.01 10.92 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.096 0.855 . . . . 1.31 111.778 176.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -82.39 135.52 35.15 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.902 -0.764 . . . . 3.55 109.29 175.02 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -104.99 114.75 29.13 Favored 'General case' 0 CA--C 1.526 0.04 0 N-CA-C 108.385 -0.969 . . . . 3.25 108.385 -178.602 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -90.5 106.45 18.51 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 108.053 -1.091 . . . . 1.83 108.053 179.684 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -143.26 89.8 2.12 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 113.361 0.875 . . . . 1.96 113.361 -166.7 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.7 t -88.62 -15.17 35.69 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.673 0.99 . . . . 2.09 113.673 -179.414 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -84.98 85.98 7.43 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 119.597 -1.939 . . . . 3.38 107.871 176.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.1 m -100.7 130.37 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 119.73 1.15 . . . . 1.98 111.941 177.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.81 135.08 55.0 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.989 -1.115 . . . . 2.34 107.989 179.241 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -119.78 84.58 2.23 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 124.868 1.267 . . . . 2.12 109.065 179.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.66 50.08 0.83 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.165 0.586 . . . . 3.66 110.207 177.229 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 67.5 m80 . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 106.582 -1.636 . . . . 7.74 106.582 -177.721 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 pp . . . . . 0 C--O 1.233 0.216 0 N-CA-C 107.587 -1.264 . . . . 4.01 107.587 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -103.43 113.17 26.46 Favored 'General case' 0 C--O 1.228 -0.069 0 C-N-CA 124.792 1.237 . . . . 3.72 108.226 179.521 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.72 153.42 35.66 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.33 1.052 . . . . 4.25 110.813 -177.047 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -85.67 138.81 35.5 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 125.035 1.334 . . . . 2.92 110.735 -177.554 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -54.1 -40.25 82.42 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.598 2.865 . . . . 0.94 112.044 -179.573 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.4 t -58.83 -49.14 78.82 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 119.009 0.822 . . . . 3.07 111.804 178.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.1 tt0 -55.25 -40.57 71.1 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 119.864 -0.734 . . . . 3.51 109.743 -178.179 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.315 37.0 pt -77.8 -11.31 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 114.823 1.416 . . . . 2.19 114.823 -179.17 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.61 -19.67 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 119.312 0.96 . . . . 2.97 111.315 -179.041 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -96.61 -125.63 0.13 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.234 -0.654 . . . . 3.34 109.234 -179.376 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -82.92 61.43 4.77 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.284 -1.126 . . . . 2.46 110.284 -169.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -151.89 -106.46 0.05 Allowed 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 127.155 2.182 . . . . 4.98 106.789 -171.799 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.6 m -77.36 -57.05 4.04 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.517 0.599 . . . . 2.78 109.897 -171.357 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -56.84 -49.73 74.56 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 123.588 0.555 . . . . 3.16 110.129 -171.231 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.6 m -70.1 -34.45 73.15 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.773 -0.649 . . . . 2.35 110.919 174.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.22 46.59 20.64 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 123.76 0.695 . . . . 2.12 111.421 175.311 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.4 m -113.98 -51.25 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 113.534 0.938 . . . . 3.06 113.534 -172.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -79.02 -58.64 0.68 Allowed Pre-proline 0 CA--C 1.54 0.594 0 CA-C-O 118.498 -0.763 . . . . 5.2 112.071 -178.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -79.37 165.02 23.66 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.096 1.864 . . . . 1.39 109.583 174.154 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.87 155.9 16.85 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.985 0.914 . . . . 4.26 109.864 174.861 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.9 24.57 0.49 Allowed 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.639 1.176 . . . . 3.56 112.122 177.376 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -143.4 30.2 1.99 Allowed Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.983 1.278 . . . . 2.15 110.891 171.431 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -103.03 155.88 18.07 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.393 0.677 . . . . 1.96 109.429 174.211 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.55 126.73 52.47 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.753 1.221 . . . . 7.01 108.168 176.817 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.86 176.3 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 108.283 -1.006 . . . . 3.1 108.283 171.147 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 22.7 mtt180 -111.33 134.48 52.88 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.689 -0.485 . . . . 4.35 109.689 166.535 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -102.93 119.88 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 107.122 -1.436 . . . . 2.03 107.122 171.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.49 125.24 4.33 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 109.643 -1.383 . . . . 0.59 109.643 -176.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.34 -133.73 1.59 Allowed Glycine 0 C--N 1.334 0.451 0 N-CA-C 109.517 -1.433 . . . . 1.52 109.517 -174.715 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.4 ptp -127.64 133.77 49.66 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.101 0.951 . . . . 3.82 109.996 175.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.7 t -95.64 143.2 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 108.716 -0.846 . . . . 3.3 108.716 175.507 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.63 175.74 3.34 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.281 -0.637 . . . . 3.27 109.281 173.656 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.5 p -106.4 65.42 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 122.897 1.332 . . . . 3.41 109.418 179.255 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 134.76 68.79 0.07 OUTLIER Glycine 0 CA--C 1.526 0.773 0 CA-C-N 113.68 -1.6 . . . . 2.34 112.429 175.517 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.0 m -136.45 8.09 3.1 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.399 -1.059 . . . . 1.93 112.729 158.739 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.8 ttp -78.85 117.39 19.91 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.011 -1.107 . . . . 3.66 108.011 176.341 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.2 m -121.02 151.71 24.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 107.829 -1.175 . . . . 1.73 107.829 175.732 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 37.8 ptt85 -141.44 144.02 34.2 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.992 0.917 . . . . 5.12 109.041 -169.154 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.33 155.12 37.24 Favored Pre-proline 0 C--O 1.236 0.361 0 N-CA-C 109.519 -0.548 . . . . 2.58 109.519 -177.002 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.13 32.11 0.42 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.508 2.805 . . . . 2.13 112.685 -176.121 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -95.69 -14.66 23.24 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.747 1.219 . . . . 1.59 109.125 163.611 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.4 m 70.23 6.82 5.96 Favored 'General case' 0 C--N 1.345 0.399 0 C-N-CA 125.105 1.362 . . . . 1.56 113.225 -178.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.7 pp -125.5 -34.28 2.69 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 127.662 2.385 . . . . 2.94 112.354 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 30.6 m-70 -87.96 124.72 33.99 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 107.809 -1.182 . . . . 1.49 107.809 -176.575 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 23.7 m -149.05 152.98 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.397 -0.964 . . . . 2.2 108.397 -175.008 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -156.02 161.93 40.39 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 121.41 -0.807 . . . . 1.51 110.803 176.706 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -155.3 160.57 40.87 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.197 0.599 . . . . 3.22 110.486 -175.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -107.87 136.0 48.32 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.251 -1.018 . . . . 1.63 108.251 175.249 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.7 t -115.74 142.1 30.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 124.942 1.297 . . . . 3.15 107.521 178.618 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -125.94 179.91 4.99 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.564 0.746 . . . . 2.21 110.056 179.303 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.8 t0 . . . . . 0 N--CA 1.445 -0.684 0 CA-C-O 121.072 0.463 . . . . 3.44 109.995 -177.624 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.616 0 N-CA-C 108.108 -1.997 . . . . 2.4 108.108 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -162.15 93.85 0.89 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.947 -1.131 . . . . 3.94 107.947 179.522 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.15 134.65 65.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 108.766 -0.827 . . . . 2.22 108.766 -175.188 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.1 mt -85.39 136.96 33.24 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.077 0.951 . . . . 1.86 109.973 177.124 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 87.1 t -124.06 133.22 69.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 107.387 -1.338 . . . . 2.0 107.387 176.363 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.7 p -111.78 158.35 19.47 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.537 1.135 . . . . 1.71 109.796 -177.105 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.428 ' CE2' ' HA ' ' A' ' 125' ' ' THR . 2.4 m-85 -148.43 133.02 17.76 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.348 1.459 . . . . 5.56 108.897 -178.279 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -104.92 6.32 33.56 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.682 1.193 . . . . 2.7 111.711 169.311 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -111.79 162.91 14.75 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 124.488 1.115 . . . . 5.03 111.123 172.287 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.9 mp -60.89 141.39 57.21 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.322 -0.853 . . . . 2.73 109.949 162.631 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 75.8 mt -81.02 159.27 68.77 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 107.426 -1.324 . . . . 2.94 107.426 175.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.54 -90.76 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.896 3.064 . . . . 2.31 111.196 179.273 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -79.46 43.54 0.56 Allowed 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.245 -0.909 . . . . 3.73 110.53 -173.537 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.3 tp 57.92 3.27 0.21 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.581 1.152 . . . . 3.82 112.978 -165.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 44.8 t80 57.78 94.23 0.03 OUTLIER 'General case' 0 C--N 1.342 0.274 0 CA-C-N 119.586 1.085 . . . . 3.71 109.237 -166.271 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -78.94 122.47 26.17 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.339 -0.986 . . . . 5.63 108.339 -178.17 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -84.13 173.06 11.38 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.093 1.357 . . . . 3.21 110.127 -172.692 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.9 34.73 89.43 Favored Glycine 0 CA--C 1.527 0.832 0 O-C-N 121.882 -0.511 . . . . 0.8 112.821 175.085 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -156.32 175.39 14.06 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.364 1.066 . . . . 3.34 108.967 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -97.68 105.88 3.22 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.973 -0.851 . . . . 1.19 110.973 -178.07 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.5 pp -111.5 157.46 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 106.547 -1.649 . . . . 2.2 106.547 -179.42 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.1 m -118.14 116.04 50.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 108.742 -0.836 . . . . 1.77 108.742 176.535 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -102.99 146.53 28.21 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 125.373 1.469 . . . . 1.83 109.875 -175.207 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -146.52 139.66 25.6 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.32 1.048 . . . . 3.58 110.106 -173.463 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 170.74 -133.82 2.91 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 106.516 -2.634 . . . . 0.85 106.516 174.762 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p -142.24 149.9 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 118.63 1.215 . . . . 1.9 109.166 -166.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.5 mt -77.31 157.18 30.85 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.693 -0.855 . . . . 3.25 108.693 -178.42 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 175.92 25.73 0.03 OUTLIER Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.345 -0.931 . . . . 2.67 115.408 175.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -150.3 46.31 0.89 Allowed 'General case' 0 C--O 1.238 0.455 0 CA-C-N 118.392 1.096 . . . . 5.91 109.533 -175.827 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 20.61 66.17 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 129.533 3.133 . . . . 3.93 111.338 173.473 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 131.13 -30.44 3.33 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 114.084 -1.416 . . . . 1.06 112.555 -175.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.32 161.13 19.48 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.548 1.174 . . . . 4.18 111.251 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 12.5 mt -121.36 131.59 54.28 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 125.442 1.497 . . . . 3.05 110.443 -169.348 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.25 99.07 11.38 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.083 -1.451 . . . . 1.64 107.083 176.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.82 155.48 16.76 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.573 -0.528 . . . . 2.03 109.573 179.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.428 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 8.8 t -134.01 -42.23 0.82 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.876 0.47 . . . . 2.0 111.365 173.254 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -87.39 105.62 17.39 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 120.179 -1.576 . . . . 4.31 108.778 177.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.88 118.62 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 123.824 0.85 . . . . 2.13 109.725 171.027 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -108.3 111.25 23.11 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.443 -0.947 . . . . 2.0 108.443 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.56 53.48 2.54 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.116 0.966 . . . . 2.23 110.628 178.424 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.2 pttt -79.88 69.72 6.28 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.79 -0.569 . . . . 3.85 110.616 -173.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 . . . . . 0 CA--C 1.529 0.158 0 C-N-CA 123.053 0.541 . . . . 5.21 110.315 -172.172 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 pt? . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 109.613 -0.514 . . . . 3.91 109.613 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -93.91 114.82 27.11 Favored 'General case' 0 C--N 1.337 0.061 0 C-N-CA 124.8 1.24 . . . . 3.69 109.792 -178.039 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -120.12 156.88 30.15 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 126.329 1.852 . . . . 3.89 109.669 -175.765 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.7 p -90.78 145.24 31.63 Favored Pre-proline 0 N--CA 1.45 -0.473 0 C-N-CA 124.422 1.089 . . . . 2.69 109.059 177.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -55.29 -36.81 94.4 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.889 2.393 . . . . 0.9 111.968 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.5 t -52.57 -35.64 54.33 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.453 -0.779 . . . . 3.46 112.041 175.247 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -83.68 5.51 24.33 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.291 0.478 . . . . 3.02 112.291 -176.408 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.6 pt -120.24 1.48 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 113.812 1.042 . . . . 1.84 113.812 173.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.1 p -97.27 -59.69 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 118.617 0.644 . . . . 3.31 112.02 176.096 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -75.65 84.42 2.67 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 120.504 -1.373 . . . . 2.07 112.042 -166.614 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.37 56.67 9.6 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 109.658 -1.377 . . . . 2.22 109.658 176.047 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -147.86 -137.3 0.09 Allowed 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 127.79 2.436 . . . . 3.16 105.861 -173.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.6 m -58.82 -47.46 84.73 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.451 1.5 . . . . 2.78 112.631 -175.776 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -38.46 -54.87 1.45 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.445 0.698 . . . . 2.48 111.311 174.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.47 -1.45 53.52 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.446 1.099 . . . . 3.0 111.738 -173.147 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 49.79 41.39 35.57 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.137 1.351 . . . . 1.38 113.408 -176.804 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.1 m -92.39 -26.41 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.53 1.165 . . . . 2.4 112.887 -176.687 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -123.04 -74.16 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 124.635 1.174 . . . . 5.94 111.497 176.663 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -73.48 121.38 7.08 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.554 1.503 . . . . 1.41 109.305 177.497 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -77.89 160.07 28.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.078 0.951 . . . . 4.4 108.893 175.325 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.68 158.06 28.39 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.324 -0.621 . . . . 1.96 109.324 169.0 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.53 -2.08 76.89 Favored Glycine 0 CA--C 1.532 1.129 0 O-C-N 121.682 -0.636 . . . . 1.04 112.572 -175.482 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -91.67 146.39 23.81 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 118.102 0.951 . . . . 2.97 109.131 178.222 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.4 mtt-85 -90.5 133.75 34.84 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.033 -0.728 . . . . 4.94 109.033 172.443 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.1 pt -144.98 169.48 7.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 105.279 -2.119 . . . . 2.41 105.279 166.607 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 37.8 mtt180 -116.94 126.65 53.27 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.656 -1.239 . . . . 3.32 107.656 169.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -90.44 135.49 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 N-CA-C 107.269 -1.382 . . . . 3.44 107.269 173.484 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -128.55 128.59 5.96 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 109.38 -1.488 . . . . 0.63 109.38 172.491 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 176.8 -167.74 39.31 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 109.939 -1.264 . . . . 0.89 109.939 -173.227 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.4 ptm -111.95 137.7 49.6 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.479 0.657 . . . . 5.96 112.42 -176.18 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.2 t -64.93 159.32 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 114.349 -1.296 . . . . 3.31 109.062 178.692 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 62.7 m -108.54 131.98 54.3 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.053 0.941 . . . . 3.09 109.984 -178.492 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.3 p -75.58 45.91 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 127.955 2.502 . . . . 3.64 111.895 179.009 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.73 49.93 0.03 OUTLIER Glycine 0 CA--C 1.522 0.473 0 C-N-CA 125.529 1.538 . . . . 2.87 109.37 179.335 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.0 m -155.59 -40.67 0.08 Allowed 'General case' 0 C--O 1.226 -0.162 0 O-C-N 122.402 -0.469 . . . . 1.99 112.029 177.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.67 115.76 1.79 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 109.691 -0.485 . . . . 3.79 109.691 171.802 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.8 m -136.51 153.57 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 108.866 -0.791 . . . . 2.29 108.866 168.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -128.07 148.61 50.57 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.873 1.269 . . . . 5.72 108.837 -178.231 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -82.84 155.9 67.78 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-N 118.119 0.418 . . . . 1.87 109.959 174.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -70.91 7.28 1.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.088 2.525 . . . . 1.22 113.599 174.452 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -72.74 -23.6 60.86 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 121.938 -0.476 . . . . 1.68 110.181 163.318 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.7 m 70.97 10.49 6.95 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.504 1.522 . . . . 2.59 112.785 -174.854 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . 0.276 1.0 OUTLIER -123.08 -36.5 2.84 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.705 1.002 . . . . 3.37 113.705 177.748 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -85.33 129.36 34.83 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 120.23 1.377 . . . . 1.45 107.566 178.415 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.0 m -138.06 145.81 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 107.92 -1.141 . . . . 2.15 107.92 176.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -144.23 147.34 33.46 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.082 -0.71 . . . . 1.39 109.082 177.784 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -157.49 155.61 30.66 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.317 -0.401 . . . . 3.57 110.39 -171.588 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.65 149.6 24.28 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.136 -0.69 . . . . 1.88 109.136 173.071 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.3 t -119.0 133.59 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 106.151 -1.796 . . . . 2.99 106.151 172.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -155.64 159.71 39.82 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 106.653 -1.61 . . . . 3.64 106.653 174.817 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 55.0 t0 . . . . . 0 C--O 1.233 0.203 0 N-CA-C 106.293 -1.743 . . . . 5.72 106.293 173.8 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.968 0 N-CA-C 109.765 -1.334 . . . . 2.54 109.765 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -164.76 148.64 9.01 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.952 -1.499 . . . . 4.06 106.952 169.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -155.14 154.48 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.79 0.723 . . . . 2.03 109.082 163.449 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 mt -109.12 131.94 54.59 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.508 1.523 . . . . 1.83 109.521 177.482 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.1 t -122.05 144.16 32.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 125.8 1.64 . . . . 2.06 108.77 -176.263 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 32.4 p -118.96 150.01 40.64 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.203 1.001 . . . . 1.45 108.49 179.008 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -149.32 109.81 4.22 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.854 -1.165 . . . . 3.68 107.854 -178.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -91.02 42.91 1.12 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.347 1.459 . . . . 2.12 112.048 -176.443 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -169.48 174.6 5.86 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.61 1.564 . . . . 2.52 108.645 173.049 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.6 mp -68.56 162.71 25.2 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.637 0.775 . . . . 2.45 112.485 -175.398 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 55.7 mt -112.67 158.6 37.04 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 126.048 1.739 . . . . 2.14 110.618 -175.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.12 -88.16 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.897 3.065 . . . . 1.99 111.365 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.441 ' C ' ' H ' ' A' ' 104' ' ' PHE . 9.8 m-20 -73.57 31.27 0.07 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.791 1.236 . . . . 3.83 112.139 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 50.73 -5.38 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 128.558 2.743 . . . . 3.13 116.387 -165.501 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.441 ' H ' ' C ' ' A' ' 102' ' ' ASP . 13.4 m-30 55.65 109.23 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.864 1.666 . . . . 5.81 110.959 -154.607 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -74.0 164.64 26.37 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.301 -1.318 . . . . 6.1 108.323 174.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -82.4 61.14 5.43 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.199 1.4 . . . . 5.11 109.727 -164.436 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 108.31 62.05 0.55 Allowed Glycine 0 CA--C 1.522 0.53 0 C-N-CA 124.509 1.052 . . . . 2.09 111.218 -173.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -111.14 168.81 9.22 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 107.891 -1.151 . . . . 3.85 107.891 158.312 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -102.91 133.7 11.52 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 111.496 -0.641 . . . . 1.39 111.496 -179.216 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.441 HD11 ' CZ ' ' A' ' 104' ' ' PHE . 33.3 pt -145.33 169.59 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.302 1.041 . . . . 2.79 109.638 -165.535 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 m -126.8 139.65 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 124.176 0.991 . . . . 1.78 108.465 170.645 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -134.95 140.08 45.44 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 124.888 1.275 . . . . 1.54 110.266 -176.695 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -135.64 145.4 46.78 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.779 1.632 . . . . 3.89 109.705 -177.871 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -178.47 -101.54 0.15 Allowed Glycine 0 C--N 1.337 0.625 0 N-CA-C 110.17 -1.172 . . . . 1.4 110.17 166.549 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.7 p -162.72 151.63 3.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 108.992 -0.744 . . . . 2.01 108.992 176.251 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -72.1 140.84 49.12 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 109.438 -0.578 . . . . 3.23 109.438 167.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -162.43 21.17 0.19 Allowed Glycine 0 CA--C 1.524 0.612 0 C-N-CA 119.709 -1.234 . . . . 2.52 113.716 172.412 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -143.57 46.96 1.48 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.755 -0.832 . . . . 5.31 108.755 -174.287 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 21.7 t70 18.09 66.12 0.02 OUTLIER 'General case' 0 C--N 1.34 0.164 0 C-N-CA 128.954 2.902 . . . . 3.57 112.487 178.409 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 137.87 -48.41 0.89 Allowed Glycine 0 CA--C 1.528 0.849 0 CA-C-N 114.614 -1.175 . . . . 1.11 111.475 -171.62 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -105.5 160.92 14.79 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.504 1.152 . . . . 3.78 109.811 -173.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.64 128.92 55.82 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.508 1.123 . . . . 3.15 109.237 -172.098 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -95.6 98.73 10.72 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.163 -1.792 . . . . 1.59 106.163 176.699 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -126.15 94.66 4.15 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.501 0.556 . . . . 1.97 112.501 -164.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.2 t -84.27 -33.4 24.02 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.906 0.706 . . . . 1.73 112.906 -178.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -82.91 95.09 7.86 Favored 'General case' 0 CA--C 1.528 0.113 0 O-C-N 120.556 -1.34 . . . . 3.61 107.733 -172.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 35.0 m -118.44 134.85 60.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 C-N-CA 123.809 0.844 . . . . 2.62 110.634 -176.221 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.59 101.66 8.8 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.241 -1.392 . . . . 2.39 107.241 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.98 107.26 12.63 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.741 -1.207 . . . . 2.21 107.741 172.355 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.29 44.79 0.72 Allowed 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 121.367 0.603 . . . . 4.06 109.983 179.515 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 7.8 p80 . . . . . 0 CA--C 1.536 0.44 0 N-CA-C 113.161 0.8 . . . . 7.15 113.161 -172.598 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.227 -0.105 0 CA-C-O 118.805 -0.617 . . . . 4.47 111.139 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -81.58 96.67 7.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.963 -0.755 . . . . 3.38 108.963 -175.48 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.96 157.32 19.39 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.836 0.854 . . . . 3.84 110.427 177.694 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 p -77.44 146.08 73.14 Favored Pre-proline 0 N--CA 1.444 -0.743 0 C-N-CA 124.08 0.952 . . . . 2.84 110.179 -177.139 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -64.2 -23.05 66.72 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.507 2.805 . . . . 0.97 112.232 175.32 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.5 p -61.52 -64.4 0.96 Allowed 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.239 0.615 . . . . 3.4 110.931 174.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -46.34 -51.13 15.38 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.071 0.948 . . . . 2.17 110.81 -171.462 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 34.0 pt -57.23 -29.07 31.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.436 1.094 . . . . 2.13 112.754 -178.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.6 t -80.42 -54.32 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 123.335 0.654 . . . . 3.25 109.885 169.601 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -50.59 -42.48 55.82 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 125.002 1.321 . . . . 5.15 112.982 -166.506 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.26 65.02 0.1 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.515 -0.85 . . . . 3.14 111.19 -178.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.93 -90.32 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 118.598 -0.715 . . . . 3.05 110.923 -170.063 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.0 m -83.18 -58.82 2.69 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.689 1.196 . . . . 2.46 109.721 -169.443 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -51.15 -44.24 61.4 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 122.393 1.092 . . . . 2.59 109.473 177.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.16 -25.47 60.82 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.397 1.479 . . . . 3.2 112.451 179.059 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 56.82 46.58 90.0 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.292 1.425 . . . . 1.18 112.552 -172.488 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.1 m -109.77 -27.43 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 114.091 1.145 . . . . 2.43 114.091 -175.422 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -122.5 -72.76 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.295 0 CA-C-O 118.237 -0.887 . . . . 4.14 111.108 -175.794 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -76.71 151.11 31.74 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 121.504 1.469 . . . . 1.26 108.834 169.632 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -108.32 159.58 16.53 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.663 1.185 . . . . 2.75 109.324 173.366 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.11 136.94 56.65 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.412 -0.958 . . . . 2.11 108.412 174.078 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.85 -1.95 30.29 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 124.234 0.921 . . . . 1.07 113.09 -173.324 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -89.02 146.9 24.56 Favored 'General case' 0 C--N 1.338 0.08 0 CA-C-N 118.87 1.335 . . . . 2.99 109.585 179.226 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.29 106.89 17.51 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 107.906 -1.146 . . . . 4.51 107.906 -173.53 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 pt -135.63 178.21 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 124.054 0.942 . . . . 2.31 108.947 -173.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -121.93 119.77 32.5 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.476 -0.935 . . . . 2.95 108.476 174.415 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 p -83.78 128.96 38.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 107.198 -1.408 . . . . 2.04 107.198 173.044 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.3 128.6 4.58 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.562 -1.015 . . . . 0.78 110.562 -177.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 179.76 -156.19 17.48 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 108.977 -1.649 . . . . 0.82 108.977 -175.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.9 ppp? -118.3 142.92 47.01 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.814 1.245 . . . . 4.85 110.095 -179.577 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.9 m -100.92 139.85 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 123.223 0.609 . . . . 3.51 109.809 -169.054 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 m -72.33 140.32 48.43 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.465 0.65 . . . . 2.33 109.71 176.064 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.0 p -47.05 -61.63 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 126.263 1.825 . . . . 2.39 111.398 172.552 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.73 73.42 1.19 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.093 -1.203 . . . . 2.0 110.093 -178.219 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.5 m -152.46 -30.98 0.15 Allowed 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 115.084 1.513 . . . . 1.27 115.084 -179.519 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.2 104.73 0.96 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.085 -1.08 . . . . 2.67 108.085 175.686 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.9 m -112.79 126.45 70.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 107.503 -1.295 . . . . 1.92 107.503 175.401 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.12 137.02 54.39 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.151 1.38 . . . . 5.31 108.191 -174.384 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.408 ' C ' ' H ' ' A' ' 76' ' ' ASN . 5.9 m-20 -88.41 145.97 36.75 Favored Pre-proline 0 C--O 1.235 0.304 0 N-CA-C 109.068 -0.716 . . . . 2.51 109.068 -179.11 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.01 25.2 0.3 Allowed 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.106 2.538 . . . . 2.77 113.589 178.733 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.408 ' H ' ' C ' ' A' ' 74' ' ' ASP . 60.0 m-80 -91.8 -24.23 19.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.802 1.241 . . . . 2.15 109.378 164.282 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.9 m 74.12 0.42 3.6 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.52 1.528 . . . . 2.78 113.203 -174.515 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.98 18.06 11.73 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.182 0.993 . . . . 3.2 112.168 -178.354 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -145.39 127.01 15.16 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.477 -1.305 . . . . 1.94 107.477 173.286 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.1 128.97 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 107.704 -1.221 . . . . 2.26 107.704 -173.252 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -141.73 148.42 38.98 Favored 'General case' 0 C--O 1.232 0.158 0 O-C-N 121.088 -1.007 . . . . 1.11 110.739 176.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -143.17 153.32 42.73 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 116.35 -0.387 . . . . 3.12 110.171 -173.416 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.86 138.14 36.42 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.928 -0.767 . . . . 1.84 108.928 172.72 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -131.97 139.67 49.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 123.844 0.857 . . . . 3.01 108.958 176.392 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -140.55 -177.71 5.17 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.665 1.586 . . . . 1.77 108.387 -173.311 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.4 t0 . . . . . 0 CA--C 1.532 0.282 0 CA-C-O 122.238 1.018 . . . . 2.71 110.149 -179.555 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.431 0 N-CA-C 109.876 -1.29 . . . . 3.56 109.876 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 66.49 87.67 0.12 Allowed 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 125.228 1.411 . . . . 3.51 110.853 -179.126 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -95.13 155.11 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 108.638 -0.875 . . . . 2.08 108.638 -178.332 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 mt -104.25 131.37 51.64 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.738 -0.838 . . . . 1.75 108.738 174.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.7 t -114.71 133.25 61.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 125.558 1.543 . . . . 2.11 107.161 178.474 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.4 p -109.55 148.52 31.1 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.782 0.833 . . . . 1.48 109.002 -179.765 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.416 ' CE2' ' HA ' ' A' ' 125' ' ' THR . 1.5 t80 -150.69 146.69 26.63 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 107.184 -1.413 . . . . 3.41 107.184 -173.709 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.7 p-10 -141.35 40.33 1.75 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.214 1.005 . . . . 2.16 112.887 -167.166 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -166.37 56.87 0.1 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.545 0.738 . . . . 2.59 111.525 -178.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 52.62 -171.4 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.62 1.168 . . . . 2.33 111.951 -169.046 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.7 mt -147.25 152.04 41.91 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 107.007 -1.479 . . . . 2.19 107.007 174.453 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -63.24 133.29 39.93 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 124.033 3.155 . . . . 2.48 110.016 177.384 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 41.77 46.92 3.45 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.027 1.331 . . . . 3.83 111.29 -173.717 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 50.26 15.1 0.18 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.085 1.754 . . . . 3.08 115.068 -175.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 27.4 t80 62.4 95.99 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 126.108 1.763 . . . . 3.79 110.113 -166.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 64.1 mtp85 -77.34 124.52 27.98 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 106.477 -1.675 . . . . 4.8 106.477 -174.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -83.36 173.2 11.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.114 0.483 . . . . 2.92 110.61 -172.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.17 42.15 98.09 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 121.859 -0.526 . . . . 0.79 112.677 176.112 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -155.01 179.03 9.53 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.576 1.55 . . . . 2.96 108.581 176.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -110.36 138.35 14.84 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 111.616 -0.594 . . . . 1.07 111.616 175.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.4 pp -140.11 169.42 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 125.686 1.595 . . . . 2.01 106.904 -177.6 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 18.8 m -123.0 145.82 29.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 107.986 -1.116 . . . . 1.95 107.986 167.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -130.83 123.8 29.88 Favored 'General case' 0 N--CA 1.461 0.079 0 C-N-CA 124.345 1.058 . . . . 1.65 109.738 -177.273 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.21 145.01 34.87 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.33 1.052 . . . . 3.99 110.091 -179.45 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 164.65 -139.88 6.1 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 108.022 -2.031 . . . . 0.95 108.022 173.575 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.5 p -134.54 143.1 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 118.342 1.071 . . . . 1.82 110.983 -166.627 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -71.72 153.68 41.86 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.126 -0.943 . . . . 2.95 108.857 171.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -170.51 -50.62 0.04 OUTLIER Glycine 0 C--N 1.332 0.329 0 N-CA-C 110.988 -0.845 . . . . 2.24 110.988 177.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -65.56 146.97 54.19 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.283 -1.006 . . . . 5.99 108.283 173.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -82.64 63.33 6.72 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.389 -0.967 . . . . 3.85 108.389 -173.733 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 127.96 11.69 3.13 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.895 1.712 . . . . 1.39 113.664 -179.223 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.73 168.57 19.41 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.194 1.497 . . . . 3.59 109.834 169.823 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.3 mp -126.57 136.11 52.13 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.375 1.07 . . . . 3.1 109.418 -171.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -97.41 103.06 14.96 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.903 -1.518 . . . . 1.77 106.903 175.326 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -122.91 121.06 35.27 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 118.398 -0.811 . . . . 1.65 108.854 -177.098 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.416 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 15.4 t -107.99 -15.61 14.49 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 123.579 0.549 . . . . 2.16 111.802 176.426 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -97.94 79.05 2.6 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 120.204 -1.56 . . . . 3.49 108.979 -176.752 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 18.2 m -88.07 130.13 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 119.596 1.089 . . . . 1.76 111.339 174.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.94 106.6 13.6 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 107.342 -1.355 . . . . 1.89 107.342 175.366 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.67 72.11 10.62 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 123.165 0.586 . . . . 1.76 110.6 -178.258 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.5 -37.06 62.38 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.811 0.671 . . . . 6.15 112.811 -178.667 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.532 0.28 0 O-C-N 121.657 -0.652 . . . . 5.52 110.095 -171.282 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.412 0 N-CA-C 112.655 0.613 . . . . 5.22 112.655 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -87.92 114.74 24.83 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 125.469 1.508 . . . . 3.41 110.717 -178.291 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -132.23 156.39 46.58 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.535 0.734 . . . . 4.72 112.363 -173.055 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.6 m -71.98 132.62 84.56 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 125.54 1.536 . . . . 3.48 110.759 -174.661 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -54.52 -37.49 90.19 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.149 2.566 . . . . 1.07 112.8 -176.711 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -37.3 -53.43 1.09 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.578 1.151 . . . . 3.13 113.228 171.541 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -78.36 -1.89 35.53 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.011 -0.431 . . . . 3.1 111.807 -173.189 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 32.7 pt -121.48 35.04 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.581 1.152 . . . . 2.22 110.193 171.716 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.6 p -121.02 -76.31 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 122.893 0.477 . . . . 3.36 111.165 158.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -83.52 109.11 17.11 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 125.214 1.405 . . . . 3.18 110.441 -160.058 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.69 37.27 40.33 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 109.528 -1.429 . . . . 2.76 109.528 177.597 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.06 -93.55 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.688 1.195 . . . . 3.43 107.836 -174.145 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.6 m -72.58 -59.0 2.94 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.141 0.976 . . . . 2.91 111.195 -177.679 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -53.45 -41.66 66.36 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 122.835 1.302 . . . . 3.08 109.575 -175.119 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.38 -19.43 42.66 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 126.524 1.93 . . . . 2.39 112.321 -179.619 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 54.69 42.56 78.12 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 126.039 1.781 . . . . 1.9 113.18 -175.383 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.5 m -100.25 -49.94 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 118.616 1.208 . . . . 3.1 113.113 -174.071 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 34.3 mmtt -97.54 -66.03 0.08 OUTLIER Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.85 0.86 . . . . 3.74 111.378 -177.485 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -75.15 68.94 5.79 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.264 1.976 . . . . 2.61 108.843 170.428 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -51.28 140.4 16.98 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.993 -0.743 . . . . 3.03 108.993 173.657 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.88 127.89 34.47 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.58 -0.896 . . . . 1.96 108.58 -176.466 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 124.39 -29.03 5.14 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.915 -0.874 . . . . 1.46 110.915 -161.609 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -79.84 137.15 36.87 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.988 1.394 . . . . 2.59 110.225 -177.338 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.03 106.28 15.3 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.919 1.688 . . . . 4.38 108.569 -172.648 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.43 168.46 23.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.7 -1.593 . . . . 3.05 106.7 -174.58 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 25.9 mtt-85 -110.17 123.15 49.23 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 106.83 -1.544 . . . . 3.12 106.83 178.232 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.4 p -86.88 130.73 36.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 107.329 -1.36 . . . . 1.98 107.329 176.066 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -133.53 128.65 5.09 Favored Glycine 0 C--N 1.332 0.344 0 N-CA-C 110.161 -1.175 . . . . 0.57 110.161 -179.497 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.1 -172.99 45.92 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.501 -1.04 . . . . 0.63 110.501 -179.417 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -90.93 138.34 31.67 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 117.404 0.602 . . . . 5.71 110.14 -178.628 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.42 144.73 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 109.388 -0.597 . . . . 3.29 109.388 178.892 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.2 m -87.92 133.39 33.93 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 125.741 1.617 . . . . 3.07 108.842 -174.84 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.8 p -46.63 -47.61 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.346 1.058 . . . . 3.23 112.879 -177.424 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -100.43 76.09 0.43 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 109.648 -1.381 . . . . 2.0 109.648 -178.856 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.9 m -146.33 -39.29 0.22 Allowed 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 117.804 0.802 . . . . 1.5 112.558 178.78 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.8 ttm -54.95 129.06 36.25 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 118.168 0.44 . . . . 3.17 110.117 173.088 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.75 122.73 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 106.119 -1.808 . . . . 1.88 106.119 160.088 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.35 139.3 49.57 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.935 1.294 . . . . 6.23 109.665 -178.138 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.46 166.06 47.37 Favored Pre-proline 0 C--O 1.235 0.324 0 CA-C-O 120.936 0.398 . . . . 1.72 111.101 -173.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.97 -25.59 13.98 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.138 2.558 . . . . 1.42 111.201 163.593 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -48.13 -30.03 4.19 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.001 0.521 . . . . 1.15 110.564 164.701 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.2 m 66.6 19.12 10.84 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 125.02 1.328 . . . . 1.47 112.324 175.147 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.33 -41.52 1.89 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 128.281 2.632 . . . . 3.22 110.993 177.604 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 71.9 m-70 -84.2 126.0 32.73 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.951 -1.5 . . . . 1.31 106.951 178.533 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.7 m -142.75 139.0 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 106.564 -1.643 . . . . 2.33 106.564 179.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -144.15 149.95 37.3 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.346 -0.613 . . . . 1.72 109.346 177.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -154.36 146.69 23.89 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 123.678 0.611 . . . . 3.37 109.468 -170.606 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.92 122.4 40.99 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 124.345 1.058 . . . . 1.82 109.248 -179.197 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.1 t -108.23 146.9 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.084 0 N-CA-C 107.389 -1.337 . . . . 2.99 107.389 177.543 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -151.1 -170.98 3.81 Favored 'General case' 0 C--O 1.226 -0.143 0 N-CA-C 107.541 -1.281 . . . . 2.33 107.541 174.045 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.521 -0.173 0 CA-C-N 118.619 0.645 . . . . 3.43 109.664 -177.576 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.112 0 N-CA-C 116.223 1.249 . . . . 1.96 116.223 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -64.09 141.04 58.91 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.7 -0.883 . . . . 2.56 110.427 171.507 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -141.56 143.91 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 107.856 -1.165 . . . . 2.24 107.856 170.97 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.3 mt -91.1 119.35 31.16 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.287 1.035 . . . . 1.96 108.973 177.523 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 51.3 t -98.24 127.99 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 106.783 -1.562 . . . . 2.1 106.783 174.548 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.6 p -113.61 148.11 36.83 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.547 -0.908 . . . . 1.95 108.547 -177.753 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.439 ' CE2' ' HA ' ' A' ' 125' ' ' THR . 0.5 OUTLIER -142.72 141.35 31.77 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.949 1.3 . . . . 4.93 108.381 -177.263 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -114.13 10.06 17.3 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.614 1.565 . . . . 2.49 111.95 173.377 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -118.92 161.77 19.62 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 125.148 1.379 . . . . 4.47 110.297 172.16 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.6 mp -64.86 122.91 18.06 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.159 -0.473 . . . . 2.64 109.939 168.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 23.0 mt -73.75 155.33 89.04 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 123.621 0.768 . . . . 2.66 110.107 173.39 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -65.9 151.94 82.79 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 123.603 2.869 . . . . 2.39 110.194 173.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 55.1 12.67 0.68 Allowed 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.983 1.475 . . . . 3.31 114.983 -177.467 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 62.99 -6.42 0.17 Allowed 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 118.644 0.656 . . . . 5.5 111.616 -162.419 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.0 t80 55.95 78.7 0.19 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.257 1.823 . . . . 3.77 109.154 -170.829 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.3 10.2 mtp180 -86.7 34.88 0.66 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 119.046 -1.061 . . . . 5.03 111.729 -177.517 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . 0.357 10.5 mm-40 82.94 178.53 0.06 Allowed 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 120.232 1.378 . . . . 5.25 110.158 149.875 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 61.14 15.07 42.42 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 115.469 0.948 . . . . 1.38 115.469 158.215 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -136.73 141.48 43.04 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.601 1.2 . . . . 2.99 108.027 -177.903 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -77.85 113.67 3.79 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.266 -1.134 . . . . 0.96 110.266 -175.069 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.1 pp -123.65 169.33 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 123.608 0.763 . . . . 2.05 109.437 -175.101 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.7 m -117.89 134.26 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 107.852 -1.166 . . . . 1.85 107.852 169.371 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -121.26 155.18 35.21 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 125.53 1.532 . . . . 1.48 108.569 177.837 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -148.09 161.83 40.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.052 0.842 . . . . 3.2 112.112 171.645 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 171.15 -111.52 0.41 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 105.702 -2.959 . . . . 0.85 105.702 167.537 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.2 p -156.81 146.39 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 118.724 1.262 . . . . 2.26 111.719 -175.737 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.67 116.68 7.15 Favored 'General case' 0 N--CA 1.457 -0.093 0 N-CA-C 107.908 -1.145 . . . . 3.18 107.908 168.729 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -136.75 13.2 3.93 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.092 -0.838 . . . . 2.39 113.17 -179.681 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -143.05 35.49 1.37 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.017 0.908 . . . . 5.19 110.678 177.625 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 26.63 52.45 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 128.124 2.57 . . . . 4.02 112.053 177.992 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 160.77 -40.3 0.43 Allowed Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.244 -0.754 . . . . 1.27 113.772 -163.488 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.83 164.11 18.05 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.934 1.367 . . . . 3.82 110.79 171.412 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.1 mt -105.72 116.67 32.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.243 1.417 . . . . 2.94 108.282 -177.307 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.41 103.7 13.79 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.553 -1.647 . . . . 1.88 106.553 171.754 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -101.39 156.16 17.62 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.433 0.693 . . . . 2.07 109.843 -179.025 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.439 ' HA ' ' CE2' ' A' ' 96' ' ' TYR 0.256 9.9 t -141.1 -36.51 0.45 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.532 0.938 . . . . 2.13 113.532 174.713 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -92.45 127.35 37.91 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 120.481 -1.387 . . . . 2.74 109.189 169.109 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.4 m -125.32 142.21 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 N-CA-C 108.394 -0.965 . . . . 2.27 108.394 164.921 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.85 101.51 7.61 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.25 -1.389 . . . . 2.17 107.25 179.071 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.85 60.56 2.87 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.247 0.619 . . . . 1.72 110.694 -177.397 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -79.41 51.77 1.27 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.601 0.76 . . . . 3.87 112.072 -173.222 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.454 -0.23 0 N-CA-C 107.32 -1.363 . . . . 5.13 107.32 -179.239 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--O 1.233 0.194 0 N-CA-C 109.894 -0.41 . . . . 3.7 109.894 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -111.59 122.58 48.19 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.288 1.435 . . . . 4.05 107.984 179.715 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -129.71 164.62 23.58 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 122.799 0.44 . . . . 4.52 111.266 173.376 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 p -85.63 146.93 45.15 Favored Pre-proline 0 N--CA 1.45 -0.431 0 C-N-CA 123.725 0.81 . . . . 2.56 110.598 -178.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -57.52 -42.18 63.77 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.94 2.426 . . . . 0.91 111.155 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.9 p -58.63 -24.15 60.46 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.904 1.681 . . . . 2.96 113.0 174.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -84.27 -48.36 9.83 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.114 -0.699 . . . . 2.26 109.114 173.093 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.266 22.3 pt -75.73 37.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 114.397 1.258 . . . . 2.21 114.397 -178.245 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.408 ' CG2' ' H ' ' A' ' 45' ' ' ASN . 0.5 OUTLIER -121.93 -87.06 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 125.39 1.476 . . . . 3.94 108.16 169.271 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.408 ' H ' ' CG2' ' A' ' 44' ' ' VAL . 28.6 m-80 -58.98 103.62 0.18 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.549 2.34 . . . . 2.28 110.469 -171.414 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.42 39.0 70.09 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.081 -0.807 . . . . 1.98 111.081 171.942 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -143.99 -102.31 0.12 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 126.175 1.79 . . . . 3.42 108.377 175.57 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 97.7 m -69.48 -68.1 0.43 Allowed 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 124.319 1.048 . . . . 2.37 110.954 -177.374 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -53.75 -43.74 69.4 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.908 0.861 . . . . 2.5 110.559 -171.188 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.27 -22.56 51.93 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.615 0.766 . . . . 2.58 112.512 176.946 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 60.69 56.86 21.93 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 125.66 1.6 . . . . 1.33 112.324 178.303 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.255 26.8 m -110.76 -64.16 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 114.1 1.148 . . . . 2.16 114.1 -179.595 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt -80.41 -62.99 0.36 Allowed Pre-proline 0 CA--C 1.538 0.513 0 O-C-N 121.302 -0.874 . . . . 4.51 112.029 -177.629 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -77.13 -179.24 5.24 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.387 2.058 . . . . 1.67 109.285 169.249 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -152.53 151.13 30.33 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.564 -1.643 . . . . 2.93 106.564 -174.875 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -55.39 161.9 1.73 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.53 0.937 . . . . 1.69 113.53 178.601 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.42 -6.09 58.49 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 119.424 -0.653 . . . . 1.02 113.075 -179.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -82.1 145.34 30.21 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.821 1.31 . . . . 2.35 108.814 175.805 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.2 ttm105 -90.19 125.86 35.62 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.709 -1.219 . . . . 5.65 107.709 174.689 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.4 pt -142.05 175.63 4.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 118.842 0.746 . . . . 1.95 109.035 175.483 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -120.05 136.74 54.46 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.874 0.47 . . . . 4.59 109.749 168.647 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.63 125.65 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 125.362 1.465 . . . . 2.09 107.91 175.768 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -128.05 112.56 1.48 Allowed Glycine 0 C--N 1.333 0.388 0 N-CA-C 109.875 -1.29 . . . . 0.53 109.875 -177.764 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.67 -171.5 33.72 Favored Glycine 0 C--N 1.332 0.348 0 N-CA-C 110.027 -1.229 . . . . 0.78 110.027 -176.623 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 18.6 ptp -88.67 138.66 31.23 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.031 0.443 . . . . 3.87 110.1 -178.209 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.7 m -91.18 150.35 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 109.401 -0.592 . . . . 3.45 109.401 170.574 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 m -91.37 143.89 26.15 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.892 -1.151 . . . . 2.74 107.892 165.358 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.9 p -59.43 -59.44 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.362 1.065 . . . . 3.44 110.088 178.272 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.36 66.79 2.89 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.328 -1.109 . . . . 1.68 110.328 178.346 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.3 m -150.13 -30.77 0.21 Allowed 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 113.942 1.09 . . . . 1.49 113.942 -179.398 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -60.14 117.23 4.88 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 119.087 0.858 . . . . 2.77 109.225 173.545 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.16 125.41 71.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 N-CA-C 107.655 -1.239 . . . . 1.71 107.655 169.808 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -109.48 147.46 32.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.235 1.014 . . . . 7.86 109.619 -178.829 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -72.42 161.76 77.42 Favored Pre-proline 0 C--O 1.239 0.533 0 C-N-CA 120.404 -0.518 . . . . 2.29 110.381 174.455 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -63.74 -34.22 62.82 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.384 2.056 . . . . 1.92 110.175 163.81 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -41.18 -47.27 3.26 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 125.273 1.429 . . . . 1.47 109.854 174.713 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.4 m 80.64 11.67 0.95 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.117 1.767 . . . . 1.65 112.423 179.668 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.17 -6.92 9.9 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.041 1.336 . . . . 2.82 111.334 175.522 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -123.4 136.64 54.73 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.919 1.287 . . . . 1.6 108.151 177.99 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.61 131.07 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 107.826 -1.176 . . . . 1.97 107.826 -172.341 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -135.81 154.32 51.24 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 119.778 1.172 . . . . 1.68 110.427 175.894 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -150.25 138.69 20.53 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.067 -0.716 . . . . 3.32 109.067 -173.805 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.07 136.57 34.44 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.938 -1.134 . . . . 1.77 107.938 173.584 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.4 m -129.63 149.5 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 107.992 -1.114 . . . . 3.89 107.992 177.436 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -153.4 177.53 10.79 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.975 0.416 . . . . 3.66 110.247 -173.951 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.7 t0 . . . . . 0 N--CA 1.449 -0.514 0 C-N-CA 123.179 0.592 . . . . 3.03 111.037 175.235 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.7 0 N-CA-C 110.133 -1.187 . . . . 2.1 110.133 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -138.86 141.47 38.61 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.921 1.688 . . . . 3.21 107.363 -175.239 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.4 tp -140.8 151.21 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 123.451 0.701 . . . . 2.31 109.247 -176.162 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mt -93.17 122.21 35.32 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.655 0.782 . . . . 2.21 109.768 -178.048 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.0 t -102.3 119.56 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 107.062 -1.459 . . . . 1.93 107.062 173.558 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 62.0 p -99.42 147.34 25.36 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.086 -1.079 . . . . 1.81 108.086 174.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -147.35 160.83 42.08 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.238 1.415 . . . . 3.72 108.521 -172.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -147.98 152.89 38.25 Favored 'General case' 0 N--CA 1.428 -1.542 0 C-N-CA 127.553 2.341 . . . . 3.56 106.616 -169.628 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 61.1 64.81 1.06 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 129.652 3.181 . . . . 2.72 110.7 -172.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.0 mp 45.05 -144.67 0.16 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.311 1.444 . . . . 2.15 109.449 -173.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.6 mt -158.76 149.78 16.3 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 104.883 -2.265 . . . . 2.14 104.883 -175.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -67.35 129.75 20.97 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 121.956 1.771 . . . . 2.66 108.14 169.757 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 23.25 53.78 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 128.207 2.603 . . . . 3.33 113.095 -178.047 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 36.6 38.42 0.08 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.509 1.524 . . . . 4.61 114.422 -179.159 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.0 p90 35.34 83.6 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.423 1.489 . . . . 4.47 112.111 -173.561 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.4 116.3 4.96 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 119.255 -2.153 . . . . 5.38 110.709 -137.594 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -77.53 167.22 21.99 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 122.267 1.032 . . . . 3.67 111.679 -147.31 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.93 41.07 56.18 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 114.841 -1.072 . . . . 0.92 110.996 -169.919 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -149.8 178.34 8.97 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.353 1.061 . . . . 2.97 109.08 171.864 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -92.89 136.22 13.05 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 110.738 -0.945 . . . . 1.01 110.738 170.632 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.4 pp -139.29 154.74 25.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 107.484 -1.302 . . . . 1.9 107.484 179.557 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 19.5 m -110.32 120.89 62.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 108.741 -0.837 . . . . 1.83 108.741 178.457 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -113.97 150.8 33.28 Favored 'General case' 0 N--CA 1.458 -0.071 0 C-N-CA 126.131 1.772 . . . . 1.55 109.494 -174.492 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -149.9 155.01 39.27 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 113.448 0.907 . . . . 3.88 113.448 177.987 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 163.48 -130.38 2.22 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 106.063 -2.815 . . . . 0.99 106.063 175.235 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.9 p -129.95 145.79 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.069 0 CA-C-N 118.337 1.068 . . . . 2.31 111.761 -164.095 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -66.3 124.33 22.41 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.199 -0.455 . . . . 2.96 111.027 174.725 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.59 130.43 9.83 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 126.257 1.884 . . . . 3.62 109.377 172.595 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 60.58 29.73 19.23 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.465 1.106 . . . . 4.58 111.458 167.553 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 40.9 39.26 0.78 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.011 1.724 . . . . 4.51 111.178 -170.375 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -160.3 -61.96 0.01 OUTLIER Glycine 0 C--N 1.34 0.792 0 O-C-N 121.472 -0.767 . . . . 1.39 111.946 -170.354 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -83.34 127.34 33.59 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.901 -0.777 . . . . 3.0 108.901 -178.842 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.35 107.32 17.94 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.384 -1.339 . . . . 3.21 107.384 177.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.85 84.74 7.46 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.361 -1.348 . . . . 1.8 107.361 -179.59 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.66 144.71 26.44 Favored 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 123.762 0.825 . . . . 1.6 109.023 -177.484 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.7 t -137.88 9.56 2.82 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.85 0.75 . . . . 1.74 112.914 173.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -132.99 119.65 20.37 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.736 -1.579 . . . . 3.61 106.736 170.272 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.4 m -123.41 131.38 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 124.589 1.156 . . . . 1.96 109.494 176.867 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -115.91 104.37 11.55 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.708 -1.219 . . . . 2.16 107.708 179.117 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.14 56.02 3.56 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.018 0.927 . . . . 1.82 110.653 -179.238 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -77.8 60.95 2.36 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.046 0.938 . . . . 4.14 111.355 -175.409 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.269 0 CA-C-O 121.686 0.755 . . . . 5.22 111.171 -172.514 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 pt? . . . . . 0 C--O 1.233 0.195 0 N-CA-C 109.663 -0.495 . . . . 2.8 109.663 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -83.07 140.0 32.91 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.534 0.734 . . . . 3.49 110.359 -178.734 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -144.67 160.13 41.7 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.925 1.29 . . . . 4.06 110.593 176.977 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.95 134.67 38.72 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 126.519 1.928 . . . . 2.36 109.972 -179.848 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -56.84 -43.46 54.22 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.263 2.642 . . . . 0.84 111.775 -179.449 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.3 p -59.94 -34.2 72.93 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 121.406 -0.809 . . . . 2.67 112.065 -178.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.02 -55.17 36.08 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.553 0.692 . . . . 3.19 109.281 175.953 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.318 20.6 pt -66.29 -14.91 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 114.64 -1.164 . . . . 2.04 112.624 -170.022 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 88.4 t -75.68 -54.87 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 123.007 0.523 . . . . 3.22 110.978 167.499 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -56.43 -71.4 0.09 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.508 0.929 . . . . 2.57 113.508 -163.328 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -146.21 55.87 0.53 Allowed Glycine 0 C--N 1.333 0.4 0 N-CA-C 108.778 -1.729 . . . . 2.87 108.778 -167.806 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -153.44 -106.85 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.928 1.691 . . . . 4.8 108.644 -171.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.5 m -72.53 -60.05 2.42 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 124.341 1.056 . . . . 2.16 111.619 -170.765 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -56.25 -40.14 73.7 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 122.048 0.928 . . . . 2.59 109.734 -176.039 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.45 -24.84 62.09 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.158 0.983 . . . . 3.1 112.805 174.482 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.48 41.38 99.54 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 126.163 1.839 . . . . 1.26 111.918 -176.015 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.9 m -102.55 -53.52 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 118.048 0.924 . . . . 2.31 113.037 -174.423 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -93.71 -65.4 0.12 Allowed Pre-proline 0 CA--C 1.533 0.326 0 CA-C-O 118.542 -0.742 . . . . 4.79 112.054 -175.282 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -78.59 140.6 16.91 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 121.681 1.587 . . . . 1.24 108.799 174.067 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -87.35 161.95 17.63 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.701 0.8 . . . . 4.97 109.255 167.738 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.95 170.15 8.73 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 122.9 0.48 . . . . 1.96 110.215 174.124 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.51 22.81 71.69 Favored Glycine 0 CA--C 1.534 1.248 0 O-C-N 121.768 -0.583 . . . . 1.05 113.583 178.308 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -102.23 162.23 13.08 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.198 0.999 . . . . 1.7 108.432 171.2 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.7 mtt180 -99.63 134.43 42.53 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.86 -0.422 . . . . 4.29 109.86 169.55 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.3 pt -143.36 176.22 3.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 106.862 -1.533 . . . . 1.81 106.862 169.024 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -123.29 123.4 40.66 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.355 -0.98 . . . . 2.91 108.355 170.474 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.9 m -89.06 129.42 40.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 107.938 -1.134 . . . . 3.77 107.938 175.007 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -128.38 128.23 5.9 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 109.197 -1.561 . . . . 0.69 109.197 178.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.67 -170.74 40.34 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 109.979 -1.248 . . . . 0.73 109.979 -174.139 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.3 ptp -100.41 123.91 45.23 Favored 'General case' 0 N--CA 1.458 -0.061 0 CA-C-O 121.316 0.579 . . . . 3.33 110.976 -174.044 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.0 t -73.24 105.23 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 123.831 0.853 . . . . 3.2 110.485 179.78 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.407 ' HG1' ' CE1' ' A' ' 85' ' ' HIS . 3.2 m -45.29 136.09 5.49 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 126.362 1.865 . . . . 2.36 111.28 164.583 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.1 p -55.54 -64.09 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.741 0.817 . . . . 2.41 111.077 177.42 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.45 72.6 2.78 Favored Glycine 0 C--N 1.332 0.36 0 N-CA-C 109.34 -1.504 . . . . 1.77 109.34 -174.586 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.6 m -150.46 -34.18 0.16 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 115.891 1.811 . . . . 1.57 115.891 -174.895 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -76.93 99.71 5.33 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 120.159 1.345 . . . . 3.3 110.313 -175.012 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.1 m -111.32 128.81 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 108.527 -0.916 . . . . 1.96 108.527 -177.819 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -111.57 143.26 42.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.725 1.61 . . . . 7.03 110.591 -175.61 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -71.83 155.82 91.74 Favored Pre-proline 0 C--O 1.232 0.155 0 CA-C-N 118.245 0.475 . . . . 1.87 109.764 177.416 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -64.16 -27.11 64.77 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.207 1.938 . . . . 1.41 111.363 166.064 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -45.31 -33.68 2.57 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.193 0.597 . . . . 1.15 110.709 164.726 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.1 m 69.27 15.99 8.48 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.446 1.498 . . . . 1.82 112.466 177.253 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.41 -38.1 2.59 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 126.324 1.85 . . . . 2.65 112.075 175.789 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -87.38 135.96 33.12 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.155 -1.424 . . . . 1.45 107.155 175.537 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.0 m -144.15 148.72 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 107.195 -1.409 . . . . 1.96 107.195 178.144 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -148.78 158.76 44.39 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.448 -0.783 . . . . 1.24 109.716 178.892 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -150.64 142.11 23.45 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.654 -0.703 . . . . 3.14 110.405 -173.884 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.97 148.56 27.54 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.16 -1.052 . . . . 1.66 108.16 163.031 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.5 p -146.84 150.46 14.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 107.661 -1.237 . . . . 3.0 107.661 171.705 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.407 ' CE1' ' HG1' ' A' ' 67' ' ' THR . 0.5 OUTLIER -146.2 176.43 9.75 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.189 0.996 . . . . 3.39 110.513 -175.345 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.5 t70 . . . . . 0 N--CA 1.454 -0.252 0 C-N-CA 123.961 0.904 . . . . 2.63 110.735 -176.57 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.819 0 N-CA-C 110.892 -0.883 . . . . 2.03 110.892 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -99.5 135.15 41.33 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 124.792 1.237 . . . . 3.1 108.98 169.18 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.57 144.89 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.654 -1.239 . . . . 2.42 107.654 167.553 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.5 mt -104.09 120.69 41.64 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.271 1.029 . . . . 1.83 108.38 176.225 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 44.0 t -103.16 136.3 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 125.422 1.489 . . . . 1.8 107.676 178.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.2 p -112.94 142.01 46.11 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.405 1.082 . . . . 1.57 108.578 178.521 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -138.42 114.63 10.24 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.529 -1.286 . . . . 3.84 107.529 -175.564 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -101.27 46.97 0.92 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.851 1.261 . . . . 2.33 112.05 -171.222 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -167.67 176.81 6.19 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.646 1.978 . . . . 2.55 107.037 170.486 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.0 mp -70.67 136.65 49.22 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.02 -1.05 . . . . 2.35 110.783 178.533 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.9 mt -69.92 160.89 78.47 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.395 1.078 . . . . 2.55 110.565 174.302 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.52 -95.82 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.837 3.024 . . . . 2.39 110.281 176.282 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.414 ' C ' ' H ' ' A' ' 104' ' ' PHE . 3.1 m-20 -78.39 49.91 0.89 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.863 1.265 . . . . 3.49 110.232 -176.543 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 52.44 -4.67 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.404 2.682 . . . . 2.99 115.918 -168.46 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.414 ' H ' ' C ' ' A' ' 102' ' ' ASP . 64.4 t80 64.26 93.96 0.06 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.727 1.611 . . . . 3.51 108.795 -159.32 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -79.81 129.02 34.13 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.663 0.744 . . . . 7.19 109.272 -179.138 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -83.95 144.17 29.34 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 128.062 2.545 . . . . 3.4 109.617 -174.002 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.29 46.59 8.02 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 112.052 -0.419 . . . . 1.08 112.052 178.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -155.8 175.52 13.82 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.567 -1.642 . . . . 2.73 106.567 170.839 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -86.24 144.49 20.03 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.095 -1.202 . . . . 1.07 110.095 167.668 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.1 pp -139.77 167.7 18.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 107.731 -1.211 . . . . 1.73 107.731 167.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 23.8 m -126.71 135.57 63.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.867 -0.79 . . . . 1.98 108.867 171.096 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -129.55 120.46 25.38 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 124.703 1.201 . . . . 1.86 110.762 -169.095 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -114.21 145.95 41.03 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 125.253 1.421 . . . . 3.47 111.022 -176.619 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 173.07 -123.09 0.96 Allowed Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 108.021 -2.032 . . . . 0.91 108.021 170.467 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.2 p -138.25 152.17 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 118.176 0.988 . . . . 1.78 109.726 -173.021 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -59.61 132.31 53.58 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 108.118 -1.067 . . . . 2.74 108.118 167.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -87.98 -104.34 0.93 Allowed Glycine 0 C--N 1.338 0.661 0 N-CA-C 110.011 -1.236 . . . . 2.31 110.011 -172.766 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -59.4 -66.15 0.56 Allowed 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.334 1.054 . . . . 4.85 108.375 172.771 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -173.0 -66.3 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.761 2.024 . . . . 4.19 105.971 175.83 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.0 -45.04 96.94 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 123.504 0.573 . . . . 1.53 112.271 177.021 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -83.28 144.13 29.93 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 122.036 -0.685 . . . . 3.36 111.257 -176.217 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -105.15 122.77 46.6 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 125.002 1.321 . . . . 3.23 108.076 -176.456 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.91 85.85 4.51 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.826 -1.175 . . . . 1.88 107.826 175.913 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.4 105.0 13.84 Favored 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 123.473 0.709 . . . . 1.7 110.378 -175.301 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.2 t -95.77 -25.82 15.91 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.903 0.881 . . . . 1.73 111.761 -177.485 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -89.33 81.52 6.64 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 120.695 -1.253 . . . . 3.28 108.708 179.279 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.6 m -90.48 125.03 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 118.112 0.415 . . . . 1.7 110.32 173.26 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -115.26 113.97 24.58 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.165 -1.42 . . . . 1.69 107.165 175.372 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.69 108.27 11.98 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 107.501 -1.296 . . . . 1.78 107.501 167.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.89 50.49 0.31 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 122.511 0.324 . . . . 4.59 110.626 -175.613 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.255 0 C-N-CA 124.852 1.261 . . . . 6.99 108.395 177.49 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 pt? . . . . . 0 N--CA 1.465 0.319 0 N-CA-C 112.052 0.39 . . . . 3.19 112.052 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -85.15 125.17 32.6 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 124.874 1.27 . . . . 3.67 110.115 179.463 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -124.27 161.19 26.33 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.628 1.571 . . . . 4.0 110.89 176.88 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 54.4 m -83.04 126.05 73.4 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 126.444 1.898 . . . . 2.88 110.433 -177.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -48.24 -43.1 32.5 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.901 3.067 . . . . 1.57 114.032 -179.133 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.1 m -54.76 -33.07 60.8 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.264 -0.897 . . . . 2.45 112.33 177.821 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -77.31 3.0 14.06 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.54 0.736 . . . . 2.63 111.994 179.548 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.278 18.3 pt -121.6 3.37 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 O-C-N 120.79 -1.194 . . . . 1.98 112.978 173.07 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.1 t -98.01 -49.0 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.031 0.932 . . . . 2.88 112.049 179.393 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -102.98 90.61 3.82 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 120.54 -1.35 . . . . 2.13 111.106 -167.843 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.35 48.47 18.77 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.905 -0.878 . . . . 2.08 110.905 178.293 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -152.85 -146.04 0.19 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 128.609 2.764 . . . . 5.3 105.067 176.481 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.1 m -43.57 -48.45 7.53 Favored 'General case' 0 C--O 1.227 -0.127 0 C-N-CA 126.198 1.799 . . . . 2.84 115.495 -170.51 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -39.16 -55.14 1.69 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.497 0.719 . . . . 2.57 111.508 172.859 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.07 -15.94 25.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.782 1.233 . . . . 2.81 110.652 -173.618 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.89 26.91 73.77 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.996 1.284 . . . . 1.12 112.438 176.818 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.2 m -80.07 -23.54 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 118.047 0.923 . . . . 1.93 112.406 -174.53 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -121.75 -75.95 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 124.172 0.989 . . . . 4.47 111.745 178.137 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.25 119.57 6.07 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 CA-C-N 120.554 1.234 . . . . 1.34 109.352 179.476 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -71.63 149.16 45.84 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.99 -0.744 . . . . 4.81 108.99 172.293 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.73 147.26 47.53 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.102 -1.073 . . . . 1.93 108.102 172.595 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.77 -1.17 27.42 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.61 1.1 . . . . 1.17 112.874 -173.732 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -102.79 148.94 24.99 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.426 1.09 . . . . 1.58 109.595 -176.614 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -86.92 125.88 34.32 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.466 -0.939 . . . . 4.39 108.466 172.605 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.5 pt -141.11 176.07 5.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 106.228 -1.767 . . . . 2.33 106.228 167.078 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -124.56 133.01 53.43 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.771 -1.196 . . . . 4.1 107.771 171.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.0 131.54 51.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 107.747 -1.205 . . . . 2.6 107.747 175.402 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -126.84 113.11 1.69 Allowed Glycine 0 C--N 1.336 0.551 0 N-CA-C 109.7 -1.36 . . . . 0.66 109.7 179.371 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.85 -168.2 17.15 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 109.966 -1.254 . . . . 0.93 109.966 -175.013 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -109.42 130.61 55.49 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.637 0.775 . . . . 3.75 110.586 -176.359 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.1 t -67.0 143.7 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 109.093 -0.706 . . . . 3.48 109.093 175.313 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.0 t -59.45 -68.45 0.28 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.627 0.371 . . . . 3.4 111.34 178.831 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.0 p 178.79 -45.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 123.633 0.773 . . . . 3.14 110.496 -173.347 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -146.43 42.82 0.92 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.164 -1.174 . . . . 2.26 110.164 -179.733 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.84 -30.71 70.96 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.322 0.649 . . . . 2.19 112.541 176.757 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.4 112.62 2.25 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 122.278 0.231 . . . . 2.75 110.387 -174.919 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.1 m -122.98 120.12 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.79 -1.559 . . . . 1.86 106.79 168.096 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.45 144.04 36.6 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.536 -1.283 . . . . 6.75 107.536 175.467 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -99.17 153.01 37.99 Favored Pre-proline 0 C--O 1.234 0.282 0 N-CA-C 108.55 -0.907 . . . . 2.55 108.55 -179.828 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.41 37.72 0.52 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.662 2.908 . . . . 1.73 112.244 -178.483 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -94.78 -35.77 11.97 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.934 1.294 . . . . 2.12 108.727 171.346 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.6 m 97.48 -19.38 0.05 OUTLIER 'General case' 0 C--N 1.342 0.243 0 C-N-CA 127.819 2.447 . . . . 2.93 111.777 -174.798 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.04 27.94 8.16 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 123.772 0.829 . . . . 4.13 112.815 -179.423 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -135.98 115.44 12.71 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.759 -0.83 . . . . 2.67 108.759 178.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.15 116.23 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 124.948 1.299 . . . . 2.17 107.932 -178.308 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -129.27 154.2 47.06 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.022 0.828 . . . . 1.38 109.484 177.674 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.506 ' CE1' ' CE1' ' A' ' 104' ' ' PHE . 33.6 p90 -157.36 145.27 19.02 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.447 -0.342 . . . . 3.19 110.469 -175.555 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.12 157.94 18.7 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.655 0.74 . . . . 1.65 109.753 167.774 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 p -141.76 149.37 19.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 106.638 -1.615 . . . . 2.99 106.638 172.181 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -128.61 -172.91 2.82 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.017 0.527 . . . . 2.15 110.322 -179.374 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.7 t70 . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 109.012 -0.736 . . . . 2.37 109.012 178.204 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.497 0 CA-C-O 119.268 -0.74 . . . . 2.59 111.604 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -62.89 111.64 2.22 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.43 -1.322 . . . . 3.4 107.43 179.173 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.2 tp -140.37 156.59 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 108.185 -1.043 . . . . 2.31 108.185 179.145 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.4 mt -119.87 129.66 54.49 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.504 -1.295 . . . . 1.59 107.504 -169.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.44 ' CG2' ' CE1' ' A' ' 82' ' ' PHE . 5.1 m -120.69 143.15 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 109.152 -0.685 . . . . 3.7 109.152 175.19 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.5 p -115.06 133.68 55.83 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.101 1.361 . . . . 1.82 107.512 -176.1 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -129.77 131.04 46.1 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.856 -1.535 . . . . 3.7 106.856 -178.348 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -122.11 34.06 5.28 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.268 1.427 . . . . 2.12 111.885 -167.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -163.46 54.89 0.17 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.353 0.596 . . . . 3.1 111.689 -174.426 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 53.77 -162.75 0.11 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.854 0.862 . . . . 2.24 110.844 -173.245 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.6 mt -148.93 155.83 40.69 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 106.381 -1.711 . . . . 2.4 106.381 179.921 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.34 -73.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.142 2.561 . . . . 2.31 110.27 -179.643 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.51 47.71 0.87 Allowed 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.926 1.29 . . . . 2.68 108.394 -178.515 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 41.61 23.88 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 115.749 1.759 . . . . 3.25 115.749 -173.226 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.506 ' CE1' ' CE1' ' A' ' 82' ' ' PHE . 51.8 t80 53.67 96.51 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.6 1.091 . . . . 4.16 110.277 -168.887 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 -75.37 123.26 25.08 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.583 -0.895 . . . . 6.57 108.583 -172.699 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -82.97 168.14 17.29 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.613 0.721 . . . . 2.98 111.403 -177.349 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 58.36 35.6 79.79 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 123.965 0.793 . . . . 1.03 113.001 179.287 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -156.23 177.66 11.19 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.049 1.34 . . . . 3.51 108.035 174.189 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -94.73 139.74 14.67 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.968 -0.853 . . . . 0.98 110.968 174.819 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.5 pp -142.67 153.78 17.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 106.642 -1.614 . . . . 2.16 106.642 178.803 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 19.9 m -115.14 128.07 72.46 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 N-CA-C 108.983 -0.747 . . . . 2.06 108.983 -179.871 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -119.59 135.92 54.59 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 125.471 1.508 . . . . 1.96 109.668 -168.83 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -136.66 144.24 43.89 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.524 1.529 . . . . 3.62 109.45 -176.491 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -177.04 -103.66 0.17 Allowed Glycine 0 C--N 1.332 0.344 0 N-CA-C 108.03 -2.028 . . . . 1.27 108.03 163.611 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.5 p -151.5 145.17 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 109.177 -0.675 . . . . 1.92 109.177 178.386 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.49 152.95 31.76 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.795 -1.187 . . . . 3.64 107.795 172.463 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -168.54 -51.91 0.03 OUTLIER Glycine 0 C--N 1.333 0.396 0 C-N-CA 119.656 -1.259 . . . . 2.4 112.318 175.929 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -61.94 155.58 23.2 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 119.151 -1.019 . . . . 4.56 109.55 172.193 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -79.38 79.09 5.85 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 105.811 -1.922 . . . . 4.11 105.811 179.47 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.08 17.64 26.82 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 126.159 1.838 . . . . 1.45 113.361 172.078 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.56 154.76 38.78 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.725 -1.583 . . . . 3.88 106.725 164.879 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.09 137.92 51.7 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 122.776 0.43 . . . . 3.29 110.237 -175.837 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.34 81.43 4.43 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 107.915 -1.143 . . . . 1.71 107.915 177.029 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -90.22 134.25 34.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.306 -0.628 . . . . 1.93 109.306 178.707 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.5 t -128.88 -23.24 3.11 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.731 0.812 . . . . 2.19 113.161 179.033 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -101.58 104.18 15.05 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.352 -1.722 . . . . 4.11 106.352 173.168 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.6 m -116.81 125.23 73.64 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 N-CA-C 109.247 -0.649 . . . . 2.06 109.247 177.002 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.51 112.12 19.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.153 -1.425 . . . . 2.01 107.153 -175.002 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -106.36 42.04 1.33 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.618 1.167 . . . . 2.54 111.613 -173.14 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.23 52.72 1.36 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.355 0.662 . . . . 5.12 111.588 -175.713 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 . . . . . 0 N--CA 1.456 -0.142 0 N-CA-C 109.583 -0.525 . . . . 5.31 109.583 -176.389 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 C--O 1.234 0.244 0 CA-C-O 120.838 0.351 . . . . 3.08 110.647 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -83.4 134.58 34.88 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.576 1.15 . . . . 3.88 109.27 -179.152 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.403 ' CE2' ' HG2' ' A' ' 42' ' ' GLU . 0.5 OUTLIER -146.8 152.04 38.11 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.198 0.999 . . . . 4.69 109.209 -169.109 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.4 p -89.76 142.42 29.16 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 118.046 0.385 . . . . 3.54 110.689 -173.191 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -55.26 -41.39 78.89 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.108 1.872 . . . . 1.11 111.701 173.797 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.0 t -47.26 -36.98 9.77 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.419 1.088 . . . . 3.2 111.527 173.187 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.403 ' HG2' ' CE2' ' A' ' 38' ' ' TYR . 0.9 OUTLIER -67.39 -59.18 3.61 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.413 -0.588 . . . . 2.25 109.413 177.775 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.5 pt -73.3 4.77 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 114.758 1.392 . . . . 1.84 114.758 -167.054 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.6 m -96.82 -28.25 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.688 1.195 . . . . 3.91 112.301 172.199 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -87.15 -87.03 0.15 Allowed 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.88 0.764 . . . . 2.43 110.472 -168.63 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -122.27 59.8 0.58 Allowed Glycine 0 C--N 1.335 0.474 0 N-CA-C 108.814 -1.714 . . . . 3.09 108.814 -176.058 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -160.96 -157.45 0.52 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.905 2.482 . . . . 2.99 105.426 -175.086 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.4 m -29.02 -59.89 0.13 Allowed 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 128.279 2.631 . . . . 2.22 116.489 -170.213 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -54.14 -37.5 64.46 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.292 0.951 . . . . 3.69 111.012 -173.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.5 m -91.04 -21.88 21.04 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.708 0.803 . . . . 2.33 110.906 176.522 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.37 31.49 68.58 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.685 1.136 . . . . 1.32 112.038 172.595 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.0 m -81.6 -55.72 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 122.295 -0.532 . . . . 2.25 111.517 -173.941 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -87.3 -67.97 0.14 Allowed Pre-proline 0 CA--C 1.534 0.36 0 CA-C-O 118.558 -0.734 . . . . 4.43 112.145 175.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -78.02 131.93 11.32 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 121.53 1.486 . . . . 1.42 109.701 -177.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -80.48 165.87 21.75 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.437 0.695 . . . . 4.88 109.191 166.883 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.5 159.91 33.65 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.392 -0.595 . . . . 2.14 109.392 166.809 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.22 3.04 57.84 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 123.271 0.462 . . . . 1.3 112.8 178.31 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -102.53 156.69 17.44 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.801 1.241 . . . . 2.07 108.584 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.3 mtm-85 -96.79 130.95 43.96 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.294 -0.632 . . . . 5.18 109.294 171.124 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.1 pt -146.58 175.26 1.94 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 106.686 -1.598 . . . . 1.79 106.686 168.409 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -124.63 124.91 43.23 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 118.2 0.455 . . . . 2.32 110.08 175.537 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.4 p -87.71 119.45 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.564 -1.272 . . . . 1.86 107.564 174.567 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -126.31 115.98 2.43 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 109.508 -1.437 . . . . 0.59 109.508 177.158 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.86 -154.77 8.11 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 108.206 -1.958 . . . . 0.71 108.206 -176.943 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 24.7 ptp -117.34 137.56 52.37 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.712 0.805 . . . . 3.47 110.459 -178.448 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 p -89.1 137.23 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 120.273 -0.571 . . . . 3.66 110.166 177.283 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.6 m -28.73 -84.62 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 128.666 2.786 . . . . 3.25 113.38 175.702 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.1 p 171.97 -40.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 125.339 1.455 . . . . 2.56 110.238 -175.633 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -148.57 48.39 0.62 Allowed Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.884 -1.287 . . . . 1.93 109.884 -178.586 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 65.2 m -101.59 -12.75 18.22 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.212 0.605 . . . . 1.54 112.472 -179.54 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 35.2 tpp -58.33 125.11 21.88 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.931 0.787 . . . . 3.1 110.826 170.67 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.5 m -129.81 142.98 42.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 108.372 -0.973 . . . . 1.86 108.372 163.496 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.9 154.9 35.25 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 124.013 0.925 . . . . 5.13 110.934 -177.623 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.53 153.68 81.38 Favored Pre-proline 0 N--CA 1.453 -0.31 0 N-CA-C 109.501 -0.555 . . . . 2.05 109.501 171.411 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -59.83 -26.45 82.31 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.607 2.204 . . . . 1.72 111.363 171.008 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -44.82 -36.24 3.15 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.791 0.836 . . . . 1.37 110.952 168.649 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 21.0 m 75.58 18.57 2.21 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.869 1.668 . . . . 1.94 112.659 178.478 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.55 -49.17 2.14 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 125.368 1.467 . . . . 2.94 111.105 172.549 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -79.09 131.7 36.33 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.489 -1.3 . . . . 1.54 107.489 -176.173 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.8 m -138.51 160.03 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 108.744 -0.836 . . . . 2.63 108.744 171.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -144.74 147.57 33.12 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.65 -0.704 . . . . 1.4 109.274 175.815 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -155.59 146.65 22.48 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.754 0.421 . . . . 3.3 110.367 -173.538 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.38 132.42 44.71 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.497 0.719 . . . . 1.56 110.077 179.604 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.9 t -119.46 133.38 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 124.704 1.202 . . . . 2.92 108.51 178.832 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -117.45 -177.33 3.2 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 123.879 0.872 . . . . 2.24 110.684 177.737 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.1 t70 . . . . . 0 N--CA 1.451 -0.417 0 CA-C-N 115.693 -0.685 . . . . 2.55 110.709 -177.088 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.518 0 CA-C-O 119.218 -0.768 . . . . 1.88 111.355 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -64.33 102.47 0.53 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.69 0.745 . . . . 3.23 109.646 175.2 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -92.56 154.14 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 107.212 -1.403 . . . . 1.83 107.212 166.911 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 mt -102.98 131.15 50.15 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 108.61 -0.885 . . . . 2.09 108.61 -179.017 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.77 137.32 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 107.316 -1.364 . . . . 1.88 107.316 178.865 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.5 p -111.74 149.14 32.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.641 -1.244 . . . . 1.66 107.641 174.72 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -147.55 114.63 6.18 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.533 -1.654 . . . . 3.18 106.533 -179.579 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -94.97 40.55 1.1 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.743 1.617 . . . . 1.92 111.604 -170.826 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -166.83 174.34 8.65 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.181 1.792 . . . . 2.9 107.111 173.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.1 mp -70.87 152.72 43.39 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.826 0.822 . . . . 1.96 111.043 178.827 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.25 150.52 37.22 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 125.146 1.378 . . . . 3.72 108.713 -173.902 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -60.56 141.28 94.87 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.157 1.905 . . . . 2.28 108.621 169.964 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 42.7 46.74 4.48 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.236 1.414 . . . . 2.8 112.155 -179.528 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 50.59 15.73 0.25 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.625 1.97 . . . . 2.88 115.645 -176.874 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.5 t80 64.93 101.75 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.266 1.427 . . . . 4.16 109.874 -162.955 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 29.7 mmm-85 -79.57 111.69 16.1 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.124 -1.065 . . . . 5.73 108.124 -179.364 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -83.26 176.32 9.24 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.469 0.652 . . . . 4.17 112.504 -177.089 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.51 38.99 97.18 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.708 1.147 . . . . 0.84 112.111 177.27 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -158.99 178.29 10.23 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.027 1.331 . . . . 3.18 108.584 -178.679 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -98.98 135.8 12.33 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 110.885 -0.886 . . . . 0.95 110.885 173.419 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.0 pp -137.83 149.39 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 105.261 -2.125 . . . . 1.82 105.261 176.506 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.2 m -112.26 122.74 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 107.741 -1.207 . . . . 1.92 107.741 177.644 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -110.96 131.26 55.2 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 124.889 1.276 . . . . 1.73 109.28 -173.452 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -125.25 150.03 47.44 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.446 1.499 . . . . 3.8 108.889 -179.693 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 171.54 -119.77 0.8 Allowed Glycine 0 C--N 1.333 0.402 0 N-CA-C 107.086 -2.405 . . . . 1.2 107.086 169.307 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.8 p -145.86 151.56 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-N 118.767 1.283 . . . . 2.16 109.648 -177.076 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -81.24 143.63 32.16 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.83 -0.804 . . . . 3.04 108.83 173.154 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -161.26 13.39 0.15 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.028 -1.082 . . . . 2.65 113.582 175.515 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -137.67 45.41 2.16 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 118.088 0.944 . . . . 6.78 108.678 -169.071 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 41.7 t0 16.73 64.91 0.01 OUTLIER 'General case' 0 C--N 1.341 0.213 0 C-N-CA 128.92 2.888 . . . . 2.99 113.203 -178.888 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 138.42 -47.81 0.91 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-N 114.79 -1.095 . . . . 1.4 111.138 -170.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.75 164.11 12.71 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.04 0.92 . . . . 2.86 109.862 -175.389 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.8 mp -121.71 131.7 54.23 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.77 1.228 . . . . 3.08 110.029 -173.067 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -97.08 89.24 4.73 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.152 -1.425 . . . . 1.86 107.152 171.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.07 88.03 2.64 Favored 'General case' 0 C--O 1.227 -0.084 0 C-N-CA 123.034 0.534 . . . . 1.67 110.536 -171.765 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.6 t -85.91 -3.77 59.0 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.123 1.157 . . . . 1.81 114.123 -172.658 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -112.44 91.42 3.65 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 119.473 1.033 . . . . 3.64 108.43 179.63 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.24 128.3 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 CA-C-N 118.39 0.541 . . . . 1.79 110.524 175.93 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.04 120.29 35.87 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.46 -1.311 . . . . 1.77 107.46 177.331 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -96.22 102.83 14.68 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.124 0.97 . . . . 2.04 108.959 176.922 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.53 13.51 5.47 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.842 1.052 . . . . 5.15 113.842 178.985 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 16.3 p80 . . . . . 0 CA--C 1.534 0.338 0 C-N-CA 124.769 1.228 . . . . 6.61 112.143 174.688 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.247 0 N-CA-C 109.674 -0.491 . . . . 5.22 109.674 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -93.65 116.61 29.12 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 124.842 1.257 . . . . 3.51 110.207 177.419 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.96 178.68 8.01 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.816 0.673 . . . . 6.52 112.816 179.915 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 38.0 p -71.11 150.13 94.65 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 123.554 0.742 . . . . 2.82 110.336 -177.122 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -60.51 -47.59 13.56 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.172 2.581 . . . . 1.32 110.685 176.001 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.4 t -46.81 -39.63 12.23 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.54 1.136 . . . . 2.55 111.853 -174.683 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -44.87 -57.46 3.75 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.068 0.547 . . . . 3.81 111.178 172.075 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.28 0.1 OUTLIER -81.22 35.52 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 113.05 0.759 . . . . 2.84 113.05 -178.872 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 52.1 t -117.76 -34.68 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 118.915 0.78 . . . . 3.46 112.419 174.694 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -126.29 116.9 21.95 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 119.574 1.079 . . . . 2.36 109.19 -169.766 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 63.4 35.47 92.1 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.62 -0.992 . . . . 2.01 110.62 179.344 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.1 mttt -144.25 -107.41 0.11 Allowed 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 126.864 2.066 . . . . 3.62 109.267 177.52 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 49.7 m -72.48 -64.62 0.92 Allowed 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 118.663 0.665 . . . . 2.27 111.237 -172.98 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -48.71 -49.06 39.62 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.964 0.888 . . . . 2.55 110.752 -176.495 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.38 -22.62 57.34 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.515 1.126 . . . . 2.43 112.922 179.043 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.11 44.17 96.52 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.577 1.56 . . . . 1.04 114.083 177.752 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.1 m -98.57 -34.09 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 118.866 1.333 . . . . 2.28 113.893 -173.691 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.72 -71.73 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.84 1.256 . . . . 4.42 112.797 -176.276 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -74.84 87.14 1.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.465 2.11 . . . . 1.81 108.816 176.697 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -67.07 158.77 30.27 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.139 -0.689 . . . . 3.36 109.139 175.884 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.7 168.01 5.3 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.769 -0.65 . . . . 1.9 111.671 -176.672 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.01 5.35 90.21 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 119.792 -0.449 . . . . 1.03 113.086 -177.928 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -99.2 151.53 20.91 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.414 1.086 . . . . 1.69 109.109 177.882 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 58.7 mtt85 -93.06 146.86 23.32 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 122.876 0.47 . . . . 5.36 109.909 173.327 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.3 pt -152.35 179.75 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 106.858 -1.534 . . . . 1.99 106.858 179.853 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.9 mmt-85 -135.05 119.39 17.84 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.698 -1.593 . . . . 6.56 106.698 167.714 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.7 p -85.18 144.68 9.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 107.768 -1.197 . . . . 2.17 107.768 176.654 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -152.82 95.83 0.16 Allowed Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 110.246 -1.142 . . . . 1.04 110.246 -176.285 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -154.93 -165.67 14.35 Favored Glycine 0 C--N 1.332 0.344 0 N-CA-C 110.112 -1.195 . . . . 0.69 110.112 -175.675 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.0 ptp -100.68 137.18 39.42 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.069 0.548 . . . . 3.2 109.661 -177.159 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.8 p -92.76 129.49 43.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.061 -0.518 . . . . 3.88 110.263 170.492 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.1 146.6 46.81 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.109 -1.071 . . . . 2.53 108.109 166.71 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 p -50.68 -60.71 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.256 1.023 . . . . 2.36 110.539 -178.891 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -86.62 56.33 4.69 Favored Glycine 0 CA--C 1.527 0.791 0 O-C-N 121.378 -0.826 . . . . 1.76 111.645 -176.77 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 62.7 m -122.28 -34.8 3.24 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.986 0.736 . . . . 1.46 112.986 -178.753 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -71.92 124.12 24.2 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.802 -0.814 . . . . 3.07 108.802 -178.576 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.8 m -131.51 131.92 62.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.735 0.814 . . . . 1.98 108.829 176.15 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.5 ptt-85 -116.8 147.71 41.85 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 124.949 1.3 . . . . 5.2 110.332 179.284 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -96.58 155.5 37.77 Favored Pre-proline 0 C--O 1.234 0.273 0 N-CA-C 108.807 -0.812 . . . . 2.39 108.807 177.474 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.74 42.86 0.99 Allowed 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.75 2.967 . . . . 1.91 111.605 175.857 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -102.9 -41.36 6.18 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 125.306 1.442 . . . . 1.43 109.217 173.605 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.9 m 104.67 -32.49 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 129.12 2.968 . . . . 2.54 110.492 -172.107 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.11 28.78 8.3 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 124.135 0.974 . . . . 3.9 112.541 -173.789 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -137.5 113.22 9.58 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.044 -1.465 . . . . 2.6 107.044 174.726 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.8 m -142.34 143.45 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 107.426 -1.324 . . . . 1.84 107.426 176.504 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -139.2 159.72 41.49 Favored 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 121.637 -0.664 . . . . 1.37 109.824 169.053 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -150.95 142.32 23.36 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 109.135 -0.691 . . . . 3.31 109.135 -178.495 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.33 143.82 30.1 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.241 -1.022 . . . . 1.65 108.241 171.543 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.8 t -128.32 138.03 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 N-CA-C 107.393 -1.336 . . . . 3.01 107.393 170.421 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -133.93 174.74 10.14 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.999 -0.741 . . . . 1.65 108.999 177.911 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.3 t70 . . . . . 0 CA--C 1.532 0.279 0 CA-C-N 115.923 -0.58 . . . . 2.63 110.793 175.557 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.785 0 N-CA-C 108.319 -1.912 . . . . 1.75 108.319 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -126.3 142.88 51.36 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.165 -1.791 . . . . 3.45 106.165 171.277 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.7 tp -131.85 147.3 32.45 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 N-CA-C 108.332 -0.988 . . . . 2.29 108.332 179.71 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.9 mt -95.91 122.72 39.02 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 122.968 0.507 . . . . 1.83 110.27 179.715 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.7 122.23 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 125.552 1.541 . . . . 1.88 107.582 176.401 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 42.3 p -100.26 152.4 20.34 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.251 1.02 . . . . 1.68 108.996 174.869 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -147.16 122.3 10.16 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.563 -1.273 . . . . 4.21 107.563 177.127 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -96.53 41.66 1.1 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.698 1.599 . . . . 2.42 110.973 -179.933 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -162.55 179.53 7.68 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.734 1.214 . . . . 2.84 108.354 172.428 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.05 165.54 23.29 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.565 1.146 . . . . 2.18 111.649 174.167 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -96.16 162.16 24.7 Favored Pre-proline 0 N--CA 1.453 -0.292 0 C-N-CA 125.833 1.653 . . . . 4.09 109.437 179.185 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -64.3 -82.14 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.236 2.624 . . . . 2.53 109.168 167.32 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -93.24 48.69 1.34 Allowed 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 124.14 0.976 . . . . 2.61 109.202 -172.196 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 48.77 4.6 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.997 2.119 . . . . 3.68 116.478 -169.944 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 35.4 t80 63.71 97.18 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.221 1.409 . . . . 3.79 109.976 -159.767 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 51.7 mtp85 -79.02 121.7 25.27 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 107.418 -1.327 . . . . 4.79 107.418 174.577 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -82.23 175.31 10.39 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.942 0.897 . . . . 3.23 110.365 -175.172 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 62.58 35.46 91.85 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 122.094 -0.378 . . . . 0.98 112.546 174.279 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -155.65 -179.92 8.58 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.24 1.416 . . . . 3.45 108.188 178.131 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -106.51 131.02 10.44 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 110.917 -0.873 . . . . 0.85 110.917 177.506 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.9 pp -128.51 154.91 39.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 106.994 -1.484 . . . . 1.72 106.994 179.039 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.2 m -106.44 137.7 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 107.418 -1.327 . . . . 2.01 107.418 173.415 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -125.97 124.29 40.42 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.056 0.943 . . . . 1.78 109.615 179.607 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.35 137.62 42.86 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.141 1.376 . . . . 3.77 108.921 -177.785 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 170.75 -148.6 11.53 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.975 -0.85 . . . . 1.07 110.975 178.099 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.11 153.69 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 C-N-CA 124.823 1.249 . . . . 1.85 107.823 -170.508 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -53.37 140.96 25.83 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.29 -0.633 . . . . 2.93 109.29 169.368 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -74.74 -153.85 3.66 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 109.818 -1.313 . . . . 2.83 109.818 178.527 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -58.46 -60.31 4.0 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.952 0.501 . . . . 5.69 109.99 -174.5 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -170.82 109.08 0.32 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.496 -2.039 . . . . 3.12 105.496 175.596 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 107.41 -39.87 2.73 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.848 -1.301 . . . . 1.22 109.848 174.783 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.03 166.71 18.56 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.243 0.617 . . . . 4.0 111.196 179.823 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 98.4 mt -116.86 134.91 54.19 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 124.43 1.092 . . . . 3.15 108.653 172.334 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -105.93 103.68 13.23 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 107.834 -1.173 . . . . 1.86 107.834 173.884 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -131.48 113.51 13.78 Favored 'General case' 0 C--N 1.341 0.232 0 N-CA-C 111.902 0.334 . . . . 1.63 111.902 -174.821 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.78 -41.63 9.56 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.753 1.221 . . . . 1.82 110.442 179.329 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -84.87 77.82 10.02 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.603 -0.888 . . . . 3.59 108.603 -167.993 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.5 m -88.76 124.06 41.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.757 1.223 . . . . 1.87 110.751 177.205 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.43 131.32 54.1 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.561 1.144 . . . . 2.0 107.978 176.669 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -100.31 74.87 1.76 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.902 0.881 . . . . 2.16 110.751 -175.11 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.3 pttm -74.36 -12.26 60.48 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.832 1.049 . . . . 5.62 113.832 -171.719 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 10.5 m170 . . . . . 0 C--N 1.338 0.093 0 O-C-N 121.866 -0.521 . . . . 5.68 110.175 172.807 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 N--CA 1.466 0.351 0 N-CA-C 112.712 0.634 . . . . 2.84 112.712 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -83.44 134.15 34.88 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.545 1.138 . . . . 3.59 110.458 -177.526 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -137.18 147.48 45.92 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.293 1.837 . . . . 4.78 109.95 -178.768 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 m -71.69 137.48 82.98 Favored Pre-proline 0 N--CA 1.448 -0.546 0 C-N-CA 124.964 1.306 . . . . 2.97 110.464 177.437 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -58.94 -49.14 12.06 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.97 2.447 . . . . 0.89 111.453 177.335 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.9 m -54.18 -33.88 59.16 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.625 0.77 . . . . 3.24 112.683 -178.719 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -53.1 -51.34 62.19 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.238 -1.023 . . . . 2.4 108.238 173.749 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.295 36.8 pt -82.4 30.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 113.652 0.982 . . . . 2.16 113.652 -171.48 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -103.87 -39.72 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 124.048 0.939 . . . . 3.31 110.702 163.161 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -72.9 -50.58 22.85 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.645 0.609 . . . . 2.81 112.645 -159.972 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.23 67.98 0.1 Allowed Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 108.139 -1.984 . . . . 2.22 108.139 -168.804 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -143.19 -106.72 0.13 Allowed 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.449 -1.685 . . . . 4.71 106.449 -175.921 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 t -65.17 -59.36 4.18 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.595 1.158 . . . . 3.82 111.192 177.269 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -57.3 -39.6 76.11 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.474 0.71 . . . . 3.02 111.553 -165.195 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.68 -7.29 37.87 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.207 1.003 . . . . 2.07 112.255 178.081 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 53.11 44.88 63.4 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.443 1.496 . . . . 1.18 113.785 178.26 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.9 m -99.05 -35.26 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 118.479 1.14 . . . . 1.88 113.228 -175.061 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.89 -71.63 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 117.837 -1.078 . . . . 5.08 112.537 -179.525 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -76.17 174.5 12.72 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 122.264 1.976 . . . . 1.4 109.157 171.653 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -147.18 147.72 30.79 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.885 2.074 . . . . 2.91 106.937 -176.929 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.44 144.03 32.61 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.66 0.784 . . . . 2.23 110.52 -179.71 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.08 -20.49 26.15 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 123.829 0.728 . . . . 1.15 112.551 -176.882 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -85.31 151.55 23.95 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 117.938 0.869 . . . . 2.26 109.657 179.798 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.0 mtt85 -97.71 137.35 36.72 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.636 -0.711 . . . . 4.93 109.709 173.789 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.7 pt -144.46 168.63 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 105.777 -1.935 . . . . 1.76 105.777 170.775 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 22.0 mtt180 -115.54 123.65 49.03 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.009 -0.737 . . . . 2.44 109.009 172.391 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.6 p -87.46 129.33 39.02 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.082 0 N-CA-C 108.016 -1.105 . . . . 1.86 108.016 176.045 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.98 116.18 1.81 Allowed Glycine 0 C--N 1.333 0.41 0 CA-C-N 118.919 0.782 . . . . 0.55 111.243 -178.157 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.89 -169.2 38.53 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 117.787 0.793 . . . . 0.96 111.313 -177.378 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.6 ptp -101.4 148.68 24.88 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.863 1.265 . . . . 3.69 110.711 -177.912 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 43.2 t -106.34 119.65 56.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 109.624 -0.51 . . . . 3.47 109.624 -177.393 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 86.1 m -44.05 122.47 2.9 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.714 1.606 . . . . 2.59 109.408 165.774 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.1 p -46.23 -57.09 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.042 0.937 . . . . 2.32 111.205 -177.86 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.2 68.84 3.4 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.833 -0.907 . . . . 2.31 110.833 -179.648 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.9 m -149.55 -31.36 0.22 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.255 1.576 . . . . 1.56 115.255 178.221 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 12.1 tpp -60.92 115.88 4.05 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.15 0.886 . . . . 3.05 109.638 173.249 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.3 m -121.09 136.1 59.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 107.971 -1.122 . . . . 1.93 107.971 172.444 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.47 136.48 49.95 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.855 1.262 . . . . 7.58 109.082 -170.842 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -83.03 154.62 67.4 Favored Pre-proline 0 N--CA 1.455 -0.209 0 N-CA-C 109.384 -0.598 . . . . 2.13 109.384 -179.359 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -71.03 10.42 0.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.12 2.547 . . . . 1.46 113.203 173.731 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -74.71 -22.58 58.76 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.868 0.467 . . . . 1.36 109.862 161.947 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.1 m 63.74 24.08 13.71 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.079 1.351 . . . . 2.88 112.621 -178.177 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.86 -43.32 2.0 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.962 1.705 . . . . 3.05 112.023 172.68 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -84.13 122.19 28.48 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 108.522 -0.918 . . . . 1.67 108.522 -178.839 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.3 m -146.83 107.69 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 106.92 -1.511 . . . . 2.1 106.92 -172.156 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -119.87 154.97 33.57 Favored 'General case' 0 C--O 1.232 0.162 0 O-C-N 121.635 -0.666 . . . . 1.04 109.838 -176.773 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -154.9 147.99 24.78 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 120.82 0.343 . . . . 3.36 111.067 -175.555 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.05 139.92 30.72 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.41 -0.959 . . . . 1.86 108.41 167.951 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.08 147.05 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.291 1.037 . . . . 3.13 108.685 178.498 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -145.04 172.15 13.47 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 126.292 1.837 . . . . 2.03 109.632 -171.045 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 50.4 t0 . . . . . 0 N--CA 1.451 -0.384 0 N-CA-C 107.31 -1.367 . . . . 2.95 107.31 170.217 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.559 0 N-CA-C 107.474 -2.251 . . . . 1.88 107.474 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -157.21 172.28 18.92 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 117.84 0.82 . . . . 3.14 109.424 179.223 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.0 tp -154.28 159.88 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.287 0.635 . . . . 2.18 109.387 176.539 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 16.7 mt -99.05 127.01 44.9 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.608 1.163 . . . . 2.1 111.283 -178.354 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 76.2 t -108.68 130.87 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 125.727 1.611 . . . . 1.88 107.989 175.502 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.8 p -111.79 134.1 53.58 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.149 -1.056 . . . . 1.63 108.149 177.675 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -135.11 139.4 44.64 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.318 -1.364 . . . . 3.64 107.318 -179.319 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -130.23 30.64 4.74 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.962 1.305 . . . . 2.19 112.702 -168.628 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -159.1 55.95 0.41 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.195 0.521 . . . . 2.45 111.207 -178.58 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 55.76 -170.4 0.08 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.102 0.961 . . . . 2.03 111.456 -176.132 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.1 mt -153.28 154.94 31.39 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 125.113 1.365 . . . . 2.16 107.643 -175.986 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -62.85 122.39 10.66 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 125.172 3.915 . . . . 2.38 109.958 -176.676 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 48.24 42.42 17.59 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 123.655 0.782 . . . . 3.38 110.498 -178.161 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 70.23 -16.9 0.28 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.886 1.274 . . . . 4.79 112.234 -177.261 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 14.2 t80 60.27 83.79 0.13 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.736 2.015 . . . . 4.54 108.954 -167.474 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -75.07 137.33 41.37 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 114.834 -1.075 . . . . 6.14 108.26 -173.642 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.5 mp0 -79.03 162.72 25.72 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 121.139 0.495 . . . . 3.42 110.522 -166.089 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.29 44.69 27.43 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 111.593 -0.603 . . . . 1.13 111.593 -178.237 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -146.37 179.5 7.48 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.733 1.613 . . . . 2.68 106.704 169.042 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -126.21 145.65 15.84 Favored Glycine 0 C--N 1.337 0.592 0 N-CA-C 111.529 -0.628 . . . . 1.4 111.529 171.708 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.36 168.5 15.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 124.424 1.09 . . . . 3.14 108.532 -175.804 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.5 m -107.49 129.78 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 107.812 -1.181 . . . . 1.97 107.812 169.519 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -119.24 133.75 55.59 Favored 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 125.457 1.503 . . . . 1.83 109.088 -179.218 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -124.98 142.4 51.51 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.28 1.032 . . . . 3.98 110.555 -177.582 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 171.51 -134.9 3.22 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 108.393 -1.883 . . . . 0.9 108.393 172.203 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.06 155.37 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 108.423 -0.954 . . . . 1.72 108.423 -170.274 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -54.39 132.73 44.81 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.86 -0.792 . . . . 3.11 108.86 167.05 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.56 -139.9 1.63 Allowed Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 109.62 -1.392 . . . . 2.63 109.62 -179.774 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -57.55 -60.6 3.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 122.865 0.466 . . . . 5.31 110.862 -177.416 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -176.81 115.48 0.1 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 105.823 -1.917 . . . . 3.49 105.823 -173.191 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 88.2 -42.64 3.09 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 125.39 1.471 . . . . 1.16 109.609 176.997 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.65 142.09 34.3 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.227 1.411 . . . . 4.04 109.918 -175.937 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.72 123.45 47.05 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 108.393 -0.966 . . . . 3.32 108.393 -176.754 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.76 83.7 3.48 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.019 -1.474 . . . . 1.55 107.019 176.096 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -94.33 142.44 27.41 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.41 -0.959 . . . . 1.61 108.41 175.202 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . 0.26 4.7 t -136.5 -4.36 2.07 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 115.47 1.656 . . . . 1.9 115.47 173.667 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -107.2 98.87 8.46 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 119.854 1.206 . . . . 3.95 107.913 164.794 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.4 m -96.47 133.79 36.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 CA-C-N 118.751 0.705 . . . . 1.91 110.833 165.056 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.71 106.75 14.86 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.299 -1.371 . . . . 1.7 107.299 175.266 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.68 42.06 1.08 Allowed 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.3 0.852 . . . . 2.22 113.3 -170.237 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.28 62.91 1.84 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.361 0.664 . . . . 5.06 111.528 179.324 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 19.2 p80 . . . . . 0 CA--C 1.532 0.262 0 N-CA-C 108.902 -0.777 . . . . 7.72 108.902 175.102 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.148 0 CA-C-O 119.75 -0.167 . . . . 5.74 110.674 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.52 ' CE1' ' HB3' ' A' ' 61' ' ' ARG . 3.1 m-85 -89.22 110.83 21.54 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.52 1.128 . . . . 5.83 110.732 179.55 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.49 176.31 8.79 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.747 0.654 . . . . 7.02 112.01 174.998 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 p -69.34 145.82 96.06 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 124.067 0.947 . . . . 2.72 110.696 -175.841 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -58.92 -37.18 94.99 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.168 1.912 . . . . 1.29 111.966 179.36 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.6 t -46.53 -40.86 13.36 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.499 0.72 . . . . 3.0 112.17 177.921 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -50.42 -47.32 56.68 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.342 -0.543 . . . . 4.88 110.499 177.131 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.279 0.2 OUTLIER -91.56 34.39 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 112.77 0.655 . . . . 2.68 112.77 178.293 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.16 -32.93 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 118.88 0.763 . . . . 3.63 112.345 170.167 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -117.44 113.42 22.03 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.156 0.889 . . . . 2.69 110.323 -173.72 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.6 43.77 98.56 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.488 -0.645 . . . . 2.11 111.488 169.307 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -142.42 -111.04 0.13 Allowed 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 126.634 1.973 . . . . 4.67 106.511 176.704 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.4 t -71.87 -47.91 49.58 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 119.43 1.013 . . . . 3.96 111.626 -176.688 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -49.89 -46.24 51.5 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 122.044 0.926 . . . . 2.79 110.724 -173.47 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.69 -11.51 45.01 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.977 1.311 . . . . 2.37 112.173 178.829 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 55.54 44.82 85.73 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 126.309 1.909 . . . . 1.39 112.43 -178.073 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.7 m -96.01 -57.87 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 118.187 0.993 . . . . 2.7 112.81 -174.047 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.5 mmmt -91.85 -60.8 0.21 Allowed Pre-proline 0 CA--C 1.536 0.43 0 CA-C-O 118.607 -0.711 . . . . 5.25 111.992 -177.02 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -85.97 110.53 1.08 Allowed 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 122.426 2.084 . . . . 1.51 108.821 175.743 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -69.28 155.98 39.53 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.779 -0.823 . . . . 3.2 108.779 167.314 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -53.76 165.78 0.4 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 122.027 0.917 . . . . 2.15 111.959 166.75 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.44 8.77 86.67 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 115.933 -0.576 . . . . 1.22 112.45 -177.768 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -102.45 155.05 18.52 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.049 0.924 . . . . 1.96 108.886 171.779 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -100.81 136.81 40.07 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.101 0.96 . . . . 4.7 108.921 175.876 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.7 pt -141.86 175.36 5.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 106.558 -1.645 . . . . 2.02 106.558 174.152 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.52 ' HB3' ' CE1' ' A' ' 37' ' ' PHE . 15.8 mtt-85 -132.52 126.27 32.52 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 106.421 -1.696 . . . . 4.45 106.421 176.196 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.7 p -98.67 118.08 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 107.81 -1.181 . . . . 2.17 107.81 -179.46 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.36 113.26 1.87 Allowed Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 108.195 -1.962 . . . . 0.92 108.195 -178.738 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.88 -163.29 27.12 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 109.446 -1.462 . . . . 0.71 109.446 -171.737 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -103.75 132.23 50.2 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.864 0.866 . . . . 3.93 109.812 -172.88 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.2 t -106.57 126.23 62.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 108.721 -0.844 . . . . 3.51 108.721 176.859 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.2 m -57.95 137.95 56.29 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.833 1.253 . . . . 2.61 108.918 169.034 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.6 p -52.27 -60.69 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 123.63 0.772 . . . . 3.17 110.782 177.507 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.14 68.44 2.32 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.309 -1.116 . . . . 1.97 110.309 -179.951 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.1 m -151.16 -34.95 0.14 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.105 0.779 . . . . 1.35 113.105 -179.042 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.1 ttp -69.37 117.73 11.37 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.438 1.017 . . . . 3.93 109.148 174.282 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.1 m -122.56 136.12 60.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 107.659 -1.237 . . . . 1.85 107.659 175.196 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -118.72 144.69 46.08 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.897 0.879 . . . . 5.39 109.963 -179.931 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -92.42 145.84 31.34 Favored Pre-proline 0 C--O 1.237 0.42 0 N-CA-C 108.957 -0.757 . . . . 2.47 108.957 177.475 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -75.58 30.24 0.38 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.048 2.499 . . . . 1.95 112.89 178.792 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -89.87 -22.7 21.91 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.09 0.956 . . . . 1.59 108.83 162.628 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.3 m 63.47 23.13 13.54 Favored 'General case' 0 C--N 1.344 0.358 0 C-N-CA 124.301 1.041 . . . . 2.03 111.806 -174.626 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . 0.251 1.4 pp -130.7 -3.18 4.18 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.581 1.552 . . . . 2.97 113.303 173.322 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -131.4 125.56 32.93 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.192 -1.04 . . . . 1.63 108.192 -179.97 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.2 m -141.64 143.57 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 107.093 -1.447 . . . . 1.79 107.093 172.08 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -142.05 158.77 43.37 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 121.783 -0.573 . . . . 1.13 109.667 176.143 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -149.51 136.04 19.29 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.402 0.681 . . . . 3.34 109.97 -177.342 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.85 138.22 33.31 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.468 -0.938 . . . . 1.71 108.468 169.944 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.8 p -117.69 155.29 19.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 125.186 1.394 . . . . 3.18 107.786 175.547 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -131.61 175.1 9.45 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.698 0.799 . . . . 2.16 109.729 -179.651 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 39.0 t70 . . . . . 0 N--CA 1.453 -0.288 0 C-N-CA 124.464 1.106 . . . . 3.33 109.632 178.861 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.428 0 N-CA-C 110.135 -1.186 . . . . 2.48 110.135 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.86 101.24 3.7 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.794 -0.817 . . . . 3.21 108.794 -172.02 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.1 152.15 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 124.221 1.008 . . . . 2.23 108.737 -177.036 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.2 mt -107.36 122.31 46.33 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.265 1.026 . . . . 1.78 109.538 -179.717 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.0 t -105.08 120.07 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 125.06 1.344 . . . . 2.06 107.651 176.961 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.6 p -105.44 144.35 32.33 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.862 1.265 . . . . 1.57 108.964 179.525 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -142.24 102.13 4.04 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.214 -1.032 . . . . 3.49 108.214 -178.771 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -94.4 45.44 1.13 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.221 1.408 . . . . 2.97 111.015 -178.905 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -163.97 48.44 0.12 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.676 1.19 . . . . 3.87 110.437 179.559 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.9 mp 54.16 -149.88 0.41 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.379 1.072 . . . . 3.37 110.776 -178.739 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.8 mt -153.44 158.35 32.72 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 127.62 2.368 . . . . 2.8 105.837 -176.996 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -75.27 -98.5 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 124.292 3.328 . . . . 2.78 110.671 -178.892 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.403 ' C ' ' H ' ' A' ' 104' ' ' PHE . 5.3 m-20 -75.77 53.62 0.75 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.16 1.384 . . . . 3.61 110.204 179.527 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 45.47 0.48 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 129.084 2.953 . . . . 3.78 116.533 -163.839 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.403 ' H ' ' C ' ' A' ' 102' ' ' ASP . 1.7 t80 50.05 105.29 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 122.462 1.125 . . . . 4.62 110.089 -153.434 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -74.51 123.43 24.73 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.434 -1.321 . . . . 5.82 107.434 178.975 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -81.66 167.81 18.8 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.832 0.853 . . . . 3.29 110.322 -167.522 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.14 44.54 93.91 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 112.067 -0.413 . . . . 1.23 112.067 173.484 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -155.85 177.72 11.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.401 -1.333 . . . . 2.6 107.401 175.344 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -85.49 137.97 15.89 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.581 -1.008 . . . . 0.98 110.581 171.055 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 4.7 pt -138.64 164.43 26.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 108.934 -0.765 . . . . 2.73 108.934 172.484 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.452 ' HB ' ' CE1' ' A' ' 37' ' ' PHE . 16.2 m -121.68 112.96 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 106.915 -1.513 . . . . 2.55 106.915 -178.545 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -118.45 127.87 54.07 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.518 1.927 . . . . 1.9 111.048 -173.423 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -126.59 157.93 37.57 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.778 1.172 . . . . 3.07 113.608 175.092 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 179.26 -104.11 0.18 Allowed Glycine 0 C--N 1.337 0.602 0 N-CA-C 109.735 -1.346 . . . . 1.2 109.735 167.943 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.8 p -151.6 154.0 8.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 118.254 1.027 . . . . 1.94 110.047 -174.563 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.01 139.41 58.76 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.63 -0.259 . . . . 2.91 111.004 173.592 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -120.04 120.92 4.73 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 126.356 1.932 . . . . 3.52 109.18 176.747 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 56.99 43.12 25.1 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.933 0.893 . . . . 5.03 111.297 168.715 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 35.47 50.46 0.57 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.177 1.791 . . . . 4.71 111.43 -176.197 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -175.56 -57.28 0.06 OUTLIER Glycine 0 C--N 1.339 0.708 0 C-N-CA 120.128 -1.034 . . . . 1.57 112.973 -175.078 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.11 152.83 22.01 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 109.068 -0.716 . . . . 3.67 109.068 -178.927 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.35 111.48 23.85 Favored 'General case' 0 C--O 1.228 -0.062 0 N-CA-C 109.128 -0.693 . . . . 3.24 109.128 -177.281 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.71 97.5 9.15 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.355 -1.35 . . . . 1.65 107.355 176.306 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.7 144.52 39.52 Favored 'General case' 0 C--O 1.227 -0.125 0 C-N-CA 122.92 0.488 . . . . 1.93 109.85 -177.806 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.6 t -131.43 -43.91 1.02 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.025 0.93 . . . . 2.01 110.907 -178.337 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -83.34 93.89 7.83 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.242 -1.392 . . . . 4.12 107.242 175.621 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 18.8 m -98.6 120.46 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 124.394 1.078 . . . . 2.0 108.424 169.65 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.73 114.15 26.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.711 -1.589 . . . . 1.96 106.711 178.868 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.5 46.28 0.84 Allowed 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.879 -1.138 . . . . 1.91 112.051 -175.628 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -81.7 60.75 4.78 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.448 -0.782 . . . . 3.64 111.376 -175.248 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.535 0.377 0 C-N-CA 123.542 0.737 . . . . 7.58 110.556 176.849 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.533 0.309 0 N-CA-C 112.666 0.617 . . . . 3.21 112.666 . . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -85.67 118.79 25.39 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.939 1.296 . . . . 3.47 110.382 179.366 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.31 162.69 23.25 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.345 1.058 . . . . 4.19 111.166 175.113 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.9 p -75.02 144.29 79.06 Favored Pre-proline 0 N--CA 1.451 -0.396 0 N-CA-C 109.237 -0.653 . . . . 2.96 109.237 176.062 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -55.64 -41.27 79.39 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.56 2.173 . . . . 1.9 111.173 169.39 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.2 m -57.0 -50.33 73.03 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 117.563 -1.208 . . . . 3.54 111.313 178.94 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.29 -53.86 12.44 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 120.308 1.413 . . . . 2.8 110.52 178.192 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.334 31.0 pt -63.01 -28.41 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-N 115.116 -0.947 . . . . 2.08 112.816 -173.058 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.0 t -74.87 -49.04 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 118.492 0.587 . . . . 3.02 110.894 166.063 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -64.89 -46.83 80.1 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 123.972 0.909 . . . . 4.54 112.877 -163.457 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.34 62.35 0.07 OUTLIER Glycine 0 C--N 1.335 0.481 0 C-N-CA 119.668 -1.253 . . . . 3.16 111.59 -174.291 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt -150.85 -97.32 0.06 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 128.235 2.614 . . . . 4.09 105.098 -178.18 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.4 m -78.89 -54.66 5.82 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 125.072 1.349 . . . . 2.97 113.095 -168.518 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -49.24 -45.1 44.22 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.905 0.859 . . . . 2.37 110.454 -178.517 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.2 m -87.58 -10.65 50.92 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.344 1.058 . . . . 2.5 113.157 178.356 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 51.75 47.08 53.72 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.821 1.677 . . . . 1.82 112.834 -175.994 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.9 m -87.0 -52.47 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 118.334 1.067 . . . . 3.14 112.313 -175.509 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -100.97 -48.51 0.2 Allowed Pre-proline 0 CA--C 1.537 0.456 0 CA-C-O 118.039 -0.982 . . . . 4.39 111.646 -178.816 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -91.29 -173.43 0.55 Allowed 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 122.863 2.376 . . . . 2.06 108.781 170.181 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -153.45 155.78 36.95 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 127.756 2.422 . . . . 3.47 106.413 -177.722 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -54.25 160.91 1.47 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.862 0.839 . . . . 2.06 111.442 173.88 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.27 29.42 60.27 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 116.043 -0.526 . . . . 1.68 111.976 176.032 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -122.07 152.51 39.75 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.177 -1.416 . . . . 1.53 107.177 167.748 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.9 mtt85 -88.61 141.21 28.71 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.282 -0.636 . . . . 4.82 109.282 170.106 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.0 pt -143.61 176.78 2.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 106.906 -1.516 . . . . 1.94 106.906 170.613 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.6 mtt180 -124.25 129.51 50.91 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.036 -0.727 . . . . 2.33 109.036 169.264 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.0 p -90.34 128.59 42.15 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 107.365 -1.346 . . . . 2.06 107.365 174.352 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.88 119.22 1.6 Allowed Glycine 0 C--N 1.335 0.515 0 N-CA-C 110.721 -0.951 . . . . 0.64 110.721 178.944 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.49 -157.5 16.96 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 108.627 -1.789 . . . . 0.72 108.627 -175.264 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.63 149.2 23.53 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 117.814 0.807 . . . . 3.32 110.339 175.683 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 77.3 t -94.65 150.19 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.451 -0.944 . . . . 3.31 108.451 169.874 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.73 -173.91 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.693 1.597 . . . . 2.59 110.191 168.545 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.9 p -126.32 72.87 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-O 122.95 1.357 . . . . 2.85 108.375 178.032 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 136.23 -7.17 4.03 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 113.686 -1.597 . . . . 2.16 113.615 174.511 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 56.6 m -63.37 -21.26 66.17 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.827 1.314 . . . . 1.73 112.653 177.343 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 29.0 tpp -56.65 121.98 11.0 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.174 -0.676 . . . . 3.19 109.174 171.455 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.8 m -125.12 131.22 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 107.627 -1.249 . . . . 1.75 107.627 166.784 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -121.87 142.61 50.08 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.7 1.2 . . . . 4.8 108.917 -175.251 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.87 154.16 58.12 Favored Pre-proline 0 CA--C 1.532 0.257 0 N-CA-C 109.859 -0.423 . . . . 2.87 109.859 176.357 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -63.51 -30.44 71.46 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.965 2.443 . . . . 2.29 110.803 172.71 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -43.04 -41.18 3.38 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.865 1.666 . . . . 2.7 110.354 177.716 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.2 m 88.49 -1.06 0.42 Allowed 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 127.159 2.184 . . . . 1.63 113.272 176.451 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.27 25.49 9.47 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.08 0.855 . . . . 3.98 112.384 173.83 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -144.58 114.78 7.49 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.32 -1.363 . . . . 1.55 107.32 175.234 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.0 m -138.44 141.68 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 106.351 -1.722 . . . . 2.23 106.351 172.814 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -137.64 155.52 49.06 Favored 'General case' 0 C--O 1.233 0.189 0 O-C-N 121.745 -0.597 . . . . 1.06 109.479 173.818 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -154.75 159.36 40.61 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.709 -0.478 . . . . 3.46 109.709 -171.371 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -109.03 136.44 48.54 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.696 -0.853 . . . . 1.69 108.696 -177.81 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.4 t -122.65 135.5 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 123.726 0.811 . . . . 3.17 109.04 179.955 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -132.63 160.8 35.61 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 125.74 1.616 . . . . 1.9 109.568 -178.123 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.9 t70 . . . . . 0 CA--C 1.53 0.183 0 O-C-N 121.699 -0.626 . . . . 2.92 110.997 176.325 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.484 0 N-CA-C 108.307 -1.917 . . . . 1.82 108.307 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -132.76 119.51 20.42 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.45 1.5 . . . . 4.18 107.687 -177.741 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -98.29 154.08 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 123.971 0.908 . . . . 2.8 108.83 -179.643 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 18.6 mt -100.25 120.57 40.12 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.385 0.674 . . . . 1.84 111.28 176.979 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 89.2 t -97.16 136.46 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 125.656 1.582 . . . . 2.27 108.684 173.172 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.4 p -112.74 145.09 41.14 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.547 1.139 . . . . 1.83 108.388 174.846 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.406 ' CE2' ' HA ' ' A' ' 125' ' ' THR . 7.8 t80 -144.27 100.13 3.49 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.72 -0.844 . . . . 3.33 108.72 -175.618 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -84.69 53.49 2.71 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.951 1.3 . . . . 2.36 111.252 -176.985 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -169.65 -173.53 1.66 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.954 1.702 . . . . 3.28 108.114 173.512 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.9 mp -78.21 131.72 37.27 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.385 1.074 . . . . 2.23 111.239 171.462 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 24.2 mt -81.19 155.03 72.4 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.051 0.94 . . . . 2.14 111.006 172.225 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -61.74 141.72 91.53 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.09 2.527 . . . . 2.3 109.401 172.673 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 48.64 27.37 1.47 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.145 1.778 . . . . 2.74 113.163 177.064 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.1 tp 56.92 11.55 0.98 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.249 1.02 . . . . 4.25 112.397 -172.924 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.1 t80 56.66 84.07 0.09 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.269 1.427 . . . . 3.83 110.061 179.881 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.3 mtp-105 -78.3 124.4 28.05 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.295 -1.372 . . . . 5.69 107.295 -174.043 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -79.94 175.32 10.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.077 0.465 . . . . 3.08 110.645 -164.192 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.33 44.49 96.81 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 111.87 -0.492 . . . . 0.83 111.87 -176.745 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -143.52 176.62 9.05 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 107.932 -1.136 . . . . 2.41 107.932 169.517 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -100.35 145.83 17.41 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 110.514 -1.035 . . . . 0.98 110.514 171.271 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.0 pp -149.94 166.31 2.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 105.936 -1.875 . . . . 1.94 105.936 177.972 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 18.0 m -126.51 130.62 71.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 108.663 -0.866 . . . . 1.83 108.663 170.948 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -117.55 135.19 54.12 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 124.988 1.315 . . . . 1.94 109.785 -175.709 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -118.65 141.11 48.91 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.462 1.505 . . . . 3.2 109.871 -178.239 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 168.14 -133.8 3.01 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 109.658 -1.377 . . . . 0.86 109.658 170.757 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.2 151.83 31.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 117.823 0.811 . . . . 1.85 110.865 -166.073 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.8 144.25 56.97 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.105 -0.498 . . . . 3.27 111.404 175.564 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -119.68 115.57 3.05 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 126.945 2.212 . . . . 3.24 108.011 175.324 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 58.91 35.22 24.07 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.399 0.68 . . . . 4.99 111.656 169.779 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.0 t0 36.15 43.81 0.24 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.174 2.19 . . . . 4.95 113.137 -170.153 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -159.96 -55.3 0.01 OUTLIER Glycine 0 C--N 1.339 0.709 0 O-C-N 121.648 -0.657 . . . . 1.69 111.79 -174.92 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -84.62 150.44 25.17 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 121.905 -0.762 . . . . 3.73 109.107 175.961 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -108.41 113.66 26.89 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 108.784 -0.821 . . . . 3.24 108.784 178.989 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -92.16 98.5 11.57 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 107.482 -1.303 . . . . 1.63 107.482 178.114 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.52 97.57 3.98 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 112.797 0.666 . . . . 2.04 112.797 -168.509 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.406 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 14.9 t -83.38 -26.29 30.58 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 122.825 0.45 . . . . 1.96 112.213 -177.831 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -89.67 85.32 6.43 Favored 'General case' 0 CA--C 1.528 0.135 0 O-C-N 120.614 -1.304 . . . . 3.37 109.35 -174.755 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.7 m -96.78 130.72 45.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 123.853 0.861 . . . . 1.93 111.176 175.978 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -119.67 106.83 12.54 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.859 1.664 . . . . 1.88 107.452 178.543 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.87 57.67 4.26 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.673 0.789 . . . . 1.75 111.488 -176.315 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 37.2 pttt -83.38 61.84 6.39 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.897 -0.502 . . . . 4.05 111.614 -174.484 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 . . . . . 0 N--CA 1.451 -0.414 0 O-C-N 121.449 -0.782 . . . . 5.27 109.105 178.425 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.467 0.389 0 N-CA-C 112.472 0.545 . . . . 3.63 112.472 . . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.47 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 87.1 m-85 -91.96 102.57 15.14 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 125.376 1.47 . . . . 3.85 110.289 177.479 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.431 ' CZ ' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -100.49 -169.91 1.79 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.598 0.759 . . . . 9.71 111.479 178.524 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 28.2 p -94.43 156.57 38.5 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 118.6 0.637 . . . . 2.72 110.709 -178.357 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.66 -14.7 33.46 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 121.5 1.467 . . . . 1.08 112.368 171.451 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 m -68.32 -25.53 65.17 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.087 -1.008 . . . . 2.48 113.102 169.498 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.84 -58.16 8.28 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.901 0.858 . . . . 3.61 109.942 -177.099 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.476 ' H ' ' CD1' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -78.82 36.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 C-N-CA 126.651 1.98 . . . . 3.04 113.042 -179.078 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 t -121.66 -37.3 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.325 1.05 . . . . 3.71 110.901 157.765 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -81.57 -46.69 14.08 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 120.995 -1.066 . . . . 4.12 112.781 -167.623 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.8 52.91 0.16 Allowed Glycine 0 C--N 1.336 0.53 0 N-CA-C 110.882 -0.887 . . . . 3.16 110.882 -171.882 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -149.28 -162.43 1.56 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.863 2.865 . . . . 3.22 106.028 178.159 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.6 m -29.09 -47.81 0.06 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 129.529 3.132 . . . . 2.62 116.714 -170.018 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -41.59 -53.1 3.61 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.088 0.858 . . . . 3.11 111.052 175.332 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 m -98.0 -23.49 15.76 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.444 -0.798 . . . . 2.01 109.831 179.224 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.82 39.38 85.72 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.258 0.933 . . . . 1.04 111.659 174.305 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.1 m -87.18 -29.58 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 112.722 0.638 . . . . 2.07 112.722 -171.94 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.6 mttp -118.19 -62.23 0.03 OUTLIER Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 125.358 1.463 . . . . 5.79 112.646 178.703 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -81.61 146.33 15.06 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 CA-C-N 121.242 1.479 . . . . 1.19 108.606 172.92 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -107.13 158.53 17.01 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.578 -1.267 . . . . 2.79 107.578 170.04 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.1 154.04 35.75 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.362 -0.607 . . . . 2.5 109.362 171.608 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.63 -2.67 45.77 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.933 0.777 . . . . 1.18 112.781 -178.41 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -95.48 160.61 14.44 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.253 1.027 . . . . 2.01 109.033 178.037 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.8 mtt180 -93.12 138.95 31.08 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.56 -0.533 . . . . 4.33 109.56 167.709 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.431 HD11 ' CZ ' ' A' ' 38' ' ' TYR . 30.8 pt -150.59 177.89 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 106.61 -1.626 . . . . 1.93 106.61 167.51 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 26.0 mtt180 -126.49 142.26 51.59 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.16 -0.681 . . . . 3.02 109.16 169.342 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.3 p -110.72 125.77 68.04 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.069 0 C-N-CA 124.727 1.211 . . . . 1.92 108.893 178.879 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -120.35 111.76 2.04 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 110.194 -1.163 . . . . 0.74 110.194 -179.803 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.18 -173.71 36.37 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.232 -0.747 . . . . 1.24 111.232 -173.603 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.3 ptp -118.19 137.54 52.93 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 124.308 1.043 . . . . 3.36 111.715 -172.508 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -61.73 145.37 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 CA-C-N 116.369 -0.378 . . . . 3.78 110.474 178.327 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.4 m -69.81 67.91 0.27 Allowed 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 109.207 -0.664 . . . . 3.19 109.207 163.653 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.252 13.9 p 20.53 68.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.345 0 C-N-CA 129.812 3.245 . . . . 3.48 114.361 161.902 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.69 50.69 1.01 Allowed Glycine 0 CA--C 1.527 0.79 0 CA-C-N 112.421 -2.172 . . . . 2.28 110.799 -177.91 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.3 m -117.48 7.59 12.76 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 123.844 0.857 . . . . 1.74 112.39 173.819 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 47.7 tpp -74.28 127.52 33.19 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.634 -0.876 . . . . 3.91 108.634 176.983 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.2 m -132.24 149.37 32.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 108.849 -0.797 . . . . 1.69 108.849 167.306 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.48 141.58 35.39 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.733 0.813 . . . . 6.36 110.658 -171.593 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.31 154.37 84.17 Favored Pre-proline 0 N--CA 1.455 -0.192 0 CA-C-N 118.606 0.639 . . . . 2.24 109.736 -179.867 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -63.03 -24.36 73.78 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.237 1.958 . . . . 1.4 111.784 168.895 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -47.86 -30.83 4.42 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.389 0.676 . . . . 1.36 110.731 166.804 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.3 m 63.91 29.82 14.42 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.794 1.238 . . . . 1.52 111.468 176.312 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.03 -48.91 1.47 Allowed 'General case' 0 C--O 1.232 0.135 0 C-N-CA 128.03 2.532 . . . . 3.09 110.466 172.078 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -80.17 127.93 32.91 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.155 -1.054 . . . . 1.4 108.155 -179.005 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.9 m -139.18 151.23 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.421 -1.325 . . . . 2.17 107.421 172.033 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -148.95 156.59 42.51 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 122.027 -0.421 . . . . 1.55 110.191 174.798 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -155.89 133.99 11.4 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.116 -0.493 . . . . 3.24 110.556 -169.867 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.52 129.4 35.09 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.163 0.585 . . . . 1.76 109.864 174.183 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.2 t -121.01 129.77 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 125.964 1.706 . . . . 2.93 107.579 -177.693 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -106.13 172.46 6.8 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.672 0.789 . . . . 2.59 110.814 179.948 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.5 t70 . . . . . 0 N--CA 1.451 -0.416 0 CA-C-O 121.89 0.852 . . . . 3.93 110.363 -174.965 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.72 0 CA-C-O 118.875 -0.958 . . . . 2.16 111.59 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -86.72 105.15 16.75 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.059 -1.089 . . . . 2.75 108.059 175.161 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.3 tp -109.98 156.22 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 108.838 -0.801 . . . . 2.74 108.838 176.763 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.8 mt -109.88 114.76 28.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.307 -1.368 . . . . 1.81 107.307 -179.995 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.9 t -92.72 136.75 24.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 106.904 -1.517 . . . . 2.12 106.904 173.75 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 80.4 p -116.86 154.74 30.24 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.051 -1.092 . . . . 2.27 108.051 179.359 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -148.74 145.45 27.63 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 124.634 1.174 . . . . 4.77 108.292 -175.556 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -128.58 7.98 5.83 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.373 1.469 . . . . 2.31 112.743 -179.574 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -134.45 55.89 1.87 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.701 1.201 . . . . 4.18 110.297 176.872 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.0 mp 50.55 -145.69 0.46 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.097 0.959 . . . . 3.41 109.979 178.794 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.7 mt -158.03 161.85 28.07 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 127.675 2.39 . . . . 2.35 105.037 177.645 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.409 ' C ' ' H ' ' A' ' 103' ' ' LEU . 71.2 Cg_endo -72.28 -89.9 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.632 2.888 . . . . 2.03 109.901 175.356 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -68.45 19.33 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.562 1.545 . . . . 3.58 114.072 -178.713 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.409 ' H ' ' C ' ' A' ' 101' ' ' PRO . 0.2 OUTLIER 54.92 1.12 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 128.784 2.834 . . . . 2.84 115.284 -166.145 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.2 t80 51.22 89.53 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.092 1.357 . . . . 5.01 110.049 -164.774 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.61 147.13 39.82 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.362 -0.977 . . . . 5.92 108.362 -176.304 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -84.68 109.67 18.19 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.85 0.86 . . . . 3.39 111.665 -162.822 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.51 45.52 0.26 Allowed Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.58 1.085 . . . . 1.24 110.965 174.063 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -158.17 178.41 10.22 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 106.155 -1.795 . . . . 2.64 106.155 177.348 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.98 142.26 13.36 Favored Glycine 0 C--N 1.335 0.502 0 CA-C-O 121.296 0.387 . . . . 1.33 112.227 173.904 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.5 pp -133.7 164.35 35.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 106.45 -1.685 . . . . 1.87 106.45 -172.406 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.47 ' HB ' ' CD1' ' A' ' 37' ' ' PHE . 34.1 m -115.59 124.43 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 108.148 -1.056 . . . . 1.98 108.148 -178.348 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -119.95 142.41 48.76 Favored 'General case' 0 C--O 1.227 -0.12 0 C-N-CA 125.057 1.343 . . . . 1.48 110.048 -167.875 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -139.32 144.55 38.33 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.34 1.056 . . . . 3.93 110.531 -176.632 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 176.61 -120.36 0.74 Allowed Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 107.874 -2.09 . . . . 1.04 107.874 169.848 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.7 p -146.38 143.84 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 117.758 0.779 . . . . 1.88 109.078 -172.602 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.0 mp -79.56 143.04 35.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 118.848 -0.596 . . . . 3.91 109.432 176.377 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -165.49 29.83 0.21 Allowed Glycine 0 CA--C 1.525 0.681 0 C-N-CA 119.882 -1.152 . . . . 2.78 113.802 -175.74 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -132.83 1.92 3.66 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.855 0.862 . . . . 5.19 111.107 177.566 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.6 t0 53.21 52.7 13.13 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 122.652 1.215 . . . . 3.26 109.888 -173.052 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 163.46 -59.36 0.27 Allowed Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.17 -1.172 . . . . 1.47 110.17 -175.302 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.71 170.59 8.24 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.965 0.906 . . . . 3.5 110.009 -173.662 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.7 mp -118.82 130.4 55.75 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.778 1.231 . . . . 3.06 108.617 -171.928 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -97.38 99.08 10.52 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.15 -1.426 . . . . 1.75 107.15 173.377 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.34 153.73 17.65 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.602 -0.518 . . . . 2.01 109.602 -179.618 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.7 t -135.54 -38.49 0.74 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.14 0.576 . . . . 1.89 112.128 174.481 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -91.16 108.8 20.12 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.843 -1.161 . . . . 3.04 108.968 174.835 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -113.9 141.19 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 119.003 0.82 . . . . 2.25 110.34 169.338 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -120.92 116.92 26.05 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.762 1.225 . . . . 2.16 107.949 179.622 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.55 62.16 1.68 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.139 0.975 . . . . 2.2 112.124 -173.872 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.71 53.83 2.83 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.472 0.709 . . . . 5.92 112.245 -179.25 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.464 0.271 0 O-C-N 121.711 -0.618 . . . . 5.34 109.761 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.9 t . . . . . 0 CA--C 1.532 0.278 0 N-CA-C 109.759 -0.46 . . . . 9.62 109.759 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -77.76 125.77 29.84 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.845 -0.798 . . . . 9.93 108.845 173.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.1 mp -67.37 172.92 4.38 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.787 0.803 . . . . 5.88 110.971 176.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -157.66 111.6 2.57 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 126.085 1.754 . . . . 6.05 108.595 -175.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -151.21 149.1 29.03 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.481 0.713 . . . . 3.13 109.515 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -99.03 126.06 44.65 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.108 1.363 . . . . 3.69 110.511 -172.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -133.27 153.98 51.09 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.148 1.379 . . . . 3.83 111.565 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.9 m -73.81 131.31 81.94 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.768 1.627 . . . . 3.17 111.307 -177.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -56.04 -52.04 8.21 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.358 2.705 . . . . 0.87 112.598 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.6 m -53.97 -35.89 62.29 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.831 0.852 . . . . 4.11 112.382 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -62.57 -58.32 7.96 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.434 -0.58 . . . . 2.09 109.434 173.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.4 pt -71.76 33.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 114.416 1.265 . . . . 2.4 114.416 -177.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.6 t -111.99 -76.41 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 105.579 -2.008 . . . . 3.64 105.579 161.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -64.38 101.3 0.42 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 126.633 1.973 . . . . 2.66 111.328 -162.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.74 40.1 53.81 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.086 -1.206 . . . . 2.43 110.086 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -139.79 -105.3 0.16 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.279 1.431 . . . . 3.99 107.815 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.8 t -72.28 -53.84 11.28 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 120.0 1.273 . . . . 4.66 109.49 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.27 -48.69 24.63 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 124.902 1.281 . . . . 3.08 109.507 -174.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.92 -5.09 42.24 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.137 -1.392 . . . . 2.47 111.069 -173.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 48.15 47.44 26.97 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 126.362 1.934 . . . . 1.32 114.371 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.7 m -98.64 -52.75 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 118.967 1.384 . . . . 2.12 113.696 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt -101.73 -68.72 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 124.0 0.92 . . . . 3.82 112.117 -173.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -71.75 177.08 7.35 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 121.876 1.718 . . . . 1.53 108.56 167.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -155.3 158.48 38.84 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.822 -1.547 . . . . 3.55 106.822 -175.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.32 125.02 24.79 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.696 -1.224 . . . . 1.88 107.696 174.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 138.67 -36.82 1.85 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 123.911 0.767 . . . . 1.9 111.343 -172.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.93 143.52 29.8 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.086 0.943 . . . . 2.86 110.617 -175.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -92.23 129.5 38.16 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.163 0.985 . . . . 6.67 108.632 172.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.7 pt -140.43 177.95 3.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 107.495 -1.298 . . . . 1.95 107.495 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -121.13 123.02 41.29 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.241 -0.652 . . . . 3.78 109.241 170.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.15 133.4 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 106.916 -1.513 . . . . 1.93 106.916 171.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -137.57 120.43 2.06 Favored Glycine 0 CA--C 1.519 0.335 0 N-CA-C 109.422 -1.471 . . . . 0.54 109.422 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -179.02 -169.36 39.49 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.243 -1.143 . . . . 0.67 110.243 -173.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.9 ptp -102.01 133.16 47.26 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.095 0.558 . . . . 3.32 111.076 -173.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.7 p -85.03 134.43 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.856 -0.794 . . . . 3.41 108.856 175.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.5 150.0 29.81 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 122.194 0.997 . . . . 2.63 108.775 176.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.0 p -48.68 -46.87 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.286 1.034 . . . . 2.6 112.003 -175.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.87 21.85 42.63 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 119.283 -0.731 . . . . 1.66 113.217 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.7 m -81.96 -36.05 28.38 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.92 1.36 . . . . 2.02 113.179 -175.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.1 tmm? -75.96 125.48 29.19 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.595 -0.52 . . . . 2.82 109.595 -169.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.0 m -134.34 123.91 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.912 -0.773 . . . . 1.95 108.912 170.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 36.0 ptt85 -100.7 152.79 20.04 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.382 1.073 . . . . 6.56 109.8 175.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -77.16 159.38 78.21 Favored Pre-proline 0 C--O 1.238 0.47 0 N-CA-C 109.439 -0.578 . . . . 2.19 109.439 167.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -63.89 -26.73 67.04 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.134 2.556 . . . . 1.39 111.009 165.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -40.91 -44.91 2.42 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 124.409 1.084 . . . . 1.16 109.47 165.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.8 m 73.86 12.17 4.41 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.324 1.45 . . . . 1.59 113.041 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.25 -30.83 6.18 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.5 1.52 . . . . 2.97 110.866 168.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -93.45 132.16 37.98 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.599 -1.259 . . . . 1.37 107.599 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.78 141.49 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 107.868 -1.16 . . . . 1.84 107.868 -174.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -144.34 154.03 42.6 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.654 -0.869 . . . . 1.03 108.654 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -146.81 142.96 28.25 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.806 -0.634 . . . . 3.52 109.723 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.05 144.86 27.34 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.657 -0.868 . . . . 1.7 108.657 168.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.88 145.02 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 108.973 -0.751 . . . . 2.93 108.973 177.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.5 p80 -142.71 -177.34 5.26 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.626 0.77 . . . . 1.76 111.012 -169.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -149.02 179.17 8.08 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.339 -0.986 . . . . 2.35 108.339 173.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.7 m -54.89 -23.49 18.94 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.11 1.764 . . . . 3.78 111.749 175.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 mt -65.51 -5.44 7.92 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.143 0.794 . . . . 6.04 113.143 175.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.66 39.83 90.39 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 119.035 0.834 . . . . 3.49 111.467 165.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -135.31 143.76 15.47 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 106.252 -2.739 . . . . 2.17 106.252 170.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -120.48 129.54 53.9 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.348 -1.353 . . . . 3.23 107.348 -177.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.18 137.98 42.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 106.664 -1.606 . . . . 2.35 106.664 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 mt -90.38 133.2 35.15 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.467 0.707 . . . . 1.81 109.451 176.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.6 t -119.28 135.51 59.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 125.168 1.387 . . . . 1.98 107.695 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.6 p -112.25 146.68 37.75 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.647 0.779 . . . . 1.46 109.414 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -146.02 136.39 23.93 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.891 1.276 . . . . 3.12 108.267 -171.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -125.18 37.17 4.44 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.821 1.248 . . . . 2.02 112.667 -164.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -158.9 179.44 9.08 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.402 1.881 . . . . 2.87 106.245 167.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.3 mp -67.91 128.96 38.45 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 120.708 -1.245 . . . . 2.23 110.75 177.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.9 mt -71.1 148.56 94.26 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 123.481 0.712 . . . . 2.1 110.836 176.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -62.44 139.16 75.09 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.003 2.469 . . . . 2.43 109.173 173.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 50.58 29.01 3.77 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.581 1.152 . . . . 3.28 112.119 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 36.8 tp 59.99 6.79 1.0 Allowed 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.043 -1.036 . . . . 4.06 112.359 -174.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.9 t80 59.24 88.67 0.07 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.714 1.606 . . . . 4.71 109.97 -170.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -73.86 136.97 43.47 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 106.776 -1.564 . . . . 5.94 106.776 -174.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.2 mp0 -84.33 168.62 15.46 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 123.165 0.586 . . . . 3.03 110.052 -171.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 62.06 47.04 92.63 Favored Glycine 0 CA--C 1.531 1.084 0 O-C-N 121.925 -0.484 . . . . 0.85 112.916 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -146.67 177.74 8.85 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.873 1.269 . . . . 3.06 108.644 171.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -117.92 116.63 3.51 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.268 -0.733 . . . . 1.05 111.268 177.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.2 pp -117.95 168.62 9.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 125.45 1.5 . . . . 2.16 108.557 -174.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 30.8 m -117.09 139.89 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 108.165 -1.05 . . . . 1.88 108.165 166.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -126.03 126.13 43.77 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.132 1.373 . . . . 1.79 108.569 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -98.91 133.97 42.44 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.872 -1.159 . . . . 3.36 107.872 175.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -162.34 170.81 38.06 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 110.812 -0.915 . . . . 2.17 110.812 -175.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.4 p -111.87 136.95 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 108.315 -0.994 . . . . 2.21 108.315 173.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.4 mp -72.1 125.09 26.4 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.073 -1.084 . . . . 3.51 108.073 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -140.77 -28.52 0.19 Allowed Glycine 0 CA--C 1.526 0.746 0 CA-C-O 119.501 -0.611 . . . . 2.22 113.336 -169.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -115.86 49.27 1.12 Allowed 'General case' 0 C--O 1.239 0.525 0 CA-C-N 118.446 1.123 . . . . 5.99 108.148 -164.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 40.9 t0 12.16 70.01 0.01 OUTLIER 'General case' 0 C--N 1.341 0.205 0 C-N-CA 130.144 3.378 . . . . 3.01 112.161 -177.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 134.52 -36.15 2.12 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 114.574 -1.194 . . . . 1.04 112.097 -172.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.41 155.32 22.35 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 118.178 0.989 . . . . 4.07 109.203 174.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.78 130.6 56.82 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 124.648 1.218 . . . . 3.07 108.074 -175.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -92.08 111.73 23.39 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.505 -1.294 . . . . 1.87 107.505 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -126.81 132.62 50.97 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 123.795 0.838 . . . . 1.7 109.525 -176.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.3 t -122.05 -20.52 6.26 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.35 0.66 . . . . 1.66 112.114 175.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -96.31 82.74 3.46 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 120.488 -1.383 . . . . 3.73 107.727 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 31.8 m -97.53 125.72 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.281 0.632 . . . . 1.86 110.324 173.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -114.78 102.36 9.93 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.742 -1.207 . . . . 1.71 107.742 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.05 56.37 3.46 Favored 'General case' 0 CA--C 1.53 0.212 0 O-C-N 121.76 -0.587 . . . . 1.89 110.908 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.87 55.39 0.69 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 122.98 0.512 . . . . 5.73 111.251 175.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -82.55 -46.94 12.72 Favored 'General case' 0 C--O 1.228 -0.067 0 O-C-N 121.241 -0.912 . . . . 8.16 109.875 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 . . . . . 0 CA--C 1.534 0.353 0 C-N-CA 125.983 1.713 . . . . 6.27 111.431 175.363 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 CA--C 1.536 0.423 0 CA-C-O 121.411 0.624 . . . . 6.09 111.665 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -103.38 92.39 4.47 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.998 2.119 . . . . 8.61 108.07 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.8 mt -142.36 146.3 34.8 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.323 0.649 . . . . 7.92 109.388 178.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -83.02 103.72 12.67 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 107.675 -1.232 . . . . 5.02 107.675 -177.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.29 152.72 20.35 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 123.249 0.619 . . . . 4.27 110.717 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -88.37 115.53 25.94 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.147 0.979 . . . . 3.93 109.261 -177.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -120.82 155.61 33.7 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.608 1.163 . . . . 4.32 109.503 175.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.8 p -85.57 146.85 45.13 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 123.787 0.835 . . . . 2.67 110.25 174.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -59.96 -44.23 31.51 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.369 2.713 . . . . 0.82 111.85 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 p -39.29 -57.39 1.37 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.548 1.539 . . . . 3.03 111.369 174.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.423 ' OE2' ' NZ ' ' A' ' 47' ' ' LYS . 2.4 tt0 -58.09 -54.51 46.19 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.294 -0.866 . . . . 2.26 110.1 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.339 26.4 pt -65.28 -12.05 12.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 114.701 1.371 . . . . 1.94 114.701 -173.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 82.1 t -75.79 -38.28 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 123.596 0.758 . . . . 2.93 111.217 166.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -106.7 92.63 4.18 Favored 'General case' 0 C--N 1.335 -0.06 0 O-C-N 120.999 -1.063 . . . . 2.17 111.121 -160.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.81 47.02 58.03 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.907 -1.277 . . . . 1.93 109.907 174.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.423 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 12.1 mmtp -156.49 -155.39 0.53 Allowed 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 128.849 2.859 . . . . 2.85 105.822 -172.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.2 m -37.07 -55.57 0.94 Allowed 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 127.389 2.276 . . . . 2.58 114.319 -174.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -38.48 -46.86 1.21 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.214 0.916 . . . . 2.41 112.626 176.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.24 -4.29 25.96 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.495 1.118 . . . . 3.05 111.387 -173.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 54.64 30.23 50.73 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.644 1.592 . . . . 0.98 113.815 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.7 m -86.1 -29.52 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 118.585 1.193 . . . . 2.18 113.124 -172.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -121.41 -71.94 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 124.161 0.984 . . . . 6.84 112.084 -176.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -66.08 128.63 19.99 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 N-CA-C 107.472 -1.78 . . . . 1.15 107.472 167.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.09 168.8 17.37 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.761 -0.829 . . . . 3.56 108.761 169.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.48 175.94 6.55 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.691 -0.855 . . . . 2.16 108.691 163.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.99 -87.75 0.47 Allowed Glycine 0 C--O 1.22 -0.749 1 N-CA-C 100.346 -5.102 . . . . 3.29 100.346 -150.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -98.93 169.99 9.05 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 105.619 -1.993 . . . . 1.78 105.619 -81.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -84.72 122.13 28.66 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 118.025 -0.988 . . . . 4.02 108.69 176.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.6 pt -148.91 175.63 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 107.195 -1.409 . . . . 1.73 107.195 171.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -121.02 127.58 51.89 Favored 'General case' 0 CA--C 1.527 0.06 0 N-CA-C 108.824 -0.806 . . . . 2.38 108.824 168.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.2 p -93.46 123.92 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 107.523 -1.288 . . . . 1.85 107.523 170.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -124.16 123.57 5.2 Favored Glycine 0 C--N 1.332 0.354 0 N-CA-C 109.862 -1.295 . . . . 0.52 109.862 -177.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -174.75 -171.22 38.71 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 110.379 -1.088 . . . . 0.61 110.379 -176.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 6.3 ptp -94.35 135.0 36.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.125 -0.695 . . . . 3.38 109.125 177.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.9 t -59.76 133.86 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 123.229 0.612 . . . . 2.94 110.27 177.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.88 -9.49 55.05 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.16 1.17 . . . . 3.56 114.16 -172.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.28 9.1 p 50.43 47.62 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 123.917 1.818 . . . . 4.13 112.551 175.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 178.98 40.48 0.07 OUTLIER Glycine 0 CA--C 1.527 0.811 0 CA-C-N 112.429 -2.169 . . . . 2.97 111.919 169.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.4 m -150.41 1.92 0.47 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.89 1.441 . . . . 2.47 114.89 175.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.0 tpt -72.69 97.15 2.13 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.922 1.237 . . . . 2.66 108.347 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.9 m -116.69 140.45 39.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.533 -0.914 . . . . 1.69 108.533 174.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.22 149.86 50.84 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.268 1.027 . . . . 5.85 109.225 -176.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -75.86 153.92 85.01 Favored Pre-proline 0 N--CA 1.454 -0.23 0 N-CA-C 109.789 -0.449 . . . . 2.23 109.789 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -62.52 -25.56 75.78 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.303 2.002 . . . . 1.42 111.055 165.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -44.27 -37.03 3.01 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.824 0.85 . . . . 1.41 110.626 165.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.6 m 72.5 24.17 2.95 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.62 1.568 . . . . 1.62 112.489 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.47 -48.25 2.07 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 125.506 1.522 . . . . 3.22 110.366 169.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -75.41 130.21 38.6 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.774 -0.825 . . . . 1.64 108.774 -177.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.6 m -142.44 131.04 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 125.191 1.397 . . . . 1.83 107.308 -176.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -139.0 146.57 41.05 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 121.806 -0.559 . . . . 1.03 109.537 177.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -149.46 160.61 43.31 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.117 0.567 . . . . 3.15 109.782 -168.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -115.52 138.55 50.92 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.42 -0.585 . . . . 1.69 109.42 174.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.9 p -127.3 137.78 56.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.202 -1.036 . . . . 2.89 108.202 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -130.68 174.26 10.1 Favored 'General case' 0 CA--C 1.522 -0.122 0 C-N-CA 124.46 1.104 . . . . 2.0 110.309 -175.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -122.47 -13.36 8.03 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.321 0.649 . . . . 2.74 109.926 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.78 13.49 7.52 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.19 1.396 . . . . 4.7 112.405 -166.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.2 mp -98.0 -34.61 10.74 Favored 'General case' 0 C--N 1.341 0.232 0 N-CA-C 113.076 0.769 . . . . 6.01 113.076 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -149.85 -45.14 0.03 OUTLIER Glycine 0 CA--C 1.525 0.709 0 CA-C-N 118.049 0.386 . . . . 4.23 112.613 -168.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -177.74 -167.94 36.61 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 108.299 -1.92 . . . . 2.58 108.299 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -120.88 151.32 39.81 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.731 1.212 . . . . 3.11 109.219 174.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.22 160.01 12.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 107.702 -1.221 . . . . 1.89 107.702 173.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.2 mt -118.2 124.42 47.88 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.133 0.973 . . . . 1.96 108.729 -172.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.7 t -114.0 138.41 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 125.609 1.564 . . . . 1.91 108.16 -173.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.7 p -112.54 155.07 24.96 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.642 1.177 . . . . 1.87 108.603 173.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -151.84 132.5 13.98 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.447 -1.686 . . . . 4.32 106.447 175.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -104.15 1.04 30.28 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.175 1.39 . . . . 2.7 113.121 -173.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -120.38 166.85 12.98 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 124.931 1.293 . . . . 3.02 108.79 167.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.8 mp -63.06 144.37 56.96 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.765 0.793 . . . . 2.01 111.2 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.3 mt -72.25 162.28 74.56 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 124.562 1.145 . . . . 2.35 110.146 171.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.21 -95.34 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.853 3.036 . . . . 2.19 109.333 173.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -76.15 44.95 0.34 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.524 1.13 . . . . 3.0 111.061 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.4 tp 60.82 -11.12 0.05 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.856 1.663 . . . . 4.07 114.87 -177.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 44.7 t80 64.57 88.36 0.1 Allowed 'General case' 0 C--N 1.343 0.288 0 C-N-CA 125.157 1.383 . . . . 4.25 107.958 -161.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.62 134.34 38.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.782 -1.562 . . . . 4.75 106.782 175.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.5 mp0 -82.05 147.89 28.89 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 123.559 0.744 . . . . 2.78 109.729 -171.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.89 47.82 23.7 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 111.671 -0.571 . . . . 0.79 111.671 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -138.16 178.37 7.18 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 107.056 -1.461 . . . . 2.88 107.056 168.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -105.29 134.19 11.94 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.909 -0.876 . . . . 1.18 110.909 171.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.82 160.01 37.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 108.673 -0.862 . . . . 1.81 108.673 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.8 m -116.91 120.54 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 107.873 -1.158 . . . . 1.84 107.873 170.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -113.77 115.85 28.45 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.762 1.225 . . . . 1.5 109.385 -173.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -116.29 140.58 49.18 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.475 1.11 . . . . 3.61 109.809 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -170.35 -104.87 0.18 Allowed Glycine 0 C--N 1.335 0.504 0 N-CA-C 107.408 -2.277 . . . . 1.42 107.408 166.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.5 p -156.12 148.47 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 107.339 -1.356 . . . . 2.17 107.339 176.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.29 150.42 43.28 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 119.028 -1.069 . . . . 3.44 109.986 175.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -105.79 -92.03 2.25 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 110.514 -1.034 . . . . 2.25 110.514 -171.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -73.42 -68.81 0.47 Allowed 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.887 -1.523 . . . . 4.63 106.887 175.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -163.12 -71.18 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.211 -1.403 . . . . 4.72 107.211 164.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.47 -23.57 72.0 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.347 0.975 . . . . 1.5 113.184 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -95.58 119.89 34.87 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.221 1.011 . . . . 3.61 108.706 173.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.66 131.22 45.01 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 108.955 -0.757 . . . . 3.5 108.955 -176.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -89.98 93.74 9.52 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 107.784 -1.191 . . . . 1.88 107.784 177.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -99.97 151.76 20.97 Favored 'General case' 0 C--N 1.337 0.065 0 CA-C-N 117.856 0.298 . . . . 1.87 110.319 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.7 t -140.12 -44.42 0.42 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 122.933 0.493 . . . . 2.18 111.66 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -82.4 84.43 7.16 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.032 -1.47 . . . . 2.91 107.032 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.0 m -96.58 94.73 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.834 1.654 . . . . 1.9 110.274 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.57 121.64 35.19 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.81 -0.811 . . . . 1.74 108.81 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.16 62.54 1.81 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.189 0.996 . . . . 1.63 111.41 -174.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.42 -24.14 59.29 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.417 0.895 . . . . 4.97 113.417 -172.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -65.23 -23.94 67.21 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 119.073 -0.489 . . . . 5.78 112.129 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.0 t70 . . . . . 0 CA--C 1.537 0.474 0 CA-C-N 118.984 0.811 . . . . 7.32 109.183 175.059 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.0 p . . . . . 0 N--CA 1.45 -0.462 0 N-CA-C 108.531 -0.915 . . . . 10.9 108.531 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -49.92 -43.71 49.86 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.957 0.799 . . . . 9.38 110.943 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.51 -25.13 35.53 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.403 1.081 . . . . 6.97 112.906 178.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -151.58 89.06 1.45 Allowed 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.644 1.178 . . . . 4.67 108.171 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -117.83 158.97 23.86 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.231 0.923 . . . . 3.34 112.087 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -84.25 120.54 26.35 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 124.467 1.107 . . . . 3.52 109.729 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.92 156.96 41.8 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.607 0.763 . . . . 3.56 112.378 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 m -86.6 124.46 69.46 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 126.074 1.75 . . . . 3.57 112.811 -167.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . 2.256 0.1 OUTLIER -6.37 -72.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.151 1 C-N-CA 128.016 5.811 . . . . 2.89 118.345 161.31 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.5 m -70.5 -29.4 65.91 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 113.996 -1.456 . . . . 3.48 113.186 -173.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -62.57 -56.44 17.86 Favored 'General case' 0 C--N 1.335 -0.041 0 N-CA-C 108.898 -0.779 . . . . 3.13 108.898 -177.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 33.1 pt -59.39 -16.15 9.43 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 114.265 1.209 . . . . 2.46 114.265 -174.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.6 t -73.19 -38.39 54.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 124.759 1.224 . . . . 2.99 111.071 172.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -104.7 85.89 2.39 Favored 'General case' 0 C--N 1.333 -0.118 0 O-C-N 121.127 -0.983 . . . . 2.03 110.783 -159.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.17 51.38 18.18 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.138 -1.185 . . . . 1.99 110.138 174.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.9 mmtt -150.18 -124.15 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.423 -1.325 . . . . 3.46 107.423 -171.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.1 m -59.19 -58.45 8.59 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.929 1.292 . . . . 2.62 110.414 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -36.81 -51.84 0.9 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 122.709 1.242 . . . . 3.23 111.12 178.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.83 -11.95 37.81 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 113.577 -1.647 . . . . 1.96 111.328 -169.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 54.26 35.37 55.15 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 126.197 1.856 . . . . 1.18 112.649 -177.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.8 m -92.92 -22.4 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 118.032 0.916 . . . . 2.03 112.715 -174.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.5 mmpp? -124.36 -78.93 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 125.343 1.457 . . . . 5.34 111.11 174.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.22 149.47 35.85 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 CA-C-N 120.95 1.375 . . . . 1.12 109.375 173.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -112.92 156.46 22.94 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.309 1.844 . . . . 2.68 108.675 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.35 160.98 2.77 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.595 0.712 . . . . 2.37 110.958 168.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.77 -12.7 62.83 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 121.705 -0.622 . . . . 1.41 112.385 -176.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -82.57 154.69 24.87 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 118.436 1.118 . . . . 2.7 109.325 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 74.2 mtt-85 -96.06 132.48 41.38 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.45 -0.944 . . . . 6.11 108.45 170.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.6 pt -145.97 177.47 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 105.839 -1.912 . . . . 1.8 105.839 165.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 -117.27 135.37 53.87 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 105.973 -1.862 . . . . 2.48 105.973 173.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.4 p -103.84 136.26 37.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 107.361 -1.348 . . . . 2.71 107.361 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.82 120.16 1.59 Allowed Glycine 0 C--N 1.334 0.422 0 N-CA-C 110.777 -0.929 . . . . 0.63 110.777 -176.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -172.15 -163.12 25.51 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 109.309 -1.516 . . . . 0.68 109.309 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.2 ptm -102.87 135.0 45.35 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.54 0.736 . . . . 5.27 109.511 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 p -98.54 135.32 33.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 109.863 -0.421 . . . . 3.46 109.863 175.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.1 m -68.63 151.72 46.33 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 122.243 1.02 . . . . 3.01 108.826 169.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.8 p -61.42 -66.24 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 114.718 -1.128 . . . . 3.19 111.218 -174.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -81.86 40.8 2.67 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 120.8 -1.187 . . . . 1.78 112.713 -172.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.6 m -108.87 -28.1 9.35 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 117.82 0.81 . . . . 1.55 112.705 -172.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.413 ' SD ' ' HB3' ' A' ' 104' ' ' PHE . 0.8 OUTLIER -79.22 103.11 8.93 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.74 0.7 . . . . 3.26 110.087 -175.063 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.6 m -100.27 147.52 7.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 107.811 -1.181 . . . . 1.77 107.811 175.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.85 137.51 29.65 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.427 0.691 . . . . 7.71 109.829 -165.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.19 153.88 94.95 Favored Pre-proline 0 N--CA 1.452 -0.327 0 N-CA-C 109.607 -0.516 . . . . 2.05 109.607 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -65.51 -25.63 55.25 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.218 1.946 . . . . 1.54 111.306 165.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -48.94 -29.98 5.4 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.934 0.494 . . . . 1.54 110.831 164.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.1 m 67.43 23.68 9.04 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 125.362 1.465 . . . . 1.62 112.114 173.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.38 -44.28 1.72 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 127.875 2.47 . . . . 2.83 110.757 177.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -84.39 129.08 34.9 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 107.692 -1.225 . . . . 1.55 107.692 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 20.1 m -147.43 145.72 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.174 -1.417 . . . . 2.04 107.174 -178.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -150.65 154.92 38.35 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.599 -0.688 . . . . 1.36 111.48 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -155.14 138.0 15.36 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 123.404 0.682 . . . . 3.21 111.573 -173.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.04 124.33 30.97 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.296 -0.631 . . . . 1.7 109.296 176.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 t -108.4 147.62 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 124.267 1.027 . . . . 2.86 108.835 173.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -144.91 178.92 7.67 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.024 -1.102 . . . . 1.81 108.024 177.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -131.59 24.02 4.73 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 122.1 0.952 . . . . 2.84 109.711 175.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.2 t 47.84 26.96 1.02 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.243 1.817 . . . . 4.1 113.809 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.5 mt -101.6 -67.66 0.85 Allowed 'General case' 0 C--N 1.339 0.111 0 C-N-CA 123.251 0.62 . . . . 5.68 110.003 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -171.44 45.04 0.19 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.779 -0.724 . . . . 3.87 111.726 -173.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 171.04 157.72 13.56 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 108.582 -1.807 . . . . 2.19 108.582 172.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -136.41 145.11 44.92 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.625 -1.991 . . . . 3.28 105.625 174.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -126.67 158.28 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.013 -1.847 . . . . 2.51 106.013 175.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.442 2.9 mt -107.69 117.49 34.25 Favored 'General case' 0 CA--C 1.545 0.77 1 N-CA-C 123.136 4.495 . . . . 2.16 123.136 164.394 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.1 t -86.52 141.29 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 107.331 -1.359 . . . . 1.87 107.331 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.2 p -120.86 149.6 42.35 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.595 1.158 . . . . 1.66 107.959 -176.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -145.65 142.25 28.88 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.588 1.155 . . . . 4.68 108.031 -176.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -115.29 14.33 16.83 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.275 1.43 . . . . 2.54 111.649 171.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -117.69 163.38 16.56 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 124.449 1.1 . . . . 4.71 110.618 170.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.8 mp -67.84 113.14 5.33 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.342 -0.845 . . . . 2.17 109.202 163.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.8 mt -62.18 156.09 61.5 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.067 0.947 . . . . 2.42 110.246 171.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -68.07 147.69 74.0 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 123.651 2.901 . . . . 2.23 110.767 174.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 41.55 49.44 3.63 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.376 1.47 . . . . 2.98 111.629 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 44.89 22.01 0.06 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 127.089 2.156 . . . . 3.27 115.326 -174.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.413 ' HB3' ' SD ' ' A' ' 71' ' ' MET . 67.1 t80 51.0 110.94 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.125 2.17 . . . . 3.87 110.764 -159.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.5 mmt85 -77.75 112.7 14.87 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.251 -1.388 . . . . 5.84 107.251 -176.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -82.36 172.75 12.72 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.416 0.627 . . . . 3.4 111.005 -170.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 62.26 43.67 98.76 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 121.861 -0.525 . . . . 1.03 112.61 171.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -157.16 176.88 12.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.092 1.357 . . . . 3.15 108.101 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -93.31 140.37 15.03 Favored Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 109.893 -1.283 . . . . 0.9 109.893 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.5 pp -148.01 165.15 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.999 -1.482 . . . . 1.88 106.999 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.25 135.89 60.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 108.373 -0.973 . . . . 2.1 108.373 174.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -128.39 152.87 47.69 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 126.285 1.834 . . . . 1.53 110.071 -170.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -147.95 155.13 41.22 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 119.439 1.018 . . . . 2.92 113.13 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 175.62 -89.07 0.08 OUTLIER Glycine 0 C--N 1.345 1.054 0 CA-C-O 119.728 -0.485 . . . . 2.17 112.473 172.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.7 p -164.24 148.78 2.76 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 C-N-CA 124.351 1.061 . . . . 2.46 109.677 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.1 mt -90.91 141.74 28.51 Favored 'General case' 0 N--CA 1.453 -0.275 0 O-C-N 122.087 -0.383 . . . . 3.61 110.69 -177.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -131.67 158.28 22.74 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 109.132 -1.587 . . . . 3.63 109.132 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 55.52 33.76 21.72 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.934 1.294 . . . . 4.33 110.629 169.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 27.25 45.06 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 128.194 2.597 . . . . 4.07 112.173 -165.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -176.37 -48.2 0.06 OUTLIER Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.07 -1.062 . . . . 1.53 113.487 -164.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -91.66 114.25 26.73 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 118.502 1.151 . . . . 3.43 109.001 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.8 mt -87.62 114.47 24.27 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 106.742 -1.577 . . . . 2.99 106.742 -174.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -88.04 98.45 11.53 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.325 -1.361 . . . . 1.77 107.325 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -101.86 159.17 15.57 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.84 -0.43 . . . . 2.04 109.84 -178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.1 t -136.05 -41.76 0.66 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.233 0.613 . . . . 2.02 111.787 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -92.84 129.84 38.63 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 120.921 -1.112 . . . . 4.12 108.367 175.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.2 m -127.47 140.07 50.15 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 C-N-CA 124.23 1.012 . . . . 2.27 109.37 168.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -114.22 87.48 2.64 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.374 -1.343 . . . . 2.47 107.374 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.44 57.35 2.36 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.613 1.165 . . . . 1.97 110.952 -174.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -79.02 47.69 0.79 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.272 1.029 . . . . 4.22 112.95 -169.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -146.59 52.62 1.11 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.402 1.081 . . . . 6.1 110.071 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.0 t0 . . . . . 0 C--O 1.232 0.162 0 N-CA-C 106.098 -1.815 . . . . 7.46 106.098 169.776 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.455 -0.224 0 CA-C-O 120.559 0.218 . . . . 10.83 110.582 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -66.56 138.17 57.29 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 108.157 -1.053 . . . . 8.85 108.157 172.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -64.37 -53.09 54.12 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.89 0.852 . . . . 6.09 109.231 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -95.66 95.78 8.57 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.814 0.846 . . . . 4.75 108.872 -171.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -138.04 172.27 13.17 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.77 0.828 . . . . 3.01 111.873 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -82.62 121.21 26.53 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.672 1.189 . . . . 3.62 110.219 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -128.27 145.36 51.07 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.422 1.089 . . . . 4.72 110.872 177.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 91.5 m -69.24 127.5 92.91 Favored Pre-proline 0 N--CA 1.45 -0.437 0 C-N-CA 126.44 1.896 . . . . 2.87 110.115 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -57.57 -41.68 68.76 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.036 1.824 . . . . 1.28 111.995 -175.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.4 m -47.17 -43.02 20.83 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.71 1.141 . . . . 2.55 113.39 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -60.74 -40.63 93.14 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.363 -0.606 . . . . 3.52 109.363 178.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 40.5 pt -102.69 35.22 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.867 1.667 . . . . 3.12 111.847 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -114.98 -31.25 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 119.322 0.965 . . . . 2.88 111.535 176.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -117.22 126.19 52.36 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.433 1.093 . . . . 3.23 108.112 -175.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.03 -69.9 0.79 Allowed Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.623 1.106 . . . . 4.8 111.66 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -30.93 -89.07 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.571 0 C-N-CA 129.639 3.175 . . . . 3.31 111.645 175.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.4 m -71.33 -51.0 26.68 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 119.48 1.036 . . . . 2.64 109.69 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -33.03 -50.23 0.27 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 128.307 2.643 . . . . 3.11 114.707 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.2 m -127.76 15.28 6.96 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.15 2.18 . . . . 4.22 109.171 -175.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 51.89 39.22 47.62 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-O 117.382 -1.788 . . . . 1.45 113.989 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.2 m -84.42 -45.13 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 121.843 2.822 . . . . 2.1 112.421 -169.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -92.76 -57.37 0.23 Allowed Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 125.128 1.371 . . . . 4.08 113.383 178.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -75.84 179.88 5.84 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.323 2.016 . . . . 1.58 108.418 172.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -135.43 128.14 30.96 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 106.716 -1.587 . . . . 5.66 106.716 -176.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.38 125.76 24.92 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.905 -0.776 . . . . 2.05 108.905 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.18 -11.46 19.88 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 119.179 -0.789 . . . . 1.12 113.021 -175.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -83.4 146.21 28.57 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 119.124 1.462 . . . . 2.51 109.332 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -86.91 139.33 30.73 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.79 -0.641 . . . . 5.1 109.998 167.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.4 pt -148.7 172.27 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 107.124 -1.436 . . . . 2.03 107.124 171.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.6 mtt180 -114.19 110.0 19.29 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 106.825 -1.546 . . . . 2.66 106.825 174.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.3 p -79.26 127.74 38.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.299 -1.371 . . . . 1.9 107.299 175.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.54 114.87 1.51 Allowed Glycine 0 C--N 1.335 0.487 0 N-CA-C 110.191 -1.164 . . . . 0.7 110.191 -177.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.05 -173.22 29.41 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.154 -1.178 . . . . 0.97 110.154 -175.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.1 ptp -101.08 126.64 47.79 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 124.027 0.931 . . . . 3.82 110.234 -176.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.0 m -89.58 157.51 3.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 109.843 -0.428 . . . . 3.52 109.843 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.8 -172.57 2.69 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.591 -0.277 . . . . 3.35 110.26 176.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.3 p -116.98 71.98 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 126.937 2.095 . . . . 3.78 106.958 174.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.65 63.82 0.09 OUTLIER Glycine 0 CA--C 1.53 0.975 0 C-N-CA 126.671 2.081 . . . . 2.55 111.311 -178.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.7 m -146.12 64.55 1.22 Allowed 'General case' 0 CA--C 1.519 -0.238 0 O-C-N 121.243 -1.151 . . . . 2.05 110.642 163.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.14 115.81 18.27 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.381 -1.34 . . . . 3.17 107.381 176.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.6 m -125.15 127.72 72.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 108.363 -0.977 . . . . 1.85 108.363 170.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.47 149.84 29.73 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.444 1.098 . . . . 6.3 110.421 175.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.405 ' C ' ' H ' ' A' ' 76' ' ' ASN . 45.6 m-20 -86.58 150.49 51.19 Favored Pre-proline 0 C--O 1.235 0.339 0 N-CA-C 109.002 -0.74 . . . . 1.94 109.002 177.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.45 28.9 0.37 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.89 2.393 . . . . 2.33 112.961 173.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.405 ' H ' ' C ' ' A' ' 74' ' ' ASP . 79.7 m-20 -89.44 -27.63 20.26 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.329 1.052 . . . . 1.38 108.847 166.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.5 m 69.95 12.29 7.83 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 125.594 1.558 . . . . 2.01 112.177 -172.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.45 32.04 3.39 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.918 1.287 . . . . 3.12 113.36 170.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -153.48 131.86 12.05 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 121.827 -0.545 . . . . 1.46 109.927 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.98 146.3 16.26 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 C-N-CA 123.666 0.786 . . . . 2.2 110.409 -172.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -152.74 156.91 40.04 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 120.659 -1.276 . . . . 1.0 110.989 175.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -155.44 160.21 40.44 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.257 0.623 . . . . 3.22 110.645 -173.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.94 139.34 39.79 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.5 -0.926 . . . . 1.76 108.5 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.6 p -125.34 143.76 37.78 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.063 0 N-CA-C 107.87 -1.159 . . . . 3.02 107.87 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -124.29 -171.04 2.25 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.63 1.172 . . . . 2.19 109.814 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -149.96 177.82 9.5 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 110.244 -0.28 . . . . 2.66 110.244 174.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 61.2 m -55.9 -34.49 65.6 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.007 1.323 . . . . 3.93 110.278 170.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.5 mt -91.86 32.25 1.14 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.535 0.734 . . . . 6.1 111.089 173.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 58.39 36.65 84.86 Favored Glycine 0 C--N 1.34 0.793 0 O-C-N 121.423 -0.798 . . . . 3.37 112.993 169.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -79.77 54.06 4.37 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-O 119.04 -0.867 . . . . 2.91 113.41 -169.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -66.79 96.15 0.39 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.042 0.921 . . . . 2.84 110.213 -173.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -121.84 140.49 45.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 107.828 -1.175 . . . . 2.79 107.828 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.2 mt -90.18 124.89 35.22 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.452 1.101 . . . . 1.71 110.048 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.1 t -106.0 119.89 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 125.082 1.353 . . . . 2.2 107.578 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 65.5 p -98.69 144.06 28.37 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.173 0.589 . . . . 1.73 109.668 175.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.411 ' CE2' HD23 ' A' ' 100' ' ' LEU . 1.9 t80 -137.89 143.13 40.71 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.721 1.608 . . . . 3.94 107.411 -173.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -85.94 -82.43 0.19 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.132 0.973 . . . . 3.12 109.764 175.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -62.29 166.83 4.6 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.455 0.645 . . . . 3.36 111.382 -168.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.4 mp -60.66 131.78 51.81 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 119.998 -1.689 . . . . 4.5 111.685 175.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.411 HD23 ' CE2' ' A' ' 96' ' ' TYR . 26.7 mt -60.61 158.02 33.72 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 114.559 -1.201 . . . . 2.33 109.757 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -67.9 -85.11 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.234 2.623 . . . . 2.29 111.145 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -122.83 52.09 1.37 Allowed 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 124.76 1.224 . . . . 3.0 108.749 -172.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 34.63 41.75 0.06 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.73 1.612 . . . . 4.55 113.096 -173.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 40.7 p90 31.48 74.56 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.34 1.856 . . . . 4.56 112.151 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.29 125.36 23.39 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 119.854 -1.779 . . . . 8.34 110.177 -124.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -72.19 143.74 48.77 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 119.826 -0.749 . . . . 4.81 109.882 -153.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.14 22.22 23.2 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.675 1.607 . . . . 1.46 113.591 -172.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -137.43 178.68 6.91 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 119.519 1.66 . . . . 3.98 110.604 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -92.71 128.1 9.27 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.997 -0.441 . . . . 1.35 111.997 170.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.3 pp -131.18 159.85 42.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 124.901 1.28 . . . . 1.8 107.915 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.1 m -113.82 140.25 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.67 -1.233 . . . . 2.06 107.67 175.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -129.68 123.5 31.31 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.063 0.945 . . . . 1.74 109.606 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -107.24 136.68 46.66 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 126.065 1.746 . . . . 4.09 109.855 -175.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 168.69 -142.4 7.38 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 108.745 -1.742 . . . . 0.91 108.745 172.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.4 p -123.97 153.0 29.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 C-N-CA 124.507 1.123 . . . . 2.48 109.949 -170.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -54.59 137.95 42.2 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.373 -0.531 . . . . 3.14 110.507 168.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -86.89 -146.45 10.23 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 109.716 -1.354 . . . . 2.84 109.716 175.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -72.34 109.08 5.81 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.408 -1.701 . . . . 5.41 106.408 172.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -6.17 72.56 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.347 1 C-N-CA 132.678 4.391 . . . . 3.65 112.835 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 154.41 -45.74 0.55 Allowed Glycine 0 CA--C 1.523 0.534 0 CA-C-N 113.679 -1.601 . . . . 1.18 111.381 -172.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.92 163.76 13.37 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.509 0.654 . . . . 3.6 111.576 177.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 11.8 mt -123.11 130.27 52.56 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.627 1.171 . . . . 2.83 108.387 176.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -103.75 106.24 16.69 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 108.38 -0.97 . . . . 2.06 108.38 176.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -131.86 126.14 33.51 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 123.075 0.55 . . . . 1.79 110.95 -176.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.9 t -113.67 -24.41 9.21 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.407 1.083 . . . . 2.04 111.367 178.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -86.62 78.79 9.09 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 119.662 -1.898 . . . . 3.43 108.141 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.0 m -91.9 130.88 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 119.333 0.97 . . . . 2.02 110.959 174.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.37 127.67 45.86 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.213 -1.032 . . . . 2.39 108.213 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.14 97.41 9.18 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.236 1.414 . . . . 1.88 108.972 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.1 pttt -93.5 23.9 4.31 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.456 0.702 . . . . 4.6 112.096 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -129.16 105.51 8.21 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.262 1.425 . . . . 5.37 107.272 173.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 N--CA 1.456 -0.145 0 C-N-CA 123.719 0.808 . . . . 5.87 109.895 174.049 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.8 p . . . . . 0 CA--C 1.531 0.238 0 N-CA-C 109.774 -0.454 . . . . 8.68 109.774 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -90.12 134.22 34.4 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 108.407 -0.96 . . . . 9.38 108.407 173.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.38 -52.72 0.31 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.715 0.406 . . . . 8.64 110.588 -177.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -158.73 136.83 10.59 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.294 -0.86 . . . . 5.15 109.966 171.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.04 155.93 42.05 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 120.545 1.52 . . . . 3.08 112.438 -175.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -86.19 117.73 25.2 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 125.374 1.47 . . . . 3.53 111.436 -174.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -116.89 151.64 36.16 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 127.207 2.203 . . . . 4.29 109.519 -175.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 57.8 m -90.54 136.43 28.18 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.27 1.428 . . . . 3.09 109.611 -175.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -61.98 -48.32 8.74 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.025 2.483 . . . . 0.82 112.879 -174.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 p -53.75 -36.06 61.94 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.973 0.806 . . . . 2.48 111.948 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -54.74 -57.67 10.6 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.316 1.046 . . . . 2.42 109.098 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.306 8.3 pt -70.0 1.68 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 114.352 1.242 . . . . 2.08 114.352 -172.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.4 t -85.64 -28.73 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.8 1.24 . . . . 3.1 111.09 170.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -128.57 93.54 3.66 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.964 -1.085 . . . . 2.2 112.344 -160.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.45 37.75 53.15 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.516 -1.034 . . . . 2.09 110.516 176.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.4 -153.87 0.5 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.786 2.834 . . . . 3.49 103.371 178.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.2 m -28.97 -58.16 0.14 Allowed 'General case' 0 C--N 1.339 0.118 0 C-N-CA 126.905 2.082 . . . . 2.13 115.444 -172.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -44.48 -47.84 10.05 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.586 0.754 . . . . 2.58 112.272 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.6 m -93.51 -23.59 18.3 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.757 0.823 . . . . 2.34 111.409 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.95 35.6 84.7 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.984 1.278 . . . . 0.99 112.381 176.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.7 m -82.08 -39.45 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 117.525 0.662 . . . . 1.8 111.816 -175.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -105.81 -63.03 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 124.482 1.113 . . . . 5.1 111.116 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -80.93 142.16 13.71 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 CA-C-N 121.07 1.418 . . . . 1.2 109.369 171.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -90.53 154.35 19.69 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.279 1.031 . . . . 2.85 109.484 167.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.58 140.73 49.93 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.114 -1.069 . . . . 1.92 108.114 169.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 105.51 16.84 14.8 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.073 0.844 . . . . 1.23 113.36 -176.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -112.73 154.38 26.25 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.746 1.219 . . . . 1.85 109.785 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.41 ' NH1' ' OE2' ' A' ' 126' ' ' GLU . 0.3 OUTLIER -84.84 127.45 34.15 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.868 0.867 . . . . 5.21 109.085 173.11 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.9 pt -144.52 177.78 1.85 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 106.554 -1.647 . . . . 1.87 106.554 166.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.3 mtm180 -122.77 122.67 39.28 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.754 -1.202 . . . . 2.65 107.754 173.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.1 p -87.75 132.98 31.6 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 N-CA-C 107.282 -1.377 . . . . 1.87 107.282 173.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -135.75 120.63 2.31 Favored Glycine 0 C--N 1.334 0.421 0 N-CA-C 109.89 -1.284 . . . . 0.71 109.89 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.39 -166.32 31.55 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.314 -1.115 . . . . 0.82 110.314 -175.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.16 130.83 51.91 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.168 0.508 . . . . 3.79 111.462 -174.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.6 t -76.29 130.65 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 124.267 1.027 . . . . 3.01 108.527 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.6 m -49.27 -85.43 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.294 1.838 . . . . 3.25 114.581 -170.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.1 p 174.45 -40.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 126.093 1.757 . . . . 2.71 109.276 -171.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -151.8 38.2 0.81 Allowed Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.214 -1.155 . . . . 1.81 110.214 175.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 57.1 m -94.74 -8.61 37.16 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 117.923 0.861 . . . . 1.58 112.221 178.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 52.8 tpp -65.52 128.89 37.75 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.794 -0.817 . . . . 3.49 108.794 172.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.5 m -127.43 141.79 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 N-CA-C 107.425 -1.324 . . . . 1.86 107.425 164.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.76 135.13 48.77 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.43 -0.952 . . . . 5.4 108.43 -172.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -82.27 152.4 67.67 Favored Pre-proline 0 C--O 1.235 0.298 0 N-CA-C 109.851 -0.426 . . . . 2.11 109.851 -176.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -70.97 3.87 3.07 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.114 2.543 . . . . 1.49 112.346 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -70.81 -33.65 70.93 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.503 -0.554 . . . . 1.32 109.503 168.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.1 m 73.63 9.51 4.93 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.405 1.482 . . . . 1.52 113.452 -173.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.27 16.56 9.08 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.583 1.553 . . . . 2.65 111.323 172.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -143.79 125.96 15.54 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.178 -1.045 . . . . 1.53 108.178 -177.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.08 140.16 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.993 1.317 . . . . 2.45 107.712 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -140.32 153.82 46.57 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.879 -0.513 . . . . 1.22 109.813 172.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -153.27 146.19 24.47 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.43 -0.35 . . . . 3.32 110.808 -170.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.3 125.66 39.08 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.382 -0.599 . . . . 1.47 109.382 175.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.3 t -106.65 132.72 53.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 107.063 -1.458 . . . . 2.97 107.063 176.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -115.53 -178.28 3.35 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.236 0.614 . . . . 2.42 111.329 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -128.79 172.53 11.19 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 124.101 0.96 . . . . 3.58 110.98 177.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 59.5 m -47.32 -43.87 23.12 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.64 1.176 . . . . 4.54 110.869 156.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.9 mt -74.41 10.15 1.42 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.229 0.826 . . . . 5.28 113.229 175.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.94 -49.65 3.76 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 120.002 1.274 . . . . 4.47 112.025 172.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -44.41 119.7 3.09 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 125.531 1.539 . . . . 1.99 110.658 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -115.75 150.5 36.78 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.237 1.015 . . . . 2.9 110.413 -174.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.49 152.95 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 107.967 -1.123 . . . . 2.41 107.967 178.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.0 mt -100.58 121.77 42.15 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.312 -0.996 . . . . 1.77 108.312 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.7 t -107.09 133.34 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 107.437 -1.32 . . . . 1.79 107.437 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 82.2 p -107.46 149.49 27.88 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.531 -0.915 . . . . 1.51 108.531 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.443 ' CE2' ' HA ' ' A' ' 125' ' ' THR . 11.2 t80 -146.65 126.9 13.87 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.026 -1.101 . . . . 3.88 108.026 -173.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -113.85 46.62 1.29 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.003 1.321 . . . . 2.06 111.745 -165.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -166.75 -179.64 4.9 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.847 2.059 . . . . 3.36 106.286 169.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.4 mp -67.68 131.38 45.47 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.399 1.0 . . . . 2.44 111.145 172.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.2 mt -83.55 155.29 65.8 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.485 1.114 . . . . 2.32 110.579 174.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.62 112.44 2.4 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.954 2.436 . . . . 2.85 109.538 175.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 39.74 47.7 1.81 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.011 1.724 . . . . 5.83 111.504 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 48.76 13.52 0.06 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 127.782 2.433 . . . . 4.1 116.374 -178.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 51.49 114.29 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 122.226 1.012 . . . . 6.27 109.987 -148.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -74.16 100.63 3.71 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 104.837 -2.282 . . . . 6.33 104.837 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -71.94 157.55 37.63 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 119.776 -0.77 . . . . 5.08 110.965 -148.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.09 37.87 6.6 Favored Glycine 0 CA--C 1.531 1.09 0 N-CA-C 110.608 -0.997 . . . . 0.94 110.608 -167.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -138.2 162.21 34.85 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.773 1.229 . . . . 3.58 108.896 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -102.3 129.79 10.01 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 110.476 -1.05 . . . . 1.23 110.476 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.5 pp -140.56 161.22 24.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 108.208 -1.034 . . . . 1.96 108.208 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.3 m -114.45 141.66 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.091 -1.078 . . . . 2.07 108.091 174.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -127.34 116.9 21.21 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.602 1.161 . . . . 2.02 108.7 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -101.12 149.38 24.02 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.135 -0.691 . . . . 3.88 109.135 175.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 162.11 -140.84 6.83 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 107.451 -2.26 . . . . 0.94 107.451 173.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.5 p -136.04 142.94 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 118.084 0.942 . . . . 1.89 109.996 -164.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.86 162.32 29.64 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.456 -0.793 . . . . 3.08 109.99 173.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -169.73 -52.35 0.03 OUTLIER Glycine 0 C--N 1.332 0.351 0 C-N-CA 119.951 -1.119 . . . . 2.39 111.726 166.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -67.0 141.25 57.65 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.55 -0.908 . . . . 4.37 108.55 174.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.08 64.8 0.54 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 128.651 2.78 . . . . 4.46 110.299 -171.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 128.51 8.22 4.04 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.635 2.064 . . . . 1.17 113.368 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.16 153.9 51.82 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.539 1.67 . . . . 3.13 109.885 177.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.3 mp -121.69 134.7 54.96 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.348 1.059 . . . . 3.13 109.714 -166.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.68 101.3 12.15 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.388 -1.338 . . . . 1.72 107.388 177.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -127.52 83.27 2.15 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 112.211 0.449 . . . . 2.15 112.211 -166.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.443 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 14.6 t -83.01 -22.25 33.66 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.959 0.726 . . . . 2.06 112.959 -174.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.41 ' OE2' ' NH1' ' A' ' 59' ' ' ARG . 20.6 mt-10 -83.5 75.11 10.04 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 120.445 -1.409 . . . . 4.48 107.981 -176.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.0 m -92.33 131.16 40.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 O-C-N 121.527 -0.733 . . . . 2.18 111.534 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.28 124.33 44.35 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.031 -1.47 . . . . 2.08 107.031 176.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -94.31 124.8 38.56 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.258 -1.016 . . . . 2.39 108.258 175.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -153.56 58.14 0.75 Allowed 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.594 0.758 . . . . 5.33 109.92 -176.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -105.78 90.48 3.4 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.229 1.412 . . . . 8.03 107.932 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.4 t70 . . . . . 0 CA--C 1.535 0.378 0 C-N-CA 124.392 1.077 . . . . 7.46 110.788 179.088 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.0 m . . . . . 0 CA--C 1.534 0.361 0 CA-C-O 120.871 0.367 . . . . 8.74 111.984 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.04 123.53 14.72 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 108.873 -0.788 . . . . 8.96 108.873 169.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.7 mp -67.49 143.94 55.94 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.694 -0.854 . . . . 6.46 108.694 168.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -151.88 109.88 3.69 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 106.998 -1.482 . . . . 5.18 106.998 -175.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -144.43 162.34 36.74 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.434 1.016 . . . . 3.09 111.361 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -83.83 123.15 29.61 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.106 1.362 . . . . 3.5 110.954 -175.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.03 156.03 43.39 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.393 1.477 . . . . 4.05 110.954 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.3 139.58 52.25 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 123.125 0.57 . . . . 3.34 111.311 -175.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.38 -35.0 99.18 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.63 2.22 . . . . 0.93 113.45 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -57.19 -29.31 63.58 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 119.988 1.267 . . . . 3.81 112.056 176.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -67.55 -56.98 7.33 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.244 -1.021 . . . . 2.32 108.244 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.0 pt -74.17 36.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.025 1.33 . . . . 1.84 113.175 -174.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 43.1 t -123.38 -68.68 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 105.757 -1.942 . . . . 3.05 105.757 168.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -79.0 102.5 8.37 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.266 1.826 . . . . 2.26 110.728 -164.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.9 32.89 74.01 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.408 -1.077 . . . . 2.1 110.408 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -140.32 -110.83 0.15 Allowed 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 126.44 1.896 . . . . 3.6 108.341 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 29.6 m -73.83 -56.68 4.67 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 119.147 0.885 . . . . 2.51 112.177 -172.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -58.55 -46.89 85.91 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 122.135 0.969 . . . . 2.85 109.068 -174.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -68.16 -35.9 78.79 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.8 -0.637 . . . . 2.45 112.345 173.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.29 47.68 42.63 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.977 1.275 . . . . 1.38 111.882 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.251 32.6 m -112.89 -70.39 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 113.984 1.105 . . . . 2.37 113.984 -174.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.7 mttt -73.14 -62.22 1.31 Allowed Pre-proline 0 CA--C 1.535 0.403 0 O-C-N 121.4 -0.813 . . . . 5.84 112.101 -172.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.36 111.65 2.64 Favored 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 121.867 1.711 . . . . 1.1 107.684 175.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -62.03 148.68 43.24 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.101 -0.703 . . . . 3.26 109.101 172.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.61 162.68 10.15 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.842 -0.617 . . . . 2.4 110.409 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.91 14.37 82.24 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 119.672 -0.516 . . . . 1.19 113.387 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -93.75 158.94 15.42 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-N 118.284 1.042 . . . . 1.66 109.433 172.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -98.38 135.37 40.07 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.448 0.699 . . . . 5.58 110.425 174.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.2 pt -150.53 178.47 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 125.821 1.649 . . . . 1.74 106.798 174.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.5 mtt180 -123.52 131.96 53.78 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.682 -1.229 . . . . 2.51 107.682 165.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.2 p -92.07 140.75 15.62 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.08 0 N-CA-C 107.359 -1.348 . . . . 1.97 107.359 171.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.19 124.37 2.41 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.002 -1.239 . . . . 0.62 110.002 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -169.3 -163.53 23.49 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 108.622 -1.791 . . . . 0.75 108.622 -175.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.71 139.43 38.97 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 117.358 0.579 . . . . 3.78 109.585 -178.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.5 m -94.24 148.98 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 110.229 -0.286 . . . . 3.45 110.229 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.9 m -84.61 146.34 27.55 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.255 1.022 . . . . 2.4 109.17 175.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.1 p -49.74 -57.43 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.489 1.516 . . . . 2.68 111.44 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.75 71.96 0.49 Allowed Glycine 0 CA--C 1.522 0.521 0 N-CA-C 109.386 -1.486 . . . . 1.62 109.386 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.6 m -153.01 48.38 0.71 Allowed 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 117.738 0.769 . . . . 2.4 111.936 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.1 ttp -141.08 132.7 27.13 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.589 -1.634 . . . . 3.51 106.589 168.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.7 m -135.51 144.28 34.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 107.334 -1.358 . . . . 1.98 107.334 173.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -127.46 149.92 49.89 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 123.974 0.91 . . . . 5.32 110.541 -174.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.59 154.25 83.61 Favored Pre-proline 0 N--CA 1.451 -0.403 0 N-CA-C 109.93 -0.396 . . . . 2.94 109.93 175.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -65.32 -24.03 58.27 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.445 2.097 . . . . 1.67 111.601 167.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -47.56 -28.81 2.45 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.509 0.724 . . . . 1.66 110.735 165.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.3 m 64.84 25.98 12.89 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 125.081 1.352 . . . . 1.44 111.472 175.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.24 -46.23 1.36 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.758 2.423 . . . . 2.74 111.127 176.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -83.29 136.35 34.41 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.628 -0.879 . . . . 1.69 108.628 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.7 m -147.25 143.54 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 107.068 -1.456 . . . . 2.08 107.068 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -144.05 154.62 43.43 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.22 -0.659 . . . . 1.01 109.22 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -148.35 151.62 35.65 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.761 -0.654 . . . . 3.15 109.887 -173.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.81 142.01 30.88 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.049 -1.093 . . . . 1.89 108.049 171.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.0 p -130.38 149.59 33.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 107.112 -1.44 . . . . 3.18 107.112 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -130.46 167.22 18.98 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.4 0.619 . . . . 2.0 109.546 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -96.94 177.47 5.6 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.779 -1.1 . . . . 3.68 109.028 -177.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.5 m -59.32 -38.86 81.36 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.895 -0.78 . . . . 4.22 108.895 163.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.5 mp -93.74 -87.72 0.24 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 109.74 -0.467 . . . . 5.25 109.74 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -113.86 -89.74 1.75 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.525 -1.03 . . . . 3.94 110.525 -177.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.18 -76.16 0.34 Allowed Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.14 -0.784 . . . . 3.13 111.14 -172.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 35.64 58.05 0.89 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.298 1.839 . . . . 4.25 111.317 -176.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -112.24 157.06 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 124.464 1.106 . . . . 2.4 109.087 -169.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.3 mt -118.44 125.6 50.3 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.832 0.853 . . . . 1.76 109.49 -173.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 75.7 t -114.26 133.28 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.791 1.236 . . . . 2.06 107.954 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 61.3 p -108.79 155.47 20.74 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.497 1.119 . . . . 1.4 110.204 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -153.48 136.85 15.79 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.504 -1.295 . . . . 3.18 107.504 -174.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.8 p-10 -128.94 49.87 2.19 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.564 1.545 . . . . 2.22 112.57 -172.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -171.72 52.43 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.982 0.913 . . . . 2.99 111.533 178.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.9 mp 52.69 -147.41 0.47 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.877 1.271 . . . . 2.36 110.417 -172.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.7 mt -150.28 158.16 36.52 Favored Pre-proline 0 N--CA 1.454 -0.226 0 N-CA-C 105.811 -1.922 . . . . 2.59 105.811 -176.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -71.27 -94.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.433 2.755 . . . . 2.0 107.923 172.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -77.4 38.17 0.23 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.554 1.142 . . . . 3.78 110.306 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 19.8 tp 52.37 23.19 2.34 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.825 -1.172 . . . . 3.83 112.716 -177.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 76.9 t80 53.9 84.05 0.07 Allowed 'General case' 0 N--CA 1.465 0.283 0 O-C-N 120.618 -1.301 . . . . 4.11 109.076 -171.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -75.86 123.14 25.18 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.94 -1.133 . . . . 6.8 107.94 -171.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -84.17 156.26 22.16 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 126.046 1.739 . . . . 3.68 110.482 -169.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.49 33.3 43.85 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 123.757 0.694 . . . . 1.19 112.267 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -156.08 178.9 9.75 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.802 1.241 . . . . 4.09 108.138 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -85.43 147.64 22.41 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.685 -0.966 . . . . 1.0 110.685 166.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.9 pp -140.23 162.5 24.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 105.618 -1.993 . . . . 1.91 105.618 166.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.3 m -125.0 135.27 64.62 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.132 0 N-CA-C 109.055 -0.72 . . . . 2.04 109.055 173.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -122.84 125.73 45.98 Favored 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 124.842 1.257 . . . . 1.83 109.919 -170.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -115.83 143.58 45.21 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.958 1.303 . . . . 3.89 110.126 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 168.79 -131.4 2.29 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 107.576 -2.21 . . . . 0.92 107.576 173.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.8 p -128.17 150.03 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 124.701 1.2 . . . . 2.3 109.752 -171.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -55.89 143.44 31.65 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.161 -0.681 . . . . 2.94 109.161 170.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.69 -150.62 10.6 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.208 -1.157 . . . . 3.0 110.208 -178.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -63.14 -67.15 0.45 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.264 0.625 . . . . 5.3 110.021 -174.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -166.45 98.62 0.59 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.759 -1.571 . . . . 3.7 106.759 -178.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 109.59 -41.27 2.28 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.378 0.99 . . . . 1.5 111.199 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -82.79 161.73 21.91 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.252 1.021 . . . . 3.71 110.662 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 mp -128.56 140.05 51.99 Favored 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 124.25 1.02 . . . . 3.24 108.3 174.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -107.9 108.96 20.35 Favored 'General case' 0 CA--C 1.527 0.083 0 N-CA-C 107.924 -1.139 . . . . 1.89 107.924 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -134.82 109.33 8.46 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.274 0.488 . . . . 1.85 111.705 -171.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.7 t -96.66 -34.24 11.46 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.957 0.903 . . . . 1.89 111.656 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.3 mp0 -83.45 89.96 7.13 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 119.863 -1.773 . . . . 3.46 108.168 175.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.4 m -96.89 124.68 49.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 123.446 0.698 . . . . 1.83 109.743 171.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -115.68 110.71 19.53 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.02 1.328 . . . . 1.81 107.797 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.47 61.4 6.57 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.121 0.968 . . . . 1.8 110.62 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -22.72 67.05 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.712 1.004 . . . . 3.57 113.712 -173.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -105.9 57.34 0.66 Allowed 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.846 0.858 . . . . 6.94 110.113 -177.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.0 t0 . . . . . 0 N--CA 1.449 -0.486 0 N-CA-C 108.06 -1.089 . . . . 7.38 108.06 174.621 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 CA--C 1.53 0.207 0 N-CA-C 108.653 -0.869 . . . . 6.66 108.653 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 -128.2 129.45 46.48 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 125.241 1.416 . . . . 9.14 107.506 169.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -72.95 -40.36 65.44 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 122.72 0.408 . . . . 9.0 111.18 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -159.47 156.0 27.51 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.026 1.73 . . . . 4.65 107.215 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -163.96 149.67 10.96 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.396 1.078 . . . . 3.48 108.924 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -88.7 131.79 34.87 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.696 0.798 . . . . 3.35 109.619 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -138.34 155.77 48.25 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.003 1.321 . . . . 3.55 110.833 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.2 m -80.57 131.16 62.04 Favored Pre-proline 0 N--CA 1.447 -0.621 0 C-N-CA 125.53 1.532 . . . . 2.96 111.048 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -57.02 -46.47 28.77 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 123.026 2.484 . . . . 0.8 112.328 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.7 t -54.41 -32.86 58.2 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 122.865 0.466 . . . . 3.04 111.419 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.27 -58.5 8.23 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.55 -0.908 . . . . 3.09 108.55 172.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.259 30.7 pt -73.19 28.8 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 114.017 1.118 . . . . 1.92 114.017 -172.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -118.62 -27.53 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.508 1.123 . . . . 3.03 111.986 160.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 -83.95 -68.62 0.7 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.599 1.09 . . . . 2.47 112.389 -163.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.02 54.25 0.59 Allowed Glycine 0 C--N 1.333 0.408 0 N-CA-C 108.668 -1.773 . . . . 2.78 108.668 -174.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -148.98 -109.64 0.07 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.641 1.976 . . . . 3.75 107.082 -167.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 41.0 m -67.59 -65.44 0.69 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.542 1.137 . . . . 2.14 111.587 -173.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -49.59 -51.07 39.81 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.816 0.817 . . . . 2.57 110.444 -172.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.79 -24.09 61.68 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.141 1.376 . . . . 2.83 112.661 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.1 39.81 97.64 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.463 1.506 . . . . 1.34 112.786 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.8 m -97.96 -35.32 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 117.986 0.893 . . . . 2.33 113.054 -172.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -107.41 -68.15 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 117.981 -1.009 . . . . 4.19 112.104 177.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -77.05 131.12 11.74 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 121.606 1.538 . . . . 1.2 108.77 175.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -76.4 157.35 32.38 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.766 -0.827 . . . . 3.02 108.766 169.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.02 170.22 4.6 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.93 0.492 . . . . 2.24 109.71 170.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.86 40.54 98.47 Favored Glycine 0 CA--C 1.531 1.081 0 O-C-N 121.63 -0.669 . . . . 1.63 112.046 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -127.2 156.7 41.42 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 107.916 -1.142 . . . . 1.58 107.916 169.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -96.71 128.47 43.69 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.002 0.921 . . . . 5.54 108.992 176.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.2 pt -137.17 168.23 21.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 108.32 -0.993 . . . . 1.77 108.32 173.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 31.2 mtm180 -117.59 111.07 18.7 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.13 -1.063 . . . . 3.4 108.13 173.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.7 p -78.87 130.14 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.812 -1.551 . . . . 1.86 106.812 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.55 125.33 2.98 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 109.629 -1.389 . . . . 0.53 109.629 -177.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.96 -155.4 17.09 Favored Glycine 0 C--N 1.334 0.423 0 N-CA-C 108.535 -1.826 . . . . 0.73 108.535 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -97.61 134.38 40.9 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.48 0.657 . . . . 3.48 109.705 177.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.4 m -68.95 159.79 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.964 -1.124 . . . . 3.44 107.964 172.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.2 m -74.03 -116.85 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 109.188 -0.671 . . . . 3.33 109.188 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.1 p -156.99 -59.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 O-C-N 120.49 -1.381 . . . . 3.2 109.418 -175.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.66 -11.05 56.06 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 121.943 -0.473 . . . . 2.26 112.591 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.1 m -67.37 -20.91 65.62 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 114.14 1.163 . . . . 1.89 114.14 -165.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 6.6 tpt -71.39 94.6 1.25 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.655 0.782 . . . . 2.91 109.814 -176.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.6 m -102.31 130.44 52.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 107.364 -1.347 . . . . 1.81 107.364 174.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -126.44 141.48 51.87 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.506 1.122 . . . . 6.93 108.323 -173.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.99 143.82 31.88 Favored Pre-proline 0 C--O 1.234 0.244 0 N-CA-C 110.34 -0.244 . . . . 2.67 110.34 -176.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -60.16 -27.16 84.32 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.125 2.55 . . . . 2.39 110.846 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -42.94 -40.63 3.05 Favored 'General case' 0 C--O 1.226 -0.151 0 C-N-CA 125.678 1.591 . . . . 2.62 110.013 172.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.4 m 78.31 12.04 1.71 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.963 1.705 . . . . 1.73 112.861 177.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.69 31.53 5.31 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.888 0.875 . . . . 4.04 112.382 165.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -150.24 131.82 14.85 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 122.05 -0.406 . . . . 1.45 110.545 175.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.59 131.26 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 125.14 1.376 . . . . 2.24 108.714 -177.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -137.9 144.08 41.16 Favored 'General case' 0 C--N 1.34 0.183 0 O-C-N 120.536 -1.352 . . . . 1.21 110.745 172.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -139.35 160.22 40.34 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.392 0.677 . . . . 3.29 109.854 -175.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.67 127.61 54.12 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.529 -1.285 . . . . 1.89 107.529 170.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.6 p -116.02 146.55 20.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.314 -0.995 . . . . 2.98 108.314 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -142.88 -178.5 5.84 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.217 1.007 . . . . 1.73 109.661 -173.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -124.98 10.27 8.2 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.581 0.705 . . . . 2.69 111.734 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.0 t 53.71 27.02 6.41 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.296 1.038 . . . . 4.52 112.481 -173.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.3 mp -98.38 -78.12 0.5 Allowed 'General case' 0 C--N 1.34 0.179 0 N-CA-C 108.23 -1.026 . . . . 5.56 108.23 166.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -173.81 75.89 0.08 OUTLIER Glycine 0 C--N 1.334 0.428 0 N-CA-C 108.727 -1.749 . . . . 3.19 108.727 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 159.78 129.72 1.07 Allowed Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 110.597 -1.001 . . . . 1.82 110.597 175.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -120.78 133.13 55.34 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.178 -1.786 . . . . 4.77 106.178 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -123.4 138.51 53.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 108.051 -1.092 . . . . 2.79 108.051 -176.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.8 mt -89.8 124.44 34.66 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.954 0.902 . . . . 1.65 110.294 -176.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.0 t -109.0 118.46 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 126.216 1.806 . . . . 1.78 107.045 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.4 p -99.54 140.06 34.27 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.723 -0.843 . . . . 1.78 108.723 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -141.71 139.61 32.96 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 107.849 -1.167 . . . . 3.72 107.849 -173.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -81.79 -91.01 0.07 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.98 0.912 . . . . 3.62 110.692 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -55.15 168.74 0.3 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.646 1.179 . . . . 3.92 113.237 -171.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 mt -57.7 116.34 3.36 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 120.197 -1.564 . . . . 3.05 110.95 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.0 mt -54.97 145.74 41.89 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 123.511 0.724 . . . . 2.34 109.839 170.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -62.32 143.3 93.65 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.598 2.199 . . . . 2.55 109.692 177.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 47.16 40.39 9.92 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.955 1.302 . . . . 2.8 111.285 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 56.05 4.75 0.14 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 128.277 2.631 . . . . 2.91 115.466 -175.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 57.0 t80 58.37 101.99 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.251 1.02 . . . . 4.35 109.089 -155.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -78.09 150.94 33.64 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.89 -1.152 . . . . 4.82 107.89 168.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -91.96 165.63 13.11 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 125.867 1.667 . . . . 3.33 109.595 -175.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 42.15 48.86 5.47 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.153 1.358 . . . . 1.07 114.408 -177.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -155.7 87.81 1.1 Allowed 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.83 1.252 . . . . 3.25 107.632 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -49.08 135.77 21.41 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 123.459 0.552 . . . . 1.3 113.857 -169.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.3 pp -139.23 168.04 19.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 124.731 1.212 . . . . 1.99 108.69 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 15.7 m -110.6 137.76 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.271 -1.011 . . . . 2.0 108.271 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -125.04 122.17 36.49 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.525 1.13 . . . . 1.73 109.333 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -99.35 127.4 45.36 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.018 -1.104 . . . . 3.3 108.018 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -159.79 169.19 35.73 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.197 -0.525 . . . . 2.05 112.36 -173.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.1 p -108.38 139.35 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 124.439 1.096 . . . . 1.88 108.184 177.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.9 mp -68.43 118.29 11.31 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.55 -0.907 . . . . 3.83 108.55 174.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.34 -91.65 0.33 Allowed Glycine 0 C--N 1.335 0.524 0 O-C-N 124.054 0.847 . . . . 2.54 111.107 -171.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -82.0 -77.86 0.21 Allowed 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.395 -1.335 . . . . 6.15 107.395 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -175.58 108.35 0.09 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.969 1.708 . . . . 3.6 107.099 173.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 118.8 -41.71 1.95 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.066 -1.214 . . . . 1.33 110.066 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.69 131.63 34.93 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.485 0.714 . . . . 3.61 110.628 -178.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -97.52 113.98 25.79 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.204 -1.036 . . . . 3.65 108.204 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -88.58 102.58 15.08 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 107.246 -1.39 . . . . 1.75 107.246 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -122.0 132.29 54.44 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 123.922 0.889 . . . . 1.91 109.306 -175.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.8 t -125.7 -8.61 6.75 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.918 0.487 . . . . 2.55 112.236 172.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -111.41 74.54 0.87 Allowed 'General case' 0 CA--C 1.532 0.254 0 O-C-N 120.473 -1.392 . . . . 3.75 108.548 -174.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 35.8 m -87.58 150.93 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 118.279 0.491 . . . . 1.9 111.08 176.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.23 135.68 51.89 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.348 -0.982 . . . . 2.05 108.348 171.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.3 122.95 34.36 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.765 -1.198 . . . . 2.75 107.765 169.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -143.9 46.34 1.46 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.352 0.661 . . . . 3.77 110.278 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -145.08 102.46 3.75 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.443 1.097 . . . . 5.98 109.317 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 . . . . . 0 N--CA 1.448 -0.539 0 C-N-CA 126.32 1.848 . . . . 5.7 109.019 173.308 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.5 m . . . . . 0 CA--C 1.536 0.42 0 CA-C-O 120.937 0.399 . . . . 10.19 111.69 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.7 m-20 -105.46 77.16 1.26 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.429 1.091 . . . . 9.39 109.133 -176.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.69 66.4 0.34 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.091 0.956 . . . . 7.58 109.374 172.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -80.32 67.6 6.22 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.314 -0.866 . . . . 4.58 110.587 -164.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.5 pp -134.27 161.41 35.02 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.029 1.732 . . . . 3.43 109.477 -173.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -90.69 116.33 28.48 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 124.146 0.978 . . . . 3.46 110.409 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.95 152.82 28.92 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.99 1.316 . . . . 4.07 110.122 175.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.0 p -83.27 133.66 47.22 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 124.814 1.246 . . . . 2.54 109.871 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.41 -40.71 72.54 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.882 2.388 . . . . 0.83 112.236 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.7 t -54.8 -29.38 54.33 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.265 0.468 . . . . 2.91 112.265 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.11 -56.46 11.38 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.751 -1.203 . . . . 3.02 107.751 175.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.8 pt -73.23 28.99 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 114.217 1.191 . . . . 1.92 114.217 -174.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.9 t -109.56 -24.42 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 126.82 2.048 . . . . 2.74 111.007 163.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -120.65 75.02 1.1 Allowed 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 121.558 -0.714 . . . . 2.07 111.197 -157.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.72 49.76 8.65 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 109.067 -1.613 . . . . 1.83 109.067 174.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -146.55 -125.5 0.07 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.131 -1.804 . . . . 3.76 106.131 -173.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.2 m -62.65 -43.0 99.92 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 119.408 1.004 . . . . 2.52 111.448 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -31.89 -72.51 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 126.655 1.982 . . . . 5.35 112.809 172.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 45.7 m -89.23 -14.45 35.92 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.816 0.846 . . . . 2.83 110.2 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.76 32.86 60.88 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.048 -0.821 . . . . 1.45 111.048 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.6 m -75.99 -36.24 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 117.702 0.751 . . . . 2.1 111.418 -173.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt -113.88 -70.37 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 124.541 1.136 . . . . 4.18 110.156 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.27 108.32 2.16 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 121.257 1.305 . . . . 1.38 109.714 176.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.55 154.37 38.87 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.819 -0.808 . . . . 2.84 108.819 169.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.98 164.1 13.36 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.188 -0.671 . . . . 1.96 109.188 169.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.42 30.69 39.94 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.252 -0.739 . . . . 1.5 111.252 -175.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -125.56 152.5 44.99 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.968 1.307 . . . . 1.58 108.458 173.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -97.51 121.24 39.18 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 108.25 -1.019 . . . . 5.52 108.25 -176.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.5 pt -144.04 177.76 2.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 124.674 1.19 . . . . 1.88 108.287 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -125.98 131.37 52.25 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.602 -0.888 . . . . 3.06 108.602 175.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.5 p -94.73 124.5 47.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 107.014 -1.476 . . . . 2.12 107.014 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.62 124.82 4.16 Favored Glycine 0 C--O 1.225 -0.437 0 N-CA-C 108.982 -1.647 . . . . 0.47 108.982 178.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.39 -166.0 33.46 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 108.701 -1.76 . . . . 0.61 108.701 -175.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.28 138.37 36.46 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.509 -0.552 . . . . 3.7 109.509 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 32.6 t -98.77 108.22 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-O 121.239 0.542 . . . . 3.39 110.087 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.442 ' HG1' ' CE1' ' A' ' 85' ' ' HIS . 4.2 m -39.15 132.75 1.32 Allowed 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 127.541 2.337 . . . . 2.41 111.356 168.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.5 p -55.49 -62.8 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.656 0.782 . . . . 2.52 110.731 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -83.27 68.5 3.54 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 109.951 -1.26 . . . . 2.19 109.951 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.3 m -152.12 -33.64 0.14 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 114.858 1.429 . . . . 1.23 114.858 -176.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.3 tpp -62.06 120.06 10.11 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 108.353 -0.98 . . . . 3.3 108.353 170.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.2 m -122.35 133.94 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.341 -1.355 . . . . 1.96 107.341 167.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.38 137.77 54.43 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.557 1.143 . . . . 7.17 109.038 -173.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.62 143.33 50.76 Favored Pre-proline 0 N--CA 1.454 -0.244 0 N-CA-C 109.738 -0.468 . . . . 2.01 109.738 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -59.85 -25.83 80.5 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.48 2.12 . . . . 1.63 110.787 170.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -40.98 -42.94 2.0 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 124.653 1.181 . . . . 1.54 110.668 168.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.6 m 84.41 -0.34 0.94 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.143 1.777 . . . . 1.39 113.647 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.2 18.35 11.55 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.321 0.964 . . . . 3.84 112.641 172.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -138.35 125.9 22.03 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.491 -1.3 . . . . 1.35 107.491 174.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.6 m -145.19 144.48 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 106.62 -1.622 . . . . 2.0 106.62 175.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -148.02 155.88 42.01 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 121.361 -0.837 . . . . 1.26 109.777 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -151.35 137.97 18.75 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.49 -0.323 . . . . 3.26 111.106 -171.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.29 138.3 33.62 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.212 -1.032 . . . . 1.61 108.212 166.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.0 p -130.79 146.61 33.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 106.412 -1.699 . . . . 2.96 106.412 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.442 ' CE1' ' HG1' ' A' ' 67' ' ' THR . 0.7 OUTLIER -143.37 175.29 10.03 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.645 0.657 . . . . 2.5 110.88 -174.209 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -142.54 -95.96 0.12 Allowed 'General case' 0 CA--C 1.531 0.222 0 O-C-N 123.465 0.478 . . . . 2.51 111.537 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.5 t -86.4 66.6 9.6 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 120.721 -1.237 . . . . 5.96 110.215 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -16.31 33.71 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.265 1 C-N-CA 133.949 4.9 . . . . 10.42 119.898 -158.014 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.18 26.41 8.74 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 126.353 1.93 . . . . 3.94 108.913 164.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -173.52 116.53 0.6 Allowed Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 109.903 -1.279 . . . . 1.88 109.903 176.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -112.37 150.64 30.79 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.37 1.468 . . . . 3.23 107.29 165.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -131.32 153.14 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 107.776 -1.194 . . . . 2.23 107.776 175.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.4 mt -110.18 115.14 29.19 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.794 0.838 . . . . 2.1 109.036 -172.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.8 t -96.5 138.58 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 124.734 1.214 . . . . 1.99 107.845 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 77.6 p -114.46 149.57 36.1 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.738 -0.838 . . . . 1.88 108.738 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.489 ' CE2' ' HA ' ' A' ' 125' ' ' THR . 6.7 t80 -149.79 116.99 6.02 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.519 -0.919 . . . . 3.25 108.519 -173.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -104.29 51.47 0.77 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.633 1.173 . . . . 2.11 111.86 -170.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -168.16 -179.37 4.03 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.527 1.931 . . . . 3.02 107.14 170.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.0 mp -67.51 148.57 51.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 118.703 0.683 . . . . 2.03 111.075 171.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.2 mt -101.81 152.24 38.09 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 125.093 1.357 . . . . 2.28 110.291 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -60.34 137.7 76.21 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 123.983 3.122 . . . . 2.05 109.756 174.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 49.27 30.3 3.09 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.944 1.698 . . . . 3.02 112.495 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.0 tp 58.15 13.29 2.22 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.211 1.004 . . . . 4.59 111.97 -175.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 17.3 t80 57.07 95.68 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.422 1.489 . . . . 4.24 109.049 -172.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -76.15 124.9 28.18 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 105.47 -2.048 . . . . 8.61 105.47 -176.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -80.47 168.14 19.31 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.902 -0.499 . . . . 2.97 110.187 -170.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.25 45.56 47.83 Favored Glycine 0 CA--C 1.528 0.906 0 O-C-N 121.505 -0.747 . . . . 0.99 112.336 174.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -155.8 170.39 22.19 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.492 1.117 . . . . 2.97 108.333 174.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.476 ' H ' ' CD2' ' A' ' 131' ' ' HIS . . . -90.9 130.33 10.22 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 111.188 -0.765 . . . . 0.9 111.188 174.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.9 pp -137.94 158.4 33.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 107.01 -1.478 . . . . 1.77 107.01 176.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.3 m -120.02 126.57 75.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 108.258 -1.016 . . . . 1.78 108.258 175.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -117.44 127.09 53.68 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 124.403 1.081 . . . . 1.94 109.929 -173.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -107.84 143.42 36.46 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.62 0.768 . . . . 4.46 110.333 -178.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 167.15 -142.46 7.58 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 110.057 -1.217 . . . . 0.99 110.057 171.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.9 p -132.31 144.91 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-O 121.517 0.675 . . . . 2.39 110.477 -164.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.402 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 3.4 mp -87.35 153.9 21.1 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.678 -1.23 . . . . 3.73 107.678 176.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -159.47 -59.79 0.01 OUTLIER Glycine 0 C--N 1.334 0.43 0 C-N-CA 119.686 -1.245 . . . . 2.67 111.646 177.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -60.41 142.74 54.61 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.809 -1.182 . . . . 4.44 107.809 167.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -78.99 57.62 2.22 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.819 1.648 . . . . 4.11 108.934 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 164.12 -32.38 0.26 Allowed Glycine 0 CA--C 1.53 0.979 0 CA-C-N 115.75 -0.659 . . . . 1.04 113.02 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -113.14 157.22 21.93 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 118.181 0.99 . . . . 3.41 109.642 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.2 mp -118.09 143.92 46.06 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.089 0.955 . . . . 3.04 108.517 -176.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -105.61 97.24 7.1 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.209 -1.404 . . . . 1.9 107.209 175.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -106.16 143.92 33.59 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.719 -0.845 . . . . 1.69 108.719 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.489 ' HA ' ' CE2' ' A' ' 96' ' ' TYR 0.254 12.1 t -129.36 -32.04 2.01 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.122 0.786 . . . . 2.08 113.122 174.622 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -84.96 84.8 7.59 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 120.713 -1.242 . . . . 3.13 108.406 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.7 m -88.76 105.77 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 119.294 0.952 . . . . 1.81 111.339 175.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -96.36 105.92 18.07 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.429 -0.952 . . . . 1.77 108.429 175.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.79 52.19 1.67 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.356 1.062 . . . . 1.81 111.574 -177.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -79.19 72.6 5.77 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.751 -0.593 . . . . 3.86 111.035 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.476 ' CD2' ' H ' ' A' ' 109' ' ' GLY . 11.0 t-80 -103.94 65.34 0.81 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.817 0.847 . . . . 5.95 111.538 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 . . . . . 0 N--CA 1.451 -0.397 0 C-N-CA 124.337 1.055 . . . . 7.69 109.384 175.405 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.8 t . . . . . 0 CA--C 1.535 0.376 0 N-CA-C 109.475 -0.565 . . . . 8.41 109.475 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -90.06 130.48 36.23 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.62 -0.881 . . . . 8.26 108.62 176.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.26 -165.67 2.18 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.818 1.247 . . . . 7.07 108.11 -173.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -79.59 86.93 5.18 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 108.373 -0.973 . . . . 4.09 108.373 -167.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.74 160.31 14.81 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 122.981 0.512 . . . . 2.85 110.396 -177.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -84.76 119.49 25.35 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.071 -0.714 . . . . 3.61 109.071 173.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.53 155.92 49.71 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.347 1.059 . . . . 3.75 109.944 -178.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.2 p -88.07 146.9 39.38 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-O 119.242 -0.409 . . . . 2.53 110.728 -173.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -52.83 -50.82 12.73 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 123.399 2.733 . . . . 1.03 110.371 173.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.7 m -48.13 -47.66 34.54 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 125.531 1.532 . . . . 2.97 112.748 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -57.54 -59.58 4.95 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.478 -0.934 . . . . 2.3 108.478 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.267 32.4 pt -61.74 -16.5 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 114.504 1.298 . . . . 2.29 114.504 -170.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.47 -57.42 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 120.056 1.298 . . . . 3.05 111.226 167.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -84.71 80.37 9.28 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.149 -0.97 . . . . 2.22 112.098 -154.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.47 48.35 5.96 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 109.653 -1.379 . . . . 1.82 109.653 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.56 -100.84 0.08 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.136 -1.061 . . . . 3.02 108.136 -177.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 92.9 m -79.28 -60.8 2.23 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 126.187 1.795 . . . . 1.97 111.043 -176.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.43 -33.25 59.14 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.321 0.964 . . . . 4.15 111.205 -178.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.28 -17.72 31.87 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.35 1.06 . . . . 2.31 112.379 178.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 52.7 43.18 59.67 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 126.158 1.837 . . . . 1.09 112.936 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.4 m -95.88 -43.06 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 118.301 1.051 . . . . 2.18 112.817 -173.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -111.88 -71.09 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.25 0 C-N-CA 124.546 1.138 . . . . 4.43 111.021 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -70.69 96.32 0.67 Allowed 'Trans proline' 0 N--CA 1.444 -1.397 0 N-CA-C 108.356 -1.44 . . . . 1.69 108.356 172.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -49.51 162.65 0.14 Allowed 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.322 1.049 . . . . 4.12 111.441 170.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.35 144.27 51.08 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.35 -0.981 . . . . 2.12 108.35 169.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.85 21.91 67.45 Favored Glycine 0 CA--C 1.536 1.396 0 O-C-N 121.554 -0.716 . . . . 1.34 113.261 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -89.62 148.55 23.28 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 118.42 1.11 . . . . 3.95 108.117 170.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.97 113.84 26.06 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.474 1.11 . . . . 4.67 108.249 -171.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.27 175.96 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 123.131 0.572 . . . . 3.05 109.477 -177.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -111.27 112.15 23.72 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 108.84 -0.8 . . . . 4.11 108.84 175.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.9 p -77.01 122.24 31.1 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.038 0 N-CA-C 106.944 -1.502 . . . . 1.92 106.944 172.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.09 120.66 2.97 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 108.537 -1.825 . . . . 0.64 108.537 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.07 -160.02 22.78 Favored Glycine 0 CA--C 1.52 0.347 0 N-CA-C 108.92 -1.672 . . . . 0.68 108.92 -174.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.6 ptp -112.7 136.29 52.45 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.229 0.612 . . . . 3.31 110.272 -176.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.8 p -93.93 138.68 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 109.091 -0.707 . . . . 3.53 109.091 172.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.99 163.32 26.8 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.221 -1.029 . . . . 3.7 108.221 168.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.6 p -58.78 -65.31 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 124.368 1.067 . . . . 2.63 110.763 173.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.25 59.44 4.33 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 121.545 -0.722 . . . . 2.06 111.388 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.5 m -126.06 -41.95 1.9 Allowed 'General case' 0 C--N 1.334 -0.07 0 C-N-CA 124.744 1.218 . . . . 1.94 111.449 -177.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -71.78 121.37 18.82 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.11 -0.7 . . . . 2.86 109.11 -178.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.8 m -127.47 130.35 70.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 108.002 -1.111 . . . . 2.11 108.002 170.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -109.49 147.26 33.19 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 124.072 0.949 . . . . 5.41 110.73 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.46 151.89 95.53 Favored Pre-proline 0 N--CA 1.45 -0.44 0 N-CA-C 109.046 -0.724 . . . . 2.18 109.046 174.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -61.67 -28.37 82.38 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.012 1.808 . . . . 1.98 110.946 166.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -44.88 -34.71 2.47 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.141 0.976 . . . . 1.43 110.655 167.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.6 m 67.63 23.87 8.65 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.084 1.354 . . . . 2.44 112.241 176.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.47 -42.37 2.23 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.848 2.059 . . . . 3.08 111.788 172.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -90.8 138.94 31.2 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.624 -1.25 . . . . 1.73 107.624 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.2 m -152.29 130.11 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 107.125 -1.435 . . . . 1.92 107.125 -173.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -135.11 146.71 49.11 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 118.929 0.786 . . . . 1.81 110.394 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -140.0 144.5 36.99 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.221 0.608 . . . . 3.29 110.171 -172.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.07 139.14 31.96 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.89 -0.782 . . . . 1.68 108.89 170.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 t -125.76 143.66 38.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 105.855 -1.906 . . . . 3.0 105.855 172.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -144.15 177.99 8.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.191 -1.04 . . . . 3.57 108.191 176.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -155.36 131.85 10.42 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.811 -0.811 . . . . 2.64 108.811 169.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 35.7 t 41.94 52.36 4.24 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.804 0.842 . . . . 4.55 111.308 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -7.16 42.11 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 130.909 3.683 . . . . 10.37 117.87 -149.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.66 -25.21 65.16 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 120.789 -1.194 . . . . 4.11 110.54 168.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 179.15 174.37 45.23 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 109.12 -1.592 . . . . 2.01 109.12 166.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -133.16 138.24 46.53 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.339 -1.356 . . . . 2.75 107.339 177.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.35 154.46 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 107.258 -1.386 . . . . 2.01 107.258 -176.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.2 mt -116.14 121.43 42.1 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.52 0.728 . . . . 1.99 109.334 -177.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.8 t -109.27 129.0 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.88 -1.155 . . . . 2.11 107.88 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 77.5 p -103.94 140.15 38.11 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.73 1.212 . . . . 1.48 109.233 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -134.41 160.23 38.63 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.112 1.765 . . . . 3.25 108.191 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -145.68 146.5 31.31 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 128.097 2.559 . . . . 3.13 105.449 -171.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 69.82 59.97 0.28 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 130.085 3.354 . . . . 3.19 111.083 -175.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 mt 55.93 -156.05 0.28 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.482 1.113 . . . . 2.57 109.27 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.5 mt -145.0 154.42 54.73 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 105.827 -1.916 . . . . 2.16 105.827 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -63.09 -82.86 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 124.276 3.317 . . . . 2.35 110.536 -176.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -76.5 35.49 0.15 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.073 0.949 . . . . 4.11 110.752 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 39.6 6.31 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 128.505 2.722 . . . . 4.12 117.538 -164.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 61.91 89.96 0.08 Allowed 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 124.846 1.258 . . . . 4.54 109.643 -166.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.272 15.0 mmm180 -91.85 30.39 1.39 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 117.859 -1.536 . . . . 6.31 111.559 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . 0.339 4.3 mt-10 79.38 172.38 0.16 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.986 1.266 . . . . 3.04 109.714 146.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 39.39 37.52 0.79 Allowed Glycine 0 CA--C 1.537 1.467 0 N-CA-C 116.143 1.217 . . . . 0.91 116.143 163.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -148.18 176.57 10.11 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.551 1.54 . . . . 3.08 107.847 -175.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -109.08 129.38 9.48 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.174 -1.17 . . . . 0.97 110.174 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.0 pp -133.99 165.39 31.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 125.475 1.51 . . . . 1.9 106.994 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.4 m -115.56 144.27 23.54 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 N-CA-C 108.087 -1.079 . . . . 2.03 108.087 170.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -134.05 129.68 36.41 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 124.073 0.949 . . . . 1.6 110.325 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.79 143.83 34.32 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.633 1.173 . . . . 4.45 111.425 177.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 166.02 -150.64 18.28 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 109.17 -1.572 . . . . 1.01 109.17 169.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.9 p -127.69 146.28 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 123.78 0.832 . . . . 1.97 109.38 -168.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.6 mp -61.71 142.65 57.09 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 122.119 -0.363 . . . . 3.34 110.483 174.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -98.38 -108.21 2.74 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 109.263 -1.535 . . . . 2.06 109.263 -169.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -60.29 -49.21 78.52 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.323 0.649 . . . . 5.18 109.259 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.2 t70 177.27 -87.86 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.364 2.266 . . . . 4.3 106.089 -177.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.23 -26.54 72.57 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.72 1.629 . . . . 2.04 113.433 -177.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -86.66 136.5 33.01 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.12 0.96 . . . . 3.82 109.935 174.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.4 mp -107.37 133.9 51.23 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 123.107 0.563 . . . . 3.31 109.495 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.09 106.5 18.81 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.58 -0.526 . . . . 1.58 109.58 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -121.27 136.99 54.89 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.719 0.808 . . . . 1.84 110.224 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.3 t -128.28 4.14 5.75 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.216 0.606 . . . . 2.03 111.885 173.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -118.6 82.03 1.78 Allowed 'General case' 0 CA--C 1.531 0.237 0 O-C-N 120.914 -1.116 . . . . 2.98 108.368 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.2 m -99.59 133.92 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 118.333 0.515 . . . . 1.72 110.701 175.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.87 118.81 27.94 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.215 -1.402 . . . . 1.86 107.215 177.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.22 84.2 7.7 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.631 0.772 . . . . 1.78 110.433 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.17 34.52 0.11 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.736 1.013 . . . . 5.14 113.736 -174.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -136.63 139.31 41.97 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 126.765 2.026 . . . . 5.02 105.596 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 13.1 t0 . . . . . 0 CA--C 1.532 0.257 0 N-CA-C 107.105 -1.443 . . . . 6.79 107.105 174.113 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.455 -0.206 0 N-CA-C 106.253 -1.758 . . . . 7.27 106.253 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -143.79 143.41 31.34 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.043 -1.095 . . . . 7.63 108.043 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 77.7 mt -144.25 152.79 41.31 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.082 1.353 . . . . 7.01 107.503 -173.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -131.09 115.2 16.11 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.908 0.883 . . . . 4.4 111.184 -176.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.4 173.4 11.82 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.224 -0.923 . . . . 3.61 109.75 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -85.68 124.78 32.6 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.724 1.209 . . . . 3.41 109.465 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.16 149.39 51.88 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.003 1.321 . . . . 4.31 110.54 -177.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.5 m -77.09 132.33 70.88 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 125.713 1.605 . . . . 2.79 110.728 -177.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -59.3 -33.05 97.77 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.968 2.445 . . . . 0.99 113.616 -176.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.5 p -61.09 -21.04 63.3 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.171 -0.956 . . . . 2.64 112.713 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -96.8 14.2 26.0 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.774 0.715 . . . . 3.7 111.753 173.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.312 8.0 pt -124.26 35.02 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 O-C-N 120.607 -1.308 . . . . 2.04 111.613 163.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.0 p -122.61 -79.11 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 O-C-N 121.922 -0.486 . . . . 3.58 110.426 163.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -69.75 103.8 2.26 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 125.497 1.519 . . . . 2.3 110.896 -162.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.96 39.33 96.39 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 109.029 -1.628 . . . . 2.21 109.029 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -141.43 -110.42 0.14 Allowed 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.521 -1.659 . . . . 2.98 106.521 -176.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 56.3 m -80.45 -48.19 13.21 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 119.96 1.254 . . . . 1.97 112.475 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -55.0 -49.33 71.77 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.828 0.823 . . . . 2.66 109.694 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -72.32 -33.47 67.38 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.371 -0.831 . . . . 1.99 111.619 175.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.22 41.04 39.86 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.744 1.164 . . . . 1.2 112.198 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.6 m -99.97 -42.3 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 117.999 0.9 . . . . 2.05 113.228 -172.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -109.29 -67.51 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.519 1.128 . . . . 4.53 111.433 -176.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -76.37 78.81 3.15 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.062 1.842 . . . . 2.27 108.828 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -55.74 140.04 43.14 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.656 0.782 . . . . 3.2 109.031 175.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.83 147.18 47.34 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.951 -0.759 . . . . 1.99 108.951 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.17 -8.28 31.04 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.839 1.209 . . . . 1.13 112.069 -170.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -96.32 140.49 30.92 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.325 1.063 . . . . 1.63 109.548 -175.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -89.31 118.56 29.07 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.274 1.029 . . . . 5.59 108.569 176.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.7 pt -142.21 175.9 4.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 107.903 -1.147 . . . . 2.55 107.903 172.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.4 mtm180 -121.15 113.57 20.19 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.197 -1.038 . . . . 2.56 108.197 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.2 p -81.24 127.86 39.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 107.108 -1.441 . . . . 2.05 107.108 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.99 114.93 1.76 Allowed Glycine 0 C--N 1.332 0.332 0 N-CA-C 109.856 -1.297 . . . . 0.48 109.856 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.57 -173.37 39.76 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.876 -0.89 . . . . 0.81 110.876 -172.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 2.4 ptp -93.37 132.82 37.25 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.947 0.899 . . . . 3.75 111.343 -171.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.1 t -102.34 137.22 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 O-C-N 123.794 0.684 . . . . 3.27 109.936 174.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.2 m -40.75 -88.0 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 128.192 2.597 . . . . 2.83 114.329 -175.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.3 p 176.18 -36.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.309 1.443 . . . . 2.82 110.038 -174.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -155.82 42.35 0.56 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.788 -1.325 . . . . 2.82 109.788 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.9 m -84.65 -11.46 55.89 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.972 0.386 . . . . 1.39 111.321 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 16.8 ptm -68.8 132.48 46.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 118.292 0.496 . . . . 3.26 110.686 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.1 m -117.65 125.45 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 106.621 -1.622 . . . . 2.48 106.621 170.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -101.4 146.77 27.16 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.535 0.734 . . . . 6.1 110.136 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -84.42 151.36 59.05 Favored Pre-proline 0 C--O 1.232 0.147 0 N-CA-C 109.381 -0.6 . . . . 2.17 109.381 170.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -67.55 -21.15 46.57 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.933 2.422 . . . . 1.99 112.367 174.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -43.7 -37.98 2.91 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.565 -0.531 . . . . 1.74 109.565 163.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.0 m 72.79 9.75 5.52 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 126.125 1.77 . . . . 1.91 111.508 177.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 pp -123.63 17.78 9.57 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.16 1.784 . . . . 2.69 110.644 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -146.1 130.19 17.42 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.588 1.555 . . . . 2.42 108.271 173.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.29 109.77 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 125.105 1.362 . . . . 2.27 107.523 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -109.38 150.07 28.58 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 109.22 -0.659 . . . . 1.68 109.22 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -150.85 142.3 23.44 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.981 0.419 . . . . 3.25 110.727 -171.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.69 135.16 33.88 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.275 -0.639 . . . . 1.88 109.275 175.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 38.7 t -115.21 152.16 16.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 126.365 1.866 . . . . 3.37 106.512 175.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -134.18 -175.93 4.02 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.376 0.67 . . . . 1.89 109.744 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -126.53 171.47 11.05 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.716 0.806 . . . . 3.93 110.506 177.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.9 m -48.48 -44.15 35.49 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.845 0.858 . . . . 3.8 110.651 159.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.51 -76.88 0.21 Allowed 'General case' 0 C--N 1.341 0.234 0 CA-C-N 118.662 0.665 . . . . 5.66 110.446 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.25 50.05 0.07 OUTLIER Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.582 -1.007 . . . . 3.17 110.582 -176.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -82.32 52.29 4.63 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 110.458 -1.057 . . . . 2.67 110.458 -178.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -65.88 111.75 3.44 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.997 -1.112 . . . . 3.59 107.997 -175.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -144.51 153.85 14.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 N-CA-C 108.416 -0.957 . . . . 2.0 108.416 -176.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mt -108.42 124.57 50.6 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.911 0.884 . . . . 2.04 109.116 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.6 t -107.21 132.55 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 107.299 -1.371 . . . . 1.82 107.299 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 76.6 p -106.25 143.6 34.14 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.513 -0.921 . . . . 1.51 108.513 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -137.67 167.05 22.47 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.775 1.23 . . . . 3.69 108.655 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -144.49 147.84 33.78 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 127.801 2.44 . . . . 3.44 107.088 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 65.78 71.86 0.41 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 129.786 3.234 . . . . 3.08 112.66 -178.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.7 mp 46.07 -148.54 0.11 Allowed 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 125.377 1.471 . . . . 2.88 109.867 -175.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.8 mt -156.31 152.18 22.68 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 105.492 -2.04 . . . . 2.12 105.492 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -71.54 108.69 2.45 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.274 2.649 . . . . 2.66 109.929 176.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 45.04 45.11 8.78 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.205 1.402 . . . . 4.3 111.706 176.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . 0.296 2.3 pp 35.69 47.3 0.37 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.259 1.424 . . . . 4.55 112.793 -172.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 20.3 p90 38.85 56.59 1.95 Allowed 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 127.647 2.379 . . . . 4.74 114.115 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.253 0.1 OUTLIER -37.91 130.45 1.12 Allowed 'General case' 0 CA--C 1.543 0.711 0 O-C-N 116.971 -3.58 . . . . 7.27 113.189 -119.073 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -74.13 154.88 38.94 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.401 -0.812 . . . . 3.54 110.345 -164.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.61 33.21 11.67 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.181 0.896 . . . . 1.01 112.395 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -156.74 178.54 10.23 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.091 1.356 . . . . 3.1 108.183 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -88.82 139.53 15.4 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 112.122 -0.391 . . . . 1.18 112.122 175.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.69 162.76 28.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 124.152 0.981 . . . . 2.15 108.54 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 17.6 m -120.2 122.74 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.304 -0.628 . . . . 1.83 109.304 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -113.67 120.98 42.74 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 125.189 1.396 . . . . 1.66 109.047 -176.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -99.67 135.28 41.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.369 -1.345 . . . . 4.14 107.369 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -169.27 -169.72 32.95 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 110.065 -1.214 . . . . 1.43 110.065 -173.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.4 p -122.98 136.94 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 107.804 -1.184 . . . . 2.07 107.804 172.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 9.6 mp -73.78 155.24 39.06 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 107.882 -1.155 . . . . 3.58 107.882 174.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -172.02 -44.42 0.04 OUTLIER Glycine 0 C--N 1.332 0.313 0 C-N-CA 119.878 -1.154 . . . . 2.65 112.215 175.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -58.9 154.85 14.33 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 119.295 -0.962 . . . . 5.17 110.083 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -80.17 72.54 6.99 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 106.511 -1.663 . . . . 4.55 106.511 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 115.24 4.53 20.35 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.413 1.482 . . . . 1.39 114.265 170.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.13 170.17 9.55 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.785 1.293 . . . . 3.7 109.342 171.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.9 mp -123.74 145.25 49.15 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.044 0.937 . . . . 3.13 109.578 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -110.85 109.76 20.08 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.426 0.691 . . . . 1.63 109.197 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -132.63 136.63 46.63 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 123.41 0.684 . . . . 1.64 110.277 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.4 t -121.44 -2.37 9.49 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.975 0.51 . . . . 2.07 111.96 173.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -111.7 83.01 1.71 Allowed 'General case' 0 CA--C 1.532 0.27 0 O-C-N 120.434 -1.416 . . . . 3.79 108.403 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.3 m -96.65 126.89 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 118.383 0.538 . . . . 1.65 110.886 174.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -113.95 106.57 14.59 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.03 -1.47 . . . . 1.98 107.03 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.1 50.01 1.93 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.979 0.912 . . . . 1.98 110.622 -178.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -78.83 64.39 3.78 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.357 0.663 . . . . 4.0 111.096 -170.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -145.32 142.1 29.13 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.592 -1.633 . . . . 5.08 106.592 -178.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 . . . . . 0 CA--C 1.532 0.252 0 C-N-CA 126.549 1.939 . . . . 6.68 112.752 179.417 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.3 m . . . . . 0 CA--C 1.534 0.355 0 N-CA-C 111.857 0.317 . . . . 8.45 111.857 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -149.8 149.12 30.04 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 121.567 -0.708 . . . . 9.34 110.327 -174.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 mt -87.11 81.12 8.12 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.834 1.254 . . . . 6.87 108.223 171.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 -81.0 73.5 8.04 Favored 'General case' 0 C--O 1.237 0.439 0 O-C-N 121.446 -0.784 . . . . 4.5 110.535 -171.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -127.7 166.11 18.74 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.581 1.152 . . . . 2.79 111.921 -176.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -91.45 135.21 34.01 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.424 1.09 . . . . 3.22 109.906 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.41 161.44 34.54 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.002 1.321 . . . . 4.23 109.883 170.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 p -83.28 144.82 47.38 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.65 1.18 . . . . 2.97 110.522 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -62.0 -44.47 20.08 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.786 2.991 . . . . 1.02 112.407 -177.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.8 p -45.83 -56.18 5.7 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.258 1.423 . . . . 3.17 110.923 176.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -46.56 -56.11 6.54 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.446 -1.252 . . . . 3.01 109.174 178.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.25 24.2 pt -70.37 11.42 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 114.862 1.43 . . . . 2.05 114.862 -173.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 82.0 t -98.4 -57.59 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 119.455 1.025 . . . . 2.9 110.934 173.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -95.68 90.27 5.63 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 121.618 -0.676 . . . . 2.29 111.822 -162.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.72 41.75 12.36 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.442 -1.063 . . . . 1.98 110.442 176.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.91 -161.61 1.17 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 104.168 -2.53 . . . . 3.8 104.168 -178.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 m -27.6 -59.04 0.11 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.797 2.439 . . . . 2.77 116.356 -175.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -57.66 -43.62 85.12 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 120.625 1.557 . . . . 3.95 110.889 -177.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.04 -34.81 75.81 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.762 0.825 . . . . 2.89 110.586 174.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.09 46.86 14.7 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.118 1.342 . . . . 1.57 111.566 177.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.7 m -99.17 -89.61 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 117.252 0.526 . . . . 2.46 111.639 177.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -58.53 -60.8 9.13 Favored Pre-proline 0 CA--C 1.538 0.49 0 O-C-N 121.33 -0.856 . . . . 3.73 112.891 -176.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.62 147.18 27.82 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.564 1.509 . . . . 1.19 109.072 172.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -116.52 135.05 54.15 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.099 1.76 . . . . 3.04 107.302 -176.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.01 146.78 45.86 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.447 -0.575 . . . . 2.09 109.447 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.59 -26.24 9.14 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 123.927 0.775 . . . . 1.01 111.915 -169.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -84.71 151.63 24.29 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.195 0.998 . . . . 1.86 109.969 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -95.23 130.68 41.88 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.806 0.842 . . . . 6.14 108.851 175.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.6 pt -141.31 177.63 3.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 125.025 1.33 . . . . 1.73 108.243 177.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.8 mtm-85 -125.7 137.83 53.86 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 122.31 -0.244 . . . . 3.57 111.115 166.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.6 p -97.66 134.07 37.16 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.171 0 C-N-CA 124.686 1.194 . . . . 2.03 108.049 172.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.09 119.14 1.76 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.602 -0.999 . . . . 0.66 110.602 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.59 -163.34 29.27 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.295 -1.522 . . . . 0.71 109.295 -175.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.44 142.04 27.87 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.011 0.905 . . . . 3.51 111.733 -177.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 39.3 t -87.44 122.55 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-N 115.545 -0.752 . . . . 3.19 109.407 172.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.5 m -30.34 -91.62 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 128.843 2.857 . . . . 3.05 115.382 -175.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.5 p -172.42 -37.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 124.061 0.944 . . . . 3.24 111.027 -177.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -158.96 40.66 0.49 Allowed Glycine 0 CA--C 1.521 0.439 0 N-CA-C 109.617 -1.393 . . . . 1.87 109.617 174.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.3 m -82.25 -17.33 46.35 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.868 -0.195 . . . . 1.79 111.093 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.1 ttp -63.23 128.79 37.47 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 122.717 0.407 . . . . 3.4 110.487 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.5 m -135.22 143.99 35.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 108.132 -1.062 . . . . 1.62 108.132 172.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 47.8 ptt85 -132.39 147.52 52.39 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 124.422 1.089 . . . . 5.98 108.516 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -99.76 154.37 37.29 Favored Pre-proline 0 C--O 1.235 0.313 0 N-CA-C 107.944 -1.132 . . . . 2.09 107.944 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.41 44.71 1.56 Allowed 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.485 2.79 . . . . 1.86 111.526 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -105.75 -41.45 5.43 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.667 1.587 . . . . 1.71 109.088 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.2 m 107.55 -30.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 129.134 2.974 . . . . 3.18 110.214 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.34 32.87 4.83 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 124.321 1.048 . . . . 4.03 111.741 -177.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -140.04 110.08 6.49 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.41 -1.33 . . . . 4.45 107.41 175.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.75 134.17 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.226 -1.398 . . . . 2.11 107.226 177.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -144.46 157.17 44.37 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 120.884 -1.135 . . . . 1.0 109.199 175.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -155.09 161.02 41.4 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.691 -0.855 . . . . 3.25 108.691 -173.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -106.74 145.21 32.33 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.548 -0.908 . . . . 1.63 108.548 175.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.9 t -127.96 140.2 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 108.473 -0.936 . . . . 2.92 108.473 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -137.17 168.96 18.61 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.552 0.741 . . . . 1.77 110.195 -178.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -115.5 10.46 15.69 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.733 0.813 . . . . 2.86 110.517 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.5 t 57.97 26.23 13.18 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.529 1.132 . . . . 4.24 112.463 -171.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.2 mt -120.72 33.4 5.59 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.377 1.471 . . . . 5.26 110.893 -176.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 62.7 39.98 98.61 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 121.679 -0.638 . . . . 3.53 111.8 177.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -153.92 124.27 1.54 Allowed Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 106.98 -2.448 . . . . 1.68 106.98 170.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -126.87 128.75 46.99 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.084 -1.821 . . . . 3.74 106.084 174.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.2 tp -108.83 160.2 7.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 C-N-CA 125.36 1.464 . . . . 2.36 108.14 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 mt -114.65 133.38 55.9 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 108.231 -1.026 . . . . 1.99 108.231 -175.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 89.2 t -127.59 131.62 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 124.76 1.224 . . . . 2.22 107.798 -174.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.0 p -107.2 150.4 26.66 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.929 0.892 . . . . 1.75 109.762 178.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -147.39 140.62 25.25 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.49 1.516 . . . . 3.21 107.064 -173.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -132.95 41.45 3.15 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.366 1.066 . . . . 2.13 112.574 -168.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -168.25 53.24 0.05 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.557 0.743 . . . . 2.68 111.631 -176.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.2 mp 51.02 -155.03 0.14 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.827 1.251 . . . . 2.28 111.067 -171.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 81.8 mt -150.18 156.99 37.63 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 106.535 -1.654 . . . . 2.45 106.535 -178.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.22 -88.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.434 2.756 . . . . 1.95 110.556 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -77.1 36.36 0.18 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.814 1.246 . . . . 3.64 111.254 -175.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 39.89 11.67 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.824 2.849 . . . . 3.03 116.983 -163.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 56.08 96.83 0.02 OUTLIER 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.681 1.128 . . . . 4.67 109.911 -161.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 7.0 mtm180 -107.92 35.15 3.22 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 117.356 -1.306 . . . . 6.87 112.448 172.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . 0.378 4.3 mm-40 78.81 157.75 0.17 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 121.443 1.928 . . . . 4.51 112.99 140.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 52.1 26.59 20.44 Favored Glycine 0 CA--C 1.534 1.219 0 O-C-N 120.578 -1.326 . . . . 1.4 113.631 167.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -139.73 163.75 31.76 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.54 1.936 . . . . 2.83 105.813 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -89.28 145.77 18.66 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.74 -0.944 . . . . 0.96 110.74 174.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.7 pp -141.26 159.98 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 106.074 -1.824 . . . . 2.01 106.074 173.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.2 m -124.02 122.82 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 108.488 -0.93 . . . . 1.76 108.488 172.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -115.32 127.77 55.66 Favored 'General case' 0 C--O 1.228 -0.072 0 C-N-CA 125.747 1.619 . . . . 1.67 109.93 -172.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -106.74 134.99 49.04 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.863 1.265 . . . . 3.25 109.502 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -173.72 -175.93 41.79 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.398 -0.429 . . . . 1.49 112.97 -174.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.6 p -124.41 141.57 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 124.58 1.152 . . . . 2.2 109.394 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.2 mp -78.11 137.74 38.36 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.276 -0.875 . . . . 3.52 109.014 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -156.42 37.16 0.59 Allowed Glycine 0 CA--C 1.521 0.453 0 N-CA-C 111.3 -0.72 . . . . 2.58 111.3 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -157.45 27.86 0.29 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.882 0.873 . . . . 4.31 109.545 -175.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 43.91 41.72 4.09 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.045 0.938 . . . . 4.0 111.915 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 159.88 -60.33 0.31 Allowed Glycine 0 CA--C 1.529 0.947 0 N-CA-C 110.837 -0.905 . . . . 1.99 110.837 -171.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.44 160.69 20.53 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 122.307 -0.525 . . . . 3.74 111.096 -173.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 mp -125.26 126.26 44.86 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.072 0.949 . . . . 3.11 110.036 -170.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -92.8 108.97 20.4 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.096 -1.076 . . . . 1.81 108.096 172.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -134.04 102.05 5.27 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.425 0.69 . . . . 1.9 111.938 -173.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.8 t -86.43 -25.01 25.46 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.193 0.997 . . . . 2.07 111.843 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -88.43 79.43 7.69 Favored 'General case' 0 N--CA 1.455 -0.22 0 O-C-N 119.84 -1.788 . . . . 2.64 109.713 -174.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.9 m -96.42 122.37 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 118.306 0.503 . . . . 1.67 110.907 174.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -112.44 113.63 25.92 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.684 -1.599 . . . . 2.09 106.684 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -99.87 26.73 6.04 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.855 0.862 . . . . 2.36 112.606 -172.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.13 42.0 0.63 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.55 0.945 . . . . 6.3 113.55 -164.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -76.05 -52.52 10.01 Favored 'General case' 0 C--N 1.333 -0.111 0 O-C-N 121.585 -0.697 . . . . 6.23 109.216 173.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.5 t70 . . . . . 0 CA--C 1.534 0.362 0 N-CA-C 109.43 -0.582 . . . . 5.82 109.43 177.227 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 CA--C 1.529 0.14 0 N-CA-C 108.737 -0.838 . . . . 7.43 108.737 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -81.35 134.53 35.58 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.349 0.66 . . . . 9.85 109.987 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.9 mp -107.25 97.03 6.84 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.349 1.06 . . . . 6.22 108.851 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -158.56 81.24 0.81 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.248 0.477 . . . . 4.83 111.595 175.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.32 169.44 14.87 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.454 1.024 . . . . 3.04 112.475 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -84.13 126.49 33.15 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.424 1.49 . . . . 3.45 110.11 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.16 150.71 52.03 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.27 1.428 . . . . 4.15 110.518 -177.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 36.2 m -76.7 124.05 87.66 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 125.73 1.612 . . . . 3.28 111.48 -175.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -55.36 -43.4 58.81 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.987 2.458 . . . . 0.76 111.857 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.6 m -60.1 -25.17 65.22 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.131 0.789 . . . . 3.63 113.131 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -68.65 -56.88 6.73 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.139 -1.06 . . . . 3.25 108.139 171.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.6 pt -72.96 30.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 114.571 1.323 . . . . 2.09 114.571 -171.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.2 p -107.51 -29.73 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 125.214 1.406 . . . . 2.9 110.827 170.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -87.1 -118.7 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.969 0.89 . . . . 3.39 109.937 -170.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -84.88 66.61 3.84 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 108.554 -1.818 . . . . 2.39 108.554 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -142.38 -125.31 0.09 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.503 1.121 . . . . 3.72 108.074 -173.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -76.66 -38.4 54.6 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 119.183 0.901 . . . . 3.76 111.387 -172.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -58.31 -50.35 73.95 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.397 0.618 . . . . 2.74 109.537 -178.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.9 m -81.04 -24.95 37.5 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.211 -0.904 . . . . 2.37 111.269 177.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.21 43.34 47.61 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.663 1.125 . . . . 1.09 111.988 175.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.0 m -98.41 -42.18 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 117.657 0.728 . . . . 1.96 112.757 -172.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -109.71 -65.77 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.777 1.231 . . . . 4.42 111.975 -176.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -76.85 171.25 18.32 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 N-CA-C 108.224 -1.491 . . . . 1.18 108.224 169.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.5 158.56 43.82 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.351 0.66 . . . . 5.41 109.39 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.57 126.94 31.26 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.489 -1.3 . . . . 1.84 107.489 175.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 127.31 -17.68 6.19 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.275 1.417 . . . . 1.18 112.198 -176.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -93.31 148.7 21.82 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.192 0.997 . . . . 2.94 110.523 -172.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -85.49 134.58 34.04 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.051 -0.722 . . . . 3.98 109.051 172.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.1 pt -145.73 175.03 2.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 105.685 -1.969 . . . . 1.8 105.685 164.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -120.89 122.99 41.44 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.329 -1.36 . . . . 2.68 107.329 171.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.7 p -88.81 131.91 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 107.558 -1.275 . . . . 1.78 107.558 176.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -135.42 121.66 2.6 Favored Glycine 0 C--N 1.336 0.529 0 CA-C-N 119.052 0.842 . . . . 0.51 111.002 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -172.88 -172.47 38.56 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.907 -0.877 . . . . 0.59 110.907 -175.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -92.48 127.79 38.09 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.579 1.152 . . . . 5.68 109.649 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.7 t -77.65 146.97 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.583 -0.735 . . . . 3.23 109.721 176.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.1 m -55.66 -90.36 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.927 1.691 . . . . 3.04 114.155 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.4 p 176.16 -44.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.757 1.623 . . . . 2.43 109.956 -170.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -150.26 39.44 0.86 Allowed Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.382 -1.087 . . . . 2.16 110.382 176.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 61.6 m -87.22 -19.09 28.86 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 117.4 0.6 . . . . 1.61 112.153 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.3 ttp -71.76 123.82 23.44 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 118.803 0.729 . . . . 3.53 109.101 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.6 m -121.61 132.49 70.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 107.592 -1.262 . . . . 1.66 107.592 173.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.7 ptt85 -117.2 153.27 33.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.939 0.895 . . . . 6.21 109.904 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.28 170.19 17.39 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 109.9 -0.407 . . . . 2.5 109.9 170.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.35 -33.28 5.7 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.424 2.749 . . . . 1.61 110.604 163.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -46.13 -40.17 10.58 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 126.221 1.808 . . . . 1.65 110.232 -177.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.2 m 78.68 17.53 1.02 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.616 1.966 . . . . 1.71 112.666 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.76 23.96 7.21 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.445 0.698 . . . . 4.46 112.407 164.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -144.87 118.75 9.3 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.183 -1.043 . . . . 1.69 108.183 177.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.8 m -139.82 143.56 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 106.928 -1.508 . . . . 2.24 106.928 173.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -139.49 159.03 43.1 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.419 -0.586 . . . . 1.02 109.419 172.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -154.84 159.17 40.36 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 122.975 0.51 . . . . 3.2 109.73 -175.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.55 147.63 26.53 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.834 -0.802 . . . . 1.84 108.834 172.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.3 p -144.6 144.77 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 109.244 -0.65 . . . . 2.91 109.244 174.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -141.0 175.84 9.3 Favored 'General case' 0 C--O 1.228 -0.053 0 C-N-CA 125.359 1.464 . . . . 1.65 107.947 -175.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -120.24 16.91 12.33 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.367 0.603 . . . . 2.67 110.97 175.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.3 m 52.93 26.54 4.75 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.344 1.058 . . . . 5.12 113.316 -175.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 71.6 mt -93.25 -62.39 1.38 Allowed 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.476 -0.565 . . . . 5.83 109.476 174.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.86 55.47 0.04 OUTLIER Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.367 -1.093 . . . . 3.41 110.367 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 175.12 148.82 6.92 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 108.345 -1.902 . . . . 1.81 108.345 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -135.67 145.78 47.12 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 105.745 -1.946 . . . . 3.32 105.745 178.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.36 139.32 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 107.351 -1.351 . . . . 2.16 107.351 176.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.0 mt -87.73 138.36 31.53 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.684 -0.858 . . . . 1.98 108.684 173.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.5 t -124.38 135.71 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 C-N-CA 126.002 1.721 . . . . 1.91 106.608 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.1 p -110.13 156.38 20.67 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.997 1.319 . . . . 1.43 108.236 178.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -151.7 108.07 3.45 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.597 -1.26 . . . . 4.19 107.597 177.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -84.17 51.36 2.05 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.733 1.213 . . . . 2.67 110.75 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -164.64 -178.17 5.19 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.867 1.267 . . . . 2.66 108.094 171.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.03 158.5 32.78 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.115 0.966 . . . . 2.19 111.563 169.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.1 mt -96.04 165.27 16.72 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 126.123 1.769 . . . . 2.67 109.923 174.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.96 -100.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.758 2.972 . . . . 2.2 109.4 172.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -78.32 54.55 1.42 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.281 1.033 . . . . 2.88 110.537 -175.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 42.1 18.58 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.822 2.449 . . . . 3.11 115.678 -171.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 6.2 t80 60.61 97.25 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.91 0.884 . . . . 3.48 110.688 -163.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 -77.91 111.45 13.77 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 105.736 -1.95 . . . . 9.27 105.736 175.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -81.99 173.78 11.88 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.778 0.323 . . . . 5.1 110.747 178.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.13 34.89 89.57 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.923 -0.471 . . . . 0.99 111.923 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -156.3 175.84 13.47 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.655 1.582 . . . . 3.22 107.136 175.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -92.87 134.89 12.39 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.565 -0.614 . . . . 1.07 111.565 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.2 pp -133.05 159.48 43.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.941 -0.763 . . . . 1.83 108.941 174.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 31.5 m -125.67 122.86 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 107.808 -1.182 . . . . 1.76 107.808 176.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -119.51 117.22 27.82 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.854 1.262 . . . . 1.42 109.901 -171.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -106.84 143.35 35.06 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.379 1.071 . . . . 3.74 110.711 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 179.66 -118.79 0.61 Allowed Glycine 0 C--N 1.335 0.501 0 N-CA-C 108.823 -1.711 . . . . 1.07 108.823 169.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.8 p -150.91 144.38 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 118.006 0.903 . . . . 2.06 109.217 -176.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.5 mt -81.98 139.36 34.61 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.306 -1.368 . . . . 3.47 107.306 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -177.43 26.4 0.06 OUTLIER Glycine 0 C--N 1.333 0.414 0 C-N-CA 119.045 -1.55 . . . . 2.64 113.053 -174.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -141.25 41.18 1.77 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.974 -0.75 . . . . 6.38 108.974 -172.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 22.28 57.84 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 129.541 3.136 . . . . 4.43 112.933 175.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 139.79 -33.84 2.08 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-N 115.377 -0.829 . . . . 1.26 112.492 -171.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.88 167.42 12.14 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.428 1.114 . . . . 3.4 110.334 -175.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.4 mt -118.15 128.94 55.21 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.659 1.183 . . . . 2.85 109.486 -174.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -89.15 94.66 10.01 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.096 -1.446 . . . . 1.68 107.096 175.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -115.5 111.29 20.52 Favored 'General case' 0 C--O 1.228 -0.069 0 C-N-CA 122.949 0.5 . . . . 1.77 110.163 -173.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.85 -43.66 8.1 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.12 0.968 . . . . 2.19 110.44 -174.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -84.51 79.06 9.7 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.95 -1.13 . . . . 3.91 107.95 -170.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.4 m -90.0 96.44 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 125.794 1.637 . . . . 1.91 111.262 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.81 149.97 20.93 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 108.81 -0.811 . . . . 2.0 108.81 175.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -126.56 70.72 1.26 Allowed 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 123.894 0.878 . . . . 2.47 109.915 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -65.27 -10.04 29.02 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.482 0.919 . . . . 4.49 113.482 -177.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -69.68 -56.89 5.98 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.468 0.707 . . . . 6.99 109.63 176.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.14 0 C-N-CA 124.177 0.991 . . . . 6.31 108.447 -178.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.0 t . . . . . 0 CA--C 1.531 0.236 0 CA-C-O 120.762 0.315 . . . . 9.54 110.681 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -144.27 170.56 15.76 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.993 1.317 . . . . 9.93 108.13 -171.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 26.8 tp -142.33 168.94 18.56 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.264 1.426 . . . . 6.0 107.886 -177.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -159.1 75.76 0.69 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.234 0.614 . . . . 5.63 112.163 -166.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.0 pp -138.35 167.25 22.28 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.631 1.105 . . . . 3.24 112.693 -176.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -92.29 127.64 37.84 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.773 1.629 . . . . 3.46 111.366 -175.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.59 152.32 50.09 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.21 1.804 . . . . 3.93 110.405 -173.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.4 m -89.91 129.35 46.62 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.103 1.361 . . . . 2.86 111.525 -174.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -57.23 -53.24 5.06 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.543 2.828 . . . . 0.83 112.594 -176.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.0 m -57.38 -12.41 2.51 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 114.29 1.219 . . . . 3.98 114.29 176.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -82.67 -53.17 6.14 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 118.861 0.755 . . . . 3.09 108.985 170.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 26.8 pt -73.27 33.11 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 114.106 1.151 . . . . 1.98 114.106 -176.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.0 m -126.64 -54.61 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 126.323 1.849 . . . . 4.04 109.786 169.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -65.23 -34.49 78.49 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.701 0.8 . . . . 2.77 112.761 -163.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.62 68.71 0.1 OUTLIER Glycine 0 C--N 1.335 0.518 0 N-CA-C 110.27 -1.132 . . . . 2.5 110.27 -177.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -165.41 -99.24 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.992 1.717 . . . . 3.87 108.36 -171.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 55.8 m -62.99 -63.71 1.12 Allowed 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 119.094 0.861 . . . . 2.13 110.561 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.2 -44.8 64.93 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.777 0.799 . . . . 3.57 111.162 -172.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.79 -17.81 52.48 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.619 1.168 . . . . 2.49 112.516 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 53.36 52.05 43.4 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.76 1.648 . . . . 1.41 112.233 -175.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.1 m -105.99 -60.33 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 117.94 0.87 . . . . 2.3 113.088 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.1 mmtt -80.18 -61.49 0.44 Allowed Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 118.512 -0.756 . . . . 4.58 112.339 -178.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -79.82 148.68 20.09 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 121.891 1.727 . . . . 1.59 108.643 174.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -93.12 145.93 24.03 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.004 -1.11 . . . . 3.7 108.004 165.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.88 169.02 5.58 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.136 0.574 . . . . 2.39 110.33 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.04 33.82 86.92 Favored Glycine 0 CA--C 1.532 1.1 0 O-C-N 121.928 -0.482 . . . . 1.25 112.57 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -118.54 159.1 24.15 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.308 1.043 . . . . 1.98 108.764 170.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.5 128.02 45.59 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.122 1.369 . . . . 5.79 108.765 -177.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.2 pt -146.17 176.84 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 124.062 0.945 . . . . 1.96 108.56 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.3 mtt85 -119.14 130.66 55.66 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.679 -0.86 . . . . 3.64 108.679 167.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.9 p -95.43 130.37 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 107.041 -1.466 . . . . 1.95 107.041 171.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.58 120.06 1.88 Allowed Glycine 0 C--N 1.332 0.36 0 N-CA-C 110.131 -1.188 . . . . 0.47 110.131 -176.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.47 -159.67 21.87 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.45 -1.46 . . . . 0.63 109.45 -178.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.69 132.22 46.19 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.918 0.866 . . . . 3.75 111.922 -174.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.1 t -86.47 111.7 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.433 -0.951 . . . . 3.04 108.433 176.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 t -5.82 -102.31 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 128.624 2.769 . . . . 4.05 114.668 163.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.7 p -158.69 -41.59 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 N-CA-C 113.548 0.944 . . . . 2.74 113.548 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -161.26 33.33 0.38 Allowed Glycine 0 C--N 1.332 0.357 0 N-CA-C 110.995 -0.842 . . . . 3.0 110.995 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.2 m -80.25 12.73 2.72 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.739 0.644 . . . . 1.87 112.739 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -78.04 107.6 10.72 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.948 -1.13 . . . . 3.08 107.948 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -106.83 127.65 62.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 108.043 -1.095 . . . . 1.69 108.043 176.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.37 142.75 38.24 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.071 0.949 . . . . 6.0 110.273 178.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -71.79 158.02 88.56 Favored Pre-proline 0 C--O 1.232 0.146 0 C-N-CA 123.18 0.592 . . . . 2.13 109.521 170.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.4 -24.64 64.1 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.73 2.287 . . . . 1.38 112.346 170.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 76.1 m-80 -44.69 -34.4 2.21 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.11 0.564 . . . . 1.43 110.886 165.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.9 m 75.2 1.53 3.73 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.801 1.64 . . . . 1.59 112.73 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.77 -13.74 8.23 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.937 1.695 . . . . 3.09 112.689 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -106.48 121.41 44.21 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 105.897 -1.89 . . . . 1.6 105.897 176.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.0 m -145.88 137.87 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 107.314 -1.365 . . . . 1.96 107.314 -172.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -139.46 152.68 47.2 Favored 'General case' 0 C--O 1.233 0.223 0 O-C-N 121.604 -0.685 . . . . 1.1 110.452 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -150.88 158.19 43.84 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.981 -0.554 . . . . 3.21 110.411 -173.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -112.51 141.72 45.92 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.688 -1.227 . . . . 1.91 107.688 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.5 p -141.87 146.16 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.244 0.618 . . . . 3.15 109.95 -174.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -145.2 -177.94 5.81 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.99 1.316 . . . . 1.84 109.49 -170.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -118.92 25.46 10.19 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.436 0.694 . . . . 2.29 109.858 175.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 67.2 m 42.3 43.35 2.93 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 125.495 1.518 . . . . 5.81 113.361 -175.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 22.4 mt -119.03 -70.02 0.82 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.918 0.887 . . . . 4.89 109.214 175.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 179.79 66.25 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 108.858 -1.697 . . . . 3.44 108.858 -176.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 170.06 113.45 0.29 Allowed Glycine 0 N--CA 1.443 -0.852 0 CA-C-O 118.748 -1.029 . . . . 2.2 111.074 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -117.61 132.08 56.57 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 108.024 -1.102 . . . . 3.5 108.024 174.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.6 tp -114.71 160.06 14.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 124.292 1.037 . . . . 2.14 108.403 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.2 mt -112.28 128.81 56.38 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.6 0.76 . . . . 1.97 109.091 -173.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.0 t -114.77 125.8 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 125.52 1.528 . . . . 2.19 107.549 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.9 p -102.22 138.9 38.55 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.904 -0.776 . . . . 1.93 108.904 175.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -132.7 111.74 11.42 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.134 1.374 . . . . 3.33 107.415 -176.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -98.79 45.96 1.0 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.161 1.384 . . . . 1.94 110.998 -176.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -164.6 -178.49 5.38 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.325 1.85 . . . . 2.74 107.526 170.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.4 mp -80.77 148.66 29.96 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.738 0.78 . . . . 2.24 111.462 176.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -76.72 159.37 79.25 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 124.955 1.302 . . . . 3.71 110.295 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.29 -90.3 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.514 2.809 . . . . 2.12 109.274 168.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.88 50.05 0.56 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.765 1.626 . . . . 3.03 110.781 178.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . 0.254 0.3 OUTLIER 44.15 7.4 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 118.53 2.789 . . . . 4.23 118.53 -177.653 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 79.4 t80 72.26 99.56 0.07 Allowed 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 126.148 1.779 . . . . 4.35 109.192 -162.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -81.38 103.45 11.14 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.092 0.957 . . . . 5.58 109.75 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -80.95 163.86 23.0 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.099 0.863 . . . . 3.19 111.932 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.56 17.4 66.68 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 118.594 -1.114 . . . . 1.47 113.372 172.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -157.29 42.13 0.33 Allowed 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 119.308 1.554 . . . . 4.45 113.452 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 31.29 141.53 0.0 OUTLIER Glycine 0 CA--C 1.531 1.079 0 C-N-CA 128.689 3.043 . . . . 2.48 118.847 -172.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.3 pp -140.39 163.23 23.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 120.099 -1.824 . . . . 2.23 107.537 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.6 m -110.28 137.05 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 107.628 -1.249 . . . . 1.9 107.628 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -123.12 128.84 50.64 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 124.076 0.95 . . . . 1.71 109.185 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -111.06 140.02 45.95 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.687 -0.486 . . . . 3.66 109.687 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 168.81 -152.04 19.3 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 121.028 -0.606 . . . . 1.07 111.606 173.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.1 p -113.76 145.73 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.008 0.923 . . . . 1.82 108.917 -169.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -55.22 142.52 31.11 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.437 -0.579 . . . . 2.95 109.437 168.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.51 -131.71 1.6 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.312 -1.115 . . . . 2.32 110.312 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -63.31 -82.24 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.339 1.056 . . . . 5.61 109.886 -177.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -159.65 62.67 0.37 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 107.828 -1.175 . . . . 3.72 107.828 173.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 163.52 -61.04 0.26 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.102 -1.199 . . . . 1.21 110.102 -172.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.18 160.87 26.76 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.692 -0.887 . . . . 3.01 108.994 -175.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 mp -122.68 137.34 54.94 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 109.62 -0.511 . . . . 3.06 109.62 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -103.37 103.24 13.22 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.365 -0.976 . . . . 1.79 108.365 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -131.15 115.42 16.36 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 122.587 0.355 . . . . 1.67 111.017 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.2 t -109.42 -15.44 14.23 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.586 1.154 . . . . 1.92 111.749 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -104.21 80.2 1.69 Allowed 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.626 -1.296 . . . . 3.15 109.081 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.6 m -90.12 149.44 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 118.784 0.72 . . . . 1.7 111.496 174.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.17 142.81 51.37 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.283 -1.006 . . . . 1.96 108.283 169.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -122.9 65.46 0.97 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.426 1.09 . . . . 1.8 111.109 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.21 42.58 1.04 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.777 0.658 . . . . 3.8 112.777 -175.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -140.45 67.05 1.37 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.666 0.786 . . . . 7.01 110.122 -175.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 . . . . . 0 CA--C 1.534 0.335 0 C-N-CA 125.921 1.688 . . . . 5.4 109.879 -176.394 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.0 t . . . . . 0 N--CA 1.454 -0.267 0 N-CA-C 107.844 -1.169 . . . . 9.33 107.844 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -165.31 56.41 0.12 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.743 0.817 . . . . 8.49 110.495 -173.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.3 mt -125.24 133.98 52.49 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.816 1.247 . . . . 6.11 108.119 177.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -160.63 88.29 0.78 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.212 1.005 . . . . 5.16 110.804 -174.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -138.13 161.65 36.26 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.653 -1.279 . . . . 2.57 112.022 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -83.72 122.36 28.53 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.433 1.093 . . . . 3.41 109.059 176.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.33 159.58 37.49 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.282 1.033 . . . . 4.57 108.853 171.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 53.3 p -79.73 148.4 68.99 Favored Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 109.147 -0.686 . . . . 2.44 109.147 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -60.87 -28.87 87.07 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 121.335 1.356 . . . . 0.99 110.697 176.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.5 p -52.67 -28.8 23.21 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.153 0.981 . . . . 2.91 112.775 171.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -81.78 -10.48 59.33 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.019 -0.425 . . . . 2.16 111.424 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.3 pt -127.68 34.19 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 O-C-N 120.788 -1.195 . . . . 1.99 113.832 -176.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.6 m -119.85 -23.66 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 119.129 0.877 . . . . 4.19 113.072 -176.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -139.21 132.28 29.59 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 107.123 -1.436 . . . . 4.04 107.123 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.59 -73.06 1.2 Allowed Glycine 0 CA--C 1.529 0.931 0 CA-C-O 122.465 1.036 . . . . 3.84 111.173 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.4 mttt -44.1 -83.77 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 129.891 3.276 . . . . 5.16 111.428 -174.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.2 m -75.63 -48.02 23.95 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 121.273 1.851 . . . . 2.48 109.803 171.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -49.74 -36.78 26.88 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.078 1.14 . . . . 3.4 114.078 -172.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.1 m -123.96 19.09 9.28 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.266 1.426 . . . . 3.34 109.602 176.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 48.13 37.01 16.36 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 117.245 -1.864 . . . . 2.25 114.7 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.257 21.9 m -82.85 -43.08 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 122.106 2.953 . . . . 2.34 113.18 -168.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -93.73 -64.01 0.14 Allowed Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.585 1.154 . . . . 5.79 112.718 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.38 166.14 30.68 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.484 2.122 . . . . 1.8 109.705 176.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -118.65 129.25 55.2 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.335 0.654 . . . . 4.67 109.907 170.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.12 111.74 1.29 Allowed 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.513 -0.551 . . . . 2.2 109.513 173.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 133.65 -20.81 4.08 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 124.363 0.982 . . . . 1.72 111.567 -176.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -83.18 155.85 23.53 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 117.758 0.779 . . . . 3.37 109.211 177.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.0 mtt-85 -87.2 144.95 26.6 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.669 -0.863 . . . . 5.61 108.669 170.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.4 pt -146.96 173.4 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 106.505 -1.665 . . . . 1.95 106.505 170.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -124.67 118.36 26.31 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.516 -1.29 . . . . 2.86 107.516 174.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.27 121.13 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.666 -1.235 . . . . 1.81 107.666 177.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -127.83 123.44 4.47 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 109.907 -1.277 . . . . 0.49 109.907 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.79 -162.66 23.52 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 108.068 -2.013 . . . . 0.64 108.068 -176.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.78 137.02 37.97 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.804 0.811 . . . . 3.46 110.565 177.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.5 t -79.23 137.86 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 108.5 -0.926 . . . . 3.17 108.5 171.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.451 ' HG1' ' CD2' ' A' ' 85' ' ' HIS . 1.1 m -89.92 148.65 23.0 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.317 -0.994 . . . . 2.79 108.317 169.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.4 p -57.67 -61.12 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.189 0.996 . . . . 2.65 110.796 178.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.55 73.46 2.05 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 109.161 -1.575 . . . . 2.15 109.161 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.5 m -148.51 -44.42 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.152 0.797 . . . . 1.65 113.152 -177.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.81 122.31 17.39 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.227 0.467 . . . . 2.69 110.162 -177.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.24 120.42 48.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 108.336 -0.987 . . . . 1.77 108.336 169.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.29 147.89 24.19 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.912 1.285 . . . . 5.42 109.407 177.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -76.34 154.92 84.15 Favored Pre-proline 0 N--CA 1.455 -0.211 0 N-CA-C 109.008 -0.738 . . . . 1.91 109.008 171.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -63.89 -22.8 68.68 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.608 2.205 . . . . 1.17 111.963 166.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -47.22 -29.12 2.19 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.401 0.68 . . . . 1.12 110.809 164.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.1 m 68.71 15.97 8.99 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 125.261 1.424 . . . . 1.57 112.081 176.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.2 pp -125.8 -41.57 1.97 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 126.712 2.005 . . . . 2.71 111.744 -178.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -85.43 132.31 34.24 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.538 -1.282 . . . . 1.42 107.538 175.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.18 127.91 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 107.058 -1.46 . . . . 1.98 107.058 176.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -130.48 149.9 51.94 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.018 -0.734 . . . . 1.0 109.018 176.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -145.3 143.35 30.15 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.33 -0.618 . . . . 3.26 109.33 -175.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.84 141.87 33.05 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.327 -0.99 . . . . 1.7 108.327 164.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.6 p -128.02 153.48 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 107.472 -1.307 . . . . 2.85 107.472 170.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.451 ' CD2' ' HG1' ' A' ' 67' ' ' THR . 5.3 p80 -140.18 179.96 6.33 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.235 0.471 . . . . 2.02 111.735 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -134.12 170.82 15.1 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.461 1.104 . . . . 2.34 108.278 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.3 m -54.95 -34.78 63.58 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.854 0.862 . . . . 3.67 110.101 166.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 12.7 mt -83.16 33.33 0.45 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.1 0.778 . . . . 5.69 113.1 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 62.83 25.07 67.26 Favored Glycine 0 CA--C 1.527 0.813 0 O-C-N 121.686 -0.634 . . . . 3.41 112.797 167.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -81.46 56.93 4.9 Favored Glycine 0 C--O 1.223 -0.559 0 CA-C-O 118.721 -1.044 . . . . 2.57 113.296 -165.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -63.43 108.57 1.37 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.295 1.547 . . . . 3.18 110.216 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -130.53 143.85 39.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 108.447 -0.945 . . . . 2.44 108.447 176.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 17.9 mt -92.02 126.01 36.94 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.273 1.029 . . . . 2.07 110.75 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.5 t -108.84 122.79 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 125.879 1.671 . . . . 1.95 107.504 175.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.6 p -102.4 136.15 42.75 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.321 1.048 . . . . 1.46 108.954 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -130.85 109.22 10.41 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.222 1.409 . . . . 3.1 107.933 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -91.93 47.91 1.39 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.885 1.274 . . . . 2.33 111.683 -176.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -167.68 173.37 8.53 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.22 1.808 . . . . 2.53 107.07 170.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.4 mp -70.37 127.02 31.32 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.981 -1.074 . . . . 2.27 111.261 -177.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.9 mt -73.44 149.67 88.91 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 123.94 0.896 . . . . 2.34 110.75 174.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -68.53 140.95 49.08 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.838 3.026 . . . . 2.22 109.696 175.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 45.85 43.92 10.48 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.307 1.443 . . . . 3.17 111.238 -175.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 47.68 16.39 0.07 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 127.229 2.212 . . . . 2.82 115.332 -171.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 69.0 t80 59.61 103.72 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.231 1.412 . . . . 4.03 110.204 -161.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -78.75 119.93 22.67 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.238 -0.892 . . . . 6.49 108.696 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -83.68 165.13 19.19 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 123.311 0.644 . . . . 3.0 111.044 -174.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.06 25.39 69.09 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 119.58 -0.567 . . . . 0.93 114.146 172.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -143.55 170.57 15.58 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.734 1.214 . . . . 3.45 108.075 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -84.92 129.28 9.14 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 109.775 -1.33 . . . . 1.0 109.775 175.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.5 pp -136.17 152.77 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 106.434 -1.691 . . . . 1.7 106.434 171.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 18.1 m -115.99 125.69 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 107.863 -1.162 . . . . 1.93 107.863 177.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -116.46 134.39 54.92 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 125.09 1.356 . . . . 1.49 109.839 -170.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -126.23 143.28 51.2 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.945 1.298 . . . . 3.14 110.628 -176.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 176.51 -123.43 0.9 Allowed Glycine 0 C--N 1.334 0.44 0 N-CA-C 108.55 -1.82 . . . . 0.83 108.55 169.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.4 p -139.46 150.98 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 118.381 1.09 . . . . 1.89 109.346 -175.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -55.61 133.81 50.69 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.871 -0.604 . . . . 2.89 109.789 171.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.74 -135.51 2.35 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 109.135 -1.586 . . . . 2.34 109.135 173.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -74.1 78.25 1.74 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 109.155 -0.683 . . . . 5.68 109.155 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.8 t0 19.34 61.37 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 129.414 3.086 . . . . 4.61 113.086 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 166.73 -54.4 0.24 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.825 -0.91 . . . . 1.42 110.825 -163.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.61 154.05 19.3 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 122.246 -0.561 . . . . 3.57 109.521 172.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -111.48 123.84 51.05 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.442 1.097 . . . . 3.1 108.646 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -97.25 93.62 6.63 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.054 -1.091 . . . . 1.69 108.054 175.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.55 136.8 47.56 Favored 'General case' 0 C--O 1.227 -0.117 0 N-CA-C 109.46 -0.57 . . . . 1.56 109.46 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.9 t -124.65 -26.68 3.79 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.236 1.014 . . . . 2.0 112.743 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -89.48 88.3 7.4 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 120.472 -1.393 . . . . 3.17 108.357 177.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.1 m -99.37 125.83 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 118.873 0.76 . . . . 1.69 110.798 174.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.03 113.12 20.46 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.171 -1.418 . . . . 1.67 107.171 178.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.41 101.85 10.12 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 108.291 -1.003 . . . . 1.98 108.291 172.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -143.21 65.84 1.32 Allowed 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.431 0.692 . . . . 3.75 109.461 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -151.74 -171.69 4.01 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.077 -1.823 . . . . 6.61 106.077 175.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 50.8 t0 . . . . . 0 C--O 1.237 0.417 0 N-CA-C 107.616 -1.253 . . . . 7.34 107.616 176.695 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.4 t . . . . . 0 CA--C 1.534 0.348 0 N-CA-C 112.054 0.39 . . . . 8.92 112.054 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -142.11 165.07 28.47 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.669 1.588 . . . . 9.01 106.833 -177.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 49.7 mt 57.38 38.11 28.26 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.149 0.979 . . . . 7.02 111.072 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -160.73 53.25 0.3 Allowed 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.246 -0.909 . . . . 5.34 112.832 176.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.74 153.24 28.05 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.063 0.847 . . . . 4.59 112.948 -170.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -85.61 122.59 29.94 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 123.812 0.845 . . . . 3.55 109.384 170.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -140.78 169.17 18.13 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.768 0.827 . . . . 4.81 109.84 171.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.2 p -91.6 148.06 36.53 Favored Pre-proline 0 N--CA 1.45 -0.471 0 C-N-CA 124.096 0.958 . . . . 3.02 110.737 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -60.98 -35.85 85.77 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.564 2.843 . . . . 1.16 111.354 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.1 p -50.57 -38.6 46.2 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.918 1.287 . . . . 3.11 112.031 174.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -60.27 -57.33 13.26 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.074 -1.084 . . . . 2.13 108.074 177.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.256 19.5 pt -74.87 21.36 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 115.128 1.529 . . . . 2.2 115.128 -166.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.7 p -107.13 -33.56 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 125.02 1.328 . . . . 3.0 112.127 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -116.57 94.14 4.5 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.29 -0.881 . . . . 2.21 110.141 -170.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.31 45.66 46.72 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.739 -0.945 . . . . 2.11 110.739 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.23 -159.33 0.88 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 103.902 -2.629 . . . . 3.17 103.902 178.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.0 m -41.32 -45.83 3.1 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.445 1.898 . . . . 2.69 115.078 -167.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -51.11 -47.72 61.9 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.833 0.742 . . . . 2.97 112.014 176.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.1 m -78.2 -32.95 50.25 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.148 0.579 . . . . 2.15 111.02 174.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.43 48.49 18.29 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.429 1.014 . . . . 1.31 111.145 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -89.37 -91.61 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 117.042 0.421 . . . . 2.26 110.677 177.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 19.0 mmmt -65.71 -56.67 17.01 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 118.452 -0.785 . . . . 4.12 111.945 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.86 120.95 5.25 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 121.426 1.417 . . . . 1.22 109.844 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.24 165.74 18.09 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.582 0.753 . . . . 4.61 109.053 170.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.41 173.63 7.63 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 109.07 -0.715 . . . . 2.29 109.07 171.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.16 -2.5 84.2 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 121.033 -1.042 . . . . 1.13 113.471 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -94.15 148.8 21.84 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.282 1.041 . . . . 1.84 109.198 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -92.78 130.04 38.52 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.105 -0.702 . . . . 5.08 109.105 172.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.5 pt -142.66 167.3 14.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 106.426 -1.694 . . . . 1.79 106.426 168.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.2 mtt180 -118.09 115.08 24.1 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.88 -1.526 . . . . 2.35 106.88 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.7 p -92.79 123.54 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.767 -1.197 . . . . 2.06 107.767 178.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.34 148.97 20.63 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 118.975 0.807 . . . . 1.24 111.682 -177.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 167.13 -100.45 0.17 Allowed Glycine 0 C--N 1.335 0.517 0 N-CA-C 109.077 -1.609 . . . . 1.79 109.077 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.7 ptp -145.46 131.23 19.02 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.738 0.769 . . . . 3.62 110.016 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.2 p -67.11 157.08 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 119.483 -0.887 . . . . 3.67 109.726 178.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.7 -9.88 31.66 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.908 1.077 . . . . 3.39 113.908 175.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.253 7.6 p 49.51 68.76 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 123.863 1.792 . . . . 4.67 111.564 177.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 142.57 47.75 0.05 OUTLIER Glycine 0 CA--C 1.526 0.731 0 CA-C-N 111.874 -2.421 . . . . 2.11 109.861 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.0 m -156.45 -7.52 0.1 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 114.824 1.416 . . . . 1.94 114.824 177.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.92 109.89 1.39 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 121.449 1.931 . . . . 2.96 108.278 171.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.2 m -124.66 134.92 65.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 108.459 -0.941 . . . . 2.01 108.459 174.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.3 ptt85 -113.67 151.05 32.35 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.424 1.089 . . . . 5.83 109.677 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.07 160.52 65.63 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 123.082 0.553 . . . . 1.81 110.268 175.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -74.54 -26.45 11.89 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.479 2.786 . . . . 1.22 110.584 171.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -43.4 -38.57 2.82 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 124.595 1.158 . . . . 1.71 109.023 169.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.2 m 79.38 2.7 2.28 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.687 1.995 . . . . 1.57 112.012 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.16 31.19 6.07 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.056 2.142 . . . . 3.15 109.27 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -156.56 132.49 9.69 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.789 -0.819 . . . . 2.13 108.789 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.89 134.47 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 125.75 1.62 . . . . 1.93 109.026 -177.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -138.03 158.64 43.91 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 120.826 -1.171 . . . . 1.02 110.783 172.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -155.36 153.4 30.4 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.363 0.665 . . . . 3.28 109.845 -174.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -112.2 134.8 53.54 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.685 0.794 . . . . 1.6 109.633 -179.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.8 t -126.04 142.78 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 108.189 -1.041 . . . . 2.9 108.189 -173.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -139.42 -175.39 4.17 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.859 -0.793 . . . . 1.97 108.859 177.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -133.62 -9.39 2.81 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.781 1.232 . . . . 2.58 109.327 177.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 62.02 26.6 16.05 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.829 1.252 . . . . 5.59 111.472 -169.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.9 mp -112.95 -91.41 0.5 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.666 -0.864 . . . . 5.69 108.666 170.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -71.98 -33.6 62.5 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.033 0.825 . . . . 5.24 113.637 -170.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 157.66 -158.8 29.35 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 109.804 -1.318 . . . . 2.68 109.804 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -116.88 159.41 22.44 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.246 2.218 . . . . 2.93 107.557 178.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -137.77 163.91 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 108.236 -1.024 . . . . 1.87 108.236 166.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.7 mt -112.94 132.52 55.31 Favored 'General case' 0 C--N 1.338 0.087 0 C-N-CA 124.625 1.17 . . . . 1.68 108.685 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.3 t -118.25 129.94 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 125.193 1.397 . . . . 1.87 107.477 -177.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.8 p -107.74 149.75 27.79 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.298 1.039 . . . . 1.68 108.299 177.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -144.1 129.75 19.17 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.05 -1.463 . . . . 4.31 107.05 176.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -69.33 -84.31 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.359 -0.838 . . . . 2.9 110.379 166.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -56.97 163.28 2.06 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.983 0.897 . . . . 2.57 112.825 -172.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 mp -63.45 145.54 55.42 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 122.225 1.012 . . . . 2.35 111.986 -174.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 24.9 mt -67.85 156.4 89.4 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 115.023 -0.99 . . . . 2.42 109.997 169.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.77 -89.4 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.492 3.461 . . . . 2.35 109.619 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.2 17.82 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.94 1.296 . . . . 2.9 113.581 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 16.5 tp 53.24 20.6 1.92 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.485 1.114 . . . . 4.56 111.937 -167.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 49.55 81.75 0.05 Allowed 'General case' 0 C--N 1.344 0.368 0 C-N-CA 124.94 1.296 . . . . 3.86 110.828 173.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.294 7.8 mmm180 -87.72 29.75 0.88 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 117.872 -1.531 . . . . 6.76 112.452 -166.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . 0.604 25.9 mt-10 80.26 161.87 0.17 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.517 1.527 . . . . 4.51 111.807 157.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 29.9 52.95 0.19 Allowed Glycine 0 CA--C 1.533 1.198 0 C-N-CA 126.346 1.927 . . . . 1.33 115.785 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -152.54 51.34 0.77 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.853 1.326 . . . . 3.43 112.536 -174.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 4.67 98.34 0.0 OUTLIER Glycine 0 CA--C 1.535 1.332 0 C-N-CA 127.888 2.661 . . . . 1.58 116.354 -174.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.0 pp -108.4 165.13 5.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 106.977 -1.49 . . . . 1.85 106.977 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.6 m -123.62 133.97 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 107.583 -1.266 . . . . 1.86 107.583 173.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -126.54 138.1 53.44 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.15 1.78 . . . . 1.87 108.891 -170.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -143.02 155.88 44.73 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.972 0.805 . . . . 3.89 112.403 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -177.08 -100.26 0.13 Allowed Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 108.386 -1.886 . . . . 1.38 108.386 172.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.9 p -155.91 151.0 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 118.153 0.976 . . . . 1.83 110.153 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.1 mp -85.64 150.95 24.26 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.226 1.01 . . . . 3.43 108.809 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -166.99 -53.86 0.03 OUTLIER Glycine 0 C--O 1.227 -0.322 0 C-N-CA 120.577 -0.82 . . . . 2.38 111.223 177.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -64.18 144.19 57.31 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.36 -0.978 . . . . 5.8 108.36 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.31 58.99 2.21 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.188 1.795 . . . . 4.84 109.268 -172.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 127.4 18.53 2.02 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 127.123 2.297 . . . . 1.74 113.6 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.29 160.63 38.98 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.937 1.369 . . . . 3.64 109.63 166.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.16 129.39 54.98 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.437 1.095 . . . . 3.43 108.351 -172.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -90.44 95.25 10.08 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 107.767 -1.197 . . . . 1.63 107.767 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.84 140.86 41.71 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 123.346 0.658 . . . . 1.57 109.972 -176.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -125.24 -47.22 1.76 Allowed 'General case' 0 C--O 1.232 0.165 0 C-N-CA 123.864 0.866 . . . . 2.14 111.254 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -83.42 101.36 11.32 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 106.3 -1.741 . . . . 3.52 106.3 -173.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.4 m -108.51 116.31 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 125.932 1.693 . . . . 1.84 109.266 -178.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.13 113.25 25.8 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.89 -1.152 . . . . 1.8 107.89 -177.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -99.82 45.64 0.98 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.322 1.049 . . . . 1.62 111.581 -176.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.43 48.91 1.08 Allowed 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.136 -0.977 . . . . 3.69 111.628 -175.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -67.17 -53.22 32.51 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.734 -0.604 . . . . 8.23 110.252 -175.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.8 t0 . . . . . 0 C--O 1.233 0.223 0 N-CA-C 105.927 -1.879 . . . . 6.3 105.927 167.161 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.0 p . . . . . 0 N--CA 1.45 -0.443 0 N-CA-C 109.925 -0.398 . . . . 9.29 109.925 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 66.49 -164.95 0.23 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.931 0.892 . . . . 9.64 109.822 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 tt 54.44 54.24 9.66 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.418 1.087 . . . . 6.18 109.574 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.37 108.63 2.32 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 107.771 -1.196 . . . . 5.4 107.771 -177.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -143.13 171.68 13.75 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.952 0.901 . . . . 2.72 110.727 -177.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -83.78 129.72 34.94 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.395 1.078 . . . . 3.29 110.138 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -132.75 144.32 50.19 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.127 1.371 . . . . 4.44 110.556 -178.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.0 m -76.39 133.67 71.01 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 125.707 1.603 . . . . 3.19 110.677 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.48 -41.35 58.24 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.527 2.151 . . . . 0.94 112.673 -178.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.7 t -47.96 -49.81 29.24 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 121.628 -0.67 . . . . 3.14 111.858 175.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -48.42 -56.3 8.58 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.901 0.88 . . . . 2.39 108.992 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 32.9 pt -70.09 -10.13 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 113.883 1.068 . . . . 2.28 113.883 -173.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.9 t -82.04 -28.68 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 118.74 0.7 . . . . 2.9 111.014 170.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -117.57 90.58 3.36 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 121.196 -0.94 . . . . 1.98 111.426 -161.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.72 41.22 89.49 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.228 -1.149 . . . . 2.09 110.228 177.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.68 -154.0 0.47 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 128.878 2.871 . . . . 3.26 103.406 174.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.2 m -26.84 -60.57 0.09 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 116.498 2.036 . . . . 2.0 116.498 -165.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -39.04 -51.46 1.84 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.265 0.939 . . . . 3.1 111.671 175.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.08 -21.81 18.89 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.171 2.188 . . . . 2.17 110.829 -175.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.12 31.34 80.52 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 126.3 1.905 . . . . 1.11 113.794 171.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.8 m -80.55 -37.3 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 118.283 1.042 . . . . 2.18 112.043 -174.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 33.0 mmtt -107.94 -75.41 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 124.665 1.186 . . . . 3.76 111.281 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -73.04 116.78 4.84 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 CA-C-N 120.782 1.315 . . . . 1.24 109.689 176.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -76.48 161.5 28.58 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.518 0.727 . . . . 3.22 109.77 170.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.9 169.64 6.41 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.079 0.951 . . . . 1.95 111.261 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.12 5.8 66.85 Favored Glycine 0 CA--C 1.532 1.137 0 O-C-N 121.803 -0.56 . . . . 1.12 113.584 176.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -91.3 155.39 18.57 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 118.319 1.06 . . . . 1.73 109.125 175.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -97.24 130.67 44.42 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.29 0.636 . . . . 3.69 109.515 177.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.1 pt -146.36 177.56 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 106.74 -1.578 . . . . 1.87 106.74 173.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 42.1 mtt85 -119.41 116.4 26.07 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.881 -1.155 . . . . 4.03 107.881 167.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.6 p -80.99 127.4 39.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 N-CA-C 107.18 -1.415 . . . . 1.97 107.18 174.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.4 122.57 3.31 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 109.678 -1.369 . . . . 0.75 109.678 -177.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -169.84 -170.09 33.85 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 109.383 -1.487 . . . . 0.83 109.383 -175.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.2 ptp -99.37 137.38 37.95 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.354 0.662 . . . . 3.71 109.508 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.4 m -100.76 135.81 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 122.606 0.362 . . . . 3.67 111.43 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.441 ' HG1' ' CD2' ' A' ' 85' ' ' HIS . 1.3 m -73.57 151.64 40.85 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.364 1.066 . . . . 2.68 109.292 176.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.5 p -55.57 -56.14 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 125.351 1.46 . . . . 2.83 111.173 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.07 71.63 1.22 Allowed Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.625 -1.39 . . . . 1.68 109.625 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.3 m -151.98 46.82 0.77 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 117.758 0.779 . . . . 2.51 112.28 -176.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.44 121.94 20.65 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 105.862 -1.903 . . . . 2.63 105.862 176.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.0 m -132.72 140.04 48.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 119.584 1.083 . . . . 1.81 108.705 170.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -122.22 150.9 41.63 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.37 1.068 . . . . 7.36 110.57 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.66 156.09 75.56 Favored Pre-proline 0 N--CA 1.453 -0.299 0 N-CA-C 109.809 -0.441 . . . . 2.0 109.809 170.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -68.3 -24.38 37.53 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.873 2.382 . . . . 1.67 111.466 166.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -45.45 -36.62 4.52 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.773 -0.454 . . . . 1.53 109.773 163.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.8 m 66.17 10.65 7.27 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 125.04 1.336 . . . . 1.74 112.999 176.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.2 pp -125.12 9.42 8.04 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 128.687 2.795 . . . . 2.6 110.2 175.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -137.79 130.34 29.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.09 -1.819 . . . . 1.58 106.09 176.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.5 146.0 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 107.036 -1.468 . . . . 2.32 107.036 -170.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -152.12 153.94 34.9 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 121.593 -0.692 . . . . 1.48 110.118 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -145.99 156.06 43.24 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.924 -0.58 . . . . 3.22 109.646 -171.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.91 140.5 37.6 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.451 -0.574 . . . . 1.93 109.451 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.0 t -120.9 151.5 23.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 106.899 -1.519 . . . . 2.97 106.899 176.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.441 ' CD2' ' HG1' ' A' ' 67' ' ' THR . 3.2 p80 -133.18 -177.25 4.43 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.685 0.794 . . . . 2.17 109.489 177.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -140.47 167.78 21.35 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.869 0.868 . . . . 3.28 109.197 177.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.4 m -41.51 -45.95 3.38 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.505 1.122 . . . . 4.24 111.198 160.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.3 mt -82.3 22.62 0.81 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.099 0.778 . . . . 5.61 113.099 178.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 58.78 39.62 93.96 Favored Glycine 0 CA--C 1.527 0.784 0 O-C-N 121.139 -0.976 . . . . 3.78 110.891 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -77.07 60.71 3.47 Favored Glycine 0 C--N 1.337 0.594 0 C-N-CA 123.844 0.735 . . . . 2.14 111.319 -174.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -63.11 114.27 3.64 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.383 0.673 . . . . 3.24 109.238 -174.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.3 153.53 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 C-N-CA 124.391 1.076 . . . . 2.17 108.606 -178.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.8 mt -114.01 129.18 56.62 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.087 0.955 . . . . 1.87 108.582 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.3 t -116.03 130.1 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.229 1.412 . . . . 1.97 107.193 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 81.6 p -106.21 150.12 26.19 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.864 0.866 . . . . 1.45 110.235 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -144.13 120.59 11.01 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.305 1.442 . . . . 3.22 107.618 -174.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -109.58 46.49 1.0 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.34 1.456 . . . . 2.07 111.985 -169.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -170.32 -178.2 2.68 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 128.334 2.654 . . . . 2.68 105.614 169.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.6 mp -71.02 141.67 50.94 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.89 1.223 . . . . 2.11 111.363 175.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.51 161.36 35.39 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.342 1.057 . . . . 3.9 110.372 171.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -68.55 -97.32 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.781 2.987 . . . . 2.24 109.395 168.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -75.79 55.73 0.89 Allowed 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.925 -1.109 . . . . 3.14 109.965 177.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 47.7 0.89 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 129.145 2.978 . . . . 3.35 118.113 -177.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 72.7 t80 70.84 94.74 0.07 Allowed 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 125.693 1.597 . . . . 4.49 108.425 -156.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 54.4 mtt180 -79.54 121.15 24.87 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.689 -1.226 . . . . 7.8 107.689 175.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -83.97 173.34 11.26 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 123.07 0.548 . . . . 3.25 111.26 -175.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 61.37 41.2 99.46 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.464 0.555 . . . . 0.89 112.95 174.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -157.47 177.56 11.29 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.842 1.257 . . . . 3.16 108.897 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -96.63 132.59 11.08 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 109.997 -1.241 . . . . 1.02 109.997 171.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.7 pp -137.44 162.2 33.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 107.238 -1.393 . . . . 1.73 107.238 174.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.4 m -124.51 135.59 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 108.857 -0.794 . . . . 1.85 108.857 178.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -124.23 117.71 25.2 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 124.93 1.292 . . . . 1.47 109.902 -170.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -105.7 142.21 35.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.479 1.512 . . . . 3.85 110.779 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 168.89 -132.79 2.65 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 107.047 -2.421 . . . . 0.82 107.047 171.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.8 p -132.93 147.38 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 C-N-CA 123.84 0.856 . . . . 1.83 110.178 -169.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -58.91 129.57 42.81 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.662 -0.866 . . . . 2.79 108.662 169.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -90.9 -101.23 1.22 Allowed Glycine 0 C--N 1.337 0.629 0 N-CA-C 110.63 -0.988 . . . . 2.12 110.63 -166.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.404 ' OE1' ' NZ ' ' A' ' 121' ' ' LYS . 28.6 tt0 -58.56 -68.31 0.27 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.901 1.28 . . . . 4.8 108.248 174.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -165.48 -70.81 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.38 -1.711 . . . . 4.19 106.38 168.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.9 -44.92 96.67 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.536 1.065 . . . . 1.8 112.227 178.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.404 ' NZ ' ' OE1' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -83.86 145.61 28.54 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.286 0.634 . . . . 3.64 110.631 -176.394 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.4 mp -106.5 140.26 39.67 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 108.55 -0.908 . . . . 3.16 108.55 -176.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -105.99 103.4 12.88 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 107.528 -1.286 . . . . 1.48 107.528 172.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -131.39 89.67 2.75 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 122.711 0.404 . . . . 1.8 111.995 -168.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.0 t -83.45 -18.08 39.87 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.761 0.652 . . . . 1.72 112.761 -176.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -98.46 82.72 2.91 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 119.303 0.956 . . . . 2.79 109.035 -177.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 33.1 m -93.76 123.5 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 123.041 0.536 . . . . 1.82 110.285 177.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -112.8 122.66 48.3 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.155 -1.424 . . . . 1.88 107.155 173.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -93.3 126.47 38.44 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.915 -1.143 . . . . 1.92 107.915 171.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.73 91.48 2.54 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 108.678 -0.86 . . . . 4.3 108.678 174.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -136.05 56.27 1.83 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.439 1.096 . . . . 8.65 109.579 -170.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 . . . . . 0 N--CA 1.452 -0.37 0 C-N-CA 124.699 1.2 . . . . 7.32 109.541 177.227 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 CA--C 1.531 0.225 0 N-CA-C 112.861 0.689 . . . . 8.0 112.861 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -142.11 150.23 40.88 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.368 -2.086 . . . . 8.26 105.368 165.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.74 -36.13 7.53 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.469 0.708 . . . . 8.34 109.994 177.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -153.53 146.08 24.13 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 105.879 -1.897 . . . . 4.1 105.879 174.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -163.74 157.89 19.62 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.564 1.075 . . . . 3.13 110.919 172.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -83.89 137.22 33.77 Favored 'General case' 0 C--N 1.338 0.072 0 C-N-CA 124.054 0.942 . . . . 3.27 110.555 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.93 148.95 34.42 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.852 1.261 . . . . 3.75 110.471 -171.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.1 m -79.74 132.59 60.74 Favored Pre-proline 0 N--CA 1.449 -0.495 0 C-N-CA 124.891 1.276 . . . . 2.57 110.667 -177.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.03 -41.05 78.59 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.554 2.17 . . . . 1.17 112.452 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 m -56.92 -23.56 45.97 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 114.392 1.256 . . . . 2.51 114.392 178.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.45 -57.91 4.65 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 106.771 -1.566 . . . . 2.46 106.771 173.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.2 pt -69.35 15.02 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 115.385 1.624 . . . . 1.86 115.385 -166.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.3 m -109.37 -21.03 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.557 1.943 . . . . 4.1 111.967 172.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -122.99 99.58 6.45 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.735 1.152 . . . . 2.23 110.892 -171.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.47 44.09 95.54 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.478 -1.049 . . . . 2.03 110.478 175.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.1 mmmt -150.83 -157.88 0.86 Allowed 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 104.455 -2.424 . . . . 4.26 104.455 -175.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.9 m -45.17 -46.82 12.28 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.301 1.84 . . . . 3.11 115.914 -170.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -40.0 -57.82 1.55 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.49 1.041 . . . . 2.57 111.037 171.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.39 -24.96 27.31 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.05 1.34 . . . . 2.12 110.382 -172.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.03 33.97 75.47 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.464 1.507 . . . . 1.16 112.438 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.7 m -81.48 -27.81 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 118.052 0.926 . . . . 2.02 112.091 -175.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -119.47 -71.67 0.02 OUTLIER Pre-proline 0 N--CA 1.451 -0.376 0 C-N-CA 124.736 1.214 . . . . 5.29 109.98 177.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -77.12 114.03 3.71 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 CA-C-N 120.456 1.199 . . . . 1.43 110.116 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -74.5 166.37 23.63 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.362 -0.607 . . . . 2.93 109.362 171.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.5 169.18 13.05 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.65 0.262 . . . . 2.53 110.461 175.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.59 5.12 87.08 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 121.748 -0.595 . . . . 1.29 112.411 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -103.1 150.97 23.1 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.455 1.102 . . . . 1.79 108.92 176.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -91.03 129.55 37.02 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.239 -0.652 . . . . 4.06 109.239 175.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.8 pt -143.2 166.54 14.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 106.11 -1.811 . . . . 1.69 106.11 167.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 47.6 mtt180 -119.61 116.01 25.14 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.337 -0.986 . . . . 3.7 108.337 175.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.3 p -84.99 122.46 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 107.518 -1.29 . . . . 2.08 107.518 176.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -124.98 119.69 3.7 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 109.622 -1.391 . . . . 0.59 109.622 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.38 -156.49 15.45 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.61 -1.396 . . . . 0.69 109.61 -175.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.4 ptp -106.64 131.15 54.12 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.805 0.812 . . . . 3.76 110.448 -172.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.7 m -84.1 152.82 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 115.491 -0.777 . . . . 3.71 109.59 -175.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.3 m -64.94 179.79 0.63 Allowed 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.478 1.111 . . . . 2.47 110.487 176.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.7 p -116.51 73.2 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 126.234 1.814 . . . . 2.89 108.25 -175.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.18 50.84 0.91 Allowed Glycine 0 CA--C 1.525 0.681 0 CA-C-N 113.154 -1.839 . . . . 2.25 111.404 171.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.7 m -110.99 8.8 22.1 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.407 0.683 . . . . 1.92 111.915 174.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.98 109.87 6.85 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 106.541 -1.651 . . . . 3.23 106.541 175.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.8 m -121.11 129.09 76.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 108.707 -0.849 . . . . 2.25 108.707 171.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.1 ptt180 -111.1 148.62 32.28 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.405 1.082 . . . . 6.35 110.793 177.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -82.37 153.21 68.46 Favored Pre-proline 0 C--O 1.234 0.26 0 N-CA-C 109.148 -0.686 . . . . 2.09 109.148 170.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -71.64 8.65 1.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.958 2.439 . . . . 1.71 113.789 176.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -69.32 -26.54 64.76 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.756 -0.59 . . . . 1.68 109.84 161.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.0 m 72.25 1.34 3.91 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.158 1.783 . . . . 1.68 113.51 -174.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.38 -3.71 8.9 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.694 1.198 . . . . 3.22 113.505 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -117.55 125.85 51.55 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.786 -1.561 . . . . 1.6 106.786 174.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.2 m -144.45 150.43 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 108.149 -1.056 . . . . 2.19 108.149 -175.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -151.58 154.82 37.21 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.875 -0.516 . . . . 1.18 110.439 -179.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.438 ' CE1' ' CE1' ' A' ' 104' ' ' PHE . 33.8 p90 -156.77 153.04 27.72 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.059 0.457 . . . . 3.34 111.69 -176.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.24 154.71 19.9 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 123.47 0.708 . . . . 1.83 109.978 170.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.3 m -132.54 163.24 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 108.191 -1.04 . . . . 3.54 108.191 163.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -137.8 -168.24 2.3 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.352 1.061 . . . . 2.33 109.885 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -137.05 176.56 8.6 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.594 0.758 . . . . 2.4 109.453 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.4 m -58.96 -41.25 87.05 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.457 -0.942 . . . . 3.75 108.457 156.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.15 22.31 0.53 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.676 0.79 . . . . 5.49 111.795 172.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 54.16 42.73 73.15 Favored Glycine 0 CA--C 1.527 0.837 0 O-C-N 121.454 -0.779 . . . . 3.71 112.598 172.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -78.29 56.8 4.06 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.129 -0.788 . . . . 2.67 111.129 -177.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -58.25 112.07 1.42 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 117.898 0.849 . . . . 4.19 110.049 -178.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.0 tp -143.79 160.27 16.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 108.093 -1.077 . . . . 2.68 108.093 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.68 129.09 50.58 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.265 1.026 . . . . 1.94 108.533 -168.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.413 ' CG2' ' CE1' ' A' ' 82' ' ' PHE . 5.3 m -115.15 146.77 19.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 109.14 -0.689 . . . . 3.92 109.14 173.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.4 p -110.19 155.77 21.53 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.963 1.705 . . . . 1.46 107.863 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -150.08 113.41 4.92 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.973 -1.491 . . . . 3.22 106.973 -175.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -101.47 45.2 0.98 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.186 1.394 . . . . 2.09 110.906 -173.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -162.95 -176.77 5.08 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.65 1.98 . . . . 2.44 106.201 170.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.1 mp -79.67 146.25 32.56 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.868 0.867 . . . . 2.48 111.081 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 78.3 mt -82.06 155.38 69.99 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 123.962 0.905 . . . . 2.72 109.412 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.99 -89.95 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.554 2.836 . . . . 2.01 110.173 176.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.78 45.72 0.43 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.284 1.434 . . . . 3.48 110.613 -176.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 44.19 8.25 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.279 2.632 . . . . 2.98 115.854 -164.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.438 ' CE1' ' CE1' ' A' ' 82' ' ' PHE . 65.4 t80 50.74 91.91 0.02 OUTLIER 'General case' 0 C--N 1.34 0.171 0 CA-C-N 119.339 0.972 . . . . 4.2 109.873 -153.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -78.6 146.17 34.32 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.814 -1.18 . . . . 7.68 107.814 173.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -93.11 167.19 11.94 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 125.401 1.481 . . . . 3.28 109.567 -169.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 47.56 44.17 22.14 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 123.532 0.587 . . . . 1.03 113.739 -177.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -153.24 120.03 5.68 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.793 1.637 . . . . 2.9 107.387 176.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -63.61 135.24 41.58 Favored Glycine 0 CA--C 1.523 0.54 0 O-C-N 121.207 -0.933 . . . . 1.15 111.368 -175.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.2 pp -135.97 166.09 27.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.817 -1.179 . . . . 1.74 107.817 177.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 17.6 m -118.79 128.94 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 108.983 -0.747 . . . . 1.76 108.983 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -120.45 118.22 29.72 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 125.023 1.329 . . . . 1.7 109.727 -168.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -114.91 150.31 35.84 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.65 1.58 . . . . 3.81 109.915 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 173.33 -122.57 0.93 Allowed Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 106.61 -2.596 . . . . 0.98 106.61 165.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.0 p -143.44 148.24 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 118.204 1.002 . . . . 2.06 109.821 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -69.85 143.03 52.97 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.251 -0.648 . . . . 3.24 109.251 168.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -166.04 26.18 0.17 Allowed Glycine 0 CA--C 1.523 0.565 0 C-N-CA 119.602 -1.285 . . . . 2.82 113.146 171.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -151.91 45.01 0.75 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.926 0.891 . . . . 6.1 108.748 -174.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 24.86 59.95 0.05 Allowed 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 128.976 2.91 . . . . 4.03 112.481 172.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 139.27 -47.93 0.88 Allowed Glycine 0 CA--C 1.529 0.949 0 CA-C-N 114.77 -1.105 . . . . 1.22 110.948 -172.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.5 151.27 20.8 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 117.885 0.842 . . . . 3.04 110.184 -174.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 mp -112.68 121.89 46.08 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.721 1.208 . . . . 3.08 109.364 -169.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -82.89 88.23 6.81 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.403 -1.702 . . . . 1.78 106.403 175.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -106.62 72.41 0.9 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.168 0.987 . . . . 1.84 110.723 -165.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.9 t -80.79 -6.66 58.82 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.037 0.754 . . . . 1.9 113.037 -168.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -113.06 88.63 2.88 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 120.799 -1.188 . . . . 4.12 108.864 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 27.0 m -96.74 125.93 49.58 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 C-N-CA 123.312 0.645 . . . . 1.89 109.826 174.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -111.94 113.33 25.57 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.68 -1.6 . . . . 2.0 106.68 177.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.34 36.79 0.25 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.078 0.551 . . . . 1.66 112.069 -178.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.0 ptmt -85.09 60.68 6.4 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.233 -0.917 . . . . 4.09 110.307 -173.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -50.53 -47.23 57.64 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.942 0.897 . . . . 6.59 111.27 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.5 t0 . . . . . 0 CA--C 1.538 0.493 0 C-N-CA 125.935 1.694 . . . . 9.36 111.536 176.208 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.2 p . . . . . 0 N--CA 1.452 -0.331 0 N-CA-C 107.459 -1.311 . . . . 6.43 107.459 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 38.5 p-10 -105.6 163.03 12.98 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.094 1.357 . . . . 9.59 109.293 174.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -151.04 167.17 28.5 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 106.408 -1.701 . . . . 6.32 106.408 -178.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -144.87 106.67 4.28 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 108.127 -1.064 . . . . 3.92 108.127 -174.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -131.81 145.34 51.52 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.029 0.932 . . . . 3.01 109.926 -173.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -92.04 111.07 22.48 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.751 1.22 . . . . 3.62 109.414 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -125.59 160.16 30.31 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.879 1.272 . . . . 4.79 110.104 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.4 p -72.09 135.58 82.46 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 109.599 -0.519 . . . . 2.43 109.599 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -55.89 -29.59 73.49 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.866 3.044 . . . . 1.04 112.337 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.0 p -66.96 -35.82 80.83 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.024 0.75 . . . . 2.86 113.024 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -45.0 -47.79 11.49 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 118.882 0.765 . . . . 3.03 110.036 177.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.34 0.2 OUTLIER -85.76 11.51 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 114.784 1.402 . . . . 3.23 114.784 -170.009 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -103.13 -8.95 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 123.445 0.698 . . . . 2.97 112.553 179.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -105.79 -58.15 1.95 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.527 0.603 . . . . 2.57 111.964 -171.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -160.71 64.56 0.28 Allowed Glycine 0 C--N 1.335 0.5 0 N-CA-C 109.266 -1.534 . . . . 2.5 109.266 -170.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt -153.96 -111.93 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 106.339 -1.726 . . . . 3.04 106.339 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.4 m -54.17 -63.03 1.28 Allowed 'General case' 0 C--N 1.343 0.323 0 C-N-CA 126.851 2.06 . . . . 2.08 113.298 177.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -49.46 -42.27 42.62 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.964 0.888 . . . . 2.42 110.993 -172.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.86 -9.54 45.97 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.338 1.855 . . . . 2.31 113.323 -178.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 48.62 48.93 28.35 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 126.26 1.886 . . . . 1.2 113.763 -174.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.5 m -95.18 -55.71 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 118.566 1.183 . . . . 2.29 112.275 -177.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.1 mmtt -87.34 -59.82 0.26 Allowed Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 123.762 0.825 . . . . 3.88 111.035 178.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -81.79 155.48 17.97 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 121.942 1.761 . . . . 1.49 109.89 174.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -124.02 60.21 1.13 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.676 1.19 . . . . 3.57 109.037 174.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 48.7 -144.46 0.42 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.318 1.047 . . . . 2.67 110.116 -174.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 40.23 30.83 0.3 Allowed Glycine 0 CA--C 1.533 1.165 0 C-N-CA 127.83 2.633 . . . . 1.37 117.527 165.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -134.62 167.41 20.87 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.857 1.663 . . . . 1.88 108.017 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -101.46 134.56 44.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.681 -0.859 . . . . 4.18 108.681 171.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.4 pt -139.22 167.68 19.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 105.055 -2.202 . . . . 2.16 105.055 168.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.8 mtm180 -126.74 122.89 36.13 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.86 -1.533 . . . . 2.63 106.86 174.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.7 m -88.56 138.12 19.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 107.691 -1.226 . . . . 3.84 107.691 177.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.0 110.4 0.58 Allowed Glycine 0 C--O 1.226 -0.393 0 N-CA-C 109.599 -1.401 . . . . 0.89 109.599 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -172.78 -161.37 23.08 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 108.862 -1.695 . . . . 0.84 108.862 -173.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.17 132.74 41.27 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 117.694 0.747 . . . . 3.65 110.843 -176.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.1 m -91.07 150.93 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-N 116.165 -0.47 . . . . 3.74 110.097 174.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.13 -179.31 0.42 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.704 0.764 . . . . 2.28 109.856 174.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.6 p -123.7 71.02 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 126.176 1.79 . . . . 2.64 107.893 175.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.33 -21.75 1.21 Allowed Glycine 0 CA--C 1.53 1.012 0 CA-C-N 114.167 -1.379 . . . . 2.46 113.93 174.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.8 m -62.12 -17.65 58.44 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.655 1.227 . . . . 1.55 113.713 -178.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.5 ttm -58.85 125.88 25.35 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 122.972 0.509 . . . . 3.09 109.87 171.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.28 130.67 67.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 107.615 -1.254 . . . . 1.87 107.615 166.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -114.46 143.59 44.69 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.599 1.159 . . . . 5.23 109.36 -177.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.49 147.05 51.76 Favored Pre-proline 0 N--CA 1.454 -0.246 0 N-CA-C 109.626 -0.509 . . . . 1.85 109.626 177.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -62.51 -25.93 76.01 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.664 2.242 . . . . 1.46 110.826 170.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -42.38 -41.64 2.93 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.572 1.549 . . . . 1.72 110.475 174.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.3 m 87.95 5.9 0.23 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 126.927 2.091 . . . . 1.51 113.064 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.84 3.79 9.45 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.011 0.924 . . . . 3.6 113.355 173.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -128.06 135.07 49.34 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 119.044 0.838 . . . . 1.45 109.633 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.2 m -149.88 138.76 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 106.928 -1.508 . . . . 1.74 106.928 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -142.11 157.93 44.33 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.46 -0.571 . . . . 1.67 109.46 174.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -156.14 152.32 27.78 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.946 -0.39 . . . . 3.25 109.946 -174.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.93 149.0 22.38 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.46 -0.57 . . . . 1.67 109.46 170.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.1 p -136.78 152.76 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.385 1.074 . . . . 3.15 108.919 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -143.01 179.5 7.0 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.43 0.692 . . . . 1.89 111.524 -174.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -137.89 -172.96 3.38 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 109.845 -0.428 . . . . 2.4 109.845 177.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.7 m -74.79 14.93 0.43 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.129 1.772 . . . . 3.42 112.369 169.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -118.74 26.6 9.44 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.327 1.051 . . . . 5.8 111.718 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 51.46 35.81 37.08 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 123.888 0.756 . . . . 3.55 111.84 174.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -117.84 130.89 9.01 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 107.802 -2.119 . . . . 1.69 107.802 -174.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -120.55 130.52 54.26 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 106.943 -1.502 . . . . 4.36 106.943 177.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -132.04 146.27 33.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.297 -1.001 . . . . 1.84 108.297 174.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 mt -101.88 128.35 48.3 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.208 1.403 . . . . 1.93 109.913 -175.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.3 t -119.33 125.83 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 124.914 1.285 . . . . 2.18 108.14 -178.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 42.3 p -95.85 152.18 18.73 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.681 0.792 . . . . 1.87 108.926 174.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -145.84 166.96 24.4 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.411 1.085 . . . . 3.9 108.733 -177.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -155.61 150.7 26.67 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 105.373 -2.084 . . . . 3.26 105.373 -169.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 62.96 61.54 1.11 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 129.299 3.039 . . . . 3.01 111.587 -176.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.3 mt 51.68 -152.32 0.23 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.552 1.141 . . . . 2.58 109.158 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.6 mt -146.57 153.69 47.59 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 105.764 -1.939 . . . . 2.0 105.764 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.84 -83.44 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 125.118 3.879 . . . . 2.64 109.853 -174.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.418 ' C ' ' H ' ' A' ' 104' ' ' PHE . 40.7 m-20 -73.75 34.09 0.08 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.34 1.456 . . . . 5.69 110.701 177.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 61.19 -22.61 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.658 1.983 . . . . 4.74 114.155 -170.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.418 ' H ' ' C ' ' A' ' 102' ' ' ASP . 64.6 t80 59.69 86.91 0.09 Allowed 'General case' 0 C--N 1.342 0.275 0 CA-C-N 120.286 1.403 . . . . 3.97 107.7 -155.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 19.8 mtp85 -82.95 127.64 33.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 105.663 -1.977 . . . . 4.87 105.663 175.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -81.37 169.33 17.35 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.101 0.477 . . . . 2.86 110.284 -170.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.15 45.67 90.76 Favored Glycine 0 CA--C 1.533 1.188 0 O-C-N 121.765 -0.585 . . . . 0.96 113.399 177.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -155.78 179.57 9.07 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.487 1.515 . . . . 3.21 107.756 175.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -94.82 133.78 11.7 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 109.625 -1.39 . . . . 0.9 109.625 170.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.4 pp -138.73 161.92 29.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 107.477 -1.305 . . . . 2.06 107.477 175.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 18.6 m -118.7 123.66 71.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.321 -0.992 . . . . 1.85 108.321 177.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -110.37 136.81 48.97 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 125.902 1.681 . . . . 1.59 109.732 -175.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -128.81 141.53 51.27 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.036 1.734 . . . . 3.08 108.612 -175.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 173.29 -121.83 0.88 Allowed Glycine 0 C--N 1.336 0.547 0 N-CA-C 109.218 -1.553 . . . . 0.9 109.218 168.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.04 153.21 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.861 -0.792 . . . . 1.89 108.861 -173.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -57.71 142.38 45.41 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.186 -0.672 . . . . 2.75 109.186 171.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -87.13 -126.27 2.15 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 109.355 -1.498 . . . . 2.51 109.355 -174.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -60.66 -64.87 0.8 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.265 0.626 . . . . 5.13 109.512 178.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -149.87 -74.08 0.17 Allowed 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 107.043 -1.465 . . . . 3.68 107.043 173.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -72.54 -39.73 55.65 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.055 -0.975 . . . . 1.96 111.626 -174.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.57 153.47 26.73 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.615 0.766 . . . . 4.79 109.699 -175.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -110.06 136.4 49.36 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 125.12 1.368 . . . . 3.21 108.275 -176.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -105.78 90.22 3.32 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.712 -1.218 . . . . 1.79 107.712 174.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.17 145.22 26.02 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 108.388 -0.968 . . . . 2.27 108.388 176.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.4 t -134.73 0.06 2.92 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.977 0.732 . . . . 2.11 112.977 169.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -129.48 99.89 5.35 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 120.669 -1.269 . . . . 2.88 109.123 171.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 29.4 m -98.69 148.27 6.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-N 118.885 0.766 . . . . 2.29 111.546 166.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.35 112.5 16.41 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.033 -1.84 . . . . 1.91 106.033 176.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -100.23 41.52 1.16 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.088 0.955 . . . . 2.4 111.482 -175.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -73.63 71.91 1.42 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.844 1.258 . . . . 5.36 111.282 -176.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -137.86 43.03 2.26 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.749 0.704 . . . . 5.02 112.697 -170.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 CA--C 1.534 0.339 0 C-N-CA 124.848 1.259 . . . . 6.0 109.598 -172.205 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 CA--C 1.539 0.52 0 N-CA-C 115.919 1.822 . . . . 6.23 115.919 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.2 t30 53.97 58.99 4.54 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.861 0.864 . . . . 9.88 112.96 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.7 mp -107.4 -112.64 0.29 Allowed 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 117.813 -1.089 . . . . 7.05 110.95 168.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.0 m-20 -70.17 94.8 0.93 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 122.792 2.542 . . . . 4.59 112.036 -129.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -129.42 163.88 24.86 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 123.935 0.894 . . . . 2.91 111.612 -167.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -82.05 132.05 35.25 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.084 0.954 . . . . 3.62 109.238 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -131.59 152.92 50.42 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.126 1.77 . . . . 5.37 108.589 176.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.9 p -94.19 143.73 26.87 Favored Pre-proline 0 N--CA 1.442 -0.853 0 C-N-CA 125.203 1.401 . . . . 3.21 108.729 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -61.57 -18.09 57.84 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.598 2.199 . . . . 1.42 112.465 178.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.0 p -47.46 -40.48 18.31 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.32 1.048 . . . . 4.92 112.181 165.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -83.11 -52.48 6.59 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.966 -1.124 . . . . 2.48 107.966 -169.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 26.8 pt -81.11 30.83 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.046 0.938 . . . . 2.0 113.126 -170.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.0 p -122.88 -44.91 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.923 1.689 . . . . 3.72 110.59 173.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -77.21 -41.6 40.72 Favored 'General case' 0 C--N 1.34 0.157 0 O-C-N 121.718 -0.614 . . . . 2.52 112.37 -162.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.04 59.66 0.13 Allowed Glycine 0 C--N 1.332 0.346 0 N-CA-C 109.439 -1.464 . . . . 2.3 109.439 -170.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -155.19 -94.48 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.522 1.929 . . . . 3.06 108.364 -178.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 97.7 m -71.95 -58.39 3.49 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 119.271 0.941 . . . . 2.56 111.877 -172.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -46.83 -53.67 11.51 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.778 0.799 . . . . 2.51 110.243 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.43 -23.8 29.83 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.747 -1.115 . . . . 2.28 111.965 -171.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.7 53.41 41.43 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.203 1.383 . . . . 1.37 111.864 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.274 31.8 m -110.13 -73.58 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 113.73 1.011 . . . . 2.41 113.73 -178.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -64.44 -56.59 21.77 Favored Pre-proline 0 CA--C 1.538 0.507 0 O-C-N 120.953 -1.092 . . . . 3.85 113.017 -176.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -87.26 159.23 8.33 Favored 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 123.391 2.728 . . . . 1.32 108.371 175.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -100.19 150.76 22.19 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.738 -0.838 . . . . 3.62 108.738 171.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.46 157.97 10.4 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.275 -0.639 . . . . 1.66 109.275 169.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.57 -0.24 70.8 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 119.041 -0.866 . . . . 1.33 113.819 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -81.39 158.97 24.46 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 119.415 1.608 . . . . 1.59 108.456 169.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 45.4 mtt180 -92.82 137.23 32.55 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.71 -0.478 . . . . 3.98 109.71 170.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.6 pt -144.7 175.07 3.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 107.482 -1.303 . . . . 2.09 107.482 167.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -121.68 124.26 43.85 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-O 119.079 -0.486 . . . . 2.72 110.236 168.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.0 p -82.59 128.5 38.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 N-CA-C 107.537 -1.283 . . . . 2.2 107.537 170.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -128.21 129.27 6.23 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 109.16 -1.576 . . . . 0.56 109.16 172.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 176.89 -150.96 10.69 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 107.576 -2.209 . . . . 0.77 107.576 -175.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.8 ppp? -125.27 155.6 39.89 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 118.473 1.136 . . . . 5.57 111.843 177.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.8 p -100.97 131.73 48.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 114.471 -1.241 . . . . 3.4 109.799 -174.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.11 159.54 20.18 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 122.228 1.013 . . . . 2.26 109.509 174.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.9 p -67.56 -34.31 67.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.859 1.264 . . . . 2.49 112.89 -175.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -120.86 84.07 0.37 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 108.956 -1.658 . . . . 2.06 108.956 175.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.3 m -140.29 -43.96 0.41 Allowed 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.909 0.884 . . . . 1.71 112.322 -176.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.16 109.77 3.19 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.567 0.747 . . . . 2.98 110.184 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.8 m -111.33 117.24 54.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 107.417 -1.327 . . . . 1.79 107.417 169.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.95 140.06 42.96 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.86 1.264 . . . . 7.19 109.416 -176.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -82.13 149.31 62.22 Favored Pre-proline 0 N--CA 1.455 -0.221 0 N-CA-C 108.903 -0.777 . . . . 1.78 108.903 176.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -66.11 -20.89 56.47 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.497 2.131 . . . . 1.76 110.227 167.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -41.53 -43.36 2.65 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 123.75 0.82 . . . . 1.2 109.415 163.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.8 m 73.49 4.2 4.74 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.055 1.342 . . . . 1.54 112.905 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.2 18.44 10.72 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.882 1.673 . . . . 2.89 110.539 173.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 48.9 m-70 -150.79 119.21 6.42 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.478 -1.675 . . . . 1.35 106.478 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.7 m -148.54 135.95 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 105.974 -1.861 . . . . 1.97 105.974 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -138.78 152.34 47.83 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 119.853 1.206 . . . . 1.15 110.799 -177.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -149.33 153.11 36.97 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.28 0.632 . . . . 3.16 109.693 -172.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.59 147.41 23.94 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.637 0.775 . . . . 2.1 109.414 169.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.0 t -124.55 146.61 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 N-CA-C 107.429 -1.323 . . . . 2.91 107.429 169.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -150.9 -167.06 2.71 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 108.603 -0.888 . . . . 1.67 108.603 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -150.65 177.73 9.78 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 107.871 -1.159 . . . . 3.57 107.871 166.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.8 t -45.57 122.53 3.66 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.362 -1.347 . . . . 3.76 107.362 150.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -0.59 40.36 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 131.533 3.933 . . . . 7.15 116.539 -145.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -84.83 51.2 4.52 Favored Glycine 0 CA--C 1.524 0.629 0 O-C-N 120.814 -1.179 . . . . 6.15 110.402 169.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 42.09 -122.21 2.85 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.973 1.273 . . . . 2.22 113.002 176.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -171.01 156.72 4.96 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.689 1.996 . . . . 2.57 106.81 168.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.5 tp -151.18 162.17 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.834 1.254 . . . . 2.41 108.19 172.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mt -124.25 131.21 53.51 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 124.545 1.138 . . . . 2.15 109.928 -176.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.6 p -135.16 142.17 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.822 0.849 . . . . 4.25 110.166 -174.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.6 p -105.28 153.46 21.57 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.172 1.389 . . . . 1.85 108.973 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -141.43 138.93 33.27 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.268 -1.753 . . . . 3.56 106.268 178.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -128.45 39.43 3.82 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.249 1.02 . . . . 2.2 112.138 -165.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -166.22 56.93 0.1 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.945 0.898 . . . . 2.9 110.934 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.8 mp 51.95 -168.35 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.911 1.284 . . . . 2.12 111.366 -170.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.2 mt -148.34 150.69 35.11 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.286 1.434 . . . . 2.31 107.215 174.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -62.16 132.75 40.41 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 123.413 2.742 . . . . 2.69 109.746 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 37.3 49.25 0.9 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.391 1.877 . . . . 4.36 111.645 -173.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 56.72 10.69 0.76 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 128.73 2.812 . . . . 3.12 115.518 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.6 t80 64.73 99.79 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.788 1.235 . . . . 4.02 108.134 -162.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 46.0 mtt180 -77.44 131.44 37.99 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.441 -1.688 . . . . 5.97 106.441 172.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -83.58 170.72 14.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.102 0.561 . . . . 4.59 109.6 -176.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.42 46.9 91.57 Favored Glycine 0 CA--C 1.531 1.058 0 O-C-N 121.924 -0.485 . . . . 0.9 112.826 174.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -151.7 179.07 8.73 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.895 1.678 . . . . 2.69 108.555 178.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -111.24 142.97 17.11 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.2 -0.76 . . . . 1.03 111.2 171.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.4 pp -145.84 168.97 6.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 125.498 1.519 . . . . 2.09 106.917 -178.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.0 m -120.77 138.73 50.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 N-CA-C 108.011 -1.107 . . . . 1.71 108.011 167.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -127.28 118.17 23.7 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 124.627 1.171 . . . . 1.47 109.439 -176.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.67 132.86 52.88 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.197 1.399 . . . . 3.37 108.639 -175.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 178.47 -160.75 26.93 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 120.858 -0.687 . . . . 1.26 112.308 -177.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.6 p -123.52 138.39 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 125.114 1.365 . . . . 2.17 110.121 -169.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.8 mp -68.56 138.8 55.42 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.768 -0.583 . . . . 3.5 111.027 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -95.98 -114.9 2.98 Favored Glycine 0 C--N 1.341 0.809 0 N-CA-C 109.943 -1.263 . . . . 2.09 109.943 -166.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -46.82 -55.92 7.12 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 117.876 0.838 . . . . 4.36 112.318 175.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 176.25 -79.08 0.0 OUTLIER 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 128.004 2.522 . . . . 3.47 105.251 -174.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.5 -25.13 76.16 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.601 1.096 . . . . 2.16 112.679 -174.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.55 152.47 21.68 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.528 1.531 . . . . 3.37 109.572 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.0 mp -117.8 156.53 28.19 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.08 0.552 . . . . 3.29 109.911 -178.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -120.07 107.42 13.03 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.065 1.346 . . . . 1.87 107.979 173.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.24 132.9 41.99 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 118.951 -0.547 . . . . 1.91 110.743 -175.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.3 t -122.2 4.4 9.78 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.38 0.672 . . . . 2.23 112.473 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -113.1 79.55 1.25 Allowed 'General case' 0 CA--C 1.531 0.229 0 O-C-N 120.587 -1.321 . . . . 2.58 109.361 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.1 m -95.41 132.42 39.53 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 C-N-CA 122.918 0.487 . . . . 1.65 110.325 174.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.06 107.13 14.14 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.245 -1.761 . . . . 1.84 106.245 175.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.52 105.4 13.54 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.194 -1.039 . . . . 1.78 108.194 175.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -121.68 71.21 0.97 Allowed 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.84 0.856 . . . . 3.76 109.618 -176.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -148.16 161.7 40.91 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.082 -1.451 . . . . 4.97 107.082 178.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 66.0 t0 . . . . . 0 N--CA 1.45 -0.468 0 N-CA-C 108.05 -1.093 . . . . 6.18 108.05 174.037 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.2 m . . . . . 0 N--CA 1.454 -0.234 0 N-CA-C 106.975 -1.491 . . . . 6.73 106.975 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -84.41 163.07 19.73 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.248 -0.649 . . . . 8.15 109.248 176.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.8 mp -108.69 138.83 44.38 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 107.341 -1.355 . . . . 7.43 107.341 170.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -129.8 90.42 2.97 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 107.638 -1.245 . . . . 5.4 107.638 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -136.41 175.28 9.75 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.57 0.748 . . . . 3.67 111.087 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -83.68 120.26 25.78 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.782 1.233 . . . . 3.83 109.695 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -116.17 163.33 16.12 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.615 1.566 . . . . 4.12 109.705 177.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.8 m -84.91 132.89 44.54 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 109.306 -0.628 . . . . 3.02 109.306 -174.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -56.45 -45.33 38.22 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 123.191 2.594 . . . . 0.95 111.741 -176.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.0 t -61.74 -23.35 66.1 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.351 -0.843 . . . . 3.1 112.341 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -66.74 -45.94 77.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.926 -1.138 . . . . 3.32 107.926 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.388 18.6 pt -65.56 -11.68 12.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 114.233 1.197 . . . . 2.23 114.233 -177.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -79.68 -30.83 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.409 0.683 . . . . 3.15 112.266 169.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -81.26 -76.4 0.25 Allowed 'General case' 0 N--CA 1.466 0.354 0 O-C-N 121.087 -1.008 . . . . 3.08 112.968 -162.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -133.34 51.26 0.85 Allowed Glycine 0 C--N 1.333 0.415 0 N-CA-C 108.055 -2.018 . . . . 3.47 108.055 -174.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.8 mmtt -147.04 -114.03 0.08 Allowed 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 125.669 1.588 . . . . 5.04 108.483 -164.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.0 m -77.12 -55.83 5.1 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 119.401 1.0 . . . . 2.19 110.877 -169.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -44.3 -59.82 2.21 Favored 'General case' 0 C--N 1.341 0.204 0 O-C-N 123.87 0.732 . . . . 3.09 110.459 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.9 m -84.47 -16.11 43.65 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.216 -0.902 . . . . 2.63 110.907 -174.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 65.19 50.44 56.79 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 124.077 0.846 . . . . 1.33 112.36 170.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.9 m -106.3 -54.31 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 117.832 0.816 . . . . 2.37 112.982 -175.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -90.06 -62.02 0.21 Allowed Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 123.645 0.778 . . . . 6.41 112.242 -176.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -80.34 170.77 15.72 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.795 2.33 . . . . 1.53 108.096 170.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.412 ' H ' ' NE2' ' A' ' 58' ' ' GLN . 22.4 tt0 -128.53 160.24 32.98 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.593 -1.632 . . . . 3.5 106.593 168.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.38 156.78 37.11 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.135 -1.061 . . . . 2.4 108.135 171.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.49 10.85 60.12 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.093 0.854 . . . . 1.04 112.316 -173.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.412 ' NE2' ' H ' ' A' ' 55' ' ' GLU . 33.5 mt-30 -110.13 149.52 29.94 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 118.195 0.997 . . . . 1.74 109.598 177.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.12 119.11 35.0 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.688 1.195 . . . . 5.31 108.0 -177.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.5 pt -143.6 179.33 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 107.881 -1.155 . . . . 1.99 107.881 177.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.3 mtt-85 -126.81 141.26 51.87 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.683 -1.229 . . . . 3.65 107.683 172.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.4 p -108.6 132.46 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 106.827 -1.546 . . . . 1.92 106.827 176.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.2 124.27 2.75 Favored Glycine 0 C--N 1.334 0.44 0 N-CA-C 109.719 -1.352 . . . . 0.52 109.719 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 179.67 -156.95 19.47 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 107.906 -2.077 . . . . 0.64 107.906 -176.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -104.66 134.6 47.55 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 118.315 1.058 . . . . 5.74 110.646 -172.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.8 m -79.92 141.04 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.736 -0.665 . . . . 3.43 109.408 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.0 m -76.87 133.61 39.26 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.802 -0.814 . . . . 2.39 108.802 172.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.1 p -45.92 -51.24 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 125.651 1.58 . . . . 2.39 112.2 177.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.63 61.74 1.18 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.296 -1.122 . . . . 2.03 110.296 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.1 m -154.83 53.15 0.64 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.589 1.194 . . . . 2.26 112.718 -176.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.14 104.88 5.34 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 107.725 -1.213 . . . . 2.54 107.725 174.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.1 m -123.6 135.13 64.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 109.17 -0.678 . . . . 1.8 109.17 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.38 147.4 50.27 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.714 1.605 . . . . 6.74 110.496 -172.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -75.79 157.19 84.15 Favored Pre-proline 0 CA--C 1.529 0.172 0 C-N-CA 122.788 0.435 . . . . 2.56 110.525 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -66.5 -19.85 54.51 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 123.032 2.488 . . . . 1.47 111.762 166.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -50.16 -35.23 25.28 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.105 0.562 . . . . 1.82 110.573 163.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.6 m 71.07 18.46 5.86 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.728 1.611 . . . . 2.07 112.813 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.18 -45.45 2.11 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 125.352 1.461 . . . . 3.67 111.429 170.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -78.46 131.66 36.96 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 107.302 -1.37 . . . . 2.13 107.302 -177.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.6 m -147.02 147.52 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 107.784 -1.191 . . . . 1.95 107.784 -174.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -149.71 156.79 42.45 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.54 -0.725 . . . . 1.78 110.217 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -154.09 161.01 42.21 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.401 -0.818 . . . . 3.46 109.93 -173.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -105.98 138.66 41.78 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.879 -0.785 . . . . 1.65 108.879 174.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 t -121.19 142.0 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 107.678 -1.23 . . . . 3.13 107.678 176.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -144.09 -175.72 4.72 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.02 -0.733 . . . . 2.42 109.02 177.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -140.29 179.23 6.76 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.054 -0.721 . . . . 2.62 109.054 165.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 55.8 p -48.28 -28.9 3.38 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.903 2.081 . . . . 3.92 111.707 171.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 15.0 mt -68.27 -5.2 17.2 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.662 1.185 . . . . 5.84 112.853 177.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.32 -39.6 2.78 Favored Glycine 0 C--N 1.337 0.61 0 O-C-N 121.587 -0.696 . . . . 3.31 111.971 166.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.1 136.21 43.19 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.912 -0.875 . . . . 1.86 110.912 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -123.36 150.78 43.25 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.435 1.894 . . . . 4.42 107.533 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 11.3 tp -146.34 146.39 19.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 122.986 0.514 . . . . 2.39 110.041 174.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.4 mt -91.05 137.26 32.5 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.452 1.101 . . . . 2.03 110.61 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.3 t -127.3 129.47 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 126.214 1.806 . . . . 2.28 107.636 -178.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 44.2 p -107.98 145.19 34.23 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.766 1.226 . . . . 1.59 109.463 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -138.7 126.89 22.74 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.685 1.594 . . . . 3.14 107.277 -175.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -108.36 44.62 1.1 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.817 1.247 . . . . 1.94 112.331 -170.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -170.7 171.98 5.98 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.593 1.957 . . . . 3.06 107.733 172.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.2 mp -66.46 137.63 56.97 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.579 -0.701 . . . . 2.29 110.661 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 19.2 mt -76.21 159.0 81.18 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.224 0.609 . . . . 2.82 109.465 176.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -64.83 -88.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.59 2.86 . . . . 2.01 109.843 170.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.6 29.4 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.171 1.388 . . . . 3.53 113.011 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 50.7 1.66 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 115.923 1.823 . . . . 3.06 115.923 -168.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 26.6 t80 58.58 93.98 0.03 OUTLIER 'General case' 0 C--N 1.342 0.281 0 C-N-CA 124.652 1.181 . . . . 4.34 109.135 -156.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 26.8 mtp85 -77.78 157.43 29.99 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 107.095 -1.446 . . . . 4.82 107.095 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -83.93 119.99 25.55 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.388 -0.968 . . . . 4.36 108.388 -169.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.3 68.02 1.73 Allowed Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.458 1.028 . . . . 1.14 113.09 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -156.64 62.61 0.53 Allowed 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 124.141 0.976 . . . . 3.34 110.519 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -27.66 119.56 0.05 OUTLIER Glycine 0 CA--C 1.529 0.93 0 C-N-CA 126.028 1.775 . . . . 1.76 114.997 -166.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.6 pp -121.68 167.88 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 108.602 -0.888 . . . . 1.78 108.602 -173.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.8 m -117.66 134.41 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.583 -0.895 . . . . 1.84 108.583 177.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -122.72 136.25 54.82 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.84 1.656 . . . . 1.41 108.623 -175.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -119.81 144.95 47.05 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.327 1.451 . . . . 4.35 108.942 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 162.82 -147.84 14.1 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 110.132 -1.187 . . . . 0.92 110.132 173.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.9 p -126.13 136.53 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 123.435 0.694 . . . . 1.77 109.801 -166.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.9 mp -80.92 153.43 27.56 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.901 -1.518 . . . . 3.61 106.901 175.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -172.21 -47.65 0.04 OUTLIER Glycine 0 C--N 1.333 0.394 0 C-N-CA 119.584 -1.293 . . . . 2.53 112.88 -178.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -62.33 158.66 16.88 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.832 -0.803 . . . . 4.77 108.832 172.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -81.5 64.0 6.04 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 122.218 1.009 . . . . 4.74 108.297 -175.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 116.07 17.93 6.11 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 126.04 1.781 . . . . 1.81 113.749 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.31 156.09 49.07 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.004 1.402 . . . . 3.55 109.591 169.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.1 mt -114.67 141.52 47.69 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.326 0.65 . . . . 3.16 110.432 -173.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -101.22 104.47 15.52 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.4 -0.963 . . . . 1.68 108.4 175.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -128.66 117.6 21.48 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 123.131 0.572 . . . . 1.5 109.78 -177.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.2 t -110.59 -6.61 14.83 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.338 1.055 . . . . 2.09 111.614 177.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -99.54 89.59 4.21 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.658 -1.277 . . . . 3.91 108.375 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.9 m -106.76 133.92 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 121.829 2.104 . . . . 1.77 111.848 175.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -123.36 104.25 8.99 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.771 1.228 . . . . 2.1 108.626 -175.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.34 59.89 3.58 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.493 -0.754 . . . . 1.85 110.832 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.34 -24.29 61.27 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.209 0.818 . . . . 4.18 113.209 -175.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -79.9 57.03 2.48 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.019 0.928 . . . . 6.17 110.546 -178.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.2 t70 . . . . . 0 CA--C 1.532 0.263 0 CA-C-O 121.535 0.683 . . . . 5.49 109.858 174.401 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.455 -0.19 0 N-CA-C 108.076 -1.083 . . . . 6.91 108.076 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.64 119.73 31.78 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 109.335 -0.617 . . . . 7.51 109.335 -176.128 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.0 tp -66.52 128.65 37.03 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 107.422 -1.325 . . . . 7.28 107.422 169.508 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -161.02 93.1 0.95 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.926 1.239 . . . . 4.44 112.297 173.406 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -141.98 164.34 30.43 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.283 0.947 . . . . 2.77 112.365 -175.345 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -83.1 119.21 24.22 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 125.168 1.387 . . . . 4.06 109.267 176.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.59 159.19 19.89 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.195 0.998 . . . . 3.58 110.808 178.889 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.36 144.01 91.4 Favored Pre-proline 0 N--CA 1.451 -0.402 0 C-N-CA 123.783 0.833 . . . . 2.58 109.313 175.019 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.52 -45.58 4.84 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.636 2.224 . . . . 1.21 111.031 179.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.5 p -45.28 -46.39 12.64 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.412 1.485 . . . . 2.88 112.34 -179.588 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.84 -57.1 10.31 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.071 -1.085 . . . . 3.62 108.071 179.589 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 31.2 pt -73.18 30.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 113.712 1.004 . . . . 1.91 113.712 -171.56 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.6 t -120.13 -18.5 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.682 1.993 . . . . 3.22 111.837 173.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -139.57 91.63 2.5 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.945 1.248 . . . . 2.49 111.826 -170.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.4 46.66 68.48 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 109.99 -1.244 . . . . 2.09 109.99 176.168 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -146.42 -139.52 0.1 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 104.404 -2.443 . . . . 6.04 104.404 172.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 94.5 m -52.19 -54.13 34.65 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 117.197 -1.383 . . . . 2.76 114.599 -178.413 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -36.36 -56.63 0.77 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.856 1.207 . . . . 2.55 111.321 174.21 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.61 -7.71 59.45 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 113.895 -1.502 . . . . 2.59 111.268 -171.409 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 56.74 35.9 69.74 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.325 1.44 . . . . 1.15 112.373 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.8 m -89.44 -42.54 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 117.893 0.847 . . . . 2.19 110.979 -178.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.7 mmtt -81.39 -63.88 0.3 Allowed Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 118.325 -0.845 . . . . 4.11 112.55 176.324 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -81.79 152.47 17.07 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.533 1.489 . . . . 2.31 110.168 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -100.4 43.05 1.08 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.261 1.424 . . . . 3.82 109.493 175.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 33.14 59.88 0.45 Allowed 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 127.232 2.213 . . . . 2.29 115.459 177.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.42 30.86 0.2 Allowed Glycine 0 CA--C 1.524 0.639 0 CA-C-N 113.757 -1.565 . . . . 2.69 112.664 177.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -121.98 154.06 37.71 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.193 0.997 . . . . 2.89 109.522 -176.118 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 13.9 ttp85 -96.82 114.07 25.67 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.101 -1.074 . . . . 5.72 108.101 -178.344 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.7 pt -132.99 178.15 6.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 C-N-CA 124.271 1.028 . . . . 2.03 109.158 -176.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -136.12 150.68 49.2 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.087 -1.079 . . . . 2.38 108.087 174.095 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.33 143.63 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.821 1.248 . . . . 2.18 107.734 177.243 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.91 123.23 1.81 Allowed Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.363 -1.095 . . . . 0.55 110.363 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -178.63 -171.36 41.81 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 109.573 -1.411 . . . . 0.69 109.573 -177.237 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.41 135.36 33.36 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.936 0.874 . . . . 3.5 110.945 178.193 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.98 131.02 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 114.99 -1.004 . . . . 3.7 108.295 167.36 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.2 m -37.77 -82.75 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 126.531 1.932 . . . . 3.26 113.128 176.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.6 p 175.84 -40.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.511 1.124 . . . . 3.57 109.497 179.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -142.45 25.34 2.31 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.923 -0.376 . . . . 1.75 112.181 179.638 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.3 m -84.21 -8.86 58.93 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 117.756 0.778 . . . . 2.01 112.461 -178.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.1 tpt -68.29 115.06 7.31 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.803 0.841 . . . . 2.67 108.85 176.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.1 m -125.84 135.61 63.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 108.363 -0.977 . . . . 1.74 108.363 171.535 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 ptm85 -128.0 133.08 49.12 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.719 1.208 . . . . 7.53 108.515 -171.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -85.36 146.23 44.27 Favored Pre-proline 0 C--O 1.234 0.287 0 N-CA-C 108.767 -0.827 . . . . 2.19 108.767 -176.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -70.69 12.97 0.38 Allowed 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.893 2.395 . . . . 1.49 113.703 178.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -75.95 -29.91 58.47 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.246 0.618 . . . . 1.12 109.655 163.415 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 m 85.47 -18.91 0.34 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.821 2.048 . . . . 1.8 112.757 -174.049 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -104.91 8.78 34.74 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.487 1.115 . . . . 3.12 113.093 -172.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 -133.55 126.81 31.82 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.334 -1.358 . . . . 1.4 107.334 172.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.93 125.3 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.001 -1.851 . . . . 2.06 106.001 -175.769 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -137.85 146.44 43.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 119.683 1.128 . . . . 0.96 109.713 179.401 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -142.89 152.36 42.02 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.008 -0.738 . . . . 3.21 109.008 -174.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.86 150.77 24.55 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.452 -0.573 . . . . 1.67 109.452 171.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.9 p -143.43 147.27 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.246 1.018 . . . . 2.99 108.331 -171.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -153.93 -179.88 8.26 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 112.136 0.421 . . . . 2.38 112.136 -174.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.69 7.6 4.46 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.912 0.885 . . . . 2.49 110.736 176.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.4 m 46.83 38.44 6.0 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.359 1.063 . . . . 5.64 112.122 -173.289 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.3 -82.04 0.64 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.827 1.251 . . . . 5.49 108.516 178.313 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -88.72 -31.51 12.74 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.002 0.811 . . . . 4.87 113.25 -174.328 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 164.53 -169.14 39.17 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 118.029 0.915 . . . . 2.72 111.065 -178.122 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -116.27 145.77 42.89 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.995 2.118 . . . . 3.5 107.731 175.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.3 tp -128.46 159.04 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 123.845 0.858 . . . . 2.3 109.35 175.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.3 mt -109.42 138.16 46.2 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.552 1.141 . . . . 1.62 110.873 -176.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.34 124.79 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 125.987 1.715 . . . . 1.89 107.383 -178.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.9 p -101.72 135.68 42.84 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.71 -0.848 . . . . 1.46 108.71 176.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -128.76 163.39 25.27 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.283 2.233 . . . . 3.68 107.997 -176.083 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -159.92 156.45 27.27 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 105.299 -2.111 . . . . 3.44 105.299 -170.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 60.16 66.81 0.92 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 130.26 3.424 . . . . 2.97 111.854 -169.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 51.65 -160.52 0.09 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.176 0.99 . . . . 2.26 109.902 -178.296 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.9 mt -145.14 157.39 53.7 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 104.555 -2.387 . . . . 2.33 104.555 175.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.01 -88.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.923 2.415 . . . . 2.21 109.585 178.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -78.07 46.82 0.62 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.366 1.066 . . . . 3.25 109.957 179.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 45.55 -2.62 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 129.437 3.095 . . . . 2.99 117.787 -171.366 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 58.2 t80 56.58 88.51 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.619 1.167 . . . . 4.08 108.858 -153.195 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 22.3 mtp-105 -79.88 155.77 27.63 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.593 -1.262 . . . . 5.81 107.593 172.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -89.88 156.44 18.46 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.139 1.376 . . . . 3.35 111.183 -170.031 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 52.15 47.38 55.29 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.274 0.94 . . . . 0.92 112.935 175.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.06 101.18 2.07 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 105.518 -2.03 . . . . 2.99 105.518 -178.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -60.87 138.61 48.09 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.714 -0.554 . . . . 1.03 111.714 -169.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.2 pp -136.75 174.71 11.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 124.25 1.02 . . . . 2.13 108.778 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.4 m -122.6 145.83 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 108.83 -0.804 . . . . 1.81 108.83 175.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -135.05 127.65 30.8 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.9 1.28 . . . . 1.74 109.501 -174.257 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -113.38 141.52 46.96 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.072 1.349 . . . . 2.96 109.628 -178.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 175.05 -136.39 3.42 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 110.919 -0.872 . . . . 0.85 110.919 164.11 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.0 p -129.62 151.3 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 123.632 0.773 . . . . 1.65 109.466 -167.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -54.55 135.5 46.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.407 -0.815 . . . . 3.19 110.714 172.084 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -94.41 -115.55 2.7 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 109.448 -1.461 . . . . 2.13 109.448 179.049 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -56.63 -55.75 30.0 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.121 0.969 . . . . 4.54 111.135 179.042 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.8 p30 179.98 -65.82 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 127.755 2.422 . . . . 4.1 107.718 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.16 -38.2 35.35 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.353 -0.699 . . . . 1.72 111.353 178.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.54 138.55 34.25 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 117.554 0.677 . . . . 3.08 110.85 -175.323 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -103.28 123.58 47.05 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 124.29 1.036 . . . . 3.46 108.506 -175.331 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.6 97.29 10.95 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.384 -0.969 . . . . 1.58 108.384 176.463 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -118.77 119.11 33.43 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 108.804 -0.813 . . . . 1.51 108.804 -177.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.8 t -117.87 10.69 13.27 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.867 0.867 . . . . 2.35 111.168 176.55 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -119.03 90.02 3.25 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 120.78 -1.2 . . . . 2.99 109.148 170.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.7 m -91.68 137.1 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 118.949 0.795 . . . . 1.94 110.018 168.19 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -118.2 120.96 39.28 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.541 -1.652 . . . . 1.94 106.541 173.021 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.05 121.47 27.07 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.884 -1.154 . . . . 2.42 107.884 171.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -130.84 25.36 5.0 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.118 0.567 . . . . 4.64 111.564 -179.674 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -154.28 82.12 1.12 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.672 -0.862 . . . . 5.68 108.672 -172.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.454 -0.264 0 N-CA-C 107.764 -1.198 . . . . 6.57 107.764 178.895 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 CA--C 1.532 0.258 0 N-CA-C 112.173 0.435 . . . . 7.17 112.173 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -153.72 -55.06 0.11 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.336 0.655 . . . . 10.47 110.101 -175.08 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 tt 54.82 57.44 5.67 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.168 1.387 . . . . 6.43 111.284 173.521 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -159.1 102.29 1.61 Allowed 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.738 -0.601 . . . . 4.01 111.987 -172.264 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -140.61 163.27 33.31 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 119.362 0.983 . . . . 2.76 112.695 -174.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -81.59 127.66 33.11 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.245 1.018 . . . . 3.28 109.871 -178.123 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -129.67 157.46 42.06 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.571 1.949 . . . . 4.0 109.065 177.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.4 p -94.01 149.37 36.81 Favored Pre-proline 0 N--CA 1.446 -0.667 0 C-N-CA 124.455 1.102 . . . . 2.88 108.6 179.206 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.26 -31.85 58.06 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.638 2.225 . . . . 1.32 112.342 174.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -46.71 -43.63 18.06 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.509 0.724 . . . . 3.25 111.827 171.268 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -76.85 -7.31 55.25 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.796 -0.565 . . . . 2.33 111.857 -175.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.3 pt -124.92 40.56 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 125.696 1.599 . . . . 2.35 110.164 176.018 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.5 p -124.27 -60.7 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 CA-C-O 121.543 0.687 . . . . 3.61 112.022 160.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -83.51 73.37 10.21 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 120.324 -1.485 . . . . 2.16 112.137 -162.504 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.79 70.93 1.09 Allowed Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.832 -1.307 . . . . 2.35 109.832 176.73 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.78 -123.06 0.06 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.05 -1.833 . . . . 4.07 106.05 175.744 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 t -63.91 -37.16 86.39 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 118.396 0.543 . . . . 2.82 110.871 -172.578 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -43.27 -42.48 4.42 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 127.058 2.143 . . . . 4.43 112.079 177.278 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.2 m -116.28 9.52 14.56 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.852 1.261 . . . . 3.07 109.991 -175.256 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 45.73 33.66 4.93 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.597 1.57 . . . . 1.31 113.667 -173.58 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.1 m -81.56 -25.75 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 119.076 1.438 . . . . 2.45 111.872 -173.073 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -121.44 -75.46 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.226 0 C-N-CA 123.922 0.889 . . . . 4.51 111.137 177.274 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -75.57 121.47 6.38 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 CA-C-N 120.48 1.207 . . . . 1.19 109.192 177.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -69.04 158.36 34.95 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.483 -0.562 . . . . 3.3 109.483 169.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.36 167.66 5.15 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.719 0.808 . . . . 2.54 110.801 174.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.3 11.31 79.58 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 119.589 -0.562 . . . . 1.12 113.589 178.187 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -95.02 147.69 23.13 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.442 1.121 . . . . 1.92 109.646 175.076 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.19 125.1 31.87 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 107.261 -1.385 . . . . 4.8 107.261 177.265 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.2 pt -140.7 176.93 4.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 107.796 -1.187 . . . . 2.03 107.796 168.091 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.0 mtt180 -130.75 127.08 38.02 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.696 -0.853 . . . . 3.13 108.696 173.616 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.5 p -92.28 127.32 44.56 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.076 0 N-CA-C 108.239 -1.023 . . . . 1.98 108.239 177.537 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -122.24 127.86 6.96 Favored Glycine 0 C--N 1.333 0.397 0 N-CA-C 110.317 -1.113 . . . . 0.87 110.317 177.314 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.49 -164.03 32.91 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 117.751 0.776 . . . . 0.91 111.294 -177.037 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.56 127.6 52.33 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.108 0.963 . . . . 3.59 109.99 -175.183 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.5 t -59.49 139.49 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 106.971 -1.492 . . . . 3.11 106.971 169.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 57.2 m -50.9 -79.93 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.198 0.599 . . . . 3.34 112.059 -176.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.1 p 172.42 -39.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 126.175 1.79 . . . . 2.67 108.286 -176.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -149.39 28.55 1.21 Allowed Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.982 -0.343 . . . . 2.38 112.345 176.059 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.3 m -86.59 4.34 40.59 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 117.713 0.757 . . . . 1.51 111.983 176.096 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.79 110.35 2.79 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.878 -1.156 . . . . 2.57 107.878 172.927 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.9 m -118.14 111.83 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 107.396 -1.335 . . . . 2.13 107.396 170.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -98.73 148.96 23.34 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.347 1.059 . . . . 6.23 110.678 175.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -84.72 151.74 58.75 Favored Pre-proline 0 C--O 1.235 0.294 0 N-CA-C 109.088 -0.708 . . . . 2.32 109.088 173.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.02 25.86 0.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.663 2.242 . . . . 1.9 112.861 168.434 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -87.62 -24.61 23.9 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.822 0.849 . . . . 1.47 108.746 163.325 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 m 67.97 11.34 8.32 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.353 1.461 . . . . 1.87 112.486 -175.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.0 pp -127.37 3.1 6.3 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.655 1.582 . . . . 2.76 112.323 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -136.65 135.68 38.47 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.071 1.348 . . . . 1.74 109.301 -178.634 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.07 130.08 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 107.659 -1.237 . . . . 2.0 107.659 -170.358 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -135.81 156.2 49.16 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 119.49 1.041 . . . . 1.62 110.195 173.559 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -150.25 144.21 25.45 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.935 -0.575 . . . . 3.47 110.382 -173.351 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.49 130.16 35.87 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.857 -0.794 . . . . 1.7 108.857 173.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.6 t -110.24 130.8 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 106.399 -1.704 . . . . 2.89 106.399 174.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -157.7 157.28 33.2 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 118.618 -0.706 . . . . 4.1 109.277 -179.736 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -148.48 168.15 23.47 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.952 0.901 . . . . 5.87 109.556 171.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.3 t -30.82 -55.81 0.21 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.729 2.412 . . . . 4.66 111.761 173.155 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -113.03 -13.61 13.07 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.154 0.982 . . . . 5.89 111.244 174.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.92 60.68 4.15 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.727 -0.949 . . . . 6.4 110.727 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 28.84 -127.42 0.08 OUTLIER Glycine 0 CA--C 1.528 0.857 0 C-N-CA 127.163 2.316 . . . . 2.27 114.371 173.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -165.88 139.31 4.31 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 104.956 -2.238 . . . . 4.2 104.956 167.231 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.6 tp -154.81 152.78 8.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 119.102 0.865 . . . . 2.11 110.461 172.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.5 mt -100.18 122.74 43.49 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.287 1.035 . . . . 1.62 110.594 -179.475 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.0 t -109.74 127.49 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 124.983 1.313 . . . . 2.07 107.8 -177.752 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.6 p -104.81 144.84 31.2 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.779 0.832 . . . . 1.81 109.585 179.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -142.78 163.27 33.25 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.981 1.712 . . . . 3.53 107.823 -174.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -148.79 146.22 27.92 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 127.742 2.417 . . . . 3.64 105.365 -174.535 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 67.87 60.84 0.43 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 129.661 3.185 . . . . 2.84 112.147 -171.403 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 mt 54.41 -169.6 0.06 Allowed 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 125.553 1.541 . . . . 3.51 111.375 176.506 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.0 mt -143.67 148.94 45.11 Favored Pre-proline 0 C--O 1.233 0.227 0 N-CA-C 106.657 -1.609 . . . . 2.36 106.657 179.374 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -64.33 111.29 1.58 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.898 2.399 . . . . 3.04 109.273 -176.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 42.09 46.69 3.75 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.252 1.421 . . . . 4.61 111.121 -174.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 48.79 11.41 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 116.246 1.943 . . . . 3.83 116.246 -176.127 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 53.38 115.92 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 123.52 0.728 . . . . 6.19 109.546 -148.059 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -74.41 113.81 12.07 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.638 -1.616 . . . . 6.42 106.638 -176.453 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -74.83 133.77 41.84 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 118.44 -1.304 . . . . 3.95 112.277 -126.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.54 53.52 3.38 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.638 1.114 . . . . 1.76 111.55 -176.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.0 54.97 1.9 Allowed 'General case' 0 C--N 1.341 0.224 0 CA-C-N 117.5 0.65 . . . . 3.8 112.021 -172.394 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -9.73 124.36 0.01 OUTLIER Glycine 0 CA--C 1.533 1.191 0 C-N-CA 128.723 3.058 . . . . 1.39 116.66 -163.735 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.7 pp -134.63 169.19 22.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 O-C-N 121.455 -1.027 . . . . 2.15 110.056 -172.761 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.6 m -121.37 139.38 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 108.718 -0.845 . . . . 1.98 108.718 175.029 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -128.34 121.0 28.14 Favored 'General case' 0 N--CA 1.458 -0.052 0 C-N-CA 125.013 1.325 . . . . 1.44 108.831 -176.568 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -103.81 142.45 34.35 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.541 0.736 . . . . 4.04 109.572 -179.341 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 171.59 -141.33 6.33 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.653 -0.979 . . . . 1.19 110.653 169.367 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.0 p -129.72 149.24 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 109.311 -0.625 . . . . 1.91 109.311 -168.42 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -56.05 132.35 49.89 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 119.666 -0.814 . . . . 3.57 109.523 170.716 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -80.29 -124.6 0.55 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 109.391 -1.484 . . . . 2.04 109.391 177.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -70.9 -67.67 0.49 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.945 -0.391 . . . . 5.2 109.945 -174.461 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -167.31 102.27 0.52 Allowed 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.177 -1.416 . . . . 3.18 107.177 174.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 104.34 -30.01 10.92 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.096 0.855 . . . . 1.31 111.778 176.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -82.39 135.52 35.15 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.902 -0.764 . . . . 3.55 109.29 175.02 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -104.99 114.75 29.13 Favored 'General case' 0 CA--C 1.526 0.04 0 N-CA-C 108.385 -0.969 . . . . 3.25 108.385 -178.602 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -90.5 106.45 18.51 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 108.053 -1.091 . . . . 1.83 108.053 179.684 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -143.26 89.8 2.12 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 113.361 0.875 . . . . 1.96 113.361 -166.7 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.7 t -88.62 -15.17 35.69 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.673 0.99 . . . . 2.09 113.673 -179.414 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -84.98 85.98 7.43 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 119.597 -1.939 . . . . 3.38 107.871 176.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.1 m -100.7 130.37 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 119.73 1.15 . . . . 1.98 111.941 177.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.81 135.08 55.0 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.989 -1.115 . . . . 2.34 107.989 179.241 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -119.78 84.58 2.23 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 124.868 1.267 . . . . 2.12 109.065 179.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.66 50.08 0.83 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.165 0.586 . . . . 3.66 110.207 177.229 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -141.74 157.97 44.39 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.582 -1.636 . . . . 7.74 106.582 -177.721 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 N--CA 1.447 -0.577 0 C-N-CA 125.921 1.689 . . . . 5.24 108.394 -172.147 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 N--CA 1.455 -0.185 0 N-CA-C 108.45 -0.944 . . . . 7.27 108.45 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.3 m-20 -77.08 110.53 11.81 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.936 0.894 . . . . 9.05 108.887 -178.771 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.8 mp -48.14 -51.04 26.54 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.349 0.66 . . . . 9.84 110.927 176.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.23 162.39 40.17 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.471 -0.937 . . . . 6.5 108.471 174.133 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 pp -155.23 144.58 21.1 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 107.587 -1.264 . . . . 4.01 107.587 176.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -103.43 113.17 26.46 Favored 'General case' 0 C--O 1.228 -0.069 0 C-N-CA 124.792 1.237 . . . . 3.72 108.226 179.521 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.72 153.42 35.66 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.33 1.052 . . . . 4.25 110.813 -177.047 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -85.67 138.81 35.5 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 125.035 1.334 . . . . 2.92 110.735 -177.554 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -54.1 -40.25 82.42 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.598 2.865 . . . . 0.94 112.044 -179.573 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.4 t -58.83 -49.14 78.82 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 119.009 0.822 . . . . 3.07 111.804 178.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.1 tt0 -55.25 -40.57 71.1 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 119.864 -0.734 . . . . 3.51 109.743 -178.179 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.315 37.0 pt -77.8 -11.31 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 114.823 1.416 . . . . 2.19 114.823 -179.17 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.61 -19.67 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 119.312 0.96 . . . . 2.97 111.315 -179.041 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -96.61 -125.63 0.13 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.234 -0.654 . . . . 3.34 109.234 -179.376 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -82.92 61.43 4.77 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.284 -1.126 . . . . 2.46 110.284 -169.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -151.89 -106.46 0.05 Allowed 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 127.155 2.182 . . . . 4.98 106.789 -171.799 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.6 m -77.36 -57.05 4.04 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.517 0.599 . . . . 2.78 109.897 -171.357 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -56.84 -49.73 74.56 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 123.588 0.555 . . . . 3.16 110.129 -171.231 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.6 m -70.1 -34.45 73.15 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.773 -0.649 . . . . 2.35 110.919 174.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.22 46.59 20.64 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 123.76 0.695 . . . . 2.12 111.421 175.311 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.4 m -113.98 -51.25 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 113.534 0.938 . . . . 3.06 113.534 -172.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -79.02 -58.64 0.68 Allowed Pre-proline 0 CA--C 1.54 0.594 0 CA-C-O 118.498 -0.763 . . . . 5.2 112.071 -178.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -79.37 165.02 23.66 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.096 1.864 . . . . 1.39 109.583 174.154 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.87 155.9 16.85 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.985 0.914 . . . . 4.26 109.864 174.861 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.9 24.57 0.49 Allowed 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.639 1.176 . . . . 3.56 112.122 177.376 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -143.4 30.2 1.99 Allowed Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.983 1.278 . . . . 2.15 110.891 171.431 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -103.03 155.88 18.07 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.393 0.677 . . . . 1.96 109.429 174.211 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.55 126.73 52.47 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.753 1.221 . . . . 7.01 108.168 176.817 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.86 176.3 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 108.283 -1.006 . . . . 3.1 108.283 171.147 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 22.7 mtt180 -111.33 134.48 52.88 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.689 -0.485 . . . . 4.35 109.689 166.535 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -102.93 119.88 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 107.122 -1.436 . . . . 2.03 107.122 171.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.49 125.24 4.33 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 109.643 -1.383 . . . . 0.59 109.643 -176.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.34 -133.73 1.59 Allowed Glycine 0 C--N 1.334 0.451 0 N-CA-C 109.517 -1.433 . . . . 1.52 109.517 -174.715 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.4 ptp -127.64 133.77 49.66 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.101 0.951 . . . . 3.82 109.996 175.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.7 t -95.64 143.2 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 108.716 -0.846 . . . . 3.3 108.716 175.507 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.63 175.74 3.34 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.281 -0.637 . . . . 3.27 109.281 173.656 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.5 p -106.4 65.42 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 122.897 1.332 . . . . 3.41 109.418 179.255 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 134.76 68.79 0.07 OUTLIER Glycine 0 CA--C 1.526 0.773 0 CA-C-N 113.68 -1.6 . . . . 2.34 112.429 175.517 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.0 m -136.45 8.09 3.1 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.399 -1.059 . . . . 1.93 112.729 158.739 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.8 ttp -78.85 117.39 19.91 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.011 -1.107 . . . . 3.66 108.011 176.341 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.2 m -121.02 151.71 24.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 107.829 -1.175 . . . . 1.73 107.829 175.732 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 37.8 ptt85 -141.44 144.02 34.2 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.992 0.917 . . . . 5.12 109.041 -169.154 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.33 155.12 37.24 Favored Pre-proline 0 C--O 1.236 0.361 0 N-CA-C 109.519 -0.548 . . . . 2.58 109.519 -177.002 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.13 32.11 0.42 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.508 2.805 . . . . 2.13 112.685 -176.121 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -95.69 -14.66 23.24 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.747 1.219 . . . . 1.59 109.125 163.611 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.4 m 70.23 6.82 5.96 Favored 'General case' 0 C--N 1.345 0.399 0 C-N-CA 125.105 1.362 . . . . 1.56 113.225 -178.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.7 pp -125.5 -34.28 2.69 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 127.662 2.385 . . . . 2.94 112.354 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 30.6 m-70 -87.96 124.72 33.99 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 107.809 -1.182 . . . . 1.49 107.809 -176.575 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 23.7 m -149.05 152.98 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.397 -0.964 . . . . 2.2 108.397 -175.008 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -156.02 161.93 40.39 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 121.41 -0.807 . . . . 1.51 110.803 176.706 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -155.3 160.57 40.87 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.197 0.599 . . . . 3.22 110.486 -175.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -107.87 136.0 48.32 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.251 -1.018 . . . . 1.63 108.251 175.249 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.7 t -115.74 142.1 30.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 124.942 1.297 . . . . 3.15 107.521 178.618 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -125.94 179.91 4.99 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.564 0.746 . . . . 2.21 110.056 179.303 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -128.87 171.91 11.83 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.072 0.463 . . . . 3.44 109.995 -177.624 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.5 p -49.11 -49.22 43.0 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.611 -1.177 . . . . 5.04 108.13 160.062 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.9 mt -77.35 27.85 0.15 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.104 1.361 . . . . 5.59 113.415 -177.473 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 50.58 37.46 33.55 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.338 -0.705 . . . . 3.66 111.338 -177.786 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.31 162.62 32.4 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 108.108 -1.997 . . . . 2.4 108.108 169.021 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -162.15 93.85 0.89 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.947 -1.131 . . . . 3.94 107.947 179.522 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.15 134.65 65.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 108.766 -0.827 . . . . 2.22 108.766 -175.188 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.1 mt -85.39 136.96 33.24 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.077 0.951 . . . . 1.86 109.973 177.124 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 87.1 t -124.06 133.22 69.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 107.387 -1.338 . . . . 2.0 107.387 176.363 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.7 p -111.78 158.35 19.47 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.537 1.135 . . . . 1.71 109.796 -177.105 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.428 ' CE2' ' HA ' ' A' ' 125' ' ' THR . 2.4 m-85 -148.43 133.02 17.76 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.348 1.459 . . . . 5.56 108.897 -178.279 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -104.92 6.32 33.56 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.682 1.193 . . . . 2.7 111.711 169.311 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -111.79 162.91 14.75 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 124.488 1.115 . . . . 5.03 111.123 172.287 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.9 mp -60.89 141.39 57.21 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.322 -0.853 . . . . 2.73 109.949 162.631 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 75.8 mt -81.02 159.27 68.77 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 107.426 -1.324 . . . . 2.94 107.426 175.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.54 -90.76 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.896 3.064 . . . . 2.31 111.196 179.273 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -79.46 43.54 0.56 Allowed 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.245 -0.909 . . . . 3.73 110.53 -173.537 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.3 tp 57.92 3.27 0.21 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.581 1.152 . . . . 3.82 112.978 -165.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 44.8 t80 57.78 94.23 0.03 OUTLIER 'General case' 0 C--N 1.342 0.274 0 CA-C-N 119.586 1.085 . . . . 3.71 109.237 -166.271 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -78.94 122.47 26.17 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.339 -0.986 . . . . 5.63 108.339 -178.17 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -84.13 173.06 11.38 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.093 1.357 . . . . 3.21 110.127 -172.692 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.9 34.73 89.43 Favored Glycine 0 CA--C 1.527 0.832 0 O-C-N 121.882 -0.511 . . . . 0.8 112.821 175.085 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -156.32 175.39 14.06 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.364 1.066 . . . . 3.34 108.967 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -97.68 105.88 3.22 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.973 -0.851 . . . . 1.19 110.973 -178.07 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.5 pp -111.5 157.46 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 106.547 -1.649 . . . . 2.2 106.547 -179.42 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.1 m -118.14 116.04 50.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 108.742 -0.836 . . . . 1.77 108.742 176.535 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -102.99 146.53 28.21 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 125.373 1.469 . . . . 1.83 109.875 -175.207 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -146.52 139.66 25.6 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.32 1.048 . . . . 3.58 110.106 -173.463 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 170.74 -133.82 2.91 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 106.516 -2.634 . . . . 0.85 106.516 174.762 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p -142.24 149.9 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 118.63 1.215 . . . . 1.9 109.166 -166.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.5 mt -77.31 157.18 30.85 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.693 -0.855 . . . . 3.25 108.693 -178.42 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 175.92 25.73 0.03 OUTLIER Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.345 -0.931 . . . . 2.67 115.408 175.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -150.3 46.31 0.89 Allowed 'General case' 0 C--O 1.238 0.455 0 CA-C-N 118.392 1.096 . . . . 5.91 109.533 -175.827 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 20.61 66.17 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 129.533 3.133 . . . . 3.93 111.338 173.473 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 131.13 -30.44 3.33 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 114.084 -1.416 . . . . 1.06 112.555 -175.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.32 161.13 19.48 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.548 1.174 . . . . 4.18 111.251 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 12.5 mt -121.36 131.59 54.28 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 125.442 1.497 . . . . 3.05 110.443 -169.348 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.25 99.07 11.38 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.083 -1.451 . . . . 1.64 107.083 176.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.82 155.48 16.76 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.573 -0.528 . . . . 2.03 109.573 179.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.428 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 8.8 t -134.01 -42.23 0.82 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.876 0.47 . . . . 2.0 111.365 173.254 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -87.39 105.62 17.39 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 120.179 -1.576 . . . . 4.31 108.778 177.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.88 118.62 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 123.824 0.85 . . . . 2.13 109.725 171.027 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -108.3 111.25 23.11 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.443 -0.947 . . . . 2.0 108.443 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.56 53.48 2.54 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.116 0.966 . . . . 2.23 110.628 178.424 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.2 pttt -79.88 69.72 6.28 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.79 -0.569 . . . . 3.85 110.616 -173.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -142.39 127.97 19.09 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.053 0.541 . . . . 5.21 110.315 -172.172 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 . . . . . 0 CA--C 1.533 0.315 0 C-N-CA 125.291 1.436 . . . . 5.58 109.689 -176.214 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.3 t . . . . . 0 CA--C 1.529 0.167 0 N-CA-C 109.65 -0.5 . . . . 8.4 109.65 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -146.62 114.22 6.39 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.05 -0.722 . . . . 9.78 109.05 -179.636 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.4 mt -125.86 66.53 1.19 Allowed 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.862 1.265 . . . . 6.88 107.744 -173.429 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -140.47 112.88 7.91 Favored 'General case' 0 C--O 1.228 -0.074 0 C-N-CA 124.098 0.959 . . . . 3.99 108.909 -173.459 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -154.93 135.33 13.31 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.566 0.746 . . . . 3.91 109.613 -178.399 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -93.91 114.82 27.11 Favored 'General case' 0 C--N 1.337 0.061 0 C-N-CA 124.8 1.24 . . . . 3.69 109.792 -178.039 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -120.12 156.88 30.15 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 126.329 1.852 . . . . 3.89 109.669 -175.765 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.7 p -90.78 145.24 31.63 Favored Pre-proline 0 N--CA 1.45 -0.473 0 C-N-CA 124.422 1.089 . . . . 2.69 109.059 177.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -55.29 -36.81 94.4 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.889 2.393 . . . . 0.9 111.968 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.5 t -52.57 -35.64 54.33 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.453 -0.779 . . . . 3.46 112.041 175.247 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -83.68 5.51 24.33 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.291 0.478 . . . . 3.02 112.291 -176.408 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.6 pt -120.24 1.48 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 113.812 1.042 . . . . 1.84 113.812 173.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.1 p -97.27 -59.69 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 118.617 0.644 . . . . 3.31 112.02 176.096 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -75.65 84.42 2.67 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 120.504 -1.373 . . . . 2.07 112.042 -166.614 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.37 56.67 9.6 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 109.658 -1.377 . . . . 2.22 109.658 176.047 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -147.86 -137.3 0.09 Allowed 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 127.79 2.436 . . . . 3.16 105.861 -173.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.6 m -58.82 -47.46 84.73 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.451 1.5 . . . . 2.78 112.631 -175.776 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -38.46 -54.87 1.45 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.445 0.698 . . . . 2.48 111.311 174.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.47 -1.45 53.52 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.446 1.099 . . . . 3.0 111.738 -173.147 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 49.79 41.39 35.57 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.137 1.351 . . . . 1.38 113.408 -176.804 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.1 m -92.39 -26.41 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.53 1.165 . . . . 2.4 112.887 -176.687 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -123.04 -74.16 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 124.635 1.174 . . . . 5.94 111.497 176.663 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -73.48 121.38 7.08 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.554 1.503 . . . . 1.41 109.305 177.497 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -77.89 160.07 28.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.078 0.951 . . . . 4.4 108.893 175.325 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.68 158.06 28.39 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.324 -0.621 . . . . 1.96 109.324 169.0 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.53 -2.08 76.89 Favored Glycine 0 CA--C 1.532 1.129 0 O-C-N 121.682 -0.636 . . . . 1.04 112.572 -175.482 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -91.67 146.39 23.81 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 118.102 0.951 . . . . 2.97 109.131 178.222 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.4 mtt-85 -90.5 133.75 34.84 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.033 -0.728 . . . . 4.94 109.033 172.443 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.1 pt -144.98 169.48 7.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 105.279 -2.119 . . . . 2.41 105.279 166.607 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 37.8 mtt180 -116.94 126.65 53.27 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.656 -1.239 . . . . 3.32 107.656 169.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -90.44 135.49 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 N-CA-C 107.269 -1.382 . . . . 3.44 107.269 173.484 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -128.55 128.59 5.96 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 109.38 -1.488 . . . . 0.63 109.38 172.491 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 176.8 -167.74 39.31 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 109.939 -1.264 . . . . 0.89 109.939 -173.227 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.4 ptm -111.95 137.7 49.6 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.479 0.657 . . . . 5.96 112.42 -176.18 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.2 t -64.93 159.32 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 114.349 -1.296 . . . . 3.31 109.062 178.692 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 62.7 m -108.54 131.98 54.3 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.053 0.941 . . . . 3.09 109.984 -178.492 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.3 p -75.58 45.91 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 127.955 2.502 . . . . 3.64 111.895 179.009 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.73 49.93 0.03 OUTLIER Glycine 0 CA--C 1.522 0.473 0 C-N-CA 125.529 1.538 . . . . 2.87 109.37 179.335 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.0 m -155.59 -40.67 0.08 Allowed 'General case' 0 C--O 1.226 -0.162 0 O-C-N 122.402 -0.469 . . . . 1.99 112.029 177.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.67 115.76 1.79 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 109.691 -0.485 . . . . 3.79 109.691 171.802 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.8 m -136.51 153.57 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 108.866 -0.791 . . . . 2.29 108.866 168.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -128.07 148.61 50.57 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.873 1.269 . . . . 5.72 108.837 -178.231 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -82.84 155.9 67.78 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-N 118.119 0.418 . . . . 1.87 109.959 174.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -70.91 7.28 1.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.088 2.525 . . . . 1.22 113.599 174.452 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -72.74 -23.6 60.86 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 121.938 -0.476 . . . . 1.68 110.181 163.318 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.7 m 70.97 10.49 6.95 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.504 1.522 . . . . 2.59 112.785 -174.854 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . 0.276 1.0 OUTLIER -123.08 -36.5 2.84 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.705 1.002 . . . . 3.37 113.705 177.748 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -85.33 129.36 34.83 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 120.23 1.377 . . . . 1.45 107.566 178.415 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.0 m -138.06 145.81 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 107.92 -1.141 . . . . 2.15 107.92 176.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -144.23 147.34 33.46 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.082 -0.71 . . . . 1.39 109.082 177.784 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -157.49 155.61 30.66 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.317 -0.401 . . . . 3.57 110.39 -171.588 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.65 149.6 24.28 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.136 -0.69 . . . . 1.88 109.136 173.071 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.3 t -119.0 133.59 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 106.151 -1.796 . . . . 2.99 106.151 172.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -155.64 159.71 39.82 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 106.653 -1.61 . . . . 3.64 106.653 174.817 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -153.5 174.1 14.84 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 106.293 -1.743 . . . . 5.72 106.293 173.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.2 p -51.77 -41.17 61.44 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.201 0.91 . . . . 4.4 111.229 179.431 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 18.5 mt -121.15 34.31 5.25 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.86 1.264 . . . . 6.18 110.275 169.766 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -101.08 5.98 56.3 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.244 -0.742 . . . . 6.41 111.244 173.224 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 51.47 -114.93 3.32 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 109.765 -1.334 . . . . 2.54 109.765 -173.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -164.76 148.64 9.01 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.952 -1.499 . . . . 4.06 106.952 169.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -155.14 154.48 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.79 0.723 . . . . 2.03 109.082 163.449 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 mt -109.12 131.94 54.59 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.508 1.523 . . . . 1.83 109.521 177.482 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.1 t -122.05 144.16 32.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 125.8 1.64 . . . . 2.06 108.77 -176.263 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 32.4 p -118.96 150.01 40.64 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.203 1.001 . . . . 1.45 108.49 179.008 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -149.32 109.81 4.22 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.854 -1.165 . . . . 3.68 107.854 -178.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -91.02 42.91 1.12 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.347 1.459 . . . . 2.12 112.048 -176.443 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -169.48 174.6 5.86 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.61 1.564 . . . . 2.52 108.645 173.049 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.6 mp -68.56 162.71 25.2 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.637 0.775 . . . . 2.45 112.485 -175.398 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 55.7 mt -112.67 158.6 37.04 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 126.048 1.739 . . . . 2.14 110.618 -175.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.12 -88.16 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.897 3.065 . . . . 1.99 111.365 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.441 ' C ' ' H ' ' A' ' 104' ' ' PHE . 9.8 m-20 -73.57 31.27 0.07 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.791 1.236 . . . . 3.83 112.139 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 50.73 -5.38 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 128.558 2.743 . . . . 3.13 116.387 -165.501 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.441 ' H ' ' C ' ' A' ' 102' ' ' ASP . 13.4 m-30 55.65 109.23 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.864 1.666 . . . . 5.81 110.959 -154.607 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -74.0 164.64 26.37 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.301 -1.318 . . . . 6.1 108.323 174.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -82.4 61.14 5.43 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.199 1.4 . . . . 5.11 109.727 -164.436 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 108.31 62.05 0.55 Allowed Glycine 0 CA--C 1.522 0.53 0 C-N-CA 124.509 1.052 . . . . 2.09 111.218 -173.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -111.14 168.81 9.22 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 107.891 -1.151 . . . . 3.85 107.891 158.312 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -102.91 133.7 11.52 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 111.496 -0.641 . . . . 1.39 111.496 -179.216 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.441 HD11 ' CZ ' ' A' ' 104' ' ' PHE . 33.3 pt -145.33 169.59 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.302 1.041 . . . . 2.79 109.638 -165.535 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 m -126.8 139.65 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 124.176 0.991 . . . . 1.78 108.465 170.645 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -134.95 140.08 45.44 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 124.888 1.275 . . . . 1.54 110.266 -176.695 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -135.64 145.4 46.78 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.779 1.632 . . . . 3.89 109.705 -177.871 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -178.47 -101.54 0.15 Allowed Glycine 0 C--N 1.337 0.625 0 N-CA-C 110.17 -1.172 . . . . 1.4 110.17 166.549 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.7 p -162.72 151.63 3.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 108.992 -0.744 . . . . 2.01 108.992 176.251 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -72.1 140.84 49.12 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 109.438 -0.578 . . . . 3.23 109.438 167.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -162.43 21.17 0.19 Allowed Glycine 0 CA--C 1.524 0.612 0 C-N-CA 119.709 -1.234 . . . . 2.52 113.716 172.412 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -143.57 46.96 1.48 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.755 -0.832 . . . . 5.31 108.755 -174.287 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 21.7 t70 18.09 66.12 0.02 OUTLIER 'General case' 0 C--N 1.34 0.164 0 C-N-CA 128.954 2.902 . . . . 3.57 112.487 178.409 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 137.87 -48.41 0.89 Allowed Glycine 0 CA--C 1.528 0.849 0 CA-C-N 114.614 -1.175 . . . . 1.11 111.475 -171.62 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -105.5 160.92 14.79 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.504 1.152 . . . . 3.78 109.811 -173.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.64 128.92 55.82 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.508 1.123 . . . . 3.15 109.237 -172.098 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -95.6 98.73 10.72 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.163 -1.792 . . . . 1.59 106.163 176.699 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -126.15 94.66 4.15 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.501 0.556 . . . . 1.97 112.501 -164.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.2 t -84.27 -33.4 24.02 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.906 0.706 . . . . 1.73 112.906 -178.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -82.91 95.09 7.86 Favored 'General case' 0 CA--C 1.528 0.113 0 O-C-N 120.556 -1.34 . . . . 3.61 107.733 -172.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 35.0 m -118.44 134.85 60.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 C-N-CA 123.809 0.844 . . . . 2.62 110.634 -176.221 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.59 101.66 8.8 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.241 -1.392 . . . . 2.39 107.241 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.98 107.26 12.63 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.741 -1.207 . . . . 2.21 107.741 172.355 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.29 44.79 0.72 Allowed 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 121.367 0.603 . . . . 4.06 109.983 179.515 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -47.34 -43.86 23.27 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.161 0.8 . . . . 7.15 113.161 -172.598 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 29.8 t70 . . . . . 0 N--CA 1.453 -0.317 0 C-N-CA 125.809 1.643 . . . . 5.88 106.77 179.485 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.446 -0.63 0 CA-C-O 121.508 0.67 . . . . 9.21 110.356 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -165.73 118.5 1.13 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.912 -0.773 . . . . 11.79 108.912 176.723 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.8 mt 62.66 56.3 2.0 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 122.21 1.005 . . . . 11.5 108.334 174.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -142.22 -171.88 3.48 Favored 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 128.112 2.565 . . . . 8.88 106.62 -170.65 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 61.94 -160.8 0.3 Allowed 'General case' 0 C--O 1.227 -0.105 0 C-N-CA 124.825 1.25 . . . . 4.47 111.139 166.442 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -81.58 96.67 7.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.963 -0.755 . . . . 3.38 108.963 -175.48 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.96 157.32 19.39 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.836 0.854 . . . . 3.84 110.427 177.694 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 p -77.44 146.08 73.14 Favored Pre-proline 0 N--CA 1.444 -0.743 0 C-N-CA 124.08 0.952 . . . . 2.84 110.179 -177.139 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -64.2 -23.05 66.72 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.507 2.805 . . . . 0.97 112.232 175.32 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.5 p -61.52 -64.4 0.96 Allowed 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.239 0.615 . . . . 3.4 110.931 174.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -46.34 -51.13 15.38 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.071 0.948 . . . . 2.17 110.81 -171.462 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 34.0 pt -57.23 -29.07 31.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.436 1.094 . . . . 2.13 112.754 -178.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.6 t -80.42 -54.32 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 123.335 0.654 . . . . 3.25 109.885 169.601 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -50.59 -42.48 55.82 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 125.002 1.321 . . . . 5.15 112.982 -166.506 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.26 65.02 0.1 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.515 -0.85 . . . . 3.14 111.19 -178.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.93 -90.32 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 118.598 -0.715 . . . . 3.05 110.923 -170.063 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.0 m -83.18 -58.82 2.69 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.689 1.196 . . . . 2.46 109.721 -169.443 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -51.15 -44.24 61.4 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 122.393 1.092 . . . . 2.59 109.473 177.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.16 -25.47 60.82 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.397 1.479 . . . . 3.2 112.451 179.059 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 56.82 46.58 90.0 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.292 1.425 . . . . 1.18 112.552 -172.488 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.1 m -109.77 -27.43 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 114.091 1.145 . . . . 2.43 114.091 -175.422 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -122.5 -72.76 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.295 0 CA-C-O 118.237 -0.887 . . . . 4.14 111.108 -175.794 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -76.71 151.11 31.74 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 121.504 1.469 . . . . 1.26 108.834 169.632 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -108.32 159.58 16.53 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.663 1.185 . . . . 2.75 109.324 173.366 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.11 136.94 56.65 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.412 -0.958 . . . . 2.11 108.412 174.078 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.85 -1.95 30.29 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 124.234 0.921 . . . . 1.07 113.09 -173.324 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -89.02 146.9 24.56 Favored 'General case' 0 C--N 1.338 0.08 0 CA-C-N 118.87 1.335 . . . . 2.99 109.585 179.226 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.29 106.89 17.51 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 107.906 -1.146 . . . . 4.51 107.906 -173.53 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 pt -135.63 178.21 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 124.054 0.942 . . . . 2.31 108.947 -173.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -121.93 119.77 32.5 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.476 -0.935 . . . . 2.95 108.476 174.415 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 p -83.78 128.96 38.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 107.198 -1.408 . . . . 2.04 107.198 173.044 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.3 128.6 4.58 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.562 -1.015 . . . . 0.78 110.562 -177.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 179.76 -156.19 17.48 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 108.977 -1.649 . . . . 0.82 108.977 -175.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.9 ppp? -118.3 142.92 47.01 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.814 1.245 . . . . 4.85 110.095 -179.577 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.9 m -100.92 139.85 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 123.223 0.609 . . . . 3.51 109.809 -169.054 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 m -72.33 140.32 48.43 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.465 0.65 . . . . 2.33 109.71 176.064 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.0 p -47.05 -61.63 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 126.263 1.825 . . . . 2.39 111.398 172.552 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.73 73.42 1.19 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.093 -1.203 . . . . 2.0 110.093 -178.219 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.5 m -152.46 -30.98 0.15 Allowed 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 115.084 1.513 . . . . 1.27 115.084 -179.519 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.2 104.73 0.96 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.085 -1.08 . . . . 2.67 108.085 175.686 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.9 m -112.79 126.45 70.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 107.503 -1.295 . . . . 1.92 107.503 175.401 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.12 137.02 54.39 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.151 1.38 . . . . 5.31 108.191 -174.384 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.408 ' C ' ' H ' ' A' ' 76' ' ' ASN . 5.9 m-20 -88.41 145.97 36.75 Favored Pre-proline 0 C--O 1.235 0.304 0 N-CA-C 109.068 -0.716 . . . . 2.51 109.068 -179.11 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.01 25.2 0.3 Allowed 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.106 2.538 . . . . 2.77 113.589 178.733 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.408 ' H ' ' C ' ' A' ' 74' ' ' ASP . 60.0 m-80 -91.8 -24.23 19.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.802 1.241 . . . . 2.15 109.378 164.282 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.9 m 74.12 0.42 3.6 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.52 1.528 . . . . 2.78 113.203 -174.515 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.98 18.06 11.73 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.182 0.993 . . . . 3.2 112.168 -178.354 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -145.39 127.01 15.16 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.477 -1.305 . . . . 1.94 107.477 173.286 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.1 128.97 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 107.704 -1.221 . . . . 2.26 107.704 -173.252 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -141.73 148.42 38.98 Favored 'General case' 0 C--O 1.232 0.158 0 O-C-N 121.088 -1.007 . . . . 1.11 110.739 176.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -143.17 153.32 42.73 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 116.35 -0.387 . . . . 3.12 110.171 -173.416 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.86 138.14 36.42 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.928 -0.767 . . . . 1.84 108.928 172.72 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -131.97 139.67 49.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 123.844 0.857 . . . . 3.01 108.958 176.392 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -140.55 -177.71 5.17 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.665 1.586 . . . . 1.77 108.387 -173.311 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -152.49 34.86 0.5 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 122.238 1.018 . . . . 2.71 110.149 -179.555 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.3 p 48.1 30.72 2.21 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.219 1.408 . . . . 3.49 113.711 -176.296 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.05 27.64 8.33 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.313 1.445 . . . . 6.02 110.206 -175.23 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 54.06 58.12 13.99 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 123.342 0.496 . . . . 3.28 112.318 176.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -128.87 -82.4 0.32 Allowed Glycine 0 C--N 1.338 0.645 0 N-CA-C 109.876 -1.29 . . . . 3.56 109.876 173.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 66.49 87.67 0.12 Allowed 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 125.228 1.411 . . . . 3.51 110.853 -179.126 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -95.13 155.11 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 108.638 -0.875 . . . . 2.08 108.638 -178.332 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 mt -104.25 131.37 51.64 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.738 -0.838 . . . . 1.75 108.738 174.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.7 t -114.71 133.25 61.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 125.558 1.543 . . . . 2.11 107.161 178.474 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.4 p -109.55 148.52 31.1 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.782 0.833 . . . . 1.48 109.002 -179.765 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.416 ' CE2' ' HA ' ' A' ' 125' ' ' THR . 1.5 t80 -150.69 146.69 26.63 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 107.184 -1.413 . . . . 3.41 107.184 -173.709 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.7 p-10 -141.35 40.33 1.75 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.214 1.005 . . . . 2.16 112.887 -167.166 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -166.37 56.87 0.1 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.545 0.738 . . . . 2.59 111.525 -178.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 52.62 -171.4 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.62 1.168 . . . . 2.33 111.951 -169.046 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.7 mt -147.25 152.04 41.91 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 107.007 -1.479 . . . . 2.19 107.007 174.453 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -63.24 133.29 39.93 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 124.033 3.155 . . . . 2.48 110.016 177.384 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 41.77 46.92 3.45 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.027 1.331 . . . . 3.83 111.29 -173.717 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 50.26 15.1 0.18 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.085 1.754 . . . . 3.08 115.068 -175.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 27.4 t80 62.4 95.99 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 126.108 1.763 . . . . 3.79 110.113 -166.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 64.1 mtp85 -77.34 124.52 27.98 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 106.477 -1.675 . . . . 4.8 106.477 -174.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -83.36 173.2 11.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.114 0.483 . . . . 2.92 110.61 -172.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.17 42.15 98.09 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 121.859 -0.526 . . . . 0.79 112.677 176.112 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -155.01 179.03 9.53 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.576 1.55 . . . . 2.96 108.581 176.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -110.36 138.35 14.84 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 111.616 -0.594 . . . . 1.07 111.616 175.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.4 pp -140.11 169.42 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 125.686 1.595 . . . . 2.01 106.904 -177.6 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 18.8 m -123.0 145.82 29.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 107.986 -1.116 . . . . 1.95 107.986 167.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -130.83 123.8 29.88 Favored 'General case' 0 N--CA 1.461 0.079 0 C-N-CA 124.345 1.058 . . . . 1.65 109.738 -177.273 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.21 145.01 34.87 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.33 1.052 . . . . 3.99 110.091 -179.45 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 164.65 -139.88 6.1 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 108.022 -2.031 . . . . 0.95 108.022 173.575 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.5 p -134.54 143.1 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 118.342 1.071 . . . . 1.82 110.983 -166.627 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -71.72 153.68 41.86 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.126 -0.943 . . . . 2.95 108.857 171.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -170.51 -50.62 0.04 OUTLIER Glycine 0 C--N 1.332 0.329 0 N-CA-C 110.988 -0.845 . . . . 2.24 110.988 177.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -65.56 146.97 54.19 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.283 -1.006 . . . . 5.99 108.283 173.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -82.64 63.33 6.72 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.389 -0.967 . . . . 3.85 108.389 -173.733 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 127.96 11.69 3.13 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.895 1.712 . . . . 1.39 113.664 -179.223 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.73 168.57 19.41 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.194 1.497 . . . . 3.59 109.834 169.823 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.3 mp -126.57 136.11 52.13 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.375 1.07 . . . . 3.1 109.418 -171.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -97.41 103.06 14.96 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.903 -1.518 . . . . 1.77 106.903 175.326 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -122.91 121.06 35.27 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 118.398 -0.811 . . . . 1.65 108.854 -177.098 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.416 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 15.4 t -107.99 -15.61 14.49 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 123.579 0.549 . . . . 2.16 111.802 176.426 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -97.94 79.05 2.6 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 120.204 -1.56 . . . . 3.49 108.979 -176.752 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 18.2 m -88.07 130.13 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 119.596 1.089 . . . . 1.76 111.339 174.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.94 106.6 13.6 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 107.342 -1.355 . . . . 1.89 107.342 175.366 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.67 72.11 10.62 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 123.165 0.586 . . . . 1.76 110.6 -178.258 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.5 -37.06 62.38 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.811 0.671 . . . . 6.15 112.811 -178.667 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -89.7 54.48 2.89 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.657 -0.652 . . . . 5.52 110.095 -171.282 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 . . . . . 0 N--CA 1.464 0.251 0 C-N-CA 124.583 1.153 . . . . 7.55 110.867 -178.968 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.4 m . . . . . 0 N--CA 1.454 -0.229 0 N-CA-C 107.119 -1.437 . . . . 6.69 107.119 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 57.8 p30 -74.91 -16.52 60.66 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.808 0.67 . . . . 9.04 112.808 -179.87 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.6 tt 71.5 53.16 0.23 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.144 1.378 . . . . 6.81 111.01 169.179 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.3 p-10 -110.83 73.69 0.84 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.826 1.25 . . . . 4.5 112.416 -168.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.01 165.93 13.5 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.809 0.844 . . . . 5.22 112.655 179.365 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -87.92 114.74 24.83 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 125.469 1.508 . . . . 3.41 110.717 -178.291 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -132.23 156.39 46.58 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.535 0.734 . . . . 4.72 112.363 -173.055 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.6 m -71.98 132.62 84.56 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 125.54 1.536 . . . . 3.48 110.759 -174.661 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -54.52 -37.49 90.19 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.149 2.566 . . . . 1.07 112.8 -176.711 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -37.3 -53.43 1.09 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.578 1.151 . . . . 3.13 113.228 171.541 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -78.36 -1.89 35.53 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.011 -0.431 . . . . 3.1 111.807 -173.189 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 32.7 pt -121.48 35.04 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.581 1.152 . . . . 2.22 110.193 171.716 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.6 p -121.02 -76.31 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 122.893 0.477 . . . . 3.36 111.165 158.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -83.52 109.11 17.11 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 125.214 1.405 . . . . 3.18 110.441 -160.058 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.69 37.27 40.33 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 109.528 -1.429 . . . . 2.76 109.528 177.597 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.06 -93.55 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.688 1.195 . . . . 3.43 107.836 -174.145 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.6 m -72.58 -59.0 2.94 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.141 0.976 . . . . 2.91 111.195 -177.679 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -53.45 -41.66 66.36 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 122.835 1.302 . . . . 3.08 109.575 -175.119 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.38 -19.43 42.66 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 126.524 1.93 . . . . 2.39 112.321 -179.619 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 54.69 42.56 78.12 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 126.039 1.781 . . . . 1.9 113.18 -175.383 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.5 m -100.25 -49.94 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 118.616 1.208 . . . . 3.1 113.113 -174.071 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 34.3 mmtt -97.54 -66.03 0.08 OUTLIER Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.85 0.86 . . . . 3.74 111.378 -177.485 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -75.15 68.94 5.79 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.264 1.976 . . . . 2.61 108.843 170.428 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -51.28 140.4 16.98 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.993 -0.743 . . . . 3.03 108.993 173.657 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.88 127.89 34.47 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.58 -0.896 . . . . 1.96 108.58 -176.466 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 124.39 -29.03 5.14 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.915 -0.874 . . . . 1.46 110.915 -161.609 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -79.84 137.15 36.87 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.988 1.394 . . . . 2.59 110.225 -177.338 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.03 106.28 15.3 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.919 1.688 . . . . 4.38 108.569 -172.648 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.43 168.46 23.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.7 -1.593 . . . . 3.05 106.7 -174.58 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 25.9 mtt-85 -110.17 123.15 49.23 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 106.83 -1.544 . . . . 3.12 106.83 178.232 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.4 p -86.88 130.73 36.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 107.329 -1.36 . . . . 1.98 107.329 176.066 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -133.53 128.65 5.09 Favored Glycine 0 C--N 1.332 0.344 0 N-CA-C 110.161 -1.175 . . . . 0.57 110.161 -179.497 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.1 -172.99 45.92 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.501 -1.04 . . . . 0.63 110.501 -179.417 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -90.93 138.34 31.67 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 117.404 0.602 . . . . 5.71 110.14 -178.628 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.6 p -106.42 144.73 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 109.388 -0.597 . . . . 3.29 109.388 178.892 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.2 m -87.92 133.39 33.93 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 125.741 1.617 . . . . 3.07 108.842 -174.84 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.8 p -46.63 -47.61 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.346 1.058 . . . . 3.23 112.879 -177.424 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -100.43 76.09 0.43 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 109.648 -1.381 . . . . 2.0 109.648 -178.856 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.9 m -146.33 -39.29 0.22 Allowed 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 117.804 0.802 . . . . 1.5 112.558 178.78 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.8 ttm -54.95 129.06 36.25 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 118.168 0.44 . . . . 3.17 110.117 173.088 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.75 122.73 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 106.119 -1.808 . . . . 1.88 106.119 160.088 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.35 139.3 49.57 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.935 1.294 . . . . 6.23 109.665 -178.138 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.46 166.06 47.37 Favored Pre-proline 0 C--O 1.235 0.324 0 CA-C-O 120.936 0.398 . . . . 1.72 111.101 -173.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.97 -25.59 13.98 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.138 2.558 . . . . 1.42 111.201 163.593 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -48.13 -30.03 4.19 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.001 0.521 . . . . 1.15 110.564 164.701 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.2 m 66.6 19.12 10.84 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 125.02 1.328 . . . . 1.47 112.324 175.147 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.33 -41.52 1.89 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 128.281 2.632 . . . . 3.22 110.993 177.604 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 71.9 m-70 -84.2 126.0 32.73 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.951 -1.5 . . . . 1.31 106.951 178.533 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.7 m -142.75 139.0 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 106.564 -1.643 . . . . 2.33 106.564 179.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -144.15 149.95 37.3 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.346 -0.613 . . . . 1.72 109.346 177.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -154.36 146.69 23.89 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 123.678 0.611 . . . . 3.37 109.468 -170.606 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.92 122.4 40.99 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 124.345 1.058 . . . . 1.82 109.248 -179.197 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.1 t -108.23 146.9 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.084 0 N-CA-C 107.389 -1.337 . . . . 2.99 107.389 177.543 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -151.1 -170.98 3.81 Favored 'General case' 0 C--O 1.226 -0.143 0 N-CA-C 107.541 -1.281 . . . . 2.33 107.541 174.045 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.71 64.84 0.42 Allowed 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 118.619 0.645 . . . . 3.43 109.664 -177.576 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.9 m 49.87 86.81 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.336 -0.853 . . . . 3.84 111.677 177.001 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 17.19 27.97 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 118.695 2.85 . . . . 8.51 118.695 -147.748 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.39 48.02 1.78 Allowed Glycine 0 CA--C 1.535 1.292 0 O-C-N 119.815 -1.803 . . . . 5.52 112.216 156.212 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 55.99 114.17 0.01 OUTLIER Glycine 0 CA--C 1.532 1.112 0 C-N-CA 127.823 2.63 . . . . 1.96 116.223 169.076 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -64.09 141.04 58.91 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.7 -0.883 . . . . 2.56 110.427 171.507 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -141.56 143.91 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 107.856 -1.165 . . . . 2.24 107.856 170.97 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.3 mt -91.1 119.35 31.16 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.287 1.035 . . . . 1.96 108.973 177.523 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 51.3 t -98.24 127.99 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 106.783 -1.562 . . . . 2.1 106.783 174.548 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.6 p -113.61 148.11 36.83 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.547 -0.908 . . . . 1.95 108.547 -177.753 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.439 ' CE2' ' HA ' ' A' ' 125' ' ' THR . 0.5 OUTLIER -142.72 141.35 31.77 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.949 1.3 . . . . 4.93 108.381 -177.263 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -114.13 10.06 17.3 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.614 1.565 . . . . 2.49 111.95 173.377 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -118.92 161.77 19.62 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 125.148 1.379 . . . . 4.47 110.297 172.16 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.6 mp -64.86 122.91 18.06 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.159 -0.473 . . . . 2.64 109.939 168.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 23.0 mt -73.75 155.33 89.04 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 123.621 0.768 . . . . 2.66 110.107 173.39 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -65.9 151.94 82.79 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 123.603 2.869 . . . . 2.39 110.194 173.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 55.1 12.67 0.68 Allowed 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.983 1.475 . . . . 3.31 114.983 -177.467 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 62.99 -6.42 0.17 Allowed 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 118.644 0.656 . . . . 5.5 111.616 -162.419 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.0 t80 55.95 78.7 0.19 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.257 1.823 . . . . 3.77 109.154 -170.829 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.3 10.2 mtp180 -86.7 34.88 0.66 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 119.046 -1.061 . . . . 5.03 111.729 -177.517 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . 0.357 10.5 mm-40 82.94 178.53 0.06 Allowed 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 120.232 1.378 . . . . 5.25 110.158 149.875 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 61.14 15.07 42.42 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 115.469 0.948 . . . . 1.38 115.469 158.215 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -136.73 141.48 43.04 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.601 1.2 . . . . 2.99 108.027 -177.903 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -77.85 113.67 3.79 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.266 -1.134 . . . . 0.96 110.266 -175.069 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.1 pp -123.65 169.33 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 123.608 0.763 . . . . 2.05 109.437 -175.101 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.7 m -117.89 134.26 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 107.852 -1.166 . . . . 1.85 107.852 169.371 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -121.26 155.18 35.21 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 125.53 1.532 . . . . 1.48 108.569 177.837 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -148.09 161.83 40.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.052 0.842 . . . . 3.2 112.112 171.645 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 171.15 -111.52 0.41 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 105.702 -2.959 . . . . 0.85 105.702 167.537 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.2 p -156.81 146.39 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 118.724 1.262 . . . . 2.26 111.719 -175.737 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.67 116.68 7.15 Favored 'General case' 0 N--CA 1.457 -0.093 0 N-CA-C 107.908 -1.145 . . . . 3.18 107.908 168.729 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -136.75 13.2 3.93 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.092 -0.838 . . . . 2.39 113.17 -179.681 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -143.05 35.49 1.37 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.017 0.908 . . . . 5.19 110.678 177.625 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 26.63 52.45 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 128.124 2.57 . . . . 4.02 112.053 177.992 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 160.77 -40.3 0.43 Allowed Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.244 -0.754 . . . . 1.27 113.772 -163.488 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.83 164.11 18.05 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.934 1.367 . . . . 3.82 110.79 171.412 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.1 mt -105.72 116.67 32.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.243 1.417 . . . . 2.94 108.282 -177.307 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.41 103.7 13.79 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.553 -1.647 . . . . 1.88 106.553 171.754 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -101.39 156.16 17.62 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.433 0.693 . . . . 2.07 109.843 -179.025 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.439 ' HA ' ' CE2' ' A' ' 96' ' ' TYR 0.256 9.9 t -141.1 -36.51 0.45 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.532 0.938 . . . . 2.13 113.532 174.713 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -92.45 127.35 37.91 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 120.481 -1.387 . . . . 2.74 109.189 169.109 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.4 m -125.32 142.21 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 N-CA-C 108.394 -0.965 . . . . 2.27 108.394 164.921 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.85 101.51 7.61 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.25 -1.389 . . . . 2.17 107.25 179.071 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.85 60.56 2.87 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.247 0.619 . . . . 1.72 110.694 -177.397 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -79.41 51.77 1.27 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.601 0.76 . . . . 3.87 112.072 -173.222 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -147.66 134.62 20.25 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.32 -1.363 . . . . 5.13 107.32 -179.239 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 48.7 t0 . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 106.659 -1.608 . . . . 5.91 106.659 172.306 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.3 t . . . . . 0 CA--C 1.532 0.264 0 CA-C-O 120.8 0.333 . . . . 7.99 110.282 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -83.72 68.5 9.9 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.802 0.841 . . . . 11.33 110.329 -176.673 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.75 160.65 29.98 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.534 0.207 . . . . 6.49 110.933 171.966 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -148.11 129.95 15.2 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 107.67 -1.233 . . . . 4.76 107.67 178.946 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -158.62 153.5 25.0 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.001 0.819 . . . . 3.7 109.894 167.269 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -111.59 122.58 48.19 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.288 1.435 . . . . 4.05 107.984 179.715 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -129.71 164.62 23.58 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 122.799 0.44 . . . . 4.52 111.266 173.376 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 p -85.63 146.93 45.15 Favored Pre-proline 0 N--CA 1.45 -0.431 0 C-N-CA 123.725 0.81 . . . . 2.56 110.598 -178.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -57.52 -42.18 63.77 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.94 2.426 . . . . 0.91 111.155 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.9 p -58.63 -24.15 60.46 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.904 1.681 . . . . 2.96 113.0 174.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -84.27 -48.36 9.83 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.114 -0.699 . . . . 2.26 109.114 173.093 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.266 22.3 pt -75.73 37.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 114.397 1.258 . . . . 2.21 114.397 -178.245 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.408 ' CG2' ' H ' ' A' ' 45' ' ' ASN . 0.5 OUTLIER -121.93 -87.06 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 125.39 1.476 . . . . 3.94 108.16 169.271 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.408 ' H ' ' CG2' ' A' ' 44' ' ' VAL . 28.6 m-80 -58.98 103.62 0.18 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.549 2.34 . . . . 2.28 110.469 -171.414 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.42 39.0 70.09 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.081 -0.807 . . . . 1.98 111.081 171.942 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -143.99 -102.31 0.12 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 126.175 1.79 . . . . 3.42 108.377 175.57 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 97.7 m -69.48 -68.1 0.43 Allowed 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 124.319 1.048 . . . . 2.37 110.954 -177.374 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -53.75 -43.74 69.4 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.908 0.861 . . . . 2.5 110.559 -171.188 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.27 -22.56 51.93 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.615 0.766 . . . . 2.58 112.512 176.946 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 60.69 56.86 21.93 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 125.66 1.6 . . . . 1.33 112.324 178.303 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.255 26.8 m -110.76 -64.16 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 114.1 1.148 . . . . 2.16 114.1 -179.595 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt -80.41 -62.99 0.36 Allowed Pre-proline 0 CA--C 1.538 0.513 0 O-C-N 121.302 -0.874 . . . . 4.51 112.029 -177.629 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -77.13 -179.24 5.24 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.387 2.058 . . . . 1.67 109.285 169.249 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -152.53 151.13 30.33 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.564 -1.643 . . . . 2.93 106.564 -174.875 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -55.39 161.9 1.73 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.53 0.937 . . . . 1.69 113.53 178.601 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.42 -6.09 58.49 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 119.424 -0.653 . . . . 1.02 113.075 -179.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -82.1 145.34 30.21 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.821 1.31 . . . . 2.35 108.814 175.805 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.2 ttm105 -90.19 125.86 35.62 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.709 -1.219 . . . . 5.65 107.709 174.689 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.4 pt -142.05 175.63 4.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 118.842 0.746 . . . . 1.95 109.035 175.483 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -120.05 136.74 54.46 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.874 0.47 . . . . 4.59 109.749 168.647 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.63 125.65 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 125.362 1.465 . . . . 2.09 107.91 175.768 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -128.05 112.56 1.48 Allowed Glycine 0 C--N 1.333 0.388 0 N-CA-C 109.875 -1.29 . . . . 0.53 109.875 -177.764 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.67 -171.5 33.72 Favored Glycine 0 C--N 1.332 0.348 0 N-CA-C 110.027 -1.229 . . . . 0.78 110.027 -176.623 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 18.6 ptp -88.67 138.66 31.23 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.031 0.443 . . . . 3.87 110.1 -178.209 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.7 m -91.18 150.35 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 109.401 -0.592 . . . . 3.45 109.401 170.574 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 m -91.37 143.89 26.15 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.892 -1.151 . . . . 2.74 107.892 165.358 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.9 p -59.43 -59.44 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.362 1.065 . . . . 3.44 110.088 178.272 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.36 66.79 2.89 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.328 -1.109 . . . . 1.68 110.328 178.346 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.3 m -150.13 -30.77 0.21 Allowed 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 113.942 1.09 . . . . 1.49 113.942 -179.398 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -60.14 117.23 4.88 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 119.087 0.858 . . . . 2.77 109.225 173.545 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.16 125.41 71.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 N-CA-C 107.655 -1.239 . . . . 1.71 107.655 169.808 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -109.48 147.46 32.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.235 1.014 . . . . 7.86 109.619 -178.829 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -72.42 161.76 77.42 Favored Pre-proline 0 C--O 1.239 0.533 0 C-N-CA 120.404 -0.518 . . . . 2.29 110.381 174.455 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -63.74 -34.22 62.82 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.384 2.056 . . . . 1.92 110.175 163.81 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -41.18 -47.27 3.26 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 125.273 1.429 . . . . 1.47 109.854 174.713 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.4 m 80.64 11.67 0.95 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.117 1.767 . . . . 1.65 112.423 179.668 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.17 -6.92 9.9 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.041 1.336 . . . . 2.82 111.334 175.522 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -123.4 136.64 54.73 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.919 1.287 . . . . 1.6 108.151 177.99 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.61 131.07 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 107.826 -1.176 . . . . 1.97 107.826 -172.341 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -135.81 154.32 51.24 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 119.778 1.172 . . . . 1.68 110.427 175.894 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -150.25 138.69 20.53 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.067 -0.716 . . . . 3.32 109.067 -173.805 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.07 136.57 34.44 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.938 -1.134 . . . . 1.77 107.938 173.584 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.4 m -129.63 149.5 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 107.992 -1.114 . . . . 3.89 107.992 177.436 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -153.4 177.53 10.79 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.975 0.416 . . . . 3.66 110.247 -173.951 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -157.34 148.7 21.9 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.179 0.592 . . . . 3.03 111.037 175.235 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 67.2 m 3.0 71.79 0.0 OUTLIER 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 128.556 2.743 . . . . 3.2 112.205 -169.977 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -10.26 40.36 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 131.282 3.833 . . . . 10.74 118.747 -148.979 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.34 -25.36 66.65 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 110.479 -1.048 . . . . 3.89 110.479 168.373 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 170.53 174.35 38.47 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.133 -1.187 . . . . 2.1 110.133 169.035 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -138.86 141.47 38.61 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.921 1.688 . . . . 3.21 107.363 -175.239 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.4 tp -140.8 151.21 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 123.451 0.701 . . . . 2.31 109.247 -176.162 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mt -93.17 122.21 35.32 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.655 0.782 . . . . 2.21 109.768 -178.048 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.0 t -102.3 119.56 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 107.062 -1.459 . . . . 1.93 107.062 173.558 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 62.0 p -99.42 147.34 25.36 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.086 -1.079 . . . . 1.81 108.086 174.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -147.35 160.83 42.08 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.238 1.415 . . . . 3.72 108.521 -172.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -147.98 152.89 38.25 Favored 'General case' 0 N--CA 1.428 -1.542 0 C-N-CA 127.553 2.341 . . . . 3.56 106.616 -169.628 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 61.1 64.81 1.06 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 129.652 3.181 . . . . 2.72 110.7 -172.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.0 mp 45.05 -144.67 0.16 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.311 1.444 . . . . 2.15 109.449 -173.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.6 mt -158.76 149.78 16.3 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 104.883 -2.265 . . . . 2.14 104.883 -175.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -67.35 129.75 20.97 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 121.956 1.771 . . . . 2.66 108.14 169.757 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 23.25 53.78 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 128.207 2.603 . . . . 3.33 113.095 -178.047 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 36.6 38.42 0.08 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.509 1.524 . . . . 4.61 114.422 -179.159 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.0 p90 35.34 83.6 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.423 1.489 . . . . 4.47 112.111 -173.561 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.4 116.3 4.96 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 119.255 -2.153 . . . . 5.38 110.709 -137.594 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -77.53 167.22 21.99 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 122.267 1.032 . . . . 3.67 111.679 -147.31 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.93 41.07 56.18 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 114.841 -1.072 . . . . 0.92 110.996 -169.919 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -149.8 178.34 8.97 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.353 1.061 . . . . 2.97 109.08 171.864 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -92.89 136.22 13.05 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 110.738 -0.945 . . . . 1.01 110.738 170.632 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.4 pp -139.29 154.74 25.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 107.484 -1.302 . . . . 1.9 107.484 179.557 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 19.5 m -110.32 120.89 62.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 108.741 -0.837 . . . . 1.83 108.741 178.457 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -113.97 150.8 33.28 Favored 'General case' 0 N--CA 1.458 -0.071 0 C-N-CA 126.131 1.772 . . . . 1.55 109.494 -174.492 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -149.9 155.01 39.27 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 113.448 0.907 . . . . 3.88 113.448 177.987 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 163.48 -130.38 2.22 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 106.063 -2.815 . . . . 0.99 106.063 175.235 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.9 p -129.95 145.79 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.069 0 CA-C-N 118.337 1.068 . . . . 2.31 111.761 -164.095 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -66.3 124.33 22.41 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.199 -0.455 . . . . 2.96 111.027 174.725 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.59 130.43 9.83 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 126.257 1.884 . . . . 3.62 109.377 172.595 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 60.58 29.73 19.23 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.465 1.106 . . . . 4.58 111.458 167.553 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 40.9 39.26 0.78 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.011 1.724 . . . . 4.51 111.178 -170.375 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -160.3 -61.96 0.01 OUTLIER Glycine 0 C--N 1.34 0.792 0 O-C-N 121.472 -0.767 . . . . 1.39 111.946 -170.354 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -83.34 127.34 33.59 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.901 -0.777 . . . . 3.0 108.901 -178.842 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.35 107.32 17.94 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.384 -1.339 . . . . 3.21 107.384 177.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.85 84.74 7.46 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.361 -1.348 . . . . 1.8 107.361 -179.59 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.66 144.71 26.44 Favored 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 123.762 0.825 . . . . 1.6 109.023 -177.484 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.7 t -137.88 9.56 2.82 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.85 0.75 . . . . 1.74 112.914 173.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -132.99 119.65 20.37 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.736 -1.579 . . . . 3.61 106.736 170.272 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.4 m -123.41 131.38 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 124.589 1.156 . . . . 1.96 109.494 176.867 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -115.91 104.37 11.55 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.708 -1.219 . . . . 2.16 107.708 179.117 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.14 56.02 3.56 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.018 0.927 . . . . 1.82 110.653 -179.238 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -77.8 60.95 2.36 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.046 0.938 . . . . 4.14 111.355 -175.409 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -132.75 47.87 2.47 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.686 0.755 . . . . 5.22 111.171 -172.514 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 CA--C 1.53 0.206 0 C-N-CA 126.361 1.865 . . . . 5.84 111.643 179.277 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 109.133 -0.692 . . . . 8.59 109.133 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -96.85 174.31 6.86 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.867 0.867 . . . . 8.42 110.127 175.002 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.19 177.65 7.67 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.015 -1.106 . . . . 5.54 108.015 165.849 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -159.78 157.67 29.76 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 107.487 -1.301 . . . . 3.81 107.487 165.86 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -160.99 169.6 22.23 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.852 0.861 . . . . 2.8 109.663 173.237 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -83.07 140.0 32.91 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.534 0.734 . . . . 3.49 110.359 -178.734 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -144.67 160.13 41.7 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.925 1.29 . . . . 4.06 110.593 176.977 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.95 134.67 38.72 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 126.519 1.928 . . . . 2.36 109.972 -179.848 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -56.84 -43.46 54.22 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.263 2.642 . . . . 0.84 111.775 -179.449 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.3 p -59.94 -34.2 72.93 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 121.406 -0.809 . . . . 2.67 112.065 -178.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.02 -55.17 36.08 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.553 0.692 . . . . 3.19 109.281 175.953 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.318 20.6 pt -66.29 -14.91 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 114.64 -1.164 . . . . 2.04 112.624 -170.022 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 88.4 t -75.68 -54.87 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 123.007 0.523 . . . . 3.22 110.978 167.499 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -56.43 -71.4 0.09 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.508 0.929 . . . . 2.57 113.508 -163.328 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -146.21 55.87 0.53 Allowed Glycine 0 C--N 1.333 0.4 0 N-CA-C 108.778 -1.729 . . . . 2.87 108.778 -167.806 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -153.44 -106.85 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.928 1.691 . . . . 4.8 108.644 -171.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.5 m -72.53 -60.05 2.42 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 124.341 1.056 . . . . 2.16 111.619 -170.765 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -56.25 -40.14 73.7 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 122.048 0.928 . . . . 2.59 109.734 -176.039 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.45 -24.84 62.09 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.158 0.983 . . . . 3.1 112.805 174.482 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.48 41.38 99.54 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 126.163 1.839 . . . . 1.26 111.918 -176.015 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.9 m -102.55 -53.52 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 118.048 0.924 . . . . 2.31 113.037 -174.423 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -93.71 -65.4 0.12 Allowed Pre-proline 0 CA--C 1.533 0.326 0 CA-C-O 118.542 -0.742 . . . . 4.79 112.054 -175.282 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -78.59 140.6 16.91 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 121.681 1.587 . . . . 1.24 108.799 174.067 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -87.35 161.95 17.63 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.701 0.8 . . . . 4.97 109.255 167.738 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.95 170.15 8.73 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 122.9 0.48 . . . . 1.96 110.215 174.124 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.51 22.81 71.69 Favored Glycine 0 CA--C 1.534 1.248 0 O-C-N 121.768 -0.583 . . . . 1.05 113.583 178.308 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -102.23 162.23 13.08 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.198 0.999 . . . . 1.7 108.432 171.2 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.7 mtt180 -99.63 134.43 42.53 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.86 -0.422 . . . . 4.29 109.86 169.55 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.3 pt -143.36 176.22 3.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 106.862 -1.533 . . . . 1.81 106.862 169.024 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -123.29 123.4 40.66 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.355 -0.98 . . . . 2.91 108.355 170.474 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.9 m -89.06 129.42 40.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 107.938 -1.134 . . . . 3.77 107.938 175.007 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -128.38 128.23 5.9 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 109.197 -1.561 . . . . 0.69 109.197 178.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.67 -170.74 40.34 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 109.979 -1.248 . . . . 0.73 109.979 -174.139 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.3 ptp -100.41 123.91 45.23 Favored 'General case' 0 N--CA 1.458 -0.061 0 CA-C-O 121.316 0.579 . . . . 3.33 110.976 -174.044 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.0 t -73.24 105.23 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 123.831 0.853 . . . . 3.2 110.485 179.78 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.407 ' HG1' ' CE1' ' A' ' 85' ' ' HIS . 3.2 m -45.29 136.09 5.49 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 126.362 1.865 . . . . 2.36 111.28 164.583 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.1 p -55.54 -64.09 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.741 0.817 . . . . 2.41 111.077 177.42 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.45 72.6 2.78 Favored Glycine 0 C--N 1.332 0.36 0 N-CA-C 109.34 -1.504 . . . . 1.77 109.34 -174.586 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.6 m -150.46 -34.18 0.16 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 115.891 1.811 . . . . 1.57 115.891 -174.895 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -76.93 99.71 5.33 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 120.159 1.345 . . . . 3.3 110.313 -175.012 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.1 m -111.32 128.81 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 108.527 -0.916 . . . . 1.96 108.527 -177.819 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -111.57 143.26 42.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.725 1.61 . . . . 7.03 110.591 -175.61 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -71.83 155.82 91.74 Favored Pre-proline 0 C--O 1.232 0.155 0 CA-C-N 118.245 0.475 . . . . 1.87 109.764 177.416 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -64.16 -27.11 64.77 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.207 1.938 . . . . 1.41 111.363 166.064 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -45.31 -33.68 2.57 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.193 0.597 . . . . 1.15 110.709 164.726 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.1 m 69.27 15.99 8.48 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.446 1.498 . . . . 1.82 112.466 177.253 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.41 -38.1 2.59 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 126.324 1.85 . . . . 2.65 112.075 175.789 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -87.38 135.96 33.12 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.155 -1.424 . . . . 1.45 107.155 175.537 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.0 m -144.15 148.72 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 107.195 -1.409 . . . . 1.96 107.195 178.144 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -148.78 158.76 44.39 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.448 -0.783 . . . . 1.24 109.716 178.892 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -150.64 142.11 23.45 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.654 -0.703 . . . . 3.14 110.405 -173.884 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.97 148.56 27.54 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.16 -1.052 . . . . 1.66 108.16 163.031 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.5 p -146.84 150.46 14.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 107.661 -1.237 . . . . 3.0 107.661 171.705 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.407 ' CE1' ' HG1' ' A' ' 67' ' ' THR . 0.5 OUTLIER -146.2 176.43 9.75 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.189 0.996 . . . . 3.39 110.513 -175.345 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -154.64 -89.11 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.961 0.904 . . . . 2.63 110.735 -176.57 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.1 t -77.12 85.05 3.61 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 106.273 -1.751 . . . . 6.84 106.273 170.638 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -39.35 17.1 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.803 1 C-N-CA 134.301 5.04 . . . . 10.22 120.921 -170.128 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -104.0 25.34 26.66 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 120.185 1.357 . . . . 4.1 110.616 159.745 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -160.78 107.6 0.32 Allowed Glycine 0 CA--C 1.527 0.819 0 CA-C-N 118.479 1.139 . . . . 2.03 110.892 -179.021 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -99.5 135.15 41.33 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 124.792 1.237 . . . . 3.1 108.98 169.18 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.57 144.89 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.654 -1.239 . . . . 2.42 107.654 167.553 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.5 mt -104.09 120.69 41.64 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.271 1.029 . . . . 1.83 108.38 176.225 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 44.0 t -103.16 136.3 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 125.422 1.489 . . . . 1.8 107.676 178.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.2 p -112.94 142.01 46.11 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.405 1.082 . . . . 1.57 108.578 178.521 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -138.42 114.63 10.24 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.529 -1.286 . . . . 3.84 107.529 -175.564 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -101.27 46.97 0.92 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.851 1.261 . . . . 2.33 112.05 -171.222 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -167.67 176.81 6.19 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.646 1.978 . . . . 2.55 107.037 170.486 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.0 mp -70.67 136.65 49.22 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.02 -1.05 . . . . 2.35 110.783 178.533 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.9 mt -69.92 160.89 78.47 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.395 1.078 . . . . 2.55 110.565 174.302 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.52 -95.82 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.837 3.024 . . . . 2.39 110.281 176.282 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.414 ' C ' ' H ' ' A' ' 104' ' ' PHE . 3.1 m-20 -78.39 49.91 0.89 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.863 1.265 . . . . 3.49 110.232 -176.543 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 52.44 -4.67 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.404 2.682 . . . . 2.99 115.918 -168.46 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.414 ' H ' ' C ' ' A' ' 102' ' ' ASP . 64.4 t80 64.26 93.96 0.06 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.727 1.611 . . . . 3.51 108.795 -159.32 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -79.81 129.02 34.13 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.663 0.744 . . . . 7.19 109.272 -179.138 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -83.95 144.17 29.34 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 128.062 2.545 . . . . 3.4 109.617 -174.002 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.29 46.59 8.02 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 112.052 -0.419 . . . . 1.08 112.052 178.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -155.8 175.52 13.82 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.567 -1.642 . . . . 2.73 106.567 170.839 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -86.24 144.49 20.03 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.095 -1.202 . . . . 1.07 110.095 167.668 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.1 pp -139.77 167.7 18.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 107.731 -1.211 . . . . 1.73 107.731 167.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 23.8 m -126.71 135.57 63.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.867 -0.79 . . . . 1.98 108.867 171.096 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -129.55 120.46 25.38 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 124.703 1.201 . . . . 1.86 110.762 -169.095 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -114.21 145.95 41.03 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 125.253 1.421 . . . . 3.47 111.022 -176.619 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 173.07 -123.09 0.96 Allowed Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 108.021 -2.032 . . . . 0.91 108.021 170.467 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.2 p -138.25 152.17 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 118.176 0.988 . . . . 1.78 109.726 -173.021 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -59.61 132.31 53.58 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 108.118 -1.067 . . . . 2.74 108.118 167.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -87.98 -104.34 0.93 Allowed Glycine 0 C--N 1.338 0.661 0 N-CA-C 110.011 -1.236 . . . . 2.31 110.011 -172.766 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -59.4 -66.15 0.56 Allowed 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.334 1.054 . . . . 4.85 108.375 172.771 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -173.0 -66.3 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.761 2.024 . . . . 4.19 105.971 175.83 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.0 -45.04 96.94 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 123.504 0.573 . . . . 1.53 112.271 177.021 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -83.28 144.13 29.93 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 122.036 -0.685 . . . . 3.36 111.257 -176.217 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -105.15 122.77 46.6 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 125.002 1.321 . . . . 3.23 108.076 -176.456 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.91 85.85 4.51 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.826 -1.175 . . . . 1.88 107.826 175.913 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.4 105.0 13.84 Favored 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 123.473 0.709 . . . . 1.7 110.378 -175.301 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.2 t -95.77 -25.82 15.91 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.903 0.881 . . . . 1.73 111.761 -177.485 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -89.33 81.52 6.64 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 120.695 -1.253 . . . . 3.28 108.708 179.279 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.6 m -90.48 125.03 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 118.112 0.415 . . . . 1.7 110.32 173.26 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -115.26 113.97 24.58 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.165 -1.42 . . . . 1.69 107.165 175.372 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.69 108.27 11.98 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 107.501 -1.296 . . . . 1.78 107.501 167.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.89 50.49 0.31 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 122.511 0.324 . . . . 4.59 110.626 -175.613 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.83 -80.25 0.6 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.852 1.261 . . . . 6.99 108.395 177.49 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.4 t70 . . . . . 0 CA--C 1.533 0.318 0 C-N-CA 123.379 0.672 . . . . 7.46 110.901 -179.507 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.3 t . . . . . 0 CA--C 1.538 0.487 0 N-CA-C 114.502 1.297 . . . . 8.38 114.502 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -155.46 158.06 37.96 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 120.007 1.276 . . . . 8.4 108.987 175.622 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 mt -130.07 141.84 50.67 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.664 1.586 . . . . 6.98 109.953 -168.287 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -90.47 88.46 7.17 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.386 1.075 . . . . 4.66 110.735 -173.515 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -119.54 162.04 19.59 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.713 0.688 . . . . 3.19 112.052 174.024 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -85.15 125.17 32.6 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 124.874 1.27 . . . . 3.67 110.115 179.463 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -124.27 161.19 26.33 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.628 1.571 . . . . 4.0 110.89 176.88 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 54.4 m -83.04 126.05 73.4 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 126.444 1.898 . . . . 2.88 110.433 -177.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -48.24 -43.1 32.5 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.901 3.067 . . . . 1.57 114.032 -179.133 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.1 m -54.76 -33.07 60.8 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.264 -0.897 . . . . 2.45 112.33 177.821 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -77.31 3.0 14.06 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.54 0.736 . . . . 2.63 111.994 179.548 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.278 18.3 pt -121.6 3.37 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 O-C-N 120.79 -1.194 . . . . 1.98 112.978 173.07 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.1 t -98.01 -49.0 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.031 0.932 . . . . 2.88 112.049 179.393 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -102.98 90.61 3.82 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 120.54 -1.35 . . . . 2.13 111.106 -167.843 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.35 48.47 18.77 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.905 -0.878 . . . . 2.08 110.905 178.293 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -152.85 -146.04 0.19 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 128.609 2.764 . . . . 5.3 105.067 176.481 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.1 m -43.57 -48.45 7.53 Favored 'General case' 0 C--O 1.227 -0.127 0 C-N-CA 126.198 1.799 . . . . 2.84 115.495 -170.51 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -39.16 -55.14 1.69 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.497 0.719 . . . . 2.57 111.508 172.859 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.07 -15.94 25.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.782 1.233 . . . . 2.81 110.652 -173.618 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.89 26.91 73.77 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.996 1.284 . . . . 1.12 112.438 176.818 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.2 m -80.07 -23.54 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 118.047 0.923 . . . . 1.93 112.406 -174.53 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -121.75 -75.95 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 124.172 0.989 . . . . 4.47 111.745 178.137 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.25 119.57 6.07 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 CA-C-N 120.554 1.234 . . . . 1.34 109.352 179.476 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -71.63 149.16 45.84 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.99 -0.744 . . . . 4.81 108.99 172.293 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.73 147.26 47.53 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.102 -1.073 . . . . 1.93 108.102 172.595 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.77 -1.17 27.42 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.61 1.1 . . . . 1.17 112.874 -173.732 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -102.79 148.94 24.99 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.426 1.09 . . . . 1.58 109.595 -176.614 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -86.92 125.88 34.32 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.466 -0.939 . . . . 4.39 108.466 172.605 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.5 pt -141.11 176.07 5.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 106.228 -1.767 . . . . 2.33 106.228 167.078 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -124.56 133.01 53.43 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.771 -1.196 . . . . 4.1 107.771 171.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.0 131.54 51.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 107.747 -1.205 . . . . 2.6 107.747 175.402 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -126.84 113.11 1.69 Allowed Glycine 0 C--N 1.336 0.551 0 N-CA-C 109.7 -1.36 . . . . 0.66 109.7 179.371 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.85 -168.2 17.15 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 109.966 -1.254 . . . . 0.93 109.966 -175.013 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -109.42 130.61 55.49 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.637 0.775 . . . . 3.75 110.586 -176.359 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.1 t -67.0 143.7 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 109.093 -0.706 . . . . 3.48 109.093 175.313 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.0 t -59.45 -68.45 0.28 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.627 0.371 . . . . 3.4 111.34 178.831 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.0 p 178.79 -45.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 123.633 0.773 . . . . 3.14 110.496 -173.347 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -146.43 42.82 0.92 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.164 -1.174 . . . . 2.26 110.164 -179.733 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.84 -30.71 70.96 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.322 0.649 . . . . 2.19 112.541 176.757 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.4 112.62 2.25 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 122.278 0.231 . . . . 2.75 110.387 -174.919 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.1 m -122.98 120.12 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.79 -1.559 . . . . 1.86 106.79 168.096 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.45 144.04 36.6 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.536 -1.283 . . . . 6.75 107.536 175.467 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -99.17 153.01 37.99 Favored Pre-proline 0 C--O 1.234 0.282 0 N-CA-C 108.55 -0.907 . . . . 2.55 108.55 -179.828 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.41 37.72 0.52 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.662 2.908 . . . . 1.73 112.244 -178.483 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -94.78 -35.77 11.97 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.934 1.294 . . . . 2.12 108.727 171.346 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.6 m 97.48 -19.38 0.05 OUTLIER 'General case' 0 C--N 1.342 0.243 0 C-N-CA 127.819 2.447 . . . . 2.93 111.777 -174.798 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.04 27.94 8.16 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 123.772 0.829 . . . . 4.13 112.815 -179.423 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -135.98 115.44 12.71 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.759 -0.83 . . . . 2.67 108.759 178.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.15 116.23 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 124.948 1.299 . . . . 2.17 107.932 -178.308 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -129.27 154.2 47.06 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.022 0.828 . . . . 1.38 109.484 177.674 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.506 ' CE1' ' CE1' ' A' ' 104' ' ' PHE . 33.6 p90 -157.36 145.27 19.02 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.447 -0.342 . . . . 3.19 110.469 -175.555 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.12 157.94 18.7 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.655 0.74 . . . . 1.65 109.753 167.774 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 p -141.76 149.37 19.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 106.638 -1.615 . . . . 2.99 106.638 172.181 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -128.61 -172.91 2.82 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.017 0.527 . . . . 2.15 110.322 -179.374 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -131.36 -177.7 4.52 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.012 -0.736 . . . . 2.37 109.012 178.204 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 60.7 m -57.32 -36.55 71.27 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.863 0.865 . . . . 3.66 110.643 172.063 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -86.29 -89.35 0.12 Allowed 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 123.112 0.258 . . . . 5.67 110.672 -177.897 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.11 36.58 0.37 Allowed Glycine 0 C--N 1.333 0.382 0 N-CA-C 110.35 -1.1 . . . . 3.11 110.35 -174.462 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -80.22 46.07 3.14 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-O 119.268 -0.74 . . . . 2.59 111.604 -176.212 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -62.89 111.64 2.22 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.43 -1.322 . . . . 3.4 107.43 179.173 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.2 tp -140.37 156.59 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 108.185 -1.043 . . . . 2.31 108.185 179.145 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.4 mt -119.87 129.66 54.49 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.504 -1.295 . . . . 1.59 107.504 -169.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.44 ' CG2' ' CE1' ' A' ' 82' ' ' PHE . 5.1 m -120.69 143.15 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 109.152 -0.685 . . . . 3.7 109.152 175.19 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.5 p -115.06 133.68 55.83 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.101 1.361 . . . . 1.82 107.512 -176.1 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -129.77 131.04 46.1 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.856 -1.535 . . . . 3.7 106.856 -178.348 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -122.11 34.06 5.28 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.268 1.427 . . . . 2.12 111.885 -167.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -163.46 54.89 0.17 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.353 0.596 . . . . 3.1 111.689 -174.426 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 53.77 -162.75 0.11 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.854 0.862 . . . . 2.24 110.844 -173.245 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.6 mt -148.93 155.83 40.69 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 106.381 -1.711 . . . . 2.4 106.381 179.921 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.34 -73.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.142 2.561 . . . . 2.31 110.27 -179.643 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.51 47.71 0.87 Allowed 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.926 1.29 . . . . 2.68 108.394 -178.515 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 41.61 23.88 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 115.749 1.759 . . . . 3.25 115.749 -173.226 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.506 ' CE1' ' CE1' ' A' ' 82' ' ' PHE . 51.8 t80 53.67 96.51 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.6 1.091 . . . . 4.16 110.277 -168.887 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 -75.37 123.26 25.08 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.583 -0.895 . . . . 6.57 108.583 -172.699 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -82.97 168.14 17.29 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.613 0.721 . . . . 2.98 111.403 -177.349 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 58.36 35.6 79.79 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 123.965 0.793 . . . . 1.03 113.001 179.287 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -156.23 177.66 11.19 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.049 1.34 . . . . 3.51 108.035 174.189 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -94.73 139.74 14.67 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.968 -0.853 . . . . 0.98 110.968 174.819 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.5 pp -142.67 153.78 17.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 106.642 -1.614 . . . . 2.16 106.642 178.803 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 19.9 m -115.14 128.07 72.46 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 N-CA-C 108.983 -0.747 . . . . 2.06 108.983 -179.871 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -119.59 135.92 54.59 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 125.471 1.508 . . . . 1.96 109.668 -168.83 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -136.66 144.24 43.89 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.524 1.529 . . . . 3.62 109.45 -176.491 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -177.04 -103.66 0.17 Allowed Glycine 0 C--N 1.332 0.344 0 N-CA-C 108.03 -2.028 . . . . 1.27 108.03 163.611 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.5 p -151.5 145.17 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 109.177 -0.675 . . . . 1.92 109.177 178.386 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.49 152.95 31.76 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.795 -1.187 . . . . 3.64 107.795 172.463 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -168.54 -51.91 0.03 OUTLIER Glycine 0 C--N 1.333 0.396 0 C-N-CA 119.656 -1.259 . . . . 2.4 112.318 175.929 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -61.94 155.58 23.2 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 119.151 -1.019 . . . . 4.56 109.55 172.193 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -79.38 79.09 5.85 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 105.811 -1.922 . . . . 4.11 105.811 179.47 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.08 17.64 26.82 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 126.159 1.838 . . . . 1.45 113.361 172.078 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.56 154.76 38.78 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.725 -1.583 . . . . 3.88 106.725 164.879 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.09 137.92 51.7 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 122.776 0.43 . . . . 3.29 110.237 -175.837 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.34 81.43 4.43 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 107.915 -1.143 . . . . 1.71 107.915 177.029 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -90.22 134.25 34.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.306 -0.628 . . . . 1.93 109.306 178.707 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.5 t -128.88 -23.24 3.11 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.731 0.812 . . . . 2.19 113.161 179.033 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -101.58 104.18 15.05 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.352 -1.722 . . . . 4.11 106.352 173.168 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.6 m -116.81 125.23 73.64 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 N-CA-C 109.247 -0.649 . . . . 2.06 109.247 177.002 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.51 112.12 19.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.153 -1.425 . . . . 2.01 107.153 -175.002 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -106.36 42.04 1.33 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.618 1.167 . . . . 2.54 111.613 -173.14 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.23 52.72 1.36 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.355 0.662 . . . . 5.12 111.588 -175.713 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -74.07 -53.47 9.91 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.583 -0.525 . . . . 5.31 109.583 -176.389 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 N--CA 1.45 -0.431 0 C-N-CA 125.523 1.529 . . . . 5.87 106.958 178.279 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 CA--C 1.539 0.54 0 N-CA-C 110.115 -0.328 . . . . 8.88 110.115 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 36.4 m-20 -140.31 136.97 33.78 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 106.773 -1.566 . . . . 10.47 106.773 173.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 tp -82.28 -55.68 4.38 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.417 -0.586 . . . . 7.44 109.417 175.926 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -111.41 94.97 5.24 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.911 1.285 . . . . 4.61 110.961 -169.313 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -127.08 166.66 17.21 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.138 1.375 . . . . 3.08 110.647 -175.746 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -83.4 134.58 34.88 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.576 1.15 . . . . 3.88 109.27 -179.152 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.403 ' CE2' ' HG2' ' A' ' 42' ' ' GLU . 0.5 OUTLIER -146.8 152.04 38.11 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.198 0.999 . . . . 4.69 109.209 -169.109 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.4 p -89.76 142.42 29.16 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 118.046 0.385 . . . . 3.54 110.689 -173.191 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -55.26 -41.39 78.89 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.108 1.872 . . . . 1.11 111.701 173.797 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.0 t -47.26 -36.98 9.77 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.419 1.088 . . . . 3.2 111.527 173.187 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.403 ' HG2' ' CE2' ' A' ' 38' ' ' TYR . 0.9 OUTLIER -67.39 -59.18 3.61 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.413 -0.588 . . . . 2.25 109.413 177.775 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.5 pt -73.3 4.77 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 114.758 1.392 . . . . 1.84 114.758 -167.054 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.6 m -96.82 -28.25 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.688 1.195 . . . . 3.91 112.301 172.199 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -87.15 -87.03 0.15 Allowed 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.88 0.764 . . . . 2.43 110.472 -168.63 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -122.27 59.8 0.58 Allowed Glycine 0 C--N 1.335 0.474 0 N-CA-C 108.814 -1.714 . . . . 3.09 108.814 -176.058 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -160.96 -157.45 0.52 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.905 2.482 . . . . 2.99 105.426 -175.086 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.4 m -29.02 -59.89 0.13 Allowed 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 128.279 2.631 . . . . 2.22 116.489 -170.213 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -54.14 -37.5 64.46 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.292 0.951 . . . . 3.69 111.012 -173.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.5 m -91.04 -21.88 21.04 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.708 0.803 . . . . 2.33 110.906 176.522 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.37 31.49 68.58 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.685 1.136 . . . . 1.32 112.038 172.595 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.0 m -81.6 -55.72 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 122.295 -0.532 . . . . 2.25 111.517 -173.941 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -87.3 -67.97 0.14 Allowed Pre-proline 0 CA--C 1.534 0.36 0 CA-C-O 118.558 -0.734 . . . . 4.43 112.145 175.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -78.02 131.93 11.32 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 121.53 1.486 . . . . 1.42 109.701 -177.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -80.48 165.87 21.75 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.437 0.695 . . . . 4.88 109.191 166.883 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.5 159.91 33.65 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.392 -0.595 . . . . 2.14 109.392 166.809 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.22 3.04 57.84 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 123.271 0.462 . . . . 1.3 112.8 178.31 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -102.53 156.69 17.44 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.801 1.241 . . . . 2.07 108.584 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.3 mtm-85 -96.79 130.95 43.96 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.294 -0.632 . . . . 5.18 109.294 171.124 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.1 pt -146.58 175.26 1.94 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 106.686 -1.598 . . . . 1.79 106.686 168.409 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -124.63 124.91 43.23 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 118.2 0.455 . . . . 2.32 110.08 175.537 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.4 p -87.71 119.45 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.564 -1.272 . . . . 1.86 107.564 174.567 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -126.31 115.98 2.43 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 109.508 -1.437 . . . . 0.59 109.508 177.158 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.86 -154.77 8.11 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 108.206 -1.958 . . . . 0.71 108.206 -176.943 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 24.7 ptp -117.34 137.56 52.37 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.712 0.805 . . . . 3.47 110.459 -178.448 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 p -89.1 137.23 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 120.273 -0.571 . . . . 3.66 110.166 177.283 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.6 m -28.73 -84.62 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 128.666 2.786 . . . . 3.25 113.38 175.702 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.1 p 171.97 -40.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 125.339 1.455 . . . . 2.56 110.238 -175.633 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -148.57 48.39 0.62 Allowed Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.884 -1.287 . . . . 1.93 109.884 -178.586 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 65.2 m -101.59 -12.75 18.22 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.212 0.605 . . . . 1.54 112.472 -179.54 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 35.2 tpp -58.33 125.11 21.88 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.931 0.787 . . . . 3.1 110.826 170.67 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.5 m -129.81 142.98 42.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 108.372 -0.973 . . . . 1.86 108.372 163.496 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.9 154.9 35.25 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 124.013 0.925 . . . . 5.13 110.934 -177.623 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.53 153.68 81.38 Favored Pre-proline 0 N--CA 1.453 -0.31 0 N-CA-C 109.501 -0.555 . . . . 2.05 109.501 171.411 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -59.83 -26.45 82.31 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.607 2.204 . . . . 1.72 111.363 171.008 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -44.82 -36.24 3.15 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.791 0.836 . . . . 1.37 110.952 168.649 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 21.0 m 75.58 18.57 2.21 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.869 1.668 . . . . 1.94 112.659 178.478 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.55 -49.17 2.14 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 125.368 1.467 . . . . 2.94 111.105 172.549 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -79.09 131.7 36.33 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.489 -1.3 . . . . 1.54 107.489 -176.173 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.8 m -138.51 160.03 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 108.744 -0.836 . . . . 2.63 108.744 171.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -144.74 147.57 33.12 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.65 -0.704 . . . . 1.4 109.274 175.815 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -155.59 146.65 22.48 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.754 0.421 . . . . 3.3 110.367 -173.538 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.38 132.42 44.71 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.497 0.719 . . . . 1.56 110.077 179.604 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.9 t -119.46 133.38 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 124.704 1.202 . . . . 2.92 108.51 178.832 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -117.45 -177.33 3.2 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 123.879 0.872 . . . . 2.24 110.684 177.737 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -125.91 -74.37 0.6 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.693 -0.685 . . . . 2.55 110.709 -177.088 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.2 t -161.45 -51.64 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.313 -1.736 . . . . 3.99 106.313 -175.342 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.4 mp -74.75 36.18 0.11 Allowed 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.58 0.956 . . . . 5.61 113.58 -179.214 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 58.22 22.99 51.8 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 121.443 -0.786 . . . . 4.1 112.205 -178.383 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -81.83 58.97 4.9 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-O 119.218 -0.768 . . . . 1.88 111.355 -169.684 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -64.33 102.47 0.53 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.69 0.745 . . . . 3.23 109.646 175.2 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -92.56 154.14 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 107.212 -1.403 . . . . 1.83 107.212 166.911 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 mt -102.98 131.15 50.15 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 108.61 -0.885 . . . . 2.09 108.61 -179.017 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.77 137.32 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 107.316 -1.364 . . . . 1.88 107.316 178.865 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.5 p -111.74 149.14 32.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.641 -1.244 . . . . 1.66 107.641 174.72 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -147.55 114.63 6.18 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.533 -1.654 . . . . 3.18 106.533 -179.579 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -94.97 40.55 1.1 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.743 1.617 . . . . 1.92 111.604 -170.826 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -166.83 174.34 8.65 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.181 1.792 . . . . 2.9 107.111 173.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.1 mp -70.87 152.72 43.39 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.826 0.822 . . . . 1.96 111.043 178.827 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.25 150.52 37.22 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 125.146 1.378 . . . . 3.72 108.713 -173.902 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -60.56 141.28 94.87 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.157 1.905 . . . . 2.28 108.621 169.964 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 42.7 46.74 4.48 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.236 1.414 . . . . 2.8 112.155 -179.528 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 50.59 15.73 0.25 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.625 1.97 . . . . 2.88 115.645 -176.874 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.5 t80 64.93 101.75 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.266 1.427 . . . . 4.16 109.874 -162.955 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 29.7 mmm-85 -79.57 111.69 16.1 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.124 -1.065 . . . . 5.73 108.124 -179.364 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -83.26 176.32 9.24 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.469 0.652 . . . . 4.17 112.504 -177.089 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.51 38.99 97.18 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.708 1.147 . . . . 0.84 112.111 177.27 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -158.99 178.29 10.23 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.027 1.331 . . . . 3.18 108.584 -178.679 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -98.98 135.8 12.33 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 110.885 -0.886 . . . . 0.95 110.885 173.419 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.0 pp -137.83 149.39 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 105.261 -2.125 . . . . 1.82 105.261 176.506 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.2 m -112.26 122.74 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 107.741 -1.207 . . . . 1.92 107.741 177.644 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -110.96 131.26 55.2 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 124.889 1.276 . . . . 1.73 109.28 -173.452 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -125.25 150.03 47.44 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.446 1.499 . . . . 3.8 108.889 -179.693 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 171.54 -119.77 0.8 Allowed Glycine 0 C--N 1.333 0.402 0 N-CA-C 107.086 -2.405 . . . . 1.2 107.086 169.307 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.8 p -145.86 151.56 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-N 118.767 1.283 . . . . 2.16 109.648 -177.076 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -81.24 143.63 32.16 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.83 -0.804 . . . . 3.04 108.83 173.154 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -161.26 13.39 0.15 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.028 -1.082 . . . . 2.65 113.582 175.515 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -137.67 45.41 2.16 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 118.088 0.944 . . . . 6.78 108.678 -169.071 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 41.7 t0 16.73 64.91 0.01 OUTLIER 'General case' 0 C--N 1.341 0.213 0 C-N-CA 128.92 2.888 . . . . 2.99 113.203 -178.888 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 138.42 -47.81 0.91 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-N 114.79 -1.095 . . . . 1.4 111.138 -170.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.75 164.11 12.71 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.04 0.92 . . . . 2.86 109.862 -175.389 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.8 mp -121.71 131.7 54.23 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.77 1.228 . . . . 3.08 110.029 -173.067 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -97.08 89.24 4.73 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.152 -1.425 . . . . 1.86 107.152 171.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.07 88.03 2.64 Favored 'General case' 0 C--O 1.227 -0.084 0 C-N-CA 123.034 0.534 . . . . 1.67 110.536 -171.765 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.6 t -85.91 -3.77 59.0 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.123 1.157 . . . . 1.81 114.123 -172.658 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -112.44 91.42 3.65 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 119.473 1.033 . . . . 3.64 108.43 179.63 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.24 128.3 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 CA-C-N 118.39 0.541 . . . . 1.79 110.524 175.93 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.04 120.29 35.87 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.46 -1.311 . . . . 1.77 107.46 177.331 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -96.22 102.83 14.68 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.124 0.97 . . . . 2.04 108.959 176.922 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.53 13.51 5.47 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.842 1.052 . . . . 5.15 113.842 178.985 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -36.72 -52.33 0.9 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.769 1.228 . . . . 6.61 112.143 174.688 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 . . . . . 0 N--CA 1.451 -0.405 0 N-CA-C 106.182 -1.784 . . . . 6.81 106.182 -179.315 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 CA--C 1.532 0.287 0 CA-C-O 121.147 0.499 . . . . 7.15 110.489 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 -99.86 148.7 24.16 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.08 1.352 . . . . 9.39 109.284 179.805 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.3 tt -80.8 151.22 28.87 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.154 -0.684 . . . . 7.36 109.154 176.039 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -152.84 150.82 29.73 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.782 0.833 . . . . 4.64 109.562 176.39 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.97 171.2 16.9 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.335 1.054 . . . . 5.22 109.674 178.581 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -93.65 116.61 29.12 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 124.842 1.257 . . . . 3.51 110.207 177.419 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.96 178.68 8.01 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.816 0.673 . . . . 6.52 112.816 179.915 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 38.0 p -71.11 150.13 94.65 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 123.554 0.742 . . . . 2.82 110.336 -177.122 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -60.51 -47.59 13.56 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.172 2.581 . . . . 1.32 110.685 176.001 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.4 t -46.81 -39.63 12.23 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.54 1.136 . . . . 2.55 111.853 -174.683 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -44.87 -57.46 3.75 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.068 0.547 . . . . 3.81 111.178 172.075 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.28 0.1 OUTLIER -81.22 35.52 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 113.05 0.759 . . . . 2.84 113.05 -178.872 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 52.1 t -117.76 -34.68 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 118.915 0.78 . . . . 3.46 112.419 174.694 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -126.29 116.9 21.95 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 119.574 1.079 . . . . 2.36 109.19 -169.766 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 63.4 35.47 92.1 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.62 -0.992 . . . . 2.01 110.62 179.344 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.1 mttt -144.25 -107.41 0.11 Allowed 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 126.864 2.066 . . . . 3.62 109.267 177.52 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 49.7 m -72.48 -64.62 0.92 Allowed 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 118.663 0.665 . . . . 2.27 111.237 -172.98 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -48.71 -49.06 39.62 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.964 0.888 . . . . 2.55 110.752 -176.495 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.38 -22.62 57.34 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.515 1.126 . . . . 2.43 112.922 179.043 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.11 44.17 96.52 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.577 1.56 . . . . 1.04 114.083 177.752 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.1 m -98.57 -34.09 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 118.866 1.333 . . . . 2.28 113.893 -173.691 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.72 -71.73 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.84 1.256 . . . . 4.42 112.797 -176.276 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -74.84 87.14 1.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.465 2.11 . . . . 1.81 108.816 176.697 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -67.07 158.77 30.27 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.139 -0.689 . . . . 3.36 109.139 175.884 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.7 168.01 5.3 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.769 -0.65 . . . . 1.9 111.671 -176.672 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.01 5.35 90.21 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 119.792 -0.449 . . . . 1.03 113.086 -177.928 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -99.2 151.53 20.91 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.414 1.086 . . . . 1.69 109.109 177.882 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 58.7 mtt85 -93.06 146.86 23.32 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 122.876 0.47 . . . . 5.36 109.909 173.327 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.3 pt -152.35 179.75 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 106.858 -1.534 . . . . 1.99 106.858 179.853 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.9 mmt-85 -135.05 119.39 17.84 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.698 -1.593 . . . . 6.56 106.698 167.714 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.7 p -85.18 144.68 9.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 107.768 -1.197 . . . . 2.17 107.768 176.654 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -152.82 95.83 0.16 Allowed Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 110.246 -1.142 . . . . 1.04 110.246 -176.285 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -154.93 -165.67 14.35 Favored Glycine 0 C--N 1.332 0.344 0 N-CA-C 110.112 -1.195 . . . . 0.69 110.112 -175.675 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.0 ptp -100.68 137.18 39.42 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.069 0.548 . . . . 3.2 109.661 -177.159 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.8 p -92.76 129.49 43.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.061 -0.518 . . . . 3.88 110.263 170.492 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.1 146.6 46.81 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.109 -1.071 . . . . 2.53 108.109 166.71 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 p -50.68 -60.71 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.256 1.023 . . . . 2.36 110.539 -178.891 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -86.62 56.33 4.69 Favored Glycine 0 CA--C 1.527 0.791 0 O-C-N 121.378 -0.826 . . . . 1.76 111.645 -176.77 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 62.7 m -122.28 -34.8 3.24 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.986 0.736 . . . . 1.46 112.986 -178.753 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -71.92 124.12 24.2 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.802 -0.814 . . . . 3.07 108.802 -178.576 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.8 m -131.51 131.92 62.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.735 0.814 . . . . 1.98 108.829 176.15 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.5 ptt-85 -116.8 147.71 41.85 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 124.949 1.3 . . . . 5.2 110.332 179.284 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -96.58 155.5 37.77 Favored Pre-proline 0 C--O 1.234 0.273 0 N-CA-C 108.807 -0.812 . . . . 2.39 108.807 177.474 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.74 42.86 0.99 Allowed 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.75 2.967 . . . . 1.91 111.605 175.857 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -102.9 -41.36 6.18 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 125.306 1.442 . . . . 1.43 109.217 173.605 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.9 m 104.67 -32.49 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 129.12 2.968 . . . . 2.54 110.492 -172.107 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.11 28.78 8.3 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 124.135 0.974 . . . . 3.9 112.541 -173.789 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -137.5 113.22 9.58 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.044 -1.465 . . . . 2.6 107.044 174.726 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.8 m -142.34 143.45 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 107.426 -1.324 . . . . 1.84 107.426 176.504 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -139.2 159.72 41.49 Favored 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 121.637 -0.664 . . . . 1.37 109.824 169.053 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -150.95 142.32 23.36 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 109.135 -0.691 . . . . 3.31 109.135 -178.495 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.33 143.82 30.1 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.241 -1.022 . . . . 1.65 108.241 171.543 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.8 t -128.32 138.03 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 N-CA-C 107.393 -1.336 . . . . 3.01 107.393 170.421 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -133.93 174.74 10.14 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.999 -0.741 . . . . 1.65 108.999 177.911 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -119.5 -3.31 10.42 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.923 -0.58 . . . . 2.63 110.793 175.557 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.0 m 59.02 27.73 16.76 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.713 1.205 . . . . 5.26 112.099 -168.449 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -102.97 9.94 38.45 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.382 1.073 . . . . 5.27 111.708 173.017 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.23 47.88 4.52 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.563 -1.015 . . . . 3.43 110.563 -175.8 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.33 126.27 1.38 Allowed Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 108.319 -1.912 . . . . 1.75 108.319 173.529 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -126.3 142.88 51.36 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.165 -1.791 . . . . 3.45 106.165 171.277 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.7 tp -131.85 147.3 32.45 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 N-CA-C 108.332 -0.988 . . . . 2.29 108.332 179.71 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.9 mt -95.91 122.72 39.02 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 122.968 0.507 . . . . 1.83 110.27 179.715 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.7 122.23 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 125.552 1.541 . . . . 1.88 107.582 176.401 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 42.3 p -100.26 152.4 20.34 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.251 1.02 . . . . 1.68 108.996 174.869 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -147.16 122.3 10.16 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.563 -1.273 . . . . 4.21 107.563 177.127 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -96.53 41.66 1.1 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.698 1.599 . . . . 2.42 110.973 -179.933 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -162.55 179.53 7.68 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.734 1.214 . . . . 2.84 108.354 172.428 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.05 165.54 23.29 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.565 1.146 . . . . 2.18 111.649 174.167 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -96.16 162.16 24.7 Favored Pre-proline 0 N--CA 1.453 -0.292 0 C-N-CA 125.833 1.653 . . . . 4.09 109.437 179.185 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -64.3 -82.14 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.236 2.624 . . . . 2.53 109.168 167.32 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -93.24 48.69 1.34 Allowed 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 124.14 0.976 . . . . 2.61 109.202 -172.196 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 48.77 4.6 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.997 2.119 . . . . 3.68 116.478 -169.944 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 35.4 t80 63.71 97.18 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.221 1.409 . . . . 3.79 109.976 -159.767 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 51.7 mtp85 -79.02 121.7 25.27 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 107.418 -1.327 . . . . 4.79 107.418 174.577 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -82.23 175.31 10.39 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.942 0.897 . . . . 3.23 110.365 -175.172 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 62.58 35.46 91.85 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 122.094 -0.378 . . . . 0.98 112.546 174.279 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -155.65 -179.92 8.58 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.24 1.416 . . . . 3.45 108.188 178.131 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -106.51 131.02 10.44 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 110.917 -0.873 . . . . 0.85 110.917 177.506 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.9 pp -128.51 154.91 39.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 106.994 -1.484 . . . . 1.72 106.994 179.039 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.2 m -106.44 137.7 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 107.418 -1.327 . . . . 2.01 107.418 173.415 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -125.97 124.29 40.42 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.056 0.943 . . . . 1.78 109.615 179.607 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.35 137.62 42.86 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.141 1.376 . . . . 3.77 108.921 -177.785 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 170.75 -148.6 11.53 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.975 -0.85 . . . . 1.07 110.975 178.099 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.11 153.69 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 C-N-CA 124.823 1.249 . . . . 1.85 107.823 -170.508 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -53.37 140.96 25.83 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.29 -0.633 . . . . 2.93 109.29 169.368 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -74.74 -153.85 3.66 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 109.818 -1.313 . . . . 2.83 109.818 178.527 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -58.46 -60.31 4.0 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.952 0.501 . . . . 5.69 109.99 -174.5 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -170.82 109.08 0.32 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.496 -2.039 . . . . 3.12 105.496 175.596 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 107.41 -39.87 2.73 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.848 -1.301 . . . . 1.22 109.848 174.783 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.03 166.71 18.56 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.243 0.617 . . . . 4.0 111.196 179.823 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 98.4 mt -116.86 134.91 54.19 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 124.43 1.092 . . . . 3.15 108.653 172.334 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -105.93 103.68 13.23 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 107.834 -1.173 . . . . 1.86 107.834 173.884 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -131.48 113.51 13.78 Favored 'General case' 0 C--N 1.341 0.232 0 N-CA-C 111.902 0.334 . . . . 1.63 111.902 -174.821 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.78 -41.63 9.56 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.753 1.221 . . . . 1.82 110.442 179.329 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -84.87 77.82 10.02 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.603 -0.888 . . . . 3.59 108.603 -167.993 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.5 m -88.76 124.06 41.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.757 1.223 . . . . 1.87 110.751 177.205 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.43 131.32 54.1 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.561 1.144 . . . . 2.0 107.978 176.669 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -100.31 74.87 1.76 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.902 0.881 . . . . 2.16 110.751 -175.11 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.3 pttm -74.36 -12.26 60.48 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.832 1.049 . . . . 5.62 113.832 -171.719 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 10.5 m170 -79.0 -42.65 26.08 Favored 'General case' 0 C--N 1.338 0.093 0 O-C-N 121.866 -0.521 . . . . 5.68 110.175 172.807 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.9 t70 . . . . . 0 N--CA 1.446 -0.63 0 N-CA-C 107.921 -1.14 . . . . 6.27 107.921 -167.288 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.3 t . . . . . 0 CA--C 1.534 0.349 0 N-CA-C 108.181 -1.044 . . . . 7.9 108.181 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -112.27 154.28 25.87 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.523 1.929 . . . . 9.68 108.822 177.979 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -153.69 -81.29 0.09 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 115.318 1.599 . . . . 6.14 115.318 -178.223 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -82.25 73.15 9.31 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.436 -1.415 . . . . 5.0 110.314 -165.301 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -125.83 166.61 16.53 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.986 0.812 . . . . 2.84 112.712 -166.477 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -83.44 134.15 34.88 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.545 1.138 . . . . 3.59 110.458 -177.526 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -137.18 147.48 45.92 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.293 1.837 . . . . 4.78 109.95 -178.768 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 m -71.69 137.48 82.98 Favored Pre-proline 0 N--CA 1.448 -0.546 0 C-N-CA 124.964 1.306 . . . . 2.97 110.464 177.437 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -58.94 -49.14 12.06 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.97 2.447 . . . . 0.89 111.453 177.335 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.9 m -54.18 -33.88 59.16 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.625 0.77 . . . . 3.24 112.683 -178.719 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -53.1 -51.34 62.19 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.238 -1.023 . . . . 2.4 108.238 173.749 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.295 36.8 pt -82.4 30.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 113.652 0.982 . . . . 2.16 113.652 -171.48 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -103.87 -39.72 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 124.048 0.939 . . . . 3.31 110.702 163.161 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -72.9 -50.58 22.85 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.645 0.609 . . . . 2.81 112.645 -159.972 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.23 67.98 0.1 Allowed Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 108.139 -1.984 . . . . 2.22 108.139 -168.804 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -143.19 -106.72 0.13 Allowed 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.449 -1.685 . . . . 4.71 106.449 -175.921 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 t -65.17 -59.36 4.18 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.595 1.158 . . . . 3.82 111.192 177.269 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -57.3 -39.6 76.11 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.474 0.71 . . . . 3.02 111.553 -165.195 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.68 -7.29 37.87 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.207 1.003 . . . . 2.07 112.255 178.081 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 53.11 44.88 63.4 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.443 1.496 . . . . 1.18 113.785 178.26 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.9 m -99.05 -35.26 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 118.479 1.14 . . . . 1.88 113.228 -175.061 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.89 -71.63 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 117.837 -1.078 . . . . 5.08 112.537 -179.525 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -76.17 174.5 12.72 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 122.264 1.976 . . . . 1.4 109.157 171.653 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -147.18 147.72 30.79 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.885 2.074 . . . . 2.91 106.937 -176.929 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.44 144.03 32.61 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.66 0.784 . . . . 2.23 110.52 -179.71 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.08 -20.49 26.15 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 123.829 0.728 . . . . 1.15 112.551 -176.882 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -85.31 151.55 23.95 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 117.938 0.869 . . . . 2.26 109.657 179.798 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.0 mtt85 -97.71 137.35 36.72 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.636 -0.711 . . . . 4.93 109.709 173.789 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.7 pt -144.46 168.63 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 105.777 -1.935 . . . . 1.76 105.777 170.775 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 22.0 mtt180 -115.54 123.65 49.03 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.009 -0.737 . . . . 2.44 109.009 172.391 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.6 p -87.46 129.33 39.02 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.082 0 N-CA-C 108.016 -1.105 . . . . 1.86 108.016 176.045 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.98 116.18 1.81 Allowed Glycine 0 C--N 1.333 0.41 0 CA-C-N 118.919 0.782 . . . . 0.55 111.243 -178.157 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.89 -169.2 38.53 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 117.787 0.793 . . . . 0.96 111.313 -177.378 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.6 ptp -101.4 148.68 24.88 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.863 1.265 . . . . 3.69 110.711 -177.912 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 43.2 t -106.34 119.65 56.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 109.624 -0.51 . . . . 3.47 109.624 -177.393 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 86.1 m -44.05 122.47 2.9 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.714 1.606 . . . . 2.59 109.408 165.774 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.1 p -46.23 -57.09 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.042 0.937 . . . . 2.32 111.205 -177.86 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.2 68.84 3.4 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.833 -0.907 . . . . 2.31 110.833 -179.648 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.9 m -149.55 -31.36 0.22 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.255 1.576 . . . . 1.56 115.255 178.221 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 12.1 tpp -60.92 115.88 4.05 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.15 0.886 . . . . 3.05 109.638 173.249 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.3 m -121.09 136.1 59.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 107.971 -1.122 . . . . 1.93 107.971 172.444 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.47 136.48 49.95 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.855 1.262 . . . . 7.58 109.082 -170.842 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -83.03 154.62 67.4 Favored Pre-proline 0 N--CA 1.455 -0.209 0 N-CA-C 109.384 -0.598 . . . . 2.13 109.384 -179.359 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -71.03 10.42 0.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.12 2.547 . . . . 1.46 113.203 173.731 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -74.71 -22.58 58.76 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.868 0.467 . . . . 1.36 109.862 161.947 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.1 m 63.74 24.08 13.71 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.079 1.351 . . . . 2.88 112.621 -178.177 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.86 -43.32 2.0 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.962 1.705 . . . . 3.05 112.023 172.68 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -84.13 122.19 28.48 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 108.522 -0.918 . . . . 1.67 108.522 -178.839 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.3 m -146.83 107.69 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 106.92 -1.511 . . . . 2.1 106.92 -172.156 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -119.87 154.97 33.57 Favored 'General case' 0 C--O 1.232 0.162 0 O-C-N 121.635 -0.666 . . . . 1.04 109.838 -176.773 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -154.9 147.99 24.78 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 120.82 0.343 . . . . 3.36 111.067 -175.555 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.05 139.92 30.72 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.41 -0.959 . . . . 1.86 108.41 167.951 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.08 147.05 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.291 1.037 . . . . 3.13 108.685 178.498 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -145.04 172.15 13.47 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 126.292 1.837 . . . . 2.03 109.632 -171.045 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.465 ' C ' ' H ' ' A' ' 88' ' ' LEU . 50.4 t0 -147.19 173.01 12.93 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.31 -1.367 . . . . 2.95 107.31 170.217 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.8 t -64.85 23.69 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.427 1.891 . . . . 4.0 113.229 174.919 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.465 ' H ' ' C ' ' A' ' 86' ' ' ASP . 3.9 mm? -106.87 16.31 24.48 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.6 1.96 . . . . 6.6 110.5 173.438 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 62.49 56.31 22.38 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 121.853 -0.529 . . . . 3.46 112.843 166.588 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -176.05 176.15 47.56 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 107.474 -2.251 . . . . 1.88 107.474 176.87 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -157.21 172.28 18.92 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 117.84 0.82 . . . . 3.14 109.424 179.223 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.0 tp -154.28 159.88 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.287 0.635 . . . . 2.18 109.387 176.539 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 16.7 mt -99.05 127.01 44.9 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.608 1.163 . . . . 2.1 111.283 -178.354 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 76.2 t -108.68 130.87 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 125.727 1.611 . . . . 1.88 107.989 175.502 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.8 p -111.79 134.1 53.58 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.149 -1.056 . . . . 1.63 108.149 177.675 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -135.11 139.4 44.64 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.318 -1.364 . . . . 3.64 107.318 -179.319 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -130.23 30.64 4.74 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.962 1.305 . . . . 2.19 112.702 -168.628 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -159.1 55.95 0.41 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.195 0.521 . . . . 2.45 111.207 -178.58 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 55.76 -170.4 0.08 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.102 0.961 . . . . 2.03 111.456 -176.132 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.1 mt -153.28 154.94 31.39 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 125.113 1.365 . . . . 2.16 107.643 -175.986 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -62.85 122.39 10.66 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 125.172 3.915 . . . . 2.38 109.958 -176.676 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 48.24 42.42 17.59 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 123.655 0.782 . . . . 3.38 110.498 -178.161 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 70.23 -16.9 0.28 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.886 1.274 . . . . 4.79 112.234 -177.261 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 14.2 t80 60.27 83.79 0.13 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.736 2.015 . . . . 4.54 108.954 -167.474 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -75.07 137.33 41.37 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 114.834 -1.075 . . . . 6.14 108.26 -173.642 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.5 mp0 -79.03 162.72 25.72 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 121.139 0.495 . . . . 3.42 110.522 -166.089 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.29 44.69 27.43 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 111.593 -0.603 . . . . 1.13 111.593 -178.237 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -146.37 179.5 7.48 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.733 1.613 . . . . 2.68 106.704 169.042 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -126.21 145.65 15.84 Favored Glycine 0 C--N 1.337 0.592 0 N-CA-C 111.529 -0.628 . . . . 1.4 111.529 171.708 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.36 168.5 15.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 124.424 1.09 . . . . 3.14 108.532 -175.804 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.5 m -107.49 129.78 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 107.812 -1.181 . . . . 1.97 107.812 169.519 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -119.24 133.75 55.59 Favored 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 125.457 1.503 . . . . 1.83 109.088 -179.218 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -124.98 142.4 51.51 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.28 1.032 . . . . 3.98 110.555 -177.582 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 171.51 -134.9 3.22 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 108.393 -1.883 . . . . 0.9 108.393 172.203 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.06 155.37 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 108.423 -0.954 . . . . 1.72 108.423 -170.274 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -54.39 132.73 44.81 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.86 -0.792 . . . . 3.11 108.86 167.05 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.56 -139.9 1.63 Allowed Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 109.62 -1.392 . . . . 2.63 109.62 -179.774 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -57.55 -60.6 3.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 122.865 0.466 . . . . 5.31 110.862 -177.416 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -176.81 115.48 0.1 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 105.823 -1.917 . . . . 3.49 105.823 -173.191 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 88.2 -42.64 3.09 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 125.39 1.471 . . . . 1.16 109.609 176.997 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.65 142.09 34.3 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.227 1.411 . . . . 4.04 109.918 -175.937 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.72 123.45 47.05 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 108.393 -0.966 . . . . 3.32 108.393 -176.754 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.76 83.7 3.48 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.019 -1.474 . . . . 1.55 107.019 176.096 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -94.33 142.44 27.41 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.41 -0.959 . . . . 1.61 108.41 175.202 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . 0.26 4.7 t -136.5 -4.36 2.07 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 115.47 1.656 . . . . 1.9 115.47 173.667 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -107.2 98.87 8.46 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 119.854 1.206 . . . . 3.95 107.913 164.794 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.4 m -96.47 133.79 36.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 CA-C-N 118.751 0.705 . . . . 1.91 110.833 165.056 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.71 106.75 14.86 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.299 -1.371 . . . . 1.7 107.299 175.266 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.68 42.06 1.08 Allowed 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.3 0.852 . . . . 2.22 113.3 -170.237 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.28 62.91 1.84 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.361 0.664 . . . . 5.06 111.528 179.324 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -77.53 -55.33 5.46 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.902 -0.777 . . . . 7.72 108.902 175.102 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 N--CA 1.454 -0.255 0 C-N-CA 125.523 1.529 . . . . 5.59 107.886 174.21 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.8 m . . . . . 0 CA--C 1.535 0.404 0 CA-C-O 120.821 0.344 . . . . 10.89 111.511 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -153.37 127.81 9.27 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 104.393 -2.447 . . . . 10.57 104.393 176.459 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -120.56 162.6 19.34 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.734 1.213 . . . . 7.16 107.977 175.806 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -114.47 111.08 20.84 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.81 -1.182 . . . . 6.32 107.81 -173.292 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.56 172.96 13.67 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.507 0.723 . . . . 5.74 110.674 -175.091 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.52 ' CE1' ' HB3' ' A' ' 61' ' ' ARG . 3.1 m-85 -89.22 110.83 21.54 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.52 1.128 . . . . 5.83 110.732 179.55 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.49 176.31 8.79 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.747 0.654 . . . . 7.02 112.01 174.998 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 p -69.34 145.82 96.06 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 124.067 0.947 . . . . 2.72 110.696 -175.841 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -58.92 -37.18 94.99 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.168 1.912 . . . . 1.29 111.966 179.36 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.6 t -46.53 -40.86 13.36 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.499 0.72 . . . . 3.0 112.17 177.921 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -50.42 -47.32 56.68 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.342 -0.543 . . . . 4.88 110.499 177.131 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.279 0.2 OUTLIER -91.56 34.39 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 112.77 0.655 . . . . 2.68 112.77 178.293 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.16 -32.93 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 118.88 0.763 . . . . 3.63 112.345 170.167 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -117.44 113.42 22.03 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.156 0.889 . . . . 2.69 110.323 -173.72 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.6 43.77 98.56 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.488 -0.645 . . . . 2.11 111.488 169.307 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -142.42 -111.04 0.13 Allowed 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 126.634 1.973 . . . . 4.67 106.511 176.704 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.4 t -71.87 -47.91 49.58 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 119.43 1.013 . . . . 3.96 111.626 -176.688 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -49.89 -46.24 51.5 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 122.044 0.926 . . . . 2.79 110.724 -173.47 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.69 -11.51 45.01 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.977 1.311 . . . . 2.37 112.173 178.829 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 55.54 44.82 85.73 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 126.309 1.909 . . . . 1.39 112.43 -178.073 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.7 m -96.01 -57.87 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 118.187 0.993 . . . . 2.7 112.81 -174.047 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.5 mmmt -91.85 -60.8 0.21 Allowed Pre-proline 0 CA--C 1.536 0.43 0 CA-C-O 118.607 -0.711 . . . . 5.25 111.992 -177.02 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -85.97 110.53 1.08 Allowed 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 122.426 2.084 . . . . 1.51 108.821 175.743 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -69.28 155.98 39.53 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.779 -0.823 . . . . 3.2 108.779 167.314 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -53.76 165.78 0.4 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 122.027 0.917 . . . . 2.15 111.959 166.75 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.44 8.77 86.67 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 115.933 -0.576 . . . . 1.22 112.45 -177.768 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -102.45 155.05 18.52 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.049 0.924 . . . . 1.96 108.886 171.779 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -100.81 136.81 40.07 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.101 0.96 . . . . 4.7 108.921 175.876 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.7 pt -141.86 175.36 5.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 106.558 -1.645 . . . . 2.02 106.558 174.152 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.52 ' HB3' ' CE1' ' A' ' 37' ' ' PHE . 15.8 mtt-85 -132.52 126.27 32.52 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 106.421 -1.696 . . . . 4.45 106.421 176.196 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.7 p -98.67 118.08 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 107.81 -1.181 . . . . 2.17 107.81 -179.46 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.36 113.26 1.87 Allowed Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 108.195 -1.962 . . . . 0.92 108.195 -178.738 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.88 -163.29 27.12 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 109.446 -1.462 . . . . 0.71 109.446 -171.737 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -103.75 132.23 50.2 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.864 0.866 . . . . 3.93 109.812 -172.88 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.2 t -106.57 126.23 62.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 108.721 -0.844 . . . . 3.51 108.721 176.859 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.2 m -57.95 137.95 56.29 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.833 1.253 . . . . 2.61 108.918 169.034 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.6 p -52.27 -60.69 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 123.63 0.772 . . . . 3.17 110.782 177.507 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.14 68.44 2.32 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.309 -1.116 . . . . 1.97 110.309 -179.951 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.1 m -151.16 -34.95 0.14 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.105 0.779 . . . . 1.35 113.105 -179.042 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.1 ttp -69.37 117.73 11.37 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.438 1.017 . . . . 3.93 109.148 174.282 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.1 m -122.56 136.12 60.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 107.659 -1.237 . . . . 1.85 107.659 175.196 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.2 ptt180 -118.72 144.69 46.08 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.897 0.879 . . . . 5.39 109.963 -179.931 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -92.42 145.84 31.34 Favored Pre-proline 0 C--O 1.237 0.42 0 N-CA-C 108.957 -0.757 . . . . 2.47 108.957 177.475 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -75.58 30.24 0.38 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.048 2.499 . . . . 1.95 112.89 178.792 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -89.87 -22.7 21.91 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.09 0.956 . . . . 1.59 108.83 162.628 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.3 m 63.47 23.13 13.54 Favored 'General case' 0 C--N 1.344 0.358 0 C-N-CA 124.301 1.041 . . . . 2.03 111.806 -174.626 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . 0.251 1.4 pp -130.7 -3.18 4.18 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.581 1.552 . . . . 2.97 113.303 173.322 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -131.4 125.56 32.93 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.192 -1.04 . . . . 1.63 108.192 -179.97 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.2 m -141.64 143.57 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 107.093 -1.447 . . . . 1.79 107.093 172.08 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -142.05 158.77 43.37 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 121.783 -0.573 . . . . 1.13 109.667 176.143 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -149.51 136.04 19.29 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.402 0.681 . . . . 3.34 109.97 -177.342 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.85 138.22 33.31 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.468 -0.938 . . . . 1.71 108.468 169.944 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.8 p -117.69 155.29 19.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 125.186 1.394 . . . . 3.18 107.786 175.547 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -131.61 175.1 9.45 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.698 0.799 . . . . 2.16 109.729 -179.651 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -140.15 166.4 24.77 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.464 1.106 . . . . 3.33 109.632 178.861 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.9 t -37.37 -51.5 1.09 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.748 1.219 . . . . 4.92 110.745 161.473 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -89.05 29.83 1.01 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.001 0.741 . . . . 6.33 113.001 -178.531 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 58.71 43.21 96.49 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.547 -1.021 . . . . 3.24 110.547 176.123 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -76.63 63.27 3.08 Favored Glycine 0 C--N 1.336 0.535 0 N-CA-C 110.135 -1.186 . . . . 2.48 110.135 -176.868 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.86 101.24 3.7 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.794 -0.817 . . . . 3.21 108.794 -172.02 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.1 152.15 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 124.221 1.008 . . . . 2.23 108.737 -177.036 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.2 mt -107.36 122.31 46.33 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.265 1.026 . . . . 1.78 109.538 -179.717 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.0 t -105.08 120.07 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 125.06 1.344 . . . . 2.06 107.651 176.961 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.6 p -105.44 144.35 32.33 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.862 1.265 . . . . 1.57 108.964 179.525 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -142.24 102.13 4.04 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.214 -1.032 . . . . 3.49 108.214 -178.771 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -94.4 45.44 1.13 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.221 1.408 . . . . 2.97 111.015 -178.905 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -163.97 48.44 0.12 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.676 1.19 . . . . 3.87 110.437 179.559 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.9 mp 54.16 -149.88 0.41 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.379 1.072 . . . . 3.37 110.776 -178.739 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.8 mt -153.44 158.35 32.72 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 127.62 2.368 . . . . 2.8 105.837 -176.996 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -75.27 -98.5 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 124.292 3.328 . . . . 2.78 110.671 -178.892 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.403 ' C ' ' H ' ' A' ' 104' ' ' PHE . 5.3 m-20 -75.77 53.62 0.75 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.16 1.384 . . . . 3.61 110.204 179.527 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 45.47 0.48 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 129.084 2.953 . . . . 3.78 116.533 -163.839 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.403 ' H ' ' C ' ' A' ' 102' ' ' ASP . 1.7 t80 50.05 105.29 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 122.462 1.125 . . . . 4.62 110.089 -153.434 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -74.51 123.43 24.73 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.434 -1.321 . . . . 5.82 107.434 178.975 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -81.66 167.81 18.8 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.832 0.853 . . . . 3.29 110.322 -167.522 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.14 44.54 93.91 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 112.067 -0.413 . . . . 1.23 112.067 173.484 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -155.85 177.72 11.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.401 -1.333 . . . . 2.6 107.401 175.344 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -85.49 137.97 15.89 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.581 -1.008 . . . . 0.98 110.581 171.055 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 4.7 pt -138.64 164.43 26.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 108.934 -0.765 . . . . 2.73 108.934 172.484 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.452 ' HB ' ' CE1' ' A' ' 37' ' ' PHE . 16.2 m -121.68 112.96 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 106.915 -1.513 . . . . 2.55 106.915 -178.545 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -118.45 127.87 54.07 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.518 1.927 . . . . 1.9 111.048 -173.423 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -126.59 157.93 37.57 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.778 1.172 . . . . 3.07 113.608 175.092 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 179.26 -104.11 0.18 Allowed Glycine 0 C--N 1.337 0.602 0 N-CA-C 109.735 -1.346 . . . . 1.2 109.735 167.943 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.8 p -151.6 154.0 8.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 118.254 1.027 . . . . 1.94 110.047 -174.563 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.01 139.41 58.76 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.63 -0.259 . . . . 2.91 111.004 173.592 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -120.04 120.92 4.73 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 126.356 1.932 . . . . 3.52 109.18 176.747 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 56.99 43.12 25.1 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.933 0.893 . . . . 5.03 111.297 168.715 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 35.47 50.46 0.57 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.177 1.791 . . . . 4.71 111.43 -176.197 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -175.56 -57.28 0.06 OUTLIER Glycine 0 C--N 1.339 0.708 0 C-N-CA 120.128 -1.034 . . . . 1.57 112.973 -175.078 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.11 152.83 22.01 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 109.068 -0.716 . . . . 3.67 109.068 -178.927 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.35 111.48 23.85 Favored 'General case' 0 C--O 1.228 -0.062 0 N-CA-C 109.128 -0.693 . . . . 3.24 109.128 -177.281 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.71 97.5 9.15 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.355 -1.35 . . . . 1.65 107.355 176.306 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.7 144.52 39.52 Favored 'General case' 0 C--O 1.227 -0.125 0 C-N-CA 122.92 0.488 . . . . 1.93 109.85 -177.806 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.6 t -131.43 -43.91 1.02 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.025 0.93 . . . . 2.01 110.907 -178.337 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -83.34 93.89 7.83 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.242 -1.392 . . . . 4.12 107.242 175.621 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 18.8 m -98.6 120.46 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 124.394 1.078 . . . . 2.0 108.424 169.65 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.73 114.15 26.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.711 -1.589 . . . . 1.96 106.711 178.868 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.5 46.28 0.84 Allowed 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.879 -1.138 . . . . 1.91 112.051 -175.628 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -81.7 60.75 4.78 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.448 -0.782 . . . . 3.64 111.376 -175.248 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.87 93.61 1.35 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.542 0.737 . . . . 7.58 110.556 176.849 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 . . . . . 0 N--CA 1.449 -0.525 0 C-N-CA 124.951 1.3 . . . . 8.27 108.419 -175.803 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.5 p . . . . . 0 CA--C 1.535 0.37 0 CA-C-O 121.351 0.596 . . . . 7.84 110.427 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -71.88 -18.44 62.05 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 114.704 1.372 . . . . 10.77 114.704 -167.19 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.322 2.0 pp -90.92 -66.63 0.91 Allowed 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.386 1.254 . . . . 6.83 114.386 -162.322 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -83.87 71.99 10.43 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 120.408 -1.432 . . . . 4.32 112.405 -162.104 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.23 162.28 25.8 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.666 0.617 . . . . 3.21 112.666 -174.161 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -85.67 118.79 25.39 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.939 1.296 . . . . 3.47 110.382 179.366 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.31 162.69 23.25 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.345 1.058 . . . . 4.19 111.166 175.113 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.9 p -75.02 144.29 79.06 Favored Pre-proline 0 N--CA 1.451 -0.396 0 N-CA-C 109.237 -0.653 . . . . 2.96 109.237 176.062 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -55.64 -41.27 79.39 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.56 2.173 . . . . 1.9 111.173 169.39 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.2 m -57.0 -50.33 73.03 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 117.563 -1.208 . . . . 3.54 111.313 178.94 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.29 -53.86 12.44 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 120.308 1.413 . . . . 2.8 110.52 178.192 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.334 31.0 pt -63.01 -28.41 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-N 115.116 -0.947 . . . . 2.08 112.816 -173.058 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.0 t -74.87 -49.04 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 118.492 0.587 . . . . 3.02 110.894 166.063 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -64.89 -46.83 80.1 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 123.972 0.909 . . . . 4.54 112.877 -163.457 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.34 62.35 0.07 OUTLIER Glycine 0 C--N 1.335 0.481 0 C-N-CA 119.668 -1.253 . . . . 3.16 111.59 -174.291 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt -150.85 -97.32 0.06 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 128.235 2.614 . . . . 4.09 105.098 -178.18 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.4 m -78.89 -54.66 5.82 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 125.072 1.349 . . . . 2.97 113.095 -168.518 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -49.24 -45.1 44.22 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.905 0.859 . . . . 2.37 110.454 -178.517 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.2 m -87.58 -10.65 50.92 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.344 1.058 . . . . 2.5 113.157 178.356 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 51.75 47.08 53.72 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.821 1.677 . . . . 1.82 112.834 -175.994 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.9 m -87.0 -52.47 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 118.334 1.067 . . . . 3.14 112.313 -175.509 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -100.97 -48.51 0.2 Allowed Pre-proline 0 CA--C 1.537 0.456 0 CA-C-O 118.039 -0.982 . . . . 4.39 111.646 -178.816 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -91.29 -173.43 0.55 Allowed 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 122.863 2.376 . . . . 2.06 108.781 170.181 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -153.45 155.78 36.95 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 127.756 2.422 . . . . 3.47 106.413 -177.722 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -54.25 160.91 1.47 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.862 0.839 . . . . 2.06 111.442 173.88 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.27 29.42 60.27 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 116.043 -0.526 . . . . 1.68 111.976 176.032 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -122.07 152.51 39.75 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.177 -1.416 . . . . 1.53 107.177 167.748 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.9 mtt85 -88.61 141.21 28.71 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.282 -0.636 . . . . 4.82 109.282 170.106 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.0 pt -143.61 176.78 2.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 106.906 -1.516 . . . . 1.94 106.906 170.613 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.6 mtt180 -124.25 129.51 50.91 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.036 -0.727 . . . . 2.33 109.036 169.264 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.0 p -90.34 128.59 42.15 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 107.365 -1.346 . . . . 2.06 107.365 174.352 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.88 119.22 1.6 Allowed Glycine 0 C--N 1.335 0.515 0 N-CA-C 110.721 -0.951 . . . . 0.64 110.721 178.944 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.49 -157.5 16.96 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 108.627 -1.789 . . . . 0.72 108.627 -175.264 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.63 149.2 23.53 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 117.814 0.807 . . . . 3.32 110.339 175.683 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 77.3 t -94.65 150.19 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.451 -0.944 . . . . 3.31 108.451 169.874 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.73 -173.91 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.693 1.597 . . . . 2.59 110.191 168.545 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.9 p -126.32 72.87 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-O 122.95 1.357 . . . . 2.85 108.375 178.032 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 136.23 -7.17 4.03 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 113.686 -1.597 . . . . 2.16 113.615 174.511 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 56.6 m -63.37 -21.26 66.17 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.827 1.314 . . . . 1.73 112.653 177.343 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 29.0 tpp -56.65 121.98 11.0 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.174 -0.676 . . . . 3.19 109.174 171.455 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.8 m -125.12 131.22 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 107.627 -1.249 . . . . 1.75 107.627 166.784 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -121.87 142.61 50.08 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.7 1.2 . . . . 4.8 108.917 -175.251 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.87 154.16 58.12 Favored Pre-proline 0 CA--C 1.532 0.257 0 N-CA-C 109.859 -0.423 . . . . 2.87 109.859 176.357 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -63.51 -30.44 71.46 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.965 2.443 . . . . 2.29 110.803 172.71 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -43.04 -41.18 3.38 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.865 1.666 . . . . 2.7 110.354 177.716 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.2 m 88.49 -1.06 0.42 Allowed 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 127.159 2.184 . . . . 1.63 113.272 176.451 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.27 25.49 9.47 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.08 0.855 . . . . 3.98 112.384 173.83 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -144.58 114.78 7.49 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.32 -1.363 . . . . 1.55 107.32 175.234 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.0 m -138.44 141.68 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 106.351 -1.722 . . . . 2.23 106.351 172.814 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -137.64 155.52 49.06 Favored 'General case' 0 C--O 1.233 0.189 0 O-C-N 121.745 -0.597 . . . . 1.06 109.479 173.818 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -154.75 159.36 40.61 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.709 -0.478 . . . . 3.46 109.709 -171.371 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -109.03 136.44 48.54 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.696 -0.853 . . . . 1.69 108.696 -177.81 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.4 t -122.65 135.5 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 123.726 0.811 . . . . 3.17 109.04 179.955 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -132.63 160.8 35.61 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 125.74 1.616 . . . . 1.9 109.568 -178.123 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -104.04 13.77 31.91 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.699 -0.626 . . . . 2.92 110.997 176.325 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.1 t 54.02 27.51 7.58 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.207 1.003 . . . . 4.27 111.93 -174.392 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.07 -66.66 0.94 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.722 1.209 . . . . 5.69 108.467 175.768 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 173.86 57.89 0.05 OUTLIER Glycine 0 C--N 1.335 0.502 0 N-CA-C 111.223 -0.751 . . . . 3.11 111.223 -179.824 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 175.13 136.69 2.33 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 108.307 -1.917 . . . . 1.82 108.307 175.917 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -132.76 119.51 20.42 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.45 1.5 . . . . 4.18 107.687 -177.741 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -98.29 154.08 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 123.971 0.908 . . . . 2.8 108.83 -179.643 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 18.6 mt -100.25 120.57 40.12 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.385 0.674 . . . . 1.84 111.28 176.979 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 89.2 t -97.16 136.46 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 125.656 1.582 . . . . 2.27 108.684 173.172 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.4 p -112.74 145.09 41.14 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.547 1.139 . . . . 1.83 108.388 174.846 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.406 ' CE2' ' HA ' ' A' ' 125' ' ' THR . 7.8 t80 -144.27 100.13 3.49 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.72 -0.844 . . . . 3.33 108.72 -175.618 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -84.69 53.49 2.71 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.951 1.3 . . . . 2.36 111.252 -176.985 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -169.65 -173.53 1.66 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.954 1.702 . . . . 3.28 108.114 173.512 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.9 mp -78.21 131.72 37.27 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.385 1.074 . . . . 2.23 111.239 171.462 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 24.2 mt -81.19 155.03 72.4 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.051 0.94 . . . . 2.14 111.006 172.225 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -61.74 141.72 91.53 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.09 2.527 . . . . 2.3 109.401 172.673 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 48.64 27.37 1.47 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.145 1.778 . . . . 2.74 113.163 177.064 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.1 tp 56.92 11.55 0.98 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.249 1.02 . . . . 4.25 112.397 -172.924 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 18.1 t80 56.66 84.07 0.09 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.269 1.427 . . . . 3.83 110.061 179.881 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.3 mtp-105 -78.3 124.4 28.05 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.295 -1.372 . . . . 5.69 107.295 -174.043 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -79.94 175.32 10.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.077 0.465 . . . . 3.08 110.645 -164.192 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.33 44.49 96.81 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 111.87 -0.492 . . . . 0.83 111.87 -176.745 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -143.52 176.62 9.05 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 107.932 -1.136 . . . . 2.41 107.932 169.517 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -100.35 145.83 17.41 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 110.514 -1.035 . . . . 0.98 110.514 171.271 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.0 pp -149.94 166.31 2.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 105.936 -1.875 . . . . 1.94 105.936 177.972 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 18.0 m -126.51 130.62 71.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 108.663 -0.866 . . . . 1.83 108.663 170.948 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -117.55 135.19 54.12 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 124.988 1.315 . . . . 1.94 109.785 -175.709 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -118.65 141.11 48.91 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.462 1.505 . . . . 3.2 109.871 -178.239 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 168.14 -133.8 3.01 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 109.658 -1.377 . . . . 0.86 109.658 170.757 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.2 151.83 31.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 117.823 0.811 . . . . 1.85 110.865 -166.073 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.8 144.25 56.97 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.105 -0.498 . . . . 3.27 111.404 175.564 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -119.68 115.57 3.05 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 126.945 2.212 . . . . 3.24 108.011 175.324 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 58.91 35.22 24.07 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.399 0.68 . . . . 4.99 111.656 169.779 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.0 t0 36.15 43.81 0.24 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.174 2.19 . . . . 4.95 113.137 -170.153 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -159.96 -55.3 0.01 OUTLIER Glycine 0 C--N 1.339 0.709 0 O-C-N 121.648 -0.657 . . . . 1.69 111.79 -174.92 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -84.62 150.44 25.17 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 121.905 -0.762 . . . . 3.73 109.107 175.961 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -108.41 113.66 26.89 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 108.784 -0.821 . . . . 3.24 108.784 178.989 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -92.16 98.5 11.57 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 107.482 -1.303 . . . . 1.63 107.482 178.114 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.52 97.57 3.98 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 112.797 0.666 . . . . 2.04 112.797 -168.509 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.406 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 14.9 t -83.38 -26.29 30.58 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 122.825 0.45 . . . . 1.96 112.213 -177.831 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -89.67 85.32 6.43 Favored 'General case' 0 CA--C 1.528 0.135 0 O-C-N 120.614 -1.304 . . . . 3.37 109.35 -174.755 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.7 m -96.78 130.72 45.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 123.853 0.861 . . . . 1.93 111.176 175.978 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -119.67 106.83 12.54 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.859 1.664 . . . . 1.88 107.452 178.543 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.87 57.67 4.26 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.673 0.789 . . . . 1.75 111.488 -176.315 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 37.2 pttt -83.38 61.84 6.39 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.897 -0.502 . . . . 4.05 111.614 -174.484 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -159.12 164.35 35.36 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 121.449 -0.782 . . . . 5.27 109.105 178.425 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.2 t70 . . . . . 0 N--CA 1.448 -0.558 0 C-N-CA 126.134 1.774 . . . . 7.26 108.629 -173.028 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.8 t . . . . . 0 CA--C 1.538 0.49 0 N-CA-C 111.313 0.116 . . . . 7.62 111.313 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -155.01 107.92 2.78 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.675 -0.64 . . . . 7.69 110.304 -175.769 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -80.08 151.78 29.69 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.408 -0.59 . . . . 6.67 109.408 171.387 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -158.44 70.62 0.54 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 119.267 -0.397 . . . . 4.22 111.636 -169.72 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.78 164.31 14.84 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.133 0.973 . . . . 3.63 112.472 -174.046 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.47 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 87.1 m-85 -91.96 102.57 15.14 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 125.376 1.47 . . . . 3.85 110.289 177.479 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.431 ' CZ ' HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -100.49 -169.91 1.79 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.598 0.759 . . . . 9.71 111.479 178.524 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 28.2 p -94.43 156.57 38.5 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 118.6 0.637 . . . . 2.72 110.709 -178.357 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.66 -14.7 33.46 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 121.5 1.467 . . . . 1.08 112.368 171.451 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 m -68.32 -25.53 65.17 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.087 -1.008 . . . . 2.48 113.102 169.498 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.84 -58.16 8.28 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.901 0.858 . . . . 3.61 109.942 -177.099 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.476 ' H ' ' CD1' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -78.82 36.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 C-N-CA 126.651 1.98 . . . . 3.04 113.042 -179.078 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 t -121.66 -37.3 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.325 1.05 . . . . 3.71 110.901 157.765 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -81.57 -46.69 14.08 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 120.995 -1.066 . . . . 4.12 112.781 -167.623 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.8 52.91 0.16 Allowed Glycine 0 C--N 1.336 0.53 0 N-CA-C 110.882 -0.887 . . . . 3.16 110.882 -171.882 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -149.28 -162.43 1.56 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.863 2.865 . . . . 3.22 106.028 178.159 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.6 m -29.09 -47.81 0.06 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 129.529 3.132 . . . . 2.62 116.714 -170.018 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -41.59 -53.1 3.61 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.088 0.858 . . . . 3.11 111.052 175.332 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 m -98.0 -23.49 15.76 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.444 -0.798 . . . . 2.01 109.831 179.224 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.82 39.38 85.72 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.258 0.933 . . . . 1.04 111.659 174.305 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.1 m -87.18 -29.58 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 112.722 0.638 . . . . 2.07 112.722 -171.94 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.6 mttp -118.19 -62.23 0.03 OUTLIER Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 125.358 1.463 . . . . 5.79 112.646 178.703 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -81.61 146.33 15.06 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 CA-C-N 121.242 1.479 . . . . 1.19 108.606 172.92 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -107.13 158.53 17.01 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.578 -1.267 . . . . 2.79 107.578 170.04 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.1 154.04 35.75 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.362 -0.607 . . . . 2.5 109.362 171.608 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.63 -2.67 45.77 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.933 0.777 . . . . 1.18 112.781 -178.41 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -95.48 160.61 14.44 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.253 1.027 . . . . 2.01 109.033 178.037 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.8 mtt180 -93.12 138.95 31.08 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.56 -0.533 . . . . 4.33 109.56 167.709 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.431 HD11 ' CZ ' ' A' ' 38' ' ' TYR . 30.8 pt -150.59 177.89 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 106.61 -1.626 . . . . 1.93 106.61 167.51 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 26.0 mtt180 -126.49 142.26 51.59 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.16 -0.681 . . . . 3.02 109.16 169.342 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.3 p -110.72 125.77 68.04 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.069 0 C-N-CA 124.727 1.211 . . . . 1.92 108.893 178.879 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -120.35 111.76 2.04 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 110.194 -1.163 . . . . 0.74 110.194 -179.803 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.18 -173.71 36.37 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.232 -0.747 . . . . 1.24 111.232 -173.603 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.3 ptp -118.19 137.54 52.93 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 124.308 1.043 . . . . 3.36 111.715 -172.508 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -61.73 145.37 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 CA-C-N 116.369 -0.378 . . . . 3.78 110.474 178.327 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.4 m -69.81 67.91 0.27 Allowed 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 109.207 -0.664 . . . . 3.19 109.207 163.653 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.252 13.9 p 20.53 68.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.345 0 C-N-CA 129.812 3.245 . . . . 3.48 114.361 161.902 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.69 50.69 1.01 Allowed Glycine 0 CA--C 1.527 0.79 0 CA-C-N 112.421 -2.172 . . . . 2.28 110.799 -177.91 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.3 m -117.48 7.59 12.76 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 123.844 0.857 . . . . 1.74 112.39 173.819 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 47.7 tpp -74.28 127.52 33.19 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.634 -0.876 . . . . 3.91 108.634 176.983 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.2 m -132.24 149.37 32.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 108.849 -0.797 . . . . 1.69 108.849 167.306 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.48 141.58 35.39 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.733 0.813 . . . . 6.36 110.658 -171.593 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.31 154.37 84.17 Favored Pre-proline 0 N--CA 1.455 -0.192 0 CA-C-N 118.606 0.639 . . . . 2.24 109.736 -179.867 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -63.03 -24.36 73.78 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.237 1.958 . . . . 1.4 111.784 168.895 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -47.86 -30.83 4.42 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.389 0.676 . . . . 1.36 110.731 166.804 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.3 m 63.91 29.82 14.42 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.794 1.238 . . . . 1.52 111.468 176.312 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.03 -48.91 1.47 Allowed 'General case' 0 C--O 1.232 0.135 0 C-N-CA 128.03 2.532 . . . . 3.09 110.466 172.078 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -80.17 127.93 32.91 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.155 -1.054 . . . . 1.4 108.155 -179.005 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.9 m -139.18 151.23 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.421 -1.325 . . . . 2.17 107.421 172.033 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -148.95 156.59 42.51 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 122.027 -0.421 . . . . 1.55 110.191 174.798 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -155.89 133.99 11.4 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.116 -0.493 . . . . 3.24 110.556 -169.867 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.52 129.4 35.09 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.163 0.585 . . . . 1.76 109.864 174.183 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.2 t -121.01 129.77 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 125.964 1.706 . . . . 2.93 107.579 -177.693 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -106.13 172.46 6.8 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.672 0.789 . . . . 2.59 110.814 179.948 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -113.73 -72.43 0.7 Allowed 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.89 0.852 . . . . 3.93 110.363 -174.965 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.0 t -168.15 -60.03 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.531 -1.655 . . . . 4.21 106.531 -171.02 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -91.01 -92.46 0.14 Allowed 'General case' 0 C--N 1.343 0.303 0 CA-C-N 117.492 0.133 . . . . 6.94 111.298 178.808 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -124.55 15.6 7.57 Favored Glycine 0 C--N 1.336 0.578 0 N-CA-C 111.343 -0.703 . . . . 4.01 111.343 -174.467 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -75.21 52.51 2.59 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 118.875 -0.958 . . . . 2.16 111.59 -178.919 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -86.72 105.15 16.75 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.059 -1.089 . . . . 2.75 108.059 175.161 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.3 tp -109.98 156.22 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 108.838 -0.801 . . . . 2.74 108.838 176.763 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.8 mt -109.88 114.76 28.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.307 -1.368 . . . . 1.81 107.307 -179.995 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.9 t -92.72 136.75 24.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 106.904 -1.517 . . . . 2.12 106.904 173.75 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 80.4 p -116.86 154.74 30.24 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.051 -1.092 . . . . 2.27 108.051 179.359 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -148.74 145.45 27.63 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 124.634 1.174 . . . . 4.77 108.292 -175.556 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -128.58 7.98 5.83 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.373 1.469 . . . . 2.31 112.743 -179.574 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -134.45 55.89 1.87 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.701 1.201 . . . . 4.18 110.297 176.872 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.0 mp 50.55 -145.69 0.46 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.097 0.959 . . . . 3.41 109.979 178.794 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.7 mt -158.03 161.85 28.07 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 127.675 2.39 . . . . 2.35 105.037 177.645 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.409 ' C ' ' H ' ' A' ' 103' ' ' LEU . 71.2 Cg_endo -72.28 -89.9 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.632 2.888 . . . . 2.03 109.901 175.356 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -68.45 19.33 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.562 1.545 . . . . 3.58 114.072 -178.713 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.409 ' H ' ' C ' ' A' ' 101' ' ' PRO . 0.2 OUTLIER 54.92 1.12 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 128.784 2.834 . . . . 2.84 115.284 -166.145 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.2 t80 51.22 89.53 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.092 1.357 . . . . 5.01 110.049 -164.774 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.61 147.13 39.82 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.362 -0.977 . . . . 5.92 108.362 -176.304 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -84.68 109.67 18.19 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.85 0.86 . . . . 3.39 111.665 -162.822 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.51 45.52 0.26 Allowed Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.58 1.085 . . . . 1.24 110.965 174.063 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -158.17 178.41 10.22 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 106.155 -1.795 . . . . 2.64 106.155 177.348 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.98 142.26 13.36 Favored Glycine 0 C--N 1.335 0.502 0 CA-C-O 121.296 0.387 . . . . 1.33 112.227 173.904 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.5 pp -133.7 164.35 35.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 106.45 -1.685 . . . . 1.87 106.45 -172.406 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.47 ' HB ' ' CD1' ' A' ' 37' ' ' PHE . 34.1 m -115.59 124.43 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 108.148 -1.056 . . . . 1.98 108.148 -178.348 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -119.95 142.41 48.76 Favored 'General case' 0 C--O 1.227 -0.12 0 C-N-CA 125.057 1.343 . . . . 1.48 110.048 -167.875 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -139.32 144.55 38.33 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.34 1.056 . . . . 3.93 110.531 -176.632 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 176.61 -120.36 0.74 Allowed Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 107.874 -2.09 . . . . 1.04 107.874 169.848 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.7 p -146.38 143.84 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 117.758 0.779 . . . . 1.88 109.078 -172.602 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.0 mp -79.56 143.04 35.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 118.848 -0.596 . . . . 3.91 109.432 176.377 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -165.49 29.83 0.21 Allowed Glycine 0 CA--C 1.525 0.681 0 C-N-CA 119.882 -1.152 . . . . 2.78 113.802 -175.74 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -132.83 1.92 3.66 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.855 0.862 . . . . 5.19 111.107 177.566 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.6 t0 53.21 52.7 13.13 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 122.652 1.215 . . . . 3.26 109.888 -173.052 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 163.46 -59.36 0.27 Allowed Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.17 -1.172 . . . . 1.47 110.17 -175.302 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.71 170.59 8.24 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.965 0.906 . . . . 3.5 110.009 -173.662 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.7 mp -118.82 130.4 55.75 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.778 1.231 . . . . 3.06 108.617 -171.928 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -97.38 99.08 10.52 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.15 -1.426 . . . . 1.75 107.15 173.377 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.34 153.73 17.65 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.602 -0.518 . . . . 2.01 109.602 -179.618 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.7 t -135.54 -38.49 0.74 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.14 0.576 . . . . 1.89 112.128 174.481 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -91.16 108.8 20.12 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.843 -1.161 . . . . 3.04 108.968 174.835 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -113.9 141.19 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 119.003 0.82 . . . . 2.25 110.34 169.338 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -120.92 116.92 26.05 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.762 1.225 . . . . 2.16 107.949 179.622 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.55 62.16 1.68 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.139 0.975 . . . . 2.2 112.124 -173.872 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.71 53.83 2.83 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.472 0.709 . . . . 5.92 112.245 -179.25 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.13 82.17 1.85 Allowed 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.711 -0.618 . . . . 5.34 109.761 -179.729 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 . . . . . 0 N--CA 1.45 -0.426 0 C-N-CA 125.048 1.339 . . . . 5.37 107.415 176.421 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.456 -0.155 0 N-CA-C 109.515 -0.55 . . . . 2.23 109.515 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -99.03 126.06 44.65 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.108 1.363 . . . . 2.3799999999999999 110.511 -172.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -133.27 153.98 51.09 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.148 1.379 . . . . 2.75 111.565 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.9 m -73.81 131.31 81.94 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.768 1.627 . . . . 2.1400000000000001 111.307 -177.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -56.04 -52.04 8.21 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.358 2.705 . . . . 0.81999999999999995 112.598 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.6 m -53.97 -35.89 62.29 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.831 0.852 . . . . 3.1400000000000001 112.382 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -62.57 -58.32 7.96 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.434 -0.58 . . . . 2.0899999999999999 109.434 173.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.4 pt -71.76 33.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 114.416 1.265 . . . . 1.3700000000000001 114.416 -177.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.6 t -111.99 -76.41 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 105.579 -2.008 . . . . 2.4100000000000001 105.579 161.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -64.38 101.3 0.42 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 126.633 1.973 . . . . 2.6600000000000001 111.328 -162.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.74 40.1 53.81 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.086 -1.206 . . . . 1.54 110.086 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -139.79 -105.3 0.16 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.279 1.431 . . . . 2.7999999999999998 107.815 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.405 HG23 ' N ' ' A' ' 49' ' ' ASP . 14.8 t -72.28 -53.84 11.28 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 120.0 1.273 . . . . 3.5899999999999999 109.49 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.405 ' N ' HG23 ' A' ' 48' ' ' THR . 0.8 OUTLIER -47.27 -48.69 24.63 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 124.902 1.281 . . . . 3.0800000000000001 109.507 -174.284 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.92 -5.09 42.24 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.137 -1.392 . . . . 1.4399999999999999 111.069 -173.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 48.15 47.44 26.97 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 126.362 1.934 . . . . 1.3200000000000001 114.371 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.7 m -98.64 -52.75 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 118.967 1.384 . . . . 1.21 113.696 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt -101.73 -68.72 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 124.0 0.92 . . . . 3.1200000000000001 112.117 -173.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -71.75 177.08 7.35 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 121.876 1.718 . . . . 1.53 108.56 167.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -155.3 158.48 38.84 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.822 -1.547 . . . . 3.2799999999999998 106.822 -175.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.32 125.02 24.79 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.696 -1.224 . . . . 1.24 107.696 174.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 138.67 -36.82 1.85 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 123.911 0.767 . . . . 1.4199999999999999 111.343 -172.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.93 143.52 29.8 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.086 0.943 . . . . 2.8599999999999999 110.617 -175.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -92.23 129.5 38.16 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.163 0.985 . . . . 5.7199999999999998 108.632 172.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.7 pt -140.43 177.95 3.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 107.495 -1.298 . . . . 0.88 107.495 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -121.13 123.02 41.29 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.241 -0.652 . . . . 3.0499999999999998 109.241 170.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.15 133.4 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 106.916 -1.513 . . . . 0.80000000000000004 106.916 171.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -137.57 120.43 2.06 Favored Glycine 0 CA--C 1.519 0.335 0 N-CA-C 109.422 -1.471 . . . . 0.54000000000000004 109.422 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -179.02 -169.36 39.49 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.243 -1.143 . . . . 0.67000000000000004 110.243 -173.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.9 ptp -102.01 133.16 47.26 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.095 0.558 . . . . 2.3999999999999999 111.076 -173.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.7 p -85.03 134.43 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.856 -0.794 . . . . 2.4199999999999999 108.856 175.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.5 150.0 29.81 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 122.194 0.997 . . . . 2.3500000000000001 108.775 176.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.0 p -48.68 -46.87 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.286 1.034 . . . . 1.8799999999999999 112.003 -175.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.87 21.85 42.63 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 119.283 -0.731 . . . . 1.6399999999999999 113.217 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.7 m -81.96 -36.05 28.38 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.92 1.36 . . . . 2.0099999999999998 113.179 -175.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.1 tmm? -75.96 125.48 29.19 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.595 -0.52 . . . . 1.75 109.595 -169.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.0 m -134.34 123.91 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.912 -0.773 . . . . 0.69999999999999996 108.912 170.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 36.0 ptt85 -100.7 152.79 20.04 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.382 1.073 . . . . 5.1600000000000001 109.8 175.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -77.16 159.38 78.21 Favored Pre-proline 0 C--O 1.238 0.47 0 N-CA-C 109.439 -0.578 . . . . 2.1899999999999999 109.439 167.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -63.89 -26.73 67.04 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.134 2.556 . . . . 1.3899999999999999 111.009 165.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -40.91 -44.91 2.42 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 124.409 1.084 . . . . 1.1599999999999999 109.47 165.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.8 m 73.86 12.17 4.41 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.324 1.45 . . . . 1.53 113.041 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.25 -30.83 6.18 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.5 1.52 . . . . 1.8600000000000001 110.866 168.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -93.45 132.16 37.98 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.599 -1.259 . . . . 1.1200000000000001 107.599 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.78 141.49 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 107.868 -1.16 . . . . 0.83999999999999997 107.868 -174.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -144.34 154.03 42.6 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.654 -0.869 . . . . 0.81000000000000005 108.654 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -146.81 142.96 28.25 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.806 -0.634 . . . . 2.1499999999999999 109.723 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.05 144.86 27.34 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.657 -0.868 . . . . 0.56999999999999995 108.657 168.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.88 145.02 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 108.973 -0.751 . . . . 1.78 108.973 177.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.5 p80 -142.71 -177.34 5.26 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.626 0.77 . . . . 1.3300000000000001 111.012 -169.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.9 t70 . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 108.339 -0.986 . . . . 2.3500000000000001 108.339 173.622 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 106.252 -2.739 . . . . 1.6200000000000001 106.252 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -120.48 129.54 53.9 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.348 -1.353 . . . . 3.23 107.348 -177.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.18 137.98 42.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 106.664 -1.606 . . . . 1.03 106.664 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 mt -90.38 133.2 35.15 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.467 0.707 . . . . 0.56000000000000005 109.451 176.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.6 t -119.28 135.51 59.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 125.168 1.387 . . . . 0.93999999999999995 107.695 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.6 p -112.25 146.68 37.75 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.647 0.779 . . . . 0.63 109.414 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -146.02 136.39 23.93 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.891 1.276 . . . . 1.96 108.267 -171.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -125.18 37.17 4.44 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.821 1.248 . . . . 2.02 112.667 -164.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -158.9 179.44 9.08 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.402 1.881 . . . . 2.8700000000000001 106.245 167.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.3 mp -67.91 128.96 38.45 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 120.708 -1.245 . . . . 1.8899999999999999 110.75 177.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.9 mt -71.1 148.56 94.26 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 123.481 0.712 . . . . 1.1399999999999999 110.836 176.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -62.44 139.16 75.09 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.003 2.469 . . . . 2.4300000000000002 109.173 173.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 50.58 29.01 3.77 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.581 1.152 . . . . 3.2799999999999998 112.119 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 36.8 tp 59.99 6.79 1.0 Allowed 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.043 -1.036 . . . . 3.27 112.359 -174.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.9 t80 59.24 88.67 0.07 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.714 1.606 . . . . 3.21 109.97 -170.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -73.86 136.97 43.47 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 106.776 -1.564 . . . . 4.79 106.776 -174.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.2 mp0 -84.33 168.62 15.46 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 123.165 0.586 . . . . 3.0299999999999998 110.052 -171.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 62.06 47.04 92.63 Favored Glycine 0 CA--C 1.531 1.084 0 O-C-N 121.925 -0.484 . . . . 0.84999999999999998 112.916 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -146.67 177.74 8.85 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.873 1.269 . . . . 2.48 108.644 171.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -117.92 116.63 3.51 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.268 -0.733 . . . . 1.05 111.268 177.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.2 pp -117.95 168.62 9.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 125.45 1.5 . . . . 0.92000000000000004 108.557 -174.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 30.8 m -117.09 139.89 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 108.165 -1.05 . . . . 0.69999999999999996 108.165 166.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.417 ' CB ' HG12 ' A' ' 127' ' ' VAL . . . -126.03 126.13 43.77 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.132 1.373 . . . . 0.56000000000000005 108.569 178.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -98.91 133.97 42.44 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.872 -1.159 . . . . 3.3599999999999999 107.872 175.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -162.34 170.81 38.06 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 110.812 -0.915 . . . . 1.74 110.812 -175.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.4 p -111.87 136.95 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 108.315 -0.994 . . . . 1.1599999999999999 108.315 173.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.626 ' HG ' HD22 ' A' ' 122' ' ' LEU . 6.4 mp -72.1 125.09 26.4 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.073 -1.084 . . . . 2.4500000000000002 108.073 176.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -140.77 -28.52 0.19 Allowed Glycine 0 CA--C 1.526 0.746 0 CA-C-O 119.501 -0.611 . . . . 2.0299999999999998 113.336 -169.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -115.86 49.27 1.12 Allowed 'General case' 0 C--O 1.239 0.525 0 CA-C-N 118.446 1.123 . . . . 5.9900000000000002 108.148 -164.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 40.9 t0 12.16 70.01 0.01 OUTLIER 'General case' 0 C--N 1.341 0.205 0 C-N-CA 130.144 3.378 . . . . 3.0099999999999998 112.161 -177.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 134.52 -36.15 2.12 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 114.574 -1.194 . . . . 1.01 112.097 -172.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.608 ' C ' HD23 ' A' ' 122' ' ' LEU . 0.1 OUTLIER -110.41 155.32 22.35 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 118.178 0.989 . . . . 3.2200000000000002 109.203 174.151 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.626 HD22 ' HG ' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -116.78 130.6 56.82 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 124.648 1.218 . . . . 2.1600000000000001 108.074 -175.736 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -92.08 111.73 23.39 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.505 -1.294 . . . . 0.70999999999999996 107.505 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -126.81 132.62 50.97 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 123.795 0.838 . . . . 1.03 109.525 -176.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.3 t -122.05 -20.52 6.26 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.35 0.66 . . . . 0.77000000000000002 112.114 175.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -96.31 82.74 3.46 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 120.488 -1.383 . . . . 3.73 107.727 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.417 HG12 ' CB ' ' A' ' 112' ' ' ALA . 31.8 m -97.53 125.72 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.281 0.632 . . . . 0.68999999999999995 110.324 173.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -114.78 102.36 9.93 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.742 -1.207 . . . . 0.69999999999999996 107.742 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.05 56.37 3.46 Favored 'General case' 0 CA--C 1.53 0.212 0 O-C-N 121.76 -0.587 . . . . 1.1899999999999999 110.908 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.87 55.39 0.69 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 122.98 0.512 . . . . 4.54 111.251 175.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 3.0 p80 . . . . . 0 C--O 1.228 -0.067 0 O-C-N 121.241 -0.912 . . . . 7.7000000000000002 109.875 -178.711 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.199 0 CA-C-O 120.375 0.131 . . . . 3.2799999999999998 110.717 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -88.37 115.53 25.94 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.147 0.979 . . . . 2.6299999999999999 109.261 -177.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -120.82 155.61 33.7 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.608 1.163 . . . . 3.1499999999999999 109.503 175.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.8 p -85.57 146.85 45.13 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 123.787 0.835 . . . . 1.6599999999999999 110.25 174.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -59.96 -44.23 31.51 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.369 2.713 . . . . 0.67000000000000004 111.85 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 p -39.29 -57.39 1.37 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.548 1.539 . . . . 2.4100000000000001 111.369 174.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.423 ' OE2' ' NZ ' ' A' ' 47' ' ' LYS . 2.4 tt0 -58.09 -54.51 46.19 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.294 -0.866 . . . . 2.2599999999999998 110.1 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.339 26.4 pt -65.28 -12.05 12.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 114.701 1.371 . . . . 1.1699999999999999 114.701 -173.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 82.1 t -75.79 -38.28 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 123.596 0.758 . . . . 1.8999999999999999 111.217 166.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -106.7 92.63 4.18 Favored 'General case' 0 C--N 1.335 -0.06 0 O-C-N 120.999 -1.063 . . . . 2.1699999999999999 111.121 -160.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.81 47.02 58.03 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.907 -1.277 . . . . 1.4299999999999999 109.907 174.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.423 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 12.1 mmtp -156.49 -155.39 0.53 Allowed 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 128.849 2.859 . . . . 2.2000000000000002 105.822 -172.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.2 m -37.07 -55.57 0.94 Allowed 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 127.389 2.276 . . . . 1.6000000000000001 114.319 -174.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -38.48 -46.86 1.21 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.214 0.916 . . . . 2.4100000000000001 112.626 176.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.24 -4.29 25.96 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.495 1.118 . . . . 1.6599999999999999 111.387 -173.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 54.64 30.23 50.73 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.644 1.592 . . . . 0.97999999999999998 113.815 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.7 m -86.1 -29.52 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 118.585 1.193 . . . . 1.6899999999999999 113.124 -172.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -121.41 -71.94 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 124.161 0.984 . . . . 5.9400000000000004 112.084 -176.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -66.08 128.63 19.99 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 N-CA-C 107.472 -1.78 . . . . 1.1499999999999999 107.472 167.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.09 168.8 17.37 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.761 -0.829 . . . . 3.5600000000000001 108.761 169.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.48 175.94 6.55 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.691 -0.855 . . . . 1.6599999999999999 108.691 163.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.99 -87.75 0.47 Allowed Glycine 0 C--O 1.22 -0.749 1 N-CA-C 100.346 -5.102 . . . . 3.29 100.346 -150.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -98.93 169.99 9.05 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 105.619 -1.993 . . . . 1.3300000000000001 105.619 -81.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -84.72 122.13 28.66 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 118.025 -0.988 . . . . 3.2000000000000002 108.69 176.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.6 pt -148.91 175.63 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 107.195 -1.409 . . . . 0.64000000000000001 107.195 171.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -121.02 127.58 51.89 Favored 'General case' 0 CA--C 1.527 0.06 0 N-CA-C 108.824 -0.806 . . . . 1.8 108.824 168.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.2 p -93.46 123.92 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 107.523 -1.288 . . . . 0.85999999999999999 107.523 170.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -124.16 123.57 5.2 Favored Glycine 0 C--N 1.332 0.354 0 N-CA-C 109.862 -1.295 . . . . 0.52000000000000002 109.862 -177.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -174.75 -171.22 38.71 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 110.379 -1.088 . . . . 0.60999999999999999 110.379 -176.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 6.3 ptp -94.35 135.0 36.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.125 -0.695 . . . . 2.4100000000000001 109.125 177.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.445 HG12 ' H ' ' A' ' 68' ' ' VAL . 78.9 t -59.76 133.86 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 123.229 0.612 . . . . 1.9399999999999999 110.27 177.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.88 -9.49 55.05 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.16 1.17 . . . . 3.4700000000000002 114.16 -172.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.445 ' H ' HG12 ' A' ' 66' ' ' VAL 0.28 9.1 p 50.43 47.62 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 123.917 1.818 . . . . 3.25 112.551 175.735 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 178.98 40.48 0.07 OUTLIER Glycine 0 CA--C 1.527 0.811 0 CA-C-N 112.429 -2.169 . . . . 2.5499999999999998 111.919 169.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.4 m -150.41 1.92 0.47 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.89 1.441 . . . . 2.4700000000000002 114.89 175.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.0 tpt -72.69 97.15 2.13 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.922 1.237 . . . . 1.74 108.347 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.9 m -116.69 140.45 39.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.533 -0.914 . . . . 0.56000000000000005 108.533 174.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.22 149.86 50.84 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.268 1.027 . . . . 4.71 109.225 -176.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -75.86 153.92 85.01 Favored Pre-proline 0 N--CA 1.454 -0.23 0 N-CA-C 109.789 -0.449 . . . . 2.23 109.789 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -62.52 -25.56 75.78 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.303 2.002 . . . . 1.4199999999999999 111.055 165.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -44.27 -37.03 3.01 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.824 0.85 . . . . 1.4099999999999999 110.626 165.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.6 m 72.5 24.17 2.95 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.62 1.568 . . . . 1.5 112.489 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.47 -48.25 2.07 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 125.506 1.522 . . . . 2.2000000000000002 110.366 169.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -75.41 130.21 38.6 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.774 -0.825 . . . . 1.3300000000000001 108.774 -177.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.582 HG23 ' HB3' ' A' ' 96' ' ' TYR . 16.6 m -142.44 131.04 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 125.191 1.397 . . . . 0.78000000000000003 107.308 -176.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -139.0 146.57 41.05 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 121.806 -0.559 . . . . 0.90000000000000002 109.537 177.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -149.46 160.61 43.31 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.117 0.567 . . . . 1.8500000000000001 109.782 -168.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -115.52 138.55 50.92 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.42 -0.585 . . . . 0.63 109.42 174.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.9 p -127.3 137.78 56.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.202 -1.036 . . . . 1.96 108.202 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -130.68 174.26 10.1 Favored 'General case' 0 CA--C 1.522 -0.122 0 C-N-CA 124.46 1.104 . . . . 1.6200000000000001 110.309 -175.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.2 t0 . . . . . 0 CA--C 1.534 0.339 0 C-N-CA 123.321 0.649 . . . . 2.7400000000000002 109.926 -179.164 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.544 0 N-CA-C 108.299 -1.92 . . . . 1.6499999999999999 108.299 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -120.88 151.32 39.81 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.731 1.212 . . . . 3.1099999999999999 109.219 174.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.22 160.01 12.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 107.702 -1.221 . . . . 0.91000000000000003 107.702 173.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.2 mt -118.2 124.42 47.88 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.133 0.973 . . . . 0.96999999999999997 108.729 -172.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.7 t -114.0 138.41 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 125.609 1.564 . . . . 0.87 108.16 -173.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.7 p -112.54 155.07 24.96 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.642 1.177 . . . . 0.52000000000000002 108.603 173.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.582 ' HB3' HG23 ' A' ' 80' ' ' VAL . 1.4 t80 -151.84 132.5 13.98 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.447 -1.686 . . . . 2.98 106.447 175.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -104.15 1.04 30.28 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.175 1.39 . . . . 2.7000000000000002 113.121 -173.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -120.38 166.85 12.98 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 124.931 1.293 . . . . 3.02 108.79 167.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.8 mp -63.06 144.37 56.96 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.765 0.793 . . . . 1.6699999999999999 111.2 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.488 HD23 HG21 ' A' ' 127' ' ' VAL . 8.3 mt -72.25 162.28 74.56 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 124.562 1.145 . . . . 1.1899999999999999 110.146 171.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.21 -95.34 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.853 3.036 . . . . 2.1899999999999999 109.333 173.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -76.15 44.95 0.34 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.524 1.13 . . . . 3.0 111.061 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.4 tp 60.82 -11.12 0.05 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.856 1.663 . . . . 3.1499999999999999 114.87 -177.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 44.7 t80 64.57 88.36 0.1 Allowed 'General case' 0 C--N 1.343 0.288 0 C-N-CA 125.157 1.383 . . . . 2.8599999999999999 107.958 -161.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.62 134.34 38.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.782 -1.562 . . . . 4.1299999999999999 106.782 175.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.5 mp0 -82.05 147.89 28.89 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 123.559 0.744 . . . . 2.7799999999999998 109.729 -171.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.89 47.82 23.7 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 111.671 -0.571 . . . . 0.73999999999999999 111.671 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -138.16 178.37 7.18 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 107.056 -1.461 . . . . 2.3500000000000001 107.056 168.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -105.29 134.19 11.94 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.909 -0.876 . . . . 0.67000000000000004 110.909 171.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.82 160.01 37.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 108.673 -0.862 . . . . 0.62 108.673 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.8 m -116.91 120.54 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 107.873 -1.158 . . . . 0.59999999999999998 107.873 170.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -113.77 115.85 28.45 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.762 1.225 . . . . 0.59999999999999998 109.385 -173.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -116.29 140.58 49.18 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.475 1.11 . . . . 3.6099999999999999 109.809 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -170.35 -104.87 0.18 Allowed Glycine 0 C--N 1.335 0.504 0 N-CA-C 107.408 -2.277 . . . . 1.4199999999999999 107.408 166.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.5 p -156.12 148.47 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 107.339 -1.356 . . . . 0.91000000000000003 107.339 176.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.592 ' HG ' HD12 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -63.29 150.42 43.28 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 119.028 -1.069 . . . . 2.3999999999999999 109.986 175.165 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -105.79 -92.03 2.25 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 110.514 -1.034 . . . . 2.0600000000000001 110.514 -171.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -73.42 -68.81 0.47 Allowed 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.887 -1.523 . . . . 4.6299999999999999 106.887 175.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -163.12 -71.18 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.211 -1.403 . . . . 4.7199999999999998 107.211 164.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.47 -23.57 72.0 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.347 0.975 . . . . 1.3999999999999999 113.184 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -95.58 119.89 34.87 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.221 1.011 . . . . 2.7400000000000002 108.706 173.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.592 HD12 ' HG ' ' A' ' 116' ' ' LEU . 0.1 OUTLIER -98.66 131.22 45.01 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 108.955 -0.757 . . . . 2.3999999999999999 108.955 -176.693 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -89.98 93.74 9.52 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 107.784 -1.191 . . . . 0.60999999999999999 107.784 177.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -99.97 151.76 20.97 Favored 'General case' 0 C--N 1.337 0.065 0 CA-C-N 117.856 0.298 . . . . 1.1399999999999999 110.319 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.7 t -140.12 -44.42 0.42 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 122.933 0.493 . . . . 1.48 111.66 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -82.4 84.43 7.16 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.032 -1.47 . . . . 2.9100000000000001 107.032 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.488 HG21 HD23 ' A' ' 100' ' ' LEU . 4.0 m -96.58 94.73 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.834 1.654 . . . . 1.21 110.274 178.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.57 121.64 35.19 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.81 -0.811 . . . . 0.62 108.81 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.16 62.54 1.81 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.189 0.996 . . . . 1.3 111.41 -174.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.42 -24.14 59.29 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.417 0.895 . . . . 3.9900000000000002 113.417 -172.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 . . . . . 0 CA--C 1.539 0.539 0 CA-C-O 119.073 -0.489 . . . . 5.2400000000000002 112.129 178.73 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 N--CA 1.466 0.341 0 N-CA-C 112.087 0.403 . . . . 2.3599999999999999 112.087 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -84.25 120.54 26.35 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 124.467 1.107 . . . . 2.2200000000000002 109.729 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.92 156.96 41.8 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.607 0.763 . . . . 2.7799999999999998 112.378 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 m -86.6 124.46 69.46 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 126.074 1.75 . . . . 2.27 112.811 -167.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . 2.256 0.1 OUTLIER -6.37 -72.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.151 1 C-N-CA 128.016 5.811 . . . . 1.55 118.345 161.31 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.5 m -70.5 -29.4 65.91 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 113.996 -1.456 . . . . 2.5899999999999999 113.186 -173.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -62.57 -56.44 17.86 Favored 'General case' 0 C--N 1.335 -0.041 0 N-CA-C 108.898 -0.779 . . . . 3.1299999999999999 108.898 -177.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 33.1 pt -59.39 -16.15 9.43 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 114.265 1.209 . . . . 1.6499999999999999 114.265 -174.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.6 t -73.19 -38.39 54.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 124.759 1.224 . . . . 2.0899999999999999 111.071 172.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -104.7 85.89 2.39 Favored 'General case' 0 C--N 1.333 -0.118 0 O-C-N 121.127 -0.983 . . . . 2.0299999999999998 110.783 -159.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.17 51.38 18.18 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.138 -1.185 . . . . 1.3899999999999999 110.138 174.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.9 mmtt -150.18 -124.15 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.423 -1.325 . . . . 2.52 107.423 -171.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.1 m -59.19 -58.45 8.59 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.929 1.292 . . . . 1.53 110.414 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -36.81 -51.84 0.9 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 122.709 1.242 . . . . 3.23 111.12 178.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.83 -11.95 37.81 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 113.577 -1.647 . . . . 1.4399999999999999 111.328 -169.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 54.26 35.37 55.15 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 126.197 1.856 . . . . 1.1799999999999999 112.649 -177.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.8 m -92.92 -22.4 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 118.032 0.916 . . . . 1.3799999999999999 112.715 -174.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.5 mmpp? -124.36 -78.93 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 125.343 1.457 . . . . 4.3399999999999999 111.11 174.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.22 149.47 35.85 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 CA-C-N 120.95 1.375 . . . . 1.1100000000000001 109.375 173.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -112.92 156.46 22.94 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.309 1.844 . . . . 2.6800000000000002 108.675 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.35 160.98 2.77 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.595 0.712 . . . . 1.22 110.958 168.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.77 -12.7 62.83 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 121.705 -0.622 . . . . 1.4099999999999999 112.385 -176.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -82.57 154.69 24.87 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 118.436 1.118 . . . . 2.6000000000000001 109.325 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 74.2 mtt-85 -96.06 132.48 41.38 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.45 -0.944 . . . . 5.1299999999999999 108.45 170.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.6 pt -145.97 177.47 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 105.839 -1.912 . . . . 0.69999999999999996 105.839 165.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 -117.27 135.37 53.87 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 105.973 -1.862 . . . . 1.96 105.973 173.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.4 p -103.84 136.26 37.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 107.361 -1.348 . . . . 1.3 107.361 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.82 120.16 1.59 Allowed Glycine 0 C--N 1.334 0.422 0 N-CA-C 110.777 -0.929 . . . . 0.63 110.777 -176.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -172.15 -163.12 25.51 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 109.309 -1.516 . . . . 0.66000000000000003 109.309 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.2 ptm -102.87 135.0 45.35 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.54 0.736 . . . . 4.1699999999999999 109.511 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 p -98.54 135.32 33.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 109.863 -0.421 . . . . 2.46 109.863 175.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.1 m -68.63 151.72 46.33 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 122.243 1.02 . . . . 2.3599999999999999 108.826 169.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.8 p -61.42 -66.24 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 114.718 -1.128 . . . . 2.4399999999999999 111.218 -174.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -81.86 40.8 2.67 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 120.8 -1.187 . . . . 1.6899999999999999 112.713 -172.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.6 m -108.87 -28.1 9.35 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 117.82 0.81 . . . . 1.55 112.705 -172.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.447 ' SD ' ' HB3' ' A' ' 104' ' ' PHE . 0.8 OUTLIER -79.22 103.11 8.93 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.74 0.7 . . . . 1.8400000000000001 110.087 -175.063 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.6 m -100.27 147.52 7.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 107.811 -1.181 . . . . 0.67000000000000004 107.811 175.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.42 ' CB ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -142.85 137.51 29.65 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.427 0.691 . . . . 6.4199999999999999 109.829 -165.969 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.19 153.88 94.95 Favored Pre-proline 0 N--CA 1.452 -0.327 0 N-CA-C 109.607 -0.516 . . . . 2.0499999999999998 109.607 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -65.51 -25.63 55.25 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.218 1.946 . . . . 1.54 111.306 165.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -48.94 -29.98 5.4 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.934 0.494 . . . . 1.4199999999999999 110.831 164.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.1 m 67.43 23.68 9.04 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 125.362 1.465 . . . . 1.54 112.114 173.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.38 -44.28 1.72 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 127.875 2.47 . . . . 1.77 110.757 177.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -84.39 129.08 34.9 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 107.692 -1.225 . . . . 1.1799999999999999 107.692 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.42 HG12 ' CB ' ' A' ' 73' ' ' ARG . 20.1 m -147.43 145.72 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.174 -1.417 . . . . 0.71999999999999997 107.174 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -150.65 154.92 38.35 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.599 -0.688 . . . . 1.1100000000000001 111.48 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -155.14 138.0 15.36 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 123.404 0.682 . . . . 1.8700000000000001 111.573 -173.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.622 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . . . -84.04 124.33 30.97 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.296 -0.631 . . . . 0.84999999999999998 109.296 176.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 t -108.4 147.62 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 124.267 1.027 . . . . 1.76 108.835 173.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -144.91 178.92 7.67 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.024 -1.102 . . . . 1.4399999999999999 108.024 177.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.4 t0 . . . . . 0 CA--C 1.532 0.264 0 CA-C-O 122.1 0.952 . . . . 2.8399999999999999 109.711 175.727 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.66 0 N-CA-C 108.582 -1.807 . . . . 1.8100000000000001 108.582 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -136.41 145.11 44.92 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.625 -1.991 . . . . 3.2799999999999998 105.625 174.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -126.67 158.28 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.013 -1.847 . . . . 1.3100000000000001 106.013 175.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.622 ' HA ' ' HA ' ' A' ' 83' ' ' ALA 0.442 2.9 mt -107.69 117.49 34.25 Favored 'General case' 0 CA--C 1.545 0.77 1 N-CA-C 123.136 4.495 . . . . 0.90000000000000002 123.136 164.394 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.1 t -86.52 141.29 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 107.331 -1.359 . . . . 0.87 107.331 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.2 p -120.86 149.6 42.35 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.595 1.158 . . . . 0.92000000000000004 107.959 -176.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.41 ' OH ' HG13 ' A' ' 127' ' ' VAL . 0.4 OUTLIER -145.65 142.25 28.88 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.588 1.155 . . . . 3.29 108.031 -176.905 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -115.29 14.33 16.83 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.275 1.43 . . . . 2.54 111.649 171.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -117.69 163.38 16.56 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 124.449 1.1 . . . . 4.71 110.618 170.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.8 mp -67.84 113.14 5.33 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.342 -0.845 . . . . 1.95 109.202 163.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.8 mt -62.18 156.09 61.5 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.067 0.947 . . . . 1.46 110.246 171.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -68.07 147.69 74.0 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 123.651 2.901 . . . . 2.23 110.767 174.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 41.55 49.44 3.63 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.376 1.47 . . . . 2.98 111.629 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 44.89 22.01 0.06 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 127.089 2.156 . . . . 2.29 115.326 -174.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.447 ' HB3' ' SD ' ' A' ' 71' ' ' MET . 67.1 t80 51.0 110.94 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.125 2.17 . . . . 2.52 110.764 -159.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.5 mmt85 -77.75 112.7 14.87 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.251 -1.388 . . . . 5.0700000000000003 107.251 -176.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -82.36 172.75 12.72 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.416 0.627 . . . . 3.3999999999999999 111.005 -170.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 62.26 43.67 98.76 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 121.861 -0.525 . . . . 0.89000000000000001 112.61 171.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -157.16 176.88 12.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.092 1.357 . . . . 2.4700000000000002 108.101 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -93.31 140.37 15.03 Favored Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 109.893 -1.283 . . . . 0.56999999999999995 109.893 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.5 pp -148.01 165.15 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.999 -1.482 . . . . 0.69999999999999996 106.999 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.25 135.89 60.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 108.373 -0.973 . . . . 0.78000000000000003 108.373 174.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.569 ' HB2' HG12 ' A' ' 127' ' ' VAL . . . -128.39 152.87 47.69 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 126.285 1.834 . . . . 0.67000000000000004 110.071 -170.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -147.95 155.13 41.22 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 119.439 1.018 . . . . 2.9199999999999999 113.13 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 175.62 -89.07 0.08 OUTLIER Glycine 0 C--N 1.345 1.054 0 CA-C-O 119.728 -0.485 . . . . 2.1699999999999999 112.473 172.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.7 p -164.24 148.78 2.76 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 C-N-CA 124.351 1.061 . . . . 1.3600000000000001 109.677 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.479 HD22 HD22 ' A' ' 122' ' ' LEU . 5.1 mt -90.91 141.74 28.51 Favored 'General case' 0 N--CA 1.453 -0.275 0 O-C-N 122.087 -0.383 . . . . 2.5699999999999998 110.69 -177.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -131.67 158.28 22.74 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 109.132 -1.587 . . . . 3.6299999999999999 109.132 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 55.52 33.76 21.72 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.934 1.294 . . . . 4.3300000000000001 110.629 169.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 27.25 45.06 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 128.194 2.597 . . . . 4.0599999999999996 112.173 -165.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -176.37 -48.2 0.06 OUTLIER Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.07 -1.062 . . . . 1.4199999999999999 113.487 -164.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -91.66 114.25 26.73 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 118.502 1.151 . . . . 2.6299999999999999 109.001 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.479 HD22 HD22 ' A' ' 116' ' ' LEU . 5.8 mt -87.62 114.47 24.27 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 106.742 -1.577 . . . . 1.8400000000000001 106.742 -174.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -88.04 98.45 11.53 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.325 -1.361 . . . . 0.56000000000000005 107.325 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -101.86 159.17 15.57 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.84 -0.43 . . . . 1.6799999999999999 109.84 -178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.402 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 7.1 t -136.05 -41.76 0.66 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.233 0.613 . . . . 1.1399999999999999 111.787 174.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -92.84 129.84 38.63 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 120.921 -1.112 . . . . 4.1200000000000001 108.367 175.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.569 HG12 ' HB2' ' A' ' 112' ' ' ALA . 1.2 m -127.47 140.07 50.15 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 C-N-CA 124.23 1.012 . . . . 1.0900000000000001 109.37 168.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -114.22 87.48 2.64 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.374 -1.343 . . . . 1.3400000000000001 107.374 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.44 57.35 2.36 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.613 1.165 . . . . 1.1899999999999999 110.952 -174.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -79.02 47.69 0.79 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.272 1.029 . . . . 3.3799999999999999 112.95 -169.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 . . . . . 0 CA--C 1.533 0.312 0 C-N-CA 124.402 1.081 . . . . 4.8899999999999997 110.071 -177.014 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 pt? . . . . . 0 N--CA 1.465 0.285 0 N-CA-C 111.873 0.323 . . . . 1.99 111.873 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -82.62 121.21 26.53 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.672 1.189 . . . . 2.3100000000000001 110.219 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -128.27 145.36 51.07 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.422 1.089 . . . . 3.3399999999999999 110.872 177.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 91.5 m -69.24 127.5 92.91 Favored Pre-proline 0 N--CA 1.45 -0.437 0 C-N-CA 126.44 1.896 . . . . 1.74 110.115 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -57.57 -41.68 68.76 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.036 1.824 . . . . 1.24 111.995 -175.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.4 m -47.17 -43.02 20.83 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.71 1.141 . . . . 1.9299999999999999 113.39 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -60.74 -40.63 93.14 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.363 -0.606 . . . . 3.52 109.363 178.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 40.5 pt -102.69 35.22 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.867 1.667 . . . . 1.95 111.847 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -114.98 -31.25 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 119.322 0.965 . . . . 2.2400000000000002 111.535 176.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -117.22 126.19 52.36 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.433 1.093 . . . . 3.23 108.112 -175.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.03 -69.9 0.79 Allowed Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.623 1.106 . . . . 4.7999999999999998 111.66 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -30.93 -89.07 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.571 0 C-N-CA 129.639 3.175 . . . . 2.4399999999999999 111.645 175.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.4 m -71.33 -51.0 26.68 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 119.48 1.036 . . . . 1.5700000000000001 109.69 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -33.03 -50.23 0.27 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 128.307 2.643 . . . . 3.1099999999999999 114.707 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.2 m -127.76 15.28 6.96 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.15 2.18 . . . . 3.5600000000000001 109.171 -175.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 51.89 39.22 47.62 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-O 117.382 -1.788 . . . . 1.4299999999999999 113.989 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.2 m -84.42 -45.13 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 121.843 2.822 . . . . 1.1699999999999999 112.421 -169.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -92.76 -57.37 0.23 Allowed Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 125.128 1.371 . . . . 3.3999999999999999 113.383 178.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -75.84 179.88 5.84 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.323 2.016 . . . . 1.5800000000000001 108.418 172.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -135.43 128.14 30.96 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 106.716 -1.587 . . . . 5.6600000000000001 106.716 -176.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.38 125.76 24.92 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.905 -0.776 . . . . 1.3600000000000001 108.905 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.18 -11.46 19.88 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 119.179 -0.789 . . . . 1.1200000000000001 113.021 -175.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -83.4 146.21 28.57 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 119.124 1.462 . . . . 2.5099999999999998 109.332 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -86.91 139.33 30.73 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.79 -0.641 . . . . 4.5199999999999996 109.998 167.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.4 pt -148.7 172.27 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 107.124 -1.436 . . . . 0.80000000000000004 107.124 171.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.6 mtt180 -114.19 110.0 19.29 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 106.825 -1.546 . . . . 1.99 106.825 174.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.3 p -79.26 127.74 38.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.299 -1.371 . . . . 0.93000000000000005 107.299 175.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.54 114.87 1.51 Allowed Glycine 0 C--N 1.335 0.487 0 N-CA-C 110.191 -1.164 . . . . 0.69999999999999996 110.191 -177.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.05 -173.22 29.41 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.154 -1.178 . . . . 0.81000000000000005 110.154 -175.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.1 ptp -101.08 126.64 47.79 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 124.027 0.931 . . . . 2.98 110.234 -176.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 108' ' ' GLN . 29.0 m -89.58 157.51 3.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 109.843 -0.428 . . . . 2.4900000000000002 109.843 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.8 -172.57 2.69 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.591 -0.277 . . . . 3.0800000000000001 110.26 176.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.3 p -116.98 71.98 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 126.937 2.095 . . . . 2.8799999999999999 106.958 174.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.65 63.82 0.09 OUTLIER Glycine 0 CA--C 1.53 0.975 0 C-N-CA 126.671 2.081 . . . . 1.8500000000000001 111.311 -178.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.7 m -146.12 64.55 1.22 Allowed 'General case' 0 CA--C 1.519 -0.238 0 O-C-N 121.243 -1.151 . . . . 2.0499999999999998 110.642 163.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.14 115.81 18.27 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.381 -1.34 . . . . 2.1800000000000002 107.381 176.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.6 m -125.15 127.72 72.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 108.363 -0.977 . . . . 0.69999999999999996 108.363 170.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.47 149.84 29.73 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.444 1.098 . . . . 4.9800000000000004 110.421 175.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -86.58 150.49 51.19 Favored Pre-proline 0 C--O 1.235 0.339 0 N-CA-C 109.002 -0.74 . . . . 1.9399999999999999 109.002 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.45 28.9 0.37 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.89 2.393 . . . . 2.3300000000000001 112.961 173.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -89.44 -27.63 20.26 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.329 1.052 . . . . 1.3799999999999999 108.847 166.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.506 ' O ' HD13 ' A' ' 99' ' ' LEU . 8.5 m 69.95 12.29 7.83 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 125.594 1.558 . . . . 1.7 112.177 -172.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.45 32.04 3.39 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.918 1.287 . . . . 2.3199999999999998 113.36 170.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -153.48 131.86 12.05 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 121.827 -0.545 . . . . 1.1399999999999999 109.927 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.98 146.3 16.26 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 C-N-CA 123.666 0.786 . . . . 1.04 110.409 -172.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -152.74 156.91 40.04 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 120.659 -1.276 . . . . 0.93999999999999995 110.989 175.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -155.44 160.21 40.44 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.257 0.623 . . . . 1.8600000000000001 110.645 -173.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.94 139.34 39.79 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.5 -0.926 . . . . 0.60999999999999999 108.5 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.6 p -125.34 143.76 37.78 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.063 0 N-CA-C 107.87 -1.159 . . . . 1.8700000000000001 107.87 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 56.2 p-80 -124.29 -171.04 2.25 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.63 1.172 . . . . 1.6599999999999999 109.814 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.0 t70 . . . . . 0 C--O 1.233 0.192 0 N-CA-C 110.244 -0.28 . . . . 2.6600000000000001 110.244 174.59 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.342 0 CA-C-O 119.04 -0.867 . . . . 2.5800000000000001 113.41 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -66.79 96.15 0.39 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.042 0.921 . . . . 2.8399999999999999 110.213 -173.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.456 HD12 HD12 ' A' ' 122' ' ' LEU . 0.3 OUTLIER -121.84 140.49 45.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 107.828 -1.175 . . . . 1.45 107.828 179.099 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.451 ' H ' HD13 ' A' ' 92' ' ' ILE . 4.2 mt -90.18 124.89 35.22 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.452 1.101 . . . . 0.65000000000000002 110.048 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.1 t -106.0 119.89 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 125.082 1.353 . . . . 0.85999999999999999 107.578 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 65.5 p -98.69 144.06 28.37 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.173 0.589 . . . . 0.59999999999999998 109.668 175.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.406 ' CE2' HD23 ' A' ' 100' ' ' LEU . 1.9 t80 -137.89 143.13 40.71 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.721 1.608 . . . . 2.5299999999999998 107.411 -173.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -85.94 -82.43 0.19 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.132 0.973 . . . . 3.1200000000000001 109.764 175.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -62.29 166.83 4.6 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.455 0.645 . . . . 3.3599999999999999 111.382 -168.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.506 HD13 ' O ' ' A' ' 77' ' ' SER . 1.4 mp -60.66 131.78 51.81 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 119.998 -1.689 . . . . 3.3999999999999999 111.685 175.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.406 HD23 ' CE2' ' A' ' 96' ' ' TYR . 26.7 mt -60.61 158.02 33.72 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 114.559 -1.201 . . . . 1.4399999999999999 109.757 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -67.9 -85.11 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.234 2.623 . . . . 2.29 111.145 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -122.83 52.09 1.37 Allowed 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 124.76 1.224 . . . . 3.0 108.749 -172.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 34.63 41.75 0.06 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.73 1.612 . . . . 3.6800000000000002 113.096 -173.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 40.7 p90 31.48 74.56 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.34 1.856 . . . . 4.0800000000000001 112.151 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.488 ' H ' ' HD3' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -60.29 125.36 23.39 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 119.854 -1.779 . . . . 6.9699999999999998 110.177 -124.967 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -72.19 143.74 48.77 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 119.826 -0.749 . . . . 4.8099999999999996 109.882 -153.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.14 22.22 23.2 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.675 1.607 . . . . 1.46 113.591 -172.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.452 ' O ' HG22 ' A' ' 66' ' ' VAL . 2.2 pt20 -137.43 178.68 6.91 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 119.519 1.66 . . . . 3.1600000000000001 110.604 178.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -92.71 128.1 9.27 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.997 -0.441 . . . . 1.0800000000000001 111.997 170.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.3 pp -131.18 159.85 42.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 124.901 1.28 . . . . 0.69999999999999996 107.915 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.1 m -113.82 140.25 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.67 -1.233 . . . . 1.02 107.67 175.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -129.68 123.5 31.31 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.063 0.945 . . . . 0.72999999999999998 109.606 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.549 ' HB2' ' HB2' ' A' ' 126' ' ' GLU . 3.8 mt-30 -107.24 136.68 46.66 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 126.065 1.746 . . . . 4.0899999999999999 109.855 -175.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 168.69 -142.4 7.38 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 108.745 -1.742 . . . . 0.91000000000000003 108.745 172.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.4 p -123.97 153.0 29.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 C-N-CA 124.507 1.123 . . . . 1.22 109.949 -170.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -54.59 137.95 42.2 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.373 -0.531 . . . . 1.97 110.507 168.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -86.89 -146.45 10.23 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 109.716 -1.354 . . . . 2.3599999999999999 109.716 175.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -72.34 109.08 5.81 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.408 -1.701 . . . . 5.4100000000000001 106.408 172.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -6.17 72.56 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.347 1 C-N-CA 132.678 4.391 . . . . 3.6499999999999999 112.835 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 154.41 -45.74 0.55 Allowed Glycine 0 CA--C 1.523 0.534 0 CA-C-N 113.679 -1.601 . . . . 1.1599999999999999 111.381 -172.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.92 163.76 13.37 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.509 0.654 . . . . 2.73 111.576 177.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.456 HD12 HD12 ' A' ' 92' ' ' ILE . 11.8 mt -123.11 130.27 52.56 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.627 1.171 . . . . 1.9199999999999999 108.387 176.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -103.75 106.24 16.69 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 108.38 -0.97 . . . . 0.75 108.38 176.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -131.86 126.14 33.51 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 123.075 0.55 . . . . 1.1799999999999999 110.95 -176.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.9 t -113.67 -24.41 9.21 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.407 1.083 . . . . 1.1699999999999999 111.367 178.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 113' ' ' GLN . 36.7 mt-10 -86.62 78.79 9.09 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 119.662 -1.898 . . . . 3.4300000000000002 108.141 178.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.427 ' C ' HD13 ' A' ' 128' ' ' LEU . 34.0 m -91.9 130.88 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 119.333 0.97 . . . . 0.85999999999999999 110.959 174.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.427 HD13 ' C ' ' A' ' 127' ' ' VAL . 0.0 OUTLIER -126.37 127.67 45.86 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.213 -1.032 . . . . 1.2 108.213 178.93 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.14 97.41 9.18 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.236 1.414 . . . . 1.3100000000000001 108.972 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.1 pttt -93.5 23.9 4.31 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.456 0.702 . . . . 3.8100000000000001 112.096 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 . . . . . 0 N--CA 1.452 -0.341 0 C-N-CA 125.262 1.425 . . . . 4.4100000000000001 107.272 173.5 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.469 0.518 0 N-CA-C 112.438 0.532 . . . . 2.1699999999999999 112.438 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -86.19 117.73 25.2 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 125.374 1.47 . . . . 2.21 111.436 -174.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -116.89 151.64 36.16 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 127.207 2.203 . . . . 3.4100000000000001 109.519 -175.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 57.8 m -90.54 136.43 28.18 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.27 1.428 . . . . 1.8400000000000001 109.611 -175.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -61.98 -48.32 8.74 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.025 2.483 . . . . 0.73999999999999999 112.879 -174.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 p -53.75 -36.06 61.94 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.973 0.806 . . . . 1.96 111.948 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -54.74 -57.67 10.6 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.316 1.046 . . . . 2.4199999999999999 109.098 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.306 8.3 pt -70.0 1.68 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 114.352 1.242 . . . . 1.1899999999999999 114.352 -172.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.4 t -85.64 -28.73 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.8 1.24 . . . . 2.1099999999999999 111.09 170.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -128.57 93.54 3.66 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.964 -1.085 . . . . 2.2000000000000002 112.344 -160.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.45 37.75 53.15 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.516 -1.034 . . . . 1.3300000000000001 110.516 176.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.4 -153.87 0.5 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.786 2.834 . . . . 2.6600000000000001 103.371 178.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.2 m -28.97 -58.16 0.14 Allowed 'General case' 0 C--N 1.339 0.118 0 C-N-CA 126.905 2.082 . . . . 1.3500000000000001 115.444 -172.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -44.48 -47.84 10.05 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.586 0.754 . . . . 2.5800000000000001 112.272 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.6 m -93.51 -23.59 18.3 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.757 0.823 . . . . 1.3600000000000001 111.409 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.95 35.6 84.7 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.984 1.278 . . . . 0.98999999999999999 112.381 176.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.7 m -82.08 -39.45 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 117.525 0.662 . . . . 1.25 111.816 -175.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -105.81 -63.03 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 124.482 1.113 . . . . 4.0999999999999996 111.116 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -80.93 142.16 13.71 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 CA-C-N 121.07 1.418 . . . . 1.2 109.369 171.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -90.53 154.35 19.69 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.279 1.031 . . . . 2.8500000000000001 109.484 167.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.58 140.73 49.93 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.114 -1.069 . . . . 1.53 108.114 169.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 105.51 16.84 14.8 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.073 0.844 . . . . 1.23 113.36 -176.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -112.73 154.38 26.25 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.746 1.219 . . . . 1.3999999999999999 109.785 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.41 ' NH1' ' OE2' ' A' ' 126' ' ' GLU . 0.3 OUTLIER -84.84 127.45 34.15 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.868 0.867 . . . . 4.5499999999999998 109.085 173.11 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.9 pt -144.52 177.78 1.85 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 106.554 -1.647 . . . . 0.70999999999999996 106.554 166.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.3 mtm180 -122.77 122.67 39.28 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.754 -1.202 . . . . 2.2599999999999998 107.754 173.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.1 p -87.75 132.98 31.6 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 N-CA-C 107.282 -1.377 . . . . 0.94999999999999996 107.282 173.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -135.75 120.63 2.31 Favored Glycine 0 C--N 1.334 0.421 0 N-CA-C 109.89 -1.284 . . . . 0.70999999999999996 109.89 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.39 -166.32 31.55 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.314 -1.115 . . . . 0.81999999999999995 110.314 -175.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.16 130.83 51.91 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.168 0.508 . . . . 2.9900000000000002 111.462 -174.06 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.6 t -76.29 130.65 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 124.267 1.027 . . . . 2.1699999999999999 108.527 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.621 HG22 HG12 ' A' ' 68' ' ' VAL . 12.6 m -49.27 -85.43 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.294 1.838 . . . . 2.9100000000000001 114.581 -170.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.621 HG12 HG22 ' A' ' 67' ' ' THR . 9.1 p 174.45 -40.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 126.093 1.757 . . . . 2.0899999999999999 109.276 -171.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -151.8 38.2 0.81 Allowed Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.214 -1.155 . . . . 1.8100000000000001 110.214 175.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 57.1 m -94.74 -8.61 37.16 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 117.923 0.861 . . . . 1.03 112.221 178.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 52.8 tpp -65.52 128.89 37.75 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.794 -0.817 . . . . 2.5800000000000001 108.794 172.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.5 m -127.43 141.79 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 N-CA-C 107.425 -1.324 . . . . 0.62 107.425 164.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.76 135.13 48.77 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.43 -0.952 . . . . 4.79 108.43 -172.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -82.27 152.4 67.67 Favored Pre-proline 0 C--O 1.235 0.298 0 N-CA-C 109.851 -0.426 . . . . 2.1099999999999999 109.851 -176.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -70.97 3.87 3.07 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.114 2.543 . . . . 1.49 112.346 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -70.81 -33.65 70.93 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.503 -0.554 . . . . 1.27 109.503 168.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.1 m 73.63 9.51 4.93 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.405 1.482 . . . . 1.2 113.452 -173.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.27 16.56 9.08 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.583 1.553 . . . . 1.7 111.323 172.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -143.79 125.96 15.54 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.178 -1.045 . . . . 1.23 108.178 -177.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.08 140.16 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.993 1.317 . . . . 1.05 107.712 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -140.32 153.82 46.57 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.879 -0.513 . . . . 0.94999999999999996 109.813 172.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -153.27 146.19 24.47 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.43 -0.35 . . . . 2.0 110.808 -170.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.3 125.66 39.08 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.382 -0.599 . . . . 0.67000000000000004 109.382 175.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.3 t -106.65 132.72 53.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 107.063 -1.458 . . . . 1.78 107.063 176.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -115.53 -178.28 3.35 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.236 0.614 . . . . 1.8799999999999999 111.329 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.0 t0 . . . . . 0 N--CA 1.445 -0.719 0 C-N-CA 124.101 0.96 . . . . 3.5800000000000001 110.98 177.227 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.622 0 N-CA-C 110.658 -0.977 . . . . 1.6599999999999999 110.658 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -115.75 150.5 36.78 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.237 1.015 . . . . 2.7999999999999998 110.413 -174.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.49 152.95 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 107.967 -1.123 . . . . 0.94999999999999996 107.967 178.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.0 mt -100.58 121.77 42.15 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.312 -0.996 . . . . 0.52000000000000002 108.312 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.7 t -107.09 133.34 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 107.437 -1.32 . . . . 0.85999999999999999 107.437 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 82.2 p -107.46 149.49 27.88 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.531 -0.915 . . . . 0.56999999999999995 108.531 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.548 ' CD2' HD21 ' A' ' 100' ' ' LEU . 11.2 t80 -146.65 126.9 13.87 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.026 -1.101 . . . . 2.4399999999999999 108.026 -173.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -113.85 46.62 1.29 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.003 1.321 . . . . 2.0600000000000001 111.745 -165.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -166.75 -179.64 4.9 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.847 2.059 . . . . 3.3599999999999999 106.286 169.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.4 mp -67.68 131.38 45.47 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.399 1.0 . . . . 1.8700000000000001 111.145 172.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.548 HD21 ' CD2' ' A' ' 96' ' ' TYR . 16.2 mt -83.55 155.29 65.8 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.485 1.114 . . . . 1.6299999999999999 110.579 174.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.62 112.44 2.4 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.954 2.436 . . . . 2.8500000000000001 109.538 175.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 39.74 47.7 1.81 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.011 1.724 . . . . 5.8300000000000001 111.504 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 48.76 13.52 0.06 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 127.782 2.433 . . . . 3.3799999999999999 116.374 -178.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 51.49 114.29 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 122.226 1.012 . . . . 4.6399999999999997 109.987 -148.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -74.16 100.63 3.71 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 104.837 -2.282 . . . . 5.25 104.837 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -71.94 157.55 37.63 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 119.776 -0.77 . . . . 5.0800000000000001 110.965 -148.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.09 37.87 6.6 Favored Glycine 0 CA--C 1.531 1.09 0 N-CA-C 110.608 -0.997 . . . . 0.89000000000000001 110.608 -167.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -138.2 162.21 34.85 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.773 1.229 . . . . 2.6600000000000001 108.896 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -102.3 129.79 10.01 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 110.476 -1.05 . . . . 0.85999999999999999 110.476 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.5 pp -140.56 161.22 24.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 108.208 -1.034 . . . . 0.87 108.208 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.3 m -114.45 141.66 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.091 -1.078 . . . . 1.0800000000000001 108.091 174.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -127.34 116.9 21.21 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.602 1.161 . . . . 0.77000000000000002 108.7 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -101.12 149.38 24.02 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.135 -0.691 . . . . 3.8799999999999999 109.135 175.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 162.11 -140.84 6.83 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 107.451 -2.26 . . . . 0.82999999999999996 107.451 173.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.5 p -136.04 142.94 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 118.084 0.942 . . . . 0.76000000000000001 109.996 -164.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.86 162.32 29.64 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.456 -0.793 . . . . 2.0299999999999998 109.99 173.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -169.73 -52.35 0.03 OUTLIER Glycine 0 C--N 1.332 0.351 0 C-N-CA 119.951 -1.119 . . . . 2.1899999999999999 111.726 166.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -67.0 141.25 57.65 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.55 -0.908 . . . . 4.3700000000000001 108.55 174.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.08 64.8 0.54 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 128.651 2.78 . . . . 4.46 110.299 -171.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 128.51 8.22 4.04 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.635 2.064 . . . . 1.1699999999999999 113.368 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.16 153.9 51.82 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.539 1.67 . . . . 2.3100000000000001 109.885 177.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.3 mp -121.69 134.7 54.96 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.348 1.059 . . . . 2.0499999999999998 109.714 -166.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.68 101.3 12.15 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.388 -1.338 . . . . 0.52000000000000002 107.388 177.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -127.52 83.27 2.15 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 112.211 0.449 . . . . 1.72 112.211 -166.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.485 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 14.6 t -83.01 -22.25 33.66 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.959 0.726 . . . . 0.84999999999999998 112.959 -174.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.41 ' OE2' ' NH1' ' A' ' 59' ' ' ARG . 20.6 mt-10 -83.5 75.11 10.04 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 120.445 -1.409 . . . . 4.4800000000000004 107.981 -176.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.0 m -92.33 131.16 40.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 O-C-N 121.527 -0.733 . . . . 1.1399999999999999 111.534 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.28 124.33 44.35 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.031 -1.47 . . . . 1.02 107.031 176.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -94.31 124.8 38.56 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.258 -1.016 . . . . 2.3900000000000001 108.258 175.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -153.56 58.14 0.75 Allowed 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.594 0.758 . . . . 4.2300000000000004 109.92 -176.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 4.9 p80 . . . . . 0 N--CA 1.454 -0.231 0 C-N-CA 125.229 1.412 . . . . 6.7199999999999998 107.932 179.81 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 pt? . . . . . 0 CA--C 1.531 0.222 0 N-CA-C 111.361 0.134 . . . . 2.21 111.361 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.435 ' CE1' ' HD2' ' A' ' 61' ' ' ARG . 80.0 m-85 -83.83 123.15 29.61 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.106 1.362 . . . . 2.2400000000000002 110.954 -175.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.03 156.03 43.39 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.393 1.477 . . . . 2.9199999999999999 110.954 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.3 139.58 52.25 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 123.125 0.57 . . . . 2.48 111.311 -175.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.38 -35.0 99.18 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.63 2.22 . . . . 0.82999999999999996 113.45 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -57.19 -29.31 63.58 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 119.988 1.267 . . . . 3.02 112.056 176.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -67.55 -56.98 7.33 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.244 -1.021 . . . . 2.3199999999999998 108.244 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.0 pt -74.17 36.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.025 1.33 . . . . 1.1399999999999999 113.175 -174.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 43.1 t -123.38 -68.68 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 105.757 -1.942 . . . . 2.04 105.757 168.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -79.0 102.5 8.37 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.266 1.826 . . . . 2.2599999999999998 110.728 -164.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.9 32.89 74.01 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.408 -1.077 . . . . 1.5700000000000001 110.408 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -140.32 -110.83 0.15 Allowed 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 126.44 1.896 . . . . 2.75 108.341 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.44 HG23 HD12 ' A' ' 116' ' ' LEU . 29.6 m -73.83 -56.68 4.67 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 119.147 0.885 . . . . 1.53 112.177 -172.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -58.55 -46.89 85.91 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 122.135 0.969 . . . . 2.8500000000000001 109.068 -174.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -68.16 -35.9 78.79 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.8 -0.637 . . . . 1.3999999999999999 112.345 173.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.29 47.68 42.63 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.977 1.275 . . . . 1.3799999999999999 111.882 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.251 32.6 m -112.89 -70.39 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 113.984 1.105 . . . . 1.6499999999999999 113.984 -174.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.7 mttt -73.14 -62.22 1.31 Allowed Pre-proline 0 CA--C 1.535 0.403 0 O-C-N 121.4 -0.813 . . . . 4.8399999999999999 112.101 -172.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.36 111.65 2.64 Favored 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 121.867 1.711 . . . . 1.1000000000000001 107.684 175.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -62.03 148.68 43.24 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.101 -0.703 . . . . 3.2599999999999998 109.101 172.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.61 162.68 10.15 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.842 -0.617 . . . . 1.21 110.409 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.91 14.37 82.24 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 119.672 -0.516 . . . . 1.02 113.387 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -93.75 158.94 15.42 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-N 118.284 1.042 . . . . 1.46 109.433 172.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -98.38 135.37 40.07 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.448 0.699 . . . . 4.9100000000000001 110.425 174.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.2 pt -150.53 178.47 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 125.821 1.649 . . . . 0.72999999999999998 106.798 174.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.435 ' HD2' ' CE1' ' A' ' 37' ' ' PHE . 13.5 mtt180 -123.52 131.96 53.78 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.682 -1.229 . . . . 1.8899999999999999 107.682 165.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.2 p -92.07 140.75 15.62 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.08 0 N-CA-C 107.359 -1.348 . . . . 0.93000000000000005 107.359 171.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.19 124.37 2.41 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.002 -1.239 . . . . 0.62 110.002 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -169.3 -163.53 23.49 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 108.622 -1.791 . . . . 0.69999999999999996 108.622 -175.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.71 139.43 38.97 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 117.358 0.579 . . . . 2.8500000000000001 109.585 -178.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.5 m -94.24 148.98 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 110.229 -0.286 . . . . 2.3900000000000001 110.229 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.9 m -84.61 146.34 27.55 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.255 1.022 . . . . 2.3100000000000001 109.17 175.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.1 p -49.74 -57.43 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.489 1.516 . . . . 2.0600000000000001 111.44 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.75 71.96 0.49 Allowed Glycine 0 CA--C 1.522 0.521 0 N-CA-C 109.386 -1.486 . . . . 1.5700000000000001 109.386 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.6 m -153.01 48.38 0.71 Allowed 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 117.738 0.769 . . . . 2.3999999999999999 111.936 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.1 ttp -141.08 132.7 27.13 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.589 -1.634 . . . . 2.3799999999999999 106.589 168.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.7 m -135.51 144.28 34.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 107.334 -1.358 . . . . 0.78000000000000003 107.334 173.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -127.46 149.92 49.89 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 123.974 0.91 . . . . 4.2800000000000002 110.541 -174.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.59 154.25 83.61 Favored Pre-proline 0 N--CA 1.451 -0.403 0 N-CA-C 109.93 -0.396 . . . . 2.9399999999999999 109.93 175.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -65.32 -24.03 58.27 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.445 2.097 . . . . 1.48 111.601 167.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -47.56 -28.81 2.45 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.509 0.724 . . . . 1.6599999999999999 110.735 165.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.3 m 64.84 25.98 12.89 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 125.081 1.352 . . . . 1.1599999999999999 111.472 175.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.24 -46.23 1.36 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.758 2.423 . . . . 1.8600000000000001 111.127 176.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -83.29 136.35 34.41 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.628 -0.879 . . . . 1.3700000000000001 108.628 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.653 HG21 ' HG ' ' A' ' 100' ' ' LEU . 19.7 m -147.25 143.54 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 107.068 -1.456 . . . . 0.77000000000000002 107.068 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -144.05 154.62 43.43 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.22 -0.659 . . . . 0.88 109.22 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -148.35 151.62 35.65 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.761 -0.654 . . . . 1.8500000000000001 109.887 -173.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.81 142.01 30.88 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.049 -1.093 . . . . 0.72999999999999998 108.049 171.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.0 p -130.38 149.59 33.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 107.112 -1.44 . . . . 1.8899999999999999 107.112 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -130.46 167.22 18.98 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.4 0.619 . . . . 1.55 109.546 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.1 t70 . . . . . 0 N--CA 1.444 -0.765 0 CA-C-N 114.779 -1.1 . . . . 3.6800000000000002 109.028 -177.285 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.807 0 N-CA-C 111.14 -0.784 . . . . 3.1299999999999999 111.14 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 35.64 58.05 0.89 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.298 1.839 . . . . 4.25 111.317 -176.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -112.24 157.06 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 124.464 1.106 . . . . 1.5 109.087 -169.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.3 mt -118.44 125.6 50.3 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.832 0.853 . . . . 0.67000000000000004 109.49 -173.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 75.7 t -114.26 133.28 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.791 1.236 . . . . 0.91000000000000003 107.954 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 61.3 p -108.79 155.47 20.74 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.497 1.119 . . . . 0.45000000000000001 110.204 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.643 ' HB3' HG23 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -153.48 136.85 15.79 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.504 -1.295 . . . . 1.97 107.504 -174.431 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.8 p-10 -128.94 49.87 2.19 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.564 1.545 . . . . 2.2200000000000002 112.57 -172.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -171.72 52.43 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.982 0.913 . . . . 2.9900000000000002 111.533 178.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.9 mp 52.69 -147.41 0.47 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.877 1.271 . . . . 2.0099999999999998 110.417 -172.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.653 ' HG ' HG21 ' A' ' 80' ' ' VAL . 13.7 mt -150.28 158.16 36.52 Favored Pre-proline 0 N--CA 1.454 -0.226 0 N-CA-C 105.811 -1.922 . . . . 1.47 105.811 -176.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -71.27 -94.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.433 2.755 . . . . 2.0 107.923 172.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -77.4 38.17 0.23 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.554 1.142 . . . . 3.7799999999999998 110.306 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 19.8 tp 52.37 23.19 2.34 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.825 -1.172 . . . . 2.8599999999999999 112.716 -177.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 76.9 t80 53.9 84.05 0.07 Allowed 'General case' 0 N--CA 1.465 0.283 0 O-C-N 120.618 -1.301 . . . . 2.8700000000000001 109.076 -171.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -75.86 123.14 25.18 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.94 -1.133 . . . . 5.3799999999999999 107.94 -171.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -84.17 156.26 22.16 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 126.046 1.739 . . . . 3.6800000000000002 110.482 -169.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.49 33.3 43.85 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 123.757 0.694 . . . . 0.97999999999999998 112.267 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -156.08 178.9 9.75 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.802 1.241 . . . . 2.9900000000000002 108.138 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -85.43 147.64 22.41 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.685 -0.966 . . . . 0.83999999999999997 110.685 166.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.9 pp -140.23 162.5 24.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 105.618 -1.993 . . . . 0.70999999999999996 105.618 166.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.3 m -125.0 135.27 64.62 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.132 0 N-CA-C 109.055 -0.72 . . . . 0.80000000000000004 109.055 173.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -122.84 125.73 45.98 Favored 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 124.842 1.257 . . . . 0.56999999999999995 109.919 -170.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 9.0 tm0? -115.83 143.58 45.21 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.958 1.303 . . . . 3.8900000000000001 110.126 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 168.79 -131.4 2.29 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 107.576 -2.21 . . . . 0.92000000000000004 107.576 173.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.8 p -128.17 150.03 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 124.701 1.2 . . . . 1.03 109.752 -171.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.44 HD12 HG23 ' A' ' 48' ' ' THR . 4.1 mm? -55.89 143.44 31.65 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.161 -0.681 . . . . 1.98 109.161 170.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.69 -150.62 10.6 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.208 -1.157 . . . . 2.3599999999999999 110.208 -178.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -63.14 -67.15 0.45 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.264 0.625 . . . . 5.2999999999999998 110.021 -174.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -166.45 98.62 0.59 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.759 -1.571 . . . . 3.7000000000000002 106.759 -178.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 109.59 -41.27 2.28 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.378 0.99 . . . . 1.1499999999999999 111.199 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -82.79 161.73 21.91 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.252 1.021 . . . . 2.8500000000000001 110.662 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 mp -128.56 140.05 51.99 Favored 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 124.25 1.02 . . . . 2.25 108.3 174.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -107.9 108.96 20.35 Favored 'General case' 0 CA--C 1.527 0.083 0 N-CA-C 107.924 -1.139 . . . . 0.83999999999999997 107.924 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -134.82 109.33 8.46 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.274 0.488 . . . . 1.3200000000000001 111.705 -171.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.7 t -96.66 -34.24 11.46 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.957 0.903 . . . . 0.92000000000000004 111.656 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.3 mp0 -83.45 89.96 7.13 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 119.863 -1.773 . . . . 3.46 108.168 175.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.4 m -96.89 124.68 49.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 123.446 0.698 . . . . 0.78000000000000003 109.743 171.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -115.68 110.71 19.53 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.02 1.328 . . . . 0.71999999999999997 107.797 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.47 61.4 6.57 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.121 0.968 . . . . 1.28 110.62 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -22.72 67.05 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.712 1.004 . . . . 2.7400000000000002 113.712 -173.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 . . . . . 0 CA--C 1.528 0.113 0 C-N-CA 123.846 0.858 . . . . 5.5800000000000001 110.113 -177.926 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.4 pt? . . . . . 0 C--O 1.232 0.15 0 N-CA-C 108.924 -0.769 . . . . 2.7000000000000002 108.924 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -88.7 131.79 34.87 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.696 0.798 . . . . 2.04 109.619 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -138.34 155.77 48.25 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.003 1.321 . . . . 2.6299999999999999 110.833 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.2 m -80.57 131.16 62.04 Favored Pre-proline 0 N--CA 1.447 -0.621 0 C-N-CA 125.53 1.532 . . . . 1.77 111.048 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -57.02 -46.47 28.77 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 123.026 2.484 . . . . 0.68000000000000005 112.328 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.7 t -54.41 -32.86 58.2 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 122.865 0.466 . . . . 2.4700000000000002 111.419 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.27 -58.5 8.23 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.55 -0.908 . . . . 3.0899999999999999 108.55 172.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.259 30.7 pt -73.19 28.8 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 114.017 1.118 . . . . 1.1699999999999999 114.017 -172.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -118.62 -27.53 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.508 1.123 . . . . 2.1499999999999999 111.986 160.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 -83.95 -68.62 0.7 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.599 1.09 . . . . 2.4700000000000002 112.389 -163.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.02 54.25 0.59 Allowed Glycine 0 C--N 1.333 0.408 0 N-CA-C 108.668 -1.773 . . . . 1.5700000000000001 108.668 -174.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -148.98 -109.64 0.07 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.641 1.976 . . . . 2.9700000000000002 107.082 -167.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.448 HG23 ' CD2' ' A' ' 116' ' ' LEU . 41.0 m -67.59 -65.44 0.69 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.542 1.137 . . . . 1.3999999999999999 111.587 -173.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -49.59 -51.07 39.81 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.816 0.817 . . . . 2.5699999999999998 110.444 -172.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.79 -24.09 61.68 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.141 1.376 . . . . 1.6000000000000001 112.661 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.1 39.81 97.64 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.463 1.506 . . . . 1.3400000000000001 112.786 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.8 m -97.96 -35.32 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 117.986 0.893 . . . . 1.75 113.054 -172.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -107.41 -68.15 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 117.981 -1.009 . . . . 3.4500000000000002 112.104 177.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -77.05 131.12 11.74 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 121.606 1.538 . . . . 1.2 108.77 175.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -76.4 157.35 32.38 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.766 -0.827 . . . . 3.02 108.766 169.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.02 170.22 4.6 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.93 0.492 . . . . 1.53 109.71 170.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.86 40.54 98.47 Favored Glycine 0 CA--C 1.531 1.081 0 O-C-N 121.63 -0.669 . . . . 1.6299999999999999 112.046 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -127.2 156.7 41.42 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 107.916 -1.142 . . . . 1.47 107.916 169.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -96.71 128.47 43.69 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.002 0.921 . . . . 4.6100000000000003 108.992 176.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.2 pt -137.17 168.23 21.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 108.32 -0.993 . . . . 0.77000000000000002 108.32 173.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 31.2 mtm180 -117.59 111.07 18.7 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.13 -1.063 . . . . 2.6800000000000002 108.13 173.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.7 p -78.87 130.14 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.812 -1.551 . . . . 0.80000000000000004 106.812 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.55 125.33 2.98 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 109.629 -1.389 . . . . 0.53000000000000003 109.629 -177.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.96 -155.4 17.09 Favored Glycine 0 C--N 1.334 0.423 0 N-CA-C 108.535 -1.826 . . . . 0.68000000000000005 108.535 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -97.61 134.38 40.9 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.48 0.657 . . . . 2.73 109.705 177.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.431 HG22 ' H ' ' A' ' 108' ' ' GLN . 9.4 m -68.95 159.79 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.964 -1.124 . . . . 2.4199999999999999 107.964 172.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.2 m -74.03 -116.85 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 109.188 -0.671 . . . . 2.5499999999999998 109.188 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.1 p -156.99 -59.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 O-C-N 120.49 -1.381 . . . . 2.3500000000000001 109.418 -175.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.66 -11.05 56.06 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 121.943 -0.473 . . . . 2.2599999999999998 112.591 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.1 m -67.37 -20.91 65.62 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 114.14 1.163 . . . . 1.21 114.14 -165.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 6.6 tpt -71.39 94.6 1.25 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.655 0.782 . . . . 1.9199999999999999 109.814 -176.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.6 m -102.31 130.44 52.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 107.364 -1.347 . . . . 0.57999999999999996 107.364 174.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -126.44 141.48 51.87 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.506 1.122 . . . . 6.0999999999999996 108.323 -173.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.99 143.82 31.88 Favored Pre-proline 0 C--O 1.234 0.244 0 N-CA-C 110.34 -0.244 . . . . 2.6699999999999999 110.34 -176.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -60.16 -27.16 84.32 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.125 2.55 . . . . 2.3900000000000001 110.846 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -42.94 -40.63 3.05 Favored 'General case' 0 C--O 1.226 -0.151 0 C-N-CA 125.678 1.591 . . . . 2.6200000000000001 110.013 172.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.4 m 78.31 12.04 1.71 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.963 1.705 . . . . 1.71 112.861 177.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.69 31.53 5.31 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.888 0.875 . . . . 2.9199999999999999 112.382 165.006 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -150.24 131.82 14.85 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 122.05 -0.406 . . . . 1.22 110.545 175.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.59 131.26 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 125.14 1.376 . . . . 1.0 108.714 -177.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -137.9 144.08 41.16 Favored 'General case' 0 C--N 1.34 0.183 0 O-C-N 120.536 -1.352 . . . . 0.91000000000000003 110.745 172.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -139.35 160.22 40.34 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.392 0.677 . . . . 1.97 109.854 -175.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.67 127.61 54.12 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.529 -1.285 . . . . 0.60999999999999999 107.529 170.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.6 p -116.02 146.55 20.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.314 -0.995 . . . . 1.8300000000000001 108.314 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -142.88 -178.5 5.84 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.217 1.007 . . . . 1.3600000000000001 109.661 -173.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.6 t70 . . . . . 0 N--CA 1.465 0.311 0 CA-C-O 121.581 0.705 . . . . 2.6899999999999999 111.734 177.967 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.91 0 N-CA-C 110.597 -1.001 . . . . 1.46 110.597 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -120.78 133.13 55.34 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.178 -1.786 . . . . 4.7699999999999996 106.178 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -123.4 138.51 53.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 108.051 -1.092 . . . . 1.45 108.051 -176.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.8 mt -89.8 124.44 34.66 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.954 0.902 . . . . 0.70999999999999996 110.294 -176.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.0 t -109.0 118.46 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 126.216 1.806 . . . . 0.82999999999999996 107.045 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.4 p -99.54 140.06 34.27 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.723 -0.843 . . . . 0.55000000000000004 108.723 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -141.71 139.61 32.96 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 107.849 -1.167 . . . . 2.2999999999999998 107.849 -173.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -81.79 -91.01 0.07 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.98 0.912 . . . . 3.6200000000000001 110.692 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -55.15 168.74 0.3 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.646 1.179 . . . . 3.9199999999999999 113.237 -171.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 mt -57.7 116.34 3.36 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 120.197 -1.564 . . . . 2.2599999999999998 110.95 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.0 mt -54.97 145.74 41.89 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 123.511 0.724 . . . . 1.4099999999999999 109.839 170.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -62.32 143.3 93.65 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.598 2.199 . . . . 2.5499999999999998 109.692 177.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 47.16 40.39 9.92 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.955 1.302 . . . . 2.7999999999999998 111.285 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 56.05 4.75 0.14 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 128.277 2.631 . . . . 2.0499999999999998 115.466 -175.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 57.0 t80 58.37 101.99 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.251 1.02 . . . . 2.9500000000000002 109.089 -155.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -78.09 150.94 33.64 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.89 -1.152 . . . . 4.0899999999999999 107.89 168.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -91.96 165.63 13.11 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 125.867 1.667 . . . . 3.3300000000000001 109.595 -175.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 42.15 48.86 5.47 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.153 1.358 . . . . 0.79000000000000004 114.408 -177.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.431 ' H ' HG22 ' A' ' 66' ' ' VAL . 1.3 pp0? -155.7 87.81 1.1 Allowed 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.83 1.252 . . . . 2.5699999999999998 107.632 -178.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -49.08 135.77 21.41 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 123.459 0.552 . . . . 0.68999999999999995 113.857 -169.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.3 pp -139.23 168.04 19.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 124.731 1.212 . . . . 0.92000000000000004 108.69 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 15.7 m -110.6 137.76 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.271 -1.011 . . . . 0.71999999999999997 108.271 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.456 ' CB ' HG12 ' A' ' 127' ' ' VAL . . . -125.04 122.17 36.49 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.525 1.13 . . . . 0.64000000000000001 109.333 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -99.35 127.4 45.36 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.018 -1.104 . . . . 3.2999999999999998 108.018 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -159.79 169.19 35.73 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.197 -0.525 . . . . 1.6399999999999999 112.36 -173.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.1 p -108.38 139.35 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 124.439 1.096 . . . . 0.84999999999999998 108.184 177.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.448 ' CD2' HG23 ' A' ' 48' ' ' THR . 3.9 mp -68.43 118.29 11.31 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.55 -0.907 . . . . 2.6600000000000001 108.55 174.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.34 -91.65 0.33 Allowed Glycine 0 C--N 1.335 0.524 0 O-C-N 124.054 0.847 . . . . 2.54 111.107 -171.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -82.0 -77.86 0.21 Allowed 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.395 -1.335 . . . . 6.1500000000000004 107.395 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -175.58 108.35 0.09 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.969 1.708 . . . . 3.6000000000000001 107.099 173.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 118.8 -41.71 1.95 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.066 -1.214 . . . . 0.97999999999999998 110.066 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.69 131.63 34.93 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.485 0.714 . . . . 2.8100000000000001 110.628 -178.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -97.52 113.98 25.79 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.204 -1.036 . . . . 2.5899999999999999 108.204 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -88.58 102.58 15.08 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 107.246 -1.39 . . . . 0.63 107.246 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -122.0 132.29 54.44 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 123.922 0.889 . . . . 1.29 109.306 -175.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.8 t -125.7 -8.61 6.75 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.918 0.487 . . . . 1.27 112.236 172.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -111.41 74.54 0.87 Allowed 'General case' 0 CA--C 1.532 0.254 0 O-C-N 120.473 -1.392 . . . . 3.75 108.548 -174.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.456 HG12 ' CB ' ' A' ' 112' ' ' ALA . 35.8 m -87.58 150.93 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 118.279 0.491 . . . . 1.27 111.08 176.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.41 HD22 ' N ' ' A' ' 128' ' ' LEU . 0.2 OUTLIER -126.23 135.68 51.89 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.348 -0.982 . . . . 0.91000000000000003 108.348 171.525 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.3 122.95 34.36 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.765 -1.198 . . . . 2.5899999999999999 107.765 169.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -143.9 46.34 1.46 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.352 0.661 . . . . 3.1000000000000001 110.278 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 . . . . . 0 N--CA 1.455 -0.179 0 C-N-CA 124.443 1.097 . . . . 4.9199999999999999 109.317 -179.079 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.52 HD11 ' CD2' ' A' ' 38' ' ' TYR . 2.5 pp . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 109.477 -0.564 . . . . 2.1699999999999999 109.477 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -90.69 116.33 28.48 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 124.146 0.978 . . . . 2.1499999999999999 110.409 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.52 ' CD2' HD11 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -112.95 152.82 28.92 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.99 1.316 . . . . 2.7799999999999998 110.122 175.148 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.0 p -83.27 133.66 47.22 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 124.814 1.246 . . . . 1.6399999999999999 109.871 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.41 -40.71 72.54 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.882 2.388 . . . . 0.68999999999999995 112.236 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.7 t -54.8 -29.38 54.33 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.265 0.468 . . . . 2.48 112.265 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.11 -56.46 11.38 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.751 -1.203 . . . . 3.02 107.751 175.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.8 pt -73.23 28.99 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 114.217 1.191 . . . . 1.0800000000000001 114.217 -174.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.9 t -109.56 -24.42 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 126.82 2.048 . . . . 1.9199999999999999 111.007 163.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -120.65 75.02 1.1 Allowed 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 121.558 -0.714 . . . . 2.0699999999999998 111.197 -157.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.72 49.76 8.65 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 109.067 -1.613 . . . . 1.3999999999999999 109.067 174.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -146.55 -125.5 0.07 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.131 -1.804 . . . . 2.5800000000000001 106.131 -173.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.2 m -62.65 -43.0 99.92 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 119.408 1.004 . . . . 1.7 111.448 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -31.89 -72.51 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 126.655 1.982 . . . . 5.3499999999999996 112.809 172.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 45.7 m -89.23 -14.45 35.92 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.816 0.846 . . . . 1.8200000000000001 110.2 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.76 32.86 60.88 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.048 -0.821 . . . . 1.45 111.048 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.6 m -75.99 -36.24 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 117.702 0.751 . . . . 1.3200000000000001 111.418 -173.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt -113.88 -70.37 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 124.541 1.136 . . . . 3.4100000000000001 110.156 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.27 108.32 2.16 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 121.257 1.305 . . . . 1.3799999999999999 109.714 176.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.55 154.37 38.87 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.819 -0.808 . . . . 2.8399999999999999 108.819 169.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.98 164.1 13.36 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.188 -0.671 . . . . 1.27 109.188 169.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.42 30.69 39.94 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.252 -0.739 . . . . 1.5 111.252 -175.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -125.56 152.5 44.99 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.968 1.307 . . . . 1.48 108.458 173.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -97.51 121.24 39.18 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 108.25 -1.019 . . . . 4.8300000000000001 108.25 -176.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.5 pt -144.04 177.76 2.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 124.674 1.19 . . . . 0.73999999999999999 108.287 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -125.98 131.37 52.25 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.602 -0.888 . . . . 2.5699999999999998 108.602 175.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.5 p -94.73 124.5 47.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 107.014 -1.476 . . . . 0.98999999999999999 107.014 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.62 124.82 4.16 Favored Glycine 0 C--O 1.225 -0.437 0 N-CA-C 108.982 -1.647 . . . . 0.46999999999999997 108.982 178.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.39 -166.0 33.46 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 108.701 -1.76 . . . . 0.60999999999999999 108.701 -175.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.28 138.37 36.46 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.509 -0.552 . . . . 2.8500000000000001 109.509 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.544 HG11 ' HE1' ' A' ' 104' ' ' PHE . 32.6 t -98.77 108.22 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-O 121.239 0.542 . . . . 2.4199999999999999 110.087 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.2 m -39.15 132.75 1.32 Allowed 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 127.541 2.337 . . . . 2.4100000000000001 111.356 168.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.5 p -55.49 -62.8 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.656 0.782 . . . . 2.1800000000000002 110.731 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -83.27 68.5 3.54 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 109.951 -1.26 . . . . 2.1899999999999999 109.951 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.3 m -152.12 -33.64 0.14 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 114.858 1.429 . . . . 1.0700000000000001 114.858 -176.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.3 tpp -62.06 120.06 10.11 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 108.353 -0.98 . . . . 2.3399999999999999 108.353 170.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.2 m -122.35 133.94 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.341 -1.355 . . . . 0.69999999999999996 107.341 167.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.38 137.77 54.43 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.557 1.143 . . . . 5.9100000000000001 109.038 -173.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.62 143.33 50.76 Favored Pre-proline 0 N--CA 1.454 -0.244 0 N-CA-C 109.738 -0.468 . . . . 2.0099999999999998 109.738 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -59.85 -25.83 80.5 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.48 2.12 . . . . 1.5 110.787 170.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -40.98 -42.94 2.0 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 124.653 1.181 . . . . 1.54 110.668 168.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.6 m 84.41 -0.34 0.94 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.143 1.777 . . . . 1.1599999999999999 113.647 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.2 18.35 11.55 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.321 0.964 . . . . 2.6600000000000001 112.641 172.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -138.35 125.9 22.03 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.491 -1.3 . . . . 1.0700000000000001 107.491 174.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.51 HG23 ' HB3' ' A' ' 96' ' ' TYR . 27.6 m -145.19 144.48 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 106.62 -1.622 . . . . 0.68999999999999995 106.62 175.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -148.02 155.88 42.01 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 121.361 -0.837 . . . . 1.02 109.777 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -151.35 137.97 18.75 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.49 -0.323 . . . . 1.96 111.106 -171.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.29 138.3 33.62 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.212 -1.032 . . . . 0.48999999999999999 108.212 166.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.0 p -130.79 146.61 33.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 106.412 -1.699 . . . . 1.78 106.412 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -143.37 175.29 10.03 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.645 0.657 . . . . 1.6899999999999999 110.88 -174.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.9 t70 . . . . . 0 CA--C 1.531 0.222 0 O-C-N 123.465 0.478 . . . . 2.5099999999999998 111.537 -178.125 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.97 0 N-CA-C 109.903 -1.279 . . . . 1.6899999999999999 109.903 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -112.37 150.64 30.79 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.37 1.468 . . . . 3.1600000000000001 107.29 165.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -131.32 153.14 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 107.776 -1.194 . . . . 1.05 107.776 175.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.4 mt -110.18 115.14 29.19 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.794 0.838 . . . . 0.77000000000000002 109.036 -172.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.8 t -96.5 138.58 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 124.734 1.214 . . . . 0.89000000000000001 107.845 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 77.6 p -114.46 149.57 36.1 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.738 -0.838 . . . . 0.55000000000000004 108.738 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.513 ' CE2' ' HA ' ' A' ' 125' ' ' THR . 6.7 t80 -149.79 116.99 6.02 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.519 -0.919 . . . . 2.0499999999999998 108.519 -173.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -104.29 51.47 0.77 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.633 1.173 . . . . 2.1099999999999999 111.86 -170.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -168.16 -179.37 4.03 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.527 1.931 . . . . 3.02 107.14 170.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.0 mp -67.51 148.57 51.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 118.703 0.683 . . . . 1.5900000000000001 111.075 171.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.458 HD21 ' CD2' ' A' ' 96' ' ' TYR . 17.2 mt -101.81 152.24 38.09 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 125.093 1.357 . . . . 1.27 110.291 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -60.34 137.7 76.21 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 123.983 3.122 . . . . 2.0499999999999998 109.756 174.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 49.27 30.3 3.09 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.944 1.698 . . . . 3.02 112.495 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.0 tp 58.15 13.29 2.22 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.211 1.004 . . . . 3.4300000000000002 111.97 -175.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.544 ' HE1' HG11 ' A' ' 66' ' ' VAL . 17.3 t80 57.07 95.68 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.422 1.489 . . . . 2.8399999999999999 109.049 -172.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -76.15 124.9 28.18 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 105.47 -2.048 . . . . 7.54 105.47 -176.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -80.47 168.14 19.31 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.902 -0.499 . . . . 2.9700000000000002 110.187 -170.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.25 45.56 47.83 Favored Glycine 0 CA--C 1.528 0.906 0 O-C-N 121.505 -0.747 . . . . 0.93000000000000005 112.336 174.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -155.8 170.39 22.19 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.492 1.117 . . . . 2.2599999999999998 108.333 174.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -90.9 130.33 10.22 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 111.188 -0.765 . . . . 0.67000000000000004 111.188 174.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.9 pp -137.94 158.4 33.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 107.01 -1.478 . . . . 0.68000000000000005 107.01 176.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.3 m -120.02 126.57 75.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 108.258 -1.016 . . . . 0.70999999999999996 108.258 175.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -117.44 127.09 53.68 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 124.403 1.081 . . . . 0.68999999999999995 109.929 -173.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -107.84 143.42 36.46 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.62 0.768 . . . . 4.46 110.333 -178.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 167.15 -142.46 7.58 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 110.057 -1.217 . . . . 0.98999999999999999 110.057 171.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.9 p -132.31 144.91 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-O 121.517 0.675 . . . . 1.02 110.477 -164.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.619 HD11 HD23 ' A' ' 122' ' ' LEU . 3.4 mp -87.35 153.9 21.1 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.678 -1.23 . . . . 2.71 107.678 176.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -159.47 -59.79 0.01 OUTLIER Glycine 0 C--N 1.334 0.43 0 C-N-CA 119.686 -1.245 . . . . 2.4500000000000002 111.646 177.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -60.41 142.74 54.61 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.809 -1.182 . . . . 4.4400000000000004 107.809 167.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -78.99 57.62 2.22 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.819 1.648 . . . . 4.1100000000000003 108.934 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 164.12 -32.38 0.26 Allowed Glycine 0 CA--C 1.53 0.979 0 CA-C-N 115.75 -0.659 . . . . 0.94999999999999996 113.02 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -113.14 157.22 21.93 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 118.181 0.99 . . . . 2.4900000000000002 109.642 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.619 HD23 HD11 ' A' ' 116' ' ' LEU . 4.2 mp -118.09 143.92 46.06 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.089 0.955 . . . . 1.95 108.517 -176.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -105.61 97.24 7.1 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.209 -1.404 . . . . 0.68000000000000005 107.209 175.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -106.16 143.92 33.59 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.719 -0.845 . . . . 1.0800000000000001 108.719 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.513 ' HA ' ' CE2' ' A' ' 96' ' ' TYR 0.254 12.1 t -129.36 -32.04 2.01 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.122 0.786 . . . . 1.04 113.122 174.622 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -84.96 84.8 7.59 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 120.713 -1.242 . . . . 3.1299999999999999 108.406 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.7 m -88.76 105.77 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 119.294 0.952 . . . . 0.84999999999999998 111.339 175.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -96.36 105.92 18.07 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.429 -0.952 . . . . 0.65000000000000002 108.429 175.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.79 52.19 1.67 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.356 1.062 . . . . 1.24 111.574 -177.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -79.19 72.6 5.77 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.751 -0.593 . . . . 3.2000000000000002 111.035 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 58.1 t60 . . . . . 0 CA--C 1.534 0.343 0 C-N-CA 123.817 0.847 . . . . 4.9199999999999999 111.538 -179.289 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.527 0.084 0 N-CA-C 110.396 -0.224 . . . . 1.9399999999999999 110.396 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -84.76 119.49 25.35 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.071 -0.714 . . . . 2.2999999999999998 109.071 173.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.53 155.92 49.71 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.347 1.059 . . . . 2.77 109.944 -178.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.2 p -88.07 146.9 39.38 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-O 119.242 -0.409 . . . . 1.8899999999999999 110.728 -173.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -52.83 -50.82 12.73 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 123.399 2.733 . . . . 0.82999999999999996 110.371 173.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.7 m -48.13 -47.66 34.54 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 125.531 1.532 . . . . 2.5899999999999999 112.748 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -57.54 -59.58 4.95 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.478 -0.934 . . . . 2.2999999999999998 108.478 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.267 32.4 pt -61.74 -16.5 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 114.504 1.298 . . . . 1.75 114.504 -170.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.47 -57.42 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 120.056 1.298 . . . . 2.0899999999999999 111.226 167.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -84.71 80.37 9.28 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.149 -0.97 . . . . 2.2200000000000002 112.098 -154.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.47 48.35 5.96 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 109.653 -1.379 . . . . 1.3999999999999999 109.653 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.56 -100.84 0.08 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.136 -1.061 . . . . 2.3999999999999999 108.136 -177.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 92.9 m -79.28 -60.8 2.23 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 126.187 1.795 . . . . 1.3700000000000001 111.043 -176.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.41 ' OD1' HD11 ' A' ' 92' ' ' ILE . 0.9 OUTLIER -54.43 -33.25 59.14 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.321 0.964 . . . . 4.1500000000000004 111.205 -178.537 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.28 -17.72 31.87 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.35 1.06 . . . . 1.51 112.379 178.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 52.7 43.18 59.67 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 126.158 1.837 . . . . 1.0900000000000001 112.936 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.4 m -95.88 -43.06 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 118.301 1.051 . . . . 1.3200000000000001 112.817 -173.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -111.88 -71.09 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.25 0 C-N-CA 124.546 1.138 . . . . 3.3799999999999999 111.021 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -70.69 96.32 0.67 Allowed 'Trans proline' 0 N--CA 1.444 -1.397 0 N-CA-C 108.356 -1.44 . . . . 1.6899999999999999 108.356 172.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -49.51 162.65 0.14 Allowed 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.322 1.049 . . . . 4.1200000000000001 111.441 170.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.35 144.27 51.08 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.35 -0.981 . . . . 1.3100000000000001 108.35 169.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.85 21.91 67.45 Favored Glycine 0 CA--C 1.536 1.396 0 O-C-N 121.554 -0.716 . . . . 1.1599999999999999 113.261 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -89.62 148.55 23.28 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 118.42 1.11 . . . . 2.8199999999999998 108.117 170.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.97 113.84 26.06 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.474 1.11 . . . . 3.5899999999999999 108.249 -171.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.27 175.96 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 123.131 0.572 . . . . 1.5800000000000001 109.477 -177.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -111.27 112.15 23.72 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 108.84 -0.8 . . . . 3.3999999999999999 108.84 175.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.9 p -77.01 122.24 31.1 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.038 0 N-CA-C 106.944 -1.502 . . . . 1.03 106.944 172.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.09 120.66 2.97 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 108.537 -1.825 . . . . 0.64000000000000001 108.537 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.07 -160.02 22.78 Favored Glycine 0 CA--C 1.52 0.347 0 N-CA-C 108.92 -1.672 . . . . 0.68000000000000005 108.92 -174.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.6 ptp -112.7 136.29 52.45 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.229 0.612 . . . . 2.52 110.272 -176.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 83' ' ' ALA . 4.8 p -93.93 138.68 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 109.091 -0.707 . . . . 2.46 109.091 172.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.99 163.32 26.8 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.221 -1.029 . . . . 2.6099999999999999 108.221 168.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.6 p -58.78 -65.31 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 124.368 1.067 . . . . 2.21 110.763 173.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.25 59.44 4.33 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 121.545 -0.722 . . . . 2.0600000000000001 111.388 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.5 m -126.06 -41.95 1.9 Allowed 'General case' 0 C--N 1.334 -0.07 0 C-N-CA 124.744 1.218 . . . . 1.8700000000000001 111.449 -177.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -71.78 121.37 18.82 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.11 -0.7 . . . . 1.9399999999999999 109.11 -178.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.8 m -127.47 130.35 70.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 108.002 -1.111 . . . . 0.85999999999999999 108.002 170.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -109.49 147.26 33.19 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 124.072 0.949 . . . . 4.3099999999999996 110.73 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.46 151.89 95.53 Favored Pre-proline 0 N--CA 1.45 -0.44 0 N-CA-C 109.046 -0.724 . . . . 2.1800000000000002 109.046 174.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -61.67 -28.37 82.38 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.012 1.808 . . . . 1.79 110.946 166.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -44.88 -34.71 2.47 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.141 0.976 . . . . 1.3700000000000001 110.655 167.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.6 m 67.63 23.87 8.65 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.084 1.354 . . . . 2.2799999999999998 112.241 176.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.47 -42.37 2.23 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.848 2.059 . . . . 2.1000000000000001 111.788 172.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -90.8 138.94 31.2 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.624 -1.25 . . . . 1.3400000000000001 107.624 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.511 HG23 ' HB3' ' A' ' 96' ' ' TYR . 17.2 m -152.29 130.11 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 107.125 -1.435 . . . . 0.72999999999999998 107.125 -173.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -135.11 146.71 49.11 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 118.929 0.786 . . . . 1.3799999999999999 110.394 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -140.0 144.5 36.99 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.221 0.608 . . . . 1.9399999999999999 110.171 -172.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.57 ' O ' HG23 ' A' ' 66' ' ' VAL . . . -85.07 139.14 31.96 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.89 -0.782 . . . . 0.59999999999999998 108.89 170.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 t -125.76 143.66 38.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 105.855 -1.906 . . . . 1.78 105.855 172.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -144.15 177.99 8.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.191 -1.04 . . . . 2.52 108.191 176.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.1 t0 . . . . . 0 N--CA 1.451 -0.425 0 N-CA-C 108.811 -0.811 . . . . 2.6400000000000001 108.811 169.887 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.626 0 N-CA-C 109.12 -1.592 . . . . 1.52 109.12 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -133.16 138.24 46.53 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.339 -1.356 . . . . 2.75 107.339 177.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.445 ' HA ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -128.35 154.46 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 107.258 -1.386 . . . . 0.90000000000000002 107.258 -176.346 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.2 mt -116.14 121.43 42.1 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.52 0.728 . . . . 0.66000000000000003 109.334 -177.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.8 t -109.27 129.0 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.88 -1.155 . . . . 0.85999999999999999 107.88 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 77.5 p -103.94 140.15 38.11 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.73 1.212 . . . . 0.64000000000000001 109.233 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.511 ' HB3' HG23 ' A' ' 80' ' ' VAL . 6.6 t80 -134.41 160.23 38.63 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.112 1.765 . . . . 2.0800000000000001 108.191 -178.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -145.68 146.5 31.31 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 128.097 2.559 . . . . 3.1299999999999999 105.449 -171.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 69.82 59.97 0.28 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 130.085 3.354 . . . . 3.1899999999999999 111.083 -175.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 mt 55.93 -156.05 0.28 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.482 1.113 . . . . 1.8300000000000001 109.27 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.572 HD13 ' HB2' ' A' ' 104' ' ' PHE . 15.5 mt -145.0 154.42 54.73 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 105.827 -1.916 . . . . 1.1000000000000001 105.827 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -63.09 -82.86 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 124.276 3.317 . . . . 2.3500000000000001 110.536 -176.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -76.5 35.49 0.15 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.073 0.949 . . . . 4.1100000000000003 110.752 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 39.6 6.31 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 128.505 2.722 . . . . 3.0499999999999998 117.538 -164.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.572 ' HB2' HD13 ' A' ' 100' ' ' LEU . 0.2 OUTLIER 61.91 89.96 0.08 Allowed 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 124.846 1.258 . . . . 3.0099999999999998 109.643 -166.021 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.272 15.0 mmm180 -91.85 30.39 1.39 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 117.859 -1.536 . . . . 5.2300000000000004 111.559 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . 0.339 4.3 mt-10 79.38 172.38 0.16 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.986 1.266 . . . . 3.04 109.714 146.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 39.39 37.52 0.79 Allowed Glycine 0 CA--C 1.537 1.467 0 N-CA-C 116.143 1.217 . . . . 0.78000000000000003 116.143 163.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -148.18 176.57 10.11 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.551 1.54 . . . . 2.1899999999999999 107.847 -175.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -109.08 129.38 9.48 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.174 -1.17 . . . . 0.64000000000000001 110.174 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.0 pp -133.99 165.39 31.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 125.475 1.51 . . . . 0.73999999999999999 106.994 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.4 m -115.56 144.27 23.54 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 N-CA-C 108.087 -1.079 . . . . 0.94999999999999996 108.087 170.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.616 ' HB2' HG12 ' A' ' 127' ' ' VAL . . . -134.05 129.68 36.41 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 124.073 0.949 . . . . 0.62 110.325 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.79 143.83 34.32 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.633 1.173 . . . . 4.4500000000000002 111.425 177.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 166.02 -150.64 18.28 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 109.17 -1.572 . . . . 1.01 109.17 169.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.9 p -127.69 146.28 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 123.78 0.832 . . . . 0.82999999999999996 109.38 -168.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.6 mp -61.71 142.65 57.09 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 122.119 -0.363 . . . . 2.0899999999999999 110.483 174.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -98.38 -108.21 2.74 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 109.263 -1.535 . . . . 1.8100000000000001 109.263 -169.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -60.29 -49.21 78.52 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.323 0.649 . . . . 5.1799999999999997 109.259 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.2 t70 177.27 -87.86 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.364 2.266 . . . . 4.2999999999999998 106.089 -177.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.23 -26.54 72.57 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.72 1.629 . . . . 1.0800000000000001 113.433 -177.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -86.66 136.5 33.01 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.12 0.96 . . . . 3.0299999999999998 109.935 174.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.4 mp -107.37 133.9 51.23 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 123.107 0.563 . . . . 2.1600000000000001 109.495 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.09 106.5 18.81 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.58 -0.526 . . . . 0.42999999999999999 109.58 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -121.27 136.99 54.89 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.719 0.808 . . . . 1.2 110.224 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.3 t -128.28 4.14 5.75 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.216 0.606 . . . . 1.0900000000000001 111.885 173.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -118.6 82.03 1.78 Allowed 'General case' 0 CA--C 1.531 0.237 0 O-C-N 120.914 -1.116 . . . . 2.98 108.368 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.616 HG12 ' HB2' ' A' ' 112' ' ' ALA . 17.2 m -99.59 133.92 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 118.333 0.515 . . . . 0.70999999999999996 110.701 175.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.87 118.81 27.94 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.215 -1.402 . . . . 0.73999999999999999 107.215 177.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.22 84.2 7.7 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.631 0.772 . . . . 1.1499999999999999 110.433 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.17 34.52 0.11 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.736 1.013 . . . . 4.1500000000000004 113.736 -174.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.529 0.15 0 C-N-CA 126.765 2.026 . . . . 4.1200000000000001 105.596 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 109.75 -0.463 . . . . 2.5 109.75 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -85.68 124.78 32.6 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.724 1.209 . . . . 2.1400000000000001 109.465 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.16 149.39 51.88 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.003 1.321 . . . . 3.02 110.54 -177.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.5 m -77.09 132.33 70.88 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 125.713 1.605 . . . . 2.0 110.728 -177.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -59.3 -33.05 97.77 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.968 2.445 . . . . 0.81000000000000005 113.616 -176.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.5 p -61.09 -21.04 63.3 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.171 -0.956 . . . . 2.2799999999999998 112.713 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -96.8 14.2 26.0 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.774 0.715 . . . . 3.7000000000000002 111.753 173.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.312 8.0 pt -124.26 35.02 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 O-C-N 120.607 -1.308 . . . . 1.23 111.613 163.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.0 p -122.61 -79.11 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 O-C-N 121.922 -0.486 . . . . 2.3500000000000001 110.426 163.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -69.75 103.8 2.26 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 125.497 1.519 . . . . 2.2999999999999998 110.896 -162.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.96 39.33 96.39 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 109.029 -1.628 . . . . 1.3400000000000001 109.029 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -141.43 -110.42 0.14 Allowed 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.521 -1.659 . . . . 2.2799999999999998 106.521 -176.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 56.3 m -80.45 -48.19 13.21 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 119.96 1.254 . . . . 1.4099999999999999 112.475 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -55.0 -49.33 71.77 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.828 0.823 . . . . 2.6600000000000001 109.694 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -72.32 -33.47 67.38 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.371 -0.831 . . . . 1.2 111.619 175.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.22 41.04 39.86 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.744 1.164 . . . . 1.2 112.198 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.6 m -99.97 -42.3 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 117.999 0.9 . . . . 1.3 113.228 -172.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -109.29 -67.51 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.519 1.128 . . . . 3.7999999999999998 111.433 -176.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -76.37 78.81 3.15 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.062 1.842 . . . . 2.27 108.828 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -55.74 140.04 43.14 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.656 0.782 . . . . 3.2000000000000002 109.031 175.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.539 ' HB1' ' HA2' ' A' ' 117' ' ' GLY . . . -61.83 147.18 47.34 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.951 -0.759 . . . . 1.1899999999999999 108.951 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.17 -8.28 31.04 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.839 1.209 . . . . 1.0900000000000001 112.069 -170.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -96.32 140.49 30.92 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.325 1.063 . . . . 1.6100000000000001 109.548 -175.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -89.31 118.56 29.07 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.274 1.029 . . . . 4.8099999999999996 108.569 176.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.7 pt -142.21 175.9 4.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 107.903 -1.147 . . . . 1.22 107.903 172.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.4 mtm180 -121.15 113.57 20.19 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.197 -1.038 . . . . 2.1400000000000001 108.197 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.2 p -81.24 127.86 39.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 107.108 -1.441 . . . . 0.78000000000000003 107.108 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.99 114.93 1.76 Allowed Glycine 0 C--N 1.332 0.332 0 N-CA-C 109.856 -1.297 . . . . 0.47999999999999998 109.856 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.57 -173.37 39.76 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.876 -0.89 . . . . 0.81000000000000005 110.876 -172.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.431 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 2.4 ptp -93.37 132.82 37.25 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.947 0.899 . . . . 2.75 111.343 -171.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.43 HG11 ' CE1' ' A' ' 104' ' ' PHE . 6.1 t -102.34 137.22 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 O-C-N 123.794 0.684 . . . . 2.2599999999999998 109.936 174.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.401 HG22 HG12 ' A' ' 68' ' ' VAL . 5.2 m -40.75 -88.0 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 128.192 2.597 . . . . 2.8300000000000001 114.329 -175.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.401 HG12 HG22 ' A' ' 67' ' ' THR . 7.3 p 176.18 -36.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.309 1.443 . . . . 2.73 110.038 -174.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -155.82 42.35 0.56 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.788 -1.325 . . . . 2.4500000000000002 109.788 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.9 m -84.65 -11.46 55.89 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.972 0.386 . . . . 1.26 111.321 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 16.8 ptm -68.8 132.48 46.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 118.292 0.496 . . . . 2.2200000000000002 110.686 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.1 m -117.65 125.45 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 106.621 -1.622 . . . . 1.23 106.621 170.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.446 ' HB3' HG12 ' A' ' 80' ' ' VAL . 16.8 ptt180 -101.4 146.77 27.16 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.535 0.734 . . . . 5.0899999999999999 110.136 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -84.42 151.36 59.05 Favored Pre-proline 0 C--O 1.232 0.147 0 N-CA-C 109.381 -0.6 . . . . 2.1699999999999999 109.381 170.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -67.55 -21.15 46.57 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.933 2.422 . . . . 1.77 112.367 174.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -43.7 -37.98 2.91 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.565 -0.531 . . . . 1.55 109.565 163.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.0 m 72.79 9.75 5.52 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 126.125 1.77 . . . . 1.6100000000000001 111.508 177.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 pp -123.63 17.78 9.57 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.16 1.784 . . . . 1.76 110.644 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -146.1 130.19 17.42 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.588 1.555 . . . . 2.0299999999999998 108.271 173.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.446 HG12 ' HB3' ' A' ' 73' ' ' ARG . 0.9 OUTLIER -145.29 109.77 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 125.105 1.362 . . . . 1.1899999999999999 107.523 -178.6 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -109.38 150.07 28.58 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 109.22 -0.659 . . . . 1.3899999999999999 109.22 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -150.85 142.3 23.44 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.981 0.419 . . . . 1.8899999999999999 110.727 -171.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.69 135.16 33.88 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.275 -0.639 . . . . 0.78000000000000003 109.275 175.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 38.7 t -115.21 152.16 16.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 126.365 1.866 . . . . 2.0299999999999998 106.512 175.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -134.18 -175.93 4.02 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.376 0.67 . . . . 1.47 109.744 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.7 t0 . . . . . 0 N--CA 1.452 -0.361 0 C-N-CA 123.716 0.806 . . . . 3.9300000000000002 110.506 177.176 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 110.458 -1.057 . . . . 2.4399999999999999 110.458 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -65.88 111.75 3.44 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.997 -1.112 . . . . 3.5899999999999999 107.997 -175.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -144.51 153.85 14.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 N-CA-C 108.416 -0.957 . . . . 0.92000000000000004 108.416 -176.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mt -108.42 124.57 50.6 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.911 0.884 . . . . 0.77000000000000002 109.116 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.6 t -107.21 132.55 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 107.299 -1.371 . . . . 0.84999999999999998 107.299 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 76.6 p -106.25 143.6 34.14 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.513 -0.921 . . . . 0.60999999999999999 108.513 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -137.67 167.05 22.47 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.775 1.23 . . . . 2.2999999999999998 108.655 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -144.49 147.84 33.78 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 127.801 2.44 . . . . 3.4399999999999999 107.088 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 65.78 71.86 0.41 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 129.786 3.234 . . . . 3.0800000000000001 112.66 -178.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.7 mp 46.07 -148.54 0.11 Allowed 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 125.377 1.471 . . . . 2.3199999999999998 109.867 -175.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.8 mt -156.31 152.18 22.68 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 105.492 -2.04 . . . . 1.3300000000000001 105.492 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -71.54 108.69 2.45 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.274 2.649 . . . . 2.6600000000000001 109.929 176.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 45.04 45.11 8.78 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.205 1.402 . . . . 4.2999999999999998 111.706 176.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . 0.296 2.3 pp 35.69 47.3 0.37 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.259 1.424 . . . . 3.6699999999999999 112.793 -172.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.43 ' CE1' HG11 ' A' ' 66' ' ' VAL . 20.3 p90 38.85 56.59 1.95 Allowed 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 127.647 2.379 . . . . 4.7400000000000002 114.115 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.707 ' CD ' ' H ' ' A' ' 105' ' ' ARG 0.253 0.1 OUTLIER -37.91 130.45 1.12 Allowed 'General case' 0 CA--C 1.543 0.711 0 O-C-N 116.971 -3.58 . . . . 6.5499999999999998 113.189 -119.073 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -74.13 154.88 38.94 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.401 -0.812 . . . . 3.54 110.345 -164.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.61 33.21 11.67 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.181 0.896 . . . . 0.83999999999999997 112.395 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -156.74 178.54 10.23 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.091 1.356 . . . . 2.77 108.183 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 65' ' ' MET . . . -88.82 139.53 15.4 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 112.122 -0.391 . . . . 0.87 112.122 175.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.69 162.76 28.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 124.152 0.981 . . . . 0.81999999999999995 108.54 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 17.6 m -120.2 122.74 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.304 -0.628 . . . . 0.53000000000000003 109.304 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -113.67 120.98 42.74 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 125.189 1.396 . . . . 0.44 109.047 -176.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -99.67 135.28 41.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.369 -1.345 . . . . 4.1399999999999997 107.369 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -169.27 -169.72 32.95 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 110.065 -1.214 . . . . 0.93000000000000005 110.065 -173.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.4 p -122.98 136.94 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 107.804 -1.184 . . . . 0.73999999999999999 107.804 172.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 9.6 mp -73.78 155.24 39.06 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 107.882 -1.155 . . . . 2.6200000000000001 107.882 174.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.539 ' HA2' ' HB1' ' A' ' 56' ' ' ALA . . . -172.02 -44.42 0.04 OUTLIER Glycine 0 C--N 1.332 0.313 0 C-N-CA 119.878 -1.154 . . . . 2.1699999999999999 112.215 175.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -58.9 154.85 14.33 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 119.295 -0.962 . . . . 5.1699999999999999 110.083 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -80.17 72.54 6.99 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 106.511 -1.663 . . . . 4.5499999999999998 106.511 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 115.24 4.53 20.35 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.413 1.482 . . . . 1.3899999999999999 114.265 170.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.13 170.17 9.55 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.785 1.293 . . . . 2.8599999999999999 109.342 171.101 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.9 mp -123.74 145.25 49.15 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.044 0.937 . . . . 2.0699999999999998 109.578 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -110.85 109.76 20.08 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.426 0.691 . . . . 0.42999999999999999 109.197 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -132.63 136.63 46.63 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 123.41 0.684 . . . . 1.1000000000000001 110.277 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.4 t -121.44 -2.37 9.49 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.975 0.51 . . . . 1.0900000000000001 111.96 173.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -111.7 83.01 1.71 Allowed 'General case' 0 CA--C 1.532 0.27 0 O-C-N 120.434 -1.416 . . . . 3.79 108.403 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.3 m -96.65 126.89 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 118.383 0.538 . . . . 0.77000000000000002 110.886 174.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -113.95 106.57 14.59 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.03 -1.47 . . . . 0.77000000000000002 107.03 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.1 50.01 1.93 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.979 0.912 . . . . 1.6000000000000001 110.622 -178.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -78.83 64.39 3.78 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.357 0.663 . . . . 3.2999999999999998 111.096 -170.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 . . . . . 0 N--CA 1.449 -0.52 0 N-CA-C 106.592 -1.633 . . . . 4.4400000000000004 106.592 -178.165 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 pt? . . . . . 0 N--CA 1.464 0.26 0 N-CA-C 111.921 0.341 . . . . 1.8999999999999999 111.921 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -91.45 135.21 34.01 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.424 1.09 . . . . 1.9299999999999999 109.906 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.41 161.44 34.54 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.002 1.321 . . . . 2.9300000000000002 109.883 170.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 p -83.28 144.82 47.38 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.65 1.18 . . . . 1.8600000000000001 110.522 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -62.0 -44.47 20.08 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.786 2.991 . . . . 0.82999999999999996 112.407 -177.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.8 p -45.83 -56.18 5.7 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.258 1.423 . . . . 2.5 110.923 176.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -46.56 -56.11 6.54 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.446 -1.252 . . . . 3.0099999999999998 109.174 178.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.25 24.2 pt -70.37 11.42 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 114.862 1.43 . . . . 1.0 114.862 -173.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 82.0 t -98.4 -57.59 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 119.455 1.025 . . . . 1.8300000000000001 110.934 173.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -95.68 90.27 5.63 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 121.618 -0.676 . . . . 2.29 111.822 -162.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.72 41.75 12.36 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.442 -1.063 . . . . 1.5 110.442 176.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.91 -161.61 1.17 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 104.168 -2.53 . . . . 3.0499999999999998 104.168 -178.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 m -27.6 -59.04 0.11 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.797 2.439 . . . . 1.72 116.356 -175.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -57.66 -43.62 85.12 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 120.625 1.557 . . . . 3.9500000000000002 110.889 -177.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.04 -34.81 75.81 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.762 0.825 . . . . 1.95 110.586 174.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.09 46.86 14.7 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.118 1.342 . . . . 1.5700000000000001 111.566 177.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.407 HG23 ' H ' ' A' ' 53' ' ' LYS . 2.7 m -99.17 -89.61 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 117.252 0.526 . . . . 1.9199999999999999 111.639 177.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.407 ' H ' HG23 ' A' ' 52' ' ' VAL . 20.0 mmmt -58.53 -60.8 9.13 Favored Pre-proline 0 CA--C 1.538 0.49 0 O-C-N 121.33 -0.856 . . . . 3.04 112.891 -176.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.62 147.18 27.82 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.564 1.509 . . . . 1.1899999999999999 109.072 172.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -116.52 135.05 54.15 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.099 1.76 . . . . 3.04 107.302 -176.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.01 146.78 45.86 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.447 -0.575 . . . . 1.1599999999999999 109.447 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.59 -26.24 9.14 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 123.927 0.775 . . . . 1.01 111.915 -169.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -84.71 151.63 24.29 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.195 0.998 . . . . 1.53 109.969 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -95.23 130.68 41.88 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.806 0.842 . . . . 5.0300000000000002 108.851 175.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.6 pt -141.31 177.63 3.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 125.025 1.33 . . . . 0.64000000000000001 108.243 177.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.8 mtm-85 -125.7 137.83 53.86 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 122.31 -0.244 . . . . 2.5899999999999999 111.115 166.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.6 p -97.66 134.07 37.16 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.171 0 C-N-CA 124.686 1.194 . . . . 0.90000000000000002 108.049 172.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.09 119.14 1.76 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.602 -0.999 . . . . 0.66000000000000003 110.602 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.59 -163.34 29.27 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.295 -1.522 . . . . 0.60999999999999999 109.295 -175.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.44 142.04 27.87 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.011 0.905 . . . . 2.5699999999999998 111.733 -177.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 39.3 t -87.44 122.55 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-N 115.545 -0.752 . . . . 2.1299999999999999 109.407 172.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.5 m -30.34 -91.62 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 128.843 2.857 . . . . 3.0499999999999998 115.382 -175.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.5 p -172.42 -37.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 124.061 0.944 . . . . 2.23 111.027 -177.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -158.96 40.66 0.49 Allowed Glycine 0 CA--C 1.521 0.439 0 N-CA-C 109.617 -1.393 . . . . 1.8700000000000001 109.617 174.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.3 m -82.25 -17.33 46.35 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.868 -0.195 . . . . 1.0700000000000001 111.093 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.1 ttp -63.23 128.79 37.47 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 122.717 0.407 . . . . 2.3799999999999999 110.487 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.5 m -135.22 143.99 35.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 108.132 -1.062 . . . . 0.56999999999999995 108.132 172.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 47.8 ptt85 -132.39 147.52 52.39 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 124.422 1.089 . . . . 4.6799999999999997 108.516 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -99.76 154.37 37.29 Favored Pre-proline 0 C--O 1.235 0.313 0 N-CA-C 107.944 -1.132 . . . . 2.0899999999999999 107.944 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.41 44.71 1.56 Allowed 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.485 2.79 . . . . 1.8600000000000001 111.526 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -105.75 -41.45 5.43 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.667 1.587 . . . . 1.71 109.088 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.2 m 107.55 -30.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 129.134 2.974 . . . . 2.8999999999999999 110.214 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.34 32.87 4.83 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 124.321 1.048 . . . . 2.7799999999999998 111.741 -177.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -140.04 110.08 6.49 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.41 -1.33 . . . . 3.2000000000000002 107.41 175.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.75 134.17 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.226 -1.398 . . . . 1.04 107.226 177.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -144.46 157.17 44.37 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 120.884 -1.135 . . . . 0.84999999999999998 109.199 175.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -155.09 161.02 41.4 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.691 -0.855 . . . . 1.95 108.691 -173.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -106.74 145.21 32.33 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.548 -0.908 . . . . 0.75 108.548 175.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.9 t -127.96 140.2 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 108.473 -0.936 . . . . 1.8300000000000001 108.473 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -137.17 168.96 18.61 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.552 0.741 . . . . 1.3899999999999999 110.195 -178.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.5 t0 . . . . . 0 CA--C 1.534 0.357 0 C-N-CA 123.733 0.813 . . . . 2.8599999999999999 110.517 179.922 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.615 0 N-CA-C 106.98 -2.448 . . . . 1.5900000000000001 106.98 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -126.87 128.75 46.99 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.084 -1.821 . . . . 3.7400000000000002 106.084 174.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.2 tp -108.83 160.2 7.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 C-N-CA 125.36 1.464 . . . . 1.1499999999999999 108.14 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 mt -114.65 133.38 55.9 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 108.231 -1.026 . . . . 0.83999999999999997 108.231 -175.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 89.2 t -127.59 131.62 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 124.76 1.224 . . . . 0.96999999999999997 107.798 -174.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.0 p -107.2 150.4 26.66 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.929 0.892 . . . . 0.60999999999999999 109.762 178.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -147.39 140.62 25.25 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.49 1.516 . . . . 2.0299999999999998 107.064 -173.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -132.95 41.45 3.15 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.366 1.066 . . . . 2.1299999999999999 112.574 -168.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -168.25 53.24 0.05 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.557 0.743 . . . . 2.6800000000000002 111.631 -176.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.2 mp 51.02 -155.03 0.14 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.827 1.251 . . . . 1.9399999999999999 111.067 -171.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 81.8 mt -150.18 156.99 37.63 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 106.535 -1.654 . . . . 1.4199999999999999 106.535 -178.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.22 -88.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.434 2.756 . . . . 1.95 110.556 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -77.1 36.36 0.18 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.814 1.246 . . . . 3.6400000000000001 111.254 -175.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 39.89 11.67 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.824 2.849 . . . . 2.1600000000000001 116.983 -163.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 56.08 96.83 0.02 OUTLIER 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.681 1.128 . . . . 3.0699999999999998 109.911 -161.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 7.0 mtm180 -107.92 35.15 3.22 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 117.356 -1.306 . . . . 5.8799999999999999 112.448 172.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . 0.378 4.3 mm-40 78.81 157.75 0.17 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 121.443 1.928 . . . . 4.5099999999999998 112.99 140.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 52.1 26.59 20.44 Favored Glycine 0 CA--C 1.534 1.219 0 O-C-N 120.578 -1.326 . . . . 1.3999999999999999 113.631 167.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -139.73 163.75 31.76 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.54 1.936 . . . . 2.0800000000000001 105.813 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -89.28 145.77 18.66 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.74 -0.944 . . . . 0.72999999999999998 110.74 174.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.7 pp -141.26 159.98 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 106.074 -1.824 . . . . 0.88 106.074 173.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.2 m -124.02 122.82 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 108.488 -0.93 . . . . 0.69999999999999996 108.488 172.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -115.32 127.77 55.66 Favored 'General case' 0 C--O 1.228 -0.072 0 C-N-CA 125.747 1.619 . . . . 0.48999999999999999 109.93 -172.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -106.74 134.99 49.04 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.863 1.265 . . . . 3.25 109.502 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -173.72 -175.93 41.79 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.398 -0.429 . . . . 1.1899999999999999 112.97 -174.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.6 p -124.41 141.57 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 124.58 1.152 . . . . 1.03 109.394 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.2 mp -78.11 137.74 38.36 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.276 -0.875 . . . . 2.3700000000000001 109.014 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -156.42 37.16 0.59 Allowed Glycine 0 CA--C 1.521 0.453 0 N-CA-C 111.3 -0.72 . . . . 2.5800000000000001 111.3 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -157.45 27.86 0.29 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.882 0.873 . . . . 4.3099999999999996 109.545 -175.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 43.91 41.72 4.09 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.045 0.938 . . . . 4.0 111.915 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 159.88 -60.33 0.31 Allowed Glycine 0 CA--C 1.529 0.947 0 N-CA-C 110.837 -0.905 . . . . 1.99 110.837 -171.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.44 160.69 20.53 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 122.307 -0.525 . . . . 2.7799999999999998 111.096 -173.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 mp -125.26 126.26 44.86 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.072 0.949 . . . . 1.96 110.036 -170.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -92.8 108.97 20.4 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.096 -1.076 . . . . 0.60999999999999999 108.096 172.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -134.04 102.05 5.27 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.425 0.69 . . . . 1.29 111.938 -173.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.8 t -86.43 -25.01 25.46 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.193 0.997 . . . . 0.96999999999999997 111.843 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -88.43 79.43 7.69 Favored 'General case' 0 N--CA 1.455 -0.22 0 O-C-N 119.84 -1.788 . . . . 2.6400000000000001 109.713 -174.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.9 m -96.42 122.37 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 118.306 0.503 . . . . 0.79000000000000004 110.907 174.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -112.44 113.63 25.92 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.684 -1.599 . . . . 0.83999999999999997 106.684 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -99.87 26.73 6.04 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.855 0.862 . . . . 2.2000000000000002 112.606 -172.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.13 42.0 0.63 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.55 0.945 . . . . 5.1900000000000004 113.55 -164.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 . . . . . 0 C--N 1.333 -0.111 0 O-C-N 121.585 -0.697 . . . . 5.0599999999999996 109.216 173.49 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.465 0.317 0 N-CA-C 112.475 0.546 . . . . 2.0899999999999999 112.475 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -84.13 126.49 33.15 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.424 1.49 . . . . 2.1499999999999999 110.11 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.16 150.71 52.03 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.27 1.428 . . . . 2.7799999999999998 110.518 -177.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 36.2 m -76.7 124.05 87.66 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 125.73 1.612 . . . . 1.9199999999999999 111.48 -175.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -55.36 -43.4 58.81 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.987 2.458 . . . . 0.73999999999999999 111.857 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.6 m -60.1 -25.17 65.22 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.131 0.789 . . . . 2.8500000000000001 113.131 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -68.65 -56.88 6.73 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.139 -1.06 . . . . 3.25 108.139 171.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.6 pt -72.96 30.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 114.571 1.323 . . . . 1.0800000000000001 114.571 -171.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.2 p -107.51 -29.73 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 125.214 1.406 . . . . 1.9299999999999999 110.827 170.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -87.1 -118.7 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.969 0.89 . . . . 3.3900000000000001 109.937 -170.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -84.88 66.61 3.84 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 108.554 -1.818 . . . . 1.3400000000000001 108.554 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -142.38 -125.31 0.09 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.503 1.121 . . . . 2.9100000000000001 108.074 -173.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.419 HG21 HD21 ' A' ' 122' ' ' LEU . 5.9 t -76.66 -38.4 54.6 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 119.183 0.901 . . . . 2.8100000000000001 111.387 -172.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -58.31 -50.35 73.95 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.397 0.618 . . . . 2.7400000000000002 109.537 -178.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.9 m -81.04 -24.95 37.5 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.211 -0.904 . . . . 1.48 111.269 177.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.21 43.34 47.61 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.663 1.125 . . . . 1.0900000000000001 111.988 175.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.0 m -98.41 -42.18 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 117.657 0.728 . . . . 1.1799999999999999 112.757 -172.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -109.71 -65.77 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.777 1.231 . . . . 3.5899999999999999 111.975 -176.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -76.85 171.25 18.32 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 N-CA-C 108.224 -1.491 . . . . 1.1799999999999999 108.224 169.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.5 158.56 43.82 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.351 0.66 . . . . 5.4100000000000001 109.39 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.57 126.94 31.26 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.489 -1.3 . . . . 1.49 107.489 175.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 127.31 -17.68 6.19 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.275 1.417 . . . . 1.1799999999999999 112.198 -176.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -93.31 148.7 21.82 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.192 0.997 . . . . 2.9399999999999999 110.523 -172.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -85.49 134.58 34.04 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.051 -0.722 . . . . 3.4900000000000002 109.051 172.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.1 pt -145.73 175.03 2.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 105.685 -1.969 . . . . 0.64000000000000001 105.685 164.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -120.89 122.99 41.44 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.329 -1.36 . . . . 2.1899999999999999 107.329 171.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.7 p -88.81 131.91 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 107.558 -1.275 . . . . 0.77000000000000002 107.558 176.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -135.42 121.66 2.6 Favored Glycine 0 C--N 1.336 0.529 0 CA-C-N 119.052 0.842 . . . . 0.51000000000000001 111.002 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -172.88 -172.47 38.56 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.907 -0.877 . . . . 0.58999999999999997 110.907 -175.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -92.48 127.79 38.09 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.579 1.152 . . . . 4.5700000000000003 109.649 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.7 t -77.65 146.97 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.583 -0.735 . . . . 2.0899999999999999 109.721 176.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.552 HG22 HG12 ' A' ' 68' ' ' VAL . 2.1 m -55.66 -90.36 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.927 1.691 . . . . 3.04 114.155 -178.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.552 HG12 HG22 ' A' ' 67' ' ' THR . 7.4 p 176.16 -44.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.757 1.623 . . . . 2.3599999999999999 109.956 -170.013 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -150.26 39.44 0.86 Allowed Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.382 -1.087 . . . . 2.1200000000000001 110.382 176.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 61.6 m -87.22 -19.09 28.86 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 117.4 0.6 . . . . 1.05 112.153 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.3 ttp -71.76 123.82 23.44 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 118.803 0.729 . . . . 2.48 109.101 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.6 m -121.61 132.49 70.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 107.592 -1.262 . . . . 0.52000000000000002 107.592 173.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.433 ' CB ' HG12 ' A' ' 80' ' ' VAL . 29.7 ptt85 -117.2 153.27 33.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.939 0.895 . . . . 4.8899999999999997 109.904 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.28 170.19 17.39 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 109.9 -0.407 . . . . 2.5 109.9 170.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.35 -33.28 5.7 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.424 2.749 . . . . 1.6100000000000001 110.604 163.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -46.13 -40.17 10.58 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 126.221 1.808 . . . . 1.6499999999999999 110.232 -177.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.2 m 78.68 17.53 1.02 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.616 1.966 . . . . 1.71 112.666 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.76 23.96 7.21 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.445 0.698 . . . . 3.1899999999999999 112.407 164.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -144.87 118.75 9.3 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.183 -1.043 . . . . 1.49 108.183 177.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.487 HG23 ' HB3' ' A' ' 96' ' ' TYR . 35.8 m -139.82 143.56 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 106.928 -1.508 . . . . 0.94999999999999996 106.928 173.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -139.49 159.03 43.1 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.419 -0.586 . . . . 0.83999999999999997 109.419 172.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -154.84 159.17 40.36 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 122.975 0.51 . . . . 1.8500000000000001 109.73 -175.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.55 147.63 26.53 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.834 -0.802 . . . . 0.59999999999999998 108.834 172.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.3 p -144.6 144.77 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 109.244 -0.65 . . . . 1.95 109.244 174.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -141.0 175.84 9.3 Favored 'General case' 0 C--O 1.228 -0.053 0 C-N-CA 125.359 1.464 . . . . 1.27 107.947 -175.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.3 t0 . . . . . 0 CA--C 1.534 0.348 0 CA-C-O 121.367 0.603 . . . . 2.6699999999999999 110.97 175.632 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 108.345 -1.902 . . . . 1.8100000000000001 108.345 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -135.67 145.78 47.12 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 105.745 -1.946 . . . . 3.3199999999999998 105.745 178.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.36 139.32 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 107.351 -1.351 . . . . 0.84999999999999998 107.351 176.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.0 mt -87.73 138.36 31.53 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.684 -0.858 . . . . 0.81999999999999995 108.684 173.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.5 t -124.38 135.71 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 C-N-CA 126.002 1.721 . . . . 0.93999999999999995 106.608 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.1 p -110.13 156.38 20.67 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.997 1.319 . . . . 0.66000000000000003 108.236 178.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.487 ' HB3' HG23 ' A' ' 80' ' ' VAL . 1.1 t80 -151.7 108.07 3.45 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.597 -1.26 . . . . 2.8300000000000001 107.597 177.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -84.17 51.36 2.05 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.733 1.213 . . . . 2.6699999999999999 110.75 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -164.64 -178.17 5.19 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.867 1.267 . . . . 2.6600000000000001 108.094 171.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.03 158.5 32.78 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.115 0.966 . . . . 1.47 111.563 169.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.489 HD13 ' HB2' ' A' ' 104' ' ' PHE . 5.1 mt -96.04 165.27 16.72 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 126.123 1.769 . . . . 1.4299999999999999 109.923 174.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.96 -100.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.758 2.972 . . . . 2.2000000000000002 109.4 172.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -78.32 54.55 1.42 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.281 1.033 . . . . 2.8799999999999999 110.537 -175.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 42.1 18.58 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.822 2.449 . . . . 2.2200000000000002 115.678 -171.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.489 ' HB2' HD13 ' A' ' 100' ' ' LEU . 6.2 t80 60.61 97.25 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.91 0.884 . . . . 2.3399999999999999 110.688 -163.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 -77.91 111.45 13.77 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 105.736 -1.95 . . . . 8.3200000000000003 105.736 175.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -81.99 173.78 11.88 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.778 0.323 . . . . 5.0999999999999996 110.747 178.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.13 34.89 89.57 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.923 -0.471 . . . . 0.81999999999999995 111.923 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -156.3 175.84 13.47 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.655 1.582 . . . . 2.46 107.136 175.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -92.87 134.89 12.39 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.565 -0.614 . . . . 0.69999999999999996 111.565 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.2 pp -133.05 159.48 43.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.941 -0.763 . . . . 0.76000000000000001 108.941 174.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 31.5 m -125.67 122.86 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 107.808 -1.182 . . . . 0.54000000000000004 107.808 176.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -119.51 117.22 27.82 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.854 1.262 . . . . 0.55000000000000004 109.901 -171.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -106.84 143.35 35.06 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.379 1.071 . . . . 3.7400000000000002 110.711 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 179.66 -118.79 0.61 Allowed Glycine 0 C--N 1.335 0.501 0 N-CA-C 108.823 -1.711 . . . . 1.0700000000000001 108.823 169.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.8 p -150.91 144.38 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 118.006 0.903 . . . . 0.88 109.217 -176.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.929 HD22 HD22 ' A' ' 122' ' ' LEU . 5.5 mt -81.98 139.36 34.61 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.306 -1.368 . . . . 2.3799999999999999 107.306 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -177.43 26.4 0.06 OUTLIER Glycine 0 C--N 1.333 0.414 0 C-N-CA 119.045 -1.55 . . . . 2.6400000000000001 113.053 -174.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -141.25 41.18 1.77 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.974 -0.75 . . . . 6.3799999999999999 108.974 -172.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 22.28 57.84 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 129.541 3.136 . . . . 4.4299999999999997 112.933 175.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 139.79 -33.84 2.08 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-N 115.377 -0.829 . . . . 1.0900000000000001 112.492 -171.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.88 167.42 12.14 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.428 1.114 . . . . 2.6299999999999999 110.334 -175.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.929 HD22 HD22 ' A' ' 116' ' ' LEU . 8.4 mt -118.15 128.94 55.21 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.659 1.183 . . . . 1.9199999999999999 109.486 -174.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -89.15 94.66 10.01 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.096 -1.446 . . . . 0.51000000000000001 107.096 175.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -115.5 111.29 20.52 Favored 'General case' 0 C--O 1.228 -0.069 0 C-N-CA 122.949 0.5 . . . . 1.3500000000000001 110.163 -173.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.85 -43.66 8.1 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.12 0.968 . . . . 1.3 110.44 -174.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -84.51 79.06 9.7 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.95 -1.13 . . . . 3.5600000000000001 107.95 -170.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.486 HG21 HD23 ' A' ' 100' ' ' LEU . 4.4 m -90.0 96.44 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 125.794 1.637 . . . . 1.4099999999999999 111.262 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.81 149.97 20.93 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 108.81 -0.811 . . . . 0.94999999999999996 108.81 175.043 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -126.56 70.72 1.26 Allowed 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 123.894 0.878 . . . . 1.49 109.915 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -65.27 -10.04 29.02 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.482 0.919 . . . . 3.6699999999999999 113.482 -177.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 76.5 m80 . . . . . 0 CA--C 1.532 0.263 0 C-N-CA 123.468 0.707 . . . . 5.4100000000000001 109.63 176.283 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.0 pp . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 112.693 0.627 . . . . 2.2599999999999998 112.693 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -92.29 127.64 37.84 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.773 1.629 . . . . 2.1800000000000002 111.366 -175.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.59 152.32 50.09 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.21 1.804 . . . . 2.71 110.405 -173.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.4 m -89.91 129.35 46.62 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.103 1.361 . . . . 1.6200000000000001 111.525 -174.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -57.23 -53.24 5.06 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.543 2.828 . . . . 0.69999999999999996 112.594 -176.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.0 m -57.38 -12.41 2.51 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 114.29 1.219 . . . . 3.1899999999999999 114.29 176.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -82.67 -53.17 6.14 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 118.861 0.755 . . . . 3.0899999999999999 108.985 170.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 26.8 pt -73.27 33.11 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 114.106 1.151 . . . . 1.22 114.106 -176.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.635 HG21 ' HA3' ' A' ' 90' ' ' GLY . 22.0 m -126.64 -54.61 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 126.323 1.849 . . . . 3.1000000000000001 109.786 169.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.438 ' N ' HG23 ' A' ' 44' ' ' VAL . 42.8 m-80 -65.23 -34.49 78.49 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.701 0.8 . . . . 2.77 112.761 -163.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.62 68.71 0.1 OUTLIER Glycine 0 C--N 1.335 0.518 0 N-CA-C 110.27 -1.132 . . . . 1.8100000000000001 110.27 -177.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -165.41 -99.24 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.992 1.717 . . . . 2.98 108.36 -171.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 55.8 m -62.99 -63.71 1.12 Allowed 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 119.094 0.861 . . . . 1.4299999999999999 110.561 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.2 -44.8 64.93 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.777 0.799 . . . . 3.5699999999999998 111.162 -172.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.79 -17.81 52.48 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.619 1.168 . . . . 1.49 112.516 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 53.36 52.05 43.4 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.76 1.648 . . . . 1.4099999999999999 112.233 -175.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.1 m -105.99 -60.33 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 117.94 0.87 . . . . 1.79 113.088 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.1 mmtt -80.18 -61.49 0.44 Allowed Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 118.512 -0.756 . . . . 3.7400000000000002 112.339 -178.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -79.82 148.68 20.09 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 121.891 1.727 . . . . 1.5900000000000001 108.643 174.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -93.12 145.93 24.03 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.004 -1.11 . . . . 3.3900000000000001 108.004 165.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.88 169.02 5.58 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.136 0.574 . . . . 1.8600000000000001 110.33 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.04 33.82 86.92 Favored Glycine 0 CA--C 1.532 1.1 0 O-C-N 121.928 -0.482 . . . . 1.25 112.57 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -118.54 159.1 24.15 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.308 1.043 . . . . 1.98 108.764 170.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.5 128.02 45.59 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.122 1.369 . . . . 4.71 108.765 -177.151 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.2 pt -146.17 176.84 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 124.062 0.945 . . . . 0.81999999999999995 108.56 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.3 mtt85 -119.14 130.66 55.66 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.679 -0.86 . . . . 2.5600000000000001 108.679 167.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.9 p -95.43 130.37 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 107.041 -1.466 . . . . 0.76000000000000001 107.041 171.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.58 120.06 1.88 Allowed Glycine 0 C--N 1.332 0.36 0 N-CA-C 110.131 -1.188 . . . . 0.46999999999999997 110.131 -176.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.47 -159.67 21.87 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.45 -1.46 . . . . 0.63 109.45 -178.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.477 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 0.0 OUTLIER -100.69 132.22 46.19 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.918 0.866 . . . . 2.8999999999999999 111.922 -174.62 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.1 t -86.47 111.7 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.433 -0.951 . . . . 1.95 108.433 176.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 t -5.82 -102.31 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 128.624 2.769 . . . . 3.1299999999999999 114.668 163.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.7 p -158.69 -41.59 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 N-CA-C 113.548 0.944 . . . . 2.3399999999999999 113.548 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -161.26 33.33 0.38 Allowed Glycine 0 C--N 1.332 0.357 0 N-CA-C 110.995 -0.842 . . . . 3.0 110.995 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.2 m -80.25 12.73 2.72 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.739 0.644 . . . . 1.3799999999999999 112.739 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -78.04 107.6 10.72 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.948 -1.13 . . . . 2.0600000000000001 107.948 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -106.83 127.65 62.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 108.043 -1.095 . . . . 0.56000000000000005 108.043 176.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.446 ' CB ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -108.37 142.75 38.24 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.071 0.949 . . . . 4.8099999999999996 110.273 178.402 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -71.79 158.02 88.56 Favored Pre-proline 0 C--O 1.232 0.146 0 C-N-CA 123.18 0.592 . . . . 2.1299999999999999 109.521 170.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.4 -24.64 64.1 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.73 2.287 . . . . 1.22 112.346 170.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 76.1 m-80 -44.69 -34.4 2.21 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.11 0.564 . . . . 1.4299999999999999 110.886 165.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.9 m 75.2 1.53 3.73 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.801 1.64 . . . . 1.51 112.73 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 79' ' ' HIS . 0.6 OUTLIER -121.77 -13.74 8.23 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.937 1.695 . . . . 2.0299999999999998 112.689 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.494 ' N ' HD12 ' A' ' 78' ' ' LEU . 36.9 m-70 -106.48 121.41 44.21 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 105.897 -1.89 . . . . 1.3500000000000001 105.897 176.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.499 HG23 ' HB3' ' A' ' 96' ' ' TYR . 31.0 m -145.88 137.87 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 107.314 -1.365 . . . . 0.79000000000000004 107.314 -172.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -139.46 152.68 47.2 Favored 'General case' 0 C--O 1.233 0.223 0 O-C-N 121.604 -0.685 . . . . 0.91000000000000003 110.452 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -150.88 158.19 43.84 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.981 -0.554 . . . . 1.8999999999999999 110.411 -173.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -112.51 141.72 45.92 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.688 -1.227 . . . . 0.69999999999999996 107.688 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.5 p -141.87 146.16 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.244 0.618 . . . . 1.8700000000000001 109.95 -174.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -145.2 -177.94 5.81 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.99 1.316 . . . . 1.47 109.49 -170.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.2 t70 . . . . . 0 CA--C 1.534 0.359 0 C-N-CA 123.436 0.694 . . . . 2.29 109.858 175.622 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.635 ' HA3' HG21 ' A' ' 44' ' ' VAL . . . . . . . . 0 N--CA 1.443 -0.852 0 CA-C-O 118.748 -1.029 . . . . 1.79 111.074 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -117.61 132.08 56.57 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 108.024 -1.102 . . . . 3.5 108.024 174.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.6 tp -114.71 160.06 14.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 124.292 1.037 . . . . 1.1000000000000001 108.403 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.2 mt -112.28 128.81 56.38 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.6 0.76 . . . . 0.76000000000000001 109.091 -173.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.0 t -114.77 125.8 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 125.52 1.528 . . . . 0.90000000000000002 107.549 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.9 p -102.22 138.9 38.55 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.904 -0.776 . . . . 0.58999999999999997 108.904 175.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.499 ' HB3' HG23 ' A' ' 80' ' ' VAL . 1.9 t80 -132.7 111.74 11.42 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.134 1.374 . . . . 2.1299999999999999 107.415 -176.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -98.79 45.96 1.0 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.161 1.384 . . . . 1.9399999999999999 110.998 -176.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -164.6 -178.49 5.38 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.325 1.85 . . . . 2.7400000000000002 107.526 170.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.4 mp -80.77 148.66 29.96 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.738 0.78 . . . . 1.8 111.462 176.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.478 HD23 HG21 ' A' ' 80' ' ' VAL . 1.5 mm? -76.72 159.37 79.25 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 124.955 1.302 . . . . 2.5 110.295 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.29 -90.3 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.514 2.809 . . . . 2.1200000000000001 109.274 168.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.88 50.05 0.56 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.765 1.626 . . . . 3.0299999999999998 110.781 178.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . 0.254 0.3 OUTLIER 44.15 7.4 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 118.53 2.789 . . . . 3.1899999999999999 118.53 -177.653 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 79.4 t80 72.26 99.56 0.07 Allowed 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 126.148 1.779 . . . . 3.1000000000000001 109.192 -162.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -81.38 103.45 11.14 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.092 0.957 . . . . 4.9199999999999999 109.75 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -80.95 163.86 23.0 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.099 0.863 . . . . 3.1899999999999999 111.932 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.56 17.4 66.68 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 118.594 -1.114 . . . . 1.47 113.372 172.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -157.29 42.13 0.33 Allowed 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 119.308 1.554 . . . . 3.6099999999999999 113.452 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 65' ' ' MET . . . 31.29 141.53 0.0 OUTLIER Glycine 0 CA--C 1.531 1.079 0 C-N-CA 128.689 3.043 . . . . 1.02 118.847 -172.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.3 pp -140.39 163.23 23.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 120.099 -1.824 . . . . 0.93999999999999995 107.537 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.6 m -110.28 137.05 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 107.628 -1.249 . . . . 0.89000000000000001 107.628 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.425 ' CB ' HG12 ' A' ' 127' ' ' VAL . . . -123.12 128.84 50.64 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 124.076 0.95 . . . . 0.48999999999999999 109.185 178.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -111.06 140.02 45.95 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.687 -0.486 . . . . 3.6600000000000001 109.687 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 168.81 -152.04 19.3 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 121.028 -0.606 . . . . 1.0700000000000001 111.606 173.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.1 p -113.76 145.73 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.008 0.923 . . . . 0.67000000000000004 108.917 -169.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -55.22 142.52 31.11 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.437 -0.579 . . . . 1.8600000000000001 109.437 168.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.51 -131.71 1.6 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.312 -1.115 . . . . 2.3199999999999998 110.312 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -63.31 -82.24 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.339 1.056 . . . . 5.6100000000000003 109.886 -177.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -159.65 62.67 0.37 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 107.828 -1.175 . . . . 3.7200000000000002 107.828 173.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 163.52 -61.04 0.26 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.102 -1.199 . . . . 1.1899999999999999 110.102 -172.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.18 160.87 26.76 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.692 -0.887 . . . . 2.1699999999999999 108.994 -175.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 mp -122.68 137.34 54.94 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 109.62 -0.511 . . . . 1.9299999999999999 109.62 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -103.37 103.24 13.22 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.365 -0.976 . . . . 0.5 108.365 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -131.15 115.42 16.36 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 122.587 0.355 . . . . 1.03 111.017 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.2 t -109.42 -15.44 14.23 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.586 1.154 . . . . 1.0 111.749 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -104.21 80.2 1.69 Allowed 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.626 -1.296 . . . . 3.1499999999999999 109.081 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.425 HG12 ' CB ' ' A' ' 112' ' ' ALA . 34.6 m -90.12 149.44 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 118.784 0.72 . . . . 0.70999999999999996 111.496 174.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.17 142.81 51.37 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.283 -1.006 . . . . 0.93000000000000005 108.283 169.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -122.9 65.46 0.97 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.426 1.09 . . . . 1.3899999999999999 111.109 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.21 42.58 1.04 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.777 0.658 . . . . 2.9700000000000002 112.777 -175.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 29.2 m170 . . . . . 0 CA--C 1.535 0.369 0 C-N-CA 123.666 0.786 . . . . 5.46 110.122 -175.487 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.6 pt? . . . . . 0 N--CA 1.464 0.248 0 N-CA-C 112.022 0.378 . . . . 1.8 112.022 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -83.72 122.36 28.53 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.433 1.093 . . . . 2.1200000000000001 109.059 176.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.33 159.58 37.49 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.282 1.033 . . . . 3.2799999999999998 108.853 171.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 53.3 p -79.73 148.4 68.99 Favored Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 109.147 -0.686 . . . . 1.5600000000000001 109.147 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -60.87 -28.87 87.07 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 121.335 1.356 . . . . 0.77000000000000002 110.697 176.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.5 p -52.67 -28.8 23.21 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.153 0.981 . . . . 2.46 112.775 171.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -81.78 -10.48 59.33 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.019 -0.425 . . . . 2.1600000000000001 111.424 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.3 pt -127.68 34.19 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 O-C-N 120.788 -1.195 . . . . 1.3999999999999999 113.832 -176.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.422 HG12 HG12 ' A' ' 92' ' ' ILE . 3.6 m -119.85 -23.66 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 119.129 0.877 . . . . 3.1699999999999999 113.072 -176.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -139.21 132.28 29.59 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 107.123 -1.436 . . . . 4.04 107.123 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.59 -73.06 1.2 Allowed Glycine 0 CA--C 1.529 0.931 0 CA-C-O 122.465 1.036 . . . . 3.8399999999999999 111.173 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.4 mttt -44.1 -83.77 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 129.891 3.276 . . . . 4.21 111.428 -174.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.2 m -75.63 -48.02 23.95 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 121.273 1.851 . . . . 1.45 109.803 171.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -49.74 -36.78 26.88 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.078 1.14 . . . . 3.3999999999999999 114.078 -172.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.1 m -123.96 19.09 9.28 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.266 1.426 . . . . 2.8500000000000001 109.602 176.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 48.13 37.01 16.36 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 117.245 -1.864 . . . . 2.25 114.7 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.257 21.9 m -82.85 -43.08 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 122.106 2.953 . . . . 2.1600000000000001 113.18 -168.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -93.73 -64.01 0.14 Allowed Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.585 1.154 . . . . 4.9100000000000001 112.718 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.38 166.14 30.68 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.484 2.122 . . . . 1.74 109.705 176.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -118.65 129.25 55.2 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.335 0.654 . . . . 4.6699999999999999 109.907 170.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.12 111.74 1.29 Allowed 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.513 -0.551 . . . . 1.3 109.513 173.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 133.65 -20.81 4.08 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 124.363 0.982 . . . . 1.1399999999999999 111.567 -176.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -83.18 155.85 23.53 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 117.758 0.779 . . . . 2.52 109.211 177.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.0 mtt-85 -87.2 144.95 26.6 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.669 -0.863 . . . . 4.2599999999999998 108.669 170.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.4 pt -146.96 173.4 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 106.505 -1.665 . . . . 0.69999999999999996 106.505 170.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -124.67 118.36 26.31 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.516 -1.29 . . . . 2.4500000000000002 107.516 174.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.27 121.13 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.666 -1.235 . . . . 0.77000000000000002 107.666 177.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -127.83 123.44 4.47 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 109.907 -1.277 . . . . 0.48999999999999999 109.907 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.79 -162.66 23.52 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 108.068 -2.013 . . . . 0.64000000000000001 108.068 -176.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.78 137.02 37.97 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.804 0.811 . . . . 2.5699999999999998 110.565 177.146 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.5 t -79.23 137.86 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 108.5 -0.926 . . . . 2.1899999999999999 108.5 171.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -89.92 148.65 23.0 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.317 -0.994 . . . . 2.4399999999999999 108.317 169.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.4 p -57.67 -61.12 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.189 0.996 . . . . 2.21 110.796 178.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.55 73.46 2.05 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 109.161 -1.575 . . . . 2.1499999999999999 109.161 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.5 m -148.51 -44.42 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.152 0.797 . . . . 1.46 113.152 -177.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.421 ' HA ' ' HE3' ' A' ' 71' ' ' MET . 0.0 OUTLIER -66.81 122.31 17.39 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.227 0.467 . . . . 1.8 110.162 -177.63 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.24 120.42 48.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 108.336 -0.987 . . . . 0.56999999999999995 108.336 169.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.29 147.89 24.19 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.912 1.285 . . . . 4.3099999999999996 109.407 177.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -76.34 154.92 84.15 Favored Pre-proline 0 N--CA 1.455 -0.211 0 N-CA-C 109.008 -0.738 . . . . 1.9099999999999999 109.008 171.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -63.89 -22.8 68.68 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.608 2.205 . . . . 1.1599999999999999 111.963 166.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -47.22 -29.12 2.19 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.401 0.68 . . . . 1.1200000000000001 110.809 164.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.1 m 68.71 15.97 8.99 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 125.261 1.424 . . . . 1.3300000000000001 112.081 176.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.2 pp -125.8 -41.57 1.97 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 126.712 2.005 . . . . 1.6699999999999999 111.744 -178.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -85.43 132.31 34.24 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.538 -1.282 . . . . 1.1000000000000001 107.538 175.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.474 ' HB ' HD12 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -140.18 127.91 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 107.058 -1.46 . . . . 0.88 107.058 176.612 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -130.48 149.9 51.94 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.018 -0.734 . . . . 0.80000000000000004 109.018 176.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -145.3 143.35 30.15 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.33 -0.618 . . . . 1.8899999999999999 109.33 -175.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.84 141.87 33.05 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.327 -0.99 . . . . 0.75 108.327 164.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.6 p -128.02 153.48 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 107.472 -1.307 . . . . 1.77 107.472 170.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -140.18 179.96 6.33 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.235 0.471 . . . . 1.55 111.735 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.2 t70 . . . . . 0 N--CA 1.448 -0.544 0 C-N-CA 124.461 1.104 . . . . 2.3399999999999999 108.278 -177.821 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.559 0 CA-C-O 118.721 -1.044 . . . . 2.2799999999999998 113.296 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -63.43 108.57 1.37 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.295 1.547 . . . . 3.1800000000000002 110.216 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.422 HG12 HG12 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -130.53 143.85 39.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 108.447 -0.945 . . . . 1.1399999999999999 108.447 176.353 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.415 ' H ' HD13 ' A' ' 92' ' ' ILE . 17.9 mt -92.02 126.01 36.94 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.273 1.029 . . . . 0.75 110.75 178.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.5 t -108.84 122.79 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 125.879 1.671 . . . . 0.87 107.504 175.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.6 p -102.4 136.15 42.75 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.321 1.048 . . . . 0.46999999999999997 108.954 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.419 ' CD2' HD21 ' A' ' 100' ' ' LEU . 2.9 t80 -130.85 109.22 10.41 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.222 1.409 . . . . 1.9399999999999999 107.933 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -91.93 47.91 1.39 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.885 1.274 . . . . 2.3300000000000001 111.683 -176.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -167.68 173.37 8.53 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.22 1.808 . . . . 2.5299999999999998 107.07 170.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.4 mp -70.37 127.02 31.32 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.981 -1.074 . . . . 1.78 111.261 -177.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.474 HD12 ' HB ' ' A' ' 80' ' ' VAL . 11.9 mt -73.44 149.67 88.91 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 123.94 0.896 . . . . 1.25 110.75 174.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -68.53 140.95 49.08 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.838 3.026 . . . . 2.2200000000000002 109.696 175.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 45.85 43.92 10.48 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.307 1.443 . . . . 3.1699999999999999 111.238 -175.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 47.68 16.39 0.07 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 127.229 2.212 . . . . 2.0600000000000001 115.332 -171.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.453 ' CB ' HD13 ' A' ' 100' ' ' LEU . 69.0 t80 59.61 103.72 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.231 1.412 . . . . 2.6499999999999999 110.204 -161.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -78.75 119.93 22.67 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.238 -0.892 . . . . 5.3399999999999999 108.696 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -83.68 165.13 19.19 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 123.311 0.644 . . . . 3.0 111.044 -174.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.06 25.39 69.09 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 119.58 -0.567 . . . . 0.72999999999999998 114.146 172.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -143.55 170.57 15.58 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.734 1.214 . . . . 2.5499999999999998 108.075 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -84.92 129.28 9.14 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 109.775 -1.33 . . . . 0.69999999999999996 109.775 175.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.5 pp -136.17 152.77 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 106.434 -1.691 . . . . 0.59999999999999998 106.434 171.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 18.1 m -115.99 125.69 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 107.863 -1.162 . . . . 0.70999999999999996 107.863 177.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -116.46 134.39 54.92 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 125.09 1.356 . . . . 0.5 109.839 -170.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -126.23 143.28 51.2 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.945 1.298 . . . . 3.1400000000000001 110.628 -176.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 176.51 -123.43 0.9 Allowed Glycine 0 C--N 1.334 0.44 0 N-CA-C 108.55 -1.82 . . . . 0.82999999999999996 108.55 169.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.4 p -139.46 150.98 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 118.381 1.09 . . . . 0.79000000000000004 109.346 -175.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -55.61 133.81 50.69 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.871 -0.604 . . . . 1.8999999999999999 109.789 171.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.74 -135.51 2.35 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 109.135 -1.586 . . . . 2.23 109.135 173.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -74.1 78.25 1.74 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 109.155 -0.683 . . . . 5.6799999999999997 109.155 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.8 t0 19.34 61.37 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 129.414 3.086 . . . . 4.6100000000000003 113.086 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 166.73 -54.4 0.24 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.825 -0.91 . . . . 0.95999999999999996 110.825 -163.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.61 154.05 19.3 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 122.246 -0.561 . . . . 2.7400000000000002 109.521 172.089 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -111.48 123.84 51.05 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.442 1.097 . . . . 2.1000000000000001 108.646 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -97.25 93.62 6.63 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.054 -1.091 . . . . 0.56999999999999995 108.054 175.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.55 136.8 47.56 Favored 'General case' 0 C--O 1.227 -0.117 0 N-CA-C 109.46 -0.57 . . . . 0.93999999999999995 109.46 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.405 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 14.9 t -124.65 -26.68 3.79 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.236 1.014 . . . . 0.95999999999999996 112.743 177.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -89.48 88.3 7.4 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 120.472 -1.393 . . . . 3.1699999999999999 108.357 177.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.1 m -99.37 125.83 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 118.873 0.76 . . . . 0.68999999999999995 110.798 174.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.03 113.12 20.46 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.171 -1.418 . . . . 0.63 107.171 178.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.41 101.85 10.12 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 108.291 -1.003 . . . . 1.48 108.291 172.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -143.21 65.84 1.32 Allowed 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.431 0.692 . . . . 3.2400000000000002 109.461 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 106.077 -1.823 . . . . 5.7300000000000004 106.077 175.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.367 0 N-CA-C 112.948 0.721 . . . . 3.3399999999999999 112.948 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -85.61 122.59 29.94 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 123.812 0.845 . . . . 2.2000000000000002 109.384 170.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -140.78 169.17 18.13 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.768 0.827 . . . . 3.8199999999999998 109.84 171.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.2 p -91.6 148.06 36.53 Favored Pre-proline 0 N--CA 1.45 -0.471 0 C-N-CA 124.096 0.958 . . . . 2.04 110.737 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -60.98 -35.85 85.77 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.564 2.843 . . . . 1.0 111.354 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.417 ' O ' HG12 ' A' ' 44' ' ' VAL . 4.1 p -50.57 -38.6 46.2 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.918 1.287 . . . . 2.5699999999999998 112.031 174.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -60.27 -57.33 13.26 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.074 -1.084 . . . . 2.1299999999999999 108.074 177.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.256 19.5 pt -74.87 21.36 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 115.128 1.529 . . . . 1.0900000000000001 115.128 -166.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 41' ' ' SER . 1.7 p -107.13 -33.56 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 125.02 1.328 . . . . 1.9299999999999999 112.127 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -116.57 94.14 4.5 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.29 -0.881 . . . . 2.21 110.141 -170.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.31 45.66 46.72 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.739 -0.945 . . . . 1.3200000000000001 110.739 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.23 -159.33 0.88 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 103.902 -2.629 . . . . 2.4199999999999999 103.902 178.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.0 m -41.32 -45.83 3.1 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.445 1.898 . . . . 1.5600000000000001 115.078 -167.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -51.11 -47.72 61.9 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.833 0.742 . . . . 2.9700000000000002 112.014 176.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.1 m -78.2 -32.95 50.25 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.148 0.579 . . . . 1.51 111.02 174.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.43 48.49 18.29 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.429 1.014 . . . . 1.3100000000000001 111.145 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 53' ' ' LYS . 0.9 OUTLIER -89.37 -91.61 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 117.042 0.421 . . . . 2.0899999999999999 110.677 177.8 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.413 ' H ' HG23 ' A' ' 52' ' ' VAL . 19.0 mmmt -65.71 -56.67 17.01 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 118.452 -0.785 . . . . 3.3300000000000001 111.945 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.86 120.95 5.25 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 121.426 1.417 . . . . 1.22 109.844 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.24 165.74 18.09 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.582 0.753 . . . . 4.6100000000000003 109.053 170.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.631 ' HB1' ' HA2' ' A' ' 117' ' ' GLY . . . -71.41 173.63 7.63 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 109.07 -0.715 . . . . 1.23 109.07 171.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.16 -2.5 84.2 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 121.033 -1.042 . . . . 1.0800000000000001 113.471 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -94.15 148.8 21.84 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.282 1.041 . . . . 1.4099999999999999 109.198 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -92.78 130.04 38.52 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.105 -0.702 . . . . 4.4199999999999999 109.105 172.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.5 pt -142.66 167.3 14.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 106.426 -1.694 . . . . 0.67000000000000004 106.426 168.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.2 mtt180 -118.09 115.08 24.1 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.88 -1.526 . . . . 1.78 106.88 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.7 p -92.79 123.54 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.767 -1.197 . . . . 0.84999999999999998 107.767 178.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.34 148.97 20.63 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 118.975 0.807 . . . . 0.85999999999999999 111.682 -177.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 167.13 -100.45 0.17 Allowed Glycine 0 C--N 1.335 0.517 0 N-CA-C 109.077 -1.609 . . . . 1.79 109.077 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.7 ptp -145.46 131.23 19.02 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.738 0.769 . . . . 2.8900000000000001 110.016 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.2 p -67.11 157.08 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 119.483 -0.887 . . . . 2.4900000000000002 109.726 178.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.7 -9.88 31.66 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.908 1.077 . . . . 3.3900000000000001 113.908 175.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.253 7.6 p 49.51 68.76 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 123.863 1.792 . . . . 3.4900000000000002 111.564 177.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 142.57 47.75 0.05 OUTLIER Glycine 0 CA--C 1.526 0.731 0 CA-C-N 111.874 -2.421 . . . . 1.8300000000000001 109.861 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.0 m -156.45 -7.52 0.1 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 114.824 1.416 . . . . 1.9399999999999999 114.824 177.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.92 109.89 1.39 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 121.449 1.931 . . . . 1.8899999999999999 108.278 171.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.2 m -124.66 134.92 65.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 108.459 -0.941 . . . . 0.80000000000000004 108.459 174.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.3 ptt85 -113.67 151.05 32.35 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.424 1.089 . . . . 4.5499999999999998 109.677 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.07 160.52 65.63 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 123.082 0.553 . . . . 1.8100000000000001 110.268 175.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -74.54 -26.45 11.89 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.479 2.786 . . . . 1.22 110.584 171.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -43.4 -38.57 2.82 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 124.595 1.158 . . . . 1.71 109.023 169.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.2 m 79.38 2.7 2.28 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.687 1.995 . . . . 1.28 112.012 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.16 31.19 6.07 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.056 2.142 . . . . 2.2200000000000002 109.27 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -156.56 132.49 9.69 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.789 -0.819 . . . . 1.6299999999999999 108.789 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.89 134.47 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 125.75 1.62 . . . . 0.83999999999999997 109.026 -177.145 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -138.03 158.64 43.91 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 120.826 -1.171 . . . . 0.80000000000000004 110.783 172.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -155.36 153.4 30.4 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.363 0.665 . . . . 1.9299999999999999 109.845 -174.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -112.2 134.8 53.54 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.685 0.794 . . . . 0.67000000000000004 109.633 -179.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.8 t -126.04 142.78 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 108.189 -1.041 . . . . 1.8300000000000001 108.189 -173.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -139.42 -175.39 4.17 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.859 -0.793 . . . . 1.5700000000000001 108.859 177.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.1 t0 . . . . . 0 CA--C 1.534 0.353 0 C-N-CA 124.781 1.232 . . . . 2.5800000000000001 109.327 177.052 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.902 0 N-CA-C 109.804 -1.318 . . . . 1.77 109.804 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -116.88 159.41 22.44 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.246 2.218 . . . . 2.9300000000000002 107.557 178.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -137.77 163.91 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 108.236 -1.024 . . . . 0.96999999999999997 108.236 166.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.7 mt -112.94 132.52 55.31 Favored 'General case' 0 C--N 1.338 0.087 0 C-N-CA 124.625 1.17 . . . . 0.59999999999999998 108.685 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.3 t -118.25 129.94 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 125.193 1.397 . . . . 0.91000000000000003 107.477 -177.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.8 p -107.74 149.75 27.79 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.298 1.039 . . . . 0.60999999999999999 108.299 177.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -144.1 129.75 19.17 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.05 -1.463 . . . . 2.9300000000000002 107.05 176.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -69.33 -84.31 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.359 -0.838 . . . . 2.8999999999999999 110.379 166.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -56.97 163.28 2.06 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.983 0.897 . . . . 2.5699999999999998 112.825 -172.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 mp -63.45 145.54 55.42 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 122.225 1.012 . . . . 1.6299999999999999 111.986 -174.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.481 HD23 HG21 ' A' ' 127' ' ' VAL . 24.9 mt -67.85 156.4 89.4 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 115.023 -0.99 . . . . 1.23 109.997 169.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.77 -89.4 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.492 3.461 . . . . 2.3500000000000001 109.619 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.2 17.82 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.94 1.296 . . . . 2.8999999999999999 113.581 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 16.5 tp 53.24 20.6 1.92 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.485 1.114 . . . . 3.5600000000000001 111.937 -167.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 49.55 81.75 0.05 Allowed 'General case' 0 C--N 1.344 0.368 0 C-N-CA 124.94 1.296 . . . . 2.5800000000000001 110.828 173.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.294 7.8 mmm180 -87.72 29.75 0.88 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 117.872 -1.531 . . . . 5.7300000000000004 112.452 -166.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . 0.604 25.9 mt-10 80.26 161.87 0.17 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.517 1.527 . . . . 4.5099999999999998 111.807 157.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 29.9 52.95 0.19 Allowed Glycine 0 CA--C 1.533 1.198 0 C-N-CA 126.346 1.927 . . . . 0.97999999999999998 115.785 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -152.54 51.34 0.77 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.853 1.326 . . . . 3.4300000000000002 112.536 -174.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 4.67 98.34 0.0 OUTLIER Glycine 0 CA--C 1.535 1.332 0 C-N-CA 127.888 2.661 . . . . 0.92000000000000004 116.354 -174.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.0 pp -108.4 165.13 5.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 106.977 -1.49 . . . . 0.64000000000000001 106.977 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.6 m -123.62 133.97 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 107.583 -1.266 . . . . 0.72999999999999998 107.583 173.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -126.54 138.1 53.44 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.15 1.78 . . . . 0.58999999999999997 108.891 -170.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -143.02 155.88 44.73 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.972 0.805 . . . . 3.8900000000000001 112.403 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -177.08 -100.26 0.13 Allowed Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 108.386 -1.886 . . . . 1.3799999999999999 108.386 172.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.9 p -155.91 151.0 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 118.153 0.976 . . . . 0.64000000000000001 110.153 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.59 ' HG ' HD12 ' A' ' 122' ' ' LEU . 1.1 mp -85.64 150.95 24.26 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.226 1.01 . . . . 2.48 108.809 176.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.631 ' HA2' ' HB1' ' A' ' 56' ' ' ALA . . . -166.99 -53.86 0.03 OUTLIER Glycine 0 C--O 1.227 -0.322 0 C-N-CA 120.577 -0.82 . . . . 2.21 111.223 177.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -64.18 144.19 57.31 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.36 -0.978 . . . . 5.7999999999999998 108.36 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.31 58.99 2.21 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.188 1.795 . . . . 4.8399999999999999 109.268 -172.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 127.4 18.53 2.02 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 127.123 2.297 . . . . 1.74 113.6 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.29 160.63 38.98 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.937 1.369 . . . . 2.71 109.63 166.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.59 HD12 ' HG ' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -119.16 129.39 54.98 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.437 1.095 . . . . 2.3799999999999999 108.351 -172.328 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -90.44 95.25 10.08 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 107.767 -1.197 . . . . 0.41999999999999998 107.767 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.84 140.86 41.71 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 123.346 0.658 . . . . 1.0600000000000001 109.972 -176.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -125.24 -47.22 1.76 Allowed 'General case' 0 C--O 1.232 0.165 0 C-N-CA 123.864 0.866 . . . . 1.0800000000000001 111.254 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -83.42 101.36 11.32 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 106.3 -1.741 . . . . 3.0 106.3 -173.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.481 HG21 HD23 ' A' ' 100' ' ' LEU . 3.4 m -108.51 116.31 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 125.932 1.693 . . . . 0.76000000000000001 109.266 -178.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.13 113.25 25.8 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.89 -1.152 . . . . 0.59999999999999998 107.89 -177.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -99.82 45.64 0.98 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.322 1.049 . . . . 1.28 111.581 -176.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.43 48.91 1.08 Allowed 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.136 -0.977 . . . . 2.8199999999999998 111.628 -175.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.5 p80 . . . . . 0 CA--C 1.53 0.205 0 O-C-N 121.734 -0.604 . . . . 7.0599999999999996 110.252 -175.633 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.6 pt? . . . . . 0 N--CA 1.463 0.209 0 N-CA-C 110.727 -0.101 . . . . 1.8 110.727 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -83.78 129.72 34.94 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.395 1.078 . . . . 2.0299999999999998 110.138 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -132.75 144.32 50.19 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.127 1.371 . . . . 3.0699999999999998 110.556 -178.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.0 m -76.39 133.67 71.01 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 125.707 1.603 . . . . 1.96 110.677 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.48 -41.35 58.24 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.527 2.151 . . . . 0.84999999999999998 112.673 -178.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.7 t -47.96 -49.81 29.24 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 121.628 -0.67 . . . . 2.8100000000000001 111.858 175.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -48.42 -56.3 8.58 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.901 0.88 . . . . 2.3900000000000001 108.992 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 32.9 pt -70.09 -10.13 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 113.883 1.068 . . . . 1.5700000000000001 113.883 -173.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.9 t -82.04 -28.68 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 118.74 0.7 . . . . 2.02 111.014 170.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -117.57 90.58 3.36 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 121.196 -0.94 . . . . 1.98 111.426 -161.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.72 41.22 89.49 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.228 -1.149 . . . . 1.49 110.228 177.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.68 -154.0 0.47 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 128.878 2.871 . . . . 2.46 103.406 174.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.2 m -26.84 -60.57 0.09 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 116.498 2.036 . . . . 1.47 116.498 -165.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -39.04 -51.46 1.84 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.265 0.939 . . . . 3.1000000000000001 111.671 175.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.08 -21.81 18.89 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.171 2.188 . . . . 1.27 110.829 -175.277 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.12 31.34 80.52 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 126.3 1.905 . . . . 1.1100000000000001 113.794 171.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.8 m -80.55 -37.3 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 118.283 1.042 . . . . 1.3200000000000001 112.043 -174.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 33.0 mmtt -107.94 -75.41 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 124.665 1.186 . . . . 3.1299999999999999 111.281 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -73.04 116.78 4.84 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 CA-C-N 120.782 1.315 . . . . 1.24 109.689 176.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -76.48 161.5 28.58 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.518 0.727 . . . . 3.2200000000000002 109.77 170.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.9 169.64 6.41 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.079 0.951 . . . . 1.26 111.261 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.12 5.8 66.85 Favored Glycine 0 CA--C 1.532 1.137 0 O-C-N 121.803 -0.56 . . . . 1.01 113.584 176.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -91.3 155.39 18.57 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 118.319 1.06 . . . . 1.3500000000000001 109.125 175.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -97.24 130.67 44.42 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.29 0.636 . . . . 3.0600000000000001 109.515 177.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.1 pt -146.36 177.56 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 106.74 -1.578 . . . . 0.63 106.74 173.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 42.1 mtt85 -119.41 116.4 26.07 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.881 -1.155 . . . . 2.8100000000000001 107.881 167.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.6 p -80.99 127.4 39.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 N-CA-C 107.18 -1.415 . . . . 0.91000000000000003 107.18 174.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.4 122.57 3.31 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 109.678 -1.369 . . . . 0.75 109.678 -177.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -169.84 -170.09 33.85 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 109.383 -1.487 . . . . 0.68999999999999995 109.383 -175.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.2 ptp -99.37 137.38 37.95 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.354 0.662 . . . . 2.8199999999999998 109.508 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.4 m -100.76 135.81 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 122.606 0.362 . . . . 2.5899999999999999 111.43 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -73.57 151.64 40.85 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.364 1.066 . . . . 2.23 109.292 176.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.5 p -55.57 -56.14 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 125.351 1.46 . . . . 2.02 111.173 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.07 71.63 1.22 Allowed Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.625 -1.39 . . . . 1.6699999999999999 109.625 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.3 m -151.98 46.82 0.77 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 117.758 0.779 . . . . 2.5099999999999998 112.28 -176.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.44 121.94 20.65 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 105.862 -1.903 . . . . 1.8400000000000001 105.862 176.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.0 m -132.72 140.04 48.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 119.584 1.083 . . . . 0.56000000000000005 108.705 170.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -122.22 150.9 41.63 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.37 1.068 . . . . 6.4699999999999998 110.57 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.66 156.09 75.56 Favored Pre-proline 0 N--CA 1.453 -0.299 0 N-CA-C 109.809 -0.441 . . . . 2.0 109.809 170.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -68.3 -24.38 37.53 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.873 2.382 . . . . 1.49 111.466 166.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -45.45 -36.62 4.52 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.773 -0.454 . . . . 1.53 109.773 163.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.8 m 66.17 10.65 7.27 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 125.04 1.336 . . . . 1.46 112.999 176.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.2 pp -125.12 9.42 8.04 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 128.687 2.795 . . . . 1.73 110.2 175.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -137.79 130.34 29.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.09 -1.819 . . . . 1.3100000000000001 106.09 176.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.5 146.0 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 107.036 -1.468 . . . . 1.1699999999999999 107.036 -170.228 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -152.12 153.94 34.9 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 121.593 -0.692 . . . . 1.1299999999999999 110.118 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -145.99 156.06 43.24 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.924 -0.58 . . . . 1.8999999999999999 109.646 -171.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.91 140.5 37.6 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.451 -0.574 . . . . 0.83999999999999997 109.451 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.0 t -120.9 151.5 23.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 106.899 -1.519 . . . . 1.75 106.899 176.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -133.18 -177.25 4.43 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.685 0.794 . . . . 1.72 109.489 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 35.3 t70 . . . . . 0 N--CA 1.45 -0.431 0 C-N-CA 123.869 0.868 . . . . 3.2799999999999998 109.197 177.963 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.447 0 N-CA-C 111.319 -0.712 . . . . 1.98 111.319 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -63.11 114.27 3.64 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.383 0.673 . . . . 3.2400000000000002 109.238 -174.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.3 153.53 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 C-N-CA 124.391 1.076 . . . . 1.3 108.606 -178.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.8 mt -114.01 129.18 56.62 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.087 0.955 . . . . 0.70999999999999996 108.582 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.3 t -116.03 130.1 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.229 1.412 . . . . 0.94999999999999996 107.193 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 81.6 p -106.21 150.12 26.19 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.864 0.866 . . . . 0.48999999999999999 110.235 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -144.13 120.59 11.01 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.305 1.442 . . . . 2.02 107.618 -174.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -109.58 46.49 1.0 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.34 1.456 . . . . 2.0699999999999998 111.985 -169.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -170.32 -178.2 2.68 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 128.334 2.654 . . . . 2.6800000000000002 105.614 169.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.6 mp -71.02 141.67 50.94 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.89 1.223 . . . . 1.7 111.363 175.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.51 161.36 35.39 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.342 1.057 . . . . 2.4100000000000001 110.372 171.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -68.55 -97.32 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.781 2.987 . . . . 2.2400000000000002 109.395 168.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -75.79 55.73 0.89 Allowed 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.925 -1.109 . . . . 3.1400000000000001 109.965 177.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 47.7 0.89 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 129.145 2.978 . . . . 2.4500000000000002 118.113 -177.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 72.7 t80 70.84 94.74 0.07 Allowed 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 125.693 1.597 . . . . 3.0800000000000001 108.425 -156.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 54.4 mtt180 -79.54 121.15 24.87 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.689 -1.226 . . . . 6.4699999999999998 107.689 175.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -83.97 173.34 11.26 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 123.07 0.548 . . . . 3.25 111.26 -175.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 61.37 41.2 99.46 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.464 0.555 . . . . 0.78000000000000003 112.95 174.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -157.47 177.56 11.29 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.842 1.257 . . . . 2.3900000000000001 108.897 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -96.63 132.59 11.08 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 109.997 -1.241 . . . . 0.70999999999999996 109.997 171.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.7 pp -137.44 162.2 33.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 107.238 -1.393 . . . . 0.56999999999999995 107.238 174.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.4 m -124.51 135.59 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 108.857 -0.794 . . . . 0.71999999999999997 108.857 178.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -124.23 117.71 25.2 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 124.93 1.292 . . . . 0.70999999999999996 109.902 -170.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -105.7 142.21 35.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.479 1.512 . . . . 3.8500000000000001 110.779 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 168.89 -132.79 2.65 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 107.047 -2.421 . . . . 0.81999999999999995 107.047 171.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.8 p -132.93 147.38 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 C-N-CA 123.84 0.856 . . . . 0.69999999999999996 110.178 -169.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -58.91 129.57 42.81 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.662 -0.866 . . . . 1.78 108.662 169.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -90.9 -101.23 1.22 Allowed Glycine 0 C--N 1.337 0.629 0 N-CA-C 110.63 -0.988 . . . . 1.8700000000000001 110.63 -166.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.404 ' OE1' ' NZ ' ' A' ' 121' ' ' LYS . 28.6 tt0 -58.56 -68.31 0.27 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.901 1.28 . . . . 4.7999999999999998 108.248 174.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -165.48 -70.81 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.38 -1.711 . . . . 4.1900000000000004 106.38 168.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.9 -44.92 96.67 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.536 1.065 . . . . 1.1000000000000001 112.227 178.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.404 ' NZ ' ' OE1' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -83.86 145.61 28.54 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.286 0.634 . . . . 2.7400000000000002 110.631 -176.394 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.4 mp -106.5 140.26 39.67 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 108.55 -0.908 . . . . 2.1099999999999999 108.55 -176.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -105.99 103.4 12.88 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 107.528 -1.286 . . . . 0.46999999999999997 107.528 172.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -131.39 89.67 2.75 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 122.711 0.404 . . . . 1.51 111.995 -168.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.0 t -83.45 -18.08 39.87 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.761 0.652 . . . . 0.78000000000000003 112.761 -176.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -98.46 82.72 2.91 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 119.303 0.956 . . . . 2.79 109.035 -177.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 33.1 m -93.76 123.5 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 123.041 0.536 . . . . 0.65000000000000002 110.285 177.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -112.8 122.66 48.3 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.155 -1.424 . . . . 0.68000000000000005 107.155 173.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -93.3 126.47 38.44 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.915 -1.143 . . . . 1.8200000000000001 107.915 171.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.73 91.48 2.54 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 108.678 -0.86 . . . . 3.3799999999999999 108.678 174.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 12.9 p80 . . . . . 0 C--N 1.33 -0.244 0 C-N-CA 124.439 1.096 . . . . 7.29 109.579 -170.391 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 N--CA 1.464 0.23 0 CA-C-O 119.983 -0.056 . . . . 2.1699999999999999 110.919 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -83.89 137.22 33.77 Favored 'General case' 0 C--N 1.338 0.072 0 C-N-CA 124.054 0.942 . . . . 1.98 110.555 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.93 148.95 34.42 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.852 1.261 . . . . 2.6299999999999999 110.471 -171.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.1 m -79.74 132.59 60.74 Favored Pre-proline 0 N--CA 1.449 -0.495 0 C-N-CA 124.891 1.276 . . . . 1.8100000000000001 110.667 -177.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.03 -41.05 78.59 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.554 2.17 . . . . 0.97999999999999998 112.452 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 m -56.92 -23.56 45.97 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 114.392 1.256 . . . . 2.1299999999999999 114.392 178.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.45 -57.91 4.65 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 106.771 -1.566 . . . . 2.46 106.771 173.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.2 pt -69.35 15.02 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 115.385 1.624 . . . . 0.97999999999999998 115.385 -166.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.3 m -109.37 -21.03 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.557 1.943 . . . . 2.9199999999999999 111.967 172.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -122.99 99.58 6.45 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.735 1.152 . . . . 2.23 110.892 -171.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.47 44.09 95.54 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.478 -1.049 . . . . 1.4199999999999999 110.478 175.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.1 mmmt -150.83 -157.88 0.86 Allowed 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 104.455 -2.424 . . . . 3.2999999999999998 104.455 -175.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.9 m -45.17 -46.82 12.28 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.301 1.84 . . . . 2.0 115.914 -170.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -40.0 -57.82 1.55 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.49 1.041 . . . . 2.5699999999999998 111.037 171.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.39 -24.96 27.31 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.05 1.34 . . . . 1.3600000000000001 110.382 -172.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.03 33.97 75.47 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.464 1.507 . . . . 1.1599999999999999 112.438 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.7 m -81.48 -27.81 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 118.052 0.926 . . . . 1.28 112.091 -175.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -119.47 -71.67 0.02 OUTLIER Pre-proline 0 N--CA 1.451 -0.376 0 C-N-CA 124.736 1.214 . . . . 4.2800000000000002 109.98 177.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -77.12 114.03 3.71 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 CA-C-N 120.456 1.199 . . . . 1.4299999999999999 110.116 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -74.5 166.37 23.63 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.362 -0.607 . . . . 2.9300000000000002 109.362 171.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.5 169.18 13.05 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.65 0.262 . . . . 1.21 110.461 175.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.59 5.12 87.08 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 121.748 -0.595 . . . . 1.1599999999999999 112.411 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -103.1 150.97 23.1 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.455 1.102 . . . . 1.4099999999999999 108.92 176.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -91.03 129.55 37.02 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.239 -0.652 . . . . 3.5099999999999998 109.239 175.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.8 pt -143.2 166.54 14.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 106.11 -1.811 . . . . 0.72999999999999998 106.11 167.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.418 ' HG2' ' CG ' ' A' ' 113' ' ' GLN . 47.6 mtt180 -119.61 116.01 25.14 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.337 -0.986 . . . . 2.8900000000000001 108.337 175.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.3 p -84.99 122.46 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 107.518 -1.29 . . . . 1.0700000000000001 107.518 176.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -124.98 119.69 3.7 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 109.622 -1.391 . . . . 0.58999999999999997 109.622 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.38 -156.49 15.45 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.61 -1.396 . . . . 0.68999999999999995 109.61 -175.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.4 ptp -106.64 131.15 54.12 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.805 0.812 . . . . 2.6600000000000001 110.448 -172.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.404 HG22 ' H ' ' A' ' 108' ' ' GLN . 9.7 m -84.1 152.82 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 115.491 -0.777 . . . . 2.5299999999999998 109.59 -175.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.464 HG22 ' H ' ' A' ' 68' ' ' VAL . 2.3 m -64.94 179.79 0.63 Allowed 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.478 1.111 . . . . 2.4700000000000002 110.487 176.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.464 ' H ' HG22 ' A' ' 67' ' ' THR . 5.7 p -116.51 73.2 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 126.234 1.814 . . . . 2.8900000000000001 108.25 -175.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.18 50.84 0.91 Allowed Glycine 0 CA--C 1.525 0.681 0 CA-C-N 113.154 -1.839 . . . . 2.0800000000000001 111.404 171.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.7 m -110.99 8.8 22.1 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.407 0.683 . . . . 1.3100000000000001 111.915 174.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.98 109.87 6.85 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 106.541 -1.651 . . . . 2.2000000000000002 106.541 175.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.8 m -121.11 129.09 76.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 108.707 -0.849 . . . . 0.92000000000000004 108.707 171.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.457 ' CB ' HG12 ' A' ' 80' ' ' VAL . 20.1 ptt180 -111.1 148.62 32.28 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.405 1.082 . . . . 5.2300000000000004 110.793 177.201 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -82.37 153.21 68.46 Favored Pre-proline 0 C--O 1.234 0.26 0 N-CA-C 109.148 -0.686 . . . . 2.0899999999999999 109.148 170.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -71.64 8.65 1.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.958 2.439 . . . . 1.71 113.789 176.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -69.32 -26.54 64.76 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.756 -0.59 . . . . 1.6799999999999999 109.84 161.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.0 m 72.25 1.34 3.91 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.158 1.783 . . . . 1.22 113.51 -174.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.38 -3.71 8.9 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.694 1.198 . . . . 2.04 113.505 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -117.55 125.85 51.55 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.786 -1.561 . . . . 1.3400000000000001 106.786 174.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.565 HG23 ' HB3' ' A' ' 96' ' ' TYR . 28.2 m -144.45 150.43 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 108.149 -1.056 . . . . 0.95999999999999996 108.149 -175.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -151.58 154.82 37.21 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.875 -0.516 . . . . 0.98999999999999999 110.439 -179.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.438 ' CE1' ' CE1' ' A' ' 104' ' ' PHE . 33.8 p90 -156.77 153.04 27.72 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.059 0.457 . . . . 2.0600000000000001 111.69 -176.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.24 154.71 19.9 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 123.47 0.708 . . . . 0.69999999999999996 109.978 170.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.3 m -132.54 163.24 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 108.191 -1.04 . . . . 2.3199999999999998 108.191 163.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -137.8 -168.24 2.3 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.352 1.061 . . . . 1.76 109.885 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.7 t70 . . . . . 0 C--O 1.234 0.278 0 C-N-CA 123.594 0.758 . . . . 2.3999999999999999 109.453 175.272 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.669 0 N-CA-C 111.129 -0.788 . . . . 2.1000000000000001 111.129 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -58.25 112.07 1.42 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 117.898 0.849 . . . . 4.1900000000000004 110.049 -178.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.0 tp -143.79 160.27 16.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 108.093 -1.077 . . . . 1.5 108.093 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.68 129.09 50.58 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.265 1.026 . . . . 0.68999999999999995 108.533 -168.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.413 ' CG2' ' CE1' ' A' ' 82' ' ' PHE . 5.3 m -115.15 146.77 19.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 109.14 -0.689 . . . . 2.3900000000000001 109.14 173.092 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.4 p -110.19 155.77 21.53 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.963 1.705 . . . . 0.46000000000000002 107.863 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.565 ' HB3' HG23 ' A' ' 80' ' ' VAL . 1.9 t80 -150.08 113.41 4.92 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.973 -1.491 . . . . 2.02 106.973 -175.076 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -101.47 45.2 0.98 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.186 1.394 . . . . 2.0899999999999999 110.906 -173.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -162.95 -176.77 5.08 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.65 1.98 . . . . 2.4399999999999999 106.201 170.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.1 mp -79.67 146.25 32.56 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.868 0.867 . . . . 1.55 111.081 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.525 ' HG ' HG21 ' A' ' 80' ' ' VAL . 78.3 mt -82.06 155.38 69.99 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 123.962 0.905 . . . . 1.49 109.412 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.99 -89.95 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.554 2.836 . . . . 2.0099999999999998 110.173 176.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.78 45.72 0.43 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.284 1.434 . . . . 3.48 110.613 -176.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 44.19 8.25 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.279 2.632 . . . . 2.1600000000000001 115.854 -164.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.438 ' CE1' ' CE1' ' A' ' 82' ' ' PHE . 65.4 t80 50.74 91.91 0.02 OUTLIER 'General case' 0 C--N 1.34 0.171 0 CA-C-N 119.339 0.972 . . . . 2.9500000000000002 109.873 -153.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -78.6 146.17 34.32 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.814 -1.18 . . . . 6.46 107.814 173.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -93.11 167.19 11.94 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 125.401 1.481 . . . . 3.2799999999999998 109.567 -169.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 47.56 44.17 22.14 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 123.532 0.587 . . . . 0.82999999999999996 113.739 -177.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.404 ' H ' HG22 ' A' ' 66' ' ' VAL . 0.7 OUTLIER -153.24 120.03 5.68 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.793 1.637 . . . . 2.2999999999999998 107.387 176.362 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -63.61 135.24 41.58 Favored Glycine 0 CA--C 1.523 0.54 0 O-C-N 121.207 -0.933 . . . . 0.63 111.368 -175.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.2 pp -135.97 166.09 27.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.817 -1.179 . . . . 0.58999999999999997 107.817 177.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 17.6 m -118.79 128.94 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 108.983 -0.747 . . . . 0.67000000000000004 108.983 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -120.45 118.22 29.72 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 125.023 1.329 . . . . 0.77000000000000002 109.727 -168.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.418 ' CG ' ' HG2' ' A' ' 61' ' ' ARG . 0.8 OUTLIER -114.91 150.31 35.84 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.65 1.58 . . . . 3.8100000000000001 109.915 -178.976 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 173.33 -122.57 0.93 Allowed Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 106.61 -2.596 . . . . 0.97999999999999998 106.61 165.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.0 p -143.44 148.24 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 118.204 1.002 . . . . 0.78000000000000003 109.821 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -69.85 143.03 52.97 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.251 -0.648 . . . . 2.29 109.251 168.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -166.04 26.18 0.17 Allowed Glycine 0 CA--C 1.523 0.565 0 C-N-CA 119.602 -1.285 . . . . 2.8199999999999998 113.146 171.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -151.91 45.01 0.75 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.926 0.891 . . . . 6.0999999999999996 108.748 -174.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 24.86 59.95 0.05 Allowed 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 128.976 2.91 . . . . 4.0300000000000002 112.481 172.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 139.27 -47.93 0.88 Allowed Glycine 0 CA--C 1.529 0.949 0 CA-C-N 114.77 -1.105 . . . . 1.1499999999999999 110.948 -172.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.5 151.27 20.8 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 117.885 0.842 . . . . 2.1699999999999999 110.184 -174.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 mp -112.68 121.89 46.08 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.721 1.208 . . . . 2.02 109.364 -169.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -82.89 88.23 6.81 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.403 -1.702 . . . . 0.65000000000000002 106.403 175.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -106.62 72.41 0.9 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.168 0.987 . . . . 1.6399999999999999 110.723 -165.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.9 t -80.79 -6.66 58.82 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.037 0.754 . . . . 1.1599999999999999 113.037 -168.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -113.06 88.63 2.88 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 120.799 -1.188 . . . . 4.1200000000000001 108.864 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 27.0 m -96.74 125.93 49.58 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 C-N-CA 123.312 0.645 . . . . 0.81999999999999995 109.826 174.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -111.94 113.33 25.57 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.68 -1.6 . . . . 0.70999999999999996 106.68 177.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.34 36.79 0.25 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.078 0.551 . . . . 1.48 112.069 -178.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.0 ptmt -85.09 60.68 6.4 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.233 -0.917 . . . . 3.2200000000000002 110.307 -173.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 7.1 p80 . . . . . 0 CA--C 1.533 0.289 0 C-N-CA 123.942 0.897 . . . . 6.21 111.27 -178.843 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 pt? . . . . . 0 N--CA 1.456 -0.132 0 N-CA-C 109.926 -0.398 . . . . 2.1400000000000001 109.926 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -92.04 111.07 22.48 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.751 1.22 . . . . 2.27 109.414 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -125.59 160.16 30.31 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.879 1.272 . . . . 3.8300000000000001 110.104 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.4 p -72.09 135.58 82.46 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 109.599 -0.519 . . . . 1.6799999999999999 109.599 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.412 ' HA ' HD11 ' A' ' 43' ' ' ILE . 33.9 Cg_endo -55.89 -29.59 73.49 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.866 3.044 . . . . 0.93000000000000005 112.337 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.487 ' O ' HG12 ' A' ' 44' ' ' VAL . 31.0 p -66.96 -35.82 80.83 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.024 0.75 . . . . 2.1699999999999999 113.024 178.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -45.0 -47.79 11.49 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 118.882 0.765 . . . . 3.0299999999999998 110.036 177.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.458 HD13 ' H ' ' A' ' 43' ' ' ILE 0.34 0.2 OUTLIER -85.76 11.51 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 114.784 1.402 . . . . 1.79 114.784 -170.009 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.487 HG12 ' O ' ' A' ' 41' ' ' SER . 0.8 OUTLIER -103.13 -8.95 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 123.445 0.698 . . . . 2.0299999999999998 112.553 179.184 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -105.79 -58.15 1.95 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.527 0.603 . . . . 2.5699999999999998 111.964 -171.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -160.71 64.56 0.28 Allowed Glycine 0 C--N 1.335 0.5 0 N-CA-C 109.266 -1.534 . . . . 1.47 109.266 -170.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 15.1 mmtt -153.96 -111.93 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 106.339 -1.726 . . . . 2.3399999999999999 106.339 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.4 m -54.17 -63.03 1.28 Allowed 'General case' 0 C--N 1.343 0.323 0 C-N-CA 126.851 2.06 . . . . 1.3799999999999999 113.298 177.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -49.46 -42.27 42.62 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.964 0.888 . . . . 2.4199999999999999 110.993 -172.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.86 -9.54 45.97 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.338 1.855 . . . . 1.3799999999999999 113.323 -178.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 48.62 48.93 28.35 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 126.26 1.886 . . . . 1.2 113.763 -174.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.5 m -95.18 -55.71 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 118.566 1.183 . . . . 1.27 112.275 -177.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.1 mmtt -87.34 -59.82 0.26 Allowed Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 123.762 0.825 . . . . 3.2000000000000002 111.035 178.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -81.79 155.48 17.97 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 121.942 1.761 . . . . 1.49 109.89 174.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -124.02 60.21 1.13 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.676 1.19 . . . . 3.5699999999999998 109.037 174.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 48.7 -144.46 0.42 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.318 1.047 . . . . 2.6699999999999999 110.116 -174.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 40.23 30.83 0.3 Allowed Glycine 0 CA--C 1.533 1.165 0 C-N-CA 127.83 2.633 . . . . 1.3700000000000001 117.527 165.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -134.62 167.41 20.87 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.857 1.663 . . . . 1.3999999999999999 108.017 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -101.46 134.56 44.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.681 -0.859 . . . . 3.5699999999999998 108.681 171.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.4 pt -139.22 167.68 19.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 105.055 -2.202 . . . . 0.89000000000000001 105.055 168.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.8 mtm180 -126.74 122.89 36.13 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.86 -1.533 . . . . 2.2000000000000002 106.86 174.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.7 m -88.56 138.12 19.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 107.691 -1.226 . . . . 2.3999999999999999 107.691 177.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.0 110.4 0.58 Allowed Glycine 0 C--O 1.226 -0.393 0 N-CA-C 109.599 -1.401 . . . . 0.89000000000000001 109.599 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -172.78 -161.37 23.08 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 108.862 -1.695 . . . . 0.72999999999999998 108.862 -173.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.17 132.74 41.27 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 117.694 0.747 . . . . 2.6499999999999999 110.843 -176.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.522 HG11 ' CE2' ' A' ' 104' ' ' PHE . 23.1 m -91.07 150.93 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-N 116.165 -0.47 . . . . 2.6499999999999999 110.097 174.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.464 HG22 ' H ' ' A' ' 68' ' ' VAL . 0.3 OUTLIER -64.13 -179.31 0.42 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.704 0.764 . . . . 2.2799999999999998 109.856 174.64 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.464 ' H ' HG22 ' A' ' 67' ' ' THR . 4.6 p -123.7 71.02 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 126.176 1.79 . . . . 2.5699999999999998 107.893 175.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.33 -21.75 1.21 Allowed Glycine 0 CA--C 1.53 1.012 0 CA-C-N 114.167 -1.379 . . . . 2.46 113.93 174.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.8 m -62.12 -17.65 58.44 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.655 1.227 . . . . 1.1699999999999999 113.713 -178.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.5 ttm -58.85 125.88 25.35 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 122.972 0.509 . . . . 2.0499999999999998 109.87 171.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.28 130.67 67.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 107.615 -1.254 . . . . 0.63 107.615 166.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -114.46 143.59 44.69 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.599 1.159 . . . . 4.21 109.36 -177.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.49 147.05 51.76 Favored Pre-proline 0 N--CA 1.454 -0.246 0 N-CA-C 109.626 -0.509 . . . . 1.8500000000000001 109.626 177.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -62.51 -25.93 76.01 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.664 2.242 . . . . 1.46 110.826 170.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -42.38 -41.64 2.93 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.572 1.549 . . . . 1.72 110.475 174.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.3 m 87.95 5.9 0.23 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 126.927 2.091 . . . . 1.4099999999999999 113.064 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.84 3.79 9.45 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.011 0.924 . . . . 2.4300000000000002 113.355 173.138 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -128.06 135.07 49.34 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 119.044 0.838 . . . . 1.1499999999999999 109.633 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.594 HG23 ' HB3' ' A' ' 96' ' ' TYR . 2.2 m -149.88 138.76 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 106.928 -1.508 . . . . 0.68000000000000005 106.928 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -142.11 157.93 44.33 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.46 -0.571 . . . . 1.29 109.46 174.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -156.14 152.32 27.78 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.946 -0.39 . . . . 1.8899999999999999 109.946 -174.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.93 149.0 22.38 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.46 -0.57 . . . . 0.55000000000000004 109.46 170.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.1 p -136.78 152.76 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.385 1.074 . . . . 1.9099999999999999 108.919 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -143.01 179.5 7.0 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.43 0.692 . . . . 1.4199999999999999 111.524 -174.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 C--N 1.341 0.223 0 N-CA-C 109.845 -0.428 . . . . 2.3999999999999999 109.845 177.703 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.654 0 N-CA-C 107.802 -2.119 . . . . 1.6899999999999999 107.802 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -120.55 130.52 54.26 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 106.943 -1.502 . . . . 4.3600000000000003 106.943 177.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -132.04 146.27 33.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.297 -1.001 . . . . 0.95999999999999996 108.297 174.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 mt -101.88 128.35 48.3 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.208 1.403 . . . . 0.80000000000000004 109.913 -175.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.3 t -119.33 125.83 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 124.914 1.285 . . . . 1.0600000000000001 108.14 -178.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 42.3 p -95.85 152.18 18.73 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.681 0.792 . . . . 0.57999999999999996 108.926 174.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.594 ' HB3' HG23 ' A' ' 80' ' ' VAL . 3.2 t80 -145.84 166.96 24.4 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.411 1.085 . . . . 2.6299999999999999 108.733 -177.322 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -155.61 150.7 26.67 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 105.373 -2.084 . . . . 3.2599999999999998 105.373 -169.255 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 62.96 61.54 1.11 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 129.299 3.039 . . . . 3.0099999999999998 111.587 -176.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.3 mt 51.68 -152.32 0.23 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.552 1.141 . . . . 1.8600000000000001 109.158 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.453 HD23 ' CZ ' ' A' ' 96' ' ' TYR . 8.6 mt -146.57 153.69 47.59 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 105.764 -1.939 . . . . 1.3700000000000001 105.764 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.84 -83.44 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 125.118 3.879 . . . . 2.6400000000000001 109.853 -174.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -73.75 34.09 0.08 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.34 1.456 . . . . 5.6900000000000004 110.701 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 61.19 -22.61 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.658 1.983 . . . . 3.5 114.155 -170.265 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.522 ' CE2' HG11 ' A' ' 66' ' ' VAL . 64.6 t80 59.69 86.91 0.09 Allowed 'General case' 0 C--N 1.342 0.275 0 CA-C-N 120.286 1.403 . . . . 2.6800000000000002 107.7 -155.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 19.8 mtp85 -82.95 127.64 33.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 105.663 -1.977 . . . . 3.9399999999999999 105.663 175.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -81.37 169.33 17.35 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.101 0.477 . . . . 2.8599999999999999 110.284 -170.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.15 45.67 90.76 Favored Glycine 0 CA--C 1.533 1.188 0 O-C-N 121.765 -0.585 . . . . 0.89000000000000001 113.399 177.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -155.78 179.57 9.07 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.487 1.515 . . . . 2.4100000000000001 107.756 175.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -94.82 133.78 11.7 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 109.625 -1.39 . . . . 0.77000000000000002 109.625 170.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.4 pp -138.73 161.92 29.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 107.477 -1.305 . . . . 0.77000000000000002 107.477 175.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 18.6 m -118.7 123.66 71.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.321 -0.992 . . . . 0.80000000000000004 108.321 177.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.572 ' CB ' HG12 ' A' ' 127' ' ' VAL . . . -110.37 136.81 48.97 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 125.902 1.681 . . . . 0.67000000000000004 109.732 -175.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -128.81 141.53 51.27 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.036 1.734 . . . . 3.0800000000000001 108.612 -175.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 173.29 -121.83 0.88 Allowed Glycine 0 C--N 1.336 0.547 0 N-CA-C 109.218 -1.553 . . . . 0.90000000000000002 109.218 168.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.04 153.21 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.861 -0.792 . . . . 0.77000000000000002 108.861 -173.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -57.71 142.38 45.41 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.186 -0.672 . . . . 1.73 109.186 171.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -87.13 -126.27 2.15 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 109.355 -1.498 . . . . 2.02 109.355 -174.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -60.66 -64.87 0.8 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.265 0.626 . . . . 5.1299999999999999 109.512 178.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -149.87 -74.08 0.17 Allowed 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 107.043 -1.465 . . . . 3.6800000000000002 107.043 173.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -72.54 -39.73 55.65 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.055 -0.975 . . . . 1.24 111.626 -174.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.57 153.47 26.73 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.615 0.766 . . . . 3.6800000000000002 109.699 -175.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -110.06 136.4 49.36 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 125.12 1.368 . . . . 2.2000000000000002 108.275 -176.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -105.78 90.22 3.32 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.712 -1.218 . . . . 0.55000000000000004 107.712 174.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.17 145.22 26.02 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 108.388 -0.968 . . . . 1.46 108.388 176.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.4 t -134.73 0.06 2.92 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.977 0.732 . . . . 1.1100000000000001 112.977 169.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -129.48 99.89 5.35 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 120.669 -1.269 . . . . 2.8799999999999999 109.123 171.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.585 HG13 ' HE2' ' A' ' 96' ' ' TYR . 29.4 m -98.69 148.27 6.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-N 118.885 0.766 . . . . 1.0600000000000001 111.546 166.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.35 112.5 16.41 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.033 -1.84 . . . . 0.76000000000000001 106.033 176.191 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -100.23 41.52 1.16 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.088 0.955 . . . . 2.04 111.482 -175.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -73.63 71.91 1.42 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.844 1.258 . . . . 4.5800000000000001 111.282 -176.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 . . . . . 0 CA--C 1.532 0.254 0 CA-C-N 118.749 0.704 . . . . 4.2000000000000002 112.697 -170.965 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 pt? . . . . . 0 C--O 1.233 0.206 0 CA-C-O 121.018 0.437 . . . . 2.0600000000000001 111.612 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -82.05 132.05 35.25 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.084 0.954 . . . . 2.3500000000000001 109.238 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -131.59 152.92 50.42 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.126 1.77 . . . . 3.8599999999999999 108.589 176.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.9 p -94.19 143.73 26.87 Favored Pre-proline 0 N--CA 1.442 -0.853 0 C-N-CA 125.203 1.401 . . . . 2.0899999999999999 108.729 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -61.57 -18.09 57.84 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.598 2.199 . . . . 1.4199999999999999 112.465 178.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.0 p -47.46 -40.48 18.31 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.32 1.048 . . . . 4.0700000000000003 112.181 165.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.48 ' HG3' ' HD3' ' A' ' 47' ' ' LYS . 7.4 tp10 -83.11 -52.48 6.59 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.966 -1.124 . . . . 2.48 107.966 -169.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 26.8 pt -81.11 30.83 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.046 0.938 . . . . 1.23 113.126 -170.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.0 p -122.88 -44.91 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.923 1.689 . . . . 2.5899999999999999 110.59 173.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -77.21 -41.6 40.72 Favored 'General case' 0 C--N 1.34 0.157 0 O-C-N 121.718 -0.614 . . . . 2.52 112.37 -162.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.04 59.66 0.13 Allowed Glycine 0 C--N 1.332 0.346 0 N-CA-C 109.439 -1.464 . . . . 1.4399999999999999 109.439 -170.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.48 ' HD3' ' HG3' ' A' ' 42' ' ' GLU . 4.6 mttt -155.19 -94.48 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.522 1.929 . . . . 2.27 108.364 -178.12 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.492 HG23 HD23 ' A' ' 116' ' ' LEU . 97.7 m -71.95 -58.39 3.49 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 119.271 0.941 . . . . 1.6000000000000001 111.877 -172.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -46.83 -53.67 11.51 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.778 0.799 . . . . 2.5099999999999998 110.243 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.43 -23.8 29.83 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.747 -1.115 . . . . 1.24 111.965 -171.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.7 53.41 41.43 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.203 1.383 . . . . 1.3700000000000001 111.864 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.274 31.8 m -110.13 -73.58 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 113.73 1.011 . . . . 1.74 113.73 -178.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -64.44 -56.59 21.77 Favored Pre-proline 0 CA--C 1.538 0.507 0 O-C-N 120.953 -1.092 . . . . 3.1299999999999999 113.017 -176.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -87.26 159.23 8.33 Favored 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 123.391 2.728 . . . . 1.3200000000000001 108.371 175.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -100.19 150.76 22.19 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.738 -0.838 . . . . 3.6200000000000001 108.738 171.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.46 157.97 10.4 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.275 -0.639 . . . . 1.1200000000000001 109.275 169.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.57 -0.24 70.8 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 119.041 -0.866 . . . . 1.26 113.819 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.475 ' O ' HD12 ' A' ' 116' ' ' LEU . 78.0 mt-30 -81.39 158.97 24.46 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 119.415 1.608 . . . . 1.4099999999999999 108.456 169.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 45.4 mtt180 -92.82 137.23 32.55 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.71 -0.478 . . . . 3.4700000000000002 109.71 170.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.6 pt -144.7 175.07 3.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 107.482 -1.303 . . . . 0.79000000000000004 107.482 167.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -121.68 124.26 43.85 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-O 119.079 -0.486 . . . . 1.99 110.236 168.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.0 p -82.59 128.5 38.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 N-CA-C 107.537 -1.283 . . . . 1.0 107.537 170.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -128.21 129.27 6.23 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 109.16 -1.576 . . . . 0.56000000000000005 109.16 172.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 176.89 -150.96 10.69 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 107.576 -2.209 . . . . 0.77000000000000002 107.576 -175.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.401 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 1.8 ppp? -125.27 155.6 39.89 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 118.473 1.136 . . . . 4.4400000000000004 111.843 177.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.8 p -100.97 131.73 48.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 114.471 -1.241 . . . . 2.3599999999999999 109.799 -174.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.11 159.54 20.18 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 122.228 1.013 . . . . 2.1200000000000001 109.509 174.087 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.9 p -67.56 -34.31 67.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.859 1.264 . . . . 1.75 112.89 -175.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -120.86 84.07 0.37 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 108.956 -1.658 . . . . 2.0600000000000001 108.956 175.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.3 m -140.29 -43.96 0.41 Allowed 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.909 0.884 . . . . 1.3300000000000001 112.322 -176.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.16 109.77 3.19 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.567 0.747 . . . . 2.0899999999999999 110.184 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.8 m -111.33 117.24 54.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 107.417 -1.327 . . . . 0.64000000000000001 107.417 169.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.95 140.06 42.96 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.86 1.264 . . . . 5.9000000000000004 109.416 -176.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -82.13 149.31 62.22 Favored Pre-proline 0 N--CA 1.455 -0.221 0 N-CA-C 108.903 -0.777 . . . . 1.78 108.903 176.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -66.11 -20.89 56.47 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.497 2.131 . . . . 1.76 110.227 167.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -41.53 -43.36 2.65 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 123.75 0.82 . . . . 1.2 109.415 163.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.8 m 73.49 4.2 4.74 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.055 1.342 . . . . 1.45 112.905 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.2 18.44 10.72 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.882 1.673 . . . . 1.8700000000000001 110.539 173.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 48.9 m-70 -150.79 119.21 6.42 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.478 -1.675 . . . . 1.1000000000000001 106.478 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.7 m -148.54 135.95 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 105.974 -1.861 . . . . 0.78000000000000003 105.974 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -138.78 152.34 47.83 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 119.853 1.206 . . . . 0.93999999999999995 110.799 -177.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -149.33 153.11 36.97 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.28 0.632 . . . . 1.8500000000000001 109.693 -172.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.59 147.41 23.94 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.637 0.775 . . . . 1.01 109.414 169.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.0 t -124.55 146.61 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 N-CA-C 107.429 -1.323 . . . . 1.8 107.429 169.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -150.9 -167.06 2.71 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 108.603 -0.888 . . . . 1.3300000000000001 108.603 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.2 t0 . . . . . 0 CA--C 1.512 -0.495 0 N-CA-C 107.871 -1.159 . . . . 3.5699999999999998 107.871 166.046 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.845 0 CA-C-O 119.034 -0.87 . . . . 2.2200000000000002 113.002 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -171.01 156.72 4.96 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.689 1.996 . . . . 2.5699999999999998 106.81 168.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.5 tp -151.18 162.17 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.834 1.254 . . . . 1.2 108.19 172.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mt -124.25 131.21 53.51 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 124.545 1.138 . . . . 0.93000000000000005 109.928 -176.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.6 p -135.16 142.17 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.822 0.849 . . . . 3.0600000000000001 110.166 -174.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.6 p -105.28 153.46 21.57 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.172 1.389 . . . . 1.3100000000000001 108.973 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.454 ' CD2' HD21 ' A' ' 100' ' ' LEU . 3.7 t80 -141.43 138.93 33.27 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.268 -1.753 . . . . 2.2200000000000002 106.268 178.421 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -128.45 39.43 3.82 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.249 1.02 . . . . 2.2000000000000002 112.138 -165.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -166.22 56.93 0.1 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.945 0.898 . . . . 2.8999999999999999 110.934 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.8 mp 51.95 -168.35 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.911 1.284 . . . . 1.77 111.366 -170.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.454 HD21 ' CD2' ' A' ' 96' ' ' TYR . 15.2 mt -148.34 150.69 35.11 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.286 1.434 . . . . 1.4199999999999999 107.215 174.364 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -62.16 132.75 40.41 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 123.413 2.742 . . . . 2.6899999999999999 109.746 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 37.3 49.25 0.9 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.391 1.877 . . . . 4.3600000000000003 111.645 -173.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 56.72 10.69 0.76 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 128.73 2.812 . . . . 2.3500000000000001 115.518 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.6 t80 64.73 99.79 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.788 1.235 . . . . 2.6699999999999999 108.134 -162.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 46.0 mtt180 -77.44 131.44 37.99 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.441 -1.688 . . . . 4.96 106.441 172.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -83.58 170.72 14.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.102 0.561 . . . . 4.5899999999999999 109.6 -176.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.42 46.9 91.57 Favored Glycine 0 CA--C 1.531 1.058 0 O-C-N 121.924 -0.485 . . . . 0.81999999999999995 112.826 174.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -151.7 179.07 8.73 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.895 1.678 . . . . 2.3700000000000001 108.555 178.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 65' ' ' MET . . . -111.24 142.97 17.11 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.2 -0.76 . . . . 0.75 111.2 171.237 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.4 pp -145.84 168.97 6.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 125.498 1.519 . . . . 0.85999999999999999 106.917 -178.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.0 m -120.77 138.73 50.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 N-CA-C 108.011 -1.107 . . . . 0.56000000000000005 108.011 167.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -127.28 118.17 23.7 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 124.627 1.171 . . . . 0.52000000000000002 109.439 -176.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.67 132.86 52.88 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.197 1.399 . . . . 3.3700000000000001 108.639 -175.169 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 178.47 -160.75 26.93 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 120.858 -0.687 . . . . 1.26 112.308 -177.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.6 p -123.52 138.39 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 125.114 1.365 . . . . 0.97999999999999998 110.121 -169.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.492 HD23 HG23 ' A' ' 48' ' ' THR . 3.8 mp -68.56 138.8 55.42 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.768 -0.583 . . . . 2.3399999999999999 111.027 -179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -95.98 -114.9 2.98 Favored Glycine 0 C--N 1.341 0.809 0 N-CA-C 109.943 -1.263 . . . . 1.79 109.943 -166.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -46.82 -55.92 7.12 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 117.876 0.838 . . . . 4.0700000000000003 112.318 175.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 176.25 -79.08 0.0 OUTLIER 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 128.004 2.522 . . . . 3.4700000000000002 105.251 -174.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.5 -25.13 76.16 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.601 1.096 . . . . 0.96999999999999997 112.679 -174.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.55 152.47 21.68 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.528 1.531 . . . . 2.5099999999999998 109.572 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.0 mp -117.8 156.53 28.19 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.08 0.552 . . . . 2.0899999999999999 109.911 -178.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -120.07 107.42 13.03 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.065 1.346 . . . . 0.73999999999999999 107.979 173.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.24 132.9 41.99 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 118.951 -0.547 . . . . 1.03 110.743 -175.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.3 t -122.2 4.4 9.78 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.38 0.672 . . . . 0.96999999999999997 112.473 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -113.1 79.55 1.25 Allowed 'General case' 0 CA--C 1.531 0.229 0 O-C-N 120.587 -1.321 . . . . 2.5800000000000001 109.361 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.1 m -95.41 132.42 39.53 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 C-N-CA 122.918 0.487 . . . . 0.71999999999999997 110.325 174.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.06 107.13 14.14 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.245 -1.761 . . . . 0.73999999999999999 106.245 175.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.52 105.4 13.54 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.194 -1.039 . . . . 1.5 108.194 175.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -121.68 71.21 0.97 Allowed 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.84 0.856 . . . . 2.9700000000000002 109.618 -176.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 107.082 -1.451 . . . . 4.1299999999999999 107.082 178.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.376 0.131 . . . . 2.6400000000000001 111.087 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -83.68 120.26 25.78 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.782 1.233 . . . . 2.5099999999999998 109.695 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -116.17 163.33 16.12 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.615 1.566 . . . . 2.8199999999999998 109.705 177.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.8 m -84.91 132.89 44.54 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 109.306 -0.628 . . . . 1.8 109.306 -174.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -56.45 -45.33 38.22 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 123.191 2.594 . . . . 0.81000000000000005 111.741 -176.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.655 ' HG ' ' N ' ' A' ' 90' ' ' GLY . 29.0 t -61.74 -23.35 66.1 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.351 -0.843 . . . . 2.52 112.341 178.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -66.74 -45.94 77.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.926 -1.138 . . . . 3.3199999999999998 107.926 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.429 HD11 HG21 ' A' ' 92' ' ' ILE 0.388 18.6 pt -65.56 -11.68 12.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 114.233 1.197 . . . . 1.3100000000000001 114.233 -177.29 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -79.68 -30.83 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.409 0.683 . . . . 1.97 112.266 169.19 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -81.26 -76.4 0.25 Allowed 'General case' 0 N--CA 1.466 0.354 0 O-C-N 121.087 -1.008 . . . . 3.0800000000000001 112.968 -162.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -133.34 51.26 0.85 Allowed Glycine 0 C--N 1.333 0.415 0 N-CA-C 108.055 -2.018 . . . . 2.1400000000000001 108.055 -174.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 1.8 mmtt -147.04 -114.03 0.08 Allowed 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 125.669 1.588 . . . . 4.1699999999999999 108.483 -164.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.0 m -77.12 -55.83 5.1 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 119.401 1.0 . . . . 1.3700000000000001 110.877 -169.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -44.3 -59.82 2.21 Favored 'General case' 0 C--N 1.341 0.204 0 O-C-N 123.87 0.732 . . . . 3.0899999999999999 110.459 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.9 m -84.47 -16.11 43.65 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.216 -0.902 . . . . 1.6299999999999999 110.907 -174.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 65.19 50.44 56.79 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 124.077 0.846 . . . . 1.3300000000000001 112.36 170.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.9 m -106.3 -54.31 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 117.832 0.816 . . . . 1.3100000000000001 112.982 -175.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -90.06 -62.02 0.21 Allowed Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 123.645 0.778 . . . . 5.5800000000000001 112.242 -176.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.41 ' CD ' ' HA ' ' A' ' 47' ' ' LYS . 29.7 Cg_endo -80.34 170.77 15.72 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.795 2.33 . . . . 1.53 108.096 170.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -128.53 160.24 32.98 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.593 -1.632 . . . . 3.23 106.593 168.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.38 156.78 37.11 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.135 -1.061 . . . . 1.1699999999999999 108.135 171.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.49 10.85 60.12 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.093 0.854 . . . . 1.04 112.316 -173.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -110.13 149.52 29.94 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 118.195 0.997 . . . . 1.3300000000000001 109.598 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.12 119.11 35.0 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.688 1.195 . . . . 4.3700000000000001 108.0 -177.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.5 pt -143.6 179.33 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 107.881 -1.155 . . . . 0.84999999999999998 107.881 177.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.3 mtt-85 -126.81 141.26 51.87 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.683 -1.229 . . . . 2.7400000000000002 107.683 172.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.4 p -108.6 132.46 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 106.827 -1.546 . . . . 0.77000000000000002 106.827 176.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.2 124.27 2.75 Favored Glycine 0 C--N 1.334 0.44 0 N-CA-C 109.719 -1.352 . . . . 0.52000000000000002 109.719 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 179.67 -156.95 19.47 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 107.906 -2.077 . . . . 0.58999999999999997 107.906 -176.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -104.66 134.6 47.55 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 118.315 1.058 . . . . 4.6399999999999997 110.646 -172.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.411 ' HB ' ' CZ ' ' A' ' 104' ' ' PHE . 2.8 m -79.92 141.04 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.736 -0.665 . . . . 2.3700000000000001 109.408 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.0 m -76.87 133.61 39.26 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.802 -0.814 . . . . 2.3900000000000001 108.802 172.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.1 p -45.92 -51.24 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 125.651 1.58 . . . . 1.78 112.2 177.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.63 61.74 1.18 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.296 -1.122 . . . . 1.98 110.296 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.1 m -154.83 53.15 0.64 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.589 1.194 . . . . 2.2599999999999998 112.718 -176.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.14 104.88 5.34 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 107.725 -1.213 . . . . 1.7 107.725 174.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.1 m -123.6 135.13 64.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 109.17 -0.678 . . . . 0.57999999999999996 109.17 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.411 ' CB ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -127.38 147.4 50.27 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.714 1.605 . . . . 5.4800000000000004 110.496 -172.807 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -75.79 157.19 84.15 Favored Pre-proline 0 CA--C 1.529 0.172 0 C-N-CA 122.788 0.435 . . . . 2.5600000000000001 110.525 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -66.5 -19.85 54.51 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 123.032 2.488 . . . . 1.24 111.762 166.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -50.16 -35.23 25.28 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.105 0.562 . . . . 1.8200000000000001 110.573 163.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.6 m 71.07 18.46 5.86 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.728 1.611 . . . . 1.53 112.813 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.18 -45.45 2.11 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 125.352 1.461 . . . . 2.5 111.429 170.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -78.46 131.66 36.96 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 107.302 -1.37 . . . . 1.8799999999999999 107.302 -177.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.556 HG23 ' HB3' ' A' ' 96' ' ' TYR . 26.6 m -147.02 147.52 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 107.784 -1.191 . . . . 0.71999999999999997 107.784 -174.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -149.71 156.79 42.45 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.54 -0.725 . . . . 1.3500000000000001 110.217 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -154.09 161.01 42.21 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.401 -0.818 . . . . 2.0899999999999999 109.93 -173.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -105.98 138.66 41.78 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.879 -0.785 . . . . 0.60999999999999999 108.879 174.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 t -121.19 142.0 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 107.678 -1.23 . . . . 1.98 107.678 176.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -144.09 -175.72 4.72 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.02 -0.733 . . . . 1.8999999999999999 109.02 177.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.8 t70 . . . . . 0 N--CA 1.449 -0.512 0 N-CA-C 109.054 -0.721 . . . . 2.6200000000000001 109.054 165.072 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.655 ' N ' ' HG ' ' A' ' 41' ' ' SER . . . . . . . . 0 CA--C 1.526 0.776 0 N-CA-C 110.912 -0.875 . . . . 1.5 110.912 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -123.36 150.78 43.25 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.435 1.894 . . . . 4.4199999999999999 107.533 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.429 HG21 HD11 ' A' ' 43' ' ' ILE . 11.3 tp -146.34 146.39 19.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 122.986 0.514 . . . . 1.3 110.041 174.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.4 mt -91.05 137.26 32.5 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.452 1.101 . . . . 0.72999999999999998 110.61 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.3 t -127.3 129.47 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 126.214 1.806 . . . . 1.01 107.636 -178.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 44.2 p -107.98 145.19 34.23 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.766 1.226 . . . . 0.72999999999999998 109.463 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.556 ' HB3' HG23 ' A' ' 80' ' ' VAL . 2.3 t80 -138.7 126.89 22.74 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.685 1.594 . . . . 1.99 107.277 -175.221 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -108.36 44.62 1.1 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.817 1.247 . . . . 1.9399999999999999 112.331 -170.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -170.7 171.98 5.98 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.593 1.957 . . . . 3.0600000000000001 107.733 172.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.2 mp -66.46 137.63 56.97 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.579 -0.701 . . . . 1.97 110.661 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.51 ' HG ' HG21 ' A' ' 80' ' ' VAL . 19.2 mt -76.21 159.0 81.18 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.224 0.609 . . . . 1.3799999999999999 109.465 176.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -64.83 -88.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.59 2.86 . . . . 2.0099999999999998 109.843 170.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.6 29.4 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.171 1.388 . . . . 3.5299999999999998 113.011 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 50.7 1.66 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 115.923 1.823 . . . . 2.1600000000000001 115.923 -168.096 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.411 ' CZ ' ' HB ' ' A' ' 66' ' ' VAL . 26.6 t80 58.58 93.98 0.03 OUTLIER 'General case' 0 C--N 1.342 0.281 0 C-N-CA 124.652 1.181 . . . . 3.1400000000000001 109.135 -156.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 26.8 mtp85 -77.78 157.43 29.99 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 107.095 -1.446 . . . . 4.2800000000000002 107.095 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -83.93 119.99 25.55 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.388 -0.968 . . . . 2.9900000000000002 108.388 -169.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.3 68.02 1.73 Allowed Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.458 1.028 . . . . 0.76000000000000001 113.09 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.45 ' O ' HG23 ' A' ' 110' ' ' ILE . 1.2 pt20 -156.64 62.61 0.53 Allowed 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 124.141 0.976 . . . . 2.7200000000000002 110.519 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -27.66 119.56 0.05 OUTLIER Glycine 0 CA--C 1.529 0.93 0 C-N-CA 126.028 1.775 . . . . 0.87 114.997 -166.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.45 HG23 ' O ' ' A' ' 108' ' ' GLN . 2.6 pp -121.68 167.88 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 108.602 -0.888 . . . . 0.75 108.602 -173.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.8 m -117.66 134.41 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.583 -0.895 . . . . 0.70999999999999996 108.583 177.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -122.72 136.25 54.82 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.84 1.656 . . . . 0.5 108.623 -175.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -119.81 144.95 47.05 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.327 1.451 . . . . 4.3499999999999996 108.942 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 162.82 -147.84 14.1 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 110.132 -1.187 . . . . 0.92000000000000004 110.132 173.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.9 p -126.13 136.53 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 123.435 0.694 . . . . 0.65000000000000002 109.801 -166.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.736 ' HG ' HD22 ' A' ' 122' ' ' LEU . 7.9 mp -80.92 153.43 27.56 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.901 -1.518 . . . . 2.71 106.901 175.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -172.21 -47.65 0.04 OUTLIER Glycine 0 C--N 1.333 0.394 0 C-N-CA 119.584 -1.293 . . . . 2.1699999999999999 112.88 -178.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -62.33 158.66 16.88 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.832 -0.803 . . . . 4.7699999999999996 108.832 172.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -81.5 64.0 6.04 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 122.218 1.009 . . . . 4.7400000000000002 108.297 -175.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 116.07 17.93 6.11 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 126.04 1.781 . . . . 1.8100000000000001 113.749 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.533 ' C ' HD23 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -134.31 156.09 49.07 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.004 1.402 . . . . 2.75 109.591 169.987 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.736 HD22 ' HG ' ' A' ' 116' ' ' LEU . 2.1 mt -114.67 141.52 47.69 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.326 0.65 . . . . 2.0 110.432 -173.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -101.22 104.47 15.52 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.4 -0.963 . . . . 0.52000000000000002 108.4 175.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -128.66 117.6 21.48 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 123.131 0.572 . . . . 0.95999999999999996 109.78 -177.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.2 t -110.59 -6.61 14.83 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.338 1.055 . . . . 0.89000000000000001 111.614 177.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -99.54 89.59 4.21 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.658 -1.277 . . . . 3.9100000000000001 108.375 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.9 m -106.76 133.92 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 121.829 2.104 . . . . 0.68000000000000005 111.848 175.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -123.36 104.25 8.99 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.771 1.228 . . . . 0.73999999999999999 108.626 -175.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.34 59.89 3.58 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.493 -0.754 . . . . 1.2 110.832 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.34 -24.29 61.27 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.209 0.818 . . . . 3.4700000000000002 113.209 -175.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 . . . . . 0 N--CA 1.466 0.362 0 C-N-CA 124.019 0.928 . . . . 5.21 110.546 -178.13 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.5 pt? . . . . . 0 N--CA 1.465 0.286 0 N-CA-C 112.365 0.506 . . . . 1.8300000000000001 112.365 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.406 ' CD1' ' HB2' ' A' ' 61' ' ' ARG . 98.3 m-85 -83.1 119.21 24.22 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 125.168 1.387 . . . . 2.7400000000000002 109.267 176.53 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.59 159.19 19.89 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.195 0.998 . . . . 2.73 110.808 178.889 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.36 144.01 91.4 Favored Pre-proline 0 N--CA 1.451 -0.402 0 C-N-CA 123.783 0.833 . . . . 1.52 109.313 175.019 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.52 -45.58 4.84 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.636 2.224 . . . . 0.92000000000000004 111.031 179.538 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.5 p -45.28 -46.39 12.64 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.412 1.485 . . . . 2.2799999999999998 112.34 -179.588 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.84 -57.1 10.31 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.071 -1.085 . . . . 3.6200000000000001 108.071 179.589 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 31.2 pt -73.18 30.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 113.712 1.004 . . . . 1.4299999999999999 113.712 -171.56 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.6 t -120.13 -18.5 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.682 1.993 . . . . 2.2000000000000002 111.837 173.574 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -139.57 91.63 2.5 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.945 1.248 . . . . 2.4900000000000002 111.826 -170.355 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.4 46.66 68.48 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 109.99 -1.244 . . . . 1.5700000000000001 109.99 176.168 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -146.42 -139.52 0.1 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 104.404 -2.443 . . . . 4.8899999999999997 104.404 172.883 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.787 HG23 HD11 ' A' ' 116' ' ' LEU . 94.5 m -52.19 -54.13 34.65 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 117.197 -1.383 . . . . 2.02 114.599 -178.413 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -36.36 -56.63 0.77 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.856 1.207 . . . . 2.5499999999999998 111.321 174.21 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.61 -7.71 59.45 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 113.895 -1.502 . . . . 1.5900000000000001 111.268 -171.409 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 56.74 35.9 69.74 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.325 1.44 . . . . 1.1499999999999999 112.373 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.8 m -89.44 -42.54 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 117.893 0.847 . . . . 1.24 110.979 -178.726 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.7 mmtt -81.39 -63.88 0.3 Allowed Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 118.325 -0.845 . . . . 3.2400000000000002 112.55 176.324 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -81.79 152.47 17.07 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.533 1.489 . . . . 1.97 110.168 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -100.4 43.05 1.08 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.261 1.424 . . . . 3.8199999999999998 109.493 175.93 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 33.14 59.88 0.45 Allowed 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 127.232 2.213 . . . . 2.29 115.459 177.578 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.42 30.86 0.2 Allowed Glycine 0 CA--C 1.524 0.639 0 CA-C-N 113.757 -1.565 . . . . 1.47 112.664 177.965 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -121.98 154.06 37.71 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.193 0.997 . . . . 2.8900000000000001 109.522 -176.118 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.446 HH12 ' NE2' ' A' ' 113' ' ' GLN . 13.9 ttp85 -96.82 114.07 25.67 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.101 -1.074 . . . . 4.7699999999999996 108.101 -178.344 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.7 pt -132.99 178.15 6.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 C-N-CA 124.271 1.028 . . . . 0.97999999999999998 109.158 -176.49 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.406 ' HB2' ' CD1' ' A' ' 37' ' ' PHE . 3.5 mtt180 -136.12 150.68 49.2 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.087 -1.079 . . . . 1.9199999999999999 108.087 174.095 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.33 143.63 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.821 1.248 . . . . 0.85999999999999999 107.734 177.243 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.91 123.23 1.81 Allowed Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.363 -1.095 . . . . 0.55000000000000004 110.363 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -178.63 -171.36 41.81 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 109.573 -1.411 . . . . 0.68999999999999995 109.573 -177.237 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.41 135.36 33.36 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.936 0.874 . . . . 2.71 110.945 178.193 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.438 HG12 ' H ' ' A' ' 66' ' ' VAL . 0.8 OUTLIER -63.98 131.02 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 114.99 -1.004 . . . . 2.5600000000000001 108.295 167.36 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.2 m -37.77 -82.75 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 126.531 1.932 . . . . 3.2599999999999998 113.128 176.91 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.6 p 175.84 -40.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.511 1.124 . . . . 2.4399999999999999 109.497 179.608 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -142.45 25.34 2.31 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.923 -0.376 . . . . 1.75 112.181 179.638 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.3 m -84.21 -8.86 58.93 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 117.756 0.778 . . . . 1.23 112.461 -178.85 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.1 tpt -68.29 115.06 7.31 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.803 0.841 . . . . 1.79 108.85 176.605 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.1 m -125.84 135.61 63.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 108.363 -0.977 . . . . 0.59999999999999998 108.363 171.535 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 ptm85 -128.0 133.08 49.12 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.719 1.208 . . . . 6.1299999999999999 108.515 -171.665 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -85.36 146.23 44.27 Favored Pre-proline 0 C--O 1.234 0.287 0 N-CA-C 108.767 -0.827 . . . . 2.1899999999999999 108.767 -176.707 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -70.69 12.97 0.38 Allowed 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.893 2.395 . . . . 1.24 113.703 178.704 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -75.95 -29.91 58.47 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.246 0.618 . . . . 1.1200000000000001 109.655 163.415 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 m 85.47 -18.91 0.34 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.821 2.048 . . . . 1.5 112.757 -174.049 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -104.91 8.78 34.74 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.487 1.115 . . . . 1.95 113.093 -172.926 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 -133.55 126.81 31.82 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.334 -1.358 . . . . 1.1499999999999999 107.334 172.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.93 125.3 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.001 -1.851 . . . . 0.85999999999999999 106.001 -175.769 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -137.85 146.44 43.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 119.683 1.128 . . . . 0.83999999999999997 109.713 179.401 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -142.89 152.36 42.02 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.008 -0.738 . . . . 1.8500000000000001 109.008 -174.903 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.86 150.77 24.55 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.452 -0.573 . . . . 0.57999999999999996 109.452 171.859 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.9 p -143.43 147.27 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.246 1.018 . . . . 1.8999999999999999 108.331 -171.787 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.414 ' HB3' ' HG3' ' A' ' 91' ' ' GLU . 0.3 OUTLIER -153.93 -179.88 8.26 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 112.136 0.421 . . . . 1.78 112.136 -174.795 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.536 0.412 0 C-N-CA 123.912 0.885 . . . . 2.4900000000000002 110.736 176.912 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.947 0 CA-C-O 119.044 -0.864 . . . . 1.79 111.065 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.414 ' HG3' ' HB3' ' A' ' 85' ' ' HIS . 12.1 tt0 -116.27 145.77 42.89 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.995 2.118 . . . . 3.5 107.731 175.633 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.3 tp -128.46 159.04 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 123.845 0.858 . . . . 1.1499999999999999 109.35 175.457 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.3 mt -109.42 138.16 46.2 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.552 1.141 . . . . 0.76000000000000001 110.873 -176.763 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.34 124.79 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 125.987 1.715 . . . . 0.92000000000000004 107.383 -178.789 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.9 p -101.72 135.68 42.84 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.71 -0.848 . . . . 0.47999999999999998 108.71 176.497 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.47 ' CE2' HG13 ' A' ' 127' ' ' VAL . 5.0 t80 -128.76 163.39 25.27 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.283 2.233 . . . . 2.3599999999999999 107.997 -176.083 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -159.92 156.45 27.27 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 105.299 -2.111 . . . . 3.4399999999999999 105.299 -170.988 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 60.16 66.81 0.92 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 130.26 3.424 . . . . 2.9700000000000002 111.854 -169.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 51.65 -160.52 0.09 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.176 0.99 . . . . 1.7 109.902 -178.296 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.9 mt -145.14 157.39 53.7 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 104.555 -2.387 . . . . 1.1699999999999999 104.555 175.33 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.01 -88.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.923 2.415 . . . . 2.21 109.585 178.915 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -78.07 46.82 0.62 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.366 1.066 . . . . 3.25 109.957 179.368 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 45.55 -2.62 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 129.437 3.095 . . . . 2.1800000000000002 117.787 -171.366 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 58.2 t80 56.58 88.51 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.619 1.167 . . . . 2.8300000000000001 108.858 -153.195 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 22.3 mtp-105 -79.88 155.77 27.63 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.593 -1.262 . . . . 4.5800000000000001 107.593 172.975 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -89.88 156.44 18.46 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.139 1.376 . . . . 3.3500000000000001 111.183 -170.031 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 52.15 47.38 55.29 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.274 0.94 . . . . 0.77000000000000002 112.935 175.897 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.06 101.18 2.07 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 105.518 -2.03 . . . . 2.3900000000000001 105.518 -178.661 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -60.87 138.61 48.09 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.714 -0.554 . . . . 0.70999999999999996 111.714 -169.705 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.2 pp -136.75 174.71 11.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 124.25 1.02 . . . . 0.92000000000000004 108.778 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.4 m -122.6 145.83 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 108.83 -0.804 . . . . 0.64000000000000001 108.83 175.701 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.403 ' HB2' HG12 ' A' ' 127' ' ' VAL . . . -135.05 127.65 30.8 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.9 1.28 . . . . 0.44 109.501 -174.257 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.446 ' NE2' HH12 ' A' ' 59' ' ' ARG . 3.9 tt0 -113.38 141.52 46.96 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.072 1.349 . . . . 2.96 109.628 -178.648 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 175.05 -136.39 3.42 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 110.919 -0.872 . . . . 0.84999999999999998 110.919 164.11 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.0 p -129.62 151.3 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 123.632 0.773 . . . . 0.63 109.466 -167.804 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.787 HD11 HG23 ' A' ' 48' ' ' THR . 3.9 mm? -54.55 135.5 46.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.407 -0.815 . . . . 2.2000000000000002 110.714 172.084 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -94.41 -115.55 2.7 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 109.448 -1.461 . . . . 1.8200000000000001 109.448 179.049 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -56.63 -55.75 30.0 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.121 0.969 . . . . 4.54 111.135 179.042 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.8 p30 179.98 -65.82 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 127.755 2.422 . . . . 4.0999999999999996 107.718 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.16 -38.2 35.35 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.353 -0.699 . . . . 1.26 111.353 178.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.54 138.55 34.25 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 117.554 0.677 . . . . 2.1600000000000001 110.85 -175.323 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -103.28 123.58 47.05 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 124.29 1.036 . . . . 2.4500000000000002 108.506 -175.331 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.6 97.29 10.95 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.384 -0.969 . . . . 0.46000000000000002 108.384 176.463 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -118.77 119.11 33.43 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 108.804 -0.813 . . . . 0.96999999999999997 108.804 -177.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.8 t -117.87 10.69 13.27 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.867 0.867 . . . . 1.1799999999999999 111.168 176.55 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -119.03 90.02 3.25 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 120.78 -1.2 . . . . 2.9900000000000002 109.148 170.256 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.47 HG13 ' CE2' ' A' ' 96' ' ' TYR . 5.7 m -91.68 137.1 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 118.949 0.795 . . . . 0.77000000000000002 110.018 168.19 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -118.2 120.96 39.28 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.541 -1.652 . . . . 0.79000000000000004 106.541 173.021 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.05 121.47 27.07 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.884 -1.154 . . . . 2.2999999999999998 107.884 171.532 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -130.84 25.36 5.0 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.118 0.567 . . . . 3.6499999999999999 111.564 -179.674 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.201 0 N-CA-C 108.672 -0.862 . . . . 4.7699999999999996 108.672 -172.887 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 N--CA 1.464 0.237 0 N-CA-C 112.695 0.628 . . . . 2.0499999999999998 112.695 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -81.59 127.66 33.11 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.245 1.018 . . . . 2.0 109.871 -178.123 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -129.67 157.46 42.06 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.571 1.949 . . . . 2.98 109.065 177.755 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.4 p -94.01 149.37 36.81 Favored Pre-proline 0 N--CA 1.446 -0.667 0 C-N-CA 124.455 1.102 . . . . 1.8100000000000001 108.6 179.206 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.26 -31.85 58.06 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.638 2.225 . . . . 1.05 112.342 174.824 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -46.71 -43.63 18.06 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.509 0.724 . . . . 2.8399999999999999 111.827 171.268 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -76.85 -7.31 55.25 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.796 -0.565 . . . . 2.3300000000000001 111.857 -175.785 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.3 pt -124.92 40.56 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 125.696 1.599 . . . . 2.0 110.164 176.018 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.5 p -124.27 -60.7 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 CA-C-O 121.543 0.687 . . . . 2.6499999999999999 112.022 160.992 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -83.51 73.37 10.21 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 120.324 -1.485 . . . . 2.1600000000000001 112.137 -162.504 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.79 70.93 1.09 Allowed Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.832 -1.307 . . . . 1.8999999999999999 109.832 176.73 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.78 -123.06 0.06 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.05 -1.833 . . . . 3.48 106.05 175.744 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 t -63.91 -37.16 86.39 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 118.396 0.543 . . . . 2.4399999999999999 110.871 -172.578 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -43.27 -42.48 4.42 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 127.058 2.143 . . . . 4.4299999999999997 112.079 177.278 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.2 m -116.28 9.52 14.56 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.852 1.261 . . . . 2.1400000000000001 109.991 -175.256 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 45.73 33.66 4.93 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.597 1.57 . . . . 1.1100000000000001 113.667 -173.58 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.1 m -81.56 -25.75 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 119.076 1.438 . . . . 1.99 111.872 -173.073 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -121.44 -75.46 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.226 0 C-N-CA 123.922 0.889 . . . . 3.48 111.137 177.274 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -75.57 121.47 6.38 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 CA-C-N 120.48 1.207 . . . . 1.1399999999999999 109.192 177.788 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -69.04 158.36 34.95 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.483 -0.562 . . . . 3.2999999999999998 109.483 169.685 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.36 167.66 5.15 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.719 0.808 . . . . 1.3799999999999999 110.801 174.902 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.3 11.31 79.58 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 119.589 -0.562 . . . . 1.0600000000000001 113.589 178.187 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -95.02 147.69 23.13 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.442 1.121 . . . . 1.52 109.646 175.076 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.19 125.1 31.87 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 107.261 -1.385 . . . . 3.8300000000000001 107.261 177.265 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.2 pt -140.7 176.93 4.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 107.796 -1.187 . . . . 0.88 107.796 168.091 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.0 mtt180 -130.75 127.08 38.02 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.696 -0.853 . . . . 2.3900000000000001 108.696 173.616 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.5 p -92.28 127.32 44.56 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.076 0 N-CA-C 108.239 -1.023 . . . . 0.83999999999999997 108.239 177.537 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -122.24 127.86 6.96 Favored Glycine 0 C--N 1.333 0.397 0 N-CA-C 110.317 -1.113 . . . . 0.87 110.317 177.314 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.49 -164.03 32.91 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 117.751 0.776 . . . . 0.91000000000000003 111.294 -177.037 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.56 127.6 52.33 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.108 0.963 . . . . 2.8399999999999999 109.99 -175.183 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.5 t -59.49 139.49 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 106.971 -1.492 . . . . 2.29 106.971 169.894 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.655 HG22 HG12 ' A' ' 68' ' ' VAL . 57.2 m -50.9 -79.93 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.198 0.599 . . . . 2.6000000000000001 112.059 -176.682 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.655 HG12 HG22 ' A' ' 67' ' ' THR . 3.1 p 172.42 -39.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 126.175 1.79 . . . . 2.04 108.286 -176.992 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -149.39 28.55 1.21 Allowed Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.982 -0.343 . . . . 2.3799999999999999 112.345 176.059 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.3 m -86.59 4.34 40.59 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 117.713 0.757 . . . . 1.1599999999999999 111.983 176.096 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.79 110.35 2.79 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.878 -1.156 . . . . 1.74 107.878 172.927 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.9 m -118.14 111.83 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 107.396 -1.335 . . . . 0.88 107.396 170.811 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -98.73 148.96 23.34 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.347 1.059 . . . . 5.1799999999999997 110.678 175.798 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -84.72 151.74 58.75 Favored Pre-proline 0 C--O 1.235 0.294 0 N-CA-C 109.088 -0.708 . . . . 2.3199999999999998 109.088 173.837 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.02 25.86 0.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.663 2.242 . . . . 1.8999999999999999 112.861 168.434 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -87.62 -24.61 23.9 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.822 0.849 . . . . 1.4299999999999999 108.746 163.325 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 m 67.97 11.34 8.32 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.353 1.461 . . . . 1.21 112.486 -175.722 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.0 pp -127.37 3.1 6.3 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.655 1.582 . . . . 1.8100000000000001 112.323 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -136.65 135.68 38.47 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.071 1.348 . . . . 1.46 109.301 -178.634 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.07 130.08 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 107.659 -1.237 . . . . 0.78000000000000003 107.659 -170.358 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -135.81 156.2 49.16 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 119.49 1.041 . . . . 1.4099999999999999 110.195 173.559 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -150.25 144.21 25.45 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.935 -0.575 . . . . 2.1299999999999999 110.382 -173.351 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.49 130.16 35.87 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.857 -0.794 . . . . 0.65000000000000002 108.857 173.748 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.6 t -110.24 130.8 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 106.399 -1.704 . . . . 1.75 106.399 174.276 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -157.7 157.28 33.2 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 118.618 -0.706 . . . . 3.3900000000000001 109.277 -179.736 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.0 t0 . . . . . 0 N--CA 1.456 -0.16 0 C-N-CA 123.952 0.901 . . . . 5.8700000000000001 109.556 171.911 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.857 0 N-CA-C 114.371 0.509 . . . . 2.27 114.371 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -165.88 139.31 4.31 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 104.956 -2.238 . . . . 4.2000000000000002 104.956 167.231 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 92' ' ' ILE . 7.6 tp -154.81 152.78 8.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 119.102 0.865 . . . . 0.91000000000000003 110.461 172.643 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.5 mt -100.18 122.74 43.49 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.287 1.035 . . . . 0.56999999999999995 110.594 -179.475 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.0 t -109.74 127.49 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 124.983 1.313 . . . . 1.03 107.8 -177.752 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.6 p -104.81 144.84 31.2 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.779 0.832 . . . . 0.70999999999999996 109.585 179.074 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.436 ' HE2' HG13 ' A' ' 127' ' ' VAL . 10.7 t80 -142.78 163.27 33.25 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.981 1.712 . . . . 2.1800000000000002 107.823 -174.8 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -148.79 146.22 27.92 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 127.742 2.417 . . . . 3.6400000000000001 105.365 -174.535 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 67.87 60.84 0.43 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 129.661 3.185 . . . . 2.8399999999999999 112.147 -171.403 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 mt 54.41 -169.6 0.06 Allowed 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 125.553 1.541 . . . . 2.5 111.375 176.506 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.421 HD21 ' CD2' ' A' ' 96' ' ' TYR . 13.0 mt -143.67 148.94 45.11 Favored Pre-proline 0 C--O 1.233 0.227 0 N-CA-C 106.657 -1.609 . . . . 2.0600000000000001 106.657 179.374 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -64.33 111.29 1.58 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.898 2.399 . . . . 3.04 109.273 -176.679 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 42.09 46.69 3.75 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.252 1.421 . . . . 4.6100000000000003 111.121 -174.95 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 48.79 11.41 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 116.246 1.943 . . . . 3.0699999999999998 116.246 -176.127 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 53.38 115.92 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 123.52 0.728 . . . . 4.5499999999999998 109.546 -148.059 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -74.41 113.81 12.07 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.638 -1.616 . . . . 5.5700000000000003 106.638 -176.453 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -74.83 133.77 41.84 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 118.44 -1.304 . . . . 3.9500000000000002 112.277 -126.665 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.54 53.52 3.38 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.638 1.114 . . . . 1.1499999999999999 111.55 -176.702 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.0 54.97 1.9 Allowed 'General case' 0 C--N 1.341 0.224 0 CA-C-N 117.5 0.65 . . . . 3.6499999999999999 112.021 -172.394 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -9.73 124.36 0.01 OUTLIER Glycine 0 CA--C 1.533 1.191 0 C-N-CA 128.723 3.058 . . . . 0.81000000000000005 116.66 -163.735 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.7 pp -134.63 169.19 22.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 O-C-N 121.455 -1.027 . . . . 0.81999999999999995 110.056 -172.761 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.6 m -121.37 139.38 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 108.718 -0.845 . . . . 0.75 108.718 175.029 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -128.34 121.0 28.14 Favored 'General case' 0 N--CA 1.458 -0.052 0 C-N-CA 125.013 1.325 . . . . 0.51000000000000001 108.831 -176.568 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -103.81 142.45 34.35 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.541 0.736 . . . . 4.04 109.572 -179.341 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 171.59 -141.33 6.33 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.653 -0.979 . . . . 1.1899999999999999 110.653 169.367 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.0 p -129.72 149.24 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 109.311 -0.625 . . . . 0.84999999999999998 109.311 -168.42 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -56.05 132.35 49.89 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 119.666 -0.814 . . . . 2.2999999999999998 109.523 170.716 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -80.29 -124.6 0.55 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 109.391 -1.484 . . . . 1.97 109.391 177.709 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -70.9 -67.67 0.49 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.945 -0.391 . . . . 5.2000000000000002 109.945 -174.461 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -167.31 102.27 0.52 Allowed 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.177 -1.416 . . . . 3.1800000000000002 107.177 174.985 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 104.34 -30.01 10.92 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.096 0.855 . . . . 1.05 111.778 176.751 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -82.39 135.52 35.15 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.902 -0.764 . . . . 2.7999999999999998 109.29 175.02 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -104.99 114.75 29.13 Favored 'General case' 0 CA--C 1.526 0.04 0 N-CA-C 108.385 -0.969 . . . . 2.2599999999999998 108.385 -178.602 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -90.5 106.45 18.51 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 108.053 -1.091 . . . . 0.64000000000000001 108.053 179.684 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -143.26 89.8 2.12 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 113.361 0.875 . . . . 1.6599999999999999 113.361 -166.7 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.429 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 14.7 t -88.62 -15.17 35.69 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.673 0.99 . . . . 1.03 113.673 -179.414 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -84.98 85.98 7.43 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 119.597 -1.939 . . . . 3.3799999999999999 107.871 176.705 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.436 HG13 ' HE2' ' A' ' 96' ' ' TYR . 16.1 m -100.7 130.37 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 119.73 1.15 . . . . 0.92000000000000004 111.941 177.719 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.81 135.08 55.0 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.989 -1.115 . . . . 1.03 107.989 179.241 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -119.78 84.58 2.23 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 124.868 1.267 . . . . 1.75 109.065 179.893 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.66 50.08 0.83 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.165 0.586 . . . . 2.9300000000000002 110.207 177.229 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 67.5 m80 . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 106.582 -1.636 . . . . 6.0700000000000003 106.582 -177.721 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 pp . . . . . 0 C--O 1.233 0.216 0 N-CA-C 107.587 -1.264 . . . . 2.8799999999999999 107.587 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.445 ' CE2' ' HD2' ' A' ' 61' ' ' ARG . 72.5 m-85 -103.43 113.17 26.46 Favored 'General case' 0 C--O 1.228 -0.069 0 C-N-CA 124.792 1.237 . . . . 2.4199999999999999 108.226 179.521 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.72 153.42 35.66 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.33 1.052 . . . . 2.8500000000000001 110.813 -177.047 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -85.67 138.81 35.5 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 125.035 1.334 . . . . 1.6799999999999999 110.735 -177.554 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -54.1 -40.25 82.42 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.598 2.865 . . . . 0.77000000000000002 112.044 -179.573 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.4 t -58.83 -49.14 78.82 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 119.009 0.822 . . . . 2.6200000000000001 111.804 178.613 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.1 tt0 -55.25 -40.57 71.1 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 119.864 -0.734 . . . . 3.5099999999999998 109.743 -178.179 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.315 37.0 pt -77.8 -11.31 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 114.823 1.416 . . . . 1.1599999999999999 114.823 -179.17 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.61 -19.67 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 119.312 0.96 . . . . 2.0099999999999998 111.315 -179.041 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -96.61 -125.63 0.13 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.234 -0.654 . . . . 3.3399999999999999 109.234 -179.376 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -82.92 61.43 4.77 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.284 -1.126 . . . . 1.52 110.284 -169.828 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -151.89 -106.46 0.05 Allowed 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 127.155 2.182 . . . . 4.0199999999999996 106.789 -171.799 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.688 ' CG2' HD21 ' A' ' 122' ' ' LEU . 22.6 m -77.36 -57.05 4.04 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.517 0.599 . . . . 1.73 109.897 -171.357 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -56.84 -49.73 74.56 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 123.588 0.555 . . . . 3.1600000000000001 110.129 -171.231 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.6 m -70.1 -34.45 73.15 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.773 -0.649 . . . . 1.96 110.919 174.733 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.22 46.59 20.64 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 123.76 0.695 . . . . 2.1200000000000001 111.421 175.311 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.4 m -113.98 -51.25 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 113.534 0.938 . . . . 2.1400000000000001 113.534 -172.956 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -79.02 -58.64 0.68 Allowed Pre-proline 0 CA--C 1.54 0.594 0 CA-C-O 118.498 -0.763 . . . . 4.25 112.071 -178.913 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -79.37 165.02 23.66 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.096 1.864 . . . . 1.3899999999999999 109.583 174.154 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.87 155.9 16.85 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.985 0.914 . . . . 4.2599999999999998 109.864 174.861 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.9 24.57 0.49 Allowed 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.639 1.176 . . . . 3.5600000000000001 112.122 177.376 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -143.4 30.2 1.99 Allowed Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.983 1.278 . . . . 0.96999999999999997 110.891 171.431 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -103.03 155.88 18.07 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.393 0.677 . . . . 1.4099999999999999 109.429 174.211 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.55 126.73 52.47 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.753 1.221 . . . . 6.1799999999999997 108.168 176.817 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.646 ' CD1' HD21 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -143.86 176.3 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 108.283 -1.006 . . . . 1.5800000000000001 108.283 171.147 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.445 ' HD2' ' CE2' ' A' ' 37' ' ' PHE . 22.7 mtt180 -111.33 134.48 52.88 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.689 -0.485 . . . . 3.3900000000000001 109.689 166.535 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -102.93 119.88 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 107.122 -1.436 . . . . 0.91000000000000003 107.122 171.669 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.49 125.24 4.33 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 109.643 -1.383 . . . . 0.58999999999999997 109.643 -176.806 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.34 -133.73 1.59 Allowed Glycine 0 C--N 1.334 0.451 0 N-CA-C 109.517 -1.433 . . . . 1.52 109.517 -174.715 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.4 ptp -127.64 133.77 49.66 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.101 0.951 . . . . 3.02 109.996 175.769 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.438 HG11 ' CZ ' ' A' ' 104' ' ' PHE . 15.7 t -95.64 143.2 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 108.716 -0.846 . . . . 2.3399999999999999 108.716 175.507 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.63 175.74 3.34 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.281 -0.637 . . . . 2.8799999999999999 109.281 173.656 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 68' ' ' VAL . 9.5 p -106.4 65.42 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 122.897 1.332 . . . . 2.4300000000000002 109.418 179.255 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 134.76 68.79 0.07 OUTLIER Glycine 0 CA--C 1.526 0.773 0 CA-C-N 113.68 -1.6 . . . . 1.6699999999999999 112.429 175.517 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.0 m -136.45 8.09 3.1 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.399 -1.059 . . . . 1.3300000000000001 112.729 158.739 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.8 ttp -78.85 117.39 19.91 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.011 -1.107 . . . . 2.5499999999999998 108.011 176.341 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.2 m -121.02 151.71 24.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 107.829 -1.175 . . . . 0.53000000000000003 107.829 175.732 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.401 ' CB ' HG12 ' A' ' 80' ' ' VAL . 37.8 ptt85 -141.44 144.02 34.2 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.992 0.917 . . . . 3.98 109.041 -169.154 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.33 155.12 37.24 Favored Pre-proline 0 C--O 1.236 0.361 0 N-CA-C 109.519 -0.548 . . . . 2.5800000000000001 109.519 -177.002 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.13 32.11 0.42 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.508 2.805 . . . . 2.1299999999999999 112.685 -176.121 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -95.69 -14.66 23.24 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.747 1.219 . . . . 1.5900000000000001 109.125 163.611 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.4 m 70.23 6.82 5.96 Favored 'General case' 0 C--N 1.345 0.399 0 C-N-CA 125.105 1.362 . . . . 1.51 113.225 -178.845 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.7 pp -125.5 -34.28 2.69 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 127.662 2.385 . . . . 1.98 112.354 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 30.6 m-70 -87.96 124.72 33.99 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 107.809 -1.182 . . . . 1.23 107.809 -176.575 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.447 HG23 ' CB ' ' A' ' 96' ' ' TYR . 23.7 m -149.05 152.98 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.397 -0.964 . . . . 1.02 108.397 -175.008 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -156.02 161.93 40.39 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 121.41 -0.807 . . . . 1.1599999999999999 110.803 176.706 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -155.3 160.57 40.87 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.197 0.599 . . . . 1.8700000000000001 110.486 -175.848 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -107.87 136.0 48.32 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.251 -1.018 . . . . 0.58999999999999997 108.251 175.249 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.7 t -115.74 142.1 30.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 124.942 1.297 . . . . 1.8400000000000001 107.521 178.618 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -125.94 179.91 4.99 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.564 0.746 . . . . 1.71 110.056 179.303 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.8 t0 . . . . . 0 N--CA 1.445 -0.684 0 CA-C-O 121.072 0.463 . . . . 3.4399999999999999 109.995 -177.624 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.616 0 N-CA-C 108.108 -1.997 . . . . 2.3999999999999999 108.108 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -162.15 93.85 0.89 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.947 -1.131 . . . . 3.9399999999999999 107.947 179.522 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.15 134.65 65.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 108.766 -0.827 . . . . 0.85999999999999999 108.766 -175.188 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.1 mt -85.39 136.96 33.24 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.077 0.951 . . . . 0.71999999999999997 109.973 177.124 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 87.1 t -124.06 133.22 69.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 107.387 -1.338 . . . . 1.04 107.387 176.363 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.7 p -111.78 158.35 19.47 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.537 1.135 . . . . 0.79000000000000004 109.796 -177.105 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.721 ' OH ' HG13 ' A' ' 127' ' ' VAL . 2.4 m-85 -148.43 133.02 17.76 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.348 1.459 . . . . 3.96 108.897 -178.279 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -104.92 6.32 33.56 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.682 1.193 . . . . 2.7000000000000002 111.711 169.311 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -111.79 162.91 14.75 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 124.488 1.115 . . . . 5.0300000000000002 111.123 172.287 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.9 mp -60.89 141.39 57.21 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.322 -0.853 . . . . 1.6499999999999999 109.949 162.631 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.525 HD13 ' CB ' ' A' ' 104' ' ' PHE . 75.8 mt -81.02 159.27 68.77 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 107.426 -1.324 . . . . 1.6200000000000001 107.426 175.849 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.54 -90.76 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.896 3.064 . . . . 2.3100000000000001 111.196 179.273 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -79.46 43.54 0.56 Allowed 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.245 -0.909 . . . . 3.73 110.53 -173.537 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.3 tp 57.92 3.27 0.21 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.581 1.152 . . . . 2.8399999999999999 112.978 -165.969 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.525 ' CB ' HD13 ' A' ' 100' ' ' LEU . 44.8 t80 57.78 94.23 0.03 OUTLIER 'General case' 0 C--N 1.342 0.274 0 CA-C-N 119.586 1.085 . . . . 2.46 109.237 -166.271 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -78.94 122.47 26.17 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.339 -0.986 . . . . 4.54 108.339 -178.17 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -84.13 173.06 11.38 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.093 1.357 . . . . 3.21 110.127 -172.692 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.9 34.73 89.43 Favored Glycine 0 CA--C 1.527 0.832 0 O-C-N 121.882 -0.511 . . . . 0.79000000000000004 112.821 175.085 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -156.32 175.39 14.06 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.364 1.066 . . . . 2.5499999999999998 108.967 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -97.68 105.88 3.22 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.973 -0.851 . . . . 1.1899999999999999 110.973 -178.07 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.5 pp -111.5 157.46 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 106.547 -1.649 . . . . 0.84999999999999998 106.547 -179.42 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.1 m -118.14 116.04 50.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 108.742 -0.836 . . . . 0.67000000000000004 108.742 176.535 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.45 ' HB2' HG12 ' A' ' 127' ' ' VAL . . . -102.99 146.53 28.21 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 125.373 1.469 . . . . 0.62 109.875 -175.207 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -146.52 139.66 25.6 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.32 1.048 . . . . 3.5800000000000001 110.106 -173.463 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 170.74 -133.82 2.91 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 106.516 -2.634 . . . . 0.84999999999999998 106.516 174.762 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p -142.24 149.9 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 118.63 1.215 . . . . 0.76000000000000001 109.166 -166.534 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 1.019 HD22 HD22 ' A' ' 122' ' ' LEU . 1.5 mt -77.31 157.18 30.85 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.693 -0.855 . . . . 1.99 108.693 -178.42 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 175.92 25.73 0.03 OUTLIER Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.345 -0.931 . . . . 2.6699999999999999 115.408 175.874 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -150.3 46.31 0.89 Allowed 'General case' 0 C--O 1.238 0.455 0 CA-C-N 118.392 1.096 . . . . 5.9100000000000001 109.533 -175.827 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 20.61 66.17 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 129.533 3.133 . . . . 3.9300000000000002 111.338 173.473 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 131.13 -30.44 3.33 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 114.084 -1.416 . . . . 1.0600000000000001 112.555 -175.516 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.32 161.13 19.48 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.548 1.174 . . . . 3.3500000000000001 111.251 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 1.019 HD22 HD22 ' A' ' 116' ' ' LEU . 12.5 mt -121.36 131.59 54.28 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 125.442 1.497 . . . . 2.0899999999999999 110.443 -169.348 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.25 99.07 11.38 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.083 -1.451 . . . . 0.55000000000000004 107.083 176.984 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.82 155.48 16.76 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.573 -0.528 . . . . 1.53 109.573 179.889 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.446 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 8.8 t -134.01 -42.23 0.82 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.876 0.47 . . . . 0.96999999999999997 111.365 173.254 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -87.39 105.62 17.39 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 120.179 -1.576 . . . . 4.3099999999999996 108.778 177.684 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.721 HG13 ' OH ' ' A' ' 96' ' ' TYR . 0.9 OUTLIER -111.88 118.62 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 123.824 0.85 . . . . 1.1399999999999999 109.725 171.027 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -108.3 111.25 23.11 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.443 -0.947 . . . . 0.94999999999999996 108.443 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.56 53.48 2.54 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.116 0.966 . . . . 1.53 110.628 178.424 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.2 pttt -79.88 69.72 6.28 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.79 -0.569 . . . . 3.21 110.616 -173.55 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 . . . . . 0 CA--C 1.529 0.158 0 C-N-CA 123.053 0.541 . . . . 4.5300000000000002 110.315 -172.172 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 pt? . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 109.613 -0.514 . . . . 2.6499999999999999 109.613 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -93.91 114.82 27.11 Favored 'General case' 0 C--N 1.337 0.061 0 C-N-CA 124.8 1.24 . . . . 2.3599999999999999 109.792 -178.039 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -120.12 156.88 30.15 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 126.329 1.852 . . . . 2.6499999999999999 109.669 -175.765 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.7 p -90.78 145.24 31.63 Favored Pre-proline 0 N--CA 1.45 -0.473 0 C-N-CA 124.422 1.089 . . . . 1.74 109.059 177.824 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -55.29 -36.81 94.4 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.889 2.393 . . . . 0.81999999999999995 111.968 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.5 t -52.57 -35.64 54.33 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.453 -0.779 . . . . 2.6299999999999999 112.041 175.247 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -83.68 5.51 24.33 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.291 0.478 . . . . 3.02 112.291 -176.408 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.6 pt -120.24 1.48 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 113.812 1.042 . . . . 1.25 113.812 173.914 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.1 p -97.27 -59.69 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 118.617 0.644 . . . . 2.1099999999999999 112.02 176.096 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -75.65 84.42 2.67 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 120.504 -1.373 . . . . 2.0699999999999998 112.042 -166.614 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.37 56.67 9.6 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 109.658 -1.377 . . . . 1.71 109.658 176.047 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -147.86 -137.3 0.09 Allowed 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 127.79 2.436 . . . . 2.3500000000000001 105.861 -173.904 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.6 m -58.82 -47.46 84.73 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.451 1.5 . . . . 1.73 112.631 -175.776 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -38.46 -54.87 1.45 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.445 0.698 . . . . 2.48 111.311 174.818 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.47 -1.45 53.52 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.446 1.099 . . . . 1.9199999999999999 111.738 -173.147 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 49.79 41.39 35.57 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.137 1.351 . . . . 1.3799999999999999 113.408 -176.804 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.1 m -92.39 -26.41 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.53 1.165 . . . . 1.96 112.887 -176.687 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -123.04 -74.16 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 124.635 1.174 . . . . 4.8099999999999996 111.497 176.663 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -73.48 121.38 7.08 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.554 1.503 . . . . 1.4099999999999999 109.305 177.497 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -77.89 160.07 28.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.078 0.951 . . . . 4.4000000000000004 108.893 175.325 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.68 158.06 28.39 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.324 -0.621 . . . . 1.1499999999999999 109.324 169.0 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.53 -2.08 76.89 Favored Glycine 0 CA--C 1.532 1.129 0 O-C-N 121.682 -0.636 . . . . 1.04 112.572 -175.482 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -91.67 146.39 23.81 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 118.102 0.951 . . . . 2.9700000000000002 109.131 178.222 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.4 mtt-85 -90.5 133.75 34.84 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.033 -0.728 . . . . 4.1299999999999999 109.033 172.443 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.1 pt -144.98 169.48 7.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 105.279 -2.119 . . . . 1.05 105.279 166.607 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 37.8 mtt180 -116.94 126.65 53.27 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.656 -1.239 . . . . 2.7599999999999998 107.656 169.406 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -90.44 135.49 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 N-CA-C 107.269 -1.382 . . . . 1.8799999999999999 107.269 173.484 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -128.55 128.59 5.96 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 109.38 -1.488 . . . . 0.63 109.38 172.491 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 176.8 -167.74 39.31 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 109.939 -1.264 . . . . 0.89000000000000001 109.939 -173.227 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.41 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 1.4 ptm -111.95 137.7 49.6 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.479 0.657 . . . . 5.0599999999999996 112.42 -176.18 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.2 t -64.93 159.32 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 114.349 -1.296 . . . . 2.3900000000000001 109.062 178.692 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 62.7 m -108.54 131.98 54.3 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.053 0.941 . . . . 3.0899999999999999 109.984 -178.492 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.3 p -75.58 45.91 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 127.955 2.502 . . . . 3.6400000000000001 111.895 179.009 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.73 49.93 0.03 OUTLIER Glycine 0 CA--C 1.522 0.473 0 C-N-CA 125.529 1.538 . . . . 2.77 109.37 179.335 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.0 m -155.59 -40.67 0.08 Allowed 'General case' 0 C--O 1.226 -0.162 0 O-C-N 122.402 -0.469 . . . . 1.6599999999999999 112.029 177.995 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.67 115.76 1.79 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 109.691 -0.485 . . . . 2.6000000000000001 109.691 171.802 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.8 m -136.51 153.57 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 108.866 -0.791 . . . . 0.98999999999999999 108.866 168.715 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -128.07 148.61 50.57 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.873 1.269 . . . . 4.8399999999999999 108.837 -178.231 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -82.84 155.9 67.78 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-N 118.119 0.418 . . . . 1.8700000000000001 109.959 174.893 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -70.91 7.28 1.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.088 2.525 . . . . 1.22 113.599 174.452 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -72.74 -23.6 60.86 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 121.938 -0.476 . . . . 1.6799999999999999 110.181 163.318 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.7 m 70.97 10.49 6.95 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.504 1.522 . . . . 1.55 112.785 -174.854 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 79' ' ' HIS 0.276 1.0 OUTLIER -123.08 -36.5 2.84 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.705 1.002 . . . . 2.3999999999999999 113.705 177.748 . . . . . . . . 4 4 . 1 . 024 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.407 ' N ' HD12 ' A' ' 78' ' ' LEU . 80.4 m-70 -85.33 129.36 34.83 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 120.23 1.377 . . . . 1.3500000000000001 107.566 178.415 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.421 HG23 ' HB3' ' A' ' 96' ' ' TYR . 30.0 m -138.06 145.81 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 107.92 -1.141 . . . . 1.05 107.92 176.974 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -144.23 147.34 33.46 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.082 -0.71 . . . . 1.3899999999999999 109.082 177.784 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -157.49 155.61 30.66 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.317 -0.401 . . . . 2.21 110.39 -171.588 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.65 149.6 24.28 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.136 -0.69 . . . . 0.52000000000000002 109.136 173.071 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.3 t -119.0 133.59 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 106.151 -1.796 . . . . 1.8899999999999999 106.151 172.849 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -155.64 159.71 39.82 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 106.653 -1.61 . . . . 3.1800000000000002 106.653 174.817 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 55.0 t0 . . . . . 0 C--O 1.233 0.203 0 N-CA-C 106.293 -1.743 . . . . 5.7199999999999998 106.293 173.8 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.968 0 N-CA-C 109.765 -1.334 . . . . 2.54 109.765 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -164.76 148.64 9.01 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.952 -1.499 . . . . 4.0599999999999996 106.952 169.948 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -155.14 154.48 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.79 0.723 . . . . 0.78000000000000003 109.082 163.449 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 mt -109.12 131.94 54.59 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.508 1.523 . . . . 0.60999999999999999 109.521 177.482 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.1 t -122.05 144.16 32.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 125.8 1.64 . . . . 0.95999999999999996 108.77 -176.263 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 32.4 p -118.96 150.01 40.64 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.203 1.001 . . . . 0.47999999999999998 108.49 179.008 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.421 ' HB3' HG23 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -149.32 109.81 4.22 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.854 -1.165 . . . . 2.2999999999999998 107.854 -178.854 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -91.02 42.91 1.12 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.347 1.459 . . . . 2.1200000000000001 112.048 -176.443 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -169.48 174.6 5.86 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.61 1.564 . . . . 2.52 108.645 173.049 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.6 mp -68.56 162.71 25.2 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.637 0.775 . . . . 1.6899999999999999 112.485 -175.398 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.452 HD22 ' CZ ' ' A' ' 104' ' ' PHE . 55.7 mt -112.67 158.6 37.04 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 126.048 1.739 . . . . 1.1899999999999999 110.618 -175.912 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.12 -88.16 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.897 3.065 . . . . 1.99 111.365 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -73.57 31.27 0.07 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.791 1.236 . . . . 3.8300000000000001 112.139 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 50.73 -5.38 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 128.558 2.743 . . . . 2.2799999999999998 116.387 -165.501 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.487 ' CZ ' HD12 ' A' ' 110' ' ' ILE . 13.4 m-30 55.65 109.23 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.864 1.666 . . . . 4.5099999999999998 110.959 -154.607 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -74.0 164.64 26.37 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.301 -1.318 . . . . 5.4900000000000002 108.323 174.865 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -82.4 61.14 5.43 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.199 1.4 . . . . 5.1100000000000003 109.727 -164.436 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 108.31 62.05 0.55 Allowed Glycine 0 CA--C 1.522 0.53 0 C-N-CA 124.509 1.052 . . . . 1.5600000000000001 111.218 -173.961 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -111.14 168.81 9.22 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 107.891 -1.151 . . . . 2.9399999999999999 107.891 158.312 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 65' ' ' MET . . . -102.91 133.7 11.52 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 111.496 -0.641 . . . . 1.0600000000000001 111.496 -179.216 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.487 HD12 ' CZ ' ' A' ' 104' ' ' PHE . 33.3 pt -145.33 169.59 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.302 1.041 . . . . 1.3300000000000001 109.638 -165.535 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 m -126.8 139.65 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 124.176 0.991 . . . . 0.68999999999999995 108.465 170.645 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -134.95 140.08 45.44 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 124.888 1.275 . . . . 0.66000000000000003 110.266 -176.695 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -135.64 145.4 46.78 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.779 1.632 . . . . 3.8900000000000001 109.705 -177.871 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -178.47 -101.54 0.15 Allowed Glycine 0 C--N 1.337 0.625 0 N-CA-C 110.17 -1.172 . . . . 1.3999999999999999 110.17 166.549 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.7 p -162.72 151.63 3.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 108.992 -0.744 . . . . 1.0 108.992 176.251 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -72.1 140.84 49.12 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 109.438 -0.578 . . . . 2.2200000000000002 109.438 167.976 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -162.43 21.17 0.19 Allowed Glycine 0 CA--C 1.524 0.612 0 C-N-CA 119.709 -1.234 . . . . 2.52 113.716 172.412 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -143.57 46.96 1.48 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.755 -0.832 . . . . 5.3099999999999996 108.755 -174.287 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 21.7 t70 18.09 66.12 0.02 OUTLIER 'General case' 0 C--N 1.34 0.164 0 C-N-CA 128.954 2.902 . . . . 3.5699999999999998 112.487 178.409 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 137.87 -48.41 0.89 Allowed Glycine 0 CA--C 1.528 0.849 0 CA-C-N 114.614 -1.175 . . . . 1.1100000000000001 111.475 -171.62 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -105.5 160.92 14.79 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.504 1.152 . . . . 2.9700000000000002 109.811 -173.862 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.64 128.92 55.82 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.508 1.123 . . . . 1.97 109.237 -172.098 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -95.6 98.73 10.72 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.163 -1.792 . . . . 0.57999999999999996 106.163 176.699 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -126.15 94.66 4.15 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.501 0.556 . . . . 1.4099999999999999 112.501 -164.933 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.2 t -84.27 -33.4 24.02 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.906 0.706 . . . . 0.90000000000000002 112.906 -178.8 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -82.91 95.09 7.86 Favored 'General case' 0 CA--C 1.528 0.113 0 O-C-N 120.556 -1.34 . . . . 3.6099999999999999 107.733 -172.816 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 35.0 m -118.44 134.85 60.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 C-N-CA 123.809 0.844 . . . . 1.3300000000000001 110.634 -176.221 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.59 101.66 8.8 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.241 -1.392 . . . . 1.03 107.241 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.98 107.26 12.63 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.741 -1.207 . . . . 2.21 107.741 172.355 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.29 44.79 0.72 Allowed 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 121.367 0.603 . . . . 3.3199999999999998 109.983 179.515 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 7.8 p80 . . . . . 0 CA--C 1.536 0.44 0 N-CA-C 113.161 0.8 . . . . 6.9800000000000004 113.161 -172.598 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.227 -0.105 0 CA-C-O 118.805 -0.617 . . . . 3.4700000000000002 111.139 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -81.58 96.67 7.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.963 -0.755 . . . . 2.0899999999999999 108.963 -175.48 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.96 157.32 19.39 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.836 0.854 . . . . 2.9500000000000002 110.427 177.694 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 p -77.44 146.08 73.14 Favored Pre-proline 0 N--CA 1.444 -0.743 0 C-N-CA 124.08 0.952 . . . . 1.77 110.179 -177.139 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -64.2 -23.05 66.72 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.507 2.805 . . . . 0.82999999999999996 112.232 175.32 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.5 p -61.52 -64.4 0.96 Allowed 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.239 0.615 . . . . 2.9500000000000002 110.931 174.932 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -46.34 -51.13 15.38 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.071 0.948 . . . . 2.1699999999999999 110.81 -171.462 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 34.0 pt -57.23 -29.07 31.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.436 1.094 . . . . 2.0800000000000001 112.754 -178.925 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.6 t -80.42 -54.32 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 123.335 0.654 . . . . 2.04 109.885 169.601 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -50.59 -42.48 55.82 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 125.002 1.321 . . . . 5.1500000000000004 112.982 -166.506 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.26 65.02 0.1 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.515 -0.85 . . . . 2.0299999999999998 111.19 -178.82 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.93 -90.32 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 118.598 -0.715 . . . . 2.46 110.923 -170.063 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.0 m -83.18 -58.82 2.69 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.689 1.196 . . . . 1.52 109.721 -169.443 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -51.15 -44.24 61.4 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 122.393 1.092 . . . . 2.5899999999999999 109.473 177.838 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.16 -25.47 60.82 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.397 1.479 . . . . 2.3799999999999999 112.451 179.059 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 56.82 46.58 90.0 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.292 1.425 . . . . 1.1799999999999999 112.552 -172.488 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.1 m -109.77 -27.43 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 114.091 1.145 . . . . 1.5 114.091 -175.422 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -122.5 -72.76 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.295 0 CA-C-O 118.237 -0.887 . . . . 3.3700000000000001 111.108 -175.794 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -76.71 151.11 31.74 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 121.504 1.469 . . . . 1.1200000000000001 108.834 169.632 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -108.32 159.58 16.53 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.663 1.185 . . . . 2.75 109.324 173.366 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.11 136.94 56.65 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.412 -0.958 . . . . 1.3100000000000001 108.412 174.078 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.85 -1.95 30.29 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 124.234 0.921 . . . . 1.0600000000000001 113.09 -173.324 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -89.02 146.9 24.56 Favored 'General case' 0 C--N 1.338 0.08 0 CA-C-N 118.87 1.335 . . . . 1.8799999999999999 109.585 179.226 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.29 106.89 17.51 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 107.906 -1.146 . . . . 3.6200000000000001 107.906 -173.53 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 pt -135.63 178.21 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 124.054 0.942 . . . . 1.1399999999999999 108.947 -173.945 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -121.93 119.77 32.5 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.476 -0.935 . . . . 2.21 108.476 174.415 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 p -83.78 128.96 38.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 107.198 -1.408 . . . . 1.04 107.198 173.044 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.3 128.6 4.58 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.562 -1.015 . . . . 0.78000000000000003 110.562 -177.998 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 179.76 -156.19 17.48 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 108.977 -1.649 . . . . 0.81999999999999995 108.977 -175.533 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.9 ppp? -118.3 142.92 47.01 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.814 1.245 . . . . 3.71 110.095 -179.577 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.9 m -100.92 139.85 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 123.223 0.609 . . . . 2.5699999999999998 109.809 -169.054 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 m -72.33 140.32 48.43 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.465 0.65 . . . . 2.3300000000000001 109.71 176.064 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.0 p -47.05 -61.63 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 126.263 1.825 . . . . 1.8400000000000001 111.398 172.552 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.73 73.42 1.19 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.093 -1.203 . . . . 2.0 110.093 -178.219 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.5 m -152.46 -30.98 0.15 Allowed 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 115.084 1.513 . . . . 0.97999999999999998 115.084 -179.519 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.2 104.73 0.96 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.085 -1.08 . . . . 1.6699999999999999 108.085 175.686 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.9 m -112.79 126.45 70.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 107.503 -1.295 . . . . 0.77000000000000002 107.503 175.401 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.12 137.02 54.39 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.151 1.38 . . . . 4.8099999999999996 108.191 -174.384 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -88.41 145.97 36.75 Favored Pre-proline 0 C--O 1.235 0.304 0 N-CA-C 109.068 -0.716 . . . . 2.5099999999999998 109.068 -179.11 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.01 25.2 0.3 Allowed 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.106 2.538 . . . . 2.4199999999999999 113.589 178.733 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -91.8 -24.23 19.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.802 1.241 . . . . 2.0800000000000001 109.378 164.282 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.9 m 74.12 0.42 3.6 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.52 1.528 . . . . 1.71 113.203 -174.515 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.98 18.06 11.73 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.182 0.993 . . . . 2.1699999999999999 112.168 -178.354 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -145.39 127.01 15.16 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.477 -1.305 . . . . 1.8300000000000001 107.477 173.286 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.1 128.97 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 107.704 -1.221 . . . . 0.89000000000000001 107.704 -173.252 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -141.73 148.42 38.98 Favored 'General case' 0 C--O 1.232 0.158 0 O-C-N 121.088 -1.007 . . . . 0.82999999999999996 110.739 176.938 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -143.17 153.32 42.73 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 116.35 -0.387 . . . . 1.8200000000000001 110.171 -173.416 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.86 138.14 36.42 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.928 -0.767 . . . . 0.75 108.928 172.72 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -131.97 139.67 49.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 123.844 0.857 . . . . 1.95 108.958 176.392 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -140.55 -177.71 5.17 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.665 1.586 . . . . 1.3799999999999999 108.387 -173.311 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.4 t0 . . . . . 0 CA--C 1.532 0.282 0 CA-C-O 122.238 1.018 . . . . 2.71 110.149 -179.555 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.431 0 N-CA-C 109.876 -1.29 . . . . 3.5600000000000001 109.876 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 66.49 87.67 0.12 Allowed 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 125.228 1.411 . . . . 3.5099999999999998 110.853 -179.126 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -95.13 155.11 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 108.638 -0.875 . . . . 1.0700000000000001 108.638 -178.332 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 mt -104.25 131.37 51.64 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.738 -0.838 . . . . 0.62 108.738 174.932 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.7 t -114.71 133.25 61.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 125.558 1.543 . . . . 0.88 107.161 178.474 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.4 p -109.55 148.52 31.1 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.782 0.833 . . . . 0.51000000000000001 109.002 -179.765 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.453 ' CE2' ' HA ' ' A' ' 125' ' ' THR . 1.5 t80 -150.69 146.69 26.63 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 107.184 -1.413 . . . . 2.2000000000000002 107.184 -173.709 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.7 p-10 -141.35 40.33 1.75 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.214 1.005 . . . . 2.1600000000000001 112.887 -167.166 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -166.37 56.87 0.1 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.545 0.738 . . . . 2.5899999999999999 111.525 -178.963 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 52.62 -171.4 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.62 1.168 . . . . 1.8 111.951 -169.046 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.552 HD13 ' HB2' ' A' ' 104' ' ' PHE . 13.7 mt -147.25 152.04 41.91 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 107.007 -1.479 . . . . 1.3100000000000001 107.007 174.453 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.434 ' HG3' HG23 ' A' ' 127' ' ' VAL . 72.0 Cg_endo -63.24 133.29 39.93 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 124.033 3.155 . . . . 2.48 110.016 177.384 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 41.77 46.92 3.45 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.027 1.331 . . . . 3.8300000000000001 111.29 -173.717 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 50.26 15.1 0.18 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.085 1.754 . . . . 2.1899999999999999 115.068 -175.93 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.552 ' HB2' HD13 ' A' ' 100' ' ' LEU . 27.4 t80 62.4 95.99 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 126.108 1.763 . . . . 2.52 110.113 -166.832 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 64.1 mtp85 -77.34 124.52 27.98 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 106.477 -1.675 . . . . 3.8700000000000001 106.477 -174.658 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -83.36 173.2 11.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.114 0.483 . . . . 2.9199999999999999 110.61 -172.559 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.17 42.15 98.09 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 121.859 -0.526 . . . . 0.68999999999999995 112.677 176.112 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -155.01 179.03 9.53 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.576 1.55 . . . . 2.1400000000000001 108.581 176.986 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -110.36 138.35 14.84 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 111.616 -0.594 . . . . 0.67000000000000004 111.616 175.788 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.4 pp -140.11 169.42 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 125.686 1.595 . . . . 0.77000000000000002 106.904 -177.6 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 18.8 m -123.0 145.82 29.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 107.986 -1.116 . . . . 0.82999999999999996 107.986 167.907 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.421 ' HB2' HG12 ' A' ' 127' ' ' VAL . . . -130.83 123.8 29.88 Favored 'General case' 0 N--CA 1.461 0.079 0 C-N-CA 124.345 1.058 . . . . 0.75 109.738 -177.273 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.21 145.01 34.87 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.33 1.052 . . . . 3.9900000000000002 110.091 -179.45 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 164.65 -139.88 6.1 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 108.022 -2.031 . . . . 0.83999999999999997 108.022 173.575 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.5 p -134.54 143.1 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 118.342 1.071 . . . . 0.73999999999999999 110.983 -166.627 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -71.72 153.68 41.86 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.126 -0.943 . . . . 1.79 108.857 171.661 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -170.51 -50.62 0.04 OUTLIER Glycine 0 C--N 1.332 0.329 0 N-CA-C 110.988 -0.845 . . . . 2.02 110.988 177.98 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -65.56 146.97 54.19 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.283 -1.006 . . . . 5.9900000000000002 108.283 173.749 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -82.64 63.33 6.72 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.389 -0.967 . . . . 3.8500000000000001 108.389 -173.733 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 127.96 11.69 3.13 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.895 1.712 . . . . 1.3899999999999999 113.664 -179.223 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.73 168.57 19.41 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.194 1.497 . . . . 2.6600000000000001 109.834 169.823 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.3 mp -126.57 136.11 52.13 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.375 1.07 . . . . 1.9299999999999999 109.418 -171.776 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -97.41 103.06 14.96 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.903 -1.518 . . . . 0.54000000000000004 106.903 175.326 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -122.91 121.06 35.27 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 118.398 -0.811 . . . . 0.95999999999999996 108.854 -177.098 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.453 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 15.4 t -107.99 -15.61 14.49 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 123.579 0.549 . . . . 0.97999999999999998 111.802 176.426 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -97.94 79.05 2.6 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 120.204 -1.56 . . . . 3.4900000000000002 108.979 -176.752 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.434 HG23 ' HG3' ' A' ' 101' ' ' PRO . 18.2 m -88.07 130.13 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 119.596 1.089 . . . . 0.78000000000000003 111.339 174.842 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.94 106.6 13.6 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 107.342 -1.355 . . . . 0.77000000000000002 107.342 175.366 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.67 72.11 10.62 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 123.165 0.586 . . . . 1.1899999999999999 110.6 -178.258 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.5 -37.06 62.38 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.811 0.671 . . . . 5.0 112.811 -178.667 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.532 0.28 0 O-C-N 121.657 -0.652 . . . . 4.6500000000000004 110.095 -171.282 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.412 0 N-CA-C 112.655 0.613 . . . . 3.98 112.655 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -87.92 114.74 24.83 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 125.469 1.508 . . . . 2.1499999999999999 110.717 -178.291 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -132.23 156.39 46.58 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.535 0.734 . . . . 3.6899999999999999 112.363 -173.055 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.6 m -71.98 132.62 84.56 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 125.54 1.536 . . . . 2.1499999999999999 110.759 -174.661 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -54.52 -37.49 90.19 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.149 2.566 . . . . 1.0700000000000001 112.8 -176.711 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -37.3 -53.43 1.09 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.578 1.151 . . . . 2.98 113.228 171.541 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -78.36 -1.89 35.53 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.011 -0.431 . . . . 3.1000000000000001 111.807 -173.189 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 32.7 pt -121.48 35.04 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.581 1.152 . . . . 1.6299999999999999 110.193 171.716 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.6 p -121.02 -76.31 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 122.893 0.477 . . . . 2.2400000000000002 111.165 158.836 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -83.52 109.11 17.11 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 125.214 1.405 . . . . 3.1800000000000002 110.441 -160.058 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.69 37.27 40.33 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 109.528 -1.429 . . . . 1.8799999999999999 109.528 177.597 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.06 -93.55 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.688 1.195 . . . . 2.79 107.836 -174.145 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.6 m -72.58 -59.0 2.94 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.141 0.976 . . . . 1.9199999999999999 111.195 -177.679 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -53.45 -41.66 66.36 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 122.835 1.302 . . . . 3.0800000000000001 109.575 -175.119 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.38 -19.43 42.66 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 126.524 1.93 . . . . 1.5900000000000001 112.321 -179.619 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 54.69 42.56 78.12 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 126.039 1.781 . . . . 1.8999999999999999 113.18 -175.383 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.5 m -100.25 -49.94 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 118.616 1.208 . . . . 2.0899999999999999 113.113 -174.071 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 34.3 mmtt -97.54 -66.03 0.08 OUTLIER Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.85 0.86 . . . . 2.9500000000000002 111.378 -177.485 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -75.15 68.94 5.79 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.264 1.976 . . . . 2.6099999999999999 108.843 170.428 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -51.28 140.4 16.98 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.993 -0.743 . . . . 3.0299999999999998 108.993 173.657 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.88 127.89 34.47 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.58 -0.896 . . . . 1.27 108.58 -176.466 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 124.39 -29.03 5.14 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.915 -0.874 . . . . 1.46 110.915 -161.609 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -79.84 137.15 36.87 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.988 1.394 . . . . 2.5899999999999999 110.225 -177.338 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.03 106.28 15.3 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.919 1.688 . . . . 3.7999999999999998 108.569 -172.648 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.43 168.46 23.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.7 -1.593 . . . . 1.3799999999999999 106.7 -174.58 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 25.9 mtt-85 -110.17 123.15 49.23 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 106.83 -1.544 . . . . 2.2599999999999998 106.83 178.232 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.4 p -86.88 130.73 36.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 107.329 -1.36 . . . . 0.79000000000000004 107.329 176.066 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -133.53 128.65 5.09 Favored Glycine 0 C--N 1.332 0.344 0 N-CA-C 110.161 -1.175 . . . . 0.56999999999999995 110.161 -179.497 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.1 -172.99 45.92 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.501 -1.04 . . . . 0.60999999999999999 110.501 -179.417 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -90.93 138.34 31.67 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 117.404 0.602 . . . . 4.5099999999999998 110.14 -178.628 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.551 HG11 ' HE1' ' A' ' 104' ' ' PHE . 7.6 p -106.42 144.73 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 109.388 -0.597 . . . . 2.2200000000000002 109.388 178.892 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.2 m -87.92 133.39 33.93 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 125.741 1.617 . . . . 2.3399999999999999 108.842 -174.84 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.444 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 10.8 p -46.63 -47.61 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.346 1.058 . . . . 2.3100000000000001 112.879 -177.424 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -100.43 76.09 0.43 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 109.648 -1.381 . . . . 2.0 109.648 -178.856 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.9 m -146.33 -39.29 0.22 Allowed 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 117.804 0.802 . . . . 1.21 112.558 178.78 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.8 ttm -54.95 129.06 36.25 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 118.168 0.44 . . . . 2.1200000000000001 110.117 173.088 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.75 122.73 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 106.119 -1.808 . . . . 0.63 106.119 160.088 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.434 ' CB ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -114.35 139.3 49.57 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.935 1.294 . . . . 5.3099999999999996 109.665 -178.138 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.46 166.06 47.37 Favored Pre-proline 0 C--O 1.235 0.324 0 CA-C-O 120.936 0.398 . . . . 1.72 111.101 -173.794 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.97 -25.59 13.98 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.138 2.558 . . . . 1.4199999999999999 111.201 163.593 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -48.13 -30.03 4.19 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.001 0.521 . . . . 1.1499999999999999 110.564 164.701 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.2 m 66.6 19.12 10.84 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 125.02 1.328 . . . . 1.3100000000000001 112.324 175.147 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.33 -41.52 1.89 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 128.281 2.632 . . . . 1.97 110.993 177.604 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 71.9 m-70 -84.2 126.0 32.73 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.951 -1.5 . . . . 1.0800000000000001 106.951 178.533 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.434 HG12 ' CB ' ' A' ' 73' ' ' ARG . 26.7 m -142.75 139.0 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 106.564 -1.643 . . . . 0.93999999999999995 106.564 179.908 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -144.15 149.95 37.3 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.346 -0.613 . . . . 1.3700000000000001 109.346 177.836 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -154.36 146.69 23.89 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 123.678 0.611 . . . . 2.02 109.468 -170.606 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.92 122.4 40.99 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 124.345 1.058 . . . . 0.94999999999999996 109.248 -179.197 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.1 t -108.23 146.9 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.084 0 N-CA-C 107.389 -1.337 . . . . 1.8600000000000001 107.389 177.543 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -151.1 -170.98 3.81 Favored 'General case' 0 C--O 1.226 -0.143 0 N-CA-C 107.541 -1.281 . . . . 1.8 107.541 174.045 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.521 -0.173 0 CA-C-N 118.619 0.645 . . . . 3.4300000000000002 109.664 -177.576 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.112 0 N-CA-C 116.223 1.249 . . . . 1.96 116.223 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -64.09 141.04 58.91 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.7 -0.883 . . . . 2.5600000000000001 110.427 171.507 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -141.56 143.91 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 107.856 -1.165 . . . . 0.91000000000000003 107.856 170.97 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.3 mt -91.1 119.35 31.16 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.287 1.035 . . . . 0.67000000000000004 108.973 177.523 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 51.3 t -98.24 127.99 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 106.783 -1.562 . . . . 1.04 106.783 174.548 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.6 p -113.61 148.11 36.83 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.547 -0.908 . . . . 1.0800000000000001 108.547 -177.753 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.473 ' CE2' ' HA ' ' A' ' 125' ' ' THR . 0.5 OUTLIER -142.72 141.35 31.77 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.949 1.3 . . . . 3.5600000000000001 108.381 -177.263 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -114.13 10.06 17.3 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.614 1.565 . . . . 2.4900000000000002 111.95 173.377 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -118.92 161.77 19.62 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 125.148 1.379 . . . . 4.4699999999999998 110.297 172.16 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.6 mp -64.86 122.91 18.06 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.159 -0.473 . . . . 1.8 109.939 168.794 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.4 HD21 ' CE1' ' A' ' 96' ' ' TYR . 23.0 mt -73.75 155.33 89.04 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 123.621 0.768 . . . . 1.6499999999999999 110.107 173.39 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -65.9 151.94 82.79 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 123.603 2.869 . . . . 2.3900000000000001 110.194 173.839 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 55.1 12.67 0.68 Allowed 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.983 1.475 . . . . 3.3100000000000001 114.983 -177.467 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.48 ' O ' HD22 ' A' ' 103' ' ' LEU . 0.4 OUTLIER 62.99 -6.42 0.17 Allowed 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 118.644 0.656 . . . . 4.5999999999999996 111.616 -162.419 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.551 ' HE1' HG11 ' A' ' 66' ' ' VAL . 5.0 t80 55.95 78.7 0.19 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.257 1.823 . . . . 2.6099999999999999 109.154 -170.829 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.3 10.2 mtp180 -86.7 34.88 0.66 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 119.046 -1.061 . . . . 4.3799999999999999 111.729 -177.517 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.444 ' HB3' ' HA ' ' A' ' 68' ' ' VAL 0.357 10.5 mm-40 82.94 178.53 0.06 Allowed 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 120.232 1.378 . . . . 5.25 110.158 149.875 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.405 ' N ' HG13 ' A' ' 66' ' ' VAL . . . 61.14 15.07 42.42 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 115.469 0.948 . . . . 1.05 115.469 158.215 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.484 ' O ' HG12 ' A' ' 66' ' ' VAL . 4.6 pt20 -136.73 141.48 43.04 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.601 1.2 . . . . 2.3500000000000001 108.027 -177.903 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -77.85 113.67 3.79 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.266 -1.134 . . . . 0.95999999999999996 110.266 -175.069 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.1 pp -123.65 169.33 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 123.608 0.763 . . . . 0.78000000000000003 109.437 -175.101 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.7 m -117.89 134.26 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 107.852 -1.166 . . . . 0.66000000000000003 107.852 169.371 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.516 ' CB ' HG12 ' A' ' 127' ' ' VAL . . . -121.26 155.18 35.21 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 125.53 1.532 . . . . 0.79000000000000004 108.569 177.837 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -148.09 161.83 40.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.052 0.842 . . . . 3.2000000000000002 112.112 171.645 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 171.15 -111.52 0.41 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 105.702 -2.959 . . . . 0.84999999999999998 105.702 167.537 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.2 p -156.81 146.39 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 118.724 1.262 . . . . 1.0800000000000001 111.719 -175.737 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.67 116.68 7.15 Favored 'General case' 0 N--CA 1.457 -0.093 0 N-CA-C 107.908 -1.145 . . . . 2.1800000000000002 107.908 168.729 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -136.75 13.2 3.93 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.092 -0.838 . . . . 2.3900000000000001 113.17 -179.681 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -143.05 35.49 1.37 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.017 0.908 . . . . 5.1900000000000004 110.678 177.625 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 26.63 52.45 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 128.124 2.57 . . . . 4.0199999999999996 112.053 177.992 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 160.77 -40.3 0.43 Allowed Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.244 -0.754 . . . . 1.27 113.772 -163.488 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.83 164.11 18.05 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.934 1.367 . . . . 2.9399999999999999 110.79 171.412 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.1 mt -105.72 116.67 32.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.243 1.417 . . . . 2.04 108.282 -177.307 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.41 103.7 13.79 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.553 -1.647 . . . . 0.64000000000000001 106.553 171.754 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -101.39 156.16 17.62 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.433 0.693 . . . . 1.71 109.843 -179.025 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.473 ' HA ' ' CE2' ' A' ' 96' ' ' TYR 0.256 9.9 t -141.1 -36.51 0.45 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.532 0.938 . . . . 1.23 113.532 174.713 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -92.45 127.35 37.91 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 120.481 -1.387 . . . . 2.7400000000000002 109.189 169.109 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.516 HG12 ' CB ' ' A' ' 112' ' ' ALA . 2.4 m -125.32 142.21 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 N-CA-C 108.394 -0.965 . . . . 0.94999999999999996 108.394 164.921 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.85 101.51 7.61 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.25 -1.389 . . . . 0.89000000000000001 107.25 179.071 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.85 60.56 2.87 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.247 0.619 . . . . 1.1499999999999999 110.694 -177.397 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -79.41 51.77 1.27 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.601 0.76 . . . . 3.04 112.072 -173.222 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.454 -0.23 0 N-CA-C 107.32 -1.363 . . . . 4.4000000000000004 107.32 -179.239 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--O 1.233 0.194 0 N-CA-C 109.894 -0.41 . . . . 2.6600000000000001 109.894 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -111.59 122.58 48.19 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.288 1.435 . . . . 2.73 107.984 179.715 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -129.71 164.62 23.58 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 122.799 0.44 . . . . 3.23 111.266 173.376 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 p -85.63 146.93 45.15 Favored Pre-proline 0 N--CA 1.45 -0.431 0 C-N-CA 123.725 0.81 . . . . 1.6499999999999999 110.598 -178.904 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -57.52 -42.18 63.77 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.94 2.426 . . . . 0.73999999999999999 111.155 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.9 p -58.63 -24.15 60.46 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.904 1.681 . . . . 2.3500000000000001 113.0 174.971 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -84.27 -48.36 9.83 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.114 -0.699 . . . . 2.2599999999999998 109.114 173.093 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.266 22.3 pt -75.73 37.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 114.397 1.258 . . . . 1.3600000000000001 114.397 -178.245 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.661 HG23 ' H ' ' A' ' 45' ' ' ASN . 0.5 OUTLIER -121.93 -87.06 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 125.39 1.476 . . . . 2.7000000000000002 108.16 169.271 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.661 ' H ' HG23 ' A' ' 44' ' ' VAL . 28.6 m-80 -58.98 103.62 0.18 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.549 2.34 . . . . 2.2799999999999998 110.469 -171.414 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.42 39.0 70.09 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.081 -0.807 . . . . 1.4099999999999999 111.081 171.942 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -143.99 -102.31 0.12 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 126.175 1.79 . . . . 2.71 108.377 175.57 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.405 HG23 HD12 ' A' ' 116' ' ' LEU . 97.7 m -69.48 -68.1 0.43 Allowed 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 124.319 1.048 . . . . 1.5 110.954 -177.374 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -53.75 -43.74 69.4 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.908 0.861 . . . . 2.5 110.559 -171.188 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.27 -22.56 51.93 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.615 0.766 . . . . 1.54 112.512 176.946 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 60.69 56.86 21.93 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 125.66 1.6 . . . . 1.3300000000000001 112.324 178.303 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.255 26.8 m -110.76 -64.16 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 114.1 1.148 . . . . 1.27 114.1 -179.595 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt -80.41 -62.99 0.36 Allowed Pre-proline 0 CA--C 1.538 0.513 0 O-C-N 121.302 -0.874 . . . . 3.6099999999999999 112.029 -177.629 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -77.13 -179.24 5.24 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.387 2.058 . . . . 1.6699999999999999 109.285 169.249 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -152.53 151.13 30.33 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.564 -1.643 . . . . 2.8100000000000001 106.564 -174.875 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -55.39 161.9 1.73 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.53 0.937 . . . . 1.1799999999999999 113.53 178.601 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.42 -6.09 58.49 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 119.424 -0.653 . . . . 1.02 113.075 -179.77 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -82.1 145.34 30.21 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.821 1.31 . . . . 1.8999999999999999 108.814 175.805 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.2 ttm105 -90.19 125.86 35.62 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.709 -1.219 . . . . 4.29 107.709 174.689 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.4 pt -142.05 175.63 4.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 118.842 0.746 . . . . 0.67000000000000004 109.035 175.483 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.445 HH11 ' HG2' ' A' ' 61' ' ' ARG . 6.2 mtt-85 -120.05 136.74 54.46 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.874 0.47 . . . . 3.4199999999999999 109.749 168.647 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.63 125.65 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 125.362 1.465 . . . . 0.81000000000000005 107.91 175.768 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -128.05 112.56 1.48 Allowed Glycine 0 C--N 1.333 0.388 0 N-CA-C 109.875 -1.29 . . . . 0.53000000000000003 109.875 -177.764 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.67 -171.5 33.72 Favored Glycine 0 C--N 1.332 0.348 0 N-CA-C 110.027 -1.229 . . . . 0.78000000000000003 110.027 -176.623 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.409 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 18.6 ptp -88.67 138.66 31.23 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.031 0.443 . . . . 2.73 110.1 -178.209 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.549 HG12 HG12 ' A' ' 84' ' ' VAL . 10.7 m -91.18 150.35 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 109.401 -0.592 . . . . 2.3300000000000001 109.401 170.574 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 m -91.37 143.89 26.15 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.892 -1.151 . . . . 2.7400000000000002 107.892 165.358 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.9 p -59.43 -59.44 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.362 1.065 . . . . 2.5699999999999998 110.088 178.272 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.36 66.79 2.89 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.328 -1.109 . . . . 1.6799999999999999 110.328 178.346 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.3 m -150.13 -30.77 0.21 Allowed 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 113.942 1.09 . . . . 1.0600000000000001 113.942 -179.398 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -60.14 117.23 4.88 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 119.087 0.858 . . . . 1.8999999999999999 109.225 173.545 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.16 125.41 71.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 N-CA-C 107.655 -1.239 . . . . 0.63 107.655 169.808 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -109.48 147.46 32.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.235 1.014 . . . . 6.6699999999999999 109.619 -178.829 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -72.42 161.76 77.42 Favored Pre-proline 0 C--O 1.239 0.533 0 C-N-CA 120.404 -0.518 . . . . 2.29 110.381 174.455 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -63.74 -34.22 62.82 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.384 2.056 . . . . 1.6299999999999999 110.175 163.81 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -41.18 -47.27 3.26 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 125.273 1.429 . . . . 1.29 109.854 174.713 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.4 m 80.64 11.67 0.95 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.117 1.767 . . . . 1.3 112.423 179.668 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.17 -6.92 9.9 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.041 1.336 . . . . 1.8500000000000001 111.334 175.522 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -123.4 136.64 54.73 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.919 1.287 . . . . 1.4199999999999999 108.151 177.99 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.61 131.07 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 107.826 -1.176 . . . . 0.89000000000000001 107.826 -172.341 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -135.81 154.32 51.24 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 119.778 1.172 . . . . 1.2 110.427 175.894 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -150.25 138.69 20.53 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.067 -0.716 . . . . 1.95 109.067 -173.805 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.07 136.57 34.44 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.938 -1.134 . . . . 0.66000000000000003 107.938 173.584 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.549 HG12 HG12 ' A' ' 66' ' ' VAL . 14.4 m -129.63 149.5 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 107.992 -1.114 . . . . 2.6800000000000002 107.992 177.436 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -153.4 177.53 10.79 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.975 0.416 . . . . 2.6499999999999999 110.247 -173.951 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.7 t0 . . . . . 0 N--CA 1.449 -0.514 0 C-N-CA 123.179 0.592 . . . . 3.0299999999999998 111.037 175.235 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.566 ' HA3' HG21 ' A' ' 44' ' ' VAL . . . . . . . . 0 N--CA 1.446 -0.7 0 N-CA-C 110.133 -1.187 . . . . 1.54 110.133 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -138.86 141.47 38.61 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.921 1.688 . . . . 3.21 107.363 -175.239 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.4 tp -140.8 151.21 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 123.451 0.701 . . . . 1.1499999999999999 109.247 -176.162 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mt -93.17 122.21 35.32 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.655 0.782 . . . . 1.1599999999999999 109.768 -178.048 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.0 t -102.3 119.56 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 107.062 -1.459 . . . . 0.89000000000000001 107.062 173.558 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 62.0 p -99.42 147.34 25.36 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.086 -1.079 . . . . 0.53000000000000003 108.086 174.976 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -147.35 160.83 42.08 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.238 1.415 . . . . 2.5 108.521 -172.957 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -147.98 152.89 38.25 Favored 'General case' 0 N--CA 1.428 -1.542 0 C-N-CA 127.553 2.341 . . . . 3.5600000000000001 106.616 -169.628 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 61.1 64.81 1.06 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 129.652 3.181 . . . . 2.7200000000000002 110.7 -172.543 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.0 mp 45.05 -144.67 0.16 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.311 1.444 . . . . 1.8799999999999999 109.449 -173.543 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.6 mt -158.76 149.78 16.3 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 104.883 -2.265 . . . . 1.1100000000000001 104.883 -175.951 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -67.35 129.75 20.97 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 121.956 1.771 . . . . 2.6600000000000001 108.14 169.757 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.582 ' O ' HD12 ' A' ' 103' ' ' LEU . 2.8 m-20 23.25 53.78 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 128.207 2.603 . . . . 3.3300000000000001 113.095 -178.047 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.616 HD13 ' OE1' ' A' ' 106' ' ' GLU . 0.7 OUTLIER 36.6 38.42 0.08 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.509 1.524 . . . . 3.4199999999999999 114.422 -179.159 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.0 p90 35.34 83.6 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.423 1.489 . . . . 3.3100000000000001 112.111 -173.561 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.4 116.3 4.96 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 119.255 -2.153 . . . . 4.5999999999999996 110.709 -137.594 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.616 ' OE1' HD13 ' A' ' 103' ' ' LEU . 9.6 mp0 -77.53 167.22 21.99 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 122.267 1.032 . . . . 3.6699999999999999 111.679 -147.31 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.93 41.07 56.18 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 114.841 -1.072 . . . . 0.80000000000000004 110.996 -169.919 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -149.8 178.34 8.97 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.353 1.061 . . . . 2.5 109.08 171.864 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' A' ' 65' ' ' MET . . . -92.89 136.22 13.05 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 110.738 -0.945 . . . . 0.77000000000000002 110.738 170.632 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.4 pp -139.29 154.74 25.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 107.484 -1.302 . . . . 0.68999999999999995 107.484 179.557 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 19.5 m -110.32 120.89 62.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 108.741 -0.837 . . . . 0.66000000000000003 108.741 178.457 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.464 ' HB2' HG12 ' A' ' 127' ' ' VAL . . . -113.97 150.8 33.28 Favored 'General case' 0 N--CA 1.458 -0.071 0 C-N-CA 126.131 1.772 . . . . 0.68000000000000005 109.494 -174.492 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -149.9 155.01 39.27 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 113.448 0.907 . . . . 3.8799999999999999 113.448 177.987 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 163.48 -130.38 2.22 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 106.063 -2.815 . . . . 0.98999999999999999 106.063 175.235 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.9 p -129.95 145.79 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.069 0 CA-C-N 118.337 1.068 . . . . 0.93000000000000005 111.761 -164.095 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.405 HD12 HG23 ' A' ' 48' ' ' THR . 4.6 mm? -66.3 124.33 22.41 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.199 -0.455 . . . . 1.95 111.027 174.725 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.59 130.43 9.83 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 126.257 1.884 . . . . 3.6200000000000001 109.377 172.595 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 60.58 29.73 19.23 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.465 1.106 . . . . 4.5800000000000001 111.458 167.553 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 40.9 39.26 0.78 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.011 1.724 . . . . 4.5099999999999998 111.178 -170.375 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -160.3 -61.96 0.01 OUTLIER Glycine 0 C--N 1.34 0.792 0 O-C-N 121.472 -0.767 . . . . 1.1699999999999999 111.946 -170.354 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -83.34 127.34 33.59 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.901 -0.777 . . . . 2.1899999999999999 108.901 -178.842 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.35 107.32 17.94 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.384 -1.339 . . . . 2.1299999999999999 107.384 177.94 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.85 84.74 7.46 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.361 -1.348 . . . . 0.57999999999999996 107.361 -179.59 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.66 144.71 26.44 Favored 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 123.762 0.825 . . . . 1.23 109.023 -177.484 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.7 t -137.88 9.56 2.82 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.85 0.75 . . . . 1.1499999999999999 112.914 173.898 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -132.99 119.65 20.37 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.736 -1.579 . . . . 3.4199999999999999 106.736 170.272 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.464 HG12 ' HB2' ' A' ' 112' ' ' ALA . 2.4 m -123.41 131.38 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 124.589 1.156 . . . . 0.82999999999999996 109.494 176.867 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -115.91 104.37 11.55 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.708 -1.219 . . . . 0.90000000000000002 107.708 179.117 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.14 56.02 3.56 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.018 0.927 . . . . 1.3999999999999999 110.653 -179.238 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -77.8 60.95 2.36 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.046 0.938 . . . . 3.2799999999999998 111.355 -175.409 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.269 0 CA-C-O 121.686 0.755 . . . . 4.4299999999999997 111.171 -172.514 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 pt? . . . . . 0 C--O 1.233 0.195 0 N-CA-C 109.663 -0.495 . . . . 1.8500000000000001 109.663 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -83.07 140.0 32.91 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.534 0.734 . . . . 2.2000000000000002 110.359 -178.734 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -144.67 160.13 41.7 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.925 1.29 . . . . 2.77 110.593 176.977 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.95 134.67 38.72 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 126.519 1.928 . . . . 1.4299999999999999 109.972 -179.848 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -56.84 -43.46 54.22 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.263 2.642 . . . . 0.76000000000000001 111.775 -179.449 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.3 p -59.94 -34.2 72.93 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 121.406 -0.809 . . . . 2.0299999999999998 112.065 -178.648 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.02 -55.17 36.08 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.553 0.692 . . . . 3.1899999999999999 109.281 175.953 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.318 20.6 pt -66.29 -14.91 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 114.64 -1.164 . . . . 1.4399999999999999 112.624 -170.022 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 88.4 t -75.68 -54.87 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 123.007 0.523 . . . . 2.0699999999999998 110.978 167.499 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -56.43 -71.4 0.09 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.508 0.929 . . . . 2.5699999999999998 113.508 -163.328 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -146.21 55.87 0.53 Allowed Glycine 0 C--N 1.333 0.4 0 N-CA-C 108.778 -1.729 . . . . 1.74 108.778 -167.806 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -153.44 -106.85 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.928 1.691 . . . . 3.6499999999999999 108.644 -171.987 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.5 m -72.53 -60.05 2.42 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 124.341 1.056 . . . . 1.5700000000000001 111.619 -170.765 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -56.25 -40.14 73.7 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 122.048 0.928 . . . . 2.5899999999999999 109.734 -176.039 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.45 -24.84 62.09 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.158 0.983 . . . . 2.0499999999999998 112.805 174.482 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.48 41.38 99.54 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 126.163 1.839 . . . . 1.26 111.918 -176.015 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.9 m -102.55 -53.52 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 118.048 0.924 . . . . 1.3300000000000001 113.037 -174.423 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -93.71 -65.4 0.12 Allowed Pre-proline 0 CA--C 1.533 0.326 0 CA-C-O 118.542 -0.742 . . . . 3.8599999999999999 112.054 -175.282 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -78.59 140.6 16.91 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 121.681 1.587 . . . . 1.24 108.799 174.067 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -87.35 161.95 17.63 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.701 0.8 . . . . 4.9699999999999998 109.255 167.738 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.95 170.15 8.73 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 122.9 0.48 . . . . 1.6000000000000001 110.215 174.124 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.51 22.81 71.69 Favored Glycine 0 CA--C 1.534 1.248 0 O-C-N 121.768 -0.583 . . . . 1.05 113.583 178.308 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -102.23 162.23 13.08 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.198 0.999 . . . . 1.7 108.432 171.2 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.7 mtt180 -99.63 134.43 42.53 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.86 -0.422 . . . . 3.7200000000000002 109.86 169.55 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.3 pt -143.36 176.22 3.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 106.862 -1.533 . . . . 0.78000000000000003 106.862 169.024 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -123.29 123.4 40.66 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.355 -0.98 . . . . 2.2200000000000002 108.355 170.474 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.9 m -89.06 129.42 40.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 107.938 -1.134 . . . . 2.2599999999999998 107.938 175.007 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -128.38 128.23 5.9 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 109.197 -1.561 . . . . 0.68999999999999995 109.197 178.967 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.67 -170.74 40.34 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 109.979 -1.248 . . . . 0.68000000000000005 109.979 -174.139 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.3 ptp -100.41 123.91 45.23 Favored 'General case' 0 N--CA 1.458 -0.061 0 CA-C-O 121.316 0.579 . . . . 2.3500000000000001 110.976 -174.044 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.0 t -73.24 105.23 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 123.831 0.853 . . . . 2.23 110.485 179.78 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.2 m -45.29 136.09 5.49 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 126.362 1.865 . . . . 2.3599999999999999 111.28 164.583 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.1 p -55.54 -64.09 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.741 0.817 . . . . 2.0099999999999998 111.077 177.42 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.45 72.6 2.78 Favored Glycine 0 C--N 1.332 0.36 0 N-CA-C 109.34 -1.504 . . . . 1.77 109.34 -174.586 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.6 m -150.46 -34.18 0.16 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 115.891 1.811 . . . . 1.1100000000000001 115.891 -174.895 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -76.93 99.71 5.33 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 120.159 1.345 . . . . 2.29 110.313 -175.012 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.1 m -111.32 128.81 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 108.527 -0.916 . . . . 0.85999999999999999 108.527 -177.819 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -111.57 143.26 42.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.725 1.61 . . . . 6.0 110.591 -175.61 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -71.83 155.82 91.74 Favored Pre-proline 0 C--O 1.232 0.155 0 CA-C-N 118.245 0.475 . . . . 1.8700000000000001 109.764 177.416 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -64.16 -27.11 64.77 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.207 1.938 . . . . 1.22 111.363 166.064 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -45.31 -33.68 2.57 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.193 0.597 . . . . 1.1499999999999999 110.709 164.726 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.1 m 69.27 15.99 8.48 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.446 1.498 . . . . 1.5600000000000001 112.466 177.253 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.41 -38.1 2.59 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 126.324 1.85 . . . . 1.7 112.075 175.789 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -87.38 135.96 33.12 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.155 -1.424 . . . . 1.1399999999999999 107.155 175.537 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.555 HG23 ' HB3' ' A' ' 96' ' ' TYR . 28.0 m -144.15 148.72 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 107.195 -1.409 . . . . 0.68000000000000005 107.195 178.144 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -148.78 158.76 44.39 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.448 -0.783 . . . . 1.0 109.716 178.892 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -150.64 142.11 23.45 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.654 -0.703 . . . . 1.8400000000000001 110.405 -173.884 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.97 148.56 27.54 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.16 -1.052 . . . . 0.65000000000000002 108.16 163.031 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.5 p -146.84 150.46 14.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 107.661 -1.237 . . . . 1.9399999999999999 107.661 171.705 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.2 176.43 9.75 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.189 0.996 . . . . 2.3399999999999999 110.513 -175.345 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.5 t70 . . . . . 0 N--CA 1.454 -0.252 0 C-N-CA 123.961 0.904 . . . . 2.6299999999999999 110.735 -176.57 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.819 0 N-CA-C 110.892 -0.883 . . . . 1.9299999999999999 110.892 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -99.5 135.15 41.33 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 124.792 1.237 . . . . 3.1000000000000001 108.98 169.18 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' A' ' 92' ' ' ILE . 0.2 OUTLIER -112.57 144.89 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.654 -1.239 . . . . 0.98999999999999999 107.654 167.553 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.5 mt -104.09 120.69 41.64 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.271 1.029 . . . . 0.66000000000000003 108.38 176.225 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 44.0 t -103.16 136.3 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 125.422 1.489 . . . . 0.83999999999999997 107.676 178.965 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.2 p -112.94 142.01 46.11 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.405 1.082 . . . . 0.52000000000000002 108.578 178.521 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.555 ' HB3' HG23 ' A' ' 80' ' ' VAL . 2.1 t80 -138.42 114.63 10.24 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.529 -1.286 . . . . 2.4100000000000001 107.529 -175.564 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -101.27 46.97 0.92 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.851 1.261 . . . . 2.3300000000000001 112.05 -171.222 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -167.67 176.81 6.19 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.646 1.978 . . . . 2.5499999999999998 107.037 170.486 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.0 mp -70.67 136.65 49.22 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.02 -1.05 . . . . 1.79 110.783 178.533 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.452 ' HG ' HG21 ' A' ' 80' ' ' VAL . 11.9 mt -69.92 160.89 78.47 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.395 1.078 . . . . 1.24 110.565 174.302 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.52 -95.82 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.837 3.024 . . . . 2.3900000000000001 110.281 176.282 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -78.39 49.91 0.89 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.863 1.265 . . . . 3.4900000000000002 110.232 -176.543 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 52.44 -4.67 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.404 2.682 . . . . 2.21 115.918 -168.46 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 64.4 t80 64.26 93.96 0.06 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.727 1.611 . . . . 2.29 108.795 -159.32 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -79.81 129.02 34.13 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.663 0.744 . . . . 5.8899999999999997 109.272 -179.138 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -83.95 144.17 29.34 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 128.062 2.545 . . . . 3.3999999999999999 109.617 -174.002 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.29 46.59 8.02 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 112.052 -0.419 . . . . 1.0800000000000001 112.052 178.989 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -155.8 175.52 13.82 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.567 -1.642 . . . . 2.1899999999999999 106.567 170.839 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -86.24 144.49 20.03 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.095 -1.202 . . . . 0.87 110.095 167.668 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.1 pp -139.77 167.7 18.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 107.731 -1.211 . . . . 0.60999999999999999 107.731 167.97 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 23.8 m -126.71 135.57 63.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.867 -0.79 . . . . 0.66000000000000003 108.867 171.096 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -129.55 120.46 25.38 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 124.703 1.201 . . . . 0.47999999999999998 110.762 -169.095 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -114.21 145.95 41.03 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 125.253 1.421 . . . . 3.4700000000000002 111.022 -176.619 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 173.07 -123.09 0.96 Allowed Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 108.021 -2.032 . . . . 0.91000000000000003 108.021 170.467 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.2 p -138.25 152.17 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 118.176 0.988 . . . . 0.72999999999999998 109.726 -173.021 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -59.61 132.31 53.58 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 108.118 -1.067 . . . . 1.7 108.118 167.982 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -87.98 -104.34 0.93 Allowed Glycine 0 C--N 1.338 0.661 0 N-CA-C 110.011 -1.236 . . . . 2.1200000000000001 110.011 -172.766 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -59.4 -66.15 0.56 Allowed 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.334 1.054 . . . . 4.8499999999999996 108.375 172.771 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -173.0 -66.3 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.761 2.024 . . . . 4.1900000000000004 105.971 175.83 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.0 -45.04 96.94 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 123.504 0.573 . . . . 1.1200000000000001 112.271 177.021 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -83.28 144.13 29.93 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 122.036 -0.685 . . . . 2.54 111.257 -176.217 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -105.15 122.77 46.6 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 125.002 1.321 . . . . 2.25 108.076 -176.456 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.91 85.85 4.51 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.826 -1.175 . . . . 0.62 107.826 175.913 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.4 105.0 13.84 Favored 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 123.473 0.709 . . . . 1.3600000000000001 110.378 -175.301 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.2 t -95.77 -25.82 15.91 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.903 0.881 . . . . 0.79000000000000004 111.761 -177.485 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -89.33 81.52 6.64 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 120.695 -1.253 . . . . 3.2799999999999998 108.708 179.279 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.6 m -90.48 125.03 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 118.112 0.415 . . . . 0.64000000000000001 110.32 173.26 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -115.26 113.97 24.58 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.165 -1.42 . . . . 0.60999999999999999 107.165 175.372 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.69 108.27 11.98 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 107.501 -1.296 . . . . 1.5900000000000001 107.501 167.845 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.89 50.49 0.31 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 122.511 0.324 . . . . 3.5299999999999998 110.626 -175.613 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.255 0 C-N-CA 124.852 1.261 . . . . 6.0199999999999996 108.395 177.49 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 pt? . . . . . 0 N--CA 1.465 0.319 0 N-CA-C 112.052 0.39 . . . . 2.1800000000000002 112.052 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -85.15 125.17 32.6 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 124.874 1.27 . . . . 2.3399999999999999 110.115 179.463 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -124.27 161.19 26.33 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.628 1.571 . . . . 3.27 110.89 176.88 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 54.4 m -83.04 126.05 73.4 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 126.444 1.898 . . . . 1.8700000000000001 110.433 -177.939 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -48.24 -43.1 32.5 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.901 3.067 . . . . 1.03 114.032 -179.133 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.1 m -54.76 -33.07 60.8 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.264 -0.897 . . . . 1.98 112.33 177.821 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -77.31 3.0 14.06 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.54 0.736 . . . . 2.6299999999999999 111.994 179.548 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.278 18.3 pt -121.6 3.37 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 O-C-N 120.79 -1.194 . . . . 1.1699999999999999 112.978 173.07 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.1 t -98.01 -49.0 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.031 0.932 . . . . 1.79 112.049 179.393 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -102.98 90.61 3.82 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 120.54 -1.35 . . . . 2.1299999999999999 111.106 -167.843 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.35 48.47 18.77 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.905 -0.878 . . . . 1.45 110.905 178.293 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -152.85 -146.04 0.19 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 128.609 2.764 . . . . 4.2599999999999998 105.067 176.481 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.1 m -43.57 -48.45 7.53 Favored 'General case' 0 C--O 1.227 -0.127 0 C-N-CA 126.198 1.799 . . . . 1.79 115.495 -170.51 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -39.16 -55.14 1.69 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.497 0.719 . . . . 2.5699999999999998 111.508 172.859 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.07 -15.94 25.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.782 1.233 . . . . 1.51 110.652 -173.618 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.89 26.91 73.77 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.996 1.284 . . . . 1.1200000000000001 112.438 176.818 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.2 m -80.07 -23.54 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 118.047 0.923 . . . . 1.27 112.406 -174.53 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -121.75 -75.95 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 124.172 0.989 . . . . 3.6800000000000002 111.745 178.137 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.25 119.57 6.07 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 CA-C-N 120.554 1.234 . . . . 1.3400000000000001 109.352 179.476 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -71.63 149.16 45.84 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.99 -0.744 . . . . 4.8099999999999996 108.99 172.293 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.73 147.26 47.53 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.102 -1.073 . . . . 1.1399999999999999 108.102 172.595 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.77 -1.17 27.42 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.61 1.1 . . . . 1.1200000000000001 112.874 -173.732 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -102.79 148.94 24.99 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.426 1.09 . . . . 1.52 109.595 -176.614 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -86.92 125.88 34.32 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.466 -0.939 . . . . 3.8700000000000001 108.466 172.605 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.5 pt -141.11 176.07 5.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 106.228 -1.767 . . . . 0.91000000000000003 106.228 167.078 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -124.56 133.01 53.43 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.771 -1.196 . . . . 3.2999999999999998 107.771 171.918 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.0 131.54 51.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 107.747 -1.205 . . . . 1.21 107.747 175.402 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -126.84 113.11 1.69 Allowed Glycine 0 C--N 1.336 0.551 0 N-CA-C 109.7 -1.36 . . . . 0.65000000000000002 109.7 179.371 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.85 -168.2 17.15 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 109.966 -1.254 . . . . 0.70999999999999996 109.966 -175.013 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -109.42 130.61 55.49 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.637 0.775 . . . . 2.79 110.586 -176.359 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.563 HG22 ' CZ ' ' A' ' 104' ' ' PHE . 26.1 t -67.0 143.7 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 109.093 -0.706 . . . . 2.27 109.093 175.313 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.0 t -59.45 -68.45 0.28 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.627 0.371 . . . . 3.3999999999999999 111.34 178.831 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.0 p 178.79 -45.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 123.633 0.773 . . . . 2.1099999999999999 110.496 -173.347 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -146.43 42.82 0.92 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.164 -1.174 . . . . 2.2599999999999998 110.164 -179.733 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.84 -30.71 70.96 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.322 0.649 . . . . 1.8600000000000001 112.541 176.757 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.4 112.62 2.25 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 122.278 0.231 . . . . 1.79 110.387 -174.919 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.1 m -122.98 120.12 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.79 -1.559 . . . . 0.71999999999999997 106.79 168.096 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.45 144.04 36.6 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.536 -1.283 . . . . 5.4800000000000004 107.536 175.467 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -99.17 153.01 37.99 Favored Pre-proline 0 C--O 1.234 0.282 0 N-CA-C 108.55 -0.907 . . . . 2.5499999999999998 108.55 -179.828 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.41 37.72 0.52 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.662 2.908 . . . . 1.73 112.244 -178.483 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -94.78 -35.77 11.97 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.934 1.294 . . . . 1.6399999999999999 108.727 171.346 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.6 m 97.48 -19.38 0.05 OUTLIER 'General case' 0 C--N 1.342 0.243 0 C-N-CA 127.819 2.447 . . . . 2.6499999999999999 111.777 -174.798 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.04 27.94 8.16 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 123.772 0.829 . . . . 2.8300000000000001 112.815 -179.423 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -135.98 115.44 12.71 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.759 -0.83 . . . . 2.1099999999999999 108.759 178.415 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.15 116.23 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 124.948 1.299 . . . . 1.0800000000000001 107.932 -178.308 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -129.27 154.2 47.06 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.022 0.828 . . . . 1.0800000000000001 109.484 177.674 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.506 ' CE1' ' CE1' ' A' ' 104' ' ' PHE . 33.6 p90 -157.36 145.27 19.02 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.447 -0.342 . . . . 1.8700000000000001 110.469 -175.555 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.12 157.94 18.7 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.655 0.74 . . . . 0.73999999999999999 109.753 167.774 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 p -141.76 149.37 19.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 106.638 -1.615 . . . . 1.9399999999999999 106.638 172.181 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -128.61 -172.91 2.82 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.017 0.527 . . . . 1.5800000000000001 110.322 -179.374 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.7 t70 . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 109.012 -0.736 . . . . 2.3700000000000001 109.012 178.204 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.497 0 CA-C-O 119.268 -0.74 . . . . 2.2999999999999998 111.604 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -62.89 111.64 2.22 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.43 -1.322 . . . . 3.3999999999999999 107.43 179.173 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.2 tp -140.37 156.59 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 108.185 -1.043 . . . . 1.1399999999999999 108.185 179.145 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.4 mt -119.87 129.66 54.49 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.504 -1.295 . . . . 0.57999999999999996 107.504 -169.998 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.44 ' CG2' ' CE1' ' A' ' 82' ' ' PHE . 5.1 m -120.69 143.15 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 109.152 -0.685 . . . . 2.3300000000000001 109.152 175.19 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.5 p -115.06 133.68 55.83 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.101 1.361 . . . . 0.78000000000000003 107.512 -176.1 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -129.77 131.04 46.1 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.856 -1.535 . . . . 2.3199999999999998 106.856 -178.348 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -122.11 34.06 5.28 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.268 1.427 . . . . 2.1200000000000001 111.885 -167.773 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -163.46 54.89 0.17 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.353 0.596 . . . . 3.1000000000000001 111.689 -174.426 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 53.77 -162.75 0.11 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.854 0.862 . . . . 1.95 110.844 -173.245 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.6 mt -148.93 155.83 40.69 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 106.381 -1.711 . . . . 1.1399999999999999 106.381 179.921 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.34 -73.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.142 2.561 . . . . 2.3100000000000001 110.27 -179.643 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.51 47.71 0.87 Allowed 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.926 1.29 . . . . 2.6800000000000002 108.394 -178.515 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 41.61 23.88 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 115.749 1.759 . . . . 2.1800000000000002 115.749 -173.226 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.563 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 51.8 t80 53.67 96.51 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.6 1.091 . . . . 2.9300000000000002 110.277 -168.887 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 -75.37 123.26 25.08 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.583 -0.895 . . . . 5.8200000000000003 108.583 -172.699 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -82.97 168.14 17.29 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.613 0.721 . . . . 2.98 111.403 -177.349 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 58.36 35.6 79.79 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 123.965 0.793 . . . . 0.85999999999999999 113.001 179.287 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -156.23 177.66 11.19 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.049 1.34 . . . . 2.8900000000000001 108.035 174.189 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -94.73 139.74 14.67 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.968 -0.853 . . . . 0.75 110.968 174.819 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.5 pp -142.67 153.78 17.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 106.642 -1.614 . . . . 0.87 106.642 178.803 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 19.9 m -115.14 128.07 72.46 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 N-CA-C 108.983 -0.747 . . . . 0.79000000000000004 108.983 -179.871 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -119.59 135.92 54.59 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 125.471 1.508 . . . . 0.73999999999999999 109.668 -168.83 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -136.66 144.24 43.89 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.524 1.529 . . . . 3.6200000000000001 109.45 -176.491 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -177.04 -103.66 0.17 Allowed Glycine 0 C--N 1.332 0.344 0 N-CA-C 108.03 -2.028 . . . . 1.27 108.03 163.611 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.5 p -151.5 145.17 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 109.177 -0.675 . . . . 0.82999999999999996 109.177 178.386 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.629 ' HG ' HD12 ' A' ' 122' ' ' LEU . 0.3 OUTLIER -78.49 152.95 31.76 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.795 -1.187 . . . . 2.71 107.795 172.463 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -168.54 -51.91 0.03 OUTLIER Glycine 0 C--N 1.333 0.396 0 C-N-CA 119.656 -1.259 . . . . 2.0699999999999998 112.318 175.929 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -61.94 155.58 23.2 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 119.151 -1.019 . . . . 4.5099999999999998 109.55 172.193 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -79.38 79.09 5.85 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 105.811 -1.922 . . . . 4.1100000000000003 105.811 179.47 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.08 17.64 26.82 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 126.159 1.838 . . . . 1.45 113.361 172.078 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.56 154.76 38.78 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.725 -1.583 . . . . 3.0899999999999999 106.725 164.879 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.629 HD12 ' HG ' ' A' ' 116' ' ' LEU . 0.8 OUTLIER -116.09 137.92 51.7 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 122.776 0.43 . . . . 2.2400000000000002 110.237 -175.837 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.34 81.43 4.43 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 107.915 -1.143 . . . . 0.53000000000000003 107.915 177.029 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -90.22 134.25 34.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.306 -0.628 . . . . 1.04 109.306 178.707 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.5 t -128.88 -23.24 3.11 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.731 0.812 . . . . 1.0 113.161 179.033 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -101.58 104.18 15.05 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.352 -1.722 . . . . 3.8399999999999999 106.352 173.168 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.6 m -116.81 125.23 73.64 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 N-CA-C 109.247 -0.649 . . . . 0.94999999999999996 109.247 177.002 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.51 112.12 19.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.153 -1.425 . . . . 0.92000000000000004 107.153 -175.002 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -106.36 42.04 1.33 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.618 1.167 . . . . 2.1600000000000001 111.613 -173.14 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.23 52.72 1.36 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.355 0.662 . . . . 4.0300000000000002 111.588 -175.713 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 . . . . . 0 N--CA 1.456 -0.142 0 N-CA-C 109.583 -0.525 . . . . 4.5 109.583 -176.389 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 C--O 1.234 0.244 0 CA-C-O 120.838 0.351 . . . . 2.1600000000000001 110.647 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -83.4 134.58 34.88 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.576 1.15 . . . . 2.5899999999999999 109.27 -179.152 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.422 ' CE2' ' HG2' ' A' ' 42' ' ' GLU . 0.5 OUTLIER -146.8 152.04 38.11 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.198 0.999 . . . . 3.21 109.209 -169.109 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.4 p -89.76 142.42 29.16 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 118.046 0.385 . . . . 2.1499999999999999 110.689 -173.191 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -55.26 -41.39 78.89 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.108 1.872 . . . . 0.85999999999999999 111.701 173.797 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.0 t -47.26 -36.98 9.77 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.419 1.088 . . . . 2.5099999999999998 111.527 173.187 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.422 ' HG2' ' CE2' ' A' ' 38' ' ' TYR . 0.9 OUTLIER -67.39 -59.18 3.61 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.413 -0.588 . . . . 2.25 109.413 177.775 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.5 pt -73.3 4.77 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 114.758 1.392 . . . . 0.96999999999999997 114.758 -167.054 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.6 m -96.82 -28.25 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.688 1.195 . . . . 2.8599999999999999 112.301 172.199 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -87.15 -87.03 0.15 Allowed 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.88 0.764 . . . . 2.4300000000000002 110.472 -168.63 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -122.27 59.8 0.58 Allowed Glycine 0 C--N 1.335 0.474 0 N-CA-C 108.814 -1.714 . . . . 1.6699999999999999 108.814 -176.058 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -160.96 -157.45 0.52 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.905 2.482 . . . . 2.4399999999999999 105.426 -175.086 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.474 HG21 HD11 ' A' ' 116' ' ' LEU . 7.4 m -29.02 -59.89 0.13 Allowed 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 128.279 2.631 . . . . 1.55 116.489 -170.213 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -54.14 -37.5 64.46 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.292 0.951 . . . . 3.6899999999999999 111.012 -173.968 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.5 m -91.04 -21.88 21.04 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.708 0.803 . . . . 1.5800000000000001 110.906 176.522 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.37 31.49 68.58 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.685 1.136 . . . . 1.3100000000000001 112.038 172.595 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.0 m -81.6 -55.72 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 122.295 -0.532 . . . . 1.5700000000000001 111.517 -173.941 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -87.3 -67.97 0.14 Allowed Pre-proline 0 CA--C 1.534 0.36 0 CA-C-O 118.558 -0.734 . . . . 3.4900000000000002 112.145 175.969 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -78.02 131.93 11.32 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 121.53 1.486 . . . . 1.4199999999999999 109.701 -177.916 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -80.48 165.87 21.75 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.437 0.695 . . . . 4.8799999999999999 109.191 166.883 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.5 159.91 33.65 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.392 -0.595 . . . . 1.3400000000000001 109.392 166.809 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.22 3.04 57.84 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 123.271 0.462 . . . . 1.25 112.8 178.31 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -102.53 156.69 17.44 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.801 1.241 . . . . 1.55 108.584 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.3 mtm-85 -96.79 130.95 43.96 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.294 -0.632 . . . . 4.0300000000000002 109.294 171.124 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.1 pt -146.58 175.26 1.94 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 106.686 -1.598 . . . . 0.70999999999999996 106.686 168.409 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -124.63 124.91 43.23 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 118.2 0.455 . . . . 1.9199999999999999 110.08 175.537 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.4 p -87.71 119.45 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.564 -1.272 . . . . 0.80000000000000004 107.564 174.567 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -126.31 115.98 2.43 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 109.508 -1.437 . . . . 0.58999999999999997 109.508 177.158 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.86 -154.77 8.11 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 108.206 -1.958 . . . . 0.70999999999999996 108.206 -176.943 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 24.7 ptp -117.34 137.56 52.37 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.712 0.805 . . . . 2.5499999999999998 110.459 -178.448 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 p -89.1 137.23 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 120.273 -0.571 . . . . 2.54 110.166 177.283 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.6 m -28.73 -84.62 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 128.666 2.786 . . . . 3.25 113.38 175.702 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.1 p 171.97 -40.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 125.339 1.455 . . . . 2.2599999999999998 110.238 -175.633 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -148.57 48.39 0.62 Allowed Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.884 -1.287 . . . . 1.8600000000000001 109.884 -178.586 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 65.2 m -101.59 -12.75 18.22 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.212 0.605 . . . . 1.04 112.472 -179.54 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 35.2 tpp -58.33 125.11 21.88 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.931 0.787 . . . . 2.1200000000000001 110.826 170.67 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.5 m -129.81 142.98 42.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 108.372 -0.973 . . . . 0.66000000000000003 108.372 163.496 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.501 ' CB ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -120.9 154.9 35.25 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 124.013 0.925 . . . . 4.1200000000000001 110.934 -177.623 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.53 153.68 81.38 Favored Pre-proline 0 N--CA 1.453 -0.31 0 N-CA-C 109.501 -0.555 . . . . 2.0499999999999998 109.501 171.411 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -59.83 -26.45 82.31 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.607 2.204 . . . . 1.53 111.363 171.008 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -44.82 -36.24 3.15 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.791 0.836 . . . . 1.24 110.952 168.649 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 21.0 m 75.58 18.57 2.21 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.869 1.668 . . . . 1.6899999999999999 112.659 178.478 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.55 -49.17 2.14 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 125.368 1.467 . . . . 1.9199999999999999 111.105 172.549 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -79.09 131.7 36.33 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.489 -1.3 . . . . 1.23 107.489 -176.173 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.501 HG12 ' CB ' ' A' ' 73' ' ' ARG . 32.8 m -138.51 160.03 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 108.744 -0.836 . . . . 1.5 108.744 171.909 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -144.74 147.57 33.12 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.65 -0.704 . . . . 1.3999999999999999 109.274 175.815 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -155.59 146.65 22.48 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.754 0.421 . . . . 1.99 110.367 -173.538 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.38 132.42 44.71 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.497 0.719 . . . . 0.59999999999999998 110.077 179.604 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.9 t -119.46 133.38 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 124.704 1.202 . . . . 1.8100000000000001 108.51 178.832 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -117.45 -177.33 3.2 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 123.879 0.872 . . . . 1.72 110.684 177.737 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.1 t70 . . . . . 0 N--CA 1.451 -0.417 0 CA-C-N 115.693 -0.685 . . . . 2.5499999999999998 110.709 -177.088 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.518 0 CA-C-O 119.218 -0.768 . . . . 1.8799999999999999 111.355 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -64.33 102.47 0.53 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.69 0.745 . . . . 3.23 109.646 175.2 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -92.56 154.14 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 107.212 -1.403 . . . . 0.85999999999999999 107.212 166.911 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 mt -102.98 131.15 50.15 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 108.61 -0.885 . . . . 0.65000000000000002 108.61 -179.017 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.77 137.32 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 107.316 -1.364 . . . . 0.89000000000000001 107.316 178.865 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.5 p -111.74 149.14 32.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.641 -1.244 . . . . 0.46000000000000002 107.641 174.72 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -147.55 114.63 6.18 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.533 -1.654 . . . . 2.0 106.533 -179.579 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -94.97 40.55 1.1 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.743 1.617 . . . . 1.9199999999999999 111.604 -170.826 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -166.83 174.34 8.65 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.181 1.792 . . . . 2.8999999999999999 107.111 173.991 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.1 mp -70.87 152.72 43.39 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.826 0.822 . . . . 1.4399999999999999 111.043 178.827 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.25 150.52 37.22 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 125.146 1.378 . . . . 2.2999999999999998 108.713 -173.902 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -60.56 141.28 94.87 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.157 1.905 . . . . 2.2799999999999998 108.621 169.964 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 42.7 46.74 4.48 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.236 1.414 . . . . 2.7999999999999998 112.155 -179.528 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 50.59 15.73 0.25 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.625 1.97 . . . . 2.0800000000000001 115.645 -176.874 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.5 t80 64.93 101.75 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.266 1.427 . . . . 2.7799999999999998 109.874 -162.955 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 29.7 mmm-85 -79.57 111.69 16.1 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.124 -1.065 . . . . 4.5899999999999999 108.124 -179.364 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -83.26 176.32 9.24 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.469 0.652 . . . . 4.1699999999999999 112.504 -177.089 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.51 38.99 97.18 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.708 1.147 . . . . 0.68000000000000005 112.111 177.27 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -158.99 178.29 10.23 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.027 1.331 . . . . 2.54 108.584 -178.679 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -98.98 135.8 12.33 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 110.885 -0.886 . . . . 0.64000000000000001 110.885 173.419 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.0 pp -137.83 149.39 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 105.261 -2.125 . . . . 0.66000000000000003 105.261 176.506 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.2 m -112.26 122.74 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 107.741 -1.207 . . . . 0.63 107.741 177.644 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.434 ' HB2' HG12 ' A' ' 127' ' ' VAL . . . -110.96 131.26 55.2 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 124.889 1.276 . . . . 0.44 109.28 -173.452 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -125.25 150.03 47.44 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.446 1.499 . . . . 3.7999999999999998 108.889 -179.693 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 171.54 -119.77 0.8 Allowed Glycine 0 C--N 1.333 0.402 0 N-CA-C 107.086 -2.405 . . . . 1.2 107.086 169.307 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.8 p -145.86 151.56 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-N 118.767 1.283 . . . . 0.93999999999999995 109.648 -177.076 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.474 HD11 HG21 ' A' ' 48' ' ' THR . 2.4 mm? -81.24 143.63 32.16 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.83 -0.804 . . . . 2.0099999999999998 108.83 173.154 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -161.26 13.39 0.15 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.028 -1.082 . . . . 2.6499999999999999 113.582 175.515 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -137.67 45.41 2.16 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 118.088 0.944 . . . . 6.7800000000000002 108.678 -169.071 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 41.7 t0 16.73 64.91 0.01 OUTLIER 'General case' 0 C--N 1.341 0.213 0 C-N-CA 128.92 2.888 . . . . 2.9900000000000002 113.203 -178.888 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 138.42 -47.81 0.91 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-N 114.79 -1.095 . . . . 1.3999999999999999 111.138 -170.978 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.75 164.11 12.71 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.04 0.92 . . . . 2.0499999999999998 109.862 -175.389 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.8 mp -121.71 131.7 54.23 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.77 1.228 . . . . 1.9399999999999999 110.029 -173.067 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -97.08 89.24 4.73 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.152 -1.425 . . . . 0.66000000000000003 107.152 171.946 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.07 88.03 2.64 Favored 'General case' 0 C--O 1.227 -0.084 0 C-N-CA 123.034 0.534 . . . . 1.51 110.536 -171.765 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.6 t -85.91 -3.77 59.0 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.123 1.157 . . . . 0.96999999999999997 114.123 -172.658 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -112.44 91.42 3.65 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 119.473 1.033 . . . . 3.6400000000000001 108.43 179.63 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.434 HG12 ' HB2' ' A' ' 112' ' ' ALA . 26.9 m -100.24 128.3 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 CA-C-N 118.39 0.541 . . . . 0.65000000000000002 110.524 175.93 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.04 120.29 35.87 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.46 -1.311 . . . . 0.64000000000000001 107.46 177.331 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -96.22 102.83 14.68 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.124 0.97 . . . . 1.3700000000000001 108.959 176.922 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.53 13.51 5.47 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.842 1.052 . . . . 4.2599999999999998 113.842 178.985 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 . . . . . 0 CA--C 1.534 0.338 0 C-N-CA 124.769 1.228 . . . . 5.7800000000000002 112.143 174.688 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.247 0 N-CA-C 109.674 -0.491 . . . . 4.1200000000000001 109.674 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -93.65 116.61 29.12 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 124.842 1.257 . . . . 2.3199999999999998 110.207 177.419 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.96 178.68 8.01 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.816 0.673 . . . . 6.0300000000000002 112.816 179.915 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 38.0 p -71.11 150.13 94.65 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 123.554 0.742 . . . . 1.95 110.336 -177.122 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -60.51 -47.59 13.56 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.172 2.581 . . . . 1.3200000000000001 110.685 176.001 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.4 t -46.81 -39.63 12.23 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.54 1.136 . . . . 2.23 111.853 -174.683 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.409 ' OE2' ' NZ ' ' A' ' 47' ' ' LYS . 60.8 tt0 -44.87 -57.46 3.75 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.068 0.547 . . . . 3.8100000000000001 111.178 172.075 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.28 0.1 OUTLIER -81.22 35.52 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 113.05 0.759 . . . . 1.8200000000000001 113.05 -178.872 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 52.1 t -117.76 -34.68 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 118.915 0.78 . . . . 2.2999999999999998 112.419 174.694 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -126.29 116.9 21.95 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 119.574 1.079 . . . . 2.3599999999999999 109.19 -169.766 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 63.4 35.47 92.1 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.62 -0.992 . . . . 1.3799999999999999 110.62 179.344 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.409 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 31.1 mttt -144.25 -107.41 0.11 Allowed 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 126.864 2.066 . . . . 2.8300000000000001 109.267 177.52 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 49.7 m -72.48 -64.62 0.92 Allowed 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 118.663 0.665 . . . . 1.3600000000000001 111.237 -172.98 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -48.71 -49.06 39.62 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.964 0.888 . . . . 2.5499999999999998 110.752 -176.495 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.38 -22.62 57.34 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.515 1.126 . . . . 1.4199999999999999 112.922 179.043 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.11 44.17 96.52 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.577 1.56 . . . . 1.04 114.083 177.752 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.1 m -98.57 -34.09 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 118.866 1.333 . . . . 1.2 113.893 -173.691 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.72 -71.73 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.84 1.256 . . . . 3.6499999999999999 112.797 -176.276 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -74.84 87.14 1.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.465 2.11 . . . . 1.8100000000000001 108.816 176.697 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -67.07 158.77 30.27 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.139 -0.689 . . . . 3.3599999999999999 109.139 175.884 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.7 168.01 5.3 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.769 -0.65 . . . . 1.3300000000000001 111.671 -176.672 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.01 5.35 90.21 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 119.792 -0.449 . . . . 1.03 113.086 -177.928 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -99.2 151.53 20.91 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.414 1.086 . . . . 1.51 109.109 177.882 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 58.7 mtt85 -93.06 146.86 23.32 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 122.876 0.47 . . . . 4.1200000000000001 109.909 173.327 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.3 pt -152.35 179.75 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 106.858 -1.534 . . . . 1.0600000000000001 106.858 179.853 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.9 mmt-85 -135.05 119.39 17.84 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.698 -1.593 . . . . 5.0999999999999996 106.698 167.714 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.7 p -85.18 144.68 9.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 107.768 -1.197 . . . . 0.98999999999999999 107.768 176.654 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -152.82 95.83 0.16 Allowed Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 110.246 -1.142 . . . . 1.04 110.246 -176.285 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -154.93 -165.67 14.35 Favored Glycine 0 C--N 1.332 0.344 0 N-CA-C 110.112 -1.195 . . . . 0.68999999999999995 110.112 -175.675 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.0 ptp -100.68 137.18 39.42 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.069 0.548 . . . . 2.3700000000000001 109.661 -177.159 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 83' ' ' ALA . 11.8 p -92.76 129.49 43.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.061 -0.518 . . . . 2.77 110.263 170.492 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.434 ' O ' HG22 ' A' ' 66' ' ' VAL . 1.0 OUTLIER -61.1 146.6 46.81 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.109 -1.071 . . . . 2.3700000000000001 108.109 166.71 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 p -50.68 -60.71 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.256 1.023 . . . . 1.99 110.539 -178.891 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -86.62 56.33 4.69 Favored Glycine 0 CA--C 1.527 0.791 0 O-C-N 121.378 -0.826 . . . . 1.72 111.645 -176.77 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 62.7 m -122.28 -34.8 3.24 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.986 0.736 . . . . 1.3700000000000001 112.986 -178.753 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -71.92 124.12 24.2 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.802 -0.814 . . . . 2.0099999999999998 108.802 -178.576 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.8 m -131.51 131.92 62.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.735 0.814 . . . . 0.75 108.829 176.15 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.5 ptt-85 -116.8 147.71 41.85 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 124.949 1.3 . . . . 4.0199999999999996 110.332 179.284 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -96.58 155.5 37.77 Favored Pre-proline 0 C--O 1.234 0.273 0 N-CA-C 108.807 -0.812 . . . . 2.3900000000000001 108.807 177.474 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.74 42.86 0.99 Allowed 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.75 2.967 . . . . 1.9099999999999999 111.605 175.857 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -102.9 -41.36 6.18 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 125.306 1.442 . . . . 1.21 109.217 173.605 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.9 m 104.67 -32.49 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 129.12 2.968 . . . . 2.27 110.492 -172.107 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.11 28.78 8.3 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 124.135 0.974 . . . . 2.5899999999999999 112.541 -173.789 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -137.5 113.22 9.58 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.044 -1.465 . . . . 2.0099999999999998 107.044 174.726 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.706 HG21 ' CD2' ' A' ' 100' ' ' LEU . 27.8 m -142.34 143.45 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 107.426 -1.324 . . . . 0.76000000000000001 107.426 176.504 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -139.2 159.72 41.49 Favored 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 121.637 -0.664 . . . . 1.3700000000000001 109.824 169.053 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -150.95 142.32 23.36 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 109.135 -0.691 . . . . 1.98 109.135 -178.495 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.59 ' O ' HG23 ' A' ' 66' ' ' VAL . . . -83.33 143.82 30.1 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.241 -1.022 . . . . 0.68999999999999995 108.241 171.543 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.8 t -128.32 138.03 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 N-CA-C 107.393 -1.336 . . . . 1.8200000000000001 107.393 170.421 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -133.93 174.74 10.14 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.999 -0.741 . . . . 1.29 108.999 177.911 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.3 t70 . . . . . 0 CA--C 1.532 0.279 0 CA-C-N 115.923 -0.58 . . . . 2.6299999999999999 110.793 175.557 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.785 0 N-CA-C 108.319 -1.912 . . . . 1.54 108.319 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -126.3 142.88 51.36 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.165 -1.791 . . . . 3.4500000000000002 106.165 171.277 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.7 tp -131.85 147.3 32.45 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 N-CA-C 108.332 -0.988 . . . . 1.1499999999999999 108.332 179.71 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.9 mt -95.91 122.72 39.02 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 122.968 0.507 . . . . 0.55000000000000004 110.27 179.715 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.7 122.23 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 125.552 1.541 . . . . 0.84999999999999998 107.582 176.401 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 42.3 p -100.26 152.4 20.34 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.251 1.02 . . . . 0.46000000000000002 108.996 174.869 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.553 ' HB3' HG23 ' A' ' 80' ' ' VAL . 1.0 OUTLIER -147.16 122.3 10.16 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.563 -1.273 . . . . 2.8599999999999999 107.563 177.127 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -96.53 41.66 1.1 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.698 1.599 . . . . 2.4199999999999999 110.973 -179.933 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -162.55 179.53 7.68 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.734 1.214 . . . . 2.8399999999999999 108.354 172.428 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.05 165.54 23.29 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.565 1.146 . . . . 1.3999999999999999 111.649 174.167 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.706 ' CD2' HG21 ' A' ' 80' ' ' VAL . 3.0 mm? -96.16 162.16 24.7 Favored Pre-proline 0 N--CA 1.453 -0.292 0 C-N-CA 125.833 1.653 . . . . 2.5899999999999999 109.437 179.185 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -64.3 -82.14 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.236 2.624 . . . . 2.5299999999999998 109.168 167.32 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -93.24 48.69 1.34 Allowed 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 124.14 0.976 . . . . 2.6099999999999999 109.202 -172.196 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 48.77 4.6 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.997 2.119 . . . . 2.6800000000000002 116.478 -169.944 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.512 ' HE1' HG21 ' A' ' 66' ' ' VAL . 35.4 t80 63.71 97.18 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.221 1.409 . . . . 2.54 109.976 -159.767 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 51.7 mtp85 -79.02 121.7 25.27 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 107.418 -1.327 . . . . 3.8599999999999999 107.418 174.577 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -82.23 175.31 10.39 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.942 0.897 . . . . 3.23 110.365 -175.172 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 62.58 35.46 91.85 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 122.094 -0.378 . . . . 0.77000000000000002 112.546 174.279 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -155.65 -179.92 8.58 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.24 1.416 . . . . 2.7599999999999998 108.188 178.131 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -106.51 131.02 10.44 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 110.917 -0.873 . . . . 0.55000000000000004 110.917 177.506 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.9 pp -128.51 154.91 39.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 106.994 -1.484 . . . . 0.60999999999999999 106.994 179.039 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.2 m -106.44 137.7 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 107.418 -1.327 . . . . 0.80000000000000004 107.418 173.415 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.437 ' HB2' HG12 ' A' ' 127' ' ' VAL . . . -125.97 124.29 40.42 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.056 0.943 . . . . 0.48999999999999999 109.615 179.607 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.35 137.62 42.86 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.141 1.376 . . . . 3.77 108.921 -177.785 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 170.75 -148.6 11.53 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.975 -0.85 . . . . 1.0700000000000001 110.975 178.099 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.11 153.69 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 C-N-CA 124.823 1.249 . . . . 0.96999999999999997 107.823 -170.508 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.488 HD13 HD23 ' A' ' 122' ' ' LEU . 3.5 mm? -53.37 140.96 25.83 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.29 -0.633 . . . . 1.8400000000000001 109.29 169.368 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -74.74 -153.85 3.66 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 109.818 -1.313 . . . . 2.25 109.818 178.527 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -58.46 -60.31 4.0 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.952 0.501 . . . . 5.6900000000000004 109.99 -174.5 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -170.82 109.08 0.32 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.496 -2.039 . . . . 3.1200000000000001 105.496 175.596 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 107.41 -39.87 2.73 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.848 -1.301 . . . . 0.98999999999999999 109.848 174.783 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.03 166.71 18.56 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.243 0.617 . . . . 3.0699999999999998 111.196 179.823 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.488 HD23 HD13 ' A' ' 116' ' ' LEU . 98.4 mt -116.86 134.91 54.19 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 124.43 1.092 . . . . 2.1899999999999999 108.653 172.334 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -105.93 103.68 13.23 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 107.834 -1.173 . . . . 0.66000000000000003 107.834 173.884 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -131.48 113.51 13.78 Favored 'General case' 0 C--N 1.341 0.232 0 N-CA-C 111.902 0.334 . . . . 1.23 111.902 -174.821 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.78 -41.63 9.56 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.753 1.221 . . . . 1.1699999999999999 110.442 179.329 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -84.87 77.82 10.02 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.603 -0.888 . . . . 3.5899999999999999 108.603 -167.993 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.437 HG12 ' HB2' ' A' ' 112' ' ' ALA . 6.5 m -88.76 124.06 41.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.757 1.223 . . . . 0.75 110.751 177.205 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.406 HD13 ' C ' ' A' ' 127' ' ' VAL . 0.0 OUTLIER -121.43 131.32 54.1 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.561 1.144 . . . . 0.81000000000000005 107.978 176.669 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -100.31 74.87 1.76 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.902 0.881 . . . . 1.3 110.751 -175.11 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.3 pttm -74.36 -12.26 60.48 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.832 1.049 . . . . 4.8399999999999999 113.832 -171.719 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 10.5 m170 . . . . . 0 C--N 1.338 0.093 0 O-C-N 121.866 -0.521 . . . . 4.6200000000000001 110.175 172.807 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 N--CA 1.466 0.351 0 N-CA-C 112.712 0.634 . . . . 1.8400000000000001 112.712 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.436 ' CZ ' ' HD2' ' A' ' 61' ' ' ARG . 93.7 m-85 -83.44 134.15 34.88 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.545 1.138 . . . . 2.27 110.458 -177.526 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -137.18 147.48 45.92 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.293 1.837 . . . . 3.3199999999999998 109.95 -178.768 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 m -71.69 137.48 82.98 Favored Pre-proline 0 N--CA 1.448 -0.546 0 C-N-CA 124.964 1.306 . . . . 1.6899999999999999 110.464 177.437 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -58.94 -49.14 12.06 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.97 2.447 . . . . 0.77000000000000002 111.453 177.335 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.9 m -54.18 -33.88 59.16 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.625 0.77 . . . . 2.8300000000000001 112.683 -178.719 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -53.1 -51.34 62.19 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.238 -1.023 . . . . 2.3999999999999999 108.238 173.749 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.295 36.8 pt -82.4 30.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 113.652 0.982 . . . . 1.29 113.652 -171.48 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -103.87 -39.72 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 124.048 0.939 . . . . 2.1400000000000001 110.702 163.161 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -72.9 -50.58 22.85 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.645 0.609 . . . . 2.8100000000000001 112.645 -159.972 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.23 67.98 0.1 Allowed Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 108.139 -1.984 . . . . 1.4199999999999999 108.139 -168.804 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -143.19 -106.72 0.13 Allowed 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.449 -1.685 . . . . 3.2999999999999998 106.449 -175.921 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 t -65.17 -59.36 4.18 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.595 1.158 . . . . 3.48 111.192 177.269 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -57.3 -39.6 76.11 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.474 0.71 . . . . 3.02 111.553 -165.195 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.68 -7.29 37.87 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.207 1.003 . . . . 1.3200000000000001 112.255 178.081 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 53.11 44.88 63.4 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.443 1.496 . . . . 1.1699999999999999 113.785 178.26 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.9 m -99.05 -35.26 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 118.479 1.14 . . . . 1.29 113.228 -175.061 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.89 -71.63 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 117.837 -1.078 . . . . 4.2000000000000002 112.537 -179.525 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -76.17 174.5 12.72 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 122.264 1.976 . . . . 1.3999999999999999 109.157 171.653 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -147.18 147.72 30.79 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.885 2.074 . . . . 2.9100000000000001 106.937 -176.929 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.44 144.03 32.61 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.66 0.784 . . . . 1.3500000000000001 110.52 -179.71 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.08 -20.49 26.15 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 123.829 0.728 . . . . 1.1499999999999999 112.551 -176.882 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -85.31 151.55 23.95 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 117.938 0.869 . . . . 1.6399999999999999 109.657 179.798 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.0 mtt85 -97.71 137.35 36.72 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.636 -0.711 . . . . 4.0300000000000002 109.709 173.789 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.7 pt -144.46 168.63 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 105.777 -1.935 . . . . 0.63 105.777 170.775 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.436 ' HD2' ' CZ ' ' A' ' 37' ' ' PHE . 22.0 mtt180 -115.54 123.65 49.03 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.009 -0.737 . . . . 1.8600000000000001 109.009 172.391 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.6 p -87.46 129.33 39.02 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.082 0 N-CA-C 108.016 -1.105 . . . . 0.92000000000000004 108.016 176.045 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.98 116.18 1.81 Allowed Glycine 0 C--N 1.333 0.41 0 CA-C-N 118.919 0.782 . . . . 0.55000000000000004 111.243 -178.157 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.89 -169.2 38.53 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 117.787 0.793 . . . . 0.95999999999999996 111.313 -177.378 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.413 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 19.6 ptp -101.4 148.68 24.88 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.863 1.265 . . . . 2.75 110.711 -177.912 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 43.2 t -106.34 119.65 56.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 109.624 -0.51 . . . . 2.46 109.624 -177.393 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 86.1 m -44.05 122.47 2.9 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.714 1.606 . . . . 2.5899999999999999 109.408 165.774 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.1 p -46.23 -57.09 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.042 0.937 . . . . 2.1200000000000001 111.205 -177.86 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.2 68.84 3.4 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.833 -0.907 . . . . 2.3100000000000001 110.833 -179.648 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.9 m -149.55 -31.36 0.22 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.255 1.576 . . . . 1.22 115.255 178.221 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 12.1 tpp -60.92 115.88 4.05 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.15 0.886 . . . . 2.02 109.638 173.249 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.3 m -121.09 136.1 59.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 107.971 -1.122 . . . . 0.76000000000000001 107.971 172.444 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.47 136.48 49.95 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.855 1.262 . . . . 6.6699999999999999 109.082 -170.842 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -83.03 154.62 67.4 Favored Pre-proline 0 N--CA 1.455 -0.209 0 N-CA-C 109.384 -0.598 . . . . 2.1299999999999999 109.384 -179.359 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -71.03 10.42 0.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.12 2.547 . . . . 1.3400000000000001 113.203 173.731 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -74.71 -22.58 58.76 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.868 0.467 . . . . 1.3600000000000001 109.862 161.947 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.1 m 63.74 24.08 13.71 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.079 1.351 . . . . 1.74 112.621 -178.177 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.86 -43.32 2.0 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.962 1.705 . . . . 2.3100000000000001 112.023 172.68 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -84.13 122.19 28.48 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 108.522 -0.918 . . . . 1.3500000000000001 108.522 -178.839 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.3 m -146.83 107.69 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 106.92 -1.511 . . . . 1.3100000000000001 106.92 -172.156 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -119.87 154.97 33.57 Favored 'General case' 0 C--O 1.232 0.162 0 O-C-N 121.635 -0.666 . . . . 0.81000000000000005 109.838 -176.773 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -154.9 147.99 24.78 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 120.82 0.343 . . . . 2.0699999999999998 111.067 -175.555 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.05 139.92 30.72 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.41 -0.959 . . . . 0.65000000000000002 108.41 167.951 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.08 147.05 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.291 1.037 . . . . 1.9199999999999999 108.685 178.498 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -145.04 172.15 13.47 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 126.292 1.837 . . . . 1.5900000000000001 109.632 -171.045 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 50.4 t0 . . . . . 0 N--CA 1.451 -0.384 0 N-CA-C 107.31 -1.367 . . . . 2.9500000000000002 107.31 170.217 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.559 0 N-CA-C 107.474 -2.251 . . . . 1.8799999999999999 107.474 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -157.21 172.28 18.92 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 117.84 0.82 . . . . 2.6400000000000001 109.424 179.223 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.0 tp -154.28 159.88 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.287 0.635 . . . . 1.01 109.387 176.539 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 16.7 mt -99.05 127.01 44.9 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.608 1.163 . . . . 0.88 111.283 -178.354 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 76.2 t -108.68 130.87 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 125.727 1.611 . . . . 0.84999999999999998 107.989 175.502 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.8 p -111.79 134.1 53.58 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.149 -1.056 . . . . 0.58999999999999997 108.149 177.675 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.417 ' CE2' ' HA ' ' A' ' 125' ' ' THR . 1.4 t80 -135.11 139.4 44.64 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.318 -1.364 . . . . 2.2599999999999998 107.318 -179.319 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -130.23 30.64 4.74 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.962 1.305 . . . . 2.1899999999999999 112.702 -168.628 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -159.1 55.95 0.41 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.195 0.521 . . . . 2.4500000000000002 111.207 -178.58 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 55.76 -170.4 0.08 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.102 0.961 . . . . 1.8500000000000001 111.456 -176.132 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.1 mt -153.28 154.94 31.39 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 125.113 1.365 . . . . 1.1799999999999999 107.643 -175.986 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.498 ' HG3' HG23 ' A' ' 127' ' ' VAL . 72.8 Cg_endo -62.85 122.39 10.66 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 125.172 3.915 . . . . 2.3799999999999999 109.958 -176.676 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 48.24 42.42 17.59 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 123.655 0.782 . . . . 3.3799999999999999 110.498 -178.161 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 70.23 -16.9 0.28 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.886 1.274 . . . . 3.79 112.234 -177.261 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 14.2 t80 60.27 83.79 0.13 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.736 2.015 . . . . 3.1499999999999999 108.954 -167.474 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -75.07 137.33 41.37 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 114.834 -1.075 . . . . 5.4100000000000001 108.26 -173.642 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.5 mp0 -79.03 162.72 25.72 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 121.139 0.495 . . . . 3.4199999999999999 110.522 -166.089 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.29 44.69 27.43 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 111.593 -0.603 . . . . 1.1299999999999999 111.593 -178.237 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -146.37 179.5 7.48 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.733 1.613 . . . . 2.0899999999999999 106.704 169.042 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 65' ' ' MET . . . -126.21 145.65 15.84 Favored Glycine 0 C--N 1.337 0.592 0 N-CA-C 111.529 -0.628 . . . . 1.1100000000000001 111.529 171.708 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.36 168.5 15.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 124.424 1.09 . . . . 1.4099999999999999 108.532 -175.804 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.5 m -107.49 129.78 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 107.812 -1.181 . . . . 0.81000000000000005 107.812 169.519 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.614 ' HB2' HG12 ' A' ' 127' ' ' VAL . . . -119.24 133.75 55.59 Favored 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 125.457 1.503 . . . . 0.51000000000000001 109.088 -179.218 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -124.98 142.4 51.51 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.28 1.032 . . . . 3.98 110.555 -177.582 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 171.51 -134.9 3.22 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 108.393 -1.883 . . . . 0.81999999999999995 108.393 172.203 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.06 155.37 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 108.423 -0.954 . . . . 0.67000000000000004 108.423 -170.274 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -54.39 132.73 44.81 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.86 -0.792 . . . . 1.95 108.86 167.05 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.56 -139.9 1.63 Allowed Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 109.62 -1.392 . . . . 1.9199999999999999 109.62 -179.774 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -57.55 -60.6 3.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 122.865 0.466 . . . . 5.3099999999999996 110.862 -177.416 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -176.81 115.48 0.1 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 105.823 -1.917 . . . . 3.4900000000000002 105.823 -173.191 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 88.2 -42.64 3.09 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 125.39 1.471 . . . . 1.1599999999999999 109.609 176.997 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.65 142.09 34.3 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.227 1.411 . . . . 3.1299999999999999 109.918 -175.937 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.72 123.45 47.05 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 108.393 -0.966 . . . . 2.2799999999999998 108.393 -176.754 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.76 83.7 3.48 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.019 -1.474 . . . . 0.46999999999999997 107.019 176.096 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -94.33 142.44 27.41 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.41 -0.959 . . . . 1.1399999999999999 108.41 175.202 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.417 ' HA ' ' CE2' ' A' ' 96' ' ' TYR 0.26 4.7 t -136.5 -4.36 2.07 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 115.47 1.656 . . . . 0.95999999999999996 115.47 173.667 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -107.2 98.87 8.46 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 119.854 1.206 . . . . 3.9500000000000002 107.913 164.794 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.614 HG12 ' HB2' ' A' ' 112' ' ' ALA . 3.4 m -96.47 133.79 36.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 CA-C-N 118.751 0.705 . . . . 0.76000000000000001 110.833 165.056 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.71 106.75 14.86 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.299 -1.371 . . . . 0.72999999999999998 107.299 175.266 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.68 42.06 1.08 Allowed 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.3 0.852 . . . . 1.45 113.3 -170.237 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.28 62.91 1.84 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.361 0.664 . . . . 4.0599999999999996 111.528 179.324 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 19.2 p80 . . . . . 0 CA--C 1.532 0.262 0 N-CA-C 108.902 -0.777 . . . . 7.3899999999999997 108.902 175.102 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.148 0 CA-C-O 119.75 -0.167 . . . . 4.4500000000000002 110.674 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.573 ' CE1' ' HB3' ' A' ' 61' ' ' ARG . 3.1 m-85 -89.22 110.83 21.54 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.52 1.128 . . . . 4.4000000000000004 110.732 179.55 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.49 176.31 8.79 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.747 0.654 . . . . 5.8099999999999996 112.01 174.998 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 p -69.34 145.82 96.06 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 124.067 0.947 . . . . 1.96 110.696 -175.841 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -58.92 -37.18 94.99 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.168 1.912 . . . . 1.29 111.966 179.36 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.6 t -46.53 -40.86 13.36 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.499 0.72 . . . . 2.6899999999999999 112.17 177.921 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -50.42 -47.32 56.68 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.342 -0.543 . . . . 4.8799999999999999 110.499 177.131 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.279 0.2 OUTLIER -91.56 34.39 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 112.77 0.655 . . . . 1.6499999999999999 112.77 178.293 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.16 -32.93 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 118.88 0.763 . . . . 2.4399999999999999 112.345 170.167 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -117.44 113.42 22.03 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.156 0.889 . . . . 2.6899999999999999 110.323 -173.72 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.6 43.77 98.56 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.488 -0.645 . . . . 1.77 111.488 169.307 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -142.42 -111.04 0.13 Allowed 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 126.634 1.973 . . . . 3.9199999999999999 106.511 176.704 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.4 t -71.87 -47.91 49.58 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 119.43 1.013 . . . . 3.0099999999999998 111.626 -176.688 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -49.89 -46.24 51.5 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 122.044 0.926 . . . . 2.79 110.724 -173.47 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.69 -11.51 45.01 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.977 1.311 . . . . 1.5700000000000001 112.173 178.829 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 55.54 44.82 85.73 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 126.309 1.909 . . . . 1.3899999999999999 112.43 -178.073 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.7 m -96.01 -57.87 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 118.187 0.993 . . . . 1.8899999999999999 112.81 -174.047 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.5 mmmt -91.85 -60.8 0.21 Allowed Pre-proline 0 CA--C 1.536 0.43 0 CA-C-O 118.607 -0.711 . . . . 4.5099999999999998 111.992 -177.02 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -85.97 110.53 1.08 Allowed 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 122.426 2.084 . . . . 1.51 108.821 175.743 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -69.28 155.98 39.53 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.779 -0.823 . . . . 3.2000000000000002 108.779 167.314 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -53.76 165.78 0.4 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 122.027 0.917 . . . . 1.3700000000000001 111.959 166.75 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.44 8.77 86.67 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 115.933 -0.576 . . . . 1.1799999999999999 112.45 -177.768 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -102.45 155.05 18.52 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.049 0.924 . . . . 1.96 108.886 171.779 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -100.81 136.81 40.07 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.101 0.96 . . . . 4.1799999999999997 108.921 175.876 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.64 HD11 HD11 ' A' ' 122' ' ' LEU . 29.7 pt -141.86 175.36 5.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 106.558 -1.645 . . . . 0.90000000000000002 106.558 174.152 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.573 ' HB3' ' CE1' ' A' ' 37' ' ' PHE . 15.8 mtt-85 -132.52 126.27 32.52 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 106.421 -1.696 . . . . 3.27 106.421 176.196 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.7 p -98.67 118.08 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 107.81 -1.181 . . . . 1.05 107.81 -179.46 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.36 113.26 1.87 Allowed Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 108.195 -1.962 . . . . 0.92000000000000004 108.195 -178.738 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.88 -163.29 27.12 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 109.446 -1.462 . . . . 0.66000000000000003 109.446 -171.737 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -103.75 132.23 50.2 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.864 0.866 . . . . 3.0 109.812 -172.88 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.2 t -106.57 126.23 62.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 108.721 -0.844 . . . . 2.3700000000000001 108.721 176.859 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.2 m -57.95 137.95 56.29 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.833 1.253 . . . . 2.29 108.918 169.034 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.6 p -52.27 -60.69 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 123.63 0.772 . . . . 2.2400000000000002 110.782 177.507 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.14 68.44 2.32 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.309 -1.116 . . . . 1.97 110.309 -179.951 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.1 m -151.16 -34.95 0.14 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.105 0.779 . . . . 1.1200000000000001 113.105 -179.042 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.1 ttp -69.37 117.73 11.37 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.438 1.017 . . . . 2.7799999999999998 109.148 174.282 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.1 m -122.56 136.12 60.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 107.659 -1.237 . . . . 0.79000000000000004 107.659 175.196 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.482 ' CB ' HG12 ' A' ' 80' ' ' VAL . 24.2 ptt180 -118.72 144.69 46.08 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.897 0.879 . . . . 4.2800000000000002 109.963 -179.931 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -92.42 145.84 31.34 Favored Pre-proline 0 C--O 1.237 0.42 0 N-CA-C 108.957 -0.757 . . . . 2.4700000000000002 108.957 177.475 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -75.58 30.24 0.38 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.048 2.499 . . . . 1.76 112.89 178.792 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -89.87 -22.7 21.91 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.09 0.956 . . . . 1.54 108.83 162.628 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.3 m 63.47 23.13 13.54 Favored 'General case' 0 C--N 1.344 0.358 0 C-N-CA 124.301 1.041 . . . . 1.3799999999999999 111.806 -174.626 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . 0.251 1.4 pp -130.7 -3.18 4.18 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.581 1.552 . . . . 2.1800000000000002 113.303 173.322 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -131.4 125.56 32.93 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.192 -1.04 . . . . 1.55 108.192 -179.97 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.482 HG12 ' CB ' ' A' ' 73' ' ' ARG . 27.2 m -141.64 143.57 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 107.093 -1.447 . . . . 0.82999999999999996 107.093 172.08 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -142.05 158.77 43.37 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 121.783 -0.573 . . . . 0.83999999999999997 109.667 176.143 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -149.51 136.04 19.29 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.402 0.681 . . . . 1.96 109.97 -177.342 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.85 138.22 33.31 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.468 -0.938 . . . . 0.67000000000000004 108.468 169.944 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.8 p -117.69 155.29 19.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 125.186 1.394 . . . . 2.04 107.786 175.547 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -131.61 175.1 9.45 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.698 0.799 . . . . 1.6699999999999999 109.729 -179.651 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 39.0 t70 . . . . . 0 N--CA 1.453 -0.288 0 C-N-CA 124.464 1.106 . . . . 3.3300000000000001 109.632 178.861 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.428 0 N-CA-C 110.135 -1.186 . . . . 2.2400000000000002 110.135 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.86 101.24 3.7 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.794 -0.817 . . . . 3.21 108.794 -172.02 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.1 152.15 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 124.221 1.008 . . . . 1.1399999999999999 108.737 -177.036 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.2 mt -107.36 122.31 46.33 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.265 1.026 . . . . 0.69999999999999996 109.538 -179.717 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.0 t -105.08 120.07 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 125.06 1.344 . . . . 1.03 107.651 176.961 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.6 p -105.44 144.35 32.33 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.862 1.265 . . . . 0.60999999999999999 108.964 179.525 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.431 ' HB3' HG23 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -142.24 102.13 4.04 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.214 -1.032 . . . . 2.25 108.214 -178.771 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -94.4 45.44 1.13 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.221 1.408 . . . . 2.9700000000000002 111.015 -178.905 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -163.97 48.44 0.12 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.676 1.19 . . . . 3.8700000000000001 110.437 179.559 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.9 mp 54.16 -149.88 0.41 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.379 1.072 . . . . 2.4500000000000002 110.776 -178.739 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.478 ' HG ' HG21 ' A' ' 80' ' ' VAL . 11.8 mt -153.44 158.35 32.72 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 127.62 2.368 . . . . 1.52 105.837 -176.996 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -75.27 -98.5 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 124.292 3.328 . . . . 2.7799999999999998 110.671 -178.892 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -75.77 53.62 0.75 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.16 1.384 . . . . 3.6099999999999999 110.204 179.527 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 45.47 0.48 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 129.084 2.953 . . . . 2.75 116.533 -163.839 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.7 t80 50.05 105.29 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 122.462 1.125 . . . . 3.2000000000000002 110.089 -153.434 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -74.51 123.43 24.73 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.434 -1.321 . . . . 4.7000000000000002 107.434 178.975 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -81.66 167.81 18.8 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.832 0.853 . . . . 3.29 110.322 -167.522 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.14 44.54 93.91 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 112.067 -0.413 . . . . 1.0700000000000001 112.067 173.484 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -155.85 177.72 11.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.401 -1.333 . . . . 2.0 107.401 175.344 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -85.49 137.97 15.89 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.581 -1.008 . . . . 0.97999999999999998 110.581 171.055 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 4.7 pt -138.64 164.43 26.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 108.934 -0.765 . . . . 1.52 108.934 172.484 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.529 ' HB ' ' CE1' ' A' ' 37' ' ' PHE . 16.2 m -121.68 112.96 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 106.915 -1.513 . . . . 1.27 106.915 -178.545 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -118.45 127.87 54.07 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.518 1.927 . . . . 0.81999999999999995 111.048 -173.423 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -126.59 157.93 37.57 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.778 1.172 . . . . 2.8700000000000001 113.608 175.092 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 179.26 -104.11 0.18 Allowed Glycine 0 C--N 1.337 0.602 0 N-CA-C 109.735 -1.346 . . . . 1.2 109.735 167.943 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.8 p -151.6 154.0 8.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 118.254 1.027 . . . . 0.92000000000000004 110.047 -174.563 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.01 139.41 58.76 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.63 -0.259 . . . . 1.77 111.004 173.592 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -120.04 120.92 4.73 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 126.356 1.932 . . . . 3.52 109.18 176.747 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 56.99 43.12 25.1 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.933 0.893 . . . . 5.0300000000000002 111.297 168.715 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 35.47 50.46 0.57 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.177 1.791 . . . . 4.71 111.43 -176.197 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -175.56 -57.28 0.06 OUTLIER Glycine 0 C--N 1.339 0.708 0 C-N-CA 120.128 -1.034 . . . . 1.22 112.973 -175.078 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.11 152.83 22.01 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 109.068 -0.716 . . . . 2.75 109.068 -178.927 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.64 HD11 HD11 ' A' ' 60' ' ' ILE . 3.3 mm? -107.35 111.48 23.85 Favored 'General case' 0 C--O 1.228 -0.062 0 N-CA-C 109.128 -0.693 . . . . 2.2400000000000002 109.128 -177.281 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.71 97.5 9.15 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.355 -1.35 . . . . 0.64000000000000001 107.355 176.306 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.7 144.52 39.52 Favored 'General case' 0 C--O 1.227 -0.125 0 C-N-CA 122.92 0.488 . . . . 1.1499999999999999 109.85 -177.806 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.6 t -131.43 -43.91 1.02 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.025 0.93 . . . . 0.97999999999999998 110.907 -178.337 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -83.34 93.89 7.83 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.242 -1.392 . . . . 4.1200000000000001 107.242 175.621 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 18.8 m -98.6 120.46 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 124.394 1.078 . . . . 0.98999999999999999 108.424 169.65 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.73 114.15 26.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.711 -1.589 . . . . 0.90000000000000002 106.711 178.868 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.5 46.28 0.84 Allowed 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.879 -1.138 . . . . 1.48 112.051 -175.628 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -81.7 60.75 4.78 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.448 -0.782 . . . . 3.02 111.376 -175.248 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.535 0.377 0 C-N-CA 123.542 0.737 . . . . 7.0899999999999999 110.556 176.849 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.533 0.309 0 N-CA-C 112.666 0.617 . . . . 2.29 112.666 . . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -85.67 118.79 25.39 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.939 1.296 . . . . 2.21 110.382 179.366 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.31 162.69 23.25 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.345 1.058 . . . . 2.8399999999999999 111.166 175.113 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.9 p -75.02 144.29 79.06 Favored Pre-proline 0 N--CA 1.451 -0.396 0 N-CA-C 109.237 -0.653 . . . . 2.2599999999999998 109.237 176.062 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -55.64 -41.27 79.39 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.56 2.173 . . . . 1.26 111.173 169.39 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.2 m -57.0 -50.33 73.03 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 117.563 -1.208 . . . . 2.6099999999999999 111.313 178.94 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.29 -53.86 12.44 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 120.308 1.413 . . . . 2.7999999999999998 110.52 178.192 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.461 ' HA ' ' HB2' ' A' ' 47' ' ' LYS 0.334 31.0 pt -63.01 -28.41 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-N 115.116 -0.947 . . . . 1.3700000000000001 112.816 -173.058 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.0 t -74.87 -49.04 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 118.492 0.587 . . . . 2.1000000000000001 110.894 166.063 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -64.89 -46.83 80.1 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 123.972 0.909 . . . . 4.54 112.877 -163.457 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.34 62.35 0.07 OUTLIER Glycine 0 C--N 1.335 0.481 0 C-N-CA 119.668 -1.253 . . . . 2.0699999999999998 111.59 -174.291 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.461 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 13.7 mmtt -150.85 -97.32 0.06 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 128.235 2.614 . . . . 3.3399999999999999 105.098 -178.18 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.751 HG21 HD11 ' A' ' 116' ' ' LEU . 9.4 m -78.89 -54.66 5.82 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 125.072 1.349 . . . . 1.78 113.095 -168.518 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -49.24 -45.1 44.22 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.905 0.859 . . . . 2.3700000000000001 110.454 -178.517 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.2 m -87.58 -10.65 50.92 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.344 1.058 . . . . 1.6699999999999999 113.157 178.356 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 51.75 47.08 53.72 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.821 1.677 . . . . 1.8200000000000001 112.834 -175.994 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.9 m -87.0 -52.47 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 118.334 1.067 . . . . 2.0499999999999998 112.313 -175.509 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -100.97 -48.51 0.2 Allowed Pre-proline 0 CA--C 1.537 0.456 0 CA-C-O 118.039 -0.982 . . . . 3.6099999999999999 111.646 -178.816 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -91.29 -173.43 0.55 Allowed 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 122.863 2.376 . . . . 2.0600000000000001 108.781 170.181 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -153.45 155.78 36.95 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 127.756 2.422 . . . . 3.4100000000000001 106.413 -177.722 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.476 ' HB2' ' CB ' ' A' ' 119' ' ' ASP . . . -54.25 160.91 1.47 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.862 0.839 . . . . 1.3799999999999999 111.442 173.88 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.27 29.42 60.27 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 116.043 -0.526 . . . . 1.6799999999999999 111.976 176.032 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -122.07 152.51 39.75 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.177 -1.416 . . . . 1.53 107.177 167.748 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.9 mtt85 -88.61 141.21 28.71 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.282 -0.636 . . . . 3.79 109.282 170.106 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.0 pt -143.61 176.78 2.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 106.906 -1.516 . . . . 0.75 106.906 170.613 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.6 mtt180 -124.25 129.51 50.91 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.036 -0.727 . . . . 1.8899999999999999 109.036 169.264 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.0 p -90.34 128.59 42.15 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 107.365 -1.346 . . . . 0.93000000000000005 107.365 174.352 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.88 119.22 1.6 Allowed Glycine 0 C--N 1.335 0.515 0 N-CA-C 110.721 -0.951 . . . . 0.64000000000000001 110.721 178.944 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.49 -157.5 16.96 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 108.627 -1.789 . . . . 0.71999999999999997 108.627 -175.264 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.63 149.2 23.53 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 117.814 0.807 . . . . 2.5 110.339 175.683 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.587 HG21 ' CE1' ' A' ' 104' ' ' PHE . 77.3 t -94.65 150.19 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.451 -0.944 . . . . 2.2200000000000002 108.451 169.874 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.73 -173.91 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.693 1.597 . . . . 2.4399999999999999 110.191 168.545 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.9 p -126.32 72.87 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-O 122.95 1.357 . . . . 2.75 108.375 178.032 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 136.23 -7.17 4.03 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 113.686 -1.597 . . . . 2.1499999999999999 113.615 174.511 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 56.6 m -63.37 -21.26 66.17 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.827 1.314 . . . . 1.0900000000000001 112.653 177.343 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 29.0 tpp -56.65 121.98 11.0 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.174 -0.676 . . . . 2.0699999999999998 109.174 171.455 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.8 m -125.12 131.22 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 107.627 -1.249 . . . . 0.60999999999999999 107.627 166.784 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.436 ' HB2' HG12 ' A' ' 80' ' ' VAL . 0.9 OUTLIER -121.87 142.61 50.08 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.7 1.2 . . . . 4.04 108.917 -175.251 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.87 154.16 58.12 Favored Pre-proline 0 CA--C 1.532 0.257 0 N-CA-C 109.859 -0.423 . . . . 2.8700000000000001 109.859 176.357 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -63.51 -30.44 71.46 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.965 2.443 . . . . 2.29 110.803 172.71 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -43.04 -41.18 3.38 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.865 1.666 . . . . 2.7000000000000002 110.354 177.716 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.2 m 88.49 -1.06 0.42 Allowed 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 127.159 2.184 . . . . 1.55 113.272 176.451 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.27 25.49 9.47 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.08 0.855 . . . . 2.8900000000000001 112.384 173.83 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -144.58 114.78 7.49 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.32 -1.363 . . . . 1.3700000000000001 107.32 175.234 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.436 HG12 ' HB2' ' A' ' 73' ' ' ARG . 34.0 m -138.44 141.68 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 106.351 -1.722 . . . . 1.04 106.351 172.814 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -137.64 155.52 49.06 Favored 'General case' 0 C--O 1.233 0.189 0 O-C-N 121.745 -0.597 . . . . 0.82999999999999996 109.479 173.818 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -154.75 159.36 40.61 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.709 -0.478 . . . . 2.0899999999999999 109.709 -171.371 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.421 ' HB1' ' HG2' ' A' ' 91' ' ' GLU . . . -109.03 136.44 48.54 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.696 -0.853 . . . . 0.69999999999999996 108.696 -177.81 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.4 t -122.65 135.5 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 123.726 0.811 . . . . 2.0499999999999998 109.04 179.955 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -132.63 160.8 35.61 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 125.74 1.616 . . . . 1.54 109.568 -178.123 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.9 t70 . . . . . 0 CA--C 1.53 0.183 0 O-C-N 121.699 -0.626 . . . . 2.9199999999999999 110.997 176.325 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.484 0 N-CA-C 108.307 -1.917 . . . . 1.48 108.307 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.421 ' HG2' ' HB1' ' A' ' 83' ' ' ALA . 37.0 tt0 -132.76 119.51 20.42 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.45 1.5 . . . . 4.1799999999999997 107.687 -177.741 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -98.29 154.08 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 123.971 0.908 . . . . 1.4199999999999999 108.83 -179.643 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 18.6 mt -100.25 120.57 40.12 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.385 0.674 . . . . 0.79000000000000004 111.28 176.979 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 89.2 t -97.16 136.46 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 125.656 1.582 . . . . 1.23 108.684 173.172 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.4 p -112.74 145.09 41.14 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.547 1.139 . . . . 0.72999999999999998 108.388 174.846 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.453 ' CE2' ' HA ' ' A' ' 125' ' ' THR . 7.8 t80 -144.27 100.13 3.49 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.72 -0.844 . . . . 2.1699999999999999 108.72 -175.618 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -84.69 53.49 2.71 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.951 1.3 . . . . 2.3599999999999999 111.252 -176.985 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -169.65 -173.53 1.66 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.954 1.702 . . . . 3.2799999999999998 108.114 173.512 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.9 mp -78.21 131.72 37.27 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.385 1.074 . . . . 1.76 111.239 171.462 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.423 HD21 ' CD2' ' A' ' 96' ' ' TYR . 24.2 mt -81.19 155.03 72.4 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.051 0.94 . . . . 1.1299999999999999 111.006 172.225 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -61.74 141.72 91.53 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.09 2.527 . . . . 2.2999999999999998 109.401 172.673 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 48.64 27.37 1.47 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.145 1.778 . . . . 2.7400000000000002 113.163 177.064 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.1 tp 56.92 11.55 0.98 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.249 1.02 . . . . 3.2599999999999998 112.397 -172.924 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.587 ' CE1' HG21 ' A' ' 66' ' ' VAL . 18.1 t80 56.66 84.07 0.09 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.269 1.427 . . . . 2.5800000000000001 110.061 179.881 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.3 mtp-105 -78.3 124.4 28.05 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.295 -1.372 . . . . 4.8600000000000003 107.295 -174.043 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -79.94 175.32 10.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.077 0.465 . . . . 3.0800000000000001 110.645 -164.192 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.33 44.49 96.81 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 111.87 -0.492 . . . . 0.69999999999999996 111.87 -176.745 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -143.52 176.62 9.05 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 107.932 -1.136 . . . . 1.8400000000000001 107.932 169.517 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -100.35 145.83 17.41 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 110.514 -1.035 . . . . 0.78000000000000003 110.514 171.271 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.0 pp -149.94 166.31 2.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 105.936 -1.875 . . . . 0.77000000000000002 105.936 177.972 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 18.0 m -126.51 130.62 71.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 108.663 -0.866 . . . . 0.71999999999999997 108.663 170.948 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -117.55 135.19 54.12 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 124.988 1.315 . . . . 0.58999999999999997 109.785 -175.709 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -118.65 141.11 48.91 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.462 1.505 . . . . 3.2000000000000002 109.871 -178.239 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 168.14 -133.8 3.01 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 109.658 -1.377 . . . . 0.85999999999999999 109.658 170.757 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.2 151.83 31.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 117.823 0.811 . . . . 0.69999999999999996 110.865 -166.073 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.751 HD11 HG21 ' A' ' 48' ' ' THR . 4.1 mm? -65.8 144.25 56.97 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.105 -0.498 . . . . 2.27 111.404 175.564 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -119.68 115.57 3.05 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 126.945 2.212 . . . . 3.2400000000000002 108.011 175.324 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 58.91 35.22 24.07 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.399 0.68 . . . . 4.9900000000000002 111.656 169.779 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.476 ' CB ' ' HB2' ' A' ' 56' ' ' ALA . 2.0 t0 36.15 43.81 0.24 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.174 2.19 . . . . 4.9500000000000002 113.137 -170.153 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -159.96 -55.3 0.01 OUTLIER Glycine 0 C--N 1.339 0.709 0 O-C-N 121.648 -0.657 . . . . 1.2 111.79 -174.92 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -84.62 150.44 25.17 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 121.905 -0.762 . . . . 2.8399999999999999 109.107 175.961 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -108.41 113.66 26.89 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 108.784 -0.821 . . . . 2.1699999999999999 108.784 178.989 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -92.16 98.5 11.57 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 107.482 -1.303 . . . . 0.52000000000000002 107.482 178.114 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.52 97.57 3.98 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 112.797 0.666 . . . . 1.3300000000000001 112.797 -168.509 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.453 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 14.9 t -83.38 -26.29 30.58 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 122.825 0.45 . . . . 0.92000000000000004 112.213 -177.831 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -89.67 85.32 6.43 Favored 'General case' 0 CA--C 1.528 0.135 0 O-C-N 120.614 -1.304 . . . . 3.3700000000000001 109.35 -174.755 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.7 m -96.78 130.72 45.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 123.853 0.861 . . . . 0.81000000000000005 111.176 175.978 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -119.67 106.83 12.54 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.859 1.664 . . . . 0.80000000000000004 107.452 178.543 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.87 57.67 4.26 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.673 0.789 . . . . 1.2 111.488 -176.315 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 37.2 pttt -83.38 61.84 6.39 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.897 -0.502 . . . . 3.3900000000000001 111.614 -174.484 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 . . . . . 0 N--CA 1.451 -0.414 0 O-C-N 121.449 -0.782 . . . . 4.71 109.105 178.425 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.467 0.389 0 N-CA-C 112.472 0.545 . . . . 2.5099999999999998 112.472 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.486 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 87.1 m-85 -91.96 102.57 15.14 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 125.376 1.47 . . . . 2.6200000000000001 110.289 177.479 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.713 ' CZ ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -100.49 -169.91 1.79 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.598 0.759 . . . . 8.5099999999999998 111.479 178.524 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 28.2 p -94.43 156.57 38.5 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 118.6 0.637 . . . . 1.79 110.709 -178.357 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.66 -14.7 33.46 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 121.5 1.467 . . . . 1.02 112.368 171.451 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 m -68.32 -25.53 65.17 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.087 -1.008 . . . . 2.0099999999999998 113.102 169.498 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.84 -58.16 8.28 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.901 0.858 . . . . 3.6099999999999999 109.942 -177.099 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.86 HD13 ' H ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -78.82 36.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 C-N-CA 126.651 1.98 . . . . 2.0600000000000001 113.042 -179.078 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 t -121.66 -37.3 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.325 1.05 . . . . 2.7000000000000002 110.901 157.765 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -81.57 -46.69 14.08 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 120.995 -1.066 . . . . 4.1200000000000001 112.781 -167.623 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.8 52.91 0.16 Allowed Glycine 0 C--N 1.336 0.53 0 N-CA-C 110.882 -0.887 . . . . 2.1200000000000001 110.882 -171.882 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -149.28 -162.43 1.56 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.863 2.865 . . . . 2.5499999999999998 106.028 178.159 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.6 m -29.09 -47.81 0.06 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 129.529 3.132 . . . . 1.6100000000000001 116.714 -170.018 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -41.59 -53.1 3.61 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.088 0.858 . . . . 3.1099999999999999 111.052 175.332 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 m -98.0 -23.49 15.76 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.444 -0.798 . . . . 1.3300000000000001 109.831 179.224 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.82 39.38 85.72 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.258 0.933 . . . . 0.97999999999999998 111.659 174.305 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.1 m -87.18 -29.58 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 112.722 0.638 . . . . 1.27 112.722 -171.94 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.6 mttp -118.19 -62.23 0.03 OUTLIER Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 125.358 1.463 . . . . 4.7199999999999998 112.646 178.703 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -81.61 146.33 15.06 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 CA-C-N 121.242 1.479 . . . . 1.1899999999999999 108.606 172.92 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -107.13 158.53 17.01 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.578 -1.267 . . . . 2.79 107.578 170.04 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.1 154.04 35.75 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.362 -0.607 . . . . 1.3500000000000001 109.362 171.608 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.63 -2.67 45.77 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.933 0.777 . . . . 1.1699999999999999 112.781 -178.41 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.525 ' O ' HD12 ' A' ' 116' ' ' LEU . 76.3 mt-30 -95.48 160.61 14.44 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.253 1.027 . . . . 1.49 109.033 178.037 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.8 mtt180 -93.12 138.95 31.08 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.56 -0.533 . . . . 3.7599999999999998 109.56 167.709 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.575 HD12 ' CZ ' ' A' ' 38' ' ' TYR . 30.8 pt -150.59 177.89 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 106.61 -1.626 . . . . 0.66000000000000003 106.61 167.51 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.426 ' HB2' ' CD1' ' A' ' 37' ' ' PHE . 26.0 mtt180 -126.49 142.26 51.59 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.16 -0.681 . . . . 2.46 109.16 169.342 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.3 p -110.72 125.77 68.04 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.069 0 C-N-CA 124.727 1.211 . . . . 0.81000000000000005 108.893 178.879 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -120.35 111.76 2.04 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 110.194 -1.163 . . . . 0.73999999999999999 110.194 -179.803 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.18 -173.71 36.37 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.232 -0.747 . . . . 1.24 111.232 -173.603 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.429 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 4.3 ptp -118.19 137.54 52.93 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 124.308 1.043 . . . . 2.4100000000000001 111.715 -172.508 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.653 HG13 ' CE2' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -61.73 145.37 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 CA-C-N 116.369 -0.378 . . . . 2.6299999999999999 110.474 178.327 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 67' ' ' THR . 31.4 m -69.81 67.91 0.27 Allowed 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 109.207 -0.664 . . . . 3.1899999999999999 109.207 163.653 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.252 13.9 p 20.53 68.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.345 0 C-N-CA 129.812 3.245 . . . . 3.0499999999999998 114.361 161.902 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.69 50.69 1.01 Allowed Glycine 0 CA--C 1.527 0.79 0 CA-C-N 112.421 -2.172 . . . . 1.8799999999999999 110.799 -177.91 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.3 m -117.48 7.59 12.76 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 123.844 0.857 . . . . 1.1599999999999999 112.39 173.819 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 47.7 tpp -74.28 127.52 33.19 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.634 -0.876 . . . . 2.96 108.634 176.983 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.2 m -132.24 149.37 32.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 108.849 -0.797 . . . . 0.64000000000000001 108.849 167.306 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.517 ' CB ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -140.48 141.58 35.39 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.733 0.813 . . . . 5.6600000000000001 110.658 -171.593 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.31 154.37 84.17 Favored Pre-proline 0 N--CA 1.455 -0.192 0 CA-C-N 118.606 0.639 . . . . 2.2400000000000002 109.736 -179.867 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -63.03 -24.36 73.78 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.237 1.958 . . . . 1.3999999999999999 111.784 168.895 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -47.86 -30.83 4.42 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.389 0.676 . . . . 1.3600000000000001 110.731 166.804 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.3 m 63.91 29.82 14.42 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.794 1.238 . . . . 1.25 111.468 176.312 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.03 -48.91 1.47 Allowed 'General case' 0 C--O 1.232 0.135 0 C-N-CA 128.03 2.532 . . . . 2.1000000000000001 110.466 172.078 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -80.17 127.93 32.91 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.155 -1.054 . . . . 1.1299999999999999 108.155 -179.005 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.517 HG12 ' CB ' ' A' ' 73' ' ' ARG . 26.9 m -139.18 151.23 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.421 -1.325 . . . . 1.0700000000000001 107.421 172.033 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -148.95 156.59 42.51 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 122.027 -0.421 . . . . 1.21 110.191 174.798 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -155.89 133.99 11.4 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.116 -0.493 . . . . 1.8700000000000001 110.556 -169.867 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.52 129.4 35.09 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.163 0.585 . . . . 1.05 109.864 174.183 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.2 t -121.01 129.77 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 125.964 1.706 . . . . 1.8400000000000001 107.579 -177.693 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -106.13 172.46 6.8 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.672 0.789 . . . . 2.02 110.814 179.948 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.5 t70 . . . . . 0 N--CA 1.451 -0.416 0 CA-C-O 121.89 0.852 . . . . 3.9300000000000002 110.363 -174.965 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.72 0 CA-C-O 118.875 -0.958 . . . . 1.74 111.59 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -86.72 105.15 16.75 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.059 -1.089 . . . . 2.75 108.059 175.161 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 92' ' ' ILE . 9.3 tp -109.98 156.22 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 108.838 -0.801 . . . . 1.24 108.838 176.763 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.8 mt -109.88 114.76 28.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.307 -1.368 . . . . 0.64000000000000001 107.307 -179.995 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.9 t -92.72 136.75 24.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 106.904 -1.517 . . . . 1.0800000000000001 106.904 173.75 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 80.4 p -116.86 154.74 30.24 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.051 -1.092 . . . . 0.93999999999999995 108.051 179.359 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.541 ' OH ' HG13 ' A' ' 127' ' ' VAL . 0.3 OUTLIER -148.74 145.45 27.63 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 124.634 1.174 . . . . 3.3799999999999999 108.292 -175.556 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -128.58 7.98 5.83 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.373 1.469 . . . . 2.3100000000000001 112.743 -179.574 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -134.45 55.89 1.87 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.701 1.201 . . . . 4.1799999999999997 110.297 176.872 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.0 mp 50.55 -145.69 0.46 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.097 0.959 . . . . 2.4500000000000002 109.979 178.794 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.7 mt -158.03 161.85 28.07 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 127.675 2.39 . . . . 1.4199999999999999 105.037 177.645 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.28 -89.9 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.632 2.888 . . . . 2.0299999999999998 109.901 175.356 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -68.45 19.33 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.562 1.545 . . . . 3.5800000000000001 114.072 -178.713 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 54.92 1.12 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 128.784 2.834 . . . . 2.0099999999999998 115.284 -166.145 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.653 ' CE2' HG13 ' A' ' 66' ' ' VAL . 1.2 t80 51.22 89.53 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.092 1.357 . . . . 3.6699999999999999 110.049 -164.774 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.61 147.13 39.82 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.362 -0.977 . . . . 4.6500000000000004 108.362 -176.304 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -84.68 109.67 18.19 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.85 0.86 . . . . 3.3900000000000001 111.665 -162.822 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.51 45.52 0.26 Allowed Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.58 1.085 . . . . 1.02 110.965 174.063 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -158.17 178.41 10.22 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 106.155 -1.795 . . . . 2.0499999999999998 106.155 177.348 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 65' ' ' MET . . . -127.98 142.26 13.36 Favored Glycine 0 C--N 1.335 0.502 0 CA-C-O 121.296 0.387 . . . . 0.93999999999999995 112.227 173.904 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.5 pp -133.7 164.35 35.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 106.45 -1.685 . . . . 0.82999999999999996 106.45 -172.406 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.486 ' HB ' ' CD1' ' A' ' 37' ' ' PHE . 34.1 m -115.59 124.43 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 108.148 -1.056 . . . . 0.68999999999999995 108.148 -178.348 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.432 ' HB2' HG12 ' A' ' 127' ' ' VAL . . . -119.95 142.41 48.76 Favored 'General case' 0 C--O 1.227 -0.12 0 C-N-CA 125.057 1.343 . . . . 0.65000000000000002 110.048 -167.875 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -139.32 144.55 38.33 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.34 1.056 . . . . 3.9300000000000002 110.531 -176.632 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 176.61 -120.36 0.74 Allowed Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 107.874 -2.09 . . . . 1.04 107.874 169.848 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.7 p -146.38 143.84 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 117.758 0.779 . . . . 0.82999999999999996 109.078 -172.602 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.526 HD11 HG12 ' A' ' 60' ' ' ILE . 4.0 mp -79.56 143.04 35.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 118.848 -0.596 . . . . 2.6800000000000002 109.432 176.377 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -165.49 29.83 0.21 Allowed Glycine 0 CA--C 1.525 0.681 0 C-N-CA 119.882 -1.152 . . . . 2.7799999999999998 113.802 -175.74 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -132.83 1.92 3.66 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.855 0.862 . . . . 5.1900000000000004 111.107 177.566 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.6 t0 53.21 52.7 13.13 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 122.652 1.215 . . . . 3.2599999999999998 109.888 -173.052 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 163.46 -59.36 0.27 Allowed Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.17 -1.172 . . . . 1.47 110.17 -175.302 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.71 170.59 8.24 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.965 0.906 . . . . 2.2599999999999998 110.009 -173.662 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.7 mp -118.82 130.4 55.75 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.778 1.231 . . . . 1.98 108.617 -171.928 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -97.38 99.08 10.52 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.15 -1.426 . . . . 0.53000000000000003 107.15 173.377 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.34 153.73 17.65 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.602 -0.518 . . . . 1.5 109.602 -179.618 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.414 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 9.7 t -135.54 -38.49 0.74 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.14 0.576 . . . . 1.1499999999999999 112.128 174.481 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -91.16 108.8 20.12 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.843 -1.161 . . . . 3.04 108.968 174.835 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.541 HG13 ' OH ' ' A' ' 96' ' ' TYR . 1.0 OUTLIER -113.9 141.19 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 119.003 0.82 . . . . 0.97999999999999998 110.34 169.338 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -120.92 116.92 26.05 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.762 1.225 . . . . 0.93000000000000005 107.949 179.622 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.55 62.16 1.68 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.139 0.975 . . . . 1.27 112.124 -173.872 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.71 53.83 2.83 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.472 0.709 . . . . 4.6600000000000001 112.245 -179.25 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.464 0.271 0 O-C-N 121.711 -0.618 . . . . 4.4500000000000002 109.761 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.9 t . . . . . 0 CA--C 1.532 0.278 0 N-CA-C 109.759 -0.46 . . . . 8.6899999999999995 109.759 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -77.76 125.77 29.84 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.845 -0.798 . . . . 9.0199999999999996 108.845 173.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.1 mp -67.37 172.92 4.38 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.787 0.803 . . . . 5.0599999999999996 110.971 176.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -157.66 111.6 2.57 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 126.085 1.754 . . . . 4.96 108.595 -175.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -151.21 149.1 29.03 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.481 0.713 . . . . 2.23 109.515 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -99.03 126.06 44.65 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.108 1.363 . . . . 2.3799999999999999 110.511 -172.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -133.27 153.98 51.09 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.148 1.379 . . . . 2.75 111.565 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.9 m -73.81 131.31 81.94 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.768 1.627 . . . . 2.1400000000000001 111.307 -177.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -56.04 -52.04 8.21 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.358 2.705 . . . . 0.81999999999999995 112.598 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.6 m -53.97 -35.89 62.29 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.831 0.852 . . . . 3.1400000000000001 112.382 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -62.57 -58.32 7.96 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.434 -0.58 . . . . 2.0899999999999999 109.434 173.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.4 pt -71.76 33.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 114.416 1.265 . . . . 1.3700000000000001 114.416 -177.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.6 t -111.99 -76.41 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 105.579 -2.008 . . . . 2.4100000000000001 105.579 161.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -64.38 101.3 0.42 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 126.633 1.973 . . . . 2.6600000000000001 111.328 -162.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.74 40.1 53.81 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.086 -1.206 . . . . 1.54 110.086 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -139.79 -105.3 0.16 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.279 1.431 . . . . 2.7999999999999998 107.815 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.405 HG23 ' N ' ' A' ' 49' ' ' ASP . 14.8 t -72.28 -53.84 11.28 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 120.0 1.273 . . . . 3.5899999999999999 109.49 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.405 ' N ' HG23 ' A' ' 48' ' ' THR . 0.8 OUTLIER -47.27 -48.69 24.63 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 124.902 1.281 . . . . 3.0800000000000001 109.507 -174.284 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.92 -5.09 42.24 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.137 -1.392 . . . . 1.4399999999999999 111.069 -173.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 48.15 47.44 26.97 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 126.362 1.934 . . . . 1.3200000000000001 114.371 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.7 m -98.64 -52.75 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 118.967 1.384 . . . . 1.21 113.696 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt -101.73 -68.72 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 124.0 0.92 . . . . 3.1200000000000001 112.117 -173.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -71.75 177.08 7.35 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 121.876 1.718 . . . . 1.53 108.56 167.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -155.3 158.48 38.84 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.822 -1.547 . . . . 3.2799999999999998 106.822 -175.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.32 125.02 24.79 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.696 -1.224 . . . . 1.24 107.696 174.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 138.67 -36.82 1.85 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 123.911 0.767 . . . . 1.4199999999999999 111.343 -172.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.93 143.52 29.8 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.086 0.943 . . . . 2.8599999999999999 110.617 -175.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -92.23 129.5 38.16 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.163 0.985 . . . . 5.7199999999999998 108.632 172.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.7 pt -140.43 177.95 3.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 107.495 -1.298 . . . . 0.88 107.495 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -121.13 123.02 41.29 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.241 -0.652 . . . . 3.0499999999999998 109.241 170.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.15 133.4 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 106.916 -1.513 . . . . 0.80000000000000004 106.916 171.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -137.57 120.43 2.06 Favored Glycine 0 CA--C 1.519 0.335 0 N-CA-C 109.422 -1.471 . . . . 0.54000000000000004 109.422 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -179.02 -169.36 39.49 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.243 -1.143 . . . . 0.67000000000000004 110.243 -173.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.9 ptp -102.01 133.16 47.26 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.095 0.558 . . . . 2.3999999999999999 111.076 -173.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.7 p -85.03 134.43 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.856 -0.794 . . . . 2.4199999999999999 108.856 175.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.5 150.0 29.81 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 122.194 0.997 . . . . 2.3500000000000001 108.775 176.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.0 p -48.68 -46.87 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.286 1.034 . . . . 1.8799999999999999 112.003 -175.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.87 21.85 42.63 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 119.283 -0.731 . . . . 1.6399999999999999 113.217 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.7 m -81.96 -36.05 28.38 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.92 1.36 . . . . 2.0099999999999998 113.179 -175.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.1 tmm? -75.96 125.48 29.19 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.595 -0.52 . . . . 1.75 109.595 -169.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.0 m -134.34 123.91 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.912 -0.773 . . . . 0.69999999999999996 108.912 170.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 36.0 ptt85 -100.7 152.79 20.04 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.382 1.073 . . . . 5.1600000000000001 109.8 175.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -77.16 159.38 78.21 Favored Pre-proline 0 C--O 1.238 0.47 0 N-CA-C 109.439 -0.578 . . . . 2.1899999999999999 109.439 167.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -63.89 -26.73 67.04 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.134 2.556 . . . . 1.3899999999999999 111.009 165.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -40.91 -44.91 2.42 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 124.409 1.084 . . . . 1.1599999999999999 109.47 165.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.8 m 73.86 12.17 4.41 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.324 1.45 . . . . 1.53 113.041 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.25 -30.83 6.18 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.5 1.52 . . . . 1.8600000000000001 110.866 168.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -93.45 132.16 37.98 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.599 -1.259 . . . . 1.1200000000000001 107.599 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.78 141.49 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 107.868 -1.16 . . . . 0.83999999999999997 107.868 -174.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -144.34 154.03 42.6 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.654 -0.869 . . . . 0.81000000000000005 108.654 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -146.81 142.96 28.25 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.806 -0.634 . . . . 2.1499999999999999 109.723 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.05 144.86 27.34 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.657 -0.868 . . . . 0.56999999999999995 108.657 168.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.88 145.02 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 108.973 -0.751 . . . . 1.78 108.973 177.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.5 p80 -142.71 -177.34 5.26 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.626 0.77 . . . . 1.3300000000000001 111.012 -169.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -149.02 179.17 8.08 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.339 -0.986 . . . . 2.3500000000000001 108.339 173.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.7 m -54.89 -23.49 18.94 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.11 1.764 . . . . 3.1499999999999999 111.749 175.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 mt -65.51 -5.44 7.92 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.143 0.794 . . . . 5.3099999999999996 113.143 175.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.66 39.83 90.39 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 119.035 0.834 . . . . 3.3300000000000001 111.467 165.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -135.31 143.76 15.47 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 106.252 -2.739 . . . . 1.6200000000000001 106.252 170.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -120.48 129.54 53.9 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.348 -1.353 . . . . 3.23 107.348 -177.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.18 137.98 42.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 106.664 -1.606 . . . . 1.03 106.664 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 mt -90.38 133.2 35.15 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.467 0.707 . . . . 0.56000000000000005 109.451 176.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.6 t -119.28 135.51 59.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 125.168 1.387 . . . . 0.93999999999999995 107.695 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.6 p -112.25 146.68 37.75 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.647 0.779 . . . . 0.63 109.414 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -146.02 136.39 23.93 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.891 1.276 . . . . 1.96 108.267 -171.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -125.18 37.17 4.44 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.821 1.248 . . . . 2.02 112.667 -164.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -158.9 179.44 9.08 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.402 1.881 . . . . 2.8700000000000001 106.245 167.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.3 mp -67.91 128.96 38.45 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 120.708 -1.245 . . . . 1.8899999999999999 110.75 177.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.9 mt -71.1 148.56 94.26 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 123.481 0.712 . . . . 1.1399999999999999 110.836 176.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -62.44 139.16 75.09 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.003 2.469 . . . . 2.4300000000000002 109.173 173.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 50.58 29.01 3.77 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.581 1.152 . . . . 3.2799999999999998 112.119 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 36.8 tp 59.99 6.79 1.0 Allowed 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.043 -1.036 . . . . 3.27 112.359 -174.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.9 t80 59.24 88.67 0.07 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.714 1.606 . . . . 3.21 109.97 -170.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -73.86 136.97 43.47 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 106.776 -1.564 . . . . 4.79 106.776 -174.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.2 mp0 -84.33 168.62 15.46 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 123.165 0.586 . . . . 3.0299999999999998 110.052 -171.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 62.06 47.04 92.63 Favored Glycine 0 CA--C 1.531 1.084 0 O-C-N 121.925 -0.484 . . . . 0.84999999999999998 112.916 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -146.67 177.74 8.85 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.873 1.269 . . . . 2.48 108.644 171.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -117.92 116.63 3.51 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.268 -0.733 . . . . 1.05 111.268 177.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.2 pp -117.95 168.62 9.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 125.45 1.5 . . . . 0.92000000000000004 108.557 -174.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 30.8 m -117.09 139.89 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 108.165 -1.05 . . . . 0.69999999999999996 108.165 166.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.417 ' CB ' HG12 ' A' ' 127' ' ' VAL . . . -126.03 126.13 43.77 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.132 1.373 . . . . 0.56000000000000005 108.569 178.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -98.91 133.97 42.44 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.872 -1.159 . . . . 3.3599999999999999 107.872 175.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -162.34 170.81 38.06 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 110.812 -0.915 . . . . 1.74 110.812 -175.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.4 p -111.87 136.95 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 108.315 -0.994 . . . . 1.1599999999999999 108.315 173.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.626 ' HG ' HD22 ' A' ' 122' ' ' LEU . 6.4 mp -72.1 125.09 26.4 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.073 -1.084 . . . . 2.4500000000000002 108.073 176.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -140.77 -28.52 0.19 Allowed Glycine 0 CA--C 1.526 0.746 0 CA-C-O 119.501 -0.611 . . . . 2.0299999999999998 113.336 -169.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -115.86 49.27 1.12 Allowed 'General case' 0 C--O 1.239 0.525 0 CA-C-N 118.446 1.123 . . . . 5.9900000000000002 108.148 -164.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 40.9 t0 12.16 70.01 0.01 OUTLIER 'General case' 0 C--N 1.341 0.205 0 C-N-CA 130.144 3.378 . . . . 3.0099999999999998 112.161 -177.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 134.52 -36.15 2.12 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 114.574 -1.194 . . . . 1.01 112.097 -172.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.608 ' C ' HD23 ' A' ' 122' ' ' LEU . 0.1 OUTLIER -110.41 155.32 22.35 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 118.178 0.989 . . . . 3.2200000000000002 109.203 174.151 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.626 HD22 ' HG ' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -116.78 130.6 56.82 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 124.648 1.218 . . . . 2.1600000000000001 108.074 -175.736 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -92.08 111.73 23.39 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.505 -1.294 . . . . 0.70999999999999996 107.505 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -126.81 132.62 50.97 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 123.795 0.838 . . . . 1.03 109.525 -176.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.3 t -122.05 -20.52 6.26 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.35 0.66 . . . . 0.77000000000000002 112.114 175.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -96.31 82.74 3.46 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 120.488 -1.383 . . . . 3.73 107.727 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.417 HG12 ' CB ' ' A' ' 112' ' ' ALA . 31.8 m -97.53 125.72 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.281 0.632 . . . . 0.68999999999999995 110.324 173.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -114.78 102.36 9.93 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.742 -1.207 . . . . 0.69999999999999996 107.742 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.05 56.37 3.46 Favored 'General case' 0 CA--C 1.53 0.212 0 O-C-N 121.76 -0.587 . . . . 1.1899999999999999 110.908 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.87 55.39 0.69 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 122.98 0.512 . . . . 4.54 111.251 175.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -82.55 -46.94 12.72 Favored 'General case' 0 C--O 1.228 -0.067 0 O-C-N 121.241 -0.912 . . . . 7.7000000000000002 109.875 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 . . . . . 0 CA--C 1.534 0.353 0 C-N-CA 125.983 1.713 . . . . 6.2699999999999996 111.431 175.363 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 CA--C 1.536 0.423 0 CA-C-O 121.411 0.624 . . . . 5.5700000000000003 111.665 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -103.38 92.39 4.47 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.998 2.119 . . . . 7.5700000000000003 108.07 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.8 mt -142.36 146.3 34.8 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.323 0.649 . . . . 7.04 109.388 178.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -83.02 103.72 12.67 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 107.675 -1.232 . . . . 4.25 107.675 -177.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.29 152.72 20.35 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 123.249 0.619 . . . . 3.2799999999999998 110.717 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -88.37 115.53 25.94 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.147 0.979 . . . . 2.6299999999999999 109.261 -177.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -120.82 155.61 33.7 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.608 1.163 . . . . 3.1499999999999999 109.503 175.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.8 p -85.57 146.85 45.13 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 123.787 0.835 . . . . 1.6599999999999999 110.25 174.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -59.96 -44.23 31.51 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.369 2.713 . . . . 0.67000000000000004 111.85 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 p -39.29 -57.39 1.37 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.548 1.539 . . . . 2.4100000000000001 111.369 174.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.423 ' OE2' ' NZ ' ' A' ' 47' ' ' LYS . 2.4 tt0 -58.09 -54.51 46.19 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.294 -0.866 . . . . 2.2599999999999998 110.1 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.339 26.4 pt -65.28 -12.05 12.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 114.701 1.371 . . . . 1.1699999999999999 114.701 -173.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 82.1 t -75.79 -38.28 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 123.596 0.758 . . . . 1.8999999999999999 111.217 166.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -106.7 92.63 4.18 Favored 'General case' 0 C--N 1.335 -0.06 0 O-C-N 120.999 -1.063 . . . . 2.1699999999999999 111.121 -160.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.81 47.02 58.03 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.907 -1.277 . . . . 1.4299999999999999 109.907 174.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.423 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 12.1 mmtp -156.49 -155.39 0.53 Allowed 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 128.849 2.859 . . . . 2.2000000000000002 105.822 -172.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.2 m -37.07 -55.57 0.94 Allowed 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 127.389 2.276 . . . . 1.6000000000000001 114.319 -174.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -38.48 -46.86 1.21 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.214 0.916 . . . . 2.4100000000000001 112.626 176.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.24 -4.29 25.96 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.495 1.118 . . . . 1.6599999999999999 111.387 -173.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 54.64 30.23 50.73 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.644 1.592 . . . . 0.97999999999999998 113.815 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.7 m -86.1 -29.52 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 118.585 1.193 . . . . 1.6899999999999999 113.124 -172.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -121.41 -71.94 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 124.161 0.984 . . . . 5.9400000000000004 112.084 -176.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -66.08 128.63 19.99 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 N-CA-C 107.472 -1.78 . . . . 1.1499999999999999 107.472 167.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.09 168.8 17.37 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.761 -0.829 . . . . 3.5600000000000001 108.761 169.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.48 175.94 6.55 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.691 -0.855 . . . . 1.6599999999999999 108.691 163.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.99 -87.75 0.47 Allowed Glycine 0 C--O 1.22 -0.749 1 N-CA-C 100.346 -5.102 . . . . 3.29 100.346 -150.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -98.93 169.99 9.05 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 105.619 -1.993 . . . . 1.3300000000000001 105.619 -81.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -84.72 122.13 28.66 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 118.025 -0.988 . . . . 3.2000000000000002 108.69 176.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.6 pt -148.91 175.63 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 107.195 -1.409 . . . . 0.64000000000000001 107.195 171.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -121.02 127.58 51.89 Favored 'General case' 0 CA--C 1.527 0.06 0 N-CA-C 108.824 -0.806 . . . . 1.8 108.824 168.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.2 p -93.46 123.92 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 107.523 -1.288 . . . . 0.85999999999999999 107.523 170.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -124.16 123.57 5.2 Favored Glycine 0 C--N 1.332 0.354 0 N-CA-C 109.862 -1.295 . . . . 0.52000000000000002 109.862 -177.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -174.75 -171.22 38.71 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 110.379 -1.088 . . . . 0.60999999999999999 110.379 -176.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 6.3 ptp -94.35 135.0 36.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.125 -0.695 . . . . 2.4100000000000001 109.125 177.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.445 HG12 ' H ' ' A' ' 68' ' ' VAL . 78.9 t -59.76 133.86 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 123.229 0.612 . . . . 1.9399999999999999 110.27 177.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.88 -9.49 55.05 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.16 1.17 . . . . 3.4700000000000002 114.16 -172.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.445 ' H ' HG12 ' A' ' 66' ' ' VAL 0.28 9.1 p 50.43 47.62 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 123.917 1.818 . . . . 3.25 112.551 175.735 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 178.98 40.48 0.07 OUTLIER Glycine 0 CA--C 1.527 0.811 0 CA-C-N 112.429 -2.169 . . . . 2.5499999999999998 111.919 169.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.4 m -150.41 1.92 0.47 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.89 1.441 . . . . 2.4700000000000002 114.89 175.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.0 tpt -72.69 97.15 2.13 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.922 1.237 . . . . 1.74 108.347 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.9 m -116.69 140.45 39.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.533 -0.914 . . . . 0.56000000000000005 108.533 174.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.22 149.86 50.84 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.268 1.027 . . . . 4.71 109.225 -176.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -75.86 153.92 85.01 Favored Pre-proline 0 N--CA 1.454 -0.23 0 N-CA-C 109.789 -0.449 . . . . 2.23 109.789 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -62.52 -25.56 75.78 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.303 2.002 . . . . 1.4199999999999999 111.055 165.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -44.27 -37.03 3.01 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.824 0.85 . . . . 1.4099999999999999 110.626 165.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.6 m 72.5 24.17 2.95 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.62 1.568 . . . . 1.5 112.489 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.47 -48.25 2.07 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 125.506 1.522 . . . . 2.2000000000000002 110.366 169.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -75.41 130.21 38.6 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.774 -0.825 . . . . 1.3300000000000001 108.774 -177.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.582 HG23 ' HB3' ' A' ' 96' ' ' TYR . 16.6 m -142.44 131.04 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 125.191 1.397 . . . . 0.78000000000000003 107.308 -176.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -139.0 146.57 41.05 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 121.806 -0.559 . . . . 0.90000000000000002 109.537 177.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -149.46 160.61 43.31 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.117 0.567 . . . . 1.8500000000000001 109.782 -168.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -115.52 138.55 50.92 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.42 -0.585 . . . . 0.63 109.42 174.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.9 p -127.3 137.78 56.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.202 -1.036 . . . . 1.96 108.202 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -130.68 174.26 10.1 Favored 'General case' 0 CA--C 1.522 -0.122 0 C-N-CA 124.46 1.104 . . . . 1.6200000000000001 110.309 -175.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -122.47 -13.36 8.03 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.321 0.649 . . . . 2.7400000000000002 109.926 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.78 13.49 7.52 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.19 1.396 . . . . 4.3600000000000003 112.405 -166.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.2 mp -98.0 -34.61 10.74 Favored 'General case' 0 C--N 1.341 0.232 0 N-CA-C 113.076 0.769 . . . . 5.1299999999999999 113.076 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -149.85 -45.14 0.03 OUTLIER Glycine 0 CA--C 1.525 0.709 0 CA-C-N 118.049 0.386 . . . . 3.0899999999999999 112.613 -168.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -177.74 -167.94 36.61 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 108.299 -1.92 . . . . 1.6499999999999999 108.299 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -120.88 151.32 39.81 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.731 1.212 . . . . 3.1099999999999999 109.219 174.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.22 160.01 12.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 107.702 -1.221 . . . . 0.91000000000000003 107.702 173.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.2 mt -118.2 124.42 47.88 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.133 0.973 . . . . 0.96999999999999997 108.729 -172.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.7 t -114.0 138.41 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 125.609 1.564 . . . . 0.87 108.16 -173.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.7 p -112.54 155.07 24.96 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.642 1.177 . . . . 0.52000000000000002 108.603 173.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.582 ' HB3' HG23 ' A' ' 80' ' ' VAL . 1.4 t80 -151.84 132.5 13.98 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.447 -1.686 . . . . 2.98 106.447 175.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -104.15 1.04 30.28 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.175 1.39 . . . . 2.7000000000000002 113.121 -173.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -120.38 166.85 12.98 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 124.931 1.293 . . . . 3.02 108.79 167.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.8 mp -63.06 144.37 56.96 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.765 0.793 . . . . 1.6699999999999999 111.2 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.488 HD23 HG21 ' A' ' 127' ' ' VAL . 8.3 mt -72.25 162.28 74.56 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 124.562 1.145 . . . . 1.1899999999999999 110.146 171.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.21 -95.34 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.853 3.036 . . . . 2.1899999999999999 109.333 173.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -76.15 44.95 0.34 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.524 1.13 . . . . 3.0 111.061 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.4 tp 60.82 -11.12 0.05 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.856 1.663 . . . . 3.1499999999999999 114.87 -177.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 44.7 t80 64.57 88.36 0.1 Allowed 'General case' 0 C--N 1.343 0.288 0 C-N-CA 125.157 1.383 . . . . 2.8599999999999999 107.958 -161.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.62 134.34 38.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.782 -1.562 . . . . 4.1299999999999999 106.782 175.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.5 mp0 -82.05 147.89 28.89 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 123.559 0.744 . . . . 2.7799999999999998 109.729 -171.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.89 47.82 23.7 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 111.671 -0.571 . . . . 0.73999999999999999 111.671 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -138.16 178.37 7.18 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 107.056 -1.461 . . . . 2.3500000000000001 107.056 168.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -105.29 134.19 11.94 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.909 -0.876 . . . . 0.67000000000000004 110.909 171.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.82 160.01 37.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 108.673 -0.862 . . . . 0.62 108.673 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.8 m -116.91 120.54 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 107.873 -1.158 . . . . 0.59999999999999998 107.873 170.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -113.77 115.85 28.45 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.762 1.225 . . . . 0.59999999999999998 109.385 -173.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -116.29 140.58 49.18 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.475 1.11 . . . . 3.6099999999999999 109.809 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -170.35 -104.87 0.18 Allowed Glycine 0 C--N 1.335 0.504 0 N-CA-C 107.408 -2.277 . . . . 1.4199999999999999 107.408 166.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.5 p -156.12 148.47 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 107.339 -1.356 . . . . 0.91000000000000003 107.339 176.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.592 ' HG ' HD12 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -63.29 150.42 43.28 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 119.028 -1.069 . . . . 2.3999999999999999 109.986 175.165 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -105.79 -92.03 2.25 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 110.514 -1.034 . . . . 2.0600000000000001 110.514 -171.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -73.42 -68.81 0.47 Allowed 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.887 -1.523 . . . . 4.6299999999999999 106.887 175.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -163.12 -71.18 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.211 -1.403 . . . . 4.7199999999999998 107.211 164.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.47 -23.57 72.0 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.347 0.975 . . . . 1.3999999999999999 113.184 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -95.58 119.89 34.87 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.221 1.011 . . . . 2.7400000000000002 108.706 173.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.592 HD12 ' HG ' ' A' ' 116' ' ' LEU . 0.1 OUTLIER -98.66 131.22 45.01 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 108.955 -0.757 . . . . 2.3999999999999999 108.955 -176.693 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -89.98 93.74 9.52 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 107.784 -1.191 . . . . 0.60999999999999999 107.784 177.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -99.97 151.76 20.97 Favored 'General case' 0 C--N 1.337 0.065 0 CA-C-N 117.856 0.298 . . . . 1.1399999999999999 110.319 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.7 t -140.12 -44.42 0.42 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 122.933 0.493 . . . . 1.48 111.66 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -82.4 84.43 7.16 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.032 -1.47 . . . . 2.9100000000000001 107.032 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.488 HG21 HD23 ' A' ' 100' ' ' LEU . 4.0 m -96.58 94.73 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.834 1.654 . . . . 1.21 110.274 178.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.57 121.64 35.19 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.81 -0.811 . . . . 0.62 108.81 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.16 62.54 1.81 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.189 0.996 . . . . 1.3 111.41 -174.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.42 -24.14 59.29 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.417 0.895 . . . . 3.9900000000000002 113.417 -172.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -65.23 -23.94 67.21 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 119.073 -0.489 . . . . 5.2400000000000002 112.129 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.0 t70 . . . . . 0 CA--C 1.537 0.474 0 CA-C-N 118.984 0.811 . . . . 7.3200000000000003 109.183 175.059 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.0 p . . . . . 0 N--CA 1.45 -0.462 0 N-CA-C 108.531 -0.915 . . . . 10.33 108.531 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -49.92 -43.71 49.86 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.957 0.799 . . . . 8.4700000000000006 110.943 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.51 -25.13 35.53 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.403 1.081 . . . . 5.9800000000000004 112.906 178.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -151.58 89.06 1.45 Allowed 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.644 1.178 . . . . 3.75 108.171 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.415 HD23 ' H ' ' A' ' 36' ' ' LEU . 1.7 pt? -117.83 158.97 23.86 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.231 0.923 . . . . 2.3599999999999999 112.087 -176.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -84.25 120.54 26.35 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 124.467 1.107 . . . . 2.2200000000000002 109.729 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.92 156.96 41.8 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.607 0.763 . . . . 2.7799999999999998 112.378 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 m -86.6 124.46 69.46 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 126.074 1.75 . . . . 2.27 112.811 -167.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . 2.256 0.1 OUTLIER -6.37 -72.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.151 1 C-N-CA 128.016 5.811 . . . . 1.55 118.345 161.31 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.5 m -70.5 -29.4 65.91 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 113.996 -1.456 . . . . 2.5899999999999999 113.186 -173.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -62.57 -56.44 17.86 Favored 'General case' 0 C--N 1.335 -0.041 0 N-CA-C 108.898 -0.779 . . . . 3.1299999999999999 108.898 -177.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 33.1 pt -59.39 -16.15 9.43 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 114.265 1.209 . . . . 1.6499999999999999 114.265 -174.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.6 t -73.19 -38.39 54.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 124.759 1.224 . . . . 2.0899999999999999 111.071 172.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -104.7 85.89 2.39 Favored 'General case' 0 C--N 1.333 -0.118 0 O-C-N 121.127 -0.983 . . . . 2.0299999999999998 110.783 -159.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.17 51.38 18.18 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.138 -1.185 . . . . 1.3899999999999999 110.138 174.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.9 mmtt -150.18 -124.15 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.423 -1.325 . . . . 2.52 107.423 -171.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.1 m -59.19 -58.45 8.59 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.929 1.292 . . . . 1.53 110.414 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -36.81 -51.84 0.9 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 122.709 1.242 . . . . 3.23 111.12 178.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.83 -11.95 37.81 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 113.577 -1.647 . . . . 1.4399999999999999 111.328 -169.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 54.26 35.37 55.15 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 126.197 1.856 . . . . 1.1799999999999999 112.649 -177.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.8 m -92.92 -22.4 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 118.032 0.916 . . . . 1.3799999999999999 112.715 -174.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.5 mmpp? -124.36 -78.93 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 125.343 1.457 . . . . 4.3399999999999999 111.11 174.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.22 149.47 35.85 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 CA-C-N 120.95 1.375 . . . . 1.1100000000000001 109.375 173.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -112.92 156.46 22.94 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.309 1.844 . . . . 2.6800000000000002 108.675 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.35 160.98 2.77 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.595 0.712 . . . . 1.22 110.958 168.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.77 -12.7 62.83 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 121.705 -0.622 . . . . 1.4099999999999999 112.385 -176.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -82.57 154.69 24.87 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 118.436 1.118 . . . . 2.6000000000000001 109.325 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 74.2 mtt-85 -96.06 132.48 41.38 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.45 -0.944 . . . . 5.1299999999999999 108.45 170.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.6 pt -145.97 177.47 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 105.839 -1.912 . . . . 0.69999999999999996 105.839 165.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 -117.27 135.37 53.87 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 105.973 -1.862 . . . . 1.96 105.973 173.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.4 p -103.84 136.26 37.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 107.361 -1.348 . . . . 1.3 107.361 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.82 120.16 1.59 Allowed Glycine 0 C--N 1.334 0.422 0 N-CA-C 110.777 -0.929 . . . . 0.63 110.777 -176.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -172.15 -163.12 25.51 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 109.309 -1.516 . . . . 0.66000000000000003 109.309 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.2 ptm -102.87 135.0 45.35 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.54 0.736 . . . . 4.1699999999999999 109.511 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 p -98.54 135.32 33.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 109.863 -0.421 . . . . 2.46 109.863 175.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.1 m -68.63 151.72 46.33 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 122.243 1.02 . . . . 2.3599999999999999 108.826 169.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.8 p -61.42 -66.24 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 114.718 -1.128 . . . . 2.4399999999999999 111.218 -174.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -81.86 40.8 2.67 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 120.8 -1.187 . . . . 1.6899999999999999 112.713 -172.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.6 m -108.87 -28.1 9.35 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 117.82 0.81 . . . . 1.55 112.705 -172.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.447 ' SD ' ' HB3' ' A' ' 104' ' ' PHE . 0.8 OUTLIER -79.22 103.11 8.93 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.74 0.7 . . . . 1.8400000000000001 110.087 -175.063 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.6 m -100.27 147.52 7.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 107.811 -1.181 . . . . 0.67000000000000004 107.811 175.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.42 ' CB ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -142.85 137.51 29.65 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.427 0.691 . . . . 6.4199999999999999 109.829 -165.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.19 153.88 94.95 Favored Pre-proline 0 N--CA 1.452 -0.327 0 N-CA-C 109.607 -0.516 . . . . 2.0499999999999998 109.607 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -65.51 -25.63 55.25 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.218 1.946 . . . . 1.54 111.306 165.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -48.94 -29.98 5.4 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.934 0.494 . . . . 1.4199999999999999 110.831 164.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.1 m 67.43 23.68 9.04 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 125.362 1.465 . . . . 1.54 112.114 173.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.38 -44.28 1.72 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 127.875 2.47 . . . . 1.77 110.757 177.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -84.39 129.08 34.9 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 107.692 -1.225 . . . . 1.1799999999999999 107.692 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.42 HG12 ' CB ' ' A' ' 73' ' ' ARG . 20.1 m -147.43 145.72 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.174 -1.417 . . . . 0.71999999999999997 107.174 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -150.65 154.92 38.35 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.599 -0.688 . . . . 1.1100000000000001 111.48 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -155.14 138.0 15.36 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 123.404 0.682 . . . . 1.8700000000000001 111.573 -173.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.622 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . . . -84.04 124.33 30.97 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.296 -0.631 . . . . 0.84999999999999998 109.296 176.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 t -108.4 147.62 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 124.267 1.027 . . . . 1.76 108.835 173.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -144.91 178.92 7.67 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.024 -1.102 . . . . 1.4399999999999999 108.024 177.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -131.59 24.02 4.73 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 122.1 0.952 . . . . 2.8399999999999999 109.711 175.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.2 t 47.84 26.96 1.02 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.243 1.817 . . . . 3.9399999999999999 113.809 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.5 mt -101.6 -67.66 0.85 Allowed 'General case' 0 C--N 1.339 0.111 0 C-N-CA 123.251 0.62 . . . . 4.9100000000000001 110.003 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -171.44 45.04 0.19 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.779 -0.724 . . . . 3.5600000000000001 111.726 -173.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 171.04 157.72 13.56 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 108.582 -1.807 . . . . 1.8100000000000001 108.582 172.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -136.41 145.11 44.92 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.625 -1.991 . . . . 3.2799999999999998 105.625 174.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -126.67 158.28 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.013 -1.847 . . . . 1.3100000000000001 106.013 175.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.622 ' HA ' ' HA ' ' A' ' 83' ' ' ALA 0.442 2.9 mt -107.69 117.49 34.25 Favored 'General case' 0 CA--C 1.545 0.77 1 N-CA-C 123.136 4.495 . . . . 0.90000000000000002 123.136 164.394 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.1 t -86.52 141.29 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 107.331 -1.359 . . . . 0.87 107.331 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.2 p -120.86 149.6 42.35 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.595 1.158 . . . . 0.92000000000000004 107.959 -176.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.41 ' OH ' HG13 ' A' ' 127' ' ' VAL . 0.4 OUTLIER -145.65 142.25 28.88 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.588 1.155 . . . . 3.29 108.031 -176.905 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -115.29 14.33 16.83 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.275 1.43 . . . . 2.54 111.649 171.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -117.69 163.38 16.56 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 124.449 1.1 . . . . 4.71 110.618 170.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.8 mp -67.84 113.14 5.33 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.342 -0.845 . . . . 1.95 109.202 163.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.8 mt -62.18 156.09 61.5 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.067 0.947 . . . . 1.46 110.246 171.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -68.07 147.69 74.0 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 123.651 2.901 . . . . 2.23 110.767 174.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 41.55 49.44 3.63 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.376 1.47 . . . . 2.98 111.629 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 44.89 22.01 0.06 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 127.089 2.156 . . . . 2.29 115.326 -174.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.447 ' HB3' ' SD ' ' A' ' 71' ' ' MET . 67.1 t80 51.0 110.94 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.125 2.17 . . . . 2.52 110.764 -159.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.5 mmt85 -77.75 112.7 14.87 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.251 -1.388 . . . . 5.0700000000000003 107.251 -176.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -82.36 172.75 12.72 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.416 0.627 . . . . 3.3999999999999999 111.005 -170.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 62.26 43.67 98.76 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 121.861 -0.525 . . . . 0.89000000000000001 112.61 171.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -157.16 176.88 12.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.092 1.357 . . . . 2.4700000000000002 108.101 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -93.31 140.37 15.03 Favored Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 109.893 -1.283 . . . . 0.56999999999999995 109.893 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.5 pp -148.01 165.15 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.999 -1.482 . . . . 0.69999999999999996 106.999 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.25 135.89 60.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 108.373 -0.973 . . . . 0.78000000000000003 108.373 174.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.569 ' HB2' HG12 ' A' ' 127' ' ' VAL . . . -128.39 152.87 47.69 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 126.285 1.834 . . . . 0.67000000000000004 110.071 -170.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -147.95 155.13 41.22 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 119.439 1.018 . . . . 2.9199999999999999 113.13 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 175.62 -89.07 0.08 OUTLIER Glycine 0 C--N 1.345 1.054 0 CA-C-O 119.728 -0.485 . . . . 2.1699999999999999 112.473 172.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.7 p -164.24 148.78 2.76 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 C-N-CA 124.351 1.061 . . . . 1.3600000000000001 109.677 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.479 HD22 HD22 ' A' ' 122' ' ' LEU . 5.1 mt -90.91 141.74 28.51 Favored 'General case' 0 N--CA 1.453 -0.275 0 O-C-N 122.087 -0.383 . . . . 2.5699999999999998 110.69 -177.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -131.67 158.28 22.74 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 109.132 -1.587 . . . . 3.6299999999999999 109.132 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 55.52 33.76 21.72 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.934 1.294 . . . . 4.3300000000000001 110.629 169.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 27.25 45.06 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 128.194 2.597 . . . . 4.0599999999999996 112.173 -165.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -176.37 -48.2 0.06 OUTLIER Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.07 -1.062 . . . . 1.4199999999999999 113.487 -164.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -91.66 114.25 26.73 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 118.502 1.151 . . . . 2.6299999999999999 109.001 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.479 HD22 HD22 ' A' ' 116' ' ' LEU . 5.8 mt -87.62 114.47 24.27 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 106.742 -1.577 . . . . 1.8400000000000001 106.742 -174.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -88.04 98.45 11.53 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.325 -1.361 . . . . 0.56000000000000005 107.325 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -101.86 159.17 15.57 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.84 -0.43 . . . . 1.6799999999999999 109.84 -178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.402 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 7.1 t -136.05 -41.76 0.66 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.233 0.613 . . . . 1.1399999999999999 111.787 174.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -92.84 129.84 38.63 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 120.921 -1.112 . . . . 4.1200000000000001 108.367 175.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.569 HG12 ' HB2' ' A' ' 112' ' ' ALA . 1.2 m -127.47 140.07 50.15 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 C-N-CA 124.23 1.012 . . . . 1.0900000000000001 109.37 168.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -114.22 87.48 2.64 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.374 -1.343 . . . . 1.3400000000000001 107.374 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.44 57.35 2.36 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.613 1.165 . . . . 1.1899999999999999 110.952 -174.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -79.02 47.69 0.79 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.272 1.029 . . . . 3.3799999999999999 112.95 -169.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -146.59 52.62 1.11 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.402 1.081 . . . . 4.8899999999999997 110.071 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.0 t0 . . . . . 0 C--O 1.232 0.162 0 N-CA-C 106.098 -1.815 . . . . 7.46 106.098 169.776 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.455 -0.224 0 CA-C-O 120.559 0.218 . . . . 10.09 110.582 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -66.56 138.17 57.29 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 108.157 -1.053 . . . . 8.0299999999999994 108.157 172.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -64.37 -53.09 54.12 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.89 0.852 . . . . 5.1399999999999997 109.231 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -95.66 95.78 8.57 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.814 0.846 . . . . 3.73 108.872 -171.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -138.04 172.27 13.17 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.77 0.828 . . . . 1.99 111.873 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -82.62 121.21 26.53 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.672 1.189 . . . . 2.3100000000000001 110.219 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -128.27 145.36 51.07 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.422 1.089 . . . . 3.3399999999999999 110.872 177.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 91.5 m -69.24 127.5 92.91 Favored Pre-proline 0 N--CA 1.45 -0.437 0 C-N-CA 126.44 1.896 . . . . 1.74 110.115 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -57.57 -41.68 68.76 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.036 1.824 . . . . 1.24 111.995 -175.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.4 m -47.17 -43.02 20.83 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.71 1.141 . . . . 1.9299999999999999 113.39 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -60.74 -40.63 93.14 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.363 -0.606 . . . . 3.52 109.363 178.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 40.5 pt -102.69 35.22 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.867 1.667 . . . . 1.95 111.847 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -114.98 -31.25 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 119.322 0.965 . . . . 2.2400000000000002 111.535 176.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -117.22 126.19 52.36 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.433 1.093 . . . . 3.23 108.112 -175.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.03 -69.9 0.79 Allowed Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.623 1.106 . . . . 4.7999999999999998 111.66 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -30.93 -89.07 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.571 0 C-N-CA 129.639 3.175 . . . . 2.4399999999999999 111.645 175.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.4 m -71.33 -51.0 26.68 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 119.48 1.036 . . . . 1.5700000000000001 109.69 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -33.03 -50.23 0.27 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 128.307 2.643 . . . . 3.1099999999999999 114.707 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.2 m -127.76 15.28 6.96 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.15 2.18 . . . . 3.5600000000000001 109.171 -175.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 51.89 39.22 47.62 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-O 117.382 -1.788 . . . . 1.4299999999999999 113.989 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.2 m -84.42 -45.13 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 121.843 2.822 . . . . 1.1699999999999999 112.421 -169.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -92.76 -57.37 0.23 Allowed Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 125.128 1.371 . . . . 3.3999999999999999 113.383 178.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -75.84 179.88 5.84 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.323 2.016 . . . . 1.5800000000000001 108.418 172.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -135.43 128.14 30.96 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 106.716 -1.587 . . . . 5.6600000000000001 106.716 -176.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.38 125.76 24.92 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.905 -0.776 . . . . 1.3600000000000001 108.905 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.18 -11.46 19.88 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 119.179 -0.789 . . . . 1.1200000000000001 113.021 -175.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -83.4 146.21 28.57 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 119.124 1.462 . . . . 2.5099999999999998 109.332 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -86.91 139.33 30.73 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.79 -0.641 . . . . 4.5199999999999996 109.998 167.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.4 pt -148.7 172.27 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 107.124 -1.436 . . . . 0.80000000000000004 107.124 171.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.6 mtt180 -114.19 110.0 19.29 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 106.825 -1.546 . . . . 1.99 106.825 174.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.3 p -79.26 127.74 38.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.299 -1.371 . . . . 0.93000000000000005 107.299 175.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.54 114.87 1.51 Allowed Glycine 0 C--N 1.335 0.487 0 N-CA-C 110.191 -1.164 . . . . 0.69999999999999996 110.191 -177.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.05 -173.22 29.41 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.154 -1.178 . . . . 0.81000000000000005 110.154 -175.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.1 ptp -101.08 126.64 47.79 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 124.027 0.931 . . . . 2.98 110.234 -176.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 108' ' ' GLN . 29.0 m -89.58 157.51 3.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 109.843 -0.428 . . . . 2.4900000000000002 109.843 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.8 -172.57 2.69 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.591 -0.277 . . . . 3.0800000000000001 110.26 176.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.3 p -116.98 71.98 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 126.937 2.095 . . . . 2.8799999999999999 106.958 174.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.65 63.82 0.09 OUTLIER Glycine 0 CA--C 1.53 0.975 0 C-N-CA 126.671 2.081 . . . . 1.8500000000000001 111.311 -178.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.7 m -146.12 64.55 1.22 Allowed 'General case' 0 CA--C 1.519 -0.238 0 O-C-N 121.243 -1.151 . . . . 2.0499999999999998 110.642 163.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.14 115.81 18.27 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.381 -1.34 . . . . 2.1800000000000002 107.381 176.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.6 m -125.15 127.72 72.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 108.363 -0.977 . . . . 0.69999999999999996 108.363 170.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.47 149.84 29.73 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.444 1.098 . . . . 4.9800000000000004 110.421 175.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -86.58 150.49 51.19 Favored Pre-proline 0 C--O 1.235 0.339 0 N-CA-C 109.002 -0.74 . . . . 1.9399999999999999 109.002 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.45 28.9 0.37 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.89 2.393 . . . . 2.3300000000000001 112.961 173.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -89.44 -27.63 20.26 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.329 1.052 . . . . 1.3799999999999999 108.847 166.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.506 ' O ' HD13 ' A' ' 99' ' ' LEU . 8.5 m 69.95 12.29 7.83 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 125.594 1.558 . . . . 1.7 112.177 -172.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.45 32.04 3.39 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.918 1.287 . . . . 2.3199999999999998 113.36 170.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -153.48 131.86 12.05 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 121.827 -0.545 . . . . 1.1399999999999999 109.927 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.98 146.3 16.26 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 C-N-CA 123.666 0.786 . . . . 1.04 110.409 -172.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -152.74 156.91 40.04 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 120.659 -1.276 . . . . 0.93999999999999995 110.989 175.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -155.44 160.21 40.44 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.257 0.623 . . . . 1.8600000000000001 110.645 -173.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.94 139.34 39.79 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.5 -0.926 . . . . 0.60999999999999999 108.5 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.6 p -125.34 143.76 37.78 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.063 0 N-CA-C 107.87 -1.159 . . . . 1.8700000000000001 107.87 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 56.2 p-80 -124.29 -171.04 2.25 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.63 1.172 . . . . 1.6599999999999999 109.814 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -149.96 177.82 9.5 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 110.244 -0.28 . . . . 2.6600000000000001 110.244 174.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 61.2 m -55.9 -34.49 65.6 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.007 1.323 . . . . 3.9300000000000002 110.278 170.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.5 mt -91.86 32.25 1.14 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.535 0.734 . . . . 5.4699999999999998 111.089 173.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 58.39 36.65 84.86 Favored Glycine 0 C--N 1.34 0.793 0 O-C-N 121.423 -0.798 . . . . 2.7599999999999998 112.993 169.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -79.77 54.06 4.37 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-O 119.04 -0.867 . . . . 2.5800000000000001 113.41 -169.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -66.79 96.15 0.39 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.042 0.921 . . . . 2.8399999999999999 110.213 -173.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.456 HD12 HD12 ' A' ' 122' ' ' LEU . 0.3 OUTLIER -121.84 140.49 45.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 107.828 -1.175 . . . . 1.45 107.828 179.099 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.451 ' H ' HD13 ' A' ' 92' ' ' ILE . 4.2 mt -90.18 124.89 35.22 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.452 1.101 . . . . 0.65000000000000002 110.048 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.1 t -106.0 119.89 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 125.082 1.353 . . . . 0.85999999999999999 107.578 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 65.5 p -98.69 144.06 28.37 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.173 0.589 . . . . 0.59999999999999998 109.668 175.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.406 ' CE2' HD23 ' A' ' 100' ' ' LEU . 1.9 t80 -137.89 143.13 40.71 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.721 1.608 . . . . 2.5299999999999998 107.411 -173.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -85.94 -82.43 0.19 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.132 0.973 . . . . 3.1200000000000001 109.764 175.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -62.29 166.83 4.6 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.455 0.645 . . . . 3.3599999999999999 111.382 -168.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.506 HD13 ' O ' ' A' ' 77' ' ' SER . 1.4 mp -60.66 131.78 51.81 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 119.998 -1.689 . . . . 3.3999999999999999 111.685 175.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.406 HD23 ' CE2' ' A' ' 96' ' ' TYR . 26.7 mt -60.61 158.02 33.72 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 114.559 -1.201 . . . . 1.4399999999999999 109.757 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -67.9 -85.11 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.234 2.623 . . . . 2.29 111.145 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -122.83 52.09 1.37 Allowed 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 124.76 1.224 . . . . 3.0 108.749 -172.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 34.63 41.75 0.06 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.73 1.612 . . . . 3.6800000000000002 113.096 -173.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 40.7 p90 31.48 74.56 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.34 1.856 . . . . 4.0800000000000001 112.151 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.488 ' H ' ' HD3' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -60.29 125.36 23.39 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 119.854 -1.779 . . . . 6.9699999999999998 110.177 -124.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -72.19 143.74 48.77 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 119.826 -0.749 . . . . 4.8099999999999996 109.882 -153.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.14 22.22 23.2 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.675 1.607 . . . . 1.46 113.591 -172.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.452 ' O ' HG22 ' A' ' 66' ' ' VAL . 2.2 pt20 -137.43 178.68 6.91 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 119.519 1.66 . . . . 3.1600000000000001 110.604 178.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -92.71 128.1 9.27 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.997 -0.441 . . . . 1.0800000000000001 111.997 170.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.3 pp -131.18 159.85 42.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 124.901 1.28 . . . . 0.69999999999999996 107.915 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.1 m -113.82 140.25 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.67 -1.233 . . . . 1.02 107.67 175.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -129.68 123.5 31.31 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.063 0.945 . . . . 0.72999999999999998 109.606 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.549 ' HB2' ' HB2' ' A' ' 126' ' ' GLU . 3.8 mt-30 -107.24 136.68 46.66 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 126.065 1.746 . . . . 4.0899999999999999 109.855 -175.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 168.69 -142.4 7.38 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 108.745 -1.742 . . . . 0.91000000000000003 108.745 172.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.4 p -123.97 153.0 29.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 C-N-CA 124.507 1.123 . . . . 1.22 109.949 -170.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -54.59 137.95 42.2 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.373 -0.531 . . . . 1.97 110.507 168.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -86.89 -146.45 10.23 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 109.716 -1.354 . . . . 2.3599999999999999 109.716 175.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -72.34 109.08 5.81 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.408 -1.701 . . . . 5.4100000000000001 106.408 172.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -6.17 72.56 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.347 1 C-N-CA 132.678 4.391 . . . . 3.6499999999999999 112.835 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 154.41 -45.74 0.55 Allowed Glycine 0 CA--C 1.523 0.534 0 CA-C-N 113.679 -1.601 . . . . 1.1599999999999999 111.381 -172.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.92 163.76 13.37 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.509 0.654 . . . . 2.73 111.576 177.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.456 HD12 HD12 ' A' ' 92' ' ' ILE . 11.8 mt -123.11 130.27 52.56 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.627 1.171 . . . . 1.9199999999999999 108.387 176.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -103.75 106.24 16.69 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 108.38 -0.97 . . . . 0.75 108.38 176.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -131.86 126.14 33.51 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 123.075 0.55 . . . . 1.1799999999999999 110.95 -176.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.9 t -113.67 -24.41 9.21 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.407 1.083 . . . . 1.1699999999999999 111.367 178.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 113' ' ' GLN . 36.7 mt-10 -86.62 78.79 9.09 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 119.662 -1.898 . . . . 3.4300000000000002 108.141 178.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.427 ' C ' HD13 ' A' ' 128' ' ' LEU . 34.0 m -91.9 130.88 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 119.333 0.97 . . . . 0.85999999999999999 110.959 174.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.427 HD13 ' C ' ' A' ' 127' ' ' VAL . 0.0 OUTLIER -126.37 127.67 45.86 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.213 -1.032 . . . . 1.2 108.213 178.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.14 97.41 9.18 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.236 1.414 . . . . 1.3100000000000001 108.972 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.1 pttt -93.5 23.9 4.31 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.456 0.702 . . . . 3.8100000000000001 112.096 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -129.16 105.51 8.21 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.262 1.425 . . . . 4.4100000000000001 107.272 173.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 N--CA 1.456 -0.145 0 C-N-CA 123.719 0.808 . . . . 5.8700000000000001 109.895 174.049 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.8 p . . . . . 0 CA--C 1.531 0.238 0 N-CA-C 109.774 -0.454 . . . . 8.5 109.774 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -90.12 134.22 34.4 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 108.407 -0.96 . . . . 8.1899999999999995 108.407 173.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.38 -52.72 0.31 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.715 0.406 . . . . 7.8399999999999999 110.588 -177.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -158.73 136.83 10.59 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.294 -0.86 . . . . 3.9399999999999999 109.966 171.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.04 155.93 42.05 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 120.545 1.52 . . . . 2.1699999999999999 112.438 -175.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -86.19 117.73 25.2 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 125.374 1.47 . . . . 2.21 111.436 -174.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -116.89 151.64 36.16 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 127.207 2.203 . . . . 3.4100000000000001 109.519 -175.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 57.8 m -90.54 136.43 28.18 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.27 1.428 . . . . 1.8400000000000001 109.611 -175.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -61.98 -48.32 8.74 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.025 2.483 . . . . 0.73999999999999999 112.879 -174.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 p -53.75 -36.06 61.94 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.973 0.806 . . . . 1.96 111.948 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -54.74 -57.67 10.6 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.316 1.046 . . . . 2.4199999999999999 109.098 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.306 8.3 pt -70.0 1.68 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 114.352 1.242 . . . . 1.1899999999999999 114.352 -172.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.4 t -85.64 -28.73 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.8 1.24 . . . . 2.1099999999999999 111.09 170.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -128.57 93.54 3.66 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.964 -1.085 . . . . 2.2000000000000002 112.344 -160.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.45 37.75 53.15 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.516 -1.034 . . . . 1.3300000000000001 110.516 176.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.4 -153.87 0.5 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.786 2.834 . . . . 2.6600000000000001 103.371 178.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.2 m -28.97 -58.16 0.14 Allowed 'General case' 0 C--N 1.339 0.118 0 C-N-CA 126.905 2.082 . . . . 1.3500000000000001 115.444 -172.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -44.48 -47.84 10.05 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.586 0.754 . . . . 2.5800000000000001 112.272 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.6 m -93.51 -23.59 18.3 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.757 0.823 . . . . 1.3600000000000001 111.409 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.95 35.6 84.7 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.984 1.278 . . . . 0.98999999999999999 112.381 176.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.7 m -82.08 -39.45 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 117.525 0.662 . . . . 1.25 111.816 -175.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -105.81 -63.03 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 124.482 1.113 . . . . 4.0999999999999996 111.116 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -80.93 142.16 13.71 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 CA-C-N 121.07 1.418 . . . . 1.2 109.369 171.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -90.53 154.35 19.69 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.279 1.031 . . . . 2.8500000000000001 109.484 167.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.58 140.73 49.93 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.114 -1.069 . . . . 1.53 108.114 169.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 105.51 16.84 14.8 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.073 0.844 . . . . 1.23 113.36 -176.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -112.73 154.38 26.25 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.746 1.219 . . . . 1.3999999999999999 109.785 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.41 ' NH1' ' OE2' ' A' ' 126' ' ' GLU . 0.3 OUTLIER -84.84 127.45 34.15 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.868 0.867 . . . . 4.5499999999999998 109.085 173.11 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.9 pt -144.52 177.78 1.85 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 106.554 -1.647 . . . . 0.70999999999999996 106.554 166.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.3 mtm180 -122.77 122.67 39.28 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.754 -1.202 . . . . 2.2599999999999998 107.754 173.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.1 p -87.75 132.98 31.6 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 N-CA-C 107.282 -1.377 . . . . 0.94999999999999996 107.282 173.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -135.75 120.63 2.31 Favored Glycine 0 C--N 1.334 0.421 0 N-CA-C 109.89 -1.284 . . . . 0.70999999999999996 109.89 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.39 -166.32 31.55 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.314 -1.115 . . . . 0.81999999999999995 110.314 -175.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.16 130.83 51.91 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.168 0.508 . . . . 2.9900000000000002 111.462 -174.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.6 t -76.29 130.65 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 124.267 1.027 . . . . 2.1699999999999999 108.527 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.621 HG22 HG12 ' A' ' 68' ' ' VAL . 12.6 m -49.27 -85.43 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.294 1.838 . . . . 2.9100000000000001 114.581 -170.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.621 HG12 HG22 ' A' ' 67' ' ' THR . 9.1 p 174.45 -40.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 126.093 1.757 . . . . 2.0899999999999999 109.276 -171.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -151.8 38.2 0.81 Allowed Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.214 -1.155 . . . . 1.8100000000000001 110.214 175.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 57.1 m -94.74 -8.61 37.16 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 117.923 0.861 . . . . 1.03 112.221 178.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 52.8 tpp -65.52 128.89 37.75 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.794 -0.817 . . . . 2.5800000000000001 108.794 172.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.5 m -127.43 141.79 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 N-CA-C 107.425 -1.324 . . . . 0.62 107.425 164.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.76 135.13 48.77 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.43 -0.952 . . . . 4.79 108.43 -172.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -82.27 152.4 67.67 Favored Pre-proline 0 C--O 1.235 0.298 0 N-CA-C 109.851 -0.426 . . . . 2.1099999999999999 109.851 -176.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -70.97 3.87 3.07 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.114 2.543 . . . . 1.49 112.346 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -70.81 -33.65 70.93 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.503 -0.554 . . . . 1.27 109.503 168.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.1 m 73.63 9.51 4.93 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.405 1.482 . . . . 1.2 113.452 -173.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.27 16.56 9.08 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.583 1.553 . . . . 1.7 111.323 172.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -143.79 125.96 15.54 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.178 -1.045 . . . . 1.23 108.178 -177.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.08 140.16 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.993 1.317 . . . . 1.05 107.712 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -140.32 153.82 46.57 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.879 -0.513 . . . . 0.94999999999999996 109.813 172.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -153.27 146.19 24.47 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.43 -0.35 . . . . 2.0 110.808 -170.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.3 125.66 39.08 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.382 -0.599 . . . . 0.67000000000000004 109.382 175.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.3 t -106.65 132.72 53.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 107.063 -1.458 . . . . 1.78 107.063 176.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -115.53 -178.28 3.35 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.236 0.614 . . . . 1.8799999999999999 111.329 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -128.79 172.53 11.19 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 124.101 0.96 . . . . 3.5800000000000001 110.98 177.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 59.5 m -47.32 -43.87 23.12 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.64 1.176 . . . . 3.7799999999999998 110.869 156.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.9 mt -74.41 10.15 1.42 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.229 0.826 . . . . 4.6600000000000001 113.229 175.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.94 -49.65 3.76 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 120.002 1.274 . . . . 4.4699999999999998 112.025 172.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -44.41 119.7 3.09 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 125.531 1.539 . . . . 1.6599999999999999 110.658 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -115.75 150.5 36.78 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.237 1.015 . . . . 2.7999999999999998 110.413 -174.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.49 152.95 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 107.967 -1.123 . . . . 0.94999999999999996 107.967 178.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.0 mt -100.58 121.77 42.15 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.312 -0.996 . . . . 0.52000000000000002 108.312 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.7 t -107.09 133.34 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 107.437 -1.32 . . . . 0.85999999999999999 107.437 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 82.2 p -107.46 149.49 27.88 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.531 -0.915 . . . . 0.56999999999999995 108.531 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.548 ' CD2' HD21 ' A' ' 100' ' ' LEU . 11.2 t80 -146.65 126.9 13.87 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.026 -1.101 . . . . 2.4399999999999999 108.026 -173.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -113.85 46.62 1.29 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.003 1.321 . . . . 2.0600000000000001 111.745 -165.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -166.75 -179.64 4.9 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.847 2.059 . . . . 3.3599999999999999 106.286 169.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.4 mp -67.68 131.38 45.47 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.399 1.0 . . . . 1.8700000000000001 111.145 172.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.548 HD21 ' CD2' ' A' ' 96' ' ' TYR . 16.2 mt -83.55 155.29 65.8 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.485 1.114 . . . . 1.6299999999999999 110.579 174.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.62 112.44 2.4 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.954 2.436 . . . . 2.8500000000000001 109.538 175.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 39.74 47.7 1.81 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.011 1.724 . . . . 5.8300000000000001 111.504 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 48.76 13.52 0.06 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 127.782 2.433 . . . . 3.3799999999999999 116.374 -178.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 51.49 114.29 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 122.226 1.012 . . . . 4.6399999999999997 109.987 -148.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -74.16 100.63 3.71 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 104.837 -2.282 . . . . 5.25 104.837 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -71.94 157.55 37.63 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 119.776 -0.77 . . . . 5.0800000000000001 110.965 -148.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.09 37.87 6.6 Favored Glycine 0 CA--C 1.531 1.09 0 N-CA-C 110.608 -0.997 . . . . 0.89000000000000001 110.608 -167.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -138.2 162.21 34.85 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.773 1.229 . . . . 2.6600000000000001 108.896 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -102.3 129.79 10.01 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 110.476 -1.05 . . . . 0.85999999999999999 110.476 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.5 pp -140.56 161.22 24.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 108.208 -1.034 . . . . 0.87 108.208 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.3 m -114.45 141.66 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.091 -1.078 . . . . 1.0800000000000001 108.091 174.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -127.34 116.9 21.21 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.602 1.161 . . . . 0.77000000000000002 108.7 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -101.12 149.38 24.02 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.135 -0.691 . . . . 3.8799999999999999 109.135 175.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 162.11 -140.84 6.83 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 107.451 -2.26 . . . . 0.82999999999999996 107.451 173.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.5 p -136.04 142.94 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 118.084 0.942 . . . . 0.76000000000000001 109.996 -164.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.86 162.32 29.64 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.456 -0.793 . . . . 2.0299999999999998 109.99 173.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -169.73 -52.35 0.03 OUTLIER Glycine 0 C--N 1.332 0.351 0 C-N-CA 119.951 -1.119 . . . . 2.1899999999999999 111.726 166.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -67.0 141.25 57.65 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.55 -0.908 . . . . 4.3700000000000001 108.55 174.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.08 64.8 0.54 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 128.651 2.78 . . . . 4.46 110.299 -171.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 128.51 8.22 4.04 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.635 2.064 . . . . 1.1699999999999999 113.368 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.16 153.9 51.82 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.539 1.67 . . . . 2.3100000000000001 109.885 177.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.3 mp -121.69 134.7 54.96 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.348 1.059 . . . . 2.0499999999999998 109.714 -166.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.68 101.3 12.15 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.388 -1.338 . . . . 0.52000000000000002 107.388 177.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -127.52 83.27 2.15 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 112.211 0.449 . . . . 1.72 112.211 -166.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.485 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 14.6 t -83.01 -22.25 33.66 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.959 0.726 . . . . 0.84999999999999998 112.959 -174.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.41 ' OE2' ' NH1' ' A' ' 59' ' ' ARG . 20.6 mt-10 -83.5 75.11 10.04 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 120.445 -1.409 . . . . 4.4800000000000004 107.981 -176.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.0 m -92.33 131.16 40.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 O-C-N 121.527 -0.733 . . . . 1.1399999999999999 111.534 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.28 124.33 44.35 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.031 -1.47 . . . . 1.02 107.031 176.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -94.31 124.8 38.56 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.258 -1.016 . . . . 2.3900000000000001 108.258 175.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -153.56 58.14 0.75 Allowed 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.594 0.758 . . . . 4.2300000000000004 109.92 -176.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -105.78 90.48 3.4 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.229 1.412 . . . . 6.7199999999999998 107.932 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.4 t70 . . . . . 0 CA--C 1.535 0.378 0 C-N-CA 124.392 1.077 . . . . 7.46 110.788 179.088 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.0 m . . . . . 0 CA--C 1.534 0.361 0 CA-C-O 120.871 0.367 . . . . 8.0500000000000007 111.984 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.04 123.53 14.72 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 108.873 -0.788 . . . . 8.0500000000000007 108.873 169.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.7 mp -67.49 143.94 55.94 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.694 -0.854 . . . . 5.6399999999999997 108.694 168.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -151.88 109.88 3.69 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 106.998 -1.482 . . . . 4.1399999999999997 106.998 -175.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -144.43 162.34 36.74 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.434 1.016 . . . . 2.21 111.361 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.435 ' CE1' ' HD2' ' A' ' 61' ' ' ARG . 80.0 m-85 -83.83 123.15 29.61 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.106 1.362 . . . . 2.2400000000000002 110.954 -175.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.03 156.03 43.39 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.393 1.477 . . . . 2.9199999999999999 110.954 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.3 139.58 52.25 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 123.125 0.57 . . . . 2.48 111.311 -175.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.38 -35.0 99.18 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.63 2.22 . . . . 0.82999999999999996 113.45 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -57.19 -29.31 63.58 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 119.988 1.267 . . . . 3.02 112.056 176.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -67.55 -56.98 7.33 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.244 -1.021 . . . . 2.3199999999999998 108.244 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.0 pt -74.17 36.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.025 1.33 . . . . 1.1399999999999999 113.175 -174.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 43.1 t -123.38 -68.68 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 105.757 -1.942 . . . . 2.04 105.757 168.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -79.0 102.5 8.37 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.266 1.826 . . . . 2.2599999999999998 110.728 -164.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.9 32.89 74.01 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.408 -1.077 . . . . 1.5700000000000001 110.408 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -140.32 -110.83 0.15 Allowed 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 126.44 1.896 . . . . 2.75 108.341 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.44 HG23 HD12 ' A' ' 116' ' ' LEU . 29.6 m -73.83 -56.68 4.67 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 119.147 0.885 . . . . 1.53 112.177 -172.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -58.55 -46.89 85.91 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 122.135 0.969 . . . . 2.8500000000000001 109.068 -174.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -68.16 -35.9 78.79 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.8 -0.637 . . . . 1.3999999999999999 112.345 173.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.29 47.68 42.63 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.977 1.275 . . . . 1.3799999999999999 111.882 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.251 32.6 m -112.89 -70.39 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 113.984 1.105 . . . . 1.6499999999999999 113.984 -174.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.7 mttt -73.14 -62.22 1.31 Allowed Pre-proline 0 CA--C 1.535 0.403 0 O-C-N 121.4 -0.813 . . . . 4.8399999999999999 112.101 -172.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.36 111.65 2.64 Favored 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 121.867 1.711 . . . . 1.1000000000000001 107.684 175.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -62.03 148.68 43.24 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.101 -0.703 . . . . 3.2599999999999998 109.101 172.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.61 162.68 10.15 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.842 -0.617 . . . . 1.21 110.409 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.91 14.37 82.24 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 119.672 -0.516 . . . . 1.02 113.387 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -93.75 158.94 15.42 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-N 118.284 1.042 . . . . 1.46 109.433 172.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -98.38 135.37 40.07 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.448 0.699 . . . . 4.9100000000000001 110.425 174.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.2 pt -150.53 178.47 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 125.821 1.649 . . . . 0.72999999999999998 106.798 174.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.435 ' HD2' ' CE1' ' A' ' 37' ' ' PHE . 13.5 mtt180 -123.52 131.96 53.78 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.682 -1.229 . . . . 1.8899999999999999 107.682 165.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.2 p -92.07 140.75 15.62 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.08 0 N-CA-C 107.359 -1.348 . . . . 0.93000000000000005 107.359 171.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.19 124.37 2.41 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.002 -1.239 . . . . 0.62 110.002 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -169.3 -163.53 23.49 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 108.622 -1.791 . . . . 0.69999999999999996 108.622 -175.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.71 139.43 38.97 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 117.358 0.579 . . . . 2.8500000000000001 109.585 -178.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.5 m -94.24 148.98 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 110.229 -0.286 . . . . 2.3900000000000001 110.229 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.9 m -84.61 146.34 27.55 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.255 1.022 . . . . 2.3100000000000001 109.17 175.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.1 p -49.74 -57.43 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.489 1.516 . . . . 2.0600000000000001 111.44 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.75 71.96 0.49 Allowed Glycine 0 CA--C 1.522 0.521 0 N-CA-C 109.386 -1.486 . . . . 1.5700000000000001 109.386 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.6 m -153.01 48.38 0.71 Allowed 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 117.738 0.769 . . . . 2.3999999999999999 111.936 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.1 ttp -141.08 132.7 27.13 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.589 -1.634 . . . . 2.3799999999999999 106.589 168.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.7 m -135.51 144.28 34.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 107.334 -1.358 . . . . 0.78000000000000003 107.334 173.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -127.46 149.92 49.89 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 123.974 0.91 . . . . 4.2800000000000002 110.541 -174.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.59 154.25 83.61 Favored Pre-proline 0 N--CA 1.451 -0.403 0 N-CA-C 109.93 -0.396 . . . . 2.9399999999999999 109.93 175.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -65.32 -24.03 58.27 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.445 2.097 . . . . 1.48 111.601 167.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -47.56 -28.81 2.45 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.509 0.724 . . . . 1.6599999999999999 110.735 165.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.3 m 64.84 25.98 12.89 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 125.081 1.352 . . . . 1.1599999999999999 111.472 175.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.24 -46.23 1.36 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.758 2.423 . . . . 1.8600000000000001 111.127 176.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -83.29 136.35 34.41 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.628 -0.879 . . . . 1.3700000000000001 108.628 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.653 HG21 ' HG ' ' A' ' 100' ' ' LEU . 19.7 m -147.25 143.54 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 107.068 -1.456 . . . . 0.77000000000000002 107.068 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -144.05 154.62 43.43 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.22 -0.659 . . . . 0.88 109.22 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -148.35 151.62 35.65 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.761 -0.654 . . . . 1.8500000000000001 109.887 -173.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.81 142.01 30.88 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.049 -1.093 . . . . 0.72999999999999998 108.049 171.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.0 p -130.38 149.59 33.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 107.112 -1.44 . . . . 1.8899999999999999 107.112 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -130.46 167.22 18.98 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.4 0.619 . . . . 1.55 109.546 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -96.94 177.47 5.6 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.779 -1.1 . . . . 3.6800000000000002 109.028 -177.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.5 m -59.32 -38.86 81.36 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.895 -0.78 . . . . 4.1500000000000004 108.895 163.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.5 mp -93.74 -87.72 0.24 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 109.74 -0.467 . . . . 4.3899999999999997 109.74 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -113.86 -89.74 1.75 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.525 -1.03 . . . . 3.9399999999999999 110.525 -177.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.18 -76.16 0.34 Allowed Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.14 -0.784 . . . . 3.1299999999999999 111.14 -172.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 35.64 58.05 0.89 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.298 1.839 . . . . 4.25 111.317 -176.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -112.24 157.06 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 124.464 1.106 . . . . 1.5 109.087 -169.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.3 mt -118.44 125.6 50.3 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.832 0.853 . . . . 0.67000000000000004 109.49 -173.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 75.7 t -114.26 133.28 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.791 1.236 . . . . 0.91000000000000003 107.954 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 61.3 p -108.79 155.47 20.74 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.497 1.119 . . . . 0.45000000000000001 110.204 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.643 ' HB3' HG23 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -153.48 136.85 15.79 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.504 -1.295 . . . . 1.97 107.504 -174.431 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.8 p-10 -128.94 49.87 2.19 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.564 1.545 . . . . 2.2200000000000002 112.57 -172.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -171.72 52.43 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.982 0.913 . . . . 2.9900000000000002 111.533 178.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.9 mp 52.69 -147.41 0.47 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.877 1.271 . . . . 2.0099999999999998 110.417 -172.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.653 ' HG ' HG21 ' A' ' 80' ' ' VAL . 13.7 mt -150.28 158.16 36.52 Favored Pre-proline 0 N--CA 1.454 -0.226 0 N-CA-C 105.811 -1.922 . . . . 1.47 105.811 -176.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -71.27 -94.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.433 2.755 . . . . 2.0 107.923 172.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -77.4 38.17 0.23 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.554 1.142 . . . . 3.7799999999999998 110.306 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 19.8 tp 52.37 23.19 2.34 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.825 -1.172 . . . . 2.8599999999999999 112.716 -177.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 76.9 t80 53.9 84.05 0.07 Allowed 'General case' 0 N--CA 1.465 0.283 0 O-C-N 120.618 -1.301 . . . . 2.8700000000000001 109.076 -171.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -75.86 123.14 25.18 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.94 -1.133 . . . . 5.3799999999999999 107.94 -171.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -84.17 156.26 22.16 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 126.046 1.739 . . . . 3.6800000000000002 110.482 -169.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.49 33.3 43.85 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 123.757 0.694 . . . . 0.97999999999999998 112.267 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -156.08 178.9 9.75 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.802 1.241 . . . . 2.9900000000000002 108.138 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -85.43 147.64 22.41 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.685 -0.966 . . . . 0.83999999999999997 110.685 166.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.9 pp -140.23 162.5 24.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 105.618 -1.993 . . . . 0.70999999999999996 105.618 166.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.3 m -125.0 135.27 64.62 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.132 0 N-CA-C 109.055 -0.72 . . . . 0.80000000000000004 109.055 173.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -122.84 125.73 45.98 Favored 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 124.842 1.257 . . . . 0.56999999999999995 109.919 -170.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -115.83 143.58 45.21 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.958 1.303 . . . . 3.8900000000000001 110.126 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 168.79 -131.4 2.29 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 107.576 -2.21 . . . . 0.92000000000000004 107.576 173.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.8 p -128.17 150.03 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 124.701 1.2 . . . . 1.03 109.752 -171.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.44 HD12 HG23 ' A' ' 48' ' ' THR . 4.1 mm? -55.89 143.44 31.65 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.161 -0.681 . . . . 1.98 109.161 170.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.69 -150.62 10.6 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.208 -1.157 . . . . 2.3599999999999999 110.208 -178.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -63.14 -67.15 0.45 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.264 0.625 . . . . 5.2999999999999998 110.021 -174.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -166.45 98.62 0.59 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.759 -1.571 . . . . 3.7000000000000002 106.759 -178.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 109.59 -41.27 2.28 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.378 0.99 . . . . 1.1499999999999999 111.199 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -82.79 161.73 21.91 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.252 1.021 . . . . 2.8500000000000001 110.662 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 mp -128.56 140.05 51.99 Favored 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 124.25 1.02 . . . . 2.25 108.3 174.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -107.9 108.96 20.35 Favored 'General case' 0 CA--C 1.527 0.083 0 N-CA-C 107.924 -1.139 . . . . 0.83999999999999997 107.924 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -134.82 109.33 8.46 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.274 0.488 . . . . 1.3200000000000001 111.705 -171.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.7 t -96.66 -34.24 11.46 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.957 0.903 . . . . 0.92000000000000004 111.656 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.3 mp0 -83.45 89.96 7.13 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 119.863 -1.773 . . . . 3.46 108.168 175.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.4 m -96.89 124.68 49.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 123.446 0.698 . . . . 0.78000000000000003 109.743 171.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -115.68 110.71 19.53 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.02 1.328 . . . . 0.71999999999999997 107.797 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.47 61.4 6.57 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.121 0.968 . . . . 1.28 110.62 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -22.72 67.05 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.712 1.004 . . . . 2.7400000000000002 113.712 -173.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -105.9 57.34 0.66 Allowed 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.846 0.858 . . . . 5.5800000000000001 110.113 -177.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.0 t0 . . . . . 0 N--CA 1.449 -0.486 0 N-CA-C 108.06 -1.089 . . . . 7.3799999999999999 108.06 174.621 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 CA--C 1.53 0.207 0 N-CA-C 108.653 -0.869 . . . . 6.3200000000000003 108.653 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 -128.2 129.45 46.48 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 125.241 1.416 . . . . 7.9699999999999998 107.506 169.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -72.95 -40.36 65.44 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 122.72 0.408 . . . . 8.1300000000000008 111.18 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -159.47 156.0 27.51 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.026 1.73 . . . . 4.1799999999999997 107.215 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -163.96 149.67 10.96 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.396 1.078 . . . . 2.7000000000000002 108.924 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -88.7 131.79 34.87 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.696 0.798 . . . . 2.04 109.619 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -138.34 155.77 48.25 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.003 1.321 . . . . 2.6299999999999999 110.833 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.2 m -80.57 131.16 62.04 Favored Pre-proline 0 N--CA 1.447 -0.621 0 C-N-CA 125.53 1.532 . . . . 1.77 111.048 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -57.02 -46.47 28.77 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 123.026 2.484 . . . . 0.68000000000000005 112.328 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.7 t -54.41 -32.86 58.2 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 122.865 0.466 . . . . 2.4700000000000002 111.419 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.27 -58.5 8.23 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.55 -0.908 . . . . 3.0899999999999999 108.55 172.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.259 30.7 pt -73.19 28.8 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 114.017 1.118 . . . . 1.1699999999999999 114.017 -172.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -118.62 -27.53 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.508 1.123 . . . . 2.1499999999999999 111.986 160.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 -83.95 -68.62 0.7 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.599 1.09 . . . . 2.4700000000000002 112.389 -163.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.02 54.25 0.59 Allowed Glycine 0 C--N 1.333 0.408 0 N-CA-C 108.668 -1.773 . . . . 1.5700000000000001 108.668 -174.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -148.98 -109.64 0.07 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.641 1.976 . . . . 2.9700000000000002 107.082 -167.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.448 HG23 ' CD2' ' A' ' 116' ' ' LEU . 41.0 m -67.59 -65.44 0.69 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.542 1.137 . . . . 1.3999999999999999 111.587 -173.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -49.59 -51.07 39.81 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.816 0.817 . . . . 2.5699999999999998 110.444 -172.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.79 -24.09 61.68 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.141 1.376 . . . . 1.6000000000000001 112.661 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.1 39.81 97.64 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.463 1.506 . . . . 1.3400000000000001 112.786 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.8 m -97.96 -35.32 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 117.986 0.893 . . . . 1.75 113.054 -172.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -107.41 -68.15 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 117.981 -1.009 . . . . 3.4500000000000002 112.104 177.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -77.05 131.12 11.74 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 121.606 1.538 . . . . 1.2 108.77 175.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -76.4 157.35 32.38 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.766 -0.827 . . . . 3.02 108.766 169.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.02 170.22 4.6 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.93 0.492 . . . . 1.53 109.71 170.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.86 40.54 98.47 Favored Glycine 0 CA--C 1.531 1.081 0 O-C-N 121.63 -0.669 . . . . 1.6299999999999999 112.046 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -127.2 156.7 41.42 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 107.916 -1.142 . . . . 1.47 107.916 169.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -96.71 128.47 43.69 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.002 0.921 . . . . 4.6100000000000003 108.992 176.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.2 pt -137.17 168.23 21.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 108.32 -0.993 . . . . 0.77000000000000002 108.32 173.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 31.2 mtm180 -117.59 111.07 18.7 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.13 -1.063 . . . . 2.6800000000000002 108.13 173.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.7 p -78.87 130.14 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.812 -1.551 . . . . 0.80000000000000004 106.812 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.55 125.33 2.98 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 109.629 -1.389 . . . . 0.53000000000000003 109.629 -177.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.96 -155.4 17.09 Favored Glycine 0 C--N 1.334 0.423 0 N-CA-C 108.535 -1.826 . . . . 0.68000000000000005 108.535 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -97.61 134.38 40.9 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.48 0.657 . . . . 2.73 109.705 177.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.431 HG22 ' H ' ' A' ' 108' ' ' GLN . 9.4 m -68.95 159.79 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.964 -1.124 . . . . 2.4199999999999999 107.964 172.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.2 m -74.03 -116.85 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 109.188 -0.671 . . . . 2.5499999999999998 109.188 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.1 p -156.99 -59.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 O-C-N 120.49 -1.381 . . . . 2.3500000000000001 109.418 -175.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.66 -11.05 56.06 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 121.943 -0.473 . . . . 2.2599999999999998 112.591 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.1 m -67.37 -20.91 65.62 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 114.14 1.163 . . . . 1.21 114.14 -165.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 6.6 tpt -71.39 94.6 1.25 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.655 0.782 . . . . 1.9199999999999999 109.814 -176.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.6 m -102.31 130.44 52.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 107.364 -1.347 . . . . 0.57999999999999996 107.364 174.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -126.44 141.48 51.87 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.506 1.122 . . . . 6.0999999999999996 108.323 -173.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.99 143.82 31.88 Favored Pre-proline 0 C--O 1.234 0.244 0 N-CA-C 110.34 -0.244 . . . . 2.6699999999999999 110.34 -176.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -60.16 -27.16 84.32 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.125 2.55 . . . . 2.3900000000000001 110.846 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -42.94 -40.63 3.05 Favored 'General case' 0 C--O 1.226 -0.151 0 C-N-CA 125.678 1.591 . . . . 2.6200000000000001 110.013 172.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.4 m 78.31 12.04 1.71 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.963 1.705 . . . . 1.71 112.861 177.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.69 31.53 5.31 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.888 0.875 . . . . 2.9199999999999999 112.382 165.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -150.24 131.82 14.85 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 122.05 -0.406 . . . . 1.22 110.545 175.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.59 131.26 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 125.14 1.376 . . . . 1.0 108.714 -177.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -137.9 144.08 41.16 Favored 'General case' 0 C--N 1.34 0.183 0 O-C-N 120.536 -1.352 . . . . 0.91000000000000003 110.745 172.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -139.35 160.22 40.34 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.392 0.677 . . . . 1.97 109.854 -175.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.67 127.61 54.12 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.529 -1.285 . . . . 0.60999999999999999 107.529 170.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.6 p -116.02 146.55 20.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.314 -0.995 . . . . 1.8300000000000001 108.314 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -142.88 -178.5 5.84 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.217 1.007 . . . . 1.3600000000000001 109.661 -173.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -124.98 10.27 8.2 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.581 0.705 . . . . 2.6899999999999999 111.734 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.0 t 53.71 27.02 6.41 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.296 1.038 . . . . 4.0800000000000001 112.481 -173.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.3 mp -98.38 -78.12 0.5 Allowed 'General case' 0 C--N 1.34 0.179 0 N-CA-C 108.23 -1.026 . . . . 4.7400000000000002 108.23 166.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -173.81 75.89 0.08 OUTLIER Glycine 0 C--N 1.334 0.428 0 N-CA-C 108.727 -1.749 . . . . 2.9900000000000002 108.727 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 159.78 129.72 1.07 Allowed Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 110.597 -1.001 . . . . 1.46 110.597 175.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -120.78 133.13 55.34 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.178 -1.786 . . . . 4.7699999999999996 106.178 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -123.4 138.51 53.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 108.051 -1.092 . . . . 1.45 108.051 -176.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.8 mt -89.8 124.44 34.66 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.954 0.902 . . . . 0.70999999999999996 110.294 -176.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.0 t -109.0 118.46 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 126.216 1.806 . . . . 0.82999999999999996 107.045 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.4 p -99.54 140.06 34.27 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.723 -0.843 . . . . 0.55000000000000004 108.723 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -141.71 139.61 32.96 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 107.849 -1.167 . . . . 2.2999999999999998 107.849 -173.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -81.79 -91.01 0.07 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.98 0.912 . . . . 3.6200000000000001 110.692 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -55.15 168.74 0.3 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.646 1.179 . . . . 3.9199999999999999 113.237 -171.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 mt -57.7 116.34 3.36 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 120.197 -1.564 . . . . 2.2599999999999998 110.95 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.0 mt -54.97 145.74 41.89 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 123.511 0.724 . . . . 1.4099999999999999 109.839 170.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -62.32 143.3 93.65 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.598 2.199 . . . . 2.5499999999999998 109.692 177.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 47.16 40.39 9.92 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.955 1.302 . . . . 2.7999999999999998 111.285 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 56.05 4.75 0.14 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 128.277 2.631 . . . . 2.0499999999999998 115.466 -175.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 57.0 t80 58.37 101.99 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.251 1.02 . . . . 2.9500000000000002 109.089 -155.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -78.09 150.94 33.64 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.89 -1.152 . . . . 4.0899999999999999 107.89 168.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -91.96 165.63 13.11 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 125.867 1.667 . . . . 3.3300000000000001 109.595 -175.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 42.15 48.86 5.47 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.153 1.358 . . . . 0.79000000000000004 114.408 -177.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.431 ' H ' HG22 ' A' ' 66' ' ' VAL . 1.3 pp0? -155.7 87.81 1.1 Allowed 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.83 1.252 . . . . 2.5699999999999998 107.632 -178.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -49.08 135.77 21.41 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 123.459 0.552 . . . . 0.68999999999999995 113.857 -169.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.3 pp -139.23 168.04 19.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 124.731 1.212 . . . . 0.92000000000000004 108.69 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 15.7 m -110.6 137.76 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.271 -1.011 . . . . 0.71999999999999997 108.271 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.456 ' CB ' HG12 ' A' ' 127' ' ' VAL . . . -125.04 122.17 36.49 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.525 1.13 . . . . 0.64000000000000001 109.333 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -99.35 127.4 45.36 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.018 -1.104 . . . . 3.2999999999999998 108.018 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -159.79 169.19 35.73 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.197 -0.525 . . . . 1.6399999999999999 112.36 -173.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.1 p -108.38 139.35 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 124.439 1.096 . . . . 0.84999999999999998 108.184 177.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.448 ' CD2' HG23 ' A' ' 48' ' ' THR . 3.9 mp -68.43 118.29 11.31 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.55 -0.907 . . . . 2.6600000000000001 108.55 174.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.34 -91.65 0.33 Allowed Glycine 0 C--N 1.335 0.524 0 O-C-N 124.054 0.847 . . . . 2.54 111.107 -171.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -82.0 -77.86 0.21 Allowed 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.395 -1.335 . . . . 6.1500000000000004 107.395 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -175.58 108.35 0.09 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.969 1.708 . . . . 3.6000000000000001 107.099 173.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 118.8 -41.71 1.95 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.066 -1.214 . . . . 0.97999999999999998 110.066 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.69 131.63 34.93 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.485 0.714 . . . . 2.8100000000000001 110.628 -178.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -97.52 113.98 25.79 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.204 -1.036 . . . . 2.5899999999999999 108.204 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -88.58 102.58 15.08 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 107.246 -1.39 . . . . 0.63 107.246 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -122.0 132.29 54.44 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 123.922 0.889 . . . . 1.29 109.306 -175.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.8 t -125.7 -8.61 6.75 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.918 0.487 . . . . 1.27 112.236 172.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -111.41 74.54 0.87 Allowed 'General case' 0 CA--C 1.532 0.254 0 O-C-N 120.473 -1.392 . . . . 3.75 108.548 -174.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.456 HG12 ' CB ' ' A' ' 112' ' ' ALA . 35.8 m -87.58 150.93 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 118.279 0.491 . . . . 1.27 111.08 176.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.41 HD22 ' N ' ' A' ' 128' ' ' LEU . 0.2 OUTLIER -126.23 135.68 51.89 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.348 -0.982 . . . . 0.91000000000000003 108.348 171.525 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.3 122.95 34.36 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.765 -1.198 . . . . 2.5899999999999999 107.765 169.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -143.9 46.34 1.46 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.352 0.661 . . . . 3.1000000000000001 110.278 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -145.08 102.46 3.75 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.443 1.097 . . . . 4.9199999999999999 109.317 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 . . . . . 0 N--CA 1.448 -0.539 0 C-N-CA 126.32 1.848 . . . . 5.7000000000000002 109.019 173.308 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.5 m . . . . . 0 CA--C 1.536 0.42 0 CA-C-O 120.937 0.399 . . . . 9.2699999999999996 111.69 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.7 m-20 -105.46 77.16 1.26 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.429 1.091 . . . . 8.2100000000000009 109.133 -176.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.69 66.4 0.34 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.091 0.956 . . . . 6.8600000000000003 109.374 172.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -80.32 67.6 6.22 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.314 -0.866 . . . . 3.5800000000000001 110.587 -164.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.52 HD11 ' CD2' ' A' ' 38' ' ' TYR . 2.5 pp -134.27 161.41 35.02 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.029 1.732 . . . . 2.1699999999999999 109.477 -173.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -90.69 116.33 28.48 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 124.146 0.978 . . . . 2.1499999999999999 110.409 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.52 ' CD2' HD11 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -112.95 152.82 28.92 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.99 1.316 . . . . 2.7799999999999998 110.122 175.148 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.0 p -83.27 133.66 47.22 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 124.814 1.246 . . . . 1.6399999999999999 109.871 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.41 -40.71 72.54 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.882 2.388 . . . . 0.68999999999999995 112.236 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.7 t -54.8 -29.38 54.33 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.265 0.468 . . . . 2.48 112.265 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.11 -56.46 11.38 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.751 -1.203 . . . . 3.02 107.751 175.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.8 pt -73.23 28.99 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 114.217 1.191 . . . . 1.0800000000000001 114.217 -174.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.9 t -109.56 -24.42 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 126.82 2.048 . . . . 1.9199999999999999 111.007 163.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -120.65 75.02 1.1 Allowed 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 121.558 -0.714 . . . . 2.0699999999999998 111.197 -157.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.72 49.76 8.65 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 109.067 -1.613 . . . . 1.3999999999999999 109.067 174.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -146.55 -125.5 0.07 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.131 -1.804 . . . . 2.5800000000000001 106.131 -173.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.2 m -62.65 -43.0 99.92 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 119.408 1.004 . . . . 1.7 111.448 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -31.89 -72.51 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 126.655 1.982 . . . . 5.3499999999999996 112.809 172.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 45.7 m -89.23 -14.45 35.92 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.816 0.846 . . . . 1.8200000000000001 110.2 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.76 32.86 60.88 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.048 -0.821 . . . . 1.45 111.048 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.6 m -75.99 -36.24 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 117.702 0.751 . . . . 1.3200000000000001 111.418 -173.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt -113.88 -70.37 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 124.541 1.136 . . . . 3.4100000000000001 110.156 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.27 108.32 2.16 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 121.257 1.305 . . . . 1.3799999999999999 109.714 176.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.55 154.37 38.87 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.819 -0.808 . . . . 2.8399999999999999 108.819 169.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.98 164.1 13.36 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.188 -0.671 . . . . 1.27 109.188 169.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.42 30.69 39.94 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.252 -0.739 . . . . 1.5 111.252 -175.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -125.56 152.5 44.99 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.968 1.307 . . . . 1.48 108.458 173.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -97.51 121.24 39.18 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 108.25 -1.019 . . . . 4.8300000000000001 108.25 -176.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.5 pt -144.04 177.76 2.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 124.674 1.19 . . . . 0.73999999999999999 108.287 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -125.98 131.37 52.25 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.602 -0.888 . . . . 2.5699999999999998 108.602 175.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.5 p -94.73 124.5 47.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 107.014 -1.476 . . . . 0.98999999999999999 107.014 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.62 124.82 4.16 Favored Glycine 0 C--O 1.225 -0.437 0 N-CA-C 108.982 -1.647 . . . . 0.46999999999999997 108.982 178.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.39 -166.0 33.46 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 108.701 -1.76 . . . . 0.60999999999999999 108.701 -175.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.28 138.37 36.46 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.509 -0.552 . . . . 2.8500000000000001 109.509 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.544 HG11 ' HE1' ' A' ' 104' ' ' PHE . 32.6 t -98.77 108.22 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-O 121.239 0.542 . . . . 2.4199999999999999 110.087 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.2 m -39.15 132.75 1.32 Allowed 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 127.541 2.337 . . . . 2.4100000000000001 111.356 168.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.5 p -55.49 -62.8 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.656 0.782 . . . . 2.1800000000000002 110.731 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -83.27 68.5 3.54 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 109.951 -1.26 . . . . 2.1899999999999999 109.951 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.3 m -152.12 -33.64 0.14 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 114.858 1.429 . . . . 1.0700000000000001 114.858 -176.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.3 tpp -62.06 120.06 10.11 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 108.353 -0.98 . . . . 2.3399999999999999 108.353 170.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.2 m -122.35 133.94 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.341 -1.355 . . . . 0.69999999999999996 107.341 167.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.38 137.77 54.43 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.557 1.143 . . . . 5.9100000000000001 109.038 -173.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.62 143.33 50.76 Favored Pre-proline 0 N--CA 1.454 -0.244 0 N-CA-C 109.738 -0.468 . . . . 2.0099999999999998 109.738 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -59.85 -25.83 80.5 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.48 2.12 . . . . 1.5 110.787 170.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -40.98 -42.94 2.0 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 124.653 1.181 . . . . 1.54 110.668 168.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.6 m 84.41 -0.34 0.94 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.143 1.777 . . . . 1.1599999999999999 113.647 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.2 18.35 11.55 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.321 0.964 . . . . 2.6600000000000001 112.641 172.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -138.35 125.9 22.03 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.491 -1.3 . . . . 1.0700000000000001 107.491 174.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.51 HG23 ' HB3' ' A' ' 96' ' ' TYR . 27.6 m -145.19 144.48 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 106.62 -1.622 . . . . 0.68999999999999995 106.62 175.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -148.02 155.88 42.01 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 121.361 -0.837 . . . . 1.02 109.777 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -151.35 137.97 18.75 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.49 -0.323 . . . . 1.96 111.106 -171.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.29 138.3 33.62 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.212 -1.032 . . . . 0.48999999999999999 108.212 166.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.0 p -130.79 146.61 33.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 106.412 -1.699 . . . . 1.78 106.412 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -143.37 175.29 10.03 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.645 0.657 . . . . 1.6899999999999999 110.88 -174.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -142.54 -95.96 0.12 Allowed 'General case' 0 CA--C 1.531 0.222 0 O-C-N 123.465 0.478 . . . . 2.5099999999999998 111.537 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.5 t -86.4 66.6 9.6 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 120.721 -1.237 . . . . 5.5 110.215 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -16.31 33.71 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.265 1 C-N-CA 133.949 4.9 . . . . 9.4700000000000006 119.898 -158.014 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.18 26.41 8.74 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 126.353 1.93 . . . . 3.1099999999999999 108.913 164.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -173.52 116.53 0.6 Allowed Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 109.903 -1.279 . . . . 1.6899999999999999 109.903 176.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -112.37 150.64 30.79 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.37 1.468 . . . . 3.1600000000000001 107.29 165.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -131.32 153.14 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 107.776 -1.194 . . . . 1.05 107.776 175.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.4 mt -110.18 115.14 29.19 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.794 0.838 . . . . 0.77000000000000002 109.036 -172.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.8 t -96.5 138.58 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 124.734 1.214 . . . . 0.89000000000000001 107.845 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 77.6 p -114.46 149.57 36.1 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.738 -0.838 . . . . 0.55000000000000004 108.738 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.513 ' CE2' ' HA ' ' A' ' 125' ' ' THR . 6.7 t80 -149.79 116.99 6.02 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.519 -0.919 . . . . 2.0499999999999998 108.519 -173.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -104.29 51.47 0.77 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.633 1.173 . . . . 2.1099999999999999 111.86 -170.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -168.16 -179.37 4.03 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.527 1.931 . . . . 3.02 107.14 170.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.0 mp -67.51 148.57 51.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 118.703 0.683 . . . . 1.5900000000000001 111.075 171.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.458 HD21 ' CD2' ' A' ' 96' ' ' TYR . 17.2 mt -101.81 152.24 38.09 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 125.093 1.357 . . . . 1.27 110.291 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -60.34 137.7 76.21 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 123.983 3.122 . . . . 2.0499999999999998 109.756 174.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 49.27 30.3 3.09 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.944 1.698 . . . . 3.02 112.495 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.0 tp 58.15 13.29 2.22 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.211 1.004 . . . . 3.4300000000000002 111.97 -175.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.544 ' HE1' HG11 ' A' ' 66' ' ' VAL . 17.3 t80 57.07 95.68 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.422 1.489 . . . . 2.8399999999999999 109.049 -172.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -76.15 124.9 28.18 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 105.47 -2.048 . . . . 7.54 105.47 -176.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -80.47 168.14 19.31 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.902 -0.499 . . . . 2.9700000000000002 110.187 -170.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.25 45.56 47.83 Favored Glycine 0 CA--C 1.528 0.906 0 O-C-N 121.505 -0.747 . . . . 0.93000000000000005 112.336 174.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -155.8 170.39 22.19 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.492 1.117 . . . . 2.2599999999999998 108.333 174.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -90.9 130.33 10.22 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 111.188 -0.765 . . . . 0.67000000000000004 111.188 174.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.9 pp -137.94 158.4 33.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 107.01 -1.478 . . . . 0.68000000000000005 107.01 176.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.3 m -120.02 126.57 75.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 108.258 -1.016 . . . . 0.70999999999999996 108.258 175.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -117.44 127.09 53.68 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 124.403 1.081 . . . . 0.68999999999999995 109.929 -173.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -107.84 143.42 36.46 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.62 0.768 . . . . 4.46 110.333 -178.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 167.15 -142.46 7.58 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 110.057 -1.217 . . . . 0.98999999999999999 110.057 171.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.9 p -132.31 144.91 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-O 121.517 0.675 . . . . 1.02 110.477 -164.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.619 HD11 HD23 ' A' ' 122' ' ' LEU . 3.4 mp -87.35 153.9 21.1 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.678 -1.23 . . . . 2.71 107.678 176.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -159.47 -59.79 0.01 OUTLIER Glycine 0 C--N 1.334 0.43 0 C-N-CA 119.686 -1.245 . . . . 2.4500000000000002 111.646 177.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -60.41 142.74 54.61 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.809 -1.182 . . . . 4.4400000000000004 107.809 167.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -78.99 57.62 2.22 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.819 1.648 . . . . 4.1100000000000003 108.934 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 164.12 -32.38 0.26 Allowed Glycine 0 CA--C 1.53 0.979 0 CA-C-N 115.75 -0.659 . . . . 0.94999999999999996 113.02 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -113.14 157.22 21.93 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 118.181 0.99 . . . . 2.4900000000000002 109.642 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.619 HD23 HD11 ' A' ' 116' ' ' LEU . 4.2 mp -118.09 143.92 46.06 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.089 0.955 . . . . 1.95 108.517 -176.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -105.61 97.24 7.1 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.209 -1.404 . . . . 0.68000000000000005 107.209 175.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -106.16 143.92 33.59 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.719 -0.845 . . . . 1.0800000000000001 108.719 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.513 ' HA ' ' CE2' ' A' ' 96' ' ' TYR 0.254 12.1 t -129.36 -32.04 2.01 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.122 0.786 . . . . 1.04 113.122 174.622 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -84.96 84.8 7.59 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 120.713 -1.242 . . . . 3.1299999999999999 108.406 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.7 m -88.76 105.77 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 119.294 0.952 . . . . 0.84999999999999998 111.339 175.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -96.36 105.92 18.07 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.429 -0.952 . . . . 0.65000000000000002 108.429 175.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.79 52.19 1.67 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.356 1.062 . . . . 1.24 111.574 -177.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -79.19 72.6 5.77 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.751 -0.593 . . . . 3.2000000000000002 111.035 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -103.94 65.34 0.81 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.817 0.847 . . . . 4.9199999999999999 111.538 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 . . . . . 0 N--CA 1.451 -0.397 0 C-N-CA 124.337 1.055 . . . . 7.6900000000000004 109.384 175.405 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.8 t . . . . . 0 CA--C 1.535 0.376 0 N-CA-C 109.475 -0.565 . . . . 7.4699999999999998 109.475 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -90.06 130.48 36.23 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.62 -0.881 . . . . 7.75 108.62 176.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.26 -165.67 2.18 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.818 1.247 . . . . 6.2699999999999996 108.11 -173.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -79.59 86.93 5.18 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 108.373 -0.973 . . . . 3.46 108.373 -167.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.74 160.31 14.81 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 122.981 0.512 . . . . 1.9399999999999999 110.396 -177.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -84.76 119.49 25.35 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.071 -0.714 . . . . 2.2999999999999998 109.071 173.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.53 155.92 49.71 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.347 1.059 . . . . 2.77 109.944 -178.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.2 p -88.07 146.9 39.38 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-O 119.242 -0.409 . . . . 1.8899999999999999 110.728 -173.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -52.83 -50.82 12.73 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 123.399 2.733 . . . . 0.82999999999999996 110.371 173.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.7 m -48.13 -47.66 34.54 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 125.531 1.532 . . . . 2.5899999999999999 112.748 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -57.54 -59.58 4.95 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.478 -0.934 . . . . 2.2999999999999998 108.478 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.267 32.4 pt -61.74 -16.5 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 114.504 1.298 . . . . 1.75 114.504 -170.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.47 -57.42 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 120.056 1.298 . . . . 2.0899999999999999 111.226 167.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -84.71 80.37 9.28 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.149 -0.97 . . . . 2.2200000000000002 112.098 -154.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.47 48.35 5.96 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 109.653 -1.379 . . . . 1.3999999999999999 109.653 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.56 -100.84 0.08 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.136 -1.061 . . . . 2.3999999999999999 108.136 -177.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 92.9 m -79.28 -60.8 2.23 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 126.187 1.795 . . . . 1.3700000000000001 111.043 -176.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.41 ' OD1' HD11 ' A' ' 92' ' ' ILE . 0.9 OUTLIER -54.43 -33.25 59.14 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.321 0.964 . . . . 4.1500000000000004 111.205 -178.537 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.28 -17.72 31.87 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.35 1.06 . . . . 1.51 112.379 178.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 52.7 43.18 59.67 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 126.158 1.837 . . . . 1.0900000000000001 112.936 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.4 m -95.88 -43.06 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 118.301 1.051 . . . . 1.3200000000000001 112.817 -173.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -111.88 -71.09 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.25 0 C-N-CA 124.546 1.138 . . . . 3.3799999999999999 111.021 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -70.69 96.32 0.67 Allowed 'Trans proline' 0 N--CA 1.444 -1.397 0 N-CA-C 108.356 -1.44 . . . . 1.6899999999999999 108.356 172.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -49.51 162.65 0.14 Allowed 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.322 1.049 . . . . 4.1200000000000001 111.441 170.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.35 144.27 51.08 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.35 -0.981 . . . . 1.3100000000000001 108.35 169.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.85 21.91 67.45 Favored Glycine 0 CA--C 1.536 1.396 0 O-C-N 121.554 -0.716 . . . . 1.1599999999999999 113.261 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -89.62 148.55 23.28 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 118.42 1.11 . . . . 2.8199999999999998 108.117 170.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.97 113.84 26.06 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.474 1.11 . . . . 3.5899999999999999 108.249 -171.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.27 175.96 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 123.131 0.572 . . . . 1.5800000000000001 109.477 -177.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -111.27 112.15 23.72 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 108.84 -0.8 . . . . 3.3999999999999999 108.84 175.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.9 p -77.01 122.24 31.1 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.038 0 N-CA-C 106.944 -1.502 . . . . 1.03 106.944 172.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.09 120.66 2.97 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 108.537 -1.825 . . . . 0.64000000000000001 108.537 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.07 -160.02 22.78 Favored Glycine 0 CA--C 1.52 0.347 0 N-CA-C 108.92 -1.672 . . . . 0.68000000000000005 108.92 -174.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.6 ptp -112.7 136.29 52.45 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.229 0.612 . . . . 2.52 110.272 -176.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 83' ' ' ALA . 4.8 p -93.93 138.68 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 109.091 -0.707 . . . . 2.46 109.091 172.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.99 163.32 26.8 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.221 -1.029 . . . . 2.6099999999999999 108.221 168.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.6 p -58.78 -65.31 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 124.368 1.067 . . . . 2.21 110.763 173.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.25 59.44 4.33 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 121.545 -0.722 . . . . 2.0600000000000001 111.388 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.5 m -126.06 -41.95 1.9 Allowed 'General case' 0 C--N 1.334 -0.07 0 C-N-CA 124.744 1.218 . . . . 1.8700000000000001 111.449 -177.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -71.78 121.37 18.82 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.11 -0.7 . . . . 1.9399999999999999 109.11 -178.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.8 m -127.47 130.35 70.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 108.002 -1.111 . . . . 0.85999999999999999 108.002 170.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -109.49 147.26 33.19 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 124.072 0.949 . . . . 4.3099999999999996 110.73 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.46 151.89 95.53 Favored Pre-proline 0 N--CA 1.45 -0.44 0 N-CA-C 109.046 -0.724 . . . . 2.1800000000000002 109.046 174.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -61.67 -28.37 82.38 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.012 1.808 . . . . 1.79 110.946 166.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -44.88 -34.71 2.47 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.141 0.976 . . . . 1.3700000000000001 110.655 167.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.6 m 67.63 23.87 8.65 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.084 1.354 . . . . 2.2799999999999998 112.241 176.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.47 -42.37 2.23 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.848 2.059 . . . . 2.1000000000000001 111.788 172.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -90.8 138.94 31.2 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.624 -1.25 . . . . 1.3400000000000001 107.624 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.511 HG23 ' HB3' ' A' ' 96' ' ' TYR . 17.2 m -152.29 130.11 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 107.125 -1.435 . . . . 0.72999999999999998 107.125 -173.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -135.11 146.71 49.11 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 118.929 0.786 . . . . 1.3799999999999999 110.394 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -140.0 144.5 36.99 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.221 0.608 . . . . 1.9399999999999999 110.171 -172.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.57 ' O ' HG23 ' A' ' 66' ' ' VAL . . . -85.07 139.14 31.96 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.89 -0.782 . . . . 0.59999999999999998 108.89 170.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 t -125.76 143.66 38.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 105.855 -1.906 . . . . 1.78 105.855 172.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -144.15 177.99 8.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.191 -1.04 . . . . 2.52 108.191 176.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -155.36 131.85 10.42 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.811 -0.811 . . . . 2.6400000000000001 108.811 169.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 35.7 t 41.94 52.36 4.24 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.804 0.842 . . . . 3.9399999999999999 111.308 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -7.16 42.11 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 130.909 3.683 . . . . 9.2799999999999994 117.87 -149.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.66 -25.21 65.16 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 120.789 -1.194 . . . . 3.4100000000000001 110.54 168.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 179.15 174.37 45.23 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 109.12 -1.592 . . . . 1.52 109.12 166.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -133.16 138.24 46.53 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.339 -1.356 . . . . 2.75 107.339 177.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.445 ' HA ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -128.35 154.46 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 107.258 -1.386 . . . . 0.90000000000000002 107.258 -176.346 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.2 mt -116.14 121.43 42.1 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.52 0.728 . . . . 0.66000000000000003 109.334 -177.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.8 t -109.27 129.0 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.88 -1.155 . . . . 0.85999999999999999 107.88 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 77.5 p -103.94 140.15 38.11 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.73 1.212 . . . . 0.64000000000000001 109.233 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.511 ' HB3' HG23 ' A' ' 80' ' ' VAL . 6.6 t80 -134.41 160.23 38.63 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.112 1.765 . . . . 2.0800000000000001 108.191 -178.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -145.68 146.5 31.31 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 128.097 2.559 . . . . 3.1299999999999999 105.449 -171.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 69.82 59.97 0.28 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 130.085 3.354 . . . . 3.1899999999999999 111.083 -175.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 mt 55.93 -156.05 0.28 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.482 1.113 . . . . 1.8300000000000001 109.27 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.572 HD13 ' HB2' ' A' ' 104' ' ' PHE . 15.5 mt -145.0 154.42 54.73 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 105.827 -1.916 . . . . 1.1000000000000001 105.827 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -63.09 -82.86 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 124.276 3.317 . . . . 2.3500000000000001 110.536 -176.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -76.5 35.49 0.15 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.073 0.949 . . . . 4.1100000000000003 110.752 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 39.6 6.31 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 128.505 2.722 . . . . 3.0499999999999998 117.538 -164.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.572 ' HB2' HD13 ' A' ' 100' ' ' LEU . 0.2 OUTLIER 61.91 89.96 0.08 Allowed 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 124.846 1.258 . . . . 3.0099999999999998 109.643 -166.021 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.272 15.0 mmm180 -91.85 30.39 1.39 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 117.859 -1.536 . . . . 5.2300000000000004 111.559 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . 0.339 4.3 mt-10 79.38 172.38 0.16 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.986 1.266 . . . . 3.04 109.714 146.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 39.39 37.52 0.79 Allowed Glycine 0 CA--C 1.537 1.467 0 N-CA-C 116.143 1.217 . . . . 0.78000000000000003 116.143 163.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -148.18 176.57 10.11 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.551 1.54 . . . . 2.1899999999999999 107.847 -175.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -109.08 129.38 9.48 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.174 -1.17 . . . . 0.64000000000000001 110.174 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.0 pp -133.99 165.39 31.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 125.475 1.51 . . . . 0.73999999999999999 106.994 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.4 m -115.56 144.27 23.54 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 N-CA-C 108.087 -1.079 . . . . 0.94999999999999996 108.087 170.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.616 ' HB2' HG12 ' A' ' 127' ' ' VAL . . . -134.05 129.68 36.41 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 124.073 0.949 . . . . 0.62 110.325 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.79 143.83 34.32 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.633 1.173 . . . . 4.4500000000000002 111.425 177.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 166.02 -150.64 18.28 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 109.17 -1.572 . . . . 1.01 109.17 169.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.9 p -127.69 146.28 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 123.78 0.832 . . . . 0.82999999999999996 109.38 -168.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.6 mp -61.71 142.65 57.09 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 122.119 -0.363 . . . . 2.0899999999999999 110.483 174.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -98.38 -108.21 2.74 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 109.263 -1.535 . . . . 1.8100000000000001 109.263 -169.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -60.29 -49.21 78.52 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.323 0.649 . . . . 5.1799999999999997 109.259 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.2 t70 177.27 -87.86 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.364 2.266 . . . . 4.2999999999999998 106.089 -177.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.23 -26.54 72.57 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.72 1.629 . . . . 1.0800000000000001 113.433 -177.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -86.66 136.5 33.01 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.12 0.96 . . . . 3.0299999999999998 109.935 174.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.4 mp -107.37 133.9 51.23 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 123.107 0.563 . . . . 2.1600000000000001 109.495 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.09 106.5 18.81 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.58 -0.526 . . . . 0.42999999999999999 109.58 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -121.27 136.99 54.89 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.719 0.808 . . . . 1.2 110.224 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.3 t -128.28 4.14 5.75 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.216 0.606 . . . . 1.0900000000000001 111.885 173.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -118.6 82.03 1.78 Allowed 'General case' 0 CA--C 1.531 0.237 0 O-C-N 120.914 -1.116 . . . . 2.98 108.368 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.616 HG12 ' HB2' ' A' ' 112' ' ' ALA . 17.2 m -99.59 133.92 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 118.333 0.515 . . . . 0.70999999999999996 110.701 175.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.87 118.81 27.94 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.215 -1.402 . . . . 0.73999999999999999 107.215 177.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.22 84.2 7.7 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.631 0.772 . . . . 1.1499999999999999 110.433 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.17 34.52 0.11 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.736 1.013 . . . . 4.1500000000000004 113.736 -174.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -136.63 139.31 41.97 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 126.765 2.026 . . . . 4.1200000000000001 105.596 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 13.1 t0 . . . . . 0 CA--C 1.532 0.257 0 N-CA-C 107.105 -1.443 . . . . 6.79 107.105 174.113 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.455 -0.206 0 N-CA-C 106.253 -1.758 . . . . 6.6900000000000004 106.253 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -143.79 143.41 31.34 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.043 -1.095 . . . . 6.8399999999999999 108.043 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 77.7 mt -144.25 152.79 41.31 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.082 1.353 . . . . 6.0499999999999998 107.503 -173.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -131.09 115.2 16.11 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.908 0.883 . . . . 3.6699999999999999 111.184 -176.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.4 173.4 11.82 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.224 -0.923 . . . . 2.5 109.75 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -85.68 124.78 32.6 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.724 1.209 . . . . 2.1400000000000001 109.465 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.16 149.39 51.88 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.003 1.321 . . . . 3.02 110.54 -177.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.5 m -77.09 132.33 70.88 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 125.713 1.605 . . . . 2.0 110.728 -177.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -59.3 -33.05 97.77 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.968 2.445 . . . . 0.81000000000000005 113.616 -176.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.5 p -61.09 -21.04 63.3 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.171 -0.956 . . . . 2.2799999999999998 112.713 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -96.8 14.2 26.0 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.774 0.715 . . . . 3.7000000000000002 111.753 173.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.312 8.0 pt -124.26 35.02 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 O-C-N 120.607 -1.308 . . . . 1.23 111.613 163.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.0 p -122.61 -79.11 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 O-C-N 121.922 -0.486 . . . . 2.3500000000000001 110.426 163.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -69.75 103.8 2.26 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 125.497 1.519 . . . . 2.2999999999999998 110.896 -162.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.96 39.33 96.39 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 109.029 -1.628 . . . . 1.3400000000000001 109.029 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -141.43 -110.42 0.14 Allowed 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.521 -1.659 . . . . 2.2799999999999998 106.521 -176.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 56.3 m -80.45 -48.19 13.21 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 119.96 1.254 . . . . 1.4099999999999999 112.475 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -55.0 -49.33 71.77 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.828 0.823 . . . . 2.6600000000000001 109.694 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -72.32 -33.47 67.38 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.371 -0.831 . . . . 1.2 111.619 175.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.22 41.04 39.86 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.744 1.164 . . . . 1.2 112.198 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.6 m -99.97 -42.3 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 117.999 0.9 . . . . 1.3 113.228 -172.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -109.29 -67.51 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.519 1.128 . . . . 3.7999999999999998 111.433 -176.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -76.37 78.81 3.15 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.062 1.842 . . . . 2.27 108.828 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -55.74 140.04 43.14 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.656 0.782 . . . . 3.2000000000000002 109.031 175.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.539 ' HB1' ' HA2' ' A' ' 117' ' ' GLY . . . -61.83 147.18 47.34 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.951 -0.759 . . . . 1.1899999999999999 108.951 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.17 -8.28 31.04 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.839 1.209 . . . . 1.0900000000000001 112.069 -170.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -96.32 140.49 30.92 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.325 1.063 . . . . 1.6100000000000001 109.548 -175.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -89.31 118.56 29.07 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.274 1.029 . . . . 4.8099999999999996 108.569 176.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.7 pt -142.21 175.9 4.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 107.903 -1.147 . . . . 1.22 107.903 172.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.4 mtm180 -121.15 113.57 20.19 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.197 -1.038 . . . . 2.1400000000000001 108.197 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.2 p -81.24 127.86 39.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 107.108 -1.441 . . . . 0.78000000000000003 107.108 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.99 114.93 1.76 Allowed Glycine 0 C--N 1.332 0.332 0 N-CA-C 109.856 -1.297 . . . . 0.47999999999999998 109.856 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.57 -173.37 39.76 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.876 -0.89 . . . . 0.81000000000000005 110.876 -172.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.431 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 2.4 ptp -93.37 132.82 37.25 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.947 0.899 . . . . 2.75 111.343 -171.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.43 HG11 ' CE1' ' A' ' 104' ' ' PHE . 6.1 t -102.34 137.22 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 O-C-N 123.794 0.684 . . . . 2.2599999999999998 109.936 174.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.401 HG22 HG12 ' A' ' 68' ' ' VAL . 5.2 m -40.75 -88.0 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 128.192 2.597 . . . . 2.8300000000000001 114.329 -175.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.401 HG12 HG22 ' A' ' 67' ' ' THR . 7.3 p 176.18 -36.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.309 1.443 . . . . 2.73 110.038 -174.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -155.82 42.35 0.56 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.788 -1.325 . . . . 2.4500000000000002 109.788 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.9 m -84.65 -11.46 55.89 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.972 0.386 . . . . 1.26 111.321 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 16.8 ptm -68.8 132.48 46.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 118.292 0.496 . . . . 2.2200000000000002 110.686 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.1 m -117.65 125.45 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 106.621 -1.622 . . . . 1.23 106.621 170.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.446 ' HB3' HG12 ' A' ' 80' ' ' VAL . 16.8 ptt180 -101.4 146.77 27.16 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.535 0.734 . . . . 5.0899999999999999 110.136 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -84.42 151.36 59.05 Favored Pre-proline 0 C--O 1.232 0.147 0 N-CA-C 109.381 -0.6 . . . . 2.1699999999999999 109.381 170.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -67.55 -21.15 46.57 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.933 2.422 . . . . 1.77 112.367 174.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -43.7 -37.98 2.91 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.565 -0.531 . . . . 1.55 109.565 163.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.0 m 72.79 9.75 5.52 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 126.125 1.77 . . . . 1.6100000000000001 111.508 177.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 pp -123.63 17.78 9.57 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.16 1.784 . . . . 1.76 110.644 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -146.1 130.19 17.42 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.588 1.555 . . . . 2.0299999999999998 108.271 173.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.446 HG12 ' HB3' ' A' ' 73' ' ' ARG . 0.9 OUTLIER -145.29 109.77 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 125.105 1.362 . . . . 1.1899999999999999 107.523 -178.6 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -109.38 150.07 28.58 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 109.22 -0.659 . . . . 1.3899999999999999 109.22 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -150.85 142.3 23.44 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.981 0.419 . . . . 1.8899999999999999 110.727 -171.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.69 135.16 33.88 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.275 -0.639 . . . . 0.78000000000000003 109.275 175.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 38.7 t -115.21 152.16 16.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 126.365 1.866 . . . . 2.0299999999999998 106.512 175.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -134.18 -175.93 4.02 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.376 0.67 . . . . 1.47 109.744 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.448 ' HB3' ' H ' ' A' ' 90' ' ' GLY . 25.7 t0 -126.53 171.47 11.05 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.716 0.806 . . . . 3.9300000000000002 110.506 177.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.9 m -48.48 -44.15 35.49 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.845 0.858 . . . . 3.71 110.651 159.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.51 -76.88 0.21 Allowed 'General case' 0 C--N 1.341 0.234 0 CA-C-N 118.662 0.665 . . . . 4.8899999999999997 110.446 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.25 50.05 0.07 OUTLIER Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.582 -1.007 . . . . 2.6200000000000001 110.582 -176.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.448 ' H ' ' HB3' ' A' ' 86' ' ' ASP . . . -82.32 52.29 4.63 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 110.458 -1.057 . . . . 2.4399999999999999 110.458 -178.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -65.88 111.75 3.44 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.997 -1.112 . . . . 3.5899999999999999 107.997 -175.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -144.51 153.85 14.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 N-CA-C 108.416 -0.957 . . . . 0.92000000000000004 108.416 -176.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mt -108.42 124.57 50.6 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.911 0.884 . . . . 0.77000000000000002 109.116 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.6 t -107.21 132.55 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 107.299 -1.371 . . . . 0.84999999999999998 107.299 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 76.6 p -106.25 143.6 34.14 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.513 -0.921 . . . . 0.60999999999999999 108.513 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -137.67 167.05 22.47 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.775 1.23 . . . . 2.2999999999999998 108.655 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -144.49 147.84 33.78 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 127.801 2.44 . . . . 3.4399999999999999 107.088 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 65.78 71.86 0.41 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 129.786 3.234 . . . . 3.0800000000000001 112.66 -178.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.7 mp 46.07 -148.54 0.11 Allowed 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 125.377 1.471 . . . . 2.3199999999999998 109.867 -175.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.8 mt -156.31 152.18 22.68 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 105.492 -2.04 . . . . 1.3300000000000001 105.492 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -71.54 108.69 2.45 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.274 2.649 . . . . 2.6600000000000001 109.929 176.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 45.04 45.11 8.78 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.205 1.402 . . . . 4.2999999999999998 111.706 176.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . 0.296 2.3 pp 35.69 47.3 0.37 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.259 1.424 . . . . 3.6699999999999999 112.793 -172.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.43 ' CE1' HG11 ' A' ' 66' ' ' VAL . 20.3 p90 38.85 56.59 1.95 Allowed 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 127.647 2.379 . . . . 4.7400000000000002 114.115 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.707 ' CD ' ' H ' ' A' ' 105' ' ' ARG 0.253 0.1 OUTLIER -37.91 130.45 1.12 Allowed 'General case' 0 CA--C 1.543 0.711 0 O-C-N 116.971 -3.58 . . . . 6.5499999999999998 113.189 -119.073 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -74.13 154.88 38.94 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.401 -0.812 . . . . 3.54 110.345 -164.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.61 33.21 11.67 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.181 0.896 . . . . 0.83999999999999997 112.395 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -156.74 178.54 10.23 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.091 1.356 . . . . 2.77 108.183 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 65' ' ' MET . . . -88.82 139.53 15.4 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 112.122 -0.391 . . . . 0.87 112.122 175.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.69 162.76 28.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 124.152 0.981 . . . . 0.81999999999999995 108.54 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 17.6 m -120.2 122.74 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.304 -0.628 . . . . 0.53000000000000003 109.304 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -113.67 120.98 42.74 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 125.189 1.396 . . . . 0.44 109.047 -176.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -99.67 135.28 41.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.369 -1.345 . . . . 4.1399999999999997 107.369 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -169.27 -169.72 32.95 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 110.065 -1.214 . . . . 0.93000000000000005 110.065 -173.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.4 p -122.98 136.94 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 107.804 -1.184 . . . . 0.73999999999999999 107.804 172.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 9.6 mp -73.78 155.24 39.06 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 107.882 -1.155 . . . . 2.6200000000000001 107.882 174.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.539 ' HA2' ' HB1' ' A' ' 56' ' ' ALA . . . -172.02 -44.42 0.04 OUTLIER Glycine 0 C--N 1.332 0.313 0 C-N-CA 119.878 -1.154 . . . . 2.1699999999999999 112.215 175.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -58.9 154.85 14.33 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 119.295 -0.962 . . . . 5.1699999999999999 110.083 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -80.17 72.54 6.99 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 106.511 -1.663 . . . . 4.5499999999999998 106.511 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 115.24 4.53 20.35 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.413 1.482 . . . . 1.3899999999999999 114.265 170.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.13 170.17 9.55 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.785 1.293 . . . . 2.8599999999999999 109.342 171.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.9 mp -123.74 145.25 49.15 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.044 0.937 . . . . 2.0699999999999998 109.578 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -110.85 109.76 20.08 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.426 0.691 . . . . 0.42999999999999999 109.197 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -132.63 136.63 46.63 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 123.41 0.684 . . . . 1.1000000000000001 110.277 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.4 t -121.44 -2.37 9.49 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.975 0.51 . . . . 1.0900000000000001 111.96 173.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -111.7 83.01 1.71 Allowed 'General case' 0 CA--C 1.532 0.27 0 O-C-N 120.434 -1.416 . . . . 3.79 108.403 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.3 m -96.65 126.89 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 118.383 0.538 . . . . 0.77000000000000002 110.886 174.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -113.95 106.57 14.59 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.03 -1.47 . . . . 0.77000000000000002 107.03 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.1 50.01 1.93 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.979 0.912 . . . . 1.6000000000000001 110.622 -178.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -78.83 64.39 3.78 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.357 0.663 . . . . 3.2999999999999998 111.096 -170.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -145.32 142.1 29.13 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.592 -1.633 . . . . 4.4400000000000004 106.592 -178.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 . . . . . 0 CA--C 1.532 0.252 0 C-N-CA 126.549 1.939 . . . . 6.6799999999999997 112.752 179.417 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.3 m . . . . . 0 CA--C 1.534 0.355 0 N-CA-C 111.857 0.317 . . . . 8.1400000000000006 111.857 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -149.8 149.12 30.04 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 121.567 -0.708 . . . . 8.1799999999999997 110.327 -174.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 mt -87.11 81.12 8.12 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.834 1.254 . . . . 6.0999999999999996 108.223 171.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 -81.0 73.5 8.04 Favored 'General case' 0 C--O 1.237 0.439 0 O-C-N 121.446 -0.784 . . . . 3.6499999999999999 110.535 -171.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -127.7 166.11 18.74 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.581 1.152 . . . . 1.8999999999999999 111.921 -176.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -91.45 135.21 34.01 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.424 1.09 . . . . 1.9299999999999999 109.906 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.41 161.44 34.54 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.002 1.321 . . . . 2.9300000000000002 109.883 170.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 p -83.28 144.82 47.38 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.65 1.18 . . . . 1.8600000000000001 110.522 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -62.0 -44.47 20.08 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.786 2.991 . . . . 0.82999999999999996 112.407 -177.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.8 p -45.83 -56.18 5.7 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.258 1.423 . . . . 2.5 110.923 176.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -46.56 -56.11 6.54 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.446 -1.252 . . . . 3.0099999999999998 109.174 178.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.25 24.2 pt -70.37 11.42 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 114.862 1.43 . . . . 1.0 114.862 -173.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 82.0 t -98.4 -57.59 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 119.455 1.025 . . . . 1.8300000000000001 110.934 173.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -95.68 90.27 5.63 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 121.618 -0.676 . . . . 2.29 111.822 -162.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.72 41.75 12.36 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.442 -1.063 . . . . 1.5 110.442 176.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.91 -161.61 1.17 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 104.168 -2.53 . . . . 3.0499999999999998 104.168 -178.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 m -27.6 -59.04 0.11 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.797 2.439 . . . . 1.72 116.356 -175.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -57.66 -43.62 85.12 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 120.625 1.557 . . . . 3.9500000000000002 110.889 -177.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.04 -34.81 75.81 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.762 0.825 . . . . 1.95 110.586 174.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.09 46.86 14.7 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.118 1.342 . . . . 1.5700000000000001 111.566 177.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.407 HG23 ' H ' ' A' ' 53' ' ' LYS . 2.7 m -99.17 -89.61 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 117.252 0.526 . . . . 1.9199999999999999 111.639 177.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.407 ' H ' HG23 ' A' ' 52' ' ' VAL . 20.0 mmmt -58.53 -60.8 9.13 Favored Pre-proline 0 CA--C 1.538 0.49 0 O-C-N 121.33 -0.856 . . . . 3.04 112.891 -176.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.62 147.18 27.82 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.564 1.509 . . . . 1.1899999999999999 109.072 172.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -116.52 135.05 54.15 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.099 1.76 . . . . 3.04 107.302 -176.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.01 146.78 45.86 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.447 -0.575 . . . . 1.1599999999999999 109.447 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.59 -26.24 9.14 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 123.927 0.775 . . . . 1.01 111.915 -169.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -84.71 151.63 24.29 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.195 0.998 . . . . 1.53 109.969 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -95.23 130.68 41.88 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.806 0.842 . . . . 5.0300000000000002 108.851 175.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.6 pt -141.31 177.63 3.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 125.025 1.33 . . . . 0.64000000000000001 108.243 177.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.8 mtm-85 -125.7 137.83 53.86 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 122.31 -0.244 . . . . 2.5899999999999999 111.115 166.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.6 p -97.66 134.07 37.16 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.171 0 C-N-CA 124.686 1.194 . . . . 0.90000000000000002 108.049 172.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.09 119.14 1.76 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.602 -0.999 . . . . 0.66000000000000003 110.602 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.59 -163.34 29.27 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.295 -1.522 . . . . 0.60999999999999999 109.295 -175.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.44 142.04 27.87 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.011 0.905 . . . . 2.5699999999999998 111.733 -177.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 39.3 t -87.44 122.55 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-N 115.545 -0.752 . . . . 2.1299999999999999 109.407 172.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.5 m -30.34 -91.62 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 128.843 2.857 . . . . 3.0499999999999998 115.382 -175.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.5 p -172.42 -37.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 124.061 0.944 . . . . 2.23 111.027 -177.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -158.96 40.66 0.49 Allowed Glycine 0 CA--C 1.521 0.439 0 N-CA-C 109.617 -1.393 . . . . 1.8700000000000001 109.617 174.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.3 m -82.25 -17.33 46.35 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.868 -0.195 . . . . 1.0700000000000001 111.093 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.1 ttp -63.23 128.79 37.47 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 122.717 0.407 . . . . 2.3799999999999999 110.487 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.5 m -135.22 143.99 35.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 108.132 -1.062 . . . . 0.56999999999999995 108.132 172.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 47.8 ptt85 -132.39 147.52 52.39 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 124.422 1.089 . . . . 4.6799999999999997 108.516 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -99.76 154.37 37.29 Favored Pre-proline 0 C--O 1.235 0.313 0 N-CA-C 107.944 -1.132 . . . . 2.0899999999999999 107.944 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.41 44.71 1.56 Allowed 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.485 2.79 . . . . 1.8600000000000001 111.526 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -105.75 -41.45 5.43 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.667 1.587 . . . . 1.71 109.088 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.2 m 107.55 -30.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 129.134 2.974 . . . . 2.8999999999999999 110.214 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.34 32.87 4.83 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 124.321 1.048 . . . . 2.7799999999999998 111.741 -177.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -140.04 110.08 6.49 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.41 -1.33 . . . . 3.2000000000000002 107.41 175.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.75 134.17 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.226 -1.398 . . . . 1.04 107.226 177.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -144.46 157.17 44.37 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 120.884 -1.135 . . . . 0.84999999999999998 109.199 175.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -155.09 161.02 41.4 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.691 -0.855 . . . . 1.95 108.691 -173.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -106.74 145.21 32.33 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.548 -0.908 . . . . 0.75 108.548 175.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.9 t -127.96 140.2 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 108.473 -0.936 . . . . 1.8300000000000001 108.473 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -137.17 168.96 18.61 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.552 0.741 . . . . 1.3899999999999999 110.195 -178.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -115.5 10.46 15.69 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.733 0.813 . . . . 2.8599999999999999 110.517 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.5 t 57.97 26.23 13.18 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.529 1.132 . . . . 4.0999999999999996 112.463 -171.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.2 mt -120.72 33.4 5.59 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.377 1.471 . . . . 4.5499999999999998 110.893 -176.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 62.7 39.98 98.61 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 121.679 -0.638 . . . . 2.98 111.8 177.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -153.92 124.27 1.54 Allowed Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 106.98 -2.448 . . . . 1.5900000000000001 106.98 170.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -126.87 128.75 46.99 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.084 -1.821 . . . . 3.7400000000000002 106.084 174.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.2 tp -108.83 160.2 7.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 C-N-CA 125.36 1.464 . . . . 1.1499999999999999 108.14 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 mt -114.65 133.38 55.9 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 108.231 -1.026 . . . . 0.83999999999999997 108.231 -175.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 89.2 t -127.59 131.62 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 124.76 1.224 . . . . 0.96999999999999997 107.798 -174.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.0 p -107.2 150.4 26.66 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.929 0.892 . . . . 0.60999999999999999 109.762 178.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -147.39 140.62 25.25 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.49 1.516 . . . . 2.0299999999999998 107.064 -173.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -132.95 41.45 3.15 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.366 1.066 . . . . 2.1299999999999999 112.574 -168.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -168.25 53.24 0.05 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.557 0.743 . . . . 2.6800000000000002 111.631 -176.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.2 mp 51.02 -155.03 0.14 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.827 1.251 . . . . 1.9399999999999999 111.067 -171.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 81.8 mt -150.18 156.99 37.63 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 106.535 -1.654 . . . . 1.4199999999999999 106.535 -178.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.22 -88.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.434 2.756 . . . . 1.95 110.556 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -77.1 36.36 0.18 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.814 1.246 . . . . 3.6400000000000001 111.254 -175.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 39.89 11.67 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.824 2.849 . . . . 2.1600000000000001 116.983 -163.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 56.08 96.83 0.02 OUTLIER 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.681 1.128 . . . . 3.0699999999999998 109.911 -161.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 7.0 mtm180 -107.92 35.15 3.22 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 117.356 -1.306 . . . . 5.8799999999999999 112.448 172.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . 0.378 4.3 mm-40 78.81 157.75 0.17 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 121.443 1.928 . . . . 4.5099999999999998 112.99 140.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 52.1 26.59 20.44 Favored Glycine 0 CA--C 1.534 1.219 0 O-C-N 120.578 -1.326 . . . . 1.3999999999999999 113.631 167.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -139.73 163.75 31.76 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.54 1.936 . . . . 2.0800000000000001 105.813 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -89.28 145.77 18.66 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.74 -0.944 . . . . 0.72999999999999998 110.74 174.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.7 pp -141.26 159.98 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 106.074 -1.824 . . . . 0.88 106.074 173.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.2 m -124.02 122.82 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 108.488 -0.93 . . . . 0.69999999999999996 108.488 172.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -115.32 127.77 55.66 Favored 'General case' 0 C--O 1.228 -0.072 0 C-N-CA 125.747 1.619 . . . . 0.48999999999999999 109.93 -172.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -106.74 134.99 49.04 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.863 1.265 . . . . 3.25 109.502 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -173.72 -175.93 41.79 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.398 -0.429 . . . . 1.1899999999999999 112.97 -174.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.6 p -124.41 141.57 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 124.58 1.152 . . . . 1.03 109.394 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.2 mp -78.11 137.74 38.36 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.276 -0.875 . . . . 2.3700000000000001 109.014 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -156.42 37.16 0.59 Allowed Glycine 0 CA--C 1.521 0.453 0 N-CA-C 111.3 -0.72 . . . . 2.5800000000000001 111.3 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -157.45 27.86 0.29 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.882 0.873 . . . . 4.3099999999999996 109.545 -175.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 43.91 41.72 4.09 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.045 0.938 . . . . 4.0 111.915 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 159.88 -60.33 0.31 Allowed Glycine 0 CA--C 1.529 0.947 0 N-CA-C 110.837 -0.905 . . . . 1.99 110.837 -171.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.44 160.69 20.53 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 122.307 -0.525 . . . . 2.7799999999999998 111.096 -173.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 mp -125.26 126.26 44.86 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.072 0.949 . . . . 1.96 110.036 -170.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -92.8 108.97 20.4 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.096 -1.076 . . . . 0.60999999999999999 108.096 172.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -134.04 102.05 5.27 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.425 0.69 . . . . 1.29 111.938 -173.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.8 t -86.43 -25.01 25.46 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.193 0.997 . . . . 0.96999999999999997 111.843 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -88.43 79.43 7.69 Favored 'General case' 0 N--CA 1.455 -0.22 0 O-C-N 119.84 -1.788 . . . . 2.6400000000000001 109.713 -174.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.9 m -96.42 122.37 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 118.306 0.503 . . . . 0.79000000000000004 110.907 174.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -112.44 113.63 25.92 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.684 -1.599 . . . . 0.83999999999999997 106.684 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -99.87 26.73 6.04 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.855 0.862 . . . . 2.2000000000000002 112.606 -172.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.13 42.0 0.63 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.55 0.945 . . . . 5.1900000000000004 113.55 -164.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -76.05 -52.52 10.01 Favored 'General case' 0 C--N 1.333 -0.111 0 O-C-N 121.585 -0.697 . . . . 5.0599999999999996 109.216 173.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.5 t70 . . . . . 0 CA--C 1.534 0.362 0 N-CA-C 109.43 -0.582 . . . . 5.8200000000000003 109.43 177.227 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 CA--C 1.529 0.14 0 N-CA-C 108.737 -0.838 . . . . 6.7599999999999998 108.737 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -81.35 134.53 35.58 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.349 0.66 . . . . 8.7100000000000009 109.987 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.9 mp -107.25 97.03 6.84 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.349 1.06 . . . . 5.4400000000000004 108.851 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -158.56 81.24 0.81 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.248 0.477 . . . . 3.7200000000000002 111.595 175.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.32 169.44 14.87 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.454 1.024 . . . . 2.0899999999999999 112.475 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -84.13 126.49 33.15 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.424 1.49 . . . . 2.1499999999999999 110.11 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.16 150.71 52.03 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.27 1.428 . . . . 2.7799999999999998 110.518 -177.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 36.2 m -76.7 124.05 87.66 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 125.73 1.612 . . . . 1.9199999999999999 111.48 -175.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -55.36 -43.4 58.81 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.987 2.458 . . . . 0.73999999999999999 111.857 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.6 m -60.1 -25.17 65.22 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.131 0.789 . . . . 2.8500000000000001 113.131 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -68.65 -56.88 6.73 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.139 -1.06 . . . . 3.25 108.139 171.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.6 pt -72.96 30.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 114.571 1.323 . . . . 1.0800000000000001 114.571 -171.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.2 p -107.51 -29.73 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 125.214 1.406 . . . . 1.9299999999999999 110.827 170.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -87.1 -118.7 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.969 0.89 . . . . 3.3900000000000001 109.937 -170.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -84.88 66.61 3.84 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 108.554 -1.818 . . . . 1.3400000000000001 108.554 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -142.38 -125.31 0.09 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.503 1.121 . . . . 2.9100000000000001 108.074 -173.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.419 HG21 HD21 ' A' ' 122' ' ' LEU . 5.9 t -76.66 -38.4 54.6 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 119.183 0.901 . . . . 2.8100000000000001 111.387 -172.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -58.31 -50.35 73.95 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.397 0.618 . . . . 2.7400000000000002 109.537 -178.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.9 m -81.04 -24.95 37.5 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.211 -0.904 . . . . 1.48 111.269 177.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.21 43.34 47.61 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.663 1.125 . . . . 1.0900000000000001 111.988 175.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.0 m -98.41 -42.18 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 117.657 0.728 . . . . 1.1799999999999999 112.757 -172.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -109.71 -65.77 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.777 1.231 . . . . 3.5899999999999999 111.975 -176.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -76.85 171.25 18.32 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 N-CA-C 108.224 -1.491 . . . . 1.1799999999999999 108.224 169.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.5 158.56 43.82 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.351 0.66 . . . . 5.4100000000000001 109.39 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.57 126.94 31.26 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.489 -1.3 . . . . 1.49 107.489 175.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 127.31 -17.68 6.19 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.275 1.417 . . . . 1.1799999999999999 112.198 -176.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -93.31 148.7 21.82 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.192 0.997 . . . . 2.9399999999999999 110.523 -172.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -85.49 134.58 34.04 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.051 -0.722 . . . . 3.4900000000000002 109.051 172.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.1 pt -145.73 175.03 2.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 105.685 -1.969 . . . . 0.64000000000000001 105.685 164.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -120.89 122.99 41.44 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.329 -1.36 . . . . 2.1899999999999999 107.329 171.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.7 p -88.81 131.91 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 107.558 -1.275 . . . . 0.77000000000000002 107.558 176.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -135.42 121.66 2.6 Favored Glycine 0 C--N 1.336 0.529 0 CA-C-N 119.052 0.842 . . . . 0.51000000000000001 111.002 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -172.88 -172.47 38.56 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.907 -0.877 . . . . 0.58999999999999997 110.907 -175.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -92.48 127.79 38.09 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.579 1.152 . . . . 4.5700000000000003 109.649 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.7 t -77.65 146.97 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.583 -0.735 . . . . 2.0899999999999999 109.721 176.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.552 HG22 HG12 ' A' ' 68' ' ' VAL . 2.1 m -55.66 -90.36 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.927 1.691 . . . . 3.04 114.155 -178.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.552 HG12 HG22 ' A' ' 67' ' ' THR . 7.4 p 176.16 -44.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.757 1.623 . . . . 2.3599999999999999 109.956 -170.013 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -150.26 39.44 0.86 Allowed Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.382 -1.087 . . . . 2.1200000000000001 110.382 176.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 61.6 m -87.22 -19.09 28.86 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 117.4 0.6 . . . . 1.05 112.153 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.3 ttp -71.76 123.82 23.44 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 118.803 0.729 . . . . 2.48 109.101 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.6 m -121.61 132.49 70.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 107.592 -1.262 . . . . 0.52000000000000002 107.592 173.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.433 ' CB ' HG12 ' A' ' 80' ' ' VAL . 29.7 ptt85 -117.2 153.27 33.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.939 0.895 . . . . 4.8899999999999997 109.904 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.28 170.19 17.39 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 109.9 -0.407 . . . . 2.5 109.9 170.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.35 -33.28 5.7 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.424 2.749 . . . . 1.6100000000000001 110.604 163.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -46.13 -40.17 10.58 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 126.221 1.808 . . . . 1.6499999999999999 110.232 -177.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.2 m 78.68 17.53 1.02 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.616 1.966 . . . . 1.71 112.666 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.76 23.96 7.21 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.445 0.698 . . . . 3.1899999999999999 112.407 164.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -144.87 118.75 9.3 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.183 -1.043 . . . . 1.49 108.183 177.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.487 HG23 ' HB3' ' A' ' 96' ' ' TYR . 35.8 m -139.82 143.56 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 106.928 -1.508 . . . . 0.94999999999999996 106.928 173.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -139.49 159.03 43.1 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.419 -0.586 . . . . 0.83999999999999997 109.419 172.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -154.84 159.17 40.36 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 122.975 0.51 . . . . 1.8500000000000001 109.73 -175.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.55 147.63 26.53 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.834 -0.802 . . . . 0.59999999999999998 108.834 172.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.3 p -144.6 144.77 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 109.244 -0.65 . . . . 1.95 109.244 174.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -141.0 175.84 9.3 Favored 'General case' 0 C--O 1.228 -0.053 0 C-N-CA 125.359 1.464 . . . . 1.27 107.947 -175.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -120.24 16.91 12.33 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.367 0.603 . . . . 2.6699999999999999 110.97 175.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.3 m 52.93 26.54 4.75 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.344 1.058 . . . . 4.6200000000000001 113.316 -175.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 71.6 mt -93.25 -62.39 1.38 Allowed 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.476 -0.565 . . . . 4.9500000000000002 109.476 174.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.86 55.47 0.04 OUTLIER Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.367 -1.093 . . . . 3.1699999999999999 110.367 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 175.12 148.82 6.92 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 108.345 -1.902 . . . . 1.8100000000000001 108.345 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -135.67 145.78 47.12 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 105.745 -1.946 . . . . 3.3199999999999998 105.745 178.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.36 139.32 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 107.351 -1.351 . . . . 0.84999999999999998 107.351 176.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.0 mt -87.73 138.36 31.53 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.684 -0.858 . . . . 0.81999999999999995 108.684 173.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.5 t -124.38 135.71 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 C-N-CA 126.002 1.721 . . . . 0.93999999999999995 106.608 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.1 p -110.13 156.38 20.67 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.997 1.319 . . . . 0.66000000000000003 108.236 178.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.487 ' HB3' HG23 ' A' ' 80' ' ' VAL . 1.1 t80 -151.7 108.07 3.45 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.597 -1.26 . . . . 2.8300000000000001 107.597 177.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -84.17 51.36 2.05 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.733 1.213 . . . . 2.6699999999999999 110.75 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -164.64 -178.17 5.19 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.867 1.267 . . . . 2.6600000000000001 108.094 171.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.03 158.5 32.78 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.115 0.966 . . . . 1.47 111.563 169.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.489 HD13 ' HB2' ' A' ' 104' ' ' PHE . 5.1 mt -96.04 165.27 16.72 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 126.123 1.769 . . . . 1.4299999999999999 109.923 174.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.96 -100.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.758 2.972 . . . . 2.2000000000000002 109.4 172.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -78.32 54.55 1.42 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.281 1.033 . . . . 2.8799999999999999 110.537 -175.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 42.1 18.58 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.822 2.449 . . . . 2.2200000000000002 115.678 -171.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.489 ' HB2' HD13 ' A' ' 100' ' ' LEU . 6.2 t80 60.61 97.25 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.91 0.884 . . . . 2.3399999999999999 110.688 -163.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 -77.91 111.45 13.77 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 105.736 -1.95 . . . . 8.3200000000000003 105.736 175.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -81.99 173.78 11.88 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.778 0.323 . . . . 5.0999999999999996 110.747 178.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.13 34.89 89.57 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.923 -0.471 . . . . 0.81999999999999995 111.923 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -156.3 175.84 13.47 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.655 1.582 . . . . 2.46 107.136 175.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -92.87 134.89 12.39 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.565 -0.614 . . . . 0.69999999999999996 111.565 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.2 pp -133.05 159.48 43.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.941 -0.763 . . . . 0.76000000000000001 108.941 174.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 31.5 m -125.67 122.86 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 107.808 -1.182 . . . . 0.54000000000000004 107.808 176.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -119.51 117.22 27.82 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.854 1.262 . . . . 0.55000000000000004 109.901 -171.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -106.84 143.35 35.06 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.379 1.071 . . . . 3.7400000000000002 110.711 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 179.66 -118.79 0.61 Allowed Glycine 0 C--N 1.335 0.501 0 N-CA-C 108.823 -1.711 . . . . 1.0700000000000001 108.823 169.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.8 p -150.91 144.38 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 118.006 0.903 . . . . 0.88 109.217 -176.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.929 HD22 HD22 ' A' ' 122' ' ' LEU . 5.5 mt -81.98 139.36 34.61 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.306 -1.368 . . . . 2.3799999999999999 107.306 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -177.43 26.4 0.06 OUTLIER Glycine 0 C--N 1.333 0.414 0 C-N-CA 119.045 -1.55 . . . . 2.6400000000000001 113.053 -174.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -141.25 41.18 1.77 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.974 -0.75 . . . . 6.3799999999999999 108.974 -172.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 22.28 57.84 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 129.541 3.136 . . . . 4.4299999999999997 112.933 175.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 139.79 -33.84 2.08 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-N 115.377 -0.829 . . . . 1.0900000000000001 112.492 -171.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.88 167.42 12.14 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.428 1.114 . . . . 2.6299999999999999 110.334 -175.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.929 HD22 HD22 ' A' ' 116' ' ' LEU . 8.4 mt -118.15 128.94 55.21 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.659 1.183 . . . . 1.9199999999999999 109.486 -174.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -89.15 94.66 10.01 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.096 -1.446 . . . . 0.51000000000000001 107.096 175.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -115.5 111.29 20.52 Favored 'General case' 0 C--O 1.228 -0.069 0 C-N-CA 122.949 0.5 . . . . 1.3500000000000001 110.163 -173.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.85 -43.66 8.1 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.12 0.968 . . . . 1.3 110.44 -174.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -84.51 79.06 9.7 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.95 -1.13 . . . . 3.5600000000000001 107.95 -170.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.486 HG21 HD23 ' A' ' 100' ' ' LEU . 4.4 m -90.0 96.44 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 125.794 1.637 . . . . 1.4099999999999999 111.262 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.81 149.97 20.93 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 108.81 -0.811 . . . . 0.94999999999999996 108.81 175.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -126.56 70.72 1.26 Allowed 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 123.894 0.878 . . . . 1.49 109.915 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -65.27 -10.04 29.02 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.482 0.919 . . . . 3.6699999999999999 113.482 -177.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -69.68 -56.89 5.98 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.468 0.707 . . . . 5.4100000000000001 109.63 176.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.14 0 C-N-CA 124.177 0.991 . . . . 6.3099999999999996 108.447 -178.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.0 t . . . . . 0 CA--C 1.531 0.236 0 CA-C-O 120.762 0.315 . . . . 8.8900000000000006 110.681 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -144.27 170.56 15.76 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.993 1.317 . . . . 8.8200000000000003 108.13 -171.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 26.8 tp -142.33 168.94 18.56 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.264 1.426 . . . . 5.2199999999999998 107.886 -177.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -159.1 75.76 0.69 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.234 0.614 . . . . 4.5899999999999999 112.163 -166.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.0 pp -138.35 167.25 22.28 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.631 1.105 . . . . 2.2599999999999998 112.693 -176.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -92.29 127.64 37.84 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.773 1.629 . . . . 2.1800000000000002 111.366 -175.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.59 152.32 50.09 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.21 1.804 . . . . 2.71 110.405 -173.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.4 m -89.91 129.35 46.62 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.103 1.361 . . . . 1.6200000000000001 111.525 -174.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -57.23 -53.24 5.06 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.543 2.828 . . . . 0.69999999999999996 112.594 -176.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.0 m -57.38 -12.41 2.51 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 114.29 1.219 . . . . 3.1899999999999999 114.29 176.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -82.67 -53.17 6.14 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 118.861 0.755 . . . . 3.0899999999999999 108.985 170.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 26.8 pt -73.27 33.11 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 114.106 1.151 . . . . 1.22 114.106 -176.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.635 HG21 ' HA3' ' A' ' 90' ' ' GLY . 22.0 m -126.64 -54.61 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 126.323 1.849 . . . . 3.1000000000000001 109.786 169.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.438 ' N ' HG23 ' A' ' 44' ' ' VAL . 42.8 m-80 -65.23 -34.49 78.49 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.701 0.8 . . . . 2.77 112.761 -163.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.62 68.71 0.1 OUTLIER Glycine 0 C--N 1.335 0.518 0 N-CA-C 110.27 -1.132 . . . . 1.8100000000000001 110.27 -177.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -165.41 -99.24 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.992 1.717 . . . . 2.98 108.36 -171.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 55.8 m -62.99 -63.71 1.12 Allowed 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 119.094 0.861 . . . . 1.4299999999999999 110.561 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.2 -44.8 64.93 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.777 0.799 . . . . 3.5699999999999998 111.162 -172.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.79 -17.81 52.48 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.619 1.168 . . . . 1.49 112.516 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 53.36 52.05 43.4 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.76 1.648 . . . . 1.4099999999999999 112.233 -175.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.1 m -105.99 -60.33 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 117.94 0.87 . . . . 1.79 113.088 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.1 mmtt -80.18 -61.49 0.44 Allowed Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 118.512 -0.756 . . . . 3.7400000000000002 112.339 -178.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -79.82 148.68 20.09 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 121.891 1.727 . . . . 1.5900000000000001 108.643 174.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -93.12 145.93 24.03 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.004 -1.11 . . . . 3.3900000000000001 108.004 165.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.88 169.02 5.58 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.136 0.574 . . . . 1.8600000000000001 110.33 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.04 33.82 86.92 Favored Glycine 0 CA--C 1.532 1.1 0 O-C-N 121.928 -0.482 . . . . 1.25 112.57 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -118.54 159.1 24.15 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.308 1.043 . . . . 1.98 108.764 170.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.5 128.02 45.59 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.122 1.369 . . . . 4.71 108.765 -177.151 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.2 pt -146.17 176.84 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 124.062 0.945 . . . . 0.81999999999999995 108.56 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.3 mtt85 -119.14 130.66 55.66 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.679 -0.86 . . . . 2.5600000000000001 108.679 167.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.9 p -95.43 130.37 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 107.041 -1.466 . . . . 0.76000000000000001 107.041 171.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.58 120.06 1.88 Allowed Glycine 0 C--N 1.332 0.36 0 N-CA-C 110.131 -1.188 . . . . 0.46999999999999997 110.131 -176.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.47 -159.67 21.87 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.45 -1.46 . . . . 0.63 109.45 -178.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.477 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 0.0 OUTLIER -100.69 132.22 46.19 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.918 0.866 . . . . 2.8999999999999999 111.922 -174.62 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.1 t -86.47 111.7 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.433 -0.951 . . . . 1.95 108.433 176.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 t -5.82 -102.31 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 128.624 2.769 . . . . 3.1299999999999999 114.668 163.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.7 p -158.69 -41.59 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 N-CA-C 113.548 0.944 . . . . 2.3399999999999999 113.548 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -161.26 33.33 0.38 Allowed Glycine 0 C--N 1.332 0.357 0 N-CA-C 110.995 -0.842 . . . . 3.0 110.995 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.2 m -80.25 12.73 2.72 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.739 0.644 . . . . 1.3799999999999999 112.739 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -78.04 107.6 10.72 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.948 -1.13 . . . . 2.0600000000000001 107.948 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -106.83 127.65 62.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 108.043 -1.095 . . . . 0.56000000000000005 108.043 176.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.446 ' CB ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -108.37 142.75 38.24 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.071 0.949 . . . . 4.8099999999999996 110.273 178.402 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -71.79 158.02 88.56 Favored Pre-proline 0 C--O 1.232 0.146 0 C-N-CA 123.18 0.592 . . . . 2.1299999999999999 109.521 170.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.4 -24.64 64.1 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.73 2.287 . . . . 1.22 112.346 170.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 76.1 m-80 -44.69 -34.4 2.21 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.11 0.564 . . . . 1.4299999999999999 110.886 165.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.9 m 75.2 1.53 3.73 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.801 1.64 . . . . 1.51 112.73 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 79' ' ' HIS . 0.6 OUTLIER -121.77 -13.74 8.23 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.937 1.695 . . . . 2.0299999999999998 112.689 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.494 ' N ' HD12 ' A' ' 78' ' ' LEU . 36.9 m-70 -106.48 121.41 44.21 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 105.897 -1.89 . . . . 1.3500000000000001 105.897 176.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.499 HG23 ' HB3' ' A' ' 96' ' ' TYR . 31.0 m -145.88 137.87 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 107.314 -1.365 . . . . 0.79000000000000004 107.314 -172.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -139.46 152.68 47.2 Favored 'General case' 0 C--O 1.233 0.223 0 O-C-N 121.604 -0.685 . . . . 0.91000000000000003 110.452 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -150.88 158.19 43.84 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.981 -0.554 . . . . 1.8999999999999999 110.411 -173.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -112.51 141.72 45.92 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.688 -1.227 . . . . 0.69999999999999996 107.688 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.5 p -141.87 146.16 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.244 0.618 . . . . 1.8700000000000001 109.95 -174.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -145.2 -177.94 5.81 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.99 1.316 . . . . 1.47 109.49 -170.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -118.92 25.46 10.19 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.436 0.694 . . . . 2.29 109.858 175.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 67.2 m 42.3 43.35 2.93 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 125.495 1.518 . . . . 5.3399999999999999 113.361 -175.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 22.4 mt -119.03 -70.02 0.82 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.918 0.887 . . . . 4.2599999999999998 109.214 175.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 179.79 66.25 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 108.858 -1.697 . . . . 2.9100000000000001 108.858 -176.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.635 ' HA3' HG21 ' A' ' 44' ' ' VAL . . . 170.06 113.45 0.29 Allowed Glycine 0 N--CA 1.443 -0.852 0 CA-C-O 118.748 -1.029 . . . . 1.79 111.074 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -117.61 132.08 56.57 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 108.024 -1.102 . . . . 3.5 108.024 174.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.6 tp -114.71 160.06 14.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 124.292 1.037 . . . . 1.1000000000000001 108.403 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.2 mt -112.28 128.81 56.38 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.6 0.76 . . . . 0.76000000000000001 109.091 -173.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.0 t -114.77 125.8 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 125.52 1.528 . . . . 0.90000000000000002 107.549 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.9 p -102.22 138.9 38.55 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.904 -0.776 . . . . 0.58999999999999997 108.904 175.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.499 ' HB3' HG23 ' A' ' 80' ' ' VAL . 1.9 t80 -132.7 111.74 11.42 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.134 1.374 . . . . 2.1299999999999999 107.415 -176.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -98.79 45.96 1.0 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.161 1.384 . . . . 1.9399999999999999 110.998 -176.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -164.6 -178.49 5.38 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.325 1.85 . . . . 2.7400000000000002 107.526 170.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.4 mp -80.77 148.66 29.96 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.738 0.78 . . . . 1.8 111.462 176.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.478 HD23 HG21 ' A' ' 80' ' ' VAL . 1.5 mm? -76.72 159.37 79.25 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 124.955 1.302 . . . . 2.5 110.295 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.29 -90.3 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.514 2.809 . . . . 2.1200000000000001 109.274 168.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.88 50.05 0.56 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.765 1.626 . . . . 3.0299999999999998 110.781 178.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . 0.254 0.3 OUTLIER 44.15 7.4 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 118.53 2.789 . . . . 3.1899999999999999 118.53 -177.653 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 79.4 t80 72.26 99.56 0.07 Allowed 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 126.148 1.779 . . . . 3.1000000000000001 109.192 -162.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -81.38 103.45 11.14 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.092 0.957 . . . . 4.9199999999999999 109.75 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -80.95 163.86 23.0 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.099 0.863 . . . . 3.1899999999999999 111.932 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.56 17.4 66.68 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 118.594 -1.114 . . . . 1.47 113.372 172.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -157.29 42.13 0.33 Allowed 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 119.308 1.554 . . . . 3.6099999999999999 113.452 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 65' ' ' MET . . . 31.29 141.53 0.0 OUTLIER Glycine 0 CA--C 1.531 1.079 0 C-N-CA 128.689 3.043 . . . . 1.02 118.847 -172.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.3 pp -140.39 163.23 23.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 120.099 -1.824 . . . . 0.93999999999999995 107.537 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.6 m -110.28 137.05 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 107.628 -1.249 . . . . 0.89000000000000001 107.628 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.425 ' CB ' HG12 ' A' ' 127' ' ' VAL . . . -123.12 128.84 50.64 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 124.076 0.95 . . . . 0.48999999999999999 109.185 178.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -111.06 140.02 45.95 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.687 -0.486 . . . . 3.6600000000000001 109.687 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 168.81 -152.04 19.3 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 121.028 -0.606 . . . . 1.0700000000000001 111.606 173.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.1 p -113.76 145.73 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.008 0.923 . . . . 0.67000000000000004 108.917 -169.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -55.22 142.52 31.11 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.437 -0.579 . . . . 1.8600000000000001 109.437 168.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.51 -131.71 1.6 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.312 -1.115 . . . . 2.3199999999999998 110.312 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -63.31 -82.24 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.339 1.056 . . . . 5.6100000000000003 109.886 -177.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -159.65 62.67 0.37 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 107.828 -1.175 . . . . 3.7200000000000002 107.828 173.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 163.52 -61.04 0.26 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.102 -1.199 . . . . 1.1899999999999999 110.102 -172.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.18 160.87 26.76 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.692 -0.887 . . . . 2.1699999999999999 108.994 -175.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 mp -122.68 137.34 54.94 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 109.62 -0.511 . . . . 1.9299999999999999 109.62 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -103.37 103.24 13.22 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.365 -0.976 . . . . 0.5 108.365 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -131.15 115.42 16.36 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 122.587 0.355 . . . . 1.03 111.017 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.2 t -109.42 -15.44 14.23 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.586 1.154 . . . . 1.0 111.749 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -104.21 80.2 1.69 Allowed 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.626 -1.296 . . . . 3.1499999999999999 109.081 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.425 HG12 ' CB ' ' A' ' 112' ' ' ALA . 34.6 m -90.12 149.44 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 118.784 0.72 . . . . 0.70999999999999996 111.496 174.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.17 142.81 51.37 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.283 -1.006 . . . . 0.93000000000000005 108.283 169.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -122.9 65.46 0.97 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.426 1.09 . . . . 1.3899999999999999 111.109 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.21 42.58 1.04 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.777 0.658 . . . . 2.9700000000000002 112.777 -175.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -140.45 67.05 1.37 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.666 0.786 . . . . 5.46 110.122 -175.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 . . . . . 0 CA--C 1.534 0.335 0 C-N-CA 125.921 1.688 . . . . 5.4000000000000004 109.879 -176.394 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.0 t . . . . . 0 N--CA 1.454 -0.267 0 N-CA-C 107.844 -1.169 . . . . 9.0399999999999991 107.844 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -165.31 56.41 0.12 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.743 0.817 . . . . 7.4400000000000004 110.495 -173.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.3 mt -125.24 133.98 52.49 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.816 1.247 . . . . 5.4000000000000004 108.119 177.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -160.63 88.29 0.78 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.212 1.005 . . . . 4.1600000000000001 110.804 -174.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -138.13 161.65 36.26 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.653 -1.279 . . . . 1.8 112.022 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -83.72 122.36 28.53 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.433 1.093 . . . . 2.1200000000000001 109.059 176.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.33 159.58 37.49 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.282 1.033 . . . . 3.2799999999999998 108.853 171.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 53.3 p -79.73 148.4 68.99 Favored Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 109.147 -0.686 . . . . 1.5600000000000001 109.147 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -60.87 -28.87 87.07 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 121.335 1.356 . . . . 0.77000000000000002 110.697 176.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.5 p -52.67 -28.8 23.21 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.153 0.981 . . . . 2.46 112.775 171.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -81.78 -10.48 59.33 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.019 -0.425 . . . . 2.1600000000000001 111.424 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.3 pt -127.68 34.19 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 O-C-N 120.788 -1.195 . . . . 1.3999999999999999 113.832 -176.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.422 HG12 HG12 ' A' ' 92' ' ' ILE . 3.6 m -119.85 -23.66 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 119.129 0.877 . . . . 3.1699999999999999 113.072 -176.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -139.21 132.28 29.59 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 107.123 -1.436 . . . . 4.04 107.123 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.59 -73.06 1.2 Allowed Glycine 0 CA--C 1.529 0.931 0 CA-C-O 122.465 1.036 . . . . 3.8399999999999999 111.173 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.4 mttt -44.1 -83.77 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 129.891 3.276 . . . . 4.21 111.428 -174.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.2 m -75.63 -48.02 23.95 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 121.273 1.851 . . . . 1.45 109.803 171.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -49.74 -36.78 26.88 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.078 1.14 . . . . 3.3999999999999999 114.078 -172.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.1 m -123.96 19.09 9.28 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.266 1.426 . . . . 2.8500000000000001 109.602 176.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 48.13 37.01 16.36 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 117.245 -1.864 . . . . 2.25 114.7 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.257 21.9 m -82.85 -43.08 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 122.106 2.953 . . . . 2.1600000000000001 113.18 -168.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -93.73 -64.01 0.14 Allowed Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.585 1.154 . . . . 4.9100000000000001 112.718 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.38 166.14 30.68 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.484 2.122 . . . . 1.74 109.705 176.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -118.65 129.25 55.2 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.335 0.654 . . . . 4.6699999999999999 109.907 170.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.12 111.74 1.29 Allowed 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.513 -0.551 . . . . 1.3 109.513 173.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 133.65 -20.81 4.08 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 124.363 0.982 . . . . 1.1399999999999999 111.567 -176.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -83.18 155.85 23.53 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 117.758 0.779 . . . . 2.52 109.211 177.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.0 mtt-85 -87.2 144.95 26.6 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.669 -0.863 . . . . 4.2599999999999998 108.669 170.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.4 pt -146.96 173.4 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 106.505 -1.665 . . . . 0.69999999999999996 106.505 170.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -124.67 118.36 26.31 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.516 -1.29 . . . . 2.4500000000000002 107.516 174.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.27 121.13 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.666 -1.235 . . . . 0.77000000000000002 107.666 177.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -127.83 123.44 4.47 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 109.907 -1.277 . . . . 0.48999999999999999 109.907 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.79 -162.66 23.52 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 108.068 -2.013 . . . . 0.64000000000000001 108.068 -176.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.78 137.02 37.97 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.804 0.811 . . . . 2.5699999999999998 110.565 177.146 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.5 t -79.23 137.86 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 108.5 -0.926 . . . . 2.1899999999999999 108.5 171.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -89.92 148.65 23.0 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.317 -0.994 . . . . 2.4399999999999999 108.317 169.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.4 p -57.67 -61.12 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.189 0.996 . . . . 2.21 110.796 178.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.55 73.46 2.05 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 109.161 -1.575 . . . . 2.1499999999999999 109.161 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.5 m -148.51 -44.42 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.152 0.797 . . . . 1.46 113.152 -177.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.421 ' HA ' ' HE3' ' A' ' 71' ' ' MET . 0.0 OUTLIER -66.81 122.31 17.39 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.227 0.467 . . . . 1.8 110.162 -177.63 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.24 120.42 48.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 108.336 -0.987 . . . . 0.56999999999999995 108.336 169.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.29 147.89 24.19 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.912 1.285 . . . . 4.3099999999999996 109.407 177.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -76.34 154.92 84.15 Favored Pre-proline 0 N--CA 1.455 -0.211 0 N-CA-C 109.008 -0.738 . . . . 1.9099999999999999 109.008 171.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -63.89 -22.8 68.68 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.608 2.205 . . . . 1.1599999999999999 111.963 166.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -47.22 -29.12 2.19 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.401 0.68 . . . . 1.1200000000000001 110.809 164.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.1 m 68.71 15.97 8.99 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 125.261 1.424 . . . . 1.3300000000000001 112.081 176.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.2 pp -125.8 -41.57 1.97 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 126.712 2.005 . . . . 1.6699999999999999 111.744 -178.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -85.43 132.31 34.24 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.538 -1.282 . . . . 1.1000000000000001 107.538 175.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.474 ' HB ' HD12 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -140.18 127.91 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 107.058 -1.46 . . . . 0.88 107.058 176.612 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -130.48 149.9 51.94 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.018 -0.734 . . . . 0.80000000000000004 109.018 176.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -145.3 143.35 30.15 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.33 -0.618 . . . . 1.8899999999999999 109.33 -175.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.84 141.87 33.05 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.327 -0.99 . . . . 0.75 108.327 164.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.6 p -128.02 153.48 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 107.472 -1.307 . . . . 1.77 107.472 170.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -140.18 179.96 6.33 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.235 0.471 . . . . 1.55 111.735 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -134.12 170.82 15.1 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.461 1.104 . . . . 2.3399999999999999 108.278 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.3 m -54.95 -34.78 63.58 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.854 0.862 . . . . 3.6099999999999999 110.101 166.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 12.7 mt -83.16 33.33 0.45 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.1 0.778 . . . . 5.0300000000000002 113.1 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 62.83 25.07 67.26 Favored Glycine 0 CA--C 1.527 0.813 0 O-C-N 121.686 -0.634 . . . . 2.96 112.797 167.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -81.46 56.93 4.9 Favored Glycine 0 C--O 1.223 -0.559 0 CA-C-O 118.721 -1.044 . . . . 2.2799999999999998 113.296 -165.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -63.43 108.57 1.37 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.295 1.547 . . . . 3.1800000000000002 110.216 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.422 HG12 HG12 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -130.53 143.85 39.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 108.447 -0.945 . . . . 1.1399999999999999 108.447 176.353 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.415 ' H ' HD13 ' A' ' 92' ' ' ILE . 17.9 mt -92.02 126.01 36.94 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.273 1.029 . . . . 0.75 110.75 178.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.5 t -108.84 122.79 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 125.879 1.671 . . . . 0.87 107.504 175.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.6 p -102.4 136.15 42.75 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.321 1.048 . . . . 0.46999999999999997 108.954 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.419 ' CD2' HD21 ' A' ' 100' ' ' LEU . 2.9 t80 -130.85 109.22 10.41 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.222 1.409 . . . . 1.9399999999999999 107.933 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -91.93 47.91 1.39 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.885 1.274 . . . . 2.3300000000000001 111.683 -176.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -167.68 173.37 8.53 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.22 1.808 . . . . 2.5299999999999998 107.07 170.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.4 mp -70.37 127.02 31.32 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.981 -1.074 . . . . 1.78 111.261 -177.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.474 HD12 ' HB ' ' A' ' 80' ' ' VAL . 11.9 mt -73.44 149.67 88.91 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 123.94 0.896 . . . . 1.25 110.75 174.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -68.53 140.95 49.08 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.838 3.026 . . . . 2.2200000000000002 109.696 175.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 45.85 43.92 10.48 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.307 1.443 . . . . 3.1699999999999999 111.238 -175.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 47.68 16.39 0.07 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 127.229 2.212 . . . . 2.0600000000000001 115.332 -171.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.453 ' CB ' HD13 ' A' ' 100' ' ' LEU . 69.0 t80 59.61 103.72 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.231 1.412 . . . . 2.6499999999999999 110.204 -161.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -78.75 119.93 22.67 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.238 -0.892 . . . . 5.3399999999999999 108.696 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -83.68 165.13 19.19 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 123.311 0.644 . . . . 3.0 111.044 -174.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.06 25.39 69.09 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 119.58 -0.567 . . . . 0.72999999999999998 114.146 172.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -143.55 170.57 15.58 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.734 1.214 . . . . 2.5499999999999998 108.075 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -84.92 129.28 9.14 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 109.775 -1.33 . . . . 0.69999999999999996 109.775 175.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.5 pp -136.17 152.77 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 106.434 -1.691 . . . . 0.59999999999999998 106.434 171.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 18.1 m -115.99 125.69 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 107.863 -1.162 . . . . 0.70999999999999996 107.863 177.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -116.46 134.39 54.92 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 125.09 1.356 . . . . 0.5 109.839 -170.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -126.23 143.28 51.2 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.945 1.298 . . . . 3.1400000000000001 110.628 -176.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 176.51 -123.43 0.9 Allowed Glycine 0 C--N 1.334 0.44 0 N-CA-C 108.55 -1.82 . . . . 0.82999999999999996 108.55 169.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.4 p -139.46 150.98 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 118.381 1.09 . . . . 0.79000000000000004 109.346 -175.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -55.61 133.81 50.69 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.871 -0.604 . . . . 1.8999999999999999 109.789 171.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.74 -135.51 2.35 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 109.135 -1.586 . . . . 2.23 109.135 173.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -74.1 78.25 1.74 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 109.155 -0.683 . . . . 5.6799999999999997 109.155 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.8 t0 19.34 61.37 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 129.414 3.086 . . . . 4.6100000000000003 113.086 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 166.73 -54.4 0.24 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.825 -0.91 . . . . 0.95999999999999996 110.825 -163.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.61 154.05 19.3 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 122.246 -0.561 . . . . 2.7400000000000002 109.521 172.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -111.48 123.84 51.05 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.442 1.097 . . . . 2.1000000000000001 108.646 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -97.25 93.62 6.63 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.054 -1.091 . . . . 0.56999999999999995 108.054 175.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.55 136.8 47.56 Favored 'General case' 0 C--O 1.227 -0.117 0 N-CA-C 109.46 -0.57 . . . . 0.93999999999999995 109.46 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.405 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 14.9 t -124.65 -26.68 3.79 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.236 1.014 . . . . 0.95999999999999996 112.743 177.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -89.48 88.3 7.4 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 120.472 -1.393 . . . . 3.1699999999999999 108.357 177.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.1 m -99.37 125.83 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 118.873 0.76 . . . . 0.68999999999999995 110.798 174.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.03 113.12 20.46 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.171 -1.418 . . . . 0.63 107.171 178.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.41 101.85 10.12 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 108.291 -1.003 . . . . 1.48 108.291 172.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -143.21 65.84 1.32 Allowed 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.431 0.692 . . . . 3.2400000000000002 109.461 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -151.74 -171.69 4.01 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.077 -1.823 . . . . 5.7300000000000004 106.077 175.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 50.8 t0 . . . . . 0 C--O 1.237 0.417 0 N-CA-C 107.616 -1.253 . . . . 7.3399999999999999 107.616 176.695 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.4 t . . . . . 0 CA--C 1.534 0.348 0 N-CA-C 112.054 0.39 . . . . 8.7300000000000004 112.054 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -142.11 165.07 28.47 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.669 1.588 . . . . 7.79 106.833 -177.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 49.7 mt 57.38 38.11 28.26 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.149 0.979 . . . . 6.2000000000000002 111.072 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -160.73 53.25 0.3 Allowed 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.246 -0.909 . . . . 4.3700000000000001 112.832 176.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.74 153.24 28.05 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.063 0.847 . . . . 3.3399999999999999 112.948 -170.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -85.61 122.59 29.94 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 123.812 0.845 . . . . 2.2000000000000002 109.384 170.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -140.78 169.17 18.13 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.768 0.827 . . . . 3.8199999999999998 109.84 171.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.2 p -91.6 148.06 36.53 Favored Pre-proline 0 N--CA 1.45 -0.471 0 C-N-CA 124.096 0.958 . . . . 2.04 110.737 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -60.98 -35.85 85.77 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.564 2.843 . . . . 1.0 111.354 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.417 ' O ' HG12 ' A' ' 44' ' ' VAL . 4.1 p -50.57 -38.6 46.2 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.918 1.287 . . . . 2.5699999999999998 112.031 174.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -60.27 -57.33 13.26 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.074 -1.084 . . . . 2.1299999999999999 108.074 177.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.256 19.5 pt -74.87 21.36 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 115.128 1.529 . . . . 1.0900000000000001 115.128 -166.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 41' ' ' SER . 1.7 p -107.13 -33.56 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 125.02 1.328 . . . . 1.9299999999999999 112.127 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -116.57 94.14 4.5 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.29 -0.881 . . . . 2.21 110.141 -170.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.31 45.66 46.72 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.739 -0.945 . . . . 1.3200000000000001 110.739 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.23 -159.33 0.88 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 103.902 -2.629 . . . . 2.4199999999999999 103.902 178.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.0 m -41.32 -45.83 3.1 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.445 1.898 . . . . 1.5600000000000001 115.078 -167.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -51.11 -47.72 61.9 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.833 0.742 . . . . 2.9700000000000002 112.014 176.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.1 m -78.2 -32.95 50.25 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.148 0.579 . . . . 1.51 111.02 174.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.43 48.49 18.29 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.429 1.014 . . . . 1.3100000000000001 111.145 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 53' ' ' LYS . 0.9 OUTLIER -89.37 -91.61 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 117.042 0.421 . . . . 2.0899999999999999 110.677 177.8 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.413 ' H ' HG23 ' A' ' 52' ' ' VAL . 19.0 mmmt -65.71 -56.67 17.01 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 118.452 -0.785 . . . . 3.3300000000000001 111.945 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.86 120.95 5.25 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 121.426 1.417 . . . . 1.22 109.844 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.24 165.74 18.09 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.582 0.753 . . . . 4.6100000000000003 109.053 170.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.631 ' HB1' ' HA2' ' A' ' 117' ' ' GLY . . . -71.41 173.63 7.63 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 109.07 -0.715 . . . . 1.23 109.07 171.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.16 -2.5 84.2 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 121.033 -1.042 . . . . 1.0800000000000001 113.471 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -94.15 148.8 21.84 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.282 1.041 . . . . 1.4099999999999999 109.198 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -92.78 130.04 38.52 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.105 -0.702 . . . . 4.4199999999999999 109.105 172.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.5 pt -142.66 167.3 14.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 106.426 -1.694 . . . . 0.67000000000000004 106.426 168.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.2 mtt180 -118.09 115.08 24.1 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.88 -1.526 . . . . 1.78 106.88 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.7 p -92.79 123.54 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.767 -1.197 . . . . 0.84999999999999998 107.767 178.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.34 148.97 20.63 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 118.975 0.807 . . . . 0.85999999999999999 111.682 -177.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 167.13 -100.45 0.17 Allowed Glycine 0 C--N 1.335 0.517 0 N-CA-C 109.077 -1.609 . . . . 1.79 109.077 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.7 ptp -145.46 131.23 19.02 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.738 0.769 . . . . 2.8900000000000001 110.016 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.2 p -67.11 157.08 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 119.483 -0.887 . . . . 2.4900000000000002 109.726 178.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.7 -9.88 31.66 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.908 1.077 . . . . 3.3900000000000001 113.908 175.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.253 7.6 p 49.51 68.76 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 123.863 1.792 . . . . 3.4900000000000002 111.564 177.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 142.57 47.75 0.05 OUTLIER Glycine 0 CA--C 1.526 0.731 0 CA-C-N 111.874 -2.421 . . . . 1.8300000000000001 109.861 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.0 m -156.45 -7.52 0.1 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 114.824 1.416 . . . . 1.9399999999999999 114.824 177.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.92 109.89 1.39 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 121.449 1.931 . . . . 1.8899999999999999 108.278 171.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.2 m -124.66 134.92 65.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 108.459 -0.941 . . . . 0.80000000000000004 108.459 174.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.3 ptt85 -113.67 151.05 32.35 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.424 1.089 . . . . 4.5499999999999998 109.677 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.07 160.52 65.63 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 123.082 0.553 . . . . 1.8100000000000001 110.268 175.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -74.54 -26.45 11.89 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.479 2.786 . . . . 1.22 110.584 171.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -43.4 -38.57 2.82 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 124.595 1.158 . . . . 1.71 109.023 169.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.2 m 79.38 2.7 2.28 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.687 1.995 . . . . 1.28 112.012 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.16 31.19 6.07 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.056 2.142 . . . . 2.2200000000000002 109.27 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -156.56 132.49 9.69 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.789 -0.819 . . . . 1.6299999999999999 108.789 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.89 134.47 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 125.75 1.62 . . . . 0.83999999999999997 109.026 -177.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -138.03 158.64 43.91 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 120.826 -1.171 . . . . 0.80000000000000004 110.783 172.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -155.36 153.4 30.4 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.363 0.665 . . . . 1.9299999999999999 109.845 -174.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -112.2 134.8 53.54 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.685 0.794 . . . . 0.67000000000000004 109.633 -179.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.8 t -126.04 142.78 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 108.189 -1.041 . . . . 1.8300000000000001 108.189 -173.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -139.42 -175.39 4.17 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.859 -0.793 . . . . 1.5700000000000001 108.859 177.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -133.62 -9.39 2.81 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.781 1.232 . . . . 2.5800000000000001 109.327 177.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 62.02 26.6 16.05 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.829 1.252 . . . . 4.8099999999999996 111.472 -169.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.9 mp -112.95 -91.41 0.5 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.666 -0.864 . . . . 4.7699999999999996 108.666 170.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -71.98 -33.6 62.5 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.033 0.825 . . . . 3.96 113.637 -170.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 157.66 -158.8 29.35 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 109.804 -1.318 . . . . 1.77 109.804 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -116.88 159.41 22.44 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.246 2.218 . . . . 2.9300000000000002 107.557 178.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -137.77 163.91 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 108.236 -1.024 . . . . 0.96999999999999997 108.236 166.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.7 mt -112.94 132.52 55.31 Favored 'General case' 0 C--N 1.338 0.087 0 C-N-CA 124.625 1.17 . . . . 0.59999999999999998 108.685 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.3 t -118.25 129.94 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 125.193 1.397 . . . . 0.91000000000000003 107.477 -177.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.8 p -107.74 149.75 27.79 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.298 1.039 . . . . 0.60999999999999999 108.299 177.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -144.1 129.75 19.17 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.05 -1.463 . . . . 2.9300000000000002 107.05 176.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -69.33 -84.31 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.359 -0.838 . . . . 2.8999999999999999 110.379 166.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -56.97 163.28 2.06 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.983 0.897 . . . . 2.5699999999999998 112.825 -172.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 mp -63.45 145.54 55.42 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 122.225 1.012 . . . . 1.6299999999999999 111.986 -174.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.481 HD23 HG21 ' A' ' 127' ' ' VAL . 24.9 mt -67.85 156.4 89.4 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 115.023 -0.99 . . . . 1.23 109.997 169.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.77 -89.4 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.492 3.461 . . . . 2.3500000000000001 109.619 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.2 17.82 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.94 1.296 . . . . 2.8999999999999999 113.581 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 16.5 tp 53.24 20.6 1.92 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.485 1.114 . . . . 3.5600000000000001 111.937 -167.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 49.55 81.75 0.05 Allowed 'General case' 0 C--N 1.344 0.368 0 C-N-CA 124.94 1.296 . . . . 2.5800000000000001 110.828 173.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.294 7.8 mmm180 -87.72 29.75 0.88 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 117.872 -1.531 . . . . 5.7300000000000004 112.452 -166.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . 0.604 25.9 mt-10 80.26 161.87 0.17 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.517 1.527 . . . . 4.5099999999999998 111.807 157.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 29.9 52.95 0.19 Allowed Glycine 0 CA--C 1.533 1.198 0 C-N-CA 126.346 1.927 . . . . 0.97999999999999998 115.785 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -152.54 51.34 0.77 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.853 1.326 . . . . 3.4300000000000002 112.536 -174.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 4.67 98.34 0.0 OUTLIER Glycine 0 CA--C 1.535 1.332 0 C-N-CA 127.888 2.661 . . . . 0.92000000000000004 116.354 -174.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.0 pp -108.4 165.13 5.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 106.977 -1.49 . . . . 0.64000000000000001 106.977 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.6 m -123.62 133.97 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 107.583 -1.266 . . . . 0.72999999999999998 107.583 173.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -126.54 138.1 53.44 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.15 1.78 . . . . 0.58999999999999997 108.891 -170.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -143.02 155.88 44.73 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.972 0.805 . . . . 3.8900000000000001 112.403 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -177.08 -100.26 0.13 Allowed Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 108.386 -1.886 . . . . 1.3799999999999999 108.386 172.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.9 p -155.91 151.0 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 118.153 0.976 . . . . 0.64000000000000001 110.153 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.59 ' HG ' HD12 ' A' ' 122' ' ' LEU . 1.1 mp -85.64 150.95 24.26 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.226 1.01 . . . . 2.48 108.809 176.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.631 ' HA2' ' HB1' ' A' ' 56' ' ' ALA . . . -166.99 -53.86 0.03 OUTLIER Glycine 0 C--O 1.227 -0.322 0 C-N-CA 120.577 -0.82 . . . . 2.21 111.223 177.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -64.18 144.19 57.31 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.36 -0.978 . . . . 5.7999999999999998 108.36 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.31 58.99 2.21 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.188 1.795 . . . . 4.8399999999999999 109.268 -172.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 127.4 18.53 2.02 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 127.123 2.297 . . . . 1.74 113.6 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.29 160.63 38.98 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.937 1.369 . . . . 2.71 109.63 166.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.59 HD12 ' HG ' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -119.16 129.39 54.98 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.437 1.095 . . . . 2.3799999999999999 108.351 -172.328 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -90.44 95.25 10.08 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 107.767 -1.197 . . . . 0.41999999999999998 107.767 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.84 140.86 41.71 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 123.346 0.658 . . . . 1.0600000000000001 109.972 -176.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -125.24 -47.22 1.76 Allowed 'General case' 0 C--O 1.232 0.165 0 C-N-CA 123.864 0.866 . . . . 1.0800000000000001 111.254 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -83.42 101.36 11.32 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 106.3 -1.741 . . . . 3.0 106.3 -173.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.481 HG21 HD23 ' A' ' 100' ' ' LEU . 3.4 m -108.51 116.31 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 125.932 1.693 . . . . 0.76000000000000001 109.266 -178.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.13 113.25 25.8 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.89 -1.152 . . . . 0.59999999999999998 107.89 -177.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -99.82 45.64 0.98 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.322 1.049 . . . . 1.28 111.581 -176.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.43 48.91 1.08 Allowed 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.136 -0.977 . . . . 2.8199999999999998 111.628 -175.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -67.17 -53.22 32.51 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.734 -0.604 . . . . 7.0599999999999996 110.252 -175.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.8 t0 . . . . . 0 C--O 1.233 0.223 0 N-CA-C 105.927 -1.879 . . . . 6.2999999999999998 105.927 167.161 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.0 p . . . . . 0 N--CA 1.45 -0.443 0 N-CA-C 109.925 -0.398 . . . . 8.5600000000000005 109.925 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 66.49 -164.95 0.23 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.931 0.892 . . . . 8.6199999999999992 109.822 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 tt 54.44 54.24 9.66 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.418 1.087 . . . . 5.3200000000000003 109.574 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.37 108.63 2.32 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 107.771 -1.196 . . . . 4.2300000000000004 107.771 -177.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -143.13 171.68 13.75 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.952 0.901 . . . . 1.8 110.727 -177.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -83.78 129.72 34.94 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.395 1.078 . . . . 2.0299999999999998 110.138 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -132.75 144.32 50.19 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.127 1.371 . . . . 3.0699999999999998 110.556 -178.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.0 m -76.39 133.67 71.01 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 125.707 1.603 . . . . 1.96 110.677 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.48 -41.35 58.24 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.527 2.151 . . . . 0.84999999999999998 112.673 -178.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.7 t -47.96 -49.81 29.24 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 121.628 -0.67 . . . . 2.8100000000000001 111.858 175.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -48.42 -56.3 8.58 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.901 0.88 . . . . 2.3900000000000001 108.992 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 32.9 pt -70.09 -10.13 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 113.883 1.068 . . . . 1.5700000000000001 113.883 -173.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.9 t -82.04 -28.68 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 118.74 0.7 . . . . 2.02 111.014 170.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -117.57 90.58 3.36 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 121.196 -0.94 . . . . 1.98 111.426 -161.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.72 41.22 89.49 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.228 -1.149 . . . . 1.49 110.228 177.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.68 -154.0 0.47 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 128.878 2.871 . . . . 2.46 103.406 174.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.2 m -26.84 -60.57 0.09 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 116.498 2.036 . . . . 1.47 116.498 -165.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -39.04 -51.46 1.84 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.265 0.939 . . . . 3.1000000000000001 111.671 175.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.08 -21.81 18.89 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.171 2.188 . . . . 1.27 110.829 -175.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.12 31.34 80.52 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 126.3 1.905 . . . . 1.1100000000000001 113.794 171.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.8 m -80.55 -37.3 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 118.283 1.042 . . . . 1.3200000000000001 112.043 -174.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 33.0 mmtt -107.94 -75.41 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 124.665 1.186 . . . . 3.1299999999999999 111.281 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -73.04 116.78 4.84 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 CA-C-N 120.782 1.315 . . . . 1.24 109.689 176.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -76.48 161.5 28.58 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.518 0.727 . . . . 3.2200000000000002 109.77 170.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.9 169.64 6.41 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.079 0.951 . . . . 1.26 111.261 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.12 5.8 66.85 Favored Glycine 0 CA--C 1.532 1.137 0 O-C-N 121.803 -0.56 . . . . 1.01 113.584 176.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -91.3 155.39 18.57 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 118.319 1.06 . . . . 1.3500000000000001 109.125 175.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -97.24 130.67 44.42 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.29 0.636 . . . . 3.0600000000000001 109.515 177.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.1 pt -146.36 177.56 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 106.74 -1.578 . . . . 0.63 106.74 173.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 42.1 mtt85 -119.41 116.4 26.07 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.881 -1.155 . . . . 2.8100000000000001 107.881 167.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.6 p -80.99 127.4 39.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 N-CA-C 107.18 -1.415 . . . . 0.91000000000000003 107.18 174.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.4 122.57 3.31 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 109.678 -1.369 . . . . 0.75 109.678 -177.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -169.84 -170.09 33.85 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 109.383 -1.487 . . . . 0.68999999999999995 109.383 -175.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.2 ptp -99.37 137.38 37.95 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.354 0.662 . . . . 2.8199999999999998 109.508 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.4 m -100.76 135.81 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 122.606 0.362 . . . . 2.5899999999999999 111.43 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -73.57 151.64 40.85 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.364 1.066 . . . . 2.23 109.292 176.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.5 p -55.57 -56.14 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 125.351 1.46 . . . . 2.02 111.173 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.07 71.63 1.22 Allowed Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.625 -1.39 . . . . 1.6699999999999999 109.625 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.3 m -151.98 46.82 0.77 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 117.758 0.779 . . . . 2.5099999999999998 112.28 -176.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.44 121.94 20.65 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 105.862 -1.903 . . . . 1.8400000000000001 105.862 176.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.0 m -132.72 140.04 48.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 119.584 1.083 . . . . 0.56000000000000005 108.705 170.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -122.22 150.9 41.63 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.37 1.068 . . . . 6.4699999999999998 110.57 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.66 156.09 75.56 Favored Pre-proline 0 N--CA 1.453 -0.299 0 N-CA-C 109.809 -0.441 . . . . 2.0 109.809 170.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -68.3 -24.38 37.53 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.873 2.382 . . . . 1.49 111.466 166.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -45.45 -36.62 4.52 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.773 -0.454 . . . . 1.53 109.773 163.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.8 m 66.17 10.65 7.27 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 125.04 1.336 . . . . 1.46 112.999 176.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.2 pp -125.12 9.42 8.04 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 128.687 2.795 . . . . 1.73 110.2 175.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -137.79 130.34 29.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.09 -1.819 . . . . 1.3100000000000001 106.09 176.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.5 146.0 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 107.036 -1.468 . . . . 1.1699999999999999 107.036 -170.228 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -152.12 153.94 34.9 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 121.593 -0.692 . . . . 1.1299999999999999 110.118 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -145.99 156.06 43.24 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.924 -0.58 . . . . 1.8999999999999999 109.646 -171.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.91 140.5 37.6 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.451 -0.574 . . . . 0.83999999999999997 109.451 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.0 t -120.9 151.5 23.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 106.899 -1.519 . . . . 1.75 106.899 176.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -133.18 -177.25 4.43 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.685 0.794 . . . . 1.72 109.489 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -140.47 167.78 21.35 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.869 0.868 . . . . 3.2799999999999998 109.197 177.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.4 m -41.51 -45.95 3.38 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.505 1.122 . . . . 3.4900000000000002 111.198 160.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.3 mt -82.3 22.62 0.81 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.099 0.778 . . . . 4.8600000000000003 113.099 178.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 58.78 39.62 93.96 Favored Glycine 0 CA--C 1.527 0.784 0 O-C-N 121.139 -0.976 . . . . 3.0899999999999999 110.891 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -77.07 60.71 3.47 Favored Glycine 0 C--N 1.337 0.594 0 C-N-CA 123.844 0.735 . . . . 1.98 111.319 -174.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -63.11 114.27 3.64 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.383 0.673 . . . . 3.2400000000000002 109.238 -174.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.3 153.53 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 C-N-CA 124.391 1.076 . . . . 1.3 108.606 -178.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.8 mt -114.01 129.18 56.62 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.087 0.955 . . . . 0.70999999999999996 108.582 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.3 t -116.03 130.1 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.229 1.412 . . . . 0.94999999999999996 107.193 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 81.6 p -106.21 150.12 26.19 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.864 0.866 . . . . 0.48999999999999999 110.235 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -144.13 120.59 11.01 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.305 1.442 . . . . 2.02 107.618 -174.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -109.58 46.49 1.0 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.34 1.456 . . . . 2.0699999999999998 111.985 -169.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -170.32 -178.2 2.68 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 128.334 2.654 . . . . 2.6800000000000002 105.614 169.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.6 mp -71.02 141.67 50.94 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.89 1.223 . . . . 1.7 111.363 175.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.51 161.36 35.39 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.342 1.057 . . . . 2.4100000000000001 110.372 171.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -68.55 -97.32 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.781 2.987 . . . . 2.2400000000000002 109.395 168.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -75.79 55.73 0.89 Allowed 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.925 -1.109 . . . . 3.1400000000000001 109.965 177.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 47.7 0.89 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 129.145 2.978 . . . . 2.4500000000000002 118.113 -177.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 72.7 t80 70.84 94.74 0.07 Allowed 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 125.693 1.597 . . . . 3.0800000000000001 108.425 -156.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 54.4 mtt180 -79.54 121.15 24.87 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.689 -1.226 . . . . 6.4699999999999998 107.689 175.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -83.97 173.34 11.26 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 123.07 0.548 . . . . 3.25 111.26 -175.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 61.37 41.2 99.46 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.464 0.555 . . . . 0.78000000000000003 112.95 174.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -157.47 177.56 11.29 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.842 1.257 . . . . 2.3900000000000001 108.897 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -96.63 132.59 11.08 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 109.997 -1.241 . . . . 0.70999999999999996 109.997 171.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.7 pp -137.44 162.2 33.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 107.238 -1.393 . . . . 0.56999999999999995 107.238 174.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.4 m -124.51 135.59 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 108.857 -0.794 . . . . 0.71999999999999997 108.857 178.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -124.23 117.71 25.2 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 124.93 1.292 . . . . 0.70999999999999996 109.902 -170.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -105.7 142.21 35.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.479 1.512 . . . . 3.8500000000000001 110.779 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 168.89 -132.79 2.65 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 107.047 -2.421 . . . . 0.81999999999999995 107.047 171.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.8 p -132.93 147.38 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 C-N-CA 123.84 0.856 . . . . 0.69999999999999996 110.178 -169.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -58.91 129.57 42.81 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.662 -0.866 . . . . 1.78 108.662 169.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -90.9 -101.23 1.22 Allowed Glycine 0 C--N 1.337 0.629 0 N-CA-C 110.63 -0.988 . . . . 1.8700000000000001 110.63 -166.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.404 ' OE1' ' NZ ' ' A' ' 121' ' ' LYS . 28.6 tt0 -58.56 -68.31 0.27 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.901 1.28 . . . . 4.7999999999999998 108.248 174.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -165.48 -70.81 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.38 -1.711 . . . . 4.1900000000000004 106.38 168.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.9 -44.92 96.67 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.536 1.065 . . . . 1.1000000000000001 112.227 178.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.404 ' NZ ' ' OE1' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -83.86 145.61 28.54 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.286 0.634 . . . . 2.7400000000000002 110.631 -176.394 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.4 mp -106.5 140.26 39.67 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 108.55 -0.908 . . . . 2.1099999999999999 108.55 -176.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -105.99 103.4 12.88 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 107.528 -1.286 . . . . 0.46999999999999997 107.528 172.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -131.39 89.67 2.75 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 122.711 0.404 . . . . 1.51 111.995 -168.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.0 t -83.45 -18.08 39.87 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.761 0.652 . . . . 0.78000000000000003 112.761 -176.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -98.46 82.72 2.91 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 119.303 0.956 . . . . 2.79 109.035 -177.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 33.1 m -93.76 123.5 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 123.041 0.536 . . . . 0.65000000000000002 110.285 177.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -112.8 122.66 48.3 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.155 -1.424 . . . . 0.68000000000000005 107.155 173.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -93.3 126.47 38.44 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.915 -1.143 . . . . 1.8200000000000001 107.915 171.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.73 91.48 2.54 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 108.678 -0.86 . . . . 3.3799999999999999 108.678 174.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -136.05 56.27 1.83 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.439 1.096 . . . . 7.29 109.579 -170.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 . . . . . 0 N--CA 1.452 -0.37 0 C-N-CA 124.699 1.2 . . . . 7.3200000000000003 109.541 177.227 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 CA--C 1.531 0.225 0 N-CA-C 112.861 0.689 . . . . 7.7800000000000002 112.861 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -142.11 150.23 40.88 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.368 -2.086 . . . . 7.4699999999999998 105.368 165.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.74 -36.13 7.53 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.469 0.708 . . . . 7.4699999999999998 109.994 177.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -153.53 146.08 24.13 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 105.879 -1.897 . . . . 3.6600000000000001 105.879 174.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -163.74 157.89 19.62 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.564 1.075 . . . . 2.1699999999999999 110.919 172.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -83.89 137.22 33.77 Favored 'General case' 0 C--N 1.338 0.072 0 C-N-CA 124.054 0.942 . . . . 1.98 110.555 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.93 148.95 34.42 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.852 1.261 . . . . 2.6299999999999999 110.471 -171.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.1 m -79.74 132.59 60.74 Favored Pre-proline 0 N--CA 1.449 -0.495 0 C-N-CA 124.891 1.276 . . . . 1.8100000000000001 110.667 -177.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.03 -41.05 78.59 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.554 2.17 . . . . 0.97999999999999998 112.452 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 m -56.92 -23.56 45.97 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 114.392 1.256 . . . . 2.1299999999999999 114.392 178.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.45 -57.91 4.65 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 106.771 -1.566 . . . . 2.46 106.771 173.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.2 pt -69.35 15.02 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 115.385 1.624 . . . . 0.97999999999999998 115.385 -166.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.3 m -109.37 -21.03 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.557 1.943 . . . . 2.9199999999999999 111.967 172.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -122.99 99.58 6.45 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.735 1.152 . . . . 2.23 110.892 -171.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.47 44.09 95.54 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.478 -1.049 . . . . 1.4199999999999999 110.478 175.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.1 mmmt -150.83 -157.88 0.86 Allowed 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 104.455 -2.424 . . . . 3.2999999999999998 104.455 -175.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.9 m -45.17 -46.82 12.28 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.301 1.84 . . . . 2.0 115.914 -170.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -40.0 -57.82 1.55 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.49 1.041 . . . . 2.5699999999999998 111.037 171.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.39 -24.96 27.31 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.05 1.34 . . . . 1.3600000000000001 110.382 -172.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.03 33.97 75.47 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.464 1.507 . . . . 1.1599999999999999 112.438 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.7 m -81.48 -27.81 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 118.052 0.926 . . . . 1.28 112.091 -175.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -119.47 -71.67 0.02 OUTLIER Pre-proline 0 N--CA 1.451 -0.376 0 C-N-CA 124.736 1.214 . . . . 4.2800000000000002 109.98 177.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -77.12 114.03 3.71 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 CA-C-N 120.456 1.199 . . . . 1.4299999999999999 110.116 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -74.5 166.37 23.63 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.362 -0.607 . . . . 2.9300000000000002 109.362 171.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.5 169.18 13.05 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.65 0.262 . . . . 1.21 110.461 175.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.59 5.12 87.08 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 121.748 -0.595 . . . . 1.1599999999999999 112.411 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -103.1 150.97 23.1 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.455 1.102 . . . . 1.4099999999999999 108.92 176.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -91.03 129.55 37.02 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.239 -0.652 . . . . 3.5099999999999998 109.239 175.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.8 pt -143.2 166.54 14.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 106.11 -1.811 . . . . 0.72999999999999998 106.11 167.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.418 ' HG2' ' CG ' ' A' ' 113' ' ' GLN . 47.6 mtt180 -119.61 116.01 25.14 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.337 -0.986 . . . . 2.8900000000000001 108.337 175.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.3 p -84.99 122.46 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 107.518 -1.29 . . . . 1.0700000000000001 107.518 176.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -124.98 119.69 3.7 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 109.622 -1.391 . . . . 0.58999999999999997 109.622 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.38 -156.49 15.45 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.61 -1.396 . . . . 0.68999999999999995 109.61 -175.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.4 ptp -106.64 131.15 54.12 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.805 0.812 . . . . 2.6600000000000001 110.448 -172.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.404 HG22 ' H ' ' A' ' 108' ' ' GLN . 9.7 m -84.1 152.82 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 115.491 -0.777 . . . . 2.5299999999999998 109.59 -175.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.464 HG22 ' H ' ' A' ' 68' ' ' VAL . 2.3 m -64.94 179.79 0.63 Allowed 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.478 1.111 . . . . 2.4700000000000002 110.487 176.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.464 ' H ' HG22 ' A' ' 67' ' ' THR . 5.7 p -116.51 73.2 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 126.234 1.814 . . . . 2.8900000000000001 108.25 -175.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.18 50.84 0.91 Allowed Glycine 0 CA--C 1.525 0.681 0 CA-C-N 113.154 -1.839 . . . . 2.0800000000000001 111.404 171.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.7 m -110.99 8.8 22.1 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.407 0.683 . . . . 1.3100000000000001 111.915 174.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.98 109.87 6.85 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 106.541 -1.651 . . . . 2.2000000000000002 106.541 175.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.8 m -121.11 129.09 76.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 108.707 -0.849 . . . . 0.92000000000000004 108.707 171.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.457 ' CB ' HG12 ' A' ' 80' ' ' VAL . 20.1 ptt180 -111.1 148.62 32.28 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.405 1.082 . . . . 5.2300000000000004 110.793 177.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -82.37 153.21 68.46 Favored Pre-proline 0 C--O 1.234 0.26 0 N-CA-C 109.148 -0.686 . . . . 2.0899999999999999 109.148 170.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -71.64 8.65 1.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.958 2.439 . . . . 1.71 113.789 176.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -69.32 -26.54 64.76 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.756 -0.59 . . . . 1.6799999999999999 109.84 161.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.0 m 72.25 1.34 3.91 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.158 1.783 . . . . 1.22 113.51 -174.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.38 -3.71 8.9 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.694 1.198 . . . . 2.04 113.505 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -117.55 125.85 51.55 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.786 -1.561 . . . . 1.3400000000000001 106.786 174.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.565 HG23 ' HB3' ' A' ' 96' ' ' TYR . 28.2 m -144.45 150.43 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 108.149 -1.056 . . . . 0.95999999999999996 108.149 -175.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -151.58 154.82 37.21 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.875 -0.516 . . . . 0.98999999999999999 110.439 -179.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.438 ' CE1' ' CE1' ' A' ' 104' ' ' PHE . 33.8 p90 -156.77 153.04 27.72 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.059 0.457 . . . . 2.0600000000000001 111.69 -176.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.24 154.71 19.9 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 123.47 0.708 . . . . 0.69999999999999996 109.978 170.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.3 m -132.54 163.24 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 108.191 -1.04 . . . . 2.3199999999999998 108.191 163.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -137.8 -168.24 2.3 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.352 1.061 . . . . 1.76 109.885 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -137.05 176.56 8.6 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.594 0.758 . . . . 2.3999999999999999 109.453 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.4 m -58.96 -41.25 87.05 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.457 -0.942 . . . . 3.5600000000000001 108.457 156.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.15 22.31 0.53 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.676 0.79 . . . . 4.6699999999999999 111.795 172.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 54.16 42.73 73.15 Favored Glycine 0 CA--C 1.527 0.837 0 O-C-N 121.454 -0.779 . . . . 2.8500000000000001 112.598 172.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -78.29 56.8 4.06 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.129 -0.788 . . . . 2.1000000000000001 111.129 -177.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -58.25 112.07 1.42 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 117.898 0.849 . . . . 4.1900000000000004 110.049 -178.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.0 tp -143.79 160.27 16.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 108.093 -1.077 . . . . 1.5 108.093 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.68 129.09 50.58 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.265 1.026 . . . . 0.68999999999999995 108.533 -168.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.413 ' CG2' ' CE1' ' A' ' 82' ' ' PHE . 5.3 m -115.15 146.77 19.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 109.14 -0.689 . . . . 2.3900000000000001 109.14 173.092 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.4 p -110.19 155.77 21.53 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.963 1.705 . . . . 0.46000000000000002 107.863 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.565 ' HB3' HG23 ' A' ' 80' ' ' VAL . 1.9 t80 -150.08 113.41 4.92 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.973 -1.491 . . . . 2.02 106.973 -175.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -101.47 45.2 0.98 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.186 1.394 . . . . 2.0899999999999999 110.906 -173.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -162.95 -176.77 5.08 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.65 1.98 . . . . 2.4399999999999999 106.201 170.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.1 mp -79.67 146.25 32.56 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.868 0.867 . . . . 1.55 111.081 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.525 ' HG ' HG21 ' A' ' 80' ' ' VAL . 78.3 mt -82.06 155.38 69.99 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 123.962 0.905 . . . . 1.49 109.412 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.99 -89.95 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.554 2.836 . . . . 2.0099999999999998 110.173 176.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.78 45.72 0.43 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.284 1.434 . . . . 3.48 110.613 -176.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 44.19 8.25 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.279 2.632 . . . . 2.1600000000000001 115.854 -164.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.438 ' CE1' ' CE1' ' A' ' 82' ' ' PHE . 65.4 t80 50.74 91.91 0.02 OUTLIER 'General case' 0 C--N 1.34 0.171 0 CA-C-N 119.339 0.972 . . . . 2.9500000000000002 109.873 -153.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -78.6 146.17 34.32 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.814 -1.18 . . . . 6.46 107.814 173.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -93.11 167.19 11.94 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 125.401 1.481 . . . . 3.2799999999999998 109.567 -169.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 47.56 44.17 22.14 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 123.532 0.587 . . . . 0.82999999999999996 113.739 -177.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.404 ' H ' HG22 ' A' ' 66' ' ' VAL . 0.7 OUTLIER -153.24 120.03 5.68 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.793 1.637 . . . . 2.2999999999999998 107.387 176.362 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -63.61 135.24 41.58 Favored Glycine 0 CA--C 1.523 0.54 0 O-C-N 121.207 -0.933 . . . . 0.63 111.368 -175.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.2 pp -135.97 166.09 27.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.817 -1.179 . . . . 0.58999999999999997 107.817 177.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 17.6 m -118.79 128.94 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 108.983 -0.747 . . . . 0.67000000000000004 108.983 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -120.45 118.22 29.72 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 125.023 1.329 . . . . 0.77000000000000002 109.727 -168.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.418 ' CG ' ' HG2' ' A' ' 61' ' ' ARG . 0.8 OUTLIER -114.91 150.31 35.84 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.65 1.58 . . . . 3.8100000000000001 109.915 -178.976 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 173.33 -122.57 0.93 Allowed Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 106.61 -2.596 . . . . 0.97999999999999998 106.61 165.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.0 p -143.44 148.24 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 118.204 1.002 . . . . 0.78000000000000003 109.821 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -69.85 143.03 52.97 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.251 -0.648 . . . . 2.29 109.251 168.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -166.04 26.18 0.17 Allowed Glycine 0 CA--C 1.523 0.565 0 C-N-CA 119.602 -1.285 . . . . 2.8199999999999998 113.146 171.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -151.91 45.01 0.75 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.926 0.891 . . . . 6.0999999999999996 108.748 -174.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 24.86 59.95 0.05 Allowed 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 128.976 2.91 . . . . 4.0300000000000002 112.481 172.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 139.27 -47.93 0.88 Allowed Glycine 0 CA--C 1.529 0.949 0 CA-C-N 114.77 -1.105 . . . . 1.1499999999999999 110.948 -172.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.5 151.27 20.8 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 117.885 0.842 . . . . 2.1699999999999999 110.184 -174.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 mp -112.68 121.89 46.08 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.721 1.208 . . . . 2.02 109.364 -169.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -82.89 88.23 6.81 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.403 -1.702 . . . . 0.65000000000000002 106.403 175.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -106.62 72.41 0.9 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.168 0.987 . . . . 1.6399999999999999 110.723 -165.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.9 t -80.79 -6.66 58.82 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.037 0.754 . . . . 1.1599999999999999 113.037 -168.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -113.06 88.63 2.88 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 120.799 -1.188 . . . . 4.1200000000000001 108.864 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 27.0 m -96.74 125.93 49.58 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 C-N-CA 123.312 0.645 . . . . 0.81999999999999995 109.826 174.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -111.94 113.33 25.57 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.68 -1.6 . . . . 0.70999999999999996 106.68 177.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.34 36.79 0.25 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.078 0.551 . . . . 1.48 112.069 -178.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.0 ptmt -85.09 60.68 6.4 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.233 -0.917 . . . . 3.2200000000000002 110.307 -173.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -50.53 -47.23 57.64 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.942 0.897 . . . . 6.21 111.27 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.5 t0 . . . . . 0 CA--C 1.538 0.493 0 C-N-CA 125.935 1.694 . . . . 9.3599999999999994 111.536 176.208 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.2 p . . . . . 0 N--CA 1.452 -0.331 0 N-CA-C 107.459 -1.311 . . . . 6.0 107.459 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 38.5 p-10 -105.6 163.03 12.98 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.094 1.357 . . . . 8.5399999999999991 109.293 174.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -151.04 167.17 28.5 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 106.408 -1.701 . . . . 5.5599999999999996 106.408 -178.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -144.87 106.67 4.28 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 108.127 -1.064 . . . . 3.46 108.127 -174.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -131.81 145.34 51.52 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.029 0.932 . . . . 2.1400000000000001 109.926 -173.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -92.04 111.07 22.48 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.751 1.22 . . . . 2.27 109.414 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -125.59 160.16 30.31 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.879 1.272 . . . . 3.8300000000000001 110.104 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.4 p -72.09 135.58 82.46 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 109.599 -0.519 . . . . 1.6799999999999999 109.599 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.412 ' HA ' HD11 ' A' ' 43' ' ' ILE . 33.9 Cg_endo -55.89 -29.59 73.49 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.866 3.044 . . . . 0.93000000000000005 112.337 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.487 ' O ' HG12 ' A' ' 44' ' ' VAL . 31.0 p -66.96 -35.82 80.83 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.024 0.75 . . . . 2.1699999999999999 113.024 178.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -45.0 -47.79 11.49 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 118.882 0.765 . . . . 3.0299999999999998 110.036 177.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.458 HD13 ' H ' ' A' ' 43' ' ' ILE 0.34 0.2 OUTLIER -85.76 11.51 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 114.784 1.402 . . . . 1.79 114.784 -170.009 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.487 HG12 ' O ' ' A' ' 41' ' ' SER . 0.8 OUTLIER -103.13 -8.95 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 123.445 0.698 . . . . 2.0299999999999998 112.553 179.184 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -105.79 -58.15 1.95 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.527 0.603 . . . . 2.5699999999999998 111.964 -171.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -160.71 64.56 0.28 Allowed Glycine 0 C--N 1.335 0.5 0 N-CA-C 109.266 -1.534 . . . . 1.47 109.266 -170.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 15.1 mmtt -153.96 -111.93 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 106.339 -1.726 . . . . 2.3399999999999999 106.339 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.4 m -54.17 -63.03 1.28 Allowed 'General case' 0 C--N 1.343 0.323 0 C-N-CA 126.851 2.06 . . . . 1.3799999999999999 113.298 177.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -49.46 -42.27 42.62 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.964 0.888 . . . . 2.4199999999999999 110.993 -172.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.86 -9.54 45.97 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.338 1.855 . . . . 1.3799999999999999 113.323 -178.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 48.62 48.93 28.35 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 126.26 1.886 . . . . 1.2 113.763 -174.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.5 m -95.18 -55.71 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 118.566 1.183 . . . . 1.27 112.275 -177.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.1 mmtt -87.34 -59.82 0.26 Allowed Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 123.762 0.825 . . . . 3.2000000000000002 111.035 178.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -81.79 155.48 17.97 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 121.942 1.761 . . . . 1.49 109.89 174.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -124.02 60.21 1.13 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.676 1.19 . . . . 3.5699999999999998 109.037 174.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 48.7 -144.46 0.42 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.318 1.047 . . . . 2.6699999999999999 110.116 -174.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 40.23 30.83 0.3 Allowed Glycine 0 CA--C 1.533 1.165 0 C-N-CA 127.83 2.633 . . . . 1.3700000000000001 117.527 165.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -134.62 167.41 20.87 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.857 1.663 . . . . 1.3999999999999999 108.017 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -101.46 134.56 44.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.681 -0.859 . . . . 3.5699999999999998 108.681 171.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.4 pt -139.22 167.68 19.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 105.055 -2.202 . . . . 0.89000000000000001 105.055 168.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.8 mtm180 -126.74 122.89 36.13 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.86 -1.533 . . . . 2.2000000000000002 106.86 174.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.7 m -88.56 138.12 19.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 107.691 -1.226 . . . . 2.3999999999999999 107.691 177.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.0 110.4 0.58 Allowed Glycine 0 C--O 1.226 -0.393 0 N-CA-C 109.599 -1.401 . . . . 0.89000000000000001 109.599 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -172.78 -161.37 23.08 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 108.862 -1.695 . . . . 0.72999999999999998 108.862 -173.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.17 132.74 41.27 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 117.694 0.747 . . . . 2.6499999999999999 110.843 -176.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.522 HG11 ' CE2' ' A' ' 104' ' ' PHE . 23.1 m -91.07 150.93 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-N 116.165 -0.47 . . . . 2.6499999999999999 110.097 174.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.464 HG22 ' H ' ' A' ' 68' ' ' VAL . 0.3 OUTLIER -64.13 -179.31 0.42 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.704 0.764 . . . . 2.2799999999999998 109.856 174.64 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.464 ' H ' HG22 ' A' ' 67' ' ' THR . 4.6 p -123.7 71.02 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 126.176 1.79 . . . . 2.5699999999999998 107.893 175.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.33 -21.75 1.21 Allowed Glycine 0 CA--C 1.53 1.012 0 CA-C-N 114.167 -1.379 . . . . 2.46 113.93 174.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.8 m -62.12 -17.65 58.44 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.655 1.227 . . . . 1.1699999999999999 113.713 -178.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.5 ttm -58.85 125.88 25.35 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 122.972 0.509 . . . . 2.0499999999999998 109.87 171.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.28 130.67 67.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 107.615 -1.254 . . . . 0.63 107.615 166.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -114.46 143.59 44.69 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.599 1.159 . . . . 4.21 109.36 -177.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.49 147.05 51.76 Favored Pre-proline 0 N--CA 1.454 -0.246 0 N-CA-C 109.626 -0.509 . . . . 1.8500000000000001 109.626 177.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -62.51 -25.93 76.01 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.664 2.242 . . . . 1.46 110.826 170.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -42.38 -41.64 2.93 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.572 1.549 . . . . 1.72 110.475 174.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.3 m 87.95 5.9 0.23 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 126.927 2.091 . . . . 1.4099999999999999 113.064 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.84 3.79 9.45 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.011 0.924 . . . . 2.4300000000000002 113.355 173.138 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -128.06 135.07 49.34 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 119.044 0.838 . . . . 1.1499999999999999 109.633 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.594 HG23 ' HB3' ' A' ' 96' ' ' TYR . 2.2 m -149.88 138.76 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 106.928 -1.508 . . . . 0.68000000000000005 106.928 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -142.11 157.93 44.33 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.46 -0.571 . . . . 1.29 109.46 174.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -156.14 152.32 27.78 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.946 -0.39 . . . . 1.8899999999999999 109.946 -174.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.93 149.0 22.38 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.46 -0.57 . . . . 0.55000000000000004 109.46 170.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.1 p -136.78 152.76 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.385 1.074 . . . . 1.9099999999999999 108.919 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -143.01 179.5 7.0 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.43 0.692 . . . . 1.4199999999999999 111.524 -174.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -137.89 -172.96 3.38 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 109.845 -0.428 . . . . 2.3999999999999999 109.845 177.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.7 m -74.79 14.93 0.43 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.129 1.772 . . . . 3.4100000000000001 112.369 169.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -118.74 26.6 9.44 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.327 1.051 . . . . 5.0800000000000001 111.718 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 51.46 35.81 37.08 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 123.888 0.756 . . . . 3.2000000000000002 111.84 174.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -117.84 130.89 9.01 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 107.802 -2.119 . . . . 1.6899999999999999 107.802 -174.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -120.55 130.52 54.26 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 106.943 -1.502 . . . . 4.3600000000000003 106.943 177.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -132.04 146.27 33.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.297 -1.001 . . . . 0.95999999999999996 108.297 174.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 mt -101.88 128.35 48.3 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.208 1.403 . . . . 0.80000000000000004 109.913 -175.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.3 t -119.33 125.83 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 124.914 1.285 . . . . 1.0600000000000001 108.14 -178.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 42.3 p -95.85 152.18 18.73 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.681 0.792 . . . . 0.57999999999999996 108.926 174.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.594 ' HB3' HG23 ' A' ' 80' ' ' VAL . 3.2 t80 -145.84 166.96 24.4 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.411 1.085 . . . . 2.6299999999999999 108.733 -177.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -155.61 150.7 26.67 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 105.373 -2.084 . . . . 3.2599999999999998 105.373 -169.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 62.96 61.54 1.11 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 129.299 3.039 . . . . 3.0099999999999998 111.587 -176.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.3 mt 51.68 -152.32 0.23 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.552 1.141 . . . . 1.8600000000000001 109.158 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.453 HD23 ' CZ ' ' A' ' 96' ' ' TYR . 8.6 mt -146.57 153.69 47.59 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 105.764 -1.939 . . . . 1.3700000000000001 105.764 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.84 -83.44 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 125.118 3.879 . . . . 2.6400000000000001 109.853 -174.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -73.75 34.09 0.08 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.34 1.456 . . . . 5.6900000000000004 110.701 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 61.19 -22.61 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.658 1.983 . . . . 3.5 114.155 -170.265 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.522 ' CE2' HG11 ' A' ' 66' ' ' VAL . 64.6 t80 59.69 86.91 0.09 Allowed 'General case' 0 C--N 1.342 0.275 0 CA-C-N 120.286 1.403 . . . . 2.6800000000000002 107.7 -155.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 19.8 mtp85 -82.95 127.64 33.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 105.663 -1.977 . . . . 3.9399999999999999 105.663 175.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -81.37 169.33 17.35 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.101 0.477 . . . . 2.8599999999999999 110.284 -170.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.15 45.67 90.76 Favored Glycine 0 CA--C 1.533 1.188 0 O-C-N 121.765 -0.585 . . . . 0.89000000000000001 113.399 177.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -155.78 179.57 9.07 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.487 1.515 . . . . 2.4100000000000001 107.756 175.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -94.82 133.78 11.7 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 109.625 -1.39 . . . . 0.77000000000000002 109.625 170.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.4 pp -138.73 161.92 29.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 107.477 -1.305 . . . . 0.77000000000000002 107.477 175.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 18.6 m -118.7 123.66 71.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.321 -0.992 . . . . 0.80000000000000004 108.321 177.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.572 ' CB ' HG12 ' A' ' 127' ' ' VAL . . . -110.37 136.81 48.97 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 125.902 1.681 . . . . 0.67000000000000004 109.732 -175.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -128.81 141.53 51.27 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.036 1.734 . . . . 3.0800000000000001 108.612 -175.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 173.29 -121.83 0.88 Allowed Glycine 0 C--N 1.336 0.547 0 N-CA-C 109.218 -1.553 . . . . 0.90000000000000002 109.218 168.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.04 153.21 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.861 -0.792 . . . . 0.77000000000000002 108.861 -173.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -57.71 142.38 45.41 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.186 -0.672 . . . . 1.73 109.186 171.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -87.13 -126.27 2.15 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 109.355 -1.498 . . . . 2.02 109.355 -174.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -60.66 -64.87 0.8 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.265 0.626 . . . . 5.1299999999999999 109.512 178.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -149.87 -74.08 0.17 Allowed 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 107.043 -1.465 . . . . 3.6800000000000002 107.043 173.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -72.54 -39.73 55.65 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.055 -0.975 . . . . 1.24 111.626 -174.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.57 153.47 26.73 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.615 0.766 . . . . 3.6800000000000002 109.699 -175.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -110.06 136.4 49.36 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 125.12 1.368 . . . . 2.2000000000000002 108.275 -176.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -105.78 90.22 3.32 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.712 -1.218 . . . . 0.55000000000000004 107.712 174.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.17 145.22 26.02 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 108.388 -0.968 . . . . 1.46 108.388 176.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.4 t -134.73 0.06 2.92 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.977 0.732 . . . . 1.1100000000000001 112.977 169.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -129.48 99.89 5.35 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 120.669 -1.269 . . . . 2.8799999999999999 109.123 171.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.585 HG13 ' HE2' ' A' ' 96' ' ' TYR . 29.4 m -98.69 148.27 6.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-N 118.885 0.766 . . . . 1.0600000000000001 111.546 166.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.35 112.5 16.41 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.033 -1.84 . . . . 0.76000000000000001 106.033 176.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -100.23 41.52 1.16 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.088 0.955 . . . . 2.04 111.482 -175.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -73.63 71.91 1.42 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.844 1.258 . . . . 4.5800000000000001 111.282 -176.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -137.86 43.03 2.26 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.749 0.704 . . . . 4.2000000000000002 112.697 -170.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 CA--C 1.534 0.339 0 C-N-CA 124.848 1.259 . . . . 6.0 109.598 -172.205 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 CA--C 1.539 0.52 0 N-CA-C 115.919 1.822 . . . . 5.7800000000000002 115.919 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.2 t30 53.97 58.99 4.54 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.861 0.864 . . . . 8.9700000000000006 112.96 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.7 mp -107.4 -112.64 0.29 Allowed 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 117.813 -1.089 . . . . 6.3300000000000001 110.95 168.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.0 m-20 -70.17 94.8 0.93 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 122.792 2.542 . . . . 3.96 112.036 -129.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -129.42 163.88 24.86 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 123.935 0.894 . . . . 2.0600000000000001 111.612 -167.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -82.05 132.05 35.25 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.084 0.954 . . . . 2.3500000000000001 109.238 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -131.59 152.92 50.42 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.126 1.77 . . . . 3.8599999999999999 108.589 176.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.9 p -94.19 143.73 26.87 Favored Pre-proline 0 N--CA 1.442 -0.853 0 C-N-CA 125.203 1.401 . . . . 2.0899999999999999 108.729 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -61.57 -18.09 57.84 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.598 2.199 . . . . 1.4199999999999999 112.465 178.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.0 p -47.46 -40.48 18.31 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.32 1.048 . . . . 4.0700000000000003 112.181 165.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.48 ' HG3' ' HD3' ' A' ' 47' ' ' LYS . 7.4 tp10 -83.11 -52.48 6.59 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.966 -1.124 . . . . 2.48 107.966 -169.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 26.8 pt -81.11 30.83 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.046 0.938 . . . . 1.23 113.126 -170.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.0 p -122.88 -44.91 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.923 1.689 . . . . 2.5899999999999999 110.59 173.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -77.21 -41.6 40.72 Favored 'General case' 0 C--N 1.34 0.157 0 O-C-N 121.718 -0.614 . . . . 2.52 112.37 -162.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.04 59.66 0.13 Allowed Glycine 0 C--N 1.332 0.346 0 N-CA-C 109.439 -1.464 . . . . 1.4399999999999999 109.439 -170.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.48 ' HD3' ' HG3' ' A' ' 42' ' ' GLU . 4.6 mttt -155.19 -94.48 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.522 1.929 . . . . 2.27 108.364 -178.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.492 HG23 HD23 ' A' ' 116' ' ' LEU . 97.7 m -71.95 -58.39 3.49 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 119.271 0.941 . . . . 1.6000000000000001 111.877 -172.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -46.83 -53.67 11.51 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.778 0.799 . . . . 2.5099999999999998 110.243 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.43 -23.8 29.83 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.747 -1.115 . . . . 1.24 111.965 -171.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.7 53.41 41.43 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.203 1.383 . . . . 1.3700000000000001 111.864 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.274 31.8 m -110.13 -73.58 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 113.73 1.011 . . . . 1.74 113.73 -178.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -64.44 -56.59 21.77 Favored Pre-proline 0 CA--C 1.538 0.507 0 O-C-N 120.953 -1.092 . . . . 3.1299999999999999 113.017 -176.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -87.26 159.23 8.33 Favored 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 123.391 2.728 . . . . 1.3200000000000001 108.371 175.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -100.19 150.76 22.19 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.738 -0.838 . . . . 3.6200000000000001 108.738 171.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.46 157.97 10.4 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.275 -0.639 . . . . 1.1200000000000001 109.275 169.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.57 -0.24 70.8 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 119.041 -0.866 . . . . 1.26 113.819 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.475 ' O ' HD12 ' A' ' 116' ' ' LEU . 78.0 mt-30 -81.39 158.97 24.46 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 119.415 1.608 . . . . 1.4099999999999999 108.456 169.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 45.4 mtt180 -92.82 137.23 32.55 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.71 -0.478 . . . . 3.4700000000000002 109.71 170.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.6 pt -144.7 175.07 3.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 107.482 -1.303 . . . . 0.79000000000000004 107.482 167.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -121.68 124.26 43.85 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-O 119.079 -0.486 . . . . 1.99 110.236 168.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.0 p -82.59 128.5 38.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 N-CA-C 107.537 -1.283 . . . . 1.0 107.537 170.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -128.21 129.27 6.23 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 109.16 -1.576 . . . . 0.56000000000000005 109.16 172.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 176.89 -150.96 10.69 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 107.576 -2.209 . . . . 0.77000000000000002 107.576 -175.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.401 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 1.8 ppp? -125.27 155.6 39.89 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 118.473 1.136 . . . . 4.4400000000000004 111.843 177.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.8 p -100.97 131.73 48.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 114.471 -1.241 . . . . 2.3599999999999999 109.799 -174.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.11 159.54 20.18 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 122.228 1.013 . . . . 2.1200000000000001 109.509 174.087 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.9 p -67.56 -34.31 67.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.859 1.264 . . . . 1.75 112.89 -175.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -120.86 84.07 0.37 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 108.956 -1.658 . . . . 2.0600000000000001 108.956 175.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.3 m -140.29 -43.96 0.41 Allowed 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.909 0.884 . . . . 1.3300000000000001 112.322 -176.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.16 109.77 3.19 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.567 0.747 . . . . 2.0899999999999999 110.184 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.8 m -111.33 117.24 54.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 107.417 -1.327 . . . . 0.64000000000000001 107.417 169.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.95 140.06 42.96 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.86 1.264 . . . . 5.9000000000000004 109.416 -176.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -82.13 149.31 62.22 Favored Pre-proline 0 N--CA 1.455 -0.221 0 N-CA-C 108.903 -0.777 . . . . 1.78 108.903 176.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -66.11 -20.89 56.47 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.497 2.131 . . . . 1.76 110.227 167.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -41.53 -43.36 2.65 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 123.75 0.82 . . . . 1.2 109.415 163.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.8 m 73.49 4.2 4.74 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.055 1.342 . . . . 1.45 112.905 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.2 18.44 10.72 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.882 1.673 . . . . 1.8700000000000001 110.539 173.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 48.9 m-70 -150.79 119.21 6.42 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.478 -1.675 . . . . 1.1000000000000001 106.478 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.7 m -148.54 135.95 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 105.974 -1.861 . . . . 0.78000000000000003 105.974 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -138.78 152.34 47.83 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 119.853 1.206 . . . . 0.93999999999999995 110.799 -177.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -149.33 153.11 36.97 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.28 0.632 . . . . 1.8500000000000001 109.693 -172.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.59 147.41 23.94 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.637 0.775 . . . . 1.01 109.414 169.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.0 t -124.55 146.61 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 N-CA-C 107.429 -1.323 . . . . 1.8 107.429 169.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -150.9 -167.06 2.71 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 108.603 -0.888 . . . . 1.3300000000000001 108.603 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -150.65 177.73 9.78 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 107.871 -1.159 . . . . 3.5699999999999998 107.871 166.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.8 t -45.57 122.53 3.66 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.362 -1.347 . . . . 3.48 107.362 150.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.417 ' CD2' ' H ' ' A' ' 88' ' ' LEU . 0.6 OUTLIER -0.59 40.36 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 131.533 3.933 . . . . 5.9699999999999998 116.539 -145.744 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -84.83 51.2 4.52 Favored Glycine 0 CA--C 1.524 0.629 0 O-C-N 120.814 -1.179 . . . . 4.9199999999999999 110.402 169.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 42.09 -122.21 2.85 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.973 1.273 . . . . 2.2200000000000002 113.002 176.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -171.01 156.72 4.96 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.689 1.996 . . . . 2.5699999999999998 106.81 168.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.5 tp -151.18 162.17 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.834 1.254 . . . . 1.2 108.19 172.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mt -124.25 131.21 53.51 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 124.545 1.138 . . . . 0.93000000000000005 109.928 -176.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.6 p -135.16 142.17 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.822 0.849 . . . . 3.0600000000000001 110.166 -174.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.6 p -105.28 153.46 21.57 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.172 1.389 . . . . 1.3100000000000001 108.973 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.454 ' CD2' HD21 ' A' ' 100' ' ' LEU . 3.7 t80 -141.43 138.93 33.27 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.268 -1.753 . . . . 2.2200000000000002 106.268 178.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -128.45 39.43 3.82 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.249 1.02 . . . . 2.2000000000000002 112.138 -165.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -166.22 56.93 0.1 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.945 0.898 . . . . 2.8999999999999999 110.934 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.8 mp 51.95 -168.35 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.911 1.284 . . . . 1.77 111.366 -170.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.454 HD21 ' CD2' ' A' ' 96' ' ' TYR . 15.2 mt -148.34 150.69 35.11 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.286 1.434 . . . . 1.4199999999999999 107.215 174.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -62.16 132.75 40.41 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 123.413 2.742 . . . . 2.6899999999999999 109.746 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 37.3 49.25 0.9 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.391 1.877 . . . . 4.3600000000000003 111.645 -173.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 56.72 10.69 0.76 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 128.73 2.812 . . . . 2.3500000000000001 115.518 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.6 t80 64.73 99.79 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.788 1.235 . . . . 2.6699999999999999 108.134 -162.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 46.0 mtt180 -77.44 131.44 37.99 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.441 -1.688 . . . . 4.96 106.441 172.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -83.58 170.72 14.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.102 0.561 . . . . 4.5899999999999999 109.6 -176.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.42 46.9 91.57 Favored Glycine 0 CA--C 1.531 1.058 0 O-C-N 121.924 -0.485 . . . . 0.81999999999999995 112.826 174.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -151.7 179.07 8.73 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.895 1.678 . . . . 2.3700000000000001 108.555 178.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 65' ' ' MET . . . -111.24 142.97 17.11 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.2 -0.76 . . . . 0.75 111.2 171.237 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.4 pp -145.84 168.97 6.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 125.498 1.519 . . . . 0.85999999999999999 106.917 -178.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.0 m -120.77 138.73 50.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 N-CA-C 108.011 -1.107 . . . . 0.56000000000000005 108.011 167.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -127.28 118.17 23.7 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 124.627 1.171 . . . . 0.52000000000000002 109.439 -176.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.67 132.86 52.88 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.197 1.399 . . . . 3.3700000000000001 108.639 -175.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 178.47 -160.75 26.93 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 120.858 -0.687 . . . . 1.26 112.308 -177.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.6 p -123.52 138.39 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 125.114 1.365 . . . . 0.97999999999999998 110.121 -169.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.492 HD23 HG23 ' A' ' 48' ' ' THR . 3.8 mp -68.56 138.8 55.42 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.768 -0.583 . . . . 2.3399999999999999 111.027 -179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -95.98 -114.9 2.98 Favored Glycine 0 C--N 1.341 0.809 0 N-CA-C 109.943 -1.263 . . . . 1.79 109.943 -166.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -46.82 -55.92 7.12 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 117.876 0.838 . . . . 4.0700000000000003 112.318 175.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 176.25 -79.08 0.0 OUTLIER 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 128.004 2.522 . . . . 3.4700000000000002 105.251 -174.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.5 -25.13 76.16 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.601 1.096 . . . . 0.96999999999999997 112.679 -174.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.55 152.47 21.68 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.528 1.531 . . . . 2.5099999999999998 109.572 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.0 mp -117.8 156.53 28.19 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.08 0.552 . . . . 2.0899999999999999 109.911 -178.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -120.07 107.42 13.03 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.065 1.346 . . . . 0.73999999999999999 107.979 173.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.24 132.9 41.99 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 118.951 -0.547 . . . . 1.03 110.743 -175.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.3 t -122.2 4.4 9.78 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.38 0.672 . . . . 0.96999999999999997 112.473 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -113.1 79.55 1.25 Allowed 'General case' 0 CA--C 1.531 0.229 0 O-C-N 120.587 -1.321 . . . . 2.5800000000000001 109.361 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.1 m -95.41 132.42 39.53 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 C-N-CA 122.918 0.487 . . . . 0.71999999999999997 110.325 174.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.06 107.13 14.14 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.245 -1.761 . . . . 0.73999999999999999 106.245 175.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.52 105.4 13.54 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.194 -1.039 . . . . 1.5 108.194 175.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -121.68 71.21 0.97 Allowed 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.84 0.856 . . . . 2.9700000000000002 109.618 -176.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -148.16 161.7 40.91 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.082 -1.451 . . . . 4.1299999999999999 107.082 178.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 66.0 t0 . . . . . 0 N--CA 1.45 -0.468 0 N-CA-C 108.05 -1.093 . . . . 6.1799999999999997 108.05 174.037 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.2 m . . . . . 0 N--CA 1.454 -0.234 0 N-CA-C 106.975 -1.491 . . . . 6.1699999999999999 106.975 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -84.41 163.07 19.73 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.248 -0.649 . . . . 7.2400000000000002 109.248 176.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.8 mp -108.69 138.83 44.38 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 107.341 -1.355 . . . . 6.7000000000000002 107.341 170.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -129.8 90.42 2.97 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 107.638 -1.245 . . . . 4.3399999999999999 107.638 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -136.41 175.28 9.75 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.57 0.748 . . . . 2.6400000000000001 111.087 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -83.68 120.26 25.78 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.782 1.233 . . . . 2.5099999999999998 109.695 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -116.17 163.33 16.12 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.615 1.566 . . . . 2.8199999999999998 109.705 177.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.8 m -84.91 132.89 44.54 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 109.306 -0.628 . . . . 1.8 109.306 -174.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -56.45 -45.33 38.22 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 123.191 2.594 . . . . 0.81000000000000005 111.741 -176.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.0 t -61.74 -23.35 66.1 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.351 -0.843 . . . . 2.52 112.341 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -66.74 -45.94 77.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.926 -1.138 . . . . 3.3199999999999998 107.926 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.429 HD11 HG21 ' A' ' 92' ' ' ILE 0.388 18.6 pt -65.56 -11.68 12.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 114.233 1.197 . . . . 1.3100000000000001 114.233 -177.29 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -79.68 -30.83 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.409 0.683 . . . . 1.97 112.266 169.19 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -81.26 -76.4 0.25 Allowed 'General case' 0 N--CA 1.466 0.354 0 O-C-N 121.087 -1.008 . . . . 3.0800000000000001 112.968 -162.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -133.34 51.26 0.85 Allowed Glycine 0 C--N 1.333 0.415 0 N-CA-C 108.055 -2.018 . . . . 2.1400000000000001 108.055 -174.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 1.8 mmtt -147.04 -114.03 0.08 Allowed 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 125.669 1.588 . . . . 4.1699999999999999 108.483 -164.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.0 m -77.12 -55.83 5.1 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 119.401 1.0 . . . . 1.3700000000000001 110.877 -169.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -44.3 -59.82 2.21 Favored 'General case' 0 C--N 1.341 0.204 0 O-C-N 123.87 0.732 . . . . 3.0899999999999999 110.459 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.9 m -84.47 -16.11 43.65 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.216 -0.902 . . . . 1.6299999999999999 110.907 -174.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 65.19 50.44 56.79 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 124.077 0.846 . . . . 1.3300000000000001 112.36 170.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.9 m -106.3 -54.31 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 117.832 0.816 . . . . 1.3100000000000001 112.982 -175.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -90.06 -62.02 0.21 Allowed Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 123.645 0.778 . . . . 5.5800000000000001 112.242 -176.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.41 ' CD ' ' HA ' ' A' ' 47' ' ' LYS . 29.7 Cg_endo -80.34 170.77 15.72 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.795 2.33 . . . . 1.53 108.096 170.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -128.53 160.24 32.98 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.593 -1.632 . . . . 3.23 106.593 168.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.38 156.78 37.11 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.135 -1.061 . . . . 1.1699999999999999 108.135 171.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.49 10.85 60.12 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.093 0.854 . . . . 1.04 112.316 -173.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -110.13 149.52 29.94 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 118.195 0.997 . . . . 1.3300000000000001 109.598 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.12 119.11 35.0 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.688 1.195 . . . . 4.3700000000000001 108.0 -177.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.5 pt -143.6 179.33 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 107.881 -1.155 . . . . 0.84999999999999998 107.881 177.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.3 mtt-85 -126.81 141.26 51.87 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.683 -1.229 . . . . 2.7400000000000002 107.683 172.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.4 p -108.6 132.46 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 106.827 -1.546 . . . . 0.77000000000000002 106.827 176.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.2 124.27 2.75 Favored Glycine 0 C--N 1.334 0.44 0 N-CA-C 109.719 -1.352 . . . . 0.52000000000000002 109.719 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 179.67 -156.95 19.47 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 107.906 -2.077 . . . . 0.58999999999999997 107.906 -176.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -104.66 134.6 47.55 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 118.315 1.058 . . . . 4.6399999999999997 110.646 -172.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.411 ' HB ' ' CZ ' ' A' ' 104' ' ' PHE . 2.8 m -79.92 141.04 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.736 -0.665 . . . . 2.3700000000000001 109.408 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.0 m -76.87 133.61 39.26 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.802 -0.814 . . . . 2.3900000000000001 108.802 172.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.1 p -45.92 -51.24 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 125.651 1.58 . . . . 1.78 112.2 177.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.63 61.74 1.18 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.296 -1.122 . . . . 1.98 110.296 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.1 m -154.83 53.15 0.64 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.589 1.194 . . . . 2.2599999999999998 112.718 -176.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.14 104.88 5.34 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 107.725 -1.213 . . . . 1.7 107.725 174.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.1 m -123.6 135.13 64.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 109.17 -0.678 . . . . 0.57999999999999996 109.17 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.411 ' CB ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -127.38 147.4 50.27 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.714 1.605 . . . . 5.4800000000000004 110.496 -172.807 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -75.79 157.19 84.15 Favored Pre-proline 0 CA--C 1.529 0.172 0 C-N-CA 122.788 0.435 . . . . 2.5600000000000001 110.525 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -66.5 -19.85 54.51 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 123.032 2.488 . . . . 1.24 111.762 166.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -50.16 -35.23 25.28 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.105 0.562 . . . . 1.8200000000000001 110.573 163.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.6 m 71.07 18.46 5.86 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.728 1.611 . . . . 1.53 112.813 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.18 -45.45 2.11 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 125.352 1.461 . . . . 2.5 111.429 170.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -78.46 131.66 36.96 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 107.302 -1.37 . . . . 1.8799999999999999 107.302 -177.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.556 HG23 ' HB3' ' A' ' 96' ' ' TYR . 26.6 m -147.02 147.52 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 107.784 -1.191 . . . . 0.71999999999999997 107.784 -174.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -149.71 156.79 42.45 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.54 -0.725 . . . . 1.3500000000000001 110.217 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -154.09 161.01 42.21 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.401 -0.818 . . . . 2.0899999999999999 109.93 -173.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -105.98 138.66 41.78 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.879 -0.785 . . . . 0.60999999999999999 108.879 174.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 t -121.19 142.0 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 107.678 -1.23 . . . . 1.98 107.678 176.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -144.09 -175.72 4.72 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.02 -0.733 . . . . 1.8999999999999999 109.02 177.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -140.29 179.23 6.76 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.054 -0.721 . . . . 2.6200000000000001 109.054 165.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 55.8 p -48.28 -28.9 3.38 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.903 2.081 . . . . 3.4500000000000002 111.707 171.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 15.0 mt -68.27 -5.2 17.2 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.662 1.185 . . . . 5.1799999999999997 112.853 177.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.32 -39.6 2.78 Favored Glycine 0 C--N 1.337 0.61 0 O-C-N 121.587 -0.696 . . . . 3.3100000000000001 111.971 166.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.1 136.21 43.19 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.912 -0.875 . . . . 1.5 110.912 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -123.36 150.78 43.25 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.435 1.894 . . . . 4.4199999999999999 107.533 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.429 HG21 HD11 ' A' ' 43' ' ' ILE . 11.3 tp -146.34 146.39 19.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 122.986 0.514 . . . . 1.3 110.041 174.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.4 mt -91.05 137.26 32.5 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.452 1.101 . . . . 0.72999999999999998 110.61 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.3 t -127.3 129.47 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 126.214 1.806 . . . . 1.01 107.636 -178.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 44.2 p -107.98 145.19 34.23 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.766 1.226 . . . . 0.72999999999999998 109.463 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.556 ' HB3' HG23 ' A' ' 80' ' ' VAL . 2.3 t80 -138.7 126.89 22.74 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.685 1.594 . . . . 1.99 107.277 -175.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -108.36 44.62 1.1 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.817 1.247 . . . . 1.9399999999999999 112.331 -170.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -170.7 171.98 5.98 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.593 1.957 . . . . 3.0600000000000001 107.733 172.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.2 mp -66.46 137.63 56.97 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.579 -0.701 . . . . 1.97 110.661 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.51 ' HG ' HG21 ' A' ' 80' ' ' VAL . 19.2 mt -76.21 159.0 81.18 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.224 0.609 . . . . 1.3799999999999999 109.465 176.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -64.83 -88.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.59 2.86 . . . . 2.0099999999999998 109.843 170.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.6 29.4 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.171 1.388 . . . . 3.5299999999999998 113.011 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 50.7 1.66 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 115.923 1.823 . . . . 2.1600000000000001 115.923 -168.096 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.411 ' CZ ' ' HB ' ' A' ' 66' ' ' VAL . 26.6 t80 58.58 93.98 0.03 OUTLIER 'General case' 0 C--N 1.342 0.281 0 C-N-CA 124.652 1.181 . . . . 3.1400000000000001 109.135 -156.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 26.8 mtp85 -77.78 157.43 29.99 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 107.095 -1.446 . . . . 4.2800000000000002 107.095 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -83.93 119.99 25.55 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.388 -0.968 . . . . 2.9900000000000002 108.388 -169.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.3 68.02 1.73 Allowed Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.458 1.028 . . . . 0.76000000000000001 113.09 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.45 ' O ' HG23 ' A' ' 110' ' ' ILE . 1.2 pt20 -156.64 62.61 0.53 Allowed 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 124.141 0.976 . . . . 2.7200000000000002 110.519 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -27.66 119.56 0.05 OUTLIER Glycine 0 CA--C 1.529 0.93 0 C-N-CA 126.028 1.775 . . . . 0.87 114.997 -166.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.45 HG23 ' O ' ' A' ' 108' ' ' GLN . 2.6 pp -121.68 167.88 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 108.602 -0.888 . . . . 0.75 108.602 -173.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.8 m -117.66 134.41 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.583 -0.895 . . . . 0.70999999999999996 108.583 177.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -122.72 136.25 54.82 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.84 1.656 . . . . 0.5 108.623 -175.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -119.81 144.95 47.05 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.327 1.451 . . . . 4.3499999999999996 108.942 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 162.82 -147.84 14.1 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 110.132 -1.187 . . . . 0.92000000000000004 110.132 173.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.9 p -126.13 136.53 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 123.435 0.694 . . . . 0.65000000000000002 109.801 -166.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.736 ' HG ' HD22 ' A' ' 122' ' ' LEU . 7.9 mp -80.92 153.43 27.56 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.901 -1.518 . . . . 2.71 106.901 175.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -172.21 -47.65 0.04 OUTLIER Glycine 0 C--N 1.333 0.394 0 C-N-CA 119.584 -1.293 . . . . 2.1699999999999999 112.88 -178.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -62.33 158.66 16.88 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.832 -0.803 . . . . 4.7699999999999996 108.832 172.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -81.5 64.0 6.04 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 122.218 1.009 . . . . 4.7400000000000002 108.297 -175.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 116.07 17.93 6.11 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 126.04 1.781 . . . . 1.8100000000000001 113.749 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.533 ' C ' HD23 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -134.31 156.09 49.07 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.004 1.402 . . . . 2.75 109.591 169.987 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.736 HD22 ' HG ' ' A' ' 116' ' ' LEU . 2.1 mt -114.67 141.52 47.69 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.326 0.65 . . . . 2.0 110.432 -173.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -101.22 104.47 15.52 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.4 -0.963 . . . . 0.52000000000000002 108.4 175.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -128.66 117.6 21.48 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 123.131 0.572 . . . . 0.95999999999999996 109.78 -177.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.2 t -110.59 -6.61 14.83 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.338 1.055 . . . . 0.89000000000000001 111.614 177.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -99.54 89.59 4.21 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.658 -1.277 . . . . 3.9100000000000001 108.375 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.9 m -106.76 133.92 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 121.829 2.104 . . . . 0.68000000000000005 111.848 175.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -123.36 104.25 8.99 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.771 1.228 . . . . 0.73999999999999999 108.626 -175.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.34 59.89 3.58 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.493 -0.754 . . . . 1.2 110.832 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.34 -24.29 61.27 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.209 0.818 . . . . 3.4700000000000002 113.209 -175.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -79.9 57.03 2.48 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.019 0.928 . . . . 5.21 110.546 -178.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.2 t70 . . . . . 0 CA--C 1.532 0.263 0 CA-C-O 121.535 0.683 . . . . 5.4900000000000002 109.858 174.401 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.455 -0.19 0 N-CA-C 108.076 -1.083 . . . . 6.3399999999999999 108.076 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.64 119.73 31.78 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 109.335 -0.617 . . . . 7.0 109.335 -176.128 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.0 tp -66.52 128.65 37.03 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 107.422 -1.325 . . . . 6.4900000000000002 107.422 169.508 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -161.02 93.1 0.95 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.926 1.239 . . . . 3.46 112.297 173.406 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -141.98 164.34 30.43 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.283 0.947 . . . . 1.8300000000000001 112.365 -175.345 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.406 ' CD1' ' HB2' ' A' ' 61' ' ' ARG . 98.3 m-85 -83.1 119.21 24.22 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 125.168 1.387 . . . . 2.7400000000000002 109.267 176.53 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.59 159.19 19.89 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.195 0.998 . . . . 2.73 110.808 178.889 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.36 144.01 91.4 Favored Pre-proline 0 N--CA 1.451 -0.402 0 C-N-CA 123.783 0.833 . . . . 1.52 109.313 175.019 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.52 -45.58 4.84 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.636 2.224 . . . . 0.92000000000000004 111.031 179.538 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.5 p -45.28 -46.39 12.64 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.412 1.485 . . . . 2.2799999999999998 112.34 -179.588 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.84 -57.1 10.31 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.071 -1.085 . . . . 3.6200000000000001 108.071 179.589 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 31.2 pt -73.18 30.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 113.712 1.004 . . . . 1.4299999999999999 113.712 -171.56 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.6 t -120.13 -18.5 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.682 1.993 . . . . 2.2000000000000002 111.837 173.574 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -139.57 91.63 2.5 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.945 1.248 . . . . 2.4900000000000002 111.826 -170.355 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.4 46.66 68.48 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 109.99 -1.244 . . . . 1.5700000000000001 109.99 176.168 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -146.42 -139.52 0.1 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 104.404 -2.443 . . . . 4.8899999999999997 104.404 172.883 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.787 HG23 HD11 ' A' ' 116' ' ' LEU . 94.5 m -52.19 -54.13 34.65 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 117.197 -1.383 . . . . 2.02 114.599 -178.413 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -36.36 -56.63 0.77 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.856 1.207 . . . . 2.5499999999999998 111.321 174.21 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.61 -7.71 59.45 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 113.895 -1.502 . . . . 1.5900000000000001 111.268 -171.409 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 56.74 35.9 69.74 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.325 1.44 . . . . 1.1499999999999999 112.373 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.8 m -89.44 -42.54 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 117.893 0.847 . . . . 1.24 110.979 -178.726 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.7 mmtt -81.39 -63.88 0.3 Allowed Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 118.325 -0.845 . . . . 3.2400000000000002 112.55 176.324 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -81.79 152.47 17.07 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.533 1.489 . . . . 1.97 110.168 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -100.4 43.05 1.08 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.261 1.424 . . . . 3.8199999999999998 109.493 175.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 33.14 59.88 0.45 Allowed 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 127.232 2.213 . . . . 2.29 115.459 177.578 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.42 30.86 0.2 Allowed Glycine 0 CA--C 1.524 0.639 0 CA-C-N 113.757 -1.565 . . . . 1.47 112.664 177.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -121.98 154.06 37.71 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.193 0.997 . . . . 2.8900000000000001 109.522 -176.118 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.446 HH12 ' NE2' ' A' ' 113' ' ' GLN . 13.9 ttp85 -96.82 114.07 25.67 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.101 -1.074 . . . . 4.7699999999999996 108.101 -178.344 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.7 pt -132.99 178.15 6.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 C-N-CA 124.271 1.028 . . . . 0.97999999999999998 109.158 -176.49 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.406 ' HB2' ' CD1' ' A' ' 37' ' ' PHE . 3.5 mtt180 -136.12 150.68 49.2 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.087 -1.079 . . . . 1.9199999999999999 108.087 174.095 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.33 143.63 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.821 1.248 . . . . 0.85999999999999999 107.734 177.243 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.91 123.23 1.81 Allowed Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.363 -1.095 . . . . 0.55000000000000004 110.363 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -178.63 -171.36 41.81 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 109.573 -1.411 . . . . 0.68999999999999995 109.573 -177.237 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.41 135.36 33.36 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.936 0.874 . . . . 2.71 110.945 178.193 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.438 HG12 ' H ' ' A' ' 66' ' ' VAL . 0.8 OUTLIER -63.98 131.02 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 114.99 -1.004 . . . . 2.5600000000000001 108.295 167.36 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.2 m -37.77 -82.75 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 126.531 1.932 . . . . 3.2599999999999998 113.128 176.91 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.6 p 175.84 -40.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.511 1.124 . . . . 2.4399999999999999 109.497 179.608 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -142.45 25.34 2.31 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.923 -0.376 . . . . 1.75 112.181 179.638 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.3 m -84.21 -8.86 58.93 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 117.756 0.778 . . . . 1.23 112.461 -178.85 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.1 tpt -68.29 115.06 7.31 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.803 0.841 . . . . 1.79 108.85 176.605 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.1 m -125.84 135.61 63.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 108.363 -0.977 . . . . 0.59999999999999998 108.363 171.535 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 ptm85 -128.0 133.08 49.12 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.719 1.208 . . . . 6.1299999999999999 108.515 -171.665 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -85.36 146.23 44.27 Favored Pre-proline 0 C--O 1.234 0.287 0 N-CA-C 108.767 -0.827 . . . . 2.1899999999999999 108.767 -176.707 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -70.69 12.97 0.38 Allowed 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.893 2.395 . . . . 1.24 113.703 178.704 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -75.95 -29.91 58.47 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.246 0.618 . . . . 1.1200000000000001 109.655 163.415 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 m 85.47 -18.91 0.34 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.821 2.048 . . . . 1.5 112.757 -174.049 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -104.91 8.78 34.74 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.487 1.115 . . . . 1.95 113.093 -172.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 -133.55 126.81 31.82 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.334 -1.358 . . . . 1.1499999999999999 107.334 172.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.93 125.3 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.001 -1.851 . . . . 0.85999999999999999 106.001 -175.769 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -137.85 146.44 43.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 119.683 1.128 . . . . 0.83999999999999997 109.713 179.401 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -142.89 152.36 42.02 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.008 -0.738 . . . . 1.8500000000000001 109.008 -174.903 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.86 150.77 24.55 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.452 -0.573 . . . . 0.57999999999999996 109.452 171.859 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.9 p -143.43 147.27 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.246 1.018 . . . . 1.8999999999999999 108.331 -171.787 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.414 ' HB3' ' HG3' ' A' ' 91' ' ' GLU . 0.3 OUTLIER -153.93 -179.88 8.26 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 112.136 0.421 . . . . 1.78 112.136 -174.795 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.69 7.6 4.46 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.912 0.885 . . . . 2.4900000000000002 110.736 176.912 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.4 m 46.83 38.44 6.0 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.359 1.063 . . . . 5.29 112.122 -173.289 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.3 -82.04 0.64 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.827 1.251 . . . . 4.7999999999999998 108.516 178.313 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -88.72 -31.51 12.74 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.002 0.811 . . . . 3.6000000000000001 113.25 -174.328 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 164.53 -169.14 39.17 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 118.029 0.915 . . . . 1.79 111.065 -178.122 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.414 ' HG3' ' HB3' ' A' ' 85' ' ' HIS . 12.1 tt0 -116.27 145.77 42.89 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.995 2.118 . . . . 3.5 107.731 175.633 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.3 tp -128.46 159.04 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 123.845 0.858 . . . . 1.1499999999999999 109.35 175.457 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.3 mt -109.42 138.16 46.2 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.552 1.141 . . . . 0.76000000000000001 110.873 -176.763 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.34 124.79 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 125.987 1.715 . . . . 0.92000000000000004 107.383 -178.789 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.9 p -101.72 135.68 42.84 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.71 -0.848 . . . . 0.47999999999999998 108.71 176.497 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.47 ' CE2' HG13 ' A' ' 127' ' ' VAL . 5.0 t80 -128.76 163.39 25.27 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.283 2.233 . . . . 2.3599999999999999 107.997 -176.083 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -159.92 156.45 27.27 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 105.299 -2.111 . . . . 3.4399999999999999 105.299 -170.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 60.16 66.81 0.92 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 130.26 3.424 . . . . 2.9700000000000002 111.854 -169.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 51.65 -160.52 0.09 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.176 0.99 . . . . 1.7 109.902 -178.296 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.9 mt -145.14 157.39 53.7 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 104.555 -2.387 . . . . 1.1699999999999999 104.555 175.33 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.01 -88.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.923 2.415 . . . . 2.21 109.585 178.915 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -78.07 46.82 0.62 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.366 1.066 . . . . 3.25 109.957 179.368 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 45.55 -2.62 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 129.437 3.095 . . . . 2.1800000000000002 117.787 -171.366 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 58.2 t80 56.58 88.51 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.619 1.167 . . . . 2.8300000000000001 108.858 -153.195 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 22.3 mtp-105 -79.88 155.77 27.63 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.593 -1.262 . . . . 4.5800000000000001 107.593 172.975 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -89.88 156.44 18.46 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.139 1.376 . . . . 3.3500000000000001 111.183 -170.031 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 52.15 47.38 55.29 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.274 0.94 . . . . 0.77000000000000002 112.935 175.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.06 101.18 2.07 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 105.518 -2.03 . . . . 2.3900000000000001 105.518 -178.661 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -60.87 138.61 48.09 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.714 -0.554 . . . . 0.70999999999999996 111.714 -169.705 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.2 pp -136.75 174.71 11.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 124.25 1.02 . . . . 0.92000000000000004 108.778 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.4 m -122.6 145.83 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 108.83 -0.804 . . . . 0.64000000000000001 108.83 175.701 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.403 ' HB2' HG12 ' A' ' 127' ' ' VAL . . . -135.05 127.65 30.8 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.9 1.28 . . . . 0.44 109.501 -174.257 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.446 ' NE2' HH12 ' A' ' 59' ' ' ARG . 3.9 tt0 -113.38 141.52 46.96 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.072 1.349 . . . . 2.96 109.628 -178.648 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 175.05 -136.39 3.42 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 110.919 -0.872 . . . . 0.84999999999999998 110.919 164.11 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.0 p -129.62 151.3 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 123.632 0.773 . . . . 0.63 109.466 -167.804 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.787 HD11 HG23 ' A' ' 48' ' ' THR . 3.9 mm? -54.55 135.5 46.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.407 -0.815 . . . . 2.2000000000000002 110.714 172.084 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -94.41 -115.55 2.7 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 109.448 -1.461 . . . . 1.8200000000000001 109.448 179.049 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -56.63 -55.75 30.0 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.121 0.969 . . . . 4.54 111.135 179.042 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.8 p30 179.98 -65.82 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 127.755 2.422 . . . . 4.0999999999999996 107.718 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.16 -38.2 35.35 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.353 -0.699 . . . . 1.26 111.353 178.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.54 138.55 34.25 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 117.554 0.677 . . . . 2.1600000000000001 110.85 -175.323 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -103.28 123.58 47.05 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 124.29 1.036 . . . . 2.4500000000000002 108.506 -175.331 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.6 97.29 10.95 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.384 -0.969 . . . . 0.46000000000000002 108.384 176.463 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -118.77 119.11 33.43 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 108.804 -0.813 . . . . 0.96999999999999997 108.804 -177.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.8 t -117.87 10.69 13.27 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.867 0.867 . . . . 1.1799999999999999 111.168 176.55 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -119.03 90.02 3.25 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 120.78 -1.2 . . . . 2.9900000000000002 109.148 170.256 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.47 HG13 ' CE2' ' A' ' 96' ' ' TYR . 5.7 m -91.68 137.1 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 118.949 0.795 . . . . 0.77000000000000002 110.018 168.19 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -118.2 120.96 39.28 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.541 -1.652 . . . . 0.79000000000000004 106.541 173.021 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.05 121.47 27.07 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.884 -1.154 . . . . 2.2999999999999998 107.884 171.532 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -130.84 25.36 5.0 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.118 0.567 . . . . 3.6499999999999999 111.564 -179.674 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -154.28 82.12 1.12 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.672 -0.862 . . . . 4.7699999999999996 108.672 -172.887 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.454 -0.264 0 N-CA-C 107.764 -1.198 . . . . 6.5700000000000003 107.764 178.895 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 CA--C 1.532 0.258 0 N-CA-C 112.173 0.435 . . . . 7.1699999999999999 112.173 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -153.72 -55.06 0.11 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.336 0.655 . . . . 9.1899999999999995 110.101 -175.08 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 tt 54.82 57.44 5.67 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.168 1.387 . . . . 5.6200000000000001 111.284 173.521 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -159.1 102.29 1.61 Allowed 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.738 -0.601 . . . . 3.5 111.987 -172.264 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -140.61 163.27 33.31 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 119.362 0.983 . . . . 2.0499999999999998 112.695 -174.864 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -81.59 127.66 33.11 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.245 1.018 . . . . 2.0 109.871 -178.123 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -129.67 157.46 42.06 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.571 1.949 . . . . 2.98 109.065 177.755 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.4 p -94.01 149.37 36.81 Favored Pre-proline 0 N--CA 1.446 -0.667 0 C-N-CA 124.455 1.102 . . . . 1.8100000000000001 108.6 179.206 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.26 -31.85 58.06 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.638 2.225 . . . . 1.05 112.342 174.824 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -46.71 -43.63 18.06 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.509 0.724 . . . . 2.8399999999999999 111.827 171.268 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -76.85 -7.31 55.25 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.796 -0.565 . . . . 2.3300000000000001 111.857 -175.785 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.3 pt -124.92 40.56 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 125.696 1.599 . . . . 2.0 110.164 176.018 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.5 p -124.27 -60.7 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 CA-C-O 121.543 0.687 . . . . 2.6499999999999999 112.022 160.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -83.51 73.37 10.21 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 120.324 -1.485 . . . . 2.1600000000000001 112.137 -162.504 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.79 70.93 1.09 Allowed Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.832 -1.307 . . . . 1.8999999999999999 109.832 176.73 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.78 -123.06 0.06 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.05 -1.833 . . . . 3.48 106.05 175.744 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 t -63.91 -37.16 86.39 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 118.396 0.543 . . . . 2.4399999999999999 110.871 -172.578 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -43.27 -42.48 4.42 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 127.058 2.143 . . . . 4.4299999999999997 112.079 177.278 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.2 m -116.28 9.52 14.56 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.852 1.261 . . . . 2.1400000000000001 109.991 -175.256 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 45.73 33.66 4.93 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.597 1.57 . . . . 1.1100000000000001 113.667 -173.58 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.1 m -81.56 -25.75 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 119.076 1.438 . . . . 1.99 111.872 -173.073 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -121.44 -75.46 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.226 0 C-N-CA 123.922 0.889 . . . . 3.48 111.137 177.274 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -75.57 121.47 6.38 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 CA-C-N 120.48 1.207 . . . . 1.1399999999999999 109.192 177.788 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -69.04 158.36 34.95 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.483 -0.562 . . . . 3.2999999999999998 109.483 169.685 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.36 167.66 5.15 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.719 0.808 . . . . 1.3799999999999999 110.801 174.902 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.3 11.31 79.58 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 119.589 -0.562 . . . . 1.0600000000000001 113.589 178.187 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -95.02 147.69 23.13 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.442 1.121 . . . . 1.52 109.646 175.076 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.19 125.1 31.87 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 107.261 -1.385 . . . . 3.8300000000000001 107.261 177.265 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.2 pt -140.7 176.93 4.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 107.796 -1.187 . . . . 0.88 107.796 168.091 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.0 mtt180 -130.75 127.08 38.02 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.696 -0.853 . . . . 2.3900000000000001 108.696 173.616 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.5 p -92.28 127.32 44.56 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.076 0 N-CA-C 108.239 -1.023 . . . . 0.83999999999999997 108.239 177.537 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -122.24 127.86 6.96 Favored Glycine 0 C--N 1.333 0.397 0 N-CA-C 110.317 -1.113 . . . . 0.87 110.317 177.314 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.49 -164.03 32.91 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 117.751 0.776 . . . . 0.91000000000000003 111.294 -177.037 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.56 127.6 52.33 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.108 0.963 . . . . 2.8399999999999999 109.99 -175.183 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.5 t -59.49 139.49 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 106.971 -1.492 . . . . 2.29 106.971 169.894 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.655 HG22 HG12 ' A' ' 68' ' ' VAL . 57.2 m -50.9 -79.93 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.198 0.599 . . . . 2.6000000000000001 112.059 -176.682 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.655 HG12 HG22 ' A' ' 67' ' ' THR . 3.1 p 172.42 -39.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 126.175 1.79 . . . . 2.04 108.286 -176.992 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -149.39 28.55 1.21 Allowed Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.982 -0.343 . . . . 2.3799999999999999 112.345 176.059 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.3 m -86.59 4.34 40.59 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 117.713 0.757 . . . . 1.1599999999999999 111.983 176.096 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.79 110.35 2.79 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.878 -1.156 . . . . 1.74 107.878 172.927 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.9 m -118.14 111.83 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 107.396 -1.335 . . . . 0.88 107.396 170.811 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -98.73 148.96 23.34 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.347 1.059 . . . . 5.1799999999999997 110.678 175.798 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -84.72 151.74 58.75 Favored Pre-proline 0 C--O 1.235 0.294 0 N-CA-C 109.088 -0.708 . . . . 2.3199999999999998 109.088 173.837 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.02 25.86 0.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.663 2.242 . . . . 1.8999999999999999 112.861 168.434 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -87.62 -24.61 23.9 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.822 0.849 . . . . 1.4299999999999999 108.746 163.325 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 m 67.97 11.34 8.32 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.353 1.461 . . . . 1.21 112.486 -175.722 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.0 pp -127.37 3.1 6.3 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.655 1.582 . . . . 1.8100000000000001 112.323 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -136.65 135.68 38.47 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.071 1.348 . . . . 1.46 109.301 -178.634 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.07 130.08 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 107.659 -1.237 . . . . 0.78000000000000003 107.659 -170.358 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -135.81 156.2 49.16 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 119.49 1.041 . . . . 1.4099999999999999 110.195 173.559 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -150.25 144.21 25.45 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.935 -0.575 . . . . 2.1299999999999999 110.382 -173.351 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.49 130.16 35.87 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.857 -0.794 . . . . 0.65000000000000002 108.857 173.748 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.6 t -110.24 130.8 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 106.399 -1.704 . . . . 1.75 106.399 174.276 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -157.7 157.28 33.2 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 118.618 -0.706 . . . . 3.3900000000000001 109.277 -179.736 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -148.48 168.15 23.47 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.952 0.901 . . . . 5.8700000000000001 109.556 171.911 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.3 t -30.82 -55.81 0.21 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.729 2.412 . . . . 4.4299999999999997 111.761 173.155 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -113.03 -13.61 13.07 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.154 0.982 . . . . 4.8799999999999999 111.244 174.726 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.92 60.68 4.15 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.727 -0.949 . . . . 5.1200000000000001 110.727 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 28.84 -127.42 0.08 OUTLIER Glycine 0 CA--C 1.528 0.857 0 C-N-CA 127.163 2.316 . . . . 2.27 114.371 173.976 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -165.88 139.31 4.31 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 104.956 -2.238 . . . . 4.2000000000000002 104.956 167.231 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 92' ' ' ILE . 7.6 tp -154.81 152.78 8.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 119.102 0.865 . . . . 0.91000000000000003 110.461 172.643 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.5 mt -100.18 122.74 43.49 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.287 1.035 . . . . 0.56999999999999995 110.594 -179.475 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.0 t -109.74 127.49 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 124.983 1.313 . . . . 1.03 107.8 -177.752 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.6 p -104.81 144.84 31.2 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.779 0.832 . . . . 0.70999999999999996 109.585 179.074 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.436 ' HE2' HG13 ' A' ' 127' ' ' VAL . 10.7 t80 -142.78 163.27 33.25 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.981 1.712 . . . . 2.1800000000000002 107.823 -174.8 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -148.79 146.22 27.92 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 127.742 2.417 . . . . 3.6400000000000001 105.365 -174.535 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 67.87 60.84 0.43 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 129.661 3.185 . . . . 2.8399999999999999 112.147 -171.403 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 mt 54.41 -169.6 0.06 Allowed 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 125.553 1.541 . . . . 2.5 111.375 176.506 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.421 HD21 ' CD2' ' A' ' 96' ' ' TYR . 13.0 mt -143.67 148.94 45.11 Favored Pre-proline 0 C--O 1.233 0.227 0 N-CA-C 106.657 -1.609 . . . . 2.0600000000000001 106.657 179.374 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -64.33 111.29 1.58 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.898 2.399 . . . . 3.04 109.273 -176.679 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 42.09 46.69 3.75 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.252 1.421 . . . . 4.6100000000000003 111.121 -174.95 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 48.79 11.41 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 116.246 1.943 . . . . 3.0699999999999998 116.246 -176.127 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 53.38 115.92 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 123.52 0.728 . . . . 4.5499999999999998 109.546 -148.059 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -74.41 113.81 12.07 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.638 -1.616 . . . . 5.5700000000000003 106.638 -176.453 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -74.83 133.77 41.84 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 118.44 -1.304 . . . . 3.9500000000000002 112.277 -126.665 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.54 53.52 3.38 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.638 1.114 . . . . 1.1499999999999999 111.55 -176.702 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.0 54.97 1.9 Allowed 'General case' 0 C--N 1.341 0.224 0 CA-C-N 117.5 0.65 . . . . 3.6499999999999999 112.021 -172.394 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -9.73 124.36 0.01 OUTLIER Glycine 0 CA--C 1.533 1.191 0 C-N-CA 128.723 3.058 . . . . 0.81000000000000005 116.66 -163.735 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.7 pp -134.63 169.19 22.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 O-C-N 121.455 -1.027 . . . . 0.81999999999999995 110.056 -172.761 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.6 m -121.37 139.38 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 108.718 -0.845 . . . . 0.75 108.718 175.029 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -128.34 121.0 28.14 Favored 'General case' 0 N--CA 1.458 -0.052 0 C-N-CA 125.013 1.325 . . . . 0.51000000000000001 108.831 -176.568 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -103.81 142.45 34.35 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.541 0.736 . . . . 4.04 109.572 -179.341 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 171.59 -141.33 6.33 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.653 -0.979 . . . . 1.1899999999999999 110.653 169.367 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.0 p -129.72 149.24 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 109.311 -0.625 . . . . 0.84999999999999998 109.311 -168.42 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -56.05 132.35 49.89 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 119.666 -0.814 . . . . 2.2999999999999998 109.523 170.716 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -80.29 -124.6 0.55 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 109.391 -1.484 . . . . 1.97 109.391 177.709 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -70.9 -67.67 0.49 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.945 -0.391 . . . . 5.2000000000000002 109.945 -174.461 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -167.31 102.27 0.52 Allowed 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.177 -1.416 . . . . 3.1800000000000002 107.177 174.985 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 104.34 -30.01 10.92 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.096 0.855 . . . . 1.05 111.778 176.751 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -82.39 135.52 35.15 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.902 -0.764 . . . . 2.7999999999999998 109.29 175.02 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -104.99 114.75 29.13 Favored 'General case' 0 CA--C 1.526 0.04 0 N-CA-C 108.385 -0.969 . . . . 2.2599999999999998 108.385 -178.602 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -90.5 106.45 18.51 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 108.053 -1.091 . . . . 0.64000000000000001 108.053 179.684 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -143.26 89.8 2.12 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 113.361 0.875 . . . . 1.6599999999999999 113.361 -166.7 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.429 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 14.7 t -88.62 -15.17 35.69 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.673 0.99 . . . . 1.03 113.673 -179.414 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -84.98 85.98 7.43 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 119.597 -1.939 . . . . 3.3799999999999999 107.871 176.705 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.436 HG13 ' HE2' ' A' ' 96' ' ' TYR . 16.1 m -100.7 130.37 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 119.73 1.15 . . . . 0.92000000000000004 111.941 177.719 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.81 135.08 55.0 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.989 -1.115 . . . . 1.03 107.989 179.241 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -119.78 84.58 2.23 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 124.868 1.267 . . . . 1.75 109.065 179.893 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.66 50.08 0.83 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.165 0.586 . . . . 2.9300000000000002 110.207 177.229 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -141.74 157.97 44.39 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.582 -1.636 . . . . 6.0700000000000003 106.582 -177.721 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 N--CA 1.447 -0.577 0 C-N-CA 125.921 1.689 . . . . 5.2400000000000002 108.394 -172.147 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 N--CA 1.455 -0.185 0 N-CA-C 108.45 -0.944 . . . . 6.54 108.45 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.3 m-20 -77.08 110.53 11.81 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.936 0.894 . . . . 7.9400000000000004 108.887 -178.771 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.8 mp -48.14 -51.04 26.54 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.349 0.66 . . . . 9.1099999999999994 110.927 176.908 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.23 162.39 40.17 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.471 -0.937 . . . . 5.3099999999999996 108.471 174.133 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 pp -155.23 144.58 21.1 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 107.587 -1.264 . . . . 2.8799999999999999 107.587 176.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.445 ' CE2' ' HD2' ' A' ' 61' ' ' ARG . 72.5 m-85 -103.43 113.17 26.46 Favored 'General case' 0 C--O 1.228 -0.069 0 C-N-CA 124.792 1.237 . . . . 2.4199999999999999 108.226 179.521 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.72 153.42 35.66 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.33 1.052 . . . . 2.8500000000000001 110.813 -177.047 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -85.67 138.81 35.5 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 125.035 1.334 . . . . 1.6799999999999999 110.735 -177.554 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -54.1 -40.25 82.42 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.598 2.865 . . . . 0.77000000000000002 112.044 -179.573 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.4 t -58.83 -49.14 78.82 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 119.009 0.822 . . . . 2.6200000000000001 111.804 178.613 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.1 tt0 -55.25 -40.57 71.1 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 119.864 -0.734 . . . . 3.5099999999999998 109.743 -178.179 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.315 37.0 pt -77.8 -11.31 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 114.823 1.416 . . . . 1.1599999999999999 114.823 -179.17 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.61 -19.67 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 119.312 0.96 . . . . 2.0099999999999998 111.315 -179.041 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -96.61 -125.63 0.13 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.234 -0.654 . . . . 3.3399999999999999 109.234 -179.376 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -82.92 61.43 4.77 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.284 -1.126 . . . . 1.52 110.284 -169.828 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -151.89 -106.46 0.05 Allowed 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 127.155 2.182 . . . . 4.0199999999999996 106.789 -171.799 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.688 ' CG2' HD21 ' A' ' 122' ' ' LEU . 22.6 m -77.36 -57.05 4.04 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.517 0.599 . . . . 1.73 109.897 -171.357 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -56.84 -49.73 74.56 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 123.588 0.555 . . . . 3.1600000000000001 110.129 -171.231 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.6 m -70.1 -34.45 73.15 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.773 -0.649 . . . . 1.96 110.919 174.733 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.22 46.59 20.64 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 123.76 0.695 . . . . 2.1200000000000001 111.421 175.311 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.4 m -113.98 -51.25 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 113.534 0.938 . . . . 2.1400000000000001 113.534 -172.956 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -79.02 -58.64 0.68 Allowed Pre-proline 0 CA--C 1.54 0.594 0 CA-C-O 118.498 -0.763 . . . . 4.25 112.071 -178.913 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -79.37 165.02 23.66 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.096 1.864 . . . . 1.3899999999999999 109.583 174.154 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.87 155.9 16.85 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.985 0.914 . . . . 4.2599999999999998 109.864 174.861 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.9 24.57 0.49 Allowed 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.639 1.176 . . . . 3.5600000000000001 112.122 177.376 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -143.4 30.2 1.99 Allowed Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.983 1.278 . . . . 0.96999999999999997 110.891 171.431 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -103.03 155.88 18.07 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.393 0.677 . . . . 1.4099999999999999 109.429 174.211 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.55 126.73 52.47 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.753 1.221 . . . . 6.1799999999999997 108.168 176.817 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.646 ' CD1' HD21 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -143.86 176.3 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 108.283 -1.006 . . . . 1.5800000000000001 108.283 171.147 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.445 ' HD2' ' CE2' ' A' ' 37' ' ' PHE . 22.7 mtt180 -111.33 134.48 52.88 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.689 -0.485 . . . . 3.3900000000000001 109.689 166.535 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -102.93 119.88 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 107.122 -1.436 . . . . 0.91000000000000003 107.122 171.669 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.49 125.24 4.33 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 109.643 -1.383 . . . . 0.58999999999999997 109.643 -176.806 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.34 -133.73 1.59 Allowed Glycine 0 C--N 1.334 0.451 0 N-CA-C 109.517 -1.433 . . . . 1.52 109.517 -174.715 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.4 ptp -127.64 133.77 49.66 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.101 0.951 . . . . 3.02 109.996 175.769 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.438 HG11 ' CZ ' ' A' ' 104' ' ' PHE . 15.7 t -95.64 143.2 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 108.716 -0.846 . . . . 2.3399999999999999 108.716 175.507 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.63 175.74 3.34 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.281 -0.637 . . . . 2.8799999999999999 109.281 173.656 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 68' ' ' VAL . 9.5 p -106.4 65.42 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 122.897 1.332 . . . . 2.4300000000000002 109.418 179.255 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 134.76 68.79 0.07 OUTLIER Glycine 0 CA--C 1.526 0.773 0 CA-C-N 113.68 -1.6 . . . . 1.6699999999999999 112.429 175.517 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.0 m -136.45 8.09 3.1 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.399 -1.059 . . . . 1.3300000000000001 112.729 158.739 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.8 ttp -78.85 117.39 19.91 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.011 -1.107 . . . . 2.5499999999999998 108.011 176.341 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.2 m -121.02 151.71 24.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 107.829 -1.175 . . . . 0.53000000000000003 107.829 175.732 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.401 ' CB ' HG12 ' A' ' 80' ' ' VAL . 37.8 ptt85 -141.44 144.02 34.2 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.992 0.917 . . . . 3.98 109.041 -169.154 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.33 155.12 37.24 Favored Pre-proline 0 C--O 1.236 0.361 0 N-CA-C 109.519 -0.548 . . . . 2.5800000000000001 109.519 -177.002 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.13 32.11 0.42 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.508 2.805 . . . . 2.1299999999999999 112.685 -176.121 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -95.69 -14.66 23.24 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.747 1.219 . . . . 1.5900000000000001 109.125 163.611 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.4 m 70.23 6.82 5.96 Favored 'General case' 0 C--N 1.345 0.399 0 C-N-CA 125.105 1.362 . . . . 1.51 113.225 -178.845 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.7 pp -125.5 -34.28 2.69 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 127.662 2.385 . . . . 1.98 112.354 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 30.6 m-70 -87.96 124.72 33.99 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 107.809 -1.182 . . . . 1.23 107.809 -176.575 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.447 HG23 ' CB ' ' A' ' 96' ' ' TYR . 23.7 m -149.05 152.98 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.397 -0.964 . . . . 1.02 108.397 -175.008 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -156.02 161.93 40.39 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 121.41 -0.807 . . . . 1.1599999999999999 110.803 176.706 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -155.3 160.57 40.87 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.197 0.599 . . . . 1.8700000000000001 110.486 -175.848 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -107.87 136.0 48.32 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.251 -1.018 . . . . 0.58999999999999997 108.251 175.249 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.7 t -115.74 142.1 30.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 124.942 1.297 . . . . 1.8400000000000001 107.521 178.618 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -125.94 179.91 4.99 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.564 0.746 . . . . 1.71 110.056 179.303 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -128.87 171.91 11.83 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.072 0.463 . . . . 3.4399999999999999 109.995 -177.624 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.5 p -49.11 -49.22 43.0 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.611 -1.177 . . . . 4.5300000000000002 108.13 160.062 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.9 mt -77.35 27.85 0.15 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.104 1.361 . . . . 4.9199999999999999 113.415 -177.473 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 50.58 37.46 33.55 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.338 -0.705 . . . . 2.9700000000000002 111.338 -177.786 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.31 162.62 32.4 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 108.108 -1.997 . . . . 2.3999999999999999 108.108 169.021 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -162.15 93.85 0.89 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.947 -1.131 . . . . 3.9399999999999999 107.947 179.522 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.15 134.65 65.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 108.766 -0.827 . . . . 0.85999999999999999 108.766 -175.188 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.1 mt -85.39 136.96 33.24 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.077 0.951 . . . . 0.71999999999999997 109.973 177.124 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 87.1 t -124.06 133.22 69.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 107.387 -1.338 . . . . 1.04 107.387 176.363 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.7 p -111.78 158.35 19.47 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.537 1.135 . . . . 0.79000000000000004 109.796 -177.105 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.721 ' OH ' HG13 ' A' ' 127' ' ' VAL . 2.4 m-85 -148.43 133.02 17.76 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.348 1.459 . . . . 3.96 108.897 -178.279 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -104.92 6.32 33.56 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.682 1.193 . . . . 2.7000000000000002 111.711 169.311 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -111.79 162.91 14.75 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 124.488 1.115 . . . . 5.0300000000000002 111.123 172.287 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.9 mp -60.89 141.39 57.21 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.322 -0.853 . . . . 1.6499999999999999 109.949 162.631 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.525 HD13 ' CB ' ' A' ' 104' ' ' PHE . 75.8 mt -81.02 159.27 68.77 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 107.426 -1.324 . . . . 1.6200000000000001 107.426 175.849 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.54 -90.76 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.896 3.064 . . . . 2.3100000000000001 111.196 179.273 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -79.46 43.54 0.56 Allowed 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.245 -0.909 . . . . 3.73 110.53 -173.537 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.3 tp 57.92 3.27 0.21 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.581 1.152 . . . . 2.8399999999999999 112.978 -165.969 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.525 ' CB ' HD13 ' A' ' 100' ' ' LEU . 44.8 t80 57.78 94.23 0.03 OUTLIER 'General case' 0 C--N 1.342 0.274 0 CA-C-N 119.586 1.085 . . . . 2.46 109.237 -166.271 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -78.94 122.47 26.17 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.339 -0.986 . . . . 4.54 108.339 -178.17 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -84.13 173.06 11.38 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.093 1.357 . . . . 3.21 110.127 -172.692 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.9 34.73 89.43 Favored Glycine 0 CA--C 1.527 0.832 0 O-C-N 121.882 -0.511 . . . . 0.79000000000000004 112.821 175.085 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -156.32 175.39 14.06 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.364 1.066 . . . . 2.5499999999999998 108.967 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -97.68 105.88 3.22 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.973 -0.851 . . . . 1.1899999999999999 110.973 -178.07 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.5 pp -111.5 157.46 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 106.547 -1.649 . . . . 0.84999999999999998 106.547 -179.42 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.1 m -118.14 116.04 50.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 108.742 -0.836 . . . . 0.67000000000000004 108.742 176.535 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.45 ' HB2' HG12 ' A' ' 127' ' ' VAL . . . -102.99 146.53 28.21 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 125.373 1.469 . . . . 0.62 109.875 -175.207 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -146.52 139.66 25.6 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.32 1.048 . . . . 3.5800000000000001 110.106 -173.463 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 170.74 -133.82 2.91 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 106.516 -2.634 . . . . 0.84999999999999998 106.516 174.762 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p -142.24 149.9 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 118.63 1.215 . . . . 0.76000000000000001 109.166 -166.534 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 1.019 HD22 HD22 ' A' ' 122' ' ' LEU . 1.5 mt -77.31 157.18 30.85 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.693 -0.855 . . . . 1.99 108.693 -178.42 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 175.92 25.73 0.03 OUTLIER Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.345 -0.931 . . . . 2.6699999999999999 115.408 175.874 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -150.3 46.31 0.89 Allowed 'General case' 0 C--O 1.238 0.455 0 CA-C-N 118.392 1.096 . . . . 5.9100000000000001 109.533 -175.827 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 20.61 66.17 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 129.533 3.133 . . . . 3.9300000000000002 111.338 173.473 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 131.13 -30.44 3.33 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 114.084 -1.416 . . . . 1.0600000000000001 112.555 -175.516 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.32 161.13 19.48 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.548 1.174 . . . . 3.3500000000000001 111.251 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 1.019 HD22 HD22 ' A' ' 116' ' ' LEU . 12.5 mt -121.36 131.59 54.28 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 125.442 1.497 . . . . 2.0899999999999999 110.443 -169.348 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.25 99.07 11.38 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.083 -1.451 . . . . 0.55000000000000004 107.083 176.984 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.82 155.48 16.76 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.573 -0.528 . . . . 1.53 109.573 179.889 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.446 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 8.8 t -134.01 -42.23 0.82 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.876 0.47 . . . . 0.96999999999999997 111.365 173.254 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -87.39 105.62 17.39 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 120.179 -1.576 . . . . 4.3099999999999996 108.778 177.684 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.721 HG13 ' OH ' ' A' ' 96' ' ' TYR . 0.9 OUTLIER -111.88 118.62 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 123.824 0.85 . . . . 1.1399999999999999 109.725 171.027 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -108.3 111.25 23.11 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.443 -0.947 . . . . 0.94999999999999996 108.443 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.56 53.48 2.54 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.116 0.966 . . . . 1.53 110.628 178.424 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.2 pttt -79.88 69.72 6.28 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.79 -0.569 . . . . 3.21 110.616 -173.55 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -142.39 127.97 19.09 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.053 0.541 . . . . 4.5300000000000002 110.315 -172.172 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 . . . . . 0 CA--C 1.533 0.315 0 C-N-CA 125.291 1.436 . . . . 5.5800000000000001 109.689 -176.214 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.3 t . . . . . 0 CA--C 1.529 0.167 0 N-CA-C 109.65 -0.5 . . . . 8.1099999999999994 109.65 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -146.62 114.22 6.39 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.05 -0.722 . . . . 8.7899999999999991 109.05 -179.636 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.4 mt -125.86 66.53 1.19 Allowed 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.862 1.265 . . . . 6.1799999999999997 107.744 -173.429 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -140.47 112.88 7.91 Favored 'General case' 0 C--O 1.228 -0.074 0 C-N-CA 124.098 0.959 . . . . 3.3300000000000001 108.909 -173.459 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -154.93 135.33 13.31 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.566 0.746 . . . . 2.6499999999999999 109.613 -178.399 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -93.91 114.82 27.11 Favored 'General case' 0 C--N 1.337 0.061 0 C-N-CA 124.8 1.24 . . . . 2.3599999999999999 109.792 -178.039 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -120.12 156.88 30.15 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 126.329 1.852 . . . . 2.6499999999999999 109.669 -175.765 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.7 p -90.78 145.24 31.63 Favored Pre-proline 0 N--CA 1.45 -0.473 0 C-N-CA 124.422 1.089 . . . . 1.74 109.059 177.824 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -55.29 -36.81 94.4 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.889 2.393 . . . . 0.81999999999999995 111.968 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.5 t -52.57 -35.64 54.33 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.453 -0.779 . . . . 2.6299999999999999 112.041 175.247 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -83.68 5.51 24.33 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.291 0.478 . . . . 3.02 112.291 -176.408 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.6 pt -120.24 1.48 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 113.812 1.042 . . . . 1.25 113.812 173.914 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.1 p -97.27 -59.69 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 118.617 0.644 . . . . 2.1099999999999999 112.02 176.096 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -75.65 84.42 2.67 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 120.504 -1.373 . . . . 2.0699999999999998 112.042 -166.614 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.37 56.67 9.6 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 109.658 -1.377 . . . . 1.71 109.658 176.047 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -147.86 -137.3 0.09 Allowed 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 127.79 2.436 . . . . 2.3500000000000001 105.861 -173.904 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.6 m -58.82 -47.46 84.73 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.451 1.5 . . . . 1.73 112.631 -175.776 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -38.46 -54.87 1.45 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.445 0.698 . . . . 2.48 111.311 174.818 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.47 -1.45 53.52 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.446 1.099 . . . . 1.9199999999999999 111.738 -173.147 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 49.79 41.39 35.57 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.137 1.351 . . . . 1.3799999999999999 113.408 -176.804 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.1 m -92.39 -26.41 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.53 1.165 . . . . 1.96 112.887 -176.687 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -123.04 -74.16 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 124.635 1.174 . . . . 4.8099999999999996 111.497 176.663 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -73.48 121.38 7.08 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.554 1.503 . . . . 1.4099999999999999 109.305 177.497 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -77.89 160.07 28.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.078 0.951 . . . . 4.4000000000000004 108.893 175.325 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.68 158.06 28.39 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.324 -0.621 . . . . 1.1499999999999999 109.324 169.0 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.53 -2.08 76.89 Favored Glycine 0 CA--C 1.532 1.129 0 O-C-N 121.682 -0.636 . . . . 1.04 112.572 -175.482 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -91.67 146.39 23.81 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 118.102 0.951 . . . . 2.9700000000000002 109.131 178.222 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.4 mtt-85 -90.5 133.75 34.84 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.033 -0.728 . . . . 4.1299999999999999 109.033 172.443 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.1 pt -144.98 169.48 7.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 105.279 -2.119 . . . . 1.05 105.279 166.607 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 37.8 mtt180 -116.94 126.65 53.27 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.656 -1.239 . . . . 2.7599999999999998 107.656 169.406 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -90.44 135.49 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 N-CA-C 107.269 -1.382 . . . . 1.8799999999999999 107.269 173.484 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -128.55 128.59 5.96 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 109.38 -1.488 . . . . 0.63 109.38 172.491 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 176.8 -167.74 39.31 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 109.939 -1.264 . . . . 0.89000000000000001 109.939 -173.227 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.41 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 1.4 ptm -111.95 137.7 49.6 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.479 0.657 . . . . 5.0599999999999996 112.42 -176.18 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.2 t -64.93 159.32 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 114.349 -1.296 . . . . 2.3900000000000001 109.062 178.692 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 62.7 m -108.54 131.98 54.3 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.053 0.941 . . . . 3.0899999999999999 109.984 -178.492 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.3 p -75.58 45.91 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 127.955 2.502 . . . . 3.6400000000000001 111.895 179.009 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.73 49.93 0.03 OUTLIER Glycine 0 CA--C 1.522 0.473 0 C-N-CA 125.529 1.538 . . . . 2.77 109.37 179.335 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.0 m -155.59 -40.67 0.08 Allowed 'General case' 0 C--O 1.226 -0.162 0 O-C-N 122.402 -0.469 . . . . 1.6599999999999999 112.029 177.995 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.67 115.76 1.79 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 109.691 -0.485 . . . . 2.6000000000000001 109.691 171.802 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.8 m -136.51 153.57 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 108.866 -0.791 . . . . 0.98999999999999999 108.866 168.715 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -128.07 148.61 50.57 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.873 1.269 . . . . 4.8399999999999999 108.837 -178.231 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -82.84 155.9 67.78 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-N 118.119 0.418 . . . . 1.8700000000000001 109.959 174.893 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -70.91 7.28 1.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.088 2.525 . . . . 1.22 113.599 174.452 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -72.74 -23.6 60.86 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 121.938 -0.476 . . . . 1.6799999999999999 110.181 163.318 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.7 m 70.97 10.49 6.95 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.504 1.522 . . . . 1.55 112.785 -174.854 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 79' ' ' HIS 0.276 1.0 OUTLIER -123.08 -36.5 2.84 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.705 1.002 . . . . 2.3999999999999999 113.705 177.748 . . . . . . . . 4 4 . 1 . 024 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.407 ' N ' HD12 ' A' ' 78' ' ' LEU . 80.4 m-70 -85.33 129.36 34.83 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 120.23 1.377 . . . . 1.3500000000000001 107.566 178.415 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.421 HG23 ' HB3' ' A' ' 96' ' ' TYR . 30.0 m -138.06 145.81 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 107.92 -1.141 . . . . 1.05 107.92 176.974 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -144.23 147.34 33.46 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.082 -0.71 . . . . 1.3899999999999999 109.082 177.784 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -157.49 155.61 30.66 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.317 -0.401 . . . . 2.21 110.39 -171.588 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.65 149.6 24.28 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.136 -0.69 . . . . 0.52000000000000002 109.136 173.071 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.3 t -119.0 133.59 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 106.151 -1.796 . . . . 1.8899999999999999 106.151 172.849 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -155.64 159.71 39.82 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 106.653 -1.61 . . . . 3.1800000000000002 106.653 174.817 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -153.5 174.1 14.84 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 106.293 -1.743 . . . . 5.7199999999999998 106.293 173.8 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.2 p -51.77 -41.17 61.44 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.201 0.91 . . . . 3.3900000000000001 111.229 179.431 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 18.5 mt -121.15 34.31 5.25 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.86 1.264 . . . . 5.3899999999999997 110.275 169.766 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -101.08 5.98 56.3 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.244 -0.742 . . . . 5.0899999999999999 111.244 173.224 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 51.47 -114.93 3.32 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 109.765 -1.334 . . . . 2.54 109.765 -173.983 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -164.76 148.64 9.01 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.952 -1.499 . . . . 4.0599999999999996 106.952 169.948 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -155.14 154.48 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.79 0.723 . . . . 0.78000000000000003 109.082 163.449 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 mt -109.12 131.94 54.59 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.508 1.523 . . . . 0.60999999999999999 109.521 177.482 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.1 t -122.05 144.16 32.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 125.8 1.64 . . . . 0.95999999999999996 108.77 -176.263 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 32.4 p -118.96 150.01 40.64 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.203 1.001 . . . . 0.47999999999999998 108.49 179.008 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.421 ' HB3' HG23 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -149.32 109.81 4.22 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.854 -1.165 . . . . 2.2999999999999998 107.854 -178.854 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -91.02 42.91 1.12 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.347 1.459 . . . . 2.1200000000000001 112.048 -176.443 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -169.48 174.6 5.86 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.61 1.564 . . . . 2.52 108.645 173.049 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.6 mp -68.56 162.71 25.2 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.637 0.775 . . . . 1.6899999999999999 112.485 -175.398 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.452 HD22 ' CZ ' ' A' ' 104' ' ' PHE . 55.7 mt -112.67 158.6 37.04 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 126.048 1.739 . . . . 1.1899999999999999 110.618 -175.912 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.12 -88.16 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.897 3.065 . . . . 1.99 111.365 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -73.57 31.27 0.07 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.791 1.236 . . . . 3.8300000000000001 112.139 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 50.73 -5.38 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 128.558 2.743 . . . . 2.2799999999999998 116.387 -165.501 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.487 ' CZ ' HD12 ' A' ' 110' ' ' ILE . 13.4 m-30 55.65 109.23 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.864 1.666 . . . . 4.5099999999999998 110.959 -154.607 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -74.0 164.64 26.37 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.301 -1.318 . . . . 5.4900000000000002 108.323 174.865 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -82.4 61.14 5.43 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.199 1.4 . . . . 5.1100000000000003 109.727 -164.436 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 108.31 62.05 0.55 Allowed Glycine 0 CA--C 1.522 0.53 0 C-N-CA 124.509 1.052 . . . . 1.5600000000000001 111.218 -173.961 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -111.14 168.81 9.22 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 107.891 -1.151 . . . . 2.9399999999999999 107.891 158.312 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 65' ' ' MET . . . -102.91 133.7 11.52 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 111.496 -0.641 . . . . 1.0600000000000001 111.496 -179.216 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.487 HD12 ' CZ ' ' A' ' 104' ' ' PHE . 33.3 pt -145.33 169.59 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.302 1.041 . . . . 1.3300000000000001 109.638 -165.535 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 m -126.8 139.65 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 124.176 0.991 . . . . 0.68999999999999995 108.465 170.645 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -134.95 140.08 45.44 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 124.888 1.275 . . . . 0.66000000000000003 110.266 -176.695 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -135.64 145.4 46.78 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.779 1.632 . . . . 3.8900000000000001 109.705 -177.871 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -178.47 -101.54 0.15 Allowed Glycine 0 C--N 1.337 0.625 0 N-CA-C 110.17 -1.172 . . . . 1.3999999999999999 110.17 166.549 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.7 p -162.72 151.63 3.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 108.992 -0.744 . . . . 1.0 108.992 176.251 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -72.1 140.84 49.12 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 109.438 -0.578 . . . . 2.2200000000000002 109.438 167.976 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -162.43 21.17 0.19 Allowed Glycine 0 CA--C 1.524 0.612 0 C-N-CA 119.709 -1.234 . . . . 2.52 113.716 172.412 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -143.57 46.96 1.48 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.755 -0.832 . . . . 5.3099999999999996 108.755 -174.287 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 21.7 t70 18.09 66.12 0.02 OUTLIER 'General case' 0 C--N 1.34 0.164 0 C-N-CA 128.954 2.902 . . . . 3.5699999999999998 112.487 178.409 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 137.87 -48.41 0.89 Allowed Glycine 0 CA--C 1.528 0.849 0 CA-C-N 114.614 -1.175 . . . . 1.1100000000000001 111.475 -171.62 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -105.5 160.92 14.79 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.504 1.152 . . . . 2.9700000000000002 109.811 -173.862 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.64 128.92 55.82 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.508 1.123 . . . . 1.97 109.237 -172.098 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -95.6 98.73 10.72 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.163 -1.792 . . . . 0.57999999999999996 106.163 176.699 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -126.15 94.66 4.15 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.501 0.556 . . . . 1.4099999999999999 112.501 -164.933 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.2 t -84.27 -33.4 24.02 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.906 0.706 . . . . 0.90000000000000002 112.906 -178.8 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -82.91 95.09 7.86 Favored 'General case' 0 CA--C 1.528 0.113 0 O-C-N 120.556 -1.34 . . . . 3.6099999999999999 107.733 -172.816 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 35.0 m -118.44 134.85 60.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 C-N-CA 123.809 0.844 . . . . 1.3300000000000001 110.634 -176.221 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.59 101.66 8.8 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.241 -1.392 . . . . 1.03 107.241 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.98 107.26 12.63 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.741 -1.207 . . . . 2.21 107.741 172.355 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.29 44.79 0.72 Allowed 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 121.367 0.603 . . . . 3.3199999999999998 109.983 179.515 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -47.34 -43.86 23.27 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.161 0.8 . . . . 6.9800000000000004 113.161 -172.598 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 29.8 t70 . . . . . 0 N--CA 1.453 -0.317 0 C-N-CA 125.809 1.643 . . . . 5.8799999999999999 106.77 179.485 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.446 -0.63 0 CA-C-O 121.508 0.67 . . . . 8.4199999999999999 110.356 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -165.73 118.5 1.13 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.912 -0.773 . . . . 10.91 108.912 176.723 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.8 mt 62.66 56.3 2.0 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 122.21 1.005 . . . . 10.75 108.334 174.97 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.506 ' HA ' HG22 ' A' ' 60' ' ' ILE . 7.2 m120 -142.22 -171.88 3.48 Favored 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 128.112 2.565 . . . . 7.6100000000000003 106.62 -170.65 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.475 HD23 ' C ' ' A' ' 35' ' ' ASN . 0.6 OUTLIER 61.94 -160.8 0.3 Allowed 'General case' 0 C--O 1.227 -0.105 0 C-N-CA 124.825 1.25 . . . . 3.4700000000000002 111.139 166.442 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -81.58 96.67 7.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.963 -0.755 . . . . 2.0899999999999999 108.963 -175.48 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.96 157.32 19.39 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.836 0.854 . . . . 2.9500000000000002 110.427 177.694 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 p -77.44 146.08 73.14 Favored Pre-proline 0 N--CA 1.444 -0.743 0 C-N-CA 124.08 0.952 . . . . 1.77 110.179 -177.139 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -64.2 -23.05 66.72 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.507 2.805 . . . . 0.82999999999999996 112.232 175.32 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.5 p -61.52 -64.4 0.96 Allowed 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.239 0.615 . . . . 2.9500000000000002 110.931 174.932 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -46.34 -51.13 15.38 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.071 0.948 . . . . 2.1699999999999999 110.81 -171.462 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 34.0 pt -57.23 -29.07 31.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.436 1.094 . . . . 2.0800000000000001 112.754 -178.925 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.6 t -80.42 -54.32 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 123.335 0.654 . . . . 2.04 109.885 169.601 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -50.59 -42.48 55.82 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 125.002 1.321 . . . . 5.1500000000000004 112.982 -166.506 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.26 65.02 0.1 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.515 -0.85 . . . . 2.0299999999999998 111.19 -178.82 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.93 -90.32 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 118.598 -0.715 . . . . 2.46 110.923 -170.063 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.0 m -83.18 -58.82 2.69 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.689 1.196 . . . . 1.52 109.721 -169.443 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -51.15 -44.24 61.4 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 122.393 1.092 . . . . 2.5899999999999999 109.473 177.838 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.16 -25.47 60.82 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.397 1.479 . . . . 2.3799999999999999 112.451 179.059 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 56.82 46.58 90.0 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.292 1.425 . . . . 1.1799999999999999 112.552 -172.488 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.1 m -109.77 -27.43 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 114.091 1.145 . . . . 1.5 114.091 -175.422 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -122.5 -72.76 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.295 0 CA-C-O 118.237 -0.887 . . . . 3.3700000000000001 111.108 -175.794 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -76.71 151.11 31.74 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 121.504 1.469 . . . . 1.1200000000000001 108.834 169.632 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -108.32 159.58 16.53 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.663 1.185 . . . . 2.75 109.324 173.366 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.11 136.94 56.65 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.412 -0.958 . . . . 1.3100000000000001 108.412 174.078 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.85 -1.95 30.29 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 124.234 0.921 . . . . 1.0600000000000001 113.09 -173.324 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -89.02 146.9 24.56 Favored 'General case' 0 C--N 1.338 0.08 0 CA-C-N 118.87 1.335 . . . . 1.8799999999999999 109.585 179.226 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.29 106.89 17.51 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 107.906 -1.146 . . . . 3.6200000000000001 107.906 -173.53 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.506 HG22 ' HA ' ' A' ' 35' ' ' ASN . 3.7 pt -135.63 178.21 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 124.054 0.942 . . . . 1.1399999999999999 108.947 -173.945 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -121.93 119.77 32.5 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.476 -0.935 . . . . 2.21 108.476 174.415 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 p -83.78 128.96 38.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 107.198 -1.408 . . . . 1.04 107.198 173.044 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.3 128.6 4.58 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.562 -1.015 . . . . 0.78000000000000003 110.562 -177.998 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 179.76 -156.19 17.48 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 108.977 -1.649 . . . . 0.81999999999999995 108.977 -175.533 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.9 ppp? -118.3 142.92 47.01 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.814 1.245 . . . . 3.71 110.095 -179.577 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.9 m -100.92 139.85 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 123.223 0.609 . . . . 2.5699999999999998 109.809 -169.054 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 m -72.33 140.32 48.43 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.465 0.65 . . . . 2.3300000000000001 109.71 176.064 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.0 p -47.05 -61.63 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 126.263 1.825 . . . . 1.8400000000000001 111.398 172.552 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.73 73.42 1.19 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.093 -1.203 . . . . 2.0 110.093 -178.219 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.5 m -152.46 -30.98 0.15 Allowed 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 115.084 1.513 . . . . 0.97999999999999998 115.084 -179.519 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.2 104.73 0.96 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.085 -1.08 . . . . 1.6699999999999999 108.085 175.686 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.9 m -112.79 126.45 70.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 107.503 -1.295 . . . . 0.77000000000000002 107.503 175.401 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.12 137.02 54.39 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.151 1.38 . . . . 4.8099999999999996 108.191 -174.384 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -88.41 145.97 36.75 Favored Pre-proline 0 C--O 1.235 0.304 0 N-CA-C 109.068 -0.716 . . . . 2.5099999999999998 109.068 -179.11 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.01 25.2 0.3 Allowed 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.106 2.538 . . . . 2.4199999999999999 113.589 178.733 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -91.8 -24.23 19.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.802 1.241 . . . . 2.0800000000000001 109.378 164.282 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.9 m 74.12 0.42 3.6 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.52 1.528 . . . . 1.71 113.203 -174.515 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.98 18.06 11.73 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.182 0.993 . . . . 2.1699999999999999 112.168 -178.354 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -145.39 127.01 15.16 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.477 -1.305 . . . . 1.8300000000000001 107.477 173.286 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.1 128.97 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 107.704 -1.221 . . . . 0.89000000000000001 107.704 -173.252 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -141.73 148.42 38.98 Favored 'General case' 0 C--O 1.232 0.158 0 O-C-N 121.088 -1.007 . . . . 0.82999999999999996 110.739 176.938 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -143.17 153.32 42.73 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 116.35 -0.387 . . . . 1.8200000000000001 110.171 -173.416 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.86 138.14 36.42 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.928 -0.767 . . . . 0.75 108.928 172.72 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -131.97 139.67 49.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 123.844 0.857 . . . . 1.95 108.958 176.392 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -140.55 -177.71 5.17 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.665 1.586 . . . . 1.3799999999999999 108.387 -173.311 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -152.49 34.86 0.5 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 122.238 1.018 . . . . 2.71 110.149 -179.555 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.3 p 48.1 30.72 2.21 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.219 1.408 . . . . 2.9500000000000002 113.711 -176.296 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.05 27.64 8.33 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.313 1.445 . . . . 5.2699999999999996 110.206 -175.23 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 54.06 58.12 13.99 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 123.342 0.496 . . . . 3.1400000000000001 112.318 176.936 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -128.87 -82.4 0.32 Allowed Glycine 0 C--N 1.338 0.645 0 N-CA-C 109.876 -1.29 . . . . 3.5600000000000001 109.876 173.775 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 66.49 87.67 0.12 Allowed 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 125.228 1.411 . . . . 3.5099999999999998 110.853 -179.126 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -95.13 155.11 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 108.638 -0.875 . . . . 1.0700000000000001 108.638 -178.332 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 mt -104.25 131.37 51.64 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.738 -0.838 . . . . 0.62 108.738 174.932 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.7 t -114.71 133.25 61.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 125.558 1.543 . . . . 0.88 107.161 178.474 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.4 p -109.55 148.52 31.1 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.782 0.833 . . . . 0.51000000000000001 109.002 -179.765 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.453 ' CE2' ' HA ' ' A' ' 125' ' ' THR . 1.5 t80 -150.69 146.69 26.63 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 107.184 -1.413 . . . . 2.2000000000000002 107.184 -173.709 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.7 p-10 -141.35 40.33 1.75 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.214 1.005 . . . . 2.1600000000000001 112.887 -167.166 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -166.37 56.87 0.1 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.545 0.738 . . . . 2.5899999999999999 111.525 -178.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 52.62 -171.4 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.62 1.168 . . . . 1.8 111.951 -169.046 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.552 HD13 ' HB2' ' A' ' 104' ' ' PHE . 13.7 mt -147.25 152.04 41.91 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 107.007 -1.479 . . . . 1.3100000000000001 107.007 174.453 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.434 ' HG3' HG23 ' A' ' 127' ' ' VAL . 72.0 Cg_endo -63.24 133.29 39.93 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 124.033 3.155 . . . . 2.48 110.016 177.384 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 41.77 46.92 3.45 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.027 1.331 . . . . 3.8300000000000001 111.29 -173.717 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 50.26 15.1 0.18 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.085 1.754 . . . . 2.1899999999999999 115.068 -175.93 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.552 ' HB2' HD13 ' A' ' 100' ' ' LEU . 27.4 t80 62.4 95.99 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 126.108 1.763 . . . . 2.52 110.113 -166.832 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 64.1 mtp85 -77.34 124.52 27.98 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 106.477 -1.675 . . . . 3.8700000000000001 106.477 -174.658 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -83.36 173.2 11.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.114 0.483 . . . . 2.9199999999999999 110.61 -172.559 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.17 42.15 98.09 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 121.859 -0.526 . . . . 0.68999999999999995 112.677 176.112 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -155.01 179.03 9.53 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.576 1.55 . . . . 2.1400000000000001 108.581 176.986 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -110.36 138.35 14.84 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 111.616 -0.594 . . . . 0.67000000000000004 111.616 175.788 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.4 pp -140.11 169.42 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 125.686 1.595 . . . . 0.77000000000000002 106.904 -177.6 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 18.8 m -123.0 145.82 29.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 107.986 -1.116 . . . . 0.82999999999999996 107.986 167.907 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.421 ' HB2' HG12 ' A' ' 127' ' ' VAL . . . -130.83 123.8 29.88 Favored 'General case' 0 N--CA 1.461 0.079 0 C-N-CA 124.345 1.058 . . . . 0.75 109.738 -177.273 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.21 145.01 34.87 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.33 1.052 . . . . 3.9900000000000002 110.091 -179.45 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 164.65 -139.88 6.1 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 108.022 -2.031 . . . . 0.83999999999999997 108.022 173.575 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.5 p -134.54 143.1 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 118.342 1.071 . . . . 0.73999999999999999 110.983 -166.627 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -71.72 153.68 41.86 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.126 -0.943 . . . . 1.79 108.857 171.661 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -170.51 -50.62 0.04 OUTLIER Glycine 0 C--N 1.332 0.329 0 N-CA-C 110.988 -0.845 . . . . 2.02 110.988 177.98 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -65.56 146.97 54.19 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.283 -1.006 . . . . 5.9900000000000002 108.283 173.749 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -82.64 63.33 6.72 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.389 -0.967 . . . . 3.8500000000000001 108.389 -173.733 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 127.96 11.69 3.13 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.895 1.712 . . . . 1.3899999999999999 113.664 -179.223 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.73 168.57 19.41 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.194 1.497 . . . . 2.6600000000000001 109.834 169.823 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.3 mp -126.57 136.11 52.13 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.375 1.07 . . . . 1.9299999999999999 109.418 -171.776 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -97.41 103.06 14.96 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.903 -1.518 . . . . 0.54000000000000004 106.903 175.326 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -122.91 121.06 35.27 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 118.398 -0.811 . . . . 0.95999999999999996 108.854 -177.098 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.453 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 15.4 t -107.99 -15.61 14.49 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 123.579 0.549 . . . . 0.97999999999999998 111.802 176.426 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -97.94 79.05 2.6 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 120.204 -1.56 . . . . 3.4900000000000002 108.979 -176.752 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.434 HG23 ' HG3' ' A' ' 101' ' ' PRO . 18.2 m -88.07 130.13 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 119.596 1.089 . . . . 0.78000000000000003 111.339 174.842 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.94 106.6 13.6 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 107.342 -1.355 . . . . 0.77000000000000002 107.342 175.366 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.67 72.11 10.62 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 123.165 0.586 . . . . 1.1899999999999999 110.6 -178.258 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.5 -37.06 62.38 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.811 0.671 . . . . 5.0 112.811 -178.667 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -89.7 54.48 2.89 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.657 -0.652 . . . . 4.6500000000000004 110.095 -171.282 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 . . . . . 0 N--CA 1.464 0.251 0 C-N-CA 124.583 1.153 . . . . 7.5499999999999998 110.867 -178.968 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.4 m . . . . . 0 N--CA 1.454 -0.229 0 N-CA-C 107.119 -1.437 . . . . 6.4299999999999997 107.119 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 57.8 p30 -74.91 -16.52 60.66 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.808 0.67 . . . . 8.0099999999999998 112.808 -179.87 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.6 tt 71.5 53.16 0.23 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.144 1.378 . . . . 5.9400000000000004 111.01 169.179 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.3 p-10 -110.83 73.69 0.84 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.826 1.25 . . . . 3.9399999999999999 112.416 -168.969 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.01 165.93 13.5 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.809 0.844 . . . . 3.98 112.655 179.365 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -87.92 114.74 24.83 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 125.469 1.508 . . . . 2.1499999999999999 110.717 -178.291 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -132.23 156.39 46.58 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.535 0.734 . . . . 3.6899999999999999 112.363 -173.055 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.6 m -71.98 132.62 84.56 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 125.54 1.536 . . . . 2.1499999999999999 110.759 -174.661 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -54.52 -37.49 90.19 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.149 2.566 . . . . 1.0700000000000001 112.8 -176.711 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -37.3 -53.43 1.09 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.578 1.151 . . . . 2.98 113.228 171.541 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -78.36 -1.89 35.53 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.011 -0.431 . . . . 3.1000000000000001 111.807 -173.189 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 32.7 pt -121.48 35.04 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.581 1.152 . . . . 1.6299999999999999 110.193 171.716 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.6 p -121.02 -76.31 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 122.893 0.477 . . . . 2.2400000000000002 111.165 158.836 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -83.52 109.11 17.11 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 125.214 1.405 . . . . 3.1800000000000002 110.441 -160.058 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.69 37.27 40.33 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 109.528 -1.429 . . . . 1.8799999999999999 109.528 177.597 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.06 -93.55 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.688 1.195 . . . . 2.79 107.836 -174.145 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.6 m -72.58 -59.0 2.94 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.141 0.976 . . . . 1.9199999999999999 111.195 -177.679 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -53.45 -41.66 66.36 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 122.835 1.302 . . . . 3.0800000000000001 109.575 -175.119 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.38 -19.43 42.66 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 126.524 1.93 . . . . 1.5900000000000001 112.321 -179.619 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 54.69 42.56 78.12 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 126.039 1.781 . . . . 1.8999999999999999 113.18 -175.383 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.5 m -100.25 -49.94 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 118.616 1.208 . . . . 2.0899999999999999 113.113 -174.071 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 34.3 mmtt -97.54 -66.03 0.08 OUTLIER Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.85 0.86 . . . . 2.9500000000000002 111.378 -177.485 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -75.15 68.94 5.79 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.264 1.976 . . . . 2.6099999999999999 108.843 170.428 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -51.28 140.4 16.98 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.993 -0.743 . . . . 3.0299999999999998 108.993 173.657 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.88 127.89 34.47 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.58 -0.896 . . . . 1.27 108.58 -176.466 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 124.39 -29.03 5.14 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.915 -0.874 . . . . 1.46 110.915 -161.609 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -79.84 137.15 36.87 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.988 1.394 . . . . 2.5899999999999999 110.225 -177.338 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.03 106.28 15.3 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.919 1.688 . . . . 3.7999999999999998 108.569 -172.648 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.43 168.46 23.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.7 -1.593 . . . . 1.3799999999999999 106.7 -174.58 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 25.9 mtt-85 -110.17 123.15 49.23 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 106.83 -1.544 . . . . 2.2599999999999998 106.83 178.232 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.4 p -86.88 130.73 36.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 107.329 -1.36 . . . . 0.79000000000000004 107.329 176.066 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -133.53 128.65 5.09 Favored Glycine 0 C--N 1.332 0.344 0 N-CA-C 110.161 -1.175 . . . . 0.56999999999999995 110.161 -179.497 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.1 -172.99 45.92 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.501 -1.04 . . . . 0.60999999999999999 110.501 -179.417 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -90.93 138.34 31.67 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 117.404 0.602 . . . . 4.5099999999999998 110.14 -178.628 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.551 HG11 ' HE1' ' A' ' 104' ' ' PHE . 7.6 p -106.42 144.73 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 109.388 -0.597 . . . . 2.2200000000000002 109.388 178.892 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.2 m -87.92 133.39 33.93 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 125.741 1.617 . . . . 2.3399999999999999 108.842 -174.84 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.444 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 10.8 p -46.63 -47.61 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.346 1.058 . . . . 2.3100000000000001 112.879 -177.424 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -100.43 76.09 0.43 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 109.648 -1.381 . . . . 2.0 109.648 -178.856 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.9 m -146.33 -39.29 0.22 Allowed 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 117.804 0.802 . . . . 1.21 112.558 178.78 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.8 ttm -54.95 129.06 36.25 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 118.168 0.44 . . . . 2.1200000000000001 110.117 173.088 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.75 122.73 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 106.119 -1.808 . . . . 0.63 106.119 160.088 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.434 ' CB ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -114.35 139.3 49.57 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.935 1.294 . . . . 5.3099999999999996 109.665 -178.138 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.46 166.06 47.37 Favored Pre-proline 0 C--O 1.235 0.324 0 CA-C-O 120.936 0.398 . . . . 1.72 111.101 -173.794 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.97 -25.59 13.98 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.138 2.558 . . . . 1.4199999999999999 111.201 163.593 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -48.13 -30.03 4.19 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.001 0.521 . . . . 1.1499999999999999 110.564 164.701 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.2 m 66.6 19.12 10.84 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 125.02 1.328 . . . . 1.3100000000000001 112.324 175.147 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.33 -41.52 1.89 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 128.281 2.632 . . . . 1.97 110.993 177.604 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 71.9 m-70 -84.2 126.0 32.73 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.951 -1.5 . . . . 1.0800000000000001 106.951 178.533 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.434 HG12 ' CB ' ' A' ' 73' ' ' ARG . 26.7 m -142.75 139.0 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 106.564 -1.643 . . . . 0.93999999999999995 106.564 179.908 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -144.15 149.95 37.3 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.346 -0.613 . . . . 1.3700000000000001 109.346 177.836 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -154.36 146.69 23.89 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 123.678 0.611 . . . . 2.02 109.468 -170.606 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.92 122.4 40.99 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 124.345 1.058 . . . . 0.94999999999999996 109.248 -179.197 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.1 t -108.23 146.9 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.084 0 N-CA-C 107.389 -1.337 . . . . 1.8600000000000001 107.389 177.543 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -151.1 -170.98 3.81 Favored 'General case' 0 C--O 1.226 -0.143 0 N-CA-C 107.541 -1.281 . . . . 1.8 107.541 174.045 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.71 64.84 0.42 Allowed 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 118.619 0.645 . . . . 3.4300000000000002 109.664 -177.576 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.9 m 49.87 86.81 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.336 -0.853 . . . . 3.4900000000000002 111.677 177.001 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 17.19 27.97 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 118.695 2.85 . . . . 7.4500000000000002 118.695 -147.748 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.39 48.02 1.78 Allowed Glycine 0 CA--C 1.535 1.292 0 O-C-N 119.815 -1.803 . . . . 5.0999999999999996 112.216 156.212 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 55.99 114.17 0.01 OUTLIER Glycine 0 CA--C 1.532 1.112 0 C-N-CA 127.823 2.63 . . . . 1.96 116.223 169.076 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -64.09 141.04 58.91 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.7 -0.883 . . . . 2.5600000000000001 110.427 171.507 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -141.56 143.91 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 107.856 -1.165 . . . . 0.91000000000000003 107.856 170.97 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.3 mt -91.1 119.35 31.16 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.287 1.035 . . . . 0.67000000000000004 108.973 177.523 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 51.3 t -98.24 127.99 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 106.783 -1.562 . . . . 1.04 106.783 174.548 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.6 p -113.61 148.11 36.83 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.547 -0.908 . . . . 1.0800000000000001 108.547 -177.753 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.473 ' CE2' ' HA ' ' A' ' 125' ' ' THR . 0.5 OUTLIER -142.72 141.35 31.77 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.949 1.3 . . . . 3.5600000000000001 108.381 -177.263 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -114.13 10.06 17.3 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.614 1.565 . . . . 2.4900000000000002 111.95 173.377 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -118.92 161.77 19.62 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 125.148 1.379 . . . . 4.4699999999999998 110.297 172.16 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.6 mp -64.86 122.91 18.06 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.159 -0.473 . . . . 1.8 109.939 168.794 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.4 HD21 ' CE1' ' A' ' 96' ' ' TYR . 23.0 mt -73.75 155.33 89.04 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 123.621 0.768 . . . . 1.6499999999999999 110.107 173.39 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -65.9 151.94 82.79 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 123.603 2.869 . . . . 2.3900000000000001 110.194 173.839 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 55.1 12.67 0.68 Allowed 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.983 1.475 . . . . 3.3100000000000001 114.983 -177.467 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.48 ' O ' HD22 ' A' ' 103' ' ' LEU . 0.4 OUTLIER 62.99 -6.42 0.17 Allowed 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 118.644 0.656 . . . . 4.5999999999999996 111.616 -162.419 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.551 ' HE1' HG11 ' A' ' 66' ' ' VAL . 5.0 t80 55.95 78.7 0.19 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.257 1.823 . . . . 2.6099999999999999 109.154 -170.829 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.3 10.2 mtp180 -86.7 34.88 0.66 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 119.046 -1.061 . . . . 4.3799999999999999 111.729 -177.517 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.444 ' HB3' ' HA ' ' A' ' 68' ' ' VAL 0.357 10.5 mm-40 82.94 178.53 0.06 Allowed 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 120.232 1.378 . . . . 5.25 110.158 149.875 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.405 ' N ' HG13 ' A' ' 66' ' ' VAL . . . 61.14 15.07 42.42 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 115.469 0.948 . . . . 1.05 115.469 158.215 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.484 ' O ' HG12 ' A' ' 66' ' ' VAL . 4.6 pt20 -136.73 141.48 43.04 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.601 1.2 . . . . 2.3500000000000001 108.027 -177.903 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -77.85 113.67 3.79 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.266 -1.134 . . . . 0.95999999999999996 110.266 -175.069 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.1 pp -123.65 169.33 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 123.608 0.763 . . . . 0.78000000000000003 109.437 -175.101 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.7 m -117.89 134.26 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 107.852 -1.166 . . . . 0.66000000000000003 107.852 169.371 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.516 ' CB ' HG12 ' A' ' 127' ' ' VAL . . . -121.26 155.18 35.21 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 125.53 1.532 . . . . 0.79000000000000004 108.569 177.837 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -148.09 161.83 40.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.052 0.842 . . . . 3.2000000000000002 112.112 171.645 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 171.15 -111.52 0.41 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 105.702 -2.959 . . . . 0.84999999999999998 105.702 167.537 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.2 p -156.81 146.39 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 118.724 1.262 . . . . 1.0800000000000001 111.719 -175.737 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.67 116.68 7.15 Favored 'General case' 0 N--CA 1.457 -0.093 0 N-CA-C 107.908 -1.145 . . . . 2.1800000000000002 107.908 168.729 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -136.75 13.2 3.93 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.092 -0.838 . . . . 2.3900000000000001 113.17 -179.681 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -143.05 35.49 1.37 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.017 0.908 . . . . 5.1900000000000004 110.678 177.625 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 26.63 52.45 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 128.124 2.57 . . . . 4.0199999999999996 112.053 177.992 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 160.77 -40.3 0.43 Allowed Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.244 -0.754 . . . . 1.27 113.772 -163.488 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.83 164.11 18.05 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.934 1.367 . . . . 2.9399999999999999 110.79 171.412 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.1 mt -105.72 116.67 32.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.243 1.417 . . . . 2.04 108.282 -177.307 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.41 103.7 13.79 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.553 -1.647 . . . . 0.64000000000000001 106.553 171.754 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -101.39 156.16 17.62 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.433 0.693 . . . . 1.71 109.843 -179.025 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.473 ' HA ' ' CE2' ' A' ' 96' ' ' TYR 0.256 9.9 t -141.1 -36.51 0.45 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.532 0.938 . . . . 1.23 113.532 174.713 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -92.45 127.35 37.91 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 120.481 -1.387 . . . . 2.7400000000000002 109.189 169.109 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.516 HG12 ' CB ' ' A' ' 112' ' ' ALA . 2.4 m -125.32 142.21 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 N-CA-C 108.394 -0.965 . . . . 0.94999999999999996 108.394 164.921 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.85 101.51 7.61 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.25 -1.389 . . . . 0.89000000000000001 107.25 179.071 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.85 60.56 2.87 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.247 0.619 . . . . 1.1499999999999999 110.694 -177.397 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -79.41 51.77 1.27 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.601 0.76 . . . . 3.04 112.072 -173.222 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -147.66 134.62 20.25 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.32 -1.363 . . . . 4.4000000000000004 107.32 -179.239 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 48.7 t0 . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 106.659 -1.608 . . . . 5.9100000000000001 106.659 172.306 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.3 t . . . . . 0 CA--C 1.532 0.264 0 CA-C-O 120.8 0.333 . . . . 7.3700000000000001 110.282 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -83.72 68.5 9.9 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.802 0.841 . . . . 10.16 110.329 -176.673 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.41 ' C ' HD22 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -68.75 160.65 29.98 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.534 0.207 . . . . 5.5599999999999996 110.933 171.966 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -148.11 129.95 15.2 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 107.67 -1.233 . . . . 4.0999999999999996 107.67 178.946 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -158.62 153.5 25.0 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.001 0.819 . . . . 2.6600000000000001 109.894 167.269 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -111.59 122.58 48.19 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.288 1.435 . . . . 2.73 107.984 179.715 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -129.71 164.62 23.58 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 122.799 0.44 . . . . 3.23 111.266 173.376 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 p -85.63 146.93 45.15 Favored Pre-proline 0 N--CA 1.45 -0.431 0 C-N-CA 123.725 0.81 . . . . 1.6499999999999999 110.598 -178.904 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -57.52 -42.18 63.77 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.94 2.426 . . . . 0.73999999999999999 111.155 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.9 p -58.63 -24.15 60.46 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.904 1.681 . . . . 2.3500000000000001 113.0 174.971 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -84.27 -48.36 9.83 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.114 -0.699 . . . . 2.2599999999999998 109.114 173.093 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.266 22.3 pt -75.73 37.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 114.397 1.258 . . . . 1.3600000000000001 114.397 -178.245 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.661 HG23 ' H ' ' A' ' 45' ' ' ASN . 0.5 OUTLIER -121.93 -87.06 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 125.39 1.476 . . . . 2.7000000000000002 108.16 169.271 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.661 ' H ' HG23 ' A' ' 44' ' ' VAL . 28.6 m-80 -58.98 103.62 0.18 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.549 2.34 . . . . 2.2799999999999998 110.469 -171.414 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.42 39.0 70.09 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.081 -0.807 . . . . 1.4099999999999999 111.081 171.942 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -143.99 -102.31 0.12 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 126.175 1.79 . . . . 2.71 108.377 175.57 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.405 HG23 HD12 ' A' ' 116' ' ' LEU . 97.7 m -69.48 -68.1 0.43 Allowed 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 124.319 1.048 . . . . 1.5 110.954 -177.374 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -53.75 -43.74 69.4 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.908 0.861 . . . . 2.5 110.559 -171.188 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.27 -22.56 51.93 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.615 0.766 . . . . 1.54 112.512 176.946 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 60.69 56.86 21.93 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 125.66 1.6 . . . . 1.3300000000000001 112.324 178.303 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.255 26.8 m -110.76 -64.16 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 114.1 1.148 . . . . 1.27 114.1 -179.595 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt -80.41 -62.99 0.36 Allowed Pre-proline 0 CA--C 1.538 0.513 0 O-C-N 121.302 -0.874 . . . . 3.6099999999999999 112.029 -177.629 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -77.13 -179.24 5.24 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.387 2.058 . . . . 1.6699999999999999 109.285 169.249 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -152.53 151.13 30.33 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.564 -1.643 . . . . 2.8100000000000001 106.564 -174.875 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -55.39 161.9 1.73 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.53 0.937 . . . . 1.1799999999999999 113.53 178.601 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.42 -6.09 58.49 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 119.424 -0.653 . . . . 1.02 113.075 -179.77 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -82.1 145.34 30.21 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.821 1.31 . . . . 1.8999999999999999 108.814 175.805 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.2 ttm105 -90.19 125.86 35.62 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.709 -1.219 . . . . 4.29 107.709 174.689 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.4 pt -142.05 175.63 4.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 118.842 0.746 . . . . 0.67000000000000004 109.035 175.483 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.445 HH11 ' HG2' ' A' ' 61' ' ' ARG . 6.2 mtt-85 -120.05 136.74 54.46 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.874 0.47 . . . . 3.4199999999999999 109.749 168.647 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.63 125.65 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 125.362 1.465 . . . . 0.81000000000000005 107.91 175.768 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -128.05 112.56 1.48 Allowed Glycine 0 C--N 1.333 0.388 0 N-CA-C 109.875 -1.29 . . . . 0.53000000000000003 109.875 -177.764 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.67 -171.5 33.72 Favored Glycine 0 C--N 1.332 0.348 0 N-CA-C 110.027 -1.229 . . . . 0.78000000000000003 110.027 -176.623 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.409 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 18.6 ptp -88.67 138.66 31.23 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.031 0.443 . . . . 2.73 110.1 -178.209 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.549 HG12 HG12 ' A' ' 84' ' ' VAL . 10.7 m -91.18 150.35 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 109.401 -0.592 . . . . 2.3300000000000001 109.401 170.574 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 m -91.37 143.89 26.15 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.892 -1.151 . . . . 2.7400000000000002 107.892 165.358 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.9 p -59.43 -59.44 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.362 1.065 . . . . 2.5699999999999998 110.088 178.272 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.36 66.79 2.89 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.328 -1.109 . . . . 1.6799999999999999 110.328 178.346 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.3 m -150.13 -30.77 0.21 Allowed 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 113.942 1.09 . . . . 1.0600000000000001 113.942 -179.398 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -60.14 117.23 4.88 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 119.087 0.858 . . . . 1.8999999999999999 109.225 173.545 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.16 125.41 71.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 N-CA-C 107.655 -1.239 . . . . 0.63 107.655 169.808 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -109.48 147.46 32.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.235 1.014 . . . . 6.6699999999999999 109.619 -178.829 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -72.42 161.76 77.42 Favored Pre-proline 0 C--O 1.239 0.533 0 C-N-CA 120.404 -0.518 . . . . 2.29 110.381 174.455 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -63.74 -34.22 62.82 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.384 2.056 . . . . 1.6299999999999999 110.175 163.81 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -41.18 -47.27 3.26 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 125.273 1.429 . . . . 1.29 109.854 174.713 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.4 m 80.64 11.67 0.95 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.117 1.767 . . . . 1.3 112.423 179.668 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.17 -6.92 9.9 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.041 1.336 . . . . 1.8500000000000001 111.334 175.522 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -123.4 136.64 54.73 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.919 1.287 . . . . 1.4199999999999999 108.151 177.99 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.61 131.07 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 107.826 -1.176 . . . . 0.89000000000000001 107.826 -172.341 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -135.81 154.32 51.24 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 119.778 1.172 . . . . 1.2 110.427 175.894 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -150.25 138.69 20.53 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.067 -0.716 . . . . 1.95 109.067 -173.805 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.07 136.57 34.44 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.938 -1.134 . . . . 0.66000000000000003 107.938 173.584 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.549 HG12 HG12 ' A' ' 66' ' ' VAL . 14.4 m -129.63 149.5 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 107.992 -1.114 . . . . 2.6800000000000002 107.992 177.436 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -153.4 177.53 10.79 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.975 0.416 . . . . 2.6499999999999999 110.247 -173.951 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -157.34 148.7 21.9 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.179 0.592 . . . . 3.0299999999999998 111.037 175.235 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 67.2 m 3.0 71.79 0.0 OUTLIER 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 128.556 2.743 . . . . 3.0299999999999998 112.205 -169.977 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -10.26 40.36 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 131.282 3.833 . . . . 9.6400000000000006 118.747 -148.979 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.34 -25.36 66.65 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 110.479 -1.048 . . . . 3.1400000000000001 110.479 168.373 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.566 ' HA3' HG21 ' A' ' 44' ' ' VAL . . . 170.53 174.35 38.47 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.133 -1.187 . . . . 1.54 110.133 169.035 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -138.86 141.47 38.61 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.921 1.688 . . . . 3.21 107.363 -175.239 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.4 tp -140.8 151.21 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 123.451 0.701 . . . . 1.1499999999999999 109.247 -176.162 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mt -93.17 122.21 35.32 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.655 0.782 . . . . 1.1599999999999999 109.768 -178.048 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.0 t -102.3 119.56 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 107.062 -1.459 . . . . 0.89000000000000001 107.062 173.558 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 62.0 p -99.42 147.34 25.36 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.086 -1.079 . . . . 0.53000000000000003 108.086 174.976 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -147.35 160.83 42.08 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.238 1.415 . . . . 2.5 108.521 -172.957 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -147.98 152.89 38.25 Favored 'General case' 0 N--CA 1.428 -1.542 0 C-N-CA 127.553 2.341 . . . . 3.5600000000000001 106.616 -169.628 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 61.1 64.81 1.06 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 129.652 3.181 . . . . 2.7200000000000002 110.7 -172.543 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.0 mp 45.05 -144.67 0.16 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.311 1.444 . . . . 1.8799999999999999 109.449 -173.543 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.6 mt -158.76 149.78 16.3 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 104.883 -2.265 . . . . 1.1100000000000001 104.883 -175.951 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -67.35 129.75 20.97 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 121.956 1.771 . . . . 2.6600000000000001 108.14 169.757 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.582 ' O ' HD12 ' A' ' 103' ' ' LEU . 2.8 m-20 23.25 53.78 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 128.207 2.603 . . . . 3.3300000000000001 113.095 -178.047 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.616 HD13 ' OE1' ' A' ' 106' ' ' GLU . 0.7 OUTLIER 36.6 38.42 0.08 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.509 1.524 . . . . 3.4199999999999999 114.422 -179.159 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.0 p90 35.34 83.6 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.423 1.489 . . . . 3.3100000000000001 112.111 -173.561 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.4 116.3 4.96 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 119.255 -2.153 . . . . 4.5999999999999996 110.709 -137.594 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.616 ' OE1' HD13 ' A' ' 103' ' ' LEU . 9.6 mp0 -77.53 167.22 21.99 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 122.267 1.032 . . . . 3.6699999999999999 111.679 -147.31 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.93 41.07 56.18 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 114.841 -1.072 . . . . 0.80000000000000004 110.996 -169.919 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -149.8 178.34 8.97 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.353 1.061 . . . . 2.5 109.08 171.864 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' A' ' 65' ' ' MET . . . -92.89 136.22 13.05 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 110.738 -0.945 . . . . 0.77000000000000002 110.738 170.632 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.4 pp -139.29 154.74 25.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 107.484 -1.302 . . . . 0.68999999999999995 107.484 179.557 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 19.5 m -110.32 120.89 62.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 108.741 -0.837 . . . . 0.66000000000000003 108.741 178.457 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.464 ' HB2' HG12 ' A' ' 127' ' ' VAL . . . -113.97 150.8 33.28 Favored 'General case' 0 N--CA 1.458 -0.071 0 C-N-CA 126.131 1.772 . . . . 0.68000000000000005 109.494 -174.492 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -149.9 155.01 39.27 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 113.448 0.907 . . . . 3.8799999999999999 113.448 177.987 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 163.48 -130.38 2.22 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 106.063 -2.815 . . . . 0.98999999999999999 106.063 175.235 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.9 p -129.95 145.79 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.069 0 CA-C-N 118.337 1.068 . . . . 0.93000000000000005 111.761 -164.095 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.405 HD12 HG23 ' A' ' 48' ' ' THR . 4.6 mm? -66.3 124.33 22.41 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.199 -0.455 . . . . 1.95 111.027 174.725 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.59 130.43 9.83 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 126.257 1.884 . . . . 3.6200000000000001 109.377 172.595 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 60.58 29.73 19.23 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.465 1.106 . . . . 4.5800000000000001 111.458 167.553 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 40.9 39.26 0.78 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.011 1.724 . . . . 4.5099999999999998 111.178 -170.375 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -160.3 -61.96 0.01 OUTLIER Glycine 0 C--N 1.34 0.792 0 O-C-N 121.472 -0.767 . . . . 1.1699999999999999 111.946 -170.354 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -83.34 127.34 33.59 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.901 -0.777 . . . . 2.1899999999999999 108.901 -178.842 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.35 107.32 17.94 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.384 -1.339 . . . . 2.1299999999999999 107.384 177.94 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.85 84.74 7.46 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.361 -1.348 . . . . 0.57999999999999996 107.361 -179.59 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.66 144.71 26.44 Favored 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 123.762 0.825 . . . . 1.23 109.023 -177.484 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.7 t -137.88 9.56 2.82 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.85 0.75 . . . . 1.1499999999999999 112.914 173.898 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -132.99 119.65 20.37 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.736 -1.579 . . . . 3.4199999999999999 106.736 170.272 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.464 HG12 ' HB2' ' A' ' 112' ' ' ALA . 2.4 m -123.41 131.38 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 124.589 1.156 . . . . 0.82999999999999996 109.494 176.867 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -115.91 104.37 11.55 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.708 -1.219 . . . . 0.90000000000000002 107.708 179.117 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.14 56.02 3.56 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.018 0.927 . . . . 1.3999999999999999 110.653 -179.238 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -77.8 60.95 2.36 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.046 0.938 . . . . 3.2799999999999998 111.355 -175.409 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -132.75 47.87 2.47 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.686 0.755 . . . . 4.4299999999999997 111.171 -172.514 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 CA--C 1.53 0.206 0 C-N-CA 126.361 1.865 . . . . 5.8399999999999999 111.643 179.277 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 109.133 -0.692 . . . . 7.6399999999999997 109.133 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -96.85 174.31 6.86 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.867 0.867 . . . . 8.0199999999999996 110.127 175.002 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.426 HD22 ' N ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -136.19 177.65 7.67 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.015 -1.106 . . . . 4.8399999999999999 108.015 165.849 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.426 ' N ' HD22 ' A' ' 34' ' ' LEU . 10.2 p30 -159.78 157.67 29.76 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 107.487 -1.301 . . . . 3.4199999999999999 107.487 165.86 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -160.99 169.6 22.23 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.852 0.861 . . . . 1.8500000000000001 109.663 173.237 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -83.07 140.0 32.91 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.534 0.734 . . . . 2.2000000000000002 110.359 -178.734 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -144.67 160.13 41.7 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.925 1.29 . . . . 2.77 110.593 176.977 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.95 134.67 38.72 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 126.519 1.928 . . . . 1.4299999999999999 109.972 -179.848 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -56.84 -43.46 54.22 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.263 2.642 . . . . 0.76000000000000001 111.775 -179.449 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.3 p -59.94 -34.2 72.93 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 121.406 -0.809 . . . . 2.0299999999999998 112.065 -178.648 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.02 -55.17 36.08 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.553 0.692 . . . . 3.1899999999999999 109.281 175.953 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.318 20.6 pt -66.29 -14.91 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 114.64 -1.164 . . . . 1.4399999999999999 112.624 -170.022 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 88.4 t -75.68 -54.87 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 123.007 0.523 . . . . 2.0699999999999998 110.978 167.499 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -56.43 -71.4 0.09 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.508 0.929 . . . . 2.5699999999999998 113.508 -163.328 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -146.21 55.87 0.53 Allowed Glycine 0 C--N 1.333 0.4 0 N-CA-C 108.778 -1.729 . . . . 1.74 108.778 -167.806 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -153.44 -106.85 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.928 1.691 . . . . 3.6499999999999999 108.644 -171.987 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.5 m -72.53 -60.05 2.42 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 124.341 1.056 . . . . 1.5700000000000001 111.619 -170.765 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -56.25 -40.14 73.7 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 122.048 0.928 . . . . 2.5899999999999999 109.734 -176.039 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.45 -24.84 62.09 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.158 0.983 . . . . 2.0499999999999998 112.805 174.482 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.48 41.38 99.54 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 126.163 1.839 . . . . 1.26 111.918 -176.015 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.9 m -102.55 -53.52 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 118.048 0.924 . . . . 1.3300000000000001 113.037 -174.423 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -93.71 -65.4 0.12 Allowed Pre-proline 0 CA--C 1.533 0.326 0 CA-C-O 118.542 -0.742 . . . . 3.8599999999999999 112.054 -175.282 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -78.59 140.6 16.91 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 121.681 1.587 . . . . 1.24 108.799 174.067 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -87.35 161.95 17.63 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.701 0.8 . . . . 4.9699999999999998 109.255 167.738 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.95 170.15 8.73 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 122.9 0.48 . . . . 1.6000000000000001 110.215 174.124 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.51 22.81 71.69 Favored Glycine 0 CA--C 1.534 1.248 0 O-C-N 121.768 -0.583 . . . . 1.05 113.583 178.308 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -102.23 162.23 13.08 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.198 0.999 . . . . 1.7 108.432 171.2 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.7 mtt180 -99.63 134.43 42.53 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.86 -0.422 . . . . 3.7200000000000002 109.86 169.55 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.3 pt -143.36 176.22 3.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 106.862 -1.533 . . . . 0.78000000000000003 106.862 169.024 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -123.29 123.4 40.66 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.355 -0.98 . . . . 2.2200000000000002 108.355 170.474 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.9 m -89.06 129.42 40.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 107.938 -1.134 . . . . 2.2599999999999998 107.938 175.007 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -128.38 128.23 5.9 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 109.197 -1.561 . . . . 0.68999999999999995 109.197 178.967 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.67 -170.74 40.34 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 109.979 -1.248 . . . . 0.68000000000000005 109.979 -174.139 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.3 ptp -100.41 123.91 45.23 Favored 'General case' 0 N--CA 1.458 -0.061 0 CA-C-O 121.316 0.579 . . . . 2.3500000000000001 110.976 -174.044 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.0 t -73.24 105.23 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 123.831 0.853 . . . . 2.23 110.485 179.78 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.2 m -45.29 136.09 5.49 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 126.362 1.865 . . . . 2.3599999999999999 111.28 164.583 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.1 p -55.54 -64.09 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.741 0.817 . . . . 2.0099999999999998 111.077 177.42 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.45 72.6 2.78 Favored Glycine 0 C--N 1.332 0.36 0 N-CA-C 109.34 -1.504 . . . . 1.77 109.34 -174.586 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.6 m -150.46 -34.18 0.16 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 115.891 1.811 . . . . 1.1100000000000001 115.891 -174.895 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -76.93 99.71 5.33 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 120.159 1.345 . . . . 2.29 110.313 -175.012 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.1 m -111.32 128.81 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 108.527 -0.916 . . . . 0.85999999999999999 108.527 -177.819 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -111.57 143.26 42.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.725 1.61 . . . . 6.0 110.591 -175.61 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -71.83 155.82 91.74 Favored Pre-proline 0 C--O 1.232 0.155 0 CA-C-N 118.245 0.475 . . . . 1.8700000000000001 109.764 177.416 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -64.16 -27.11 64.77 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.207 1.938 . . . . 1.22 111.363 166.064 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -45.31 -33.68 2.57 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.193 0.597 . . . . 1.1499999999999999 110.709 164.726 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.1 m 69.27 15.99 8.48 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.446 1.498 . . . . 1.5600000000000001 112.466 177.253 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.41 -38.1 2.59 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 126.324 1.85 . . . . 1.7 112.075 175.789 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -87.38 135.96 33.12 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.155 -1.424 . . . . 1.1399999999999999 107.155 175.537 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.555 HG23 ' HB3' ' A' ' 96' ' ' TYR . 28.0 m -144.15 148.72 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 107.195 -1.409 . . . . 0.68000000000000005 107.195 178.144 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -148.78 158.76 44.39 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.448 -0.783 . . . . 1.0 109.716 178.892 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -150.64 142.11 23.45 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.654 -0.703 . . . . 1.8400000000000001 110.405 -173.884 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.97 148.56 27.54 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.16 -1.052 . . . . 0.65000000000000002 108.16 163.031 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.5 p -146.84 150.46 14.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 107.661 -1.237 . . . . 1.9399999999999999 107.661 171.705 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.2 176.43 9.75 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.189 0.996 . . . . 2.3399999999999999 110.513 -175.345 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -154.64 -89.11 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.961 0.904 . . . . 2.6299999999999999 110.735 -176.57 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.1 t -77.12 85.05 3.61 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 106.273 -1.751 . . . . 6.0199999999999996 106.273 170.638 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -39.35 17.1 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.803 1 C-N-CA 134.301 5.04 . . . . 9.25 120.921 -170.128 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -104.0 25.34 26.66 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 120.185 1.357 . . . . 3.2599999999999998 110.616 159.745 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -160.78 107.6 0.32 Allowed Glycine 0 CA--C 1.527 0.819 0 CA-C-N 118.479 1.139 . . . . 1.9299999999999999 110.892 -179.021 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -99.5 135.15 41.33 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 124.792 1.237 . . . . 3.1000000000000001 108.98 169.18 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' A' ' 92' ' ' ILE . 0.2 OUTLIER -112.57 144.89 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.654 -1.239 . . . . 0.98999999999999999 107.654 167.553 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.5 mt -104.09 120.69 41.64 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.271 1.029 . . . . 0.66000000000000003 108.38 176.225 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 44.0 t -103.16 136.3 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 125.422 1.489 . . . . 0.83999999999999997 107.676 178.965 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.2 p -112.94 142.01 46.11 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.405 1.082 . . . . 0.52000000000000002 108.578 178.521 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.555 ' HB3' HG23 ' A' ' 80' ' ' VAL . 2.1 t80 -138.42 114.63 10.24 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.529 -1.286 . . . . 2.4100000000000001 107.529 -175.564 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -101.27 46.97 0.92 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.851 1.261 . . . . 2.3300000000000001 112.05 -171.222 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -167.67 176.81 6.19 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.646 1.978 . . . . 2.5499999999999998 107.037 170.486 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.0 mp -70.67 136.65 49.22 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.02 -1.05 . . . . 1.79 110.783 178.533 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.452 ' HG ' HG21 ' A' ' 80' ' ' VAL . 11.9 mt -69.92 160.89 78.47 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.395 1.078 . . . . 1.24 110.565 174.302 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.52 -95.82 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.837 3.024 . . . . 2.3900000000000001 110.281 176.282 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -78.39 49.91 0.89 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.863 1.265 . . . . 3.4900000000000002 110.232 -176.543 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 52.44 -4.67 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.404 2.682 . . . . 2.21 115.918 -168.46 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 64.4 t80 64.26 93.96 0.06 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.727 1.611 . . . . 2.29 108.795 -159.32 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -79.81 129.02 34.13 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.663 0.744 . . . . 5.8899999999999997 109.272 -179.138 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -83.95 144.17 29.34 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 128.062 2.545 . . . . 3.3999999999999999 109.617 -174.002 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.29 46.59 8.02 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 112.052 -0.419 . . . . 1.0800000000000001 112.052 178.989 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -155.8 175.52 13.82 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.567 -1.642 . . . . 2.1899999999999999 106.567 170.839 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -86.24 144.49 20.03 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.095 -1.202 . . . . 0.87 110.095 167.668 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.1 pp -139.77 167.7 18.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 107.731 -1.211 . . . . 0.60999999999999999 107.731 167.97 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 23.8 m -126.71 135.57 63.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.867 -0.79 . . . . 0.66000000000000003 108.867 171.096 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -129.55 120.46 25.38 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 124.703 1.201 . . . . 0.47999999999999998 110.762 -169.095 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -114.21 145.95 41.03 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 125.253 1.421 . . . . 3.4700000000000002 111.022 -176.619 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 173.07 -123.09 0.96 Allowed Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 108.021 -2.032 . . . . 0.91000000000000003 108.021 170.467 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.2 p -138.25 152.17 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 118.176 0.988 . . . . 0.72999999999999998 109.726 -173.021 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -59.61 132.31 53.58 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 108.118 -1.067 . . . . 1.7 108.118 167.982 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -87.98 -104.34 0.93 Allowed Glycine 0 C--N 1.338 0.661 0 N-CA-C 110.011 -1.236 . . . . 2.1200000000000001 110.011 -172.766 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -59.4 -66.15 0.56 Allowed 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.334 1.054 . . . . 4.8499999999999996 108.375 172.771 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -173.0 -66.3 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.761 2.024 . . . . 4.1900000000000004 105.971 175.83 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.0 -45.04 96.94 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 123.504 0.573 . . . . 1.1200000000000001 112.271 177.021 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -83.28 144.13 29.93 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 122.036 -0.685 . . . . 2.54 111.257 -176.217 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -105.15 122.77 46.6 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 125.002 1.321 . . . . 2.25 108.076 -176.456 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.91 85.85 4.51 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.826 -1.175 . . . . 0.62 107.826 175.913 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.4 105.0 13.84 Favored 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 123.473 0.709 . . . . 1.3600000000000001 110.378 -175.301 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.2 t -95.77 -25.82 15.91 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.903 0.881 . . . . 0.79000000000000004 111.761 -177.485 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -89.33 81.52 6.64 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 120.695 -1.253 . . . . 3.2799999999999998 108.708 179.279 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.6 m -90.48 125.03 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 118.112 0.415 . . . . 0.64000000000000001 110.32 173.26 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -115.26 113.97 24.58 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.165 -1.42 . . . . 0.60999999999999999 107.165 175.372 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.69 108.27 11.98 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 107.501 -1.296 . . . . 1.5900000000000001 107.501 167.845 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.89 50.49 0.31 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 122.511 0.324 . . . . 3.5299999999999998 110.626 -175.613 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.83 -80.25 0.6 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.852 1.261 . . . . 6.0199999999999996 108.395 177.49 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.4 t70 . . . . . 0 CA--C 1.533 0.318 0 C-N-CA 123.379 0.672 . . . . 7.46 110.901 -179.507 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.3 t . . . . . 0 CA--C 1.538 0.487 0 N-CA-C 114.502 1.297 . . . . 8.3800000000000008 114.502 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -155.46 158.06 37.96 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 120.007 1.276 . . . . 7.4000000000000004 108.987 175.622 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 mt -130.07 141.84 50.67 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.664 1.586 . . . . 6.2599999999999998 109.953 -168.287 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -90.47 88.46 7.17 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.386 1.075 . . . . 3.8300000000000001 110.735 -173.515 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -119.54 162.04 19.59 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.713 0.688 . . . . 2.1800000000000002 112.052 174.024 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -85.15 125.17 32.6 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 124.874 1.27 . . . . 2.3399999999999999 110.115 179.463 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -124.27 161.19 26.33 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.628 1.571 . . . . 3.27 110.89 176.88 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 54.4 m -83.04 126.05 73.4 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 126.444 1.898 . . . . 1.8700000000000001 110.433 -177.939 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -48.24 -43.1 32.5 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.901 3.067 . . . . 1.03 114.032 -179.133 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.1 m -54.76 -33.07 60.8 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.264 -0.897 . . . . 1.98 112.33 177.821 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -77.31 3.0 14.06 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.54 0.736 . . . . 2.6299999999999999 111.994 179.548 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.278 18.3 pt -121.6 3.37 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 O-C-N 120.79 -1.194 . . . . 1.1699999999999999 112.978 173.07 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.1 t -98.01 -49.0 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.031 0.932 . . . . 1.79 112.049 179.393 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -102.98 90.61 3.82 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 120.54 -1.35 . . . . 2.1299999999999999 111.106 -167.843 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.35 48.47 18.77 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.905 -0.878 . . . . 1.45 110.905 178.293 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -152.85 -146.04 0.19 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 128.609 2.764 . . . . 4.2599999999999998 105.067 176.481 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.1 m -43.57 -48.45 7.53 Favored 'General case' 0 C--O 1.227 -0.127 0 C-N-CA 126.198 1.799 . . . . 1.79 115.495 -170.51 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -39.16 -55.14 1.69 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.497 0.719 . . . . 2.5699999999999998 111.508 172.859 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.07 -15.94 25.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.782 1.233 . . . . 1.51 110.652 -173.618 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.89 26.91 73.77 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.996 1.284 . . . . 1.1200000000000001 112.438 176.818 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.2 m -80.07 -23.54 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 118.047 0.923 . . . . 1.27 112.406 -174.53 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -121.75 -75.95 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 124.172 0.989 . . . . 3.6800000000000002 111.745 178.137 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.25 119.57 6.07 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 CA-C-N 120.554 1.234 . . . . 1.3400000000000001 109.352 179.476 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -71.63 149.16 45.84 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.99 -0.744 . . . . 4.8099999999999996 108.99 172.293 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.73 147.26 47.53 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.102 -1.073 . . . . 1.1399999999999999 108.102 172.595 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.77 -1.17 27.42 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.61 1.1 . . . . 1.1200000000000001 112.874 -173.732 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -102.79 148.94 24.99 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.426 1.09 . . . . 1.52 109.595 -176.614 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -86.92 125.88 34.32 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.466 -0.939 . . . . 3.8700000000000001 108.466 172.605 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.5 pt -141.11 176.07 5.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 106.228 -1.767 . . . . 0.91000000000000003 106.228 167.078 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -124.56 133.01 53.43 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.771 -1.196 . . . . 3.2999999999999998 107.771 171.918 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.0 131.54 51.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 107.747 -1.205 . . . . 1.21 107.747 175.402 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -126.84 113.11 1.69 Allowed Glycine 0 C--N 1.336 0.551 0 N-CA-C 109.7 -1.36 . . . . 0.65000000000000002 109.7 179.371 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.85 -168.2 17.15 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 109.966 -1.254 . . . . 0.70999999999999996 109.966 -175.013 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -109.42 130.61 55.49 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.637 0.775 . . . . 2.79 110.586 -176.359 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.563 HG22 ' CZ ' ' A' ' 104' ' ' PHE . 26.1 t -67.0 143.7 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 109.093 -0.706 . . . . 2.27 109.093 175.313 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.0 t -59.45 -68.45 0.28 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.627 0.371 . . . . 3.3999999999999999 111.34 178.831 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.0 p 178.79 -45.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 123.633 0.773 . . . . 2.1099999999999999 110.496 -173.347 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -146.43 42.82 0.92 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.164 -1.174 . . . . 2.2599999999999998 110.164 -179.733 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.84 -30.71 70.96 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.322 0.649 . . . . 1.8600000000000001 112.541 176.757 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.4 112.62 2.25 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 122.278 0.231 . . . . 1.79 110.387 -174.919 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.1 m -122.98 120.12 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.79 -1.559 . . . . 0.71999999999999997 106.79 168.096 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.45 144.04 36.6 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.536 -1.283 . . . . 5.4800000000000004 107.536 175.467 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -99.17 153.01 37.99 Favored Pre-proline 0 C--O 1.234 0.282 0 N-CA-C 108.55 -0.907 . . . . 2.5499999999999998 108.55 -179.828 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.41 37.72 0.52 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.662 2.908 . . . . 1.73 112.244 -178.483 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -94.78 -35.77 11.97 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.934 1.294 . . . . 1.6399999999999999 108.727 171.346 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.6 m 97.48 -19.38 0.05 OUTLIER 'General case' 0 C--N 1.342 0.243 0 C-N-CA 127.819 2.447 . . . . 2.6499999999999999 111.777 -174.798 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.04 27.94 8.16 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 123.772 0.829 . . . . 2.8300000000000001 112.815 -179.423 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -135.98 115.44 12.71 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.759 -0.83 . . . . 2.1099999999999999 108.759 178.415 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.15 116.23 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 124.948 1.299 . . . . 1.0800000000000001 107.932 -178.308 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -129.27 154.2 47.06 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.022 0.828 . . . . 1.0800000000000001 109.484 177.674 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.506 ' CE1' ' CE1' ' A' ' 104' ' ' PHE . 33.6 p90 -157.36 145.27 19.02 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.447 -0.342 . . . . 1.8700000000000001 110.469 -175.555 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.12 157.94 18.7 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.655 0.74 . . . . 0.73999999999999999 109.753 167.774 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 p -141.76 149.37 19.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 106.638 -1.615 . . . . 1.9399999999999999 106.638 172.181 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -128.61 -172.91 2.82 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.017 0.527 . . . . 1.5800000000000001 110.322 -179.374 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -131.36 -177.7 4.52 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.012 -0.736 . . . . 2.3700000000000001 109.012 178.204 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 60.7 m -57.32 -36.55 71.27 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.863 0.865 . . . . 3.5299999999999998 110.643 172.063 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -86.29 -89.35 0.12 Allowed 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 123.112 0.258 . . . . 4.8799999999999999 110.672 -177.897 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.11 36.58 0.37 Allowed Glycine 0 C--N 1.333 0.382 0 N-CA-C 110.35 -1.1 . . . . 2.6499999999999999 110.35 -174.462 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -80.22 46.07 3.14 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-O 119.268 -0.74 . . . . 2.2999999999999998 111.604 -176.212 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -62.89 111.64 2.22 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.43 -1.322 . . . . 3.3999999999999999 107.43 179.173 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.2 tp -140.37 156.59 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 108.185 -1.043 . . . . 1.1399999999999999 108.185 179.145 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.4 mt -119.87 129.66 54.49 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.504 -1.295 . . . . 0.57999999999999996 107.504 -169.998 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.44 ' CG2' ' CE1' ' A' ' 82' ' ' PHE . 5.1 m -120.69 143.15 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 109.152 -0.685 . . . . 2.3300000000000001 109.152 175.19 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.5 p -115.06 133.68 55.83 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.101 1.361 . . . . 0.78000000000000003 107.512 -176.1 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -129.77 131.04 46.1 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.856 -1.535 . . . . 2.3199999999999998 106.856 -178.348 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -122.11 34.06 5.28 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.268 1.427 . . . . 2.1200000000000001 111.885 -167.773 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -163.46 54.89 0.17 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.353 0.596 . . . . 3.1000000000000001 111.689 -174.426 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 53.77 -162.75 0.11 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.854 0.862 . . . . 1.95 110.844 -173.245 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.6 mt -148.93 155.83 40.69 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 106.381 -1.711 . . . . 1.1399999999999999 106.381 179.921 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.34 -73.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.142 2.561 . . . . 2.3100000000000001 110.27 -179.643 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.51 47.71 0.87 Allowed 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.926 1.29 . . . . 2.6800000000000002 108.394 -178.515 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 41.61 23.88 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 115.749 1.759 . . . . 2.1800000000000002 115.749 -173.226 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.563 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 51.8 t80 53.67 96.51 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.6 1.091 . . . . 2.9300000000000002 110.277 -168.887 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 -75.37 123.26 25.08 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.583 -0.895 . . . . 5.8200000000000003 108.583 -172.699 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -82.97 168.14 17.29 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.613 0.721 . . . . 2.98 111.403 -177.349 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 58.36 35.6 79.79 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 123.965 0.793 . . . . 0.85999999999999999 113.001 179.287 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -156.23 177.66 11.19 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.049 1.34 . . . . 2.8900000000000001 108.035 174.189 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -94.73 139.74 14.67 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.968 -0.853 . . . . 0.75 110.968 174.819 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.5 pp -142.67 153.78 17.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 106.642 -1.614 . . . . 0.87 106.642 178.803 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 19.9 m -115.14 128.07 72.46 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 N-CA-C 108.983 -0.747 . . . . 0.79000000000000004 108.983 -179.871 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -119.59 135.92 54.59 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 125.471 1.508 . . . . 0.73999999999999999 109.668 -168.83 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -136.66 144.24 43.89 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.524 1.529 . . . . 3.6200000000000001 109.45 -176.491 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -177.04 -103.66 0.17 Allowed Glycine 0 C--N 1.332 0.344 0 N-CA-C 108.03 -2.028 . . . . 1.27 108.03 163.611 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.5 p -151.5 145.17 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 109.177 -0.675 . . . . 0.82999999999999996 109.177 178.386 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.629 ' HG ' HD12 ' A' ' 122' ' ' LEU . 0.3 OUTLIER -78.49 152.95 31.76 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.795 -1.187 . . . . 2.71 107.795 172.463 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -168.54 -51.91 0.03 OUTLIER Glycine 0 C--N 1.333 0.396 0 C-N-CA 119.656 -1.259 . . . . 2.0699999999999998 112.318 175.929 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -61.94 155.58 23.2 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 119.151 -1.019 . . . . 4.5099999999999998 109.55 172.193 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -79.38 79.09 5.85 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 105.811 -1.922 . . . . 4.1100000000000003 105.811 179.47 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.08 17.64 26.82 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 126.159 1.838 . . . . 1.45 113.361 172.078 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.56 154.76 38.78 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.725 -1.583 . . . . 3.0899999999999999 106.725 164.879 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.629 HD12 ' HG ' ' A' ' 116' ' ' LEU . 0.8 OUTLIER -116.09 137.92 51.7 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 122.776 0.43 . . . . 2.2400000000000002 110.237 -175.837 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.34 81.43 4.43 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 107.915 -1.143 . . . . 0.53000000000000003 107.915 177.029 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -90.22 134.25 34.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.306 -0.628 . . . . 1.04 109.306 178.707 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.5 t -128.88 -23.24 3.11 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.731 0.812 . . . . 1.0 113.161 179.033 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -101.58 104.18 15.05 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.352 -1.722 . . . . 3.8399999999999999 106.352 173.168 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.6 m -116.81 125.23 73.64 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 N-CA-C 109.247 -0.649 . . . . 0.94999999999999996 109.247 177.002 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.51 112.12 19.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.153 -1.425 . . . . 0.92000000000000004 107.153 -175.002 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -106.36 42.04 1.33 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.618 1.167 . . . . 2.1600000000000001 111.613 -173.14 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.23 52.72 1.36 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.355 0.662 . . . . 4.0300000000000002 111.588 -175.713 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -74.07 -53.47 9.91 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.583 -0.525 . . . . 4.5 109.583 -176.389 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 N--CA 1.45 -0.431 0 C-N-CA 125.523 1.529 . . . . 5.8700000000000001 106.958 178.279 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 CA--C 1.539 0.54 0 N-CA-C 110.115 -0.328 . . . . 8.5700000000000003 110.115 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 36.4 m-20 -140.31 136.97 33.78 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 106.773 -1.566 . . . . 9.3200000000000003 106.773 173.839 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 tp -82.28 -55.68 4.38 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.417 -0.586 . . . . 6.5 109.417 175.926 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -111.41 94.97 5.24 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.911 1.285 . . . . 3.6400000000000001 110.961 -169.313 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -127.08 166.66 17.21 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.138 1.375 . . . . 2.1600000000000001 110.647 -175.746 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -83.4 134.58 34.88 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.576 1.15 . . . . 2.5899999999999999 109.27 -179.152 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.422 ' CE2' ' HG2' ' A' ' 42' ' ' GLU . 0.5 OUTLIER -146.8 152.04 38.11 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.198 0.999 . . . . 3.21 109.209 -169.109 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.4 p -89.76 142.42 29.16 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 118.046 0.385 . . . . 2.1499999999999999 110.689 -173.191 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -55.26 -41.39 78.89 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.108 1.872 . . . . 0.85999999999999999 111.701 173.797 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.0 t -47.26 -36.98 9.77 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.419 1.088 . . . . 2.5099999999999998 111.527 173.187 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.422 ' HG2' ' CE2' ' A' ' 38' ' ' TYR . 0.9 OUTLIER -67.39 -59.18 3.61 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.413 -0.588 . . . . 2.25 109.413 177.775 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.5 pt -73.3 4.77 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 114.758 1.392 . . . . 0.96999999999999997 114.758 -167.054 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.6 m -96.82 -28.25 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.688 1.195 . . . . 2.8599999999999999 112.301 172.199 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -87.15 -87.03 0.15 Allowed 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.88 0.764 . . . . 2.4300000000000002 110.472 -168.63 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -122.27 59.8 0.58 Allowed Glycine 0 C--N 1.335 0.474 0 N-CA-C 108.814 -1.714 . . . . 1.6699999999999999 108.814 -176.058 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -160.96 -157.45 0.52 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.905 2.482 . . . . 2.4399999999999999 105.426 -175.086 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.474 HG21 HD11 ' A' ' 116' ' ' LEU . 7.4 m -29.02 -59.89 0.13 Allowed 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 128.279 2.631 . . . . 1.55 116.489 -170.213 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -54.14 -37.5 64.46 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.292 0.951 . . . . 3.6899999999999999 111.012 -173.968 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.5 m -91.04 -21.88 21.04 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.708 0.803 . . . . 1.5800000000000001 110.906 176.522 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.37 31.49 68.58 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.685 1.136 . . . . 1.3100000000000001 112.038 172.595 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.0 m -81.6 -55.72 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 122.295 -0.532 . . . . 1.5700000000000001 111.517 -173.941 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -87.3 -67.97 0.14 Allowed Pre-proline 0 CA--C 1.534 0.36 0 CA-C-O 118.558 -0.734 . . . . 3.4900000000000002 112.145 175.969 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -78.02 131.93 11.32 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 121.53 1.486 . . . . 1.4199999999999999 109.701 -177.916 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -80.48 165.87 21.75 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.437 0.695 . . . . 4.8799999999999999 109.191 166.883 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.5 159.91 33.65 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.392 -0.595 . . . . 1.3400000000000001 109.392 166.809 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.22 3.04 57.84 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 123.271 0.462 . . . . 1.25 112.8 178.31 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -102.53 156.69 17.44 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.801 1.241 . . . . 1.55 108.584 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.3 mtm-85 -96.79 130.95 43.96 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.294 -0.632 . . . . 4.0300000000000002 109.294 171.124 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.1 pt -146.58 175.26 1.94 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 106.686 -1.598 . . . . 0.70999999999999996 106.686 168.409 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -124.63 124.91 43.23 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 118.2 0.455 . . . . 1.9199999999999999 110.08 175.537 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.4 p -87.71 119.45 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.564 -1.272 . . . . 0.80000000000000004 107.564 174.567 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -126.31 115.98 2.43 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 109.508 -1.437 . . . . 0.58999999999999997 109.508 177.158 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.86 -154.77 8.11 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 108.206 -1.958 . . . . 0.70999999999999996 108.206 -176.943 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 24.7 ptp -117.34 137.56 52.37 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.712 0.805 . . . . 2.5499999999999998 110.459 -178.448 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 p -89.1 137.23 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 120.273 -0.571 . . . . 2.54 110.166 177.283 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.6 m -28.73 -84.62 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 128.666 2.786 . . . . 3.25 113.38 175.702 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.1 p 171.97 -40.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 125.339 1.455 . . . . 2.2599999999999998 110.238 -175.633 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -148.57 48.39 0.62 Allowed Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.884 -1.287 . . . . 1.8600000000000001 109.884 -178.586 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 65.2 m -101.59 -12.75 18.22 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.212 0.605 . . . . 1.04 112.472 -179.54 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 35.2 tpp -58.33 125.11 21.88 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.931 0.787 . . . . 2.1200000000000001 110.826 170.67 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.5 m -129.81 142.98 42.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 108.372 -0.973 . . . . 0.66000000000000003 108.372 163.496 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.501 ' CB ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -120.9 154.9 35.25 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 124.013 0.925 . . . . 4.1200000000000001 110.934 -177.623 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.53 153.68 81.38 Favored Pre-proline 0 N--CA 1.453 -0.31 0 N-CA-C 109.501 -0.555 . . . . 2.0499999999999998 109.501 171.411 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -59.83 -26.45 82.31 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.607 2.204 . . . . 1.53 111.363 171.008 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -44.82 -36.24 3.15 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.791 0.836 . . . . 1.24 110.952 168.649 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 21.0 m 75.58 18.57 2.21 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.869 1.668 . . . . 1.6899999999999999 112.659 178.478 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.55 -49.17 2.14 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 125.368 1.467 . . . . 1.9199999999999999 111.105 172.549 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -79.09 131.7 36.33 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.489 -1.3 . . . . 1.23 107.489 -176.173 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.501 HG12 ' CB ' ' A' ' 73' ' ' ARG . 32.8 m -138.51 160.03 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 108.744 -0.836 . . . . 1.5 108.744 171.909 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -144.74 147.57 33.12 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.65 -0.704 . . . . 1.3999999999999999 109.274 175.815 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -155.59 146.65 22.48 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.754 0.421 . . . . 1.99 110.367 -173.538 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.38 132.42 44.71 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.497 0.719 . . . . 0.59999999999999998 110.077 179.604 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.9 t -119.46 133.38 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 124.704 1.202 . . . . 1.8100000000000001 108.51 178.832 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -117.45 -177.33 3.2 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 123.879 0.872 . . . . 1.72 110.684 177.737 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -125.91 -74.37 0.6 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.693 -0.685 . . . . 2.5499999999999998 110.709 -177.088 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.2 t -161.45 -51.64 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.313 -1.736 . . . . 3.4399999999999999 106.313 -175.342 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.4 mp -74.75 36.18 0.11 Allowed 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.58 0.956 . . . . 4.8200000000000003 113.58 -179.214 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 58.22 22.99 51.8 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 121.443 -0.786 . . . . 3.6000000000000001 112.205 -178.383 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -81.83 58.97 4.9 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-O 119.218 -0.768 . . . . 1.8799999999999999 111.355 -169.684 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -64.33 102.47 0.53 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.69 0.745 . . . . 3.23 109.646 175.2 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -92.56 154.14 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 107.212 -1.403 . . . . 0.85999999999999999 107.212 166.911 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 mt -102.98 131.15 50.15 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 108.61 -0.885 . . . . 0.65000000000000002 108.61 -179.017 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.77 137.32 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 107.316 -1.364 . . . . 0.89000000000000001 107.316 178.865 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.5 p -111.74 149.14 32.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.641 -1.244 . . . . 0.46000000000000002 107.641 174.72 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -147.55 114.63 6.18 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.533 -1.654 . . . . 2.0 106.533 -179.579 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -94.97 40.55 1.1 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.743 1.617 . . . . 1.9199999999999999 111.604 -170.826 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -166.83 174.34 8.65 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.181 1.792 . . . . 2.8999999999999999 107.111 173.991 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.1 mp -70.87 152.72 43.39 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.826 0.822 . . . . 1.4399999999999999 111.043 178.827 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.25 150.52 37.22 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 125.146 1.378 . . . . 2.2999999999999998 108.713 -173.902 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -60.56 141.28 94.87 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.157 1.905 . . . . 2.2799999999999998 108.621 169.964 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 42.7 46.74 4.48 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.236 1.414 . . . . 2.7999999999999998 112.155 -179.528 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 50.59 15.73 0.25 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.625 1.97 . . . . 2.0800000000000001 115.645 -176.874 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.5 t80 64.93 101.75 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.266 1.427 . . . . 2.7799999999999998 109.874 -162.955 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 29.7 mmm-85 -79.57 111.69 16.1 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.124 -1.065 . . . . 4.5899999999999999 108.124 -179.364 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -83.26 176.32 9.24 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.469 0.652 . . . . 4.1699999999999999 112.504 -177.089 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.51 38.99 97.18 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.708 1.147 . . . . 0.68000000000000005 112.111 177.27 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -158.99 178.29 10.23 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.027 1.331 . . . . 2.54 108.584 -178.679 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -98.98 135.8 12.33 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 110.885 -0.886 . . . . 0.64000000000000001 110.885 173.419 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.0 pp -137.83 149.39 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 105.261 -2.125 . . . . 0.66000000000000003 105.261 176.506 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.2 m -112.26 122.74 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 107.741 -1.207 . . . . 0.63 107.741 177.644 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.434 ' HB2' HG12 ' A' ' 127' ' ' VAL . . . -110.96 131.26 55.2 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 124.889 1.276 . . . . 0.44 109.28 -173.452 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -125.25 150.03 47.44 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.446 1.499 . . . . 3.7999999999999998 108.889 -179.693 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 171.54 -119.77 0.8 Allowed Glycine 0 C--N 1.333 0.402 0 N-CA-C 107.086 -2.405 . . . . 1.2 107.086 169.307 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.8 p -145.86 151.56 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-N 118.767 1.283 . . . . 0.93999999999999995 109.648 -177.076 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.474 HD11 HG21 ' A' ' 48' ' ' THR . 2.4 mm? -81.24 143.63 32.16 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.83 -0.804 . . . . 2.0099999999999998 108.83 173.154 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -161.26 13.39 0.15 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.028 -1.082 . . . . 2.6499999999999999 113.582 175.515 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -137.67 45.41 2.16 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 118.088 0.944 . . . . 6.7800000000000002 108.678 -169.071 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 41.7 t0 16.73 64.91 0.01 OUTLIER 'General case' 0 C--N 1.341 0.213 0 C-N-CA 128.92 2.888 . . . . 2.9900000000000002 113.203 -178.888 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 138.42 -47.81 0.91 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-N 114.79 -1.095 . . . . 1.3999999999999999 111.138 -170.978 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.75 164.11 12.71 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.04 0.92 . . . . 2.0499999999999998 109.862 -175.389 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.8 mp -121.71 131.7 54.23 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.77 1.228 . . . . 1.9399999999999999 110.029 -173.067 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -97.08 89.24 4.73 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.152 -1.425 . . . . 0.66000000000000003 107.152 171.946 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.07 88.03 2.64 Favored 'General case' 0 C--O 1.227 -0.084 0 C-N-CA 123.034 0.534 . . . . 1.51 110.536 -171.765 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.6 t -85.91 -3.77 59.0 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.123 1.157 . . . . 0.96999999999999997 114.123 -172.658 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -112.44 91.42 3.65 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 119.473 1.033 . . . . 3.6400000000000001 108.43 179.63 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.434 HG12 ' HB2' ' A' ' 112' ' ' ALA . 26.9 m -100.24 128.3 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 CA-C-N 118.39 0.541 . . . . 0.65000000000000002 110.524 175.93 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.04 120.29 35.87 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.46 -1.311 . . . . 0.64000000000000001 107.46 177.331 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -96.22 102.83 14.68 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.124 0.97 . . . . 1.3700000000000001 108.959 176.922 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.53 13.51 5.47 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.842 1.052 . . . . 4.2599999999999998 113.842 178.985 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -36.72 -52.33 0.9 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.769 1.228 . . . . 5.7800000000000002 112.143 174.688 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 . . . . . 0 N--CA 1.451 -0.405 0 N-CA-C 106.182 -1.784 . . . . 6.8099999999999996 106.182 -179.315 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 CA--C 1.532 0.287 0 CA-C-O 121.147 0.499 . . . . 6.7400000000000002 110.489 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 -99.86 148.7 24.16 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.08 1.352 . . . . 8.2300000000000004 109.284 179.805 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.3 tt -80.8 151.22 28.87 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.154 -0.684 . . . . 6.4500000000000002 109.154 176.039 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -152.84 150.82 29.73 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.782 0.833 . . . . 3.8300000000000001 109.562 176.39 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.97 171.2 16.9 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.335 1.054 . . . . 4.1200000000000001 109.674 178.581 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -93.65 116.61 29.12 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 124.842 1.257 . . . . 2.3199999999999998 110.207 177.419 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.96 178.68 8.01 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.816 0.673 . . . . 6.0300000000000002 112.816 179.915 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 38.0 p -71.11 150.13 94.65 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 123.554 0.742 . . . . 1.95 110.336 -177.122 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -60.51 -47.59 13.56 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.172 2.581 . . . . 1.3200000000000001 110.685 176.001 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.4 t -46.81 -39.63 12.23 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.54 1.136 . . . . 2.23 111.853 -174.683 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.409 ' OE2' ' NZ ' ' A' ' 47' ' ' LYS . 60.8 tt0 -44.87 -57.46 3.75 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.068 0.547 . . . . 3.8100000000000001 111.178 172.075 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.28 0.1 OUTLIER -81.22 35.52 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 113.05 0.759 . . . . 1.8200000000000001 113.05 -178.872 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 52.1 t -117.76 -34.68 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 118.915 0.78 . . . . 2.2999999999999998 112.419 174.694 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -126.29 116.9 21.95 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 119.574 1.079 . . . . 2.3599999999999999 109.19 -169.766 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 63.4 35.47 92.1 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.62 -0.992 . . . . 1.3799999999999999 110.62 179.344 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.409 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 31.1 mttt -144.25 -107.41 0.11 Allowed 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 126.864 2.066 . . . . 2.8300000000000001 109.267 177.52 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 49.7 m -72.48 -64.62 0.92 Allowed 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 118.663 0.665 . . . . 1.3600000000000001 111.237 -172.98 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -48.71 -49.06 39.62 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.964 0.888 . . . . 2.5499999999999998 110.752 -176.495 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.38 -22.62 57.34 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.515 1.126 . . . . 1.4199999999999999 112.922 179.043 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.11 44.17 96.52 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.577 1.56 . . . . 1.04 114.083 177.752 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.1 m -98.57 -34.09 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 118.866 1.333 . . . . 1.2 113.893 -173.691 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.72 -71.73 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.84 1.256 . . . . 3.6499999999999999 112.797 -176.276 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -74.84 87.14 1.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.465 2.11 . . . . 1.8100000000000001 108.816 176.697 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -67.07 158.77 30.27 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.139 -0.689 . . . . 3.3599999999999999 109.139 175.884 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.7 168.01 5.3 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.769 -0.65 . . . . 1.3300000000000001 111.671 -176.672 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.01 5.35 90.21 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 119.792 -0.449 . . . . 1.03 113.086 -177.928 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -99.2 151.53 20.91 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.414 1.086 . . . . 1.51 109.109 177.882 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 58.7 mtt85 -93.06 146.86 23.32 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 122.876 0.47 . . . . 4.1200000000000001 109.909 173.327 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.3 pt -152.35 179.75 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 106.858 -1.534 . . . . 1.0600000000000001 106.858 179.853 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.9 mmt-85 -135.05 119.39 17.84 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.698 -1.593 . . . . 5.0999999999999996 106.698 167.714 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.7 p -85.18 144.68 9.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 107.768 -1.197 . . . . 0.98999999999999999 107.768 176.654 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -152.82 95.83 0.16 Allowed Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 110.246 -1.142 . . . . 1.04 110.246 -176.285 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -154.93 -165.67 14.35 Favored Glycine 0 C--N 1.332 0.344 0 N-CA-C 110.112 -1.195 . . . . 0.68999999999999995 110.112 -175.675 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.0 ptp -100.68 137.18 39.42 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.069 0.548 . . . . 2.3700000000000001 109.661 -177.159 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 83' ' ' ALA . 11.8 p -92.76 129.49 43.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.061 -0.518 . . . . 2.77 110.263 170.492 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.434 ' O ' HG22 ' A' ' 66' ' ' VAL . 1.0 OUTLIER -61.1 146.6 46.81 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.109 -1.071 . . . . 2.3700000000000001 108.109 166.71 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 p -50.68 -60.71 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.256 1.023 . . . . 1.99 110.539 -178.891 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -86.62 56.33 4.69 Favored Glycine 0 CA--C 1.527 0.791 0 O-C-N 121.378 -0.826 . . . . 1.72 111.645 -176.77 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 62.7 m -122.28 -34.8 3.24 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.986 0.736 . . . . 1.3700000000000001 112.986 -178.753 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -71.92 124.12 24.2 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.802 -0.814 . . . . 2.0099999999999998 108.802 -178.576 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.8 m -131.51 131.92 62.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.735 0.814 . . . . 0.75 108.829 176.15 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.5 ptt-85 -116.8 147.71 41.85 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 124.949 1.3 . . . . 4.0199999999999996 110.332 179.284 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -96.58 155.5 37.77 Favored Pre-proline 0 C--O 1.234 0.273 0 N-CA-C 108.807 -0.812 . . . . 2.3900000000000001 108.807 177.474 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.74 42.86 0.99 Allowed 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.75 2.967 . . . . 1.9099999999999999 111.605 175.857 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -102.9 -41.36 6.18 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 125.306 1.442 . . . . 1.21 109.217 173.605 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.9 m 104.67 -32.49 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 129.12 2.968 . . . . 2.27 110.492 -172.107 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.11 28.78 8.3 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 124.135 0.974 . . . . 2.5899999999999999 112.541 -173.789 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -137.5 113.22 9.58 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.044 -1.465 . . . . 2.0099999999999998 107.044 174.726 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.706 HG21 ' CD2' ' A' ' 100' ' ' LEU . 27.8 m -142.34 143.45 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 107.426 -1.324 . . . . 0.76000000000000001 107.426 176.504 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -139.2 159.72 41.49 Favored 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 121.637 -0.664 . . . . 1.3700000000000001 109.824 169.053 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -150.95 142.32 23.36 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 109.135 -0.691 . . . . 1.98 109.135 -178.495 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.59 ' O ' HG23 ' A' ' 66' ' ' VAL . . . -83.33 143.82 30.1 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.241 -1.022 . . . . 0.68999999999999995 108.241 171.543 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.8 t -128.32 138.03 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 N-CA-C 107.393 -1.336 . . . . 1.8200000000000001 107.393 170.421 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -133.93 174.74 10.14 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.999 -0.741 . . . . 1.29 108.999 177.911 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -119.5 -3.31 10.42 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.923 -0.58 . . . . 2.6299999999999999 110.793 175.557 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.0 m 59.02 27.73 16.76 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.713 1.205 . . . . 4.9000000000000004 112.099 -168.449 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -102.97 9.94 38.45 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.382 1.073 . . . . 4.4299999999999997 111.708 173.017 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.23 47.88 4.52 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.563 -1.015 . . . . 3.1499999999999999 110.563 -175.8 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.33 126.27 1.38 Allowed Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 108.319 -1.912 . . . . 1.54 108.319 173.529 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -126.3 142.88 51.36 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.165 -1.791 . . . . 3.4500000000000002 106.165 171.277 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.7 tp -131.85 147.3 32.45 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 N-CA-C 108.332 -0.988 . . . . 1.1499999999999999 108.332 179.71 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.9 mt -95.91 122.72 39.02 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 122.968 0.507 . . . . 0.55000000000000004 110.27 179.715 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.7 122.23 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 125.552 1.541 . . . . 0.84999999999999998 107.582 176.401 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 42.3 p -100.26 152.4 20.34 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.251 1.02 . . . . 0.46000000000000002 108.996 174.869 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.553 ' HB3' HG23 ' A' ' 80' ' ' VAL . 1.0 OUTLIER -147.16 122.3 10.16 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.563 -1.273 . . . . 2.8599999999999999 107.563 177.127 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -96.53 41.66 1.1 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.698 1.599 . . . . 2.4199999999999999 110.973 -179.933 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -162.55 179.53 7.68 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.734 1.214 . . . . 2.8399999999999999 108.354 172.428 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.05 165.54 23.29 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.565 1.146 . . . . 1.3999999999999999 111.649 174.167 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.706 ' CD2' HG21 ' A' ' 80' ' ' VAL . 3.0 mm? -96.16 162.16 24.7 Favored Pre-proline 0 N--CA 1.453 -0.292 0 C-N-CA 125.833 1.653 . . . . 2.5899999999999999 109.437 179.185 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -64.3 -82.14 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.236 2.624 . . . . 2.5299999999999998 109.168 167.32 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -93.24 48.69 1.34 Allowed 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 124.14 0.976 . . . . 2.6099999999999999 109.202 -172.196 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 48.77 4.6 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.997 2.119 . . . . 2.6800000000000002 116.478 -169.944 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.512 ' HE1' HG21 ' A' ' 66' ' ' VAL . 35.4 t80 63.71 97.18 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.221 1.409 . . . . 2.54 109.976 -159.767 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 51.7 mtp85 -79.02 121.7 25.27 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 107.418 -1.327 . . . . 3.8599999999999999 107.418 174.577 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -82.23 175.31 10.39 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.942 0.897 . . . . 3.23 110.365 -175.172 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 62.58 35.46 91.85 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 122.094 -0.378 . . . . 0.77000000000000002 112.546 174.279 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -155.65 -179.92 8.58 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.24 1.416 . . . . 2.7599999999999998 108.188 178.131 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -106.51 131.02 10.44 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 110.917 -0.873 . . . . 0.55000000000000004 110.917 177.506 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.9 pp -128.51 154.91 39.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 106.994 -1.484 . . . . 0.60999999999999999 106.994 179.039 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.2 m -106.44 137.7 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 107.418 -1.327 . . . . 0.80000000000000004 107.418 173.415 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.437 ' HB2' HG12 ' A' ' 127' ' ' VAL . . . -125.97 124.29 40.42 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.056 0.943 . . . . 0.48999999999999999 109.615 179.607 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.35 137.62 42.86 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.141 1.376 . . . . 3.77 108.921 -177.785 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 170.75 -148.6 11.53 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.975 -0.85 . . . . 1.0700000000000001 110.975 178.099 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.11 153.69 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 C-N-CA 124.823 1.249 . . . . 0.96999999999999997 107.823 -170.508 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.488 HD13 HD23 ' A' ' 122' ' ' LEU . 3.5 mm? -53.37 140.96 25.83 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.29 -0.633 . . . . 1.8400000000000001 109.29 169.368 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -74.74 -153.85 3.66 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 109.818 -1.313 . . . . 2.25 109.818 178.527 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -58.46 -60.31 4.0 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.952 0.501 . . . . 5.6900000000000004 109.99 -174.5 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -170.82 109.08 0.32 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.496 -2.039 . . . . 3.1200000000000001 105.496 175.596 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 107.41 -39.87 2.73 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.848 -1.301 . . . . 0.98999999999999999 109.848 174.783 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.03 166.71 18.56 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.243 0.617 . . . . 3.0699999999999998 111.196 179.823 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.488 HD23 HD13 ' A' ' 116' ' ' LEU . 98.4 mt -116.86 134.91 54.19 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 124.43 1.092 . . . . 2.1899999999999999 108.653 172.334 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -105.93 103.68 13.23 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 107.834 -1.173 . . . . 0.66000000000000003 107.834 173.884 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -131.48 113.51 13.78 Favored 'General case' 0 C--N 1.341 0.232 0 N-CA-C 111.902 0.334 . . . . 1.23 111.902 -174.821 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.78 -41.63 9.56 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.753 1.221 . . . . 1.1699999999999999 110.442 179.329 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -84.87 77.82 10.02 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.603 -0.888 . . . . 3.5899999999999999 108.603 -167.993 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.437 HG12 ' HB2' ' A' ' 112' ' ' ALA . 6.5 m -88.76 124.06 41.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.757 1.223 . . . . 0.75 110.751 177.205 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.406 HD13 ' C ' ' A' ' 127' ' ' VAL . 0.0 OUTLIER -121.43 131.32 54.1 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.561 1.144 . . . . 0.81000000000000005 107.978 176.669 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -100.31 74.87 1.76 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.902 0.881 . . . . 1.3 110.751 -175.11 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.3 pttm -74.36 -12.26 60.48 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.832 1.049 . . . . 4.8399999999999999 113.832 -171.719 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 10.5 m170 -79.0 -42.65 26.08 Favored 'General case' 0 C--N 1.338 0.093 0 O-C-N 121.866 -0.521 . . . . 4.6200000000000001 110.175 172.807 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.9 t70 . . . . . 0 N--CA 1.446 -0.63 0 N-CA-C 107.921 -1.14 . . . . 6.2699999999999996 107.921 -167.288 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.3 t . . . . . 0 CA--C 1.534 0.349 0 N-CA-C 108.181 -1.044 . . . . 7.1500000000000004 108.181 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -112.27 154.28 25.87 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.523 1.929 . . . . 8.9100000000000001 108.822 177.979 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -153.69 -81.29 0.09 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 115.318 1.599 . . . . 5.3700000000000001 115.318 -178.223 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -82.25 73.15 9.31 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.436 -1.415 . . . . 3.98 110.314 -165.301 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -125.83 166.61 16.53 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.986 0.812 . . . . 1.8400000000000001 112.712 -166.477 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.436 ' CZ ' ' HD2' ' A' ' 61' ' ' ARG . 93.7 m-85 -83.44 134.15 34.88 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.545 1.138 . . . . 2.27 110.458 -177.526 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -137.18 147.48 45.92 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.293 1.837 . . . . 3.3199999999999998 109.95 -178.768 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 m -71.69 137.48 82.98 Favored Pre-proline 0 N--CA 1.448 -0.546 0 C-N-CA 124.964 1.306 . . . . 1.6899999999999999 110.464 177.437 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -58.94 -49.14 12.06 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.97 2.447 . . . . 0.77000000000000002 111.453 177.335 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.9 m -54.18 -33.88 59.16 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.625 0.77 . . . . 2.8300000000000001 112.683 -178.719 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -53.1 -51.34 62.19 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.238 -1.023 . . . . 2.3999999999999999 108.238 173.749 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.295 36.8 pt -82.4 30.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 113.652 0.982 . . . . 1.29 113.652 -171.48 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -103.87 -39.72 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 124.048 0.939 . . . . 2.1400000000000001 110.702 163.161 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -72.9 -50.58 22.85 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.645 0.609 . . . . 2.8100000000000001 112.645 -159.972 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.23 67.98 0.1 Allowed Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 108.139 -1.984 . . . . 1.4199999999999999 108.139 -168.804 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -143.19 -106.72 0.13 Allowed 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.449 -1.685 . . . . 3.2999999999999998 106.449 -175.921 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 t -65.17 -59.36 4.18 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.595 1.158 . . . . 3.48 111.192 177.269 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -57.3 -39.6 76.11 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.474 0.71 . . . . 3.02 111.553 -165.195 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.68 -7.29 37.87 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.207 1.003 . . . . 1.3200000000000001 112.255 178.081 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 53.11 44.88 63.4 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.443 1.496 . . . . 1.1699999999999999 113.785 178.26 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.9 m -99.05 -35.26 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 118.479 1.14 . . . . 1.29 113.228 -175.061 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.89 -71.63 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 117.837 -1.078 . . . . 4.2000000000000002 112.537 -179.525 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -76.17 174.5 12.72 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 122.264 1.976 . . . . 1.3999999999999999 109.157 171.653 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -147.18 147.72 30.79 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.885 2.074 . . . . 2.9100000000000001 106.937 -176.929 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.44 144.03 32.61 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.66 0.784 . . . . 1.3500000000000001 110.52 -179.71 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.08 -20.49 26.15 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 123.829 0.728 . . . . 1.1499999999999999 112.551 -176.882 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -85.31 151.55 23.95 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 117.938 0.869 . . . . 1.6399999999999999 109.657 179.798 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.0 mtt85 -97.71 137.35 36.72 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.636 -0.711 . . . . 4.0300000000000002 109.709 173.789 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.7 pt -144.46 168.63 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 105.777 -1.935 . . . . 0.63 105.777 170.775 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.436 ' HD2' ' CZ ' ' A' ' 37' ' ' PHE . 22.0 mtt180 -115.54 123.65 49.03 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.009 -0.737 . . . . 1.8600000000000001 109.009 172.391 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.6 p -87.46 129.33 39.02 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.082 0 N-CA-C 108.016 -1.105 . . . . 0.92000000000000004 108.016 176.045 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.98 116.18 1.81 Allowed Glycine 0 C--N 1.333 0.41 0 CA-C-N 118.919 0.782 . . . . 0.55000000000000004 111.243 -178.157 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.89 -169.2 38.53 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 117.787 0.793 . . . . 0.95999999999999996 111.313 -177.378 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.413 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 19.6 ptp -101.4 148.68 24.88 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.863 1.265 . . . . 2.75 110.711 -177.912 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 43.2 t -106.34 119.65 56.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 109.624 -0.51 . . . . 2.46 109.624 -177.393 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 86.1 m -44.05 122.47 2.9 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.714 1.606 . . . . 2.5899999999999999 109.408 165.774 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.1 p -46.23 -57.09 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.042 0.937 . . . . 2.1200000000000001 111.205 -177.86 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.2 68.84 3.4 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.833 -0.907 . . . . 2.3100000000000001 110.833 -179.648 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.9 m -149.55 -31.36 0.22 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.255 1.576 . . . . 1.22 115.255 178.221 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 12.1 tpp -60.92 115.88 4.05 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.15 0.886 . . . . 2.02 109.638 173.249 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.3 m -121.09 136.1 59.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 107.971 -1.122 . . . . 0.76000000000000001 107.971 172.444 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.47 136.48 49.95 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.855 1.262 . . . . 6.6699999999999999 109.082 -170.842 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -83.03 154.62 67.4 Favored Pre-proline 0 N--CA 1.455 -0.209 0 N-CA-C 109.384 -0.598 . . . . 2.1299999999999999 109.384 -179.359 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -71.03 10.42 0.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.12 2.547 . . . . 1.3400000000000001 113.203 173.731 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -74.71 -22.58 58.76 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.868 0.467 . . . . 1.3600000000000001 109.862 161.947 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.1 m 63.74 24.08 13.71 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.079 1.351 . . . . 1.74 112.621 -178.177 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.86 -43.32 2.0 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.962 1.705 . . . . 2.3100000000000001 112.023 172.68 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -84.13 122.19 28.48 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 108.522 -0.918 . . . . 1.3500000000000001 108.522 -178.839 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.3 m -146.83 107.69 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 106.92 -1.511 . . . . 1.3100000000000001 106.92 -172.156 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -119.87 154.97 33.57 Favored 'General case' 0 C--O 1.232 0.162 0 O-C-N 121.635 -0.666 . . . . 0.81000000000000005 109.838 -176.773 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -154.9 147.99 24.78 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 120.82 0.343 . . . . 2.0699999999999998 111.067 -175.555 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.05 139.92 30.72 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.41 -0.959 . . . . 0.65000000000000002 108.41 167.951 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.08 147.05 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.291 1.037 . . . . 1.9199999999999999 108.685 178.498 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -145.04 172.15 13.47 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 126.292 1.837 . . . . 1.5900000000000001 109.632 -171.045 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.42 ' C ' ' H ' ' A' ' 88' ' ' LEU . 50.4 t0 -147.19 173.01 12.93 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.31 -1.367 . . . . 2.9500000000000002 107.31 170.217 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.8 t -64.85 23.69 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.427 1.891 . . . . 3.6200000000000001 113.229 174.919 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.42 ' H ' ' C ' ' A' ' 86' ' ' ASP . 3.9 mm? -106.87 16.31 24.48 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.6 1.96 . . . . 5.6500000000000004 110.5 173.438 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 62.49 56.31 22.38 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 121.853 -0.529 . . . . 3.2200000000000002 112.843 166.588 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -176.05 176.15 47.56 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 107.474 -2.251 . . . . 1.8799999999999999 107.474 176.87 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -157.21 172.28 18.92 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 117.84 0.82 . . . . 2.6400000000000001 109.424 179.223 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.0 tp -154.28 159.88 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.287 0.635 . . . . 1.01 109.387 176.539 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 16.7 mt -99.05 127.01 44.9 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.608 1.163 . . . . 0.88 111.283 -178.354 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 76.2 t -108.68 130.87 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 125.727 1.611 . . . . 0.84999999999999998 107.989 175.502 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.8 p -111.79 134.1 53.58 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.149 -1.056 . . . . 0.58999999999999997 108.149 177.675 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.417 ' CE2' ' HA ' ' A' ' 125' ' ' THR . 1.4 t80 -135.11 139.4 44.64 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.318 -1.364 . . . . 2.2599999999999998 107.318 -179.319 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -130.23 30.64 4.74 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.962 1.305 . . . . 2.1899999999999999 112.702 -168.628 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -159.1 55.95 0.41 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.195 0.521 . . . . 2.4500000000000002 111.207 -178.58 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 55.76 -170.4 0.08 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.102 0.961 . . . . 1.8500000000000001 111.456 -176.132 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.1 mt -153.28 154.94 31.39 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 125.113 1.365 . . . . 1.1799999999999999 107.643 -175.986 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.498 ' HG3' HG23 ' A' ' 127' ' ' VAL . 72.8 Cg_endo -62.85 122.39 10.66 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 125.172 3.915 . . . . 2.3799999999999999 109.958 -176.676 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 48.24 42.42 17.59 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 123.655 0.782 . . . . 3.3799999999999999 110.498 -178.161 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 70.23 -16.9 0.28 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.886 1.274 . . . . 3.79 112.234 -177.261 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 14.2 t80 60.27 83.79 0.13 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.736 2.015 . . . . 3.1499999999999999 108.954 -167.474 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -75.07 137.33 41.37 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 114.834 -1.075 . . . . 5.4100000000000001 108.26 -173.642 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.5 mp0 -79.03 162.72 25.72 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 121.139 0.495 . . . . 3.4199999999999999 110.522 -166.089 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.29 44.69 27.43 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 111.593 -0.603 . . . . 1.1299999999999999 111.593 -178.237 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -146.37 179.5 7.48 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.733 1.613 . . . . 2.0899999999999999 106.704 169.042 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 65' ' ' MET . . . -126.21 145.65 15.84 Favored Glycine 0 C--N 1.337 0.592 0 N-CA-C 111.529 -0.628 . . . . 1.1100000000000001 111.529 171.708 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.36 168.5 15.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 124.424 1.09 . . . . 1.4099999999999999 108.532 -175.804 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.5 m -107.49 129.78 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 107.812 -1.181 . . . . 0.81000000000000005 107.812 169.519 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.614 ' HB2' HG12 ' A' ' 127' ' ' VAL . . . -119.24 133.75 55.59 Favored 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 125.457 1.503 . . . . 0.51000000000000001 109.088 -179.218 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -124.98 142.4 51.51 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.28 1.032 . . . . 3.98 110.555 -177.582 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 171.51 -134.9 3.22 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 108.393 -1.883 . . . . 0.81999999999999995 108.393 172.203 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.06 155.37 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 108.423 -0.954 . . . . 0.67000000000000004 108.423 -170.274 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -54.39 132.73 44.81 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.86 -0.792 . . . . 1.95 108.86 167.05 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.56 -139.9 1.63 Allowed Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 109.62 -1.392 . . . . 1.9199999999999999 109.62 -179.774 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -57.55 -60.6 3.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 122.865 0.466 . . . . 5.3099999999999996 110.862 -177.416 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -176.81 115.48 0.1 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 105.823 -1.917 . . . . 3.4900000000000002 105.823 -173.191 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 88.2 -42.64 3.09 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 125.39 1.471 . . . . 1.1599999999999999 109.609 176.997 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.65 142.09 34.3 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.227 1.411 . . . . 3.1299999999999999 109.918 -175.937 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.72 123.45 47.05 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 108.393 -0.966 . . . . 2.2799999999999998 108.393 -176.754 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.76 83.7 3.48 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.019 -1.474 . . . . 0.46999999999999997 107.019 176.096 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -94.33 142.44 27.41 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.41 -0.959 . . . . 1.1399999999999999 108.41 175.202 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.417 ' HA ' ' CE2' ' A' ' 96' ' ' TYR 0.26 4.7 t -136.5 -4.36 2.07 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 115.47 1.656 . . . . 0.95999999999999996 115.47 173.667 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -107.2 98.87 8.46 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 119.854 1.206 . . . . 3.9500000000000002 107.913 164.794 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.614 HG12 ' HB2' ' A' ' 112' ' ' ALA . 3.4 m -96.47 133.79 36.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 CA-C-N 118.751 0.705 . . . . 0.76000000000000001 110.833 165.056 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.71 106.75 14.86 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.299 -1.371 . . . . 0.72999999999999998 107.299 175.266 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.68 42.06 1.08 Allowed 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.3 0.852 . . . . 1.45 113.3 -170.237 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.28 62.91 1.84 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.361 0.664 . . . . 4.0599999999999996 111.528 179.324 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -77.53 -55.33 5.46 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.902 -0.777 . . . . 7.3899999999999997 108.902 175.102 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 N--CA 1.454 -0.255 0 C-N-CA 125.523 1.529 . . . . 5.5899999999999999 107.886 174.21 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.8 m . . . . . 0 CA--C 1.535 0.404 0 CA-C-O 120.821 0.344 . . . . 10.029999999999999 111.511 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -153.37 127.81 9.27 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 104.393 -2.447 . . . . 9.5199999999999996 104.393 176.459 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -120.56 162.6 19.34 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.734 1.213 . . . . 6.1900000000000004 107.977 175.806 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -114.47 111.08 20.84 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.81 -1.182 . . . . 5.2400000000000002 107.81 -173.292 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.56 172.96 13.67 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.507 0.723 . . . . 4.4500000000000002 110.674 -175.091 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.573 ' CE1' ' HB3' ' A' ' 61' ' ' ARG . 3.1 m-85 -89.22 110.83 21.54 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.52 1.128 . . . . 4.4000000000000004 110.732 179.55 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.49 176.31 8.79 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.747 0.654 . . . . 5.8099999999999996 112.01 174.998 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 p -69.34 145.82 96.06 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 124.067 0.947 . . . . 1.96 110.696 -175.841 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -58.92 -37.18 94.99 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.168 1.912 . . . . 1.29 111.966 179.36 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.6 t -46.53 -40.86 13.36 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.499 0.72 . . . . 2.6899999999999999 112.17 177.921 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -50.42 -47.32 56.68 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.342 -0.543 . . . . 4.8799999999999999 110.499 177.131 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.279 0.2 OUTLIER -91.56 34.39 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 112.77 0.655 . . . . 1.6499999999999999 112.77 178.293 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.16 -32.93 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 118.88 0.763 . . . . 2.4399999999999999 112.345 170.167 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -117.44 113.42 22.03 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.156 0.889 . . . . 2.6899999999999999 110.323 -173.72 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.6 43.77 98.56 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.488 -0.645 . . . . 1.77 111.488 169.307 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -142.42 -111.04 0.13 Allowed 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 126.634 1.973 . . . . 3.9199999999999999 106.511 176.704 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.4 t -71.87 -47.91 49.58 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 119.43 1.013 . . . . 3.0099999999999998 111.626 -176.688 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -49.89 -46.24 51.5 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 122.044 0.926 . . . . 2.79 110.724 -173.47 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.69 -11.51 45.01 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.977 1.311 . . . . 1.5700000000000001 112.173 178.829 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 55.54 44.82 85.73 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 126.309 1.909 . . . . 1.3899999999999999 112.43 -178.073 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.7 m -96.01 -57.87 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 118.187 0.993 . . . . 1.8899999999999999 112.81 -174.047 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.5 mmmt -91.85 -60.8 0.21 Allowed Pre-proline 0 CA--C 1.536 0.43 0 CA-C-O 118.607 -0.711 . . . . 4.5099999999999998 111.992 -177.02 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -85.97 110.53 1.08 Allowed 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 122.426 2.084 . . . . 1.51 108.821 175.743 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -69.28 155.98 39.53 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.779 -0.823 . . . . 3.2000000000000002 108.779 167.314 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -53.76 165.78 0.4 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 122.027 0.917 . . . . 1.3700000000000001 111.959 166.75 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.44 8.77 86.67 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 115.933 -0.576 . . . . 1.1799999999999999 112.45 -177.768 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -102.45 155.05 18.52 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.049 0.924 . . . . 1.96 108.886 171.779 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -100.81 136.81 40.07 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.101 0.96 . . . . 4.1799999999999997 108.921 175.876 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.64 HD11 HD11 ' A' ' 122' ' ' LEU . 29.7 pt -141.86 175.36 5.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 106.558 -1.645 . . . . 0.90000000000000002 106.558 174.152 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.573 ' HB3' ' CE1' ' A' ' 37' ' ' PHE . 15.8 mtt-85 -132.52 126.27 32.52 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 106.421 -1.696 . . . . 3.27 106.421 176.196 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.7 p -98.67 118.08 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 107.81 -1.181 . . . . 1.05 107.81 -179.46 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.36 113.26 1.87 Allowed Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 108.195 -1.962 . . . . 0.92000000000000004 108.195 -178.738 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.88 -163.29 27.12 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 109.446 -1.462 . . . . 0.66000000000000003 109.446 -171.737 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -103.75 132.23 50.2 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.864 0.866 . . . . 3.0 109.812 -172.88 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.2 t -106.57 126.23 62.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 108.721 -0.844 . . . . 2.3700000000000001 108.721 176.859 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.2 m -57.95 137.95 56.29 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.833 1.253 . . . . 2.29 108.918 169.034 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.6 p -52.27 -60.69 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 123.63 0.772 . . . . 2.2400000000000002 110.782 177.507 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.14 68.44 2.32 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.309 -1.116 . . . . 1.97 110.309 -179.951 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.1 m -151.16 -34.95 0.14 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.105 0.779 . . . . 1.1200000000000001 113.105 -179.042 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.1 ttp -69.37 117.73 11.37 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.438 1.017 . . . . 2.7799999999999998 109.148 174.282 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.1 m -122.56 136.12 60.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 107.659 -1.237 . . . . 0.79000000000000004 107.659 175.196 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.482 ' CB ' HG12 ' A' ' 80' ' ' VAL . 24.2 ptt180 -118.72 144.69 46.08 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.897 0.879 . . . . 4.2800000000000002 109.963 -179.931 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -92.42 145.84 31.34 Favored Pre-proline 0 C--O 1.237 0.42 0 N-CA-C 108.957 -0.757 . . . . 2.4700000000000002 108.957 177.475 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -75.58 30.24 0.38 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.048 2.499 . . . . 1.76 112.89 178.792 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -89.87 -22.7 21.91 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.09 0.956 . . . . 1.54 108.83 162.628 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.3 m 63.47 23.13 13.54 Favored 'General case' 0 C--N 1.344 0.358 0 C-N-CA 124.301 1.041 . . . . 1.3799999999999999 111.806 -174.626 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . 0.251 1.4 pp -130.7 -3.18 4.18 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.581 1.552 . . . . 2.1800000000000002 113.303 173.322 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -131.4 125.56 32.93 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.192 -1.04 . . . . 1.55 108.192 -179.97 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.482 HG12 ' CB ' ' A' ' 73' ' ' ARG . 27.2 m -141.64 143.57 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 107.093 -1.447 . . . . 0.82999999999999996 107.093 172.08 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -142.05 158.77 43.37 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 121.783 -0.573 . . . . 0.83999999999999997 109.667 176.143 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -149.51 136.04 19.29 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.402 0.681 . . . . 1.96 109.97 -177.342 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.85 138.22 33.31 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.468 -0.938 . . . . 0.67000000000000004 108.468 169.944 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.8 p -117.69 155.29 19.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 125.186 1.394 . . . . 2.04 107.786 175.547 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -131.61 175.1 9.45 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.698 0.799 . . . . 1.6699999999999999 109.729 -179.651 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -140.15 166.4 24.77 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.464 1.106 . . . . 3.3300000000000001 109.632 178.861 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.9 t -37.37 -51.5 1.09 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.748 1.219 . . . . 4.21 110.745 161.473 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -89.05 29.83 1.01 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.001 0.741 . . . . 5.5 113.001 -178.531 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 58.71 43.21 96.49 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.547 -1.021 . . . . 2.6600000000000001 110.547 176.123 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -76.63 63.27 3.08 Favored Glycine 0 C--N 1.336 0.535 0 N-CA-C 110.135 -1.186 . . . . 2.2400000000000002 110.135 -176.868 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.86 101.24 3.7 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.794 -0.817 . . . . 3.21 108.794 -172.02 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.1 152.15 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 124.221 1.008 . . . . 1.1399999999999999 108.737 -177.036 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.2 mt -107.36 122.31 46.33 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.265 1.026 . . . . 0.69999999999999996 109.538 -179.717 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.0 t -105.08 120.07 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 125.06 1.344 . . . . 1.03 107.651 176.961 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.6 p -105.44 144.35 32.33 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.862 1.265 . . . . 0.60999999999999999 108.964 179.525 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.431 ' HB3' HG23 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -142.24 102.13 4.04 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.214 -1.032 . . . . 2.25 108.214 -178.771 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -94.4 45.44 1.13 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.221 1.408 . . . . 2.9700000000000002 111.015 -178.905 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -163.97 48.44 0.12 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.676 1.19 . . . . 3.8700000000000001 110.437 179.559 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.9 mp 54.16 -149.88 0.41 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.379 1.072 . . . . 2.4500000000000002 110.776 -178.739 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.478 ' HG ' HG21 ' A' ' 80' ' ' VAL . 11.8 mt -153.44 158.35 32.72 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 127.62 2.368 . . . . 1.52 105.837 -176.996 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -75.27 -98.5 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 124.292 3.328 . . . . 2.7799999999999998 110.671 -178.892 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -75.77 53.62 0.75 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.16 1.384 . . . . 3.6099999999999999 110.204 179.527 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 45.47 0.48 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 129.084 2.953 . . . . 2.75 116.533 -163.839 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.7 t80 50.05 105.29 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 122.462 1.125 . . . . 3.2000000000000002 110.089 -153.434 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -74.51 123.43 24.73 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.434 -1.321 . . . . 4.7000000000000002 107.434 178.975 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -81.66 167.81 18.8 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.832 0.853 . . . . 3.29 110.322 -167.522 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.14 44.54 93.91 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 112.067 -0.413 . . . . 1.0700000000000001 112.067 173.484 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -155.85 177.72 11.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.401 -1.333 . . . . 2.0 107.401 175.344 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -85.49 137.97 15.89 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.581 -1.008 . . . . 0.97999999999999998 110.581 171.055 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 4.7 pt -138.64 164.43 26.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 108.934 -0.765 . . . . 1.52 108.934 172.484 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.529 ' HB ' ' CE1' ' A' ' 37' ' ' PHE . 16.2 m -121.68 112.96 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 106.915 -1.513 . . . . 1.27 106.915 -178.545 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -118.45 127.87 54.07 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.518 1.927 . . . . 0.81999999999999995 111.048 -173.423 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -126.59 157.93 37.57 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.778 1.172 . . . . 2.8700000000000001 113.608 175.092 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 179.26 -104.11 0.18 Allowed Glycine 0 C--N 1.337 0.602 0 N-CA-C 109.735 -1.346 . . . . 1.2 109.735 167.943 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.8 p -151.6 154.0 8.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 118.254 1.027 . . . . 0.92000000000000004 110.047 -174.563 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.01 139.41 58.76 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.63 -0.259 . . . . 1.77 111.004 173.592 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -120.04 120.92 4.73 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 126.356 1.932 . . . . 3.52 109.18 176.747 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 56.99 43.12 25.1 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.933 0.893 . . . . 5.0300000000000002 111.297 168.715 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 35.47 50.46 0.57 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.177 1.791 . . . . 4.71 111.43 -176.197 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -175.56 -57.28 0.06 OUTLIER Glycine 0 C--N 1.339 0.708 0 C-N-CA 120.128 -1.034 . . . . 1.22 112.973 -175.078 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.11 152.83 22.01 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 109.068 -0.716 . . . . 2.75 109.068 -178.927 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.64 HD11 HD11 ' A' ' 60' ' ' ILE . 3.3 mm? -107.35 111.48 23.85 Favored 'General case' 0 C--O 1.228 -0.062 0 N-CA-C 109.128 -0.693 . . . . 2.2400000000000002 109.128 -177.281 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.71 97.5 9.15 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.355 -1.35 . . . . 0.64000000000000001 107.355 176.306 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.7 144.52 39.52 Favored 'General case' 0 C--O 1.227 -0.125 0 C-N-CA 122.92 0.488 . . . . 1.1499999999999999 109.85 -177.806 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.6 t -131.43 -43.91 1.02 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.025 0.93 . . . . 0.97999999999999998 110.907 -178.337 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -83.34 93.89 7.83 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.242 -1.392 . . . . 4.1200000000000001 107.242 175.621 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 18.8 m -98.6 120.46 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 124.394 1.078 . . . . 0.98999999999999999 108.424 169.65 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.73 114.15 26.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.711 -1.589 . . . . 0.90000000000000002 106.711 178.868 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.5 46.28 0.84 Allowed 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.879 -1.138 . . . . 1.48 112.051 -175.628 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -81.7 60.75 4.78 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.448 -0.782 . . . . 3.02 111.376 -175.248 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.87 93.61 1.35 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.542 0.737 . . . . 7.0899999999999999 110.556 176.849 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 . . . . . 0 N--CA 1.449 -0.525 0 C-N-CA 124.951 1.3 . . . . 8.2699999999999996 108.419 -175.803 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.5 p . . . . . 0 CA--C 1.535 0.37 0 CA-C-O 121.351 0.596 . . . . 7.6100000000000003 110.427 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -71.88 -18.44 62.05 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 114.704 1.372 . . . . 9.6300000000000008 114.704 -167.19 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.322 2.0 pp -90.92 -66.63 0.91 Allowed 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.386 1.254 . . . . 5.9400000000000004 114.386 -162.322 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -83.87 71.99 10.43 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 120.408 -1.432 . . . . 3.4199999999999999 112.405 -162.104 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.23 162.28 25.8 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.666 0.617 . . . . 2.29 112.666 -174.161 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -85.67 118.79 25.39 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.939 1.296 . . . . 2.21 110.382 179.366 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.31 162.69 23.25 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.345 1.058 . . . . 2.8399999999999999 111.166 175.113 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.9 p -75.02 144.29 79.06 Favored Pre-proline 0 N--CA 1.451 -0.396 0 N-CA-C 109.237 -0.653 . . . . 2.2599999999999998 109.237 176.062 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -55.64 -41.27 79.39 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.56 2.173 . . . . 1.26 111.173 169.39 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.2 m -57.0 -50.33 73.03 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 117.563 -1.208 . . . . 2.6099999999999999 111.313 178.94 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.29 -53.86 12.44 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 120.308 1.413 . . . . 2.7999999999999998 110.52 178.192 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.461 ' HA ' ' HB2' ' A' ' 47' ' ' LYS 0.334 31.0 pt -63.01 -28.41 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-N 115.116 -0.947 . . . . 1.3700000000000001 112.816 -173.058 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.0 t -74.87 -49.04 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 118.492 0.587 . . . . 2.1000000000000001 110.894 166.063 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -64.89 -46.83 80.1 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 123.972 0.909 . . . . 4.54 112.877 -163.457 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.34 62.35 0.07 OUTLIER Glycine 0 C--N 1.335 0.481 0 C-N-CA 119.668 -1.253 . . . . 2.0699999999999998 111.59 -174.291 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.461 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 13.7 mmtt -150.85 -97.32 0.06 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 128.235 2.614 . . . . 3.3399999999999999 105.098 -178.18 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.751 HG21 HD11 ' A' ' 116' ' ' LEU . 9.4 m -78.89 -54.66 5.82 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 125.072 1.349 . . . . 1.78 113.095 -168.518 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -49.24 -45.1 44.22 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.905 0.859 . . . . 2.3700000000000001 110.454 -178.517 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.2 m -87.58 -10.65 50.92 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.344 1.058 . . . . 1.6699999999999999 113.157 178.356 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 51.75 47.08 53.72 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.821 1.677 . . . . 1.8200000000000001 112.834 -175.994 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.9 m -87.0 -52.47 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 118.334 1.067 . . . . 2.0499999999999998 112.313 -175.509 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -100.97 -48.51 0.2 Allowed Pre-proline 0 CA--C 1.537 0.456 0 CA-C-O 118.039 -0.982 . . . . 3.6099999999999999 111.646 -178.816 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -91.29 -173.43 0.55 Allowed 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 122.863 2.376 . . . . 2.0600000000000001 108.781 170.181 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -153.45 155.78 36.95 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 127.756 2.422 . . . . 3.4100000000000001 106.413 -177.722 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.476 ' HB2' ' CB ' ' A' ' 119' ' ' ASP . . . -54.25 160.91 1.47 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.862 0.839 . . . . 1.3799999999999999 111.442 173.88 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.27 29.42 60.27 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 116.043 -0.526 . . . . 1.6799999999999999 111.976 176.032 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -122.07 152.51 39.75 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.177 -1.416 . . . . 1.53 107.177 167.748 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.9 mtt85 -88.61 141.21 28.71 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.282 -0.636 . . . . 3.79 109.282 170.106 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.0 pt -143.61 176.78 2.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 106.906 -1.516 . . . . 0.75 106.906 170.613 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.6 mtt180 -124.25 129.51 50.91 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.036 -0.727 . . . . 1.8899999999999999 109.036 169.264 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.0 p -90.34 128.59 42.15 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 107.365 -1.346 . . . . 0.93000000000000005 107.365 174.352 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.88 119.22 1.6 Allowed Glycine 0 C--N 1.335 0.515 0 N-CA-C 110.721 -0.951 . . . . 0.64000000000000001 110.721 178.944 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.49 -157.5 16.96 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 108.627 -1.789 . . . . 0.71999999999999997 108.627 -175.264 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.63 149.2 23.53 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 117.814 0.807 . . . . 2.5 110.339 175.683 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.587 HG21 ' CE1' ' A' ' 104' ' ' PHE . 77.3 t -94.65 150.19 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.451 -0.944 . . . . 2.2200000000000002 108.451 169.874 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.73 -173.91 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.693 1.597 . . . . 2.4399999999999999 110.191 168.545 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.9 p -126.32 72.87 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-O 122.95 1.357 . . . . 2.75 108.375 178.032 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 136.23 -7.17 4.03 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 113.686 -1.597 . . . . 2.1499999999999999 113.615 174.511 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 56.6 m -63.37 -21.26 66.17 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.827 1.314 . . . . 1.0900000000000001 112.653 177.343 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 29.0 tpp -56.65 121.98 11.0 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.174 -0.676 . . . . 2.0699999999999998 109.174 171.455 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.8 m -125.12 131.22 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 107.627 -1.249 . . . . 0.60999999999999999 107.627 166.784 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.436 ' HB2' HG12 ' A' ' 80' ' ' VAL . 0.9 OUTLIER -121.87 142.61 50.08 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.7 1.2 . . . . 4.04 108.917 -175.251 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.87 154.16 58.12 Favored Pre-proline 0 CA--C 1.532 0.257 0 N-CA-C 109.859 -0.423 . . . . 2.8700000000000001 109.859 176.357 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -63.51 -30.44 71.46 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.965 2.443 . . . . 2.29 110.803 172.71 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -43.04 -41.18 3.38 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.865 1.666 . . . . 2.7000000000000002 110.354 177.716 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.2 m 88.49 -1.06 0.42 Allowed 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 127.159 2.184 . . . . 1.55 113.272 176.451 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.27 25.49 9.47 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.08 0.855 . . . . 2.8900000000000001 112.384 173.83 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -144.58 114.78 7.49 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.32 -1.363 . . . . 1.3700000000000001 107.32 175.234 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.436 HG12 ' HB2' ' A' ' 73' ' ' ARG . 34.0 m -138.44 141.68 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 106.351 -1.722 . . . . 1.04 106.351 172.814 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -137.64 155.52 49.06 Favored 'General case' 0 C--O 1.233 0.189 0 O-C-N 121.745 -0.597 . . . . 0.82999999999999996 109.479 173.818 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -154.75 159.36 40.61 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.709 -0.478 . . . . 2.0899999999999999 109.709 -171.371 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.421 ' HB1' ' HG2' ' A' ' 91' ' ' GLU . . . -109.03 136.44 48.54 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.696 -0.853 . . . . 0.69999999999999996 108.696 -177.81 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.4 t -122.65 135.5 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 123.726 0.811 . . . . 2.0499999999999998 109.04 179.955 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -132.63 160.8 35.61 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 125.74 1.616 . . . . 1.54 109.568 -178.123 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -104.04 13.77 31.91 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.699 -0.626 . . . . 2.9199999999999999 110.997 176.325 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.1 t 54.02 27.51 7.58 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.207 1.003 . . . . 3.7000000000000002 111.93 -174.392 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.07 -66.66 0.94 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.722 1.209 . . . . 4.9400000000000004 108.467 175.768 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 173.86 57.89 0.05 OUTLIER Glycine 0 C--N 1.335 0.502 0 N-CA-C 111.223 -0.751 . . . . 2.8999999999999999 111.223 -179.824 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 175.13 136.69 2.33 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 108.307 -1.917 . . . . 1.48 108.307 175.917 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.421 ' HG2' ' HB1' ' A' ' 83' ' ' ALA . 37.0 tt0 -132.76 119.51 20.42 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.45 1.5 . . . . 4.1799999999999997 107.687 -177.741 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -98.29 154.08 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 123.971 0.908 . . . . 1.4199999999999999 108.83 -179.643 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 18.6 mt -100.25 120.57 40.12 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.385 0.674 . . . . 0.79000000000000004 111.28 176.979 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 89.2 t -97.16 136.46 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 125.656 1.582 . . . . 1.23 108.684 173.172 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.4 p -112.74 145.09 41.14 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.547 1.139 . . . . 0.72999999999999998 108.388 174.846 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.453 ' CE2' ' HA ' ' A' ' 125' ' ' THR . 7.8 t80 -144.27 100.13 3.49 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.72 -0.844 . . . . 2.1699999999999999 108.72 -175.618 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -84.69 53.49 2.71 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.951 1.3 . . . . 2.3599999999999999 111.252 -176.985 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -169.65 -173.53 1.66 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.954 1.702 . . . . 3.2799999999999998 108.114 173.512 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.9 mp -78.21 131.72 37.27 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.385 1.074 . . . . 1.76 111.239 171.462 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.423 HD21 ' CD2' ' A' ' 96' ' ' TYR . 24.2 mt -81.19 155.03 72.4 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.051 0.94 . . . . 1.1299999999999999 111.006 172.225 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -61.74 141.72 91.53 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.09 2.527 . . . . 2.2999999999999998 109.401 172.673 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 48.64 27.37 1.47 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.145 1.778 . . . . 2.7400000000000002 113.163 177.064 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.1 tp 56.92 11.55 0.98 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.249 1.02 . . . . 3.2599999999999998 112.397 -172.924 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.587 ' CE1' HG21 ' A' ' 66' ' ' VAL . 18.1 t80 56.66 84.07 0.09 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.269 1.427 . . . . 2.5800000000000001 110.061 179.881 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.3 mtp-105 -78.3 124.4 28.05 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.295 -1.372 . . . . 4.8600000000000003 107.295 -174.043 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -79.94 175.32 10.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.077 0.465 . . . . 3.0800000000000001 110.645 -164.192 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.33 44.49 96.81 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 111.87 -0.492 . . . . 0.69999999999999996 111.87 -176.745 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -143.52 176.62 9.05 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 107.932 -1.136 . . . . 1.8400000000000001 107.932 169.517 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -100.35 145.83 17.41 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 110.514 -1.035 . . . . 0.78000000000000003 110.514 171.271 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.0 pp -149.94 166.31 2.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 105.936 -1.875 . . . . 0.77000000000000002 105.936 177.972 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 18.0 m -126.51 130.62 71.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 108.663 -0.866 . . . . 0.71999999999999997 108.663 170.948 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -117.55 135.19 54.12 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 124.988 1.315 . . . . 0.58999999999999997 109.785 -175.709 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -118.65 141.11 48.91 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.462 1.505 . . . . 3.2000000000000002 109.871 -178.239 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 168.14 -133.8 3.01 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 109.658 -1.377 . . . . 0.85999999999999999 109.658 170.757 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.2 151.83 31.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 117.823 0.811 . . . . 0.69999999999999996 110.865 -166.073 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.751 HD11 HG21 ' A' ' 48' ' ' THR . 4.1 mm? -65.8 144.25 56.97 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.105 -0.498 . . . . 2.27 111.404 175.564 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -119.68 115.57 3.05 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 126.945 2.212 . . . . 3.2400000000000002 108.011 175.324 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 58.91 35.22 24.07 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.399 0.68 . . . . 4.9900000000000002 111.656 169.779 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.476 ' CB ' ' HB2' ' A' ' 56' ' ' ALA . 2.0 t0 36.15 43.81 0.24 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.174 2.19 . . . . 4.9500000000000002 113.137 -170.153 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -159.96 -55.3 0.01 OUTLIER Glycine 0 C--N 1.339 0.709 0 O-C-N 121.648 -0.657 . . . . 1.2 111.79 -174.92 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -84.62 150.44 25.17 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 121.905 -0.762 . . . . 2.8399999999999999 109.107 175.961 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -108.41 113.66 26.89 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 108.784 -0.821 . . . . 2.1699999999999999 108.784 178.989 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -92.16 98.5 11.57 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 107.482 -1.303 . . . . 0.52000000000000002 107.482 178.114 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.52 97.57 3.98 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 112.797 0.666 . . . . 1.3300000000000001 112.797 -168.509 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.453 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 14.9 t -83.38 -26.29 30.58 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 122.825 0.45 . . . . 0.92000000000000004 112.213 -177.831 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -89.67 85.32 6.43 Favored 'General case' 0 CA--C 1.528 0.135 0 O-C-N 120.614 -1.304 . . . . 3.3700000000000001 109.35 -174.755 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.7 m -96.78 130.72 45.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 123.853 0.861 . . . . 0.81000000000000005 111.176 175.978 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -119.67 106.83 12.54 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.859 1.664 . . . . 0.80000000000000004 107.452 178.543 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.87 57.67 4.26 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.673 0.789 . . . . 1.2 111.488 -176.315 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 37.2 pttt -83.38 61.84 6.39 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.897 -0.502 . . . . 3.3900000000000001 111.614 -174.484 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -159.12 164.35 35.36 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 121.449 -0.782 . . . . 4.71 109.105 178.425 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.2 t70 . . . . . 0 N--CA 1.448 -0.558 0 C-N-CA 126.134 1.774 . . . . 7.2599999999999998 108.629 -173.028 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.8 t . . . . . 0 CA--C 1.538 0.49 0 N-CA-C 111.313 0.116 . . . . 6.9500000000000002 111.313 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -155.01 107.92 2.78 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.675 -0.64 . . . . 6.8700000000000001 110.304 -175.769 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -80.08 151.78 29.69 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.408 -0.59 . . . . 5.8399999999999999 109.408 171.387 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -158.44 70.62 0.54 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 119.267 -0.397 . . . . 3.4399999999999999 111.636 -169.72 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.78 164.31 14.84 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.133 0.973 . . . . 2.5099999999999998 112.472 -174.046 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.486 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 87.1 m-85 -91.96 102.57 15.14 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 125.376 1.47 . . . . 2.6200000000000001 110.289 177.479 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.713 ' CZ ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -100.49 -169.91 1.79 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.598 0.759 . . . . 8.5099999999999998 111.479 178.524 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 28.2 p -94.43 156.57 38.5 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 118.6 0.637 . . . . 1.79 110.709 -178.357 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.66 -14.7 33.46 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 121.5 1.467 . . . . 1.02 112.368 171.451 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 m -68.32 -25.53 65.17 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.087 -1.008 . . . . 2.0099999999999998 113.102 169.498 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.84 -58.16 8.28 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.901 0.858 . . . . 3.6099999999999999 109.942 -177.099 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.86 HD13 ' H ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -78.82 36.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 C-N-CA 126.651 1.98 . . . . 2.0600000000000001 113.042 -179.078 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 t -121.66 -37.3 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.325 1.05 . . . . 2.7000000000000002 110.901 157.765 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -81.57 -46.69 14.08 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 120.995 -1.066 . . . . 4.1200000000000001 112.781 -167.623 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.8 52.91 0.16 Allowed Glycine 0 C--N 1.336 0.53 0 N-CA-C 110.882 -0.887 . . . . 2.1200000000000001 110.882 -171.882 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -149.28 -162.43 1.56 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.863 2.865 . . . . 2.5499999999999998 106.028 178.159 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.6 m -29.09 -47.81 0.06 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 129.529 3.132 . . . . 1.6100000000000001 116.714 -170.018 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -41.59 -53.1 3.61 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.088 0.858 . . . . 3.1099999999999999 111.052 175.332 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 m -98.0 -23.49 15.76 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.444 -0.798 . . . . 1.3300000000000001 109.831 179.224 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.82 39.38 85.72 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.258 0.933 . . . . 0.97999999999999998 111.659 174.305 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.1 m -87.18 -29.58 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 112.722 0.638 . . . . 1.27 112.722 -171.94 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.6 mttp -118.19 -62.23 0.03 OUTLIER Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 125.358 1.463 . . . . 4.7199999999999998 112.646 178.703 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -81.61 146.33 15.06 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 CA-C-N 121.242 1.479 . . . . 1.1899999999999999 108.606 172.92 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -107.13 158.53 17.01 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.578 -1.267 . . . . 2.79 107.578 170.04 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.1 154.04 35.75 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.362 -0.607 . . . . 1.3500000000000001 109.362 171.608 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.63 -2.67 45.77 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.933 0.777 . . . . 1.1699999999999999 112.781 -178.41 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.525 ' O ' HD12 ' A' ' 116' ' ' LEU . 76.3 mt-30 -95.48 160.61 14.44 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.253 1.027 . . . . 1.49 109.033 178.037 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.8 mtt180 -93.12 138.95 31.08 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.56 -0.533 . . . . 3.7599999999999998 109.56 167.709 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.575 HD12 ' CZ ' ' A' ' 38' ' ' TYR . 30.8 pt -150.59 177.89 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 106.61 -1.626 . . . . 0.66000000000000003 106.61 167.51 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.426 ' HB2' ' CD1' ' A' ' 37' ' ' PHE . 26.0 mtt180 -126.49 142.26 51.59 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.16 -0.681 . . . . 2.46 109.16 169.342 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.3 p -110.72 125.77 68.04 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.069 0 C-N-CA 124.727 1.211 . . . . 0.81000000000000005 108.893 178.879 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -120.35 111.76 2.04 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 110.194 -1.163 . . . . 0.73999999999999999 110.194 -179.803 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.18 -173.71 36.37 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.232 -0.747 . . . . 1.24 111.232 -173.603 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.429 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 4.3 ptp -118.19 137.54 52.93 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 124.308 1.043 . . . . 2.4100000000000001 111.715 -172.508 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.653 HG13 ' CE2' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -61.73 145.37 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 CA-C-N 116.369 -0.378 . . . . 2.6299999999999999 110.474 178.327 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 67' ' ' THR . 31.4 m -69.81 67.91 0.27 Allowed 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 109.207 -0.664 . . . . 3.1899999999999999 109.207 163.653 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.252 13.9 p 20.53 68.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.345 0 C-N-CA 129.812 3.245 . . . . 3.0499999999999998 114.361 161.902 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.69 50.69 1.01 Allowed Glycine 0 CA--C 1.527 0.79 0 CA-C-N 112.421 -2.172 . . . . 1.8799999999999999 110.799 -177.91 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.3 m -117.48 7.59 12.76 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 123.844 0.857 . . . . 1.1599999999999999 112.39 173.819 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 47.7 tpp -74.28 127.52 33.19 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.634 -0.876 . . . . 2.96 108.634 176.983 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.2 m -132.24 149.37 32.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 108.849 -0.797 . . . . 0.64000000000000001 108.849 167.306 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.517 ' CB ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -140.48 141.58 35.39 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.733 0.813 . . . . 5.6600000000000001 110.658 -171.593 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.31 154.37 84.17 Favored Pre-proline 0 N--CA 1.455 -0.192 0 CA-C-N 118.606 0.639 . . . . 2.2400000000000002 109.736 -179.867 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -63.03 -24.36 73.78 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.237 1.958 . . . . 1.3999999999999999 111.784 168.895 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -47.86 -30.83 4.42 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.389 0.676 . . . . 1.3600000000000001 110.731 166.804 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.3 m 63.91 29.82 14.42 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.794 1.238 . . . . 1.25 111.468 176.312 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.03 -48.91 1.47 Allowed 'General case' 0 C--O 1.232 0.135 0 C-N-CA 128.03 2.532 . . . . 2.1000000000000001 110.466 172.078 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -80.17 127.93 32.91 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.155 -1.054 . . . . 1.1299999999999999 108.155 -179.005 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.517 HG12 ' CB ' ' A' ' 73' ' ' ARG . 26.9 m -139.18 151.23 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.421 -1.325 . . . . 1.0700000000000001 107.421 172.033 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -148.95 156.59 42.51 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 122.027 -0.421 . . . . 1.21 110.191 174.798 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -155.89 133.99 11.4 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.116 -0.493 . . . . 1.8700000000000001 110.556 -169.867 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.52 129.4 35.09 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.163 0.585 . . . . 1.05 109.864 174.183 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.2 t -121.01 129.77 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 125.964 1.706 . . . . 1.8400000000000001 107.579 -177.693 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -106.13 172.46 6.8 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.672 0.789 . . . . 2.02 110.814 179.948 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -113.73 -72.43 0.7 Allowed 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.89 0.852 . . . . 3.9300000000000002 110.363 -174.965 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.0 t -168.15 -60.03 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.531 -1.655 . . . . 3.71 106.531 -171.02 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -91.01 -92.46 0.14 Allowed 'General case' 0 C--N 1.343 0.303 0 CA-C-N 117.492 0.133 . . . . 5.9800000000000004 111.298 178.808 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -124.55 15.6 7.57 Favored Glycine 0 C--N 1.336 0.578 0 N-CA-C 111.343 -0.703 . . . . 3.1699999999999999 111.343 -174.467 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -75.21 52.51 2.59 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 118.875 -0.958 . . . . 1.74 111.59 -178.919 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -86.72 105.15 16.75 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.059 -1.089 . . . . 2.75 108.059 175.161 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 92' ' ' ILE . 9.3 tp -109.98 156.22 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 108.838 -0.801 . . . . 1.24 108.838 176.763 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.8 mt -109.88 114.76 28.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.307 -1.368 . . . . 0.64000000000000001 107.307 -179.995 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.9 t -92.72 136.75 24.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 106.904 -1.517 . . . . 1.0800000000000001 106.904 173.75 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 80.4 p -116.86 154.74 30.24 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.051 -1.092 . . . . 0.93999999999999995 108.051 179.359 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.541 ' OH ' HG13 ' A' ' 127' ' ' VAL . 0.3 OUTLIER -148.74 145.45 27.63 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 124.634 1.174 . . . . 3.3799999999999999 108.292 -175.556 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -128.58 7.98 5.83 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.373 1.469 . . . . 2.3100000000000001 112.743 -179.574 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -134.45 55.89 1.87 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.701 1.201 . . . . 4.1799999999999997 110.297 176.872 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.0 mp 50.55 -145.69 0.46 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.097 0.959 . . . . 2.4500000000000002 109.979 178.794 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.7 mt -158.03 161.85 28.07 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 127.675 2.39 . . . . 1.4199999999999999 105.037 177.645 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.28 -89.9 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.632 2.888 . . . . 2.0299999999999998 109.901 175.356 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -68.45 19.33 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.562 1.545 . . . . 3.5800000000000001 114.072 -178.713 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 54.92 1.12 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 128.784 2.834 . . . . 2.0099999999999998 115.284 -166.145 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.653 ' CE2' HG13 ' A' ' 66' ' ' VAL . 1.2 t80 51.22 89.53 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.092 1.357 . . . . 3.6699999999999999 110.049 -164.774 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.61 147.13 39.82 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.362 -0.977 . . . . 4.6500000000000004 108.362 -176.304 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -84.68 109.67 18.19 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.85 0.86 . . . . 3.3900000000000001 111.665 -162.822 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.51 45.52 0.26 Allowed Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.58 1.085 . . . . 1.02 110.965 174.063 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -158.17 178.41 10.22 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 106.155 -1.795 . . . . 2.0499999999999998 106.155 177.348 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 65' ' ' MET . . . -127.98 142.26 13.36 Favored Glycine 0 C--N 1.335 0.502 0 CA-C-O 121.296 0.387 . . . . 0.93999999999999995 112.227 173.904 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.5 pp -133.7 164.35 35.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 106.45 -1.685 . . . . 0.82999999999999996 106.45 -172.406 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.486 ' HB ' ' CD1' ' A' ' 37' ' ' PHE . 34.1 m -115.59 124.43 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 108.148 -1.056 . . . . 0.68999999999999995 108.148 -178.348 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.432 ' HB2' HG12 ' A' ' 127' ' ' VAL . . . -119.95 142.41 48.76 Favored 'General case' 0 C--O 1.227 -0.12 0 C-N-CA 125.057 1.343 . . . . 0.65000000000000002 110.048 -167.875 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -139.32 144.55 38.33 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.34 1.056 . . . . 3.9300000000000002 110.531 -176.632 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 176.61 -120.36 0.74 Allowed Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 107.874 -2.09 . . . . 1.04 107.874 169.848 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.7 p -146.38 143.84 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 117.758 0.779 . . . . 0.82999999999999996 109.078 -172.602 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.526 HD11 HG12 ' A' ' 60' ' ' ILE . 4.0 mp -79.56 143.04 35.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 118.848 -0.596 . . . . 2.6800000000000002 109.432 176.377 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -165.49 29.83 0.21 Allowed Glycine 0 CA--C 1.525 0.681 0 C-N-CA 119.882 -1.152 . . . . 2.7799999999999998 113.802 -175.74 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -132.83 1.92 3.66 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.855 0.862 . . . . 5.1900000000000004 111.107 177.566 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.6 t0 53.21 52.7 13.13 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 122.652 1.215 . . . . 3.2599999999999998 109.888 -173.052 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 163.46 -59.36 0.27 Allowed Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.17 -1.172 . . . . 1.47 110.17 -175.302 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.71 170.59 8.24 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.965 0.906 . . . . 2.2599999999999998 110.009 -173.662 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.7 mp -118.82 130.4 55.75 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.778 1.231 . . . . 1.98 108.617 -171.928 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -97.38 99.08 10.52 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.15 -1.426 . . . . 0.53000000000000003 107.15 173.377 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.34 153.73 17.65 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.602 -0.518 . . . . 1.5 109.602 -179.618 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.414 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 9.7 t -135.54 -38.49 0.74 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.14 0.576 . . . . 1.1499999999999999 112.128 174.481 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -91.16 108.8 20.12 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.843 -1.161 . . . . 3.04 108.968 174.835 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.541 HG13 ' OH ' ' A' ' 96' ' ' TYR . 1.0 OUTLIER -113.9 141.19 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 119.003 0.82 . . . . 0.97999999999999998 110.34 169.338 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -120.92 116.92 26.05 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.762 1.225 . . . . 0.93000000000000005 107.949 179.622 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.55 62.16 1.68 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.139 0.975 . . . . 1.27 112.124 -173.872 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.71 53.83 2.83 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.472 0.709 . . . . 4.6600000000000001 112.245 -179.25 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.13 82.17 1.85 Allowed 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.711 -0.618 . . . . 4.4500000000000002 109.761 -179.729 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 . . . . . 0 N--CA 1.45 -0.426 0 C-N-CA 125.048 1.339 . . . . 5.3700000000000001 107.415 176.421 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.456 -0.155 0 N-CA-C 109.515 -0.55 . . . . 2.23 109.515 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -99.03 126.06 44.65 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.108 1.363 . . . . 2.3799999999999999 110.511 -172.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -133.27 153.98 51.09 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.148 1.379 . . . . 2.75 111.565 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.9 m -73.81 131.31 81.94 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.768 1.627 . . . . 2.1400000000000001 111.307 -177.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -56.04 -52.04 8.21 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.358 2.705 . . . . 0.81999999999999995 112.598 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.6 m -53.97 -35.89 62.29 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.831 0.852 . . . . 3.1400000000000001 112.382 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -62.57 -58.32 7.96 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.434 -0.58 . . . . 2.0899999999999999 109.434 173.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.4 pt -71.76 33.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 114.416 1.265 . . . . 1.3700000000000001 114.416 -177.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.6 t -111.99 -76.41 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 105.579 -2.008 . . . . 2.4100000000000001 105.579 161.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -64.38 101.3 0.42 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 126.633 1.973 . . . . 2.6600000000000001 111.328 -162.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.74 40.1 53.81 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.086 -1.206 . . . . 1.54 110.086 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -139.79 -105.3 0.16 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.279 1.431 . . . . 2.7999999999999998 107.815 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.405 HG23 ' N ' ' A' ' 49' ' ' ASP . 14.8 t -72.28 -53.84 11.28 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 120.0 1.273 . . . . 3.5899999999999999 109.49 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.405 ' N ' HG23 ' A' ' 48' ' ' THR . 0.8 OUTLIER -47.27 -48.69 24.63 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 124.902 1.281 . . . . 3.0800000000000001 109.507 -174.284 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.92 -5.09 42.24 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.137 -1.392 . . . . 1.4399999999999999 111.069 -173.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 48.15 47.44 26.97 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 126.362 1.934 . . . . 1.3200000000000001 114.371 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.7 m -98.64 -52.75 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 118.967 1.384 . . . . 1.21 113.696 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt -101.73 -68.72 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 124.0 0.92 . . . . 3.1200000000000001 112.117 -173.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -71.75 177.08 7.35 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 121.876 1.718 . . . . 1.53 108.56 167.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -155.3 158.48 38.84 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.822 -1.547 . . . . 3.2799999999999998 106.822 -175.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.32 125.02 24.79 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.696 -1.224 . . . . 1.24 107.696 174.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 138.67 -36.82 1.85 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 123.911 0.767 . . . . 1.4199999999999999 111.343 -172.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.93 143.52 29.8 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.086 0.943 . . . . 2.8599999999999999 110.617 -175.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -92.23 129.5 38.16 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.163 0.985 . . . . 5.7199999999999998 108.632 172.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.7 pt -140.43 177.95 3.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 107.495 -1.298 . . . . 0.88 107.495 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -121.13 123.02 41.29 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.241 -0.652 . . . . 3.0499999999999998 109.241 170.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.15 133.4 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 106.916 -1.513 . . . . 0.80000000000000004 106.916 171.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -137.57 120.43 2.06 Favored Glycine 0 CA--C 1.519 0.335 0 N-CA-C 109.422 -1.471 . . . . 0.54000000000000004 109.422 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -179.02 -169.36 39.49 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.243 -1.143 . . . . 0.67000000000000004 110.243 -173.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.9 ptp -102.01 133.16 47.26 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.095 0.558 . . . . 2.3999999999999999 111.076 -173.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.7 p -85.03 134.43 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.856 -0.794 . . . . 2.4199999999999999 108.856 175.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.5 150.0 29.81 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 122.194 0.997 . . . . 2.3500000000000001 108.775 176.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.0 p -48.68 -46.87 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.286 1.034 . . . . 1.8799999999999999 112.003 -175.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.87 21.85 42.63 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 119.283 -0.731 . . . . 1.6399999999999999 113.217 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.7 m -81.96 -36.05 28.38 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.92 1.36 . . . . 2.0099999999999998 113.179 -175.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.1 tmm? -75.96 125.48 29.19 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.595 -0.52 . . . . 1.75 109.595 -169.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.0 m -134.34 123.91 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.912 -0.773 . . . . 0.69999999999999996 108.912 170.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 36.0 ptt85 -100.7 152.79 20.04 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.382 1.073 . . . . 5.1600000000000001 109.8 175.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -77.16 159.38 78.21 Favored Pre-proline 0 C--O 1.238 0.47 0 N-CA-C 109.439 -0.578 . . . . 2.1899999999999999 109.439 167.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -63.89 -26.73 67.04 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.134 2.556 . . . . 1.3899999999999999 111.009 165.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -40.91 -44.91 2.42 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 124.409 1.084 . . . . 1.1599999999999999 109.47 165.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.8 m 73.86 12.17 4.41 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.324 1.45 . . . . 1.53 113.041 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.25 -30.83 6.18 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.5 1.52 . . . . 1.8600000000000001 110.866 168.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -93.45 132.16 37.98 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.599 -1.259 . . . . 1.1200000000000001 107.599 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.78 141.49 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 107.868 -1.16 . . . . 0.83999999999999997 107.868 -174.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -144.34 154.03 42.6 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.654 -0.869 . . . . 0.81000000000000005 108.654 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -146.81 142.96 28.25 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.806 -0.634 . . . . 2.1499999999999999 109.723 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.05 144.86 27.34 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.657 -0.868 . . . . 0.56999999999999995 108.657 168.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.88 145.02 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 108.973 -0.751 . . . . 1.78 108.973 177.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.5 p80 -142.71 -177.34 5.26 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.626 0.77 . . . . 1.3300000000000001 111.012 -169.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.9 t70 . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 108.339 -0.986 . . . . 2.3500000000000001 108.339 173.622 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 106.252 -2.739 . . . . 1.6200000000000001 106.252 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -120.48 129.54 53.9 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.348 -1.353 . . . . 3.23 107.348 -177.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.18 137.98 42.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 106.664 -1.606 . . . . 1.03 106.664 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 mt -90.38 133.2 35.15 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.467 0.707 . . . . 0.56000000000000005 109.451 176.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.6 t -119.28 135.51 59.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 125.168 1.387 . . . . 0.93999999999999995 107.695 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.6 p -112.25 146.68 37.75 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.647 0.779 . . . . 0.63 109.414 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -146.02 136.39 23.93 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.891 1.276 . . . . 1.96 108.267 -171.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -125.18 37.17 4.44 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.821 1.248 . . . . 2.02 112.667 -164.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -158.9 179.44 9.08 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.402 1.881 . . . . 2.8700000000000001 106.245 167.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.3 mp -67.91 128.96 38.45 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 120.708 -1.245 . . . . 1.8899999999999999 110.75 177.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.9 mt -71.1 148.56 94.26 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 123.481 0.712 . . . . 1.1399999999999999 110.836 176.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -62.44 139.16 75.09 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.003 2.469 . . . . 2.4300000000000002 109.173 173.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 50.58 29.01 3.77 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.581 1.152 . . . . 3.2799999999999998 112.119 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 36.8 tp 59.99 6.79 1.0 Allowed 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.043 -1.036 . . . . 3.27 112.359 -174.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.9 t80 59.24 88.67 0.07 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.714 1.606 . . . . 3.21 109.97 -170.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -73.86 136.97 43.47 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 106.776 -1.564 . . . . 4.79 106.776 -174.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.2 mp0 -84.33 168.62 15.46 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 123.165 0.586 . . . . 3.0299999999999998 110.052 -171.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 62.06 47.04 92.63 Favored Glycine 0 CA--C 1.531 1.084 0 O-C-N 121.925 -0.484 . . . . 0.84999999999999998 112.916 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -146.67 177.74 8.85 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.873 1.269 . . . . 2.48 108.644 171.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -117.92 116.63 3.51 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.268 -0.733 . . . . 1.05 111.268 177.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.2 pp -117.95 168.62 9.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 125.45 1.5 . . . . 0.92000000000000004 108.557 -174.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 30.8 m -117.09 139.89 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 108.165 -1.05 . . . . 0.69999999999999996 108.165 166.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.417 ' CB ' HG12 ' A' ' 127' ' ' VAL . . . -126.03 126.13 43.77 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.132 1.373 . . . . 0.56000000000000005 108.569 178.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -98.91 133.97 42.44 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.872 -1.159 . . . . 3.3599999999999999 107.872 175.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -162.34 170.81 38.06 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 110.812 -0.915 . . . . 1.74 110.812 -175.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.4 p -111.87 136.95 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 108.315 -0.994 . . . . 1.1599999999999999 108.315 173.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.626 ' HG ' HD22 ' A' ' 122' ' ' LEU . 6.4 mp -72.1 125.09 26.4 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.073 -1.084 . . . . 2.4500000000000002 108.073 176.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -140.77 -28.52 0.19 Allowed Glycine 0 CA--C 1.526 0.746 0 CA-C-O 119.501 -0.611 . . . . 2.0299999999999998 113.336 -169.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -115.86 49.27 1.12 Allowed 'General case' 0 C--O 1.239 0.525 0 CA-C-N 118.446 1.123 . . . . 5.9900000000000002 108.148 -164.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 40.9 t0 12.16 70.01 0.01 OUTLIER 'General case' 0 C--N 1.341 0.205 0 C-N-CA 130.144 3.378 . . . . 3.0099999999999998 112.161 -177.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 134.52 -36.15 2.12 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 114.574 -1.194 . . . . 1.01 112.097 -172.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.608 ' C ' HD23 ' A' ' 122' ' ' LEU . 0.1 OUTLIER -110.41 155.32 22.35 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 118.178 0.989 . . . . 3.2200000000000002 109.203 174.151 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.626 HD22 ' HG ' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -116.78 130.6 56.82 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 124.648 1.218 . . . . 2.1600000000000001 108.074 -175.736 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -92.08 111.73 23.39 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.505 -1.294 . . . . 0.70999999999999996 107.505 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -126.81 132.62 50.97 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 123.795 0.838 . . . . 1.03 109.525 -176.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.3 t -122.05 -20.52 6.26 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.35 0.66 . . . . 0.77000000000000002 112.114 175.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -96.31 82.74 3.46 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 120.488 -1.383 . . . . 3.73 107.727 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.417 HG12 ' CB ' ' A' ' 112' ' ' ALA . 31.8 m -97.53 125.72 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.281 0.632 . . . . 0.68999999999999995 110.324 173.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -114.78 102.36 9.93 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.742 -1.207 . . . . 0.69999999999999996 107.742 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.05 56.37 3.46 Favored 'General case' 0 CA--C 1.53 0.212 0 O-C-N 121.76 -0.587 . . . . 1.1899999999999999 110.908 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.87 55.39 0.69 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 122.98 0.512 . . . . 4.54 111.251 175.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 3.0 p80 . . . . . 0 C--O 1.228 -0.067 0 O-C-N 121.241 -0.912 . . . . 7.7000000000000002 109.875 -178.711 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.199 0 CA-C-O 120.375 0.131 . . . . 3.2799999999999998 110.717 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -88.37 115.53 25.94 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.147 0.979 . . . . 2.6299999999999999 109.261 -177.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -120.82 155.61 33.7 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.608 1.163 . . . . 3.1499999999999999 109.503 175.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.8 p -85.57 146.85 45.13 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 123.787 0.835 . . . . 1.6599999999999999 110.25 174.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -59.96 -44.23 31.51 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.369 2.713 . . . . 0.67000000000000004 111.85 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 p -39.29 -57.39 1.37 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.548 1.539 . . . . 2.4100000000000001 111.369 174.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.423 ' OE2' ' NZ ' ' A' ' 47' ' ' LYS . 2.4 tt0 -58.09 -54.51 46.19 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.294 -0.866 . . . . 2.2599999999999998 110.1 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.339 26.4 pt -65.28 -12.05 12.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 114.701 1.371 . . . . 1.1699999999999999 114.701 -173.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 82.1 t -75.79 -38.28 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 123.596 0.758 . . . . 1.8999999999999999 111.217 166.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -106.7 92.63 4.18 Favored 'General case' 0 C--N 1.335 -0.06 0 O-C-N 120.999 -1.063 . . . . 2.1699999999999999 111.121 -160.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.81 47.02 58.03 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.907 -1.277 . . . . 1.4299999999999999 109.907 174.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.423 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 12.1 mmtp -156.49 -155.39 0.53 Allowed 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 128.849 2.859 . . . . 2.2000000000000002 105.822 -172.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.2 m -37.07 -55.57 0.94 Allowed 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 127.389 2.276 . . . . 1.6000000000000001 114.319 -174.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -38.48 -46.86 1.21 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.214 0.916 . . . . 2.4100000000000001 112.626 176.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.24 -4.29 25.96 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.495 1.118 . . . . 1.6599999999999999 111.387 -173.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 54.64 30.23 50.73 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.644 1.592 . . . . 0.97999999999999998 113.815 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.7 m -86.1 -29.52 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 118.585 1.193 . . . . 1.6899999999999999 113.124 -172.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -121.41 -71.94 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 124.161 0.984 . . . . 5.9400000000000004 112.084 -176.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -66.08 128.63 19.99 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 N-CA-C 107.472 -1.78 . . . . 1.1499999999999999 107.472 167.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.09 168.8 17.37 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.761 -0.829 . . . . 3.5600000000000001 108.761 169.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.48 175.94 6.55 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.691 -0.855 . . . . 1.6599999999999999 108.691 163.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.99 -87.75 0.47 Allowed Glycine 0 C--O 1.22 -0.749 1 N-CA-C 100.346 -5.102 . . . . 3.29 100.346 -150.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -98.93 169.99 9.05 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 105.619 -1.993 . . . . 1.3300000000000001 105.619 -81.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -84.72 122.13 28.66 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 118.025 -0.988 . . . . 3.2000000000000002 108.69 176.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.6 pt -148.91 175.63 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 107.195 -1.409 . . . . 0.64000000000000001 107.195 171.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -121.02 127.58 51.89 Favored 'General case' 0 CA--C 1.527 0.06 0 N-CA-C 108.824 -0.806 . . . . 1.8 108.824 168.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.2 p -93.46 123.92 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 107.523 -1.288 . . . . 0.85999999999999999 107.523 170.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -124.16 123.57 5.2 Favored Glycine 0 C--N 1.332 0.354 0 N-CA-C 109.862 -1.295 . . . . 0.52000000000000002 109.862 -177.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -174.75 -171.22 38.71 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 110.379 -1.088 . . . . 0.60999999999999999 110.379 -176.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 6.3 ptp -94.35 135.0 36.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.125 -0.695 . . . . 2.4100000000000001 109.125 177.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.445 HG12 ' H ' ' A' ' 68' ' ' VAL . 78.9 t -59.76 133.86 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 123.229 0.612 . . . . 1.9399999999999999 110.27 177.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.88 -9.49 55.05 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.16 1.17 . . . . 3.4700000000000002 114.16 -172.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.445 ' H ' HG12 ' A' ' 66' ' ' VAL 0.28 9.1 p 50.43 47.62 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 123.917 1.818 . . . . 3.25 112.551 175.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 178.98 40.48 0.07 OUTLIER Glycine 0 CA--C 1.527 0.811 0 CA-C-N 112.429 -2.169 . . . . 2.5499999999999998 111.919 169.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.4 m -150.41 1.92 0.47 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.89 1.441 . . . . 2.4700000000000002 114.89 175.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.0 tpt -72.69 97.15 2.13 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.922 1.237 . . . . 1.74 108.347 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.9 m -116.69 140.45 39.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.533 -0.914 . . . . 0.56000000000000005 108.533 174.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.22 149.86 50.84 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.268 1.027 . . . . 4.71 109.225 -176.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -75.86 153.92 85.01 Favored Pre-proline 0 N--CA 1.454 -0.23 0 N-CA-C 109.789 -0.449 . . . . 2.23 109.789 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -62.52 -25.56 75.78 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.303 2.002 . . . . 1.4199999999999999 111.055 165.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -44.27 -37.03 3.01 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.824 0.85 . . . . 1.4099999999999999 110.626 165.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.6 m 72.5 24.17 2.95 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.62 1.568 . . . . 1.5 112.489 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.47 -48.25 2.07 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 125.506 1.522 . . . . 2.2000000000000002 110.366 169.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -75.41 130.21 38.6 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.774 -0.825 . . . . 1.3300000000000001 108.774 -177.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.582 HG23 ' HB3' ' A' ' 96' ' ' TYR . 16.6 m -142.44 131.04 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 125.191 1.397 . . . . 0.78000000000000003 107.308 -176.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -139.0 146.57 41.05 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 121.806 -0.559 . . . . 0.90000000000000002 109.537 177.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -149.46 160.61 43.31 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.117 0.567 . . . . 1.8500000000000001 109.782 -168.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -115.52 138.55 50.92 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.42 -0.585 . . . . 0.63 109.42 174.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.9 p -127.3 137.78 56.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.202 -1.036 . . . . 1.96 108.202 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -130.68 174.26 10.1 Favored 'General case' 0 CA--C 1.522 -0.122 0 C-N-CA 124.46 1.104 . . . . 1.6200000000000001 110.309 -175.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.2 t0 . . . . . 0 CA--C 1.534 0.339 0 C-N-CA 123.321 0.649 . . . . 2.7400000000000002 109.926 -179.164 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.544 0 N-CA-C 108.299 -1.92 . . . . 1.6499999999999999 108.299 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -120.88 151.32 39.81 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.731 1.212 . . . . 3.1099999999999999 109.219 174.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.22 160.01 12.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 107.702 -1.221 . . . . 0.91000000000000003 107.702 173.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.2 mt -118.2 124.42 47.88 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.133 0.973 . . . . 0.96999999999999997 108.729 -172.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.7 t -114.0 138.41 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 125.609 1.564 . . . . 0.87 108.16 -173.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.7 p -112.54 155.07 24.96 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.642 1.177 . . . . 0.52000000000000002 108.603 173.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.582 ' HB3' HG23 ' A' ' 80' ' ' VAL . 1.4 t80 -151.84 132.5 13.98 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.447 -1.686 . . . . 2.98 106.447 175.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -104.15 1.04 30.28 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.175 1.39 . . . . 2.7000000000000002 113.121 -173.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -120.38 166.85 12.98 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 124.931 1.293 . . . . 3.02 108.79 167.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.8 mp -63.06 144.37 56.96 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.765 0.793 . . . . 1.6699999999999999 111.2 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.488 HD23 HG21 ' A' ' 127' ' ' VAL . 8.3 mt -72.25 162.28 74.56 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 124.562 1.145 . . . . 1.1899999999999999 110.146 171.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.21 -95.34 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.853 3.036 . . . . 2.1899999999999999 109.333 173.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -76.15 44.95 0.34 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.524 1.13 . . . . 3.0 111.061 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.4 tp 60.82 -11.12 0.05 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.856 1.663 . . . . 3.1499999999999999 114.87 -177.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 44.7 t80 64.57 88.36 0.1 Allowed 'General case' 0 C--N 1.343 0.288 0 C-N-CA 125.157 1.383 . . . . 2.8599999999999999 107.958 -161.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.62 134.34 38.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.782 -1.562 . . . . 4.1299999999999999 106.782 175.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.5 mp0 -82.05 147.89 28.89 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 123.559 0.744 . . . . 2.7799999999999998 109.729 -171.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.89 47.82 23.7 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 111.671 -0.571 . . . . 0.73999999999999999 111.671 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -138.16 178.37 7.18 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 107.056 -1.461 . . . . 2.3500000000000001 107.056 168.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -105.29 134.19 11.94 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.909 -0.876 . . . . 0.67000000000000004 110.909 171.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.82 160.01 37.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 108.673 -0.862 . . . . 0.62 108.673 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.8 m -116.91 120.54 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 107.873 -1.158 . . . . 0.59999999999999998 107.873 170.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -113.77 115.85 28.45 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.762 1.225 . . . . 0.59999999999999998 109.385 -173.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -116.29 140.58 49.18 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.475 1.11 . . . . 3.6099999999999999 109.809 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -170.35 -104.87 0.18 Allowed Glycine 0 C--N 1.335 0.504 0 N-CA-C 107.408 -2.277 . . . . 1.4199999999999999 107.408 166.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.5 p -156.12 148.47 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 107.339 -1.356 . . . . 0.91000000000000003 107.339 176.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.592 ' HG ' HD12 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -63.29 150.42 43.28 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 119.028 -1.069 . . . . 2.3999999999999999 109.986 175.165 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -105.79 -92.03 2.25 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 110.514 -1.034 . . . . 2.0600000000000001 110.514 -171.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -73.42 -68.81 0.47 Allowed 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.887 -1.523 . . . . 4.6299999999999999 106.887 175.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -163.12 -71.18 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.211 -1.403 . . . . 4.7199999999999998 107.211 164.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.47 -23.57 72.0 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.347 0.975 . . . . 1.3999999999999999 113.184 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -95.58 119.89 34.87 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.221 1.011 . . . . 2.7400000000000002 108.706 173.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.592 HD12 ' HG ' ' A' ' 116' ' ' LEU . 0.1 OUTLIER -98.66 131.22 45.01 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 108.955 -0.757 . . . . 2.3999999999999999 108.955 -176.693 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -89.98 93.74 9.52 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 107.784 -1.191 . . . . 0.60999999999999999 107.784 177.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -99.97 151.76 20.97 Favored 'General case' 0 C--N 1.337 0.065 0 CA-C-N 117.856 0.298 . . . . 1.1399999999999999 110.319 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.7 t -140.12 -44.42 0.42 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 122.933 0.493 . . . . 1.48 111.66 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -82.4 84.43 7.16 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.032 -1.47 . . . . 2.9100000000000001 107.032 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.488 HG21 HD23 ' A' ' 100' ' ' LEU . 4.0 m -96.58 94.73 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.834 1.654 . . . . 1.21 110.274 178.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.57 121.64 35.19 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.81 -0.811 . . . . 0.62 108.81 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.16 62.54 1.81 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.189 0.996 . . . . 1.3 111.41 -174.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.42 -24.14 59.29 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.417 0.895 . . . . 3.9900000000000002 113.417 -172.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 . . . . . 0 CA--C 1.539 0.539 0 CA-C-O 119.073 -0.489 . . . . 5.2400000000000002 112.129 178.73 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 N--CA 1.466 0.341 0 N-CA-C 112.087 0.403 . . . . 2.3599999999999999 112.087 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -84.25 120.54 26.35 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 124.467 1.107 . . . . 2.2200000000000002 109.729 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.92 156.96 41.8 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.607 0.763 . . . . 2.7799999999999998 112.378 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 m -86.6 124.46 69.46 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 126.074 1.75 . . . . 2.27 112.811 -167.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . 2.256 0.1 OUTLIER -6.37 -72.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.151 1 C-N-CA 128.016 5.811 . . . . 1.55 118.345 161.31 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.5 m -70.5 -29.4 65.91 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 113.996 -1.456 . . . . 2.5899999999999999 113.186 -173.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -62.57 -56.44 17.86 Favored 'General case' 0 C--N 1.335 -0.041 0 N-CA-C 108.898 -0.779 . . . . 3.1299999999999999 108.898 -177.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 33.1 pt -59.39 -16.15 9.43 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 114.265 1.209 . . . . 1.6499999999999999 114.265 -174.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.6 t -73.19 -38.39 54.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 124.759 1.224 . . . . 2.0899999999999999 111.071 172.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -104.7 85.89 2.39 Favored 'General case' 0 C--N 1.333 -0.118 0 O-C-N 121.127 -0.983 . . . . 2.0299999999999998 110.783 -159.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.17 51.38 18.18 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.138 -1.185 . . . . 1.3899999999999999 110.138 174.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.9 mmtt -150.18 -124.15 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.423 -1.325 . . . . 2.52 107.423 -171.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.1 m -59.19 -58.45 8.59 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.929 1.292 . . . . 1.53 110.414 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -36.81 -51.84 0.9 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 122.709 1.242 . . . . 3.23 111.12 178.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.83 -11.95 37.81 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 113.577 -1.647 . . . . 1.4399999999999999 111.328 -169.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 54.26 35.37 55.15 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 126.197 1.856 . . . . 1.1799999999999999 112.649 -177.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.8 m -92.92 -22.4 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 118.032 0.916 . . . . 1.3799999999999999 112.715 -174.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.5 mmpp? -124.36 -78.93 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 125.343 1.457 . . . . 4.3399999999999999 111.11 174.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.22 149.47 35.85 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 CA-C-N 120.95 1.375 . . . . 1.1100000000000001 109.375 173.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -112.92 156.46 22.94 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.309 1.844 . . . . 2.6800000000000002 108.675 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.35 160.98 2.77 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.595 0.712 . . . . 1.22 110.958 168.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.77 -12.7 62.83 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 121.705 -0.622 . . . . 1.4099999999999999 112.385 -176.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -82.57 154.69 24.87 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 118.436 1.118 . . . . 2.6000000000000001 109.325 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 74.2 mtt-85 -96.06 132.48 41.38 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.45 -0.944 . . . . 5.1299999999999999 108.45 170.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.6 pt -145.97 177.47 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 105.839 -1.912 . . . . 0.69999999999999996 105.839 165.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 -117.27 135.37 53.87 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 105.973 -1.862 . . . . 1.96 105.973 173.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.4 p -103.84 136.26 37.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 107.361 -1.348 . . . . 1.3 107.361 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.82 120.16 1.59 Allowed Glycine 0 C--N 1.334 0.422 0 N-CA-C 110.777 -0.929 . . . . 0.63 110.777 -176.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -172.15 -163.12 25.51 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 109.309 -1.516 . . . . 0.66000000000000003 109.309 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.2 ptm -102.87 135.0 45.35 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.54 0.736 . . . . 4.1699999999999999 109.511 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 p -98.54 135.32 33.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 109.863 -0.421 . . . . 2.46 109.863 175.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.1 m -68.63 151.72 46.33 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 122.243 1.02 . . . . 2.3599999999999999 108.826 169.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.8 p -61.42 -66.24 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 114.718 -1.128 . . . . 2.4399999999999999 111.218 -174.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -81.86 40.8 2.67 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 120.8 -1.187 . . . . 1.6899999999999999 112.713 -172.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.6 m -108.87 -28.1 9.35 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 117.82 0.81 . . . . 1.55 112.705 -172.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.447 ' SD ' ' HB3' ' A' ' 104' ' ' PHE . 0.8 OUTLIER -79.22 103.11 8.93 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.74 0.7 . . . . 1.8400000000000001 110.087 -175.063 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.6 m -100.27 147.52 7.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 107.811 -1.181 . . . . 0.67000000000000004 107.811 175.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.42 ' CB ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -142.85 137.51 29.65 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.427 0.691 . . . . 6.4199999999999999 109.829 -165.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.19 153.88 94.95 Favored Pre-proline 0 N--CA 1.452 -0.327 0 N-CA-C 109.607 -0.516 . . . . 2.0499999999999998 109.607 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -65.51 -25.63 55.25 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.218 1.946 . . . . 1.54 111.306 165.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -48.94 -29.98 5.4 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.934 0.494 . . . . 1.4199999999999999 110.831 164.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.1 m 67.43 23.68 9.04 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 125.362 1.465 . . . . 1.54 112.114 173.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.38 -44.28 1.72 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 127.875 2.47 . . . . 1.77 110.757 177.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -84.39 129.08 34.9 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 107.692 -1.225 . . . . 1.1799999999999999 107.692 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.42 HG12 ' CB ' ' A' ' 73' ' ' ARG . 20.1 m -147.43 145.72 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.174 -1.417 . . . . 0.71999999999999997 107.174 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -150.65 154.92 38.35 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.599 -0.688 . . . . 1.1100000000000001 111.48 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -155.14 138.0 15.36 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 123.404 0.682 . . . . 1.8700000000000001 111.573 -173.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.622 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . . . -84.04 124.33 30.97 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.296 -0.631 . . . . 0.84999999999999998 109.296 176.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 t -108.4 147.62 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 124.267 1.027 . . . . 1.76 108.835 173.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -144.91 178.92 7.67 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.024 -1.102 . . . . 1.4399999999999999 108.024 177.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.4 t0 . . . . . 0 CA--C 1.532 0.264 0 CA-C-O 122.1 0.952 . . . . 2.8399999999999999 109.711 175.727 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.66 0 N-CA-C 108.582 -1.807 . . . . 1.8100000000000001 108.582 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -136.41 145.11 44.92 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.625 -1.991 . . . . 3.2799999999999998 105.625 174.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -126.67 158.28 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.013 -1.847 . . . . 1.3100000000000001 106.013 175.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.622 ' HA ' ' HA ' ' A' ' 83' ' ' ALA 0.442 2.9 mt -107.69 117.49 34.25 Favored 'General case' 0 CA--C 1.545 0.77 1 N-CA-C 123.136 4.495 . . . . 0.90000000000000002 123.136 164.394 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.1 t -86.52 141.29 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 107.331 -1.359 . . . . 0.87 107.331 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.2 p -120.86 149.6 42.35 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.595 1.158 . . . . 0.92000000000000004 107.959 -176.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.41 ' OH ' HG13 ' A' ' 127' ' ' VAL . 0.4 OUTLIER -145.65 142.25 28.88 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.588 1.155 . . . . 3.29 108.031 -176.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -115.29 14.33 16.83 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.275 1.43 . . . . 2.54 111.649 171.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -117.69 163.38 16.56 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 124.449 1.1 . . . . 4.71 110.618 170.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.8 mp -67.84 113.14 5.33 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.342 -0.845 . . . . 1.95 109.202 163.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.8 mt -62.18 156.09 61.5 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.067 0.947 . . . . 1.46 110.246 171.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -68.07 147.69 74.0 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 123.651 2.901 . . . . 2.23 110.767 174.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 41.55 49.44 3.63 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.376 1.47 . . . . 2.98 111.629 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 44.89 22.01 0.06 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 127.089 2.156 . . . . 2.29 115.326 -174.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.447 ' HB3' ' SD ' ' A' ' 71' ' ' MET . 67.1 t80 51.0 110.94 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.125 2.17 . . . . 2.52 110.764 -159.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.5 mmt85 -77.75 112.7 14.87 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.251 -1.388 . . . . 5.0700000000000003 107.251 -176.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -82.36 172.75 12.72 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.416 0.627 . . . . 3.3999999999999999 111.005 -170.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 62.26 43.67 98.76 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 121.861 -0.525 . . . . 0.89000000000000001 112.61 171.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -157.16 176.88 12.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.092 1.357 . . . . 2.4700000000000002 108.101 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -93.31 140.37 15.03 Favored Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 109.893 -1.283 . . . . 0.56999999999999995 109.893 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.5 pp -148.01 165.15 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.999 -1.482 . . . . 0.69999999999999996 106.999 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.25 135.89 60.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 108.373 -0.973 . . . . 0.78000000000000003 108.373 174.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.569 ' HB2' HG12 ' A' ' 127' ' ' VAL . . . -128.39 152.87 47.69 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 126.285 1.834 . . . . 0.67000000000000004 110.071 -170.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -147.95 155.13 41.22 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 119.439 1.018 . . . . 2.9199999999999999 113.13 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 175.62 -89.07 0.08 OUTLIER Glycine 0 C--N 1.345 1.054 0 CA-C-O 119.728 -0.485 . . . . 2.1699999999999999 112.473 172.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.7 p -164.24 148.78 2.76 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 C-N-CA 124.351 1.061 . . . . 1.3600000000000001 109.677 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.479 HD22 HD22 ' A' ' 122' ' ' LEU . 5.1 mt -90.91 141.74 28.51 Favored 'General case' 0 N--CA 1.453 -0.275 0 O-C-N 122.087 -0.383 . . . . 2.5699999999999998 110.69 -177.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -131.67 158.28 22.74 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 109.132 -1.587 . . . . 3.6299999999999999 109.132 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 55.52 33.76 21.72 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.934 1.294 . . . . 4.3300000000000001 110.629 169.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 27.25 45.06 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 128.194 2.597 . . . . 4.0599999999999996 112.173 -165.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -176.37 -48.2 0.06 OUTLIER Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.07 -1.062 . . . . 1.4199999999999999 113.487 -164.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -91.66 114.25 26.73 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 118.502 1.151 . . . . 2.6299999999999999 109.001 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.479 HD22 HD22 ' A' ' 116' ' ' LEU . 5.8 mt -87.62 114.47 24.27 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 106.742 -1.577 . . . . 1.8400000000000001 106.742 -174.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -88.04 98.45 11.53 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.325 -1.361 . . . . 0.56000000000000005 107.325 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -101.86 159.17 15.57 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.84 -0.43 . . . . 1.6799999999999999 109.84 -178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.402 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 7.1 t -136.05 -41.76 0.66 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.233 0.613 . . . . 1.1399999999999999 111.787 174.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -92.84 129.84 38.63 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 120.921 -1.112 . . . . 4.1200000000000001 108.367 175.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.569 HG12 ' HB2' ' A' ' 112' ' ' ALA . 1.2 m -127.47 140.07 50.15 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 C-N-CA 124.23 1.012 . . . . 1.0900000000000001 109.37 168.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -114.22 87.48 2.64 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.374 -1.343 . . . . 1.3400000000000001 107.374 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.44 57.35 2.36 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.613 1.165 . . . . 1.1899999999999999 110.952 -174.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -79.02 47.69 0.79 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.272 1.029 . . . . 3.3799999999999999 112.95 -169.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 . . . . . 0 CA--C 1.533 0.312 0 C-N-CA 124.402 1.081 . . . . 4.8899999999999997 110.071 -177.014 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 pt? . . . . . 0 N--CA 1.465 0.285 0 N-CA-C 111.873 0.323 . . . . 1.99 111.873 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -82.62 121.21 26.53 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.672 1.189 . . . . 2.3100000000000001 110.219 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -128.27 145.36 51.07 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.422 1.089 . . . . 3.3399999999999999 110.872 177.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 91.5 m -69.24 127.5 92.91 Favored Pre-proline 0 N--CA 1.45 -0.437 0 C-N-CA 126.44 1.896 . . . . 1.74 110.115 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -57.57 -41.68 68.76 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.036 1.824 . . . . 1.24 111.995 -175.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.4 m -47.17 -43.02 20.83 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.71 1.141 . . . . 1.9299999999999999 113.39 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -60.74 -40.63 93.14 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.363 -0.606 . . . . 3.52 109.363 178.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 40.5 pt -102.69 35.22 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.867 1.667 . . . . 1.95 111.847 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -114.98 -31.25 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 119.322 0.965 . . . . 2.2400000000000002 111.535 176.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -117.22 126.19 52.36 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.433 1.093 . . . . 3.23 108.112 -175.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.03 -69.9 0.79 Allowed Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.623 1.106 . . . . 4.7999999999999998 111.66 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -30.93 -89.07 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.571 0 C-N-CA 129.639 3.175 . . . . 2.4399999999999999 111.645 175.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.4 m -71.33 -51.0 26.68 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 119.48 1.036 . . . . 1.5700000000000001 109.69 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -33.03 -50.23 0.27 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 128.307 2.643 . . . . 3.1099999999999999 114.707 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.2 m -127.76 15.28 6.96 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.15 2.18 . . . . 3.5600000000000001 109.171 -175.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 51.89 39.22 47.62 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-O 117.382 -1.788 . . . . 1.4299999999999999 113.989 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.2 m -84.42 -45.13 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 121.843 2.822 . . . . 1.1699999999999999 112.421 -169.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -92.76 -57.37 0.23 Allowed Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 125.128 1.371 . . . . 3.3999999999999999 113.383 178.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -75.84 179.88 5.84 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.323 2.016 . . . . 1.5800000000000001 108.418 172.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -135.43 128.14 30.96 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 106.716 -1.587 . . . . 5.6600000000000001 106.716 -176.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.38 125.76 24.92 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.905 -0.776 . . . . 1.3600000000000001 108.905 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.18 -11.46 19.88 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 119.179 -0.789 . . . . 1.1200000000000001 113.021 -175.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -83.4 146.21 28.57 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 119.124 1.462 . . . . 2.5099999999999998 109.332 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -86.91 139.33 30.73 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.79 -0.641 . . . . 4.5199999999999996 109.998 167.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.4 pt -148.7 172.27 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 107.124 -1.436 . . . . 0.80000000000000004 107.124 171.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.6 mtt180 -114.19 110.0 19.29 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 106.825 -1.546 . . . . 1.99 106.825 174.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.3 p -79.26 127.74 38.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.299 -1.371 . . . . 0.93000000000000005 107.299 175.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.54 114.87 1.51 Allowed Glycine 0 C--N 1.335 0.487 0 N-CA-C 110.191 -1.164 . . . . 0.69999999999999996 110.191 -177.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.05 -173.22 29.41 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.154 -1.178 . . . . 0.81000000000000005 110.154 -175.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.1 ptp -101.08 126.64 47.79 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 124.027 0.931 . . . . 2.98 110.234 -176.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 108' ' ' GLN . 29.0 m -89.58 157.51 3.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 109.843 -0.428 . . . . 2.4900000000000002 109.843 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.8 -172.57 2.69 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.591 -0.277 . . . . 3.0800000000000001 110.26 176.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.3 p -116.98 71.98 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 126.937 2.095 . . . . 2.8799999999999999 106.958 174.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.65 63.82 0.09 OUTLIER Glycine 0 CA--C 1.53 0.975 0 C-N-CA 126.671 2.081 . . . . 1.8500000000000001 111.311 -178.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.7 m -146.12 64.55 1.22 Allowed 'General case' 0 CA--C 1.519 -0.238 0 O-C-N 121.243 -1.151 . . . . 2.0499999999999998 110.642 163.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.14 115.81 18.27 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.381 -1.34 . . . . 2.1800000000000002 107.381 176.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.6 m -125.15 127.72 72.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 108.363 -0.977 . . . . 0.69999999999999996 108.363 170.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.47 149.84 29.73 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.444 1.098 . . . . 4.9800000000000004 110.421 175.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -86.58 150.49 51.19 Favored Pre-proline 0 C--O 1.235 0.339 0 N-CA-C 109.002 -0.74 . . . . 1.9399999999999999 109.002 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.45 28.9 0.37 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.89 2.393 . . . . 2.3300000000000001 112.961 173.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -89.44 -27.63 20.26 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.329 1.052 . . . . 1.3799999999999999 108.847 166.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.506 ' O ' HD13 ' A' ' 99' ' ' LEU . 8.5 m 69.95 12.29 7.83 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 125.594 1.558 . . . . 1.7 112.177 -172.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.45 32.04 3.39 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.918 1.287 . . . . 2.3199999999999998 113.36 170.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -153.48 131.86 12.05 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 121.827 -0.545 . . . . 1.1399999999999999 109.927 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.98 146.3 16.26 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 C-N-CA 123.666 0.786 . . . . 1.04 110.409 -172.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -152.74 156.91 40.04 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 120.659 -1.276 . . . . 0.93999999999999995 110.989 175.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -155.44 160.21 40.44 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.257 0.623 . . . . 1.8600000000000001 110.645 -173.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.94 139.34 39.79 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.5 -0.926 . . . . 0.60999999999999999 108.5 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.6 p -125.34 143.76 37.78 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.063 0 N-CA-C 107.87 -1.159 . . . . 1.8700000000000001 107.87 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -124.29 -171.04 2.25 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.63 1.172 . . . . 1.6599999999999999 109.814 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.0 t70 . . . . . 0 C--O 1.233 0.192 0 N-CA-C 110.244 -0.28 . . . . 2.6600000000000001 110.244 174.59 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.342 0 CA-C-O 119.04 -0.867 . . . . 2.5800000000000001 113.41 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -66.79 96.15 0.39 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.042 0.921 . . . . 2.8399999999999999 110.213 -173.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.456 HD12 HD12 ' A' ' 122' ' ' LEU . 0.3 OUTLIER -121.84 140.49 45.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 107.828 -1.175 . . . . 1.45 107.828 179.099 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.451 ' H ' HD13 ' A' ' 92' ' ' ILE . 4.2 mt -90.18 124.89 35.22 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.452 1.101 . . . . 0.65000000000000002 110.048 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.1 t -106.0 119.89 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 125.082 1.353 . . . . 0.85999999999999999 107.578 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 65.5 p -98.69 144.06 28.37 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.173 0.589 . . . . 0.59999999999999998 109.668 175.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.406 ' CE2' HD23 ' A' ' 100' ' ' LEU . 1.9 t80 -137.89 143.13 40.71 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.721 1.608 . . . . 2.5299999999999998 107.411 -173.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -85.94 -82.43 0.19 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.132 0.973 . . . . 3.1200000000000001 109.764 175.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -62.29 166.83 4.6 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.455 0.645 . . . . 3.3599999999999999 111.382 -168.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.506 HD13 ' O ' ' A' ' 77' ' ' SER . 1.4 mp -60.66 131.78 51.81 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 119.998 -1.689 . . . . 3.3999999999999999 111.685 175.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.406 HD23 ' CE2' ' A' ' 96' ' ' TYR . 26.7 mt -60.61 158.02 33.72 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 114.559 -1.201 . . . . 1.4399999999999999 109.757 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -67.9 -85.11 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.234 2.623 . . . . 2.29 111.145 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -122.83 52.09 1.37 Allowed 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 124.76 1.224 . . . . 3.0 108.749 -172.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 34.63 41.75 0.06 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.73 1.612 . . . . 3.6800000000000002 113.096 -173.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 40.7 p90 31.48 74.56 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.34 1.856 . . . . 4.0800000000000001 112.151 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.488 ' H ' ' HD3' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -60.29 125.36 23.39 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 119.854 -1.779 . . . . 6.9699999999999998 110.177 -124.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -72.19 143.74 48.77 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 119.826 -0.749 . . . . 4.8099999999999996 109.882 -153.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.14 22.22 23.2 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.675 1.607 . . . . 1.46 113.591 -172.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.452 ' O ' HG22 ' A' ' 66' ' ' VAL . 2.2 pt20 -137.43 178.68 6.91 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 119.519 1.66 . . . . 3.1600000000000001 110.604 178.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -92.71 128.1 9.27 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.997 -0.441 . . . . 1.0800000000000001 111.997 170.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.3 pp -131.18 159.85 42.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 124.901 1.28 . . . . 0.69999999999999996 107.915 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.1 m -113.82 140.25 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.67 -1.233 . . . . 1.02 107.67 175.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -129.68 123.5 31.31 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.063 0.945 . . . . 0.72999999999999998 109.606 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.549 ' HB2' ' HB2' ' A' ' 126' ' ' GLU . 3.8 mt-30 -107.24 136.68 46.66 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 126.065 1.746 . . . . 4.0899999999999999 109.855 -175.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 168.69 -142.4 7.38 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 108.745 -1.742 . . . . 0.91000000000000003 108.745 172.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.4 p -123.97 153.0 29.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 C-N-CA 124.507 1.123 . . . . 1.22 109.949 -170.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -54.59 137.95 42.2 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.373 -0.531 . . . . 1.97 110.507 168.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -86.89 -146.45 10.23 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 109.716 -1.354 . . . . 2.3599999999999999 109.716 175.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -72.34 109.08 5.81 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.408 -1.701 . . . . 5.4100000000000001 106.408 172.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -6.17 72.56 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.347 1 C-N-CA 132.678 4.391 . . . . 3.6499999999999999 112.835 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 154.41 -45.74 0.55 Allowed Glycine 0 CA--C 1.523 0.534 0 CA-C-N 113.679 -1.601 . . . . 1.1599999999999999 111.381 -172.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.92 163.76 13.37 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.509 0.654 . . . . 2.73 111.576 177.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.456 HD12 HD12 ' A' ' 92' ' ' ILE . 11.8 mt -123.11 130.27 52.56 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.627 1.171 . . . . 1.9199999999999999 108.387 176.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -103.75 106.24 16.69 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 108.38 -0.97 . . . . 0.75 108.38 176.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -131.86 126.14 33.51 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 123.075 0.55 . . . . 1.1799999999999999 110.95 -176.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.9 t -113.67 -24.41 9.21 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.407 1.083 . . . . 1.1699999999999999 111.367 178.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 113' ' ' GLN . 36.7 mt-10 -86.62 78.79 9.09 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 119.662 -1.898 . . . . 3.4300000000000002 108.141 178.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.427 ' C ' HD13 ' A' ' 128' ' ' LEU . 34.0 m -91.9 130.88 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 119.333 0.97 . . . . 0.85999999999999999 110.959 174.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.427 HD13 ' C ' ' A' ' 127' ' ' VAL . 0.0 OUTLIER -126.37 127.67 45.86 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.213 -1.032 . . . . 1.2 108.213 178.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.14 97.41 9.18 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.236 1.414 . . . . 1.3100000000000001 108.972 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.1 pttt -93.5 23.9 4.31 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.456 0.702 . . . . 3.8100000000000001 112.096 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 . . . . . 0 N--CA 1.452 -0.341 0 C-N-CA 125.262 1.425 . . . . 4.4100000000000001 107.272 173.5 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.469 0.518 0 N-CA-C 112.438 0.532 . . . . 2.1699999999999999 112.438 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -86.19 117.73 25.2 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 125.374 1.47 . . . . 2.21 111.436 -174.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -116.89 151.64 36.16 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 127.207 2.203 . . . . 3.4100000000000001 109.519 -175.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 57.8 m -90.54 136.43 28.18 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.27 1.428 . . . . 1.8400000000000001 109.611 -175.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -61.98 -48.32 8.74 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.025 2.483 . . . . 0.73999999999999999 112.879 -174.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 p -53.75 -36.06 61.94 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.973 0.806 . . . . 1.96 111.948 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -54.74 -57.67 10.6 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.316 1.046 . . . . 2.4199999999999999 109.098 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.306 8.3 pt -70.0 1.68 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 114.352 1.242 . . . . 1.1899999999999999 114.352 -172.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.4 t -85.64 -28.73 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.8 1.24 . . . . 2.1099999999999999 111.09 170.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -128.57 93.54 3.66 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.964 -1.085 . . . . 2.2000000000000002 112.344 -160.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.45 37.75 53.15 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.516 -1.034 . . . . 1.3300000000000001 110.516 176.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.4 -153.87 0.5 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.786 2.834 . . . . 2.6600000000000001 103.371 178.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.2 m -28.97 -58.16 0.14 Allowed 'General case' 0 C--N 1.339 0.118 0 C-N-CA 126.905 2.082 . . . . 1.3500000000000001 115.444 -172.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -44.48 -47.84 10.05 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.586 0.754 . . . . 2.5800000000000001 112.272 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.6 m -93.51 -23.59 18.3 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.757 0.823 . . . . 1.3600000000000001 111.409 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.95 35.6 84.7 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.984 1.278 . . . . 0.98999999999999999 112.381 176.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.7 m -82.08 -39.45 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 117.525 0.662 . . . . 1.25 111.816 -175.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -105.81 -63.03 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 124.482 1.113 . . . . 4.0999999999999996 111.116 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -80.93 142.16 13.71 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 CA-C-N 121.07 1.418 . . . . 1.2 109.369 171.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -90.53 154.35 19.69 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.279 1.031 . . . . 2.8500000000000001 109.484 167.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.58 140.73 49.93 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.114 -1.069 . . . . 1.53 108.114 169.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 105.51 16.84 14.8 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.073 0.844 . . . . 1.23 113.36 -176.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -112.73 154.38 26.25 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.746 1.219 . . . . 1.3999999999999999 109.785 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.41 ' NH1' ' OE2' ' A' ' 126' ' ' GLU . 0.3 OUTLIER -84.84 127.45 34.15 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.868 0.867 . . . . 4.5499999999999998 109.085 173.11 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.9 pt -144.52 177.78 1.85 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 106.554 -1.647 . . . . 0.70999999999999996 106.554 166.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.3 mtm180 -122.77 122.67 39.28 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.754 -1.202 . . . . 2.2599999999999998 107.754 173.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.1 p -87.75 132.98 31.6 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 N-CA-C 107.282 -1.377 . . . . 0.94999999999999996 107.282 173.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -135.75 120.63 2.31 Favored Glycine 0 C--N 1.334 0.421 0 N-CA-C 109.89 -1.284 . . . . 0.70999999999999996 109.89 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.39 -166.32 31.55 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.314 -1.115 . . . . 0.81999999999999995 110.314 -175.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.16 130.83 51.91 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.168 0.508 . . . . 2.9900000000000002 111.462 -174.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.6 t -76.29 130.65 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 124.267 1.027 . . . . 2.1699999999999999 108.527 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.621 HG22 HG12 ' A' ' 68' ' ' VAL . 12.6 m -49.27 -85.43 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.294 1.838 . . . . 2.9100000000000001 114.581 -170.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.621 HG12 HG22 ' A' ' 67' ' ' THR . 9.1 p 174.45 -40.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 126.093 1.757 . . . . 2.0899999999999999 109.276 -171.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -151.8 38.2 0.81 Allowed Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.214 -1.155 . . . . 1.8100000000000001 110.214 175.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 57.1 m -94.74 -8.61 37.16 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 117.923 0.861 . . . . 1.03 112.221 178.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 52.8 tpp -65.52 128.89 37.75 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.794 -0.817 . . . . 2.5800000000000001 108.794 172.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.5 m -127.43 141.79 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 N-CA-C 107.425 -1.324 . . . . 0.62 107.425 164.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.76 135.13 48.77 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.43 -0.952 . . . . 4.79 108.43 -172.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -82.27 152.4 67.67 Favored Pre-proline 0 C--O 1.235 0.298 0 N-CA-C 109.851 -0.426 . . . . 2.1099999999999999 109.851 -176.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -70.97 3.87 3.07 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.114 2.543 . . . . 1.49 112.346 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -70.81 -33.65 70.93 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.503 -0.554 . . . . 1.27 109.503 168.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.1 m 73.63 9.51 4.93 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.405 1.482 . . . . 1.2 113.452 -173.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.27 16.56 9.08 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.583 1.553 . . . . 1.7 111.323 172.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -143.79 125.96 15.54 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.178 -1.045 . . . . 1.23 108.178 -177.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.08 140.16 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.993 1.317 . . . . 1.05 107.712 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -140.32 153.82 46.57 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.879 -0.513 . . . . 0.94999999999999996 109.813 172.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -153.27 146.19 24.47 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.43 -0.35 . . . . 2.0 110.808 -170.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.3 125.66 39.08 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.382 -0.599 . . . . 0.67000000000000004 109.382 175.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.3 t -106.65 132.72 53.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 107.063 -1.458 . . . . 1.78 107.063 176.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -115.53 -178.28 3.35 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.236 0.614 . . . . 1.8799999999999999 111.329 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.0 t0 . . . . . 0 N--CA 1.445 -0.719 0 C-N-CA 124.101 0.96 . . . . 3.5800000000000001 110.98 177.227 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.622 0 N-CA-C 110.658 -0.977 . . . . 1.6599999999999999 110.658 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -115.75 150.5 36.78 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.237 1.015 . . . . 2.7999999999999998 110.413 -174.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.49 152.95 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 107.967 -1.123 . . . . 0.94999999999999996 107.967 178.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.0 mt -100.58 121.77 42.15 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.312 -0.996 . . . . 0.52000000000000002 108.312 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.7 t -107.09 133.34 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 107.437 -1.32 . . . . 0.85999999999999999 107.437 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 82.2 p -107.46 149.49 27.88 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.531 -0.915 . . . . 0.56999999999999995 108.531 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.548 ' CD2' HD21 ' A' ' 100' ' ' LEU . 11.2 t80 -146.65 126.9 13.87 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.026 -1.101 . . . . 2.4399999999999999 108.026 -173.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -113.85 46.62 1.29 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.003 1.321 . . . . 2.0600000000000001 111.745 -165.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -166.75 -179.64 4.9 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.847 2.059 . . . . 3.3599999999999999 106.286 169.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.4 mp -67.68 131.38 45.47 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.399 1.0 . . . . 1.8700000000000001 111.145 172.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.548 HD21 ' CD2' ' A' ' 96' ' ' TYR . 16.2 mt -83.55 155.29 65.8 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.485 1.114 . . . . 1.6299999999999999 110.579 174.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.62 112.44 2.4 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.954 2.436 . . . . 2.8500000000000001 109.538 175.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 39.74 47.7 1.81 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.011 1.724 . . . . 5.8300000000000001 111.504 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 48.76 13.52 0.06 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 127.782 2.433 . . . . 3.3799999999999999 116.374 -178.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 51.49 114.29 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 122.226 1.012 . . . . 4.6399999999999997 109.987 -148.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -74.16 100.63 3.71 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 104.837 -2.282 . . . . 5.25 104.837 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -71.94 157.55 37.63 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 119.776 -0.77 . . . . 5.0800000000000001 110.965 -148.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.09 37.87 6.6 Favored Glycine 0 CA--C 1.531 1.09 0 N-CA-C 110.608 -0.997 . . . . 0.89000000000000001 110.608 -167.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -138.2 162.21 34.85 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.773 1.229 . . . . 2.6600000000000001 108.896 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -102.3 129.79 10.01 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 110.476 -1.05 . . . . 0.85999999999999999 110.476 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.5 pp -140.56 161.22 24.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 108.208 -1.034 . . . . 0.87 108.208 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.3 m -114.45 141.66 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.091 -1.078 . . . . 1.0800000000000001 108.091 174.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -127.34 116.9 21.21 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.602 1.161 . . . . 0.77000000000000002 108.7 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -101.12 149.38 24.02 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.135 -0.691 . . . . 3.8799999999999999 109.135 175.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 162.11 -140.84 6.83 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 107.451 -2.26 . . . . 0.82999999999999996 107.451 173.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.5 p -136.04 142.94 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 118.084 0.942 . . . . 0.76000000000000001 109.996 -164.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.86 162.32 29.64 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.456 -0.793 . . . . 2.0299999999999998 109.99 173.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -169.73 -52.35 0.03 OUTLIER Glycine 0 C--N 1.332 0.351 0 C-N-CA 119.951 -1.119 . . . . 2.1899999999999999 111.726 166.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -67.0 141.25 57.65 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.55 -0.908 . . . . 4.3700000000000001 108.55 174.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.08 64.8 0.54 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 128.651 2.78 . . . . 4.46 110.299 -171.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 128.51 8.22 4.04 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.635 2.064 . . . . 1.1699999999999999 113.368 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.16 153.9 51.82 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.539 1.67 . . . . 2.3100000000000001 109.885 177.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.3 mp -121.69 134.7 54.96 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.348 1.059 . . . . 2.0499999999999998 109.714 -166.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.68 101.3 12.15 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.388 -1.338 . . . . 0.52000000000000002 107.388 177.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -127.52 83.27 2.15 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 112.211 0.449 . . . . 1.72 112.211 -166.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.485 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 14.6 t -83.01 -22.25 33.66 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.959 0.726 . . . . 0.84999999999999998 112.959 -174.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.41 ' OE2' ' NH1' ' A' ' 59' ' ' ARG . 20.6 mt-10 -83.5 75.11 10.04 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 120.445 -1.409 . . . . 4.4800000000000004 107.981 -176.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.0 m -92.33 131.16 40.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 O-C-N 121.527 -0.733 . . . . 1.1399999999999999 111.534 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.28 124.33 44.35 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.031 -1.47 . . . . 1.02 107.031 176.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -94.31 124.8 38.56 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.258 -1.016 . . . . 2.3900000000000001 108.258 175.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -153.56 58.14 0.75 Allowed 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.594 0.758 . . . . 4.2300000000000004 109.92 -176.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 4.9 p80 . . . . . 0 N--CA 1.454 -0.231 0 C-N-CA 125.229 1.412 . . . . 6.7199999999999998 107.932 179.81 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 pt? . . . . . 0 CA--C 1.531 0.222 0 N-CA-C 111.361 0.134 . . . . 2.21 111.361 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.435 ' CE1' ' HD2' ' A' ' 61' ' ' ARG . 80.0 m-85 -83.83 123.15 29.61 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.106 1.362 . . . . 2.2400000000000002 110.954 -175.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.03 156.03 43.39 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.393 1.477 . . . . 2.9199999999999999 110.954 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.3 139.58 52.25 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 123.125 0.57 . . . . 2.48 111.311 -175.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.38 -35.0 99.18 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.63 2.22 . . . . 0.82999999999999996 113.45 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -57.19 -29.31 63.58 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 119.988 1.267 . . . . 3.02 112.056 176.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -67.55 -56.98 7.33 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.244 -1.021 . . . . 2.3199999999999998 108.244 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.0 pt -74.17 36.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.025 1.33 . . . . 1.1399999999999999 113.175 -174.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 43.1 t -123.38 -68.68 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 105.757 -1.942 . . . . 2.04 105.757 168.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -79.0 102.5 8.37 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.266 1.826 . . . . 2.2599999999999998 110.728 -164.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.9 32.89 74.01 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.408 -1.077 . . . . 1.5700000000000001 110.408 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -140.32 -110.83 0.15 Allowed 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 126.44 1.896 . . . . 2.75 108.341 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.44 HG23 HD12 ' A' ' 116' ' ' LEU . 29.6 m -73.83 -56.68 4.67 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 119.147 0.885 . . . . 1.53 112.177 -172.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -58.55 -46.89 85.91 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 122.135 0.969 . . . . 2.8500000000000001 109.068 -174.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -68.16 -35.9 78.79 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.8 -0.637 . . . . 1.3999999999999999 112.345 173.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.29 47.68 42.63 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.977 1.275 . . . . 1.3799999999999999 111.882 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.251 32.6 m -112.89 -70.39 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 113.984 1.105 . . . . 1.6499999999999999 113.984 -174.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.7 mttt -73.14 -62.22 1.31 Allowed Pre-proline 0 CA--C 1.535 0.403 0 O-C-N 121.4 -0.813 . . . . 4.8399999999999999 112.101 -172.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.36 111.65 2.64 Favored 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 121.867 1.711 . . . . 1.1000000000000001 107.684 175.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -62.03 148.68 43.24 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.101 -0.703 . . . . 3.2599999999999998 109.101 172.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.61 162.68 10.15 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.842 -0.617 . . . . 1.21 110.409 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.91 14.37 82.24 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 119.672 -0.516 . . . . 1.02 113.387 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -93.75 158.94 15.42 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-N 118.284 1.042 . . . . 1.46 109.433 172.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -98.38 135.37 40.07 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.448 0.699 . . . . 4.9100000000000001 110.425 174.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.2 pt -150.53 178.47 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 125.821 1.649 . . . . 0.72999999999999998 106.798 174.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.435 ' HD2' ' CE1' ' A' ' 37' ' ' PHE . 13.5 mtt180 -123.52 131.96 53.78 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.682 -1.229 . . . . 1.8899999999999999 107.682 165.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.2 p -92.07 140.75 15.62 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.08 0 N-CA-C 107.359 -1.348 . . . . 0.93000000000000005 107.359 171.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.19 124.37 2.41 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.002 -1.239 . . . . 0.62 110.002 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -169.3 -163.53 23.49 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 108.622 -1.791 . . . . 0.69999999999999996 108.622 -175.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.71 139.43 38.97 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 117.358 0.579 . . . . 2.8500000000000001 109.585 -178.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.5 m -94.24 148.98 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 110.229 -0.286 . . . . 2.3900000000000001 110.229 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.9 m -84.61 146.34 27.55 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.255 1.022 . . . . 2.3100000000000001 109.17 175.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.1 p -49.74 -57.43 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.489 1.516 . . . . 2.0600000000000001 111.44 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.75 71.96 0.49 Allowed Glycine 0 CA--C 1.522 0.521 0 N-CA-C 109.386 -1.486 . . . . 1.5700000000000001 109.386 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.6 m -153.01 48.38 0.71 Allowed 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 117.738 0.769 . . . . 2.3999999999999999 111.936 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.1 ttp -141.08 132.7 27.13 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.589 -1.634 . . . . 2.3799999999999999 106.589 168.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.7 m -135.51 144.28 34.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 107.334 -1.358 . . . . 0.78000000000000003 107.334 173.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -127.46 149.92 49.89 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 123.974 0.91 . . . . 4.2800000000000002 110.541 -174.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.59 154.25 83.61 Favored Pre-proline 0 N--CA 1.451 -0.403 0 N-CA-C 109.93 -0.396 . . . . 2.9399999999999999 109.93 175.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -65.32 -24.03 58.27 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.445 2.097 . . . . 1.48 111.601 167.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -47.56 -28.81 2.45 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.509 0.724 . . . . 1.6599999999999999 110.735 165.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.3 m 64.84 25.98 12.89 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 125.081 1.352 . . . . 1.1599999999999999 111.472 175.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.24 -46.23 1.36 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.758 2.423 . . . . 1.8600000000000001 111.127 176.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -83.29 136.35 34.41 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.628 -0.879 . . . . 1.3700000000000001 108.628 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.653 HG21 ' HG ' ' A' ' 100' ' ' LEU . 19.7 m -147.25 143.54 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 107.068 -1.456 . . . . 0.77000000000000002 107.068 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -144.05 154.62 43.43 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.22 -0.659 . . . . 0.88 109.22 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -148.35 151.62 35.65 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.761 -0.654 . . . . 1.8500000000000001 109.887 -173.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.81 142.01 30.88 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.049 -1.093 . . . . 0.72999999999999998 108.049 171.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.0 p -130.38 149.59 33.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 107.112 -1.44 . . . . 1.8899999999999999 107.112 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -130.46 167.22 18.98 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.4 0.619 . . . . 1.55 109.546 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.1 t70 . . . . . 0 N--CA 1.444 -0.765 0 CA-C-N 114.779 -1.1 . . . . 3.6800000000000002 109.028 -177.285 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.807 0 N-CA-C 111.14 -0.784 . . . . 3.1299999999999999 111.14 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 35.64 58.05 0.89 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.298 1.839 . . . . 4.25 111.317 -176.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -112.24 157.06 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 124.464 1.106 . . . . 1.5 109.087 -169.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.3 mt -118.44 125.6 50.3 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.832 0.853 . . . . 0.67000000000000004 109.49 -173.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 75.7 t -114.26 133.28 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.791 1.236 . . . . 0.91000000000000003 107.954 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 61.3 p -108.79 155.47 20.74 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.497 1.119 . . . . 0.45000000000000001 110.204 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.643 ' HB3' HG23 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -153.48 136.85 15.79 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.504 -1.295 . . . . 1.97 107.504 -174.431 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.8 p-10 -128.94 49.87 2.19 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.564 1.545 . . . . 2.2200000000000002 112.57 -172.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -171.72 52.43 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.982 0.913 . . . . 2.9900000000000002 111.533 178.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.9 mp 52.69 -147.41 0.47 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.877 1.271 . . . . 2.0099999999999998 110.417 -172.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.653 ' HG ' HG21 ' A' ' 80' ' ' VAL . 13.7 mt -150.28 158.16 36.52 Favored Pre-proline 0 N--CA 1.454 -0.226 0 N-CA-C 105.811 -1.922 . . . . 1.47 105.811 -176.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -71.27 -94.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.433 2.755 . . . . 2.0 107.923 172.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -77.4 38.17 0.23 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.554 1.142 . . . . 3.7799999999999998 110.306 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 19.8 tp 52.37 23.19 2.34 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.825 -1.172 . . . . 2.8599999999999999 112.716 -177.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 76.9 t80 53.9 84.05 0.07 Allowed 'General case' 0 N--CA 1.465 0.283 0 O-C-N 120.618 -1.301 . . . . 2.8700000000000001 109.076 -171.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -75.86 123.14 25.18 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.94 -1.133 . . . . 5.3799999999999999 107.94 -171.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -84.17 156.26 22.16 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 126.046 1.739 . . . . 3.6800000000000002 110.482 -169.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.49 33.3 43.85 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 123.757 0.694 . . . . 0.97999999999999998 112.267 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -156.08 178.9 9.75 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.802 1.241 . . . . 2.9900000000000002 108.138 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -85.43 147.64 22.41 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.685 -0.966 . . . . 0.83999999999999997 110.685 166.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.9 pp -140.23 162.5 24.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 105.618 -1.993 . . . . 0.70999999999999996 105.618 166.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.3 m -125.0 135.27 64.62 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.132 0 N-CA-C 109.055 -0.72 . . . . 0.80000000000000004 109.055 173.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -122.84 125.73 45.98 Favored 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 124.842 1.257 . . . . 0.56999999999999995 109.919 -170.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -115.83 143.58 45.21 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.958 1.303 . . . . 3.8900000000000001 110.126 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 168.79 -131.4 2.29 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 107.576 -2.21 . . . . 0.92000000000000004 107.576 173.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.8 p -128.17 150.03 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 124.701 1.2 . . . . 1.03 109.752 -171.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.44 HD12 HG23 ' A' ' 48' ' ' THR . 4.1 mm? -55.89 143.44 31.65 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.161 -0.681 . . . . 1.98 109.161 170.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.69 -150.62 10.6 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.208 -1.157 . . . . 2.3599999999999999 110.208 -178.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -63.14 -67.15 0.45 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.264 0.625 . . . . 5.2999999999999998 110.021 -174.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -166.45 98.62 0.59 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.759 -1.571 . . . . 3.7000000000000002 106.759 -178.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 109.59 -41.27 2.28 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.378 0.99 . . . . 1.1499999999999999 111.199 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -82.79 161.73 21.91 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.252 1.021 . . . . 2.8500000000000001 110.662 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 mp -128.56 140.05 51.99 Favored 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 124.25 1.02 . . . . 2.25 108.3 174.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -107.9 108.96 20.35 Favored 'General case' 0 CA--C 1.527 0.083 0 N-CA-C 107.924 -1.139 . . . . 0.83999999999999997 107.924 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -134.82 109.33 8.46 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.274 0.488 . . . . 1.3200000000000001 111.705 -171.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.7 t -96.66 -34.24 11.46 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.957 0.903 . . . . 0.92000000000000004 111.656 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.3 mp0 -83.45 89.96 7.13 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 119.863 -1.773 . . . . 3.46 108.168 175.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.4 m -96.89 124.68 49.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 123.446 0.698 . . . . 0.78000000000000003 109.743 171.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -115.68 110.71 19.53 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.02 1.328 . . . . 0.71999999999999997 107.797 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.47 61.4 6.57 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.121 0.968 . . . . 1.28 110.62 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -22.72 67.05 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.712 1.004 . . . . 2.7400000000000002 113.712 -173.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 . . . . . 0 CA--C 1.528 0.113 0 C-N-CA 123.846 0.858 . . . . 5.5800000000000001 110.113 -177.926 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.4 pt? . . . . . 0 C--O 1.232 0.15 0 N-CA-C 108.924 -0.769 . . . . 2.7000000000000002 108.924 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -88.7 131.79 34.87 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.696 0.798 . . . . 2.04 109.619 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -138.34 155.77 48.25 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.003 1.321 . . . . 2.6299999999999999 110.833 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.2 m -80.57 131.16 62.04 Favored Pre-proline 0 N--CA 1.447 -0.621 0 C-N-CA 125.53 1.532 . . . . 1.77 111.048 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -57.02 -46.47 28.77 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 123.026 2.484 . . . . 0.68000000000000005 112.328 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.7 t -54.41 -32.86 58.2 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 122.865 0.466 . . . . 2.4700000000000002 111.419 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.27 -58.5 8.23 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.55 -0.908 . . . . 3.0899999999999999 108.55 172.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.259 30.7 pt -73.19 28.8 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 114.017 1.118 . . . . 1.1699999999999999 114.017 -172.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -118.62 -27.53 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.508 1.123 . . . . 2.1499999999999999 111.986 160.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 -83.95 -68.62 0.7 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.599 1.09 . . . . 2.4700000000000002 112.389 -163.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.02 54.25 0.59 Allowed Glycine 0 C--N 1.333 0.408 0 N-CA-C 108.668 -1.773 . . . . 1.5700000000000001 108.668 -174.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -148.98 -109.64 0.07 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.641 1.976 . . . . 2.9700000000000002 107.082 -167.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.448 HG23 ' CD2' ' A' ' 116' ' ' LEU . 41.0 m -67.59 -65.44 0.69 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.542 1.137 . . . . 1.3999999999999999 111.587 -173.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -49.59 -51.07 39.81 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.816 0.817 . . . . 2.5699999999999998 110.444 -172.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.79 -24.09 61.68 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.141 1.376 . . . . 1.6000000000000001 112.661 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.1 39.81 97.64 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.463 1.506 . . . . 1.3400000000000001 112.786 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.8 m -97.96 -35.32 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 117.986 0.893 . . . . 1.75 113.054 -172.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -107.41 -68.15 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 117.981 -1.009 . . . . 3.4500000000000002 112.104 177.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -77.05 131.12 11.74 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 121.606 1.538 . . . . 1.2 108.77 175.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -76.4 157.35 32.38 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.766 -0.827 . . . . 3.02 108.766 169.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.02 170.22 4.6 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.93 0.492 . . . . 1.53 109.71 170.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.86 40.54 98.47 Favored Glycine 0 CA--C 1.531 1.081 0 O-C-N 121.63 -0.669 . . . . 1.6299999999999999 112.046 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -127.2 156.7 41.42 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 107.916 -1.142 . . . . 1.47 107.916 169.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -96.71 128.47 43.69 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.002 0.921 . . . . 4.6100000000000003 108.992 176.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.2 pt -137.17 168.23 21.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 108.32 -0.993 . . . . 0.77000000000000002 108.32 173.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 31.2 mtm180 -117.59 111.07 18.7 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.13 -1.063 . . . . 2.6800000000000002 108.13 173.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.7 p -78.87 130.14 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.812 -1.551 . . . . 0.80000000000000004 106.812 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.55 125.33 2.98 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 109.629 -1.389 . . . . 0.53000000000000003 109.629 -177.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.96 -155.4 17.09 Favored Glycine 0 C--N 1.334 0.423 0 N-CA-C 108.535 -1.826 . . . . 0.68000000000000005 108.535 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -97.61 134.38 40.9 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.48 0.657 . . . . 2.73 109.705 177.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.431 HG22 ' H ' ' A' ' 108' ' ' GLN . 9.4 m -68.95 159.79 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.964 -1.124 . . . . 2.4199999999999999 107.964 172.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.2 m -74.03 -116.85 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 109.188 -0.671 . . . . 2.5499999999999998 109.188 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.1 p -156.99 -59.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 O-C-N 120.49 -1.381 . . . . 2.3500000000000001 109.418 -175.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.66 -11.05 56.06 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 121.943 -0.473 . . . . 2.2599999999999998 112.591 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.1 m -67.37 -20.91 65.62 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 114.14 1.163 . . . . 1.21 114.14 -165.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 6.6 tpt -71.39 94.6 1.25 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.655 0.782 . . . . 1.9199999999999999 109.814 -176.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.6 m -102.31 130.44 52.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 107.364 -1.347 . . . . 0.57999999999999996 107.364 174.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -126.44 141.48 51.87 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.506 1.122 . . . . 6.0999999999999996 108.323 -173.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.99 143.82 31.88 Favored Pre-proline 0 C--O 1.234 0.244 0 N-CA-C 110.34 -0.244 . . . . 2.6699999999999999 110.34 -176.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -60.16 -27.16 84.32 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.125 2.55 . . . . 2.3900000000000001 110.846 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -42.94 -40.63 3.05 Favored 'General case' 0 C--O 1.226 -0.151 0 C-N-CA 125.678 1.591 . . . . 2.6200000000000001 110.013 172.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.4 m 78.31 12.04 1.71 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.963 1.705 . . . . 1.71 112.861 177.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.69 31.53 5.31 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.888 0.875 . . . . 2.9199999999999999 112.382 165.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -150.24 131.82 14.85 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 122.05 -0.406 . . . . 1.22 110.545 175.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.59 131.26 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 125.14 1.376 . . . . 1.0 108.714 -177.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -137.9 144.08 41.16 Favored 'General case' 0 C--N 1.34 0.183 0 O-C-N 120.536 -1.352 . . . . 0.91000000000000003 110.745 172.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -139.35 160.22 40.34 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.392 0.677 . . . . 1.97 109.854 -175.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.67 127.61 54.12 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.529 -1.285 . . . . 0.60999999999999999 107.529 170.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.6 p -116.02 146.55 20.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.314 -0.995 . . . . 1.8300000000000001 108.314 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -142.88 -178.5 5.84 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.217 1.007 . . . . 1.3600000000000001 109.661 -173.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.6 t70 . . . . . 0 N--CA 1.465 0.311 0 CA-C-O 121.581 0.705 . . . . 2.6899999999999999 111.734 177.967 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.91 0 N-CA-C 110.597 -1.001 . . . . 1.46 110.597 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -120.78 133.13 55.34 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.178 -1.786 . . . . 4.7699999999999996 106.178 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -123.4 138.51 53.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 108.051 -1.092 . . . . 1.45 108.051 -176.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.8 mt -89.8 124.44 34.66 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.954 0.902 . . . . 0.70999999999999996 110.294 -176.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.0 t -109.0 118.46 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 126.216 1.806 . . . . 0.82999999999999996 107.045 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.4 p -99.54 140.06 34.27 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.723 -0.843 . . . . 0.55000000000000004 108.723 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -141.71 139.61 32.96 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 107.849 -1.167 . . . . 2.2999999999999998 107.849 -173.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -81.79 -91.01 0.07 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.98 0.912 . . . . 3.6200000000000001 110.692 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -55.15 168.74 0.3 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.646 1.179 . . . . 3.9199999999999999 113.237 -171.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 mt -57.7 116.34 3.36 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 120.197 -1.564 . . . . 2.2599999999999998 110.95 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.0 mt -54.97 145.74 41.89 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 123.511 0.724 . . . . 1.4099999999999999 109.839 170.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -62.32 143.3 93.65 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.598 2.199 . . . . 2.5499999999999998 109.692 177.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 47.16 40.39 9.92 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.955 1.302 . . . . 2.7999999999999998 111.285 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 56.05 4.75 0.14 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 128.277 2.631 . . . . 2.0499999999999998 115.466 -175.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 57.0 t80 58.37 101.99 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.251 1.02 . . . . 2.9500000000000002 109.089 -155.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -78.09 150.94 33.64 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.89 -1.152 . . . . 4.0899999999999999 107.89 168.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -91.96 165.63 13.11 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 125.867 1.667 . . . . 3.3300000000000001 109.595 -175.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 42.15 48.86 5.47 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.153 1.358 . . . . 0.79000000000000004 114.408 -177.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.431 ' H ' HG22 ' A' ' 66' ' ' VAL . 1.3 pp0? -155.7 87.81 1.1 Allowed 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.83 1.252 . . . . 2.5699999999999998 107.632 -178.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -49.08 135.77 21.41 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 123.459 0.552 . . . . 0.68999999999999995 113.857 -169.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.3 pp -139.23 168.04 19.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 124.731 1.212 . . . . 0.92000000000000004 108.69 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 15.7 m -110.6 137.76 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.271 -1.011 . . . . 0.71999999999999997 108.271 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.456 ' CB ' HG12 ' A' ' 127' ' ' VAL . . . -125.04 122.17 36.49 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.525 1.13 . . . . 0.64000000000000001 109.333 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -99.35 127.4 45.36 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.018 -1.104 . . . . 3.2999999999999998 108.018 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -159.79 169.19 35.73 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.197 -0.525 . . . . 1.6399999999999999 112.36 -173.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.1 p -108.38 139.35 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 124.439 1.096 . . . . 0.84999999999999998 108.184 177.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.448 ' CD2' HG23 ' A' ' 48' ' ' THR . 3.9 mp -68.43 118.29 11.31 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.55 -0.907 . . . . 2.6600000000000001 108.55 174.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.34 -91.65 0.33 Allowed Glycine 0 C--N 1.335 0.524 0 O-C-N 124.054 0.847 . . . . 2.54 111.107 -171.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -82.0 -77.86 0.21 Allowed 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.395 -1.335 . . . . 6.1500000000000004 107.395 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -175.58 108.35 0.09 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.969 1.708 . . . . 3.6000000000000001 107.099 173.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 118.8 -41.71 1.95 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.066 -1.214 . . . . 0.97999999999999998 110.066 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.69 131.63 34.93 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.485 0.714 . . . . 2.8100000000000001 110.628 -178.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -97.52 113.98 25.79 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.204 -1.036 . . . . 2.5899999999999999 108.204 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -88.58 102.58 15.08 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 107.246 -1.39 . . . . 0.63 107.246 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -122.0 132.29 54.44 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 123.922 0.889 . . . . 1.29 109.306 -175.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.8 t -125.7 -8.61 6.75 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.918 0.487 . . . . 1.27 112.236 172.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -111.41 74.54 0.87 Allowed 'General case' 0 CA--C 1.532 0.254 0 O-C-N 120.473 -1.392 . . . . 3.75 108.548 -174.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.456 HG12 ' CB ' ' A' ' 112' ' ' ALA . 35.8 m -87.58 150.93 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 118.279 0.491 . . . . 1.27 111.08 176.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.41 HD22 ' N ' ' A' ' 128' ' ' LEU . 0.2 OUTLIER -126.23 135.68 51.89 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.348 -0.982 . . . . 0.91000000000000003 108.348 171.525 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.3 122.95 34.36 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.765 -1.198 . . . . 2.5899999999999999 107.765 169.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -143.9 46.34 1.46 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.352 0.661 . . . . 3.1000000000000001 110.278 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 . . . . . 0 N--CA 1.455 -0.179 0 C-N-CA 124.443 1.097 . . . . 4.9199999999999999 109.317 -179.079 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.52 HD11 ' CD2' ' A' ' 38' ' ' TYR . 2.5 pp . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 109.477 -0.564 . . . . 2.1699999999999999 109.477 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -90.69 116.33 28.48 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 124.146 0.978 . . . . 2.1499999999999999 110.409 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.52 ' CD2' HD11 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -112.95 152.82 28.92 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.99 1.316 . . . . 2.7799999999999998 110.122 175.148 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.0 p -83.27 133.66 47.22 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 124.814 1.246 . . . . 1.6399999999999999 109.871 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.41 -40.71 72.54 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.882 2.388 . . . . 0.68999999999999995 112.236 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.7 t -54.8 -29.38 54.33 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.265 0.468 . . . . 2.48 112.265 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.11 -56.46 11.38 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.751 -1.203 . . . . 3.02 107.751 175.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.8 pt -73.23 28.99 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 114.217 1.191 . . . . 1.0800000000000001 114.217 -174.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.9 t -109.56 -24.42 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 126.82 2.048 . . . . 1.9199999999999999 111.007 163.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -120.65 75.02 1.1 Allowed 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 121.558 -0.714 . . . . 2.0699999999999998 111.197 -157.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.72 49.76 8.65 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 109.067 -1.613 . . . . 1.3999999999999999 109.067 174.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -146.55 -125.5 0.07 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.131 -1.804 . . . . 2.5800000000000001 106.131 -173.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.2 m -62.65 -43.0 99.92 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 119.408 1.004 . . . . 1.7 111.448 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -31.89 -72.51 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 126.655 1.982 . . . . 5.3499999999999996 112.809 172.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 45.7 m -89.23 -14.45 35.92 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.816 0.846 . . . . 1.8200000000000001 110.2 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.76 32.86 60.88 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.048 -0.821 . . . . 1.45 111.048 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.6 m -75.99 -36.24 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 117.702 0.751 . . . . 1.3200000000000001 111.418 -173.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt -113.88 -70.37 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 124.541 1.136 . . . . 3.4100000000000001 110.156 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.27 108.32 2.16 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 121.257 1.305 . . . . 1.3799999999999999 109.714 176.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.55 154.37 38.87 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.819 -0.808 . . . . 2.8399999999999999 108.819 169.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.98 164.1 13.36 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.188 -0.671 . . . . 1.27 109.188 169.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.42 30.69 39.94 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.252 -0.739 . . . . 1.5 111.252 -175.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -125.56 152.5 44.99 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.968 1.307 . . . . 1.48 108.458 173.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -97.51 121.24 39.18 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 108.25 -1.019 . . . . 4.8300000000000001 108.25 -176.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.5 pt -144.04 177.76 2.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 124.674 1.19 . . . . 0.73999999999999999 108.287 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -125.98 131.37 52.25 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.602 -0.888 . . . . 2.5699999999999998 108.602 175.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.5 p -94.73 124.5 47.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 107.014 -1.476 . . . . 0.98999999999999999 107.014 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.62 124.82 4.16 Favored Glycine 0 C--O 1.225 -0.437 0 N-CA-C 108.982 -1.647 . . . . 0.46999999999999997 108.982 178.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.39 -166.0 33.46 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 108.701 -1.76 . . . . 0.60999999999999999 108.701 -175.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.28 138.37 36.46 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.509 -0.552 . . . . 2.8500000000000001 109.509 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.544 HG11 ' HE1' ' A' ' 104' ' ' PHE . 32.6 t -98.77 108.22 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-O 121.239 0.542 . . . . 2.4199999999999999 110.087 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.2 m -39.15 132.75 1.32 Allowed 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 127.541 2.337 . . . . 2.4100000000000001 111.356 168.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.5 p -55.49 -62.8 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.656 0.782 . . . . 2.1800000000000002 110.731 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -83.27 68.5 3.54 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 109.951 -1.26 . . . . 2.1899999999999999 109.951 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.3 m -152.12 -33.64 0.14 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 114.858 1.429 . . . . 1.0700000000000001 114.858 -176.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.3 tpp -62.06 120.06 10.11 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 108.353 -0.98 . . . . 2.3399999999999999 108.353 170.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.2 m -122.35 133.94 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.341 -1.355 . . . . 0.69999999999999996 107.341 167.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.38 137.77 54.43 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.557 1.143 . . . . 5.9100000000000001 109.038 -173.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.62 143.33 50.76 Favored Pre-proline 0 N--CA 1.454 -0.244 0 N-CA-C 109.738 -0.468 . . . . 2.0099999999999998 109.738 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -59.85 -25.83 80.5 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.48 2.12 . . . . 1.5 110.787 170.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -40.98 -42.94 2.0 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 124.653 1.181 . . . . 1.54 110.668 168.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.6 m 84.41 -0.34 0.94 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.143 1.777 . . . . 1.1599999999999999 113.647 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.2 18.35 11.55 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.321 0.964 . . . . 2.6600000000000001 112.641 172.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -138.35 125.9 22.03 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.491 -1.3 . . . . 1.0700000000000001 107.491 174.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.51 HG23 ' HB3' ' A' ' 96' ' ' TYR . 27.6 m -145.19 144.48 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 106.62 -1.622 . . . . 0.68999999999999995 106.62 175.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -148.02 155.88 42.01 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 121.361 -0.837 . . . . 1.02 109.777 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -151.35 137.97 18.75 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.49 -0.323 . . . . 1.96 111.106 -171.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.29 138.3 33.62 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.212 -1.032 . . . . 0.48999999999999999 108.212 166.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.0 p -130.79 146.61 33.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 106.412 -1.699 . . . . 1.78 106.412 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -143.37 175.29 10.03 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.645 0.657 . . . . 1.6899999999999999 110.88 -174.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.9 t70 . . . . . 0 CA--C 1.531 0.222 0 O-C-N 123.465 0.478 . . . . 2.5099999999999998 111.537 -178.125 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.97 0 N-CA-C 109.903 -1.279 . . . . 1.6899999999999999 109.903 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -112.37 150.64 30.79 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.37 1.468 . . . . 3.1600000000000001 107.29 165.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -131.32 153.14 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 107.776 -1.194 . . . . 1.05 107.776 175.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.4 mt -110.18 115.14 29.19 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.794 0.838 . . . . 0.77000000000000002 109.036 -172.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.8 t -96.5 138.58 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 124.734 1.214 . . . . 0.89000000000000001 107.845 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 77.6 p -114.46 149.57 36.1 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.738 -0.838 . . . . 0.55000000000000004 108.738 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.513 ' CE2' ' HA ' ' A' ' 125' ' ' THR . 6.7 t80 -149.79 116.99 6.02 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.519 -0.919 . . . . 2.0499999999999998 108.519 -173.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -104.29 51.47 0.77 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.633 1.173 . . . . 2.1099999999999999 111.86 -170.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -168.16 -179.37 4.03 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.527 1.931 . . . . 3.02 107.14 170.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.0 mp -67.51 148.57 51.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 118.703 0.683 . . . . 1.5900000000000001 111.075 171.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.458 HD21 ' CD2' ' A' ' 96' ' ' TYR . 17.2 mt -101.81 152.24 38.09 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 125.093 1.357 . . . . 1.27 110.291 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -60.34 137.7 76.21 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 123.983 3.122 . . . . 2.0499999999999998 109.756 174.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 49.27 30.3 3.09 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.944 1.698 . . . . 3.02 112.495 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.0 tp 58.15 13.29 2.22 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.211 1.004 . . . . 3.4300000000000002 111.97 -175.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.544 ' HE1' HG11 ' A' ' 66' ' ' VAL . 17.3 t80 57.07 95.68 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.422 1.489 . . . . 2.8399999999999999 109.049 -172.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -76.15 124.9 28.18 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 105.47 -2.048 . . . . 7.54 105.47 -176.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -80.47 168.14 19.31 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.902 -0.499 . . . . 2.9700000000000002 110.187 -170.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.25 45.56 47.83 Favored Glycine 0 CA--C 1.528 0.906 0 O-C-N 121.505 -0.747 . . . . 0.93000000000000005 112.336 174.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -155.8 170.39 22.19 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.492 1.117 . . . . 2.2599999999999998 108.333 174.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.51 ' H ' ' CD2' ' A' ' 131' ' ' HIS . . . -90.9 130.33 10.22 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 111.188 -0.765 . . . . 0.67000000000000004 111.188 174.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.9 pp -137.94 158.4 33.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 107.01 -1.478 . . . . 0.68000000000000005 107.01 176.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.3 m -120.02 126.57 75.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 108.258 -1.016 . . . . 0.70999999999999996 108.258 175.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -117.44 127.09 53.68 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 124.403 1.081 . . . . 0.68999999999999995 109.929 -173.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -107.84 143.42 36.46 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.62 0.768 . . . . 4.46 110.333 -178.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 167.15 -142.46 7.58 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 110.057 -1.217 . . . . 0.98999999999999999 110.057 171.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.9 p -132.31 144.91 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-O 121.517 0.675 . . . . 1.02 110.477 -164.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.619 HD11 HD23 ' A' ' 122' ' ' LEU . 3.4 mp -87.35 153.9 21.1 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.678 -1.23 . . . . 2.71 107.678 176.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -159.47 -59.79 0.01 OUTLIER Glycine 0 C--N 1.334 0.43 0 C-N-CA 119.686 -1.245 . . . . 2.4500000000000002 111.646 177.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -60.41 142.74 54.61 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.809 -1.182 . . . . 4.4400000000000004 107.809 167.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -78.99 57.62 2.22 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.819 1.648 . . . . 4.1100000000000003 108.934 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 164.12 -32.38 0.26 Allowed Glycine 0 CA--C 1.53 0.979 0 CA-C-N 115.75 -0.659 . . . . 0.94999999999999996 113.02 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -113.14 157.22 21.93 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 118.181 0.99 . . . . 2.4900000000000002 109.642 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.619 HD23 HD11 ' A' ' 116' ' ' LEU . 4.2 mp -118.09 143.92 46.06 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.089 0.955 . . . . 1.95 108.517 -176.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -105.61 97.24 7.1 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.209 -1.404 . . . . 0.68000000000000005 107.209 175.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -106.16 143.92 33.59 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.719 -0.845 . . . . 1.0800000000000001 108.719 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.513 ' HA ' ' CE2' ' A' ' 96' ' ' TYR 0.254 12.1 t -129.36 -32.04 2.01 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.122 0.786 . . . . 1.04 113.122 174.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -84.96 84.8 7.59 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 120.713 -1.242 . . . . 3.1299999999999999 108.406 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.7 m -88.76 105.77 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 119.294 0.952 . . . . 0.84999999999999998 111.339 175.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -96.36 105.92 18.07 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.429 -0.952 . . . . 0.65000000000000002 108.429 175.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.79 52.19 1.67 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.356 1.062 . . . . 1.24 111.574 -177.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -79.19 72.6 5.77 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.751 -0.593 . . . . 3.2000000000000002 111.035 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.51 ' CD2' ' H ' ' A' ' 109' ' ' GLY . 11.0 t-80 . . . . . 0 CA--C 1.534 0.343 0 C-N-CA 123.817 0.847 . . . . 4.9199999999999999 111.538 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.527 0.084 0 N-CA-C 110.396 -0.224 . . . . 1.9399999999999999 110.396 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -84.76 119.49 25.35 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.071 -0.714 . . . . 2.2999999999999998 109.071 173.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.53 155.92 49.71 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.347 1.059 . . . . 2.77 109.944 -178.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.2 p -88.07 146.9 39.38 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-O 119.242 -0.409 . . . . 1.8899999999999999 110.728 -173.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -52.83 -50.82 12.73 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 123.399 2.733 . . . . 0.82999999999999996 110.371 173.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.7 m -48.13 -47.66 34.54 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 125.531 1.532 . . . . 2.5899999999999999 112.748 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -57.54 -59.58 4.95 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.478 -0.934 . . . . 2.2999999999999998 108.478 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.267 32.4 pt -61.74 -16.5 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 114.504 1.298 . . . . 1.75 114.504 -170.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.47 -57.42 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 120.056 1.298 . . . . 2.0899999999999999 111.226 167.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -84.71 80.37 9.28 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.149 -0.97 . . . . 2.2200000000000002 112.098 -154.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.47 48.35 5.96 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 109.653 -1.379 . . . . 1.3999999999999999 109.653 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.56 -100.84 0.08 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.136 -1.061 . . . . 2.3999999999999999 108.136 -177.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 92.9 m -79.28 -60.8 2.23 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 126.187 1.795 . . . . 1.3700000000000001 111.043 -176.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.41 ' OD1' HD11 ' A' ' 92' ' ' ILE . 0.9 OUTLIER -54.43 -33.25 59.14 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.321 0.964 . . . . 4.1500000000000004 111.205 -178.537 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.28 -17.72 31.87 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.35 1.06 . . . . 1.51 112.379 178.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 52.7 43.18 59.67 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 126.158 1.837 . . . . 1.0900000000000001 112.936 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.4 m -95.88 -43.06 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 118.301 1.051 . . . . 1.3200000000000001 112.817 -173.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -111.88 -71.09 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.25 0 C-N-CA 124.546 1.138 . . . . 3.3799999999999999 111.021 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -70.69 96.32 0.67 Allowed 'Trans proline' 0 N--CA 1.444 -1.397 0 N-CA-C 108.356 -1.44 . . . . 1.6899999999999999 108.356 172.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -49.51 162.65 0.14 Allowed 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.322 1.049 . . . . 4.1200000000000001 111.441 170.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.35 144.27 51.08 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.35 -0.981 . . . . 1.3100000000000001 108.35 169.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.85 21.91 67.45 Favored Glycine 0 CA--C 1.536 1.396 0 O-C-N 121.554 -0.716 . . . . 1.1599999999999999 113.261 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -89.62 148.55 23.28 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 118.42 1.11 . . . . 2.8199999999999998 108.117 170.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.97 113.84 26.06 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.474 1.11 . . . . 3.5899999999999999 108.249 -171.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.27 175.96 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 123.131 0.572 . . . . 1.5800000000000001 109.477 -177.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -111.27 112.15 23.72 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 108.84 -0.8 . . . . 3.3999999999999999 108.84 175.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.9 p -77.01 122.24 31.1 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.038 0 N-CA-C 106.944 -1.502 . . . . 1.03 106.944 172.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.09 120.66 2.97 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 108.537 -1.825 . . . . 0.64000000000000001 108.537 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.07 -160.02 22.78 Favored Glycine 0 CA--C 1.52 0.347 0 N-CA-C 108.92 -1.672 . . . . 0.68000000000000005 108.92 -174.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.6 ptp -112.7 136.29 52.45 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.229 0.612 . . . . 2.52 110.272 -176.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 83' ' ' ALA . 4.8 p -93.93 138.68 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 109.091 -0.707 . . . . 2.46 109.091 172.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.99 163.32 26.8 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.221 -1.029 . . . . 2.6099999999999999 108.221 168.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.6 p -58.78 -65.31 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 124.368 1.067 . . . . 2.21 110.763 173.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.25 59.44 4.33 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 121.545 -0.722 . . . . 2.0600000000000001 111.388 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.5 m -126.06 -41.95 1.9 Allowed 'General case' 0 C--N 1.334 -0.07 0 C-N-CA 124.744 1.218 . . . . 1.8700000000000001 111.449 -177.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -71.78 121.37 18.82 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.11 -0.7 . . . . 1.9399999999999999 109.11 -178.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.8 m -127.47 130.35 70.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 108.002 -1.111 . . . . 0.85999999999999999 108.002 170.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -109.49 147.26 33.19 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 124.072 0.949 . . . . 4.3099999999999996 110.73 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.46 151.89 95.53 Favored Pre-proline 0 N--CA 1.45 -0.44 0 N-CA-C 109.046 -0.724 . . . . 2.1800000000000002 109.046 174.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -61.67 -28.37 82.38 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.012 1.808 . . . . 1.79 110.946 166.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -44.88 -34.71 2.47 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.141 0.976 . . . . 1.3700000000000001 110.655 167.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.6 m 67.63 23.87 8.65 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.084 1.354 . . . . 2.2799999999999998 112.241 176.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.47 -42.37 2.23 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.848 2.059 . . . . 2.1000000000000001 111.788 172.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -90.8 138.94 31.2 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.624 -1.25 . . . . 1.3400000000000001 107.624 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.511 HG23 ' HB3' ' A' ' 96' ' ' TYR . 17.2 m -152.29 130.11 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 107.125 -1.435 . . . . 0.72999999999999998 107.125 -173.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -135.11 146.71 49.11 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 118.929 0.786 . . . . 1.3799999999999999 110.394 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -140.0 144.5 36.99 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.221 0.608 . . . . 1.9399999999999999 110.171 -172.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.57 ' O ' HG23 ' A' ' 66' ' ' VAL . . . -85.07 139.14 31.96 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.89 -0.782 . . . . 0.59999999999999998 108.89 170.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 t -125.76 143.66 38.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 105.855 -1.906 . . . . 1.78 105.855 172.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -144.15 177.99 8.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.191 -1.04 . . . . 2.52 108.191 176.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.1 t0 . . . . . 0 N--CA 1.451 -0.425 0 N-CA-C 108.811 -0.811 . . . . 2.6400000000000001 108.811 169.887 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.626 0 N-CA-C 109.12 -1.592 . . . . 1.52 109.12 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -133.16 138.24 46.53 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.339 -1.356 . . . . 2.75 107.339 177.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.445 ' HA ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -128.35 154.46 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 107.258 -1.386 . . . . 0.90000000000000002 107.258 -176.346 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.2 mt -116.14 121.43 42.1 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.52 0.728 . . . . 0.66000000000000003 109.334 -177.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.8 t -109.27 129.0 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.88 -1.155 . . . . 0.85999999999999999 107.88 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 77.5 p -103.94 140.15 38.11 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.73 1.212 . . . . 0.64000000000000001 109.233 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.511 ' HB3' HG23 ' A' ' 80' ' ' VAL . 6.6 t80 -134.41 160.23 38.63 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.112 1.765 . . . . 2.0800000000000001 108.191 -178.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -145.68 146.5 31.31 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 128.097 2.559 . . . . 3.1299999999999999 105.449 -171.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 69.82 59.97 0.28 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 130.085 3.354 . . . . 3.1899999999999999 111.083 -175.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 mt 55.93 -156.05 0.28 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.482 1.113 . . . . 1.8300000000000001 109.27 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.572 HD13 ' HB2' ' A' ' 104' ' ' PHE . 15.5 mt -145.0 154.42 54.73 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 105.827 -1.916 . . . . 1.1000000000000001 105.827 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -63.09 -82.86 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 124.276 3.317 . . . . 2.3500000000000001 110.536 -176.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -76.5 35.49 0.15 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.073 0.949 . . . . 4.1100000000000003 110.752 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 39.6 6.31 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 128.505 2.722 . . . . 3.0499999999999998 117.538 -164.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.572 ' HB2' HD13 ' A' ' 100' ' ' LEU . 0.2 OUTLIER 61.91 89.96 0.08 Allowed 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 124.846 1.258 . . . . 3.0099999999999998 109.643 -166.021 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.272 15.0 mmm180 -91.85 30.39 1.39 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 117.859 -1.536 . . . . 5.2300000000000004 111.559 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . 0.339 4.3 mt-10 79.38 172.38 0.16 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.986 1.266 . . . . 3.04 109.714 146.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 39.39 37.52 0.79 Allowed Glycine 0 CA--C 1.537 1.467 0 N-CA-C 116.143 1.217 . . . . 0.78000000000000003 116.143 163.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -148.18 176.57 10.11 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.551 1.54 . . . . 2.1899999999999999 107.847 -175.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -109.08 129.38 9.48 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.174 -1.17 . . . . 0.64000000000000001 110.174 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.0 pp -133.99 165.39 31.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 125.475 1.51 . . . . 0.73999999999999999 106.994 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.4 m -115.56 144.27 23.54 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 N-CA-C 108.087 -1.079 . . . . 0.94999999999999996 108.087 170.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.616 ' HB2' HG12 ' A' ' 127' ' ' VAL . . . -134.05 129.68 36.41 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 124.073 0.949 . . . . 0.62 110.325 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.79 143.83 34.32 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.633 1.173 . . . . 4.4500000000000002 111.425 177.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 166.02 -150.64 18.28 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 109.17 -1.572 . . . . 1.01 109.17 169.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.9 p -127.69 146.28 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 123.78 0.832 . . . . 0.82999999999999996 109.38 -168.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.6 mp -61.71 142.65 57.09 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 122.119 -0.363 . . . . 2.0899999999999999 110.483 174.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -98.38 -108.21 2.74 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 109.263 -1.535 . . . . 1.8100000000000001 109.263 -169.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -60.29 -49.21 78.52 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.323 0.649 . . . . 5.1799999999999997 109.259 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.2 t70 177.27 -87.86 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.364 2.266 . . . . 4.2999999999999998 106.089 -177.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.23 -26.54 72.57 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.72 1.629 . . . . 1.0800000000000001 113.433 -177.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -86.66 136.5 33.01 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.12 0.96 . . . . 3.0299999999999998 109.935 174.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.4 mp -107.37 133.9 51.23 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 123.107 0.563 . . . . 2.1600000000000001 109.495 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.09 106.5 18.81 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.58 -0.526 . . . . 0.42999999999999999 109.58 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -121.27 136.99 54.89 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.719 0.808 . . . . 1.2 110.224 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.3 t -128.28 4.14 5.75 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.216 0.606 . . . . 1.0900000000000001 111.885 173.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -118.6 82.03 1.78 Allowed 'General case' 0 CA--C 1.531 0.237 0 O-C-N 120.914 -1.116 . . . . 2.98 108.368 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.616 HG12 ' HB2' ' A' ' 112' ' ' ALA . 17.2 m -99.59 133.92 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 118.333 0.515 . . . . 0.70999999999999996 110.701 175.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.87 118.81 27.94 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.215 -1.402 . . . . 0.73999999999999999 107.215 177.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.22 84.2 7.7 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.631 0.772 . . . . 1.1499999999999999 110.433 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.17 34.52 0.11 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.736 1.013 . . . . 4.1500000000000004 113.736 -174.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.529 0.15 0 C-N-CA 126.765 2.026 . . . . 4.1200000000000001 105.596 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 109.75 -0.463 . . . . 2.5 109.75 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -85.68 124.78 32.6 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.724 1.209 . . . . 2.1400000000000001 109.465 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.16 149.39 51.88 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.003 1.321 . . . . 3.02 110.54 -177.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.5 m -77.09 132.33 70.88 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 125.713 1.605 . . . . 2.0 110.728 -177.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -59.3 -33.05 97.77 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.968 2.445 . . . . 0.81000000000000005 113.616 -176.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.5 p -61.09 -21.04 63.3 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.171 -0.956 . . . . 2.2799999999999998 112.713 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -96.8 14.2 26.0 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.774 0.715 . . . . 3.7000000000000002 111.753 173.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.312 8.0 pt -124.26 35.02 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 O-C-N 120.607 -1.308 . . . . 1.23 111.613 163.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.0 p -122.61 -79.11 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 O-C-N 121.922 -0.486 . . . . 2.3500000000000001 110.426 163.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -69.75 103.8 2.26 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 125.497 1.519 . . . . 2.2999999999999998 110.896 -162.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.96 39.33 96.39 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 109.029 -1.628 . . . . 1.3400000000000001 109.029 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -141.43 -110.42 0.14 Allowed 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.521 -1.659 . . . . 2.2799999999999998 106.521 -176.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 56.3 m -80.45 -48.19 13.21 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 119.96 1.254 . . . . 1.4099999999999999 112.475 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -55.0 -49.33 71.77 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.828 0.823 . . . . 2.6600000000000001 109.694 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -72.32 -33.47 67.38 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.371 -0.831 . . . . 1.2 111.619 175.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.22 41.04 39.86 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.744 1.164 . . . . 1.2 112.198 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.6 m -99.97 -42.3 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 117.999 0.9 . . . . 1.3 113.228 -172.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -109.29 -67.51 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.519 1.128 . . . . 3.7999999999999998 111.433 -176.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -76.37 78.81 3.15 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.062 1.842 . . . . 2.27 108.828 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -55.74 140.04 43.14 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.656 0.782 . . . . 3.2000000000000002 109.031 175.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.539 ' HB1' ' HA2' ' A' ' 117' ' ' GLY . . . -61.83 147.18 47.34 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.951 -0.759 . . . . 1.1899999999999999 108.951 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.17 -8.28 31.04 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.839 1.209 . . . . 1.0900000000000001 112.069 -170.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -96.32 140.49 30.92 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.325 1.063 . . . . 1.6100000000000001 109.548 -175.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -89.31 118.56 29.07 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.274 1.029 . . . . 4.8099999999999996 108.569 176.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.7 pt -142.21 175.9 4.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 107.903 -1.147 . . . . 1.22 107.903 172.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.4 mtm180 -121.15 113.57 20.19 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.197 -1.038 . . . . 2.1400000000000001 108.197 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.2 p -81.24 127.86 39.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 107.108 -1.441 . . . . 0.78000000000000003 107.108 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.99 114.93 1.76 Allowed Glycine 0 C--N 1.332 0.332 0 N-CA-C 109.856 -1.297 . . . . 0.47999999999999998 109.856 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.57 -173.37 39.76 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.876 -0.89 . . . . 0.81000000000000005 110.876 -172.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.431 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 2.4 ptp -93.37 132.82 37.25 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.947 0.899 . . . . 2.75 111.343 -171.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.43 HG11 ' CE1' ' A' ' 104' ' ' PHE . 6.1 t -102.34 137.22 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 O-C-N 123.794 0.684 . . . . 2.2599999999999998 109.936 174.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.401 HG22 HG12 ' A' ' 68' ' ' VAL . 5.2 m -40.75 -88.0 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 128.192 2.597 . . . . 2.8300000000000001 114.329 -175.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.401 HG12 HG22 ' A' ' 67' ' ' THR . 7.3 p 176.18 -36.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.309 1.443 . . . . 2.73 110.038 -174.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -155.82 42.35 0.56 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.788 -1.325 . . . . 2.4500000000000002 109.788 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.9 m -84.65 -11.46 55.89 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.972 0.386 . . . . 1.26 111.321 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 16.8 ptm -68.8 132.48 46.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 118.292 0.496 . . . . 2.2200000000000002 110.686 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.1 m -117.65 125.45 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 106.621 -1.622 . . . . 1.23 106.621 170.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.446 ' HB3' HG12 ' A' ' 80' ' ' VAL . 16.8 ptt180 -101.4 146.77 27.16 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.535 0.734 . . . . 5.0899999999999999 110.136 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -84.42 151.36 59.05 Favored Pre-proline 0 C--O 1.232 0.147 0 N-CA-C 109.381 -0.6 . . . . 2.1699999999999999 109.381 170.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -67.55 -21.15 46.57 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.933 2.422 . . . . 1.77 112.367 174.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -43.7 -37.98 2.91 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.565 -0.531 . . . . 1.55 109.565 163.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.0 m 72.79 9.75 5.52 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 126.125 1.77 . . . . 1.6100000000000001 111.508 177.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 pp -123.63 17.78 9.57 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.16 1.784 . . . . 1.76 110.644 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -146.1 130.19 17.42 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.588 1.555 . . . . 2.0299999999999998 108.271 173.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.446 HG12 ' HB3' ' A' ' 73' ' ' ARG . 0.9 OUTLIER -145.29 109.77 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 125.105 1.362 . . . . 1.1899999999999999 107.523 -178.6 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -109.38 150.07 28.58 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 109.22 -0.659 . . . . 1.3899999999999999 109.22 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -150.85 142.3 23.44 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.981 0.419 . . . . 1.8899999999999999 110.727 -171.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.69 135.16 33.88 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.275 -0.639 . . . . 0.78000000000000003 109.275 175.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 38.7 t -115.21 152.16 16.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 126.365 1.866 . . . . 2.0299999999999998 106.512 175.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -134.18 -175.93 4.02 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.376 0.67 . . . . 1.47 109.744 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.7 t0 . . . . . 0 N--CA 1.452 -0.361 0 C-N-CA 123.716 0.806 . . . . 3.9300000000000002 110.506 177.176 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 110.458 -1.057 . . . . 2.4399999999999999 110.458 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -65.88 111.75 3.44 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.997 -1.112 . . . . 3.5899999999999999 107.997 -175.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -144.51 153.85 14.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 N-CA-C 108.416 -0.957 . . . . 0.92000000000000004 108.416 -176.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mt -108.42 124.57 50.6 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.911 0.884 . . . . 0.77000000000000002 109.116 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.6 t -107.21 132.55 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 107.299 -1.371 . . . . 0.84999999999999998 107.299 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 76.6 p -106.25 143.6 34.14 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.513 -0.921 . . . . 0.60999999999999999 108.513 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -137.67 167.05 22.47 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.775 1.23 . . . . 2.2999999999999998 108.655 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -144.49 147.84 33.78 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 127.801 2.44 . . . . 3.4399999999999999 107.088 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 65.78 71.86 0.41 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 129.786 3.234 . . . . 3.0800000000000001 112.66 -178.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.7 mp 46.07 -148.54 0.11 Allowed 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 125.377 1.471 . . . . 2.3199999999999998 109.867 -175.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.8 mt -156.31 152.18 22.68 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 105.492 -2.04 . . . . 1.3300000000000001 105.492 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -71.54 108.69 2.45 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.274 2.649 . . . . 2.6600000000000001 109.929 176.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 45.04 45.11 8.78 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.205 1.402 . . . . 4.2999999999999998 111.706 176.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . 0.296 2.3 pp 35.69 47.3 0.37 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.259 1.424 . . . . 3.6699999999999999 112.793 -172.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.43 ' CE1' HG11 ' A' ' 66' ' ' VAL . 20.3 p90 38.85 56.59 1.95 Allowed 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 127.647 2.379 . . . . 4.7400000000000002 114.115 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.707 ' CD ' ' H ' ' A' ' 105' ' ' ARG 0.253 0.1 OUTLIER -37.91 130.45 1.12 Allowed 'General case' 0 CA--C 1.543 0.711 0 O-C-N 116.971 -3.58 . . . . 6.5499999999999998 113.189 -119.073 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -74.13 154.88 38.94 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.401 -0.812 . . . . 3.54 110.345 -164.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.61 33.21 11.67 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.181 0.896 . . . . 0.83999999999999997 112.395 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -156.74 178.54 10.23 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.091 1.356 . . . . 2.77 108.183 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 65' ' ' MET . . . -88.82 139.53 15.4 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 112.122 -0.391 . . . . 0.87 112.122 175.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.69 162.76 28.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 124.152 0.981 . . . . 0.81999999999999995 108.54 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 17.6 m -120.2 122.74 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.304 -0.628 . . . . 0.53000000000000003 109.304 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -113.67 120.98 42.74 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 125.189 1.396 . . . . 0.44 109.047 -176.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -99.67 135.28 41.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.369 -1.345 . . . . 4.1399999999999997 107.369 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -169.27 -169.72 32.95 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 110.065 -1.214 . . . . 0.93000000000000005 110.065 -173.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.4 p -122.98 136.94 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 107.804 -1.184 . . . . 0.73999999999999999 107.804 172.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 9.6 mp -73.78 155.24 39.06 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 107.882 -1.155 . . . . 2.6200000000000001 107.882 174.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.539 ' HA2' ' HB1' ' A' ' 56' ' ' ALA . . . -172.02 -44.42 0.04 OUTLIER Glycine 0 C--N 1.332 0.313 0 C-N-CA 119.878 -1.154 . . . . 2.1699999999999999 112.215 175.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -58.9 154.85 14.33 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 119.295 -0.962 . . . . 5.1699999999999999 110.083 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -80.17 72.54 6.99 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 106.511 -1.663 . . . . 4.5499999999999998 106.511 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 115.24 4.53 20.35 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.413 1.482 . . . . 1.3899999999999999 114.265 170.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.13 170.17 9.55 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.785 1.293 . . . . 2.8599999999999999 109.342 171.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.9 mp -123.74 145.25 49.15 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.044 0.937 . . . . 2.0699999999999998 109.578 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -110.85 109.76 20.08 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.426 0.691 . . . . 0.42999999999999999 109.197 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -132.63 136.63 46.63 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 123.41 0.684 . . . . 1.1000000000000001 110.277 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.4 t -121.44 -2.37 9.49 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.975 0.51 . . . . 1.0900000000000001 111.96 173.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -111.7 83.01 1.71 Allowed 'General case' 0 CA--C 1.532 0.27 0 O-C-N 120.434 -1.416 . . . . 3.79 108.403 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.3 m -96.65 126.89 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 118.383 0.538 . . . . 0.77000000000000002 110.886 174.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -113.95 106.57 14.59 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.03 -1.47 . . . . 0.77000000000000002 107.03 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.1 50.01 1.93 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.979 0.912 . . . . 1.6000000000000001 110.622 -178.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -78.83 64.39 3.78 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.357 0.663 . . . . 3.2999999999999998 111.096 -170.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 . . . . . 0 N--CA 1.449 -0.52 0 N-CA-C 106.592 -1.633 . . . . 4.4400000000000004 106.592 -178.165 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 pt? . . . . . 0 N--CA 1.464 0.26 0 N-CA-C 111.921 0.341 . . . . 1.8999999999999999 111.921 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -91.45 135.21 34.01 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.424 1.09 . . . . 1.9299999999999999 109.906 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.41 161.44 34.54 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.002 1.321 . . . . 2.9300000000000002 109.883 170.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 p -83.28 144.82 47.38 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.65 1.18 . . . . 1.8600000000000001 110.522 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -62.0 -44.47 20.08 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.786 2.991 . . . . 0.82999999999999996 112.407 -177.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.8 p -45.83 -56.18 5.7 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.258 1.423 . . . . 2.5 110.923 176.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -46.56 -56.11 6.54 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.446 -1.252 . . . . 3.0099999999999998 109.174 178.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.25 24.2 pt -70.37 11.42 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 114.862 1.43 . . . . 1.0 114.862 -173.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 82.0 t -98.4 -57.59 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 119.455 1.025 . . . . 1.8300000000000001 110.934 173.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -95.68 90.27 5.63 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 121.618 -0.676 . . . . 2.29 111.822 -162.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.72 41.75 12.36 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.442 -1.063 . . . . 1.5 110.442 176.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.91 -161.61 1.17 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 104.168 -2.53 . . . . 3.0499999999999998 104.168 -178.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 m -27.6 -59.04 0.11 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.797 2.439 . . . . 1.72 116.356 -175.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -57.66 -43.62 85.12 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 120.625 1.557 . . . . 3.9500000000000002 110.889 -177.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.04 -34.81 75.81 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.762 0.825 . . . . 1.95 110.586 174.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.09 46.86 14.7 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.118 1.342 . . . . 1.5700000000000001 111.566 177.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.407 HG23 ' H ' ' A' ' 53' ' ' LYS . 2.7 m -99.17 -89.61 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 117.252 0.526 . . . . 1.9199999999999999 111.639 177.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.407 ' H ' HG23 ' A' ' 52' ' ' VAL . 20.0 mmmt -58.53 -60.8 9.13 Favored Pre-proline 0 CA--C 1.538 0.49 0 O-C-N 121.33 -0.856 . . . . 3.04 112.891 -176.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.62 147.18 27.82 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.564 1.509 . . . . 1.1899999999999999 109.072 172.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -116.52 135.05 54.15 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.099 1.76 . . . . 3.04 107.302 -176.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.01 146.78 45.86 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.447 -0.575 . . . . 1.1599999999999999 109.447 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.59 -26.24 9.14 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 123.927 0.775 . . . . 1.01 111.915 -169.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -84.71 151.63 24.29 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.195 0.998 . . . . 1.53 109.969 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -95.23 130.68 41.88 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.806 0.842 . . . . 5.0300000000000002 108.851 175.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.6 pt -141.31 177.63 3.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 125.025 1.33 . . . . 0.64000000000000001 108.243 177.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.8 mtm-85 -125.7 137.83 53.86 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 122.31 -0.244 . . . . 2.5899999999999999 111.115 166.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.6 p -97.66 134.07 37.16 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.171 0 C-N-CA 124.686 1.194 . . . . 0.90000000000000002 108.049 172.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.09 119.14 1.76 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.602 -0.999 . . . . 0.66000000000000003 110.602 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.59 -163.34 29.27 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.295 -1.522 . . . . 0.60999999999999999 109.295 -175.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.44 142.04 27.87 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.011 0.905 . . . . 2.5699999999999998 111.733 -177.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 39.3 t -87.44 122.55 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-N 115.545 -0.752 . . . . 2.1299999999999999 109.407 172.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.5 m -30.34 -91.62 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 128.843 2.857 . . . . 3.0499999999999998 115.382 -175.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.5 p -172.42 -37.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 124.061 0.944 . . . . 2.23 111.027 -177.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -158.96 40.66 0.49 Allowed Glycine 0 CA--C 1.521 0.439 0 N-CA-C 109.617 -1.393 . . . . 1.8700000000000001 109.617 174.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.3 m -82.25 -17.33 46.35 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.868 -0.195 . . . . 1.0700000000000001 111.093 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.1 ttp -63.23 128.79 37.47 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 122.717 0.407 . . . . 2.3799999999999999 110.487 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.5 m -135.22 143.99 35.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 108.132 -1.062 . . . . 0.56999999999999995 108.132 172.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 47.8 ptt85 -132.39 147.52 52.39 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 124.422 1.089 . . . . 4.6799999999999997 108.516 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -99.76 154.37 37.29 Favored Pre-proline 0 C--O 1.235 0.313 0 N-CA-C 107.944 -1.132 . . . . 2.0899999999999999 107.944 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.41 44.71 1.56 Allowed 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.485 2.79 . . . . 1.8600000000000001 111.526 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -105.75 -41.45 5.43 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.667 1.587 . . . . 1.71 109.088 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.2 m 107.55 -30.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 129.134 2.974 . . . . 2.8999999999999999 110.214 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.34 32.87 4.83 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 124.321 1.048 . . . . 2.7799999999999998 111.741 -177.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -140.04 110.08 6.49 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.41 -1.33 . . . . 3.2000000000000002 107.41 175.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.75 134.17 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.226 -1.398 . . . . 1.04 107.226 177.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -144.46 157.17 44.37 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 120.884 -1.135 . . . . 0.84999999999999998 109.199 175.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -155.09 161.02 41.4 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.691 -0.855 . . . . 1.95 108.691 -173.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -106.74 145.21 32.33 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.548 -0.908 . . . . 0.75 108.548 175.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.9 t -127.96 140.2 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 108.473 -0.936 . . . . 1.8300000000000001 108.473 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -137.17 168.96 18.61 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.552 0.741 . . . . 1.3899999999999999 110.195 -178.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.5 t0 . . . . . 0 CA--C 1.534 0.357 0 C-N-CA 123.733 0.813 . . . . 2.8599999999999999 110.517 179.922 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.615 0 N-CA-C 106.98 -2.448 . . . . 1.5900000000000001 106.98 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -126.87 128.75 46.99 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.084 -1.821 . . . . 3.7400000000000002 106.084 174.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.2 tp -108.83 160.2 7.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 C-N-CA 125.36 1.464 . . . . 1.1499999999999999 108.14 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 mt -114.65 133.38 55.9 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 108.231 -1.026 . . . . 0.83999999999999997 108.231 -175.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 89.2 t -127.59 131.62 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 124.76 1.224 . . . . 0.96999999999999997 107.798 -174.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.0 p -107.2 150.4 26.66 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.929 0.892 . . . . 0.60999999999999999 109.762 178.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -147.39 140.62 25.25 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.49 1.516 . . . . 2.0299999999999998 107.064 -173.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -132.95 41.45 3.15 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.366 1.066 . . . . 2.1299999999999999 112.574 -168.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -168.25 53.24 0.05 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.557 0.743 . . . . 2.6800000000000002 111.631 -176.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.2 mp 51.02 -155.03 0.14 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.827 1.251 . . . . 1.9399999999999999 111.067 -171.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 81.8 mt -150.18 156.99 37.63 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 106.535 -1.654 . . . . 1.4199999999999999 106.535 -178.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.22 -88.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.434 2.756 . . . . 1.95 110.556 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -77.1 36.36 0.18 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.814 1.246 . . . . 3.6400000000000001 111.254 -175.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 39.89 11.67 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.824 2.849 . . . . 2.1600000000000001 116.983 -163.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 56.08 96.83 0.02 OUTLIER 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.681 1.128 . . . . 3.0699999999999998 109.911 -161.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 7.0 mtm180 -107.92 35.15 3.22 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 117.356 -1.306 . . . . 5.8799999999999999 112.448 172.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . 0.378 4.3 mm-40 78.81 157.75 0.17 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 121.443 1.928 . . . . 4.5099999999999998 112.99 140.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 52.1 26.59 20.44 Favored Glycine 0 CA--C 1.534 1.219 0 O-C-N 120.578 -1.326 . . . . 1.3999999999999999 113.631 167.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -139.73 163.75 31.76 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.54 1.936 . . . . 2.0800000000000001 105.813 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -89.28 145.77 18.66 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.74 -0.944 . . . . 0.72999999999999998 110.74 174.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.7 pp -141.26 159.98 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 106.074 -1.824 . . . . 0.88 106.074 173.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.2 m -124.02 122.82 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 108.488 -0.93 . . . . 0.69999999999999996 108.488 172.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -115.32 127.77 55.66 Favored 'General case' 0 C--O 1.228 -0.072 0 C-N-CA 125.747 1.619 . . . . 0.48999999999999999 109.93 -172.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -106.74 134.99 49.04 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.863 1.265 . . . . 3.25 109.502 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -173.72 -175.93 41.79 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.398 -0.429 . . . . 1.1899999999999999 112.97 -174.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.6 p -124.41 141.57 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 124.58 1.152 . . . . 1.03 109.394 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.2 mp -78.11 137.74 38.36 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.276 -0.875 . . . . 2.3700000000000001 109.014 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -156.42 37.16 0.59 Allowed Glycine 0 CA--C 1.521 0.453 0 N-CA-C 111.3 -0.72 . . . . 2.5800000000000001 111.3 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -157.45 27.86 0.29 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.882 0.873 . . . . 4.3099999999999996 109.545 -175.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 43.91 41.72 4.09 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.045 0.938 . . . . 4.0 111.915 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 159.88 -60.33 0.31 Allowed Glycine 0 CA--C 1.529 0.947 0 N-CA-C 110.837 -0.905 . . . . 1.99 110.837 -171.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.44 160.69 20.53 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 122.307 -0.525 . . . . 2.7799999999999998 111.096 -173.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 mp -125.26 126.26 44.86 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.072 0.949 . . . . 1.96 110.036 -170.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -92.8 108.97 20.4 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.096 -1.076 . . . . 0.60999999999999999 108.096 172.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -134.04 102.05 5.27 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.425 0.69 . . . . 1.29 111.938 -173.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.8 t -86.43 -25.01 25.46 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.193 0.997 . . . . 0.96999999999999997 111.843 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -88.43 79.43 7.69 Favored 'General case' 0 N--CA 1.455 -0.22 0 O-C-N 119.84 -1.788 . . . . 2.6400000000000001 109.713 -174.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.9 m -96.42 122.37 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 118.306 0.503 . . . . 0.79000000000000004 110.907 174.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -112.44 113.63 25.92 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.684 -1.599 . . . . 0.83999999999999997 106.684 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -99.87 26.73 6.04 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.855 0.862 . . . . 2.2000000000000002 112.606 -172.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.13 42.0 0.63 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.55 0.945 . . . . 5.1900000000000004 113.55 -164.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 . . . . . 0 C--N 1.333 -0.111 0 O-C-N 121.585 -0.697 . . . . 5.0599999999999996 109.216 173.49 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.465 0.317 0 N-CA-C 112.475 0.546 . . . . 2.0899999999999999 112.475 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -84.13 126.49 33.15 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.424 1.49 . . . . 2.1499999999999999 110.11 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.16 150.71 52.03 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.27 1.428 . . . . 2.7799999999999998 110.518 -177.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 36.2 m -76.7 124.05 87.66 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 125.73 1.612 . . . . 1.9199999999999999 111.48 -175.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -55.36 -43.4 58.81 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.987 2.458 . . . . 0.73999999999999999 111.857 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.6 m -60.1 -25.17 65.22 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.131 0.789 . . . . 2.8500000000000001 113.131 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -68.65 -56.88 6.73 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.139 -1.06 . . . . 3.25 108.139 171.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.6 pt -72.96 30.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 114.571 1.323 . . . . 1.0800000000000001 114.571 -171.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.2 p -107.51 -29.73 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 125.214 1.406 . . . . 1.9299999999999999 110.827 170.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -87.1 -118.7 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.969 0.89 . . . . 3.3900000000000001 109.937 -170.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -84.88 66.61 3.84 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 108.554 -1.818 . . . . 1.3400000000000001 108.554 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -142.38 -125.31 0.09 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.503 1.121 . . . . 2.9100000000000001 108.074 -173.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.419 HG21 HD21 ' A' ' 122' ' ' LEU . 5.9 t -76.66 -38.4 54.6 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 119.183 0.901 . . . . 2.8100000000000001 111.387 -172.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -58.31 -50.35 73.95 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.397 0.618 . . . . 2.7400000000000002 109.537 -178.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.9 m -81.04 -24.95 37.5 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.211 -0.904 . . . . 1.48 111.269 177.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.21 43.34 47.61 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.663 1.125 . . . . 1.0900000000000001 111.988 175.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.0 m -98.41 -42.18 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 117.657 0.728 . . . . 1.1799999999999999 112.757 -172.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -109.71 -65.77 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.777 1.231 . . . . 3.5899999999999999 111.975 -176.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -76.85 171.25 18.32 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 N-CA-C 108.224 -1.491 . . . . 1.1799999999999999 108.224 169.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.5 158.56 43.82 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.351 0.66 . . . . 5.4100000000000001 109.39 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.57 126.94 31.26 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.489 -1.3 . . . . 1.49 107.489 175.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 127.31 -17.68 6.19 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.275 1.417 . . . . 1.1799999999999999 112.198 -176.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -93.31 148.7 21.82 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.192 0.997 . . . . 2.9399999999999999 110.523 -172.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -85.49 134.58 34.04 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.051 -0.722 . . . . 3.4900000000000002 109.051 172.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.1 pt -145.73 175.03 2.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 105.685 -1.969 . . . . 0.64000000000000001 105.685 164.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -120.89 122.99 41.44 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.329 -1.36 . . . . 2.1899999999999999 107.329 171.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.7 p -88.81 131.91 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 107.558 -1.275 . . . . 0.77000000000000002 107.558 176.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -135.42 121.66 2.6 Favored Glycine 0 C--N 1.336 0.529 0 CA-C-N 119.052 0.842 . . . . 0.51000000000000001 111.002 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -172.88 -172.47 38.56 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.907 -0.877 . . . . 0.58999999999999997 110.907 -175.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -92.48 127.79 38.09 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.579 1.152 . . . . 4.5700000000000003 109.649 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.7 t -77.65 146.97 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.583 -0.735 . . . . 2.0899999999999999 109.721 176.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.552 HG22 HG12 ' A' ' 68' ' ' VAL . 2.1 m -55.66 -90.36 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.927 1.691 . . . . 3.04 114.155 -178.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.552 HG12 HG22 ' A' ' 67' ' ' THR . 7.4 p 176.16 -44.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.757 1.623 . . . . 2.3599999999999999 109.956 -170.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -150.26 39.44 0.86 Allowed Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.382 -1.087 . . . . 2.1200000000000001 110.382 176.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 61.6 m -87.22 -19.09 28.86 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 117.4 0.6 . . . . 1.05 112.153 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.3 ttp -71.76 123.82 23.44 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 118.803 0.729 . . . . 2.48 109.101 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.6 m -121.61 132.49 70.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 107.592 -1.262 . . . . 0.52000000000000002 107.592 173.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.433 ' CB ' HG12 ' A' ' 80' ' ' VAL . 29.7 ptt85 -117.2 153.27 33.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.939 0.895 . . . . 4.8899999999999997 109.904 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.28 170.19 17.39 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 109.9 -0.407 . . . . 2.5 109.9 170.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.35 -33.28 5.7 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.424 2.749 . . . . 1.6100000000000001 110.604 163.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -46.13 -40.17 10.58 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 126.221 1.808 . . . . 1.6499999999999999 110.232 -177.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.2 m 78.68 17.53 1.02 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.616 1.966 . . . . 1.71 112.666 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.76 23.96 7.21 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.445 0.698 . . . . 3.1899999999999999 112.407 164.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -144.87 118.75 9.3 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.183 -1.043 . . . . 1.49 108.183 177.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.487 HG23 ' HB3' ' A' ' 96' ' ' TYR . 35.8 m -139.82 143.56 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 106.928 -1.508 . . . . 0.94999999999999996 106.928 173.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -139.49 159.03 43.1 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.419 -0.586 . . . . 0.83999999999999997 109.419 172.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -154.84 159.17 40.36 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 122.975 0.51 . . . . 1.8500000000000001 109.73 -175.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.55 147.63 26.53 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.834 -0.802 . . . . 0.59999999999999998 108.834 172.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.3 p -144.6 144.77 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 109.244 -0.65 . . . . 1.95 109.244 174.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -141.0 175.84 9.3 Favored 'General case' 0 C--O 1.228 -0.053 0 C-N-CA 125.359 1.464 . . . . 1.27 107.947 -175.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.3 t0 . . . . . 0 CA--C 1.534 0.348 0 CA-C-O 121.367 0.603 . . . . 2.6699999999999999 110.97 175.632 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 108.345 -1.902 . . . . 1.8100000000000001 108.345 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -135.67 145.78 47.12 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 105.745 -1.946 . . . . 3.3199999999999998 105.745 178.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.36 139.32 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 107.351 -1.351 . . . . 0.84999999999999998 107.351 176.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.0 mt -87.73 138.36 31.53 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.684 -0.858 . . . . 0.81999999999999995 108.684 173.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.5 t -124.38 135.71 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 C-N-CA 126.002 1.721 . . . . 0.93999999999999995 106.608 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.1 p -110.13 156.38 20.67 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.997 1.319 . . . . 0.66000000000000003 108.236 178.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.487 ' HB3' HG23 ' A' ' 80' ' ' VAL . 1.1 t80 -151.7 108.07 3.45 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.597 -1.26 . . . . 2.8300000000000001 107.597 177.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -84.17 51.36 2.05 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.733 1.213 . . . . 2.6699999999999999 110.75 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -164.64 -178.17 5.19 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.867 1.267 . . . . 2.6600000000000001 108.094 171.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.03 158.5 32.78 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.115 0.966 . . . . 1.47 111.563 169.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.489 HD13 ' HB2' ' A' ' 104' ' ' PHE . 5.1 mt -96.04 165.27 16.72 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 126.123 1.769 . . . . 1.4299999999999999 109.923 174.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.96 -100.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.758 2.972 . . . . 2.2000000000000002 109.4 172.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -78.32 54.55 1.42 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.281 1.033 . . . . 2.8799999999999999 110.537 -175.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 42.1 18.58 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.822 2.449 . . . . 2.2200000000000002 115.678 -171.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.489 ' HB2' HD13 ' A' ' 100' ' ' LEU . 6.2 t80 60.61 97.25 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.91 0.884 . . . . 2.3399999999999999 110.688 -163.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 -77.91 111.45 13.77 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 105.736 -1.95 . . . . 8.3200000000000003 105.736 175.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -81.99 173.78 11.88 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.778 0.323 . . . . 5.0999999999999996 110.747 178.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.13 34.89 89.57 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.923 -0.471 . . . . 0.81999999999999995 111.923 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -156.3 175.84 13.47 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.655 1.582 . . . . 2.46 107.136 175.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -92.87 134.89 12.39 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.565 -0.614 . . . . 0.69999999999999996 111.565 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.2 pp -133.05 159.48 43.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.941 -0.763 . . . . 0.76000000000000001 108.941 174.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 31.5 m -125.67 122.86 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 107.808 -1.182 . . . . 0.54000000000000004 107.808 176.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -119.51 117.22 27.82 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.854 1.262 . . . . 0.55000000000000004 109.901 -171.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -106.84 143.35 35.06 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.379 1.071 . . . . 3.7400000000000002 110.711 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 179.66 -118.79 0.61 Allowed Glycine 0 C--N 1.335 0.501 0 N-CA-C 108.823 -1.711 . . . . 1.0700000000000001 108.823 169.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.8 p -150.91 144.38 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 118.006 0.903 . . . . 0.88 109.217 -176.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.929 HD22 HD22 ' A' ' 122' ' ' LEU . 5.5 mt -81.98 139.36 34.61 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.306 -1.368 . . . . 2.3799999999999999 107.306 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -177.43 26.4 0.06 OUTLIER Glycine 0 C--N 1.333 0.414 0 C-N-CA 119.045 -1.55 . . . . 2.6400000000000001 113.053 -174.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -141.25 41.18 1.77 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.974 -0.75 . . . . 6.3799999999999999 108.974 -172.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 22.28 57.84 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 129.541 3.136 . . . . 4.4299999999999997 112.933 175.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 139.79 -33.84 2.08 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-N 115.377 -0.829 . . . . 1.0900000000000001 112.492 -171.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.88 167.42 12.14 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.428 1.114 . . . . 2.6299999999999999 110.334 -175.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.929 HD22 HD22 ' A' ' 116' ' ' LEU . 8.4 mt -118.15 128.94 55.21 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.659 1.183 . . . . 1.9199999999999999 109.486 -174.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -89.15 94.66 10.01 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.096 -1.446 . . . . 0.51000000000000001 107.096 175.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -115.5 111.29 20.52 Favored 'General case' 0 C--O 1.228 -0.069 0 C-N-CA 122.949 0.5 . . . . 1.3500000000000001 110.163 -173.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.85 -43.66 8.1 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.12 0.968 . . . . 1.3 110.44 -174.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -84.51 79.06 9.7 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.95 -1.13 . . . . 3.5600000000000001 107.95 -170.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.486 HG21 HD23 ' A' ' 100' ' ' LEU . 4.4 m -90.0 96.44 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 125.794 1.637 . . . . 1.4099999999999999 111.262 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.81 149.97 20.93 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 108.81 -0.811 . . . . 0.94999999999999996 108.81 175.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -126.56 70.72 1.26 Allowed 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 123.894 0.878 . . . . 1.49 109.915 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -65.27 -10.04 29.02 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.482 0.919 . . . . 3.6699999999999999 113.482 -177.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 76.5 m80 . . . . . 0 CA--C 1.532 0.263 0 C-N-CA 123.468 0.707 . . . . 5.4100000000000001 109.63 176.283 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.0 pp . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 112.693 0.627 . . . . 2.2599999999999998 112.693 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -92.29 127.64 37.84 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.773 1.629 . . . . 2.1800000000000002 111.366 -175.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.59 152.32 50.09 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.21 1.804 . . . . 2.71 110.405 -173.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.4 m -89.91 129.35 46.62 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.103 1.361 . . . . 1.6200000000000001 111.525 -174.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -57.23 -53.24 5.06 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.543 2.828 . . . . 0.69999999999999996 112.594 -176.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.0 m -57.38 -12.41 2.51 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 114.29 1.219 . . . . 3.1899999999999999 114.29 176.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -82.67 -53.17 6.14 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 118.861 0.755 . . . . 3.0899999999999999 108.985 170.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 26.8 pt -73.27 33.11 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 114.106 1.151 . . . . 1.22 114.106 -176.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.635 HG21 ' HA3' ' A' ' 90' ' ' GLY . 22.0 m -126.64 -54.61 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 126.323 1.849 . . . . 3.1000000000000001 109.786 169.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.438 ' N ' HG23 ' A' ' 44' ' ' VAL . 42.8 m-80 -65.23 -34.49 78.49 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.701 0.8 . . . . 2.77 112.761 -163.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.62 68.71 0.1 OUTLIER Glycine 0 C--N 1.335 0.518 0 N-CA-C 110.27 -1.132 . . . . 1.8100000000000001 110.27 -177.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -165.41 -99.24 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.992 1.717 . . . . 2.98 108.36 -171.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 55.8 m -62.99 -63.71 1.12 Allowed 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 119.094 0.861 . . . . 1.4299999999999999 110.561 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.2 -44.8 64.93 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.777 0.799 . . . . 3.5699999999999998 111.162 -172.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.79 -17.81 52.48 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.619 1.168 . . . . 1.49 112.516 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 53.36 52.05 43.4 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.76 1.648 . . . . 1.4099999999999999 112.233 -175.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.1 m -105.99 -60.33 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 117.94 0.87 . . . . 1.79 113.088 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.1 mmtt -80.18 -61.49 0.44 Allowed Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 118.512 -0.756 . . . . 3.7400000000000002 112.339 -178.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -79.82 148.68 20.09 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 121.891 1.727 . . . . 1.5900000000000001 108.643 174.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -93.12 145.93 24.03 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.004 -1.11 . . . . 3.3900000000000001 108.004 165.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.88 169.02 5.58 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.136 0.574 . . . . 1.8600000000000001 110.33 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.04 33.82 86.92 Favored Glycine 0 CA--C 1.532 1.1 0 O-C-N 121.928 -0.482 . . . . 1.25 112.57 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -118.54 159.1 24.15 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.308 1.043 . . . . 1.98 108.764 170.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.5 128.02 45.59 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.122 1.369 . . . . 4.71 108.765 -177.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.2 pt -146.17 176.84 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 124.062 0.945 . . . . 0.81999999999999995 108.56 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.3 mtt85 -119.14 130.66 55.66 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.679 -0.86 . . . . 2.5600000000000001 108.679 167.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.9 p -95.43 130.37 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 107.041 -1.466 . . . . 0.76000000000000001 107.041 171.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.58 120.06 1.88 Allowed Glycine 0 C--N 1.332 0.36 0 N-CA-C 110.131 -1.188 . . . . 0.46999999999999997 110.131 -176.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.47 -159.67 21.87 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.45 -1.46 . . . . 0.63 109.45 -178.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.477 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 0.0 OUTLIER -100.69 132.22 46.19 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.918 0.866 . . . . 2.8999999999999999 111.922 -174.62 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.1 t -86.47 111.7 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.433 -0.951 . . . . 1.95 108.433 176.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 t -5.82 -102.31 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 128.624 2.769 . . . . 3.1299999999999999 114.668 163.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.7 p -158.69 -41.59 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 N-CA-C 113.548 0.944 . . . . 2.3399999999999999 113.548 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -161.26 33.33 0.38 Allowed Glycine 0 C--N 1.332 0.357 0 N-CA-C 110.995 -0.842 . . . . 3.0 110.995 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.2 m -80.25 12.73 2.72 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.739 0.644 . . . . 1.3799999999999999 112.739 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -78.04 107.6 10.72 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.948 -1.13 . . . . 2.0600000000000001 107.948 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -106.83 127.65 62.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 108.043 -1.095 . . . . 0.56000000000000005 108.043 176.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.446 ' CB ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -108.37 142.75 38.24 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.071 0.949 . . . . 4.8099999999999996 110.273 178.402 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -71.79 158.02 88.56 Favored Pre-proline 0 C--O 1.232 0.146 0 C-N-CA 123.18 0.592 . . . . 2.1299999999999999 109.521 170.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.4 -24.64 64.1 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.73 2.287 . . . . 1.22 112.346 170.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 76.1 m-80 -44.69 -34.4 2.21 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.11 0.564 . . . . 1.4299999999999999 110.886 165.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.9 m 75.2 1.53 3.73 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.801 1.64 . . . . 1.51 112.73 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 79' ' ' HIS . 0.6 OUTLIER -121.77 -13.74 8.23 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.937 1.695 . . . . 2.0299999999999998 112.689 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.494 ' N ' HD12 ' A' ' 78' ' ' LEU . 36.9 m-70 -106.48 121.41 44.21 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 105.897 -1.89 . . . . 1.3500000000000001 105.897 176.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.499 HG23 ' HB3' ' A' ' 96' ' ' TYR . 31.0 m -145.88 137.87 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 107.314 -1.365 . . . . 0.79000000000000004 107.314 -172.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -139.46 152.68 47.2 Favored 'General case' 0 C--O 1.233 0.223 0 O-C-N 121.604 -0.685 . . . . 0.91000000000000003 110.452 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -150.88 158.19 43.84 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.981 -0.554 . . . . 1.8999999999999999 110.411 -173.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -112.51 141.72 45.92 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.688 -1.227 . . . . 0.69999999999999996 107.688 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.5 p -141.87 146.16 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.244 0.618 . . . . 1.8700000000000001 109.95 -174.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -145.2 -177.94 5.81 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.99 1.316 . . . . 1.47 109.49 -170.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.2 t70 . . . . . 0 CA--C 1.534 0.359 0 C-N-CA 123.436 0.694 . . . . 2.29 109.858 175.622 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.635 ' HA3' HG21 ' A' ' 44' ' ' VAL . . . . . . . . 0 N--CA 1.443 -0.852 0 CA-C-O 118.748 -1.029 . . . . 1.79 111.074 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -117.61 132.08 56.57 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 108.024 -1.102 . . . . 3.5 108.024 174.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.6 tp -114.71 160.06 14.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 124.292 1.037 . . . . 1.1000000000000001 108.403 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.2 mt -112.28 128.81 56.38 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.6 0.76 . . . . 0.76000000000000001 109.091 -173.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.0 t -114.77 125.8 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 125.52 1.528 . . . . 0.90000000000000002 107.549 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.9 p -102.22 138.9 38.55 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.904 -0.776 . . . . 0.58999999999999997 108.904 175.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.499 ' HB3' HG23 ' A' ' 80' ' ' VAL . 1.9 t80 -132.7 111.74 11.42 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.134 1.374 . . . . 2.1299999999999999 107.415 -176.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -98.79 45.96 1.0 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.161 1.384 . . . . 1.9399999999999999 110.998 -176.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -164.6 -178.49 5.38 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.325 1.85 . . . . 2.7400000000000002 107.526 170.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.4 mp -80.77 148.66 29.96 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.738 0.78 . . . . 1.8 111.462 176.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.478 HD23 HG21 ' A' ' 80' ' ' VAL . 1.5 mm? -76.72 159.37 79.25 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 124.955 1.302 . . . . 2.5 110.295 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.29 -90.3 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.514 2.809 . . . . 2.1200000000000001 109.274 168.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.88 50.05 0.56 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.765 1.626 . . . . 3.0299999999999998 110.781 178.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . 0.254 0.3 OUTLIER 44.15 7.4 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 118.53 2.789 . . . . 3.1899999999999999 118.53 -177.653 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 79.4 t80 72.26 99.56 0.07 Allowed 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 126.148 1.779 . . . . 3.1000000000000001 109.192 -162.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -81.38 103.45 11.14 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.092 0.957 . . . . 4.9199999999999999 109.75 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -80.95 163.86 23.0 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.099 0.863 . . . . 3.1899999999999999 111.932 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.56 17.4 66.68 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 118.594 -1.114 . . . . 1.47 113.372 172.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -157.29 42.13 0.33 Allowed 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 119.308 1.554 . . . . 3.6099999999999999 113.452 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 65' ' ' MET . . . 31.29 141.53 0.0 OUTLIER Glycine 0 CA--C 1.531 1.079 0 C-N-CA 128.689 3.043 . . . . 1.02 118.847 -172.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.3 pp -140.39 163.23 23.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 120.099 -1.824 . . . . 0.93999999999999995 107.537 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.6 m -110.28 137.05 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 107.628 -1.249 . . . . 0.89000000000000001 107.628 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.425 ' CB ' HG12 ' A' ' 127' ' ' VAL . . . -123.12 128.84 50.64 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 124.076 0.95 . . . . 0.48999999999999999 109.185 178.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -111.06 140.02 45.95 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.687 -0.486 . . . . 3.6600000000000001 109.687 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 168.81 -152.04 19.3 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 121.028 -0.606 . . . . 1.0700000000000001 111.606 173.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.1 p -113.76 145.73 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.008 0.923 . . . . 0.67000000000000004 108.917 -169.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -55.22 142.52 31.11 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.437 -0.579 . . . . 1.8600000000000001 109.437 168.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.51 -131.71 1.6 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.312 -1.115 . . . . 2.3199999999999998 110.312 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -63.31 -82.24 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.339 1.056 . . . . 5.6100000000000003 109.886 -177.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -159.65 62.67 0.37 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 107.828 -1.175 . . . . 3.7200000000000002 107.828 173.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 163.52 -61.04 0.26 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.102 -1.199 . . . . 1.1899999999999999 110.102 -172.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.18 160.87 26.76 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.692 -0.887 . . . . 2.1699999999999999 108.994 -175.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 mp -122.68 137.34 54.94 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 109.62 -0.511 . . . . 1.9299999999999999 109.62 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -103.37 103.24 13.22 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.365 -0.976 . . . . 0.5 108.365 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -131.15 115.42 16.36 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 122.587 0.355 . . . . 1.03 111.017 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.2 t -109.42 -15.44 14.23 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.586 1.154 . . . . 1.0 111.749 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -104.21 80.2 1.69 Allowed 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.626 -1.296 . . . . 3.1499999999999999 109.081 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.425 HG12 ' CB ' ' A' ' 112' ' ' ALA . 34.6 m -90.12 149.44 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 118.784 0.72 . . . . 0.70999999999999996 111.496 174.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.17 142.81 51.37 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.283 -1.006 . . . . 0.93000000000000005 108.283 169.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -122.9 65.46 0.97 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.426 1.09 . . . . 1.3899999999999999 111.109 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.21 42.58 1.04 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.777 0.658 . . . . 2.9700000000000002 112.777 -175.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 29.2 m170 . . . . . 0 CA--C 1.535 0.369 0 C-N-CA 123.666 0.786 . . . . 5.46 110.122 -175.487 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.6 pt? . . . . . 0 N--CA 1.464 0.248 0 N-CA-C 112.022 0.378 . . . . 1.8 112.022 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -83.72 122.36 28.53 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.433 1.093 . . . . 2.1200000000000001 109.059 176.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.33 159.58 37.49 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.282 1.033 . . . . 3.2799999999999998 108.853 171.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 53.3 p -79.73 148.4 68.99 Favored Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 109.147 -0.686 . . . . 1.5600000000000001 109.147 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -60.87 -28.87 87.07 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 121.335 1.356 . . . . 0.77000000000000002 110.697 176.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.5 p -52.67 -28.8 23.21 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.153 0.981 . . . . 2.46 112.775 171.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -81.78 -10.48 59.33 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.019 -0.425 . . . . 2.1600000000000001 111.424 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.3 pt -127.68 34.19 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 O-C-N 120.788 -1.195 . . . . 1.3999999999999999 113.832 -176.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.422 HG12 HG12 ' A' ' 92' ' ' ILE . 3.6 m -119.85 -23.66 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 119.129 0.877 . . . . 3.1699999999999999 113.072 -176.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -139.21 132.28 29.59 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 107.123 -1.436 . . . . 4.04 107.123 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.59 -73.06 1.2 Allowed Glycine 0 CA--C 1.529 0.931 0 CA-C-O 122.465 1.036 . . . . 3.8399999999999999 111.173 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.4 mttt -44.1 -83.77 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 129.891 3.276 . . . . 4.21 111.428 -174.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.2 m -75.63 -48.02 23.95 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 121.273 1.851 . . . . 1.45 109.803 171.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -49.74 -36.78 26.88 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.078 1.14 . . . . 3.3999999999999999 114.078 -172.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.1 m -123.96 19.09 9.28 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.266 1.426 . . . . 2.8500000000000001 109.602 176.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 48.13 37.01 16.36 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 117.245 -1.864 . . . . 2.25 114.7 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.257 21.9 m -82.85 -43.08 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 122.106 2.953 . . . . 2.1600000000000001 113.18 -168.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -93.73 -64.01 0.14 Allowed Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.585 1.154 . . . . 4.9100000000000001 112.718 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.38 166.14 30.68 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.484 2.122 . . . . 1.74 109.705 176.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -118.65 129.25 55.2 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.335 0.654 . . . . 4.6699999999999999 109.907 170.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.12 111.74 1.29 Allowed 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.513 -0.551 . . . . 1.3 109.513 173.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 133.65 -20.81 4.08 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 124.363 0.982 . . . . 1.1399999999999999 111.567 -176.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -83.18 155.85 23.53 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 117.758 0.779 . . . . 2.52 109.211 177.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.0 mtt-85 -87.2 144.95 26.6 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.669 -0.863 . . . . 4.2599999999999998 108.669 170.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.4 pt -146.96 173.4 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 106.505 -1.665 . . . . 0.69999999999999996 106.505 170.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -124.67 118.36 26.31 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.516 -1.29 . . . . 2.4500000000000002 107.516 174.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.27 121.13 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.666 -1.235 . . . . 0.77000000000000002 107.666 177.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -127.83 123.44 4.47 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 109.907 -1.277 . . . . 0.48999999999999999 109.907 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.79 -162.66 23.52 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 108.068 -2.013 . . . . 0.64000000000000001 108.068 -176.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.78 137.02 37.97 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.804 0.811 . . . . 2.5699999999999998 110.565 177.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.5 t -79.23 137.86 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 108.5 -0.926 . . . . 2.1899999999999999 108.5 171.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -89.92 148.65 23.0 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.317 -0.994 . . . . 2.4399999999999999 108.317 169.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.4 p -57.67 -61.12 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.189 0.996 . . . . 2.21 110.796 178.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.55 73.46 2.05 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 109.161 -1.575 . . . . 2.1499999999999999 109.161 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.5 m -148.51 -44.42 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.152 0.797 . . . . 1.46 113.152 -177.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.421 ' HA ' ' HE3' ' A' ' 71' ' ' MET . 0.0 OUTLIER -66.81 122.31 17.39 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.227 0.467 . . . . 1.8 110.162 -177.63 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.24 120.42 48.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 108.336 -0.987 . . . . 0.56999999999999995 108.336 169.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.29 147.89 24.19 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.912 1.285 . . . . 4.3099999999999996 109.407 177.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -76.34 154.92 84.15 Favored Pre-proline 0 N--CA 1.455 -0.211 0 N-CA-C 109.008 -0.738 . . . . 1.9099999999999999 109.008 171.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -63.89 -22.8 68.68 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.608 2.205 . . . . 1.1599999999999999 111.963 166.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -47.22 -29.12 2.19 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.401 0.68 . . . . 1.1200000000000001 110.809 164.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.1 m 68.71 15.97 8.99 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 125.261 1.424 . . . . 1.3300000000000001 112.081 176.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.2 pp -125.8 -41.57 1.97 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 126.712 2.005 . . . . 1.6699999999999999 111.744 -178.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -85.43 132.31 34.24 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.538 -1.282 . . . . 1.1000000000000001 107.538 175.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.474 ' HB ' HD12 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -140.18 127.91 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 107.058 -1.46 . . . . 0.88 107.058 176.612 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -130.48 149.9 51.94 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.018 -0.734 . . . . 0.80000000000000004 109.018 176.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -145.3 143.35 30.15 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.33 -0.618 . . . . 1.8899999999999999 109.33 -175.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.84 141.87 33.05 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.327 -0.99 . . . . 0.75 108.327 164.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.6 p -128.02 153.48 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 107.472 -1.307 . . . . 1.77 107.472 170.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -140.18 179.96 6.33 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.235 0.471 . . . . 1.55 111.735 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.2 t70 . . . . . 0 N--CA 1.448 -0.544 0 C-N-CA 124.461 1.104 . . . . 2.3399999999999999 108.278 -177.821 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.559 0 CA-C-O 118.721 -1.044 . . . . 2.2799999999999998 113.296 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -63.43 108.57 1.37 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.295 1.547 . . . . 3.1800000000000002 110.216 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.422 HG12 HG12 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -130.53 143.85 39.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 108.447 -0.945 . . . . 1.1399999999999999 108.447 176.353 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.415 ' H ' HD13 ' A' ' 92' ' ' ILE . 17.9 mt -92.02 126.01 36.94 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.273 1.029 . . . . 0.75 110.75 178.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.5 t -108.84 122.79 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 125.879 1.671 . . . . 0.87 107.504 175.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.6 p -102.4 136.15 42.75 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.321 1.048 . . . . 0.46999999999999997 108.954 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.419 ' CD2' HD21 ' A' ' 100' ' ' LEU . 2.9 t80 -130.85 109.22 10.41 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.222 1.409 . . . . 1.9399999999999999 107.933 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -91.93 47.91 1.39 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.885 1.274 . . . . 2.3300000000000001 111.683 -176.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -167.68 173.37 8.53 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.22 1.808 . . . . 2.5299999999999998 107.07 170.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.4 mp -70.37 127.02 31.32 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.981 -1.074 . . . . 1.78 111.261 -177.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.474 HD12 ' HB ' ' A' ' 80' ' ' VAL . 11.9 mt -73.44 149.67 88.91 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 123.94 0.896 . . . . 1.25 110.75 174.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -68.53 140.95 49.08 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.838 3.026 . . . . 2.2200000000000002 109.696 175.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 45.85 43.92 10.48 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.307 1.443 . . . . 3.1699999999999999 111.238 -175.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 47.68 16.39 0.07 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 127.229 2.212 . . . . 2.0600000000000001 115.332 -171.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.453 ' CB ' HD13 ' A' ' 100' ' ' LEU . 69.0 t80 59.61 103.72 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.231 1.412 . . . . 2.6499999999999999 110.204 -161.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -78.75 119.93 22.67 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.238 -0.892 . . . . 5.3399999999999999 108.696 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -83.68 165.13 19.19 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 123.311 0.644 . . . . 3.0 111.044 -174.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.06 25.39 69.09 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 119.58 -0.567 . . . . 0.72999999999999998 114.146 172.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -143.55 170.57 15.58 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.734 1.214 . . . . 2.5499999999999998 108.075 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -84.92 129.28 9.14 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 109.775 -1.33 . . . . 0.69999999999999996 109.775 175.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.5 pp -136.17 152.77 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 106.434 -1.691 . . . . 0.59999999999999998 106.434 171.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 18.1 m -115.99 125.69 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 107.863 -1.162 . . . . 0.70999999999999996 107.863 177.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -116.46 134.39 54.92 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 125.09 1.356 . . . . 0.5 109.839 -170.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -126.23 143.28 51.2 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.945 1.298 . . . . 3.1400000000000001 110.628 -176.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 176.51 -123.43 0.9 Allowed Glycine 0 C--N 1.334 0.44 0 N-CA-C 108.55 -1.82 . . . . 0.82999999999999996 108.55 169.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.4 p -139.46 150.98 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 118.381 1.09 . . . . 0.79000000000000004 109.346 -175.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -55.61 133.81 50.69 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.871 -0.604 . . . . 1.8999999999999999 109.789 171.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.74 -135.51 2.35 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 109.135 -1.586 . . . . 2.23 109.135 173.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -74.1 78.25 1.74 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 109.155 -0.683 . . . . 5.6799999999999997 109.155 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.8 t0 19.34 61.37 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 129.414 3.086 . . . . 4.6100000000000003 113.086 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 166.73 -54.4 0.24 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.825 -0.91 . . . . 0.95999999999999996 110.825 -163.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.61 154.05 19.3 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 122.246 -0.561 . . . . 2.7400000000000002 109.521 172.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -111.48 123.84 51.05 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.442 1.097 . . . . 2.1000000000000001 108.646 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -97.25 93.62 6.63 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.054 -1.091 . . . . 0.56999999999999995 108.054 175.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.55 136.8 47.56 Favored 'General case' 0 C--O 1.227 -0.117 0 N-CA-C 109.46 -0.57 . . . . 0.93999999999999995 109.46 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.405 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 14.9 t -124.65 -26.68 3.79 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.236 1.014 . . . . 0.95999999999999996 112.743 177.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -89.48 88.3 7.4 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 120.472 -1.393 . . . . 3.1699999999999999 108.357 177.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.1 m -99.37 125.83 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 118.873 0.76 . . . . 0.68999999999999995 110.798 174.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.03 113.12 20.46 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.171 -1.418 . . . . 0.63 107.171 178.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.41 101.85 10.12 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 108.291 -1.003 . . . . 1.48 108.291 172.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -143.21 65.84 1.32 Allowed 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.431 0.692 . . . . 3.2400000000000002 109.461 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 106.077 -1.823 . . . . 5.7300000000000004 106.077 175.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.367 0 N-CA-C 112.948 0.721 . . . . 3.3399999999999999 112.948 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -85.61 122.59 29.94 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 123.812 0.845 . . . . 2.2000000000000002 109.384 170.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -140.78 169.17 18.13 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.768 0.827 . . . . 3.8199999999999998 109.84 171.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.2 p -91.6 148.06 36.53 Favored Pre-proline 0 N--CA 1.45 -0.471 0 C-N-CA 124.096 0.958 . . . . 2.04 110.737 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -60.98 -35.85 85.77 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.564 2.843 . . . . 1.0 111.354 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.417 ' O ' HG12 ' A' ' 44' ' ' VAL . 4.1 p -50.57 -38.6 46.2 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.918 1.287 . . . . 2.5699999999999998 112.031 174.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -60.27 -57.33 13.26 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.074 -1.084 . . . . 2.1299999999999999 108.074 177.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.256 19.5 pt -74.87 21.36 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 115.128 1.529 . . . . 1.0900000000000001 115.128 -166.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 41' ' ' SER . 1.7 p -107.13 -33.56 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 125.02 1.328 . . . . 1.9299999999999999 112.127 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -116.57 94.14 4.5 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.29 -0.881 . . . . 2.21 110.141 -170.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.31 45.66 46.72 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.739 -0.945 . . . . 1.3200000000000001 110.739 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.23 -159.33 0.88 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 103.902 -2.629 . . . . 2.4199999999999999 103.902 178.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.0 m -41.32 -45.83 3.1 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.445 1.898 . . . . 1.5600000000000001 115.078 -167.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -51.11 -47.72 61.9 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.833 0.742 . . . . 2.9700000000000002 112.014 176.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.1 m -78.2 -32.95 50.25 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.148 0.579 . . . . 1.51 111.02 174.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.43 48.49 18.29 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.429 1.014 . . . . 1.3100000000000001 111.145 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 53' ' ' LYS . 0.9 OUTLIER -89.37 -91.61 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 117.042 0.421 . . . . 2.0899999999999999 110.677 177.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.413 ' H ' HG23 ' A' ' 52' ' ' VAL . 19.0 mmmt -65.71 -56.67 17.01 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 118.452 -0.785 . . . . 3.3300000000000001 111.945 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.86 120.95 5.25 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 121.426 1.417 . . . . 1.22 109.844 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.24 165.74 18.09 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.582 0.753 . . . . 4.6100000000000003 109.053 170.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.631 ' HB1' ' HA2' ' A' ' 117' ' ' GLY . . . -71.41 173.63 7.63 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 109.07 -0.715 . . . . 1.23 109.07 171.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.16 -2.5 84.2 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 121.033 -1.042 . . . . 1.0800000000000001 113.471 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -94.15 148.8 21.84 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.282 1.041 . . . . 1.4099999999999999 109.198 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -92.78 130.04 38.52 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.105 -0.702 . . . . 4.4199999999999999 109.105 172.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.5 pt -142.66 167.3 14.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 106.426 -1.694 . . . . 0.67000000000000004 106.426 168.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.2 mtt180 -118.09 115.08 24.1 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.88 -1.526 . . . . 1.78 106.88 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.7 p -92.79 123.54 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.767 -1.197 . . . . 0.84999999999999998 107.767 178.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.34 148.97 20.63 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 118.975 0.807 . . . . 0.85999999999999999 111.682 -177.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 167.13 -100.45 0.17 Allowed Glycine 0 C--N 1.335 0.517 0 N-CA-C 109.077 -1.609 . . . . 1.79 109.077 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.7 ptp -145.46 131.23 19.02 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.738 0.769 . . . . 2.8900000000000001 110.016 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.2 p -67.11 157.08 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 119.483 -0.887 . . . . 2.4900000000000002 109.726 178.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.7 -9.88 31.66 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.908 1.077 . . . . 3.3900000000000001 113.908 175.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.253 7.6 p 49.51 68.76 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 123.863 1.792 . . . . 3.4900000000000002 111.564 177.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 142.57 47.75 0.05 OUTLIER Glycine 0 CA--C 1.526 0.731 0 CA-C-N 111.874 -2.421 . . . . 1.8300000000000001 109.861 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.0 m -156.45 -7.52 0.1 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 114.824 1.416 . . . . 1.9399999999999999 114.824 177.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.92 109.89 1.39 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 121.449 1.931 . . . . 1.8899999999999999 108.278 171.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.2 m -124.66 134.92 65.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 108.459 -0.941 . . . . 0.80000000000000004 108.459 174.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.3 ptt85 -113.67 151.05 32.35 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.424 1.089 . . . . 4.5499999999999998 109.677 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.07 160.52 65.63 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 123.082 0.553 . . . . 1.8100000000000001 110.268 175.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -74.54 -26.45 11.89 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.479 2.786 . . . . 1.22 110.584 171.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -43.4 -38.57 2.82 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 124.595 1.158 . . . . 1.71 109.023 169.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.2 m 79.38 2.7 2.28 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.687 1.995 . . . . 1.28 112.012 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.16 31.19 6.07 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.056 2.142 . . . . 2.2200000000000002 109.27 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -156.56 132.49 9.69 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.789 -0.819 . . . . 1.6299999999999999 108.789 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.89 134.47 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 125.75 1.62 . . . . 0.83999999999999997 109.026 -177.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -138.03 158.64 43.91 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 120.826 -1.171 . . . . 0.80000000000000004 110.783 172.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -155.36 153.4 30.4 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.363 0.665 . . . . 1.9299999999999999 109.845 -174.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -112.2 134.8 53.54 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.685 0.794 . . . . 0.67000000000000004 109.633 -179.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.8 t -126.04 142.78 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 108.189 -1.041 . . . . 1.8300000000000001 108.189 -173.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -139.42 -175.39 4.17 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.859 -0.793 . . . . 1.5700000000000001 108.859 177.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.1 t0 . . . . . 0 CA--C 1.534 0.353 0 C-N-CA 124.781 1.232 . . . . 2.5800000000000001 109.327 177.052 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.902 0 N-CA-C 109.804 -1.318 . . . . 1.77 109.804 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -116.88 159.41 22.44 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.246 2.218 . . . . 2.9300000000000002 107.557 178.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -137.77 163.91 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 108.236 -1.024 . . . . 0.96999999999999997 108.236 166.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.7 mt -112.94 132.52 55.31 Favored 'General case' 0 C--N 1.338 0.087 0 C-N-CA 124.625 1.17 . . . . 0.59999999999999998 108.685 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.3 t -118.25 129.94 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 125.193 1.397 . . . . 0.91000000000000003 107.477 -177.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.8 p -107.74 149.75 27.79 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.298 1.039 . . . . 0.60999999999999999 108.299 177.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -144.1 129.75 19.17 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.05 -1.463 . . . . 2.9300000000000002 107.05 176.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -69.33 -84.31 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.359 -0.838 . . . . 2.8999999999999999 110.379 166.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -56.97 163.28 2.06 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.983 0.897 . . . . 2.5699999999999998 112.825 -172.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 mp -63.45 145.54 55.42 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 122.225 1.012 . . . . 1.6299999999999999 111.986 -174.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.481 HD23 HG21 ' A' ' 127' ' ' VAL . 24.9 mt -67.85 156.4 89.4 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 115.023 -0.99 . . . . 1.23 109.997 169.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.77 -89.4 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.492 3.461 . . . . 2.3500000000000001 109.619 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.2 17.82 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.94 1.296 . . . . 2.8999999999999999 113.581 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 16.5 tp 53.24 20.6 1.92 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.485 1.114 . . . . 3.5600000000000001 111.937 -167.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 49.55 81.75 0.05 Allowed 'General case' 0 C--N 1.344 0.368 0 C-N-CA 124.94 1.296 . . . . 2.5800000000000001 110.828 173.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.294 7.8 mmm180 -87.72 29.75 0.88 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 117.872 -1.531 . . . . 5.7300000000000004 112.452 -166.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . 0.604 25.9 mt-10 80.26 161.87 0.17 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.517 1.527 . . . . 4.5099999999999998 111.807 157.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 29.9 52.95 0.19 Allowed Glycine 0 CA--C 1.533 1.198 0 C-N-CA 126.346 1.927 . . . . 0.97999999999999998 115.785 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -152.54 51.34 0.77 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.853 1.326 . . . . 3.4300000000000002 112.536 -174.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 4.67 98.34 0.0 OUTLIER Glycine 0 CA--C 1.535 1.332 0 C-N-CA 127.888 2.661 . . . . 0.92000000000000004 116.354 -174.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.0 pp -108.4 165.13 5.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 106.977 -1.49 . . . . 0.64000000000000001 106.977 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.6 m -123.62 133.97 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 107.583 -1.266 . . . . 0.72999999999999998 107.583 173.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -126.54 138.1 53.44 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.15 1.78 . . . . 0.58999999999999997 108.891 -170.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -143.02 155.88 44.73 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.972 0.805 . . . . 3.8900000000000001 112.403 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -177.08 -100.26 0.13 Allowed Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 108.386 -1.886 . . . . 1.3799999999999999 108.386 172.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.9 p -155.91 151.0 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 118.153 0.976 . . . . 0.64000000000000001 110.153 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.59 ' HG ' HD12 ' A' ' 122' ' ' LEU . 1.1 mp -85.64 150.95 24.26 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.226 1.01 . . . . 2.48 108.809 176.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.631 ' HA2' ' HB1' ' A' ' 56' ' ' ALA . . . -166.99 -53.86 0.03 OUTLIER Glycine 0 C--O 1.227 -0.322 0 C-N-CA 120.577 -0.82 . . . . 2.21 111.223 177.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -64.18 144.19 57.31 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.36 -0.978 . . . . 5.7999999999999998 108.36 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.31 58.99 2.21 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.188 1.795 . . . . 4.8399999999999999 109.268 -172.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 127.4 18.53 2.02 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 127.123 2.297 . . . . 1.74 113.6 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.29 160.63 38.98 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.937 1.369 . . . . 2.71 109.63 166.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.59 HD12 ' HG ' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -119.16 129.39 54.98 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.437 1.095 . . . . 2.3799999999999999 108.351 -172.328 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -90.44 95.25 10.08 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 107.767 -1.197 . . . . 0.41999999999999998 107.767 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.84 140.86 41.71 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 123.346 0.658 . . . . 1.0600000000000001 109.972 -176.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -125.24 -47.22 1.76 Allowed 'General case' 0 C--O 1.232 0.165 0 C-N-CA 123.864 0.866 . . . . 1.0800000000000001 111.254 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -83.42 101.36 11.32 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 106.3 -1.741 . . . . 3.0 106.3 -173.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.481 HG21 HD23 ' A' ' 100' ' ' LEU . 3.4 m -108.51 116.31 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 125.932 1.693 . . . . 0.76000000000000001 109.266 -178.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.13 113.25 25.8 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.89 -1.152 . . . . 0.59999999999999998 107.89 -177.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -99.82 45.64 0.98 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.322 1.049 . . . . 1.28 111.581 -176.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.43 48.91 1.08 Allowed 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.136 -0.977 . . . . 2.8199999999999998 111.628 -175.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.5 p80 . . . . . 0 CA--C 1.53 0.205 0 O-C-N 121.734 -0.604 . . . . 7.0599999999999996 110.252 -175.633 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.6 pt? . . . . . 0 N--CA 1.463 0.209 0 N-CA-C 110.727 -0.101 . . . . 1.8 110.727 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -83.78 129.72 34.94 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.395 1.078 . . . . 2.0299999999999998 110.138 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -132.75 144.32 50.19 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.127 1.371 . . . . 3.0699999999999998 110.556 -178.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.0 m -76.39 133.67 71.01 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 125.707 1.603 . . . . 1.96 110.677 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.48 -41.35 58.24 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.527 2.151 . . . . 0.84999999999999998 112.673 -178.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.7 t -47.96 -49.81 29.24 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 121.628 -0.67 . . . . 2.8100000000000001 111.858 175.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -48.42 -56.3 8.58 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.901 0.88 . . . . 2.3900000000000001 108.992 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 32.9 pt -70.09 -10.13 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 113.883 1.068 . . . . 1.5700000000000001 113.883 -173.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.9 t -82.04 -28.68 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 118.74 0.7 . . . . 2.02 111.014 170.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -117.57 90.58 3.36 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 121.196 -0.94 . . . . 1.98 111.426 -161.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.72 41.22 89.49 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.228 -1.149 . . . . 1.49 110.228 177.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.68 -154.0 0.47 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 128.878 2.871 . . . . 2.46 103.406 174.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.2 m -26.84 -60.57 0.09 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 116.498 2.036 . . . . 1.47 116.498 -165.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -39.04 -51.46 1.84 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.265 0.939 . . . . 3.1000000000000001 111.671 175.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.08 -21.81 18.89 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.171 2.188 . . . . 1.27 110.829 -175.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.12 31.34 80.52 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 126.3 1.905 . . . . 1.1100000000000001 113.794 171.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.8 m -80.55 -37.3 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 118.283 1.042 . . . . 1.3200000000000001 112.043 -174.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 33.0 mmtt -107.94 -75.41 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 124.665 1.186 . . . . 3.1299999999999999 111.281 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -73.04 116.78 4.84 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 CA-C-N 120.782 1.315 . . . . 1.24 109.689 176.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -76.48 161.5 28.58 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.518 0.727 . . . . 3.2200000000000002 109.77 170.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.9 169.64 6.41 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.079 0.951 . . . . 1.26 111.261 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.12 5.8 66.85 Favored Glycine 0 CA--C 1.532 1.137 0 O-C-N 121.803 -0.56 . . . . 1.01 113.584 176.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -91.3 155.39 18.57 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 118.319 1.06 . . . . 1.3500000000000001 109.125 175.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -97.24 130.67 44.42 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.29 0.636 . . . . 3.0600000000000001 109.515 177.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.1 pt -146.36 177.56 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 106.74 -1.578 . . . . 0.63 106.74 173.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 42.1 mtt85 -119.41 116.4 26.07 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.881 -1.155 . . . . 2.8100000000000001 107.881 167.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.6 p -80.99 127.4 39.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 N-CA-C 107.18 -1.415 . . . . 0.91000000000000003 107.18 174.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.4 122.57 3.31 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 109.678 -1.369 . . . . 0.75 109.678 -177.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -169.84 -170.09 33.85 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 109.383 -1.487 . . . . 0.68999999999999995 109.383 -175.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.2 ptp -99.37 137.38 37.95 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.354 0.662 . . . . 2.8199999999999998 109.508 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.4 m -100.76 135.81 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 122.606 0.362 . . . . 2.5899999999999999 111.43 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -73.57 151.64 40.85 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.364 1.066 . . . . 2.23 109.292 176.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.5 p -55.57 -56.14 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 125.351 1.46 . . . . 2.02 111.173 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.07 71.63 1.22 Allowed Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.625 -1.39 . . . . 1.6699999999999999 109.625 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.3 m -151.98 46.82 0.77 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 117.758 0.779 . . . . 2.5099999999999998 112.28 -176.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.44 121.94 20.65 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 105.862 -1.903 . . . . 1.8400000000000001 105.862 176.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.0 m -132.72 140.04 48.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 119.584 1.083 . . . . 0.56000000000000005 108.705 170.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -122.22 150.9 41.63 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.37 1.068 . . . . 6.4699999999999998 110.57 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.66 156.09 75.56 Favored Pre-proline 0 N--CA 1.453 -0.299 0 N-CA-C 109.809 -0.441 . . . . 2.0 109.809 170.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -68.3 -24.38 37.53 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.873 2.382 . . . . 1.49 111.466 166.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -45.45 -36.62 4.52 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.773 -0.454 . . . . 1.53 109.773 163.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.8 m 66.17 10.65 7.27 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 125.04 1.336 . . . . 1.46 112.999 176.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.2 pp -125.12 9.42 8.04 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 128.687 2.795 . . . . 1.73 110.2 175.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -137.79 130.34 29.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.09 -1.819 . . . . 1.3100000000000001 106.09 176.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.5 146.0 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 107.036 -1.468 . . . . 1.1699999999999999 107.036 -170.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -152.12 153.94 34.9 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 121.593 -0.692 . . . . 1.1299999999999999 110.118 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -145.99 156.06 43.24 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.924 -0.58 . . . . 1.8999999999999999 109.646 -171.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.91 140.5 37.6 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.451 -0.574 . . . . 0.83999999999999997 109.451 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.0 t -120.9 151.5 23.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 106.899 -1.519 . . . . 1.75 106.899 176.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -133.18 -177.25 4.43 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.685 0.794 . . . . 1.72 109.489 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 35.3 t70 . . . . . 0 N--CA 1.45 -0.431 0 C-N-CA 123.869 0.868 . . . . 3.2799999999999998 109.197 177.963 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.447 0 N-CA-C 111.319 -0.712 . . . . 1.98 111.319 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -63.11 114.27 3.64 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.383 0.673 . . . . 3.2400000000000002 109.238 -174.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.3 153.53 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 C-N-CA 124.391 1.076 . . . . 1.3 108.606 -178.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.8 mt -114.01 129.18 56.62 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.087 0.955 . . . . 0.70999999999999996 108.582 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.3 t -116.03 130.1 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.229 1.412 . . . . 0.94999999999999996 107.193 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 81.6 p -106.21 150.12 26.19 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.864 0.866 . . . . 0.48999999999999999 110.235 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -144.13 120.59 11.01 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.305 1.442 . . . . 2.02 107.618 -174.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -109.58 46.49 1.0 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.34 1.456 . . . . 2.0699999999999998 111.985 -169.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -170.32 -178.2 2.68 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 128.334 2.654 . . . . 2.6800000000000002 105.614 169.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.6 mp -71.02 141.67 50.94 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.89 1.223 . . . . 1.7 111.363 175.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.51 161.36 35.39 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.342 1.057 . . . . 2.4100000000000001 110.372 171.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -68.55 -97.32 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.781 2.987 . . . . 2.2400000000000002 109.395 168.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -75.79 55.73 0.89 Allowed 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.925 -1.109 . . . . 3.1400000000000001 109.965 177.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 47.7 0.89 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 129.145 2.978 . . . . 2.4500000000000002 118.113 -177.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 72.7 t80 70.84 94.74 0.07 Allowed 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 125.693 1.597 . . . . 3.0800000000000001 108.425 -156.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 54.4 mtt180 -79.54 121.15 24.87 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.689 -1.226 . . . . 6.4699999999999998 107.689 175.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -83.97 173.34 11.26 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 123.07 0.548 . . . . 3.25 111.26 -175.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 61.37 41.2 99.46 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.464 0.555 . . . . 0.78000000000000003 112.95 174.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -157.47 177.56 11.29 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.842 1.257 . . . . 2.3900000000000001 108.897 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -96.63 132.59 11.08 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 109.997 -1.241 . . . . 0.70999999999999996 109.997 171.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.7 pp -137.44 162.2 33.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 107.238 -1.393 . . . . 0.56999999999999995 107.238 174.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.4 m -124.51 135.59 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 108.857 -0.794 . . . . 0.71999999999999997 108.857 178.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -124.23 117.71 25.2 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 124.93 1.292 . . . . 0.70999999999999996 109.902 -170.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -105.7 142.21 35.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.479 1.512 . . . . 3.8500000000000001 110.779 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 168.89 -132.79 2.65 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 107.047 -2.421 . . . . 0.81999999999999995 107.047 171.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.8 p -132.93 147.38 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 C-N-CA 123.84 0.856 . . . . 0.69999999999999996 110.178 -169.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -58.91 129.57 42.81 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.662 -0.866 . . . . 1.78 108.662 169.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -90.9 -101.23 1.22 Allowed Glycine 0 C--N 1.337 0.629 0 N-CA-C 110.63 -0.988 . . . . 1.8700000000000001 110.63 -166.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.404 ' OE1' ' NZ ' ' A' ' 121' ' ' LYS . 28.6 tt0 -58.56 -68.31 0.27 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.901 1.28 . . . . 4.7999999999999998 108.248 174.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -165.48 -70.81 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.38 -1.711 . . . . 4.1900000000000004 106.38 168.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.9 -44.92 96.67 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.536 1.065 . . . . 1.1000000000000001 112.227 178.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.404 ' NZ ' ' OE1' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -83.86 145.61 28.54 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.286 0.634 . . . . 2.7400000000000002 110.631 -176.394 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.4 mp -106.5 140.26 39.67 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 108.55 -0.908 . . . . 2.1099999999999999 108.55 -176.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -105.99 103.4 12.88 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 107.528 -1.286 . . . . 0.46999999999999997 107.528 172.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -131.39 89.67 2.75 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 122.711 0.404 . . . . 1.51 111.995 -168.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.0 t -83.45 -18.08 39.87 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.761 0.652 . . . . 0.78000000000000003 112.761 -176.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -98.46 82.72 2.91 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 119.303 0.956 . . . . 2.79 109.035 -177.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 33.1 m -93.76 123.5 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 123.041 0.536 . . . . 0.65000000000000002 110.285 177.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -112.8 122.66 48.3 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.155 -1.424 . . . . 0.68000000000000005 107.155 173.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -93.3 126.47 38.44 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.915 -1.143 . . . . 1.8200000000000001 107.915 171.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.73 91.48 2.54 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 108.678 -0.86 . . . . 3.3799999999999999 108.678 174.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 12.9 p80 . . . . . 0 C--N 1.33 -0.244 0 C-N-CA 124.439 1.096 . . . . 7.29 109.579 -170.391 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 N--CA 1.464 0.23 0 CA-C-O 119.983 -0.056 . . . . 2.1699999999999999 110.919 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -83.89 137.22 33.77 Favored 'General case' 0 C--N 1.338 0.072 0 C-N-CA 124.054 0.942 . . . . 1.98 110.555 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.93 148.95 34.42 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.852 1.261 . . . . 2.6299999999999999 110.471 -171.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.1 m -79.74 132.59 60.74 Favored Pre-proline 0 N--CA 1.449 -0.495 0 C-N-CA 124.891 1.276 . . . . 1.8100000000000001 110.667 -177.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.03 -41.05 78.59 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.554 2.17 . . . . 0.97999999999999998 112.452 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 m -56.92 -23.56 45.97 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 114.392 1.256 . . . . 2.1299999999999999 114.392 178.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.45 -57.91 4.65 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 106.771 -1.566 . . . . 2.46 106.771 173.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.2 pt -69.35 15.02 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 115.385 1.624 . . . . 0.97999999999999998 115.385 -166.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.3 m -109.37 -21.03 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.557 1.943 . . . . 2.9199999999999999 111.967 172.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -122.99 99.58 6.45 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.735 1.152 . . . . 2.23 110.892 -171.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.47 44.09 95.54 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.478 -1.049 . . . . 1.4199999999999999 110.478 175.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.1 mmmt -150.83 -157.88 0.86 Allowed 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 104.455 -2.424 . . . . 3.2999999999999998 104.455 -175.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.9 m -45.17 -46.82 12.28 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.301 1.84 . . . . 2.0 115.914 -170.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -40.0 -57.82 1.55 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.49 1.041 . . . . 2.5699999999999998 111.037 171.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.39 -24.96 27.31 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.05 1.34 . . . . 1.3600000000000001 110.382 -172.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.03 33.97 75.47 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.464 1.507 . . . . 1.1599999999999999 112.438 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.7 m -81.48 -27.81 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 118.052 0.926 . . . . 1.28 112.091 -175.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -119.47 -71.67 0.02 OUTLIER Pre-proline 0 N--CA 1.451 -0.376 0 C-N-CA 124.736 1.214 . . . . 4.2800000000000002 109.98 177.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -77.12 114.03 3.71 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 CA-C-N 120.456 1.199 . . . . 1.4299999999999999 110.116 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -74.5 166.37 23.63 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.362 -0.607 . . . . 2.9300000000000002 109.362 171.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.5 169.18 13.05 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.65 0.262 . . . . 1.21 110.461 175.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.59 5.12 87.08 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 121.748 -0.595 . . . . 1.1599999999999999 112.411 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -103.1 150.97 23.1 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.455 1.102 . . . . 1.4099999999999999 108.92 176.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -91.03 129.55 37.02 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.239 -0.652 . . . . 3.5099999999999998 109.239 175.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.8 pt -143.2 166.54 14.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 106.11 -1.811 . . . . 0.72999999999999998 106.11 167.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.418 ' HG2' ' CG ' ' A' ' 113' ' ' GLN . 47.6 mtt180 -119.61 116.01 25.14 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.337 -0.986 . . . . 2.8900000000000001 108.337 175.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.3 p -84.99 122.46 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 107.518 -1.29 . . . . 1.0700000000000001 107.518 176.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -124.98 119.69 3.7 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 109.622 -1.391 . . . . 0.58999999999999997 109.622 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.38 -156.49 15.45 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.61 -1.396 . . . . 0.68999999999999995 109.61 -175.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.4 ptp -106.64 131.15 54.12 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.805 0.812 . . . . 2.6600000000000001 110.448 -172.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.404 HG22 ' H ' ' A' ' 108' ' ' GLN . 9.7 m -84.1 152.82 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 115.491 -0.777 . . . . 2.5299999999999998 109.59 -175.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.464 HG22 ' H ' ' A' ' 68' ' ' VAL . 2.3 m -64.94 179.79 0.63 Allowed 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.478 1.111 . . . . 2.4700000000000002 110.487 176.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.464 ' H ' HG22 ' A' ' 67' ' ' THR . 5.7 p -116.51 73.2 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 126.234 1.814 . . . . 2.8900000000000001 108.25 -175.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.18 50.84 0.91 Allowed Glycine 0 CA--C 1.525 0.681 0 CA-C-N 113.154 -1.839 . . . . 2.0800000000000001 111.404 171.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.7 m -110.99 8.8 22.1 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.407 0.683 . . . . 1.3100000000000001 111.915 174.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.98 109.87 6.85 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 106.541 -1.651 . . . . 2.2000000000000002 106.541 175.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.8 m -121.11 129.09 76.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 108.707 -0.849 . . . . 0.92000000000000004 108.707 171.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.457 ' CB ' HG12 ' A' ' 80' ' ' VAL . 20.1 ptt180 -111.1 148.62 32.28 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.405 1.082 . . . . 5.2300000000000004 110.793 177.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -82.37 153.21 68.46 Favored Pre-proline 0 C--O 1.234 0.26 0 N-CA-C 109.148 -0.686 . . . . 2.0899999999999999 109.148 170.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -71.64 8.65 1.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.958 2.439 . . . . 1.71 113.789 176.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -69.32 -26.54 64.76 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.756 -0.59 . . . . 1.6799999999999999 109.84 161.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.0 m 72.25 1.34 3.91 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.158 1.783 . . . . 1.22 113.51 -174.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.38 -3.71 8.9 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.694 1.198 . . . . 2.04 113.505 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -117.55 125.85 51.55 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.786 -1.561 . . . . 1.3400000000000001 106.786 174.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.565 HG23 ' HB3' ' A' ' 96' ' ' TYR . 28.2 m -144.45 150.43 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 108.149 -1.056 . . . . 0.95999999999999996 108.149 -175.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -151.58 154.82 37.21 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.875 -0.516 . . . . 0.98999999999999999 110.439 -179.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.438 ' CE1' ' CE1' ' A' ' 104' ' ' PHE . 33.8 p90 -156.77 153.04 27.72 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.059 0.457 . . . . 2.0600000000000001 111.69 -176.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.24 154.71 19.9 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 123.47 0.708 . . . . 0.69999999999999996 109.978 170.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.3 m -132.54 163.24 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 108.191 -1.04 . . . . 2.3199999999999998 108.191 163.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -137.8 -168.24 2.3 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.352 1.061 . . . . 1.76 109.885 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.7 t70 . . . . . 0 C--O 1.234 0.278 0 C-N-CA 123.594 0.758 . . . . 2.3999999999999999 109.453 175.272 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.669 0 N-CA-C 111.129 -0.788 . . . . 2.1000000000000001 111.129 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -58.25 112.07 1.42 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 117.898 0.849 . . . . 4.1900000000000004 110.049 -178.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.0 tp -143.79 160.27 16.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 108.093 -1.077 . . . . 1.5 108.093 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.68 129.09 50.58 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.265 1.026 . . . . 0.68999999999999995 108.533 -168.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.413 ' CG2' ' CE1' ' A' ' 82' ' ' PHE . 5.3 m -115.15 146.77 19.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 109.14 -0.689 . . . . 2.3900000000000001 109.14 173.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.4 p -110.19 155.77 21.53 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.963 1.705 . . . . 0.46000000000000002 107.863 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.565 ' HB3' HG23 ' A' ' 80' ' ' VAL . 1.9 t80 -150.08 113.41 4.92 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.973 -1.491 . . . . 2.02 106.973 -175.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -101.47 45.2 0.98 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.186 1.394 . . . . 2.0899999999999999 110.906 -173.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -162.95 -176.77 5.08 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.65 1.98 . . . . 2.4399999999999999 106.201 170.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.1 mp -79.67 146.25 32.56 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.868 0.867 . . . . 1.55 111.081 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.525 ' HG ' HG21 ' A' ' 80' ' ' VAL . 78.3 mt -82.06 155.38 69.99 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 123.962 0.905 . . . . 1.49 109.412 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.99 -89.95 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.554 2.836 . . . . 2.0099999999999998 110.173 176.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.78 45.72 0.43 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.284 1.434 . . . . 3.48 110.613 -176.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 44.19 8.25 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.279 2.632 . . . . 2.1600000000000001 115.854 -164.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.438 ' CE1' ' CE1' ' A' ' 82' ' ' PHE . 65.4 t80 50.74 91.91 0.02 OUTLIER 'General case' 0 C--N 1.34 0.171 0 CA-C-N 119.339 0.972 . . . . 2.9500000000000002 109.873 -153.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -78.6 146.17 34.32 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.814 -1.18 . . . . 6.46 107.814 173.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -93.11 167.19 11.94 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 125.401 1.481 . . . . 3.2799999999999998 109.567 -169.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 47.56 44.17 22.14 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 123.532 0.587 . . . . 0.82999999999999996 113.739 -177.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.404 ' H ' HG22 ' A' ' 66' ' ' VAL . 0.7 OUTLIER -153.24 120.03 5.68 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.793 1.637 . . . . 2.2999999999999998 107.387 176.362 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -63.61 135.24 41.58 Favored Glycine 0 CA--C 1.523 0.54 0 O-C-N 121.207 -0.933 . . . . 0.63 111.368 -175.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.2 pp -135.97 166.09 27.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.817 -1.179 . . . . 0.58999999999999997 107.817 177.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 17.6 m -118.79 128.94 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 108.983 -0.747 . . . . 0.67000000000000004 108.983 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -120.45 118.22 29.72 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 125.023 1.329 . . . . 0.77000000000000002 109.727 -168.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.418 ' CG ' ' HG2' ' A' ' 61' ' ' ARG . 0.8 OUTLIER -114.91 150.31 35.84 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.65 1.58 . . . . 3.8100000000000001 109.915 -178.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 173.33 -122.57 0.93 Allowed Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 106.61 -2.596 . . . . 0.97999999999999998 106.61 165.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.0 p -143.44 148.24 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 118.204 1.002 . . . . 0.78000000000000003 109.821 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -69.85 143.03 52.97 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.251 -0.648 . . . . 2.29 109.251 168.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -166.04 26.18 0.17 Allowed Glycine 0 CA--C 1.523 0.565 0 C-N-CA 119.602 -1.285 . . . . 2.8199999999999998 113.146 171.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -151.91 45.01 0.75 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.926 0.891 . . . . 6.0999999999999996 108.748 -174.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 24.86 59.95 0.05 Allowed 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 128.976 2.91 . . . . 4.0300000000000002 112.481 172.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 139.27 -47.93 0.88 Allowed Glycine 0 CA--C 1.529 0.949 0 CA-C-N 114.77 -1.105 . . . . 1.1499999999999999 110.948 -172.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.5 151.27 20.8 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 117.885 0.842 . . . . 2.1699999999999999 110.184 -174.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 mp -112.68 121.89 46.08 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.721 1.208 . . . . 2.02 109.364 -169.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -82.89 88.23 6.81 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.403 -1.702 . . . . 0.65000000000000002 106.403 175.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -106.62 72.41 0.9 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.168 0.987 . . . . 1.6399999999999999 110.723 -165.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.9 t -80.79 -6.66 58.82 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.037 0.754 . . . . 1.1599999999999999 113.037 -168.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -113.06 88.63 2.88 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 120.799 -1.188 . . . . 4.1200000000000001 108.864 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 27.0 m -96.74 125.93 49.58 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 C-N-CA 123.312 0.645 . . . . 0.81999999999999995 109.826 174.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -111.94 113.33 25.57 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.68 -1.6 . . . . 0.70999999999999996 106.68 177.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.34 36.79 0.25 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.078 0.551 . . . . 1.48 112.069 -178.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.0 ptmt -85.09 60.68 6.4 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.233 -0.917 . . . . 3.2200000000000002 110.307 -173.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 7.1 p80 . . . . . 0 CA--C 1.533 0.289 0 C-N-CA 123.942 0.897 . . . . 6.21 111.27 -178.843 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 pt? . . . . . 0 N--CA 1.456 -0.132 0 N-CA-C 109.926 -0.398 . . . . 2.1400000000000001 109.926 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -92.04 111.07 22.48 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.751 1.22 . . . . 2.27 109.414 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -125.59 160.16 30.31 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.879 1.272 . . . . 3.8300000000000001 110.104 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.4 p -72.09 135.58 82.46 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 109.599 -0.519 . . . . 1.6799999999999999 109.599 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.412 ' HA ' HD11 ' A' ' 43' ' ' ILE . 33.9 Cg_endo -55.89 -29.59 73.49 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.866 3.044 . . . . 0.93000000000000005 112.337 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.487 ' O ' HG12 ' A' ' 44' ' ' VAL . 31.0 p -66.96 -35.82 80.83 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.024 0.75 . . . . 2.1699999999999999 113.024 178.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -45.0 -47.79 11.49 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 118.882 0.765 . . . . 3.0299999999999998 110.036 177.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.458 HD13 ' H ' ' A' ' 43' ' ' ILE 0.34 0.2 OUTLIER -85.76 11.51 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 114.784 1.402 . . . . 1.79 114.784 -170.009 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.487 HG12 ' O ' ' A' ' 41' ' ' SER . 0.8 OUTLIER -103.13 -8.95 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 123.445 0.698 . . . . 2.0299999999999998 112.553 179.184 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -105.79 -58.15 1.95 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.527 0.603 . . . . 2.5699999999999998 111.964 -171.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -160.71 64.56 0.28 Allowed Glycine 0 C--N 1.335 0.5 0 N-CA-C 109.266 -1.534 . . . . 1.47 109.266 -170.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 15.1 mmtt -153.96 -111.93 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 106.339 -1.726 . . . . 2.3399999999999999 106.339 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.4 m -54.17 -63.03 1.28 Allowed 'General case' 0 C--N 1.343 0.323 0 C-N-CA 126.851 2.06 . . . . 1.3799999999999999 113.298 177.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -49.46 -42.27 42.62 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.964 0.888 . . . . 2.4199999999999999 110.993 -172.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.86 -9.54 45.97 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.338 1.855 . . . . 1.3799999999999999 113.323 -178.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 48.62 48.93 28.35 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 126.26 1.886 . . . . 1.2 113.763 -174.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.5 m -95.18 -55.71 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 118.566 1.183 . . . . 1.27 112.275 -177.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.1 mmtt -87.34 -59.82 0.26 Allowed Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 123.762 0.825 . . . . 3.2000000000000002 111.035 178.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -81.79 155.48 17.97 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 121.942 1.761 . . . . 1.49 109.89 174.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -124.02 60.21 1.13 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.676 1.19 . . . . 3.5699999999999998 109.037 174.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 48.7 -144.46 0.42 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.318 1.047 . . . . 2.6699999999999999 110.116 -174.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 40.23 30.83 0.3 Allowed Glycine 0 CA--C 1.533 1.165 0 C-N-CA 127.83 2.633 . . . . 1.3700000000000001 117.527 165.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -134.62 167.41 20.87 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.857 1.663 . . . . 1.3999999999999999 108.017 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -101.46 134.56 44.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.681 -0.859 . . . . 3.5699999999999998 108.681 171.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.4 pt -139.22 167.68 19.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 105.055 -2.202 . . . . 0.89000000000000001 105.055 168.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.8 mtm180 -126.74 122.89 36.13 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.86 -1.533 . . . . 2.2000000000000002 106.86 174.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.7 m -88.56 138.12 19.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 107.691 -1.226 . . . . 2.3999999999999999 107.691 177.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.0 110.4 0.58 Allowed Glycine 0 C--O 1.226 -0.393 0 N-CA-C 109.599 -1.401 . . . . 0.89000000000000001 109.599 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -172.78 -161.37 23.08 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 108.862 -1.695 . . . . 0.72999999999999998 108.862 -173.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.17 132.74 41.27 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 117.694 0.747 . . . . 2.6499999999999999 110.843 -176.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.522 HG11 ' CE2' ' A' ' 104' ' ' PHE . 23.1 m -91.07 150.93 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-N 116.165 -0.47 . . . . 2.6499999999999999 110.097 174.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.464 HG22 ' H ' ' A' ' 68' ' ' VAL . 0.3 OUTLIER -64.13 -179.31 0.42 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.704 0.764 . . . . 2.2799999999999998 109.856 174.64 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.464 ' H ' HG22 ' A' ' 67' ' ' THR . 4.6 p -123.7 71.02 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 126.176 1.79 . . . . 2.5699999999999998 107.893 175.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.33 -21.75 1.21 Allowed Glycine 0 CA--C 1.53 1.012 0 CA-C-N 114.167 -1.379 . . . . 2.46 113.93 174.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.8 m -62.12 -17.65 58.44 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.655 1.227 . . . . 1.1699999999999999 113.713 -178.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.5 ttm -58.85 125.88 25.35 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 122.972 0.509 . . . . 2.0499999999999998 109.87 171.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.28 130.67 67.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 107.615 -1.254 . . . . 0.63 107.615 166.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -114.46 143.59 44.69 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.599 1.159 . . . . 4.21 109.36 -177.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.49 147.05 51.76 Favored Pre-proline 0 N--CA 1.454 -0.246 0 N-CA-C 109.626 -0.509 . . . . 1.8500000000000001 109.626 177.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -62.51 -25.93 76.01 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.664 2.242 . . . . 1.46 110.826 170.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -42.38 -41.64 2.93 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.572 1.549 . . . . 1.72 110.475 174.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.3 m 87.95 5.9 0.23 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 126.927 2.091 . . . . 1.4099999999999999 113.064 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.84 3.79 9.45 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.011 0.924 . . . . 2.4300000000000002 113.355 173.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -128.06 135.07 49.34 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 119.044 0.838 . . . . 1.1499999999999999 109.633 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.594 HG23 ' HB3' ' A' ' 96' ' ' TYR . 2.2 m -149.88 138.76 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 106.928 -1.508 . . . . 0.68000000000000005 106.928 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -142.11 157.93 44.33 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.46 -0.571 . . . . 1.29 109.46 174.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -156.14 152.32 27.78 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.946 -0.39 . . . . 1.8899999999999999 109.946 -174.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.93 149.0 22.38 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.46 -0.57 . . . . 0.55000000000000004 109.46 170.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.1 p -136.78 152.76 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.385 1.074 . . . . 1.9099999999999999 108.919 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -143.01 179.5 7.0 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.43 0.692 . . . . 1.4199999999999999 111.524 -174.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 C--N 1.341 0.223 0 N-CA-C 109.845 -0.428 . . . . 2.3999999999999999 109.845 177.703 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.654 0 N-CA-C 107.802 -2.119 . . . . 1.6899999999999999 107.802 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -120.55 130.52 54.26 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 106.943 -1.502 . . . . 4.3600000000000003 106.943 177.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -132.04 146.27 33.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.297 -1.001 . . . . 0.95999999999999996 108.297 174.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 mt -101.88 128.35 48.3 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.208 1.403 . . . . 0.80000000000000004 109.913 -175.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.3 t -119.33 125.83 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 124.914 1.285 . . . . 1.0600000000000001 108.14 -178.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 42.3 p -95.85 152.18 18.73 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.681 0.792 . . . . 0.57999999999999996 108.926 174.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.594 ' HB3' HG23 ' A' ' 80' ' ' VAL . 3.2 t80 -145.84 166.96 24.4 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.411 1.085 . . . . 2.6299999999999999 108.733 -177.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -155.61 150.7 26.67 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 105.373 -2.084 . . . . 3.2599999999999998 105.373 -169.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 62.96 61.54 1.11 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 129.299 3.039 . . . . 3.0099999999999998 111.587 -176.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.3 mt 51.68 -152.32 0.23 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.552 1.141 . . . . 1.8600000000000001 109.158 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.453 HD23 ' CZ ' ' A' ' 96' ' ' TYR . 8.6 mt -146.57 153.69 47.59 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 105.764 -1.939 . . . . 1.3700000000000001 105.764 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.84 -83.44 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 125.118 3.879 . . . . 2.6400000000000001 109.853 -174.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -73.75 34.09 0.08 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.34 1.456 . . . . 5.6900000000000004 110.701 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 61.19 -22.61 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.658 1.983 . . . . 3.5 114.155 -170.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.522 ' CE2' HG11 ' A' ' 66' ' ' VAL . 64.6 t80 59.69 86.91 0.09 Allowed 'General case' 0 C--N 1.342 0.275 0 CA-C-N 120.286 1.403 . . . . 2.6800000000000002 107.7 -155.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 19.8 mtp85 -82.95 127.64 33.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 105.663 -1.977 . . . . 3.9399999999999999 105.663 175.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -81.37 169.33 17.35 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.101 0.477 . . . . 2.8599999999999999 110.284 -170.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.15 45.67 90.76 Favored Glycine 0 CA--C 1.533 1.188 0 O-C-N 121.765 -0.585 . . . . 0.89000000000000001 113.399 177.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -155.78 179.57 9.07 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.487 1.515 . . . . 2.4100000000000001 107.756 175.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -94.82 133.78 11.7 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 109.625 -1.39 . . . . 0.77000000000000002 109.625 170.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.4 pp -138.73 161.92 29.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 107.477 -1.305 . . . . 0.77000000000000002 107.477 175.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 18.6 m -118.7 123.66 71.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.321 -0.992 . . . . 0.80000000000000004 108.321 177.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.572 ' CB ' HG12 ' A' ' 127' ' ' VAL . . . -110.37 136.81 48.97 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 125.902 1.681 . . . . 0.67000000000000004 109.732 -175.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -128.81 141.53 51.27 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.036 1.734 . . . . 3.0800000000000001 108.612 -175.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 173.29 -121.83 0.88 Allowed Glycine 0 C--N 1.336 0.547 0 N-CA-C 109.218 -1.553 . . . . 0.90000000000000002 109.218 168.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.04 153.21 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.861 -0.792 . . . . 0.77000000000000002 108.861 -173.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -57.71 142.38 45.41 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.186 -0.672 . . . . 1.73 109.186 171.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -87.13 -126.27 2.15 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 109.355 -1.498 . . . . 2.02 109.355 -174.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -60.66 -64.87 0.8 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.265 0.626 . . . . 5.1299999999999999 109.512 178.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -149.87 -74.08 0.17 Allowed 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 107.043 -1.465 . . . . 3.6800000000000002 107.043 173.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -72.54 -39.73 55.65 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.055 -0.975 . . . . 1.24 111.626 -174.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.57 153.47 26.73 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.615 0.766 . . . . 3.6800000000000002 109.699 -175.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -110.06 136.4 49.36 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 125.12 1.368 . . . . 2.2000000000000002 108.275 -176.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -105.78 90.22 3.32 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.712 -1.218 . . . . 0.55000000000000004 107.712 174.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.17 145.22 26.02 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 108.388 -0.968 . . . . 1.46 108.388 176.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.4 t -134.73 0.06 2.92 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.977 0.732 . . . . 1.1100000000000001 112.977 169.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -129.48 99.89 5.35 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 120.669 -1.269 . . . . 2.8799999999999999 109.123 171.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.585 HG13 ' HE2' ' A' ' 96' ' ' TYR . 29.4 m -98.69 148.27 6.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-N 118.885 0.766 . . . . 1.0600000000000001 111.546 166.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.35 112.5 16.41 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.033 -1.84 . . . . 0.76000000000000001 106.033 176.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -100.23 41.52 1.16 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.088 0.955 . . . . 2.04 111.482 -175.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -73.63 71.91 1.42 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.844 1.258 . . . . 4.5800000000000001 111.282 -176.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 . . . . . 0 CA--C 1.532 0.254 0 CA-C-N 118.749 0.704 . . . . 4.2000000000000002 112.697 -170.965 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 pt? . . . . . 0 C--O 1.233 0.206 0 CA-C-O 121.018 0.437 . . . . 2.0600000000000001 111.612 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -82.05 132.05 35.25 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.084 0.954 . . . . 2.3500000000000001 109.238 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -131.59 152.92 50.42 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.126 1.77 . . . . 3.8599999999999999 108.589 176.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.9 p -94.19 143.73 26.87 Favored Pre-proline 0 N--CA 1.442 -0.853 0 C-N-CA 125.203 1.401 . . . . 2.0899999999999999 108.729 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -61.57 -18.09 57.84 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.598 2.199 . . . . 1.4199999999999999 112.465 178.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.0 p -47.46 -40.48 18.31 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.32 1.048 . . . . 4.0700000000000003 112.181 165.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.48 ' HG3' ' HD3' ' A' ' 47' ' ' LYS . 7.4 tp10 -83.11 -52.48 6.59 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.966 -1.124 . . . . 2.48 107.966 -169.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 26.8 pt -81.11 30.83 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.046 0.938 . . . . 1.23 113.126 -170.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.0 p -122.88 -44.91 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.923 1.689 . . . . 2.5899999999999999 110.59 173.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -77.21 -41.6 40.72 Favored 'General case' 0 C--N 1.34 0.157 0 O-C-N 121.718 -0.614 . . . . 2.52 112.37 -162.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.04 59.66 0.13 Allowed Glycine 0 C--N 1.332 0.346 0 N-CA-C 109.439 -1.464 . . . . 1.4399999999999999 109.439 -170.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.48 ' HD3' ' HG3' ' A' ' 42' ' ' GLU . 4.6 mttt -155.19 -94.48 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.522 1.929 . . . . 2.27 108.364 -178.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.492 HG23 HD23 ' A' ' 116' ' ' LEU . 97.7 m -71.95 -58.39 3.49 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 119.271 0.941 . . . . 1.6000000000000001 111.877 -172.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -46.83 -53.67 11.51 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.778 0.799 . . . . 2.5099999999999998 110.243 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.43 -23.8 29.83 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.747 -1.115 . . . . 1.24 111.965 -171.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.7 53.41 41.43 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.203 1.383 . . . . 1.3700000000000001 111.864 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.274 31.8 m -110.13 -73.58 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 113.73 1.011 . . . . 1.74 113.73 -178.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -64.44 -56.59 21.77 Favored Pre-proline 0 CA--C 1.538 0.507 0 O-C-N 120.953 -1.092 . . . . 3.1299999999999999 113.017 -176.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -87.26 159.23 8.33 Favored 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 123.391 2.728 . . . . 1.3200000000000001 108.371 175.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -100.19 150.76 22.19 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.738 -0.838 . . . . 3.6200000000000001 108.738 171.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.46 157.97 10.4 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.275 -0.639 . . . . 1.1200000000000001 109.275 169.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.57 -0.24 70.8 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 119.041 -0.866 . . . . 1.26 113.819 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.475 ' O ' HD12 ' A' ' 116' ' ' LEU . 31.4 mt-30 -81.39 158.97 24.46 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 119.415 1.608 . . . . 1.4099999999999999 108.456 169.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 45.4 mtt180 -92.82 137.23 32.55 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.71 -0.478 . . . . 3.4700000000000002 109.71 170.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.6 pt -144.7 175.07 3.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 107.482 -1.303 . . . . 0.79000000000000004 107.482 167.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -121.68 124.26 43.85 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-O 119.079 -0.486 . . . . 1.99 110.236 168.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.0 p -82.59 128.5 38.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 N-CA-C 107.537 -1.283 . . . . 1.0 107.537 170.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -128.21 129.27 6.23 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 109.16 -1.576 . . . . 0.56000000000000005 109.16 172.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 176.89 -150.96 10.69 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 107.576 -2.209 . . . . 0.77000000000000002 107.576 -175.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.401 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 1.8 ppp? -125.27 155.6 39.89 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 118.473 1.136 . . . . 4.4400000000000004 111.843 177.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.8 p -100.97 131.73 48.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 114.471 -1.241 . . . . 2.3599999999999999 109.799 -174.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.11 159.54 20.18 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 122.228 1.013 . . . . 2.1200000000000001 109.509 174.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.9 p -67.56 -34.31 67.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.859 1.264 . . . . 1.75 112.89 -175.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -120.86 84.07 0.37 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 108.956 -1.658 . . . . 2.0600000000000001 108.956 175.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.3 m -140.29 -43.96 0.41 Allowed 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.909 0.884 . . . . 1.3300000000000001 112.322 -176.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.16 109.77 3.19 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.567 0.747 . . . . 2.0899999999999999 110.184 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.8 m -111.33 117.24 54.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 107.417 -1.327 . . . . 0.64000000000000001 107.417 169.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.95 140.06 42.96 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.86 1.264 . . . . 5.9000000000000004 109.416 -176.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -82.13 149.31 62.22 Favored Pre-proline 0 N--CA 1.455 -0.221 0 N-CA-C 108.903 -0.777 . . . . 1.78 108.903 176.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -66.11 -20.89 56.47 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.497 2.131 . . . . 1.76 110.227 167.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -41.53 -43.36 2.65 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 123.75 0.82 . . . . 1.2 109.415 163.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.8 m 73.49 4.2 4.74 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.055 1.342 . . . . 1.45 112.905 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.2 18.44 10.72 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.882 1.673 . . . . 1.8700000000000001 110.539 173.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 48.9 m-70 -150.79 119.21 6.42 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.478 -1.675 . . . . 1.1000000000000001 106.478 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.7 m -148.54 135.95 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 105.974 -1.861 . . . . 0.78000000000000003 105.974 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -138.78 152.34 47.83 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 119.853 1.206 . . . . 0.93999999999999995 110.799 -177.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -149.33 153.11 36.97 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.28 0.632 . . . . 1.8500000000000001 109.693 -172.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.59 147.41 23.94 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.637 0.775 . . . . 1.01 109.414 169.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.0 t -124.55 146.61 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 N-CA-C 107.429 -1.323 . . . . 1.8 107.429 169.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -150.9 -167.06 2.71 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 108.603 -0.888 . . . . 1.3300000000000001 108.603 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.2 t0 . . . . . 0 CA--C 1.512 -0.495 0 N-CA-C 107.871 -1.159 . . . . 3.5699999999999998 107.871 166.046 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.845 0 CA-C-O 119.034 -0.87 . . . . 2.2200000000000002 113.002 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -171.01 156.72 4.96 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.689 1.996 . . . . 2.5699999999999998 106.81 168.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.5 tp -151.18 162.17 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.834 1.254 . . . . 1.2 108.19 172.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mt -124.25 131.21 53.51 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 124.545 1.138 . . . . 0.93000000000000005 109.928 -176.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.6 p -135.16 142.17 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.822 0.849 . . . . 3.0600000000000001 110.166 -174.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.6 p -105.28 153.46 21.57 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.172 1.389 . . . . 1.3100000000000001 108.973 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.454 ' CD2' HD21 ' A' ' 100' ' ' LEU . 3.7 t80 -141.43 138.93 33.27 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.268 -1.753 . . . . 2.2200000000000002 106.268 178.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -128.45 39.43 3.82 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.249 1.02 . . . . 2.2000000000000002 112.138 -165.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -166.22 56.93 0.1 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.945 0.898 . . . . 2.8999999999999999 110.934 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.8 mp 51.95 -168.35 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.911 1.284 . . . . 1.77 111.366 -170.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.454 HD21 ' CD2' ' A' ' 96' ' ' TYR . 15.2 mt -148.34 150.69 35.11 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.286 1.434 . . . . 1.4199999999999999 107.215 174.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -62.16 132.75 40.41 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 123.413 2.742 . . . . 2.6899999999999999 109.746 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 37.3 49.25 0.9 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.391 1.877 . . . . 4.3600000000000003 111.645 -173.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 56.72 10.69 0.76 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 128.73 2.812 . . . . 2.3500000000000001 115.518 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.6 t80 64.73 99.79 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.788 1.235 . . . . 2.6699999999999999 108.134 -162.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 46.0 mtt180 -77.44 131.44 37.99 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.441 -1.688 . . . . 4.96 106.441 172.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -83.58 170.72 14.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.102 0.561 . . . . 4.5899999999999999 109.6 -176.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.42 46.9 91.57 Favored Glycine 0 CA--C 1.531 1.058 0 O-C-N 121.924 -0.485 . . . . 0.81999999999999995 112.826 174.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -151.7 179.07 8.73 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.895 1.678 . . . . 2.3700000000000001 108.555 178.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 65' ' ' MET . . . -111.24 142.97 17.11 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.2 -0.76 . . . . 0.75 111.2 171.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.4 pp -145.84 168.97 6.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 125.498 1.519 . . . . 0.85999999999999999 106.917 -178.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.0 m -120.77 138.73 50.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 N-CA-C 108.011 -1.107 . . . . 0.56000000000000005 108.011 167.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -127.28 118.17 23.7 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 124.627 1.171 . . . . 0.52000000000000002 109.439 -176.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.67 132.86 52.88 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.197 1.399 . . . . 3.3700000000000001 108.639 -175.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 178.47 -160.75 26.93 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 120.858 -0.687 . . . . 1.26 112.308 -177.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.6 p -123.52 138.39 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 125.114 1.365 . . . . 0.97999999999999998 110.121 -169.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.492 HD23 HG23 ' A' ' 48' ' ' THR . 3.8 mp -68.56 138.8 55.42 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.768 -0.583 . . . . 2.3399999999999999 111.027 -179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -95.98 -114.9 2.98 Favored Glycine 0 C--N 1.341 0.809 0 N-CA-C 109.943 -1.263 . . . . 1.79 109.943 -166.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -46.82 -55.92 7.12 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 117.876 0.838 . . . . 4.0700000000000003 112.318 175.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 176.25 -79.08 0.0 OUTLIER 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 128.004 2.522 . . . . 3.4700000000000002 105.251 -174.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.5 -25.13 76.16 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.601 1.096 . . . . 0.96999999999999997 112.679 -174.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.55 152.47 21.68 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.528 1.531 . . . . 2.5099999999999998 109.572 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.0 mp -117.8 156.53 28.19 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.08 0.552 . . . . 2.0899999999999999 109.911 -178.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -120.07 107.42 13.03 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.065 1.346 . . . . 0.73999999999999999 107.979 173.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.24 132.9 41.99 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 118.951 -0.547 . . . . 1.03 110.743 -175.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.3 t -122.2 4.4 9.78 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.38 0.672 . . . . 0.96999999999999997 112.473 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -113.1 79.55 1.25 Allowed 'General case' 0 CA--C 1.531 0.229 0 O-C-N 120.587 -1.321 . . . . 2.5800000000000001 109.361 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.1 m -95.41 132.42 39.53 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 C-N-CA 122.918 0.487 . . . . 0.71999999999999997 110.325 174.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.06 107.13 14.14 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.245 -1.761 . . . . 0.73999999999999999 106.245 175.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.52 105.4 13.54 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.194 -1.039 . . . . 1.5 108.194 175.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -121.68 71.21 0.97 Allowed 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.84 0.856 . . . . 2.9700000000000002 109.618 -176.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 107.082 -1.451 . . . . 4.1299999999999999 107.082 178.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.376 0.131 . . . . 2.6400000000000001 111.087 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -83.68 120.26 25.78 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.782 1.233 . . . . 2.5099999999999998 109.695 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -116.17 163.33 16.12 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.615 1.566 . . . . 2.8199999999999998 109.705 177.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.8 m -84.91 132.89 44.54 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 109.306 -0.628 . . . . 1.8 109.306 -174.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -56.45 -45.33 38.22 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 123.191 2.594 . . . . 0.81000000000000005 111.741 -176.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.655 ' HG ' ' N ' ' A' ' 90' ' ' GLY . 29.0 t -61.74 -23.35 66.1 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.351 -0.843 . . . . 2.52 112.341 178.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -66.74 -45.94 77.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.926 -1.138 . . . . 3.3199999999999998 107.926 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.429 HD11 HG21 ' A' ' 92' ' ' ILE 0.388 18.6 pt -65.56 -11.68 12.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 114.233 1.197 . . . . 1.3100000000000001 114.233 -177.29 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -79.68 -30.83 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.409 0.683 . . . . 1.97 112.266 169.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -81.26 -76.4 0.25 Allowed 'General case' 0 N--CA 1.466 0.354 0 O-C-N 121.087 -1.008 . . . . 3.0800000000000001 112.968 -162.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -133.34 51.26 0.85 Allowed Glycine 0 C--N 1.333 0.415 0 N-CA-C 108.055 -2.018 . . . . 2.1400000000000001 108.055 -174.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 1.8 mmtt -147.04 -114.03 0.08 Allowed 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 125.669 1.588 . . . . 4.1699999999999999 108.483 -164.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.0 m -77.12 -55.83 5.1 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 119.401 1.0 . . . . 1.3700000000000001 110.877 -169.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -44.3 -59.82 2.21 Favored 'General case' 0 C--N 1.341 0.204 0 O-C-N 123.87 0.732 . . . . 3.0899999999999999 110.459 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.9 m -84.47 -16.11 43.65 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.216 -0.902 . . . . 1.6299999999999999 110.907 -174.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 65.19 50.44 56.79 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 124.077 0.846 . . . . 1.3300000000000001 112.36 170.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.9 m -106.3 -54.31 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 117.832 0.816 . . . . 1.3100000000000001 112.982 -175.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -90.06 -62.02 0.21 Allowed Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 123.645 0.778 . . . . 5.5800000000000001 112.242 -176.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.41 ' CD ' ' HA ' ' A' ' 47' ' ' LYS . 29.7 Cg_endo -80.34 170.77 15.72 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.795 2.33 . . . . 1.53 108.096 170.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -128.53 160.24 32.98 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.593 -1.632 . . . . 3.23 106.593 168.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.38 156.78 37.11 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.135 -1.061 . . . . 1.1699999999999999 108.135 171.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.49 10.85 60.12 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.093 0.854 . . . . 1.04 112.316 -173.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -110.13 149.52 29.94 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 118.195 0.997 . . . . 1.3300000000000001 109.598 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.12 119.11 35.0 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.688 1.195 . . . . 4.3700000000000001 108.0 -177.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.5 pt -143.6 179.33 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 107.881 -1.155 . . . . 0.84999999999999998 107.881 177.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.3 mtt-85 -126.81 141.26 51.87 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.683 -1.229 . . . . 2.7400000000000002 107.683 172.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.4 p -108.6 132.46 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 106.827 -1.546 . . . . 0.77000000000000002 106.827 176.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.2 124.27 2.75 Favored Glycine 0 C--N 1.334 0.44 0 N-CA-C 109.719 -1.352 . . . . 0.52000000000000002 109.719 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 179.67 -156.95 19.47 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 107.906 -2.077 . . . . 0.58999999999999997 107.906 -176.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -104.66 134.6 47.55 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 118.315 1.058 . . . . 4.6399999999999997 110.646 -172.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.411 ' HB ' ' CZ ' ' A' ' 104' ' ' PHE . 2.8 m -79.92 141.04 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.736 -0.665 . . . . 2.3700000000000001 109.408 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.0 m -76.87 133.61 39.26 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.802 -0.814 . . . . 2.3900000000000001 108.802 172.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.1 p -45.92 -51.24 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 125.651 1.58 . . . . 1.78 112.2 177.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.63 61.74 1.18 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.296 -1.122 . . . . 1.98 110.296 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.1 m -154.83 53.15 0.64 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.589 1.194 . . . . 2.2599999999999998 112.718 -176.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.14 104.88 5.34 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 107.725 -1.213 . . . . 1.7 107.725 174.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.1 m -123.6 135.13 64.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 109.17 -0.678 . . . . 0.57999999999999996 109.17 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.411 ' CB ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -127.38 147.4 50.27 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.714 1.605 . . . . 5.4800000000000004 110.496 -172.807 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -75.79 157.19 84.15 Favored Pre-proline 0 CA--C 1.529 0.172 0 C-N-CA 122.788 0.435 . . . . 2.5600000000000001 110.525 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -66.5 -19.85 54.51 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 123.032 2.488 . . . . 1.24 111.762 166.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -50.16 -35.23 25.28 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.105 0.562 . . . . 1.8200000000000001 110.573 163.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.6 m 71.07 18.46 5.86 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.728 1.611 . . . . 1.53 112.813 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.18 -45.45 2.11 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 125.352 1.461 . . . . 2.5 111.429 170.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -78.46 131.66 36.96 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 107.302 -1.37 . . . . 1.8799999999999999 107.302 -177.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.556 HG23 ' HB3' ' A' ' 96' ' ' TYR . 26.6 m -147.02 147.52 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 107.784 -1.191 . . . . 0.71999999999999997 107.784 -174.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -149.71 156.79 42.45 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.54 -0.725 . . . . 1.3500000000000001 110.217 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -154.09 161.01 42.21 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.401 -0.818 . . . . 2.0899999999999999 109.93 -173.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -105.98 138.66 41.78 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.879 -0.785 . . . . 0.60999999999999999 108.879 174.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 t -121.19 142.0 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 107.678 -1.23 . . . . 1.98 107.678 176.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -144.09 -175.72 4.72 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.02 -0.733 . . . . 1.8999999999999999 109.02 177.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.8 t70 . . . . . 0 N--CA 1.449 -0.512 0 N-CA-C 109.054 -0.721 . . . . 2.6200000000000001 109.054 165.072 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.655 ' N ' ' HG ' ' A' ' 41' ' ' SER . . . . . . . . 0 CA--C 1.526 0.776 0 N-CA-C 110.912 -0.875 . . . . 1.5 110.912 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -123.36 150.78 43.25 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.435 1.894 . . . . 4.4199999999999999 107.533 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.429 HG21 HD11 ' A' ' 43' ' ' ILE . 11.3 tp -146.34 146.39 19.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 122.986 0.514 . . . . 1.3 110.041 174.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.4 mt -91.05 137.26 32.5 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.452 1.101 . . . . 0.72999999999999998 110.61 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.3 t -127.3 129.47 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 126.214 1.806 . . . . 1.01 107.636 -178.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 44.2 p -107.98 145.19 34.23 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.766 1.226 . . . . 0.72999999999999998 109.463 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.556 ' HB3' HG23 ' A' ' 80' ' ' VAL . 2.3 t80 -138.7 126.89 22.74 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.685 1.594 . . . . 1.99 107.277 -175.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -108.36 44.62 1.1 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.817 1.247 . . . . 1.9399999999999999 112.331 -170.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -170.7 171.98 5.98 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.593 1.957 . . . . 3.0600000000000001 107.733 172.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.2 mp -66.46 137.63 56.97 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.579 -0.701 . . . . 1.97 110.661 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.51 ' HG ' HG21 ' A' ' 80' ' ' VAL . 19.2 mt -76.21 159.0 81.18 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.224 0.609 . . . . 1.3799999999999999 109.465 176.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -64.83 -88.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.59 2.86 . . . . 2.0099999999999998 109.843 170.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.6 29.4 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.171 1.388 . . . . 3.5299999999999998 113.011 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 50.7 1.66 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 115.923 1.823 . . . . 2.1600000000000001 115.923 -168.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.411 ' CZ ' ' HB ' ' A' ' 66' ' ' VAL . 26.6 t80 58.58 93.98 0.03 OUTLIER 'General case' 0 C--N 1.342 0.281 0 C-N-CA 124.652 1.181 . . . . 3.1400000000000001 109.135 -156.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 26.8 mtp85 -77.78 157.43 29.99 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 107.095 -1.446 . . . . 4.2800000000000002 107.095 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -83.93 119.99 25.55 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.388 -0.968 . . . . 2.9900000000000002 108.388 -169.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.3 68.02 1.73 Allowed Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.458 1.028 . . . . 0.76000000000000001 113.09 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.45 ' O ' HG23 ' A' ' 110' ' ' ILE . 1.2 pt20 -156.64 62.61 0.53 Allowed 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 124.141 0.976 . . . . 2.7200000000000002 110.519 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -27.66 119.56 0.05 OUTLIER Glycine 0 CA--C 1.529 0.93 0 C-N-CA 126.028 1.775 . . . . 0.87 114.997 -166.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.45 HG23 ' O ' ' A' ' 108' ' ' GLN . 2.6 pp -121.68 167.88 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 108.602 -0.888 . . . . 0.75 108.602 -173.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.8 m -117.66 134.41 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.583 -0.895 . . . . 0.70999999999999996 108.583 177.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -122.72 136.25 54.82 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.84 1.656 . . . . 0.5 108.623 -175.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -119.81 144.95 47.05 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.327 1.451 . . . . 4.3499999999999996 108.942 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 162.82 -147.84 14.1 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 110.132 -1.187 . . . . 0.92000000000000004 110.132 173.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.9 p -126.13 136.53 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 123.435 0.694 . . . . 0.65000000000000002 109.801 -166.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.736 ' HG ' HD22 ' A' ' 122' ' ' LEU . 7.9 mp -80.92 153.43 27.56 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.901 -1.518 . . . . 2.71 106.901 175.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -172.21 -47.65 0.04 OUTLIER Glycine 0 C--N 1.333 0.394 0 C-N-CA 119.584 -1.293 . . . . 2.1699999999999999 112.88 -178.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -62.33 158.66 16.88 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.832 -0.803 . . . . 4.7699999999999996 108.832 172.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -81.5 64.0 6.04 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 122.218 1.009 . . . . 4.7400000000000002 108.297 -175.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 116.07 17.93 6.11 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 126.04 1.781 . . . . 1.8100000000000001 113.749 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.533 ' C ' HD23 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -134.31 156.09 49.07 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.004 1.402 . . . . 2.75 109.591 169.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.736 HD22 ' HG ' ' A' ' 116' ' ' LEU . 2.1 mt -114.67 141.52 47.69 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.326 0.65 . . . . 2.0 110.432 -173.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -101.22 104.47 15.52 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.4 -0.963 . . . . 0.52000000000000002 108.4 175.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -128.66 117.6 21.48 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 123.131 0.572 . . . . 0.95999999999999996 109.78 -177.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.2 t -110.59 -6.61 14.83 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.338 1.055 . . . . 0.89000000000000001 111.614 177.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -99.54 89.59 4.21 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.658 -1.277 . . . . 3.9100000000000001 108.375 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.9 m -106.76 133.92 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 121.829 2.104 . . . . 0.68000000000000005 111.848 175.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -123.36 104.25 8.99 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.771 1.228 . . . . 0.73999999999999999 108.626 -175.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.34 59.89 3.58 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.493 -0.754 . . . . 1.2 110.832 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.34 -24.29 61.27 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.209 0.818 . . . . 3.4700000000000002 113.209 -175.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 . . . . . 0 N--CA 1.466 0.362 0 C-N-CA 124.019 0.928 . . . . 5.21 110.546 -178.13 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.5 pt? . . . . . 0 N--CA 1.465 0.286 0 N-CA-C 112.365 0.506 . . . . 1.8300000000000001 112.365 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.406 ' CD1' ' HB2' ' A' ' 61' ' ' ARG . 98.3 m-85 -83.1 119.21 24.22 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 125.168 1.387 . . . . 2.7400000000000002 109.267 176.53 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.59 159.19 19.89 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.195 0.998 . . . . 2.73 110.808 178.889 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.36 144.01 91.4 Favored Pre-proline 0 N--CA 1.451 -0.402 0 C-N-CA 123.783 0.833 . . . . 1.52 109.313 175.019 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.52 -45.58 4.84 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.636 2.224 . . . . 0.92000000000000004 111.031 179.538 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.5 p -45.28 -46.39 12.64 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.412 1.485 . . . . 2.2799999999999998 112.34 -179.588 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.84 -57.1 10.31 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.071 -1.085 . . . . 3.6200000000000001 108.071 179.589 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 31.2 pt -73.18 30.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 113.712 1.004 . . . . 1.4299999999999999 113.712 -171.56 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.6 t -120.13 -18.5 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.682 1.993 . . . . 2.2000000000000002 111.837 173.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -139.57 91.63 2.5 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.945 1.248 . . . . 2.4900000000000002 111.826 -170.355 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.4 46.66 68.48 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 109.99 -1.244 . . . . 1.5700000000000001 109.99 176.168 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -146.42 -139.52 0.1 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 104.404 -2.443 . . . . 4.8899999999999997 104.404 172.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.787 HG23 HD11 ' A' ' 116' ' ' LEU . 94.5 m -52.19 -54.13 34.65 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 117.197 -1.383 . . . . 2.02 114.599 -178.413 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -36.36 -56.63 0.77 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.856 1.207 . . . . 2.5499999999999998 111.321 174.21 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.61 -7.71 59.45 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 113.895 -1.502 . . . . 1.5900000000000001 111.268 -171.409 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 56.74 35.9 69.74 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.325 1.44 . . . . 1.1499999999999999 112.373 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.8 m -89.44 -42.54 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 117.893 0.847 . . . . 1.24 110.979 -178.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.7 mmtt -81.39 -63.88 0.3 Allowed Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 118.325 -0.845 . . . . 3.2400000000000002 112.55 176.324 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -81.79 152.47 17.07 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.533 1.489 . . . . 1.97 110.168 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -100.4 43.05 1.08 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.261 1.424 . . . . 3.8199999999999998 109.493 175.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 33.14 59.88 0.45 Allowed 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 127.232 2.213 . . . . 2.29 115.459 177.578 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.42 30.86 0.2 Allowed Glycine 0 CA--C 1.524 0.639 0 CA-C-N 113.757 -1.565 . . . . 1.47 112.664 177.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -121.98 154.06 37.71 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.193 0.997 . . . . 2.8900000000000001 109.522 -176.118 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.446 HH12 ' NE2' ' A' ' 113' ' ' GLN . 13.9 ttp85 -96.82 114.07 25.67 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.101 -1.074 . . . . 4.7699999999999996 108.101 -178.344 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.7 pt -132.99 178.15 6.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 C-N-CA 124.271 1.028 . . . . 0.97999999999999998 109.158 -176.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.406 ' HB2' ' CD1' ' A' ' 37' ' ' PHE . 3.5 mtt180 -136.12 150.68 49.2 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.087 -1.079 . . . . 1.9199999999999999 108.087 174.095 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.33 143.63 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.821 1.248 . . . . 0.85999999999999999 107.734 177.243 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.91 123.23 1.81 Allowed Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.363 -1.095 . . . . 0.55000000000000004 110.363 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -178.63 -171.36 41.81 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 109.573 -1.411 . . . . 0.68999999999999995 109.573 -177.237 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.41 135.36 33.36 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.936 0.874 . . . . 2.71 110.945 178.193 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.438 HG12 ' H ' ' A' ' 66' ' ' VAL . 0.8 OUTLIER -63.98 131.02 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 114.99 -1.004 . . . . 2.5600000000000001 108.295 167.36 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.2 m -37.77 -82.75 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 126.531 1.932 . . . . 3.2599999999999998 113.128 176.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.6 p 175.84 -40.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.511 1.124 . . . . 2.4399999999999999 109.497 179.608 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -142.45 25.34 2.31 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.923 -0.376 . . . . 1.75 112.181 179.638 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.3 m -84.21 -8.86 58.93 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 117.756 0.778 . . . . 1.23 112.461 -178.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.1 tpt -68.29 115.06 7.31 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.803 0.841 . . . . 1.79 108.85 176.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.1 m -125.84 135.61 63.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 108.363 -0.977 . . . . 0.59999999999999998 108.363 171.535 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 ptm85 -128.0 133.08 49.12 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.719 1.208 . . . . 6.1299999999999999 108.515 -171.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -85.36 146.23 44.27 Favored Pre-proline 0 C--O 1.234 0.287 0 N-CA-C 108.767 -0.827 . . . . 2.1899999999999999 108.767 -176.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -70.69 12.97 0.38 Allowed 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.893 2.395 . . . . 1.24 113.703 178.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -75.95 -29.91 58.47 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.246 0.618 . . . . 1.1200000000000001 109.655 163.415 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 m 85.47 -18.91 0.34 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.821 2.048 . . . . 1.5 112.757 -174.049 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -104.91 8.78 34.74 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.487 1.115 . . . . 1.95 113.093 -172.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 -133.55 126.81 31.82 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.334 -1.358 . . . . 1.1499999999999999 107.334 172.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.93 125.3 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.001 -1.851 . . . . 0.85999999999999999 106.001 -175.769 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -137.85 146.44 43.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 119.683 1.128 . . . . 0.83999999999999997 109.713 179.401 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -142.89 152.36 42.02 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.008 -0.738 . . . . 1.8500000000000001 109.008 -174.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.86 150.77 24.55 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.452 -0.573 . . . . 0.57999999999999996 109.452 171.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.9 p -143.43 147.27 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.246 1.018 . . . . 1.8999999999999999 108.331 -171.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.414 ' HB3' ' HG3' ' A' ' 91' ' ' GLU . 0.3 OUTLIER -153.93 -179.88 8.26 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 112.136 0.421 . . . . 1.78 112.136 -174.795 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.536 0.412 0 C-N-CA 123.912 0.885 . . . . 2.4900000000000002 110.736 176.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.947 0 CA-C-O 119.044 -0.864 . . . . 1.79 111.065 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.414 ' HG3' ' HB3' ' A' ' 85' ' ' HIS . 12.1 tt0 -116.27 145.77 42.89 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.995 2.118 . . . . 3.5 107.731 175.633 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.3 tp -128.46 159.04 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 123.845 0.858 . . . . 1.1499999999999999 109.35 175.457 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.3 mt -109.42 138.16 46.2 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.552 1.141 . . . . 0.76000000000000001 110.873 -176.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.34 124.79 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 125.987 1.715 . . . . 0.92000000000000004 107.383 -178.789 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.9 p -101.72 135.68 42.84 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.71 -0.848 . . . . 0.47999999999999998 108.71 176.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.47 ' CE2' HG13 ' A' ' 127' ' ' VAL . 5.0 t80 -128.76 163.39 25.27 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.283 2.233 . . . . 2.3599999999999999 107.997 -176.083 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -159.92 156.45 27.27 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 105.299 -2.111 . . . . 3.4399999999999999 105.299 -170.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 60.16 66.81 0.92 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 130.26 3.424 . . . . 2.9700000000000002 111.854 -169.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 51.65 -160.52 0.09 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.176 0.99 . . . . 1.7 109.902 -178.296 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.9 mt -145.14 157.39 53.7 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 104.555 -2.387 . . . . 1.1699999999999999 104.555 175.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.01 -88.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.923 2.415 . . . . 2.21 109.585 178.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -78.07 46.82 0.62 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.366 1.066 . . . . 3.25 109.957 179.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 45.55 -2.62 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 129.437 3.095 . . . . 2.1800000000000002 117.787 -171.366 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 58.2 t80 56.58 88.51 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.619 1.167 . . . . 2.8300000000000001 108.858 -153.195 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 22.3 mtp-105 -79.88 155.77 27.63 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.593 -1.262 . . . . 4.5800000000000001 107.593 172.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -89.88 156.44 18.46 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.139 1.376 . . . . 3.3500000000000001 111.183 -170.031 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 52.15 47.38 55.29 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.274 0.94 . . . . 0.77000000000000002 112.935 175.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.06 101.18 2.07 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 105.518 -2.03 . . . . 2.3900000000000001 105.518 -178.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -60.87 138.61 48.09 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.714 -0.554 . . . . 0.70999999999999996 111.714 -169.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.2 pp -136.75 174.71 11.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 124.25 1.02 . . . . 0.92000000000000004 108.778 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.4 m -122.6 145.83 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 108.83 -0.804 . . . . 0.64000000000000001 108.83 175.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.403 ' HB2' HG12 ' A' ' 127' ' ' VAL . . . -135.05 127.65 30.8 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.9 1.28 . . . . 0.44 109.501 -174.257 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.446 ' NE2' HH12 ' A' ' 59' ' ' ARG . 3.9 tt0 -113.38 141.52 46.96 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.072 1.349 . . . . 2.96 109.628 -178.648 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 175.05 -136.39 3.42 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 110.919 -0.872 . . . . 0.84999999999999998 110.919 164.11 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.0 p -129.62 151.3 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 123.632 0.773 . . . . 0.63 109.466 -167.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.787 HD11 HG23 ' A' ' 48' ' ' THR . 3.9 mm? -54.55 135.5 46.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.407 -0.815 . . . . 2.2000000000000002 110.714 172.084 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -94.41 -115.55 2.7 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 109.448 -1.461 . . . . 1.8200000000000001 109.448 179.049 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -56.63 -55.75 30.0 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.121 0.969 . . . . 4.54 111.135 179.042 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.8 p30 179.98 -65.82 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 127.755 2.422 . . . . 4.0999999999999996 107.718 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.16 -38.2 35.35 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.353 -0.699 . . . . 1.26 111.353 178.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.54 138.55 34.25 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 117.554 0.677 . . . . 2.1600000000000001 110.85 -175.323 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -103.28 123.58 47.05 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 124.29 1.036 . . . . 2.4500000000000002 108.506 -175.331 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.6 97.29 10.95 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.384 -0.969 . . . . 0.46000000000000002 108.384 176.463 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -118.77 119.11 33.43 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 108.804 -0.813 . . . . 0.96999999999999997 108.804 -177.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.8 t -117.87 10.69 13.27 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.867 0.867 . . . . 1.1799999999999999 111.168 176.55 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -119.03 90.02 3.25 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 120.78 -1.2 . . . . 2.9900000000000002 109.148 170.256 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.47 HG13 ' CE2' ' A' ' 96' ' ' TYR . 5.7 m -91.68 137.1 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 118.949 0.795 . . . . 0.77000000000000002 110.018 168.19 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -118.2 120.96 39.28 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.541 -1.652 . . . . 0.79000000000000004 106.541 173.021 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.05 121.47 27.07 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.884 -1.154 . . . . 2.2999999999999998 107.884 171.532 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -130.84 25.36 5.0 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.118 0.567 . . . . 3.6499999999999999 111.564 -179.674 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.201 0 N-CA-C 108.672 -0.862 . . . . 4.7699999999999996 108.672 -172.887 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 N--CA 1.464 0.237 0 N-CA-C 112.695 0.628 . . . . 2.0499999999999998 112.695 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -81.59 127.66 33.11 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.245 1.018 . . . . 2.0 109.871 -178.123 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -129.67 157.46 42.06 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.571 1.949 . . . . 2.98 109.065 177.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.4 p -94.01 149.37 36.81 Favored Pre-proline 0 N--CA 1.446 -0.667 0 C-N-CA 124.455 1.102 . . . . 1.8100000000000001 108.6 179.206 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.26 -31.85 58.06 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.638 2.225 . . . . 1.05 112.342 174.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -46.71 -43.63 18.06 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.509 0.724 . . . . 2.8399999999999999 111.827 171.268 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -76.85 -7.31 55.25 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.796 -0.565 . . . . 2.3300000000000001 111.857 -175.785 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.3 pt -124.92 40.56 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 125.696 1.599 . . . . 2.0 110.164 176.018 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.5 p -124.27 -60.7 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 CA-C-O 121.543 0.687 . . . . 2.6499999999999999 112.022 160.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -83.51 73.37 10.21 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 120.324 -1.485 . . . . 2.1600000000000001 112.137 -162.504 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.79 70.93 1.09 Allowed Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.832 -1.307 . . . . 1.8999999999999999 109.832 176.73 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.78 -123.06 0.06 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.05 -1.833 . . . . 3.48 106.05 175.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 t -63.91 -37.16 86.39 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 118.396 0.543 . . . . 2.4399999999999999 110.871 -172.578 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -43.27 -42.48 4.42 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 127.058 2.143 . . . . 4.4299999999999997 112.079 177.278 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.2 m -116.28 9.52 14.56 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.852 1.261 . . . . 2.1400000000000001 109.991 -175.256 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 45.73 33.66 4.93 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.597 1.57 . . . . 1.1100000000000001 113.667 -173.58 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.1 m -81.56 -25.75 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 119.076 1.438 . . . . 1.99 111.872 -173.073 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -121.44 -75.46 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.226 0 C-N-CA 123.922 0.889 . . . . 3.48 111.137 177.274 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -75.57 121.47 6.38 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 CA-C-N 120.48 1.207 . . . . 1.1399999999999999 109.192 177.788 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -69.04 158.36 34.95 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.483 -0.562 . . . . 3.2999999999999998 109.483 169.685 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.36 167.66 5.15 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.719 0.808 . . . . 1.3799999999999999 110.801 174.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.3 11.31 79.58 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 119.589 -0.562 . . . . 1.0600000000000001 113.589 178.187 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -95.02 147.69 23.13 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.442 1.121 . . . . 1.52 109.646 175.076 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.19 125.1 31.87 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 107.261 -1.385 . . . . 3.8300000000000001 107.261 177.265 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.2 pt -140.7 176.93 4.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 107.796 -1.187 . . . . 0.88 107.796 168.091 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.0 mtt180 -130.75 127.08 38.02 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.696 -0.853 . . . . 2.3900000000000001 108.696 173.616 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.5 p -92.28 127.32 44.56 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.076 0 N-CA-C 108.239 -1.023 . . . . 0.83999999999999997 108.239 177.537 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -122.24 127.86 6.96 Favored Glycine 0 C--N 1.333 0.397 0 N-CA-C 110.317 -1.113 . . . . 0.87 110.317 177.314 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.49 -164.03 32.91 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 117.751 0.776 . . . . 0.91000000000000003 111.294 -177.037 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.56 127.6 52.33 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.108 0.963 . . . . 2.8399999999999999 109.99 -175.183 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.5 t -59.49 139.49 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 106.971 -1.492 . . . . 2.29 106.971 169.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.655 HG22 HG12 ' A' ' 68' ' ' VAL . 57.2 m -50.9 -79.93 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.198 0.599 . . . . 2.6000000000000001 112.059 -176.682 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.655 HG12 HG22 ' A' ' 67' ' ' THR . 3.1 p 172.42 -39.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 126.175 1.79 . . . . 2.04 108.286 -176.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -149.39 28.55 1.21 Allowed Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.982 -0.343 . . . . 2.3799999999999999 112.345 176.059 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.3 m -86.59 4.34 40.59 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 117.713 0.757 . . . . 1.1599999999999999 111.983 176.096 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.79 110.35 2.79 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.878 -1.156 . . . . 1.74 107.878 172.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.9 m -118.14 111.83 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 107.396 -1.335 . . . . 0.88 107.396 170.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -98.73 148.96 23.34 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.347 1.059 . . . . 5.1799999999999997 110.678 175.798 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -84.72 151.74 58.75 Favored Pre-proline 0 C--O 1.235 0.294 0 N-CA-C 109.088 -0.708 . . . . 2.3199999999999998 109.088 173.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.02 25.86 0.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.663 2.242 . . . . 1.8999999999999999 112.861 168.434 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -87.62 -24.61 23.9 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.822 0.849 . . . . 1.4299999999999999 108.746 163.325 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 m 67.97 11.34 8.32 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.353 1.461 . . . . 1.21 112.486 -175.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.0 pp -127.37 3.1 6.3 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.655 1.582 . . . . 1.8100000000000001 112.323 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -136.65 135.68 38.47 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.071 1.348 . . . . 1.46 109.301 -178.634 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.07 130.08 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 107.659 -1.237 . . . . 0.78000000000000003 107.659 -170.358 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -135.81 156.2 49.16 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 119.49 1.041 . . . . 1.4099999999999999 110.195 173.559 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -150.25 144.21 25.45 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.935 -0.575 . . . . 2.1299999999999999 110.382 -173.351 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.49 130.16 35.87 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.857 -0.794 . . . . 0.65000000000000002 108.857 173.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.6 t -110.24 130.8 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 106.399 -1.704 . . . . 1.75 106.399 174.276 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -157.7 157.28 33.2 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 118.618 -0.706 . . . . 3.3900000000000001 109.277 -179.736 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.0 t0 . . . . . 0 N--CA 1.456 -0.16 0 C-N-CA 123.952 0.901 . . . . 5.8700000000000001 109.556 171.911 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.857 0 N-CA-C 114.371 0.509 . . . . 2.27 114.371 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -165.88 139.31 4.31 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 104.956 -2.238 . . . . 4.2000000000000002 104.956 167.231 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 92' ' ' ILE . 7.6 tp -154.81 152.78 8.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 119.102 0.865 . . . . 0.91000000000000003 110.461 172.643 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.5 mt -100.18 122.74 43.49 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.287 1.035 . . . . 0.56999999999999995 110.594 -179.475 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.0 t -109.74 127.49 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 124.983 1.313 . . . . 1.03 107.8 -177.752 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.6 p -104.81 144.84 31.2 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.779 0.832 . . . . 0.70999999999999996 109.585 179.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.436 ' HE2' HG13 ' A' ' 127' ' ' VAL . 10.7 t80 -142.78 163.27 33.25 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.981 1.712 . . . . 2.1800000000000002 107.823 -174.8 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -148.79 146.22 27.92 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 127.742 2.417 . . . . 3.6400000000000001 105.365 -174.535 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 67.87 60.84 0.43 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 129.661 3.185 . . . . 2.8399999999999999 112.147 -171.403 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 mt 54.41 -169.6 0.06 Allowed 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 125.553 1.541 . . . . 2.5 111.375 176.506 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.421 HD21 ' CD2' ' A' ' 96' ' ' TYR . 13.0 mt -143.67 148.94 45.11 Favored Pre-proline 0 C--O 1.233 0.227 0 N-CA-C 106.657 -1.609 . . . . 2.0600000000000001 106.657 179.374 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -64.33 111.29 1.58 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.898 2.399 . . . . 3.04 109.273 -176.679 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 42.09 46.69 3.75 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.252 1.421 . . . . 4.6100000000000003 111.121 -174.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 48.79 11.41 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 116.246 1.943 . . . . 3.0699999999999998 116.246 -176.127 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 53.38 115.92 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 123.52 0.728 . . . . 4.5499999999999998 109.546 -148.059 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -74.41 113.81 12.07 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.638 -1.616 . . . . 5.5700000000000003 106.638 -176.453 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -74.83 133.77 41.84 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 118.44 -1.304 . . . . 3.9500000000000002 112.277 -126.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.54 53.52 3.38 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.638 1.114 . . . . 1.1499999999999999 111.55 -176.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.0 54.97 1.9 Allowed 'General case' 0 C--N 1.341 0.224 0 CA-C-N 117.5 0.65 . . . . 3.6499999999999999 112.021 -172.394 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -9.73 124.36 0.01 OUTLIER Glycine 0 CA--C 1.533 1.191 0 C-N-CA 128.723 3.058 . . . . 0.81000000000000005 116.66 -163.735 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.7 pp -134.63 169.19 22.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 O-C-N 121.455 -1.027 . . . . 0.81999999999999995 110.056 -172.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.6 m -121.37 139.38 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 108.718 -0.845 . . . . 0.75 108.718 175.029 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -128.34 121.0 28.14 Favored 'General case' 0 N--CA 1.458 -0.052 0 C-N-CA 125.013 1.325 . . . . 0.51000000000000001 108.831 -176.568 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -103.81 142.45 34.35 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.541 0.736 . . . . 4.04 109.572 -179.341 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 171.59 -141.33 6.33 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.653 -0.979 . . . . 1.1899999999999999 110.653 169.367 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.0 p -129.72 149.24 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 109.311 -0.625 . . . . 0.84999999999999998 109.311 -168.42 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -56.05 132.35 49.89 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 119.666 -0.814 . . . . 2.2999999999999998 109.523 170.716 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -80.29 -124.6 0.55 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 109.391 -1.484 . . . . 1.97 109.391 177.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -70.9 -67.67 0.49 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.945 -0.391 . . . . 5.2000000000000002 109.945 -174.461 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -167.31 102.27 0.52 Allowed 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.177 -1.416 . . . . 3.1800000000000002 107.177 174.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 104.34 -30.01 10.92 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.096 0.855 . . . . 1.05 111.778 176.751 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -82.39 135.52 35.15 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.902 -0.764 . . . . 2.7999999999999998 109.29 175.02 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -104.99 114.75 29.13 Favored 'General case' 0 CA--C 1.526 0.04 0 N-CA-C 108.385 -0.969 . . . . 2.2599999999999998 108.385 -178.602 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -90.5 106.45 18.51 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 108.053 -1.091 . . . . 0.64000000000000001 108.053 179.684 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -143.26 89.8 2.12 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 113.361 0.875 . . . . 1.6599999999999999 113.361 -166.7 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.429 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 14.7 t -88.62 -15.17 35.69 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.673 0.99 . . . . 1.03 113.673 -179.414 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -84.98 85.98 7.43 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 119.597 -1.939 . . . . 3.3799999999999999 107.871 176.705 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.436 HG13 ' HE2' ' A' ' 96' ' ' TYR . 16.1 m -100.7 130.37 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 119.73 1.15 . . . . 0.92000000000000004 111.941 177.719 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.81 135.08 55.0 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.989 -1.115 . . . . 1.03 107.989 179.241 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -119.78 84.58 2.23 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 124.868 1.267 . . . . 1.75 109.065 179.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.66 50.08 0.83 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.165 0.586 . . . . 2.9300000000000002 110.207 177.229 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 67.5 m80 . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 106.582 -1.636 . . . . 6.0700000000000003 106.582 -177.721 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 pp . . . . . 0 C--O 1.233 0.216 0 N-CA-C 107.587 -1.264 . . . . 2.8799999999999999 107.587 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.445 ' CE2' ' HD2' ' A' ' 61' ' ' ARG . 72.5 m-85 -103.43 113.17 26.46 Favored 'General case' 0 C--O 1.228 -0.069 0 C-N-CA 124.792 1.237 . . . . 2.4199999999999999 108.226 179.521 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.72 153.42 35.66 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.33 1.052 . . . . 2.8500000000000001 110.813 -177.047 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -85.67 138.81 35.5 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 125.035 1.334 . . . . 1.6799999999999999 110.735 -177.554 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -54.1 -40.25 82.42 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.598 2.865 . . . . 0.77000000000000002 112.044 -179.573 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.4 t -58.83 -49.14 78.82 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 119.009 0.822 . . . . 2.6200000000000001 111.804 178.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.1 tt0 -55.25 -40.57 71.1 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 119.864 -0.734 . . . . 3.5099999999999998 109.743 -178.179 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.315 37.0 pt -77.8 -11.31 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 114.823 1.416 . . . . 1.1599999999999999 114.823 -179.17 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.61 -19.67 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 119.312 0.96 . . . . 2.0099999999999998 111.315 -179.041 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -96.61 -125.63 0.13 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.234 -0.654 . . . . 3.3399999999999999 109.234 -179.376 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -82.92 61.43 4.77 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.284 -1.126 . . . . 1.52 110.284 -169.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -151.89 -106.46 0.05 Allowed 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 127.155 2.182 . . . . 4.0199999999999996 106.789 -171.799 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.688 ' CG2' HD21 ' A' ' 122' ' ' LEU . 22.6 m -77.36 -57.05 4.04 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.517 0.599 . . . . 1.73 109.897 -171.357 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -56.84 -49.73 74.56 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 123.588 0.555 . . . . 3.1600000000000001 110.129 -171.231 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.6 m -70.1 -34.45 73.15 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.773 -0.649 . . . . 1.96 110.919 174.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.22 46.59 20.64 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 123.76 0.695 . . . . 2.1200000000000001 111.421 175.311 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.4 m -113.98 -51.25 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 113.534 0.938 . . . . 2.1400000000000001 113.534 -172.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -79.02 -58.64 0.68 Allowed Pre-proline 0 CA--C 1.54 0.594 0 CA-C-O 118.498 -0.763 . . . . 4.25 112.071 -178.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -79.37 165.02 23.66 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.096 1.864 . . . . 1.3899999999999999 109.583 174.154 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.87 155.9 16.85 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.985 0.914 . . . . 4.2599999999999998 109.864 174.861 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.9 24.57 0.49 Allowed 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.639 1.176 . . . . 3.5600000000000001 112.122 177.376 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -143.4 30.2 1.99 Allowed Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.983 1.278 . . . . 0.96999999999999997 110.891 171.431 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -103.03 155.88 18.07 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.393 0.677 . . . . 1.4099999999999999 109.429 174.211 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.55 126.73 52.47 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.753 1.221 . . . . 6.1799999999999997 108.168 176.817 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.646 ' CD1' HD21 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -143.86 176.3 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 108.283 -1.006 . . . . 1.5800000000000001 108.283 171.147 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.445 ' HD2' ' CE2' ' A' ' 37' ' ' PHE . 22.7 mtt180 -111.33 134.48 52.88 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.689 -0.485 . . . . 3.3900000000000001 109.689 166.535 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -102.93 119.88 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 107.122 -1.436 . . . . 0.91000000000000003 107.122 171.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.49 125.24 4.33 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 109.643 -1.383 . . . . 0.58999999999999997 109.643 -176.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.34 -133.73 1.59 Allowed Glycine 0 C--N 1.334 0.451 0 N-CA-C 109.517 -1.433 . . . . 1.52 109.517 -174.715 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.4 ptp -127.64 133.77 49.66 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.101 0.951 . . . . 3.02 109.996 175.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.438 HG11 ' CZ ' ' A' ' 104' ' ' PHE . 15.7 t -95.64 143.2 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 108.716 -0.846 . . . . 2.3399999999999999 108.716 175.507 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.63 175.74 3.34 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.281 -0.637 . . . . 2.8799999999999999 109.281 173.656 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 68' ' ' VAL . 9.5 p -106.4 65.42 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 122.897 1.332 . . . . 2.4300000000000002 109.418 179.255 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 134.76 68.79 0.07 OUTLIER Glycine 0 CA--C 1.526 0.773 0 CA-C-N 113.68 -1.6 . . . . 1.6699999999999999 112.429 175.517 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.0 m -136.45 8.09 3.1 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.399 -1.059 . . . . 1.3300000000000001 112.729 158.739 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.8 ttp -78.85 117.39 19.91 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.011 -1.107 . . . . 2.5499999999999998 108.011 176.341 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.2 m -121.02 151.71 24.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 107.829 -1.175 . . . . 0.53000000000000003 107.829 175.732 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.401 ' CB ' HG12 ' A' ' 80' ' ' VAL . 37.8 ptt85 -141.44 144.02 34.2 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.992 0.917 . . . . 3.98 109.041 -169.154 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.33 155.12 37.24 Favored Pre-proline 0 C--O 1.236 0.361 0 N-CA-C 109.519 -0.548 . . . . 2.5800000000000001 109.519 -177.002 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.13 32.11 0.42 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.508 2.805 . . . . 2.1299999999999999 112.685 -176.121 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -95.69 -14.66 23.24 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.747 1.219 . . . . 1.5900000000000001 109.125 163.611 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.4 m 70.23 6.82 5.96 Favored 'General case' 0 C--N 1.345 0.399 0 C-N-CA 125.105 1.362 . . . . 1.51 113.225 -178.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.7 pp -125.5 -34.28 2.69 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 127.662 2.385 . . . . 1.98 112.354 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 30.6 m-70 -87.96 124.72 33.99 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 107.809 -1.182 . . . . 1.23 107.809 -176.575 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.447 HG23 ' CB ' ' A' ' 96' ' ' TYR . 23.7 m -149.05 152.98 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.397 -0.964 . . . . 1.02 108.397 -175.008 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -156.02 161.93 40.39 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 121.41 -0.807 . . . . 1.1599999999999999 110.803 176.706 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -155.3 160.57 40.87 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.197 0.599 . . . . 1.8700000000000001 110.486 -175.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -107.87 136.0 48.32 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.251 -1.018 . . . . 0.58999999999999997 108.251 175.249 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.7 t -115.74 142.1 30.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 124.942 1.297 . . . . 1.8400000000000001 107.521 178.618 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -125.94 179.91 4.99 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.564 0.746 . . . . 1.71 110.056 179.303 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.8 t0 . . . . . 0 N--CA 1.445 -0.684 0 CA-C-O 121.072 0.463 . . . . 3.4399999999999999 109.995 -177.624 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.616 0 N-CA-C 108.108 -1.997 . . . . 2.3999999999999999 108.108 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -162.15 93.85 0.89 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.947 -1.131 . . . . 3.9399999999999999 107.947 179.522 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.15 134.65 65.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 108.766 -0.827 . . . . 0.85999999999999999 108.766 -175.188 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.1 mt -85.39 136.96 33.24 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.077 0.951 . . . . 0.71999999999999997 109.973 177.124 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 87.1 t -124.06 133.22 69.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 107.387 -1.338 . . . . 1.04 107.387 176.363 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.7 p -111.78 158.35 19.47 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.537 1.135 . . . . 0.79000000000000004 109.796 -177.105 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.721 ' OH ' HG13 ' A' ' 127' ' ' VAL . 2.4 m-85 -148.43 133.02 17.76 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.348 1.459 . . . . 3.96 108.897 -178.279 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -104.92 6.32 33.56 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.682 1.193 . . . . 2.7000000000000002 111.711 169.311 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -111.79 162.91 14.75 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 124.488 1.115 . . . . 5.0300000000000002 111.123 172.287 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.9 mp -60.89 141.39 57.21 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.322 -0.853 . . . . 1.6499999999999999 109.949 162.631 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.525 HD13 ' CB ' ' A' ' 104' ' ' PHE . 75.8 mt -81.02 159.27 68.77 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 107.426 -1.324 . . . . 1.6200000000000001 107.426 175.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.54 -90.76 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.896 3.064 . . . . 2.3100000000000001 111.196 179.273 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -79.46 43.54 0.56 Allowed 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.245 -0.909 . . . . 3.73 110.53 -173.537 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.3 tp 57.92 3.27 0.21 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.581 1.152 . . . . 2.8399999999999999 112.978 -165.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.525 ' CB ' HD13 ' A' ' 100' ' ' LEU . 44.8 t80 57.78 94.23 0.03 OUTLIER 'General case' 0 C--N 1.342 0.274 0 CA-C-N 119.586 1.085 . . . . 2.46 109.237 -166.271 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -78.94 122.47 26.17 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.339 -0.986 . . . . 4.54 108.339 -178.17 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -84.13 173.06 11.38 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.093 1.357 . . . . 3.21 110.127 -172.692 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.9 34.73 89.43 Favored Glycine 0 CA--C 1.527 0.832 0 O-C-N 121.882 -0.511 . . . . 0.79000000000000004 112.821 175.085 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -156.32 175.39 14.06 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.364 1.066 . . . . 2.5499999999999998 108.967 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -97.68 105.88 3.22 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.973 -0.851 . . . . 1.1899999999999999 110.973 -178.07 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.5 pp -111.5 157.46 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 106.547 -1.649 . . . . 0.84999999999999998 106.547 -179.42 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.1 m -118.14 116.04 50.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 108.742 -0.836 . . . . 0.67000000000000004 108.742 176.535 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.45 ' HB2' HG12 ' A' ' 127' ' ' VAL . . . -102.99 146.53 28.21 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 125.373 1.469 . . . . 0.62 109.875 -175.207 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -146.52 139.66 25.6 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.32 1.048 . . . . 3.5800000000000001 110.106 -173.463 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 170.74 -133.82 2.91 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 106.516 -2.634 . . . . 0.84999999999999998 106.516 174.762 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p -142.24 149.9 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 118.63 1.215 . . . . 0.76000000000000001 109.166 -166.534 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 1.019 HD22 HD22 ' A' ' 122' ' ' LEU . 1.5 mt -77.31 157.18 30.85 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.693 -0.855 . . . . 1.99 108.693 -178.42 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 175.92 25.73 0.03 OUTLIER Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.345 -0.931 . . . . 2.6699999999999999 115.408 175.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -150.3 46.31 0.89 Allowed 'General case' 0 C--O 1.238 0.455 0 CA-C-N 118.392 1.096 . . . . 5.9100000000000001 109.533 -175.827 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 20.61 66.17 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 129.533 3.133 . . . . 3.9300000000000002 111.338 173.473 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 131.13 -30.44 3.33 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 114.084 -1.416 . . . . 1.0600000000000001 112.555 -175.516 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.32 161.13 19.48 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.548 1.174 . . . . 3.3500000000000001 111.251 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 1.019 HD22 HD22 ' A' ' 116' ' ' LEU . 12.5 mt -121.36 131.59 54.28 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 125.442 1.497 . . . . 2.0899999999999999 110.443 -169.348 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.25 99.07 11.38 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.083 -1.451 . . . . 0.55000000000000004 107.083 176.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.82 155.48 16.76 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.573 -0.528 . . . . 1.53 109.573 179.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.446 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 8.8 t -134.01 -42.23 0.82 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.876 0.47 . . . . 0.96999999999999997 111.365 173.254 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -87.39 105.62 17.39 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 120.179 -1.576 . . . . 4.3099999999999996 108.778 177.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.721 HG13 ' OH ' ' A' ' 96' ' ' TYR . 0.9 OUTLIER -111.88 118.62 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 123.824 0.85 . . . . 1.1399999999999999 109.725 171.027 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -108.3 111.25 23.11 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.443 -0.947 . . . . 0.94999999999999996 108.443 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.56 53.48 2.54 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.116 0.966 . . . . 1.53 110.628 178.424 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.2 pttt -79.88 69.72 6.28 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.79 -0.569 . . . . 3.21 110.616 -173.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 . . . . . 0 CA--C 1.529 0.158 0 C-N-CA 123.053 0.541 . . . . 4.5300000000000002 110.315 -172.172 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 pt? . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 109.613 -0.514 . . . . 2.6499999999999999 109.613 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -93.91 114.82 27.11 Favored 'General case' 0 C--N 1.337 0.061 0 C-N-CA 124.8 1.24 . . . . 2.3599999999999999 109.792 -178.039 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -120.12 156.88 30.15 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 126.329 1.852 . . . . 2.6499999999999999 109.669 -175.765 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.7 p -90.78 145.24 31.63 Favored Pre-proline 0 N--CA 1.45 -0.473 0 C-N-CA 124.422 1.089 . . . . 1.74 109.059 177.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -55.29 -36.81 94.4 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.889 2.393 . . . . 0.81999999999999995 111.968 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.5 t -52.57 -35.64 54.33 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.453 -0.779 . . . . 2.6299999999999999 112.041 175.247 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -83.68 5.51 24.33 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.291 0.478 . . . . 3.02 112.291 -176.408 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.6 pt -120.24 1.48 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 113.812 1.042 . . . . 1.25 113.812 173.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.1 p -97.27 -59.69 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 118.617 0.644 . . . . 2.1099999999999999 112.02 176.096 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -75.65 84.42 2.67 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 120.504 -1.373 . . . . 2.0699999999999998 112.042 -166.614 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.37 56.67 9.6 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 109.658 -1.377 . . . . 1.71 109.658 176.047 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -147.86 -137.3 0.09 Allowed 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 127.79 2.436 . . . . 2.3500000000000001 105.861 -173.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.6 m -58.82 -47.46 84.73 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.451 1.5 . . . . 1.73 112.631 -175.776 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -38.46 -54.87 1.45 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.445 0.698 . . . . 2.48 111.311 174.818 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.47 -1.45 53.52 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.446 1.099 . . . . 1.9199999999999999 111.738 -173.147 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 49.79 41.39 35.57 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.137 1.351 . . . . 1.3799999999999999 113.408 -176.804 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.1 m -92.39 -26.41 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.53 1.165 . . . . 1.96 112.887 -176.687 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -123.04 -74.16 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 124.635 1.174 . . . . 4.8099999999999996 111.497 176.663 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -73.48 121.38 7.08 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.554 1.503 . . . . 1.4099999999999999 109.305 177.497 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -77.89 160.07 28.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.078 0.951 . . . . 4.4000000000000004 108.893 175.325 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.68 158.06 28.39 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.324 -0.621 . . . . 1.1499999999999999 109.324 169.0 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.53 -2.08 76.89 Favored Glycine 0 CA--C 1.532 1.129 0 O-C-N 121.682 -0.636 . . . . 1.04 112.572 -175.482 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -91.67 146.39 23.81 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 118.102 0.951 . . . . 2.9700000000000002 109.131 178.222 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.4 mtt-85 -90.5 133.75 34.84 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.033 -0.728 . . . . 4.1299999999999999 109.033 172.443 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.1 pt -144.98 169.48 7.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 105.279 -2.119 . . . . 1.05 105.279 166.607 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 37.8 mtt180 -116.94 126.65 53.27 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.656 -1.239 . . . . 2.7599999999999998 107.656 169.406 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -90.44 135.49 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 N-CA-C 107.269 -1.382 . . . . 1.8799999999999999 107.269 173.484 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -128.55 128.59 5.96 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 109.38 -1.488 . . . . 0.63 109.38 172.491 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 176.8 -167.74 39.31 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 109.939 -1.264 . . . . 0.89000000000000001 109.939 -173.227 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.41 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 1.4 ptm -111.95 137.7 49.6 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.479 0.657 . . . . 5.0599999999999996 112.42 -176.18 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.2 t -64.93 159.32 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 114.349 -1.296 . . . . 2.3900000000000001 109.062 178.692 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 62.7 m -108.54 131.98 54.3 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.053 0.941 . . . . 3.0899999999999999 109.984 -178.492 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.3 p -75.58 45.91 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 127.955 2.502 . . . . 3.6400000000000001 111.895 179.009 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.73 49.93 0.03 OUTLIER Glycine 0 CA--C 1.522 0.473 0 C-N-CA 125.529 1.538 . . . . 2.77 109.37 179.335 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.0 m -155.59 -40.67 0.08 Allowed 'General case' 0 C--O 1.226 -0.162 0 O-C-N 122.402 -0.469 . . . . 1.6599999999999999 112.029 177.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.67 115.76 1.79 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 109.691 -0.485 . . . . 2.6000000000000001 109.691 171.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.8 m -136.51 153.57 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 108.866 -0.791 . . . . 0.98999999999999999 108.866 168.715 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -128.07 148.61 50.57 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.873 1.269 . . . . 4.8399999999999999 108.837 -178.231 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -82.84 155.9 67.78 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-N 118.119 0.418 . . . . 1.8700000000000001 109.959 174.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -70.91 7.28 1.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.088 2.525 . . . . 1.22 113.599 174.452 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -72.74 -23.6 60.86 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 121.938 -0.476 . . . . 1.6799999999999999 110.181 163.318 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.7 m 70.97 10.49 6.95 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.504 1.522 . . . . 1.55 112.785 -174.854 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 79' ' ' HIS 0.276 1.0 OUTLIER -123.08 -36.5 2.84 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.705 1.002 . . . . 2.3999999999999999 113.705 177.748 . . . . . . . . 4 4 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.407 ' N ' HD12 ' A' ' 78' ' ' LEU . 80.4 m-70 -85.33 129.36 34.83 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 120.23 1.377 . . . . 1.3500000000000001 107.566 178.415 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.421 HG23 ' HB3' ' A' ' 96' ' ' TYR . 30.0 m -138.06 145.81 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 107.92 -1.141 . . . . 1.05 107.92 176.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -144.23 147.34 33.46 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.082 -0.71 . . . . 1.3899999999999999 109.082 177.784 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -157.49 155.61 30.66 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.317 -0.401 . . . . 2.21 110.39 -171.588 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.65 149.6 24.28 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.136 -0.69 . . . . 0.52000000000000002 109.136 173.071 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.3 t -119.0 133.59 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 106.151 -1.796 . . . . 1.8899999999999999 106.151 172.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -155.64 159.71 39.82 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 106.653 -1.61 . . . . 3.1800000000000002 106.653 174.817 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 55.0 t0 . . . . . 0 C--O 1.233 0.203 0 N-CA-C 106.293 -1.743 . . . . 5.7199999999999998 106.293 173.8 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.968 0 N-CA-C 109.765 -1.334 . . . . 2.54 109.765 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -164.76 148.64 9.01 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.952 -1.499 . . . . 4.0599999999999996 106.952 169.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -155.14 154.48 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.79 0.723 . . . . 0.78000000000000003 109.082 163.449 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 mt -109.12 131.94 54.59 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.508 1.523 . . . . 0.60999999999999999 109.521 177.482 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.1 t -122.05 144.16 32.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 125.8 1.64 . . . . 0.95999999999999996 108.77 -176.263 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 32.4 p -118.96 150.01 40.64 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.203 1.001 . . . . 0.47999999999999998 108.49 179.008 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.421 ' HB3' HG23 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -149.32 109.81 4.22 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.854 -1.165 . . . . 2.2999999999999998 107.854 -178.854 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -91.02 42.91 1.12 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.347 1.459 . . . . 2.1200000000000001 112.048 -176.443 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -169.48 174.6 5.86 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.61 1.564 . . . . 2.52 108.645 173.049 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.6 mp -68.56 162.71 25.2 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.637 0.775 . . . . 1.6899999999999999 112.485 -175.398 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.452 HD22 ' CZ ' ' A' ' 104' ' ' PHE . 55.7 mt -112.67 158.6 37.04 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 126.048 1.739 . . . . 1.1899999999999999 110.618 -175.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.12 -88.16 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.897 3.065 . . . . 1.99 111.365 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -73.57 31.27 0.07 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.791 1.236 . . . . 3.8300000000000001 112.139 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 50.73 -5.38 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 128.558 2.743 . . . . 2.2799999999999998 116.387 -165.501 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.487 ' CZ ' HD12 ' A' ' 110' ' ' ILE . 13.4 m-30 55.65 109.23 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.864 1.666 . . . . 4.5099999999999998 110.959 -154.607 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -74.0 164.64 26.37 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.301 -1.318 . . . . 5.4900000000000002 108.323 174.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -82.4 61.14 5.43 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.199 1.4 . . . . 5.1100000000000003 109.727 -164.436 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 108.31 62.05 0.55 Allowed Glycine 0 CA--C 1.522 0.53 0 C-N-CA 124.509 1.052 . . . . 1.5600000000000001 111.218 -173.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -111.14 168.81 9.22 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 107.891 -1.151 . . . . 2.9399999999999999 107.891 158.312 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 65' ' ' MET . . . -102.91 133.7 11.52 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 111.496 -0.641 . . . . 1.0600000000000001 111.496 -179.216 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.487 HD12 ' CZ ' ' A' ' 104' ' ' PHE . 33.3 pt -145.33 169.59 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.302 1.041 . . . . 1.3300000000000001 109.638 -165.535 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 m -126.8 139.65 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 124.176 0.991 . . . . 0.68999999999999995 108.465 170.645 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -134.95 140.08 45.44 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 124.888 1.275 . . . . 0.66000000000000003 110.266 -176.695 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -135.64 145.4 46.78 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.779 1.632 . . . . 3.8900000000000001 109.705 -177.871 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -178.47 -101.54 0.15 Allowed Glycine 0 C--N 1.337 0.625 0 N-CA-C 110.17 -1.172 . . . . 1.3999999999999999 110.17 166.549 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.7 p -162.72 151.63 3.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 108.992 -0.744 . . . . 1.0 108.992 176.251 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -72.1 140.84 49.12 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 109.438 -0.578 . . . . 2.2200000000000002 109.438 167.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -162.43 21.17 0.19 Allowed Glycine 0 CA--C 1.524 0.612 0 C-N-CA 119.709 -1.234 . . . . 2.52 113.716 172.412 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -143.57 46.96 1.48 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.755 -0.832 . . . . 5.3099999999999996 108.755 -174.287 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 21.7 t70 18.09 66.12 0.02 OUTLIER 'General case' 0 C--N 1.34 0.164 0 C-N-CA 128.954 2.902 . . . . 3.5699999999999998 112.487 178.409 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 137.87 -48.41 0.89 Allowed Glycine 0 CA--C 1.528 0.849 0 CA-C-N 114.614 -1.175 . . . . 1.1100000000000001 111.475 -171.62 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -105.5 160.92 14.79 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.504 1.152 . . . . 2.9700000000000002 109.811 -173.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.64 128.92 55.82 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.508 1.123 . . . . 1.97 109.237 -172.098 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -95.6 98.73 10.72 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.163 -1.792 . . . . 0.57999999999999996 106.163 176.699 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -126.15 94.66 4.15 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.501 0.556 . . . . 1.4099999999999999 112.501 -164.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.2 t -84.27 -33.4 24.02 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.906 0.706 . . . . 0.90000000000000002 112.906 -178.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -82.91 95.09 7.86 Favored 'General case' 0 CA--C 1.528 0.113 0 O-C-N 120.556 -1.34 . . . . 3.6099999999999999 107.733 -172.816 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 35.0 m -118.44 134.85 60.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 C-N-CA 123.809 0.844 . . . . 1.3300000000000001 110.634 -176.221 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.59 101.66 8.8 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.241 -1.392 . . . . 1.03 107.241 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.98 107.26 12.63 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.741 -1.207 . . . . 2.21 107.741 172.355 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.29 44.79 0.72 Allowed 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 121.367 0.603 . . . . 3.3199999999999998 109.983 179.515 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 7.8 p80 . . . . . 0 CA--C 1.536 0.44 0 N-CA-C 113.161 0.8 . . . . 6.9800000000000004 113.161 -172.598 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.227 -0.105 0 CA-C-O 118.805 -0.617 . . . . 3.4700000000000002 111.139 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -81.58 96.67 7.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.963 -0.755 . . . . 2.0899999999999999 108.963 -175.48 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.96 157.32 19.39 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.836 0.854 . . . . 2.9500000000000002 110.427 177.694 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 p -77.44 146.08 73.14 Favored Pre-proline 0 N--CA 1.444 -0.743 0 C-N-CA 124.08 0.952 . . . . 1.77 110.179 -177.139 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -64.2 -23.05 66.72 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.507 2.805 . . . . 0.82999999999999996 112.232 175.32 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.5 p -61.52 -64.4 0.96 Allowed 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.239 0.615 . . . . 2.9500000000000002 110.931 174.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -46.34 -51.13 15.38 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.071 0.948 . . . . 2.1699999999999999 110.81 -171.462 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 34.0 pt -57.23 -29.07 31.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.436 1.094 . . . . 2.0800000000000001 112.754 -178.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.6 t -80.42 -54.32 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 123.335 0.654 . . . . 2.04 109.885 169.601 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -50.59 -42.48 55.82 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 125.002 1.321 . . . . 5.1500000000000004 112.982 -166.506 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.26 65.02 0.1 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.515 -0.85 . . . . 2.0299999999999998 111.19 -178.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.93 -90.32 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 118.598 -0.715 . . . . 2.46 110.923 -170.063 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.0 m -83.18 -58.82 2.69 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.689 1.196 . . . . 1.52 109.721 -169.443 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -51.15 -44.24 61.4 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 122.393 1.092 . . . . 2.5899999999999999 109.473 177.838 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.16 -25.47 60.82 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.397 1.479 . . . . 2.3799999999999999 112.451 179.059 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 56.82 46.58 90.0 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.292 1.425 . . . . 1.1799999999999999 112.552 -172.488 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.1 m -109.77 -27.43 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 114.091 1.145 . . . . 1.5 114.091 -175.422 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -122.5 -72.76 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.295 0 CA-C-O 118.237 -0.887 . . . . 3.3700000000000001 111.108 -175.794 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -76.71 151.11 31.74 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 121.504 1.469 . . . . 1.1200000000000001 108.834 169.632 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -108.32 159.58 16.53 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.663 1.185 . . . . 2.75 109.324 173.366 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.11 136.94 56.65 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.412 -0.958 . . . . 1.3100000000000001 108.412 174.078 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.85 -1.95 30.29 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 124.234 0.921 . . . . 1.0600000000000001 113.09 -173.324 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -89.02 146.9 24.56 Favored 'General case' 0 C--N 1.338 0.08 0 CA-C-N 118.87 1.335 . . . . 1.8799999999999999 109.585 179.226 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.29 106.89 17.51 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 107.906 -1.146 . . . . 3.6200000000000001 107.906 -173.53 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.7 pt -135.63 178.21 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 124.054 0.942 . . . . 1.1399999999999999 108.947 -173.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -121.93 119.77 32.5 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.476 -0.935 . . . . 2.21 108.476 174.415 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 p -83.78 128.96 38.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 107.198 -1.408 . . . . 1.04 107.198 173.044 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.3 128.6 4.58 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.562 -1.015 . . . . 0.78000000000000003 110.562 -177.998 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 179.76 -156.19 17.48 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 108.977 -1.649 . . . . 0.81999999999999995 108.977 -175.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.9 ppp? -118.3 142.92 47.01 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.814 1.245 . . . . 3.71 110.095 -179.577 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.9 m -100.92 139.85 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 123.223 0.609 . . . . 2.5699999999999998 109.809 -169.054 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 m -72.33 140.32 48.43 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.465 0.65 . . . . 2.3300000000000001 109.71 176.064 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.0 p -47.05 -61.63 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 126.263 1.825 . . . . 1.8400000000000001 111.398 172.552 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.73 73.42 1.19 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.093 -1.203 . . . . 2.0 110.093 -178.219 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.5 m -152.46 -30.98 0.15 Allowed 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 115.084 1.513 . . . . 0.97999999999999998 115.084 -179.519 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.2 104.73 0.96 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.085 -1.08 . . . . 1.6699999999999999 108.085 175.686 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.9 m -112.79 126.45 70.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 107.503 -1.295 . . . . 0.77000000000000002 107.503 175.401 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.12 137.02 54.39 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.151 1.38 . . . . 4.8099999999999996 108.191 -174.384 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -88.41 145.97 36.75 Favored Pre-proline 0 C--O 1.235 0.304 0 N-CA-C 109.068 -0.716 . . . . 2.5099999999999998 109.068 -179.11 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.01 25.2 0.3 Allowed 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.106 2.538 . . . . 2.4199999999999999 113.589 178.733 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -91.8 -24.23 19.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.802 1.241 . . . . 2.0800000000000001 109.378 164.282 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.9 m 74.12 0.42 3.6 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.52 1.528 . . . . 1.71 113.203 -174.515 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.98 18.06 11.73 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.182 0.993 . . . . 2.1699999999999999 112.168 -178.354 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -145.39 127.01 15.16 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.477 -1.305 . . . . 1.8300000000000001 107.477 173.286 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.1 128.97 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 107.704 -1.221 . . . . 0.89000000000000001 107.704 -173.252 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -141.73 148.42 38.98 Favored 'General case' 0 C--O 1.232 0.158 0 O-C-N 121.088 -1.007 . . . . 0.82999999999999996 110.739 176.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -143.17 153.32 42.73 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 116.35 -0.387 . . . . 1.8200000000000001 110.171 -173.416 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.86 138.14 36.42 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.928 -0.767 . . . . 0.75 108.928 172.72 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -131.97 139.67 49.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 123.844 0.857 . . . . 1.95 108.958 176.392 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -140.55 -177.71 5.17 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.665 1.586 . . . . 1.3799999999999999 108.387 -173.311 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.4 t0 . . . . . 0 CA--C 1.532 0.282 0 CA-C-O 122.238 1.018 . . . . 2.71 110.149 -179.555 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.431 0 N-CA-C 109.876 -1.29 . . . . 3.5600000000000001 109.876 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 66.49 87.67 0.12 Allowed 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 125.228 1.411 . . . . 3.5099999999999998 110.853 -179.126 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -95.13 155.11 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 108.638 -0.875 . . . . 1.0700000000000001 108.638 -178.332 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 mt -104.25 131.37 51.64 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.738 -0.838 . . . . 0.62 108.738 174.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.7 t -114.71 133.25 61.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 125.558 1.543 . . . . 0.88 107.161 178.474 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.4 p -109.55 148.52 31.1 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.782 0.833 . . . . 0.51000000000000001 109.002 -179.765 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.453 ' CE2' ' HA ' ' A' ' 125' ' ' THR . 1.5 t80 -150.69 146.69 26.63 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 107.184 -1.413 . . . . 2.2000000000000002 107.184 -173.709 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.7 p-10 -141.35 40.33 1.75 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.214 1.005 . . . . 2.1600000000000001 112.887 -167.166 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -166.37 56.87 0.1 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.545 0.738 . . . . 2.5899999999999999 111.525 -178.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 52.62 -171.4 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.62 1.168 . . . . 1.8 111.951 -169.046 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.552 HD13 ' HB2' ' A' ' 104' ' ' PHE . 13.7 mt -147.25 152.04 41.91 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 107.007 -1.479 . . . . 1.3100000000000001 107.007 174.453 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.434 ' HG3' HG23 ' A' ' 127' ' ' VAL . 72.0 Cg_endo -63.24 133.29 39.93 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 124.033 3.155 . . . . 2.48 110.016 177.384 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 41.77 46.92 3.45 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.027 1.331 . . . . 3.8300000000000001 111.29 -173.717 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 50.26 15.1 0.18 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.085 1.754 . . . . 2.1899999999999999 115.068 -175.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.552 ' HB2' HD13 ' A' ' 100' ' ' LEU . 27.4 t80 62.4 95.99 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 126.108 1.763 . . . . 2.52 110.113 -166.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 64.1 mtp85 -77.34 124.52 27.98 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 106.477 -1.675 . . . . 3.8700000000000001 106.477 -174.658 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -83.36 173.2 11.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.114 0.483 . . . . 2.9199999999999999 110.61 -172.559 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.17 42.15 98.09 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 121.859 -0.526 . . . . 0.68999999999999995 112.677 176.112 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -155.01 179.03 9.53 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.576 1.55 . . . . 2.1400000000000001 108.581 176.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -110.36 138.35 14.84 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 111.616 -0.594 . . . . 0.67000000000000004 111.616 175.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.4 pp -140.11 169.42 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 125.686 1.595 . . . . 0.77000000000000002 106.904 -177.6 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 18.8 m -123.0 145.82 29.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 107.986 -1.116 . . . . 0.82999999999999996 107.986 167.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.421 ' HB2' HG12 ' A' ' 127' ' ' VAL . . . -130.83 123.8 29.88 Favored 'General case' 0 N--CA 1.461 0.079 0 C-N-CA 124.345 1.058 . . . . 0.75 109.738 -177.273 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.21 145.01 34.87 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.33 1.052 . . . . 3.9900000000000002 110.091 -179.45 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 164.65 -139.88 6.1 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 108.022 -2.031 . . . . 0.83999999999999997 108.022 173.575 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.5 p -134.54 143.1 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 118.342 1.071 . . . . 0.73999999999999999 110.983 -166.627 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -71.72 153.68 41.86 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.126 -0.943 . . . . 1.79 108.857 171.661 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -170.51 -50.62 0.04 OUTLIER Glycine 0 C--N 1.332 0.329 0 N-CA-C 110.988 -0.845 . . . . 2.02 110.988 177.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -65.56 146.97 54.19 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.283 -1.006 . . . . 5.9900000000000002 108.283 173.749 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -82.64 63.33 6.72 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.389 -0.967 . . . . 3.8500000000000001 108.389 -173.733 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 127.96 11.69 3.13 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.895 1.712 . . . . 1.3899999999999999 113.664 -179.223 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.73 168.57 19.41 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.194 1.497 . . . . 2.6600000000000001 109.834 169.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.3 mp -126.57 136.11 52.13 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.375 1.07 . . . . 1.9299999999999999 109.418 -171.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -97.41 103.06 14.96 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.903 -1.518 . . . . 0.54000000000000004 106.903 175.326 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -122.91 121.06 35.27 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 118.398 -0.811 . . . . 0.95999999999999996 108.854 -177.098 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.453 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 15.4 t -107.99 -15.61 14.49 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 123.579 0.549 . . . . 0.97999999999999998 111.802 176.426 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -97.94 79.05 2.6 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 120.204 -1.56 . . . . 3.4900000000000002 108.979 -176.752 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.434 HG23 ' HG3' ' A' ' 101' ' ' PRO . 18.2 m -88.07 130.13 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 119.596 1.089 . . . . 0.78000000000000003 111.339 174.842 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.94 106.6 13.6 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 107.342 -1.355 . . . . 0.77000000000000002 107.342 175.366 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.67 72.11 10.62 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 123.165 0.586 . . . . 1.1899999999999999 110.6 -178.258 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.5 -37.06 62.38 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.811 0.671 . . . . 5.0 112.811 -178.667 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.532 0.28 0 O-C-N 121.657 -0.652 . . . . 4.6500000000000004 110.095 -171.282 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.412 0 N-CA-C 112.655 0.613 . . . . 3.98 112.655 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -87.92 114.74 24.83 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 125.469 1.508 . . . . 2.1499999999999999 110.717 -178.291 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -132.23 156.39 46.58 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.535 0.734 . . . . 3.6899999999999999 112.363 -173.055 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.6 m -71.98 132.62 84.56 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 125.54 1.536 . . . . 2.1499999999999999 110.759 -174.661 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -54.52 -37.49 90.19 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.149 2.566 . . . . 1.0700000000000001 112.8 -176.711 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -37.3 -53.43 1.09 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.578 1.151 . . . . 2.98 113.228 171.541 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -78.36 -1.89 35.53 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.011 -0.431 . . . . 3.1000000000000001 111.807 -173.189 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 32.7 pt -121.48 35.04 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.581 1.152 . . . . 1.6299999999999999 110.193 171.716 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.6 p -121.02 -76.31 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 122.893 0.477 . . . . 2.2400000000000002 111.165 158.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -83.52 109.11 17.11 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 125.214 1.405 . . . . 3.1800000000000002 110.441 -160.058 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.69 37.27 40.33 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 109.528 -1.429 . . . . 1.8799999999999999 109.528 177.597 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.06 -93.55 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.688 1.195 . . . . 2.79 107.836 -174.145 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.6 m -72.58 -59.0 2.94 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.141 0.976 . . . . 1.9199999999999999 111.195 -177.679 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -53.45 -41.66 66.36 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 122.835 1.302 . . . . 3.0800000000000001 109.575 -175.119 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.38 -19.43 42.66 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 126.524 1.93 . . . . 1.5900000000000001 112.321 -179.619 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 54.69 42.56 78.12 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 126.039 1.781 . . . . 1.8999999999999999 113.18 -175.383 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.5 m -100.25 -49.94 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 118.616 1.208 . . . . 2.0899999999999999 113.113 -174.071 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 34.3 mmtt -97.54 -66.03 0.08 OUTLIER Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.85 0.86 . . . . 2.9500000000000002 111.378 -177.485 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -75.15 68.94 5.79 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.264 1.976 . . . . 2.6099999999999999 108.843 170.428 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -51.28 140.4 16.98 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.993 -0.743 . . . . 3.0299999999999998 108.993 173.657 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.88 127.89 34.47 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.58 -0.896 . . . . 1.27 108.58 -176.466 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 124.39 -29.03 5.14 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.915 -0.874 . . . . 1.46 110.915 -161.609 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -79.84 137.15 36.87 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.988 1.394 . . . . 2.5899999999999999 110.225 -177.338 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.03 106.28 15.3 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.919 1.688 . . . . 3.7999999999999998 108.569 -172.648 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.43 168.46 23.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.7 -1.593 . . . . 1.3799999999999999 106.7 -174.58 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 25.9 mtt-85 -110.17 123.15 49.23 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 106.83 -1.544 . . . . 2.2599999999999998 106.83 178.232 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.4 p -86.88 130.73 36.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 107.329 -1.36 . . . . 0.79000000000000004 107.329 176.066 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -133.53 128.65 5.09 Favored Glycine 0 C--N 1.332 0.344 0 N-CA-C 110.161 -1.175 . . . . 0.56999999999999995 110.161 -179.497 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.1 -172.99 45.92 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.501 -1.04 . . . . 0.60999999999999999 110.501 -179.417 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -90.93 138.34 31.67 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 117.404 0.602 . . . . 4.5099999999999998 110.14 -178.628 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.551 HG11 ' HE1' ' A' ' 104' ' ' PHE . 7.6 p -106.42 144.73 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 109.388 -0.597 . . . . 2.2200000000000002 109.388 178.892 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.2 m -87.92 133.39 33.93 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 125.741 1.617 . . . . 2.3399999999999999 108.842 -174.84 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.444 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 10.8 p -46.63 -47.61 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.346 1.058 . . . . 2.3100000000000001 112.879 -177.424 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -100.43 76.09 0.43 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 109.648 -1.381 . . . . 2.0 109.648 -178.856 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.9 m -146.33 -39.29 0.22 Allowed 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 117.804 0.802 . . . . 1.21 112.558 178.78 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.8 ttm -54.95 129.06 36.25 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 118.168 0.44 . . . . 2.1200000000000001 110.117 173.088 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.75 122.73 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 106.119 -1.808 . . . . 0.63 106.119 160.088 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.434 ' CB ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -114.35 139.3 49.57 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.935 1.294 . . . . 5.3099999999999996 109.665 -178.138 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.46 166.06 47.37 Favored Pre-proline 0 C--O 1.235 0.324 0 CA-C-O 120.936 0.398 . . . . 1.72 111.101 -173.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.97 -25.59 13.98 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.138 2.558 . . . . 1.4199999999999999 111.201 163.593 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -48.13 -30.03 4.19 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.001 0.521 . . . . 1.1499999999999999 110.564 164.701 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.2 m 66.6 19.12 10.84 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 125.02 1.328 . . . . 1.3100000000000001 112.324 175.147 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.33 -41.52 1.89 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 128.281 2.632 . . . . 1.97 110.993 177.604 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 71.9 m-70 -84.2 126.0 32.73 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.951 -1.5 . . . . 1.0800000000000001 106.951 178.533 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.434 HG12 ' CB ' ' A' ' 73' ' ' ARG . 26.7 m -142.75 139.0 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 106.564 -1.643 . . . . 0.93999999999999995 106.564 179.908 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -144.15 149.95 37.3 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.346 -0.613 . . . . 1.3700000000000001 109.346 177.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -154.36 146.69 23.89 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 123.678 0.611 . . . . 2.02 109.468 -170.606 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.92 122.4 40.99 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 124.345 1.058 . . . . 0.94999999999999996 109.248 -179.197 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.1 t -108.23 146.9 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.084 0 N-CA-C 107.389 -1.337 . . . . 1.8600000000000001 107.389 177.543 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -151.1 -170.98 3.81 Favored 'General case' 0 C--O 1.226 -0.143 0 N-CA-C 107.541 -1.281 . . . . 1.8 107.541 174.045 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.521 -0.173 0 CA-C-N 118.619 0.645 . . . . 3.4300000000000002 109.664 -177.576 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.112 0 N-CA-C 116.223 1.249 . . . . 1.96 116.223 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -64.09 141.04 58.91 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.7 -0.883 . . . . 2.5600000000000001 110.427 171.507 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -141.56 143.91 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 107.856 -1.165 . . . . 0.91000000000000003 107.856 170.97 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.3 mt -91.1 119.35 31.16 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.287 1.035 . . . . 0.67000000000000004 108.973 177.523 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 51.3 t -98.24 127.99 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 106.783 -1.562 . . . . 1.04 106.783 174.548 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.6 p -113.61 148.11 36.83 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.547 -0.908 . . . . 1.0800000000000001 108.547 -177.753 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.473 ' CE2' ' HA ' ' A' ' 125' ' ' THR . 0.5 OUTLIER -142.72 141.35 31.77 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.949 1.3 . . . . 3.5600000000000001 108.381 -177.263 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -114.13 10.06 17.3 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.614 1.565 . . . . 2.4900000000000002 111.95 173.377 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -118.92 161.77 19.62 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 125.148 1.379 . . . . 4.4699999999999998 110.297 172.16 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.6 mp -64.86 122.91 18.06 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.159 -0.473 . . . . 1.8 109.939 168.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.4 HD21 ' CE1' ' A' ' 96' ' ' TYR . 23.0 mt -73.75 155.33 89.04 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 123.621 0.768 . . . . 1.6499999999999999 110.107 173.39 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -65.9 151.94 82.79 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 123.603 2.869 . . . . 2.3900000000000001 110.194 173.839 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 55.1 12.67 0.68 Allowed 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.983 1.475 . . . . 3.3100000000000001 114.983 -177.467 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.48 ' O ' HD22 ' A' ' 103' ' ' LEU . 0.4 OUTLIER 62.99 -6.42 0.17 Allowed 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 118.644 0.656 . . . . 4.5999999999999996 111.616 -162.419 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.551 ' HE1' HG11 ' A' ' 66' ' ' VAL . 5.0 t80 55.95 78.7 0.19 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.257 1.823 . . . . 2.6099999999999999 109.154 -170.829 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.3 10.2 mtp180 -86.7 34.88 0.66 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 119.046 -1.061 . . . . 4.3799999999999999 111.729 -177.517 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.444 ' HB3' ' HA ' ' A' ' 68' ' ' VAL 0.357 10.5 mm-40 82.94 178.53 0.06 Allowed 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 120.232 1.378 . . . . 5.25 110.158 149.875 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.405 ' N ' HG13 ' A' ' 66' ' ' VAL . . . 61.14 15.07 42.42 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 115.469 0.948 . . . . 1.05 115.469 158.215 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.484 ' O ' HG12 ' A' ' 66' ' ' VAL . 4.6 pt20 -136.73 141.48 43.04 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.601 1.2 . . . . 2.3500000000000001 108.027 -177.903 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -77.85 113.67 3.79 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.266 -1.134 . . . . 0.95999999999999996 110.266 -175.069 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.1 pp -123.65 169.33 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 123.608 0.763 . . . . 0.78000000000000003 109.437 -175.101 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.7 m -117.89 134.26 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 107.852 -1.166 . . . . 0.66000000000000003 107.852 169.371 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.516 ' CB ' HG12 ' A' ' 127' ' ' VAL . . . -121.26 155.18 35.21 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 125.53 1.532 . . . . 0.79000000000000004 108.569 177.837 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -148.09 161.83 40.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.052 0.842 . . . . 3.2000000000000002 112.112 171.645 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 171.15 -111.52 0.41 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 105.702 -2.959 . . . . 0.84999999999999998 105.702 167.537 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.2 p -156.81 146.39 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 118.724 1.262 . . . . 1.0800000000000001 111.719 -175.737 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.67 116.68 7.15 Favored 'General case' 0 N--CA 1.457 -0.093 0 N-CA-C 107.908 -1.145 . . . . 2.1800000000000002 107.908 168.729 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -136.75 13.2 3.93 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.092 -0.838 . . . . 2.3900000000000001 113.17 -179.681 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -143.05 35.49 1.37 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.017 0.908 . . . . 5.1900000000000004 110.678 177.625 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 26.63 52.45 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 128.124 2.57 . . . . 4.0199999999999996 112.053 177.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 160.77 -40.3 0.43 Allowed Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.244 -0.754 . . . . 1.27 113.772 -163.488 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.83 164.11 18.05 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.934 1.367 . . . . 2.9399999999999999 110.79 171.412 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.1 mt -105.72 116.67 32.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.243 1.417 . . . . 2.04 108.282 -177.307 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.41 103.7 13.79 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.553 -1.647 . . . . 0.64000000000000001 106.553 171.754 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -101.39 156.16 17.62 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.433 0.693 . . . . 1.71 109.843 -179.025 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.473 ' HA ' ' CE2' ' A' ' 96' ' ' TYR 0.256 9.9 t -141.1 -36.51 0.45 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.532 0.938 . . . . 1.23 113.532 174.713 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -92.45 127.35 37.91 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 120.481 -1.387 . . . . 2.7400000000000002 109.189 169.109 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.516 HG12 ' CB ' ' A' ' 112' ' ' ALA . 2.4 m -125.32 142.21 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 N-CA-C 108.394 -0.965 . . . . 0.94999999999999996 108.394 164.921 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.85 101.51 7.61 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.25 -1.389 . . . . 0.89000000000000001 107.25 179.071 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.85 60.56 2.87 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.247 0.619 . . . . 1.1499999999999999 110.694 -177.397 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -79.41 51.77 1.27 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.601 0.76 . . . . 3.04 112.072 -173.222 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.454 -0.23 0 N-CA-C 107.32 -1.363 . . . . 4.4000000000000004 107.32 -179.239 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--O 1.233 0.194 0 N-CA-C 109.894 -0.41 . . . . 2.6600000000000001 109.894 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -111.59 122.58 48.19 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.288 1.435 . . . . 2.73 107.984 179.715 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -129.71 164.62 23.58 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 122.799 0.44 . . . . 3.23 111.266 173.376 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 p -85.63 146.93 45.15 Favored Pre-proline 0 N--CA 1.45 -0.431 0 C-N-CA 123.725 0.81 . . . . 1.6499999999999999 110.598 -178.904 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -57.52 -42.18 63.77 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.94 2.426 . . . . 0.73999999999999999 111.155 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.9 p -58.63 -24.15 60.46 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.904 1.681 . . . . 2.3500000000000001 113.0 174.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -84.27 -48.36 9.83 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.114 -0.699 . . . . 2.2599999999999998 109.114 173.093 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.266 22.3 pt -75.73 37.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 114.397 1.258 . . . . 1.3600000000000001 114.397 -178.245 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.661 HG23 ' H ' ' A' ' 45' ' ' ASN . 0.5 OUTLIER -121.93 -87.06 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 125.39 1.476 . . . . 2.7000000000000002 108.16 169.271 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.661 ' H ' HG23 ' A' ' 44' ' ' VAL . 28.6 m-80 -58.98 103.62 0.18 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.549 2.34 . . . . 2.2799999999999998 110.469 -171.414 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.42 39.0 70.09 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.081 -0.807 . . . . 1.4099999999999999 111.081 171.942 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -143.99 -102.31 0.12 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 126.175 1.79 . . . . 2.71 108.377 175.57 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.405 HG23 HD12 ' A' ' 116' ' ' LEU . 97.7 m -69.48 -68.1 0.43 Allowed 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 124.319 1.048 . . . . 1.5 110.954 -177.374 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -53.75 -43.74 69.4 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.908 0.861 . . . . 2.5 110.559 -171.188 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.27 -22.56 51.93 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.615 0.766 . . . . 1.54 112.512 176.946 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 60.69 56.86 21.93 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 125.66 1.6 . . . . 1.3300000000000001 112.324 178.303 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.255 26.8 m -110.76 -64.16 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 114.1 1.148 . . . . 1.27 114.1 -179.595 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt -80.41 -62.99 0.36 Allowed Pre-proline 0 CA--C 1.538 0.513 0 O-C-N 121.302 -0.874 . . . . 3.6099999999999999 112.029 -177.629 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -77.13 -179.24 5.24 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.387 2.058 . . . . 1.6699999999999999 109.285 169.249 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -152.53 151.13 30.33 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.564 -1.643 . . . . 2.8100000000000001 106.564 -174.875 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -55.39 161.9 1.73 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.53 0.937 . . . . 1.1799999999999999 113.53 178.601 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.42 -6.09 58.49 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 119.424 -0.653 . . . . 1.02 113.075 -179.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -82.1 145.34 30.21 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.821 1.31 . . . . 1.8999999999999999 108.814 175.805 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.2 ttm105 -90.19 125.86 35.62 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.709 -1.219 . . . . 4.29 107.709 174.689 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.4 pt -142.05 175.63 4.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 118.842 0.746 . . . . 0.67000000000000004 109.035 175.483 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.445 HH11 ' HG2' ' A' ' 61' ' ' ARG . 6.2 mtt-85 -120.05 136.74 54.46 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.874 0.47 . . . . 3.4199999999999999 109.749 168.647 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.63 125.65 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 125.362 1.465 . . . . 0.81000000000000005 107.91 175.768 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -128.05 112.56 1.48 Allowed Glycine 0 C--N 1.333 0.388 0 N-CA-C 109.875 -1.29 . . . . 0.53000000000000003 109.875 -177.764 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.67 -171.5 33.72 Favored Glycine 0 C--N 1.332 0.348 0 N-CA-C 110.027 -1.229 . . . . 0.78000000000000003 110.027 -176.623 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.409 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 18.6 ptp -88.67 138.66 31.23 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.031 0.443 . . . . 2.73 110.1 -178.209 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.549 HG12 HG12 ' A' ' 84' ' ' VAL . 10.7 m -91.18 150.35 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 109.401 -0.592 . . . . 2.3300000000000001 109.401 170.574 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 m -91.37 143.89 26.15 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.892 -1.151 . . . . 2.7400000000000002 107.892 165.358 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.9 p -59.43 -59.44 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.362 1.065 . . . . 2.5699999999999998 110.088 178.272 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.36 66.79 2.89 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.328 -1.109 . . . . 1.6799999999999999 110.328 178.346 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.3 m -150.13 -30.77 0.21 Allowed 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 113.942 1.09 . . . . 1.0600000000000001 113.942 -179.398 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -60.14 117.23 4.88 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 119.087 0.858 . . . . 1.8999999999999999 109.225 173.545 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.16 125.41 71.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 N-CA-C 107.655 -1.239 . . . . 0.63 107.655 169.808 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -109.48 147.46 32.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.235 1.014 . . . . 6.6699999999999999 109.619 -178.829 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -72.42 161.76 77.42 Favored Pre-proline 0 C--O 1.239 0.533 0 C-N-CA 120.404 -0.518 . . . . 2.29 110.381 174.455 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -63.74 -34.22 62.82 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.384 2.056 . . . . 1.6299999999999999 110.175 163.81 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -41.18 -47.27 3.26 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 125.273 1.429 . . . . 1.29 109.854 174.713 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.4 m 80.64 11.67 0.95 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.117 1.767 . . . . 1.3 112.423 179.668 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.17 -6.92 9.9 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.041 1.336 . . . . 1.8500000000000001 111.334 175.522 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -123.4 136.64 54.73 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.919 1.287 . . . . 1.4199999999999999 108.151 177.99 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.61 131.07 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 107.826 -1.176 . . . . 0.89000000000000001 107.826 -172.341 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -135.81 154.32 51.24 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 119.778 1.172 . . . . 1.2 110.427 175.894 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -150.25 138.69 20.53 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.067 -0.716 . . . . 1.95 109.067 -173.805 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.07 136.57 34.44 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.938 -1.134 . . . . 0.66000000000000003 107.938 173.584 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.549 HG12 HG12 ' A' ' 66' ' ' VAL . 14.4 m -129.63 149.5 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 107.992 -1.114 . . . . 2.6800000000000002 107.992 177.436 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -153.4 177.53 10.79 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.975 0.416 . . . . 2.6499999999999999 110.247 -173.951 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.7 t0 . . . . . 0 N--CA 1.449 -0.514 0 C-N-CA 123.179 0.592 . . . . 3.0299999999999998 111.037 175.235 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.566 ' HA3' HG21 ' A' ' 44' ' ' VAL . . . . . . . . 0 N--CA 1.446 -0.7 0 N-CA-C 110.133 -1.187 . . . . 1.54 110.133 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -138.86 141.47 38.61 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.921 1.688 . . . . 3.21 107.363 -175.239 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.4 tp -140.8 151.21 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 123.451 0.701 . . . . 1.1499999999999999 109.247 -176.162 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mt -93.17 122.21 35.32 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.655 0.782 . . . . 1.1599999999999999 109.768 -178.048 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.0 t -102.3 119.56 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 107.062 -1.459 . . . . 0.89000000000000001 107.062 173.558 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 62.0 p -99.42 147.34 25.36 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.086 -1.079 . . . . 0.53000000000000003 108.086 174.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -147.35 160.83 42.08 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.238 1.415 . . . . 2.5 108.521 -172.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -147.98 152.89 38.25 Favored 'General case' 0 N--CA 1.428 -1.542 0 C-N-CA 127.553 2.341 . . . . 3.5600000000000001 106.616 -169.628 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 61.1 64.81 1.06 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 129.652 3.181 . . . . 2.7200000000000002 110.7 -172.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.0 mp 45.05 -144.67 0.16 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.311 1.444 . . . . 1.8799999999999999 109.449 -173.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.6 mt -158.76 149.78 16.3 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 104.883 -2.265 . . . . 1.1100000000000001 104.883 -175.951 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -67.35 129.75 20.97 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 121.956 1.771 . . . . 2.6600000000000001 108.14 169.757 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.582 ' O ' HD12 ' A' ' 103' ' ' LEU . 2.8 m-20 23.25 53.78 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 128.207 2.603 . . . . 3.3300000000000001 113.095 -178.047 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.616 HD13 ' OE1' ' A' ' 106' ' ' GLU . 0.7 OUTLIER 36.6 38.42 0.08 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.509 1.524 . . . . 3.4199999999999999 114.422 -179.159 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.0 p90 35.34 83.6 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.423 1.489 . . . . 3.3100000000000001 112.111 -173.561 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.4 116.3 4.96 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 119.255 -2.153 . . . . 4.5999999999999996 110.709 -137.594 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.616 ' OE1' HD13 ' A' ' 103' ' ' LEU . 9.6 mp0 -77.53 167.22 21.99 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 122.267 1.032 . . . . 3.6699999999999999 111.679 -147.31 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.93 41.07 56.18 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 114.841 -1.072 . . . . 0.80000000000000004 110.996 -169.919 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -149.8 178.34 8.97 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.353 1.061 . . . . 2.5 109.08 171.864 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' A' ' 65' ' ' MET . . . -92.89 136.22 13.05 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 110.738 -0.945 . . . . 0.77000000000000002 110.738 170.632 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.4 pp -139.29 154.74 25.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 107.484 -1.302 . . . . 0.68999999999999995 107.484 179.557 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 19.5 m -110.32 120.89 62.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 108.741 -0.837 . . . . 0.66000000000000003 108.741 178.457 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.464 ' HB2' HG12 ' A' ' 127' ' ' VAL . . . -113.97 150.8 33.28 Favored 'General case' 0 N--CA 1.458 -0.071 0 C-N-CA 126.131 1.772 . . . . 0.68000000000000005 109.494 -174.492 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -149.9 155.01 39.27 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 113.448 0.907 . . . . 3.8799999999999999 113.448 177.987 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 163.48 -130.38 2.22 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 106.063 -2.815 . . . . 0.98999999999999999 106.063 175.235 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.9 p -129.95 145.79 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.069 0 CA-C-N 118.337 1.068 . . . . 0.93000000000000005 111.761 -164.095 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.405 HD12 HG23 ' A' ' 48' ' ' THR . 4.6 mm? -66.3 124.33 22.41 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.199 -0.455 . . . . 1.95 111.027 174.725 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.59 130.43 9.83 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 126.257 1.884 . . . . 3.6200000000000001 109.377 172.595 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 60.58 29.73 19.23 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.465 1.106 . . . . 4.5800000000000001 111.458 167.553 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 40.9 39.26 0.78 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.011 1.724 . . . . 4.5099999999999998 111.178 -170.375 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -160.3 -61.96 0.01 OUTLIER Glycine 0 C--N 1.34 0.792 0 O-C-N 121.472 -0.767 . . . . 1.1699999999999999 111.946 -170.354 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -83.34 127.34 33.59 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.901 -0.777 . . . . 2.1899999999999999 108.901 -178.842 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.35 107.32 17.94 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.384 -1.339 . . . . 2.1299999999999999 107.384 177.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.85 84.74 7.46 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.361 -1.348 . . . . 0.57999999999999996 107.361 -179.59 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.66 144.71 26.44 Favored 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 123.762 0.825 . . . . 1.23 109.023 -177.484 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.7 t -137.88 9.56 2.82 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.85 0.75 . . . . 1.1499999999999999 112.914 173.898 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -132.99 119.65 20.37 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.736 -1.579 . . . . 3.4199999999999999 106.736 170.272 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.464 HG12 ' HB2' ' A' ' 112' ' ' ALA . 2.4 m -123.41 131.38 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 124.589 1.156 . . . . 0.82999999999999996 109.494 176.867 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -115.91 104.37 11.55 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.708 -1.219 . . . . 0.90000000000000002 107.708 179.117 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.14 56.02 3.56 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.018 0.927 . . . . 1.3999999999999999 110.653 -179.238 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -77.8 60.95 2.36 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.046 0.938 . . . . 3.2799999999999998 111.355 -175.409 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.269 0 CA-C-O 121.686 0.755 . . . . 4.4299999999999997 111.171 -172.514 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 pt? . . . . . 0 C--O 1.233 0.195 0 N-CA-C 109.663 -0.495 . . . . 1.8500000000000001 109.663 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -83.07 140.0 32.91 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.534 0.734 . . . . 2.2000000000000002 110.359 -178.734 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -144.67 160.13 41.7 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.925 1.29 . . . . 2.77 110.593 176.977 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.95 134.67 38.72 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 126.519 1.928 . . . . 1.4299999999999999 109.972 -179.848 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -56.84 -43.46 54.22 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.263 2.642 . . . . 0.76000000000000001 111.775 -179.449 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.3 p -59.94 -34.2 72.93 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 121.406 -0.809 . . . . 2.0299999999999998 112.065 -178.648 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.02 -55.17 36.08 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.553 0.692 . . . . 3.1899999999999999 109.281 175.953 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.318 20.6 pt -66.29 -14.91 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 114.64 -1.164 . . . . 1.4399999999999999 112.624 -170.022 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 88.4 t -75.68 -54.87 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 123.007 0.523 . . . . 2.0699999999999998 110.978 167.499 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -56.43 -71.4 0.09 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.508 0.929 . . . . 2.5699999999999998 113.508 -163.328 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -146.21 55.87 0.53 Allowed Glycine 0 C--N 1.333 0.4 0 N-CA-C 108.778 -1.729 . . . . 1.74 108.778 -167.806 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -153.44 -106.85 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.928 1.691 . . . . 3.6499999999999999 108.644 -171.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.5 m -72.53 -60.05 2.42 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 124.341 1.056 . . . . 1.5700000000000001 111.619 -170.765 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -56.25 -40.14 73.7 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 122.048 0.928 . . . . 2.5899999999999999 109.734 -176.039 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.45 -24.84 62.09 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.158 0.983 . . . . 2.0499999999999998 112.805 174.482 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.48 41.38 99.54 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 126.163 1.839 . . . . 1.26 111.918 -176.015 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.9 m -102.55 -53.52 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 118.048 0.924 . . . . 1.3300000000000001 113.037 -174.423 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -93.71 -65.4 0.12 Allowed Pre-proline 0 CA--C 1.533 0.326 0 CA-C-O 118.542 -0.742 . . . . 3.8599999999999999 112.054 -175.282 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -78.59 140.6 16.91 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 121.681 1.587 . . . . 1.24 108.799 174.067 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -87.35 161.95 17.63 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.701 0.8 . . . . 4.9699999999999998 109.255 167.738 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.95 170.15 8.73 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 122.9 0.48 . . . . 1.6000000000000001 110.215 174.124 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.51 22.81 71.69 Favored Glycine 0 CA--C 1.534 1.248 0 O-C-N 121.768 -0.583 . . . . 1.05 113.583 178.308 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -102.23 162.23 13.08 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.198 0.999 . . . . 1.7 108.432 171.2 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.7 mtt180 -99.63 134.43 42.53 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.86 -0.422 . . . . 3.7200000000000002 109.86 169.55 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.3 pt -143.36 176.22 3.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 106.862 -1.533 . . . . 0.78000000000000003 106.862 169.024 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -123.29 123.4 40.66 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.355 -0.98 . . . . 2.2200000000000002 108.355 170.474 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.9 m -89.06 129.42 40.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 107.938 -1.134 . . . . 2.2599999999999998 107.938 175.007 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -128.38 128.23 5.9 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 109.197 -1.561 . . . . 0.68999999999999995 109.197 178.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.67 -170.74 40.34 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 109.979 -1.248 . . . . 0.68000000000000005 109.979 -174.139 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.3 ptp -100.41 123.91 45.23 Favored 'General case' 0 N--CA 1.458 -0.061 0 CA-C-O 121.316 0.579 . . . . 2.3500000000000001 110.976 -174.044 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.0 t -73.24 105.23 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 123.831 0.853 . . . . 2.23 110.485 179.78 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.2 m -45.29 136.09 5.49 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 126.362 1.865 . . . . 2.3599999999999999 111.28 164.583 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.1 p -55.54 -64.09 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.741 0.817 . . . . 2.0099999999999998 111.077 177.42 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.45 72.6 2.78 Favored Glycine 0 C--N 1.332 0.36 0 N-CA-C 109.34 -1.504 . . . . 1.77 109.34 -174.586 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.6 m -150.46 -34.18 0.16 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 115.891 1.811 . . . . 1.1100000000000001 115.891 -174.895 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -76.93 99.71 5.33 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 120.159 1.345 . . . . 2.29 110.313 -175.012 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.1 m -111.32 128.81 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 108.527 -0.916 . . . . 0.85999999999999999 108.527 -177.819 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -111.57 143.26 42.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.725 1.61 . . . . 6.0 110.591 -175.61 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -71.83 155.82 91.74 Favored Pre-proline 0 C--O 1.232 0.155 0 CA-C-N 118.245 0.475 . . . . 1.8700000000000001 109.764 177.416 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -64.16 -27.11 64.77 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.207 1.938 . . . . 1.22 111.363 166.064 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -45.31 -33.68 2.57 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.193 0.597 . . . . 1.1499999999999999 110.709 164.726 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.1 m 69.27 15.99 8.48 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.446 1.498 . . . . 1.5600000000000001 112.466 177.253 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.41 -38.1 2.59 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 126.324 1.85 . . . . 1.7 112.075 175.789 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -87.38 135.96 33.12 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.155 -1.424 . . . . 1.1399999999999999 107.155 175.537 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.555 HG23 ' HB3' ' A' ' 96' ' ' TYR . 28.0 m -144.15 148.72 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 107.195 -1.409 . . . . 0.68000000000000005 107.195 178.144 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -148.78 158.76 44.39 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.448 -0.783 . . . . 1.0 109.716 178.892 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -150.64 142.11 23.45 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.654 -0.703 . . . . 1.8400000000000001 110.405 -173.884 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.97 148.56 27.54 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.16 -1.052 . . . . 0.65000000000000002 108.16 163.031 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.5 p -146.84 150.46 14.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 107.661 -1.237 . . . . 1.9399999999999999 107.661 171.705 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.2 176.43 9.75 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.189 0.996 . . . . 2.3399999999999999 110.513 -175.345 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.5 t70 . . . . . 0 N--CA 1.454 -0.252 0 C-N-CA 123.961 0.904 . . . . 2.6299999999999999 110.735 -176.57 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.819 0 N-CA-C 110.892 -0.883 . . . . 1.9299999999999999 110.892 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -99.5 135.15 41.33 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 124.792 1.237 . . . . 3.1000000000000001 108.98 169.18 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' A' ' 92' ' ' ILE . 0.2 OUTLIER -112.57 144.89 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.654 -1.239 . . . . 0.98999999999999999 107.654 167.553 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.5 mt -104.09 120.69 41.64 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.271 1.029 . . . . 0.66000000000000003 108.38 176.225 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 44.0 t -103.16 136.3 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 125.422 1.489 . . . . 0.83999999999999997 107.676 178.965 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.2 p -112.94 142.01 46.11 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.405 1.082 . . . . 0.52000000000000002 108.578 178.521 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.555 ' HB3' HG23 ' A' ' 80' ' ' VAL . 2.1 t80 -138.42 114.63 10.24 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.529 -1.286 . . . . 2.4100000000000001 107.529 -175.564 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -101.27 46.97 0.92 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.851 1.261 . . . . 2.3300000000000001 112.05 -171.222 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -167.67 176.81 6.19 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.646 1.978 . . . . 2.5499999999999998 107.037 170.486 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.0 mp -70.67 136.65 49.22 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.02 -1.05 . . . . 1.79 110.783 178.533 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.452 ' HG ' HG21 ' A' ' 80' ' ' VAL . 11.9 mt -69.92 160.89 78.47 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.395 1.078 . . . . 1.24 110.565 174.302 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.52 -95.82 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.837 3.024 . . . . 2.3900000000000001 110.281 176.282 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -78.39 49.91 0.89 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.863 1.265 . . . . 3.4900000000000002 110.232 -176.543 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 52.44 -4.67 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.404 2.682 . . . . 2.21 115.918 -168.46 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 64.4 t80 64.26 93.96 0.06 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.727 1.611 . . . . 2.29 108.795 -159.32 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -79.81 129.02 34.13 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.663 0.744 . . . . 5.8899999999999997 109.272 -179.138 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -83.95 144.17 29.34 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 128.062 2.545 . . . . 3.3999999999999999 109.617 -174.002 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.29 46.59 8.02 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 112.052 -0.419 . . . . 1.0800000000000001 112.052 178.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -155.8 175.52 13.82 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.567 -1.642 . . . . 2.1899999999999999 106.567 170.839 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -86.24 144.49 20.03 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.095 -1.202 . . . . 0.87 110.095 167.668 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.1 pp -139.77 167.7 18.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 107.731 -1.211 . . . . 0.60999999999999999 107.731 167.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 23.8 m -126.71 135.57 63.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.867 -0.79 . . . . 0.66000000000000003 108.867 171.096 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -129.55 120.46 25.38 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 124.703 1.201 . . . . 0.47999999999999998 110.762 -169.095 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -114.21 145.95 41.03 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 125.253 1.421 . . . . 3.4700000000000002 111.022 -176.619 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 173.07 -123.09 0.96 Allowed Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 108.021 -2.032 . . . . 0.91000000000000003 108.021 170.467 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.2 p -138.25 152.17 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 118.176 0.988 . . . . 0.72999999999999998 109.726 -173.021 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -59.61 132.31 53.58 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 108.118 -1.067 . . . . 1.7 108.118 167.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -87.98 -104.34 0.93 Allowed Glycine 0 C--N 1.338 0.661 0 N-CA-C 110.011 -1.236 . . . . 2.1200000000000001 110.011 -172.766 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -59.4 -66.15 0.56 Allowed 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.334 1.054 . . . . 4.8499999999999996 108.375 172.771 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -173.0 -66.3 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.761 2.024 . . . . 4.1900000000000004 105.971 175.83 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.0 -45.04 96.94 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 123.504 0.573 . . . . 1.1200000000000001 112.271 177.021 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -83.28 144.13 29.93 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 122.036 -0.685 . . . . 2.54 111.257 -176.217 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -105.15 122.77 46.6 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 125.002 1.321 . . . . 2.25 108.076 -176.456 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.91 85.85 4.51 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.826 -1.175 . . . . 0.62 107.826 175.913 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.4 105.0 13.84 Favored 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 123.473 0.709 . . . . 1.3600000000000001 110.378 -175.301 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.2 t -95.77 -25.82 15.91 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.903 0.881 . . . . 0.79000000000000004 111.761 -177.485 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -89.33 81.52 6.64 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 120.695 -1.253 . . . . 3.2799999999999998 108.708 179.279 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.6 m -90.48 125.03 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 118.112 0.415 . . . . 0.64000000000000001 110.32 173.26 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -115.26 113.97 24.58 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.165 -1.42 . . . . 0.60999999999999999 107.165 175.372 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.69 108.27 11.98 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 107.501 -1.296 . . . . 1.5900000000000001 107.501 167.845 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.89 50.49 0.31 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 122.511 0.324 . . . . 3.5299999999999998 110.626 -175.613 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.255 0 C-N-CA 124.852 1.261 . . . . 6.0199999999999996 108.395 177.49 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 pt? . . . . . 0 N--CA 1.465 0.319 0 N-CA-C 112.052 0.39 . . . . 2.1800000000000002 112.052 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -85.15 125.17 32.6 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 124.874 1.27 . . . . 2.3399999999999999 110.115 179.463 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -124.27 161.19 26.33 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.628 1.571 . . . . 3.27 110.89 176.88 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 54.4 m -83.04 126.05 73.4 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 126.444 1.898 . . . . 1.8700000000000001 110.433 -177.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -48.24 -43.1 32.5 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.901 3.067 . . . . 1.03 114.032 -179.133 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.1 m -54.76 -33.07 60.8 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.264 -0.897 . . . . 1.98 112.33 177.821 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -77.31 3.0 14.06 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.54 0.736 . . . . 2.6299999999999999 111.994 179.548 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.278 18.3 pt -121.6 3.37 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 O-C-N 120.79 -1.194 . . . . 1.1699999999999999 112.978 173.07 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.1 t -98.01 -49.0 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.031 0.932 . . . . 1.79 112.049 179.393 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -102.98 90.61 3.82 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 120.54 -1.35 . . . . 2.1299999999999999 111.106 -167.843 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.35 48.47 18.77 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.905 -0.878 . . . . 1.45 110.905 178.293 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -152.85 -146.04 0.19 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 128.609 2.764 . . . . 4.2599999999999998 105.067 176.481 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.1 m -43.57 -48.45 7.53 Favored 'General case' 0 C--O 1.227 -0.127 0 C-N-CA 126.198 1.799 . . . . 1.79 115.495 -170.51 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -39.16 -55.14 1.69 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.497 0.719 . . . . 2.5699999999999998 111.508 172.859 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.07 -15.94 25.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.782 1.233 . . . . 1.51 110.652 -173.618 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.89 26.91 73.77 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.996 1.284 . . . . 1.1200000000000001 112.438 176.818 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.2 m -80.07 -23.54 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 118.047 0.923 . . . . 1.27 112.406 -174.53 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -121.75 -75.95 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 124.172 0.989 . . . . 3.6800000000000002 111.745 178.137 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.25 119.57 6.07 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 CA-C-N 120.554 1.234 . . . . 1.3400000000000001 109.352 179.476 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -71.63 149.16 45.84 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.99 -0.744 . . . . 4.8099999999999996 108.99 172.293 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.73 147.26 47.53 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.102 -1.073 . . . . 1.1399999999999999 108.102 172.595 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.77 -1.17 27.42 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.61 1.1 . . . . 1.1200000000000001 112.874 -173.732 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -102.79 148.94 24.99 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.426 1.09 . . . . 1.52 109.595 -176.614 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -86.92 125.88 34.32 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.466 -0.939 . . . . 3.8700000000000001 108.466 172.605 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.5 pt -141.11 176.07 5.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 106.228 -1.767 . . . . 0.91000000000000003 106.228 167.078 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -124.56 133.01 53.43 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.771 -1.196 . . . . 3.2999999999999998 107.771 171.918 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.0 131.54 51.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 107.747 -1.205 . . . . 1.21 107.747 175.402 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -126.84 113.11 1.69 Allowed Glycine 0 C--N 1.336 0.551 0 N-CA-C 109.7 -1.36 . . . . 0.65000000000000002 109.7 179.371 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.85 -168.2 17.15 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 109.966 -1.254 . . . . 0.70999999999999996 109.966 -175.013 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -109.42 130.61 55.49 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.637 0.775 . . . . 2.79 110.586 -176.359 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.563 HG22 ' CZ ' ' A' ' 104' ' ' PHE . 26.1 t -67.0 143.7 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 109.093 -0.706 . . . . 2.27 109.093 175.313 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.0 t -59.45 -68.45 0.28 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.627 0.371 . . . . 3.3999999999999999 111.34 178.831 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.0 p 178.79 -45.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 123.633 0.773 . . . . 2.1099999999999999 110.496 -173.347 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -146.43 42.82 0.92 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.164 -1.174 . . . . 2.2599999999999998 110.164 -179.733 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.84 -30.71 70.96 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.322 0.649 . . . . 1.8600000000000001 112.541 176.757 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.4 112.62 2.25 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 122.278 0.231 . . . . 1.79 110.387 -174.919 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.1 m -122.98 120.12 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.79 -1.559 . . . . 0.71999999999999997 106.79 168.096 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.45 144.04 36.6 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.536 -1.283 . . . . 5.4800000000000004 107.536 175.467 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -99.17 153.01 37.99 Favored Pre-proline 0 C--O 1.234 0.282 0 N-CA-C 108.55 -0.907 . . . . 2.5499999999999998 108.55 -179.828 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.41 37.72 0.52 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.662 2.908 . . . . 1.73 112.244 -178.483 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -94.78 -35.77 11.97 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.934 1.294 . . . . 1.6399999999999999 108.727 171.346 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.6 m 97.48 -19.38 0.05 OUTLIER 'General case' 0 C--N 1.342 0.243 0 C-N-CA 127.819 2.447 . . . . 2.6499999999999999 111.777 -174.798 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.04 27.94 8.16 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 123.772 0.829 . . . . 2.8300000000000001 112.815 -179.423 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -135.98 115.44 12.71 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.759 -0.83 . . . . 2.1099999999999999 108.759 178.415 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.15 116.23 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 124.948 1.299 . . . . 1.0800000000000001 107.932 -178.308 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -129.27 154.2 47.06 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.022 0.828 . . . . 1.0800000000000001 109.484 177.674 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.506 ' CE1' ' CE1' ' A' ' 104' ' ' PHE . 33.6 p90 -157.36 145.27 19.02 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.447 -0.342 . . . . 1.8700000000000001 110.469 -175.555 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.12 157.94 18.7 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.655 0.74 . . . . 0.73999999999999999 109.753 167.774 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 p -141.76 149.37 19.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 106.638 -1.615 . . . . 1.9399999999999999 106.638 172.181 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -128.61 -172.91 2.82 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.017 0.527 . . . . 1.5800000000000001 110.322 -179.374 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.7 t70 . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 109.012 -0.736 . . . . 2.3700000000000001 109.012 178.204 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.497 0 CA-C-O 119.268 -0.74 . . . . 2.2999999999999998 111.604 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -62.89 111.64 2.22 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.43 -1.322 . . . . 3.3999999999999999 107.43 179.173 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.2 tp -140.37 156.59 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 108.185 -1.043 . . . . 1.1399999999999999 108.185 179.145 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.4 mt -119.87 129.66 54.49 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.504 -1.295 . . . . 0.57999999999999996 107.504 -169.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.44 ' CG2' ' CE1' ' A' ' 82' ' ' PHE . 5.1 m -120.69 143.15 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 109.152 -0.685 . . . . 2.3300000000000001 109.152 175.19 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.5 p -115.06 133.68 55.83 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.101 1.361 . . . . 0.78000000000000003 107.512 -176.1 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -129.77 131.04 46.1 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.856 -1.535 . . . . 2.3199999999999998 106.856 -178.348 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -122.11 34.06 5.28 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.268 1.427 . . . . 2.1200000000000001 111.885 -167.773 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -163.46 54.89 0.17 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.353 0.596 . . . . 3.1000000000000001 111.689 -174.426 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 53.77 -162.75 0.11 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.854 0.862 . . . . 1.95 110.844 -173.245 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.6 mt -148.93 155.83 40.69 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 106.381 -1.711 . . . . 1.1399999999999999 106.381 179.921 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.34 -73.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.142 2.561 . . . . 2.3100000000000001 110.27 -179.643 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.51 47.71 0.87 Allowed 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.926 1.29 . . . . 2.6800000000000002 108.394 -178.515 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 41.61 23.88 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 115.749 1.759 . . . . 2.1800000000000002 115.749 -173.226 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.563 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 51.8 t80 53.67 96.51 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.6 1.091 . . . . 2.9300000000000002 110.277 -168.887 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 -75.37 123.26 25.08 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.583 -0.895 . . . . 5.8200000000000003 108.583 -172.699 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -82.97 168.14 17.29 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.613 0.721 . . . . 2.98 111.403 -177.349 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 58.36 35.6 79.79 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 123.965 0.793 . . . . 0.85999999999999999 113.001 179.287 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -156.23 177.66 11.19 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.049 1.34 . . . . 2.8900000000000001 108.035 174.189 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -94.73 139.74 14.67 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.968 -0.853 . . . . 0.75 110.968 174.819 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.5 pp -142.67 153.78 17.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 106.642 -1.614 . . . . 0.87 106.642 178.803 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 19.9 m -115.14 128.07 72.46 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 N-CA-C 108.983 -0.747 . . . . 0.79000000000000004 108.983 -179.871 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -119.59 135.92 54.59 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 125.471 1.508 . . . . 0.73999999999999999 109.668 -168.83 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -136.66 144.24 43.89 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.524 1.529 . . . . 3.6200000000000001 109.45 -176.491 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -177.04 -103.66 0.17 Allowed Glycine 0 C--N 1.332 0.344 0 N-CA-C 108.03 -2.028 . . . . 1.27 108.03 163.611 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.5 p -151.5 145.17 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 109.177 -0.675 . . . . 0.82999999999999996 109.177 178.386 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.629 ' HG ' HD12 ' A' ' 122' ' ' LEU . 0.3 OUTLIER -78.49 152.95 31.76 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.795 -1.187 . . . . 2.71 107.795 172.463 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -168.54 -51.91 0.03 OUTLIER Glycine 0 C--N 1.333 0.396 0 C-N-CA 119.656 -1.259 . . . . 2.0699999999999998 112.318 175.929 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -61.94 155.58 23.2 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 119.151 -1.019 . . . . 4.5099999999999998 109.55 172.193 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -79.38 79.09 5.85 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 105.811 -1.922 . . . . 4.1100000000000003 105.811 179.47 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.08 17.64 26.82 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 126.159 1.838 . . . . 1.45 113.361 172.078 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.56 154.76 38.78 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.725 -1.583 . . . . 3.0899999999999999 106.725 164.879 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.629 HD12 ' HG ' ' A' ' 116' ' ' LEU . 0.8 OUTLIER -116.09 137.92 51.7 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 122.776 0.43 . . . . 2.2400000000000002 110.237 -175.837 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.34 81.43 4.43 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 107.915 -1.143 . . . . 0.53000000000000003 107.915 177.029 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -90.22 134.25 34.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.306 -0.628 . . . . 1.04 109.306 178.707 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.5 t -128.88 -23.24 3.11 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.731 0.812 . . . . 1.0 113.161 179.033 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -101.58 104.18 15.05 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.352 -1.722 . . . . 3.8399999999999999 106.352 173.168 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.6 m -116.81 125.23 73.64 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 N-CA-C 109.247 -0.649 . . . . 0.94999999999999996 109.247 177.002 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.51 112.12 19.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.153 -1.425 . . . . 0.92000000000000004 107.153 -175.002 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -106.36 42.04 1.33 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.618 1.167 . . . . 2.1600000000000001 111.613 -173.14 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.23 52.72 1.36 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.355 0.662 . . . . 4.0300000000000002 111.588 -175.713 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 . . . . . 0 N--CA 1.456 -0.142 0 N-CA-C 109.583 -0.525 . . . . 4.5 109.583 -176.389 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 C--O 1.234 0.244 0 CA-C-O 120.838 0.351 . . . . 2.1600000000000001 110.647 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -83.4 134.58 34.88 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.576 1.15 . . . . 2.5899999999999999 109.27 -179.152 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.422 ' CE2' ' HG2' ' A' ' 42' ' ' GLU . 0.5 OUTLIER -146.8 152.04 38.11 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.198 0.999 . . . . 3.21 109.209 -169.109 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.4 p -89.76 142.42 29.16 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 118.046 0.385 . . . . 2.1499999999999999 110.689 -173.191 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -55.26 -41.39 78.89 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.108 1.872 . . . . 0.85999999999999999 111.701 173.797 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.0 t -47.26 -36.98 9.77 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.419 1.088 . . . . 2.5099999999999998 111.527 173.187 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.422 ' HG2' ' CE2' ' A' ' 38' ' ' TYR . 0.9 OUTLIER -67.39 -59.18 3.61 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.413 -0.588 . . . . 2.25 109.413 177.775 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.5 pt -73.3 4.77 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 114.758 1.392 . . . . 0.96999999999999997 114.758 -167.054 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.6 m -96.82 -28.25 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.688 1.195 . . . . 2.8599999999999999 112.301 172.199 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -87.15 -87.03 0.15 Allowed 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.88 0.764 . . . . 2.4300000000000002 110.472 -168.63 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -122.27 59.8 0.58 Allowed Glycine 0 C--N 1.335 0.474 0 N-CA-C 108.814 -1.714 . . . . 1.6699999999999999 108.814 -176.058 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -160.96 -157.45 0.52 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.905 2.482 . . . . 2.4399999999999999 105.426 -175.086 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.474 HG21 HD11 ' A' ' 116' ' ' LEU . 7.4 m -29.02 -59.89 0.13 Allowed 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 128.279 2.631 . . . . 1.55 116.489 -170.213 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -54.14 -37.5 64.46 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.292 0.951 . . . . 3.6899999999999999 111.012 -173.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.5 m -91.04 -21.88 21.04 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.708 0.803 . . . . 1.5800000000000001 110.906 176.522 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.37 31.49 68.58 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.685 1.136 . . . . 1.3100000000000001 112.038 172.595 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.0 m -81.6 -55.72 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 122.295 -0.532 . . . . 1.5700000000000001 111.517 -173.941 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -87.3 -67.97 0.14 Allowed Pre-proline 0 CA--C 1.534 0.36 0 CA-C-O 118.558 -0.734 . . . . 3.4900000000000002 112.145 175.969 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -78.02 131.93 11.32 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 121.53 1.486 . . . . 1.4199999999999999 109.701 -177.916 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -80.48 165.87 21.75 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.437 0.695 . . . . 4.8799999999999999 109.191 166.883 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.5 159.91 33.65 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.392 -0.595 . . . . 1.3400000000000001 109.392 166.809 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.22 3.04 57.84 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 123.271 0.462 . . . . 1.25 112.8 178.31 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -102.53 156.69 17.44 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.801 1.241 . . . . 1.55 108.584 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.3 mtm-85 -96.79 130.95 43.96 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.294 -0.632 . . . . 4.0300000000000002 109.294 171.124 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.1 pt -146.58 175.26 1.94 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 106.686 -1.598 . . . . 0.70999999999999996 106.686 168.409 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -124.63 124.91 43.23 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 118.2 0.455 . . . . 1.9199999999999999 110.08 175.537 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.4 p -87.71 119.45 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.564 -1.272 . . . . 0.80000000000000004 107.564 174.567 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -126.31 115.98 2.43 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 109.508 -1.437 . . . . 0.58999999999999997 109.508 177.158 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.86 -154.77 8.11 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 108.206 -1.958 . . . . 0.70999999999999996 108.206 -176.943 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 24.7 ptp -117.34 137.56 52.37 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.712 0.805 . . . . 2.5499999999999998 110.459 -178.448 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 p -89.1 137.23 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 120.273 -0.571 . . . . 2.54 110.166 177.283 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.6 m -28.73 -84.62 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 128.666 2.786 . . . . 3.25 113.38 175.702 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.1 p 171.97 -40.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 125.339 1.455 . . . . 2.2599999999999998 110.238 -175.633 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -148.57 48.39 0.62 Allowed Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.884 -1.287 . . . . 1.8600000000000001 109.884 -178.586 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 65.2 m -101.59 -12.75 18.22 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.212 0.605 . . . . 1.04 112.472 -179.54 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 35.2 tpp -58.33 125.11 21.88 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.931 0.787 . . . . 2.1200000000000001 110.826 170.67 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.5 m -129.81 142.98 42.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 108.372 -0.973 . . . . 0.66000000000000003 108.372 163.496 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.501 ' CB ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -120.9 154.9 35.25 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 124.013 0.925 . . . . 4.1200000000000001 110.934 -177.623 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.53 153.68 81.38 Favored Pre-proline 0 N--CA 1.453 -0.31 0 N-CA-C 109.501 -0.555 . . . . 2.0499999999999998 109.501 171.411 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -59.83 -26.45 82.31 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.607 2.204 . . . . 1.53 111.363 171.008 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -44.82 -36.24 3.15 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.791 0.836 . . . . 1.24 110.952 168.649 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 21.0 m 75.58 18.57 2.21 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.869 1.668 . . . . 1.6899999999999999 112.659 178.478 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.55 -49.17 2.14 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 125.368 1.467 . . . . 1.9199999999999999 111.105 172.549 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -79.09 131.7 36.33 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.489 -1.3 . . . . 1.23 107.489 -176.173 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.501 HG12 ' CB ' ' A' ' 73' ' ' ARG . 32.8 m -138.51 160.03 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 108.744 -0.836 . . . . 1.5 108.744 171.909 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -144.74 147.57 33.12 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.65 -0.704 . . . . 1.3999999999999999 109.274 175.815 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -155.59 146.65 22.48 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.754 0.421 . . . . 1.99 110.367 -173.538 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.38 132.42 44.71 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.497 0.719 . . . . 0.59999999999999998 110.077 179.604 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.9 t -119.46 133.38 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 124.704 1.202 . . . . 1.8100000000000001 108.51 178.832 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -117.45 -177.33 3.2 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 123.879 0.872 . . . . 1.72 110.684 177.737 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.1 t70 . . . . . 0 N--CA 1.451 -0.417 0 CA-C-N 115.693 -0.685 . . . . 2.5499999999999998 110.709 -177.088 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.518 0 CA-C-O 119.218 -0.768 . . . . 1.8799999999999999 111.355 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -64.33 102.47 0.53 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.69 0.745 . . . . 3.23 109.646 175.2 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -92.56 154.14 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 107.212 -1.403 . . . . 0.85999999999999999 107.212 166.911 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 mt -102.98 131.15 50.15 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 108.61 -0.885 . . . . 0.65000000000000002 108.61 -179.017 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.77 137.32 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 107.316 -1.364 . . . . 0.89000000000000001 107.316 178.865 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.5 p -111.74 149.14 32.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.641 -1.244 . . . . 0.46000000000000002 107.641 174.72 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -147.55 114.63 6.18 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.533 -1.654 . . . . 2.0 106.533 -179.579 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -94.97 40.55 1.1 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.743 1.617 . . . . 1.9199999999999999 111.604 -170.826 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -166.83 174.34 8.65 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.181 1.792 . . . . 2.8999999999999999 107.111 173.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.1 mp -70.87 152.72 43.39 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.826 0.822 . . . . 1.4399999999999999 111.043 178.827 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.25 150.52 37.22 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 125.146 1.378 . . . . 2.2999999999999998 108.713 -173.902 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -60.56 141.28 94.87 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.157 1.905 . . . . 2.2799999999999998 108.621 169.964 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 42.7 46.74 4.48 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.236 1.414 . . . . 2.7999999999999998 112.155 -179.528 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 50.59 15.73 0.25 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.625 1.97 . . . . 2.0800000000000001 115.645 -176.874 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.5 t80 64.93 101.75 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.266 1.427 . . . . 2.7799999999999998 109.874 -162.955 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 29.7 mmm-85 -79.57 111.69 16.1 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.124 -1.065 . . . . 4.5899999999999999 108.124 -179.364 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -83.26 176.32 9.24 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.469 0.652 . . . . 4.1699999999999999 112.504 -177.089 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.51 38.99 97.18 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.708 1.147 . . . . 0.68000000000000005 112.111 177.27 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -158.99 178.29 10.23 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.027 1.331 . . . . 2.54 108.584 -178.679 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -98.98 135.8 12.33 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 110.885 -0.886 . . . . 0.64000000000000001 110.885 173.419 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.0 pp -137.83 149.39 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 105.261 -2.125 . . . . 0.66000000000000003 105.261 176.506 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.2 m -112.26 122.74 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 107.741 -1.207 . . . . 0.63 107.741 177.644 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.434 ' HB2' HG12 ' A' ' 127' ' ' VAL . . . -110.96 131.26 55.2 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 124.889 1.276 . . . . 0.44 109.28 -173.452 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -125.25 150.03 47.44 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.446 1.499 . . . . 3.7999999999999998 108.889 -179.693 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 171.54 -119.77 0.8 Allowed Glycine 0 C--N 1.333 0.402 0 N-CA-C 107.086 -2.405 . . . . 1.2 107.086 169.307 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.8 p -145.86 151.56 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-N 118.767 1.283 . . . . 0.93999999999999995 109.648 -177.076 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.474 HD11 HG21 ' A' ' 48' ' ' THR . 2.4 mm? -81.24 143.63 32.16 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.83 -0.804 . . . . 2.0099999999999998 108.83 173.154 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -161.26 13.39 0.15 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.028 -1.082 . . . . 2.6499999999999999 113.582 175.515 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -137.67 45.41 2.16 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 118.088 0.944 . . . . 6.7800000000000002 108.678 -169.071 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 41.7 t0 16.73 64.91 0.01 OUTLIER 'General case' 0 C--N 1.341 0.213 0 C-N-CA 128.92 2.888 . . . . 2.9900000000000002 113.203 -178.888 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 138.42 -47.81 0.91 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-N 114.79 -1.095 . . . . 1.3999999999999999 111.138 -170.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.75 164.11 12.71 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.04 0.92 . . . . 2.0499999999999998 109.862 -175.389 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.8 mp -121.71 131.7 54.23 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.77 1.228 . . . . 1.9399999999999999 110.029 -173.067 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -97.08 89.24 4.73 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.152 -1.425 . . . . 0.66000000000000003 107.152 171.946 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.07 88.03 2.64 Favored 'General case' 0 C--O 1.227 -0.084 0 C-N-CA 123.034 0.534 . . . . 1.51 110.536 -171.765 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.6 t -85.91 -3.77 59.0 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.123 1.157 . . . . 0.96999999999999997 114.123 -172.658 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -112.44 91.42 3.65 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 119.473 1.033 . . . . 3.6400000000000001 108.43 179.63 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.434 HG12 ' HB2' ' A' ' 112' ' ' ALA . 26.9 m -100.24 128.3 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 CA-C-N 118.39 0.541 . . . . 0.65000000000000002 110.524 175.93 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.04 120.29 35.87 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.46 -1.311 . . . . 0.64000000000000001 107.46 177.331 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -96.22 102.83 14.68 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.124 0.97 . . . . 1.3700000000000001 108.959 176.922 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.53 13.51 5.47 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.842 1.052 . . . . 4.2599999999999998 113.842 178.985 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 16.3 p80 . . . . . 0 CA--C 1.534 0.338 0 C-N-CA 124.769 1.228 . . . . 5.7800000000000002 112.143 174.688 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.247 0 N-CA-C 109.674 -0.491 . . . . 4.1200000000000001 109.674 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -93.65 116.61 29.12 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 124.842 1.257 . . . . 2.3199999999999998 110.207 177.419 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.96 178.68 8.01 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.816 0.673 . . . . 6.0300000000000002 112.816 179.915 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 38.0 p -71.11 150.13 94.65 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 123.554 0.742 . . . . 1.95 110.336 -177.122 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -60.51 -47.59 13.56 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.172 2.581 . . . . 1.3200000000000001 110.685 176.001 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.4 t -46.81 -39.63 12.23 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.54 1.136 . . . . 2.23 111.853 -174.683 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.409 ' OE2' ' NZ ' ' A' ' 47' ' ' LYS . 60.8 tt0 -44.87 -57.46 3.75 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.068 0.547 . . . . 3.8100000000000001 111.178 172.075 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.28 0.1 OUTLIER -81.22 35.52 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 113.05 0.759 . . . . 1.8200000000000001 113.05 -178.872 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 52.1 t -117.76 -34.68 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 118.915 0.78 . . . . 2.2999999999999998 112.419 174.694 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -126.29 116.9 21.95 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 119.574 1.079 . . . . 2.3599999999999999 109.19 -169.766 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 63.4 35.47 92.1 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.62 -0.992 . . . . 1.3799999999999999 110.62 179.344 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.409 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 31.1 mttt -144.25 -107.41 0.11 Allowed 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 126.864 2.066 . . . . 2.8300000000000001 109.267 177.52 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 49.7 m -72.48 -64.62 0.92 Allowed 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 118.663 0.665 . . . . 1.3600000000000001 111.237 -172.98 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -48.71 -49.06 39.62 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.964 0.888 . . . . 2.5499999999999998 110.752 -176.495 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.38 -22.62 57.34 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.515 1.126 . . . . 1.4199999999999999 112.922 179.043 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.11 44.17 96.52 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.577 1.56 . . . . 1.04 114.083 177.752 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.1 m -98.57 -34.09 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 118.866 1.333 . . . . 1.2 113.893 -173.691 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.72 -71.73 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.84 1.256 . . . . 3.6499999999999999 112.797 -176.276 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -74.84 87.14 1.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.465 2.11 . . . . 1.8100000000000001 108.816 176.697 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -67.07 158.77 30.27 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.139 -0.689 . . . . 3.3599999999999999 109.139 175.884 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.7 168.01 5.3 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.769 -0.65 . . . . 1.3300000000000001 111.671 -176.672 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.01 5.35 90.21 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 119.792 -0.449 . . . . 1.03 113.086 -177.928 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -99.2 151.53 20.91 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.414 1.086 . . . . 1.51 109.109 177.882 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 58.7 mtt85 -93.06 146.86 23.32 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 122.876 0.47 . . . . 4.1200000000000001 109.909 173.327 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.3 pt -152.35 179.75 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 106.858 -1.534 . . . . 1.0600000000000001 106.858 179.853 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.9 mmt-85 -135.05 119.39 17.84 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.698 -1.593 . . . . 5.0999999999999996 106.698 167.714 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.7 p -85.18 144.68 9.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 107.768 -1.197 . . . . 0.98999999999999999 107.768 176.654 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -152.82 95.83 0.16 Allowed Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 110.246 -1.142 . . . . 1.04 110.246 -176.285 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -154.93 -165.67 14.35 Favored Glycine 0 C--N 1.332 0.344 0 N-CA-C 110.112 -1.195 . . . . 0.68999999999999995 110.112 -175.675 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.0 ptp -100.68 137.18 39.42 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.069 0.548 . . . . 2.3700000000000001 109.661 -177.159 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 83' ' ' ALA . 11.8 p -92.76 129.49 43.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.061 -0.518 . . . . 2.77 110.263 170.492 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.434 ' O ' HG22 ' A' ' 66' ' ' VAL . 1.0 OUTLIER -61.1 146.6 46.81 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.109 -1.071 . . . . 2.3700000000000001 108.109 166.71 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 p -50.68 -60.71 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.256 1.023 . . . . 1.99 110.539 -178.891 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -86.62 56.33 4.69 Favored Glycine 0 CA--C 1.527 0.791 0 O-C-N 121.378 -0.826 . . . . 1.72 111.645 -176.77 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 62.7 m -122.28 -34.8 3.24 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.986 0.736 . . . . 1.3700000000000001 112.986 -178.753 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -71.92 124.12 24.2 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.802 -0.814 . . . . 2.0099999999999998 108.802 -178.576 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.8 m -131.51 131.92 62.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.735 0.814 . . . . 0.75 108.829 176.15 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.5 ptt-85 -116.8 147.71 41.85 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 124.949 1.3 . . . . 4.0199999999999996 110.332 179.284 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -96.58 155.5 37.77 Favored Pre-proline 0 C--O 1.234 0.273 0 N-CA-C 108.807 -0.812 . . . . 2.3900000000000001 108.807 177.474 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.74 42.86 0.99 Allowed 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.75 2.967 . . . . 1.9099999999999999 111.605 175.857 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -102.9 -41.36 6.18 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 125.306 1.442 . . . . 1.21 109.217 173.605 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.9 m 104.67 -32.49 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 129.12 2.968 . . . . 2.27 110.492 -172.107 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.11 28.78 8.3 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 124.135 0.974 . . . . 2.5899999999999999 112.541 -173.789 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -137.5 113.22 9.58 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.044 -1.465 . . . . 2.0099999999999998 107.044 174.726 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.706 HG21 ' CD2' ' A' ' 100' ' ' LEU . 27.8 m -142.34 143.45 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 107.426 -1.324 . . . . 0.76000000000000001 107.426 176.504 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -139.2 159.72 41.49 Favored 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 121.637 -0.664 . . . . 1.3700000000000001 109.824 169.053 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -150.95 142.32 23.36 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 109.135 -0.691 . . . . 1.98 109.135 -178.495 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.59 ' O ' HG23 ' A' ' 66' ' ' VAL . . . -83.33 143.82 30.1 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.241 -1.022 . . . . 0.68999999999999995 108.241 171.543 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.8 t -128.32 138.03 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 N-CA-C 107.393 -1.336 . . . . 1.8200000000000001 107.393 170.421 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -133.93 174.74 10.14 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.999 -0.741 . . . . 1.29 108.999 177.911 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.3 t70 . . . . . 0 CA--C 1.532 0.279 0 CA-C-N 115.923 -0.58 . . . . 2.6299999999999999 110.793 175.557 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.785 0 N-CA-C 108.319 -1.912 . . . . 1.54 108.319 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -126.3 142.88 51.36 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.165 -1.791 . . . . 3.4500000000000002 106.165 171.277 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.7 tp -131.85 147.3 32.45 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 N-CA-C 108.332 -0.988 . . . . 1.1499999999999999 108.332 179.71 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.9 mt -95.91 122.72 39.02 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 122.968 0.507 . . . . 0.55000000000000004 110.27 179.715 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.7 122.23 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 125.552 1.541 . . . . 0.84999999999999998 107.582 176.401 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 42.3 p -100.26 152.4 20.34 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.251 1.02 . . . . 0.46000000000000002 108.996 174.869 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.553 ' HB3' HG23 ' A' ' 80' ' ' VAL . 1.0 OUTLIER -147.16 122.3 10.16 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.563 -1.273 . . . . 2.8599999999999999 107.563 177.127 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -96.53 41.66 1.1 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.698 1.599 . . . . 2.4199999999999999 110.973 -179.933 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -162.55 179.53 7.68 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.734 1.214 . . . . 2.8399999999999999 108.354 172.428 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.05 165.54 23.29 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.565 1.146 . . . . 1.3999999999999999 111.649 174.167 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.706 ' CD2' HG21 ' A' ' 80' ' ' VAL . 3.0 mm? -96.16 162.16 24.7 Favored Pre-proline 0 N--CA 1.453 -0.292 0 C-N-CA 125.833 1.653 . . . . 2.5899999999999999 109.437 179.185 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -64.3 -82.14 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.236 2.624 . . . . 2.5299999999999998 109.168 167.32 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -93.24 48.69 1.34 Allowed 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 124.14 0.976 . . . . 2.6099999999999999 109.202 -172.196 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 48.77 4.6 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.997 2.119 . . . . 2.6800000000000002 116.478 -169.944 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.512 ' HE1' HG21 ' A' ' 66' ' ' VAL . 35.4 t80 63.71 97.18 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.221 1.409 . . . . 2.54 109.976 -159.767 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 51.7 mtp85 -79.02 121.7 25.27 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 107.418 -1.327 . . . . 3.8599999999999999 107.418 174.577 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -82.23 175.31 10.39 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.942 0.897 . . . . 3.23 110.365 -175.172 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 62.58 35.46 91.85 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 122.094 -0.378 . . . . 0.77000000000000002 112.546 174.279 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -155.65 -179.92 8.58 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.24 1.416 . . . . 2.7599999999999998 108.188 178.131 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -106.51 131.02 10.44 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 110.917 -0.873 . . . . 0.55000000000000004 110.917 177.506 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.9 pp -128.51 154.91 39.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 106.994 -1.484 . . . . 0.60999999999999999 106.994 179.039 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.2 m -106.44 137.7 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 107.418 -1.327 . . . . 0.80000000000000004 107.418 173.415 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.437 ' HB2' HG12 ' A' ' 127' ' ' VAL . . . -125.97 124.29 40.42 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.056 0.943 . . . . 0.48999999999999999 109.615 179.607 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.35 137.62 42.86 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.141 1.376 . . . . 3.77 108.921 -177.785 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 170.75 -148.6 11.53 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.975 -0.85 . . . . 1.0700000000000001 110.975 178.099 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.11 153.69 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 C-N-CA 124.823 1.249 . . . . 0.96999999999999997 107.823 -170.508 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.488 HD13 HD23 ' A' ' 122' ' ' LEU . 3.5 mm? -53.37 140.96 25.83 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.29 -0.633 . . . . 1.8400000000000001 109.29 169.368 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -74.74 -153.85 3.66 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 109.818 -1.313 . . . . 2.25 109.818 178.527 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -58.46 -60.31 4.0 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.952 0.501 . . . . 5.6900000000000004 109.99 -174.5 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -170.82 109.08 0.32 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.496 -2.039 . . . . 3.1200000000000001 105.496 175.596 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 107.41 -39.87 2.73 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.848 -1.301 . . . . 0.98999999999999999 109.848 174.783 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.03 166.71 18.56 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.243 0.617 . . . . 3.0699999999999998 111.196 179.823 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.488 HD23 HD13 ' A' ' 116' ' ' LEU . 98.4 mt -116.86 134.91 54.19 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 124.43 1.092 . . . . 2.1899999999999999 108.653 172.334 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -105.93 103.68 13.23 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 107.834 -1.173 . . . . 0.66000000000000003 107.834 173.884 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -131.48 113.51 13.78 Favored 'General case' 0 C--N 1.341 0.232 0 N-CA-C 111.902 0.334 . . . . 1.23 111.902 -174.821 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.78 -41.63 9.56 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.753 1.221 . . . . 1.1699999999999999 110.442 179.329 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -84.87 77.82 10.02 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.603 -0.888 . . . . 3.5899999999999999 108.603 -167.993 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.437 HG12 ' HB2' ' A' ' 112' ' ' ALA . 6.5 m -88.76 124.06 41.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.757 1.223 . . . . 0.75 110.751 177.205 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.406 HD13 ' C ' ' A' ' 127' ' ' VAL . 0.0 OUTLIER -121.43 131.32 54.1 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.561 1.144 . . . . 0.81000000000000005 107.978 176.669 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -100.31 74.87 1.76 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.902 0.881 . . . . 1.3 110.751 -175.11 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.3 pttm -74.36 -12.26 60.48 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.832 1.049 . . . . 4.8399999999999999 113.832 -171.719 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 10.5 m170 . . . . . 0 C--N 1.338 0.093 0 O-C-N 121.866 -0.521 . . . . 4.6200000000000001 110.175 172.807 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 N--CA 1.466 0.351 0 N-CA-C 112.712 0.634 . . . . 1.8400000000000001 112.712 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.436 ' CZ ' ' HD2' ' A' ' 61' ' ' ARG . 93.7 m-85 -83.44 134.15 34.88 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.545 1.138 . . . . 2.27 110.458 -177.526 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -137.18 147.48 45.92 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.293 1.837 . . . . 3.3199999999999998 109.95 -178.768 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 m -71.69 137.48 82.98 Favored Pre-proline 0 N--CA 1.448 -0.546 0 C-N-CA 124.964 1.306 . . . . 1.6899999999999999 110.464 177.437 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -58.94 -49.14 12.06 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.97 2.447 . . . . 0.77000000000000002 111.453 177.335 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.9 m -54.18 -33.88 59.16 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.625 0.77 . . . . 2.8300000000000001 112.683 -178.719 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -53.1 -51.34 62.19 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.238 -1.023 . . . . 2.3999999999999999 108.238 173.749 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.295 36.8 pt -82.4 30.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 113.652 0.982 . . . . 1.29 113.652 -171.48 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -103.87 -39.72 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 124.048 0.939 . . . . 2.1400000000000001 110.702 163.161 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -72.9 -50.58 22.85 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.645 0.609 . . . . 2.8100000000000001 112.645 -159.972 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.23 67.98 0.1 Allowed Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 108.139 -1.984 . . . . 1.4199999999999999 108.139 -168.804 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -143.19 -106.72 0.13 Allowed 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.449 -1.685 . . . . 3.2999999999999998 106.449 -175.921 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 t -65.17 -59.36 4.18 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.595 1.158 . . . . 3.48 111.192 177.269 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -57.3 -39.6 76.11 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.474 0.71 . . . . 3.02 111.553 -165.195 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.68 -7.29 37.87 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.207 1.003 . . . . 1.3200000000000001 112.255 178.081 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 53.11 44.88 63.4 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.443 1.496 . . . . 1.1699999999999999 113.785 178.26 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.9 m -99.05 -35.26 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 118.479 1.14 . . . . 1.29 113.228 -175.061 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.89 -71.63 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 117.837 -1.078 . . . . 4.2000000000000002 112.537 -179.525 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -76.17 174.5 12.72 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 122.264 1.976 . . . . 1.3999999999999999 109.157 171.653 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -147.18 147.72 30.79 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.885 2.074 . . . . 2.9100000000000001 106.937 -176.929 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.44 144.03 32.61 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.66 0.784 . . . . 1.3500000000000001 110.52 -179.71 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.08 -20.49 26.15 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 123.829 0.728 . . . . 1.1499999999999999 112.551 -176.882 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -85.31 151.55 23.95 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 117.938 0.869 . . . . 1.6399999999999999 109.657 179.798 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.0 mtt85 -97.71 137.35 36.72 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.636 -0.711 . . . . 4.0300000000000002 109.709 173.789 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.7 pt -144.46 168.63 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 105.777 -1.935 . . . . 0.63 105.777 170.775 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.436 ' HD2' ' CZ ' ' A' ' 37' ' ' PHE . 22.0 mtt180 -115.54 123.65 49.03 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.009 -0.737 . . . . 1.8600000000000001 109.009 172.391 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.6 p -87.46 129.33 39.02 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.082 0 N-CA-C 108.016 -1.105 . . . . 0.92000000000000004 108.016 176.045 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.98 116.18 1.81 Allowed Glycine 0 C--N 1.333 0.41 0 CA-C-N 118.919 0.782 . . . . 0.55000000000000004 111.243 -178.157 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.89 -169.2 38.53 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 117.787 0.793 . . . . 0.95999999999999996 111.313 -177.378 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.413 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 19.6 ptp -101.4 148.68 24.88 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.863 1.265 . . . . 2.75 110.711 -177.912 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 43.2 t -106.34 119.65 56.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 109.624 -0.51 . . . . 2.46 109.624 -177.393 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 86.1 m -44.05 122.47 2.9 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.714 1.606 . . . . 2.5899999999999999 109.408 165.774 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.1 p -46.23 -57.09 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.042 0.937 . . . . 2.1200000000000001 111.205 -177.86 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.2 68.84 3.4 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.833 -0.907 . . . . 2.3100000000000001 110.833 -179.648 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.9 m -149.55 -31.36 0.22 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.255 1.576 . . . . 1.22 115.255 178.221 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 12.1 tpp -60.92 115.88 4.05 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.15 0.886 . . . . 2.02 109.638 173.249 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.3 m -121.09 136.1 59.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 107.971 -1.122 . . . . 0.76000000000000001 107.971 172.444 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.47 136.48 49.95 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.855 1.262 . . . . 6.6699999999999999 109.082 -170.842 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -83.03 154.62 67.4 Favored Pre-proline 0 N--CA 1.455 -0.209 0 N-CA-C 109.384 -0.598 . . . . 2.1299999999999999 109.384 -179.359 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -71.03 10.42 0.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.12 2.547 . . . . 1.3400000000000001 113.203 173.731 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -74.71 -22.58 58.76 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.868 0.467 . . . . 1.3600000000000001 109.862 161.947 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.1 m 63.74 24.08 13.71 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.079 1.351 . . . . 1.74 112.621 -178.177 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.86 -43.32 2.0 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.962 1.705 . . . . 2.3100000000000001 112.023 172.68 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -84.13 122.19 28.48 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 108.522 -0.918 . . . . 1.3500000000000001 108.522 -178.839 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.3 m -146.83 107.69 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 106.92 -1.511 . . . . 1.3100000000000001 106.92 -172.156 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -119.87 154.97 33.57 Favored 'General case' 0 C--O 1.232 0.162 0 O-C-N 121.635 -0.666 . . . . 0.81000000000000005 109.838 -176.773 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -154.9 147.99 24.78 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 120.82 0.343 . . . . 2.0699999999999998 111.067 -175.555 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.05 139.92 30.72 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.41 -0.959 . . . . 0.65000000000000002 108.41 167.951 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.08 147.05 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.291 1.037 . . . . 1.9199999999999999 108.685 178.498 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -145.04 172.15 13.47 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 126.292 1.837 . . . . 1.5900000000000001 109.632 -171.045 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 50.4 t0 . . . . . 0 N--CA 1.451 -0.384 0 N-CA-C 107.31 -1.367 . . . . 2.9500000000000002 107.31 170.217 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.559 0 N-CA-C 107.474 -2.251 . . . . 1.8799999999999999 107.474 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -157.21 172.28 18.92 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 117.84 0.82 . . . . 2.6400000000000001 109.424 179.223 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.0 tp -154.28 159.88 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.287 0.635 . . . . 1.01 109.387 176.539 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 16.7 mt -99.05 127.01 44.9 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.608 1.163 . . . . 0.88 111.283 -178.354 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 76.2 t -108.68 130.87 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 125.727 1.611 . . . . 0.84999999999999998 107.989 175.502 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.8 p -111.79 134.1 53.58 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.149 -1.056 . . . . 0.58999999999999997 108.149 177.675 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.417 ' CE2' ' HA ' ' A' ' 125' ' ' THR . 1.4 t80 -135.11 139.4 44.64 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.318 -1.364 . . . . 2.2599999999999998 107.318 -179.319 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -130.23 30.64 4.74 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.962 1.305 . . . . 2.1899999999999999 112.702 -168.628 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -159.1 55.95 0.41 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.195 0.521 . . . . 2.4500000000000002 111.207 -178.58 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 55.76 -170.4 0.08 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.102 0.961 . . . . 1.8500000000000001 111.456 -176.132 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.1 mt -153.28 154.94 31.39 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 125.113 1.365 . . . . 1.1799999999999999 107.643 -175.986 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.498 ' HG3' HG23 ' A' ' 127' ' ' VAL . 72.8 Cg_endo -62.85 122.39 10.66 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 125.172 3.915 . . . . 2.3799999999999999 109.958 -176.676 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 48.24 42.42 17.59 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 123.655 0.782 . . . . 3.3799999999999999 110.498 -178.161 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 70.23 -16.9 0.28 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.886 1.274 . . . . 3.79 112.234 -177.261 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 14.2 t80 60.27 83.79 0.13 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.736 2.015 . . . . 3.1499999999999999 108.954 -167.474 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -75.07 137.33 41.37 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 114.834 -1.075 . . . . 5.4100000000000001 108.26 -173.642 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.5 mp0 -79.03 162.72 25.72 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 121.139 0.495 . . . . 3.4199999999999999 110.522 -166.089 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.29 44.69 27.43 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 111.593 -0.603 . . . . 1.1299999999999999 111.593 -178.237 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -146.37 179.5 7.48 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.733 1.613 . . . . 2.0899999999999999 106.704 169.042 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 65' ' ' MET . . . -126.21 145.65 15.84 Favored Glycine 0 C--N 1.337 0.592 0 N-CA-C 111.529 -0.628 . . . . 1.1100000000000001 111.529 171.708 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.36 168.5 15.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 124.424 1.09 . . . . 1.4099999999999999 108.532 -175.804 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.5 m -107.49 129.78 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 107.812 -1.181 . . . . 0.81000000000000005 107.812 169.519 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.614 ' HB2' HG12 ' A' ' 127' ' ' VAL . . . -119.24 133.75 55.59 Favored 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 125.457 1.503 . . . . 0.51000000000000001 109.088 -179.218 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -124.98 142.4 51.51 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.28 1.032 . . . . 3.98 110.555 -177.582 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 171.51 -134.9 3.22 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 108.393 -1.883 . . . . 0.81999999999999995 108.393 172.203 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.06 155.37 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 108.423 -0.954 . . . . 0.67000000000000004 108.423 -170.274 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -54.39 132.73 44.81 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.86 -0.792 . . . . 1.95 108.86 167.05 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.56 -139.9 1.63 Allowed Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 109.62 -1.392 . . . . 1.9199999999999999 109.62 -179.774 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -57.55 -60.6 3.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 122.865 0.466 . . . . 5.3099999999999996 110.862 -177.416 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -176.81 115.48 0.1 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 105.823 -1.917 . . . . 3.4900000000000002 105.823 -173.191 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 88.2 -42.64 3.09 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 125.39 1.471 . . . . 1.1599999999999999 109.609 176.997 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.65 142.09 34.3 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.227 1.411 . . . . 3.1299999999999999 109.918 -175.937 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.72 123.45 47.05 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 108.393 -0.966 . . . . 2.2799999999999998 108.393 -176.754 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.76 83.7 3.48 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.019 -1.474 . . . . 0.46999999999999997 107.019 176.096 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -94.33 142.44 27.41 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.41 -0.959 . . . . 1.1399999999999999 108.41 175.202 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.417 ' HA ' ' CE2' ' A' ' 96' ' ' TYR 0.26 4.7 t -136.5 -4.36 2.07 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 115.47 1.656 . . . . 0.95999999999999996 115.47 173.667 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -107.2 98.87 8.46 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 119.854 1.206 . . . . 3.9500000000000002 107.913 164.794 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.614 HG12 ' HB2' ' A' ' 112' ' ' ALA . 3.4 m -96.47 133.79 36.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 CA-C-N 118.751 0.705 . . . . 0.76000000000000001 110.833 165.056 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.71 106.75 14.86 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.299 -1.371 . . . . 0.72999999999999998 107.299 175.266 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.68 42.06 1.08 Allowed 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.3 0.852 . . . . 1.45 113.3 -170.237 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.28 62.91 1.84 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.361 0.664 . . . . 4.0599999999999996 111.528 179.324 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 19.2 p80 . . . . . 0 CA--C 1.532 0.262 0 N-CA-C 108.902 -0.777 . . . . 7.3899999999999997 108.902 175.102 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.148 0 CA-C-O 119.75 -0.167 . . . . 4.4500000000000002 110.674 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.573 ' CE1' ' HB3' ' A' ' 61' ' ' ARG . 3.1 m-85 -89.22 110.83 21.54 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.52 1.128 . . . . 4.4000000000000004 110.732 179.55 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.49 176.31 8.79 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.747 0.654 . . . . 5.8099999999999996 112.01 174.998 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 p -69.34 145.82 96.06 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 124.067 0.947 . . . . 1.96 110.696 -175.841 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -58.92 -37.18 94.99 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.168 1.912 . . . . 1.29 111.966 179.36 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.6 t -46.53 -40.86 13.36 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.499 0.72 . . . . 2.6899999999999999 112.17 177.921 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -50.42 -47.32 56.68 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.342 -0.543 . . . . 4.8799999999999999 110.499 177.131 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.279 0.2 OUTLIER -91.56 34.39 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 112.77 0.655 . . . . 1.6499999999999999 112.77 178.293 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.16 -32.93 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 118.88 0.763 . . . . 2.4399999999999999 112.345 170.167 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -117.44 113.42 22.03 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.156 0.889 . . . . 2.6899999999999999 110.323 -173.72 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.6 43.77 98.56 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.488 -0.645 . . . . 1.77 111.488 169.307 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -142.42 -111.04 0.13 Allowed 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 126.634 1.973 . . . . 3.9199999999999999 106.511 176.704 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.4 t -71.87 -47.91 49.58 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 119.43 1.013 . . . . 3.0099999999999998 111.626 -176.688 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -49.89 -46.24 51.5 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 122.044 0.926 . . . . 2.79 110.724 -173.47 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.69 -11.51 45.01 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.977 1.311 . . . . 1.5700000000000001 112.173 178.829 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 55.54 44.82 85.73 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 126.309 1.909 . . . . 1.3899999999999999 112.43 -178.073 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.7 m -96.01 -57.87 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 118.187 0.993 . . . . 1.8899999999999999 112.81 -174.047 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.5 mmmt -91.85 -60.8 0.21 Allowed Pre-proline 0 CA--C 1.536 0.43 0 CA-C-O 118.607 -0.711 . . . . 4.5099999999999998 111.992 -177.02 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -85.97 110.53 1.08 Allowed 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 122.426 2.084 . . . . 1.51 108.821 175.743 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -69.28 155.98 39.53 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.779 -0.823 . . . . 3.2000000000000002 108.779 167.314 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -53.76 165.78 0.4 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 122.027 0.917 . . . . 1.3700000000000001 111.959 166.75 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.44 8.77 86.67 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 115.933 -0.576 . . . . 1.1799999999999999 112.45 -177.768 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -102.45 155.05 18.52 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.049 0.924 . . . . 1.96 108.886 171.779 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -100.81 136.81 40.07 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.101 0.96 . . . . 4.1799999999999997 108.921 175.876 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.64 HD11 HD11 ' A' ' 122' ' ' LEU . 29.7 pt -141.86 175.36 5.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 106.558 -1.645 . . . . 0.90000000000000002 106.558 174.152 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.573 ' HB3' ' CE1' ' A' ' 37' ' ' PHE . 15.8 mtt-85 -132.52 126.27 32.52 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 106.421 -1.696 . . . . 3.27 106.421 176.196 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.7 p -98.67 118.08 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 107.81 -1.181 . . . . 1.05 107.81 -179.46 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.36 113.26 1.87 Allowed Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 108.195 -1.962 . . . . 0.92000000000000004 108.195 -178.738 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.88 -163.29 27.12 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 109.446 -1.462 . . . . 0.66000000000000003 109.446 -171.737 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -103.75 132.23 50.2 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.864 0.866 . . . . 3.0 109.812 -172.88 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.2 t -106.57 126.23 62.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 108.721 -0.844 . . . . 2.3700000000000001 108.721 176.859 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.2 m -57.95 137.95 56.29 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.833 1.253 . . . . 2.29 108.918 169.034 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.6 p -52.27 -60.69 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 123.63 0.772 . . . . 2.2400000000000002 110.782 177.507 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.14 68.44 2.32 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.309 -1.116 . . . . 1.97 110.309 -179.951 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.1 m -151.16 -34.95 0.14 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.105 0.779 . . . . 1.1200000000000001 113.105 -179.042 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.1 ttp -69.37 117.73 11.37 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.438 1.017 . . . . 2.7799999999999998 109.148 174.282 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.1 m -122.56 136.12 60.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 107.659 -1.237 . . . . 0.79000000000000004 107.659 175.196 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.482 ' CB ' HG12 ' A' ' 80' ' ' VAL . 24.2 ptt180 -118.72 144.69 46.08 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.897 0.879 . . . . 4.2800000000000002 109.963 -179.931 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -92.42 145.84 31.34 Favored Pre-proline 0 C--O 1.237 0.42 0 N-CA-C 108.957 -0.757 . . . . 2.4700000000000002 108.957 177.475 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -75.58 30.24 0.38 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.048 2.499 . . . . 1.76 112.89 178.792 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -89.87 -22.7 21.91 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.09 0.956 . . . . 1.54 108.83 162.628 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.3 m 63.47 23.13 13.54 Favored 'General case' 0 C--N 1.344 0.358 0 C-N-CA 124.301 1.041 . . . . 1.3799999999999999 111.806 -174.626 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . 0.251 1.4 pp -130.7 -3.18 4.18 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.581 1.552 . . . . 2.1800000000000002 113.303 173.322 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -131.4 125.56 32.93 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.192 -1.04 . . . . 1.55 108.192 -179.97 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.482 HG12 ' CB ' ' A' ' 73' ' ' ARG . 27.2 m -141.64 143.57 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 107.093 -1.447 . . . . 0.82999999999999996 107.093 172.08 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -142.05 158.77 43.37 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 121.783 -0.573 . . . . 0.83999999999999997 109.667 176.143 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -149.51 136.04 19.29 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.402 0.681 . . . . 1.96 109.97 -177.342 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.85 138.22 33.31 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.468 -0.938 . . . . 0.67000000000000004 108.468 169.944 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.8 p -117.69 155.29 19.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 125.186 1.394 . . . . 2.04 107.786 175.547 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -131.61 175.1 9.45 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.698 0.799 . . . . 1.6699999999999999 109.729 -179.651 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 39.0 t70 . . . . . 0 N--CA 1.453 -0.288 0 C-N-CA 124.464 1.106 . . . . 3.3300000000000001 109.632 178.861 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.428 0 N-CA-C 110.135 -1.186 . . . . 2.2400000000000002 110.135 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.86 101.24 3.7 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.794 -0.817 . . . . 3.21 108.794 -172.02 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.1 152.15 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 124.221 1.008 . . . . 1.1399999999999999 108.737 -177.036 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.2 mt -107.36 122.31 46.33 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.265 1.026 . . . . 0.69999999999999996 109.538 -179.717 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.0 t -105.08 120.07 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 125.06 1.344 . . . . 1.03 107.651 176.961 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.6 p -105.44 144.35 32.33 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.862 1.265 . . . . 0.60999999999999999 108.964 179.525 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.431 ' HB3' HG23 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -142.24 102.13 4.04 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.214 -1.032 . . . . 2.25 108.214 -178.771 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -94.4 45.44 1.13 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.221 1.408 . . . . 2.9700000000000002 111.015 -178.905 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -163.97 48.44 0.12 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.676 1.19 . . . . 3.8700000000000001 110.437 179.559 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.9 mp 54.16 -149.88 0.41 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.379 1.072 . . . . 2.4500000000000002 110.776 -178.739 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.478 ' HG ' HG21 ' A' ' 80' ' ' VAL . 11.8 mt -153.44 158.35 32.72 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 127.62 2.368 . . . . 1.52 105.837 -176.996 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -75.27 -98.5 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 124.292 3.328 . . . . 2.7799999999999998 110.671 -178.892 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -75.77 53.62 0.75 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.16 1.384 . . . . 3.6099999999999999 110.204 179.527 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 45.47 0.48 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 129.084 2.953 . . . . 2.75 116.533 -163.839 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.7 t80 50.05 105.29 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 122.462 1.125 . . . . 3.2000000000000002 110.089 -153.434 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -74.51 123.43 24.73 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.434 -1.321 . . . . 4.7000000000000002 107.434 178.975 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -81.66 167.81 18.8 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.832 0.853 . . . . 3.29 110.322 -167.522 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.14 44.54 93.91 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 112.067 -0.413 . . . . 1.0700000000000001 112.067 173.484 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -155.85 177.72 11.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.401 -1.333 . . . . 2.0 107.401 175.344 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -85.49 137.97 15.89 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.581 -1.008 . . . . 0.97999999999999998 110.581 171.055 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 4.7 pt -138.64 164.43 26.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 108.934 -0.765 . . . . 1.52 108.934 172.484 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.529 ' HB ' ' CE1' ' A' ' 37' ' ' PHE . 16.2 m -121.68 112.96 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 106.915 -1.513 . . . . 1.27 106.915 -178.545 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -118.45 127.87 54.07 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.518 1.927 . . . . 0.81999999999999995 111.048 -173.423 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -126.59 157.93 37.57 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.778 1.172 . . . . 2.8700000000000001 113.608 175.092 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 179.26 -104.11 0.18 Allowed Glycine 0 C--N 1.337 0.602 0 N-CA-C 109.735 -1.346 . . . . 1.2 109.735 167.943 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.8 p -151.6 154.0 8.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 118.254 1.027 . . . . 0.92000000000000004 110.047 -174.563 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.01 139.41 58.76 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.63 -0.259 . . . . 1.77 111.004 173.592 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -120.04 120.92 4.73 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 126.356 1.932 . . . . 3.52 109.18 176.747 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 56.99 43.12 25.1 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.933 0.893 . . . . 5.0300000000000002 111.297 168.715 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 35.47 50.46 0.57 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.177 1.791 . . . . 4.71 111.43 -176.197 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -175.56 -57.28 0.06 OUTLIER Glycine 0 C--N 1.339 0.708 0 C-N-CA 120.128 -1.034 . . . . 1.22 112.973 -175.078 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.11 152.83 22.01 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 109.068 -0.716 . . . . 2.75 109.068 -178.927 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.64 HD11 HD11 ' A' ' 60' ' ' ILE . 3.3 mm? -107.35 111.48 23.85 Favored 'General case' 0 C--O 1.228 -0.062 0 N-CA-C 109.128 -0.693 . . . . 2.2400000000000002 109.128 -177.281 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.71 97.5 9.15 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.355 -1.35 . . . . 0.64000000000000001 107.355 176.306 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.7 144.52 39.52 Favored 'General case' 0 C--O 1.227 -0.125 0 C-N-CA 122.92 0.488 . . . . 1.1499999999999999 109.85 -177.806 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.6 t -131.43 -43.91 1.02 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.025 0.93 . . . . 0.97999999999999998 110.907 -178.337 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -83.34 93.89 7.83 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.242 -1.392 . . . . 4.1200000000000001 107.242 175.621 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 18.8 m -98.6 120.46 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 124.394 1.078 . . . . 0.98999999999999999 108.424 169.65 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.73 114.15 26.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.711 -1.589 . . . . 0.90000000000000002 106.711 178.868 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.5 46.28 0.84 Allowed 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.879 -1.138 . . . . 1.48 112.051 -175.628 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -81.7 60.75 4.78 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.448 -0.782 . . . . 3.02 111.376 -175.248 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.535 0.377 0 C-N-CA 123.542 0.737 . . . . 7.0899999999999999 110.556 176.849 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.533 0.309 0 N-CA-C 112.666 0.617 . . . . 2.29 112.666 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -85.67 118.79 25.39 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.939 1.296 . . . . 2.21 110.382 179.366 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.31 162.69 23.25 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.345 1.058 . . . . 2.8399999999999999 111.166 175.113 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.9 p -75.02 144.29 79.06 Favored Pre-proline 0 N--CA 1.451 -0.396 0 N-CA-C 109.237 -0.653 . . . . 2.2599999999999998 109.237 176.062 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -55.64 -41.27 79.39 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.56 2.173 . . . . 1.26 111.173 169.39 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.2 m -57.0 -50.33 73.03 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 117.563 -1.208 . . . . 2.6099999999999999 111.313 178.94 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.29 -53.86 12.44 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 120.308 1.413 . . . . 2.7999999999999998 110.52 178.192 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.461 ' HA ' ' HB2' ' A' ' 47' ' ' LYS 0.334 31.0 pt -63.01 -28.41 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-N 115.116 -0.947 . . . . 1.3700000000000001 112.816 -173.058 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.0 t -74.87 -49.04 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 118.492 0.587 . . . . 2.1000000000000001 110.894 166.063 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -64.89 -46.83 80.1 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 123.972 0.909 . . . . 4.54 112.877 -163.457 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.34 62.35 0.07 OUTLIER Glycine 0 C--N 1.335 0.481 0 C-N-CA 119.668 -1.253 . . . . 2.0699999999999998 111.59 -174.291 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.461 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 13.7 mmtt -150.85 -97.32 0.06 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 128.235 2.614 . . . . 3.3399999999999999 105.098 -178.18 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.751 HG21 HD11 ' A' ' 116' ' ' LEU . 9.4 m -78.89 -54.66 5.82 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 125.072 1.349 . . . . 1.78 113.095 -168.518 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -49.24 -45.1 44.22 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.905 0.859 . . . . 2.3700000000000001 110.454 -178.517 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.2 m -87.58 -10.65 50.92 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.344 1.058 . . . . 1.6699999999999999 113.157 178.356 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 51.75 47.08 53.72 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.821 1.677 . . . . 1.8200000000000001 112.834 -175.994 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.9 m -87.0 -52.47 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 118.334 1.067 . . . . 2.0499999999999998 112.313 -175.509 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -100.97 -48.51 0.2 Allowed Pre-proline 0 CA--C 1.537 0.456 0 CA-C-O 118.039 -0.982 . . . . 3.6099999999999999 111.646 -178.816 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -91.29 -173.43 0.55 Allowed 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 122.863 2.376 . . . . 2.0600000000000001 108.781 170.181 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -153.45 155.78 36.95 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 127.756 2.422 . . . . 3.4100000000000001 106.413 -177.722 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.476 ' HB2' ' CB ' ' A' ' 119' ' ' ASP . . . -54.25 160.91 1.47 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.862 0.839 . . . . 1.3799999999999999 111.442 173.88 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.27 29.42 60.27 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 116.043 -0.526 . . . . 1.6799999999999999 111.976 176.032 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -122.07 152.51 39.75 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.177 -1.416 . . . . 1.53 107.177 167.748 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.9 mtt85 -88.61 141.21 28.71 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.282 -0.636 . . . . 3.79 109.282 170.106 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.0 pt -143.61 176.78 2.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 106.906 -1.516 . . . . 0.75 106.906 170.613 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.6 mtt180 -124.25 129.51 50.91 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.036 -0.727 . . . . 1.8899999999999999 109.036 169.264 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.0 p -90.34 128.59 42.15 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 107.365 -1.346 . . . . 0.93000000000000005 107.365 174.352 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.88 119.22 1.6 Allowed Glycine 0 C--N 1.335 0.515 0 N-CA-C 110.721 -0.951 . . . . 0.64000000000000001 110.721 178.944 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.49 -157.5 16.96 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 108.627 -1.789 . . . . 0.71999999999999997 108.627 -175.264 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.63 149.2 23.53 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 117.814 0.807 . . . . 2.5 110.339 175.683 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.587 HG21 ' CE1' ' A' ' 104' ' ' PHE . 77.3 t -94.65 150.19 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.451 -0.944 . . . . 2.2200000000000002 108.451 169.874 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.73 -173.91 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.693 1.597 . . . . 2.4399999999999999 110.191 168.545 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.9 p -126.32 72.87 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-O 122.95 1.357 . . . . 2.75 108.375 178.032 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 136.23 -7.17 4.03 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 113.686 -1.597 . . . . 2.1499999999999999 113.615 174.511 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 56.6 m -63.37 -21.26 66.17 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.827 1.314 . . . . 1.0900000000000001 112.653 177.343 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 29.0 tpp -56.65 121.98 11.0 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.174 -0.676 . . . . 2.0699999999999998 109.174 171.455 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.8 m -125.12 131.22 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 107.627 -1.249 . . . . 0.60999999999999999 107.627 166.784 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.436 ' HB2' HG12 ' A' ' 80' ' ' VAL . 0.9 OUTLIER -121.87 142.61 50.08 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.7 1.2 . . . . 4.04 108.917 -175.251 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.87 154.16 58.12 Favored Pre-proline 0 CA--C 1.532 0.257 0 N-CA-C 109.859 -0.423 . . . . 2.8700000000000001 109.859 176.357 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -63.51 -30.44 71.46 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.965 2.443 . . . . 2.29 110.803 172.71 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -43.04 -41.18 3.38 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.865 1.666 . . . . 2.7000000000000002 110.354 177.716 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.2 m 88.49 -1.06 0.42 Allowed 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 127.159 2.184 . . . . 1.55 113.272 176.451 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.27 25.49 9.47 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.08 0.855 . . . . 2.8900000000000001 112.384 173.83 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -144.58 114.78 7.49 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.32 -1.363 . . . . 1.3700000000000001 107.32 175.234 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.436 HG12 ' HB2' ' A' ' 73' ' ' ARG . 34.0 m -138.44 141.68 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 106.351 -1.722 . . . . 1.04 106.351 172.814 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -137.64 155.52 49.06 Favored 'General case' 0 C--O 1.233 0.189 0 O-C-N 121.745 -0.597 . . . . 0.82999999999999996 109.479 173.818 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -154.75 159.36 40.61 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.709 -0.478 . . . . 2.0899999999999999 109.709 -171.371 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.421 ' HB1' ' HG2' ' A' ' 91' ' ' GLU . . . -109.03 136.44 48.54 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.696 -0.853 . . . . 0.69999999999999996 108.696 -177.81 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.4 t -122.65 135.5 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 123.726 0.811 . . . . 2.0499999999999998 109.04 179.955 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -132.63 160.8 35.61 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 125.74 1.616 . . . . 1.54 109.568 -178.123 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.9 t70 . . . . . 0 CA--C 1.53 0.183 0 O-C-N 121.699 -0.626 . . . . 2.9199999999999999 110.997 176.325 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.484 0 N-CA-C 108.307 -1.917 . . . . 1.48 108.307 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.421 ' HG2' ' HB1' ' A' ' 83' ' ' ALA . 37.0 tt0 -132.76 119.51 20.42 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.45 1.5 . . . . 4.1799999999999997 107.687 -177.741 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -98.29 154.08 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 123.971 0.908 . . . . 1.4199999999999999 108.83 -179.643 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 18.6 mt -100.25 120.57 40.12 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.385 0.674 . . . . 0.79000000000000004 111.28 176.979 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 89.2 t -97.16 136.46 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 125.656 1.582 . . . . 1.23 108.684 173.172 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.4 p -112.74 145.09 41.14 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.547 1.139 . . . . 0.72999999999999998 108.388 174.846 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.453 ' CE2' ' HA ' ' A' ' 125' ' ' THR . 7.8 t80 -144.27 100.13 3.49 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.72 -0.844 . . . . 2.1699999999999999 108.72 -175.618 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -84.69 53.49 2.71 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.951 1.3 . . . . 2.3599999999999999 111.252 -176.985 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -169.65 -173.53 1.66 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.954 1.702 . . . . 3.2799999999999998 108.114 173.512 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.9 mp -78.21 131.72 37.27 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.385 1.074 . . . . 1.76 111.239 171.462 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.423 HD21 ' CD2' ' A' ' 96' ' ' TYR . 24.2 mt -81.19 155.03 72.4 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.051 0.94 . . . . 1.1299999999999999 111.006 172.225 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -61.74 141.72 91.53 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.09 2.527 . . . . 2.2999999999999998 109.401 172.673 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 48.64 27.37 1.47 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.145 1.778 . . . . 2.7400000000000002 113.163 177.064 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.1 tp 56.92 11.55 0.98 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.249 1.02 . . . . 3.2599999999999998 112.397 -172.924 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.587 ' CE1' HG21 ' A' ' 66' ' ' VAL . 18.1 t80 56.66 84.07 0.09 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.269 1.427 . . . . 2.5800000000000001 110.061 179.881 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.3 mtp-105 -78.3 124.4 28.05 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.295 -1.372 . . . . 4.8600000000000003 107.295 -174.043 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -79.94 175.32 10.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.077 0.465 . . . . 3.0800000000000001 110.645 -164.192 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.33 44.49 96.81 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 111.87 -0.492 . . . . 0.69999999999999996 111.87 -176.745 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -143.52 176.62 9.05 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 107.932 -1.136 . . . . 1.8400000000000001 107.932 169.517 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -100.35 145.83 17.41 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 110.514 -1.035 . . . . 0.78000000000000003 110.514 171.271 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.0 pp -149.94 166.31 2.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 105.936 -1.875 . . . . 0.77000000000000002 105.936 177.972 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 18.0 m -126.51 130.62 71.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 108.663 -0.866 . . . . 0.71999999999999997 108.663 170.948 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -117.55 135.19 54.12 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 124.988 1.315 . . . . 0.58999999999999997 109.785 -175.709 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -118.65 141.11 48.91 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.462 1.505 . . . . 3.2000000000000002 109.871 -178.239 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 168.14 -133.8 3.01 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 109.658 -1.377 . . . . 0.85999999999999999 109.658 170.757 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.2 151.83 31.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 117.823 0.811 . . . . 0.69999999999999996 110.865 -166.073 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.751 HD11 HG21 ' A' ' 48' ' ' THR . 4.1 mm? -65.8 144.25 56.97 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.105 -0.498 . . . . 2.27 111.404 175.564 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -119.68 115.57 3.05 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 126.945 2.212 . . . . 3.2400000000000002 108.011 175.324 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 58.91 35.22 24.07 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.399 0.68 . . . . 4.9900000000000002 111.656 169.779 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.476 ' CB ' ' HB2' ' A' ' 56' ' ' ALA . 2.0 t0 36.15 43.81 0.24 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.174 2.19 . . . . 4.9500000000000002 113.137 -170.153 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -159.96 -55.3 0.01 OUTLIER Glycine 0 C--N 1.339 0.709 0 O-C-N 121.648 -0.657 . . . . 1.2 111.79 -174.92 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -84.62 150.44 25.17 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 121.905 -0.762 . . . . 2.8399999999999999 109.107 175.961 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -108.41 113.66 26.89 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 108.784 -0.821 . . . . 2.1699999999999999 108.784 178.989 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -92.16 98.5 11.57 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 107.482 -1.303 . . . . 0.52000000000000002 107.482 178.114 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.52 97.57 3.98 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 112.797 0.666 . . . . 1.3300000000000001 112.797 -168.509 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.453 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 14.9 t -83.38 -26.29 30.58 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 122.825 0.45 . . . . 0.92000000000000004 112.213 -177.831 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -89.67 85.32 6.43 Favored 'General case' 0 CA--C 1.528 0.135 0 O-C-N 120.614 -1.304 . . . . 3.3700000000000001 109.35 -174.755 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.7 m -96.78 130.72 45.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 123.853 0.861 . . . . 0.81000000000000005 111.176 175.978 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -119.67 106.83 12.54 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.859 1.664 . . . . 0.80000000000000004 107.452 178.543 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.87 57.67 4.26 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.673 0.789 . . . . 1.2 111.488 -176.315 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 37.2 pttt -83.38 61.84 6.39 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.897 -0.502 . . . . 3.3900000000000001 111.614 -174.484 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 . . . . . 0 N--CA 1.451 -0.414 0 O-C-N 121.449 -0.782 . . . . 4.71 109.105 178.425 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.467 0.389 0 N-CA-C 112.472 0.545 . . . . 2.5099999999999998 112.472 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.486 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 87.1 m-85 -91.96 102.57 15.14 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 125.376 1.47 . . . . 2.6200000000000001 110.289 177.479 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.713 ' CZ ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -100.49 -169.91 1.79 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.598 0.759 . . . . 8.5099999999999998 111.479 178.524 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 28.2 p -94.43 156.57 38.5 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 118.6 0.637 . . . . 1.79 110.709 -178.357 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.66 -14.7 33.46 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 121.5 1.467 . . . . 1.02 112.368 171.451 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 m -68.32 -25.53 65.17 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.087 -1.008 . . . . 2.0099999999999998 113.102 169.498 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.84 -58.16 8.28 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.901 0.858 . . . . 3.6099999999999999 109.942 -177.099 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.86 HD13 ' H ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -78.82 36.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 C-N-CA 126.651 1.98 . . . . 2.0600000000000001 113.042 -179.078 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 t -121.66 -37.3 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.325 1.05 . . . . 2.7000000000000002 110.901 157.765 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -81.57 -46.69 14.08 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 120.995 -1.066 . . . . 4.1200000000000001 112.781 -167.623 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.8 52.91 0.16 Allowed Glycine 0 C--N 1.336 0.53 0 N-CA-C 110.882 -0.887 . . . . 2.1200000000000001 110.882 -171.882 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -149.28 -162.43 1.56 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.863 2.865 . . . . 2.5499999999999998 106.028 178.159 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.6 m -29.09 -47.81 0.06 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 129.529 3.132 . . . . 1.6100000000000001 116.714 -170.018 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -41.59 -53.1 3.61 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.088 0.858 . . . . 3.1099999999999999 111.052 175.332 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 m -98.0 -23.49 15.76 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.444 -0.798 . . . . 1.3300000000000001 109.831 179.224 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.82 39.38 85.72 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.258 0.933 . . . . 0.97999999999999998 111.659 174.305 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.1 m -87.18 -29.58 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 112.722 0.638 . . . . 1.27 112.722 -171.94 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.6 mttp -118.19 -62.23 0.03 OUTLIER Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 125.358 1.463 . . . . 4.7199999999999998 112.646 178.703 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -81.61 146.33 15.06 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 CA-C-N 121.242 1.479 . . . . 1.1899999999999999 108.606 172.92 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -107.13 158.53 17.01 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.578 -1.267 . . . . 2.79 107.578 170.04 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.1 154.04 35.75 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.362 -0.607 . . . . 1.3500000000000001 109.362 171.608 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.63 -2.67 45.77 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.933 0.777 . . . . 1.1699999999999999 112.781 -178.41 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.525 ' O ' HD12 ' A' ' 116' ' ' LEU . 39.8 mt-30 -95.48 160.61 14.44 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.253 1.027 . . . . 1.49 109.033 178.037 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.8 mtt180 -93.12 138.95 31.08 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.56 -0.533 . . . . 3.7599999999999998 109.56 167.709 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.575 HD12 ' CZ ' ' A' ' 38' ' ' TYR . 30.8 pt -150.59 177.89 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 106.61 -1.626 . . . . 0.66000000000000003 106.61 167.51 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.426 ' HB2' ' CD1' ' A' ' 37' ' ' PHE . 26.0 mtt180 -126.49 142.26 51.59 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.16 -0.681 . . . . 2.46 109.16 169.342 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.3 p -110.72 125.77 68.04 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.069 0 C-N-CA 124.727 1.211 . . . . 0.81000000000000005 108.893 178.879 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -120.35 111.76 2.04 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 110.194 -1.163 . . . . 0.73999999999999999 110.194 -179.803 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.18 -173.71 36.37 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.232 -0.747 . . . . 1.24 111.232 -173.603 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.429 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 4.3 ptp -118.19 137.54 52.93 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 124.308 1.043 . . . . 2.4100000000000001 111.715 -172.508 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.653 HG13 ' CE2' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -61.73 145.37 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 CA-C-N 116.369 -0.378 . . . . 2.6299999999999999 110.474 178.327 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 67' ' ' THR . 31.4 m -69.81 67.91 0.27 Allowed 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 109.207 -0.664 . . . . 3.1899999999999999 109.207 163.653 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.252 13.9 p 20.53 68.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.345 0 C-N-CA 129.812 3.245 . . . . 3.0499999999999998 114.361 161.902 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.69 50.69 1.01 Allowed Glycine 0 CA--C 1.527 0.79 0 CA-C-N 112.421 -2.172 . . . . 1.8799999999999999 110.799 -177.91 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.3 m -117.48 7.59 12.76 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 123.844 0.857 . . . . 1.1599999999999999 112.39 173.819 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 47.7 tpp -74.28 127.52 33.19 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.634 -0.876 . . . . 2.96 108.634 176.983 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.2 m -132.24 149.37 32.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 108.849 -0.797 . . . . 0.64000000000000001 108.849 167.306 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.517 ' CB ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -140.48 141.58 35.39 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.733 0.813 . . . . 5.6600000000000001 110.658 -171.593 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.31 154.37 84.17 Favored Pre-proline 0 N--CA 1.455 -0.192 0 CA-C-N 118.606 0.639 . . . . 2.2400000000000002 109.736 -179.867 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -63.03 -24.36 73.78 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.237 1.958 . . . . 1.3999999999999999 111.784 168.895 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -47.86 -30.83 4.42 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.389 0.676 . . . . 1.3600000000000001 110.731 166.804 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.3 m 63.91 29.82 14.42 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.794 1.238 . . . . 1.25 111.468 176.312 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.03 -48.91 1.47 Allowed 'General case' 0 C--O 1.232 0.135 0 C-N-CA 128.03 2.532 . . . . 2.1000000000000001 110.466 172.078 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -80.17 127.93 32.91 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.155 -1.054 . . . . 1.1299999999999999 108.155 -179.005 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.517 HG12 ' CB ' ' A' ' 73' ' ' ARG . 26.9 m -139.18 151.23 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.421 -1.325 . . . . 1.0700000000000001 107.421 172.033 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -148.95 156.59 42.51 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 122.027 -0.421 . . . . 1.21 110.191 174.798 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -155.89 133.99 11.4 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.116 -0.493 . . . . 1.8700000000000001 110.556 -169.867 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.52 129.4 35.09 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.163 0.585 . . . . 1.05 109.864 174.183 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.2 t -121.01 129.77 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 125.964 1.706 . . . . 1.8400000000000001 107.579 -177.693 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -106.13 172.46 6.8 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.672 0.789 . . . . 2.02 110.814 179.948 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.5 t70 . . . . . 0 N--CA 1.451 -0.416 0 CA-C-O 121.89 0.852 . . . . 3.9300000000000002 110.363 -174.965 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.72 0 CA-C-O 118.875 -0.958 . . . . 1.74 111.59 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -86.72 105.15 16.75 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.059 -1.089 . . . . 2.75 108.059 175.161 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 92' ' ' ILE . 9.3 tp -109.98 156.22 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 108.838 -0.801 . . . . 1.24 108.838 176.763 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.8 mt -109.88 114.76 28.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.307 -1.368 . . . . 0.64000000000000001 107.307 -179.995 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.9 t -92.72 136.75 24.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 106.904 -1.517 . . . . 1.0800000000000001 106.904 173.75 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 80.4 p -116.86 154.74 30.24 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.051 -1.092 . . . . 0.93999999999999995 108.051 179.359 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.541 ' OH ' HG13 ' A' ' 127' ' ' VAL . 0.3 OUTLIER -148.74 145.45 27.63 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 124.634 1.174 . . . . 3.3799999999999999 108.292 -175.556 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -128.58 7.98 5.83 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.373 1.469 . . . . 2.3100000000000001 112.743 -179.574 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -134.45 55.89 1.87 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.701 1.201 . . . . 4.1799999999999997 110.297 176.872 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.0 mp 50.55 -145.69 0.46 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.097 0.959 . . . . 2.4500000000000002 109.979 178.794 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.7 mt -158.03 161.85 28.07 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 127.675 2.39 . . . . 1.4199999999999999 105.037 177.645 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.28 -89.9 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.632 2.888 . . . . 2.0299999999999998 109.901 175.356 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -68.45 19.33 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.562 1.545 . . . . 3.5800000000000001 114.072 -178.713 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 54.92 1.12 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 128.784 2.834 . . . . 2.0099999999999998 115.284 -166.145 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.653 ' CE2' HG13 ' A' ' 66' ' ' VAL . 1.2 t80 51.22 89.53 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.092 1.357 . . . . 3.6699999999999999 110.049 -164.774 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.61 147.13 39.82 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.362 -0.977 . . . . 4.6500000000000004 108.362 -176.304 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -84.68 109.67 18.19 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.85 0.86 . . . . 3.3900000000000001 111.665 -162.822 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.51 45.52 0.26 Allowed Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.58 1.085 . . . . 1.02 110.965 174.063 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -158.17 178.41 10.22 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 106.155 -1.795 . . . . 2.0499999999999998 106.155 177.348 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 65' ' ' MET . . . -127.98 142.26 13.36 Favored Glycine 0 C--N 1.335 0.502 0 CA-C-O 121.296 0.387 . . . . 0.93999999999999995 112.227 173.904 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.5 pp -133.7 164.35 35.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 106.45 -1.685 . . . . 0.82999999999999996 106.45 -172.406 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.486 ' HB ' ' CD1' ' A' ' 37' ' ' PHE . 34.1 m -115.59 124.43 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 108.148 -1.056 . . . . 0.68999999999999995 108.148 -178.348 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.432 ' HB2' HG12 ' A' ' 127' ' ' VAL . . . -119.95 142.41 48.76 Favored 'General case' 0 C--O 1.227 -0.12 0 C-N-CA 125.057 1.343 . . . . 0.65000000000000002 110.048 -167.875 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -139.32 144.55 38.33 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.34 1.056 . . . . 3.9300000000000002 110.531 -176.632 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 176.61 -120.36 0.74 Allowed Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 107.874 -2.09 . . . . 1.04 107.874 169.848 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.7 p -146.38 143.84 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 117.758 0.779 . . . . 0.82999999999999996 109.078 -172.602 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.526 HD11 HG12 ' A' ' 60' ' ' ILE . 4.0 mp -79.56 143.04 35.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 118.848 -0.596 . . . . 2.6800000000000002 109.432 176.377 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -165.49 29.83 0.21 Allowed Glycine 0 CA--C 1.525 0.681 0 C-N-CA 119.882 -1.152 . . . . 2.7799999999999998 113.802 -175.74 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -132.83 1.92 3.66 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.855 0.862 . . . . 5.1900000000000004 111.107 177.566 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.6 t0 53.21 52.7 13.13 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 122.652 1.215 . . . . 3.2599999999999998 109.888 -173.052 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 163.46 -59.36 0.27 Allowed Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.17 -1.172 . . . . 1.47 110.17 -175.302 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.71 170.59 8.24 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.965 0.906 . . . . 2.2599999999999998 110.009 -173.662 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.7 mp -118.82 130.4 55.75 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.778 1.231 . . . . 1.98 108.617 -171.928 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -97.38 99.08 10.52 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.15 -1.426 . . . . 0.53000000000000003 107.15 173.377 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.34 153.73 17.65 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.602 -0.518 . . . . 1.5 109.602 -179.618 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.414 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 9.7 t -135.54 -38.49 0.74 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.14 0.576 . . . . 1.1499999999999999 112.128 174.481 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -91.16 108.8 20.12 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.843 -1.161 . . . . 3.04 108.968 174.835 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.541 HG13 ' OH ' ' A' ' 96' ' ' TYR . 1.0 OUTLIER -113.9 141.19 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 119.003 0.82 . . . . 0.97999999999999998 110.34 169.338 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -120.92 116.92 26.05 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.762 1.225 . . . . 0.93000000000000005 107.949 179.622 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.55 62.16 1.68 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.139 0.975 . . . . 1.27 112.124 -173.872 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.71 53.83 2.83 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.472 0.709 . . . . 4.6600000000000001 112.245 -179.25 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.464 0.271 0 O-C-N 121.711 -0.618 . . . . 4.4500000000000002 109.761 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.9 t . . . . . 0 CA--C 1.532 0.278 0 N-CA-C 109.759 -0.46 . . . . 8.6899999999999995 109.759 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -77.76 125.77 29.84 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.845 -0.798 . . . . 9.0199999999999996 108.845 173.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.1 mp -67.37 172.92 4.38 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.787 0.803 . . . . 5.0599999999999996 110.971 176.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -157.66 111.6 2.57 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 126.085 1.754 . . . . 4.96 108.595 -175.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -151.21 149.1 29.03 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.481 0.713 . . . . 2.23 109.515 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -99.03 126.06 44.65 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.108 1.363 . . . . 2.3799999999999999 110.511 -172.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -133.27 153.98 51.09 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.148 1.379 . . . . 2.75 111.565 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.9 m -73.81 131.31 81.94 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.768 1.627 . . . . 2.1400000000000001 111.307 -177.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -56.04 -52.04 8.21 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.358 2.705 . . . . 0.81999999999999995 112.598 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.6 m -53.97 -35.89 62.29 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.831 0.852 . . . . 3.1400000000000001 112.382 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -62.57 -58.32 7.96 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.434 -0.58 . . . . 2.0899999999999999 109.434 173.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 39.4 pt -71.76 33.0 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 114.416 1.265 . . . . 1.3700000000000001 114.416 -177.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 30.6 t -111.99 -76.41 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 105.579 -2.008 . . . . 2.4100000000000001 105.579 161.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -64.38 101.3 0.42 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 126.633 1.973 . . . . 2.6600000000000001 111.328 -162.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.74 40.1 53.81 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.086 -1.206 . . . . 1.54 110.086 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -139.79 -105.3 0.16 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.279 1.431 . . . . 2.7999999999999998 107.815 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.405 HG23 ' N ' ' A' ' 49' ' ' ASP . 14.8 t -72.28 -53.84 11.28 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 120.0 1.273 . . . . 3.5899999999999999 109.49 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.405 ' N ' HG23 ' A' ' 48' ' ' THR . 0.8 OUTLIER -47.27 -48.69 24.63 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 124.902 1.281 . . . . 3.0800000000000001 109.507 -174.284 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.92 -5.09 42.24 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.137 -1.392 . . . . 1.4399999999999999 111.069 -173.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 48.15 47.44 26.97 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 126.362 1.934 . . . . 1.3200000000000001 114.371 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.7 m -98.64 -52.75 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 118.967 1.384 . . . . 1.21 113.696 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt -101.73 -68.72 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 124.0 0.92 . . . . 3.1200000000000001 112.117 -173.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -71.75 177.08 7.35 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 121.876 1.718 . . . . 1.53 108.56 167.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -155.3 158.48 38.84 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.822 -1.547 . . . . 3.2799999999999998 106.822 -175.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.32 125.02 24.79 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.696 -1.224 . . . . 1.24 107.696 174.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 138.67 -36.82 1.85 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 123.911 0.767 . . . . 1.4199999999999999 111.343 -172.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.93 143.52 29.8 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.086 0.943 . . . . 2.8599999999999999 110.617 -175.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 48.1 ttp180 -92.23 129.5 38.16 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.163 0.985 . . . . 5.7199999999999998 108.632 172.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.7 pt -140.43 177.95 3.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 107.495 -1.298 . . . . 0.88 107.495 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -121.13 123.02 41.29 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.241 -0.652 . . . . 3.0499999999999998 109.241 170.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.15 133.4 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 106.916 -1.513 . . . . 0.80000000000000004 106.916 171.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -137.57 120.43 2.06 Favored Glycine 0 CA--C 1.519 0.335 0 N-CA-C 109.422 -1.471 . . . . 0.54000000000000004 109.422 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -179.02 -169.36 39.49 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.243 -1.143 . . . . 0.67000000000000004 110.243 -173.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.9 ptp -102.01 133.16 47.26 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.095 0.558 . . . . 2.3999999999999999 111.076 -173.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.7 p -85.03 134.43 27.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.856 -0.794 . . . . 2.4199999999999999 108.856 175.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.5 150.0 29.81 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 122.194 0.997 . . . . 2.3500000000000001 108.775 176.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.0 p -48.68 -46.87 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.286 1.034 . . . . 1.8799999999999999 112.003 -175.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.87 21.85 42.63 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 119.283 -0.731 . . . . 1.6399999999999999 113.217 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.7 m -81.96 -36.05 28.38 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.92 1.36 . . . . 2.0099999999999998 113.179 -175.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.1 tmm? -75.96 125.48 29.19 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.595 -0.52 . . . . 1.75 109.595 -169.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.0 m -134.34 123.91 44.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 108.912 -0.773 . . . . 0.69999999999999996 108.912 170.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 36.0 ptt85 -100.7 152.79 20.04 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.382 1.073 . . . . 5.1600000000000001 109.8 175.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -77.16 159.38 78.21 Favored Pre-proline 0 C--O 1.238 0.47 0 N-CA-C 109.439 -0.578 . . . . 2.1899999999999999 109.439 167.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -63.89 -26.73 67.04 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.134 2.556 . . . . 1.3899999999999999 111.009 165.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -40.91 -44.91 2.42 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 124.409 1.084 . . . . 1.1599999999999999 109.47 165.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.8 m 73.86 12.17 4.41 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.324 1.45 . . . . 1.53 113.041 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.25 -30.83 6.18 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.5 1.52 . . . . 1.8600000000000001 110.866 168.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -93.45 132.16 37.98 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.599 -1.259 . . . . 1.1200000000000001 107.599 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.78 141.49 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 107.868 -1.16 . . . . 0.83999999999999997 107.868 -174.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -144.34 154.03 42.6 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.654 -0.869 . . . . 0.81000000000000005 108.654 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -146.81 142.96 28.25 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.806 -0.634 . . . . 2.1499999999999999 109.723 -177.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.05 144.86 27.34 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.657 -0.868 . . . . 0.56999999999999995 108.657 168.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.88 145.02 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 108.973 -0.751 . . . . 1.78 108.973 177.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.5 p80 -142.71 -177.34 5.26 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.626 0.77 . . . . 1.3300000000000001 111.012 -169.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -149.02 179.17 8.08 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.339 -0.986 . . . . 2.3500000000000001 108.339 173.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.7 m -54.89 -23.49 18.94 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.11 1.764 . . . . 3.1499999999999999 111.749 175.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 mt -65.51 -5.44 7.92 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.143 0.794 . . . . 5.3099999999999996 113.143 175.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.66 39.83 90.39 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 119.035 0.834 . . . . 3.3300000000000001 111.467 165.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -135.31 143.76 15.47 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 106.252 -2.739 . . . . 1.6200000000000001 106.252 170.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -120.48 129.54 53.9 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.348 -1.353 . . . . 3.23 107.348 -177.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.18 137.98 42.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 106.664 -1.606 . . . . 1.03 106.664 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 mt -90.38 133.2 35.15 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.467 0.707 . . . . 0.56000000000000005 109.451 176.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.6 t -119.28 135.51 59.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 125.168 1.387 . . . . 0.93999999999999995 107.695 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.6 p -112.25 146.68 37.75 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.647 0.779 . . . . 0.63 109.414 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -146.02 136.39 23.93 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.891 1.276 . . . . 1.96 108.267 -171.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -125.18 37.17 4.44 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.821 1.248 . . . . 2.02 112.667 -164.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -158.9 179.44 9.08 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.402 1.881 . . . . 2.8700000000000001 106.245 167.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.3 mp -67.91 128.96 38.45 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 120.708 -1.245 . . . . 1.8899999999999999 110.75 177.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.9 mt -71.1 148.56 94.26 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 123.481 0.712 . . . . 1.1399999999999999 110.836 176.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -62.44 139.16 75.09 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.003 2.469 . . . . 2.4300000000000002 109.173 173.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 50.58 29.01 3.77 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.581 1.152 . . . . 3.2799999999999998 112.119 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 36.8 tp 59.99 6.79 1.0 Allowed 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.043 -1.036 . . . . 3.27 112.359 -174.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 13.9 t80 59.24 88.67 0.07 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.714 1.606 . . . . 3.21 109.97 -170.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -73.86 136.97 43.47 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 106.776 -1.564 . . . . 4.79 106.776 -174.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.2 mp0 -84.33 168.62 15.46 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 123.165 0.586 . . . . 3.0299999999999998 110.052 -171.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 62.06 47.04 92.63 Favored Glycine 0 CA--C 1.531 1.084 0 O-C-N 121.925 -0.484 . . . . 0.84999999999999998 112.916 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -146.67 177.74 8.85 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.873 1.269 . . . . 2.48 108.644 171.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -117.92 116.63 3.51 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.268 -0.733 . . . . 1.05 111.268 177.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.2 pp -117.95 168.62 9.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 125.45 1.5 . . . . 0.92000000000000004 108.557 -174.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 30.8 m -117.09 139.89 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 108.165 -1.05 . . . . 0.69999999999999996 108.165 166.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.417 ' CB ' HG12 ' A' ' 127' ' ' VAL . . . -126.03 126.13 43.77 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.132 1.373 . . . . 0.56000000000000005 108.569 178.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -98.91 133.97 42.44 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.872 -1.159 . . . . 3.3599999999999999 107.872 175.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -162.34 170.81 38.06 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 110.812 -0.915 . . . . 1.74 110.812 -175.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.4 p -111.87 136.95 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 108.315 -0.994 . . . . 1.1599999999999999 108.315 173.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.626 ' HG ' HD22 ' A' ' 122' ' ' LEU . 6.4 mp -72.1 125.09 26.4 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.073 -1.084 . . . . 2.4500000000000002 108.073 176.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -140.77 -28.52 0.19 Allowed Glycine 0 CA--C 1.526 0.746 0 CA-C-O 119.501 -0.611 . . . . 2.0299999999999998 113.336 -169.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -115.86 49.27 1.12 Allowed 'General case' 0 C--O 1.239 0.525 0 CA-C-N 118.446 1.123 . . . . 5.9900000000000002 108.148 -164.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 40.9 t0 12.16 70.01 0.01 OUTLIER 'General case' 0 C--N 1.341 0.205 0 C-N-CA 130.144 3.378 . . . . 3.0099999999999998 112.161 -177.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 134.52 -36.15 2.12 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 114.574 -1.194 . . . . 1.01 112.097 -172.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.608 ' C ' HD23 ' A' ' 122' ' ' LEU . 0.1 OUTLIER -110.41 155.32 22.35 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 118.178 0.989 . . . . 3.2200000000000002 109.203 174.151 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.626 HD22 ' HG ' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -116.78 130.6 56.82 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 124.648 1.218 . . . . 2.1600000000000001 108.074 -175.736 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -92.08 111.73 23.39 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.505 -1.294 . . . . 0.70999999999999996 107.505 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -126.81 132.62 50.97 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 123.795 0.838 . . . . 1.03 109.525 -176.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.3 t -122.05 -20.52 6.26 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.35 0.66 . . . . 0.77000000000000002 112.114 175.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -96.31 82.74 3.46 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 120.488 -1.383 . . . . 3.73 107.727 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.417 HG12 ' CB ' ' A' ' 112' ' ' ALA . 31.8 m -97.53 125.72 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.281 0.632 . . . . 0.68999999999999995 110.324 173.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -114.78 102.36 9.93 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.742 -1.207 . . . . 0.69999999999999996 107.742 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.05 56.37 3.46 Favored 'General case' 0 CA--C 1.53 0.212 0 O-C-N 121.76 -0.587 . . . . 1.1899999999999999 110.908 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.87 55.39 0.69 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 122.98 0.512 . . . . 4.54 111.251 175.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -82.55 -46.94 12.72 Favored 'General case' 0 C--O 1.228 -0.067 0 O-C-N 121.241 -0.912 . . . . 7.7000000000000002 109.875 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 . . . . . 0 CA--C 1.534 0.353 0 C-N-CA 125.983 1.713 . . . . 6.2699999999999996 111.431 175.363 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 CA--C 1.536 0.423 0 CA-C-O 121.411 0.624 . . . . 5.5700000000000003 111.665 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -103.38 92.39 4.47 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.998 2.119 . . . . 7.5700000000000003 108.07 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.8 mt -142.36 146.3 34.8 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.323 0.649 . . . . 7.04 109.388 178.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -83.02 103.72 12.67 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 107.675 -1.232 . . . . 4.25 107.675 -177.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.29 152.72 20.35 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 123.249 0.619 . . . . 3.2799999999999998 110.717 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -88.37 115.53 25.94 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.147 0.979 . . . . 2.6299999999999999 109.261 -177.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -120.82 155.61 33.7 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.608 1.163 . . . . 3.1499999999999999 109.503 175.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.8 p -85.57 146.85 45.13 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 123.787 0.835 . . . . 1.6599999999999999 110.25 174.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -59.96 -44.23 31.51 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.369 2.713 . . . . 0.67000000000000004 111.85 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.0 p -39.29 -57.39 1.37 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.548 1.539 . . . . 2.4100000000000001 111.369 174.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.423 ' OE2' ' NZ ' ' A' ' 47' ' ' LYS . 2.4 tt0 -58.09 -54.51 46.19 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 115.294 -0.866 . . . . 2.2599999999999998 110.1 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.339 26.4 pt -65.28 -12.05 12.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 114.701 1.371 . . . . 1.1699999999999999 114.701 -173.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 82.1 t -75.79 -38.28 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 123.596 0.758 . . . . 1.8999999999999999 111.217 166.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -106.7 92.63 4.18 Favored 'General case' 0 C--N 1.335 -0.06 0 O-C-N 120.999 -1.063 . . . . 2.1699999999999999 111.121 -160.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.81 47.02 58.03 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.907 -1.277 . . . . 1.4299999999999999 109.907 174.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.423 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 12.1 mmtp -156.49 -155.39 0.53 Allowed 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 128.849 2.859 . . . . 2.2000000000000002 105.822 -172.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.2 m -37.07 -55.57 0.94 Allowed 'General case' 0 C--O 1.221 -0.429 0 C-N-CA 127.389 2.276 . . . . 1.6000000000000001 114.319 -174.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -38.48 -46.86 1.21 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 119.214 0.916 . . . . 2.4100000000000001 112.626 176.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.24 -4.29 25.96 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.495 1.118 . . . . 1.6599999999999999 111.387 -173.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 54.64 30.23 50.73 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.644 1.592 . . . . 0.97999999999999998 113.815 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.7 m -86.1 -29.52 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 118.585 1.193 . . . . 1.6899999999999999 113.124 -172.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -121.41 -71.94 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 124.161 0.984 . . . . 5.9400000000000004 112.084 -176.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -66.08 128.63 19.99 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 N-CA-C 107.472 -1.78 . . . . 1.1499999999999999 107.472 167.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.09 168.8 17.37 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.761 -0.829 . . . . 3.5600000000000001 108.761 169.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.48 175.94 6.55 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.691 -0.855 . . . . 1.6599999999999999 108.691 163.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.99 -87.75 0.47 Allowed Glycine 0 C--O 1.22 -0.749 1 N-CA-C 100.346 -5.102 . . . . 3.29 100.346 -150.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -98.93 169.99 9.05 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 105.619 -1.993 . . . . 1.3300000000000001 105.619 -81.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -84.72 122.13 28.66 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 118.025 -0.988 . . . . 3.2000000000000002 108.69 176.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.6 pt -148.91 175.63 1.11 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 107.195 -1.409 . . . . 0.64000000000000001 107.195 171.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -121.02 127.58 51.89 Favored 'General case' 0 CA--C 1.527 0.06 0 N-CA-C 108.824 -0.806 . . . . 1.8 108.824 168.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.2 p -93.46 123.92 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 107.523 -1.288 . . . . 0.85999999999999999 107.523 170.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -124.16 123.57 5.2 Favored Glycine 0 C--N 1.332 0.354 0 N-CA-C 109.862 -1.295 . . . . 0.52000000000000002 109.862 -177.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -174.75 -171.22 38.71 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 110.379 -1.088 . . . . 0.60999999999999999 110.379 -176.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 6.3 ptp -94.35 135.0 36.24 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.125 -0.695 . . . . 2.4100000000000001 109.125 177.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.445 HG12 ' H ' ' A' ' 68' ' ' VAL . 78.9 t -59.76 133.86 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 123.229 0.612 . . . . 1.9399999999999999 110.27 177.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.88 -9.49 55.05 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.16 1.17 . . . . 3.4700000000000002 114.16 -172.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.445 ' H ' HG12 ' A' ' 66' ' ' VAL 0.28 9.1 p 50.43 47.62 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 123.917 1.818 . . . . 3.25 112.551 175.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 178.98 40.48 0.07 OUTLIER Glycine 0 CA--C 1.527 0.811 0 CA-C-N 112.429 -2.169 . . . . 2.5499999999999998 111.919 169.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.4 m -150.41 1.92 0.47 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.89 1.441 . . . . 2.4700000000000002 114.89 175.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.0 tpt -72.69 97.15 2.13 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.922 1.237 . . . . 1.74 108.347 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.9 m -116.69 140.45 39.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.533 -0.914 . . . . 0.56000000000000005 108.533 174.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.22 149.86 50.84 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.268 1.027 . . . . 4.71 109.225 -176.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -75.86 153.92 85.01 Favored Pre-proline 0 N--CA 1.454 -0.23 0 N-CA-C 109.789 -0.449 . . . . 2.23 109.789 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -62.52 -25.56 75.78 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.303 2.002 . . . . 1.4199999999999999 111.055 165.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -44.27 -37.03 3.01 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.824 0.85 . . . . 1.4099999999999999 110.626 165.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.6 m 72.5 24.17 2.95 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.62 1.568 . . . . 1.5 112.489 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.47 -48.25 2.07 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 125.506 1.522 . . . . 2.2000000000000002 110.366 169.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -75.41 130.21 38.6 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.774 -0.825 . . . . 1.3300000000000001 108.774 -177.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.582 HG23 ' HB3' ' A' ' 96' ' ' TYR . 16.6 m -142.44 131.04 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 125.191 1.397 . . . . 0.78000000000000003 107.308 -176.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -139.0 146.57 41.05 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 121.806 -0.559 . . . . 0.90000000000000002 109.537 177.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -149.46 160.61 43.31 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.117 0.567 . . . . 1.8500000000000001 109.782 -168.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -115.52 138.55 50.92 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.42 -0.585 . . . . 0.63 109.42 174.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.9 p -127.3 137.78 56.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.202 -1.036 . . . . 1.96 108.202 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -130.68 174.26 10.1 Favored 'General case' 0 CA--C 1.522 -0.122 0 C-N-CA 124.46 1.104 . . . . 1.6200000000000001 110.309 -175.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -122.47 -13.36 8.03 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.321 0.649 . . . . 2.7400000000000002 109.926 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.78 13.49 7.52 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.19 1.396 . . . . 4.3600000000000003 112.405 -166.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.2 mp -98.0 -34.61 10.74 Favored 'General case' 0 C--N 1.341 0.232 0 N-CA-C 113.076 0.769 . . . . 5.1299999999999999 113.076 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -149.85 -45.14 0.03 OUTLIER Glycine 0 CA--C 1.525 0.709 0 CA-C-N 118.049 0.386 . . . . 3.0899999999999999 112.613 -168.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -177.74 -167.94 36.61 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 108.299 -1.92 . . . . 1.6499999999999999 108.299 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -120.88 151.32 39.81 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.731 1.212 . . . . 3.1099999999999999 109.219 174.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.22 160.01 12.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 107.702 -1.221 . . . . 0.91000000000000003 107.702 173.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.2 mt -118.2 124.42 47.88 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.133 0.973 . . . . 0.96999999999999997 108.729 -172.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.7 t -114.0 138.41 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 125.609 1.564 . . . . 0.87 108.16 -173.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.7 p -112.54 155.07 24.96 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.642 1.177 . . . . 0.52000000000000002 108.603 173.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.582 ' HB3' HG23 ' A' ' 80' ' ' VAL . 1.4 t80 -151.84 132.5 13.98 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.447 -1.686 . . . . 2.98 106.447 175.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -104.15 1.04 30.28 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.175 1.39 . . . . 2.7000000000000002 113.121 -173.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -120.38 166.85 12.98 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 124.931 1.293 . . . . 3.02 108.79 167.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.8 mp -63.06 144.37 56.96 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.765 0.793 . . . . 1.6699999999999999 111.2 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.488 HD23 HG21 ' A' ' 127' ' ' VAL . 8.3 mt -72.25 162.28 74.56 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 124.562 1.145 . . . . 1.1899999999999999 110.146 171.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.21 -95.34 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.853 3.036 . . . . 2.1899999999999999 109.333 173.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -76.15 44.95 0.34 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.524 1.13 . . . . 3.0 111.061 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.4 tp 60.82 -11.12 0.05 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.856 1.663 . . . . 3.1499999999999999 114.87 -177.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 44.7 t80 64.57 88.36 0.1 Allowed 'General case' 0 C--N 1.343 0.288 0 C-N-CA 125.157 1.383 . . . . 2.8599999999999999 107.958 -161.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -77.62 134.34 38.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.782 -1.562 . . . . 4.1299999999999999 106.782 175.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.5 mp0 -82.05 147.89 28.89 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 123.559 0.744 . . . . 2.7799999999999998 109.729 -171.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.89 47.82 23.7 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 111.671 -0.571 . . . . 0.73999999999999999 111.671 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -138.16 178.37 7.18 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 107.056 -1.461 . . . . 2.3500000000000001 107.056 168.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -105.29 134.19 11.94 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.909 -0.876 . . . . 0.67000000000000004 110.909 171.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.82 160.01 37.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 108.673 -0.862 . . . . 0.62 108.673 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.8 m -116.91 120.54 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 107.873 -1.158 . . . . 0.59999999999999998 107.873 170.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -113.77 115.85 28.45 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.762 1.225 . . . . 0.59999999999999998 109.385 -173.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -116.29 140.58 49.18 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.475 1.11 . . . . 3.6099999999999999 109.809 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -170.35 -104.87 0.18 Allowed Glycine 0 C--N 1.335 0.504 0 N-CA-C 107.408 -2.277 . . . . 1.4199999999999999 107.408 166.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.5 p -156.12 148.47 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 107.339 -1.356 . . . . 0.91000000000000003 107.339 176.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.592 ' HG ' HD12 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -63.29 150.42 43.28 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 119.028 -1.069 . . . . 2.3999999999999999 109.986 175.165 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -105.79 -92.03 2.25 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 110.514 -1.034 . . . . 2.0600000000000001 110.514 -171.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -73.42 -68.81 0.47 Allowed 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.887 -1.523 . . . . 4.6299999999999999 106.887 175.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -163.12 -71.18 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.211 -1.403 . . . . 4.7199999999999998 107.211 164.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.47 -23.57 72.0 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.347 0.975 . . . . 1.3999999999999999 113.184 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -95.58 119.89 34.87 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.221 1.011 . . . . 2.7400000000000002 108.706 173.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.592 HD12 ' HG ' ' A' ' 116' ' ' LEU . 0.1 OUTLIER -98.66 131.22 45.01 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 108.955 -0.757 . . . . 2.3999999999999999 108.955 -176.693 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -89.98 93.74 9.52 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 107.784 -1.191 . . . . 0.60999999999999999 107.784 177.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -99.97 151.76 20.97 Favored 'General case' 0 C--N 1.337 0.065 0 CA-C-N 117.856 0.298 . . . . 1.1399999999999999 110.319 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.7 t -140.12 -44.42 0.42 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 122.933 0.493 . . . . 1.48 111.66 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -82.4 84.43 7.16 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.032 -1.47 . . . . 2.9100000000000001 107.032 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.488 HG21 HD23 ' A' ' 100' ' ' LEU . 4.0 m -96.58 94.73 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.834 1.654 . . . . 1.21 110.274 178.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.57 121.64 35.19 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.81 -0.811 . . . . 0.62 108.81 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.16 62.54 1.81 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.189 0.996 . . . . 1.3 111.41 -174.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.42 -24.14 59.29 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.417 0.895 . . . . 3.9900000000000002 113.417 -172.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -65.23 -23.94 67.21 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 119.073 -0.489 . . . . 5.2400000000000002 112.129 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.0 t70 . . . . . 0 CA--C 1.537 0.474 0 CA-C-N 118.984 0.811 . . . . 7.3200000000000003 109.183 175.059 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.0 p . . . . . 0 N--CA 1.45 -0.462 0 N-CA-C 108.531 -0.915 . . . . 10.33 108.531 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -49.92 -43.71 49.86 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.957 0.799 . . . . 8.4700000000000006 110.943 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.51 -25.13 35.53 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.403 1.081 . . . . 5.9800000000000004 112.906 178.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -151.58 89.06 1.45 Allowed 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.644 1.178 . . . . 3.75 108.171 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.415 HD23 ' H ' ' A' ' 36' ' ' LEU . 1.7 pt? -117.83 158.97 23.86 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.231 0.923 . . . . 2.3599999999999999 112.087 -176.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -84.25 120.54 26.35 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 124.467 1.107 . . . . 2.2200000000000002 109.729 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.92 156.96 41.8 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.607 0.763 . . . . 2.7799999999999998 112.378 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 m -86.6 124.46 69.46 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 126.074 1.75 . . . . 2.27 112.811 -167.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . 2.256 0.1 OUTLIER -6.37 -72.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.151 1 C-N-CA 128.016 5.811 . . . . 1.55 118.345 161.31 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.5 m -70.5 -29.4 65.91 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 113.996 -1.456 . . . . 2.5899999999999999 113.186 -173.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -62.57 -56.44 17.86 Favored 'General case' 0 C--N 1.335 -0.041 0 N-CA-C 108.898 -0.779 . . . . 3.1299999999999999 108.898 -177.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 33.1 pt -59.39 -16.15 9.43 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 114.265 1.209 . . . . 1.6499999999999999 114.265 -174.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.6 t -73.19 -38.39 54.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 124.759 1.224 . . . . 2.0899999999999999 111.071 172.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -104.7 85.89 2.39 Favored 'General case' 0 C--N 1.333 -0.118 0 O-C-N 121.127 -0.983 . . . . 2.0299999999999998 110.783 -159.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.17 51.38 18.18 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.138 -1.185 . . . . 1.3899999999999999 110.138 174.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.9 mmtt -150.18 -124.15 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.423 -1.325 . . . . 2.52 107.423 -171.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.1 m -59.19 -58.45 8.59 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.929 1.292 . . . . 1.53 110.414 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -36.81 -51.84 0.9 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 122.709 1.242 . . . . 3.23 111.12 178.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.83 -11.95 37.81 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 113.577 -1.647 . . . . 1.4399999999999999 111.328 -169.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 54.26 35.37 55.15 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 126.197 1.856 . . . . 1.1799999999999999 112.649 -177.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.8 m -92.92 -22.4 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 118.032 0.916 . . . . 1.3799999999999999 112.715 -174.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.5 mmpp? -124.36 -78.93 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 125.343 1.457 . . . . 4.3399999999999999 111.11 174.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.22 149.47 35.85 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 CA-C-N 120.95 1.375 . . . . 1.1100000000000001 109.375 173.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -112.92 156.46 22.94 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.309 1.844 . . . . 2.6800000000000002 108.675 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.35 160.98 2.77 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.595 0.712 . . . . 1.22 110.958 168.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.77 -12.7 62.83 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 121.705 -0.622 . . . . 1.4099999999999999 112.385 -176.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -82.57 154.69 24.87 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 118.436 1.118 . . . . 2.6000000000000001 109.325 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 74.2 mtt-85 -96.06 132.48 41.38 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.45 -0.944 . . . . 5.1299999999999999 108.45 170.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.6 pt -145.97 177.47 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 105.839 -1.912 . . . . 0.69999999999999996 105.839 165.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 -117.27 135.37 53.87 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 105.973 -1.862 . . . . 1.96 105.973 173.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.4 p -103.84 136.26 37.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 107.361 -1.348 . . . . 1.3 107.361 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.82 120.16 1.59 Allowed Glycine 0 C--N 1.334 0.422 0 N-CA-C 110.777 -0.929 . . . . 0.63 110.777 -176.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -172.15 -163.12 25.51 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 109.309 -1.516 . . . . 0.66000000000000003 109.309 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.2 ptm -102.87 135.0 45.35 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.54 0.736 . . . . 4.1699999999999999 109.511 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.1 p -98.54 135.32 33.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 109.863 -0.421 . . . . 2.46 109.863 175.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.1 m -68.63 151.72 46.33 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 122.243 1.02 . . . . 2.3599999999999999 108.826 169.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.8 p -61.42 -66.24 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 114.718 -1.128 . . . . 2.4399999999999999 111.218 -174.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -81.86 40.8 2.67 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 120.8 -1.187 . . . . 1.6899999999999999 112.713 -172.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.6 m -108.87 -28.1 9.35 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 117.82 0.81 . . . . 1.55 112.705 -172.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.447 ' SD ' ' HB3' ' A' ' 104' ' ' PHE . 0.8 OUTLIER -79.22 103.11 8.93 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.74 0.7 . . . . 1.8400000000000001 110.087 -175.063 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.6 m -100.27 147.52 7.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 107.811 -1.181 . . . . 0.67000000000000004 107.811 175.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.42 ' CB ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -142.85 137.51 29.65 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.427 0.691 . . . . 6.4199999999999999 109.829 -165.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.19 153.88 94.95 Favored Pre-proline 0 N--CA 1.452 -0.327 0 N-CA-C 109.607 -0.516 . . . . 2.0499999999999998 109.607 -179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -65.51 -25.63 55.25 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.218 1.946 . . . . 1.54 111.306 165.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -48.94 -29.98 5.4 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.934 0.494 . . . . 1.4199999999999999 110.831 164.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.1 m 67.43 23.68 9.04 Favored 'General case' 0 C--N 1.342 0.249 0 C-N-CA 125.362 1.465 . . . . 1.54 112.114 173.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.38 -44.28 1.72 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 127.875 2.47 . . . . 1.77 110.757 177.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -84.39 129.08 34.9 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 107.692 -1.225 . . . . 1.1799999999999999 107.692 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.42 HG12 ' CB ' ' A' ' 73' ' ' ARG . 20.1 m -147.43 145.72 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.174 -1.417 . . . . 0.71999999999999997 107.174 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -150.65 154.92 38.35 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.599 -0.688 . . . . 1.1100000000000001 111.48 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -155.14 138.0 15.36 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 123.404 0.682 . . . . 1.8700000000000001 111.573 -173.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.622 ' HA ' ' HA ' ' A' ' 93' ' ' LEU . . . -84.04 124.33 30.97 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.296 -0.631 . . . . 0.84999999999999998 109.296 176.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 t -108.4 147.62 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 124.267 1.027 . . . . 1.76 108.835 173.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -144.91 178.92 7.67 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.024 -1.102 . . . . 1.4399999999999999 108.024 177.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -131.59 24.02 4.73 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 122.1 0.952 . . . . 2.8399999999999999 109.711 175.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 12.2 t 47.84 26.96 1.02 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.243 1.817 . . . . 3.9399999999999999 113.809 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 14.5 mt -101.6 -67.66 0.85 Allowed 'General case' 0 C--N 1.339 0.111 0 C-N-CA 123.251 0.62 . . . . 4.9100000000000001 110.003 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -171.44 45.04 0.19 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.779 -0.724 . . . . 3.5600000000000001 111.726 -173.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 171.04 157.72 13.56 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 108.582 -1.807 . . . . 1.8100000000000001 108.582 172.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -136.41 145.11 44.92 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.625 -1.991 . . . . 3.2799999999999998 105.625 174.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -126.67 158.28 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.013 -1.847 . . . . 1.3100000000000001 106.013 175.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.622 ' HA ' ' HA ' ' A' ' 83' ' ' ALA 0.442 2.9 mt -107.69 117.49 34.25 Favored 'General case' 0 CA--C 1.545 0.77 1 N-CA-C 123.136 4.495 . . . . 0.90000000000000002 123.136 164.394 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 61.1 t -86.52 141.29 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 107.331 -1.359 . . . . 0.87 107.331 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.2 p -120.86 149.6 42.35 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.595 1.158 . . . . 0.92000000000000004 107.959 -176.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.41 ' OH ' HG13 ' A' ' 127' ' ' VAL . 0.4 OUTLIER -145.65 142.25 28.88 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.588 1.155 . . . . 3.29 108.031 -176.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -115.29 14.33 16.83 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.275 1.43 . . . . 2.54 111.649 171.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -117.69 163.38 16.56 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 124.449 1.1 . . . . 4.71 110.618 170.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.8 mp -67.84 113.14 5.33 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.342 -0.845 . . . . 1.95 109.202 163.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.8 mt -62.18 156.09 61.5 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.067 0.947 . . . . 1.46 110.246 171.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -68.07 147.69 74.0 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 123.651 2.901 . . . . 2.23 110.767 174.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 41.55 49.44 3.63 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.376 1.47 . . . . 2.98 111.629 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 44.89 22.01 0.06 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 127.089 2.156 . . . . 2.29 115.326 -174.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.447 ' HB3' ' SD ' ' A' ' 71' ' ' MET . 67.1 t80 51.0 110.94 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 127.125 2.17 . . . . 2.52 110.764 -159.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.5 mmt85 -77.75 112.7 14.87 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.251 -1.388 . . . . 5.0700000000000003 107.251 -176.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -82.36 172.75 12.72 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.416 0.627 . . . . 3.3999999999999999 111.005 -170.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 62.26 43.67 98.76 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 121.861 -0.525 . . . . 0.89000000000000001 112.61 171.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -157.16 176.88 12.14 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.092 1.357 . . . . 2.4700000000000002 108.101 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -93.31 140.37 15.03 Favored Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 109.893 -1.283 . . . . 0.56999999999999995 109.893 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.5 pp -148.01 165.15 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.999 -1.482 . . . . 0.69999999999999996 106.999 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.25 135.89 60.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 108.373 -0.973 . . . . 0.78000000000000003 108.373 174.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.569 ' HB2' HG12 ' A' ' 127' ' ' VAL . . . -128.39 152.87 47.69 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 126.285 1.834 . . . . 0.67000000000000004 110.071 -170.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -147.95 155.13 41.22 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 119.439 1.018 . . . . 2.9199999999999999 113.13 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 175.62 -89.07 0.08 OUTLIER Glycine 0 C--N 1.345 1.054 0 CA-C-O 119.728 -0.485 . . . . 2.1699999999999999 112.473 172.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.7 p -164.24 148.78 2.76 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 C-N-CA 124.351 1.061 . . . . 1.3600000000000001 109.677 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.479 HD22 HD22 ' A' ' 122' ' ' LEU . 5.1 mt -90.91 141.74 28.51 Favored 'General case' 0 N--CA 1.453 -0.275 0 O-C-N 122.087 -0.383 . . . . 2.5699999999999998 110.69 -177.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -131.67 158.28 22.74 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 109.132 -1.587 . . . . 3.6299999999999999 109.132 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 55.52 33.76 21.72 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.934 1.294 . . . . 4.3300000000000001 110.629 169.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 27.25 45.06 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 128.194 2.597 . . . . 4.0599999999999996 112.173 -165.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -176.37 -48.2 0.06 OUTLIER Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.07 -1.062 . . . . 1.4199999999999999 113.487 -164.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -91.66 114.25 26.73 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 118.502 1.151 . . . . 2.6299999999999999 109.001 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.479 HD22 HD22 ' A' ' 116' ' ' LEU . 5.8 mt -87.62 114.47 24.27 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 106.742 -1.577 . . . . 1.8400000000000001 106.742 -174.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -88.04 98.45 11.53 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.325 -1.361 . . . . 0.56000000000000005 107.325 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -101.86 159.17 15.57 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.84 -0.43 . . . . 1.6799999999999999 109.84 -178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.402 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 7.1 t -136.05 -41.76 0.66 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.233 0.613 . . . . 1.1399999999999999 111.787 174.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -92.84 129.84 38.63 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 120.921 -1.112 . . . . 4.1200000000000001 108.367 175.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.569 HG12 ' HB2' ' A' ' 112' ' ' ALA . 1.2 m -127.47 140.07 50.15 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 C-N-CA 124.23 1.012 . . . . 1.0900000000000001 109.37 168.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -114.22 87.48 2.64 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.374 -1.343 . . . . 1.3400000000000001 107.374 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.44 57.35 2.36 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.613 1.165 . . . . 1.1899999999999999 110.952 -174.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -79.02 47.69 0.79 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.272 1.029 . . . . 3.3799999999999999 112.95 -169.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -146.59 52.62 1.11 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.402 1.081 . . . . 4.8899999999999997 110.071 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.0 t0 . . . . . 0 C--O 1.232 0.162 0 N-CA-C 106.098 -1.815 . . . . 7.46 106.098 169.776 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.455 -0.224 0 CA-C-O 120.559 0.218 . . . . 10.09 110.582 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -66.56 138.17 57.29 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 108.157 -1.053 . . . . 8.0299999999999994 108.157 172.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -64.37 -53.09 54.12 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.89 0.852 . . . . 5.1399999999999997 109.231 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -95.66 95.78 8.57 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 123.814 0.846 . . . . 3.73 108.872 -171.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -138.04 172.27 13.17 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.77 0.828 . . . . 1.99 111.873 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -82.62 121.21 26.53 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.672 1.189 . . . . 2.3100000000000001 110.219 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -128.27 145.36 51.07 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.422 1.089 . . . . 3.3399999999999999 110.872 177.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 91.5 m -69.24 127.5 92.91 Favored Pre-proline 0 N--CA 1.45 -0.437 0 C-N-CA 126.44 1.896 . . . . 1.74 110.115 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -57.57 -41.68 68.76 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.036 1.824 . . . . 1.24 111.995 -175.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.4 m -47.17 -43.02 20.83 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.71 1.141 . . . . 1.9299999999999999 113.39 177.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -60.74 -40.63 93.14 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.363 -0.606 . . . . 3.52 109.363 178.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 40.5 pt -102.69 35.22 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.867 1.667 . . . . 1.95 111.847 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -114.98 -31.25 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 119.322 0.965 . . . . 2.2400000000000002 111.535 176.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -117.22 126.19 52.36 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.433 1.093 . . . . 3.23 108.112 -175.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.03 -69.9 0.79 Allowed Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.623 1.106 . . . . 4.7999999999999998 111.66 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -30.93 -89.07 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.571 0 C-N-CA 129.639 3.175 . . . . 2.4399999999999999 111.645 175.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.4 m -71.33 -51.0 26.68 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 119.48 1.036 . . . . 1.5700000000000001 109.69 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -33.03 -50.23 0.27 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 128.307 2.643 . . . . 3.1099999999999999 114.707 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.2 m -127.76 15.28 6.96 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.15 2.18 . . . . 3.5600000000000001 109.171 -175.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 51.89 39.22 47.62 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-O 117.382 -1.788 . . . . 1.4299999999999999 113.989 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.2 m -84.42 -45.13 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 CA-C-N 121.843 2.822 . . . . 1.1699999999999999 112.421 -169.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -92.76 -57.37 0.23 Allowed Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 125.128 1.371 . . . . 3.3999999999999999 113.383 178.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -75.84 179.88 5.84 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.323 2.016 . . . . 1.5800000000000001 108.418 172.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -135.43 128.14 30.96 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 106.716 -1.587 . . . . 5.6600000000000001 106.716 -176.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.38 125.76 24.92 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.905 -0.776 . . . . 1.3600000000000001 108.905 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.18 -11.46 19.88 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 119.179 -0.789 . . . . 1.1200000000000001 113.021 -175.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -83.4 146.21 28.57 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 119.124 1.462 . . . . 2.5099999999999998 109.332 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -86.91 139.33 30.73 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.79 -0.641 . . . . 4.5199999999999996 109.998 167.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.4 pt -148.7 172.27 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 107.124 -1.436 . . . . 0.80000000000000004 107.124 171.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.6 mtt180 -114.19 110.0 19.29 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 106.825 -1.546 . . . . 1.99 106.825 174.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.3 p -79.26 127.74 38.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.299 -1.371 . . . . 0.93000000000000005 107.299 175.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.54 114.87 1.51 Allowed Glycine 0 C--N 1.335 0.487 0 N-CA-C 110.191 -1.164 . . . . 0.69999999999999996 110.191 -177.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.05 -173.22 29.41 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.154 -1.178 . . . . 0.81000000000000005 110.154 -175.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.1 ptp -101.08 126.64 47.79 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 124.027 0.931 . . . . 2.98 110.234 -176.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 108' ' ' GLN . 29.0 m -89.58 157.51 3.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 109.843 -0.428 . . . . 2.4900000000000002 109.843 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.8 -172.57 2.69 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.591 -0.277 . . . . 3.0800000000000001 110.26 176.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.3 p -116.98 71.98 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 126.937 2.095 . . . . 2.8799999999999999 106.958 174.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 131.65 63.82 0.09 OUTLIER Glycine 0 CA--C 1.53 0.975 0 C-N-CA 126.671 2.081 . . . . 1.8500000000000001 111.311 -178.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.7 m -146.12 64.55 1.22 Allowed 'General case' 0 CA--C 1.519 -0.238 0 O-C-N 121.243 -1.151 . . . . 2.0499999999999998 110.642 163.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.14 115.81 18.27 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.381 -1.34 . . . . 2.1800000000000002 107.381 176.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.6 m -125.15 127.72 72.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 108.363 -0.977 . . . . 0.69999999999999996 108.363 170.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.47 149.84 29.73 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.444 1.098 . . . . 4.9800000000000004 110.421 175.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -86.58 150.49 51.19 Favored Pre-proline 0 C--O 1.235 0.339 0 N-CA-C 109.002 -0.74 . . . . 1.9399999999999999 109.002 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.45 28.9 0.37 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.89 2.393 . . . . 2.3300000000000001 112.961 173.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -89.44 -27.63 20.26 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.329 1.052 . . . . 1.3799999999999999 108.847 166.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.506 ' O ' HD13 ' A' ' 99' ' ' LEU . 8.5 m 69.95 12.29 7.83 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 125.594 1.558 . . . . 1.7 112.177 -172.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.45 32.04 3.39 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.918 1.287 . . . . 2.3199999999999998 113.36 170.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -153.48 131.86 12.05 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 121.827 -0.545 . . . . 1.1399999999999999 109.927 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.98 146.3 16.26 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 C-N-CA 123.666 0.786 . . . . 1.04 110.409 -172.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -152.74 156.91 40.04 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 120.659 -1.276 . . . . 0.93999999999999995 110.989 175.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -155.44 160.21 40.44 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.257 0.623 . . . . 1.8600000000000001 110.645 -173.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.94 139.34 39.79 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.5 -0.926 . . . . 0.60999999999999999 108.5 177.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.6 p -125.34 143.76 37.78 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.063 0 N-CA-C 107.87 -1.159 . . . . 1.8700000000000001 107.87 173.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -124.29 -171.04 2.25 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.63 1.172 . . . . 1.6599999999999999 109.814 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -149.96 177.82 9.5 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 110.244 -0.28 . . . . 2.6600000000000001 110.244 174.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 61.2 m -55.9 -34.49 65.6 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.007 1.323 . . . . 3.9300000000000002 110.278 170.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.5 mt -91.86 32.25 1.14 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.535 0.734 . . . . 5.4699999999999998 111.089 173.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 58.39 36.65 84.86 Favored Glycine 0 C--N 1.34 0.793 0 O-C-N 121.423 -0.798 . . . . 2.7599999999999998 112.993 169.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -79.77 54.06 4.37 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-O 119.04 -0.867 . . . . 2.5800000000000001 113.41 -169.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -66.79 96.15 0.39 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.042 0.921 . . . . 2.8399999999999999 110.213 -173.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.456 HD12 HD12 ' A' ' 122' ' ' LEU . 0.3 OUTLIER -121.84 140.49 45.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 107.828 -1.175 . . . . 1.45 107.828 179.099 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.451 ' H ' HD13 ' A' ' 92' ' ' ILE . 4.2 mt -90.18 124.89 35.22 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.452 1.101 . . . . 0.65000000000000002 110.048 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.1 t -106.0 119.89 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 125.082 1.353 . . . . 0.85999999999999999 107.578 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 65.5 p -98.69 144.06 28.37 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.173 0.589 . . . . 0.59999999999999998 109.668 175.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.406 ' CE2' HD23 ' A' ' 100' ' ' LEU . 1.9 t80 -137.89 143.13 40.71 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.721 1.608 . . . . 2.5299999999999998 107.411 -173.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.2 p30 -85.94 -82.43 0.19 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.132 0.973 . . . . 3.1200000000000001 109.764 175.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -62.29 166.83 4.6 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.455 0.645 . . . . 3.3599999999999999 111.382 -168.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.506 HD13 ' O ' ' A' ' 77' ' ' SER . 1.4 mp -60.66 131.78 51.81 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 119.998 -1.689 . . . . 3.3999999999999999 111.685 175.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.406 HD23 ' CE2' ' A' ' 96' ' ' TYR . 26.7 mt -60.61 158.02 33.72 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 114.559 -1.201 . . . . 1.4399999999999999 109.757 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -67.9 -85.11 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.234 2.623 . . . . 2.29 111.145 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -122.83 52.09 1.37 Allowed 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 124.76 1.224 . . . . 3.0 108.749 -172.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 34.63 41.75 0.06 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.73 1.612 . . . . 3.6800000000000002 113.096 -173.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 40.7 p90 31.48 74.56 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.34 1.856 . . . . 4.0800000000000001 112.151 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.488 ' H ' ' HD3' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -60.29 125.36 23.39 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 119.854 -1.779 . . . . 6.9699999999999998 110.177 -124.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -72.19 143.74 48.77 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 119.826 -0.749 . . . . 4.8099999999999996 109.882 -153.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.14 22.22 23.2 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.675 1.607 . . . . 1.46 113.591 -172.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.452 ' O ' HG22 ' A' ' 66' ' ' VAL . 2.2 pt20 -137.43 178.68 6.91 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 119.519 1.66 . . . . 3.1600000000000001 110.604 178.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -92.71 128.1 9.27 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.997 -0.441 . . . . 1.0800000000000001 111.997 170.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.3 pp -131.18 159.85 42.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 124.901 1.28 . . . . 0.69999999999999996 107.915 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 4.1 m -113.82 140.25 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.67 -1.233 . . . . 1.02 107.67 175.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -129.68 123.5 31.31 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.063 0.945 . . . . 0.72999999999999998 109.606 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.549 ' HB2' ' HB2' ' A' ' 126' ' ' GLU . 3.8 mt-30 -107.24 136.68 46.66 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 126.065 1.746 . . . . 4.0899999999999999 109.855 -175.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 168.69 -142.4 7.38 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 108.745 -1.742 . . . . 0.91000000000000003 108.745 172.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.4 p -123.97 153.0 29.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 C-N-CA 124.507 1.123 . . . . 1.22 109.949 -170.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -54.59 137.95 42.2 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.373 -0.531 . . . . 1.97 110.507 168.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -86.89 -146.45 10.23 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 109.716 -1.354 . . . . 2.3599999999999999 109.716 175.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -72.34 109.08 5.81 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.408 -1.701 . . . . 5.4100000000000001 106.408 172.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -6.17 72.56 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.347 1 C-N-CA 132.678 4.391 . . . . 3.6499999999999999 112.835 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 154.41 -45.74 0.55 Allowed Glycine 0 CA--C 1.523 0.534 0 CA-C-N 113.679 -1.601 . . . . 1.1599999999999999 111.381 -172.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.92 163.76 13.37 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.509 0.654 . . . . 2.73 111.576 177.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.456 HD12 HD12 ' A' ' 92' ' ' ILE . 11.8 mt -123.11 130.27 52.56 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.627 1.171 . . . . 1.9199999999999999 108.387 176.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -103.75 106.24 16.69 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 108.38 -0.97 . . . . 0.75 108.38 176.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -131.86 126.14 33.51 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 123.075 0.55 . . . . 1.1799999999999999 110.95 -176.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.9 t -113.67 -24.41 9.21 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.407 1.083 . . . . 1.1699999999999999 111.367 178.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 113' ' ' GLN . 36.7 mt-10 -86.62 78.79 9.09 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 119.662 -1.898 . . . . 3.4300000000000002 108.141 178.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.427 ' C ' HD13 ' A' ' 128' ' ' LEU . 34.0 m -91.9 130.88 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 119.333 0.97 . . . . 0.85999999999999999 110.959 174.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.427 HD13 ' C ' ' A' ' 127' ' ' VAL . 0.0 OUTLIER -126.37 127.67 45.86 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.213 -1.032 . . . . 1.2 108.213 178.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.14 97.41 9.18 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.236 1.414 . . . . 1.3100000000000001 108.972 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.1 pttt -93.5 23.9 4.31 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.456 0.702 . . . . 3.8100000000000001 112.096 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -129.16 105.51 8.21 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.262 1.425 . . . . 4.4100000000000001 107.272 173.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 N--CA 1.456 -0.145 0 C-N-CA 123.719 0.808 . . . . 5.8700000000000001 109.895 174.049 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.8 p . . . . . 0 CA--C 1.531 0.238 0 N-CA-C 109.774 -0.454 . . . . 8.5 109.774 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -90.12 134.22 34.4 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 108.407 -0.96 . . . . 8.1899999999999995 108.407 173.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.38 -52.72 0.31 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.715 0.406 . . . . 7.8399999999999999 110.588 -177.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -158.73 136.83 10.59 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.294 -0.86 . . . . 3.9399999999999999 109.966 171.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.04 155.93 42.05 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 120.545 1.52 . . . . 2.1699999999999999 112.438 -175.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -86.19 117.73 25.2 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 125.374 1.47 . . . . 2.21 111.436 -174.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -116.89 151.64 36.16 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 127.207 2.203 . . . . 3.4100000000000001 109.519 -175.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 57.8 m -90.54 136.43 28.18 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.27 1.428 . . . . 1.8400000000000001 109.611 -175.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -61.98 -48.32 8.74 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.025 2.483 . . . . 0.73999999999999999 112.879 -174.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 p -53.75 -36.06 61.94 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 118.973 0.806 . . . . 1.96 111.948 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -54.74 -57.67 10.6 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.316 1.046 . . . . 2.4199999999999999 109.098 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.306 8.3 pt -70.0 1.68 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 114.352 1.242 . . . . 1.1899999999999999 114.352 -172.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.4 t -85.64 -28.73 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.8 1.24 . . . . 2.1099999999999999 111.09 170.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -128.57 93.54 3.66 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.964 -1.085 . . . . 2.2000000000000002 112.344 -160.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.45 37.75 53.15 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.516 -1.034 . . . . 1.3300000000000001 110.516 176.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.4 -153.87 0.5 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.786 2.834 . . . . 2.6600000000000001 103.371 178.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.2 m -28.97 -58.16 0.14 Allowed 'General case' 0 C--N 1.339 0.118 0 C-N-CA 126.905 2.082 . . . . 1.3500000000000001 115.444 -172.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -44.48 -47.84 10.05 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.586 0.754 . . . . 2.5800000000000001 112.272 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.6 m -93.51 -23.59 18.3 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.757 0.823 . . . . 1.3600000000000001 111.409 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.95 35.6 84.7 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.984 1.278 . . . . 0.98999999999999999 112.381 176.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.7 m -82.08 -39.45 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 117.525 0.662 . . . . 1.25 111.816 -175.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -105.81 -63.03 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 124.482 1.113 . . . . 4.0999999999999996 111.116 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -80.93 142.16 13.71 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 CA-C-N 121.07 1.418 . . . . 1.2 109.369 171.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -90.53 154.35 19.69 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.279 1.031 . . . . 2.8500000000000001 109.484 167.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.58 140.73 49.93 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.114 -1.069 . . . . 1.53 108.114 169.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 105.51 16.84 14.8 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.073 0.844 . . . . 1.23 113.36 -176.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -112.73 154.38 26.25 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 124.746 1.219 . . . . 1.3999999999999999 109.785 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.41 ' NH1' ' OE2' ' A' ' 126' ' ' GLU . 0.3 OUTLIER -84.84 127.45 34.15 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.868 0.867 . . . . 4.5499999999999998 109.085 173.11 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.9 pt -144.52 177.78 1.85 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 106.554 -1.647 . . . . 0.70999999999999996 106.554 166.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.3 mtm180 -122.77 122.67 39.28 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.754 -1.202 . . . . 2.2599999999999998 107.754 173.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.1 p -87.75 132.98 31.6 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 N-CA-C 107.282 -1.377 . . . . 0.94999999999999996 107.282 173.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -135.75 120.63 2.31 Favored Glycine 0 C--N 1.334 0.421 0 N-CA-C 109.89 -1.284 . . . . 0.70999999999999996 109.89 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.39 -166.32 31.55 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.314 -1.115 . . . . 0.81999999999999995 110.314 -175.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.16 130.83 51.91 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.168 0.508 . . . . 2.9900000000000002 111.462 -174.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.6 t -76.29 130.65 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 124.267 1.027 . . . . 2.1699999999999999 108.527 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.621 HG22 HG12 ' A' ' 68' ' ' VAL . 12.6 m -49.27 -85.43 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.294 1.838 . . . . 2.9100000000000001 114.581 -170.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.621 HG12 HG22 ' A' ' 67' ' ' THR . 9.1 p 174.45 -40.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 126.093 1.757 . . . . 2.0899999999999999 109.276 -171.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -151.8 38.2 0.81 Allowed Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.214 -1.155 . . . . 1.8100000000000001 110.214 175.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 57.1 m -94.74 -8.61 37.16 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 117.923 0.861 . . . . 1.03 112.221 178.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 52.8 tpp -65.52 128.89 37.75 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.794 -0.817 . . . . 2.5800000000000001 108.794 172.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.5 m -127.43 141.79 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 N-CA-C 107.425 -1.324 . . . . 0.62 107.425 164.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.76 135.13 48.77 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.43 -0.952 . . . . 4.79 108.43 -172.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -82.27 152.4 67.67 Favored Pre-proline 0 C--O 1.235 0.298 0 N-CA-C 109.851 -0.426 . . . . 2.1099999999999999 109.851 -176.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -70.97 3.87 3.07 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.114 2.543 . . . . 1.49 112.346 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -70.81 -33.65 70.93 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.503 -0.554 . . . . 1.27 109.503 168.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.1 m 73.63 9.51 4.93 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.405 1.482 . . . . 1.2 113.452 -173.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.27 16.56 9.08 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.583 1.553 . . . . 1.7 111.323 172.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -143.79 125.96 15.54 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.178 -1.045 . . . . 1.23 108.178 -177.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.08 140.16 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.993 1.317 . . . . 1.05 107.712 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -140.32 153.82 46.57 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.879 -0.513 . . . . 0.94999999999999996 109.813 172.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -153.27 146.19 24.47 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.43 -0.35 . . . . 2.0 110.808 -170.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.3 125.66 39.08 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.382 -0.599 . . . . 0.67000000000000004 109.382 175.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.3 t -106.65 132.72 53.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 107.063 -1.458 . . . . 1.78 107.063 176.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -115.53 -178.28 3.35 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.236 0.614 . . . . 1.8799999999999999 111.329 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -128.79 172.53 11.19 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 124.101 0.96 . . . . 3.5800000000000001 110.98 177.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 59.5 m -47.32 -43.87 23.12 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.64 1.176 . . . . 3.7799999999999998 110.869 156.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.9 mt -74.41 10.15 1.42 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.229 0.826 . . . . 4.6600000000000001 113.229 175.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.94 -49.65 3.76 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 120.002 1.274 . . . . 4.4699999999999998 112.025 172.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -44.41 119.7 3.09 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 125.531 1.539 . . . . 1.6599999999999999 110.658 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -115.75 150.5 36.78 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.237 1.015 . . . . 2.7999999999999998 110.413 -174.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.49 152.95 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 107.967 -1.123 . . . . 0.94999999999999996 107.967 178.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.0 mt -100.58 121.77 42.15 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.312 -0.996 . . . . 0.52000000000000002 108.312 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.7 t -107.09 133.34 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 107.437 -1.32 . . . . 0.85999999999999999 107.437 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 82.2 p -107.46 149.49 27.88 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.531 -0.915 . . . . 0.56999999999999995 108.531 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.548 ' CD2' HD21 ' A' ' 100' ' ' LEU . 11.2 t80 -146.65 126.9 13.87 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.026 -1.101 . . . . 2.4399999999999999 108.026 -173.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -113.85 46.62 1.29 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.003 1.321 . . . . 2.0600000000000001 111.745 -165.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -166.75 -179.64 4.9 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.847 2.059 . . . . 3.3599999999999999 106.286 169.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.4 mp -67.68 131.38 45.47 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.399 1.0 . . . . 1.8700000000000001 111.145 172.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.548 HD21 ' CD2' ' A' ' 96' ' ' TYR . 16.2 mt -83.55 155.29 65.8 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.485 1.114 . . . . 1.6299999999999999 110.579 174.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.62 112.44 2.4 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.954 2.436 . . . . 2.8500000000000001 109.538 175.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 39.74 47.7 1.81 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.011 1.724 . . . . 5.8300000000000001 111.504 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 48.76 13.52 0.06 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 127.782 2.433 . . . . 3.3799999999999999 116.374 -178.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 51.49 114.29 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 122.226 1.012 . . . . 4.6399999999999997 109.987 -148.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -74.16 100.63 3.71 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 104.837 -2.282 . . . . 5.25 104.837 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -71.94 157.55 37.63 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 119.776 -0.77 . . . . 5.0800000000000001 110.965 -148.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.09 37.87 6.6 Favored Glycine 0 CA--C 1.531 1.09 0 N-CA-C 110.608 -0.997 . . . . 0.89000000000000001 110.608 -167.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -138.2 162.21 34.85 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.773 1.229 . . . . 2.6600000000000001 108.896 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -102.3 129.79 10.01 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 110.476 -1.05 . . . . 0.85999999999999999 110.476 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.5 pp -140.56 161.22 24.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 108.208 -1.034 . . . . 0.87 108.208 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.3 m -114.45 141.66 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.091 -1.078 . . . . 1.0800000000000001 108.091 174.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -127.34 116.9 21.21 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.602 1.161 . . . . 0.77000000000000002 108.7 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -101.12 149.38 24.02 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.135 -0.691 . . . . 3.8799999999999999 109.135 175.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 162.11 -140.84 6.83 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 107.451 -2.26 . . . . 0.82999999999999996 107.451 173.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.5 p -136.04 142.94 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 118.084 0.942 . . . . 0.76000000000000001 109.996 -164.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.86 162.32 29.64 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.456 -0.793 . . . . 2.0299999999999998 109.99 173.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -169.73 -52.35 0.03 OUTLIER Glycine 0 C--N 1.332 0.351 0 C-N-CA 119.951 -1.119 . . . . 2.1899999999999999 111.726 166.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -67.0 141.25 57.65 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.55 -0.908 . . . . 4.3700000000000001 108.55 174.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.08 64.8 0.54 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 128.651 2.78 . . . . 4.46 110.299 -171.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 128.51 8.22 4.04 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.635 2.064 . . . . 1.1699999999999999 113.368 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.16 153.9 51.82 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.539 1.67 . . . . 2.3100000000000001 109.885 177.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.3 mp -121.69 134.7 54.96 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.348 1.059 . . . . 2.0499999999999998 109.714 -166.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.68 101.3 12.15 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.388 -1.338 . . . . 0.52000000000000002 107.388 177.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -127.52 83.27 2.15 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 112.211 0.449 . . . . 1.72 112.211 -166.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.485 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 14.6 t -83.01 -22.25 33.66 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.959 0.726 . . . . 0.84999999999999998 112.959 -174.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.41 ' OE2' ' NH1' ' A' ' 59' ' ' ARG . 20.6 mt-10 -83.5 75.11 10.04 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 120.445 -1.409 . . . . 4.4800000000000004 107.981 -176.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.0 m -92.33 131.16 40.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 O-C-N 121.527 -0.733 . . . . 1.1399999999999999 111.534 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.28 124.33 44.35 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.031 -1.47 . . . . 1.02 107.031 176.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -94.31 124.8 38.56 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.258 -1.016 . . . . 2.3900000000000001 108.258 175.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -153.56 58.14 0.75 Allowed 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.594 0.758 . . . . 4.2300000000000004 109.92 -176.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -105.78 90.48 3.4 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.229 1.412 . . . . 6.7199999999999998 107.932 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.4 t70 . . . . . 0 CA--C 1.535 0.378 0 C-N-CA 124.392 1.077 . . . . 7.46 110.788 179.088 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.0 m . . . . . 0 CA--C 1.534 0.361 0 CA-C-O 120.871 0.367 . . . . 8.0500000000000007 111.984 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -56.04 123.53 14.72 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 108.873 -0.788 . . . . 8.0500000000000007 108.873 169.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.7 mp -67.49 143.94 55.94 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.694 -0.854 . . . . 5.6399999999999997 108.694 168.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -151.88 109.88 3.69 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 106.998 -1.482 . . . . 4.1399999999999997 106.998 -175.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -144.43 162.34 36.74 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.434 1.016 . . . . 2.21 111.361 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.435 ' CE1' ' HD2' ' A' ' 61' ' ' ARG . 80.0 m-85 -83.83 123.15 29.61 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 125.106 1.362 . . . . 2.2400000000000002 110.954 -175.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.03 156.03 43.39 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.393 1.477 . . . . 2.9199999999999999 110.954 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.3 139.58 52.25 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 123.125 0.57 . . . . 2.48 111.311 -175.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.38 -35.0 99.18 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.63 2.22 . . . . 0.82999999999999996 113.45 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -57.19 -29.31 63.58 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 119.988 1.267 . . . . 3.02 112.056 176.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -67.55 -56.98 7.33 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.244 -1.021 . . . . 2.3199999999999998 108.244 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.0 pt -74.17 36.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.025 1.33 . . . . 1.1399999999999999 113.175 -174.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 43.1 t -123.38 -68.68 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 105.757 -1.942 . . . . 2.04 105.757 168.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -79.0 102.5 8.37 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.266 1.826 . . . . 2.2599999999999998 110.728 -164.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.9 32.89 74.01 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.408 -1.077 . . . . 1.5700000000000001 110.408 177.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -140.32 -110.83 0.15 Allowed 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 126.44 1.896 . . . . 2.75 108.341 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.44 HG23 HD12 ' A' ' 116' ' ' LEU . 29.6 m -73.83 -56.68 4.67 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 119.147 0.885 . . . . 1.53 112.177 -172.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -58.55 -46.89 85.91 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 122.135 0.969 . . . . 2.8500000000000001 109.068 -174.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -68.16 -35.9 78.79 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.8 -0.637 . . . . 1.3999999999999999 112.345 173.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.29 47.68 42.63 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.977 1.275 . . . . 1.3799999999999999 111.882 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.251 32.6 m -112.89 -70.39 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 N-CA-C 113.984 1.105 . . . . 1.6499999999999999 113.984 -174.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.7 mttt -73.14 -62.22 1.31 Allowed Pre-proline 0 CA--C 1.535 0.403 0 O-C-N 121.4 -0.813 . . . . 4.8399999999999999 112.101 -172.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.36 111.65 2.64 Favored 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 121.867 1.711 . . . . 1.1000000000000001 107.684 175.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -62.03 148.68 43.24 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.101 -0.703 . . . . 3.2599999999999998 109.101 172.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.61 162.68 10.15 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.842 -0.617 . . . . 1.21 110.409 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.91 14.37 82.24 Favored Glycine 0 CA--C 1.534 1.239 0 CA-C-O 119.672 -0.516 . . . . 1.02 113.387 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -93.75 158.94 15.42 Favored 'General case' 0 C--O 1.23 0.074 0 CA-C-N 118.284 1.042 . . . . 1.46 109.433 172.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -98.38 135.37 40.07 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.448 0.699 . . . . 4.9100000000000001 110.425 174.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 43.2 pt -150.53 178.47 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 125.821 1.649 . . . . 0.72999999999999998 106.798 174.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.435 ' HD2' ' CE1' ' A' ' 37' ' ' PHE . 13.5 mtt180 -123.52 131.96 53.78 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.682 -1.229 . . . . 1.8899999999999999 107.682 165.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.2 p -92.07 140.75 15.62 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.08 0 N-CA-C 107.359 -1.348 . . . . 0.93000000000000005 107.359 171.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.19 124.37 2.41 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.002 -1.239 . . . . 0.62 110.002 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -169.3 -163.53 23.49 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 108.622 -1.791 . . . . 0.69999999999999996 108.622 -175.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.71 139.43 38.97 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 117.358 0.579 . . . . 2.8500000000000001 109.585 -178.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.5 m -94.24 148.98 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 110.229 -0.286 . . . . 2.3900000000000001 110.229 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.9 m -84.61 146.34 27.55 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.255 1.022 . . . . 2.3100000000000001 109.17 175.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.1 p -49.74 -57.43 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.489 1.516 . . . . 2.0600000000000001 111.44 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.75 71.96 0.49 Allowed Glycine 0 CA--C 1.522 0.521 0 N-CA-C 109.386 -1.486 . . . . 1.5700000000000001 109.386 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.6 m -153.01 48.38 0.71 Allowed 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 117.738 0.769 . . . . 2.3999999999999999 111.936 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.1 ttp -141.08 132.7 27.13 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.589 -1.634 . . . . 2.3799999999999999 106.589 168.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.7 m -135.51 144.28 34.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 107.334 -1.358 . . . . 0.78000000000000003 107.334 173.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -127.46 149.92 49.89 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 123.974 0.91 . . . . 4.2800000000000002 110.541 -174.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.59 154.25 83.61 Favored Pre-proline 0 N--CA 1.451 -0.403 0 N-CA-C 109.93 -0.396 . . . . 2.9399999999999999 109.93 175.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -65.32 -24.03 58.27 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.445 2.097 . . . . 1.48 111.601 167.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -47.56 -28.81 2.45 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.509 0.724 . . . . 1.6599999999999999 110.735 165.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.3 m 64.84 25.98 12.89 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 125.081 1.352 . . . . 1.1599999999999999 111.472 175.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.24 -46.23 1.36 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.758 2.423 . . . . 1.8600000000000001 111.127 176.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -83.29 136.35 34.41 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.628 -0.879 . . . . 1.3700000000000001 108.628 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.653 HG21 ' HG ' ' A' ' 100' ' ' LEU . 19.7 m -147.25 143.54 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 107.068 -1.456 . . . . 0.77000000000000002 107.068 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -144.05 154.62 43.43 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.22 -0.659 . . . . 0.88 109.22 176.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -148.35 151.62 35.65 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.761 -0.654 . . . . 1.8500000000000001 109.887 -173.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.81 142.01 30.88 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.049 -1.093 . . . . 0.72999999999999998 108.049 171.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.0 p -130.38 149.59 33.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 107.112 -1.44 . . . . 1.8899999999999999 107.112 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -130.46 167.22 18.98 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.4 0.619 . . . . 1.55 109.546 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -96.94 177.47 5.6 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.779 -1.1 . . . . 3.6800000000000002 109.028 -177.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 68.5 m -59.32 -38.86 81.36 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.895 -0.78 . . . . 4.1500000000000004 108.895 163.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.5 mp -93.74 -87.72 0.24 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 109.74 -0.467 . . . . 4.3899999999999997 109.74 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -113.86 -89.74 1.75 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.525 -1.03 . . . . 3.9399999999999999 110.525 -177.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.18 -76.16 0.34 Allowed Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.14 -0.784 . . . . 3.1299999999999999 111.14 -172.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 35.64 58.05 0.89 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.298 1.839 . . . . 4.25 111.317 -176.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -112.24 157.06 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 124.464 1.106 . . . . 1.5 109.087 -169.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.3 mt -118.44 125.6 50.3 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.832 0.853 . . . . 0.67000000000000004 109.49 -173.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 75.7 t -114.26 133.28 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.791 1.236 . . . . 0.91000000000000003 107.954 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 61.3 p -108.79 155.47 20.74 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.497 1.119 . . . . 0.45000000000000001 110.204 178.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.643 ' HB3' HG23 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -153.48 136.85 15.79 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.504 -1.295 . . . . 1.97 107.504 -174.431 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.8 p-10 -128.94 49.87 2.19 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.564 1.545 . . . . 2.2200000000000002 112.57 -172.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -171.72 52.43 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.982 0.913 . . . . 2.9900000000000002 111.533 178.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.9 mp 52.69 -147.41 0.47 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.877 1.271 . . . . 2.0099999999999998 110.417 -172.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.653 ' HG ' HG21 ' A' ' 80' ' ' VAL . 13.7 mt -150.28 158.16 36.52 Favored Pre-proline 0 N--CA 1.454 -0.226 0 N-CA-C 105.811 -1.922 . . . . 1.47 105.811 -176.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -71.27 -94.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.433 2.755 . . . . 2.0 107.923 172.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -77.4 38.17 0.23 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.554 1.142 . . . . 3.7799999999999998 110.306 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 19.8 tp 52.37 23.19 2.34 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.825 -1.172 . . . . 2.8599999999999999 112.716 -177.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 76.9 t80 53.9 84.05 0.07 Allowed 'General case' 0 N--CA 1.465 0.283 0 O-C-N 120.618 -1.301 . . . . 2.8700000000000001 109.076 -171.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.3 mmm180 -75.86 123.14 25.18 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.94 -1.133 . . . . 5.3799999999999999 107.94 -171.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -84.17 156.26 22.16 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 126.046 1.739 . . . . 3.6800000000000002 110.482 -169.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.49 33.3 43.85 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 123.757 0.694 . . . . 0.97999999999999998 112.267 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -156.08 178.9 9.75 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.802 1.241 . . . . 2.9900000000000002 108.138 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -85.43 147.64 22.41 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.685 -0.966 . . . . 0.83999999999999997 110.685 166.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.9 pp -140.23 162.5 24.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 105.618 -1.993 . . . . 0.70999999999999996 105.618 166.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.3 m -125.0 135.27 64.62 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.132 0 N-CA-C 109.055 -0.72 . . . . 0.80000000000000004 109.055 173.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -122.84 125.73 45.98 Favored 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 124.842 1.257 . . . . 0.56999999999999995 109.919 -170.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -115.83 143.58 45.21 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.958 1.303 . . . . 3.8900000000000001 110.126 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 168.79 -131.4 2.29 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 107.576 -2.21 . . . . 0.92000000000000004 107.576 173.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.8 p -128.17 150.03 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 124.701 1.2 . . . . 1.03 109.752 -171.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.44 HD12 HG23 ' A' ' 48' ' ' THR . 4.1 mm? -55.89 143.44 31.65 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.161 -0.681 . . . . 1.98 109.161 170.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.69 -150.62 10.6 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.208 -1.157 . . . . 2.3599999999999999 110.208 -178.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -63.14 -67.15 0.45 Allowed 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.264 0.625 . . . . 5.2999999999999998 110.021 -174.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -166.45 98.62 0.59 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.759 -1.571 . . . . 3.7000000000000002 106.759 -178.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 109.59 -41.27 2.28 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.378 0.99 . . . . 1.1499999999999999 111.199 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -82.79 161.73 21.91 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.252 1.021 . . . . 2.8500000000000001 110.662 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 mp -128.56 140.05 51.99 Favored 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 124.25 1.02 . . . . 2.25 108.3 174.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -107.9 108.96 20.35 Favored 'General case' 0 CA--C 1.527 0.083 0 N-CA-C 107.924 -1.139 . . . . 0.83999999999999997 107.924 178.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -134.82 109.33 8.46 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.274 0.488 . . . . 1.3200000000000001 111.705 -171.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.7 t -96.66 -34.24 11.46 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.957 0.903 . . . . 0.92000000000000004 111.656 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.3 mp0 -83.45 89.96 7.13 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 119.863 -1.773 . . . . 3.46 108.168 175.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.4 m -96.89 124.68 49.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 123.446 0.698 . . . . 0.78000000000000003 109.743 171.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -115.68 110.71 19.53 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.02 1.328 . . . . 0.71999999999999997 107.797 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.47 61.4 6.57 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.121 0.968 . . . . 1.28 110.62 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -22.72 67.05 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.712 1.004 . . . . 2.7400000000000002 113.712 -173.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -105.9 57.34 0.66 Allowed 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.846 0.858 . . . . 5.5800000000000001 110.113 -177.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.0 t0 . . . . . 0 N--CA 1.449 -0.486 0 N-CA-C 108.06 -1.089 . . . . 7.3799999999999999 108.06 174.621 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 CA--C 1.53 0.207 0 N-CA-C 108.653 -0.869 . . . . 6.3200000000000003 108.653 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 -128.2 129.45 46.48 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 125.241 1.416 . . . . 7.9699999999999998 107.506 169.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -72.95 -40.36 65.44 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 122.72 0.408 . . . . 8.1300000000000008 111.18 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -159.47 156.0 27.51 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.026 1.73 . . . . 4.1799999999999997 107.215 176.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -163.96 149.67 10.96 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.396 1.078 . . . . 2.7000000000000002 108.924 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -88.7 131.79 34.87 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.696 0.798 . . . . 2.04 109.619 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -138.34 155.77 48.25 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.003 1.321 . . . . 2.6299999999999999 110.833 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.2 m -80.57 131.16 62.04 Favored Pre-proline 0 N--CA 1.447 -0.621 0 C-N-CA 125.53 1.532 . . . . 1.77 111.048 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -57.02 -46.47 28.77 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 123.026 2.484 . . . . 0.68000000000000005 112.328 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.7 t -54.41 -32.86 58.2 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 122.865 0.466 . . . . 2.4700000000000002 111.419 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.27 -58.5 8.23 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.55 -0.908 . . . . 3.0899999999999999 108.55 172.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.259 30.7 pt -73.19 28.8 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 114.017 1.118 . . . . 1.1699999999999999 114.017 -172.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -118.62 -27.53 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.508 1.123 . . . . 2.1499999999999999 111.986 160.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 -83.95 -68.62 0.7 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.599 1.09 . . . . 2.4700000000000002 112.389 -163.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.02 54.25 0.59 Allowed Glycine 0 C--N 1.333 0.408 0 N-CA-C 108.668 -1.773 . . . . 1.5700000000000001 108.668 -174.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -148.98 -109.64 0.07 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.641 1.976 . . . . 2.9700000000000002 107.082 -167.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.448 HG23 ' CD2' ' A' ' 116' ' ' LEU . 41.0 m -67.59 -65.44 0.69 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.542 1.137 . . . . 1.3999999999999999 111.587 -173.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -49.59 -51.07 39.81 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.816 0.817 . . . . 2.5699999999999998 110.444 -172.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.79 -24.09 61.68 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.141 1.376 . . . . 1.6000000000000001 112.661 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.1 39.81 97.64 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.463 1.506 . . . . 1.3400000000000001 112.786 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.8 m -97.96 -35.32 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 117.986 0.893 . . . . 1.75 113.054 -172.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -107.41 -68.15 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.397 0 CA-C-O 117.981 -1.009 . . . . 3.4500000000000002 112.104 177.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -77.05 131.12 11.74 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 121.606 1.538 . . . . 1.2 108.77 175.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -76.4 157.35 32.38 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.766 -0.827 . . . . 3.02 108.766 169.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.02 170.22 4.6 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.93 0.492 . . . . 1.53 109.71 170.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.86 40.54 98.47 Favored Glycine 0 CA--C 1.531 1.081 0 O-C-N 121.63 -0.669 . . . . 1.6299999999999999 112.046 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -127.2 156.7 41.42 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 107.916 -1.142 . . . . 1.47 107.916 169.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -96.71 128.47 43.69 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.002 0.921 . . . . 4.6100000000000003 108.992 176.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.2 pt -137.17 168.23 21.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 108.32 -0.993 . . . . 0.77000000000000002 108.32 173.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 31.2 mtm180 -117.59 111.07 18.7 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.13 -1.063 . . . . 2.6800000000000002 108.13 173.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.7 p -78.87 130.14 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.812 -1.551 . . . . 0.80000000000000004 106.812 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.55 125.33 2.98 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 109.629 -1.389 . . . . 0.53000000000000003 109.629 -177.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.96 -155.4 17.09 Favored Glycine 0 C--N 1.334 0.423 0 N-CA-C 108.535 -1.826 . . . . 0.68000000000000005 108.535 -176.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -97.61 134.38 40.9 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.48 0.657 . . . . 2.73 109.705 177.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.431 HG22 ' H ' ' A' ' 108' ' ' GLN . 9.4 m -68.95 159.79 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.964 -1.124 . . . . 2.4199999999999999 107.964 172.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.2 m -74.03 -116.85 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 109.188 -0.671 . . . . 2.5499999999999998 109.188 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.1 p -156.99 -59.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 O-C-N 120.49 -1.381 . . . . 2.3500000000000001 109.418 -175.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.66 -11.05 56.06 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 121.943 -0.473 . . . . 2.2599999999999998 112.591 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.1 m -67.37 -20.91 65.62 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 114.14 1.163 . . . . 1.21 114.14 -165.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 6.6 tpt -71.39 94.6 1.25 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.655 0.782 . . . . 1.9199999999999999 109.814 -176.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.6 m -102.31 130.44 52.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 107.364 -1.347 . . . . 0.57999999999999996 107.364 174.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -126.44 141.48 51.87 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.506 1.122 . . . . 6.0999999999999996 108.323 -173.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.99 143.82 31.88 Favored Pre-proline 0 C--O 1.234 0.244 0 N-CA-C 110.34 -0.244 . . . . 2.6699999999999999 110.34 -176.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -60.16 -27.16 84.32 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.125 2.55 . . . . 2.3900000000000001 110.846 175.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -42.94 -40.63 3.05 Favored 'General case' 0 C--O 1.226 -0.151 0 C-N-CA 125.678 1.591 . . . . 2.6200000000000001 110.013 172.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.4 m 78.31 12.04 1.71 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.963 1.705 . . . . 1.71 112.861 177.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.69 31.53 5.31 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.888 0.875 . . . . 2.9199999999999999 112.382 165.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -150.24 131.82 14.85 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 122.05 -0.406 . . . . 1.22 110.545 175.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.59 131.26 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 125.14 1.376 . . . . 1.0 108.714 -177.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -137.9 144.08 41.16 Favored 'General case' 0 C--N 1.34 0.183 0 O-C-N 120.536 -1.352 . . . . 0.91000000000000003 110.745 172.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -139.35 160.22 40.34 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.392 0.677 . . . . 1.97 109.854 -175.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.67 127.61 54.12 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.529 -1.285 . . . . 0.60999999999999999 107.529 170.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.6 p -116.02 146.55 20.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.314 -0.995 . . . . 1.8300000000000001 108.314 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -142.88 -178.5 5.84 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.217 1.007 . . . . 1.3600000000000001 109.661 -173.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -124.98 10.27 8.2 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.581 0.705 . . . . 2.6899999999999999 111.734 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.0 t 53.71 27.02 6.41 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.296 1.038 . . . . 4.0800000000000001 112.481 -173.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.3 mp -98.38 -78.12 0.5 Allowed 'General case' 0 C--N 1.34 0.179 0 N-CA-C 108.23 -1.026 . . . . 4.7400000000000002 108.23 166.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -173.81 75.89 0.08 OUTLIER Glycine 0 C--N 1.334 0.428 0 N-CA-C 108.727 -1.749 . . . . 2.9900000000000002 108.727 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 159.78 129.72 1.07 Allowed Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 110.597 -1.001 . . . . 1.46 110.597 175.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -120.78 133.13 55.34 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.178 -1.786 . . . . 4.7699999999999996 106.178 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -123.4 138.51 53.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 108.051 -1.092 . . . . 1.45 108.051 -176.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.8 mt -89.8 124.44 34.66 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.954 0.902 . . . . 0.70999999999999996 110.294 -176.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.0 t -109.0 118.46 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 126.216 1.806 . . . . 0.82999999999999996 107.045 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.4 p -99.54 140.06 34.27 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.723 -0.843 . . . . 0.55000000000000004 108.723 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -141.71 139.61 32.96 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 107.849 -1.167 . . . . 2.2999999999999998 107.849 -173.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -81.79 -91.01 0.07 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.98 0.912 . . . . 3.6200000000000001 110.692 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -55.15 168.74 0.3 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.646 1.179 . . . . 3.9199999999999999 113.237 -171.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 mt -57.7 116.34 3.36 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 120.197 -1.564 . . . . 2.2599999999999998 110.95 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.0 mt -54.97 145.74 41.89 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 123.511 0.724 . . . . 1.4099999999999999 109.839 170.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -62.32 143.3 93.65 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.598 2.199 . . . . 2.5499999999999998 109.692 177.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 47.16 40.39 9.92 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.955 1.302 . . . . 2.7999999999999998 111.285 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 56.05 4.75 0.14 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 128.277 2.631 . . . . 2.0499999999999998 115.466 -175.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 57.0 t80 58.37 101.99 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.251 1.02 . . . . 2.9500000000000002 109.089 -155.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -78.09 150.94 33.64 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.89 -1.152 . . . . 4.0899999999999999 107.89 168.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -91.96 165.63 13.11 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 125.867 1.667 . . . . 3.3300000000000001 109.595 -175.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 42.15 48.86 5.47 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.153 1.358 . . . . 0.79000000000000004 114.408 -177.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.431 ' H ' HG22 ' A' ' 66' ' ' VAL . 1.3 pp0? -155.7 87.81 1.1 Allowed 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.83 1.252 . . . . 2.5699999999999998 107.632 -178.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -49.08 135.77 21.41 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 123.459 0.552 . . . . 0.68999999999999995 113.857 -169.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.3 pp -139.23 168.04 19.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 124.731 1.212 . . . . 0.92000000000000004 108.69 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 15.7 m -110.6 137.76 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.271 -1.011 . . . . 0.71999999999999997 108.271 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.456 ' CB ' HG12 ' A' ' 127' ' ' VAL . . . -125.04 122.17 36.49 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.525 1.13 . . . . 0.64000000000000001 109.333 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -99.35 127.4 45.36 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.018 -1.104 . . . . 3.2999999999999998 108.018 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -159.79 169.19 35.73 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.197 -0.525 . . . . 1.6399999999999999 112.36 -173.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.1 p -108.38 139.35 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 C-N-CA 124.439 1.096 . . . . 0.84999999999999998 108.184 177.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.448 ' CD2' HG23 ' A' ' 48' ' ' THR . 3.9 mp -68.43 118.29 11.31 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.55 -0.907 . . . . 2.6600000000000001 108.55 174.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.34 -91.65 0.33 Allowed Glycine 0 C--N 1.335 0.524 0 O-C-N 124.054 0.847 . . . . 2.54 111.107 -171.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -82.0 -77.86 0.21 Allowed 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.395 -1.335 . . . . 6.1500000000000004 107.395 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -175.58 108.35 0.09 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.969 1.708 . . . . 3.6000000000000001 107.099 173.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 118.8 -41.71 1.95 Allowed Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.066 -1.214 . . . . 0.97999999999999998 110.066 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.69 131.63 34.93 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.485 0.714 . . . . 2.8100000000000001 110.628 -178.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -97.52 113.98 25.79 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.204 -1.036 . . . . 2.5899999999999999 108.204 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -88.58 102.58 15.08 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 107.246 -1.39 . . . . 0.63 107.246 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -122.0 132.29 54.44 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 123.922 0.889 . . . . 1.29 109.306 -175.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.8 t -125.7 -8.61 6.75 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.918 0.487 . . . . 1.27 112.236 172.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -111.41 74.54 0.87 Allowed 'General case' 0 CA--C 1.532 0.254 0 O-C-N 120.473 -1.392 . . . . 3.75 108.548 -174.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.456 HG12 ' CB ' ' A' ' 112' ' ' ALA . 35.8 m -87.58 150.93 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 118.279 0.491 . . . . 1.27 111.08 176.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.41 HD22 ' N ' ' A' ' 128' ' ' LEU . 0.2 OUTLIER -126.23 135.68 51.89 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 108.348 -0.982 . . . . 0.91000000000000003 108.348 171.525 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.3 122.95 34.36 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.765 -1.198 . . . . 2.5899999999999999 107.765 169.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -143.9 46.34 1.46 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.352 0.661 . . . . 3.1000000000000001 110.278 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -145.08 102.46 3.75 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.443 1.097 . . . . 4.9199999999999999 109.317 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 . . . . . 0 N--CA 1.448 -0.539 0 C-N-CA 126.32 1.848 . . . . 5.7000000000000002 109.019 173.308 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.5 m . . . . . 0 CA--C 1.536 0.42 0 CA-C-O 120.937 0.399 . . . . 9.2699999999999996 111.69 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.7 m-20 -105.46 77.16 1.26 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.429 1.091 . . . . 8.2100000000000009 109.133 -176.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.69 66.4 0.34 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.091 0.956 . . . . 6.8600000000000003 109.374 172.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -80.32 67.6 6.22 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.314 -0.866 . . . . 3.5800000000000001 110.587 -164.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.52 HD11 ' CD2' ' A' ' 38' ' ' TYR . 2.5 pp -134.27 161.41 35.02 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.029 1.732 . . . . 2.1699999999999999 109.477 -173.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -90.69 116.33 28.48 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 124.146 0.978 . . . . 2.1499999999999999 110.409 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.52 ' CD2' HD11 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -112.95 152.82 28.92 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.99 1.316 . . . . 2.7799999999999998 110.122 175.148 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.0 p -83.27 133.66 47.22 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 124.814 1.246 . . . . 1.6399999999999999 109.871 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.41 -40.71 72.54 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.882 2.388 . . . . 0.68999999999999995 112.236 -176.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.7 t -54.8 -29.38 54.33 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.265 0.468 . . . . 2.48 112.265 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.11 -56.46 11.38 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.751 -1.203 . . . . 3.02 107.751 175.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.8 pt -73.23 28.99 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 114.217 1.191 . . . . 1.0800000000000001 114.217 -174.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.9 t -109.56 -24.42 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 126.82 2.048 . . . . 1.9199999999999999 111.007 163.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -120.65 75.02 1.1 Allowed 'General case' 0 N--CA 1.456 -0.168 0 O-C-N 121.558 -0.714 . . . . 2.0699999999999998 111.197 -157.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.72 49.76 8.65 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 109.067 -1.613 . . . . 1.3999999999999999 109.067 174.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -146.55 -125.5 0.07 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.131 -1.804 . . . . 2.5800000000000001 106.131 -173.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.2 m -62.65 -43.0 99.92 Favored 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 119.408 1.004 . . . . 1.7 111.448 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -31.89 -72.51 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 126.655 1.982 . . . . 5.3499999999999996 112.809 172.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 45.7 m -89.23 -14.45 35.92 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.816 0.846 . . . . 1.8200000000000001 110.2 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.76 32.86 60.88 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.048 -0.821 . . . . 1.45 111.048 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.6 m -75.99 -36.24 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 117.702 0.751 . . . . 1.3200000000000001 111.418 -173.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt -113.88 -70.37 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 124.541 1.136 . . . . 3.4100000000000001 110.156 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.27 108.32 2.16 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 121.257 1.305 . . . . 1.3799999999999999 109.714 176.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.55 154.37 38.87 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.819 -0.808 . . . . 2.8399999999999999 108.819 169.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.98 164.1 13.36 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.188 -0.671 . . . . 1.27 109.188 169.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.42 30.69 39.94 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.252 -0.739 . . . . 1.5 111.252 -175.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -125.56 152.5 44.99 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.968 1.307 . . . . 1.48 108.458 173.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -97.51 121.24 39.18 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 108.25 -1.019 . . . . 4.8300000000000001 108.25 -176.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.5 pt -144.04 177.76 2.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 124.674 1.19 . . . . 0.73999999999999999 108.287 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -125.98 131.37 52.25 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.602 -0.888 . . . . 2.5699999999999998 108.602 175.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.5 p -94.73 124.5 47.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 107.014 -1.476 . . . . 0.98999999999999999 107.014 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.62 124.82 4.16 Favored Glycine 0 C--O 1.225 -0.437 0 N-CA-C 108.982 -1.647 . . . . 0.46999999999999997 108.982 178.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.39 -166.0 33.46 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 108.701 -1.76 . . . . 0.60999999999999999 108.701 -175.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.28 138.37 36.46 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.509 -0.552 . . . . 2.8500000000000001 109.509 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.544 HG11 ' HE1' ' A' ' 104' ' ' PHE . 32.6 t -98.77 108.22 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-O 121.239 0.542 . . . . 2.4199999999999999 110.087 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.2 m -39.15 132.75 1.32 Allowed 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 127.541 2.337 . . . . 2.4100000000000001 111.356 168.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.5 p -55.49 -62.8 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 123.656 0.782 . . . . 2.1800000000000002 110.731 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -83.27 68.5 3.54 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 109.951 -1.26 . . . . 2.1899999999999999 109.951 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.3 m -152.12 -33.64 0.14 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 114.858 1.429 . . . . 1.0700000000000001 114.858 -176.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.3 tpp -62.06 120.06 10.11 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 108.353 -0.98 . . . . 2.3399999999999999 108.353 170.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.2 m -122.35 133.94 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.341 -1.355 . . . . 0.69999999999999996 107.341 167.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.38 137.77 54.43 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.557 1.143 . . . . 5.9100000000000001 109.038 -173.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.62 143.33 50.76 Favored Pre-proline 0 N--CA 1.454 -0.244 0 N-CA-C 109.738 -0.468 . . . . 2.0099999999999998 109.738 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -59.85 -25.83 80.5 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.48 2.12 . . . . 1.5 110.787 170.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -40.98 -42.94 2.0 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 124.653 1.181 . . . . 1.54 110.668 168.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.6 m 84.41 -0.34 0.94 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.143 1.777 . . . . 1.1599999999999999 113.647 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.2 18.35 11.55 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.321 0.964 . . . . 2.6600000000000001 112.641 172.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -138.35 125.9 22.03 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.491 -1.3 . . . . 1.0700000000000001 107.491 174.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.51 HG23 ' HB3' ' A' ' 96' ' ' TYR . 27.6 m -145.19 144.48 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 106.62 -1.622 . . . . 0.68999999999999995 106.62 175.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -148.02 155.88 42.01 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 121.361 -0.837 . . . . 1.02 109.777 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -151.35 137.97 18.75 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.49 -0.323 . . . . 1.96 111.106 -171.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.29 138.3 33.62 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.212 -1.032 . . . . 0.48999999999999999 108.212 166.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.0 p -130.79 146.61 33.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 106.412 -1.699 . . . . 1.78 106.412 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -143.37 175.29 10.03 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.645 0.657 . . . . 1.6899999999999999 110.88 -174.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -142.54 -95.96 0.12 Allowed 'General case' 0 CA--C 1.531 0.222 0 O-C-N 123.465 0.478 . . . . 2.5099999999999998 111.537 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.5 t -86.4 66.6 9.6 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 120.721 -1.237 . . . . 5.5 110.215 -176.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -16.31 33.71 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.265 1 C-N-CA 133.949 4.9 . . . . 9.4700000000000006 119.898 -158.014 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.18 26.41 8.74 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 126.353 1.93 . . . . 3.1099999999999999 108.913 164.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -173.52 116.53 0.6 Allowed Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 109.903 -1.279 . . . . 1.6899999999999999 109.903 176.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -112.37 150.64 30.79 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.37 1.468 . . . . 3.1600000000000001 107.29 165.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -131.32 153.14 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 107.776 -1.194 . . . . 1.05 107.776 175.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.4 mt -110.18 115.14 29.19 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.794 0.838 . . . . 0.77000000000000002 109.036 -172.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.8 t -96.5 138.58 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 124.734 1.214 . . . . 0.89000000000000001 107.845 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 77.6 p -114.46 149.57 36.1 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.738 -0.838 . . . . 0.55000000000000004 108.738 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.513 ' CE2' ' HA ' ' A' ' 125' ' ' THR . 6.7 t80 -149.79 116.99 6.02 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.519 -0.919 . . . . 2.0499999999999998 108.519 -173.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -104.29 51.47 0.77 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.633 1.173 . . . . 2.1099999999999999 111.86 -170.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -168.16 -179.37 4.03 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.527 1.931 . . . . 3.02 107.14 170.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.0 mp -67.51 148.57 51.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 118.703 0.683 . . . . 1.5900000000000001 111.075 171.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.458 HD21 ' CD2' ' A' ' 96' ' ' TYR . 17.2 mt -101.81 152.24 38.09 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 125.093 1.357 . . . . 1.27 110.291 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -60.34 137.7 76.21 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 123.983 3.122 . . . . 2.0499999999999998 109.756 174.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 49.27 30.3 3.09 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.944 1.698 . . . . 3.02 112.495 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.0 tp 58.15 13.29 2.22 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.211 1.004 . . . . 3.4300000000000002 111.97 -175.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.544 ' HE1' HG11 ' A' ' 66' ' ' VAL . 17.3 t80 57.07 95.68 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.422 1.489 . . . . 2.8399999999999999 109.049 -172.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -76.15 124.9 28.18 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 105.47 -2.048 . . . . 7.54 105.47 -176.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -80.47 168.14 19.31 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.902 -0.499 . . . . 2.9700000000000002 110.187 -170.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.25 45.56 47.83 Favored Glycine 0 CA--C 1.528 0.906 0 O-C-N 121.505 -0.747 . . . . 0.93000000000000005 112.336 174.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -155.8 170.39 22.19 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.492 1.117 . . . . 2.2599999999999998 108.333 174.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.51 ' H ' ' CD2' ' A' ' 131' ' ' HIS . . . -90.9 130.33 10.22 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 111.188 -0.765 . . . . 0.67000000000000004 111.188 174.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.9 pp -137.94 158.4 33.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 107.01 -1.478 . . . . 0.68000000000000005 107.01 176.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.3 m -120.02 126.57 75.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 108.258 -1.016 . . . . 0.70999999999999996 108.258 175.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -117.44 127.09 53.68 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 124.403 1.081 . . . . 0.68999999999999995 109.929 -173.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -107.84 143.42 36.46 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.62 0.768 . . . . 4.46 110.333 -178.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 167.15 -142.46 7.58 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 110.057 -1.217 . . . . 0.98999999999999999 110.057 171.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.9 p -132.31 144.91 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-O 121.517 0.675 . . . . 1.02 110.477 -164.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.619 HD11 HD23 ' A' ' 122' ' ' LEU . 3.4 mp -87.35 153.9 21.1 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.678 -1.23 . . . . 2.71 107.678 176.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -159.47 -59.79 0.01 OUTLIER Glycine 0 C--N 1.334 0.43 0 C-N-CA 119.686 -1.245 . . . . 2.4500000000000002 111.646 177.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -60.41 142.74 54.61 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.809 -1.182 . . . . 4.4400000000000004 107.809 167.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -78.99 57.62 2.22 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.819 1.648 . . . . 4.1100000000000003 108.934 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 164.12 -32.38 0.26 Allowed Glycine 0 CA--C 1.53 0.979 0 CA-C-N 115.75 -0.659 . . . . 0.94999999999999996 113.02 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -113.14 157.22 21.93 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 118.181 0.99 . . . . 2.4900000000000002 109.642 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.619 HD23 HD11 ' A' ' 116' ' ' LEU . 4.2 mp -118.09 143.92 46.06 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.089 0.955 . . . . 1.95 108.517 -176.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -105.61 97.24 7.1 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.209 -1.404 . . . . 0.68000000000000005 107.209 175.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -106.16 143.92 33.59 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.719 -0.845 . . . . 1.0800000000000001 108.719 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.513 ' HA ' ' CE2' ' A' ' 96' ' ' TYR 0.254 12.1 t -129.36 -32.04 2.01 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.122 0.786 . . . . 1.04 113.122 174.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -84.96 84.8 7.59 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 120.713 -1.242 . . . . 3.1299999999999999 108.406 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.7 m -88.76 105.77 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 119.294 0.952 . . . . 0.84999999999999998 111.339 175.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -96.36 105.92 18.07 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.429 -0.952 . . . . 0.65000000000000002 108.429 175.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.79 52.19 1.67 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.356 1.062 . . . . 1.24 111.574 -177.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -79.19 72.6 5.77 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.751 -0.593 . . . . 3.2000000000000002 111.035 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.51 ' CD2' ' H ' ' A' ' 109' ' ' GLY . 11.0 t-80 -103.94 65.34 0.81 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.817 0.847 . . . . 4.9199999999999999 111.538 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 . . . . . 0 N--CA 1.451 -0.397 0 C-N-CA 124.337 1.055 . . . . 7.6900000000000004 109.384 175.405 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.8 t . . . . . 0 CA--C 1.535 0.376 0 N-CA-C 109.475 -0.565 . . . . 7.4699999999999998 109.475 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -90.06 130.48 36.23 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.62 -0.881 . . . . 7.75 108.62 176.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.26 -165.67 2.18 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.818 1.247 . . . . 6.2699999999999996 108.11 -173.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -79.59 86.93 5.18 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 108.373 -0.973 . . . . 3.46 108.373 -167.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.74 160.31 14.81 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 122.981 0.512 . . . . 1.9399999999999999 110.396 -177.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -84.76 119.49 25.35 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.071 -0.714 . . . . 2.2999999999999998 109.071 173.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.53 155.92 49.71 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.347 1.059 . . . . 2.77 109.944 -178.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.2 p -88.07 146.9 39.38 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-O 119.242 -0.409 . . . . 1.8899999999999999 110.728 -173.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -52.83 -50.82 12.73 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 123.399 2.733 . . . . 0.82999999999999996 110.371 173.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.7 m -48.13 -47.66 34.54 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 125.531 1.532 . . . . 2.5899999999999999 112.748 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.3 tp10 -57.54 -59.58 4.95 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.478 -0.934 . . . . 2.2999999999999998 108.478 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.267 32.4 pt -61.74 -16.5 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 114.504 1.298 . . . . 1.75 114.504 -170.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.47 -57.42 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 120.056 1.298 . . . . 2.0899999999999999 111.226 167.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -84.71 80.37 9.28 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.149 -0.97 . . . . 2.2200000000000002 112.098 -154.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.47 48.35 5.96 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 109.653 -1.379 . . . . 1.3999999999999999 109.653 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.56 -100.84 0.08 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 108.136 -1.061 . . . . 2.3999999999999999 108.136 -177.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 92.9 m -79.28 -60.8 2.23 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 126.187 1.795 . . . . 1.3700000000000001 111.043 -176.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.41 ' OD1' HD11 ' A' ' 92' ' ' ILE . 0.9 OUTLIER -54.43 -33.25 59.14 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.321 0.964 . . . . 4.1500000000000004 111.205 -178.537 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.28 -17.72 31.87 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.35 1.06 . . . . 1.51 112.379 178.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 52.7 43.18 59.67 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 126.158 1.837 . . . . 1.0900000000000001 112.936 -177.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.4 m -95.88 -43.06 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 118.301 1.051 . . . . 1.3200000000000001 112.817 -173.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -111.88 -71.09 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.25 0 C-N-CA 124.546 1.138 . . . . 3.3799999999999999 111.021 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -70.69 96.32 0.67 Allowed 'Trans proline' 0 N--CA 1.444 -1.397 0 N-CA-C 108.356 -1.44 . . . . 1.6899999999999999 108.356 172.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -49.51 162.65 0.14 Allowed 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.322 1.049 . . . . 4.1200000000000001 111.441 170.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.35 144.27 51.08 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.35 -0.981 . . . . 1.3100000000000001 108.35 169.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.85 21.91 67.45 Favored Glycine 0 CA--C 1.536 1.396 0 O-C-N 121.554 -0.716 . . . . 1.1599999999999999 113.261 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -89.62 148.55 23.28 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 118.42 1.11 . . . . 2.8199999999999998 108.117 170.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.97 113.84 26.06 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.474 1.11 . . . . 3.5899999999999999 108.249 -171.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.27 175.96 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 123.131 0.572 . . . . 1.5800000000000001 109.477 -177.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.1 mtm180 -111.27 112.15 23.72 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 108.84 -0.8 . . . . 3.3999999999999999 108.84 175.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.9 p -77.01 122.24 31.1 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.038 0 N-CA-C 106.944 -1.502 . . . . 1.03 106.944 172.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.09 120.66 2.97 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 108.537 -1.825 . . . . 0.64000000000000001 108.537 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.07 -160.02 22.78 Favored Glycine 0 CA--C 1.52 0.347 0 N-CA-C 108.92 -1.672 . . . . 0.68000000000000005 108.92 -174.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.6 ptp -112.7 136.29 52.45 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.229 0.612 . . . . 2.52 110.272 -176.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 83' ' ' ALA . 4.8 p -93.93 138.68 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 109.091 -0.707 . . . . 2.46 109.091 172.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.99 163.32 26.8 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.221 -1.029 . . . . 2.6099999999999999 108.221 168.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.6 p -58.78 -65.31 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 124.368 1.067 . . . . 2.21 110.763 173.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.25 59.44 4.33 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 121.545 -0.722 . . . . 2.0600000000000001 111.388 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.5 m -126.06 -41.95 1.9 Allowed 'General case' 0 C--N 1.334 -0.07 0 C-N-CA 124.744 1.218 . . . . 1.8700000000000001 111.449 -177.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -71.78 121.37 18.82 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.11 -0.7 . . . . 1.9399999999999999 109.11 -178.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.8 m -127.47 130.35 70.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 108.002 -1.111 . . . . 0.85999999999999999 108.002 170.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.5 ptt180 -109.49 147.26 33.19 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 124.072 0.949 . . . . 4.3099999999999996 110.73 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.46 151.89 95.53 Favored Pre-proline 0 N--CA 1.45 -0.44 0 N-CA-C 109.046 -0.724 . . . . 2.1800000000000002 109.046 174.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -61.67 -28.37 82.38 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.012 1.808 . . . . 1.79 110.946 166.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -44.88 -34.71 2.47 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.141 0.976 . . . . 1.3700000000000001 110.655 167.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.6 m 67.63 23.87 8.65 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.084 1.354 . . . . 2.2799999999999998 112.241 176.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.47 -42.37 2.23 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.848 2.059 . . . . 2.1000000000000001 111.788 172.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -90.8 138.94 31.2 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.624 -1.25 . . . . 1.3400000000000001 107.624 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.511 HG23 ' HB3' ' A' ' 96' ' ' TYR . 17.2 m -152.29 130.11 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 107.125 -1.435 . . . . 0.72999999999999998 107.125 -173.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -135.11 146.71 49.11 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 118.929 0.786 . . . . 1.3799999999999999 110.394 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -140.0 144.5 36.99 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.221 0.608 . . . . 1.9399999999999999 110.171 -172.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.57 ' O ' HG23 ' A' ' 66' ' ' VAL . . . -85.07 139.14 31.96 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.89 -0.782 . . . . 0.59999999999999998 108.89 170.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 t -125.76 143.66 38.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 105.855 -1.906 . . . . 1.78 105.855 172.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -144.15 177.99 8.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.191 -1.04 . . . . 2.52 108.191 176.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -155.36 131.85 10.42 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.811 -0.811 . . . . 2.6400000000000001 108.811 169.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 35.7 t 41.94 52.36 4.24 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.804 0.842 . . . . 3.9399999999999999 111.308 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -7.16 42.11 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 130.909 3.683 . . . . 9.2799999999999994 117.87 -149.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.66 -25.21 65.16 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 120.789 -1.194 . . . . 3.4100000000000001 110.54 168.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 179.15 174.37 45.23 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 109.12 -1.592 . . . . 1.52 109.12 166.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -133.16 138.24 46.53 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.339 -1.356 . . . . 2.75 107.339 177.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.445 ' HA ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -128.35 154.46 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 107.258 -1.386 . . . . 0.90000000000000002 107.258 -176.346 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.2 mt -116.14 121.43 42.1 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.52 0.728 . . . . 0.66000000000000003 109.334 -177.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.8 t -109.27 129.0 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.88 -1.155 . . . . 0.85999999999999999 107.88 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 77.5 p -103.94 140.15 38.11 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.73 1.212 . . . . 0.64000000000000001 109.233 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.511 ' HB3' HG23 ' A' ' 80' ' ' VAL . 6.6 t80 -134.41 160.23 38.63 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.112 1.765 . . . . 2.0800000000000001 108.191 -178.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -145.68 146.5 31.31 Favored 'General case' 0 N--CA 1.434 -1.257 0 C-N-CA 128.097 2.559 . . . . 3.1299999999999999 105.449 -171.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 69.82 59.97 0.28 Allowed 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 130.085 3.354 . . . . 3.1899999999999999 111.083 -175.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 mt 55.93 -156.05 0.28 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.482 1.113 . . . . 1.8300000000000001 109.27 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.572 HD13 ' HB2' ' A' ' 104' ' ' PHE . 15.5 mt -145.0 154.42 54.73 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 105.827 -1.916 . . . . 1.1000000000000001 105.827 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -63.09 -82.86 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 124.276 3.317 . . . . 2.3500000000000001 110.536 -176.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -76.5 35.49 0.15 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.073 0.949 . . . . 4.1100000000000003 110.752 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 39.6 6.31 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 128.505 2.722 . . . . 3.0499999999999998 117.538 -164.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.572 ' HB2' HD13 ' A' ' 100' ' ' LEU . 0.2 OUTLIER 61.91 89.96 0.08 Allowed 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 124.846 1.258 . . . . 3.0099999999999998 109.643 -166.021 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.272 15.0 mmm180 -91.85 30.39 1.39 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 117.859 -1.536 . . . . 5.2300000000000004 111.559 178.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . 0.339 4.3 mt-10 79.38 172.38 0.16 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.986 1.266 . . . . 3.04 109.714 146.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 39.39 37.52 0.79 Allowed Glycine 0 CA--C 1.537 1.467 0 N-CA-C 116.143 1.217 . . . . 0.78000000000000003 116.143 163.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -148.18 176.57 10.11 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.551 1.54 . . . . 2.1899999999999999 107.847 -175.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -109.08 129.38 9.48 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.174 -1.17 . . . . 0.64000000000000001 110.174 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.0 pp -133.99 165.39 31.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 125.475 1.51 . . . . 0.73999999999999999 106.994 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.4 m -115.56 144.27 23.54 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 N-CA-C 108.087 -1.079 . . . . 0.94999999999999996 108.087 170.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.616 ' HB2' HG12 ' A' ' 127' ' ' VAL . . . -134.05 129.68 36.41 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 124.073 0.949 . . . . 0.62 110.325 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.79 143.83 34.32 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.633 1.173 . . . . 4.4500000000000002 111.425 177.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 166.02 -150.64 18.28 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 109.17 -1.572 . . . . 1.01 109.17 169.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.9 p -127.69 146.28 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 123.78 0.832 . . . . 0.82999999999999996 109.38 -168.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.6 mp -61.71 142.65 57.09 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 122.119 -0.363 . . . . 2.0899999999999999 110.483 174.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -98.38 -108.21 2.74 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 109.263 -1.535 . . . . 1.8100000000000001 109.263 -169.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -60.29 -49.21 78.52 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.323 0.649 . . . . 5.1799999999999997 109.259 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.2 t70 177.27 -87.86 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.364 2.266 . . . . 4.2999999999999998 106.089 -177.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.23 -26.54 72.57 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.72 1.629 . . . . 1.0800000000000001 113.433 -177.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -86.66 136.5 33.01 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.12 0.96 . . . . 3.0299999999999998 109.935 174.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.4 mp -107.37 133.9 51.23 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 123.107 0.563 . . . . 2.1600000000000001 109.495 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -98.09 106.5 18.81 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.58 -0.526 . . . . 0.42999999999999999 109.58 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -121.27 136.99 54.89 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.719 0.808 . . . . 1.2 110.224 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.3 t -128.28 4.14 5.75 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.216 0.606 . . . . 1.0900000000000001 111.885 173.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -118.6 82.03 1.78 Allowed 'General case' 0 CA--C 1.531 0.237 0 O-C-N 120.914 -1.116 . . . . 2.98 108.368 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.616 HG12 ' HB2' ' A' ' 112' ' ' ALA . 17.2 m -99.59 133.92 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 118.333 0.515 . . . . 0.70999999999999996 110.701 175.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.87 118.81 27.94 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.215 -1.402 . . . . 0.73999999999999999 107.215 177.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.22 84.2 7.7 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.631 0.772 . . . . 1.1499999999999999 110.433 -177.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.17 34.52 0.11 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.736 1.013 . . . . 4.1500000000000004 113.736 -174.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -136.63 139.31 41.97 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 126.765 2.026 . . . . 4.1200000000000001 105.596 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 13.1 t0 . . . . . 0 CA--C 1.532 0.257 0 N-CA-C 107.105 -1.443 . . . . 6.79 107.105 174.113 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.455 -0.206 0 N-CA-C 106.253 -1.758 . . . . 6.6900000000000004 106.253 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -143.79 143.41 31.34 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.043 -1.095 . . . . 6.8399999999999999 108.043 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 77.7 mt -144.25 152.79 41.31 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.082 1.353 . . . . 6.0499999999999998 107.503 -173.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -131.09 115.2 16.11 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.908 0.883 . . . . 3.6699999999999999 111.184 -176.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.4 173.4 11.82 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.224 -0.923 . . . . 2.5 109.75 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -85.68 124.78 32.6 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.724 1.209 . . . . 2.1400000000000001 109.465 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.16 149.39 51.88 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.003 1.321 . . . . 3.02 110.54 -177.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.5 m -77.09 132.33 70.88 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 125.713 1.605 . . . . 2.0 110.728 -177.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -59.3 -33.05 97.77 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.968 2.445 . . . . 0.81000000000000005 113.616 -176.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.5 p -61.09 -21.04 63.3 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.171 -0.956 . . . . 2.2799999999999998 112.713 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -96.8 14.2 26.0 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.774 0.715 . . . . 3.7000000000000002 111.753 173.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.312 8.0 pt -124.26 35.02 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 O-C-N 120.607 -1.308 . . . . 1.23 111.613 163.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.0 p -122.61 -79.11 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 O-C-N 121.922 -0.486 . . . . 2.3500000000000001 110.426 163.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -69.75 103.8 2.26 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 125.497 1.519 . . . . 2.2999999999999998 110.896 -162.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.96 39.33 96.39 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 109.029 -1.628 . . . . 1.3400000000000001 109.029 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -141.43 -110.42 0.14 Allowed 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.521 -1.659 . . . . 2.2799999999999998 106.521 -176.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 56.3 m -80.45 -48.19 13.21 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 119.96 1.254 . . . . 1.4099999999999999 112.475 -176.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -55.0 -49.33 71.77 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 121.828 0.823 . . . . 2.6600000000000001 109.694 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -72.32 -33.47 67.38 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.371 -0.831 . . . . 1.2 111.619 175.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.22 41.04 39.86 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.744 1.164 . . . . 1.2 112.198 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 23.6 m -99.97 -42.3 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 117.999 0.9 . . . . 1.3 113.228 -172.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -109.29 -67.51 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 124.519 1.128 . . . . 3.7999999999999998 111.433 -176.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -76.37 78.81 3.15 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.062 1.842 . . . . 2.27 108.828 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -55.74 140.04 43.14 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.656 0.782 . . . . 3.2000000000000002 109.031 175.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.539 ' HB1' ' HA2' ' A' ' 117' ' ' GLY . . . -61.83 147.18 47.34 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.951 -0.759 . . . . 1.1899999999999999 108.951 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.17 -8.28 31.04 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.839 1.209 . . . . 1.0900000000000001 112.069 -170.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -96.32 140.49 30.92 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.325 1.063 . . . . 1.6100000000000001 109.548 -175.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -89.31 118.56 29.07 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.274 1.029 . . . . 4.8099999999999996 108.569 176.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.7 pt -142.21 175.9 4.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 107.903 -1.147 . . . . 1.22 107.903 172.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.4 mtm180 -121.15 113.57 20.19 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.197 -1.038 . . . . 2.1400000000000001 108.197 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.2 p -81.24 127.86 39.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 107.108 -1.441 . . . . 0.78000000000000003 107.108 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -129.99 114.93 1.76 Allowed Glycine 0 C--N 1.332 0.332 0 N-CA-C 109.856 -1.297 . . . . 0.47999999999999998 109.856 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.57 -173.37 39.76 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.876 -0.89 . . . . 0.81000000000000005 110.876 -172.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.431 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 2.4 ptp -93.37 132.82 37.25 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.947 0.899 . . . . 2.75 111.343 -171.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.43 HG11 ' CE1' ' A' ' 104' ' ' PHE . 6.1 t -102.34 137.22 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 O-C-N 123.794 0.684 . . . . 2.2599999999999998 109.936 174.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.401 HG22 HG12 ' A' ' 68' ' ' VAL . 5.2 m -40.75 -88.0 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 128.192 2.597 . . . . 2.8300000000000001 114.329 -175.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.401 HG12 HG22 ' A' ' 67' ' ' THR . 7.3 p 176.18 -36.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.309 1.443 . . . . 2.73 110.038 -174.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -155.82 42.35 0.56 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 109.788 -1.325 . . . . 2.4500000000000002 109.788 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.9 m -84.65 -11.46 55.89 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.972 0.386 . . . . 1.26 111.321 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 16.8 ptm -68.8 132.48 46.86 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 118.292 0.496 . . . . 2.2200000000000002 110.686 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.1 m -117.65 125.45 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 106.621 -1.622 . . . . 1.23 106.621 170.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.446 ' HB3' HG12 ' A' ' 80' ' ' VAL . 16.8 ptt180 -101.4 146.77 27.16 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.535 0.734 . . . . 5.0899999999999999 110.136 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -84.42 151.36 59.05 Favored Pre-proline 0 C--O 1.232 0.147 0 N-CA-C 109.381 -0.6 . . . . 2.1699999999999999 109.381 170.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -67.55 -21.15 46.57 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.933 2.422 . . . . 1.77 112.367 174.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -43.7 -37.98 2.91 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.565 -0.531 . . . . 1.55 109.565 163.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.0 m 72.79 9.75 5.52 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 126.125 1.77 . . . . 1.6100000000000001 111.508 177.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 pp -123.63 17.78 9.57 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.16 1.784 . . . . 1.76 110.644 178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -146.1 130.19 17.42 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.588 1.555 . . . . 2.0299999999999998 108.271 173.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.446 HG12 ' HB3' ' A' ' 73' ' ' ARG . 0.9 OUTLIER -145.29 109.77 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 125.105 1.362 . . . . 1.1899999999999999 107.523 -178.6 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -109.38 150.07 28.58 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 109.22 -0.659 . . . . 1.3899999999999999 109.22 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -150.85 142.3 23.44 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.981 0.419 . . . . 1.8899999999999999 110.727 -171.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.69 135.16 33.88 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.275 -0.639 . . . . 0.78000000000000003 109.275 175.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 38.7 t -115.21 152.16 16.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 126.365 1.866 . . . . 2.0299999999999998 106.512 175.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -134.18 -175.93 4.02 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.376 0.67 . . . . 1.47 109.744 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.448 ' HB3' ' H ' ' A' ' 90' ' ' GLY . 25.7 t0 -126.53 171.47 11.05 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.716 0.806 . . . . 3.9300000000000002 110.506 177.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.9 m -48.48 -44.15 35.49 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.845 0.858 . . . . 3.71 110.651 159.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.51 -76.88 0.21 Allowed 'General case' 0 C--N 1.341 0.234 0 CA-C-N 118.662 0.665 . . . . 4.8899999999999997 110.446 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.25 50.05 0.07 OUTLIER Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.582 -1.007 . . . . 2.6200000000000001 110.582 -176.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.448 ' H ' ' HB3' ' A' ' 86' ' ' ASP . . . -82.32 52.29 4.63 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 110.458 -1.057 . . . . 2.4399999999999999 110.458 -178.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -65.88 111.75 3.44 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.997 -1.112 . . . . 3.5899999999999999 107.997 -175.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -144.51 153.85 14.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 N-CA-C 108.416 -0.957 . . . . 0.92000000000000004 108.416 -176.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mt -108.42 124.57 50.6 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.911 0.884 . . . . 0.77000000000000002 109.116 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.6 t -107.21 132.55 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 107.299 -1.371 . . . . 0.84999999999999998 107.299 177.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 76.6 p -106.25 143.6 34.14 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.513 -0.921 . . . . 0.60999999999999999 108.513 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -137.67 167.05 22.47 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.775 1.23 . . . . 2.2999999999999998 108.655 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -144.49 147.84 33.78 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 127.801 2.44 . . . . 3.4399999999999999 107.088 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 65.78 71.86 0.41 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 129.786 3.234 . . . . 3.0800000000000001 112.66 -178.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.7 mp 46.07 -148.54 0.11 Allowed 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 125.377 1.471 . . . . 2.3199999999999998 109.867 -175.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.8 mt -156.31 152.18 22.68 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 105.492 -2.04 . . . . 1.3300000000000001 105.492 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -71.54 108.69 2.45 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.274 2.649 . . . . 2.6600000000000001 109.929 176.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 45.04 45.11 8.78 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.205 1.402 . . . . 4.2999999999999998 111.706 176.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . 0.296 2.3 pp 35.69 47.3 0.37 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.259 1.424 . . . . 3.6699999999999999 112.793 -172.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.43 ' CE1' HG11 ' A' ' 66' ' ' VAL . 20.3 p90 38.85 56.59 1.95 Allowed 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 127.647 2.379 . . . . 4.7400000000000002 114.115 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.707 ' CD ' ' H ' ' A' ' 105' ' ' ARG 0.253 0.1 OUTLIER -37.91 130.45 1.12 Allowed 'General case' 0 CA--C 1.543 0.711 0 O-C-N 116.971 -3.58 . . . . 6.5499999999999998 113.189 -119.073 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -74.13 154.88 38.94 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.401 -0.812 . . . . 3.54 110.345 -164.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 87.61 33.21 11.67 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.181 0.896 . . . . 0.83999999999999997 112.395 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -156.74 178.54 10.23 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.091 1.356 . . . . 2.77 108.183 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 65' ' ' MET . . . -88.82 139.53 15.4 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 112.122 -0.391 . . . . 0.87 112.122 175.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.69 162.76 28.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 124.152 0.981 . . . . 0.81999999999999995 108.54 -178.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 17.6 m -120.2 122.74 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.304 -0.628 . . . . 0.53000000000000003 109.304 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -113.67 120.98 42.74 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 125.189 1.396 . . . . 0.44 109.047 -176.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -99.67 135.28 41.33 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.369 -1.345 . . . . 4.1399999999999997 107.369 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -169.27 -169.72 32.95 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 110.065 -1.214 . . . . 0.93000000000000005 110.065 -173.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.4 p -122.98 136.94 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 107.804 -1.184 . . . . 0.73999999999999999 107.804 172.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 9.6 mp -73.78 155.24 39.06 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 107.882 -1.155 . . . . 2.6200000000000001 107.882 174.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.539 ' HA2' ' HB1' ' A' ' 56' ' ' ALA . . . -172.02 -44.42 0.04 OUTLIER Glycine 0 C--N 1.332 0.313 0 C-N-CA 119.878 -1.154 . . . . 2.1699999999999999 112.215 175.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -58.9 154.85 14.33 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 119.295 -0.962 . . . . 5.1699999999999999 110.083 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -80.17 72.54 6.99 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 106.511 -1.663 . . . . 4.5499999999999998 106.511 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 115.24 4.53 20.35 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.413 1.482 . . . . 1.3899999999999999 114.265 170.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.13 170.17 9.55 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.785 1.293 . . . . 2.8599999999999999 109.342 171.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.9 mp -123.74 145.25 49.15 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.044 0.937 . . . . 2.0699999999999998 109.578 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -110.85 109.76 20.08 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.426 0.691 . . . . 0.42999999999999999 109.197 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -132.63 136.63 46.63 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 123.41 0.684 . . . . 1.1000000000000001 110.277 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.4 t -121.44 -2.37 9.49 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.975 0.51 . . . . 1.0900000000000001 111.96 173.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -111.7 83.01 1.71 Allowed 'General case' 0 CA--C 1.532 0.27 0 O-C-N 120.434 -1.416 . . . . 3.79 108.403 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.3 m -96.65 126.89 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 118.383 0.538 . . . . 0.77000000000000002 110.886 174.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -113.95 106.57 14.59 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.03 -1.47 . . . . 0.77000000000000002 107.03 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.1 50.01 1.93 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.979 0.912 . . . . 1.6000000000000001 110.622 -178.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -78.83 64.39 3.78 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.357 0.663 . . . . 3.2999999999999998 111.096 -170.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -145.32 142.1 29.13 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.592 -1.633 . . . . 4.4400000000000004 106.592 -178.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 . . . . . 0 CA--C 1.532 0.252 0 C-N-CA 126.549 1.939 . . . . 6.6799999999999997 112.752 179.417 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.3 m . . . . . 0 CA--C 1.534 0.355 0 N-CA-C 111.857 0.317 . . . . 8.1400000000000006 111.857 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -149.8 149.12 30.04 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 121.567 -0.708 . . . . 8.1799999999999997 110.327 -174.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 mt -87.11 81.12 8.12 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.834 1.254 . . . . 6.0999999999999996 108.223 171.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 -81.0 73.5 8.04 Favored 'General case' 0 C--O 1.237 0.439 0 O-C-N 121.446 -0.784 . . . . 3.6499999999999999 110.535 -171.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -127.7 166.11 18.74 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.581 1.152 . . . . 1.8999999999999999 111.921 -176.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -91.45 135.21 34.01 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.424 1.09 . . . . 1.9299999999999999 109.906 173.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.41 161.44 34.54 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.002 1.321 . . . . 2.9300000000000002 109.883 170.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 p -83.28 144.82 47.38 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.65 1.18 . . . . 1.8600000000000001 110.522 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -62.0 -44.47 20.08 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.786 2.991 . . . . 0.82999999999999996 112.407 -177.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.8 p -45.83 -56.18 5.7 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.258 1.423 . . . . 2.5 110.923 176.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -46.56 -56.11 6.54 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.446 -1.252 . . . . 3.0099999999999998 109.174 178.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.25 24.2 pt -70.37 11.42 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 114.862 1.43 . . . . 1.0 114.862 -173.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 82.0 t -98.4 -57.59 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 119.455 1.025 . . . . 1.8300000000000001 110.934 173.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -95.68 90.27 5.63 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 121.618 -0.676 . . . . 2.29 111.822 -162.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.72 41.75 12.36 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.442 -1.063 . . . . 1.5 110.442 176.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.91 -161.61 1.17 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 104.168 -2.53 . . . . 3.0499999999999998 104.168 -178.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 m -27.6 -59.04 0.11 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.797 2.439 . . . . 1.72 116.356 -175.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -57.66 -43.62 85.12 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 120.625 1.557 . . . . 3.9500000000000002 110.889 -177.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.04 -34.81 75.81 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.762 0.825 . . . . 1.95 110.586 174.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.09 46.86 14.7 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.118 1.342 . . . . 1.5700000000000001 111.566 177.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.407 HG23 ' H ' ' A' ' 53' ' ' LYS . 2.7 m -99.17 -89.61 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 117.252 0.526 . . . . 1.9199999999999999 111.639 177.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.407 ' H ' HG23 ' A' ' 52' ' ' VAL . 20.0 mmmt -58.53 -60.8 9.13 Favored Pre-proline 0 CA--C 1.538 0.49 0 O-C-N 121.33 -0.856 . . . . 3.04 112.891 -176.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.62 147.18 27.82 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.564 1.509 . . . . 1.1899999999999999 109.072 172.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -116.52 135.05 54.15 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.099 1.76 . . . . 3.04 107.302 -176.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.01 146.78 45.86 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.447 -0.575 . . . . 1.1599999999999999 109.447 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.59 -26.24 9.14 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 123.927 0.775 . . . . 1.01 111.915 -169.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -84.71 151.63 24.29 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.195 0.998 . . . . 1.53 109.969 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -95.23 130.68 41.88 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.806 0.842 . . . . 5.0300000000000002 108.851 175.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.6 pt -141.31 177.63 3.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 125.025 1.33 . . . . 0.64000000000000001 108.243 177.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.8 mtm-85 -125.7 137.83 53.86 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 122.31 -0.244 . . . . 2.5899999999999999 111.115 166.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.6 p -97.66 134.07 37.16 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.171 0 C-N-CA 124.686 1.194 . . . . 0.90000000000000002 108.049 172.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.09 119.14 1.76 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.602 -0.999 . . . . 0.66000000000000003 110.602 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.59 -163.34 29.27 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.295 -1.522 . . . . 0.60999999999999999 109.295 -175.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.44 142.04 27.87 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.011 0.905 . . . . 2.5699999999999998 111.733 -177.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 39.3 t -87.44 122.55 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-N 115.545 -0.752 . . . . 2.1299999999999999 109.407 172.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.5 m -30.34 -91.62 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 128.843 2.857 . . . . 3.0499999999999998 115.382 -175.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.5 p -172.42 -37.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 124.061 0.944 . . . . 2.23 111.027 -177.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -158.96 40.66 0.49 Allowed Glycine 0 CA--C 1.521 0.439 0 N-CA-C 109.617 -1.393 . . . . 1.8700000000000001 109.617 174.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.3 m -82.25 -17.33 46.35 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.868 -0.195 . . . . 1.0700000000000001 111.093 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.1 ttp -63.23 128.79 37.47 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 122.717 0.407 . . . . 2.3799999999999999 110.487 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.5 m -135.22 143.99 35.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 108.132 -1.062 . . . . 0.56999999999999995 108.132 172.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 47.8 ptt85 -132.39 147.52 52.39 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 124.422 1.089 . . . . 4.6799999999999997 108.516 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -99.76 154.37 37.29 Favored Pre-proline 0 C--O 1.235 0.313 0 N-CA-C 107.944 -1.132 . . . . 2.0899999999999999 107.944 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.41 44.71 1.56 Allowed 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.485 2.79 . . . . 1.8600000000000001 111.526 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -105.75 -41.45 5.43 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.667 1.587 . . . . 1.71 109.088 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.2 m 107.55 -30.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 129.134 2.974 . . . . 2.8999999999999999 110.214 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.34 32.87 4.83 Favored 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 124.321 1.048 . . . . 2.7799999999999998 111.741 -177.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -140.04 110.08 6.49 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.41 -1.33 . . . . 3.2000000000000002 107.41 175.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.75 134.17 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.226 -1.398 . . . . 1.04 107.226 177.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -144.46 157.17 44.37 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 120.884 -1.135 . . . . 0.84999999999999998 109.199 175.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -155.09 161.02 41.4 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.691 -0.855 . . . . 1.95 108.691 -173.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -106.74 145.21 32.33 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.548 -0.908 . . . . 0.75 108.548 175.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.9 t -127.96 140.2 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 108.473 -0.936 . . . . 1.8300000000000001 108.473 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -137.17 168.96 18.61 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.552 0.741 . . . . 1.3899999999999999 110.195 -178.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -115.5 10.46 15.69 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.733 0.813 . . . . 2.8599999999999999 110.517 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.5 t 57.97 26.23 13.18 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.529 1.132 . . . . 4.0999999999999996 112.463 -171.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.2 mt -120.72 33.4 5.59 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.377 1.471 . . . . 4.5499999999999998 110.893 -176.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 62.7 39.98 98.61 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 121.679 -0.638 . . . . 2.98 111.8 177.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -153.92 124.27 1.54 Allowed Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 106.98 -2.448 . . . . 1.5900000000000001 106.98 170.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -126.87 128.75 46.99 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.084 -1.821 . . . . 3.7400000000000002 106.084 174.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.2 tp -108.83 160.2 7.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 C-N-CA 125.36 1.464 . . . . 1.1499999999999999 108.14 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 mt -114.65 133.38 55.9 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 108.231 -1.026 . . . . 0.83999999999999997 108.231 -175.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 89.2 t -127.59 131.62 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 124.76 1.224 . . . . 0.96999999999999997 107.798 -174.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 47.0 p -107.2 150.4 26.66 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.929 0.892 . . . . 0.60999999999999999 109.762 178.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -147.39 140.62 25.25 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.49 1.516 . . . . 2.0299999999999998 107.064 -173.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -132.95 41.45 3.15 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.366 1.066 . . . . 2.1299999999999999 112.574 -168.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -168.25 53.24 0.05 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.557 0.743 . . . . 2.6800000000000002 111.631 -176.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.2 mp 51.02 -155.03 0.14 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.827 1.251 . . . . 1.9399999999999999 111.067 -171.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 81.8 mt -150.18 156.99 37.63 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 106.535 -1.654 . . . . 1.4199999999999999 106.535 -178.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.22 -88.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.434 2.756 . . . . 1.95 110.556 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -77.1 36.36 0.18 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.814 1.246 . . . . 3.6400000000000001 111.254 -175.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 39.89 11.67 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 128.824 2.849 . . . . 2.1600000000000001 116.983 -163.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 56.08 96.83 0.02 OUTLIER 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.681 1.128 . . . . 3.0699999999999998 109.911 -161.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 7.0 mtm180 -107.92 35.15 3.22 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 117.356 -1.306 . . . . 5.8799999999999999 112.448 172.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . 0.378 4.3 mm-40 78.81 157.75 0.17 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 121.443 1.928 . . . . 4.5099999999999998 112.99 140.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 52.1 26.59 20.44 Favored Glycine 0 CA--C 1.534 1.219 0 O-C-N 120.578 -1.326 . . . . 1.3999999999999999 113.631 167.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -139.73 163.75 31.76 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.54 1.936 . . . . 2.0800000000000001 105.813 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -89.28 145.77 18.66 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.74 -0.944 . . . . 0.72999999999999998 110.74 174.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.7 pp -141.26 159.98 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 106.074 -1.824 . . . . 0.88 106.074 173.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.2 m -124.02 122.82 65.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 108.488 -0.93 . . . . 0.69999999999999996 108.488 172.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -115.32 127.77 55.66 Favored 'General case' 0 C--O 1.228 -0.072 0 C-N-CA 125.747 1.619 . . . . 0.48999999999999999 109.93 -172.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -106.74 134.99 49.04 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.863 1.265 . . . . 3.25 109.502 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -173.72 -175.93 41.79 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 121.398 -0.429 . . . . 1.1899999999999999 112.97 -174.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.6 p -124.41 141.57 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 124.58 1.152 . . . . 1.03 109.394 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.2 mp -78.11 137.74 38.36 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.276 -0.875 . . . . 2.3700000000000001 109.014 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -156.42 37.16 0.59 Allowed Glycine 0 CA--C 1.521 0.453 0 N-CA-C 111.3 -0.72 . . . . 2.5800000000000001 111.3 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -157.45 27.86 0.29 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.882 0.873 . . . . 4.3099999999999996 109.545 -175.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 43.91 41.72 4.09 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.045 0.938 . . . . 4.0 111.915 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 159.88 -60.33 0.31 Allowed Glycine 0 CA--C 1.529 0.947 0 N-CA-C 110.837 -0.905 . . . . 1.99 110.837 -171.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.44 160.69 20.53 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 122.307 -0.525 . . . . 2.7799999999999998 111.096 -173.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 mp -125.26 126.26 44.86 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.072 0.949 . . . . 1.96 110.036 -170.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -92.8 108.97 20.4 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.096 -1.076 . . . . 0.60999999999999999 108.096 172.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -134.04 102.05 5.27 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.425 0.69 . . . . 1.29 111.938 -173.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 8.8 t -86.43 -25.01 25.46 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.193 0.997 . . . . 0.96999999999999997 111.843 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -88.43 79.43 7.69 Favored 'General case' 0 N--CA 1.455 -0.22 0 O-C-N 119.84 -1.788 . . . . 2.6400000000000001 109.713 -174.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.9 m -96.42 122.37 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 118.306 0.503 . . . . 0.79000000000000004 110.907 174.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -112.44 113.63 25.92 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.684 -1.599 . . . . 0.83999999999999997 106.684 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -99.87 26.73 6.04 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.855 0.862 . . . . 2.2000000000000002 112.606 -172.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.13 42.0 0.63 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.55 0.945 . . . . 5.1900000000000004 113.55 -164.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -76.05 -52.52 10.01 Favored 'General case' 0 C--N 1.333 -0.111 0 O-C-N 121.585 -0.697 . . . . 5.0599999999999996 109.216 173.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.5 t70 . . . . . 0 CA--C 1.534 0.362 0 N-CA-C 109.43 -0.582 . . . . 5.8200000000000003 109.43 177.227 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 CA--C 1.529 0.14 0 N-CA-C 108.737 -0.838 . . . . 6.7599999999999998 108.737 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -81.35 134.53 35.58 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.349 0.66 . . . . 8.7100000000000009 109.987 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.9 mp -107.25 97.03 6.84 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.349 1.06 . . . . 5.4400000000000004 108.851 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -158.56 81.24 0.81 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.248 0.477 . . . . 3.7200000000000002 111.595 175.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.32 169.44 14.87 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.454 1.024 . . . . 2.0899999999999999 112.475 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -84.13 126.49 33.15 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.424 1.49 . . . . 2.1499999999999999 110.11 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.16 150.71 52.03 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.27 1.428 . . . . 2.7799999999999998 110.518 -177.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 36.2 m -76.7 124.05 87.66 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 125.73 1.612 . . . . 1.9199999999999999 111.48 -175.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -55.36 -43.4 58.81 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.987 2.458 . . . . 0.73999999999999999 111.857 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.6 m -60.1 -25.17 65.22 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.131 0.789 . . . . 2.8500000000000001 113.131 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -68.65 -56.88 6.73 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.139 -1.06 . . . . 3.25 108.139 171.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.6 pt -72.96 30.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 114.571 1.323 . . . . 1.0800000000000001 114.571 -171.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.2 p -107.51 -29.73 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 125.214 1.406 . . . . 1.9299999999999999 110.827 170.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -87.1 -118.7 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.969 0.89 . . . . 3.3900000000000001 109.937 -170.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -84.88 66.61 3.84 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 108.554 -1.818 . . . . 1.3400000000000001 108.554 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -142.38 -125.31 0.09 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.503 1.121 . . . . 2.9100000000000001 108.074 -173.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.419 HG21 HD21 ' A' ' 122' ' ' LEU . 5.9 t -76.66 -38.4 54.6 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 119.183 0.901 . . . . 2.8100000000000001 111.387 -172.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -58.31 -50.35 73.95 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.397 0.618 . . . . 2.7400000000000002 109.537 -178.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.9 m -81.04 -24.95 37.5 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.211 -0.904 . . . . 1.48 111.269 177.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.21 43.34 47.61 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.663 1.125 . . . . 1.0900000000000001 111.988 175.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.0 m -98.41 -42.18 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 117.657 0.728 . . . . 1.1799999999999999 112.757 -172.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -109.71 -65.77 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.777 1.231 . . . . 3.5899999999999999 111.975 -176.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -76.85 171.25 18.32 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 N-CA-C 108.224 -1.491 . . . . 1.1799999999999999 108.224 169.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.5 158.56 43.82 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.351 0.66 . . . . 5.4100000000000001 109.39 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.57 126.94 31.26 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.489 -1.3 . . . . 1.49 107.489 175.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 127.31 -17.68 6.19 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.275 1.417 . . . . 1.1799999999999999 112.198 -176.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.3 mt-30 -93.31 148.7 21.82 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.192 0.997 . . . . 2.9399999999999999 110.523 -172.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -85.49 134.58 34.04 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.051 -0.722 . . . . 3.4900000000000002 109.051 172.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.1 pt -145.73 175.03 2.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 105.685 -1.969 . . . . 0.64000000000000001 105.685 164.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -120.89 122.99 41.44 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.329 -1.36 . . . . 2.1899999999999999 107.329 171.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.7 p -88.81 131.91 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 107.558 -1.275 . . . . 0.77000000000000002 107.558 176.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -135.42 121.66 2.6 Favored Glycine 0 C--N 1.336 0.529 0 CA-C-N 119.052 0.842 . . . . 0.51000000000000001 111.002 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -172.88 -172.47 38.56 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.907 -0.877 . . . . 0.58999999999999997 110.907 -175.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -92.48 127.79 38.09 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.579 1.152 . . . . 4.5700000000000003 109.649 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.7 t -77.65 146.97 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.583 -0.735 . . . . 2.0899999999999999 109.721 176.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.552 HG22 HG12 ' A' ' 68' ' ' VAL . 2.1 m -55.66 -90.36 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.927 1.691 . . . . 3.04 114.155 -178.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.552 HG12 HG22 ' A' ' 67' ' ' THR . 7.4 p 176.16 -44.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.757 1.623 . . . . 2.3599999999999999 109.956 -170.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -150.26 39.44 0.86 Allowed Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.382 -1.087 . . . . 2.1200000000000001 110.382 176.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 61.6 m -87.22 -19.09 28.86 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 117.4 0.6 . . . . 1.05 112.153 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.3 ttp -71.76 123.82 23.44 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 118.803 0.729 . . . . 2.48 109.101 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.6 m -121.61 132.49 70.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 107.592 -1.262 . . . . 0.52000000000000002 107.592 173.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.433 ' CB ' HG12 ' A' ' 80' ' ' VAL . 29.7 ptt85 -117.2 153.27 33.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.939 0.895 . . . . 4.8899999999999997 109.904 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.28 170.19 17.39 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 109.9 -0.407 . . . . 2.5 109.9 170.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.35 -33.28 5.7 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.424 2.749 . . . . 1.6100000000000001 110.604 163.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -46.13 -40.17 10.58 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 126.221 1.808 . . . . 1.6499999999999999 110.232 -177.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.2 m 78.68 17.53 1.02 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.616 1.966 . . . . 1.71 112.666 178.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.76 23.96 7.21 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.445 0.698 . . . . 3.1899999999999999 112.407 164.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -144.87 118.75 9.3 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.183 -1.043 . . . . 1.49 108.183 177.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.487 HG23 ' HB3' ' A' ' 96' ' ' TYR . 35.8 m -139.82 143.56 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 106.928 -1.508 . . . . 0.94999999999999996 106.928 173.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -139.49 159.03 43.1 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.419 -0.586 . . . . 0.83999999999999997 109.419 172.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -154.84 159.17 40.36 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 122.975 0.51 . . . . 1.8500000000000001 109.73 -175.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.55 147.63 26.53 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.834 -0.802 . . . . 0.59999999999999998 108.834 172.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.3 p -144.6 144.77 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 109.244 -0.65 . . . . 1.95 109.244 174.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -141.0 175.84 9.3 Favored 'General case' 0 C--O 1.228 -0.053 0 C-N-CA 125.359 1.464 . . . . 1.27 107.947 -175.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -120.24 16.91 12.33 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.367 0.603 . . . . 2.6699999999999999 110.97 175.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.3 m 52.93 26.54 4.75 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.344 1.058 . . . . 4.6200000000000001 113.316 -175.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 71.6 mt -93.25 -62.39 1.38 Allowed 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.476 -0.565 . . . . 4.9500000000000002 109.476 174.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 169.86 55.47 0.04 OUTLIER Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.367 -1.093 . . . . 3.1699999999999999 110.367 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 175.12 148.82 6.92 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 108.345 -1.902 . . . . 1.8100000000000001 108.345 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -135.67 145.78 47.12 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 105.745 -1.946 . . . . 3.3199999999999998 105.745 178.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.36 139.32 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 107.351 -1.351 . . . . 0.84999999999999998 107.351 176.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.0 mt -87.73 138.36 31.53 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.684 -0.858 . . . . 0.81999999999999995 108.684 173.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.5 t -124.38 135.71 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 C-N-CA 126.002 1.721 . . . . 0.93999999999999995 106.608 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.1 p -110.13 156.38 20.67 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 124.997 1.319 . . . . 0.66000000000000003 108.236 178.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.487 ' HB3' HG23 ' A' ' 80' ' ' VAL . 1.1 t80 -151.7 108.07 3.45 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.597 -1.26 . . . . 2.8300000000000001 107.597 177.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -84.17 51.36 2.05 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.733 1.213 . . . . 2.6699999999999999 110.75 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -164.64 -178.17 5.19 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.867 1.267 . . . . 2.6600000000000001 108.094 171.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.03 158.5 32.78 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.115 0.966 . . . . 1.47 111.563 169.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.489 HD13 ' HB2' ' A' ' 104' ' ' PHE . 5.1 mt -96.04 165.27 16.72 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 126.123 1.769 . . . . 1.4299999999999999 109.923 174.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.96 -100.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.758 2.972 . . . . 2.2000000000000002 109.4 172.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -78.32 54.55 1.42 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.281 1.033 . . . . 2.8799999999999999 110.537 -175.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 42.1 18.58 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.822 2.449 . . . . 2.2200000000000002 115.678 -171.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.489 ' HB2' HD13 ' A' ' 100' ' ' LEU . 6.2 t80 60.61 97.25 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.91 0.884 . . . . 2.3399999999999999 110.688 -163.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 -77.91 111.45 13.77 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 105.736 -1.95 . . . . 8.3200000000000003 105.736 175.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -81.99 173.78 11.88 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.778 0.323 . . . . 5.0999999999999996 110.747 178.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.13 34.89 89.57 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.923 -0.471 . . . . 0.81999999999999995 111.923 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -156.3 175.84 13.47 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.655 1.582 . . . . 2.46 107.136 175.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -92.87 134.89 12.39 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.565 -0.614 . . . . 0.69999999999999996 111.565 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.2 pp -133.05 159.48 43.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.941 -0.763 . . . . 0.76000000000000001 108.941 174.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 31.5 m -125.67 122.86 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 107.808 -1.182 . . . . 0.54000000000000004 107.808 176.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -119.51 117.22 27.82 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.854 1.262 . . . . 0.55000000000000004 109.901 -171.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -106.84 143.35 35.06 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.379 1.071 . . . . 3.7400000000000002 110.711 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 179.66 -118.79 0.61 Allowed Glycine 0 C--N 1.335 0.501 0 N-CA-C 108.823 -1.711 . . . . 1.0700000000000001 108.823 169.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.8 p -150.91 144.38 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 118.006 0.903 . . . . 0.88 109.217 -176.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.929 HD22 HD22 ' A' ' 122' ' ' LEU . 5.5 mt -81.98 139.36 34.61 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.306 -1.368 . . . . 2.3799999999999999 107.306 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -177.43 26.4 0.06 OUTLIER Glycine 0 C--N 1.333 0.414 0 C-N-CA 119.045 -1.55 . . . . 2.6400000000000001 113.053 -174.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -141.25 41.18 1.77 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.974 -0.75 . . . . 6.3799999999999999 108.974 -172.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 22.28 57.84 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 129.541 3.136 . . . . 4.4299999999999997 112.933 175.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 139.79 -33.84 2.08 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-N 115.377 -0.829 . . . . 1.0900000000000001 112.492 -171.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.88 167.42 12.14 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.428 1.114 . . . . 2.6299999999999999 110.334 -175.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.929 HD22 HD22 ' A' ' 116' ' ' LEU . 8.4 mt -118.15 128.94 55.21 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.659 1.183 . . . . 1.9199999999999999 109.486 -174.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -89.15 94.66 10.01 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.096 -1.446 . . . . 0.51000000000000001 107.096 175.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -115.5 111.29 20.52 Favored 'General case' 0 C--O 1.228 -0.069 0 C-N-CA 122.949 0.5 . . . . 1.3500000000000001 110.163 -173.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.85 -43.66 8.1 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.12 0.968 . . . . 1.3 110.44 -174.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -84.51 79.06 9.7 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.95 -1.13 . . . . 3.5600000000000001 107.95 -170.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.486 HG21 HD23 ' A' ' 100' ' ' LEU . 4.4 m -90.0 96.44 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 125.794 1.637 . . . . 1.4099999999999999 111.262 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.81 149.97 20.93 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 108.81 -0.811 . . . . 0.94999999999999996 108.81 175.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -126.56 70.72 1.26 Allowed 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 123.894 0.878 . . . . 1.49 109.915 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -65.27 -10.04 29.02 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.482 0.919 . . . . 3.6699999999999999 113.482 -177.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -69.68 -56.89 5.98 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.468 0.707 . . . . 5.4100000000000001 109.63 176.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.14 0 C-N-CA 124.177 0.991 . . . . 6.3099999999999996 108.447 -178.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.0 t . . . . . 0 CA--C 1.531 0.236 0 CA-C-O 120.762 0.315 . . . . 8.8900000000000006 110.681 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -144.27 170.56 15.76 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.993 1.317 . . . . 8.8200000000000003 108.13 -171.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 26.8 tp -142.33 168.94 18.56 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.264 1.426 . . . . 5.2199999999999998 107.886 -177.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -159.1 75.76 0.69 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.234 0.614 . . . . 4.5899999999999999 112.163 -166.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.0 pp -138.35 167.25 22.28 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.631 1.105 . . . . 2.2599999999999998 112.693 -176.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -92.29 127.64 37.84 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.773 1.629 . . . . 2.1800000000000002 111.366 -175.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.59 152.32 50.09 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.21 1.804 . . . . 2.71 110.405 -173.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.4 m -89.91 129.35 46.62 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.103 1.361 . . . . 1.6200000000000001 111.525 -174.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -57.23 -53.24 5.06 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.543 2.828 . . . . 0.69999999999999996 112.594 -176.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 51.0 m -57.38 -12.41 2.51 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 114.29 1.219 . . . . 3.1899999999999999 114.29 176.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -82.67 -53.17 6.14 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 118.861 0.755 . . . . 3.0899999999999999 108.985 170.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 26.8 pt -73.27 33.11 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 114.106 1.151 . . . . 1.22 114.106 -176.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.635 HG21 ' HA3' ' A' ' 90' ' ' GLY . 22.0 m -126.64 -54.61 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 126.323 1.849 . . . . 3.1000000000000001 109.786 169.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.438 ' N ' HG23 ' A' ' 44' ' ' VAL . 42.8 m-80 -65.23 -34.49 78.49 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.701 0.8 . . . . 2.77 112.761 -163.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.62 68.71 0.1 OUTLIER Glycine 0 C--N 1.335 0.518 0 N-CA-C 110.27 -1.132 . . . . 1.8100000000000001 110.27 -177.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -165.41 -99.24 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.992 1.717 . . . . 2.98 108.36 -171.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 55.8 m -62.99 -63.71 1.12 Allowed 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 119.094 0.861 . . . . 1.4299999999999999 110.561 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.2 -44.8 64.93 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.777 0.799 . . . . 3.5699999999999998 111.162 -172.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.79 -17.81 52.48 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.619 1.168 . . . . 1.49 112.516 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 53.36 52.05 43.4 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.76 1.648 . . . . 1.4099999999999999 112.233 -175.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.1 m -105.99 -60.33 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 117.94 0.87 . . . . 1.79 113.088 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 35.1 mmtt -80.18 -61.49 0.44 Allowed Pre-proline 0 CA--C 1.534 0.356 0 CA-C-O 118.512 -0.756 . . . . 3.7400000000000002 112.339 -178.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -79.82 148.68 20.09 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 121.891 1.727 . . . . 1.5900000000000001 108.643 174.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -93.12 145.93 24.03 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.004 -1.11 . . . . 3.3900000000000001 108.004 165.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.88 169.02 5.58 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.136 0.574 . . . . 1.8600000000000001 110.33 174.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.04 33.82 86.92 Favored Glycine 0 CA--C 1.532 1.1 0 O-C-N 121.928 -0.482 . . . . 1.25 112.57 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -118.54 159.1 24.15 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.308 1.043 . . . . 1.98 108.764 170.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.5 128.02 45.59 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.122 1.369 . . . . 4.71 108.765 -177.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.2 pt -146.17 176.84 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 124.062 0.945 . . . . 0.81999999999999995 108.56 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.3 mtt85 -119.14 130.66 55.66 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.679 -0.86 . . . . 2.5600000000000001 108.679 167.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.9 p -95.43 130.37 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 107.041 -1.466 . . . . 0.76000000000000001 107.041 171.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.58 120.06 1.88 Allowed Glycine 0 C--N 1.332 0.36 0 N-CA-C 110.131 -1.188 . . . . 0.46999999999999997 110.131 -176.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.47 -159.67 21.87 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.45 -1.46 . . . . 0.63 109.45 -178.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.477 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 0.0 OUTLIER -100.69 132.22 46.19 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.918 0.866 . . . . 2.8999999999999999 111.922 -174.62 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.1 t -86.47 111.7 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 N-CA-C 108.433 -0.951 . . . . 1.95 108.433 176.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 t -5.82 -102.31 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 128.624 2.769 . . . . 3.1299999999999999 114.668 163.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.7 p -158.69 -41.59 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 N-CA-C 113.548 0.944 . . . . 2.3399999999999999 113.548 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -161.26 33.33 0.38 Allowed Glycine 0 C--N 1.332 0.357 0 N-CA-C 110.995 -0.842 . . . . 3.0 110.995 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.2 m -80.25 12.73 2.72 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.739 0.644 . . . . 1.3799999999999999 112.739 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -78.04 107.6 10.72 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.948 -1.13 . . . . 2.0600000000000001 107.948 176.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -106.83 127.65 62.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 108.043 -1.095 . . . . 0.56000000000000005 108.043 176.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.446 ' CB ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -108.37 142.75 38.24 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.071 0.949 . . . . 4.8099999999999996 110.273 178.402 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -71.79 158.02 88.56 Favored Pre-proline 0 C--O 1.232 0.146 0 C-N-CA 123.18 0.592 . . . . 2.1299999999999999 109.521 170.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.4 -24.64 64.1 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.73 2.287 . . . . 1.22 112.346 170.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 76.1 m-80 -44.69 -34.4 2.21 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.11 0.564 . . . . 1.4299999999999999 110.886 165.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.9 m 75.2 1.53 3.73 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.801 1.64 . . . . 1.51 112.73 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 79' ' ' HIS . 0.6 OUTLIER -121.77 -13.74 8.23 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.937 1.695 . . . . 2.0299999999999998 112.689 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.494 ' N ' HD12 ' A' ' 78' ' ' LEU . 36.9 m-70 -106.48 121.41 44.21 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 105.897 -1.89 . . . . 1.3500000000000001 105.897 176.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.499 HG23 ' HB3' ' A' ' 96' ' ' TYR . 31.0 m -145.88 137.87 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 107.314 -1.365 . . . . 0.79000000000000004 107.314 -172.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -139.46 152.68 47.2 Favored 'General case' 0 C--O 1.233 0.223 0 O-C-N 121.604 -0.685 . . . . 0.91000000000000003 110.452 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -150.88 158.19 43.84 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.981 -0.554 . . . . 1.8999999999999999 110.411 -173.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -112.51 141.72 45.92 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.688 -1.227 . . . . 0.69999999999999996 107.688 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.5 p -141.87 146.16 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.244 0.618 . . . . 1.8700000000000001 109.95 -174.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -145.2 -177.94 5.81 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 124.99 1.316 . . . . 1.47 109.49 -170.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -118.92 25.46 10.19 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.436 0.694 . . . . 2.29 109.858 175.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 67.2 m 42.3 43.35 2.93 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 125.495 1.518 . . . . 5.3399999999999999 113.361 -175.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 22.4 mt -119.03 -70.02 0.82 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.918 0.887 . . . . 4.2599999999999998 109.214 175.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 179.79 66.25 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 108.858 -1.697 . . . . 2.9100000000000001 108.858 -176.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.635 ' HA3' HG21 ' A' ' 44' ' ' VAL . . . 170.06 113.45 0.29 Allowed Glycine 0 N--CA 1.443 -0.852 0 CA-C-O 118.748 -1.029 . . . . 1.79 111.074 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -117.61 132.08 56.57 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 108.024 -1.102 . . . . 3.5 108.024 174.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.6 tp -114.71 160.06 14.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 124.292 1.037 . . . . 1.1000000000000001 108.403 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.2 mt -112.28 128.81 56.38 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.6 0.76 . . . . 0.76000000000000001 109.091 -173.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.0 t -114.77 125.8 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 125.52 1.528 . . . . 0.90000000000000002 107.549 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.9 p -102.22 138.9 38.55 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.904 -0.776 . . . . 0.58999999999999997 108.904 175.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.499 ' HB3' HG23 ' A' ' 80' ' ' VAL . 1.9 t80 -132.7 111.74 11.42 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.134 1.374 . . . . 2.1299999999999999 107.415 -176.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -98.79 45.96 1.0 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.161 1.384 . . . . 1.9399999999999999 110.998 -176.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -164.6 -178.49 5.38 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.325 1.85 . . . . 2.7400000000000002 107.526 170.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.4 mp -80.77 148.66 29.96 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.738 0.78 . . . . 1.8 111.462 176.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.478 HD23 HG21 ' A' ' 80' ' ' VAL . 1.5 mm? -76.72 159.37 79.25 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 124.955 1.302 . . . . 2.5 110.295 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.29 -90.3 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.514 2.809 . . . . 2.1200000000000001 109.274 168.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.88 50.05 0.56 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.765 1.626 . . . . 3.0299999999999998 110.781 178.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . 0.254 0.3 OUTLIER 44.15 7.4 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 118.53 2.789 . . . . 3.1899999999999999 118.53 -177.653 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 79.4 t80 72.26 99.56 0.07 Allowed 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 126.148 1.779 . . . . 3.1000000000000001 109.192 -162.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -81.38 103.45 11.14 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.092 0.957 . . . . 4.9199999999999999 109.75 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.5 mp0 -80.95 163.86 23.0 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.099 0.863 . . . . 3.1899999999999999 111.932 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.56 17.4 66.68 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 118.594 -1.114 . . . . 1.47 113.372 172.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -157.29 42.13 0.33 Allowed 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 119.308 1.554 . . . . 3.6099999999999999 113.452 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 65' ' ' MET . . . 31.29 141.53 0.0 OUTLIER Glycine 0 CA--C 1.531 1.079 0 C-N-CA 128.689 3.043 . . . . 1.02 118.847 -172.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.3 pp -140.39 163.23 23.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 O-C-N 120.099 -1.824 . . . . 0.93999999999999995 107.537 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 6.6 m -110.28 137.05 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 107.628 -1.249 . . . . 0.89000000000000001 107.628 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.425 ' CB ' HG12 ' A' ' 127' ' ' VAL . . . -123.12 128.84 50.64 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 124.076 0.95 . . . . 0.48999999999999999 109.185 178.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -111.06 140.02 45.95 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.687 -0.486 . . . . 3.6600000000000001 109.687 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 168.81 -152.04 19.3 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 121.028 -0.606 . . . . 1.0700000000000001 111.606 173.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.1 p -113.76 145.73 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.008 0.923 . . . . 0.67000000000000004 108.917 -169.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -55.22 142.52 31.11 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.437 -0.579 . . . . 1.8600000000000001 109.437 168.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.51 -131.71 1.6 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.312 -1.115 . . . . 2.3199999999999998 110.312 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -63.31 -82.24 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.339 1.056 . . . . 5.6100000000000003 109.886 -177.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -159.65 62.67 0.37 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 107.828 -1.175 . . . . 3.7200000000000002 107.828 173.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 163.52 -61.04 0.26 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.102 -1.199 . . . . 1.1899999999999999 110.102 -172.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.18 160.87 26.76 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.692 -0.887 . . . . 2.1699999999999999 108.994 -175.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 mp -122.68 137.34 54.94 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 109.62 -0.511 . . . . 1.9299999999999999 109.62 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -103.37 103.24 13.22 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.365 -0.976 . . . . 0.5 108.365 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -131.15 115.42 16.36 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 122.587 0.355 . . . . 1.03 111.017 -176.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.2 t -109.42 -15.44 14.23 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.586 1.154 . . . . 1.0 111.749 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -104.21 80.2 1.69 Allowed 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.626 -1.296 . . . . 3.1499999999999999 109.081 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.425 HG12 ' CB ' ' A' ' 112' ' ' ALA . 34.6 m -90.12 149.44 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 118.784 0.72 . . . . 0.70999999999999996 111.496 174.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.17 142.81 51.37 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.283 -1.006 . . . . 0.93000000000000005 108.283 169.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -122.9 65.46 0.97 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.426 1.09 . . . . 1.3899999999999999 111.109 -177.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.21 42.58 1.04 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.777 0.658 . . . . 2.9700000000000002 112.777 -175.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -140.45 67.05 1.37 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.666 0.786 . . . . 5.46 110.122 -175.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 . . . . . 0 CA--C 1.534 0.335 0 C-N-CA 125.921 1.688 . . . . 5.4000000000000004 109.879 -176.394 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.0 t . . . . . 0 N--CA 1.454 -0.267 0 N-CA-C 107.844 -1.169 . . . . 9.0399999999999991 107.844 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -165.31 56.41 0.12 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.743 0.817 . . . . 7.4400000000000004 110.495 -173.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.3 mt -125.24 133.98 52.49 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.816 1.247 . . . . 5.4000000000000004 108.119 177.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -160.63 88.29 0.78 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.212 1.005 . . . . 4.1600000000000001 110.804 -174.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -138.13 161.65 36.26 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.653 -1.279 . . . . 1.8 112.022 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -83.72 122.36 28.53 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.433 1.093 . . . . 2.1200000000000001 109.059 176.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.33 159.58 37.49 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.282 1.033 . . . . 3.2799999999999998 108.853 171.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 53.3 p -79.73 148.4 68.99 Favored Pre-proline 0 N--CA 1.446 -0.631 0 N-CA-C 109.147 -0.686 . . . . 1.5600000000000001 109.147 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -60.87 -28.87 87.07 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 121.335 1.356 . . . . 0.77000000000000002 110.697 176.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.5 p -52.67 -28.8 23.21 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.153 0.981 . . . . 2.46 112.775 171.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -81.78 -10.48 59.33 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.019 -0.425 . . . . 2.1600000000000001 111.424 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.3 pt -127.68 34.19 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 O-C-N 120.788 -1.195 . . . . 1.3999999999999999 113.832 -176.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.422 HG12 HG12 ' A' ' 92' ' ' ILE . 3.6 m -119.85 -23.66 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 119.129 0.877 . . . . 3.1699999999999999 113.072 -176.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -139.21 132.28 29.59 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 107.123 -1.436 . . . . 4.04 107.123 -178.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.59 -73.06 1.2 Allowed Glycine 0 CA--C 1.529 0.931 0 CA-C-O 122.465 1.036 . . . . 3.8399999999999999 111.173 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 37.4 mttt -44.1 -83.77 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 129.891 3.276 . . . . 4.21 111.428 -174.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.2 m -75.63 -48.02 23.95 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 121.273 1.851 . . . . 1.45 109.803 171.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -49.74 -36.78 26.88 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.078 1.14 . . . . 3.3999999999999999 114.078 -172.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 44.1 m -123.96 19.09 9.28 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.266 1.426 . . . . 2.8500000000000001 109.602 176.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 48.13 37.01 16.36 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-O 117.245 -1.864 . . . . 2.25 114.7 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.257 21.9 m -82.85 -43.08 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 122.106 2.953 . . . . 2.1600000000000001 113.18 -168.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -93.73 -64.01 0.14 Allowed Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.585 1.154 . . . . 4.9100000000000001 112.718 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.38 166.14 30.68 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.484 2.122 . . . . 1.74 109.705 176.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -118.65 129.25 55.2 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.335 0.654 . . . . 4.6699999999999999 109.907 170.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.12 111.74 1.29 Allowed 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.513 -0.551 . . . . 1.3 109.513 173.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 133.65 -20.81 4.08 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 124.363 0.982 . . . . 1.1399999999999999 111.567 -176.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -83.18 155.85 23.53 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 117.758 0.779 . . . . 2.52 109.211 177.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.0 mtt-85 -87.2 144.95 26.6 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.669 -0.863 . . . . 4.2599999999999998 108.669 170.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 11.4 pt -146.96 173.4 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 106.505 -1.665 . . . . 0.69999999999999996 106.505 170.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -124.67 118.36 26.31 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.516 -1.29 . . . . 2.4500000000000002 107.516 174.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -89.27 121.13 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.666 -1.235 . . . . 0.77000000000000002 107.666 177.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -127.83 123.44 4.47 Favored Glycine 0 C--N 1.334 0.438 0 N-CA-C 109.907 -1.277 . . . . 0.48999999999999999 109.907 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.79 -162.66 23.52 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 108.068 -2.013 . . . . 0.64000000000000001 108.068 -176.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.78 137.02 37.97 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.804 0.811 . . . . 2.5699999999999998 110.565 177.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.5 t -79.23 137.86 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 108.5 -0.926 . . . . 2.1899999999999999 108.5 171.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -89.92 148.65 23.0 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.317 -0.994 . . . . 2.4399999999999999 108.317 169.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.4 p -57.67 -61.12 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.189 0.996 . . . . 2.21 110.796 178.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.55 73.46 2.05 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 109.161 -1.575 . . . . 2.1499999999999999 109.161 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.5 m -148.51 -44.42 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.152 0.797 . . . . 1.46 113.152 -177.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.421 ' HA ' ' HE3' ' A' ' 71' ' ' MET . 0.0 OUTLIER -66.81 122.31 17.39 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.227 0.467 . . . . 1.8 110.162 -177.63 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.24 120.42 48.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 108.336 -0.987 . . . . 0.56999999999999995 108.336 169.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.29 147.89 24.19 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.912 1.285 . . . . 4.3099999999999996 109.407 177.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -76.34 154.92 84.15 Favored Pre-proline 0 N--CA 1.455 -0.211 0 N-CA-C 109.008 -0.738 . . . . 1.9099999999999999 109.008 171.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -63.89 -22.8 68.68 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.608 2.205 . . . . 1.1599999999999999 111.963 166.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -47.22 -29.12 2.19 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.401 0.68 . . . . 1.1200000000000001 110.809 164.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.1 m 68.71 15.97 8.99 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 125.261 1.424 . . . . 1.3300000000000001 112.081 176.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.2 pp -125.8 -41.57 1.97 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 126.712 2.005 . . . . 1.6699999999999999 111.744 -178.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -85.43 132.31 34.24 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.538 -1.282 . . . . 1.1000000000000001 107.538 175.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.474 ' HB ' HD12 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -140.18 127.91 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 107.058 -1.46 . . . . 0.88 107.058 176.612 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -130.48 149.9 51.94 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.018 -0.734 . . . . 0.80000000000000004 109.018 176.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -145.3 143.35 30.15 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.33 -0.618 . . . . 1.8899999999999999 109.33 -175.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.84 141.87 33.05 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.327 -0.99 . . . . 0.75 108.327 164.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.6 p -128.02 153.48 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 107.472 -1.307 . . . . 1.77 107.472 170.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -140.18 179.96 6.33 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.235 0.471 . . . . 1.55 111.735 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -134.12 170.82 15.1 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.461 1.104 . . . . 2.3399999999999999 108.278 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.3 m -54.95 -34.78 63.58 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.854 0.862 . . . . 3.6099999999999999 110.101 166.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 12.7 mt -83.16 33.33 0.45 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.1 0.778 . . . . 5.0300000000000002 113.1 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 62.83 25.07 67.26 Favored Glycine 0 CA--C 1.527 0.813 0 O-C-N 121.686 -0.634 . . . . 2.96 112.797 167.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -81.46 56.93 4.9 Favored Glycine 0 C--O 1.223 -0.559 0 CA-C-O 118.721 -1.044 . . . . 2.2799999999999998 113.296 -165.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -63.43 108.57 1.37 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.295 1.547 . . . . 3.1800000000000002 110.216 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.422 HG12 HG12 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -130.53 143.85 39.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 108.447 -0.945 . . . . 1.1399999999999999 108.447 176.353 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.415 ' H ' HD13 ' A' ' 92' ' ' ILE . 17.9 mt -92.02 126.01 36.94 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.273 1.029 . . . . 0.75 110.75 178.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.5 t -108.84 122.79 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 125.879 1.671 . . . . 0.87 107.504 175.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.6 p -102.4 136.15 42.75 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.321 1.048 . . . . 0.46999999999999997 108.954 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.419 ' CD2' HD21 ' A' ' 100' ' ' LEU . 2.9 t80 -130.85 109.22 10.41 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.222 1.409 . . . . 1.9399999999999999 107.933 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -91.93 47.91 1.39 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.885 1.274 . . . . 2.3300000000000001 111.683 -176.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -167.68 173.37 8.53 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.22 1.808 . . . . 2.5299999999999998 107.07 170.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.4 mp -70.37 127.02 31.32 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.981 -1.074 . . . . 1.78 111.261 -177.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.474 HD12 ' HB ' ' A' ' 80' ' ' VAL . 11.9 mt -73.44 149.67 88.91 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 123.94 0.896 . . . . 1.25 110.75 174.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -68.53 140.95 49.08 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.838 3.026 . . . . 2.2200000000000002 109.696 175.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 45.85 43.92 10.48 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.307 1.443 . . . . 3.1699999999999999 111.238 -175.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 47.68 16.39 0.07 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 127.229 2.212 . . . . 2.0600000000000001 115.332 -171.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.453 ' CB ' HD13 ' A' ' 100' ' ' LEU . 69.0 t80 59.61 103.72 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.231 1.412 . . . . 2.6499999999999999 110.204 -161.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -78.75 119.93 22.67 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.238 -0.892 . . . . 5.3399999999999999 108.696 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -83.68 165.13 19.19 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 123.311 0.644 . . . . 3.0 111.044 -174.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.06 25.39 69.09 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 119.58 -0.567 . . . . 0.72999999999999998 114.146 172.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -143.55 170.57 15.58 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.734 1.214 . . . . 2.5499999999999998 108.075 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -84.92 129.28 9.14 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 109.775 -1.33 . . . . 0.69999999999999996 109.775 175.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.5 pp -136.17 152.77 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 106.434 -1.691 . . . . 0.59999999999999998 106.434 171.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 18.1 m -115.99 125.69 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 107.863 -1.162 . . . . 0.70999999999999996 107.863 177.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -116.46 134.39 54.92 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 125.09 1.356 . . . . 0.5 109.839 -170.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -126.23 143.28 51.2 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.945 1.298 . . . . 3.1400000000000001 110.628 -176.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 176.51 -123.43 0.9 Allowed Glycine 0 C--N 1.334 0.44 0 N-CA-C 108.55 -1.82 . . . . 0.82999999999999996 108.55 169.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.4 p -139.46 150.98 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 118.381 1.09 . . . . 0.79000000000000004 109.346 -175.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -55.61 133.81 50.69 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.871 -0.604 . . . . 1.8999999999999999 109.789 171.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -82.74 -135.51 2.35 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 109.135 -1.586 . . . . 2.23 109.135 173.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -74.1 78.25 1.74 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 109.155 -0.683 . . . . 5.6799999999999997 109.155 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.8 t0 19.34 61.37 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 129.414 3.086 . . . . 4.6100000000000003 113.086 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 166.73 -54.4 0.24 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.825 -0.91 . . . . 0.95999999999999996 110.825 -163.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.61 154.05 19.3 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 122.246 -0.561 . . . . 2.7400000000000002 109.521 172.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -111.48 123.84 51.05 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 124.442 1.097 . . . . 2.1000000000000001 108.646 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -97.25 93.62 6.63 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.054 -1.091 . . . . 0.56999999999999995 108.054 175.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.55 136.8 47.56 Favored 'General case' 0 C--O 1.227 -0.117 0 N-CA-C 109.46 -0.57 . . . . 0.93999999999999995 109.46 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.405 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 14.9 t -124.65 -26.68 3.79 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.236 1.014 . . . . 0.95999999999999996 112.743 177.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -89.48 88.3 7.4 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 120.472 -1.393 . . . . 3.1699999999999999 108.357 177.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.1 m -99.37 125.83 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 118.873 0.76 . . . . 0.68999999999999995 110.798 174.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.03 113.12 20.46 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.171 -1.418 . . . . 0.63 107.171 178.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.41 101.85 10.12 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 108.291 -1.003 . . . . 1.48 108.291 172.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -143.21 65.84 1.32 Allowed 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.431 0.692 . . . . 3.2400000000000002 109.461 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -151.74 -171.69 4.01 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.077 -1.823 . . . . 5.7300000000000004 106.077 175.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 50.8 t0 . . . . . 0 C--O 1.237 0.417 0 N-CA-C 107.616 -1.253 . . . . 7.3399999999999999 107.616 176.695 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.4 t . . . . . 0 CA--C 1.534 0.348 0 N-CA-C 112.054 0.39 . . . . 8.7300000000000004 112.054 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -142.11 165.07 28.47 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.669 1.588 . . . . 7.79 106.833 -177.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 49.7 mt 57.38 38.11 28.26 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.149 0.979 . . . . 6.2000000000000002 111.072 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -160.73 53.25 0.3 Allowed 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.246 -0.909 . . . . 4.3700000000000001 112.832 176.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.74 153.24 28.05 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.063 0.847 . . . . 3.3399999999999999 112.948 -170.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -85.61 122.59 29.94 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 123.812 0.845 . . . . 2.2000000000000002 109.384 170.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -140.78 169.17 18.13 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.768 0.827 . . . . 3.8199999999999998 109.84 171.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.2 p -91.6 148.06 36.53 Favored Pre-proline 0 N--CA 1.45 -0.471 0 C-N-CA 124.096 0.958 . . . . 2.04 110.737 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -60.98 -35.85 85.77 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.564 2.843 . . . . 1.0 111.354 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.417 ' O ' HG12 ' A' ' 44' ' ' VAL . 4.1 p -50.57 -38.6 46.2 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.918 1.287 . . . . 2.5699999999999998 112.031 174.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -60.27 -57.33 13.26 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.074 -1.084 . . . . 2.1299999999999999 108.074 177.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.256 19.5 pt -74.87 21.36 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 115.128 1.529 . . . . 1.0900000000000001 115.128 -166.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 41' ' ' SER . 1.7 p -107.13 -33.56 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 125.02 1.328 . . . . 1.9299999999999999 112.127 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -116.57 94.14 4.5 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.29 -0.881 . . . . 2.21 110.141 -170.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.31 45.66 46.72 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.739 -0.945 . . . . 1.3200000000000001 110.739 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.23 -159.33 0.88 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 103.902 -2.629 . . . . 2.4199999999999999 103.902 178.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.0 m -41.32 -45.83 3.1 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.445 1.898 . . . . 1.5600000000000001 115.078 -167.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -51.11 -47.72 61.9 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.833 0.742 . . . . 2.9700000000000002 112.014 176.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.1 m -78.2 -32.95 50.25 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.148 0.579 . . . . 1.51 111.02 174.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.43 48.49 18.29 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.429 1.014 . . . . 1.3100000000000001 111.145 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 53' ' ' LYS . 0.9 OUTLIER -89.37 -91.61 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 117.042 0.421 . . . . 2.0899999999999999 110.677 177.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.413 ' H ' HG23 ' A' ' 52' ' ' VAL . 19.0 mmmt -65.71 -56.67 17.01 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 118.452 -0.785 . . . . 3.3300000000000001 111.945 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.86 120.95 5.25 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 121.426 1.417 . . . . 1.22 109.844 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.24 165.74 18.09 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.582 0.753 . . . . 4.6100000000000003 109.053 170.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.631 ' HB1' ' HA2' ' A' ' 117' ' ' GLY . . . -71.41 173.63 7.63 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 109.07 -0.715 . . . . 1.23 109.07 171.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.16 -2.5 84.2 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 121.033 -1.042 . . . . 1.0800000000000001 113.471 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -94.15 148.8 21.84 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.282 1.041 . . . . 1.4099999999999999 109.198 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -92.78 130.04 38.52 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.105 -0.702 . . . . 4.4199999999999999 109.105 172.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.5 pt -142.66 167.3 14.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 106.426 -1.694 . . . . 0.67000000000000004 106.426 168.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.2 mtt180 -118.09 115.08 24.1 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.88 -1.526 . . . . 1.78 106.88 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.7 p -92.79 123.54 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.767 -1.197 . . . . 0.84999999999999998 107.767 178.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.34 148.97 20.63 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 118.975 0.807 . . . . 0.85999999999999999 111.682 -177.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 167.13 -100.45 0.17 Allowed Glycine 0 C--N 1.335 0.517 0 N-CA-C 109.077 -1.609 . . . . 1.79 109.077 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.7 ptp -145.46 131.23 19.02 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.738 0.769 . . . . 2.8900000000000001 110.016 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.2 p -67.11 157.08 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 119.483 -0.887 . . . . 2.4900000000000002 109.726 178.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.7 -9.88 31.66 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 113.908 1.077 . . . . 3.3900000000000001 113.908 175.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.253 7.6 p 49.51 68.76 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 123.863 1.792 . . . . 3.4900000000000002 111.564 177.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 142.57 47.75 0.05 OUTLIER Glycine 0 CA--C 1.526 0.731 0 CA-C-N 111.874 -2.421 . . . . 1.8300000000000001 109.861 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.0 m -156.45 -7.52 0.1 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 114.824 1.416 . . . . 1.9399999999999999 114.824 177.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.92 109.89 1.39 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 121.449 1.931 . . . . 1.8899999999999999 108.278 171.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.2 m -124.66 134.92 65.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 108.459 -0.941 . . . . 0.80000000000000004 108.459 174.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.3 ptt85 -113.67 151.05 32.35 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.424 1.089 . . . . 4.5499999999999998 109.677 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.07 160.52 65.63 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 123.082 0.553 . . . . 1.8100000000000001 110.268 175.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -74.54 -26.45 11.89 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.479 2.786 . . . . 1.22 110.584 171.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -43.4 -38.57 2.82 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 124.595 1.158 . . . . 1.71 109.023 169.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.2 m 79.38 2.7 2.28 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.687 1.995 . . . . 1.28 112.012 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.16 31.19 6.07 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.056 2.142 . . . . 2.2200000000000002 109.27 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -156.56 132.49 9.69 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.789 -0.819 . . . . 1.6299999999999999 108.789 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.89 134.47 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 125.75 1.62 . . . . 0.83999999999999997 109.026 -177.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -138.03 158.64 43.91 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 120.826 -1.171 . . . . 0.80000000000000004 110.783 172.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -155.36 153.4 30.4 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.363 0.665 . . . . 1.9299999999999999 109.845 -174.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -112.2 134.8 53.54 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.685 0.794 . . . . 0.67000000000000004 109.633 -179.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.8 t -126.04 142.78 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 108.189 -1.041 . . . . 1.8300000000000001 108.189 -173.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -139.42 -175.39 4.17 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.859 -0.793 . . . . 1.5700000000000001 108.859 177.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -133.62 -9.39 2.81 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.781 1.232 . . . . 2.5800000000000001 109.327 177.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 62.02 26.6 16.05 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.829 1.252 . . . . 4.8099999999999996 111.472 -169.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.9 mp -112.95 -91.41 0.5 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.666 -0.864 . . . . 4.7699999999999996 108.666 170.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -71.98 -33.6 62.5 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.033 0.825 . . . . 3.96 113.637 -170.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 157.66 -158.8 29.35 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 109.804 -1.318 . . . . 1.77 109.804 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -116.88 159.41 22.44 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.246 2.218 . . . . 2.9300000000000002 107.557 178.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -137.77 163.91 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 108.236 -1.024 . . . . 0.96999999999999997 108.236 166.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.7 mt -112.94 132.52 55.31 Favored 'General case' 0 C--N 1.338 0.087 0 C-N-CA 124.625 1.17 . . . . 0.59999999999999998 108.685 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.3 t -118.25 129.94 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 125.193 1.397 . . . . 0.91000000000000003 107.477 -177.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.8 p -107.74 149.75 27.79 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.298 1.039 . . . . 0.60999999999999999 108.299 177.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -144.1 129.75 19.17 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.05 -1.463 . . . . 2.9300000000000002 107.05 176.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -69.33 -84.31 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.359 -0.838 . . . . 2.8999999999999999 110.379 166.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -56.97 163.28 2.06 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.983 0.897 . . . . 2.5699999999999998 112.825 -172.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 mp -63.45 145.54 55.42 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 122.225 1.012 . . . . 1.6299999999999999 111.986 -174.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.481 HD23 HG21 ' A' ' 127' ' ' VAL . 24.9 mt -67.85 156.4 89.4 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 115.023 -0.99 . . . . 1.23 109.997 169.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.77 -89.4 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.492 3.461 . . . . 2.3500000000000001 109.619 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.2 17.82 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.94 1.296 . . . . 2.8999999999999999 113.581 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 16.5 tp 53.24 20.6 1.92 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.485 1.114 . . . . 3.5600000000000001 111.937 -167.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER 49.55 81.75 0.05 Allowed 'General case' 0 C--N 1.344 0.368 0 C-N-CA 124.94 1.296 . . . . 2.5800000000000001 110.828 173.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.294 7.8 mmm180 -87.72 29.75 0.88 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 117.872 -1.531 . . . . 5.7300000000000004 112.452 -166.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . 0.604 25.9 mt-10 80.26 161.87 0.17 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.517 1.527 . . . . 4.5099999999999998 111.807 157.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 29.9 52.95 0.19 Allowed Glycine 0 CA--C 1.533 1.198 0 C-N-CA 126.346 1.927 . . . . 0.97999999999999998 115.785 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -152.54 51.34 0.77 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.853 1.326 . . . . 3.4300000000000002 112.536 -174.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 4.67 98.34 0.0 OUTLIER Glycine 0 CA--C 1.535 1.332 0 C-N-CA 127.888 2.661 . . . . 0.92000000000000004 116.354 -174.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.0 pp -108.4 165.13 5.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 106.977 -1.49 . . . . 0.64000000000000001 106.977 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.6 m -123.62 133.97 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 107.583 -1.266 . . . . 0.72999999999999998 107.583 173.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -126.54 138.1 53.44 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.15 1.78 . . . . 0.58999999999999997 108.891 -170.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -143.02 155.88 44.73 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.972 0.805 . . . . 3.8900000000000001 112.403 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -177.08 -100.26 0.13 Allowed Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 108.386 -1.886 . . . . 1.3799999999999999 108.386 172.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.9 p -155.91 151.0 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 118.153 0.976 . . . . 0.64000000000000001 110.153 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.59 ' HG ' HD12 ' A' ' 122' ' ' LEU . 1.1 mp -85.64 150.95 24.26 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.226 1.01 . . . . 2.48 108.809 176.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.631 ' HA2' ' HB1' ' A' ' 56' ' ' ALA . . . -166.99 -53.86 0.03 OUTLIER Glycine 0 C--O 1.227 -0.322 0 C-N-CA 120.577 -0.82 . . . . 2.21 111.223 177.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -64.18 144.19 57.31 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.36 -0.978 . . . . 5.7999999999999998 108.36 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.31 58.99 2.21 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.188 1.795 . . . . 4.8399999999999999 109.268 -172.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 127.4 18.53 2.02 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 127.123 2.297 . . . . 1.74 113.6 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.29 160.63 38.98 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.937 1.369 . . . . 2.71 109.63 166.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.59 HD12 ' HG ' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -119.16 129.39 54.98 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.437 1.095 . . . . 2.3799999999999999 108.351 -172.328 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -90.44 95.25 10.08 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 107.767 -1.197 . . . . 0.41999999999999998 107.767 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.84 140.86 41.71 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 123.346 0.658 . . . . 1.0600000000000001 109.972 -176.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -125.24 -47.22 1.76 Allowed 'General case' 0 C--O 1.232 0.165 0 C-N-CA 123.864 0.866 . . . . 1.0800000000000001 111.254 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -83.42 101.36 11.32 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 106.3 -1.741 . . . . 3.0 106.3 -173.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.481 HG21 HD23 ' A' ' 100' ' ' LEU . 3.4 m -108.51 116.31 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 125.932 1.693 . . . . 0.76000000000000001 109.266 -178.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.13 113.25 25.8 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.89 -1.152 . . . . 0.59999999999999998 107.89 -177.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -99.82 45.64 0.98 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.322 1.049 . . . . 1.28 111.581 -176.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.43 48.91 1.08 Allowed 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.136 -0.977 . . . . 2.8199999999999998 111.628 -175.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -67.17 -53.22 32.51 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.734 -0.604 . . . . 7.0599999999999996 110.252 -175.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.8 t0 . . . . . 0 C--O 1.233 0.223 0 N-CA-C 105.927 -1.879 . . . . 6.2999999999999998 105.927 167.161 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.0 p . . . . . 0 N--CA 1.45 -0.443 0 N-CA-C 109.925 -0.398 . . . . 8.5600000000000005 109.925 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 66.49 -164.95 0.23 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.931 0.892 . . . . 8.6199999999999992 109.822 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 tt 54.44 54.24 9.66 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.418 1.087 . . . . 5.3200000000000003 109.574 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.37 108.63 2.32 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 107.771 -1.196 . . . . 4.2300000000000004 107.771 -177.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -143.13 171.68 13.75 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.952 0.901 . . . . 1.8 110.727 -177.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -83.78 129.72 34.94 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.395 1.078 . . . . 2.0299999999999998 110.138 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -132.75 144.32 50.19 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.127 1.371 . . . . 3.0699999999999998 110.556 -178.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.0 m -76.39 133.67 71.01 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 125.707 1.603 . . . . 1.96 110.677 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.48 -41.35 58.24 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.527 2.151 . . . . 0.84999999999999998 112.673 -178.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.7 t -47.96 -49.81 29.24 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 121.628 -0.67 . . . . 2.8100000000000001 111.858 175.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -48.42 -56.3 8.58 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.901 0.88 . . . . 2.3900000000000001 108.992 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 32.9 pt -70.09 -10.13 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 113.883 1.068 . . . . 1.5700000000000001 113.883 -173.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.9 t -82.04 -28.68 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 118.74 0.7 . . . . 2.02 111.014 170.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -117.57 90.58 3.36 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 121.196 -0.94 . . . . 1.98 111.426 -161.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.72 41.22 89.49 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.228 -1.149 . . . . 1.49 110.228 177.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.68 -154.0 0.47 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 128.878 2.871 . . . . 2.46 103.406 174.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.2 m -26.84 -60.57 0.09 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 116.498 2.036 . . . . 1.47 116.498 -165.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -39.04 -51.46 1.84 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.265 0.939 . . . . 3.1000000000000001 111.671 175.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.08 -21.81 18.89 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.171 2.188 . . . . 1.27 110.829 -175.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.12 31.34 80.52 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 126.3 1.905 . . . . 1.1100000000000001 113.794 171.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.8 m -80.55 -37.3 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 118.283 1.042 . . . . 1.3200000000000001 112.043 -174.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 33.0 mmtt -107.94 -75.41 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 124.665 1.186 . . . . 3.1299999999999999 111.281 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -73.04 116.78 4.84 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 CA-C-N 120.782 1.315 . . . . 1.24 109.689 176.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -76.48 161.5 28.58 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.518 0.727 . . . . 3.2200000000000002 109.77 170.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.9 169.64 6.41 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.079 0.951 . . . . 1.26 111.261 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.12 5.8 66.85 Favored Glycine 0 CA--C 1.532 1.137 0 O-C-N 121.803 -0.56 . . . . 1.01 113.584 176.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -91.3 155.39 18.57 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 118.319 1.06 . . . . 1.3500000000000001 109.125 175.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -97.24 130.67 44.42 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.29 0.636 . . . . 3.0600000000000001 109.515 177.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.1 pt -146.36 177.56 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 106.74 -1.578 . . . . 0.63 106.74 173.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 42.1 mtt85 -119.41 116.4 26.07 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.881 -1.155 . . . . 2.8100000000000001 107.881 167.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.6 p -80.99 127.4 39.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 N-CA-C 107.18 -1.415 . . . . 0.91000000000000003 107.18 174.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.4 122.57 3.31 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 109.678 -1.369 . . . . 0.75 109.678 -177.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -169.84 -170.09 33.85 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 109.383 -1.487 . . . . 0.68999999999999995 109.383 -175.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 3.2 ptp -99.37 137.38 37.95 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.354 0.662 . . . . 2.8199999999999998 109.508 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.4 m -100.76 135.81 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 122.606 0.362 . . . . 2.5899999999999999 111.43 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -73.57 151.64 40.85 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.364 1.066 . . . . 2.23 109.292 176.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.5 p -55.57 -56.14 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 125.351 1.46 . . . . 2.02 111.173 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.07 71.63 1.22 Allowed Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.625 -1.39 . . . . 1.6699999999999999 109.625 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.3 m -151.98 46.82 0.77 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 117.758 0.779 . . . . 2.5099999999999998 112.28 -176.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.44 121.94 20.65 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 105.862 -1.903 . . . . 1.8400000000000001 105.862 176.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.0 m -132.72 140.04 48.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 119.584 1.083 . . . . 0.56000000000000005 108.705 170.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -122.22 150.9 41.63 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.37 1.068 . . . . 6.4699999999999998 110.57 -176.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.66 156.09 75.56 Favored Pre-proline 0 N--CA 1.453 -0.299 0 N-CA-C 109.809 -0.441 . . . . 2.0 109.809 170.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -68.3 -24.38 37.53 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.873 2.382 . . . . 1.49 111.466 166.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -45.45 -36.62 4.52 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.773 -0.454 . . . . 1.53 109.773 163.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.8 m 66.17 10.65 7.27 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 125.04 1.336 . . . . 1.46 112.999 176.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.2 pp -125.12 9.42 8.04 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 128.687 2.795 . . . . 1.73 110.2 175.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -137.79 130.34 29.59 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.09 -1.819 . . . . 1.3100000000000001 106.09 176.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.5 146.0 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 107.036 -1.468 . . . . 1.1699999999999999 107.036 -170.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -152.12 153.94 34.9 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 121.593 -0.692 . . . . 1.1299999999999999 110.118 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -145.99 156.06 43.24 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.924 -0.58 . . . . 1.8999999999999999 109.646 -171.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.91 140.5 37.6 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.451 -0.574 . . . . 0.83999999999999997 109.451 176.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.0 t -120.9 151.5 23.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 106.899 -1.519 . . . . 1.75 106.899 176.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -133.18 -177.25 4.43 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.685 0.794 . . . . 1.72 109.489 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -140.47 167.78 21.35 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.869 0.868 . . . . 3.2799999999999998 109.197 177.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.4 m -41.51 -45.95 3.38 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.505 1.122 . . . . 3.4900000000000002 111.198 160.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.3 mt -82.3 22.62 0.81 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.099 0.778 . . . . 4.8600000000000003 113.099 178.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 58.78 39.62 93.96 Favored Glycine 0 CA--C 1.527 0.784 0 O-C-N 121.139 -0.976 . . . . 3.0899999999999999 110.891 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -77.07 60.71 3.47 Favored Glycine 0 C--N 1.337 0.594 0 C-N-CA 123.844 0.735 . . . . 1.98 111.319 -174.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -63.11 114.27 3.64 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.383 0.673 . . . . 3.2400000000000002 109.238 -174.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.3 153.53 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 C-N-CA 124.391 1.076 . . . . 1.3 108.606 -178.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.8 mt -114.01 129.18 56.62 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.087 0.955 . . . . 0.70999999999999996 108.582 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 42.3 t -116.03 130.1 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 125.229 1.412 . . . . 0.94999999999999996 107.193 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 81.6 p -106.21 150.12 26.19 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.864 0.866 . . . . 0.48999999999999999 110.235 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -144.13 120.59 11.01 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.305 1.442 . . . . 2.02 107.618 -174.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -109.58 46.49 1.0 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.34 1.456 . . . . 2.0699999999999998 111.985 -169.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -170.32 -178.2 2.68 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 128.334 2.654 . . . . 2.6800000000000002 105.614 169.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.6 mp -71.02 141.67 50.94 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.89 1.223 . . . . 1.7 111.363 175.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.51 161.36 35.39 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.342 1.057 . . . . 2.4100000000000001 110.372 171.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -68.55 -97.32 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.781 2.987 . . . . 2.2400000000000002 109.395 168.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -75.79 55.73 0.89 Allowed 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.925 -1.109 . . . . 3.1400000000000001 109.965 177.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 47.7 0.89 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 129.145 2.978 . . . . 2.4500000000000002 118.113 -177.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 72.7 t80 70.84 94.74 0.07 Allowed 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 125.693 1.597 . . . . 3.0800000000000001 108.425 -156.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 54.4 mtt180 -79.54 121.15 24.87 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.689 -1.226 . . . . 6.4699999999999998 107.689 175.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 -83.97 173.34 11.26 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 123.07 0.548 . . . . 3.25 111.26 -175.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 61.37 41.2 99.46 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.464 0.555 . . . . 0.78000000000000003 112.95 174.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -157.47 177.56 11.29 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.842 1.257 . . . . 2.3900000000000001 108.897 178.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -96.63 132.59 11.08 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 109.997 -1.241 . . . . 0.70999999999999996 109.997 171.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.7 pp -137.44 162.2 33.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 107.238 -1.393 . . . . 0.56999999999999995 107.238 174.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.4 m -124.51 135.59 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 108.857 -0.794 . . . . 0.71999999999999997 108.857 178.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -124.23 117.71 25.2 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 124.93 1.292 . . . . 0.70999999999999996 109.902 -170.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -105.7 142.21 35.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.479 1.512 . . . . 3.8500000000000001 110.779 -179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 168.89 -132.79 2.65 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 107.047 -2.421 . . . . 0.81999999999999995 107.047 171.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.8 p -132.93 147.38 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 C-N-CA 123.84 0.856 . . . . 0.69999999999999996 110.178 -169.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -58.91 129.57 42.81 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.662 -0.866 . . . . 1.78 108.662 169.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -90.9 -101.23 1.22 Allowed Glycine 0 C--N 1.337 0.629 0 N-CA-C 110.63 -0.988 . . . . 1.8700000000000001 110.63 -166.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.404 ' OE1' ' NZ ' ' A' ' 121' ' ' LYS . 28.6 tt0 -58.56 -68.31 0.27 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.901 1.28 . . . . 4.7999999999999998 108.248 174.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -165.48 -70.81 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.38 -1.711 . . . . 4.1900000000000004 106.38 168.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.9 -44.92 96.67 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.536 1.065 . . . . 1.1000000000000001 112.227 178.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.404 ' NZ ' ' OE1' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -83.86 145.61 28.54 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.286 0.634 . . . . 2.7400000000000002 110.631 -176.394 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.4 mp -106.5 140.26 39.67 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 108.55 -0.908 . . . . 2.1099999999999999 108.55 -176.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -105.99 103.4 12.88 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 107.528 -1.286 . . . . 0.46999999999999997 107.528 172.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -131.39 89.67 2.75 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 122.711 0.404 . . . . 1.51 111.995 -168.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.0 t -83.45 -18.08 39.87 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.761 0.652 . . . . 0.78000000000000003 112.761 -176.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -98.46 82.72 2.91 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 119.303 0.956 . . . . 2.79 109.035 -177.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 33.1 m -93.76 123.5 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 123.041 0.536 . . . . 0.65000000000000002 110.285 177.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -112.8 122.66 48.3 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.155 -1.424 . . . . 0.68000000000000005 107.155 173.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -93.3 126.47 38.44 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.915 -1.143 . . . . 1.8200000000000001 107.915 171.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.73 91.48 2.54 Favored 'General case' 0 CA--C 1.527 0.093 0 N-CA-C 108.678 -0.86 . . . . 3.3799999999999999 108.678 174.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -136.05 56.27 1.83 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.439 1.096 . . . . 7.29 109.579 -170.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 . . . . . 0 N--CA 1.452 -0.37 0 C-N-CA 124.699 1.2 . . . . 7.3200000000000003 109.541 177.227 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 CA--C 1.531 0.225 0 N-CA-C 112.861 0.689 . . . . 7.7800000000000002 112.861 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -142.11 150.23 40.88 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.368 -2.086 . . . . 7.4699999999999998 105.368 165.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.74 -36.13 7.53 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.469 0.708 . . . . 7.4699999999999998 109.994 177.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -153.53 146.08 24.13 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 105.879 -1.897 . . . . 3.6600000000000001 105.879 174.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -163.74 157.89 19.62 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.564 1.075 . . . . 2.1699999999999999 110.919 172.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -83.89 137.22 33.77 Favored 'General case' 0 C--N 1.338 0.072 0 C-N-CA 124.054 0.942 . . . . 1.98 110.555 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.93 148.95 34.42 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.852 1.261 . . . . 2.6299999999999999 110.471 -171.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.1 m -79.74 132.59 60.74 Favored Pre-proline 0 N--CA 1.449 -0.495 0 C-N-CA 124.891 1.276 . . . . 1.8100000000000001 110.667 -177.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.03 -41.05 78.59 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.554 2.17 . . . . 0.97999999999999998 112.452 178.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 m -56.92 -23.56 45.97 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 114.392 1.256 . . . . 2.1299999999999999 114.392 178.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.45 -57.91 4.65 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 106.771 -1.566 . . . . 2.46 106.771 173.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.2 pt -69.35 15.02 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 115.385 1.624 . . . . 0.97999999999999998 115.385 -166.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.3 m -109.37 -21.03 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.557 1.943 . . . . 2.9199999999999999 111.967 172.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -122.99 99.58 6.45 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.735 1.152 . . . . 2.23 110.892 -171.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 58.47 44.09 95.54 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.478 -1.049 . . . . 1.4199999999999999 110.478 175.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.1 mmmt -150.83 -157.88 0.86 Allowed 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 104.455 -2.424 . . . . 3.2999999999999998 104.455 -175.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.9 m -45.17 -46.82 12.28 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.301 1.84 . . . . 2.0 115.914 -170.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -40.0 -57.82 1.55 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.49 1.041 . . . . 2.5699999999999998 111.037 171.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.39 -24.96 27.31 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.05 1.34 . . . . 1.3600000000000001 110.382 -172.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.03 33.97 75.47 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.464 1.507 . . . . 1.1599999999999999 112.438 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.7 m -81.48 -27.81 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 118.052 0.926 . . . . 1.28 112.091 -175.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -119.47 -71.67 0.02 OUTLIER Pre-proline 0 N--CA 1.451 -0.376 0 C-N-CA 124.736 1.214 . . . . 4.2800000000000002 109.98 177.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -77.12 114.03 3.71 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 CA-C-N 120.456 1.199 . . . . 1.4299999999999999 110.116 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -74.5 166.37 23.63 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.362 -0.607 . . . . 2.9300000000000002 109.362 171.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.5 169.18 13.05 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.65 0.262 . . . . 1.21 110.461 175.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.59 5.12 87.08 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 121.748 -0.595 . . . . 1.1599999999999999 112.411 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -103.1 150.97 23.1 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.455 1.102 . . . . 1.4099999999999999 108.92 176.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -91.03 129.55 37.02 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.239 -0.652 . . . . 3.5099999999999998 109.239 175.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.8 pt -143.2 166.54 14.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 106.11 -1.811 . . . . 0.72999999999999998 106.11 167.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.418 ' HG2' ' CG ' ' A' ' 113' ' ' GLN . 47.6 mtt180 -119.61 116.01 25.14 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.337 -0.986 . . . . 2.8900000000000001 108.337 175.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.3 p -84.99 122.46 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 107.518 -1.29 . . . . 1.0700000000000001 107.518 176.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -124.98 119.69 3.7 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 109.622 -1.391 . . . . 0.58999999999999997 109.622 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.38 -156.49 15.45 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.61 -1.396 . . . . 0.68999999999999995 109.61 -175.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 19.4 ptp -106.64 131.15 54.12 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.805 0.812 . . . . 2.6600000000000001 110.448 -172.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.404 HG22 ' H ' ' A' ' 108' ' ' GLN . 9.7 m -84.1 152.82 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 115.491 -0.777 . . . . 2.5299999999999998 109.59 -175.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.464 HG22 ' H ' ' A' ' 68' ' ' VAL . 2.3 m -64.94 179.79 0.63 Allowed 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.478 1.111 . . . . 2.4700000000000002 110.487 176.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.464 ' H ' HG22 ' A' ' 67' ' ' THR . 5.7 p -116.51 73.2 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 126.234 1.814 . . . . 2.8900000000000001 108.25 -175.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.18 50.84 0.91 Allowed Glycine 0 CA--C 1.525 0.681 0 CA-C-N 113.154 -1.839 . . . . 2.0800000000000001 111.404 171.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.7 m -110.99 8.8 22.1 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.407 0.683 . . . . 1.3100000000000001 111.915 174.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.98 109.87 6.85 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 106.541 -1.651 . . . . 2.2000000000000002 106.541 175.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.8 m -121.11 129.09 76.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 108.707 -0.849 . . . . 0.92000000000000004 108.707 171.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.457 ' CB ' HG12 ' A' ' 80' ' ' VAL . 20.1 ptt180 -111.1 148.62 32.28 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 124.405 1.082 . . . . 5.2300000000000004 110.793 177.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -82.37 153.21 68.46 Favored Pre-proline 0 C--O 1.234 0.26 0 N-CA-C 109.148 -0.686 . . . . 2.0899999999999999 109.148 170.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -71.64 8.65 1.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.958 2.439 . . . . 1.71 113.789 176.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -69.32 -26.54 64.76 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.756 -0.59 . . . . 1.6799999999999999 109.84 161.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.0 m 72.25 1.34 3.91 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.158 1.783 . . . . 1.22 113.51 -174.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.38 -3.71 8.9 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.694 1.198 . . . . 2.04 113.505 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -117.55 125.85 51.55 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.786 -1.561 . . . . 1.3400000000000001 106.786 174.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.565 HG23 ' HB3' ' A' ' 96' ' ' TYR . 28.2 m -144.45 150.43 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 108.149 -1.056 . . . . 0.95999999999999996 108.149 -175.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -151.58 154.82 37.21 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.875 -0.516 . . . . 0.98999999999999999 110.439 -179.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.438 ' CE1' ' CE1' ' A' ' 104' ' ' PHE . 33.8 p90 -156.77 153.04 27.72 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.059 0.457 . . . . 2.0600000000000001 111.69 -176.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.24 154.71 19.9 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 123.47 0.708 . . . . 0.69999999999999996 109.978 170.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.3 m -132.54 163.24 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 108.191 -1.04 . . . . 2.3199999999999998 108.191 163.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -137.8 -168.24 2.3 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.352 1.061 . . . . 1.76 109.885 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -137.05 176.56 8.6 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.594 0.758 . . . . 2.3999999999999999 109.453 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.4 m -58.96 -41.25 87.05 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.457 -0.942 . . . . 3.5600000000000001 108.457 156.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.15 22.31 0.53 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.676 0.79 . . . . 4.6699999999999999 111.795 172.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 54.16 42.73 73.15 Favored Glycine 0 CA--C 1.527 0.837 0 O-C-N 121.454 -0.779 . . . . 2.8500000000000001 112.598 172.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -78.29 56.8 4.06 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.129 -0.788 . . . . 2.1000000000000001 111.129 -177.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -58.25 112.07 1.42 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 117.898 0.849 . . . . 4.1900000000000004 110.049 -178.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.0 tp -143.79 160.27 16.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 108.093 -1.077 . . . . 1.5 108.093 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.68 129.09 50.58 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.265 1.026 . . . . 0.68999999999999995 108.533 -168.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.413 ' CG2' ' CE1' ' A' ' 82' ' ' PHE . 5.3 m -115.15 146.77 19.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 109.14 -0.689 . . . . 2.3900000000000001 109.14 173.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.4 p -110.19 155.77 21.53 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.963 1.705 . . . . 0.46000000000000002 107.863 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.565 ' HB3' HG23 ' A' ' 80' ' ' VAL . 1.9 t80 -150.08 113.41 4.92 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.973 -1.491 . . . . 2.02 106.973 -175.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -101.47 45.2 0.98 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.186 1.394 . . . . 2.0899999999999999 110.906 -173.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -162.95 -176.77 5.08 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.65 1.98 . . . . 2.4399999999999999 106.201 170.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.1 mp -79.67 146.25 32.56 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.868 0.867 . . . . 1.55 111.081 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.525 ' HG ' HG21 ' A' ' 80' ' ' VAL . 78.3 mt -82.06 155.38 69.99 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 123.962 0.905 . . . . 1.49 109.412 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -69.99 -89.95 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.554 2.836 . . . . 2.0099999999999998 110.173 176.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.78 45.72 0.43 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.284 1.434 . . . . 3.48 110.613 -176.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 44.19 8.25 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.279 2.632 . . . . 2.1600000000000001 115.854 -164.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.438 ' CE1' ' CE1' ' A' ' 82' ' ' PHE . 65.4 t80 50.74 91.91 0.02 OUTLIER 'General case' 0 C--N 1.34 0.171 0 CA-C-N 119.339 0.972 . . . . 2.9500000000000002 109.873 -153.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -78.6 146.17 34.32 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.814 -1.18 . . . . 6.46 107.814 173.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -93.11 167.19 11.94 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 125.401 1.481 . . . . 3.2799999999999998 109.567 -169.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 47.56 44.17 22.14 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 123.532 0.587 . . . . 0.82999999999999996 113.739 -177.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.404 ' H ' HG22 ' A' ' 66' ' ' VAL . 0.7 OUTLIER -153.24 120.03 5.68 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.793 1.637 . . . . 2.2999999999999998 107.387 176.362 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -63.61 135.24 41.58 Favored Glycine 0 CA--C 1.523 0.54 0 O-C-N 121.207 -0.933 . . . . 0.63 111.368 -175.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.2 pp -135.97 166.09 27.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.817 -1.179 . . . . 0.58999999999999997 107.817 177.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 17.6 m -118.79 128.94 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 108.983 -0.747 . . . . 0.67000000000000004 108.983 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -120.45 118.22 29.72 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 125.023 1.329 . . . . 0.77000000000000002 109.727 -168.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.418 ' CG ' ' HG2' ' A' ' 61' ' ' ARG . 0.8 OUTLIER -114.91 150.31 35.84 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.65 1.58 . . . . 3.8100000000000001 109.915 -178.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 173.33 -122.57 0.93 Allowed Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 106.61 -2.596 . . . . 0.97999999999999998 106.61 165.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.0 p -143.44 148.24 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 118.204 1.002 . . . . 0.78000000000000003 109.821 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -69.85 143.03 52.97 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.251 -0.648 . . . . 2.29 109.251 168.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -166.04 26.18 0.17 Allowed Glycine 0 CA--C 1.523 0.565 0 C-N-CA 119.602 -1.285 . . . . 2.8199999999999998 113.146 171.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -151.91 45.01 0.75 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.926 0.891 . . . . 6.0999999999999996 108.748 -174.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 24.86 59.95 0.05 Allowed 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 128.976 2.91 . . . . 4.0300000000000002 112.481 172.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 139.27 -47.93 0.88 Allowed Glycine 0 CA--C 1.529 0.949 0 CA-C-N 114.77 -1.105 . . . . 1.1499999999999999 110.948 -172.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.5 151.27 20.8 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 117.885 0.842 . . . . 2.1699999999999999 110.184 -174.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 mp -112.68 121.89 46.08 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.721 1.208 . . . . 2.02 109.364 -169.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -82.89 88.23 6.81 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.403 -1.702 . . . . 0.65000000000000002 106.403 175.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -106.62 72.41 0.9 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.168 0.987 . . . . 1.6399999999999999 110.723 -165.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.9 t -80.79 -6.66 58.82 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.037 0.754 . . . . 1.1599999999999999 113.037 -168.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -113.06 88.63 2.88 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 120.799 -1.188 . . . . 4.1200000000000001 108.864 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 27.0 m -96.74 125.93 49.58 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 C-N-CA 123.312 0.645 . . . . 0.81999999999999995 109.826 174.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -111.94 113.33 25.57 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.68 -1.6 . . . . 0.70999999999999996 106.68 177.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.34 36.79 0.25 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.078 0.551 . . . . 1.48 112.069 -178.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.0 ptmt -85.09 60.68 6.4 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.233 -0.917 . . . . 3.2200000000000002 110.307 -173.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -50.53 -47.23 57.64 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.942 0.897 . . . . 6.21 111.27 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.5 t0 . . . . . 0 CA--C 1.538 0.493 0 C-N-CA 125.935 1.694 . . . . 9.3599999999999994 111.536 176.208 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.2 p . . . . . 0 N--CA 1.452 -0.331 0 N-CA-C 107.459 -1.311 . . . . 6.0 107.459 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 38.5 p-10 -105.6 163.03 12.98 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.094 1.357 . . . . 8.5399999999999991 109.293 174.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -151.04 167.17 28.5 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 106.408 -1.701 . . . . 5.5599999999999996 106.408 -178.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -144.87 106.67 4.28 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 108.127 -1.064 . . . . 3.46 108.127 -174.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -131.81 145.34 51.52 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.029 0.932 . . . . 2.1400000000000001 109.926 -173.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -92.04 111.07 22.48 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.751 1.22 . . . . 2.27 109.414 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -125.59 160.16 30.31 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.879 1.272 . . . . 3.8300000000000001 110.104 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.4 p -72.09 135.58 82.46 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 109.599 -0.519 . . . . 1.6799999999999999 109.599 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.412 ' HA ' HD11 ' A' ' 43' ' ' ILE . 33.9 Cg_endo -55.89 -29.59 73.49 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.866 3.044 . . . . 0.93000000000000005 112.337 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.487 ' O ' HG12 ' A' ' 44' ' ' VAL . 31.0 p -66.96 -35.82 80.83 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 113.024 0.75 . . . . 2.1699999999999999 113.024 178.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -45.0 -47.79 11.49 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 118.882 0.765 . . . . 3.0299999999999998 110.036 177.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.458 HD13 ' H ' ' A' ' 43' ' ' ILE 0.34 0.2 OUTLIER -85.76 11.51 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 114.784 1.402 . . . . 1.79 114.784 -170.009 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.487 HG12 ' O ' ' A' ' 41' ' ' SER . 0.8 OUTLIER -103.13 -8.95 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 123.445 0.698 . . . . 2.0299999999999998 112.553 179.184 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -105.79 -58.15 1.95 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.527 0.603 . . . . 2.5699999999999998 111.964 -171.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -160.71 64.56 0.28 Allowed Glycine 0 C--N 1.335 0.5 0 N-CA-C 109.266 -1.534 . . . . 1.47 109.266 -170.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 15.1 mmtt -153.96 -111.93 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 106.339 -1.726 . . . . 2.3399999999999999 106.339 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 28.4 m -54.17 -63.03 1.28 Allowed 'General case' 0 C--N 1.343 0.323 0 C-N-CA 126.851 2.06 . . . . 1.3799999999999999 113.298 177.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -49.46 -42.27 42.62 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.964 0.888 . . . . 2.4199999999999999 110.993 -172.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.86 -9.54 45.97 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.338 1.855 . . . . 1.3799999999999999 113.323 -178.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 48.62 48.93 28.35 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 126.26 1.886 . . . . 1.2 113.763 -174.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.5 m -95.18 -55.71 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 118.566 1.183 . . . . 1.27 112.275 -177.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.1 mmtt -87.34 -59.82 0.26 Allowed Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 123.762 0.825 . . . . 3.2000000000000002 111.035 178.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -81.79 155.48 17.97 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 121.942 1.761 . . . . 1.49 109.89 174.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -124.02 60.21 1.13 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.676 1.19 . . . . 3.5699999999999998 109.037 174.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 48.7 -144.46 0.42 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.318 1.047 . . . . 2.6699999999999999 110.116 -174.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 40.23 30.83 0.3 Allowed Glycine 0 CA--C 1.533 1.165 0 C-N-CA 127.83 2.633 . . . . 1.3700000000000001 117.527 165.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -134.62 167.41 20.87 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.857 1.663 . . . . 1.3999999999999999 108.017 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -101.46 134.56 44.36 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.681 -0.859 . . . . 3.5699999999999998 108.681 171.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.4 pt -139.22 167.68 19.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 105.055 -2.202 . . . . 0.89000000000000001 105.055 168.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.8 mtm180 -126.74 122.89 36.13 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.86 -1.533 . . . . 2.2000000000000002 106.86 174.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.7 m -88.56 138.12 19.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 107.691 -1.226 . . . . 2.3999999999999999 107.691 177.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.0 110.4 0.58 Allowed Glycine 0 C--O 1.226 -0.393 0 N-CA-C 109.599 -1.401 . . . . 0.89000000000000001 109.599 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -172.78 -161.37 23.08 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 108.862 -1.695 . . . . 0.72999999999999998 108.862 -173.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.17 132.74 41.27 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 117.694 0.747 . . . . 2.6499999999999999 110.843 -176.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.522 HG11 ' CE2' ' A' ' 104' ' ' PHE . 23.1 m -91.07 150.93 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-N 116.165 -0.47 . . . . 2.6499999999999999 110.097 174.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.464 HG22 ' H ' ' A' ' 68' ' ' VAL . 0.3 OUTLIER -64.13 -179.31 0.42 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.704 0.764 . . . . 2.2799999999999998 109.856 174.64 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.464 ' H ' HG22 ' A' ' 67' ' ' THR . 4.6 p -123.7 71.02 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 126.176 1.79 . . . . 2.5699999999999998 107.893 175.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.33 -21.75 1.21 Allowed Glycine 0 CA--C 1.53 1.012 0 CA-C-N 114.167 -1.379 . . . . 2.46 113.93 174.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.8 m -62.12 -17.65 58.44 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.655 1.227 . . . . 1.1699999999999999 113.713 -178.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.5 ttm -58.85 125.88 25.35 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 122.972 0.509 . . . . 2.0499999999999998 109.87 171.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.28 130.67 67.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 107.615 -1.254 . . . . 0.63 107.615 166.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -114.46 143.59 44.69 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.599 1.159 . . . . 4.21 109.36 -177.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.49 147.05 51.76 Favored Pre-proline 0 N--CA 1.454 -0.246 0 N-CA-C 109.626 -0.509 . . . . 1.8500000000000001 109.626 177.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -62.51 -25.93 76.01 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.664 2.242 . . . . 1.46 110.826 170.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -42.38 -41.64 2.93 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.572 1.549 . . . . 1.72 110.475 174.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.3 m 87.95 5.9 0.23 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 126.927 2.091 . . . . 1.4099999999999999 113.064 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.84 3.79 9.45 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.011 0.924 . . . . 2.4300000000000002 113.355 173.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -128.06 135.07 49.34 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 119.044 0.838 . . . . 1.1499999999999999 109.633 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.594 HG23 ' HB3' ' A' ' 96' ' ' TYR . 2.2 m -149.88 138.76 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 106.928 -1.508 . . . . 0.68000000000000005 106.928 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -142.11 157.93 44.33 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.46 -0.571 . . . . 1.29 109.46 174.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -156.14 152.32 27.78 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.946 -0.39 . . . . 1.8899999999999999 109.946 -174.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.93 149.0 22.38 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.46 -0.57 . . . . 0.55000000000000004 109.46 170.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.1 p -136.78 152.76 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.385 1.074 . . . . 1.9099999999999999 108.919 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -143.01 179.5 7.0 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.43 0.692 . . . . 1.4199999999999999 111.524 -174.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -137.89 -172.96 3.38 Favored 'General case' 0 C--N 1.341 0.223 0 N-CA-C 109.845 -0.428 . . . . 2.3999999999999999 109.845 177.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 66.7 m -74.79 14.93 0.43 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.129 1.772 . . . . 3.4100000000000001 112.369 169.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -118.74 26.6 9.44 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.327 1.051 . . . . 5.0800000000000001 111.718 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 51.46 35.81 37.08 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 123.888 0.756 . . . . 3.2000000000000002 111.84 174.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -117.84 130.89 9.01 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 107.802 -2.119 . . . . 1.6899999999999999 107.802 -174.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -120.55 130.52 54.26 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 106.943 -1.502 . . . . 4.3600000000000003 106.943 177.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -132.04 146.27 33.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.297 -1.001 . . . . 0.95999999999999996 108.297 174.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 mt -101.88 128.35 48.3 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.208 1.403 . . . . 0.80000000000000004 109.913 -175.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.3 t -119.33 125.83 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 124.914 1.285 . . . . 1.0600000000000001 108.14 -178.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 42.3 p -95.85 152.18 18.73 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.681 0.792 . . . . 0.57999999999999996 108.926 174.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.594 ' HB3' HG23 ' A' ' 80' ' ' VAL . 3.2 t80 -145.84 166.96 24.4 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.411 1.085 . . . . 2.6299999999999999 108.733 -177.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -155.61 150.7 26.67 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 105.373 -2.084 . . . . 3.2599999999999998 105.373 -169.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 62.96 61.54 1.11 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 129.299 3.039 . . . . 3.0099999999999998 111.587 -176.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.3 mt 51.68 -152.32 0.23 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.552 1.141 . . . . 1.8600000000000001 109.158 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.453 HD23 ' CZ ' ' A' ' 96' ' ' TYR . 8.6 mt -146.57 153.69 47.59 Favored Pre-proline 0 N--CA 1.449 -0.481 0 N-CA-C 105.764 -1.939 . . . . 1.3700000000000001 105.764 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.84 -83.44 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 125.118 3.879 . . . . 2.6400000000000001 109.853 -174.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -73.75 34.09 0.08 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.34 1.456 . . . . 5.6900000000000004 110.701 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 61.19 -22.61 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.658 1.983 . . . . 3.5 114.155 -170.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.522 ' CE2' HG11 ' A' ' 66' ' ' VAL . 64.6 t80 59.69 86.91 0.09 Allowed 'General case' 0 C--N 1.342 0.275 0 CA-C-N 120.286 1.403 . . . . 2.6800000000000002 107.7 -155.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 19.8 mtp85 -82.95 127.64 33.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 105.663 -1.977 . . . . 3.9399999999999999 105.663 175.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -81.37 169.33 17.35 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.101 0.477 . . . . 2.8599999999999999 110.284 -170.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.15 45.67 90.76 Favored Glycine 0 CA--C 1.533 1.188 0 O-C-N 121.765 -0.585 . . . . 0.89000000000000001 113.399 177.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -155.78 179.57 9.07 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.487 1.515 . . . . 2.4100000000000001 107.756 175.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -94.82 133.78 11.7 Favored Glycine 0 CA--C 1.52 0.37 0 N-CA-C 109.625 -1.39 . . . . 0.77000000000000002 109.625 170.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.4 pp -138.73 161.92 29.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 107.477 -1.305 . . . . 0.77000000000000002 107.477 175.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 18.6 m -118.7 123.66 71.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.321 -0.992 . . . . 0.80000000000000004 108.321 177.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.572 ' CB ' HG12 ' A' ' 127' ' ' VAL . . . -110.37 136.81 48.97 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 125.902 1.681 . . . . 0.67000000000000004 109.732 -175.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -128.81 141.53 51.27 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.036 1.734 . . . . 3.0800000000000001 108.612 -175.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 173.29 -121.83 0.88 Allowed Glycine 0 C--N 1.336 0.547 0 N-CA-C 109.218 -1.553 . . . . 0.90000000000000002 109.218 168.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.04 153.21 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.861 -0.792 . . . . 0.77000000000000002 108.861 -173.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -57.71 142.38 45.41 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.186 -0.672 . . . . 1.73 109.186 171.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -87.13 -126.27 2.15 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 109.355 -1.498 . . . . 2.02 109.355 -174.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -60.66 -64.87 0.8 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.265 0.626 . . . . 5.1299999999999999 109.512 178.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -149.87 -74.08 0.17 Allowed 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 107.043 -1.465 . . . . 3.6800000000000002 107.043 173.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -72.54 -39.73 55.65 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.055 -0.975 . . . . 1.24 111.626 -174.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.57 153.47 26.73 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.615 0.766 . . . . 3.6800000000000002 109.699 -175.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -110.06 136.4 49.36 Favored 'General case' 0 N--CA 1.46 0.072 0 C-N-CA 125.12 1.368 . . . . 2.2000000000000002 108.275 -176.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -105.78 90.22 3.32 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.712 -1.218 . . . . 0.55000000000000004 107.712 174.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -88.17 145.22 26.02 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 108.388 -0.968 . . . . 1.46 108.388 176.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.4 t -134.73 0.06 2.92 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.977 0.732 . . . . 1.1100000000000001 112.977 169.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -129.48 99.89 5.35 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 120.669 -1.269 . . . . 2.8799999999999999 109.123 171.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.585 HG13 ' HE2' ' A' ' 96' ' ' TYR . 29.4 m -98.69 148.27 6.21 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 CA-C-N 118.885 0.766 . . . . 1.0600000000000001 111.546 166.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.35 112.5 16.41 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.033 -1.84 . . . . 0.76000000000000001 106.033 176.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -100.23 41.52 1.16 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.088 0.955 . . . . 2.04 111.482 -175.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -73.63 71.91 1.42 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.844 1.258 . . . . 4.5800000000000001 111.282 -176.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -137.86 43.03 2.26 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.749 0.704 . . . . 4.2000000000000002 112.697 -170.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 CA--C 1.534 0.339 0 C-N-CA 124.848 1.259 . . . . 6.0 109.598 -172.205 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 CA--C 1.539 0.52 0 N-CA-C 115.919 1.822 . . . . 5.7800000000000002 115.919 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.2 t30 53.97 58.99 4.54 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.861 0.864 . . . . 8.9700000000000006 112.96 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.7 mp -107.4 -112.64 0.29 Allowed 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 117.813 -1.089 . . . . 6.3300000000000001 110.95 168.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.0 m-20 -70.17 94.8 0.93 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 122.792 2.542 . . . . 3.96 112.036 -129.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -129.42 163.88 24.86 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 123.935 0.894 . . . . 2.0600000000000001 111.612 -167.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -82.05 132.05 35.25 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.084 0.954 . . . . 2.3500000000000001 109.238 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -131.59 152.92 50.42 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.126 1.77 . . . . 3.8599999999999999 108.589 176.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.9 p -94.19 143.73 26.87 Favored Pre-proline 0 N--CA 1.442 -0.853 0 C-N-CA 125.203 1.401 . . . . 2.0899999999999999 108.729 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -61.57 -18.09 57.84 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.598 2.199 . . . . 1.4199999999999999 112.465 178.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.0 p -47.46 -40.48 18.31 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.32 1.048 . . . . 4.0700000000000003 112.181 165.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.48 ' HG3' ' HD3' ' A' ' 47' ' ' LYS . 7.4 tp10 -83.11 -52.48 6.59 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.966 -1.124 . . . . 2.48 107.966 -169.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 26.8 pt -81.11 30.83 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.046 0.938 . . . . 1.23 113.126 -170.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 9.0 p -122.88 -44.91 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.923 1.689 . . . . 2.5899999999999999 110.59 173.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -77.21 -41.6 40.72 Favored 'General case' 0 C--N 1.34 0.157 0 O-C-N 121.718 -0.614 . . . . 2.52 112.37 -162.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.04 59.66 0.13 Allowed Glycine 0 C--N 1.332 0.346 0 N-CA-C 109.439 -1.464 . . . . 1.4399999999999999 109.439 -170.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.48 ' HD3' ' HG3' ' A' ' 42' ' ' GLU . 4.6 mttt -155.19 -94.48 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.522 1.929 . . . . 2.27 108.364 -178.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.492 HG23 HD23 ' A' ' 116' ' ' LEU . 97.7 m -71.95 -58.39 3.49 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 119.271 0.941 . . . . 1.6000000000000001 111.877 -172.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -46.83 -53.67 11.51 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.778 0.799 . . . . 2.5099999999999998 110.243 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.43 -23.8 29.83 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.747 -1.115 . . . . 1.24 111.965 -171.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.7 53.41 41.43 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.203 1.383 . . . . 1.3700000000000001 111.864 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.274 31.8 m -110.13 -73.58 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 113.73 1.011 . . . . 1.74 113.73 -178.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -64.44 -56.59 21.77 Favored Pre-proline 0 CA--C 1.538 0.507 0 O-C-N 120.953 -1.092 . . . . 3.1299999999999999 113.017 -176.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -87.26 159.23 8.33 Favored 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 123.391 2.728 . . . . 1.3200000000000001 108.371 175.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -100.19 150.76 22.19 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.738 -0.838 . . . . 3.6200000000000001 108.738 171.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.46 157.97 10.4 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.275 -0.639 . . . . 1.1200000000000001 109.275 169.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.57 -0.24 70.8 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 119.041 -0.866 . . . . 1.26 113.819 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.475 ' O ' HD12 ' A' ' 116' ' ' LEU . 31.4 mt-30 -81.39 158.97 24.46 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 119.415 1.608 . . . . 1.4099999999999999 108.456 169.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 45.4 mtt180 -92.82 137.23 32.55 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.71 -0.478 . . . . 3.4700000000000002 109.71 170.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.6 pt -144.7 175.07 3.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 107.482 -1.303 . . . . 0.79000000000000004 107.482 167.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -121.68 124.26 43.85 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-O 119.079 -0.486 . . . . 1.99 110.236 168.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.0 p -82.59 128.5 38.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 N-CA-C 107.537 -1.283 . . . . 1.0 107.537 170.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -128.21 129.27 6.23 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 109.16 -1.576 . . . . 0.56000000000000005 109.16 172.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 176.89 -150.96 10.69 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 107.576 -2.209 . . . . 0.77000000000000002 107.576 -175.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.401 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 1.8 ppp? -125.27 155.6 39.89 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 118.473 1.136 . . . . 4.4400000000000004 111.843 177.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.8 p -100.97 131.73 48.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 114.471 -1.241 . . . . 2.3599999999999999 109.799 -174.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.11 159.54 20.18 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 122.228 1.013 . . . . 2.1200000000000001 109.509 174.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.9 p -67.56 -34.31 67.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.859 1.264 . . . . 1.75 112.89 -175.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -120.86 84.07 0.37 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 108.956 -1.658 . . . . 2.0600000000000001 108.956 175.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.3 m -140.29 -43.96 0.41 Allowed 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.909 0.884 . . . . 1.3300000000000001 112.322 -176.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.16 109.77 3.19 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.567 0.747 . . . . 2.0899999999999999 110.184 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.8 m -111.33 117.24 54.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 107.417 -1.327 . . . . 0.64000000000000001 107.417 169.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.95 140.06 42.96 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.86 1.264 . . . . 5.9000000000000004 109.416 -176.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -82.13 149.31 62.22 Favored Pre-proline 0 N--CA 1.455 -0.221 0 N-CA-C 108.903 -0.777 . . . . 1.78 108.903 176.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -66.11 -20.89 56.47 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.497 2.131 . . . . 1.76 110.227 167.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -41.53 -43.36 2.65 Favored 'General case' 0 C--O 1.222 -0.37 0 C-N-CA 123.75 0.82 . . . . 1.2 109.415 163.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.8 m 73.49 4.2 4.74 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.055 1.342 . . . . 1.45 112.905 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.2 18.44 10.72 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.882 1.673 . . . . 1.8700000000000001 110.539 173.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 48.9 m-70 -150.79 119.21 6.42 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.478 -1.675 . . . . 1.1000000000000001 106.478 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.7 m -148.54 135.95 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 105.974 -1.861 . . . . 0.78000000000000003 105.974 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -138.78 152.34 47.83 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 119.853 1.206 . . . . 0.93999999999999995 110.799 -177.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -149.33 153.11 36.97 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.28 0.632 . . . . 1.8500000000000001 109.693 -172.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.59 147.41 23.94 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.637 0.775 . . . . 1.01 109.414 169.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.0 t -124.55 146.61 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 N-CA-C 107.429 -1.323 . . . . 1.8 107.429 169.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -150.9 -167.06 2.71 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 108.603 -0.888 . . . . 1.3300000000000001 108.603 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -150.65 177.73 9.78 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 107.871 -1.159 . . . . 3.5699999999999998 107.871 166.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.8 t -45.57 122.53 3.66 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.362 -1.347 . . . . 3.48 107.362 150.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.417 ' CD2' ' H ' ' A' ' 88' ' ' LEU . 0.6 OUTLIER -0.59 40.36 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 131.533 3.933 . . . . 5.9699999999999998 116.539 -145.744 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -84.83 51.2 4.52 Favored Glycine 0 CA--C 1.524 0.629 0 O-C-N 120.814 -1.179 . . . . 4.9199999999999999 110.402 169.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 42.09 -122.21 2.85 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.973 1.273 . . . . 2.2200000000000002 113.002 176.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -171.01 156.72 4.96 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.689 1.996 . . . . 2.5699999999999998 106.81 168.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.5 tp -151.18 162.17 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.834 1.254 . . . . 1.2 108.19 172.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 mt -124.25 131.21 53.51 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 124.545 1.138 . . . . 0.93000000000000005 109.928 -176.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.6 p -135.16 142.17 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.822 0.849 . . . . 3.0600000000000001 110.166 -174.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 31.6 p -105.28 153.46 21.57 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.172 1.389 . . . . 1.3100000000000001 108.973 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.454 ' CD2' HD21 ' A' ' 100' ' ' LEU . 3.7 t80 -141.43 138.93 33.27 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.268 -1.753 . . . . 2.2200000000000002 106.268 178.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -128.45 39.43 3.82 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.249 1.02 . . . . 2.2000000000000002 112.138 -165.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -166.22 56.93 0.1 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.945 0.898 . . . . 2.8999999999999999 110.934 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.8 mp 51.95 -168.35 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.911 1.284 . . . . 1.77 111.366 -170.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.454 HD21 ' CD2' ' A' ' 96' ' ' TYR . 15.2 mt -148.34 150.69 35.11 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.286 1.434 . . . . 1.4199999999999999 107.215 174.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -62.16 132.75 40.41 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 123.413 2.742 . . . . 2.6899999999999999 109.746 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 37.3 49.25 0.9 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.391 1.877 . . . . 4.3600000000000003 111.645 -173.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 56.72 10.69 0.76 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 128.73 2.812 . . . . 2.3500000000000001 115.518 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.6 t80 64.73 99.79 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.788 1.235 . . . . 2.6699999999999999 108.134 -162.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 46.0 mtt180 -77.44 131.44 37.99 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.441 -1.688 . . . . 4.96 106.441 172.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -83.58 170.72 14.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.102 0.561 . . . . 4.5899999999999999 109.6 -176.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.42 46.9 91.57 Favored Glycine 0 CA--C 1.531 1.058 0 O-C-N 121.924 -0.485 . . . . 0.81999999999999995 112.826 174.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -151.7 179.07 8.73 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.895 1.678 . . . . 2.3700000000000001 108.555 178.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 65' ' ' MET . . . -111.24 142.97 17.11 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.2 -0.76 . . . . 0.75 111.2 171.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.4 pp -145.84 168.97 6.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 125.498 1.519 . . . . 0.85999999999999999 106.917 -178.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 11.0 m -120.77 138.73 50.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 N-CA-C 108.011 -1.107 . . . . 0.56000000000000005 108.011 167.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -127.28 118.17 23.7 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 124.627 1.171 . . . . 0.52000000000000002 109.439 -176.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.67 132.86 52.88 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.197 1.399 . . . . 3.3700000000000001 108.639 -175.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 178.47 -160.75 26.93 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 120.858 -0.687 . . . . 1.26 112.308 -177.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.6 p -123.52 138.39 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 125.114 1.365 . . . . 0.97999999999999998 110.121 -169.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.492 HD23 HG23 ' A' ' 48' ' ' THR . 3.8 mp -68.56 138.8 55.42 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.768 -0.583 . . . . 2.3399999999999999 111.027 -179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -95.98 -114.9 2.98 Favored Glycine 0 C--N 1.341 0.809 0 N-CA-C 109.943 -1.263 . . . . 1.79 109.943 -166.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -46.82 -55.92 7.12 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 117.876 0.838 . . . . 4.0700000000000003 112.318 175.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 176.25 -79.08 0.0 OUTLIER 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 128.004 2.522 . . . . 3.4700000000000002 105.251 -174.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.5 -25.13 76.16 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.601 1.096 . . . . 0.96999999999999997 112.679 -174.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.55 152.47 21.68 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.528 1.531 . . . . 2.5099999999999998 109.572 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.0 mp -117.8 156.53 28.19 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.08 0.552 . . . . 2.0899999999999999 109.911 -178.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -120.07 107.42 13.03 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.065 1.346 . . . . 0.73999999999999999 107.979 173.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.24 132.9 41.99 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 118.951 -0.547 . . . . 1.03 110.743 -175.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.3 t -122.2 4.4 9.78 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.38 0.672 . . . . 0.96999999999999997 112.473 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -113.1 79.55 1.25 Allowed 'General case' 0 CA--C 1.531 0.229 0 O-C-N 120.587 -1.321 . . . . 2.5800000000000001 109.361 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 19.1 m -95.41 132.42 39.53 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 C-N-CA 122.918 0.487 . . . . 0.71999999999999997 110.325 174.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.06 107.13 14.14 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.245 -1.761 . . . . 0.73999999999999999 106.245 175.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.52 105.4 13.54 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.194 -1.039 . . . . 1.5 108.194 175.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -121.68 71.21 0.97 Allowed 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.84 0.856 . . . . 2.9700000000000002 109.618 -176.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -148.16 161.7 40.91 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.082 -1.451 . . . . 4.1299999999999999 107.082 178.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 66.0 t0 . . . . . 0 N--CA 1.45 -0.468 0 N-CA-C 108.05 -1.093 . . . . 6.1799999999999997 108.05 174.037 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.2 m . . . . . 0 N--CA 1.454 -0.234 0 N-CA-C 106.975 -1.491 . . . . 6.1699999999999999 106.975 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -84.41 163.07 19.73 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.248 -0.649 . . . . 7.2400000000000002 109.248 176.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.8 mp -108.69 138.83 44.38 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 107.341 -1.355 . . . . 6.7000000000000002 107.341 170.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -129.8 90.42 2.97 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 107.638 -1.245 . . . . 4.3399999999999999 107.638 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -136.41 175.28 9.75 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.57 0.748 . . . . 2.6400000000000001 111.087 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -83.68 120.26 25.78 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.782 1.233 . . . . 2.5099999999999998 109.695 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -116.17 163.33 16.12 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.615 1.566 . . . . 2.8199999999999998 109.705 177.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.8 m -84.91 132.89 44.54 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 109.306 -0.628 . . . . 1.8 109.306 -174.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -56.45 -45.33 38.22 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 123.191 2.594 . . . . 0.81000000000000005 111.741 -176.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.0 t -61.74 -23.35 66.1 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.351 -0.843 . . . . 2.52 112.341 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -66.74 -45.94 77.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.926 -1.138 . . . . 3.3199999999999998 107.926 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.429 HD11 HG21 ' A' ' 92' ' ' ILE 0.388 18.6 pt -65.56 -11.68 12.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 N-CA-C 114.233 1.197 . . . . 1.3100000000000001 114.233 -177.29 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -79.68 -30.83 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.409 0.683 . . . . 1.97 112.266 169.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -81.26 -76.4 0.25 Allowed 'General case' 0 N--CA 1.466 0.354 0 O-C-N 121.087 -1.008 . . . . 3.0800000000000001 112.968 -162.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -133.34 51.26 0.85 Allowed Glycine 0 C--N 1.333 0.415 0 N-CA-C 108.055 -2.018 . . . . 2.1400000000000001 108.055 -174.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 1.8 mmtt -147.04 -114.03 0.08 Allowed 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 125.669 1.588 . . . . 4.1699999999999999 108.483 -164.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.0 m -77.12 -55.83 5.1 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 119.401 1.0 . . . . 1.3700000000000001 110.877 -169.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -44.3 -59.82 2.21 Favored 'General case' 0 C--N 1.341 0.204 0 O-C-N 123.87 0.732 . . . . 3.0899999999999999 110.459 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.9 m -84.47 -16.11 43.65 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.216 -0.902 . . . . 1.6299999999999999 110.907 -174.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 65.19 50.44 56.79 Favored Glycine 0 C--N 1.339 0.703 0 C-N-CA 124.077 0.846 . . . . 1.3300000000000001 112.36 170.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.9 m -106.3 -54.31 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 117.832 0.816 . . . . 1.3100000000000001 112.982 -175.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.3 mttt -90.06 -62.02 0.21 Allowed Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 123.645 0.778 . . . . 5.5800000000000001 112.242 -176.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.41 ' CD ' ' HA ' ' A' ' 47' ' ' LYS . 29.7 Cg_endo -80.34 170.77 15.72 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.795 2.33 . . . . 1.53 108.096 170.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -128.53 160.24 32.98 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.593 -1.632 . . . . 3.23 106.593 168.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.38 156.78 37.11 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.135 -1.061 . . . . 1.1699999999999999 108.135 171.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.49 10.85 60.12 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.093 0.854 . . . . 1.04 112.316 -173.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -110.13 149.52 29.94 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 118.195 0.997 . . . . 1.3300000000000001 109.598 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.12 119.11 35.0 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.688 1.195 . . . . 4.3700000000000001 108.0 -177.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.5 pt -143.6 179.33 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 107.881 -1.155 . . . . 0.84999999999999998 107.881 177.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.3 mtt-85 -126.81 141.26 51.87 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.683 -1.229 . . . . 2.7400000000000002 107.683 172.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.4 p -108.6 132.46 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 106.827 -1.546 . . . . 0.77000000000000002 106.827 176.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.2 124.27 2.75 Favored Glycine 0 C--N 1.334 0.44 0 N-CA-C 109.719 -1.352 . . . . 0.52000000000000002 109.719 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 179.67 -156.95 19.47 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 107.906 -2.077 . . . . 0.58999999999999997 107.906 -176.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -104.66 134.6 47.55 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 118.315 1.058 . . . . 4.6399999999999997 110.646 -172.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.411 ' HB ' ' CZ ' ' A' ' 104' ' ' PHE . 2.8 m -79.92 141.04 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.736 -0.665 . . . . 2.3700000000000001 109.408 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.0 m -76.87 133.61 39.26 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.802 -0.814 . . . . 2.3900000000000001 108.802 172.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.1 p -45.92 -51.24 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 125.651 1.58 . . . . 1.78 112.2 177.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.63 61.74 1.18 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.296 -1.122 . . . . 1.98 110.296 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.1 m -154.83 53.15 0.64 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.589 1.194 . . . . 2.2599999999999998 112.718 -176.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.14 104.88 5.34 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 107.725 -1.213 . . . . 1.7 107.725 174.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.1 m -123.6 135.13 64.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 109.17 -0.678 . . . . 0.57999999999999996 109.17 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.411 ' CB ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -127.38 147.4 50.27 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.714 1.605 . . . . 5.4800000000000004 110.496 -172.807 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -75.79 157.19 84.15 Favored Pre-proline 0 CA--C 1.529 0.172 0 C-N-CA 122.788 0.435 . . . . 2.5600000000000001 110.525 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -66.5 -19.85 54.51 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 123.032 2.488 . . . . 1.24 111.762 166.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -50.16 -35.23 25.28 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.105 0.562 . . . . 1.8200000000000001 110.573 163.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.6 m 71.07 18.46 5.86 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.728 1.611 . . . . 1.53 112.813 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.18 -45.45 2.11 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 125.352 1.461 . . . . 2.5 111.429 170.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -78.46 131.66 36.96 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 107.302 -1.37 . . . . 1.8799999999999999 107.302 -177.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.556 HG23 ' HB3' ' A' ' 96' ' ' TYR . 26.6 m -147.02 147.52 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 107.784 -1.191 . . . . 0.71999999999999997 107.784 -174.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -149.71 156.79 42.45 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.54 -0.725 . . . . 1.3500000000000001 110.217 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -154.09 161.01 42.21 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.401 -0.818 . . . . 2.0899999999999999 109.93 -173.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -105.98 138.66 41.78 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.879 -0.785 . . . . 0.60999999999999999 108.879 174.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.5 t -121.19 142.0 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 107.678 -1.23 . . . . 1.98 107.678 176.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -144.09 -175.72 4.72 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.02 -0.733 . . . . 1.8999999999999999 109.02 177.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -140.29 179.23 6.76 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.054 -0.721 . . . . 2.6200000000000001 109.054 165.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 55.8 p -48.28 -28.9 3.38 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.903 2.081 . . . . 3.4500000000000002 111.707 171.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 15.0 mt -68.27 -5.2 17.2 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.662 1.185 . . . . 5.1799999999999997 112.853 177.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.32 -39.6 2.78 Favored Glycine 0 C--N 1.337 0.61 0 O-C-N 121.587 -0.696 . . . . 3.3100000000000001 111.971 166.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.1 136.21 43.19 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.912 -0.875 . . . . 1.5 110.912 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -123.36 150.78 43.25 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 126.435 1.894 . . . . 4.4199999999999999 107.533 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.429 HG21 HD11 ' A' ' 43' ' ' ILE . 11.3 tp -146.34 146.39 19.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 122.986 0.514 . . . . 1.3 110.041 174.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.4 mt -91.05 137.26 32.5 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.452 1.101 . . . . 0.72999999999999998 110.61 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.3 t -127.3 129.47 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 126.214 1.806 . . . . 1.01 107.636 -178.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 44.2 p -107.98 145.19 34.23 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.766 1.226 . . . . 0.72999999999999998 109.463 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.556 ' HB3' HG23 ' A' ' 80' ' ' VAL . 2.3 t80 -138.7 126.89 22.74 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.685 1.594 . . . . 1.99 107.277 -175.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -108.36 44.62 1.1 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.817 1.247 . . . . 1.9399999999999999 112.331 -170.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -170.7 171.98 5.98 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.593 1.957 . . . . 3.0600000000000001 107.733 172.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.2 mp -66.46 137.63 56.97 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.579 -0.701 . . . . 1.97 110.661 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.51 ' HG ' HG21 ' A' ' 80' ' ' VAL . 19.2 mt -76.21 159.0 81.18 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.224 0.609 . . . . 1.3799999999999999 109.465 176.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -64.83 -88.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.59 2.86 . . . . 2.0099999999999998 109.843 170.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.6 29.4 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.171 1.388 . . . . 3.5299999999999998 113.011 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 50.7 1.66 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 115.923 1.823 . . . . 2.1600000000000001 115.923 -168.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.411 ' CZ ' ' HB ' ' A' ' 66' ' ' VAL . 26.6 t80 58.58 93.98 0.03 OUTLIER 'General case' 0 C--N 1.342 0.281 0 C-N-CA 124.652 1.181 . . . . 3.1400000000000001 109.135 -156.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 26.8 mtp85 -77.78 157.43 29.99 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 107.095 -1.446 . . . . 4.2800000000000002 107.095 177.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -83.93 119.99 25.55 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.388 -0.968 . . . . 2.9900000000000002 108.388 -169.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.3 68.02 1.73 Allowed Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.458 1.028 . . . . 0.76000000000000001 113.09 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.45 ' O ' HG23 ' A' ' 110' ' ' ILE . 1.2 pt20 -156.64 62.61 0.53 Allowed 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 124.141 0.976 . . . . 2.7200000000000002 110.519 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -27.66 119.56 0.05 OUTLIER Glycine 0 CA--C 1.529 0.93 0 C-N-CA 126.028 1.775 . . . . 0.87 114.997 -166.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.45 HG23 ' O ' ' A' ' 108' ' ' GLN . 2.6 pp -121.68 167.88 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 N-CA-C 108.602 -0.888 . . . . 0.75 108.602 -173.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.8 m -117.66 134.41 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 108.583 -0.895 . . . . 0.70999999999999996 108.583 177.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -122.72 136.25 54.82 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.84 1.656 . . . . 0.5 108.623 -175.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -119.81 144.95 47.05 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.327 1.451 . . . . 4.3499999999999996 108.942 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 162.82 -147.84 14.1 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 110.132 -1.187 . . . . 0.92000000000000004 110.132 173.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.9 p -126.13 136.53 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 123.435 0.694 . . . . 0.65000000000000002 109.801 -166.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.736 ' HG ' HD22 ' A' ' 122' ' ' LEU . 7.9 mp -80.92 153.43 27.56 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.901 -1.518 . . . . 2.71 106.901 175.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -172.21 -47.65 0.04 OUTLIER Glycine 0 C--N 1.333 0.394 0 C-N-CA 119.584 -1.293 . . . . 2.1699999999999999 112.88 -178.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -62.33 158.66 16.88 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.832 -0.803 . . . . 4.7699999999999996 108.832 172.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -81.5 64.0 6.04 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 122.218 1.009 . . . . 4.7400000000000002 108.297 -175.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 116.07 17.93 6.11 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 126.04 1.781 . . . . 1.8100000000000001 113.749 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.533 ' C ' HD23 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -134.31 156.09 49.07 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.004 1.402 . . . . 2.75 109.591 169.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.736 HD22 ' HG ' ' A' ' 116' ' ' LEU . 2.1 mt -114.67 141.52 47.69 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.326 0.65 . . . . 2.0 110.432 -173.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -101.22 104.47 15.52 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.4 -0.963 . . . . 0.52000000000000002 108.4 175.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -128.66 117.6 21.48 Favored 'General case' 0 C--O 1.225 -0.194 0 C-N-CA 123.131 0.572 . . . . 0.95999999999999996 109.78 -177.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 9.2 t -110.59 -6.61 14.83 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.338 1.055 . . . . 0.89000000000000001 111.614 177.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -99.54 89.59 4.21 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 120.658 -1.277 . . . . 3.9100000000000001 108.375 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.9 m -106.76 133.92 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 121.829 2.104 . . . . 0.68000000000000005 111.848 175.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -123.36 104.25 8.99 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.771 1.228 . . . . 0.73999999999999999 108.626 -175.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.34 59.89 3.58 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.493 -0.754 . . . . 1.2 110.832 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.34 -24.29 61.27 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.209 0.818 . . . . 3.4700000000000002 113.209 -175.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -79.9 57.03 2.48 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.019 0.928 . . . . 5.21 110.546 -178.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.2 t70 . . . . . 0 CA--C 1.532 0.263 0 CA-C-O 121.535 0.683 . . . . 5.4900000000000002 109.858 174.401 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.455 -0.19 0 N-CA-C 108.076 -1.083 . . . . 6.3399999999999999 108.076 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.64 119.73 31.78 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 109.335 -0.617 . . . . 7.0 109.335 -176.128 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.0 tp -66.52 128.65 37.03 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 107.422 -1.325 . . . . 6.4900000000000002 107.422 169.508 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -161.02 93.1 0.95 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.926 1.239 . . . . 3.46 112.297 173.406 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -141.98 164.34 30.43 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.283 0.947 . . . . 1.8300000000000001 112.365 -175.345 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.406 ' CD1' ' HB2' ' A' ' 61' ' ' ARG . 98.3 m-85 -83.1 119.21 24.22 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 125.168 1.387 . . . . 2.7400000000000002 109.267 176.53 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.59 159.19 19.89 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.195 0.998 . . . . 2.73 110.808 178.889 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.36 144.01 91.4 Favored Pre-proline 0 N--CA 1.451 -0.402 0 C-N-CA 123.783 0.833 . . . . 1.52 109.313 175.019 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.52 -45.58 4.84 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.636 2.224 . . . . 0.92000000000000004 111.031 179.538 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.5 p -45.28 -46.39 12.64 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.412 1.485 . . . . 2.2799999999999998 112.34 -179.588 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.84 -57.1 10.31 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.071 -1.085 . . . . 3.6200000000000001 108.071 179.589 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 31.2 pt -73.18 30.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 113.712 1.004 . . . . 1.4299999999999999 113.712 -171.56 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.6 t -120.13 -18.5 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 126.682 1.993 . . . . 2.2000000000000002 111.837 173.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -139.57 91.63 2.5 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.945 1.248 . . . . 2.4900000000000002 111.826 -170.355 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.4 46.66 68.48 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 109.99 -1.244 . . . . 1.5700000000000001 109.99 176.168 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -146.42 -139.52 0.1 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 104.404 -2.443 . . . . 4.8899999999999997 104.404 172.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.787 HG23 HD11 ' A' ' 116' ' ' LEU . 94.5 m -52.19 -54.13 34.65 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 117.197 -1.383 . . . . 2.02 114.599 -178.413 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -36.36 -56.63 0.77 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.856 1.207 . . . . 2.5499999999999998 111.321 174.21 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.61 -7.71 59.45 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 113.895 -1.502 . . . . 1.5900000000000001 111.268 -171.409 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 56.74 35.9 69.74 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.325 1.44 . . . . 1.1499999999999999 112.373 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.8 m -89.44 -42.54 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 117.893 0.847 . . . . 1.24 110.979 -178.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.7 mmtt -81.39 -63.88 0.3 Allowed Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 118.325 -0.845 . . . . 3.2400000000000002 112.55 176.324 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -81.79 152.47 17.07 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.533 1.489 . . . . 1.97 110.168 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -100.4 43.05 1.08 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.261 1.424 . . . . 3.8199999999999998 109.493 175.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 33.14 59.88 0.45 Allowed 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 127.232 2.213 . . . . 2.29 115.459 177.578 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.42 30.86 0.2 Allowed Glycine 0 CA--C 1.524 0.639 0 CA-C-N 113.757 -1.565 . . . . 1.47 112.664 177.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -121.98 154.06 37.71 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.193 0.997 . . . . 2.8900000000000001 109.522 -176.118 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.446 HH12 ' NE2' ' A' ' 113' ' ' GLN . 13.9 ttp85 -96.82 114.07 25.67 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.101 -1.074 . . . . 4.7699999999999996 108.101 -178.344 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.7 pt -132.99 178.15 6.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 C-N-CA 124.271 1.028 . . . . 0.97999999999999998 109.158 -176.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.406 ' HB2' ' CD1' ' A' ' 37' ' ' PHE . 3.5 mtt180 -136.12 150.68 49.2 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 108.087 -1.079 . . . . 1.9199999999999999 108.087 174.095 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.33 143.63 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.821 1.248 . . . . 0.85999999999999999 107.734 177.243 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.91 123.23 1.81 Allowed Glycine 0 CA--C 1.522 0.486 0 N-CA-C 110.363 -1.095 . . . . 0.55000000000000004 110.363 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -178.63 -171.36 41.81 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 109.573 -1.411 . . . . 0.68999999999999995 109.573 -177.237 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.41 135.36 33.36 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.936 0.874 . . . . 2.71 110.945 178.193 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.438 HG12 ' H ' ' A' ' 66' ' ' VAL . 0.8 OUTLIER -63.98 131.02 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 114.99 -1.004 . . . . 2.5600000000000001 108.295 167.36 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.2 m -37.77 -82.75 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 126.531 1.932 . . . . 3.2599999999999998 113.128 176.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.6 p 175.84 -40.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.511 1.124 . . . . 2.4399999999999999 109.497 179.608 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -142.45 25.34 2.31 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.923 -0.376 . . . . 1.75 112.181 179.638 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.3 m -84.21 -8.86 58.93 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 117.756 0.778 . . . . 1.23 112.461 -178.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.1 tpt -68.29 115.06 7.31 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.803 0.841 . . . . 1.79 108.85 176.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.1 m -125.84 135.61 63.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 108.363 -0.977 . . . . 0.59999999999999998 108.363 171.535 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.6 ptm85 -128.0 133.08 49.12 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.719 1.208 . . . . 6.1299999999999999 108.515 -171.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -85.36 146.23 44.27 Favored Pre-proline 0 C--O 1.234 0.287 0 N-CA-C 108.767 -0.827 . . . . 2.1899999999999999 108.767 -176.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -70.69 12.97 0.38 Allowed 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.893 2.395 . . . . 1.24 113.703 178.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -75.95 -29.91 58.47 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.246 0.618 . . . . 1.1200000000000001 109.655 163.415 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 m 85.47 -18.91 0.34 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.821 2.048 . . . . 1.5 112.757 -174.049 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -104.91 8.78 34.74 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.487 1.115 . . . . 1.95 113.093 -172.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 -133.55 126.81 31.82 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.334 -1.358 . . . . 1.1499999999999999 107.334 172.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.93 125.3 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.001 -1.851 . . . . 0.85999999999999999 106.001 -175.769 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -137.85 146.44 43.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 119.683 1.128 . . . . 0.83999999999999997 109.713 179.401 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -142.89 152.36 42.02 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.008 -0.738 . . . . 1.8500000000000001 109.008 -174.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.86 150.77 24.55 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.452 -0.573 . . . . 0.57999999999999996 109.452 171.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.9 p -143.43 147.27 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.246 1.018 . . . . 1.8999999999999999 108.331 -171.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.414 ' HB3' ' HG3' ' A' ' 91' ' ' GLU . 0.3 OUTLIER -153.93 -179.88 8.26 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 112.136 0.421 . . . . 1.78 112.136 -174.795 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.69 7.6 4.46 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.912 0.885 . . . . 2.4900000000000002 110.736 176.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.4 m 46.83 38.44 6.0 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.359 1.063 . . . . 5.29 112.122 -173.289 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.3 -82.04 0.64 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.827 1.251 . . . . 4.7999999999999998 108.516 178.313 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -88.72 -31.51 12.74 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.002 0.811 . . . . 3.6000000000000001 113.25 -174.328 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 164.53 -169.14 39.17 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 118.029 0.915 . . . . 1.79 111.065 -178.122 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.414 ' HG3' ' HB3' ' A' ' 85' ' ' HIS . 12.1 tt0 -116.27 145.77 42.89 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.995 2.118 . . . . 3.5 107.731 175.633 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.3 tp -128.46 159.04 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 C-N-CA 123.845 0.858 . . . . 1.1499999999999999 109.35 175.457 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.3 mt -109.42 138.16 46.2 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.552 1.141 . . . . 0.76000000000000001 110.873 -176.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.34 124.79 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 125.987 1.715 . . . . 0.92000000000000004 107.383 -178.789 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.9 p -101.72 135.68 42.84 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.71 -0.848 . . . . 0.47999999999999998 108.71 176.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.47 ' CE2' HG13 ' A' ' 127' ' ' VAL . 5.0 t80 -128.76 163.39 25.27 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.283 2.233 . . . . 2.3599999999999999 107.997 -176.083 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -159.92 156.45 27.27 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 105.299 -2.111 . . . . 3.4399999999999999 105.299 -170.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 60.16 66.81 0.92 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 130.26 3.424 . . . . 2.9700000000000002 111.854 -169.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 51.65 -160.52 0.09 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.176 0.99 . . . . 1.7 109.902 -178.296 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.9 mt -145.14 157.39 53.7 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 104.555 -2.387 . . . . 1.1699999999999999 104.555 175.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.01 -88.46 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.923 2.415 . . . . 2.21 109.585 178.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -78.07 46.82 0.62 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.366 1.066 . . . . 3.25 109.957 179.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 45.55 -2.62 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 129.437 3.095 . . . . 2.1800000000000002 117.787 -171.366 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 58.2 t80 56.58 88.51 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.619 1.167 . . . . 2.8300000000000001 108.858 -153.195 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 22.3 mtp-105 -79.88 155.77 27.63 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.593 -1.262 . . . . 4.5800000000000001 107.593 172.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -89.88 156.44 18.46 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 125.139 1.376 . . . . 3.3500000000000001 111.183 -170.031 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 52.15 47.38 55.29 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.274 0.94 . . . . 0.77000000000000002 112.935 175.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.06 101.18 2.07 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 105.518 -2.03 . . . . 2.3900000000000001 105.518 -178.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -60.87 138.61 48.09 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.714 -0.554 . . . . 0.70999999999999996 111.714 -169.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.2 pp -136.75 174.71 11.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 124.25 1.02 . . . . 0.92000000000000004 108.778 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.4 m -122.6 145.83 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 108.83 -0.804 . . . . 0.64000000000000001 108.83 175.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.403 ' HB2' HG12 ' A' ' 127' ' ' VAL . . . -135.05 127.65 30.8 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.9 1.28 . . . . 0.44 109.501 -174.257 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.446 ' NE2' HH12 ' A' ' 59' ' ' ARG . 3.9 tt0 -113.38 141.52 46.96 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.072 1.349 . . . . 2.96 109.628 -178.648 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 175.05 -136.39 3.42 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 110.919 -0.872 . . . . 0.84999999999999998 110.919 164.11 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.0 p -129.62 151.3 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 123.632 0.773 . . . . 0.63 109.466 -167.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.787 HD11 HG23 ' A' ' 48' ' ' THR . 3.9 mm? -54.55 135.5 46.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.407 -0.815 . . . . 2.2000000000000002 110.714 172.084 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -94.41 -115.55 2.7 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 109.448 -1.461 . . . . 1.8200000000000001 109.448 179.049 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -56.63 -55.75 30.0 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.121 0.969 . . . . 4.54 111.135 179.042 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.8 p30 179.98 -65.82 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 127.755 2.422 . . . . 4.0999999999999996 107.718 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.16 -38.2 35.35 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.353 -0.699 . . . . 1.26 111.353 178.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.54 138.55 34.25 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 117.554 0.677 . . . . 2.1600000000000001 110.85 -175.323 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -103.28 123.58 47.05 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 124.29 1.036 . . . . 2.4500000000000002 108.506 -175.331 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -91.6 97.29 10.95 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.384 -0.969 . . . . 0.46000000000000002 108.384 176.463 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -118.77 119.11 33.43 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 108.804 -0.813 . . . . 0.96999999999999997 108.804 -177.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.8 t -117.87 10.69 13.27 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.867 0.867 . . . . 1.1799999999999999 111.168 176.55 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -119.03 90.02 3.25 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 120.78 -1.2 . . . . 2.9900000000000002 109.148 170.256 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.47 HG13 ' CE2' ' A' ' 96' ' ' TYR . 5.7 m -91.68 137.1 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 118.949 0.795 . . . . 0.77000000000000002 110.018 168.19 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -118.2 120.96 39.28 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.541 -1.652 . . . . 0.79000000000000004 106.541 173.021 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.05 121.47 27.07 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.884 -1.154 . . . . 2.2999999999999998 107.884 171.532 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -130.84 25.36 5.0 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.118 0.567 . . . . 3.6499999999999999 111.564 -179.674 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -154.28 82.12 1.12 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.672 -0.862 . . . . 4.7699999999999996 108.672 -172.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.454 -0.264 0 N-CA-C 107.764 -1.198 . . . . 6.5700000000000003 107.764 178.895 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 CA--C 1.532 0.258 0 N-CA-C 112.173 0.435 . . . . 7.1699999999999999 112.173 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -153.72 -55.06 0.11 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.336 0.655 . . . . 9.1899999999999995 110.101 -175.08 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 tt 54.82 57.44 5.67 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.168 1.387 . . . . 5.6200000000000001 111.284 173.521 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -159.1 102.29 1.61 Allowed 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.738 -0.601 . . . . 3.5 111.987 -172.264 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -140.61 163.27 33.31 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 119.362 0.983 . . . . 2.0499999999999998 112.695 -174.864 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -81.59 127.66 33.11 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.245 1.018 . . . . 2.0 109.871 -178.123 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -129.67 157.46 42.06 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 126.571 1.949 . . . . 2.98 109.065 177.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.4 p -94.01 149.37 36.81 Favored Pre-proline 0 N--CA 1.446 -0.667 0 C-N-CA 124.455 1.102 . . . . 1.8100000000000001 108.6 179.206 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.26 -31.85 58.06 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.638 2.225 . . . . 1.05 112.342 174.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -46.71 -43.63 18.06 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.509 0.724 . . . . 2.8399999999999999 111.827 171.268 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -76.85 -7.31 55.25 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 121.796 -0.565 . . . . 2.3300000000000001 111.857 -175.785 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.3 pt -124.92 40.56 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 125.696 1.599 . . . . 2.0 110.164 176.018 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.5 p -124.27 -60.7 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 CA-C-O 121.543 0.687 . . . . 2.6499999999999999 112.022 160.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -83.51 73.37 10.21 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 120.324 -1.485 . . . . 2.1600000000000001 112.137 -162.504 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.79 70.93 1.09 Allowed Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.832 -1.307 . . . . 1.8999999999999999 109.832 176.73 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.78 -123.06 0.06 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.05 -1.833 . . . . 3.48 106.05 175.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 t -63.91 -37.16 86.39 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 118.396 0.543 . . . . 2.4399999999999999 110.871 -172.578 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -43.27 -42.48 4.42 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 127.058 2.143 . . . . 4.4299999999999997 112.079 177.278 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.2 m -116.28 9.52 14.56 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.852 1.261 . . . . 2.1400000000000001 109.991 -175.256 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 45.73 33.66 4.93 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.597 1.57 . . . . 1.1100000000000001 113.667 -173.58 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.1 m -81.56 -25.75 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 119.076 1.438 . . . . 1.99 111.872 -173.073 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -121.44 -75.46 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.226 0 C-N-CA 123.922 0.889 . . . . 3.48 111.137 177.274 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -75.57 121.47 6.38 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 CA-C-N 120.48 1.207 . . . . 1.1399999999999999 109.192 177.788 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -69.04 158.36 34.95 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.483 -0.562 . . . . 3.2999999999999998 109.483 169.685 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.36 167.66 5.15 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.719 0.808 . . . . 1.3799999999999999 110.801 174.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.3 11.31 79.58 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 119.589 -0.562 . . . . 1.0600000000000001 113.589 178.187 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -95.02 147.69 23.13 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.442 1.121 . . . . 1.52 109.646 175.076 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.19 125.1 31.87 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 107.261 -1.385 . . . . 3.8300000000000001 107.261 177.265 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.2 pt -140.7 176.93 4.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 107.796 -1.187 . . . . 0.88 107.796 168.091 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.0 mtt180 -130.75 127.08 38.02 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 108.696 -0.853 . . . . 2.3900000000000001 108.696 173.616 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.5 p -92.28 127.32 44.56 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.076 0 N-CA-C 108.239 -1.023 . . . . 0.83999999999999997 108.239 177.537 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -122.24 127.86 6.96 Favored Glycine 0 C--N 1.333 0.397 0 N-CA-C 110.317 -1.113 . . . . 0.87 110.317 177.314 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.49 -164.03 32.91 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 117.751 0.776 . . . . 0.91000000000000003 111.294 -177.037 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.56 127.6 52.33 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.108 0.963 . . . . 2.8399999999999999 109.99 -175.183 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.5 t -59.49 139.49 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 106.971 -1.492 . . . . 2.29 106.971 169.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.655 HG22 HG12 ' A' ' 68' ' ' VAL . 57.2 m -50.9 -79.93 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.198 0.599 . . . . 2.6000000000000001 112.059 -176.682 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.655 HG12 HG22 ' A' ' 67' ' ' THR . 3.1 p 172.42 -39.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 126.175 1.79 . . . . 2.04 108.286 -176.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -149.39 28.55 1.21 Allowed Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.982 -0.343 . . . . 2.3799999999999999 112.345 176.059 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.3 m -86.59 4.34 40.59 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 117.713 0.757 . . . . 1.1599999999999999 111.983 176.096 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.79 110.35 2.79 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.878 -1.156 . . . . 1.74 107.878 172.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.9 m -118.14 111.83 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 107.396 -1.335 . . . . 0.88 107.396 170.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -98.73 148.96 23.34 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.347 1.059 . . . . 5.1799999999999997 110.678 175.798 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -84.72 151.74 58.75 Favored Pre-proline 0 C--O 1.235 0.294 0 N-CA-C 109.088 -0.708 . . . . 2.3199999999999998 109.088 173.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -75.02 25.86 0.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.663 2.242 . . . . 1.8999999999999999 112.861 168.434 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -87.62 -24.61 23.9 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.822 0.849 . . . . 1.4299999999999999 108.746 163.325 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 m 67.97 11.34 8.32 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.353 1.461 . . . . 1.21 112.486 -175.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.0 pp -127.37 3.1 6.3 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.655 1.582 . . . . 1.8100000000000001 112.323 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -136.65 135.68 38.47 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.071 1.348 . . . . 1.46 109.301 -178.634 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.07 130.08 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 107.659 -1.237 . . . . 0.78000000000000003 107.659 -170.358 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -135.81 156.2 49.16 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 119.49 1.041 . . . . 1.4099999999999999 110.195 173.559 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -150.25 144.21 25.45 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.935 -0.575 . . . . 2.1299999999999999 110.382 -173.351 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.49 130.16 35.87 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.857 -0.794 . . . . 0.65000000000000002 108.857 173.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.6 t -110.24 130.8 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 N-CA-C 106.399 -1.704 . . . . 1.75 106.399 174.276 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -157.7 157.28 33.2 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 118.618 -0.706 . . . . 3.3900000000000001 109.277 -179.736 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -148.48 168.15 23.47 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.952 0.901 . . . . 5.8700000000000001 109.556 171.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.3 t -30.82 -55.81 0.21 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.729 2.412 . . . . 4.4299999999999997 111.761 173.155 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -113.03 -13.61 13.07 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.154 0.982 . . . . 4.8799999999999999 111.244 174.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.92 60.68 4.15 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 110.727 -0.949 . . . . 5.1200000000000001 110.727 -179.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 28.84 -127.42 0.08 OUTLIER Glycine 0 CA--C 1.528 0.857 0 C-N-CA 127.163 2.316 . . . . 2.27 114.371 173.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -165.88 139.31 4.31 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 104.956 -2.238 . . . . 4.2000000000000002 104.956 167.231 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 92' ' ' ILE . 7.6 tp -154.81 152.78 8.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 119.102 0.865 . . . . 0.91000000000000003 110.461 172.643 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.5 mt -100.18 122.74 43.49 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.287 1.035 . . . . 0.56999999999999995 110.594 -179.475 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.0 t -109.74 127.49 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 124.983 1.313 . . . . 1.03 107.8 -177.752 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.6 p -104.81 144.84 31.2 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.779 0.832 . . . . 0.70999999999999996 109.585 179.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.436 ' HE2' HG13 ' A' ' 127' ' ' VAL . 10.7 t80 -142.78 163.27 33.25 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.981 1.712 . . . . 2.1800000000000002 107.823 -174.8 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -148.79 146.22 27.92 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 127.742 2.417 . . . . 3.6400000000000001 105.365 -174.535 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 67.87 60.84 0.43 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 129.661 3.185 . . . . 2.8399999999999999 112.147 -171.403 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.8 mt 54.41 -169.6 0.06 Allowed 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 125.553 1.541 . . . . 2.5 111.375 176.506 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.421 HD21 ' CD2' ' A' ' 96' ' ' TYR . 13.0 mt -143.67 148.94 45.11 Favored Pre-proline 0 C--O 1.233 0.227 0 N-CA-C 106.657 -1.609 . . . . 2.0600000000000001 106.657 179.374 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -64.33 111.29 1.58 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.898 2.399 . . . . 3.04 109.273 -176.679 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 42.09 46.69 3.75 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.252 1.421 . . . . 4.6100000000000003 111.121 -174.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 48.79 11.41 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 116.246 1.943 . . . . 3.0699999999999998 116.246 -176.127 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 53.38 115.92 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 123.52 0.728 . . . . 4.5499999999999998 109.546 -148.059 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -74.41 113.81 12.07 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.638 -1.616 . . . . 5.5700000000000003 106.638 -176.453 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -74.83 133.77 41.84 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 118.44 -1.304 . . . . 3.9500000000000002 112.277 -126.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 83.54 53.52 3.38 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.638 1.114 . . . . 1.1499999999999999 111.55 -176.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.0 54.97 1.9 Allowed 'General case' 0 C--N 1.341 0.224 0 CA-C-N 117.5 0.65 . . . . 3.6499999999999999 112.021 -172.394 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -9.73 124.36 0.01 OUTLIER Glycine 0 CA--C 1.533 1.191 0 C-N-CA 128.723 3.058 . . . . 0.81000000000000005 116.66 -163.735 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.7 pp -134.63 169.19 22.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 O-C-N 121.455 -1.027 . . . . 0.81999999999999995 110.056 -172.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.6 m -121.37 139.38 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 108.718 -0.845 . . . . 0.75 108.718 175.029 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -128.34 121.0 28.14 Favored 'General case' 0 N--CA 1.458 -0.052 0 C-N-CA 125.013 1.325 . . . . 0.51000000000000001 108.831 -176.568 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -103.81 142.45 34.35 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.541 0.736 . . . . 4.04 109.572 -179.341 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 171.59 -141.33 6.33 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.653 -0.979 . . . . 1.1899999999999999 110.653 169.367 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.0 p -129.72 149.24 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 109.311 -0.625 . . . . 0.84999999999999998 109.311 -168.42 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -56.05 132.35 49.89 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 119.666 -0.814 . . . . 2.2999999999999998 109.523 170.716 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -80.29 -124.6 0.55 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 109.391 -1.484 . . . . 1.97 109.391 177.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -70.9 -67.67 0.49 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.945 -0.391 . . . . 5.2000000000000002 109.945 -174.461 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -167.31 102.27 0.52 Allowed 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.177 -1.416 . . . . 3.1800000000000002 107.177 174.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 104.34 -30.01 10.92 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.096 0.855 . . . . 1.05 111.778 176.751 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -82.39 135.52 35.15 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.902 -0.764 . . . . 2.7999999999999998 109.29 175.02 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -104.99 114.75 29.13 Favored 'General case' 0 CA--C 1.526 0.04 0 N-CA-C 108.385 -0.969 . . . . 2.2599999999999998 108.385 -178.602 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -90.5 106.45 18.51 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 108.053 -1.091 . . . . 0.64000000000000001 108.053 179.684 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -143.26 89.8 2.12 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 113.361 0.875 . . . . 1.6599999999999999 113.361 -166.7 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.429 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 14.7 t -88.62 -15.17 35.69 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.673 0.99 . . . . 1.03 113.673 -179.414 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -84.98 85.98 7.43 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 119.597 -1.939 . . . . 3.3799999999999999 107.871 176.705 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.436 HG13 ' HE2' ' A' ' 96' ' ' TYR . 16.1 m -100.7 130.37 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 119.73 1.15 . . . . 0.92000000000000004 111.941 177.719 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.81 135.08 55.0 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 107.989 -1.115 . . . . 1.03 107.989 179.241 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -119.78 84.58 2.23 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 124.868 1.267 . . . . 1.75 109.065 179.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.66 50.08 0.83 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.165 0.586 . . . . 2.9300000000000002 110.207 177.229 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -141.74 157.97 44.39 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.582 -1.636 . . . . 6.0700000000000003 106.582 -177.721 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 N--CA 1.447 -0.577 0 C-N-CA 125.921 1.689 . . . . 5.2400000000000002 108.394 -172.147 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 N--CA 1.455 -0.185 0 N-CA-C 108.45 -0.944 . . . . 6.54 108.45 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.3 m-20 -77.08 110.53 11.81 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.936 0.894 . . . . 7.9400000000000004 108.887 -178.771 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.8 mp -48.14 -51.04 26.54 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.349 0.66 . . . . 9.1099999999999994 110.927 176.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.23 162.39 40.17 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 108.471 -0.937 . . . . 5.3099999999999996 108.471 174.133 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 pp -155.23 144.58 21.1 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 107.587 -1.264 . . . . 2.8799999999999999 107.587 176.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.445 ' CE2' ' HD2' ' A' ' 61' ' ' ARG . 72.5 m-85 -103.43 113.17 26.46 Favored 'General case' 0 C--O 1.228 -0.069 0 C-N-CA 124.792 1.237 . . . . 2.4199999999999999 108.226 179.521 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -119.72 153.42 35.66 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.33 1.052 . . . . 2.8500000000000001 110.813 -177.047 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -85.67 138.81 35.5 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 125.035 1.334 . . . . 1.6799999999999999 110.735 -177.554 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -54.1 -40.25 82.42 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.598 2.865 . . . . 0.77000000000000002 112.044 -179.573 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.4 t -58.83 -49.14 78.82 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 119.009 0.822 . . . . 2.6200000000000001 111.804 178.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.1 tt0 -55.25 -40.57 71.1 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 119.864 -0.734 . . . . 3.5099999999999998 109.743 -178.179 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.315 37.0 pt -77.8 -11.31 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 114.823 1.416 . . . . 1.1599999999999999 114.823 -179.17 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.61 -19.67 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 119.312 0.96 . . . . 2.0099999999999998 111.315 -179.041 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -96.61 -125.63 0.13 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.234 -0.654 . . . . 3.3399999999999999 109.234 -179.376 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -82.92 61.43 4.77 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.284 -1.126 . . . . 1.52 110.284 -169.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -151.89 -106.46 0.05 Allowed 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 127.155 2.182 . . . . 4.0199999999999996 106.789 -171.799 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.688 ' CG2' HD21 ' A' ' 122' ' ' LEU . 22.6 m -77.36 -57.05 4.04 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 118.517 0.599 . . . . 1.73 109.897 -171.357 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -56.84 -49.73 74.56 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 123.588 0.555 . . . . 3.1600000000000001 110.129 -171.231 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.6 m -70.1 -34.45 73.15 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.773 -0.649 . . . . 1.96 110.919 174.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.22 46.59 20.64 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 123.76 0.695 . . . . 2.1200000000000001 111.421 175.311 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.4 m -113.98 -51.25 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 113.534 0.938 . . . . 2.1400000000000001 113.534 -172.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -79.02 -58.64 0.68 Allowed Pre-proline 0 CA--C 1.54 0.594 0 CA-C-O 118.498 -0.763 . . . . 4.25 112.071 -178.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -79.37 165.02 23.66 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.096 1.864 . . . . 1.3899999999999999 109.583 174.154 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.87 155.9 16.85 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.985 0.914 . . . . 4.2599999999999998 109.864 174.861 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.9 24.57 0.49 Allowed 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 124.639 1.176 . . . . 3.5600000000000001 112.122 177.376 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -143.4 30.2 1.99 Allowed Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.983 1.278 . . . . 0.96999999999999997 110.891 171.431 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -103.03 155.88 18.07 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.393 0.677 . . . . 1.4099999999999999 109.429 174.211 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.55 126.73 52.47 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.753 1.221 . . . . 6.1799999999999997 108.168 176.817 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.646 ' CD1' HD21 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -143.86 176.3 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 108.283 -1.006 . . . . 1.5800000000000001 108.283 171.147 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.445 ' HD2' ' CE2' ' A' ' 37' ' ' PHE . 22.7 mtt180 -111.33 134.48 52.88 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.689 -0.485 . . . . 3.3900000000000001 109.689 166.535 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -102.93 119.88 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 107.122 -1.436 . . . . 0.91000000000000003 107.122 171.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.49 125.24 4.33 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 109.643 -1.383 . . . . 0.58999999999999997 109.643 -176.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.34 -133.73 1.59 Allowed Glycine 0 C--N 1.334 0.451 0 N-CA-C 109.517 -1.433 . . . . 1.52 109.517 -174.715 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.4 ptp -127.64 133.77 49.66 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.101 0.951 . . . . 3.02 109.996 175.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.438 HG11 ' CZ ' ' A' ' 104' ' ' PHE . 15.7 t -95.64 143.2 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 108.716 -0.846 . . . . 2.3399999999999999 108.716 175.507 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.63 175.74 3.34 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.281 -0.637 . . . . 2.8799999999999999 109.281 173.656 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 68' ' ' VAL . 9.5 p -106.4 65.42 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 122.897 1.332 . . . . 2.4300000000000002 109.418 179.255 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 134.76 68.79 0.07 OUTLIER Glycine 0 CA--C 1.526 0.773 0 CA-C-N 113.68 -1.6 . . . . 1.6699999999999999 112.429 175.517 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.0 m -136.45 8.09 3.1 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.399 -1.059 . . . . 1.3300000000000001 112.729 158.739 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.8 ttp -78.85 117.39 19.91 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.011 -1.107 . . . . 2.5499999999999998 108.011 176.341 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.2 m -121.02 151.71 24.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 107.829 -1.175 . . . . 0.53000000000000003 107.829 175.732 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.401 ' CB ' HG12 ' A' ' 80' ' ' VAL . 37.8 ptt85 -141.44 144.02 34.2 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.992 0.917 . . . . 3.98 109.041 -169.154 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.33 155.12 37.24 Favored Pre-proline 0 C--O 1.236 0.361 0 N-CA-C 109.519 -0.548 . . . . 2.5800000000000001 109.519 -177.002 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.13 32.11 0.42 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.508 2.805 . . . . 2.1299999999999999 112.685 -176.121 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -95.69 -14.66 23.24 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.747 1.219 . . . . 1.5900000000000001 109.125 163.611 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.4 m 70.23 6.82 5.96 Favored 'General case' 0 C--N 1.345 0.399 0 C-N-CA 125.105 1.362 . . . . 1.51 113.225 -178.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.7 pp -125.5 -34.28 2.69 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 127.662 2.385 . . . . 1.98 112.354 -179.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 30.6 m-70 -87.96 124.72 33.99 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 107.809 -1.182 . . . . 1.23 107.809 -176.575 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.447 HG23 ' CB ' ' A' ' 96' ' ' TYR . 23.7 m -149.05 152.98 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.397 -0.964 . . . . 1.02 108.397 -175.008 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -156.02 161.93 40.39 Favored 'General case' 0 C--N 1.332 -0.181 0 O-C-N 121.41 -0.807 . . . . 1.1599999999999999 110.803 176.706 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -155.3 160.57 40.87 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.197 0.599 . . . . 1.8700000000000001 110.486 -175.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -107.87 136.0 48.32 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.251 -1.018 . . . . 0.58999999999999997 108.251 175.249 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.7 t -115.74 142.1 30.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 124.942 1.297 . . . . 1.8400000000000001 107.521 178.618 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -125.94 179.91 4.99 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.564 0.746 . . . . 1.71 110.056 179.303 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -128.87 171.91 11.83 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.072 0.463 . . . . 3.4399999999999999 109.995 -177.624 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 45.5 p -49.11 -49.22 43.0 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.611 -1.177 . . . . 4.5300000000000002 108.13 160.062 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 6.9 mt -77.35 27.85 0.15 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.104 1.361 . . . . 4.9199999999999999 113.415 -177.473 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 50.58 37.46 33.55 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.338 -0.705 . . . . 2.9700000000000002 111.338 -177.786 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.31 162.62 32.4 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 108.108 -1.997 . . . . 2.3999999999999999 108.108 169.021 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -162.15 93.85 0.89 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.947 -1.131 . . . . 3.9399999999999999 107.947 179.522 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.15 134.65 65.55 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 108.766 -0.827 . . . . 0.85999999999999999 108.766 -175.188 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.1 mt -85.39 136.96 33.24 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.077 0.951 . . . . 0.71999999999999997 109.973 177.124 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 87.1 t -124.06 133.22 69.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 107.387 -1.338 . . . . 1.04 107.387 176.363 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.7 p -111.78 158.35 19.47 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.537 1.135 . . . . 0.79000000000000004 109.796 -177.105 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.721 ' OH ' HG13 ' A' ' 127' ' ' VAL . 2.4 m-85 -148.43 133.02 17.76 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.348 1.459 . . . . 3.96 108.897 -178.279 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -104.92 6.32 33.56 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.682 1.193 . . . . 2.7000000000000002 111.711 169.311 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -111.79 162.91 14.75 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 124.488 1.115 . . . . 5.0300000000000002 111.123 172.287 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.9 mp -60.89 141.39 57.21 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.322 -0.853 . . . . 1.6499999999999999 109.949 162.631 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.525 HD13 ' CB ' ' A' ' 104' ' ' PHE . 75.8 mt -81.02 159.27 68.77 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 107.426 -1.324 . . . . 1.6200000000000001 107.426 175.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.54 -90.76 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.896 3.064 . . . . 2.3100000000000001 111.196 179.273 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -79.46 43.54 0.56 Allowed 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.245 -0.909 . . . . 3.73 110.53 -173.537 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.3 tp 57.92 3.27 0.21 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.581 1.152 . . . . 2.8399999999999999 112.978 -165.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.525 ' CB ' HD13 ' A' ' 100' ' ' LEU . 44.8 t80 57.78 94.23 0.03 OUTLIER 'General case' 0 C--N 1.342 0.274 0 CA-C-N 119.586 1.085 . . . . 2.46 109.237 -166.271 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -78.94 122.47 26.17 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.339 -0.986 . . . . 4.54 108.339 -178.17 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -84.13 173.06 11.38 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.093 1.357 . . . . 3.21 110.127 -172.692 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.9 34.73 89.43 Favored Glycine 0 CA--C 1.527 0.832 0 O-C-N 121.882 -0.511 . . . . 0.79000000000000004 112.821 175.085 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -156.32 175.39 14.06 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.364 1.066 . . . . 2.5499999999999998 108.967 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -97.68 105.88 3.22 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.973 -0.851 . . . . 1.1899999999999999 110.973 -178.07 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.5 pp -111.5 157.46 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 106.547 -1.649 . . . . 0.84999999999999998 106.547 -179.42 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.1 m -118.14 116.04 50.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 108.742 -0.836 . . . . 0.67000000000000004 108.742 176.535 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.45 ' HB2' HG12 ' A' ' 127' ' ' VAL . . . -102.99 146.53 28.21 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 125.373 1.469 . . . . 0.62 109.875 -175.207 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -146.52 139.66 25.6 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.32 1.048 . . . . 3.5800000000000001 110.106 -173.463 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 170.74 -133.82 2.91 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 106.516 -2.634 . . . . 0.84999999999999998 106.516 174.762 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p -142.24 149.9 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 118.63 1.215 . . . . 0.76000000000000001 109.166 -166.534 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 1.019 HD22 HD22 ' A' ' 122' ' ' LEU . 1.5 mt -77.31 157.18 30.85 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.693 -0.855 . . . . 1.99 108.693 -178.42 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 175.92 25.73 0.03 OUTLIER Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.345 -0.931 . . . . 2.6699999999999999 115.408 175.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -150.3 46.31 0.89 Allowed 'General case' 0 C--O 1.238 0.455 0 CA-C-N 118.392 1.096 . . . . 5.9100000000000001 109.533 -175.827 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 20.61 66.17 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 129.533 3.133 . . . . 3.9300000000000002 111.338 173.473 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 131.13 -30.44 3.33 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 114.084 -1.416 . . . . 1.0600000000000001 112.555 -175.516 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.32 161.13 19.48 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.548 1.174 . . . . 3.3500000000000001 111.251 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 1.019 HD22 HD22 ' A' ' 116' ' ' LEU . 12.5 mt -121.36 131.59 54.28 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 125.442 1.497 . . . . 2.0899999999999999 110.443 -169.348 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.25 99.07 11.38 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.083 -1.451 . . . . 0.55000000000000004 107.083 176.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.82 155.48 16.76 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.573 -0.528 . . . . 1.53 109.573 179.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.446 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 8.8 t -134.01 -42.23 0.82 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.876 0.47 . . . . 0.96999999999999997 111.365 173.254 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -87.39 105.62 17.39 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 120.179 -1.576 . . . . 4.3099999999999996 108.778 177.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.721 HG13 ' OH ' ' A' ' 96' ' ' TYR . 0.9 OUTLIER -111.88 118.62 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 123.824 0.85 . . . . 1.1399999999999999 109.725 171.027 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -108.3 111.25 23.11 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.443 -0.947 . . . . 0.94999999999999996 108.443 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.56 53.48 2.54 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.116 0.966 . . . . 1.53 110.628 178.424 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.2 pttt -79.88 69.72 6.28 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.79 -0.569 . . . . 3.21 110.616 -173.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -142.39 127.97 19.09 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.053 0.541 . . . . 4.5300000000000002 110.315 -172.172 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 . . . . . 0 CA--C 1.533 0.315 0 C-N-CA 125.291 1.436 . . . . 5.5800000000000001 109.689 -176.214 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.3 t . . . . . 0 CA--C 1.529 0.167 0 N-CA-C 109.65 -0.5 . . . . 8.1099999999999994 109.65 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -146.62 114.22 6.39 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.05 -0.722 . . . . 8.7899999999999991 109.05 -179.636 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.4 mt -125.86 66.53 1.19 Allowed 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.862 1.265 . . . . 6.1799999999999997 107.744 -173.429 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -140.47 112.88 7.91 Favored 'General case' 0 C--O 1.228 -0.074 0 C-N-CA 124.098 0.959 . . . . 3.3300000000000001 108.909 -173.459 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -154.93 135.33 13.31 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.566 0.746 . . . . 2.6499999999999999 109.613 -178.399 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -93.91 114.82 27.11 Favored 'General case' 0 C--N 1.337 0.061 0 C-N-CA 124.8 1.24 . . . . 2.3599999999999999 109.792 -178.039 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -120.12 156.88 30.15 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 126.329 1.852 . . . . 2.6499999999999999 109.669 -175.765 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.7 p -90.78 145.24 31.63 Favored Pre-proline 0 N--CA 1.45 -0.473 0 C-N-CA 124.422 1.089 . . . . 1.74 109.059 177.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -55.29 -36.81 94.4 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.889 2.393 . . . . 0.81999999999999995 111.968 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.5 t -52.57 -35.64 54.33 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.453 -0.779 . . . . 2.6299999999999999 112.041 175.247 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -83.68 5.51 24.33 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.291 0.478 . . . . 3.02 112.291 -176.408 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.6 pt -120.24 1.48 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 113.812 1.042 . . . . 1.25 113.812 173.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.1 p -97.27 -59.69 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 118.617 0.644 . . . . 2.1099999999999999 112.02 176.096 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -75.65 84.42 2.67 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 120.504 -1.373 . . . . 2.0699999999999998 112.042 -166.614 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.37 56.67 9.6 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 109.658 -1.377 . . . . 1.71 109.658 176.047 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -147.86 -137.3 0.09 Allowed 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 127.79 2.436 . . . . 2.3500000000000001 105.861 -173.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.6 m -58.82 -47.46 84.73 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.451 1.5 . . . . 1.73 112.631 -175.776 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -38.46 -54.87 1.45 Allowed 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.445 0.698 . . . . 2.48 111.311 174.818 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.47 -1.45 53.52 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.446 1.099 . . . . 1.9199999999999999 111.738 -173.147 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 49.79 41.39 35.57 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.137 1.351 . . . . 1.3799999999999999 113.408 -176.804 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.1 m -92.39 -26.41 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.53 1.165 . . . . 1.96 112.887 -176.687 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -123.04 -74.16 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 124.635 1.174 . . . . 4.8099999999999996 111.497 176.663 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -73.48 121.38 7.08 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 121.554 1.503 . . . . 1.4099999999999999 109.305 177.497 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -77.89 160.07 28.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.078 0.951 . . . . 4.4000000000000004 108.893 175.325 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.68 158.06 28.39 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.324 -0.621 . . . . 1.1499999999999999 109.324 169.0 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.53 -2.08 76.89 Favored Glycine 0 CA--C 1.532 1.129 0 O-C-N 121.682 -0.636 . . . . 1.04 112.572 -175.482 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -91.67 146.39 23.81 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 118.102 0.951 . . . . 2.9700000000000002 109.131 178.222 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.4 mtt-85 -90.5 133.75 34.84 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.033 -0.728 . . . . 4.1299999999999999 109.033 172.443 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.1 pt -144.98 169.48 7.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 105.279 -2.119 . . . . 1.05 105.279 166.607 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 37.8 mtt180 -116.94 126.65 53.27 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.656 -1.239 . . . . 2.7599999999999998 107.656 169.406 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -90.44 135.49 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 N-CA-C 107.269 -1.382 . . . . 1.8799999999999999 107.269 173.484 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -128.55 128.59 5.96 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 109.38 -1.488 . . . . 0.63 109.38 172.491 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 176.8 -167.74 39.31 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 109.939 -1.264 . . . . 0.89000000000000001 109.939 -173.227 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.41 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 1.4 ptm -111.95 137.7 49.6 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.479 0.657 . . . . 5.0599999999999996 112.42 -176.18 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.2 t -64.93 159.32 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 114.349 -1.296 . . . . 2.3900000000000001 109.062 178.692 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 62.7 m -108.54 131.98 54.3 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.053 0.941 . . . . 3.0899999999999999 109.984 -178.492 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.3 p -75.58 45.91 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 127.955 2.502 . . . . 3.6400000000000001 111.895 179.009 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.73 49.93 0.03 OUTLIER Glycine 0 CA--C 1.522 0.473 0 C-N-CA 125.529 1.538 . . . . 2.77 109.37 179.335 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.0 m -155.59 -40.67 0.08 Allowed 'General case' 0 C--O 1.226 -0.162 0 O-C-N 122.402 -0.469 . . . . 1.6599999999999999 112.029 177.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.67 115.76 1.79 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 109.691 -0.485 . . . . 2.6000000000000001 109.691 171.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.8 m -136.51 153.57 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 108.866 -0.791 . . . . 0.98999999999999999 108.866 168.715 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -128.07 148.61 50.57 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.873 1.269 . . . . 4.8399999999999999 108.837 -178.231 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -82.84 155.9 67.78 Favored Pre-proline 0 C--O 1.234 0.241 0 CA-C-N 118.119 0.418 . . . . 1.8700000000000001 109.959 174.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -70.91 7.28 1.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.088 2.525 . . . . 1.22 113.599 174.452 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -72.74 -23.6 60.86 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 121.938 -0.476 . . . . 1.6799999999999999 110.181 163.318 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.7 m 70.97 10.49 6.95 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.504 1.522 . . . . 1.55 112.785 -174.854 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 79' ' ' HIS 0.276 1.0 OUTLIER -123.08 -36.5 2.84 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.705 1.002 . . . . 2.3999999999999999 113.705 177.748 . . . . . . . . 4 4 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.407 ' N ' HD12 ' A' ' 78' ' ' LEU . 80.4 m-70 -85.33 129.36 34.83 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 120.23 1.377 . . . . 1.3500000000000001 107.566 178.415 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.421 HG23 ' HB3' ' A' ' 96' ' ' TYR . 30.0 m -138.06 145.81 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 107.92 -1.141 . . . . 1.05 107.92 176.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -144.23 147.34 33.46 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 109.082 -0.71 . . . . 1.3899999999999999 109.082 177.784 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -157.49 155.61 30.66 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.317 -0.401 . . . . 2.21 110.39 -171.588 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.65 149.6 24.28 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.136 -0.69 . . . . 0.52000000000000002 109.136 173.071 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.3 t -119.0 133.59 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 106.151 -1.796 . . . . 1.8899999999999999 106.151 172.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -155.64 159.71 39.82 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 106.653 -1.61 . . . . 3.1800000000000002 106.653 174.817 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -153.5 174.1 14.84 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 106.293 -1.743 . . . . 5.7199999999999998 106.293 173.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.2 p -51.77 -41.17 61.44 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.201 0.91 . . . . 3.3900000000000001 111.229 179.431 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 18.5 mt -121.15 34.31 5.25 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.86 1.264 . . . . 5.3899999999999997 110.275 169.766 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -101.08 5.98 56.3 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.244 -0.742 . . . . 5.0899999999999999 111.244 173.224 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 51.47 -114.93 3.32 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 109.765 -1.334 . . . . 2.54 109.765 -173.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -164.76 148.64 9.01 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.952 -1.499 . . . . 4.0599999999999996 106.952 169.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -155.14 154.48 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.79 0.723 . . . . 0.78000000000000003 109.082 163.449 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 mt -109.12 131.94 54.59 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.508 1.523 . . . . 0.60999999999999999 109.521 177.482 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 12.1 t -122.05 144.16 32.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 125.8 1.64 . . . . 0.95999999999999996 108.77 -176.263 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 32.4 p -118.96 150.01 40.64 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.203 1.001 . . . . 0.47999999999999998 108.49 179.008 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.421 ' HB3' HG23 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -149.32 109.81 4.22 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.854 -1.165 . . . . 2.2999999999999998 107.854 -178.854 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -91.02 42.91 1.12 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.347 1.459 . . . . 2.1200000000000001 112.048 -176.443 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -169.48 174.6 5.86 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.61 1.564 . . . . 2.52 108.645 173.049 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.6 mp -68.56 162.71 25.2 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.637 0.775 . . . . 1.6899999999999999 112.485 -175.398 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.452 HD22 ' CZ ' ' A' ' 104' ' ' PHE . 55.7 mt -112.67 158.6 37.04 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 126.048 1.739 . . . . 1.1899999999999999 110.618 -175.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.12 -88.16 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.897 3.065 . . . . 1.99 111.365 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -73.57 31.27 0.07 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.791 1.236 . . . . 3.8300000000000001 112.139 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 50.73 -5.38 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 128.558 2.743 . . . . 2.2799999999999998 116.387 -165.501 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.487 ' CZ ' HD12 ' A' ' 110' ' ' ILE . 13.4 m-30 55.65 109.23 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 125.864 1.666 . . . . 4.5099999999999998 110.959 -154.607 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -74.0 164.64 26.37 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 114.301 -1.318 . . . . 5.4900000000000002 108.323 174.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -82.4 61.14 5.43 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.199 1.4 . . . . 5.1100000000000003 109.727 -164.436 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 108.31 62.05 0.55 Allowed Glycine 0 CA--C 1.522 0.53 0 C-N-CA 124.509 1.052 . . . . 1.5600000000000001 111.218 -173.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -111.14 168.81 9.22 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 107.891 -1.151 . . . . 2.9399999999999999 107.891 158.312 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 65' ' ' MET . . . -102.91 133.7 11.52 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 111.496 -0.641 . . . . 1.0600000000000001 111.496 -179.216 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.487 HD12 ' CZ ' ' A' ' 104' ' ' PHE . 33.3 pt -145.33 169.59 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.302 1.041 . . . . 1.3300000000000001 109.638 -165.535 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 m -126.8 139.65 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 124.176 0.991 . . . . 0.68999999999999995 108.465 170.645 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -134.95 140.08 45.44 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 124.888 1.275 . . . . 0.66000000000000003 110.266 -176.695 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -135.64 145.4 46.78 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.779 1.632 . . . . 3.8900000000000001 109.705 -177.871 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -178.47 -101.54 0.15 Allowed Glycine 0 C--N 1.337 0.625 0 N-CA-C 110.17 -1.172 . . . . 1.3999999999999999 110.17 166.549 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.7 p -162.72 151.63 3.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 108.992 -0.744 . . . . 1.0 108.992 176.251 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -72.1 140.84 49.12 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 109.438 -0.578 . . . . 2.2200000000000002 109.438 167.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -162.43 21.17 0.19 Allowed Glycine 0 CA--C 1.524 0.612 0 C-N-CA 119.709 -1.234 . . . . 2.52 113.716 172.412 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -143.57 46.96 1.48 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.755 -0.832 . . . . 5.3099999999999996 108.755 -174.287 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 21.7 t70 18.09 66.12 0.02 OUTLIER 'General case' 0 C--N 1.34 0.164 0 C-N-CA 128.954 2.902 . . . . 3.5699999999999998 112.487 178.409 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 137.87 -48.41 0.89 Allowed Glycine 0 CA--C 1.528 0.849 0 CA-C-N 114.614 -1.175 . . . . 1.1100000000000001 111.475 -171.62 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -105.5 160.92 14.79 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.504 1.152 . . . . 2.9700000000000002 109.811 -173.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.64 128.92 55.82 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.508 1.123 . . . . 1.97 109.237 -172.098 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -95.6 98.73 10.72 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.163 -1.792 . . . . 0.57999999999999996 106.163 176.699 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -126.15 94.66 4.15 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.501 0.556 . . . . 1.4099999999999999 112.501 -164.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 10.2 t -84.27 -33.4 24.02 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.906 0.706 . . . . 0.90000000000000002 112.906 -178.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -82.91 95.09 7.86 Favored 'General case' 0 CA--C 1.528 0.113 0 O-C-N 120.556 -1.34 . . . . 3.6099999999999999 107.733 -172.816 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 35.0 m -118.44 134.85 60.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 C-N-CA 123.809 0.844 . . . . 1.3300000000000001 110.634 -176.221 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.59 101.66 8.8 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.241 -1.392 . . . . 1.03 107.241 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.98 107.26 12.63 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.741 -1.207 . . . . 2.21 107.741 172.355 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.29 44.79 0.72 Allowed 'General case' 0 C--O 1.222 -0.353 0 CA-C-O 121.367 0.603 . . . . 3.3199999999999998 109.983 179.515 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -47.34 -43.86 23.27 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.161 0.8 . . . . 6.9800000000000004 113.161 -172.598 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 29.8 t70 . . . . . 0 N--CA 1.453 -0.317 0 C-N-CA 125.809 1.643 . . . . 5.8799999999999999 106.77 179.485 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.446 -0.63 0 CA-C-O 121.508 0.67 . . . . 8.4199999999999999 110.356 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -165.73 118.5 1.13 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.912 -0.773 . . . . 10.91 108.912 176.723 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.8 mt 62.66 56.3 2.0 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 122.21 1.005 . . . . 10.75 108.334 174.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.506 ' HA ' HG22 ' A' ' 60' ' ' ILE . 7.2 m120 -142.22 -171.88 3.48 Favored 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 128.112 2.565 . . . . 7.6100000000000003 106.62 -170.65 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.475 HD23 ' C ' ' A' ' 35' ' ' ASN . 0.6 OUTLIER 61.94 -160.8 0.3 Allowed 'General case' 0 C--O 1.227 -0.105 0 C-N-CA 124.825 1.25 . . . . 3.4700000000000002 111.139 166.442 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -81.58 96.67 7.54 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.963 -0.755 . . . . 2.0899999999999999 108.963 -175.48 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.96 157.32 19.39 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.836 0.854 . . . . 2.9500000000000002 110.427 177.694 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 p -77.44 146.08 73.14 Favored Pre-proline 0 N--CA 1.444 -0.743 0 C-N-CA 124.08 0.952 . . . . 1.77 110.179 -177.139 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -64.2 -23.05 66.72 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.507 2.805 . . . . 0.82999999999999996 112.232 175.32 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.5 p -61.52 -64.4 0.96 Allowed 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.239 0.615 . . . . 2.9500000000000002 110.931 174.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -46.34 -51.13 15.38 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.071 0.948 . . . . 2.1699999999999999 110.81 -171.462 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 34.0 pt -57.23 -29.07 31.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.436 1.094 . . . . 2.0800000000000001 112.754 -178.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.6 t -80.42 -54.32 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 123.335 0.654 . . . . 2.04 109.885 169.601 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -50.59 -42.48 55.82 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 125.002 1.321 . . . . 5.1500000000000004 112.982 -166.506 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.26 65.02 0.1 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.515 -0.85 . . . . 2.0299999999999998 111.19 -178.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.93 -90.32 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 118.598 -0.715 . . . . 2.46 110.923 -170.063 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.0 m -83.18 -58.82 2.69 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.689 1.196 . . . . 1.52 109.721 -169.443 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -51.15 -44.24 61.4 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 122.393 1.092 . . . . 2.5899999999999999 109.473 177.838 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.16 -25.47 60.82 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.397 1.479 . . . . 2.3799999999999999 112.451 179.059 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 56.82 46.58 90.0 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.292 1.425 . . . . 1.1799999999999999 112.552 -172.488 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 29.1 m -109.77 -27.43 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 114.091 1.145 . . . . 1.5 114.091 -175.422 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -122.5 -72.76 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.295 0 CA-C-O 118.237 -0.887 . . . . 3.3700000000000001 111.108 -175.794 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -76.71 151.11 31.74 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 121.504 1.469 . . . . 1.1200000000000001 108.834 169.632 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -108.32 159.58 16.53 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.663 1.185 . . . . 2.75 109.324 173.366 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.11 136.94 56.65 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.412 -0.958 . . . . 1.3100000000000001 108.412 174.078 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.85 -1.95 30.29 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 124.234 0.921 . . . . 1.0600000000000001 113.09 -173.324 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -89.02 146.9 24.56 Favored 'General case' 0 C--N 1.338 0.08 0 CA-C-N 118.87 1.335 . . . . 1.8799999999999999 109.585 179.226 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.29 106.89 17.51 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 107.906 -1.146 . . . . 3.6200000000000001 107.906 -173.53 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.506 HG22 ' HA ' ' A' ' 35' ' ' ASN . 3.7 pt -135.63 178.21 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 124.054 0.942 . . . . 1.1399999999999999 108.947 -173.945 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -121.93 119.77 32.5 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.476 -0.935 . . . . 2.21 108.476 174.415 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 p -83.78 128.96 38.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 107.198 -1.408 . . . . 1.04 107.198 173.044 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.3 128.6 4.58 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 110.562 -1.015 . . . . 0.78000000000000003 110.562 -177.998 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 179.76 -156.19 17.48 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 108.977 -1.649 . . . . 0.81999999999999995 108.977 -175.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.9 ppp? -118.3 142.92 47.01 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.814 1.245 . . . . 3.71 110.095 -179.577 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.9 m -100.92 139.85 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 123.223 0.609 . . . . 2.5699999999999998 109.809 -169.054 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 m -72.33 140.32 48.43 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.465 0.65 . . . . 2.3300000000000001 109.71 176.064 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.0 p -47.05 -61.63 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 126.263 1.825 . . . . 1.8400000000000001 111.398 172.552 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.73 73.42 1.19 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.093 -1.203 . . . . 2.0 110.093 -178.219 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.5 m -152.46 -30.98 0.15 Allowed 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 115.084 1.513 . . . . 0.97999999999999998 115.084 -179.519 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.2 104.73 0.96 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.085 -1.08 . . . . 1.6699999999999999 108.085 175.686 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.9 m -112.79 126.45 70.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 107.503 -1.295 . . . . 0.77000000000000002 107.503 175.401 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.12 137.02 54.39 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.151 1.38 . . . . 4.8099999999999996 108.191 -174.384 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -88.41 145.97 36.75 Favored Pre-proline 0 C--O 1.235 0.304 0 N-CA-C 109.068 -0.716 . . . . 2.5099999999999998 109.068 -179.11 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.01 25.2 0.3 Allowed 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.106 2.538 . . . . 2.4199999999999999 113.589 178.733 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -91.8 -24.23 19.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.802 1.241 . . . . 2.0800000000000001 109.378 164.282 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 11.9 m 74.12 0.42 3.6 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.52 1.528 . . . . 1.71 113.203 -174.515 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.98 18.06 11.73 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.182 0.993 . . . . 2.1699999999999999 112.168 -178.354 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -145.39 127.01 15.16 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.477 -1.305 . . . . 1.8300000000000001 107.477 173.286 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.1 128.97 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 107.704 -1.221 . . . . 0.89000000000000001 107.704 -173.252 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -141.73 148.42 38.98 Favored 'General case' 0 C--O 1.232 0.158 0 O-C-N 121.088 -1.007 . . . . 0.82999999999999996 110.739 176.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -143.17 153.32 42.73 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 116.35 -0.387 . . . . 1.8200000000000001 110.171 -173.416 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.86 138.14 36.42 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.928 -0.767 . . . . 0.75 108.928 172.72 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -131.97 139.67 49.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 123.844 0.857 . . . . 1.95 108.958 176.392 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -140.55 -177.71 5.17 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.665 1.586 . . . . 1.3799999999999999 108.387 -173.311 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -152.49 34.86 0.5 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 122.238 1.018 . . . . 2.71 110.149 -179.555 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.3 p 48.1 30.72 2.21 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.219 1.408 . . . . 2.9500000000000002 113.711 -176.296 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.05 27.64 8.33 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.313 1.445 . . . . 5.2699999999999996 110.206 -175.23 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 54.06 58.12 13.99 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 123.342 0.496 . . . . 3.1400000000000001 112.318 176.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -128.87 -82.4 0.32 Allowed Glycine 0 C--N 1.338 0.645 0 N-CA-C 109.876 -1.29 . . . . 3.5600000000000001 109.876 173.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 66.49 87.67 0.12 Allowed 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 125.228 1.411 . . . . 3.5099999999999998 110.853 -179.126 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -95.13 155.11 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 108.638 -0.875 . . . . 1.0700000000000001 108.638 -178.332 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 mt -104.25 131.37 51.64 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.738 -0.838 . . . . 0.62 108.738 174.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.7 t -114.71 133.25 61.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 125.558 1.543 . . . . 0.88 107.161 178.474 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 33.4 p -109.55 148.52 31.1 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.782 0.833 . . . . 0.51000000000000001 109.002 -179.765 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.453 ' CE2' ' HA ' ' A' ' 125' ' ' THR . 1.5 t80 -150.69 146.69 26.63 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 107.184 -1.413 . . . . 2.2000000000000002 107.184 -173.709 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.7 p-10 -141.35 40.33 1.75 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.214 1.005 . . . . 2.1600000000000001 112.887 -167.166 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -166.37 56.87 0.1 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.545 0.738 . . . . 2.5899999999999999 111.525 -178.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 52.62 -171.4 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.62 1.168 . . . . 1.8 111.951 -169.046 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.552 HD13 ' HB2' ' A' ' 104' ' ' PHE . 13.7 mt -147.25 152.04 41.91 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 107.007 -1.479 . . . . 1.3100000000000001 107.007 174.453 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.434 ' HG3' HG23 ' A' ' 127' ' ' VAL . 72.0 Cg_endo -63.24 133.29 39.93 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 124.033 3.155 . . . . 2.48 110.016 177.384 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 41.77 46.92 3.45 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.027 1.331 . . . . 3.8300000000000001 111.29 -173.717 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 50.26 15.1 0.18 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.085 1.754 . . . . 2.1899999999999999 115.068 -175.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.552 ' HB2' HD13 ' A' ' 100' ' ' LEU . 27.4 t80 62.4 95.99 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 126.108 1.763 . . . . 2.52 110.113 -166.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 64.1 mtp85 -77.34 124.52 27.98 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 106.477 -1.675 . . . . 3.8700000000000001 106.477 -174.658 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -83.36 173.2 11.76 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.114 0.483 . . . . 2.9199999999999999 110.61 -172.559 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.17 42.15 98.09 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 121.859 -0.526 . . . . 0.68999999999999995 112.677 176.112 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -155.01 179.03 9.53 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 125.576 1.55 . . . . 2.1400000000000001 108.581 176.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -110.36 138.35 14.84 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 111.616 -0.594 . . . . 0.67000000000000004 111.616 175.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.4 pp -140.11 169.42 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 125.686 1.595 . . . . 0.77000000000000002 106.904 -177.6 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 18.8 m -123.0 145.82 29.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 107.986 -1.116 . . . . 0.82999999999999996 107.986 167.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.421 ' HB2' HG12 ' A' ' 127' ' ' VAL . . . -130.83 123.8 29.88 Favored 'General case' 0 N--CA 1.461 0.079 0 C-N-CA 124.345 1.058 . . . . 0.75 109.738 -177.273 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.21 145.01 34.87 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.33 1.052 . . . . 3.9900000000000002 110.091 -179.45 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 164.65 -139.88 6.1 Favored Glycine 0 C--N 1.334 0.424 0 N-CA-C 108.022 -2.031 . . . . 0.83999999999999997 108.022 173.575 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.5 p -134.54 143.1 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 118.342 1.071 . . . . 0.73999999999999999 110.983 -166.627 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -71.72 153.68 41.86 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.126 -0.943 . . . . 1.79 108.857 171.661 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -170.51 -50.62 0.04 OUTLIER Glycine 0 C--N 1.332 0.329 0 N-CA-C 110.988 -0.845 . . . . 2.02 110.988 177.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -65.56 146.97 54.19 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.283 -1.006 . . . . 5.9900000000000002 108.283 173.749 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -82.64 63.33 6.72 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.389 -0.967 . . . . 3.8500000000000001 108.389 -173.733 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 127.96 11.69 3.13 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.895 1.712 . . . . 1.3899999999999999 113.664 -179.223 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.73 168.57 19.41 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.194 1.497 . . . . 2.6600000000000001 109.834 169.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.3 mp -126.57 136.11 52.13 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.375 1.07 . . . . 1.9299999999999999 109.418 -171.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -97.41 103.06 14.96 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.903 -1.518 . . . . 0.54000000000000004 106.903 175.326 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -122.91 121.06 35.27 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 118.398 -0.811 . . . . 0.95999999999999996 108.854 -177.098 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.453 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 15.4 t -107.99 -15.61 14.49 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 123.579 0.549 . . . . 0.97999999999999998 111.802 176.426 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -97.94 79.05 2.6 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 120.204 -1.56 . . . . 3.4900000000000002 108.979 -176.752 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.434 HG23 ' HG3' ' A' ' 101' ' ' PRO . 18.2 m -88.07 130.13 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 119.596 1.089 . . . . 0.78000000000000003 111.339 174.842 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.94 106.6 13.6 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 107.342 -1.355 . . . . 0.77000000000000002 107.342 175.366 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.67 72.11 10.62 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 123.165 0.586 . . . . 1.1899999999999999 110.6 -178.258 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.5 -37.06 62.38 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.811 0.671 . . . . 5.0 112.811 -178.667 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -89.7 54.48 2.89 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 121.657 -0.652 . . . . 4.6500000000000004 110.095 -171.282 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 . . . . . 0 N--CA 1.464 0.251 0 C-N-CA 124.583 1.153 . . . . 7.5499999999999998 110.867 -178.968 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.4 m . . . . . 0 N--CA 1.454 -0.229 0 N-CA-C 107.119 -1.437 . . . . 6.4299999999999997 107.119 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 57.8 p30 -74.91 -16.52 60.66 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.808 0.67 . . . . 8.0099999999999998 112.808 -179.87 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.6 tt 71.5 53.16 0.23 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.144 1.378 . . . . 5.9400000000000004 111.01 169.179 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 45.3 p-10 -110.83 73.69 0.84 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.826 1.25 . . . . 3.9399999999999999 112.416 -168.969 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.01 165.93 13.5 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.809 0.844 . . . . 3.98 112.655 179.365 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -87.92 114.74 24.83 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 125.469 1.508 . . . . 2.1499999999999999 110.717 -178.291 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -132.23 156.39 46.58 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.535 0.734 . . . . 3.6899999999999999 112.363 -173.055 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.6 m -71.98 132.62 84.56 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 125.54 1.536 . . . . 2.1499999999999999 110.759 -174.661 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -54.52 -37.49 90.19 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.149 2.566 . . . . 1.0700000000000001 112.8 -176.711 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -37.3 -53.43 1.09 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.578 1.151 . . . . 2.98 113.228 171.541 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -78.36 -1.89 35.53 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.011 -0.431 . . . . 3.1000000000000001 111.807 -173.189 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 32.7 pt -121.48 35.04 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.581 1.152 . . . . 1.6299999999999999 110.193 171.716 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.6 p -121.02 -76.31 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 122.893 0.477 . . . . 2.2400000000000002 111.165 158.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -83.52 109.11 17.11 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 125.214 1.405 . . . . 3.1800000000000002 110.441 -160.058 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.69 37.27 40.33 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 109.528 -1.429 . . . . 1.8799999999999999 109.528 177.597 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.06 -93.55 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.688 1.195 . . . . 2.79 107.836 -174.145 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.6 m -72.58 -59.0 2.94 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.141 0.976 . . . . 1.9199999999999999 111.195 -177.679 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -53.45 -41.66 66.36 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 122.835 1.302 . . . . 3.0800000000000001 109.575 -175.119 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.38 -19.43 42.66 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 126.524 1.93 . . . . 1.5900000000000001 112.321 -179.619 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 54.69 42.56 78.12 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 126.039 1.781 . . . . 1.8999999999999999 113.18 -175.383 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.5 m -100.25 -49.94 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 118.616 1.208 . . . . 2.0899999999999999 113.113 -174.071 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 34.3 mmtt -97.54 -66.03 0.08 OUTLIER Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.85 0.86 . . . . 2.9500000000000002 111.378 -177.485 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -75.15 68.94 5.79 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.264 1.976 . . . . 2.6099999999999999 108.843 170.428 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -51.28 140.4 16.98 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.993 -0.743 . . . . 3.0299999999999998 108.993 173.657 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.88 127.89 34.47 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.58 -0.896 . . . . 1.27 108.58 -176.466 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 124.39 -29.03 5.14 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.915 -0.874 . . . . 1.46 110.915 -161.609 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -79.84 137.15 36.87 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.988 1.394 . . . . 2.5899999999999999 110.225 -177.338 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.03 106.28 15.3 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.919 1.688 . . . . 3.7999999999999998 108.569 -172.648 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.43 168.46 23.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.7 -1.593 . . . . 1.3799999999999999 106.7 -174.58 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 25.9 mtt-85 -110.17 123.15 49.23 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 106.83 -1.544 . . . . 2.2599999999999998 106.83 178.232 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.4 p -86.88 130.73 36.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 107.329 -1.36 . . . . 0.79000000000000004 107.329 176.066 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -133.53 128.65 5.09 Favored Glycine 0 C--N 1.332 0.344 0 N-CA-C 110.161 -1.175 . . . . 0.56999999999999995 110.161 -179.497 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 177.1 -172.99 45.92 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.501 -1.04 . . . . 0.60999999999999999 110.501 -179.417 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -90.93 138.34 31.67 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 117.404 0.602 . . . . 4.5099999999999998 110.14 -178.628 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.551 HG11 ' HE1' ' A' ' 104' ' ' PHE . 7.6 p -106.42 144.73 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 109.388 -0.597 . . . . 2.2200000000000002 109.388 178.892 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.2 m -87.92 133.39 33.93 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 125.741 1.617 . . . . 2.3399999999999999 108.842 -174.84 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.444 ' HA ' ' HB3' ' A' ' 106' ' ' GLU . 10.8 p -46.63 -47.61 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.346 1.058 . . . . 2.3100000000000001 112.879 -177.424 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -100.43 76.09 0.43 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 109.648 -1.381 . . . . 2.0 109.648 -178.856 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.9 m -146.33 -39.29 0.22 Allowed 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 117.804 0.802 . . . . 1.21 112.558 178.78 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 17.8 ttm -54.95 129.06 36.25 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 118.168 0.44 . . . . 2.1200000000000001 110.117 173.088 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.75 122.73 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 106.119 -1.808 . . . . 0.63 106.119 160.088 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.434 ' CB ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -114.35 139.3 49.57 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.935 1.294 . . . . 5.3099999999999996 109.665 -178.138 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.46 166.06 47.37 Favored Pre-proline 0 C--O 1.235 0.324 0 CA-C-O 120.936 0.398 . . . . 1.72 111.101 -173.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.97 -25.59 13.98 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.138 2.558 . . . . 1.4199999999999999 111.201 163.593 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -48.13 -30.03 4.19 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.001 0.521 . . . . 1.1499999999999999 110.564 164.701 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.2 m 66.6 19.12 10.84 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 125.02 1.328 . . . . 1.3100000000000001 112.324 175.147 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.33 -41.52 1.89 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 128.281 2.632 . . . . 1.97 110.993 177.604 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 71.9 m-70 -84.2 126.0 32.73 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.951 -1.5 . . . . 1.0800000000000001 106.951 178.533 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.434 HG12 ' CB ' ' A' ' 73' ' ' ARG . 26.7 m -142.75 139.0 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 106.564 -1.643 . . . . 0.93999999999999995 106.564 179.908 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -144.15 149.95 37.3 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.346 -0.613 . . . . 1.3700000000000001 109.346 177.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -154.36 146.69 23.89 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 123.678 0.611 . . . . 2.02 109.468 -170.606 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.92 122.4 40.99 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 124.345 1.058 . . . . 0.94999999999999996 109.248 -179.197 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.1 t -108.23 146.9 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.084 0 N-CA-C 107.389 -1.337 . . . . 1.8600000000000001 107.389 177.543 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -151.1 -170.98 3.81 Favored 'General case' 0 C--O 1.226 -0.143 0 N-CA-C 107.541 -1.281 . . . . 1.8 107.541 174.045 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.71 64.84 0.42 Allowed 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 118.619 0.645 . . . . 3.4300000000000002 109.664 -177.576 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.9 m 49.87 86.81 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.336 -0.853 . . . . 3.4900000000000002 111.677 177.001 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 17.19 27.97 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 118.695 2.85 . . . . 7.4500000000000002 118.695 -147.748 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.39 48.02 1.78 Allowed Glycine 0 CA--C 1.535 1.292 0 O-C-N 119.815 -1.803 . . . . 5.0999999999999996 112.216 156.212 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 55.99 114.17 0.01 OUTLIER Glycine 0 CA--C 1.532 1.112 0 C-N-CA 127.823 2.63 . . . . 1.96 116.223 169.076 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -64.09 141.04 58.91 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.7 -0.883 . . . . 2.5600000000000001 110.427 171.507 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -141.56 143.91 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 107.856 -1.165 . . . . 0.91000000000000003 107.856 170.97 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.3 mt -91.1 119.35 31.16 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.287 1.035 . . . . 0.67000000000000004 108.973 177.523 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 51.3 t -98.24 127.99 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 106.783 -1.562 . . . . 1.04 106.783 174.548 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.6 p -113.61 148.11 36.83 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.547 -0.908 . . . . 1.0800000000000001 108.547 -177.753 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.473 ' CE2' ' HA ' ' A' ' 125' ' ' THR . 0.5 OUTLIER -142.72 141.35 31.77 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.949 1.3 . . . . 3.5600000000000001 108.381 -177.263 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -114.13 10.06 17.3 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.614 1.565 . . . . 2.4900000000000002 111.95 173.377 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -118.92 161.77 19.62 Favored 'General case' 0 C--N 1.342 0.272 0 C-N-CA 125.148 1.379 . . . . 4.4699999999999998 110.297 172.16 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.6 mp -64.86 122.91 18.06 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.159 -0.473 . . . . 1.8 109.939 168.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.4 HD21 ' CE1' ' A' ' 96' ' ' TYR . 23.0 mt -73.75 155.33 89.04 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 123.621 0.768 . . . . 1.6499999999999999 110.107 173.39 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -65.9 151.94 82.79 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 123.603 2.869 . . . . 2.3900000000000001 110.194 173.839 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 55.1 12.67 0.68 Allowed 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 114.983 1.475 . . . . 3.3100000000000001 114.983 -177.467 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.48 ' O ' HD22 ' A' ' 103' ' ' LEU . 0.4 OUTLIER 62.99 -6.42 0.17 Allowed 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 118.644 0.656 . . . . 4.5999999999999996 111.616 -162.419 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.551 ' HE1' HG11 ' A' ' 66' ' ' VAL . 5.0 t80 55.95 78.7 0.19 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.257 1.823 . . . . 2.6099999999999999 109.154 -170.829 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.3 10.2 mtp180 -86.7 34.88 0.66 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 119.046 -1.061 . . . . 4.3799999999999999 111.729 -177.517 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.444 ' HB3' ' HA ' ' A' ' 68' ' ' VAL 0.357 10.5 mm-40 82.94 178.53 0.06 Allowed 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 120.232 1.378 . . . . 5.25 110.158 149.875 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.405 ' N ' HG13 ' A' ' 66' ' ' VAL . . . 61.14 15.07 42.42 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 115.469 0.948 . . . . 1.05 115.469 158.215 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.484 ' O ' HG12 ' A' ' 66' ' ' VAL . 4.6 pt20 -136.73 141.48 43.04 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.601 1.2 . . . . 2.3500000000000001 108.027 -177.903 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -77.85 113.67 3.79 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 110.266 -1.134 . . . . 0.95999999999999996 110.266 -175.069 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.1 pp -123.65 169.33 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 123.608 0.763 . . . . 0.78000000000000003 109.437 -175.101 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 5.7 m -117.89 134.26 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 107.852 -1.166 . . . . 0.66000000000000003 107.852 169.371 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.516 ' CB ' HG12 ' A' ' 127' ' ' VAL . . . -121.26 155.18 35.21 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 125.53 1.532 . . . . 0.79000000000000004 108.569 177.837 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -148.09 161.83 40.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.052 0.842 . . . . 3.2000000000000002 112.112 171.645 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 171.15 -111.52 0.41 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 105.702 -2.959 . . . . 0.84999999999999998 105.702 167.537 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.2 p -156.81 146.39 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 118.724 1.262 . . . . 1.0800000000000001 111.719 -175.737 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.67 116.68 7.15 Favored 'General case' 0 N--CA 1.457 -0.093 0 N-CA-C 107.908 -1.145 . . . . 2.1800000000000002 107.908 168.729 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -136.75 13.2 3.93 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.092 -0.838 . . . . 2.3900000000000001 113.17 -179.681 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -143.05 35.49 1.37 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 118.017 0.908 . . . . 5.1900000000000004 110.678 177.625 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 26.63 52.45 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 128.124 2.57 . . . . 4.0199999999999996 112.053 177.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 160.77 -40.3 0.43 Allowed Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.244 -0.754 . . . . 1.27 113.772 -163.488 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.83 164.11 18.05 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.934 1.367 . . . . 2.9399999999999999 110.79 171.412 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.1 mt -105.72 116.67 32.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.243 1.417 . . . . 2.04 108.282 -177.307 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.41 103.7 13.79 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.553 -1.647 . . . . 0.64000000000000001 106.553 171.754 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -101.39 156.16 17.62 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.433 0.693 . . . . 1.71 109.843 -179.025 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.473 ' HA ' ' CE2' ' A' ' 96' ' ' TYR 0.256 9.9 t -141.1 -36.51 0.45 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.532 0.938 . . . . 1.23 113.532 174.713 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -92.45 127.35 37.91 Favored 'General case' 0 N--CA 1.463 0.224 0 O-C-N 120.481 -1.387 . . . . 2.7400000000000002 109.189 169.109 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.516 HG12 ' CB ' ' A' ' 112' ' ' ALA . 2.4 m -125.32 142.21 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 N-CA-C 108.394 -0.965 . . . . 0.94999999999999996 108.394 164.921 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.85 101.51 7.61 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.25 -1.389 . . . . 0.89000000000000001 107.25 179.071 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.85 60.56 2.87 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.247 0.619 . . . . 1.1499999999999999 110.694 -177.397 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -79.41 51.77 1.27 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.601 0.76 . . . . 3.04 112.072 -173.222 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -147.66 134.62 20.25 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.32 -1.363 . . . . 4.4000000000000004 107.32 -179.239 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 48.7 t0 . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 106.659 -1.608 . . . . 5.9100000000000001 106.659 172.306 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.3 t . . . . . 0 CA--C 1.532 0.264 0 CA-C-O 120.8 0.333 . . . . 7.3700000000000001 110.282 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -83.72 68.5 9.9 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.802 0.841 . . . . 10.16 110.329 -176.673 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.41 ' C ' HD22 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -68.75 160.65 29.98 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.534 0.207 . . . . 5.5599999999999996 110.933 171.966 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -148.11 129.95 15.2 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 107.67 -1.233 . . . . 4.0999999999999996 107.67 178.946 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -158.62 153.5 25.0 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.001 0.819 . . . . 2.6600000000000001 109.894 167.269 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -111.59 122.58 48.19 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.288 1.435 . . . . 2.73 107.984 179.715 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -129.71 164.62 23.58 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 122.799 0.44 . . . . 3.23 111.266 173.376 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 p -85.63 146.93 45.15 Favored Pre-proline 0 N--CA 1.45 -0.431 0 C-N-CA 123.725 0.81 . . . . 1.6499999999999999 110.598 -178.904 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -57.52 -42.18 63.77 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.94 2.426 . . . . 0.73999999999999999 111.155 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.9 p -58.63 -24.15 60.46 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.904 1.681 . . . . 2.3500000000000001 113.0 174.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -84.27 -48.36 9.83 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.114 -0.699 . . . . 2.2599999999999998 109.114 173.093 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.266 22.3 pt -75.73 37.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 114.397 1.258 . . . . 1.3600000000000001 114.397 -178.245 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.661 HG23 ' H ' ' A' ' 45' ' ' ASN . 0.5 OUTLIER -121.93 -87.06 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 125.39 1.476 . . . . 2.7000000000000002 108.16 169.271 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.661 ' H ' HG23 ' A' ' 44' ' ' VAL . 28.6 m-80 -58.98 103.62 0.18 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.549 2.34 . . . . 2.2799999999999998 110.469 -171.414 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.42 39.0 70.09 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.081 -0.807 . . . . 1.4099999999999999 111.081 171.942 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -143.99 -102.31 0.12 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 126.175 1.79 . . . . 2.71 108.377 175.57 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.405 HG23 HD12 ' A' ' 116' ' ' LEU . 97.7 m -69.48 -68.1 0.43 Allowed 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 124.319 1.048 . . . . 1.5 110.954 -177.374 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -53.75 -43.74 69.4 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.908 0.861 . . . . 2.5 110.559 -171.188 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.27 -22.56 51.93 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.615 0.766 . . . . 1.54 112.512 176.946 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 60.69 56.86 21.93 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 125.66 1.6 . . . . 1.3300000000000001 112.324 178.303 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.255 26.8 m -110.76 -64.16 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 114.1 1.148 . . . . 1.27 114.1 -179.595 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.4 mmmt -80.41 -62.99 0.36 Allowed Pre-proline 0 CA--C 1.538 0.513 0 O-C-N 121.302 -0.874 . . . . 3.6099999999999999 112.029 -177.629 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -77.13 -179.24 5.24 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.387 2.058 . . . . 1.6699999999999999 109.285 169.249 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -152.53 151.13 30.33 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.564 -1.643 . . . . 2.8100000000000001 106.564 -174.875 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -55.39 161.9 1.73 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.53 0.937 . . . . 1.1799999999999999 113.53 178.601 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.42 -6.09 58.49 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 119.424 -0.653 . . . . 1.02 113.075 -179.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -82.1 145.34 30.21 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.821 1.31 . . . . 1.8999999999999999 108.814 175.805 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.2 ttm105 -90.19 125.86 35.62 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.709 -1.219 . . . . 4.29 107.709 174.689 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.4 pt -142.05 175.63 4.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 118.842 0.746 . . . . 0.67000000000000004 109.035 175.483 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.445 HH11 ' HG2' ' A' ' 61' ' ' ARG . 6.2 mtt-85 -120.05 136.74 54.46 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.874 0.47 . . . . 3.4199999999999999 109.749 168.647 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.63 125.65 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 125.362 1.465 . . . . 0.81000000000000005 107.91 175.768 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -128.05 112.56 1.48 Allowed Glycine 0 C--N 1.333 0.388 0 N-CA-C 109.875 -1.29 . . . . 0.53000000000000003 109.875 -177.764 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.67 -171.5 33.72 Favored Glycine 0 C--N 1.332 0.348 0 N-CA-C 110.027 -1.229 . . . . 0.78000000000000003 110.027 -176.623 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.409 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 18.6 ptp -88.67 138.66 31.23 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.031 0.443 . . . . 2.73 110.1 -178.209 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.549 HG12 HG12 ' A' ' 84' ' ' VAL . 10.7 m -91.18 150.35 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 109.401 -0.592 . . . . 2.3300000000000001 109.401 170.574 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 m -91.37 143.89 26.15 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.892 -1.151 . . . . 2.7400000000000002 107.892 165.358 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.9 p -59.43 -59.44 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.362 1.065 . . . . 2.5699999999999998 110.088 178.272 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.36 66.79 2.89 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.328 -1.109 . . . . 1.6799999999999999 110.328 178.346 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.3 m -150.13 -30.77 0.21 Allowed 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 113.942 1.09 . . . . 1.0600000000000001 113.942 -179.398 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -60.14 117.23 4.88 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 119.087 0.858 . . . . 1.8999999999999999 109.225 173.545 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.16 125.41 71.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 N-CA-C 107.655 -1.239 . . . . 0.63 107.655 169.808 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -109.48 147.46 32.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.235 1.014 . . . . 6.6699999999999999 109.619 -178.829 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -72.42 161.76 77.42 Favored Pre-proline 0 C--O 1.239 0.533 0 C-N-CA 120.404 -0.518 . . . . 2.29 110.381 174.455 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -63.74 -34.22 62.82 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.384 2.056 . . . . 1.6299999999999999 110.175 163.81 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -41.18 -47.27 3.26 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 125.273 1.429 . . . . 1.29 109.854 174.713 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.4 m 80.64 11.67 0.95 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.117 1.767 . . . . 1.3 112.423 179.668 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.17 -6.92 9.9 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.041 1.336 . . . . 1.8500000000000001 111.334 175.522 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -123.4 136.64 54.73 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.919 1.287 . . . . 1.4199999999999999 108.151 177.99 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.61 131.07 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 107.826 -1.176 . . . . 0.89000000000000001 107.826 -172.341 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -135.81 154.32 51.24 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 119.778 1.172 . . . . 1.2 110.427 175.894 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -150.25 138.69 20.53 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.067 -0.716 . . . . 1.95 109.067 -173.805 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.07 136.57 34.44 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.938 -1.134 . . . . 0.66000000000000003 107.938 173.584 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.549 HG12 HG12 ' A' ' 66' ' ' VAL . 14.4 m -129.63 149.5 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 107.992 -1.114 . . . . 2.6800000000000002 107.992 177.436 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -153.4 177.53 10.79 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.975 0.416 . . . . 2.6499999999999999 110.247 -173.951 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -157.34 148.7 21.9 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.179 0.592 . . . . 3.0299999999999998 111.037 175.235 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 67.2 m 3.0 71.79 0.0 OUTLIER 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 128.556 2.743 . . . . 3.0299999999999998 112.205 -169.977 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -10.26 40.36 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 131.282 3.833 . . . . 9.6400000000000006 118.747 -148.979 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.34 -25.36 66.65 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 110.479 -1.048 . . . . 3.1400000000000001 110.479 168.373 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.566 ' HA3' HG21 ' A' ' 44' ' ' VAL . . . 170.53 174.35 38.47 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.133 -1.187 . . . . 1.54 110.133 169.035 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -138.86 141.47 38.61 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.921 1.688 . . . . 3.21 107.363 -175.239 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.4 tp -140.8 151.21 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 123.451 0.701 . . . . 1.1499999999999999 109.247 -176.162 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mt -93.17 122.21 35.32 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.655 0.782 . . . . 1.1599999999999999 109.768 -178.048 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.0 t -102.3 119.56 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 107.062 -1.459 . . . . 0.89000000000000001 107.062 173.558 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 62.0 p -99.42 147.34 25.36 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.086 -1.079 . . . . 0.53000000000000003 108.086 174.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -147.35 160.83 42.08 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.238 1.415 . . . . 2.5 108.521 -172.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -147.98 152.89 38.25 Favored 'General case' 0 N--CA 1.428 -1.542 0 C-N-CA 127.553 2.341 . . . . 3.5600000000000001 106.616 -169.628 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 61.1 64.81 1.06 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 129.652 3.181 . . . . 2.7200000000000002 110.7 -172.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.0 mp 45.05 -144.67 0.16 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.311 1.444 . . . . 1.8799999999999999 109.449 -173.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.6 mt -158.76 149.78 16.3 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 104.883 -2.265 . . . . 1.1100000000000001 104.883 -175.951 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -67.35 129.75 20.97 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 121.956 1.771 . . . . 2.6600000000000001 108.14 169.757 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.582 ' O ' HD12 ' A' ' 103' ' ' LEU . 2.8 m-20 23.25 53.78 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 128.207 2.603 . . . . 3.3300000000000001 113.095 -178.047 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.616 HD13 ' OE1' ' A' ' 106' ' ' GLU . 0.7 OUTLIER 36.6 38.42 0.08 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.509 1.524 . . . . 3.4199999999999999 114.422 -179.159 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.0 p90 35.34 83.6 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.423 1.489 . . . . 3.3100000000000001 112.111 -173.561 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.4 116.3 4.96 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 119.255 -2.153 . . . . 4.5999999999999996 110.709 -137.594 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.616 ' OE1' HD13 ' A' ' 103' ' ' LEU . 9.6 mp0 -77.53 167.22 21.99 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 122.267 1.032 . . . . 3.6699999999999999 111.679 -147.31 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.93 41.07 56.18 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 114.841 -1.072 . . . . 0.80000000000000004 110.996 -169.919 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -149.8 178.34 8.97 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.353 1.061 . . . . 2.5 109.08 171.864 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' A' ' 65' ' ' MET . . . -92.89 136.22 13.05 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 110.738 -0.945 . . . . 0.77000000000000002 110.738 170.632 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.4 pp -139.29 154.74 25.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 107.484 -1.302 . . . . 0.68999999999999995 107.484 179.557 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 19.5 m -110.32 120.89 62.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 108.741 -0.837 . . . . 0.66000000000000003 108.741 178.457 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.464 ' HB2' HG12 ' A' ' 127' ' ' VAL . . . -113.97 150.8 33.28 Favored 'General case' 0 N--CA 1.458 -0.071 0 C-N-CA 126.131 1.772 . . . . 0.68000000000000005 109.494 -174.492 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -149.9 155.01 39.27 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 113.448 0.907 . . . . 3.8799999999999999 113.448 177.987 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 163.48 -130.38 2.22 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 106.063 -2.815 . . . . 0.98999999999999999 106.063 175.235 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.9 p -129.95 145.79 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.069 0 CA-C-N 118.337 1.068 . . . . 0.93000000000000005 111.761 -164.095 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.405 HD12 HG23 ' A' ' 48' ' ' THR . 4.6 mm? -66.3 124.33 22.41 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.199 -0.455 . . . . 1.95 111.027 174.725 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.59 130.43 9.83 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 126.257 1.884 . . . . 3.6200000000000001 109.377 172.595 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 60.58 29.73 19.23 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.465 1.106 . . . . 4.5800000000000001 111.458 167.553 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 40.9 39.26 0.78 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.011 1.724 . . . . 4.5099999999999998 111.178 -170.375 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -160.3 -61.96 0.01 OUTLIER Glycine 0 C--N 1.34 0.792 0 O-C-N 121.472 -0.767 . . . . 1.1699999999999999 111.946 -170.354 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -83.34 127.34 33.59 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.901 -0.777 . . . . 2.1899999999999999 108.901 -178.842 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.35 107.32 17.94 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.384 -1.339 . . . . 2.1299999999999999 107.384 177.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.85 84.74 7.46 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.361 -1.348 . . . . 0.57999999999999996 107.361 -179.59 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.66 144.71 26.44 Favored 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 123.762 0.825 . . . . 1.23 109.023 -177.484 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.7 t -137.88 9.56 2.82 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.85 0.75 . . . . 1.1499999999999999 112.914 173.898 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -132.99 119.65 20.37 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 106.736 -1.579 . . . . 3.4199999999999999 106.736 170.272 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.464 HG12 ' HB2' ' A' ' 112' ' ' ALA . 2.4 m -123.41 131.38 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 C-N-CA 124.589 1.156 . . . . 0.82999999999999996 109.494 176.867 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -115.91 104.37 11.55 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.708 -1.219 . . . . 0.90000000000000002 107.708 179.117 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.14 56.02 3.56 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.018 0.927 . . . . 1.3999999999999999 110.653 -179.238 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -77.8 60.95 2.36 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.046 0.938 . . . . 3.2799999999999998 111.355 -175.409 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -132.75 47.87 2.47 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.686 0.755 . . . . 4.4299999999999997 111.171 -172.514 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 CA--C 1.53 0.206 0 C-N-CA 126.361 1.865 . . . . 5.8399999999999999 111.643 179.277 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 109.133 -0.692 . . . . 7.6399999999999997 109.133 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -96.85 174.31 6.86 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.867 0.867 . . . . 8.0199999999999996 110.127 175.002 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.426 HD22 ' N ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -136.19 177.65 7.67 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.015 -1.106 . . . . 4.8399999999999999 108.015 165.849 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.426 ' N ' HD22 ' A' ' 34' ' ' LEU . 10.2 p30 -159.78 157.67 29.76 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 107.487 -1.301 . . . . 3.4199999999999999 107.487 165.86 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -160.99 169.6 22.23 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.852 0.861 . . . . 1.8500000000000001 109.663 173.237 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -83.07 140.0 32.91 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.534 0.734 . . . . 2.2000000000000002 110.359 -178.734 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -144.67 160.13 41.7 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.925 1.29 . . . . 2.77 110.593 176.977 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.95 134.67 38.72 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 126.519 1.928 . . . . 1.4299999999999999 109.972 -179.848 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -56.84 -43.46 54.22 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.263 2.642 . . . . 0.76000000000000001 111.775 -179.449 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.3 p -59.94 -34.2 72.93 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 121.406 -0.809 . . . . 2.0299999999999998 112.065 -178.648 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.02 -55.17 36.08 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.553 0.692 . . . . 3.1899999999999999 109.281 175.953 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.318 20.6 pt -66.29 -14.91 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 114.64 -1.164 . . . . 1.4399999999999999 112.624 -170.022 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 88.4 t -75.68 -54.87 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 123.007 0.523 . . . . 2.0699999999999998 110.978 167.499 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -56.43 -71.4 0.09 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.508 0.929 . . . . 2.5699999999999998 113.508 -163.328 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -146.21 55.87 0.53 Allowed Glycine 0 C--N 1.333 0.4 0 N-CA-C 108.778 -1.729 . . . . 1.74 108.778 -167.806 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -153.44 -106.85 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.928 1.691 . . . . 3.6499999999999999 108.644 -171.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.5 m -72.53 -60.05 2.42 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 124.341 1.056 . . . . 1.5700000000000001 111.619 -170.765 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -56.25 -40.14 73.7 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 122.048 0.928 . . . . 2.5899999999999999 109.734 -176.039 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.45 -24.84 62.09 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.158 0.983 . . . . 2.0499999999999998 112.805 174.482 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.48 41.38 99.54 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 126.163 1.839 . . . . 1.26 111.918 -176.015 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.9 m -102.55 -53.52 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 118.048 0.924 . . . . 1.3300000000000001 113.037 -174.423 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -93.71 -65.4 0.12 Allowed Pre-proline 0 CA--C 1.533 0.326 0 CA-C-O 118.542 -0.742 . . . . 3.8599999999999999 112.054 -175.282 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -78.59 140.6 16.91 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 121.681 1.587 . . . . 1.24 108.799 174.067 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -87.35 161.95 17.63 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.701 0.8 . . . . 4.9699999999999998 109.255 167.738 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.95 170.15 8.73 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 122.9 0.48 . . . . 1.6000000000000001 110.215 174.124 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.51 22.81 71.69 Favored Glycine 0 CA--C 1.534 1.248 0 O-C-N 121.768 -0.583 . . . . 1.05 113.583 178.308 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -102.23 162.23 13.08 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.198 0.999 . . . . 1.7 108.432 171.2 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.7 mtt180 -99.63 134.43 42.53 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.86 -0.422 . . . . 3.7200000000000002 109.86 169.55 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.3 pt -143.36 176.22 3.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 106.862 -1.533 . . . . 0.78000000000000003 106.862 169.024 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.7 mtt180 -123.29 123.4 40.66 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.355 -0.98 . . . . 2.2200000000000002 108.355 170.474 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.9 m -89.06 129.42 40.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 107.938 -1.134 . . . . 2.2599999999999998 107.938 175.007 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -128.38 128.23 5.9 Favored Glycine 0 CA--C 1.52 0.359 0 N-CA-C 109.197 -1.561 . . . . 0.68999999999999995 109.197 178.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.67 -170.74 40.34 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 109.979 -1.248 . . . . 0.68000000000000005 109.979 -174.139 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.3 ptp -100.41 123.91 45.23 Favored 'General case' 0 N--CA 1.458 -0.061 0 CA-C-O 121.316 0.579 . . . . 2.3500000000000001 110.976 -174.044 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.0 t -73.24 105.23 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 123.831 0.853 . . . . 2.23 110.485 179.78 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.2 m -45.29 136.09 5.49 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 126.362 1.865 . . . . 2.3599999999999999 111.28 164.583 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.1 p -55.54 -64.09 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 123.741 0.817 . . . . 2.0099999999999998 111.077 177.42 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.45 72.6 2.78 Favored Glycine 0 C--N 1.332 0.36 0 N-CA-C 109.34 -1.504 . . . . 1.77 109.34 -174.586 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.6 m -150.46 -34.18 0.16 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 115.891 1.811 . . . . 1.1100000000000001 115.891 -174.895 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -76.93 99.71 5.33 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 120.159 1.345 . . . . 2.29 110.313 -175.012 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.1 m -111.32 128.81 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 108.527 -0.916 . . . . 0.85999999999999999 108.527 -177.819 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -111.57 143.26 42.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.725 1.61 . . . . 6.0 110.591 -175.61 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -71.83 155.82 91.74 Favored Pre-proline 0 C--O 1.232 0.155 0 CA-C-N 118.245 0.475 . . . . 1.8700000000000001 109.764 177.416 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -64.16 -27.11 64.77 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.207 1.938 . . . . 1.22 111.363 166.064 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -45.31 -33.68 2.57 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.193 0.597 . . . . 1.1499999999999999 110.709 164.726 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.1 m 69.27 15.99 8.48 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.446 1.498 . . . . 1.5600000000000001 112.466 177.253 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.41 -38.1 2.59 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 126.324 1.85 . . . . 1.7 112.075 175.789 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -87.38 135.96 33.12 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.155 -1.424 . . . . 1.1399999999999999 107.155 175.537 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.555 HG23 ' HB3' ' A' ' 96' ' ' TYR . 28.0 m -144.15 148.72 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 107.195 -1.409 . . . . 0.68000000000000005 107.195 178.144 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -148.78 158.76 44.39 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 121.448 -0.783 . . . . 1.0 109.716 178.892 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -150.64 142.11 23.45 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.654 -0.703 . . . . 1.8400000000000001 110.405 -173.884 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.97 148.56 27.54 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.16 -1.052 . . . . 0.65000000000000002 108.16 163.031 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.5 p -146.84 150.46 14.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 107.661 -1.237 . . . . 1.9399999999999999 107.661 171.705 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.2 176.43 9.75 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.189 0.996 . . . . 2.3399999999999999 110.513 -175.345 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -154.64 -89.11 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.961 0.904 . . . . 2.6299999999999999 110.735 -176.57 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.1 t -77.12 85.05 3.61 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 106.273 -1.751 . . . . 6.0199999999999996 106.273 170.638 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -39.35 17.1 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.803 1 C-N-CA 134.301 5.04 . . . . 9.25 120.921 -170.128 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -104.0 25.34 26.66 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 120.185 1.357 . . . . 3.2599999999999998 110.616 159.745 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -160.78 107.6 0.32 Allowed Glycine 0 CA--C 1.527 0.819 0 CA-C-N 118.479 1.139 . . . . 1.9299999999999999 110.892 -179.021 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -99.5 135.15 41.33 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 124.792 1.237 . . . . 3.1000000000000001 108.98 169.18 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' A' ' 92' ' ' ILE . 0.2 OUTLIER -112.57 144.89 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.654 -1.239 . . . . 0.98999999999999999 107.654 167.553 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.5 mt -104.09 120.69 41.64 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.271 1.029 . . . . 0.66000000000000003 108.38 176.225 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 44.0 t -103.16 136.3 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 125.422 1.489 . . . . 0.83999999999999997 107.676 178.965 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.2 p -112.94 142.01 46.11 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.405 1.082 . . . . 0.52000000000000002 108.578 178.521 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.555 ' HB3' HG23 ' A' ' 80' ' ' VAL . 2.1 t80 -138.42 114.63 10.24 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 107.529 -1.286 . . . . 2.4100000000000001 107.529 -175.564 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -101.27 46.97 0.92 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.851 1.261 . . . . 2.3300000000000001 112.05 -171.222 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -167.67 176.81 6.19 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.646 1.978 . . . . 2.5499999999999998 107.037 170.486 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.0 mp -70.67 136.65 49.22 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.02 -1.05 . . . . 1.79 110.783 178.533 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.452 ' HG ' HG21 ' A' ' 80' ' ' VAL . 11.9 mt -69.92 160.89 78.47 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.395 1.078 . . . . 1.24 110.565 174.302 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.52 -95.82 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.837 3.024 . . . . 2.3900000000000001 110.281 176.282 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -78.39 49.91 0.89 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.863 1.265 . . . . 3.4900000000000002 110.232 -176.543 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 52.44 -4.67 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.404 2.682 . . . . 2.21 115.918 -168.46 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 64.4 t80 64.26 93.96 0.06 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.727 1.611 . . . . 2.29 108.795 -159.32 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -79.81 129.02 34.13 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.663 0.744 . . . . 5.8899999999999997 109.272 -179.138 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -83.95 144.17 29.34 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 128.062 2.545 . . . . 3.3999999999999999 109.617 -174.002 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.29 46.59 8.02 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 112.052 -0.419 . . . . 1.0800000000000001 112.052 178.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -155.8 175.52 13.82 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.567 -1.642 . . . . 2.1899999999999999 106.567 170.839 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -86.24 144.49 20.03 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.095 -1.202 . . . . 0.87 110.095 167.668 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.1 pp -139.77 167.7 18.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 107.731 -1.211 . . . . 0.60999999999999999 107.731 167.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 23.8 m -126.71 135.57 63.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.867 -0.79 . . . . 0.66000000000000003 108.867 171.096 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -129.55 120.46 25.38 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 124.703 1.201 . . . . 0.47999999999999998 110.762 -169.095 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -114.21 145.95 41.03 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 125.253 1.421 . . . . 3.4700000000000002 111.022 -176.619 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 173.07 -123.09 0.96 Allowed Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 108.021 -2.032 . . . . 0.91000000000000003 108.021 170.467 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.2 p -138.25 152.17 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 118.176 0.988 . . . . 0.72999999999999998 109.726 -173.021 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -59.61 132.31 53.58 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 108.118 -1.067 . . . . 1.7 108.118 167.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -87.98 -104.34 0.93 Allowed Glycine 0 C--N 1.338 0.661 0 N-CA-C 110.011 -1.236 . . . . 2.1200000000000001 110.011 -172.766 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -59.4 -66.15 0.56 Allowed 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.334 1.054 . . . . 4.8499999999999996 108.375 172.771 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -173.0 -66.3 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.761 2.024 . . . . 4.1900000000000004 105.971 175.83 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.0 -45.04 96.94 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 123.504 0.573 . . . . 1.1200000000000001 112.271 177.021 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -83.28 144.13 29.93 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 122.036 -0.685 . . . . 2.54 111.257 -176.217 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -105.15 122.77 46.6 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 125.002 1.321 . . . . 2.25 108.076 -176.456 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -94.91 85.85 4.51 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.826 -1.175 . . . . 0.62 107.826 175.913 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.4 105.0 13.84 Favored 'General case' 0 C--O 1.226 -0.176 0 C-N-CA 123.473 0.709 . . . . 1.3600000000000001 110.378 -175.301 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.2 t -95.77 -25.82 15.91 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.903 0.881 . . . . 0.79000000000000004 111.761 -177.485 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -89.33 81.52 6.64 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 120.695 -1.253 . . . . 3.2799999999999998 108.708 179.279 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.6 m -90.48 125.03 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 118.112 0.415 . . . . 0.64000000000000001 110.32 173.26 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -115.26 113.97 24.58 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.165 -1.42 . . . . 0.60999999999999999 107.165 175.372 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -78.69 108.27 11.98 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 107.501 -1.296 . . . . 1.5900000000000001 107.501 167.845 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.89 50.49 0.31 Allowed 'General case' 0 C--O 1.234 0.273 0 C-N-CA 122.511 0.324 . . . . 3.5299999999999998 110.626 -175.613 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.83 -80.25 0.6 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.852 1.261 . . . . 6.0199999999999996 108.395 177.49 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.4 t70 . . . . . 0 CA--C 1.533 0.318 0 C-N-CA 123.379 0.672 . . . . 7.46 110.901 -179.507 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.3 t . . . . . 0 CA--C 1.538 0.487 0 N-CA-C 114.502 1.297 . . . . 8.3800000000000008 114.502 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -155.46 158.06 37.96 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 120.007 1.276 . . . . 7.4000000000000004 108.987 175.622 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 mt -130.07 141.84 50.67 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.664 1.586 . . . . 6.2599999999999998 109.953 -168.287 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -90.47 88.46 7.17 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.386 1.075 . . . . 3.8300000000000001 110.735 -173.515 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -119.54 162.04 19.59 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.713 0.688 . . . . 2.1800000000000002 112.052 174.024 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -85.15 125.17 32.6 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 124.874 1.27 . . . . 2.3399999999999999 110.115 179.463 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -124.27 161.19 26.33 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.628 1.571 . . . . 3.27 110.89 176.88 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 54.4 m -83.04 126.05 73.4 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 126.444 1.898 . . . . 1.8700000000000001 110.433 -177.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -48.24 -43.1 32.5 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.901 3.067 . . . . 1.03 114.032 -179.133 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.1 m -54.76 -33.07 60.8 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.264 -0.897 . . . . 1.98 112.33 177.821 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -77.31 3.0 14.06 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.54 0.736 . . . . 2.6299999999999999 111.994 179.548 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.278 18.3 pt -121.6 3.37 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 O-C-N 120.79 -1.194 . . . . 1.1699999999999999 112.978 173.07 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.1 t -98.01 -49.0 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.031 0.932 . . . . 1.79 112.049 179.393 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -102.98 90.61 3.82 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 120.54 -1.35 . . . . 2.1299999999999999 111.106 -167.843 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 73.35 48.47 18.77 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.905 -0.878 . . . . 1.45 110.905 178.293 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -152.85 -146.04 0.19 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 128.609 2.764 . . . . 4.2599999999999998 105.067 176.481 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.1 m -43.57 -48.45 7.53 Favored 'General case' 0 C--O 1.227 -0.127 0 C-N-CA 126.198 1.799 . . . . 1.79 115.495 -170.51 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -39.16 -55.14 1.69 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.497 0.719 . . . . 2.5699999999999998 111.508 172.859 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.07 -15.94 25.53 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.782 1.233 . . . . 1.51 110.652 -173.618 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 67.89 26.91 73.77 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.996 1.284 . . . . 1.1200000000000001 112.438 176.818 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.2 m -80.07 -23.54 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 118.047 0.923 . . . . 1.27 112.406 -174.53 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.8 mmtt -121.75 -75.95 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 124.172 0.989 . . . . 3.6800000000000002 111.745 178.137 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.25 119.57 6.07 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 CA-C-N 120.554 1.234 . . . . 1.3400000000000001 109.352 179.476 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -71.63 149.16 45.84 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.99 -0.744 . . . . 4.8099999999999996 108.99 172.293 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.73 147.26 47.53 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.102 -1.073 . . . . 1.1399999999999999 108.102 172.595 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.77 -1.17 27.42 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.61 1.1 . . . . 1.1200000000000001 112.874 -173.732 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -102.79 148.94 24.99 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.426 1.09 . . . . 1.52 109.595 -176.614 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -86.92 125.88 34.32 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.466 -0.939 . . . . 3.8700000000000001 108.466 172.605 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.5 pt -141.11 176.07 5.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 106.228 -1.767 . . . . 0.91000000000000003 106.228 167.078 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.3 mtm180 -124.56 133.01 53.43 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.771 -1.196 . . . . 3.2999999999999998 107.771 171.918 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.0 131.54 51.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 107.747 -1.205 . . . . 1.21 107.747 175.402 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -126.84 113.11 1.69 Allowed Glycine 0 C--N 1.336 0.551 0 N-CA-C 109.7 -1.36 . . . . 0.65000000000000002 109.7 179.371 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.85 -168.2 17.15 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 109.966 -1.254 . . . . 0.70999999999999996 109.966 -175.013 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -109.42 130.61 55.49 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.637 0.775 . . . . 2.79 110.586 -176.359 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.563 HG22 ' CZ ' ' A' ' 104' ' ' PHE . 26.1 t -67.0 143.7 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 109.093 -0.706 . . . . 2.27 109.093 175.313 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.0 t -59.45 -68.45 0.28 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.627 0.371 . . . . 3.3999999999999999 111.34 178.831 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.0 p 178.79 -45.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 123.633 0.773 . . . . 2.1099999999999999 110.496 -173.347 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -146.43 42.82 0.92 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.164 -1.174 . . . . 2.2599999999999998 110.164 -179.733 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.84 -30.71 70.96 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.322 0.649 . . . . 1.8600000000000001 112.541 176.757 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.4 112.62 2.25 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 122.278 0.231 . . . . 1.79 110.387 -174.919 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.1 m -122.98 120.12 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 106.79 -1.559 . . . . 0.71999999999999997 106.79 168.096 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.45 144.04 36.6 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.536 -1.283 . . . . 5.4800000000000004 107.536 175.467 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -99.17 153.01 37.99 Favored Pre-proline 0 C--O 1.234 0.282 0 N-CA-C 108.55 -0.907 . . . . 2.5499999999999998 108.55 -179.828 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -75.41 37.72 0.52 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.662 2.908 . . . . 1.73 112.244 -178.483 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -94.78 -35.77 11.97 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.934 1.294 . . . . 1.6399999999999999 108.727 171.346 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.6 m 97.48 -19.38 0.05 OUTLIER 'General case' 0 C--N 1.342 0.243 0 C-N-CA 127.819 2.447 . . . . 2.6499999999999999 111.777 -174.798 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.04 27.94 8.16 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 123.772 0.829 . . . . 2.8300000000000001 112.815 -179.423 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -135.98 115.44 12.71 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.759 -0.83 . . . . 2.1099999999999999 108.759 178.415 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.15 116.23 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 124.948 1.299 . . . . 1.0800000000000001 107.932 -178.308 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -129.27 154.2 47.06 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.022 0.828 . . . . 1.0800000000000001 109.484 177.674 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.506 ' CE1' ' CE1' ' A' ' 104' ' ' PHE . 33.6 p90 -157.36 145.27 19.02 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.447 -0.342 . . . . 1.8700000000000001 110.469 -175.555 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.12 157.94 18.7 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.655 0.74 . . . . 0.73999999999999999 109.753 167.774 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 p -141.76 149.37 19.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 106.638 -1.615 . . . . 1.9399999999999999 106.638 172.181 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -128.61 -172.91 2.82 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.017 0.527 . . . . 1.5800000000000001 110.322 -179.374 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -131.36 -177.7 4.52 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.012 -0.736 . . . . 2.3700000000000001 109.012 178.204 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 60.7 m -57.32 -36.55 71.27 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.863 0.865 . . . . 3.5299999999999998 110.643 172.063 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -86.29 -89.35 0.12 Allowed 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 123.112 0.258 . . . . 4.8799999999999999 110.672 -177.897 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.11 36.58 0.37 Allowed Glycine 0 C--N 1.333 0.382 0 N-CA-C 110.35 -1.1 . . . . 2.6499999999999999 110.35 -174.462 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -80.22 46.07 3.14 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-O 119.268 -0.74 . . . . 2.2999999999999998 111.604 -176.212 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -62.89 111.64 2.22 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.43 -1.322 . . . . 3.3999999999999999 107.43 179.173 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.2 tp -140.37 156.59 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 108.185 -1.043 . . . . 1.1399999999999999 108.185 179.145 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.4 mt -119.87 129.66 54.49 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.504 -1.295 . . . . 0.57999999999999996 107.504 -169.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.44 ' CG2' ' CE1' ' A' ' 82' ' ' PHE . 5.1 m -120.69 143.15 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 109.152 -0.685 . . . . 2.3300000000000001 109.152 175.19 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 23.5 p -115.06 133.68 55.83 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.101 1.361 . . . . 0.78000000000000003 107.512 -176.1 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -129.77 131.04 46.1 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.856 -1.535 . . . . 2.3199999999999998 106.856 -178.348 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -122.11 34.06 5.28 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.268 1.427 . . . . 2.1200000000000001 111.885 -167.773 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -163.46 54.89 0.17 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.353 0.596 . . . . 3.1000000000000001 111.689 -174.426 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 53.77 -162.75 0.11 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.854 0.862 . . . . 1.95 110.844 -173.245 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.6 mt -148.93 155.83 40.69 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 106.381 -1.711 . . . . 1.1399999999999999 106.381 179.921 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.34 -73.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.142 2.561 . . . . 2.3100000000000001 110.27 -179.643 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.51 47.71 0.87 Allowed 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.926 1.29 . . . . 2.6800000000000002 108.394 -178.515 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 41.61 23.88 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 115.749 1.759 . . . . 2.1800000000000002 115.749 -173.226 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.563 ' CZ ' HG22 ' A' ' 66' ' ' VAL . 51.8 t80 53.67 96.51 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.6 1.091 . . . . 2.9300000000000002 110.277 -168.887 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 -75.37 123.26 25.08 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.583 -0.895 . . . . 5.8200000000000003 108.583 -172.699 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -82.97 168.14 17.29 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.613 0.721 . . . . 2.98 111.403 -177.349 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 58.36 35.6 79.79 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 123.965 0.793 . . . . 0.85999999999999999 113.001 179.287 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -156.23 177.66 11.19 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.049 1.34 . . . . 2.8900000000000001 108.035 174.189 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -94.73 139.74 14.67 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.968 -0.853 . . . . 0.75 110.968 174.819 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.5 pp -142.67 153.78 17.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 106.642 -1.614 . . . . 0.87 106.642 178.803 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 19.9 m -115.14 128.07 72.46 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 N-CA-C 108.983 -0.747 . . . . 0.79000000000000004 108.983 -179.871 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -119.59 135.92 54.59 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 125.471 1.508 . . . . 0.73999999999999999 109.668 -168.83 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -136.66 144.24 43.89 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 125.524 1.529 . . . . 3.6200000000000001 109.45 -176.491 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -177.04 -103.66 0.17 Allowed Glycine 0 C--N 1.332 0.344 0 N-CA-C 108.03 -2.028 . . . . 1.27 108.03 163.611 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.5 p -151.5 145.17 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 109.177 -0.675 . . . . 0.82999999999999996 109.177 178.386 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.629 ' HG ' HD12 ' A' ' 122' ' ' LEU . 0.3 OUTLIER -78.49 152.95 31.76 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.795 -1.187 . . . . 2.71 107.795 172.463 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -168.54 -51.91 0.03 OUTLIER Glycine 0 C--N 1.333 0.396 0 C-N-CA 119.656 -1.259 . . . . 2.0699999999999998 112.318 175.929 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -61.94 155.58 23.2 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 119.151 -1.019 . . . . 4.5099999999999998 109.55 172.193 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -79.38 79.09 5.85 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 105.811 -1.922 . . . . 4.1100000000000003 105.811 179.47 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.08 17.64 26.82 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 126.159 1.838 . . . . 1.45 113.361 172.078 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.56 154.76 38.78 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.725 -1.583 . . . . 3.0899999999999999 106.725 164.879 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.629 HD12 ' HG ' ' A' ' 116' ' ' LEU . 0.8 OUTLIER -116.09 137.92 51.7 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 122.776 0.43 . . . . 2.2400000000000002 110.237 -175.837 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -93.34 81.43 4.43 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 107.915 -1.143 . . . . 0.53000000000000003 107.915 177.029 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -90.22 134.25 34.41 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.306 -0.628 . . . . 1.04 109.306 178.707 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 13.5 t -128.88 -23.24 3.11 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.731 0.812 . . . . 1.0 113.161 179.033 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -101.58 104.18 15.05 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.352 -1.722 . . . . 3.8399999999999999 106.352 173.168 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.6 m -116.81 125.23 73.64 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 N-CA-C 109.247 -0.649 . . . . 0.94999999999999996 109.247 177.002 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.51 112.12 19.51 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.153 -1.425 . . . . 0.92000000000000004 107.153 -175.002 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -106.36 42.04 1.33 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.618 1.167 . . . . 2.1600000000000001 111.613 -173.14 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.23 52.72 1.36 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.355 0.662 . . . . 4.0300000000000002 111.588 -175.713 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -74.07 -53.47 9.91 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.583 -0.525 . . . . 4.5 109.583 -176.389 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 N--CA 1.45 -0.431 0 C-N-CA 125.523 1.529 . . . . 5.8700000000000001 106.958 178.279 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 CA--C 1.539 0.54 0 N-CA-C 110.115 -0.328 . . . . 8.5700000000000003 110.115 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 36.4 m-20 -140.31 136.97 33.78 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 106.773 -1.566 . . . . 9.3200000000000003 106.773 173.839 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 tp -82.28 -55.68 4.38 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.417 -0.586 . . . . 6.5 109.417 175.926 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -111.41 94.97 5.24 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.911 1.285 . . . . 3.6400000000000001 110.961 -169.313 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -127.08 166.66 17.21 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.138 1.375 . . . . 2.1600000000000001 110.647 -175.746 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -83.4 134.58 34.88 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.576 1.15 . . . . 2.5899999999999999 109.27 -179.152 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.422 ' CE2' ' HG2' ' A' ' 42' ' ' GLU . 0.5 OUTLIER -146.8 152.04 38.11 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.198 0.999 . . . . 3.21 109.209 -169.109 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.4 p -89.76 142.42 29.16 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 118.046 0.385 . . . . 2.1499999999999999 110.689 -173.191 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -55.26 -41.39 78.89 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.108 1.872 . . . . 0.85999999999999999 111.701 173.797 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.0 t -47.26 -36.98 9.77 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.419 1.088 . . . . 2.5099999999999998 111.527 173.187 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.422 ' HG2' ' CE2' ' A' ' 38' ' ' TYR . 0.9 OUTLIER -67.39 -59.18 3.61 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.413 -0.588 . . . . 2.25 109.413 177.775 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.5 pt -73.3 4.77 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 114.758 1.392 . . . . 0.96999999999999997 114.758 -167.054 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.6 m -96.82 -28.25 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.688 1.195 . . . . 2.8599999999999999 112.301 172.199 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -87.15 -87.03 0.15 Allowed 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.88 0.764 . . . . 2.4300000000000002 110.472 -168.63 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -122.27 59.8 0.58 Allowed Glycine 0 C--N 1.335 0.474 0 N-CA-C 108.814 -1.714 . . . . 1.6699999999999999 108.814 -176.058 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -160.96 -157.45 0.52 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.905 2.482 . . . . 2.4399999999999999 105.426 -175.086 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.474 HG21 HD11 ' A' ' 116' ' ' LEU . 7.4 m -29.02 -59.89 0.13 Allowed 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 128.279 2.631 . . . . 1.55 116.489 -170.213 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -54.14 -37.5 64.46 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.292 0.951 . . . . 3.6899999999999999 111.012 -173.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.5 m -91.04 -21.88 21.04 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.708 0.803 . . . . 1.5800000000000001 110.906 176.522 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.37 31.49 68.58 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.685 1.136 . . . . 1.3100000000000001 112.038 172.595 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.0 m -81.6 -55.72 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 O-C-N 122.295 -0.532 . . . . 1.5700000000000001 111.517 -173.941 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -87.3 -67.97 0.14 Allowed Pre-proline 0 CA--C 1.534 0.36 0 CA-C-O 118.558 -0.734 . . . . 3.4900000000000002 112.145 175.969 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -78.02 131.93 11.32 Favored 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 121.53 1.486 . . . . 1.4199999999999999 109.701 -177.916 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -80.48 165.87 21.75 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.437 0.695 . . . . 4.8799999999999999 109.191 166.883 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.5 159.91 33.65 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.392 -0.595 . . . . 1.3400000000000001 109.392 166.809 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.22 3.04 57.84 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 123.271 0.462 . . . . 1.25 112.8 178.31 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -102.53 156.69 17.44 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.801 1.241 . . . . 1.55 108.584 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.3 mtm-85 -96.79 130.95 43.96 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.294 -0.632 . . . . 4.0300000000000002 109.294 171.124 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.1 pt -146.58 175.26 1.94 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 106.686 -1.598 . . . . 0.70999999999999996 106.686 168.409 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -124.63 124.91 43.23 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 118.2 0.455 . . . . 1.9199999999999999 110.08 175.537 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.4 p -87.71 119.45 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.564 -1.272 . . . . 0.80000000000000004 107.564 174.567 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -126.31 115.98 2.43 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 109.508 -1.437 . . . . 0.58999999999999997 109.508 177.158 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.86 -154.77 8.11 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 108.206 -1.958 . . . . 0.70999999999999996 108.206 -176.943 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 24.7 ptp -117.34 137.56 52.37 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.712 0.805 . . . . 2.5499999999999998 110.459 -178.448 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 p -89.1 137.23 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 120.273 -0.571 . . . . 2.54 110.166 177.283 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.6 m -28.73 -84.62 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 128.666 2.786 . . . . 3.25 113.38 175.702 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.1 p 171.97 -40.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 125.339 1.455 . . . . 2.2599999999999998 110.238 -175.633 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -148.57 48.39 0.62 Allowed Glycine 0 CA--C 1.524 0.607 0 N-CA-C 109.884 -1.287 . . . . 1.8600000000000001 109.884 -178.586 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 65.2 m -101.59 -12.75 18.22 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.212 0.605 . . . . 1.04 112.472 -179.54 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 35.2 tpp -58.33 125.11 21.88 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.931 0.787 . . . . 2.1200000000000001 110.826 170.67 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.5 m -129.81 142.98 42.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 108.372 -0.973 . . . . 0.66000000000000003 108.372 163.496 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.501 ' CB ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -120.9 154.9 35.25 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 124.013 0.925 . . . . 4.1200000000000001 110.934 -177.623 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.53 153.68 81.38 Favored Pre-proline 0 N--CA 1.453 -0.31 0 N-CA-C 109.501 -0.555 . . . . 2.0499999999999998 109.501 171.411 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -59.83 -26.45 82.31 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.607 2.204 . . . . 1.53 111.363 171.008 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -44.82 -36.24 3.15 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.791 0.836 . . . . 1.24 110.952 168.649 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 21.0 m 75.58 18.57 2.21 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.869 1.668 . . . . 1.6899999999999999 112.659 178.478 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.55 -49.17 2.14 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 125.368 1.467 . . . . 1.9199999999999999 111.105 172.549 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -79.09 131.7 36.33 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.489 -1.3 . . . . 1.23 107.489 -176.173 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.501 HG12 ' CB ' ' A' ' 73' ' ' ARG . 32.8 m -138.51 160.03 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 108.744 -0.836 . . . . 1.5 108.744 171.909 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -144.74 147.57 33.12 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.65 -0.704 . . . . 1.3999999999999999 109.274 175.815 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -155.59 146.65 22.48 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.754 0.421 . . . . 1.99 110.367 -173.538 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.38 132.42 44.71 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.497 0.719 . . . . 0.59999999999999998 110.077 179.604 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.9 t -119.46 133.38 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 124.704 1.202 . . . . 1.8100000000000001 108.51 178.832 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -117.45 -177.33 3.2 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 123.879 0.872 . . . . 1.72 110.684 177.737 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -125.91 -74.37 0.6 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.693 -0.685 . . . . 2.5499999999999998 110.709 -177.088 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 33.2 t -161.45 -51.64 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.313 -1.736 . . . . 3.4399999999999999 106.313 -175.342 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.4 mp -74.75 36.18 0.11 Allowed 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 113.58 0.956 . . . . 4.8200000000000003 113.58 -179.214 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 58.22 22.99 51.8 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 121.443 -0.786 . . . . 3.6000000000000001 112.205 -178.383 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -81.83 58.97 4.9 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-O 119.218 -0.768 . . . . 1.8799999999999999 111.355 -169.684 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -64.33 102.47 0.53 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.69 0.745 . . . . 3.23 109.646 175.2 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -92.56 154.14 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 107.212 -1.403 . . . . 0.85999999999999999 107.212 166.911 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 mt -102.98 131.15 50.15 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 108.61 -0.885 . . . . 0.65000000000000002 108.61 -179.017 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.77 137.32 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 107.316 -1.364 . . . . 0.89000000000000001 107.316 178.865 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 24.5 p -111.74 149.14 32.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.641 -1.244 . . . . 0.46000000000000002 107.641 174.72 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -147.55 114.63 6.18 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.533 -1.654 . . . . 2.0 106.533 -179.579 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -94.97 40.55 1.1 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.743 1.617 . . . . 1.9199999999999999 111.604 -170.826 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -166.83 174.34 8.65 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.181 1.792 . . . . 2.8999999999999999 107.111 173.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.1 mp -70.87 152.72 43.39 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.826 0.822 . . . . 1.4399999999999999 111.043 178.827 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.25 150.52 37.22 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 125.146 1.378 . . . . 2.2999999999999998 108.713 -173.902 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -60.56 141.28 94.87 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.157 1.905 . . . . 2.2799999999999998 108.621 169.964 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 42.7 46.74 4.48 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.236 1.414 . . . . 2.7999999999999998 112.155 -179.528 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 50.59 15.73 0.25 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.625 1.97 . . . . 2.0800000000000001 115.645 -176.874 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.5 t80 64.93 101.75 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.266 1.427 . . . . 2.7799999999999998 109.874 -162.955 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 29.7 mmm-85 -79.57 111.69 16.1 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.124 -1.065 . . . . 4.5899999999999999 108.124 -179.364 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -83.26 176.32 9.24 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.469 0.652 . . . . 4.1699999999999999 112.504 -177.089 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.51 38.99 97.18 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.708 1.147 . . . . 0.68000000000000005 112.111 177.27 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -158.99 178.29 10.23 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.027 1.331 . . . . 2.54 108.584 -178.679 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -98.98 135.8 12.33 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 110.885 -0.886 . . . . 0.64000000000000001 110.885 173.419 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.0 pp -137.83 149.39 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 105.261 -2.125 . . . . 0.66000000000000003 105.261 176.506 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 8.2 m -112.26 122.74 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 107.741 -1.207 . . . . 0.63 107.741 177.644 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.434 ' HB2' HG12 ' A' ' 127' ' ' VAL . . . -110.96 131.26 55.2 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 124.889 1.276 . . . . 0.44 109.28 -173.452 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -125.25 150.03 47.44 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.446 1.499 . . . . 3.7999999999999998 108.889 -179.693 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 171.54 -119.77 0.8 Allowed Glycine 0 C--N 1.333 0.402 0 N-CA-C 107.086 -2.405 . . . . 1.2 107.086 169.307 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.8 p -145.86 151.56 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-N 118.767 1.283 . . . . 0.93999999999999995 109.648 -177.076 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.474 HD11 HG21 ' A' ' 48' ' ' THR . 2.4 mm? -81.24 143.63 32.16 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.83 -0.804 . . . . 2.0099999999999998 108.83 173.154 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -161.26 13.39 0.15 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.028 -1.082 . . . . 2.6499999999999999 113.582 175.515 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -137.67 45.41 2.16 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 118.088 0.944 . . . . 6.7800000000000002 108.678 -169.071 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 41.7 t0 16.73 64.91 0.01 OUTLIER 'General case' 0 C--N 1.341 0.213 0 C-N-CA 128.92 2.888 . . . . 2.9900000000000002 113.203 -178.888 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 138.42 -47.81 0.91 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-N 114.79 -1.095 . . . . 1.3999999999999999 111.138 -170.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.75 164.11 12.71 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.04 0.92 . . . . 2.0499999999999998 109.862 -175.389 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.8 mp -121.71 131.7 54.23 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.77 1.228 . . . . 1.9399999999999999 110.029 -173.067 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -97.08 89.24 4.73 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.152 -1.425 . . . . 0.66000000000000003 107.152 171.946 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.07 88.03 2.64 Favored 'General case' 0 C--O 1.227 -0.084 0 C-N-CA 123.034 0.534 . . . . 1.51 110.536 -171.765 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.6 t -85.91 -3.77 59.0 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 114.123 1.157 . . . . 0.96999999999999997 114.123 -172.658 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -112.44 91.42 3.65 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 119.473 1.033 . . . . 3.6400000000000001 108.43 179.63 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.434 HG12 ' HB2' ' A' ' 112' ' ' ALA . 26.9 m -100.24 128.3 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 CA-C-N 118.39 0.541 . . . . 0.65000000000000002 110.524 175.93 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.04 120.29 35.87 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.46 -1.311 . . . . 0.64000000000000001 107.46 177.331 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -96.22 102.83 14.68 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.124 0.97 . . . . 1.3700000000000001 108.959 176.922 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.53 13.51 5.47 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.842 1.052 . . . . 4.2599999999999998 113.842 178.985 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -36.72 -52.33 0.9 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.769 1.228 . . . . 5.7800000000000002 112.143 174.688 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 . . . . . 0 N--CA 1.451 -0.405 0 N-CA-C 106.182 -1.784 . . . . 6.8099999999999996 106.182 -179.315 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 CA--C 1.532 0.287 0 CA-C-O 121.147 0.499 . . . . 6.7400000000000002 110.489 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 57.7 m-80 -99.86 148.7 24.16 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.08 1.352 . . . . 8.2300000000000004 109.284 179.805 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.3 tt -80.8 151.22 28.87 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.154 -0.684 . . . . 6.4500000000000002 109.154 176.039 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -152.84 150.82 29.73 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.782 0.833 . . . . 3.8300000000000001 109.562 176.39 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.97 171.2 16.9 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.335 1.054 . . . . 4.1200000000000001 109.674 178.581 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -93.65 116.61 29.12 Favored 'General case' 0 C--N 1.34 0.169 0 C-N-CA 124.842 1.257 . . . . 2.3199999999999998 110.207 177.419 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.96 178.68 8.01 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.816 0.673 . . . . 6.0300000000000002 112.816 179.915 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 38.0 p -71.11 150.13 94.65 Favored Pre-proline 0 N--CA 1.449 -0.479 0 C-N-CA 123.554 0.742 . . . . 1.95 110.336 -177.122 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -60.51 -47.59 13.56 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.172 2.581 . . . . 1.3200000000000001 110.685 176.001 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.4 t -46.81 -39.63 12.23 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.54 1.136 . . . . 2.23 111.853 -174.683 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.409 ' OE2' ' NZ ' ' A' ' 47' ' ' LYS . 60.8 tt0 -44.87 -57.46 3.75 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.068 0.547 . . . . 3.8100000000000001 111.178 172.075 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.28 0.1 OUTLIER -81.22 35.52 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 113.05 0.759 . . . . 1.8200000000000001 113.05 -178.872 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 52.1 t -117.76 -34.68 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 118.915 0.78 . . . . 2.2999999999999998 112.419 174.694 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -126.29 116.9 21.95 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 119.574 1.079 . . . . 2.3599999999999999 109.19 -169.766 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 63.4 35.47 92.1 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.62 -0.992 . . . . 1.3799999999999999 110.62 179.344 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.409 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 31.1 mttt -144.25 -107.41 0.11 Allowed 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 126.864 2.066 . . . . 2.8300000000000001 109.267 177.52 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 49.7 m -72.48 -64.62 0.92 Allowed 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 118.663 0.665 . . . . 1.3600000000000001 111.237 -172.98 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -48.71 -49.06 39.62 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.964 0.888 . . . . 2.5499999999999998 110.752 -176.495 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.38 -22.62 57.34 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.515 1.126 . . . . 1.4199999999999999 112.922 179.043 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.11 44.17 96.52 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.577 1.56 . . . . 1.04 114.083 177.752 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.1 m -98.57 -34.09 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 118.866 1.333 . . . . 1.2 113.893 -173.691 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.72 -71.73 0.02 OUTLIER Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.84 1.256 . . . . 3.6499999999999999 112.797 -176.276 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -74.84 87.14 1.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.465 2.11 . . . . 1.8100000000000001 108.816 176.697 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -67.07 158.77 30.27 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.139 -0.689 . . . . 3.3599999999999999 109.139 175.884 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -63.7 168.01 5.3 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.769 -0.65 . . . . 1.3300000000000001 111.671 -176.672 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.01 5.35 90.21 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 119.792 -0.449 . . . . 1.03 113.086 -177.928 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -99.2 151.53 20.91 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.414 1.086 . . . . 1.51 109.109 177.882 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 58.7 mtt85 -93.06 146.86 23.32 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 122.876 0.47 . . . . 4.1200000000000001 109.909 173.327 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 39.3 pt -152.35 179.75 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 106.858 -1.534 . . . . 1.0600000000000001 106.858 179.853 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.9 mmt-85 -135.05 119.39 17.84 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.698 -1.593 . . . . 5.0999999999999996 106.698 167.714 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.7 p -85.18 144.68 9.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 107.768 -1.197 . . . . 0.98999999999999999 107.768 176.654 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -152.82 95.83 0.16 Allowed Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 110.246 -1.142 . . . . 1.04 110.246 -176.285 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -154.93 -165.67 14.35 Favored Glycine 0 C--N 1.332 0.344 0 N-CA-C 110.112 -1.195 . . . . 0.68999999999999995 110.112 -175.675 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 4.0 ptp -100.68 137.18 39.42 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.069 0.548 . . . . 2.3700000000000001 109.661 -177.159 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 83' ' ' ALA . 11.8 p -92.76 129.49 43.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.061 -0.518 . . . . 2.77 110.263 170.492 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.434 ' O ' HG22 ' A' ' 66' ' ' VAL . 1.0 OUTLIER -61.1 146.6 46.81 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.109 -1.071 . . . . 2.3700000000000001 108.109 166.71 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 p -50.68 -60.71 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.256 1.023 . . . . 1.99 110.539 -178.891 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -86.62 56.33 4.69 Favored Glycine 0 CA--C 1.527 0.791 0 O-C-N 121.378 -0.826 . . . . 1.72 111.645 -176.77 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 62.7 m -122.28 -34.8 3.24 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 112.986 0.736 . . . . 1.3700000000000001 112.986 -178.753 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -71.92 124.12 24.2 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.802 -0.814 . . . . 2.0099999999999998 108.802 -178.576 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.8 m -131.51 131.92 62.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.735 0.814 . . . . 0.75 108.829 176.15 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.5 ptt-85 -116.8 147.71 41.85 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 124.949 1.3 . . . . 4.0199999999999996 110.332 179.284 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -96.58 155.5 37.77 Favored Pre-proline 0 C--O 1.234 0.273 0 N-CA-C 108.807 -0.812 . . . . 2.3900000000000001 108.807 177.474 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.74 42.86 0.99 Allowed 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.75 2.967 . . . . 1.9099999999999999 111.605 175.857 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -102.9 -41.36 6.18 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 125.306 1.442 . . . . 1.21 109.217 173.605 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.9 m 104.67 -32.49 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 129.12 2.968 . . . . 2.27 110.492 -172.107 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.11 28.78 8.3 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 124.135 0.974 . . . . 2.5899999999999999 112.541 -173.789 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -137.5 113.22 9.58 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.044 -1.465 . . . . 2.0099999999999998 107.044 174.726 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.706 HG21 ' CD2' ' A' ' 100' ' ' LEU . 27.8 m -142.34 143.45 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 107.426 -1.324 . . . . 0.76000000000000001 107.426 176.504 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -139.2 159.72 41.49 Favored 'General case' 0 CA--C 1.519 -0.235 0 O-C-N 121.637 -0.664 . . . . 1.3700000000000001 109.824 169.053 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -150.95 142.32 23.36 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 109.135 -0.691 . . . . 1.98 109.135 -178.495 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.59 ' O ' HG23 ' A' ' 66' ' ' VAL . . . -83.33 143.82 30.1 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.241 -1.022 . . . . 0.68999999999999995 108.241 171.543 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.8 t -128.32 138.03 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 N-CA-C 107.393 -1.336 . . . . 1.8200000000000001 107.393 170.421 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -133.93 174.74 10.14 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.999 -0.741 . . . . 1.29 108.999 177.911 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -119.5 -3.31 10.42 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.923 -0.58 . . . . 2.6299999999999999 110.793 175.557 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.0 m 59.02 27.73 16.76 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.713 1.205 . . . . 4.9000000000000004 112.099 -168.449 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -102.97 9.94 38.45 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.382 1.073 . . . . 4.4299999999999997 111.708 173.017 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.23 47.88 4.52 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.563 -1.015 . . . . 3.1499999999999999 110.563 -175.8 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.33 126.27 1.38 Allowed Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 108.319 -1.912 . . . . 1.54 108.319 173.529 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -126.3 142.88 51.36 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.165 -1.791 . . . . 3.4500000000000002 106.165 171.277 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.7 tp -131.85 147.3 32.45 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 N-CA-C 108.332 -0.988 . . . . 1.1499999999999999 108.332 179.71 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.9 mt -95.91 122.72 39.02 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 122.968 0.507 . . . . 0.55000000000000004 110.27 179.715 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.7 122.23 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 125.552 1.541 . . . . 0.84999999999999998 107.582 176.401 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 42.3 p -100.26 152.4 20.34 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.251 1.02 . . . . 0.46000000000000002 108.996 174.869 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.553 ' HB3' HG23 ' A' ' 80' ' ' VAL . 1.0 OUTLIER -147.16 122.3 10.16 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.563 -1.273 . . . . 2.8599999999999999 107.563 177.127 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.5 p-10 -96.53 41.66 1.1 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.698 1.599 . . . . 2.4199999999999999 110.973 -179.933 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -162.55 179.53 7.68 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.734 1.214 . . . . 2.8399999999999999 108.354 172.428 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.05 165.54 23.29 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.565 1.146 . . . . 1.3999999999999999 111.649 174.167 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.706 ' CD2' HG21 ' A' ' 80' ' ' VAL . 3.0 mm? -96.16 162.16 24.7 Favored Pre-proline 0 N--CA 1.453 -0.292 0 C-N-CA 125.833 1.653 . . . . 2.5899999999999999 109.437 179.185 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -64.3 -82.14 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.236 2.624 . . . . 2.5299999999999998 109.168 167.32 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -93.24 48.69 1.34 Allowed 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 124.14 0.976 . . . . 2.6099999999999999 109.202 -172.196 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 48.77 4.6 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.997 2.119 . . . . 2.6800000000000002 116.478 -169.944 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.512 ' HE1' HG21 ' A' ' 66' ' ' VAL . 35.4 t80 63.71 97.18 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.221 1.409 . . . . 2.54 109.976 -159.767 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 51.7 mtp85 -79.02 121.7 25.27 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 107.418 -1.327 . . . . 3.8599999999999999 107.418 174.577 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -82.23 175.31 10.39 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 123.942 0.897 . . . . 3.23 110.365 -175.172 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 62.58 35.46 91.85 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 122.094 -0.378 . . . . 0.77000000000000002 112.546 174.279 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -155.65 -179.92 8.58 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.24 1.416 . . . . 2.7599999999999998 108.188 178.131 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -106.51 131.02 10.44 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 110.917 -0.873 . . . . 0.55000000000000004 110.917 177.506 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.9 pp -128.51 154.91 39.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 106.994 -1.484 . . . . 0.60999999999999999 106.994 179.039 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.2 m -106.44 137.7 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 107.418 -1.327 . . . . 0.80000000000000004 107.418 173.415 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.437 ' HB2' HG12 ' A' ' 127' ' ' VAL . . . -125.97 124.29 40.42 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.056 0.943 . . . . 0.48999999999999999 109.615 179.607 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.35 137.62 42.86 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.141 1.376 . . . . 3.77 108.921 -177.785 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 170.75 -148.6 11.53 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.975 -0.85 . . . . 1.0700000000000001 110.975 178.099 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.11 153.69 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 C-N-CA 124.823 1.249 . . . . 0.96999999999999997 107.823 -170.508 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.488 HD13 HD23 ' A' ' 122' ' ' LEU . 3.5 mm? -53.37 140.96 25.83 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.29 -0.633 . . . . 1.8400000000000001 109.29 169.368 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -74.74 -153.85 3.66 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 109.818 -1.313 . . . . 2.25 109.818 178.527 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -58.46 -60.31 4.0 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.952 0.501 . . . . 5.6900000000000004 109.99 -174.5 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -170.82 109.08 0.32 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.496 -2.039 . . . . 3.1200000000000001 105.496 175.596 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 107.41 -39.87 2.73 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.848 -1.301 . . . . 0.98999999999999999 109.848 174.783 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.03 166.71 18.56 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.243 0.617 . . . . 3.0699999999999998 111.196 179.823 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.488 HD23 HD13 ' A' ' 116' ' ' LEU . 98.4 mt -116.86 134.91 54.19 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 124.43 1.092 . . . . 2.1899999999999999 108.653 172.334 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -105.93 103.68 13.23 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 107.834 -1.173 . . . . 0.66000000000000003 107.834 173.884 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -131.48 113.51 13.78 Favored 'General case' 0 C--N 1.341 0.232 0 N-CA-C 111.902 0.334 . . . . 1.23 111.902 -174.821 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.78 -41.63 9.56 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.753 1.221 . . . . 1.1699999999999999 110.442 179.329 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -84.87 77.82 10.02 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.603 -0.888 . . . . 3.5899999999999999 108.603 -167.993 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.437 HG12 ' HB2' ' A' ' 112' ' ' ALA . 6.5 m -88.76 124.06 41.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.757 1.223 . . . . 0.75 110.751 177.205 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.406 HD13 ' C ' ' A' ' 127' ' ' VAL . 0.0 OUTLIER -121.43 131.32 54.1 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.561 1.144 . . . . 0.81000000000000005 107.978 176.669 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -100.31 74.87 1.76 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.902 0.881 . . . . 1.3 110.751 -175.11 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.3 pttm -74.36 -12.26 60.48 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.832 1.049 . . . . 4.8399999999999999 113.832 -171.719 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 10.5 m170 -79.0 -42.65 26.08 Favored 'General case' 0 C--N 1.338 0.093 0 O-C-N 121.866 -0.521 . . . . 4.6200000000000001 110.175 172.807 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.9 t70 . . . . . 0 N--CA 1.446 -0.63 0 N-CA-C 107.921 -1.14 . . . . 6.2699999999999996 107.921 -167.288 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.3 t . . . . . 0 CA--C 1.534 0.349 0 N-CA-C 108.181 -1.044 . . . . 7.1500000000000004 108.181 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -112.27 154.28 25.87 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.523 1.929 . . . . 8.9100000000000001 108.822 177.979 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -153.69 -81.29 0.09 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 115.318 1.599 . . . . 5.3700000000000001 115.318 -178.223 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -82.25 73.15 9.31 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.436 -1.415 . . . . 3.98 110.314 -165.301 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -125.83 166.61 16.53 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.986 0.812 . . . . 1.8400000000000001 112.712 -166.477 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.436 ' CZ ' ' HD2' ' A' ' 61' ' ' ARG . 93.7 m-85 -83.44 134.15 34.88 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.545 1.138 . . . . 2.27 110.458 -177.526 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -137.18 147.48 45.92 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.293 1.837 . . . . 3.3199999999999998 109.95 -178.768 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 m -71.69 137.48 82.98 Favored Pre-proline 0 N--CA 1.448 -0.546 0 C-N-CA 124.964 1.306 . . . . 1.6899999999999999 110.464 177.437 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -58.94 -49.14 12.06 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.97 2.447 . . . . 0.77000000000000002 111.453 177.335 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.9 m -54.18 -33.88 59.16 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.625 0.77 . . . . 2.8300000000000001 112.683 -178.719 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -53.1 -51.34 62.19 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.238 -1.023 . . . . 2.3999999999999999 108.238 173.749 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.295 36.8 pt -82.4 30.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 113.652 0.982 . . . . 1.29 113.652 -171.48 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -103.87 -39.72 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 124.048 0.939 . . . . 2.1400000000000001 110.702 163.161 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -72.9 -50.58 22.85 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.645 0.609 . . . . 2.8100000000000001 112.645 -159.972 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.23 67.98 0.1 Allowed Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 108.139 -1.984 . . . . 1.4199999999999999 108.139 -168.804 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -143.19 -106.72 0.13 Allowed 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.449 -1.685 . . . . 3.2999999999999998 106.449 -175.921 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 t -65.17 -59.36 4.18 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.595 1.158 . . . . 3.48 111.192 177.269 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -57.3 -39.6 76.11 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.474 0.71 . . . . 3.02 111.553 -165.195 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.68 -7.29 37.87 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.207 1.003 . . . . 1.3200000000000001 112.255 178.081 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 53.11 44.88 63.4 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.443 1.496 . . . . 1.1699999999999999 113.785 178.26 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.9 m -99.05 -35.26 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 118.479 1.14 . . . . 1.29 113.228 -175.061 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.89 -71.63 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 117.837 -1.078 . . . . 4.2000000000000002 112.537 -179.525 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -76.17 174.5 12.72 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 122.264 1.976 . . . . 1.3999999999999999 109.157 171.653 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -147.18 147.72 30.79 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 126.885 2.074 . . . . 2.9100000000000001 106.937 -176.929 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.44 144.03 32.61 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.66 0.784 . . . . 1.3500000000000001 110.52 -179.71 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.08 -20.49 26.15 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 123.829 0.728 . . . . 1.1499999999999999 112.551 -176.882 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -85.31 151.55 23.95 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 117.938 0.869 . . . . 1.6399999999999999 109.657 179.798 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.0 mtt85 -97.71 137.35 36.72 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.636 -0.711 . . . . 4.0300000000000002 109.709 173.789 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.7 pt -144.46 168.63 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 105.777 -1.935 . . . . 0.63 105.777 170.775 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.436 ' HD2' ' CZ ' ' A' ' 37' ' ' PHE . 22.0 mtt180 -115.54 123.65 49.03 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.009 -0.737 . . . . 1.8600000000000001 109.009 172.391 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.6 p -87.46 129.33 39.02 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.082 0 N-CA-C 108.016 -1.105 . . . . 0.92000000000000004 108.016 176.045 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.98 116.18 1.81 Allowed Glycine 0 C--N 1.333 0.41 0 CA-C-N 118.919 0.782 . . . . 0.55000000000000004 111.243 -178.157 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.89 -169.2 38.53 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 117.787 0.793 . . . . 0.95999999999999996 111.313 -177.378 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.413 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 19.6 ptp -101.4 148.68 24.88 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.863 1.265 . . . . 2.75 110.711 -177.912 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 43.2 t -106.34 119.65 56.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 109.624 -0.51 . . . . 2.46 109.624 -177.393 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 86.1 m -44.05 122.47 2.9 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.714 1.606 . . . . 2.5899999999999999 109.408 165.774 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.1 p -46.23 -57.09 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.042 0.937 . . . . 2.1200000000000001 111.205 -177.86 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -85.2 68.84 3.4 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.833 -0.907 . . . . 2.3100000000000001 110.833 -179.648 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.9 m -149.55 -31.36 0.22 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.255 1.576 . . . . 1.22 115.255 178.221 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 12.1 tpp -60.92 115.88 4.05 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.15 0.886 . . . . 2.02 109.638 173.249 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.3 m -121.09 136.1 59.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 N-CA-C 107.971 -1.122 . . . . 0.76000000000000001 107.971 172.444 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.47 136.48 49.95 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.855 1.262 . . . . 6.6699999999999999 109.082 -170.842 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -83.03 154.62 67.4 Favored Pre-proline 0 N--CA 1.455 -0.209 0 N-CA-C 109.384 -0.598 . . . . 2.1299999999999999 109.384 -179.359 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -71.03 10.42 0.67 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.12 2.547 . . . . 1.3400000000000001 113.203 173.731 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -74.71 -22.58 58.76 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.868 0.467 . . . . 1.3600000000000001 109.862 161.947 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.1 m 63.74 24.08 13.71 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.079 1.351 . . . . 1.74 112.621 -178.177 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.86 -43.32 2.0 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.962 1.705 . . . . 2.3100000000000001 112.023 172.68 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -84.13 122.19 28.48 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 108.522 -0.918 . . . . 1.3500000000000001 108.522 -178.839 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.3 m -146.83 107.69 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 106.92 -1.511 . . . . 1.3100000000000001 106.92 -172.156 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -119.87 154.97 33.57 Favored 'General case' 0 C--O 1.232 0.162 0 O-C-N 121.635 -0.666 . . . . 0.81000000000000005 109.838 -176.773 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -154.9 147.99 24.78 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 120.82 0.343 . . . . 2.0699999999999998 111.067 -175.555 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.05 139.92 30.72 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.41 -0.959 . . . . 0.65000000000000002 108.41 167.951 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.08 147.05 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.291 1.037 . . . . 1.9199999999999999 108.685 178.498 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -145.04 172.15 13.47 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 126.292 1.837 . . . . 1.5900000000000001 109.632 -171.045 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.42 ' C ' ' H ' ' A' ' 88' ' ' LEU . 50.4 t0 -147.19 173.01 12.93 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.31 -1.367 . . . . 2.9500000000000002 107.31 170.217 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 21.8 t -64.85 23.69 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.427 1.891 . . . . 3.6200000000000001 113.229 174.919 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.42 ' H ' ' C ' ' A' ' 86' ' ' ASP . 3.9 mm? -106.87 16.31 24.48 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.6 1.96 . . . . 5.6500000000000004 110.5 173.438 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 62.49 56.31 22.38 Favored Glycine 0 CA--C 1.528 0.858 0 O-C-N 121.853 -0.529 . . . . 3.2200000000000002 112.843 166.588 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -176.05 176.15 47.56 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 107.474 -2.251 . . . . 1.8799999999999999 107.474 176.87 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -157.21 172.28 18.92 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 117.84 0.82 . . . . 2.6400000000000001 109.424 179.223 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.0 tp -154.28 159.88 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.287 0.635 . . . . 1.01 109.387 176.539 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 16.7 mt -99.05 127.01 44.9 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.608 1.163 . . . . 0.88 111.283 -178.354 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 76.2 t -108.68 130.87 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 125.727 1.611 . . . . 0.84999999999999998 107.989 175.502 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.8 p -111.79 134.1 53.58 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.149 -1.056 . . . . 0.58999999999999997 108.149 177.675 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.417 ' CE2' ' HA ' ' A' ' 125' ' ' THR . 1.4 t80 -135.11 139.4 44.64 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.318 -1.364 . . . . 2.2599999999999998 107.318 -179.319 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -130.23 30.64 4.74 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.962 1.305 . . . . 2.1899999999999999 112.702 -168.628 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -159.1 55.95 0.41 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.195 0.521 . . . . 2.4500000000000002 111.207 -178.58 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 55.76 -170.4 0.08 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.102 0.961 . . . . 1.8500000000000001 111.456 -176.132 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.1 mt -153.28 154.94 31.39 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 125.113 1.365 . . . . 1.1799999999999999 107.643 -175.986 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.498 ' HG3' HG23 ' A' ' 127' ' ' VAL . 72.8 Cg_endo -62.85 122.39 10.66 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 125.172 3.915 . . . . 2.3799999999999999 109.958 -176.676 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 48.24 42.42 17.59 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 123.655 0.782 . . . . 3.3799999999999999 110.498 -178.161 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 70.23 -16.9 0.28 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.886 1.274 . . . . 3.79 112.234 -177.261 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 14.2 t80 60.27 83.79 0.13 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.736 2.015 . . . . 3.1499999999999999 108.954 -167.474 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 -75.07 137.33 41.37 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 114.834 -1.075 . . . . 5.4100000000000001 108.26 -173.642 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.5 mp0 -79.03 162.72 25.72 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 121.139 0.495 . . . . 3.4199999999999999 110.522 -166.089 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.29 44.69 27.43 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 111.593 -0.603 . . . . 1.1299999999999999 111.593 -178.237 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -146.37 179.5 7.48 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.733 1.613 . . . . 2.0899999999999999 106.704 169.042 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 65' ' ' MET . . . -126.21 145.65 15.84 Favored Glycine 0 C--N 1.337 0.592 0 N-CA-C 111.529 -0.628 . . . . 1.1100000000000001 111.529 171.708 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.36 168.5 15.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 124.424 1.09 . . . . 1.4099999999999999 108.532 -175.804 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 16.5 m -107.49 129.78 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 107.812 -1.181 . . . . 0.81000000000000005 107.812 169.519 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.614 ' HB2' HG12 ' A' ' 127' ' ' VAL . . . -119.24 133.75 55.59 Favored 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 125.457 1.503 . . . . 0.51000000000000001 109.088 -179.218 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -124.98 142.4 51.51 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.28 1.032 . . . . 3.98 110.555 -177.582 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 171.51 -134.9 3.22 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 108.393 -1.883 . . . . 0.81999999999999995 108.393 172.203 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.06 155.37 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 N-CA-C 108.423 -0.954 . . . . 0.67000000000000004 108.423 -170.274 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -54.39 132.73 44.81 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.86 -0.792 . . . . 1.95 108.86 167.05 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.56 -139.9 1.63 Allowed Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 109.62 -1.392 . . . . 1.9199999999999999 109.62 -179.774 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -57.55 -60.6 3.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 122.865 0.466 . . . . 5.3099999999999996 110.862 -177.416 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -176.81 115.48 0.1 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 105.823 -1.917 . . . . 3.4900000000000002 105.823 -173.191 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 88.2 -42.64 3.09 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 125.39 1.471 . . . . 1.1599999999999999 109.609 176.997 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.65 142.09 34.3 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.227 1.411 . . . . 3.1299999999999999 109.918 -175.937 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.72 123.45 47.05 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 108.393 -0.966 . . . . 2.2799999999999998 108.393 -176.754 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -96.76 83.7 3.48 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.019 -1.474 . . . . 0.46999999999999997 107.019 176.096 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -94.33 142.44 27.41 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.41 -0.959 . . . . 1.1399999999999999 108.41 175.202 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.417 ' HA ' ' CE2' ' A' ' 96' ' ' TYR 0.26 4.7 t -136.5 -4.36 2.07 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 115.47 1.656 . . . . 0.95999999999999996 115.47 173.667 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -107.2 98.87 8.46 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 119.854 1.206 . . . . 3.9500000000000002 107.913 164.794 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.614 HG12 ' HB2' ' A' ' 112' ' ' ALA . 3.4 m -96.47 133.79 36.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 CA-C-N 118.751 0.705 . . . . 0.76000000000000001 110.833 165.056 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.71 106.75 14.86 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.299 -1.371 . . . . 0.72999999999999998 107.299 175.266 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.68 42.06 1.08 Allowed 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.3 0.852 . . . . 1.45 113.3 -170.237 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.28 62.91 1.84 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.361 0.664 . . . . 4.0599999999999996 111.528 179.324 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -77.53 -55.33 5.46 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.902 -0.777 . . . . 7.3899999999999997 108.902 175.102 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 N--CA 1.454 -0.255 0 C-N-CA 125.523 1.529 . . . . 5.5899999999999999 107.886 174.21 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.8 m . . . . . 0 CA--C 1.535 0.404 0 CA-C-O 120.821 0.344 . . . . 10.029999999999999 111.511 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -153.37 127.81 9.27 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 104.393 -2.447 . . . . 9.5199999999999996 104.393 176.459 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -120.56 162.6 19.34 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.734 1.213 . . . . 6.1900000000000004 107.977 175.806 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -114.47 111.08 20.84 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.81 -1.182 . . . . 5.2400000000000002 107.81 -173.292 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.56 172.96 13.67 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.507 0.723 . . . . 4.4500000000000002 110.674 -175.091 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.573 ' CE1' ' HB3' ' A' ' 61' ' ' ARG . 3.1 m-85 -89.22 110.83 21.54 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.52 1.128 . . . . 4.4000000000000004 110.732 179.55 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.49 176.31 8.79 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.747 0.654 . . . . 5.8099999999999996 112.01 174.998 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 p -69.34 145.82 96.06 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 124.067 0.947 . . . . 1.96 110.696 -175.841 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -58.92 -37.18 94.99 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.168 1.912 . . . . 1.29 111.966 179.36 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.6 t -46.53 -40.86 13.36 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.499 0.72 . . . . 2.6899999999999999 112.17 177.921 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -50.42 -47.32 56.68 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.342 -0.543 . . . . 4.8799999999999999 110.499 177.131 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.279 0.2 OUTLIER -91.56 34.39 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 112.77 0.655 . . . . 1.6499999999999999 112.77 178.293 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.16 -32.93 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 118.88 0.763 . . . . 2.4399999999999999 112.345 170.167 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -117.44 113.42 22.03 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.156 0.889 . . . . 2.6899999999999999 110.323 -173.72 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.6 43.77 98.56 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.488 -0.645 . . . . 1.77 111.488 169.307 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.2 mtpt -142.42 -111.04 0.13 Allowed 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 126.634 1.973 . . . . 3.9199999999999999 106.511 176.704 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.4 t -71.87 -47.91 49.58 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 119.43 1.013 . . . . 3.0099999999999998 111.626 -176.688 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -49.89 -46.24 51.5 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 122.044 0.926 . . . . 2.79 110.724 -173.47 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.69 -11.51 45.01 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.977 1.311 . . . . 1.5700000000000001 112.173 178.829 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 55.54 44.82 85.73 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 126.309 1.909 . . . . 1.3899999999999999 112.43 -178.073 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.7 m -96.01 -57.87 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 118.187 0.993 . . . . 1.8899999999999999 112.81 -174.047 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.5 mmmt -91.85 -60.8 0.21 Allowed Pre-proline 0 CA--C 1.536 0.43 0 CA-C-O 118.607 -0.711 . . . . 4.5099999999999998 111.992 -177.02 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -85.97 110.53 1.08 Allowed 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 122.426 2.084 . . . . 1.51 108.821 175.743 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -69.28 155.98 39.53 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.779 -0.823 . . . . 3.2000000000000002 108.779 167.314 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -53.76 165.78 0.4 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 122.027 0.917 . . . . 1.3700000000000001 111.959 166.75 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.44 8.77 86.67 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 115.933 -0.576 . . . . 1.1799999999999999 112.45 -177.768 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -102.45 155.05 18.52 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.049 0.924 . . . . 1.96 108.886 171.779 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -100.81 136.81 40.07 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.101 0.96 . . . . 4.1799999999999997 108.921 175.876 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.64 HD11 HD11 ' A' ' 122' ' ' LEU . 29.7 pt -141.86 175.36 5.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 106.558 -1.645 . . . . 0.90000000000000002 106.558 174.152 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.573 ' HB3' ' CE1' ' A' ' 37' ' ' PHE . 15.8 mtt-85 -132.52 126.27 32.52 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 106.421 -1.696 . . . . 3.27 106.421 176.196 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.7 p -98.67 118.08 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 107.81 -1.181 . . . . 1.05 107.81 -179.46 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.36 113.26 1.87 Allowed Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 108.195 -1.962 . . . . 0.92000000000000004 108.195 -178.738 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.88 -163.29 27.12 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 109.446 -1.462 . . . . 0.66000000000000003 109.446 -171.737 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -103.75 132.23 50.2 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.864 0.866 . . . . 3.0 109.812 -172.88 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.2 t -106.57 126.23 62.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 108.721 -0.844 . . . . 2.3700000000000001 108.721 176.859 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.2 m -57.95 137.95 56.29 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.833 1.253 . . . . 2.29 108.918 169.034 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.6 p -52.27 -60.69 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 123.63 0.772 . . . . 2.2400000000000002 110.782 177.507 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.14 68.44 2.32 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.309 -1.116 . . . . 1.97 110.309 -179.951 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.1 m -151.16 -34.95 0.14 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.105 0.779 . . . . 1.1200000000000001 113.105 -179.042 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 5.1 ttp -69.37 117.73 11.37 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.438 1.017 . . . . 2.7799999999999998 109.148 174.282 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.1 m -122.56 136.12 60.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 107.659 -1.237 . . . . 0.79000000000000004 107.659 175.196 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.482 ' CB ' HG12 ' A' ' 80' ' ' VAL . 24.2 ptt180 -118.72 144.69 46.08 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.897 0.879 . . . . 4.2800000000000002 109.963 -179.931 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -92.42 145.84 31.34 Favored Pre-proline 0 C--O 1.237 0.42 0 N-CA-C 108.957 -0.757 . . . . 2.4700000000000002 108.957 177.475 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -75.58 30.24 0.38 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.048 2.499 . . . . 1.76 112.89 178.792 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -89.87 -22.7 21.91 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.09 0.956 . . . . 1.54 108.83 162.628 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.3 m 63.47 23.13 13.54 Favored 'General case' 0 C--N 1.344 0.358 0 C-N-CA 124.301 1.041 . . . . 1.3799999999999999 111.806 -174.626 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . 0.251 1.4 pp -130.7 -3.18 4.18 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.581 1.552 . . . . 2.1800000000000002 113.303 173.322 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -131.4 125.56 32.93 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.192 -1.04 . . . . 1.55 108.192 -179.97 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.482 HG12 ' CB ' ' A' ' 73' ' ' ARG . 27.2 m -141.64 143.57 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 107.093 -1.447 . . . . 0.82999999999999996 107.093 172.08 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -142.05 158.77 43.37 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 121.783 -0.573 . . . . 0.83999999999999997 109.667 176.143 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -149.51 136.04 19.29 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 123.402 0.681 . . . . 1.96 109.97 -177.342 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.85 138.22 33.31 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.468 -0.938 . . . . 0.67000000000000004 108.468 169.944 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.8 p -117.69 155.29 19.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 125.186 1.394 . . . . 2.04 107.786 175.547 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -131.61 175.1 9.45 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.698 0.799 . . . . 1.6699999999999999 109.729 -179.651 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -140.15 166.4 24.77 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.464 1.106 . . . . 3.3300000000000001 109.632 178.861 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.9 t -37.37 -51.5 1.09 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.748 1.219 . . . . 4.21 110.745 161.473 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -89.05 29.83 1.01 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.001 0.741 . . . . 5.5 113.001 -178.531 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 58.71 43.21 96.49 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.547 -1.021 . . . . 2.6600000000000001 110.547 176.123 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -76.63 63.27 3.08 Favored Glycine 0 C--N 1.336 0.535 0 N-CA-C 110.135 -1.186 . . . . 2.2400000000000002 110.135 -176.868 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.86 101.24 3.7 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.794 -0.817 . . . . 3.21 108.794 -172.02 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.1 152.15 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 124.221 1.008 . . . . 1.1399999999999999 108.737 -177.036 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.2 mt -107.36 122.31 46.33 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.265 1.026 . . . . 0.69999999999999996 109.538 -179.717 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.0 t -105.08 120.07 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 125.06 1.344 . . . . 1.03 107.651 176.961 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.6 p -105.44 144.35 32.33 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.862 1.265 . . . . 0.60999999999999999 108.964 179.525 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.431 ' HB3' HG23 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -142.24 102.13 4.04 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.214 -1.032 . . . . 2.25 108.214 -178.771 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -94.4 45.44 1.13 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.221 1.408 . . . . 2.9700000000000002 111.015 -178.905 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -163.97 48.44 0.12 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.676 1.19 . . . . 3.8700000000000001 110.437 179.559 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.9 mp 54.16 -149.88 0.41 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.379 1.072 . . . . 2.4500000000000002 110.776 -178.739 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.478 ' HG ' HG21 ' A' ' 80' ' ' VAL . 11.8 mt -153.44 158.35 32.72 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 127.62 2.368 . . . . 1.52 105.837 -176.996 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -75.27 -98.5 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 124.292 3.328 . . . . 2.7799999999999998 110.671 -178.892 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -75.77 53.62 0.75 Allowed 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.16 1.384 . . . . 3.6099999999999999 110.204 179.527 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 45.47 0.48 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 129.084 2.953 . . . . 2.75 116.533 -163.839 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.7 t80 50.05 105.29 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 122.462 1.125 . . . . 3.2000000000000002 110.089 -153.434 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -74.51 123.43 24.73 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.434 -1.321 . . . . 4.7000000000000002 107.434 178.975 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -81.66 167.81 18.8 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.832 0.853 . . . . 3.29 110.322 -167.522 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.14 44.54 93.91 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 112.067 -0.413 . . . . 1.0700000000000001 112.067 173.484 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -155.85 177.72 11.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.401 -1.333 . . . . 2.0 107.401 175.344 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -85.49 137.97 15.89 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.581 -1.008 . . . . 0.97999999999999998 110.581 171.055 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 4.7 pt -138.64 164.43 26.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 108.934 -0.765 . . . . 1.52 108.934 172.484 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.529 ' HB ' ' CE1' ' A' ' 37' ' ' PHE . 16.2 m -121.68 112.96 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 106.915 -1.513 . . . . 1.27 106.915 -178.545 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -118.45 127.87 54.07 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.518 1.927 . . . . 0.81999999999999995 111.048 -173.423 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -126.59 157.93 37.57 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.778 1.172 . . . . 2.8700000000000001 113.608 175.092 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 179.26 -104.11 0.18 Allowed Glycine 0 C--N 1.337 0.602 0 N-CA-C 109.735 -1.346 . . . . 1.2 109.735 167.943 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.8 p -151.6 154.0 8.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 118.254 1.027 . . . . 0.92000000000000004 110.047 -174.563 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.01 139.41 58.76 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.63 -0.259 . . . . 1.77 111.004 173.592 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -120.04 120.92 4.73 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 126.356 1.932 . . . . 3.52 109.18 176.747 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 56.99 43.12 25.1 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.933 0.893 . . . . 5.0300000000000002 111.297 168.715 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 35.47 50.46 0.57 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.177 1.791 . . . . 4.71 111.43 -176.197 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -175.56 -57.28 0.06 OUTLIER Glycine 0 C--N 1.339 0.708 0 C-N-CA 120.128 -1.034 . . . . 1.22 112.973 -175.078 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.11 152.83 22.01 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 109.068 -0.716 . . . . 2.75 109.068 -178.927 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.64 HD11 HD11 ' A' ' 60' ' ' ILE . 3.3 mm? -107.35 111.48 23.85 Favored 'General case' 0 C--O 1.228 -0.062 0 N-CA-C 109.128 -0.693 . . . . 2.2400000000000002 109.128 -177.281 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.71 97.5 9.15 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.355 -1.35 . . . . 0.64000000000000001 107.355 176.306 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.7 144.52 39.52 Favored 'General case' 0 C--O 1.227 -0.125 0 C-N-CA 122.92 0.488 . . . . 1.1499999999999999 109.85 -177.806 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.6 t -131.43 -43.91 1.02 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.025 0.93 . . . . 0.97999999999999998 110.907 -178.337 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -83.34 93.89 7.83 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.242 -1.392 . . . . 4.1200000000000001 107.242 175.621 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 18.8 m -98.6 120.46 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 124.394 1.078 . . . . 0.98999999999999999 108.424 169.65 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.73 114.15 26.59 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.711 -1.589 . . . . 0.90000000000000002 106.711 178.868 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.5 46.28 0.84 Allowed 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.879 -1.138 . . . . 1.48 112.051 -175.628 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -81.7 60.75 4.78 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.448 -0.782 . . . . 3.02 111.376 -175.248 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -71.87 93.61 1.35 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.542 0.737 . . . . 7.0899999999999999 110.556 176.849 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 . . . . . 0 N--CA 1.449 -0.525 0 C-N-CA 124.951 1.3 . . . . 8.2699999999999996 108.419 -175.803 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.5 p . . . . . 0 CA--C 1.535 0.37 0 CA-C-O 121.351 0.596 . . . . 7.6100000000000003 110.427 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -71.88 -18.44 62.05 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 114.704 1.372 . . . . 9.6300000000000008 114.704 -167.19 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.322 2.0 pp -90.92 -66.63 0.91 Allowed 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.386 1.254 . . . . 5.9400000000000004 114.386 -162.322 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -83.87 71.99 10.43 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 120.408 -1.432 . . . . 3.4199999999999999 112.405 -162.104 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.23 162.28 25.8 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.666 0.617 . . . . 2.29 112.666 -174.161 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -85.67 118.79 25.39 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.939 1.296 . . . . 2.21 110.382 179.366 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -124.31 162.69 23.25 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.345 1.058 . . . . 2.8399999999999999 111.166 175.113 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.9 p -75.02 144.29 79.06 Favored Pre-proline 0 N--CA 1.451 -0.396 0 N-CA-C 109.237 -0.653 . . . . 2.2599999999999998 109.237 176.062 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -55.64 -41.27 79.39 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.56 2.173 . . . . 1.26 111.173 169.39 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.2 m -57.0 -50.33 73.03 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 117.563 -1.208 . . . . 2.6099999999999999 111.313 178.94 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -47.29 -53.86 12.44 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 120.308 1.413 . . . . 2.7999999999999998 110.52 178.192 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.461 ' HA ' ' HB2' ' A' ' 47' ' ' LYS 0.334 31.0 pt -63.01 -28.41 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 CA-C-N 115.116 -0.947 . . . . 1.3700000000000001 112.816 -173.058 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.0 t -74.87 -49.04 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 118.492 0.587 . . . . 2.1000000000000001 110.894 166.063 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -64.89 -46.83 80.1 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 123.972 0.909 . . . . 4.54 112.877 -163.457 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.34 62.35 0.07 OUTLIER Glycine 0 C--N 1.335 0.481 0 C-N-CA 119.668 -1.253 . . . . 2.0699999999999998 111.59 -174.291 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.461 ' HB2' ' HA ' ' A' ' 43' ' ' ILE . 13.7 mmtt -150.85 -97.32 0.06 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 128.235 2.614 . . . . 3.3399999999999999 105.098 -178.18 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.751 HG21 HD11 ' A' ' 116' ' ' LEU . 9.4 m -78.89 -54.66 5.82 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 125.072 1.349 . . . . 1.78 113.095 -168.518 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -49.24 -45.1 44.22 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.905 0.859 . . . . 2.3700000000000001 110.454 -178.517 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.2 m -87.58 -10.65 50.92 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.344 1.058 . . . . 1.6699999999999999 113.157 178.356 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 51.75 47.08 53.72 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.821 1.677 . . . . 1.8200000000000001 112.834 -175.994 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.9 m -87.0 -52.47 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 118.334 1.067 . . . . 2.0499999999999998 112.313 -175.509 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -100.97 -48.51 0.2 Allowed Pre-proline 0 CA--C 1.537 0.456 0 CA-C-O 118.039 -0.982 . . . . 3.6099999999999999 111.646 -178.816 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -91.29 -173.43 0.55 Allowed 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 122.863 2.376 . . . . 2.0600000000000001 108.781 170.181 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -153.45 155.78 36.95 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 127.756 2.422 . . . . 3.4100000000000001 106.413 -177.722 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.476 ' HB2' ' CB ' ' A' ' 119' ' ' ASP . . . -54.25 160.91 1.47 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.862 0.839 . . . . 1.3799999999999999 111.442 173.88 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.27 29.42 60.27 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 116.043 -0.526 . . . . 1.6799999999999999 111.976 176.032 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -122.07 152.51 39.75 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.177 -1.416 . . . . 1.53 107.177 167.748 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.9 mtt85 -88.61 141.21 28.71 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.282 -0.636 . . . . 3.79 109.282 170.106 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.0 pt -143.61 176.78 2.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 106.906 -1.516 . . . . 0.75 106.906 170.613 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.6 mtt180 -124.25 129.51 50.91 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.036 -0.727 . . . . 1.8899999999999999 109.036 169.264 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.0 p -90.34 128.59 42.15 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 107.365 -1.346 . . . . 0.93000000000000005 107.365 174.352 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -139.88 119.22 1.6 Allowed Glycine 0 C--N 1.335 0.515 0 N-CA-C 110.721 -0.951 . . . . 0.64000000000000001 110.721 178.944 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -175.49 -157.5 16.96 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 108.627 -1.789 . . . . 0.71999999999999997 108.627 -175.264 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.63 149.2 23.53 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 117.814 0.807 . . . . 2.5 110.339 175.683 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.587 HG21 ' CE1' ' A' ' 104' ' ' PHE . 77.3 t -94.65 150.19 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 108.451 -0.944 . . . . 2.2200000000000002 108.451 169.874 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.73 -173.91 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.693 1.597 . . . . 2.4399999999999999 110.191 168.545 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.9 p -126.32 72.87 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-O 122.95 1.357 . . . . 2.75 108.375 178.032 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 136.23 -7.17 4.03 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 113.686 -1.597 . . . . 2.1499999999999999 113.615 174.511 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 56.6 m -63.37 -21.26 66.17 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.827 1.314 . . . . 1.0900000000000001 112.653 177.343 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 29.0 tpp -56.65 121.98 11.0 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.174 -0.676 . . . . 2.0699999999999998 109.174 171.455 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.8 m -125.12 131.22 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 107.627 -1.249 . . . . 0.60999999999999999 107.627 166.784 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.436 ' HB2' HG12 ' A' ' 80' ' ' VAL . 0.9 OUTLIER -121.87 142.61 50.08 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.7 1.2 . . . . 4.04 108.917 -175.251 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.87 154.16 58.12 Favored Pre-proline 0 CA--C 1.532 0.257 0 N-CA-C 109.859 -0.423 . . . . 2.8700000000000001 109.859 176.357 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -63.51 -30.44 71.46 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.965 2.443 . . . . 2.29 110.803 172.71 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -43.04 -41.18 3.38 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.865 1.666 . . . . 2.7000000000000002 110.354 177.716 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.2 m 88.49 -1.06 0.42 Allowed 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 127.159 2.184 . . . . 1.55 113.272 176.451 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.27 25.49 9.47 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.08 0.855 . . . . 2.8900000000000001 112.384 173.83 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -144.58 114.78 7.49 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.32 -1.363 . . . . 1.3700000000000001 107.32 175.234 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.436 HG12 ' HB2' ' A' ' 73' ' ' ARG . 34.0 m -138.44 141.68 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 106.351 -1.722 . . . . 1.04 106.351 172.814 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -137.64 155.52 49.06 Favored 'General case' 0 C--O 1.233 0.189 0 O-C-N 121.745 -0.597 . . . . 0.82999999999999996 109.479 173.818 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -154.75 159.36 40.61 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.709 -0.478 . . . . 2.0899999999999999 109.709 -171.371 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.421 ' HB1' ' HG2' ' A' ' 91' ' ' GLU . . . -109.03 136.44 48.54 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.696 -0.853 . . . . 0.69999999999999996 108.696 -177.81 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.4 t -122.65 135.5 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 123.726 0.811 . . . . 2.0499999999999998 109.04 179.955 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -132.63 160.8 35.61 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 125.74 1.616 . . . . 1.54 109.568 -178.123 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -104.04 13.77 31.91 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.699 -0.626 . . . . 2.9199999999999999 110.997 176.325 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 19.1 t 54.02 27.51 7.58 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.207 1.003 . . . . 3.7000000000000002 111.93 -174.392 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.07 -66.66 0.94 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.722 1.209 . . . . 4.9400000000000004 108.467 175.768 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 173.86 57.89 0.05 OUTLIER Glycine 0 C--N 1.335 0.502 0 N-CA-C 111.223 -0.751 . . . . 2.8999999999999999 111.223 -179.824 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 175.13 136.69 2.33 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 108.307 -1.917 . . . . 1.48 108.307 175.917 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.421 ' HG2' ' HB1' ' A' ' 83' ' ' ALA . 37.0 tt0 -132.76 119.51 20.42 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.45 1.5 . . . . 4.1799999999999997 107.687 -177.741 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -98.29 154.08 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 123.971 0.908 . . . . 1.4199999999999999 108.83 -179.643 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 18.6 mt -100.25 120.57 40.12 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.385 0.674 . . . . 0.79000000000000004 111.28 176.979 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 89.2 t -97.16 136.46 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 125.656 1.582 . . . . 1.23 108.684 173.172 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.4 p -112.74 145.09 41.14 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.547 1.139 . . . . 0.72999999999999998 108.388 174.846 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.453 ' CE2' ' HA ' ' A' ' 125' ' ' THR . 7.8 t80 -144.27 100.13 3.49 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.72 -0.844 . . . . 2.1699999999999999 108.72 -175.618 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -84.69 53.49 2.71 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.951 1.3 . . . . 2.3599999999999999 111.252 -176.985 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -169.65 -173.53 1.66 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.954 1.702 . . . . 3.2799999999999998 108.114 173.512 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.9 mp -78.21 131.72 37.27 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.385 1.074 . . . . 1.76 111.239 171.462 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.423 HD21 ' CD2' ' A' ' 96' ' ' TYR . 24.2 mt -81.19 155.03 72.4 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.051 0.94 . . . . 1.1299999999999999 111.006 172.225 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -61.74 141.72 91.53 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.09 2.527 . . . . 2.2999999999999998 109.401 172.673 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 48.64 27.37 1.47 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.145 1.778 . . . . 2.7400000000000002 113.163 177.064 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.1 tp 56.92 11.55 0.98 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.249 1.02 . . . . 3.2599999999999998 112.397 -172.924 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.587 ' CE1' HG21 ' A' ' 66' ' ' VAL . 18.1 t80 56.66 84.07 0.09 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.269 1.427 . . . . 2.5800000000000001 110.061 179.881 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.3 mtp-105 -78.3 124.4 28.05 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.295 -1.372 . . . . 4.8600000000000003 107.295 -174.043 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -79.94 175.32 10.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.077 0.465 . . . . 3.0800000000000001 110.645 -164.192 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.33 44.49 96.81 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 111.87 -0.492 . . . . 0.69999999999999996 111.87 -176.745 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -143.52 176.62 9.05 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 107.932 -1.136 . . . . 1.8400000000000001 107.932 169.517 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -100.35 145.83 17.41 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 110.514 -1.035 . . . . 0.78000000000000003 110.514 171.271 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.0 pp -149.94 166.31 2.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 105.936 -1.875 . . . . 0.77000000000000002 105.936 177.972 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 18.0 m -126.51 130.62 71.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 108.663 -0.866 . . . . 0.71999999999999997 108.663 170.948 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -117.55 135.19 54.12 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 124.988 1.315 . . . . 0.58999999999999997 109.785 -175.709 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -118.65 141.11 48.91 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.462 1.505 . . . . 3.2000000000000002 109.871 -178.239 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 168.14 -133.8 3.01 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 109.658 -1.377 . . . . 0.85999999999999999 109.658 170.757 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.2 151.83 31.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 117.823 0.811 . . . . 0.69999999999999996 110.865 -166.073 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.751 HD11 HG21 ' A' ' 48' ' ' THR . 4.1 mm? -65.8 144.25 56.97 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.105 -0.498 . . . . 2.27 111.404 175.564 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -119.68 115.57 3.05 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 126.945 2.212 . . . . 3.2400000000000002 108.011 175.324 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 58.91 35.22 24.07 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.399 0.68 . . . . 4.9900000000000002 111.656 169.779 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.476 ' CB ' ' HB2' ' A' ' 56' ' ' ALA . 2.0 t0 36.15 43.81 0.24 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.174 2.19 . . . . 4.9500000000000002 113.137 -170.153 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -159.96 -55.3 0.01 OUTLIER Glycine 0 C--N 1.339 0.709 0 O-C-N 121.648 -0.657 . . . . 1.2 111.79 -174.92 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -84.62 150.44 25.17 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 121.905 -0.762 . . . . 2.8399999999999999 109.107 175.961 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -108.41 113.66 26.89 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 108.784 -0.821 . . . . 2.1699999999999999 108.784 178.989 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -92.16 98.5 11.57 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 107.482 -1.303 . . . . 0.52000000000000002 107.482 178.114 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.52 97.57 3.98 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 112.797 0.666 . . . . 1.3300000000000001 112.797 -168.509 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.453 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 14.9 t -83.38 -26.29 30.58 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 122.825 0.45 . . . . 0.92000000000000004 112.213 -177.831 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -89.67 85.32 6.43 Favored 'General case' 0 CA--C 1.528 0.135 0 O-C-N 120.614 -1.304 . . . . 3.3700000000000001 109.35 -174.755 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.7 m -96.78 130.72 45.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 123.853 0.861 . . . . 0.81000000000000005 111.176 175.978 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -119.67 106.83 12.54 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.859 1.664 . . . . 0.80000000000000004 107.452 178.543 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.87 57.67 4.26 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.673 0.789 . . . . 1.2 111.488 -176.315 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 37.2 pttt -83.38 61.84 6.39 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.897 -0.502 . . . . 3.3900000000000001 111.614 -174.484 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -159.12 164.35 35.36 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 121.449 -0.782 . . . . 4.71 109.105 178.425 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.2 t70 . . . . . 0 N--CA 1.448 -0.558 0 C-N-CA 126.134 1.774 . . . . 7.2599999999999998 108.629 -173.028 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.8 t . . . . . 0 CA--C 1.538 0.49 0 N-CA-C 111.313 0.116 . . . . 6.9500000000000002 111.313 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -155.01 107.92 2.78 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.675 -0.64 . . . . 6.8700000000000001 110.304 -175.769 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -80.08 151.78 29.69 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.408 -0.59 . . . . 5.8399999999999999 109.408 171.387 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -158.44 70.62 0.54 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 119.267 -0.397 . . . . 3.4399999999999999 111.636 -169.72 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.78 164.31 14.84 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.133 0.973 . . . . 2.5099999999999998 112.472 -174.046 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.486 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 87.1 m-85 -91.96 102.57 15.14 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 125.376 1.47 . . . . 2.6200000000000001 110.289 177.479 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.713 ' CZ ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -100.49 -169.91 1.79 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.598 0.759 . . . . 8.5099999999999998 111.479 178.524 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 28.2 p -94.43 156.57 38.5 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 118.6 0.637 . . . . 1.79 110.709 -178.357 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.66 -14.7 33.46 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 121.5 1.467 . . . . 1.02 112.368 171.451 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 m -68.32 -25.53 65.17 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 121.087 -1.008 . . . . 2.0099999999999998 113.102 169.498 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.84 -58.16 8.28 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.901 0.858 . . . . 3.6099999999999999 109.942 -177.099 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.86 HD13 ' H ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -78.82 36.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 C-N-CA 126.651 1.98 . . . . 2.0600000000000001 113.042 -179.078 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 t -121.66 -37.3 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.325 1.05 . . . . 2.7000000000000002 110.901 157.765 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -81.57 -46.69 14.08 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 120.995 -1.066 . . . . 4.1200000000000001 112.781 -167.623 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.8 52.91 0.16 Allowed Glycine 0 C--N 1.336 0.53 0 N-CA-C 110.882 -0.887 . . . . 2.1200000000000001 110.882 -171.882 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -149.28 -162.43 1.56 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.863 2.865 . . . . 2.5499999999999998 106.028 178.159 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.6 m -29.09 -47.81 0.06 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 129.529 3.132 . . . . 1.6100000000000001 116.714 -170.018 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -41.59 -53.1 3.61 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.088 0.858 . . . . 3.1099999999999999 111.052 175.332 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 m -98.0 -23.49 15.76 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.444 -0.798 . . . . 1.3300000000000001 109.831 179.224 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.82 39.38 85.72 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.258 0.933 . . . . 0.97999999999999998 111.659 174.305 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.1 m -87.18 -29.58 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 112.722 0.638 . . . . 1.27 112.722 -171.94 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.6 mttp -118.19 -62.23 0.03 OUTLIER Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 125.358 1.463 . . . . 4.7199999999999998 112.646 178.703 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -81.61 146.33 15.06 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 CA-C-N 121.242 1.479 . . . . 1.1899999999999999 108.606 172.92 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -107.13 158.53 17.01 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.578 -1.267 . . . . 2.79 107.578 170.04 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.1 154.04 35.75 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.362 -0.607 . . . . 1.3500000000000001 109.362 171.608 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.63 -2.67 45.77 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.933 0.777 . . . . 1.1699999999999999 112.781 -178.41 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.525 ' O ' HD12 ' A' ' 116' ' ' LEU . 39.8 mt-30 -95.48 160.61 14.44 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.253 1.027 . . . . 1.49 109.033 178.037 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.8 mtt180 -93.12 138.95 31.08 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.56 -0.533 . . . . 3.7599999999999998 109.56 167.709 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.575 HD12 ' CZ ' ' A' ' 38' ' ' TYR . 30.8 pt -150.59 177.89 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 106.61 -1.626 . . . . 0.66000000000000003 106.61 167.51 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.426 ' HB2' ' CD1' ' A' ' 37' ' ' PHE . 26.0 mtt180 -126.49 142.26 51.59 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.16 -0.681 . . . . 2.46 109.16 169.342 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.3 p -110.72 125.77 68.04 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.069 0 C-N-CA 124.727 1.211 . . . . 0.81000000000000005 108.893 178.879 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -120.35 111.76 2.04 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 110.194 -1.163 . . . . 0.73999999999999999 110.194 -179.803 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.18 -173.71 36.37 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.232 -0.747 . . . . 1.24 111.232 -173.603 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.429 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 4.3 ptp -118.19 137.54 52.93 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 124.308 1.043 . . . . 2.4100000000000001 111.715 -172.508 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.653 HG13 ' CE2' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -61.73 145.37 13.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 CA-C-N 116.369 -0.378 . . . . 2.6299999999999999 110.474 178.327 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 67' ' ' THR . 31.4 m -69.81 67.91 0.27 Allowed 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 109.207 -0.664 . . . . 3.1899999999999999 109.207 163.653 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.252 13.9 p 20.53 68.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.345 0 C-N-CA 129.812 3.245 . . . . 3.0499999999999998 114.361 161.902 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.69 50.69 1.01 Allowed Glycine 0 CA--C 1.527 0.79 0 CA-C-N 112.421 -2.172 . . . . 1.8799999999999999 110.799 -177.91 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.3 m -117.48 7.59 12.76 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 123.844 0.857 . . . . 1.1599999999999999 112.39 173.819 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 47.7 tpp -74.28 127.52 33.19 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.634 -0.876 . . . . 2.96 108.634 176.983 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.2 m -132.24 149.37 32.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 108.849 -0.797 . . . . 0.64000000000000001 108.849 167.306 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.517 ' CB ' HG12 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -140.48 141.58 35.39 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.733 0.813 . . . . 5.6600000000000001 110.658 -171.593 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.31 154.37 84.17 Favored Pre-proline 0 N--CA 1.455 -0.192 0 CA-C-N 118.606 0.639 . . . . 2.2400000000000002 109.736 -179.867 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -63.03 -24.36 73.78 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.237 1.958 . . . . 1.3999999999999999 111.784 168.895 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -47.86 -30.83 4.42 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.389 0.676 . . . . 1.3600000000000001 110.731 166.804 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.3 m 63.91 29.82 14.42 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.794 1.238 . . . . 1.25 111.468 176.312 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.03 -48.91 1.47 Allowed 'General case' 0 C--O 1.232 0.135 0 C-N-CA 128.03 2.532 . . . . 2.1000000000000001 110.466 172.078 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -80.17 127.93 32.91 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.155 -1.054 . . . . 1.1299999999999999 108.155 -179.005 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.517 HG12 ' CB ' ' A' ' 73' ' ' ARG . 26.9 m -139.18 151.23 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 107.421 -1.325 . . . . 1.0700000000000001 107.421 172.033 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -148.95 156.59 42.51 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 122.027 -0.421 . . . . 1.21 110.191 174.798 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -155.89 133.99 11.4 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 116.116 -0.493 . . . . 1.8700000000000001 110.556 -169.867 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.52 129.4 35.09 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.163 0.585 . . . . 1.05 109.864 174.183 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.2 t -121.01 129.77 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 125.964 1.706 . . . . 1.8400000000000001 107.579 -177.693 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -106.13 172.46 6.8 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.672 0.789 . . . . 2.02 110.814 179.948 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -113.73 -72.43 0.7 Allowed 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.89 0.852 . . . . 3.9300000000000002 110.363 -174.965 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 30.0 t -168.15 -60.03 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.531 -1.655 . . . . 3.71 106.531 -171.02 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -91.01 -92.46 0.14 Allowed 'General case' 0 C--N 1.343 0.303 0 CA-C-N 117.492 0.133 . . . . 5.9800000000000004 111.298 178.808 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -124.55 15.6 7.57 Favored Glycine 0 C--N 1.336 0.578 0 N-CA-C 111.343 -0.703 . . . . 3.1699999999999999 111.343 -174.467 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -75.21 52.51 2.59 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 118.875 -0.958 . . . . 1.74 111.59 -178.919 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -86.72 105.15 16.75 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.059 -1.089 . . . . 2.75 108.059 175.161 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 92' ' ' ILE . 9.3 tp -109.98 156.22 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 108.838 -0.801 . . . . 1.24 108.838 176.763 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.8 mt -109.88 114.76 28.58 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.307 -1.368 . . . . 0.64000000000000001 107.307 -179.995 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.9 t -92.72 136.75 24.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 106.904 -1.517 . . . . 1.0800000000000001 106.904 173.75 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 80.4 p -116.86 154.74 30.24 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.051 -1.092 . . . . 0.93999999999999995 108.051 179.359 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.541 ' OH ' HG13 ' A' ' 127' ' ' VAL . 0.3 OUTLIER -148.74 145.45 27.63 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 124.634 1.174 . . . . 3.3799999999999999 108.292 -175.556 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -128.58 7.98 5.83 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.373 1.469 . . . . 2.3100000000000001 112.743 -179.574 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -134.45 55.89 1.87 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.701 1.201 . . . . 4.1799999999999997 110.297 176.872 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.0 mp 50.55 -145.69 0.46 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.097 0.959 . . . . 2.4500000000000002 109.979 178.794 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 17.7 mt -158.03 161.85 28.07 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 127.675 2.39 . . . . 1.4199999999999999 105.037 177.645 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -72.28 -89.9 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.632 2.888 . . . . 2.0299999999999998 109.901 175.356 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -68.45 19.33 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.562 1.545 . . . . 3.5800000000000001 114.072 -178.713 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 54.92 1.12 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 128.784 2.834 . . . . 2.0099999999999998 115.284 -166.145 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.653 ' CE2' HG13 ' A' ' 66' ' ' VAL . 1.2 t80 51.22 89.53 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.092 1.357 . . . . 3.6699999999999999 110.049 -164.774 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.61 147.13 39.82 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.362 -0.977 . . . . 4.6500000000000004 108.362 -176.304 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -84.68 109.67 18.19 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.85 0.86 . . . . 3.3900000000000001 111.665 -162.822 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 124.51 45.52 0.26 Allowed Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.58 1.085 . . . . 1.02 110.965 174.063 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -158.17 178.41 10.22 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 106.155 -1.795 . . . . 2.0499999999999998 106.155 177.348 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 65' ' ' MET . . . -127.98 142.26 13.36 Favored Glycine 0 C--N 1.335 0.502 0 CA-C-O 121.296 0.387 . . . . 0.93999999999999995 112.227 173.904 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.5 pp -133.7 164.35 35.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 106.45 -1.685 . . . . 0.82999999999999996 106.45 -172.406 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.486 ' HB ' ' CD1' ' A' ' 37' ' ' PHE . 34.1 m -115.59 124.43 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 108.148 -1.056 . . . . 0.68999999999999995 108.148 -178.348 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.432 ' HB2' HG12 ' A' ' 127' ' ' VAL . . . -119.95 142.41 48.76 Favored 'General case' 0 C--O 1.227 -0.12 0 C-N-CA 125.057 1.343 . . . . 0.65000000000000002 110.048 -167.875 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -139.32 144.55 38.33 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.34 1.056 . . . . 3.9300000000000002 110.531 -176.632 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 176.61 -120.36 0.74 Allowed Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 107.874 -2.09 . . . . 1.04 107.874 169.848 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.7 p -146.38 143.84 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 117.758 0.779 . . . . 0.82999999999999996 109.078 -172.602 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.526 HD11 HG12 ' A' ' 60' ' ' ILE . 4.0 mp -79.56 143.04 35.17 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 118.848 -0.596 . . . . 2.6800000000000002 109.432 176.377 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -165.49 29.83 0.21 Allowed Glycine 0 CA--C 1.525 0.681 0 C-N-CA 119.882 -1.152 . . . . 2.7799999999999998 113.802 -175.74 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -132.83 1.92 3.66 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.855 0.862 . . . . 5.1900000000000004 111.107 177.566 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 27.6 t0 53.21 52.7 13.13 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 122.652 1.215 . . . . 3.2599999999999998 109.888 -173.052 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 163.46 -59.36 0.27 Allowed Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.17 -1.172 . . . . 1.47 110.17 -175.302 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.71 170.59 8.24 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.965 0.906 . . . . 2.2599999999999998 110.009 -173.662 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.7 mp -118.82 130.4 55.75 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.778 1.231 . . . . 1.98 108.617 -171.928 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -97.38 99.08 10.52 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.15 -1.426 . . . . 0.53000000000000003 107.15 173.377 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -96.34 153.73 17.65 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.602 -0.518 . . . . 1.5 109.602 -179.618 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.414 ' HA ' ' CE2' ' A' ' 96' ' ' TYR . 9.7 t -135.54 -38.49 0.74 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.14 0.576 . . . . 1.1499999999999999 112.128 174.481 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -91.16 108.8 20.12 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.843 -1.161 . . . . 3.04 108.968 174.835 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.541 HG13 ' OH ' ' A' ' 96' ' ' TYR . 1.0 OUTLIER -113.9 141.19 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 119.003 0.82 . . . . 0.97999999999999998 110.34 169.338 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -120.92 116.92 26.05 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.762 1.225 . . . . 0.93000000000000005 107.949 179.622 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.55 62.16 1.68 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.139 0.975 . . . . 1.27 112.124 -173.872 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.71 53.83 2.83 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.472 0.709 . . . . 4.6600000000000001 112.245 -179.25 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.13 82.17 1.85 Allowed 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.711 -0.618 . . . . 4.4500000000000002 109.761 -179.729 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 . . . . . 0 N--CA 1.45 -0.426 0 C-N-CA 125.048 1.339 . . . . 5.3700000000000001 107.415 176.421 . . . . . . . . 0 0 . 1 stop_ save_